PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Snider, AJ; Kawamori, T; Bradshaw, SG; Orr, KA; Gilkeson, GS; Hannun, YA; Obeid, LM				Snider, Ashley J.; Kawamori, Toshihiko; Bradshaw, Sarah G.; Orr, K. Alexa; Gilkeson, Gary S.; Hannun, Yusuf A.; Obeid, Lina M.			A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis	FASEB JOURNAL			English	Article						sphingosine-1-phosphate; tumor necrosis factor alpha; cyclooxygenase-2; inflammation; ceramide	TUMOR-NECROSIS-FACTOR; TNF-ALPHA; LYMPHOCYTE EGRESS; COLON CARCINOGENESIS; ENDOTHELIAL-CELLS; COX-2 INHIBITOR; 1-PHOSPHATE; MIGRATION; RECEPTOR; MICE	The bioactive lipid sphingosine-1-phosphate (S1P) is emerging as an important mediator of immune and inflammatory responses. S1P formation is catalyzed by sphingosine kinase (SK), of which the SK1 isoenzyme is activated by tumor necrosis alpha (TNF-alpha). SK1 has been shown to be required for mediating TNF-alpha inflammatory responses in cells, including induction of cyclooxygenase 2 (COX-2). Because TNF-alpha and COX-2 are increased in patients with inflammatory bowel disease (IBD), we investigated the role of SK1 in a murine model of colitis. SK1(-/-) mice treated with dextran sulfate sodium (DSS) had significantly less blood loss, weight loss, colon shortening, colon histological damage, and splenomegaly than did wild-type (WT) mice. In addition, SK1(-/-) mice had no systemic inflammatory response. Moreover, WT but not SK1(-/-) mice treated with dextran sulfate sodium had significant increases in blood S1P levels, colon SK1 message and activity, and colon neutrophilic infiltrate. Unlike WT mice, SK1(-/-) mice failed to show colonic COX-2 induction despite an exaggerated TNF-alpha response; thus implicating for the first time SK1 in TNF-alpha-mediated COX-2 induction in vivo. Inhibition of SK1 may prove to be a valuable therapeutic target by inhibiting systemic and local inflammation in IBD.-Snider, A. J., Kawamori, T., Bradshaw, S. G., Orr, K. A., Gilkeson, G. S., Hannun, Y. A., Obeid, L. M. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J. 23, 143-152 (2009)	[Snider, Ashley J.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Kawamori, Toshihiko] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Orr, K. Alexa] Med Univ S Carolina, Dept Mol & Cellular Biol & Pathobiol, Charleston, SC 29425 USA; [Hannun, Yusuf A.; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Bradshaw, Sarah G.; Gilkeson, Gary S.; Obeid, Lina M.] Ralph H Johnson VA Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, 114 Doughty St,MSC 779, Charleston, SC 29425 USA.	obeidl@musc.edu	Kawamori, Toshihiko/G-7636-2012	obeid, lina/0000-0002-0734-0847	U.S. National Institutes of Health (NIH) [GM062887, C06 RR018823]; Veterans Affairs (VA) Merit Award; American College of Rheumatology Research and Education Foundation's; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs (VA) Merit Award(US Department of Veterans Affairs); American College of Rheumatology Research and Education Foundation's; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) grant GM062887 and a Veterans Affairs (VA) Merit Award (L.M.O.) and by the American College of Rheumatology Research and Education Foundation's Within Our Reach: Finding a Cure for Arthritis campaign (G.S.G.). Lipid analysis was conducted by the Lipidomics Core at MUSC and was supported by NIH grant C06 RR018823. We thank Dr. Richard Proia (NIDDK, Bethesda, MD, USA) for supplying the SK1<SUP>-/-</SUP> mice; George Washington, DeAnna Baker, Samer Maalouf, and Tatsuya Kaneshiro for technical help; Margaret H. Romano and the Core Histology Laboratory for their technical assistance; Chris Clarke for careful examination of the manuscript; and Kathy Wiita-Fisk for her administrative assistance.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; BREESE EJ, 1994, GASTROENTEROLOGY, V106, P1455, DOI 10.1016/0016-5085(94)90398-0; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Cuzzocrea S, 2001, EUR J PHARMACOL, V431, P91, DOI 10.1016/S0014-2999(01)01403-0; Daniel C, 2007, MOL IMMUNOL, V44, P3305, DOI 10.1016/j.molimm.2007.02.026; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; De Palma C, 2006, ARTERIOSCL THROM VAS, V26, P99, DOI 10.1161/01.ATV.0000194074.59584.42; Eigenbrod S, 2006, IMMUNOL INVEST, V35, P149, DOI 10.1080/08820130600616490; Gonzalez-Juanatey C, 2005, ATHEROSCLEROSIS, V181, P209, DOI 10.1016/j.atherosclerosis.2005.02.031; Hendel J, 1997, AM J GASTROENTEROL, V92, P1170; Inoue T., 2008, Inflammopharmacology, V16, P36, DOI 10.1007/s10787-006-1543-3; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Kaneider NC, 2002, BIOCHEM BIOPH RES CO, V297, P806, DOI 10.1016/S0006-291X(02)02304-5; Kawa S, 1997, FEBS LETT, V420, P196, DOI 10.1016/S0014-5793(97)01516-0; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kohno H, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-46; Kohno T, 2008, GENES CELLS, V13, P747, DOI 10.1111/j.1365-2443.2008.01202.x; Lee C, 1998, VISUAL NEUROSCI, V15, P27, DOI 10.1017/S0952523898146151; Lin CI, 2006, J CELL BIOCHEM, V99, P1216, DOI 10.1002/jcb.20963; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martin AR, 2005, INFLAMM RES, V54, P145, DOI 10.1007/s00011-004-1337-2; Martino A, 2007, J BIOSCIENCES, V32, P1207, DOI 10.1007/s12038-007-0122-0; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; MURCH SH, 1993, GUT, V34, P1705, DOI 10.1136/gut.34.12.1705; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; OLSON AD, 1993, J PEDIATR GASTR NUTR, V16, P241, DOI 10.1097/00005176-199304000-00003; Osterman Mark T, 2007, Curr Treat Options Gastroenterol, V10, P195, DOI 10.1007/s11938-007-0013-3; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Rosen H, 2003, IMMUNOL REV, V195, P160, DOI 10.1034/j.1600-065X.2003.00068.x; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P27610; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Suzuki R, 2006, CARCINOGENESIS, V27, P162, DOI 10.1093/carcin/bgi205; Tsubouchi R, 2006, DIGESTION, V74, P91, DOI 10.1159/000097657; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Vlasenko LP, 2005, J IMMUNOL, V174, P6456, DOI 10.4049/jimmunol.174.10.6456; von Wenckstern H, 2006, ARCH IMMUNOL THER EX, V54, P239, DOI 10.1007/s00005-006-0028-9; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Zemann B, 2007, IMMUNOL LETT, V109, P56, DOI 10.1016/j.imlet.2007.01.001; Zhi L, 2006, J CELL PHYSIOL, V208, P109, DOI 10.1002/jcp.20646; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	52	152	161	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					143	152		10.1096/fj.08-118109	http://dx.doi.org/10.1096/fj.08-118109			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18815359	Green Published			2022-12-25	WOS:000262095500017
J	Saini, Y; Harkema, JR; Lapres, JJ				Saini, Yogesh; Harkema, Jack R.; Lapres, John J.			HIF1 alpha Is Essential for Normal Intrauterine Differentiation of Alveolar Epithelium and Surfactant Production in the Newborn Lung of Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; FACTOR 1-ALPHA; C/EBP-ALPHA; CELL-DEATH; MATURATION; GENE; MORPHOGENESIS; HIF-1-ALPHA; VASCULARIZATION; DEFICIENCY	Neonatal respiratory distress syndrome (RDS) is mainly the result of perturbation in surfactant production and is a common complication seen in premature infants. Normal fetal lung development and alveolar cell differentiation is regulated by a network of transcription factors. Functional loss of any of these factors will alter the developmental program and impact surfactant production and normal gas exchange. During development, the fetus is exposed to varying oxygen concentrations and must be able to quickly adapt to these changes in order to survive. Hypoxia-inducible factor 1 alpha(HIF1 alpha) is the primary transcription factor that is responsible for regulating the cellular response to changes in oxygen tension and is essential for normal development. Its role in lung maturation is not well defined and to address this knowledge gap, a lung-specific HIF1 alpha knock-out model has been developed. Loss of HIF1 alpha early in lung development leads to pups that die within hours of parturition, exhibiting symptoms similar to RDS. Lungs from these pups display impaired alveolar epithelial differentiation and an almost complete loss of surfactant protein expression. Ultrastructural analysis of lungs from HIF1 alpha deletion pups had high levels of glycogen, aberrant septal development, and decreased expression of several factors necessary for proper lung development, including HIF2 alpha, beta-catenin, and vascular endothelial growth factor. These results suggest that HIF1 alpha is essential for proper lung maturation and alteration in its normal signaling during premature delivery might explain the pathophysiology of neonatal RDS.	[Saini, Yogesh; Lapres, John J.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Saini, Yogesh; Lapres, John J.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Harkema, Jack R.] Michigan State Univ, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [Saini, Yogesh; Harkema, Jack R.; Lapres, John J.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA; [Lapres, John J.] Michigan State Univ, Natl Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University	Lapres, JJ (corresponding author), 224 Biochem Bldg, E Lansing, MI 48824 USA.	lapres@Msu.edu	Saini, Yogesh/AAM-5046-2020; saini, yogesh/D-1080-2010	saini, yogesh/0000-0002-8324-2122	National Institutes of Health [R01-ES12186, P42 ES04911-17]; Michigan Agriculture Experimental Station; Michigan State University Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004911, R01ES012186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Agriculture Experimental Station; Michigan State University Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-ES12186 and P42 ES04911-17. This work was also supported by the Michigan Agriculture Experimental Station and the Michigan State University Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asikainen TM, 2006, FASEB J, V20, P1698, DOI 10.1096/fj.06-5887fje; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cassel TN, 2000, ANN NY ACAD SCI, V923, P300; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Devriendt K, 1998, NEW ENGL J MED, V338, P1317, DOI 10.1056/NEJM199804303381817; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Groenman F, 2005, BIOL NEONATE, V87, P164, DOI 10.1159/000082595; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Liu C, 2002, AM J PHYSIOL-LUNG C, V283, pL468, DOI 10.1152/ajplung.00044.2002; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; METCALFE J, 1967, PHYSIOL REV, V47, P782, DOI 10.1152/physrev.1967.47.4.782; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Ryan HE, 2000, CANCER RES, V60, P4010; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza Gregg L, 2005, Proc Am Thorac Soc, V2, P68, DOI 10.1513/pats.200404-029MS; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL202, DOI 10.1152/ajplung.2001.281.1.L202; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Vengellur A, 2004, TOXICOL SCI, V82, P638, DOI 10.1093/toxsci/kfh278; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912	29	54	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33650	33657		10.1074/jbc.M805927200	http://dx.doi.org/10.1074/jbc.M805927200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18801745	Green Published, hybrid			2022-12-25	WOS:000261183700071
J	Karradt, A; Sobanski, J; Mattow, J; Lockau, W; Baier, K				Karradt, Anne; Sobanski, Johanna; Mattow, Jens; Lockau, Wolfgang; Baier, Kerstin			NblA, a Key Protein of Phycobilisome Degradation, Interacts with ClpC, a HSP100 Chaperone Partner of a Cyanobacterial Clp Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-7120; ADAPTER PROTEIN; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; RESPONSE REGULATOR; NITROGEN; COMPETENCE; EXPRESSION; STRESS; GENE	When cyanobacteria are starved for nitrogen, expression of the NblA protein increases and thereby induces proteolytic degradation of phycobilisomes, light-harvesting complexes of pigmented proteins. Phycobilisome degradation leads to a color change of the cells from blue-green to yellow-green, referred to as bleaching or chlorosis. As reported previously, NblA binds via a conserved region at its C terminus to the alpha-subunits of phycobiliproteins, the main components of phycobilisomes. We demonstrate here that a highly conserved stretch of amino acids in the N-terminal helix of NblA is essential for protein function in vivo. Affinity purification of glutathione S-transferase-tagged NblA, expressed in a Nostoc sp. PCC7120 mutant lacking wildtype NblA, resulted in co-precipitation of ClpC, encoded by open reading frame alr2999 of the Nostoc chromosome. ClpC is a HSP100 chaperone partner of the Clp protease. ATP-dependent binding of NblA to ClpC was corroborated by in vitro pull-down assays. Introducing amino acid exchanges, we verified that the conserved N-terminal motif of NblA mediates the interaction with ClpC. Further results indicate that NblA binds phycobiliprotein subunits and ClpC simultaneously, thus bringing the proteins into close proximity. Altogether these results suggest that NblA may act as an adaptor protein that guides a ClpC.ClpP complex to the phycobiliprotein disks in the rods of phycobilisomes, thereby initiating the degradation process.	[Karradt, Anne; Sobanski, Johanna; Lockau, Wolfgang; Baier, Kerstin] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Mattow, Jens] Max Planck Inst Infekt Biol, Immunol Abt, D-10117 Berlin, Germany	Humboldt University of Berlin; Max Planck Society	Lockau, W (corresponding author), Humboldt Univ, Inst Biol, Chausseestr 117, D-10115 Berlin, Germany.				Deutsche Forschungsgemeinschaft [LO 286/8-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Grant LO 286/8-2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; ALLEN MM, 1969, ARCH MIKROBIOL, V69, P114, DOI 10.1007/BF00409755; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; Baier K, 2001, FEMS MICROBIOL LETT, V195, P35, DOI 10.1111/j.1574-6968.2001.tb10494.x; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; BLACK TA, 1994, J BACTERIOL, V176, P2282, DOI 10.1128/JB.176.8.2282-2292.1994; BOGORAD L, 1975, ANNU REV PLANT PHYS, V26, P369, DOI 10.1146/annurev.pp.26.060175.002101; Boresch K., 1910, LOTOS, V58, P344; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Clarke AK, 1996, PLANT MOL BIOL, V31, P721, DOI 10.1007/BF00019460; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Dines M, 2008, J BIOL CHEM, V283, P30330, DOI 10.1074/jbc.M804241200; Dines M, 2007, J STRUCT BIOL, V158, P116, DOI 10.1016/j.jsb.2006.10.021; Doherty NS, 1998, ELECTROPHORESIS, V19, P355, DOI 10.1002/elps.1150190234; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; GLAZER AN, 1982, ANNU REV MICROBIOL, V36, P173, DOI 10.1146/annurev.mi.36.100182.001133; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Horwich AL, 1999, P NATL ACAD SCI USA, V96, P11033, DOI 10.1073/pnas.96.20.11033; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU RH, 1977, J BACTERIOL, V132, P771, DOI 10.1128/JB.132.3.771-778.1977; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Li H, 2002, ARCH MICROBIOL, V178, P256, DOI 10.1007/s00203-002-0446-y; Luque I, 2003, MOL MICROBIOL, V50, P1043, DOI 10.1046/j.1365-2958.2003.03768.x; Luque I, 2001, MOL MICROBIOL, V41, P937, DOI 10.1046/j.1365-2958.2001.02566.x; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MARSH JL, 1984, GENE, V32, P481, DOI 10.1016/0378-1119(84)90022-2; Mattow J, 2007, PROTEOMICS, V7, P1687, DOI 10.1002/pmic.200600928; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Persuh M, 2002, J BACTERIOL, V184, P2310, DOI 10.1128/JB.184.8.2310-2313.2002; Richaud C, 2001, J BACTERIOL, V183, P2989, DOI 10.1128/JB.183.10.2989-2994.2001; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Schwarz R, 1998, P NATL ACAD SCI USA, V95, P11008, DOI 10.1073/pnas.95.18.11008; Sendersky E, 2005, MOL MICROBIOL, V58, P659, DOI 10.1111/j.1365-2958.2005.04844.x; SHANKLIN J, 1995, PLANT CELL, V7, P1713, DOI 10.1105/tpc.7.10.1713; Shin DH, 1996, J MOL BIOL, V262, P71, DOI 10.1006/jmbi.1996.0499; SINGH SK, 1994, J BIOL CHEM, V269, P29537; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; TANDAEU DMN, 1988, METHOD ENZYMOL, V167, P318; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 2001, MOL MICROBIOL, V42, P717, DOI 10.1046/j.1365-2958.2001.02623.x; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; van Waasbergen LG, 2002, J BACTERIOL, V184, P2481, DOI 10.1128/JB.184.9.2481-2490.2002; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; WOLK CP, 1973, BACTERIOL REV, V37, P32, DOI 10.1128/MMBR.37.1.32-101.1973; YAMANAKA G, 1980, ARCH MICROBIOL, V124, P39, DOI 10.1007/BF00407026; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	74	60	61	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32394	32403		10.1074/jbc.M805823200	http://dx.doi.org/10.1074/jbc.M805823200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818204	hybrid			2022-12-25	WOS:000260893700027
J	Gaffaney, JD; Dunning, FM; Wang, Z; Hui, E; Chapman, ER				Gaffaney, Jon D.; Dunning, F. Mark; Wang, Zhao; Hui, Enfu; Chapman, Edwin R.			Synaptotagmin C2B Domain Regulates Ca2+-triggered Fusion in Vitro CRITICAL RESIDUES REVEALED BY SCANNING ALANINE MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PENETRATION ACTIVITY; CRACKED PC12 CELLS; NEUROTRANSMITTER RELEASE; SNARE INTERACTIONS; PLASMA-MEMBRANE; CA2+ BINDING; T-SNARE; SYNAPTIC-TRANSMISSION; VESICLE EXOCYTOSIS; LIPID-COMPOSITION	Synaptotagmin (syt) 1 is localized to synaptic vesicles, binds Ca2+, and regulates neuronal exocytosis. Syt 1 harbors two Ca2+-binding motifs referred to as C2A and C2B. In this study we examine the function of the isolated C2 domains of Syt 1 using a reconstituted, SNARE (soluble N-ethylmaleimide-sensitive factor attachment receptor)-mediated, fusion assay. We report that inclusion of phosphatidylethanolamine into reconstituted SNARE vesicles enabled isolated C2B, but not C2A, to regulate Ca2+-triggered fusion. The isolated C2B domain had a 6-fold lower EC50 for Ca2+-activated fusion than the intact cytosolic domain of Syt 1 (C2AB). Phosphatidylethanolamine increased both the rate and efficiency of C2AB- and C2B-regulated fusion without affecting their abilities to bind membrane-embedded syntaxin-SNAP-25 (t-SNARE) complexes. At equimolar concentrations, the isolated C2A domain was an effective inhibitor of C2B-, but not C2AB-regulated fusion; hence, C2A has markedly different effects in the fusion assay depending on whether it is tethered to C2B. Finally, scanning alanine mutagenesis of C2AB revealed four distinct groups of mutations within the C2B domain that play roles in the regulation of SNARE-mediated fusion. Surprisingly, substitution of Arg-398 with alanine, which lies on the opposite end of C2B from the Ca2+/membrane-binding loops, decreases C2AB t-SNARE binding and Ca2+-triggered fusion in vitro without affecting Ca(2+-)triggered interactions with phosphatidylserine or vesicle aggregation. In addition, some mutations uncouple the clamping and stimulatory functions of syt 1, suggesting that these two activities are mediated by distinct structural determinants in C2B.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), 1300 Univ Ave,129 SMI, Madison, WI 53706 USA.	chapman@physiology.wisc.edu	Hui, Enfu/C-2806-2012; Wang, Zhao/C-2168-2014	Chapman, Edwin/0000-0001-9787-8140; WANG, ZHAO/0000-0002-4233-9884	National Institutes of Health [GM 56827, MH 61876]; American Heart Association [0440168N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 56827 and MH 61876. This work was also supported by American Heart Association Grant 0440168N.	Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; BRECKENRIDGE WC, 1973, BIOCHIM BIOPHYS ACTA, V320, P681, DOI 10.1016/0304-4165(73)90148-7; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; FONTAINE RN, 1980, J NEUROCHEM, V34, P269, DOI 10.1111/j.1471-4159.1980.tb06592.x; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P496, DOI 10.1098/rspb.1965.0017; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Lynch KL, 2007, MOL BIOL CELL, V18, P4957, DOI 10.1091/mbc.E07-04-0368; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; PERIN MS, 1991, J BIOL CHEM, V266, P623; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shin OH, 2004, P NATL ACAD SCI USA, V101, P2554, DOI 10.1073/pnas.0308477100; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Shin OH, 2002, NAT NEUROSCI, V5, P649, DOI 10.1038/nn869; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; Wang P, 2003, J BIOL CHEM, V278, P47030, DOI 10.1074/jbc.M306728200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	47	55	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31763	31775		10.1074/jbc.M803355200	http://dx.doi.org/10.1074/jbc.M803355200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784080	hybrid, Green Published			2022-12-25	WOS:000260760800059
J	Liu, Y; Borchert, GL; Surazynski, A; Phang, JM				Liu, Y.; Borchert, G. L.; Surazynski, A.; Phang, J. M.			Proline oxidase, a p53-induced gene, targets COX-2/PGE(2) signaling to induce apoptosis and inhibit tumor growth in colorectal cancers	ONCOGENE			English	Article						proline oxidase; COX-2; signaling cross talk; colorectal cancer; tumor suppressor	FACTOR RECEPTOR; COLON-CANCER; POSTTRANSCRIPTIONAL CONTROL; CYCLOOXYGENASE-2; EXPRESSION; CARCINOGENESIS; PATHWAY; OXYGEN; CELLS; CHEMOPREVENTION	Proline oxidase (POX), a flavoenzyme localized at the inner mitochondrial membrane, catalyzes the first step of proline degradation by converting proline to pyrroline-5-carboxylate (P5C). POX is markedly elevated during p53-induced apoptosis and generates proline-dependent reactive oxygen species (ROS), specifically superoxide radicals, to induce apoptosis through both mitochondrial and death receptor pathways. These previous studies also showed suppression of the mitogen-activated protein kinase pathway leading us to broaden our exploration of proliferative signaling. In our current report, we used DLD-1 colorectal cancer cells stably transfected with the POX gene under the control of a tetracycline-inducible promoter and found that three pathways which cross talk with each other were downregulated by POX: the cyclooxygenase-2(COX-2) pathway, the epidermal growth factor receptor (EGFR) pathway and the Wnt/beta-catenin pathway. First, POX markedly reduced COX-2 expression, suppressed the production of prostaglandin E2 (PGE2) and importantly, the growth inhibition by POX was partially reversed by treatment with PGE2. Phosphorylation of EGFR was decreased with POX expression and the addition of EGF partially reversed the POX-dependent downregulation of COX-2. Wnt/beta-catenin signaling was decreased by POX in that phosphorylation of glycogen synthase kinase-3 beta (GSK-3 beta) was decreased on the one hand and phosphorylation of beta-catenin was increased on the other. There changes led to decreased accumulation of beta-catenin and decreased beta-catenin/TCF/LEF-mediated transcription. Our newly described POX-mediated suppression of proliferative signaling together with the previously reported induction of apoptosis suggested that POX could function as a tumor suppressor. Indeed, in human colorectal tissue samples, immunohistochemically-monitored POX was dramatically decreased in tumors compared with normal counterparts. Thus, POX metabolism of substrate proline affects multiple signaling pathways, modulating both apoptosis and tumor growth, and could be an attractive target to metabolically control the cancer phenotypes.	[Liu, Y.; Borchert, G. L.] NCI, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [Surazynski, A.; Phang, J. M.] NCI, Ctr Canc Res, Comparat Carcinogenesis Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, Y (corresponding author), NCI, Basic Res Program, SAIC Frederick Inc, Bldg 538,Room 144, Frederick, MD 21702 USA.	liuy@ncifcrf.gov	Surażynski, Arkadiusz/ABG-2795-2020	Surażynski, Arkadiusz/0000-0003-4475-873X	NIH [N01-CO-12400]; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project also has been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health under Contract No. N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Araki Y, 2003, CANCER RES, V63, P728; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen JJ, 2005, MOL BIOL CELL, V16, P5579, DOI 10.1091/mbc.E05-08-0778; Dannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2004, CURR PHARM DESIGN, V10, P635, DOI 10.2174/1381612043453171; Donald SP, 2001, CANCER RES, V61, P1810; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; HAGEDORN CH, 1986, ARCH BIOCHEM BIOPHYS, V248, P166, DOI 10.1016/0003-9861(86)90413-3; Huang B, 2002, ACTA NEUROPATHOL, V103, P415, DOI 10.1007/s00401-001-0479-3; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kawamori T, 1998, CANCER RES, V58, P409; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korswagen HC, 2006, DEV CELL, V10, P687, DOI 10.1016/j.devcel.2006.05.007; Liu LZ, 2004, SER INF MANAGE SCI, V3, P279; Liu XL, 2006, ADV ANAT PATHOL, V13, P270, DOI 10.1097/01.pap.0000213046.61941.5c; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Liu YM, 2005, CARCINOGENESIS, V26, P1335, DOI 10.1093/carcin/bgi083; Maxwell SA, 2003, J BIOL CHEM, V278, P9784, DOI 10.1074/jbc.M210012200; McDonald-McGinn DM, 2006, AM J MED GENET A, V140A, P906, DOI 10.1002/ajmg.a.31199; Merida Isabel, 2006, Clin Transl Oncol, V8, P711, DOI 10.1007/s12094-006-0117-6; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pandhare J, 2006, J BIOL CHEM, V281, P2044, DOI 10.1074/jbc.M507867200; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prescott SM, 2000, BBA-REV CANCER, V1470, pM69, DOI 10.1016/S0304-419X(00)00006-8; Rivera A, 2005, J BIOL CHEM, V280, P29346, DOI 10.1074/jbc.M504852200; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Shao JY, 2004, J BIOL CHEM, V279, P14287, DOI 10.1074/jbc.M313276200; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Surazynski A, 2008, INT J CANCER, V122, P1435, DOI 10.1002/ijc.23263; Williams CS, 1997, J CLIN INVEST, V100, P1325, DOI 10.1172/JCI119651; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Worthley DL, 2007, WORLD J GASTROENTERO, V13, P3784; YEH GC, 1988, J BIOL CHEM, V263, P13083	38	82	84	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2008	27	53					6729	6737		10.1038/onc.2008.322	http://dx.doi.org/10.1038/onc.2008.322			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	371XO	18794809	Green Accepted			2022-12-25	WOS:000260866200003
J	Liu, HY; Wen, GB; Han, JM; Hong, T; Zhuo, DG; Liu, ZQ; Cao, WH				Liu, Hui-Yu; Wen, Ge-Bo; Han, Jianmin; Hong, Tao; Zhuo, Degen; Liu, Zhenqi; Cao, Wenhong			Inhibition of Gluconeogenesis in Primary Hepatocytes by Stromal Cell-derived Factor-1 (SDF-1) through a c-Src/Akt-dependent Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCOSE-PRODUCTION; CHEMOKINE RECEPTOR CXCR4; MICE LACKING; MIGRATION; EXPRESSION; KINASES; LIVER; ACTIVATION; CANCER	Hepatic gluconeogenesis is elevated in diabetes and a major contributor to hyperglycemia. Stromal cell-derived factor-1 (SDF-1) is a chemokine and an activator of Akt. In this study, we tested the hypothesis that SDF-1 suppresses hepatic gluconeogenesis through Akt. Our results from isolated primary hepatocytes show that SDF-1 alpha and SDF-1 beta inhibited glucose production via gluconeogenesis and reduced transcript levels of key gluconeogenic genes glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK). Additionally, SDF-1 alpha and SDF-1 beta both inhibited activation of the PEPCK promoter. In examining the mechanism by which SDF-1 inhibits gluconeogenesis, we found that SDF-1 promoted phosphorylation of Akt, FoxO1, and c-Src, but did not activate insulin receptor substrate-1-like insulin. Blockade of Akt activation by LY294002, FoxO1 translocation by constitutively nuclear FoxO1 mutant, or c-Src activation by the chemical inhibitor PP2, respectively, blunted SDF-1 suppression of gluconeogenesis. Finally, our results show that knocking down the level of SDF-1 receptor CXCR4 mRNA blocked SDF-1 suppression of gluconeogenesis. Together, our results demonstrate that SDF-1 is capable of inhibiting gluconeogenesis in primary hepatocytes through a signaling pathway distinct from the insulin signaling.	[Liu, Hui-Yu; Han, Jianmin; Hong, Tao; Zhuo, Degen; Cao, Wenhong] Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA; [Wen, Ge-Bo; Hong, Tao] Univ S China, Hengyang 421001, Hunan, Peoples R China; [Liu, Zhenqi] Univ Virginia, Dept Med Endocrinol, Charlottesville, VA 22908 USA; [Cao, Wenhong] Duke Univ, Med Ctr, Dept Med Endocrinol, Durham, NC 27710 USA	The Hamner Institutes for Health Sciences; University of South China; University of Virginia; Duke University	Cao, WH (corresponding author), 6 Davis Dr, Res Triangle Pk, NC 27709 USA.	hliu@thehamner.org; wcao@thehamner.org			National Institutes of Health NIDDK [R01DK076039]; Hamner Institutes for Health Sciences; American Heart Association [SDG-0530244N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hamner Institutes for Health Sciences; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grant R01DK076039 (to W. C.). This work was also supported by the Investigator Development Fund from the Hamner Institutes for Health Sciences (to W. C.) and American Heart Association Grant SDG-0530244N (to W. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Barbieri F, 2007, J MOL ENDOCRINOL, V38, P383, DOI 10.1677/JME-06-0014; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Chang YC, 2007, CELL TRANSPLANT, V16, P171; Choudhury GG, 2006, CELL SIGNAL, V18, P1854, DOI 10.1016/j.cellsig.2006.02.003; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; De Paepe B, 2008, FRONT BIOSCI-LANDMRK, V13, P2548, DOI 10.2741/2866; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gronthos S, 2007, TRENDS ENDOCRIN MET, V18, P108, DOI 10.1016/j.tem.2007.02.002; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Han W, 2006, CELL RES, V16, P189, DOI 10.1038/sj.cr.7310026; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang YC, 2007, BIOCHEM PHARMACOL, V74, P1702, DOI 10.1016/j.bcp.2007.08.025; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Matin K, 2002, IMMUNOLOGY, V107, P222, DOI 10.1046/j.1365-2567.2002.01478.x; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; MCGARRIGLE D, 2007, SCI STKE, pPE35, DOI DOI 10.1126/STKE.3922007PE35; Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Poggi A, 2007, CURR MED CHEM, V14, P3166, DOI 10.2174/092986707782793835; Schober A, 2007, THROMB HAEMOSTASIS, V97, P730, DOI 10.1160/TH07-02-0085; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Shibuta K, 2002, JPN J CANCER RES, V93, P789, DOI 10.1111/j.1349-7006.2002.tb01321.x; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786.MCR-06-0103; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tsutsumi H, 2007, BIOPOLYMERS, V88, P279, DOI 10.1002/bip.20653; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wu MH, 2008, J CELL BIOCHEM, V103, P245, DOI 10.1002/jcb.21400; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	54	20	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30642	30649		10.1074/jbc.M803698200	http://dx.doi.org/10.1074/jbc.M803698200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18786922	Green Published, hybrid			2022-12-25	WOS:000260544800021
J	Pata, M; Heraud, C; Vacher, J				Pata, Monica; Heraud, Celine; Vacher, Jean			OSTM1 Bone Defect Reveals an Intercellular Hematopoietic Crosstalk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; OSTEOCLAST DEVELOPMENT; A3 SUBUNIT; T-CELLS; MOUSE; GENE; MUTATIONS; MARROW; PU.1; MICE	The most severe form of bone autosomal recessive osteopetrosis both in humans and in the gray-lethal (gl/gl) mouse is caused by mutations in the Ostm1 gene. Although osteopetrosis is usually associated with a defect in the hematopoietic-derived osteoclast cells, this study determined that Ostm1 is expressed in many hematopoietic cells of the myeloid and lymphoid B- and T-lineages. Hematopoiesis in gl/gl mice is characterized by a marked expansion of the osteoclast lineage but also by deregulation of the lymphoid lineages with a decrease in B- lymphoid cell populations and altered distribution in T-lymphoid double and single CD4 CD8-positive cells. In committed gl/gl osteoclasts, specific Ostm1 transgene targeting showed a requirement of additional factors and/or cells for normal osteoclast function, and importantly, defined the gl osteopetrotic defect as non-cell autonomous. By contrast, gl/gl osteoclast, B- and T-lymphoid lineage phenotypes were rescued when Ostm1 is expressed under PU.1 regulation from a bacterial artificial chromosome transgene, which established an essential role for Ostm1 in hematopoietic cells in addition to osteoclasts. Together these experiments are the first to demonstrate the existence of hematopoietic crosstalk for the production of functional and active osteoclasts.	[Pata, Monica; Heraud, Celine; Vacher, Jean] Univ Montreal, Fac Med, Inst Rech Clin Montreal, Dept Cellular Interact & Dev, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Vacher, J (corresponding author), Univ Montreal, Fac Med, Inst Rech Clin Montreal, Dept Cellular Interact & Dev, 110 Ave Pins W, Montreal, PQ H2W 1R7, Canada.	vacherj@ircm.qc.ca		Heraud, Celine/0000-0002-9208-2335	Canadian Institutes of Health Research; National Sciences and Engineering Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research and National Sciences and Engineering Council of Canada grants (to J. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Balemans W, 2005, CALCIFIED TISSUE INT, V77, P263, DOI 10.1007/s00223-005-0027-6; Blin-Wakkach C, 2004, LEUKEMIA, V18, P1505, DOI 10.1038/sj.leu.2403449; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao MY, 1999, J EXP MED, V190, P1527, DOI 10.1084/jem.190.10.1527; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Eapen M, 1998, BONE MARROW TRANSPL, V22, P941, DOI 10.1038/sj.bmt.1701474; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; GERRITSEN EJA, 1994, J PEDIATR-US, V125, P896, DOI 10.1016/S0022-3476(05)82004-9; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Hayase Y, 1997, EXP HEMATOL, V25, P19; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; ISCOVE NN, 1974, J CELL PHYSIOL, V83, P309, DOI 10.1002/jcp.1040830218; Janssens K, 2002, HUM MOL GENET, V11, P2385, DOI 10.1093/hmg/11.20.2385; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lazner F, 1999, HUM MOL GENET, V8, P1839, DOI 10.1093/hmg/8.10.1839; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Lorenzo J, 2000, J CLIN INVEST, V106, P749, DOI 10.1172/JCI11089; Maranda B, 2008, J BONE MINER RES, V23, P296, DOI 10.1359/JBMR.071015; Menaa C, 2000, BIOCHEM BIOPH RES CO, V267, P943, DOI 10.1006/bbrc.1999.2042; Michigami T, 2002, BONE, V30, P436, DOI 10.1016/S8756-3282(01)00684-6; NILSSON SK, 1994, DEV BIOL, V164, P456, DOI 10.1006/dbio.1994.1215; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Quarello P, 2004, J BONE MINER RES, V19, P1194, DOI 10.1359/JBMR.040407; Rajapurohitam V, 2001, BONE, V28, P513, DOI 10.1016/S8756-3282(01)00416-1; REDDY SV, 1993, J BONE MINER RES, V8, P1263; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Scimeca JC, 2003, HUM MUTAT, V21, P151, DOI 10.1002/humu.10165; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; Tagaya H, 2000, BLOOD, V95, P3363, DOI 10.1182/blood.V95.11.3363.011k29_3363_3370; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; WALKER DG, 1975, SCIENCE, V190, P784, DOI 10.1126/science.1105786; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Wilson CJ, 2000, ARCH DIS CHILD, V83, P449, DOI 10.1136/adc.83.5.449; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	46	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30522	30530		10.1074/jbc.M805242200	http://dx.doi.org/10.1074/jbc.M805242200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18790735	Green Published, hybrid			2022-12-25	WOS:000260544800010
J	Yu, WD; Ramakrishnan, R; Wang, Y; Chiang, K; Sung, TL; Rice, AP				Yu, Wendong; Ramakrishnan, Rajesh; Wang, Yan; Chiang, Karen; Sung, Tzu-Ling; Rice, Andrew P.			Cyclin T1-Dependent Genes in Activated CD4(+) T and Macrophage Cell Lines Appear Enriched in HIV-1 Co-Factors	PLOS ONE			English	Article								HIV-1 is dependent upon cellular co-factors to mediate its replication cycle in CD4(+) T cells and macrophages, the two major cell types infected by the virus in vivo. One critical co-factor is Cyclin T1, a subunit of a general RNA polymerase II elongation factor known as P-TEFb. Cyclin T1 is targeted directly by the viral Tat protein to activate proviral transcription. Cyclin T1 is up-regulated when resting CD4(+) T cells are activated and during macrophage differentiation or activation, conditions that are also necessary for high levels of HIV-1 replication. Because Cyclin T1 is a subunit of a transcription factor, the up-regulation of Cyclin T1 in these cells results in the induction of cellular genes, some of which might be HIV-1 co-factors. Using shRNA depletions of Cyclin T1 and transcriptional profiling, we identified 54 cellular mRNAs that appear to be Cyclin T1-dependent for their induction in activated CD4(+) T Jurkat T cells and during differentiation and activation of MM6 cells, a human monocytic cell line. The promoters for these Cyclin T1-dependent genes (CTDGs) are over-represented in two transcription factor binding sites, SREBP1 and ARP1. Notably, 10 of these CTDGs have been reported to be involved in HIV-1 replication, a significant over-representation of such genes when compared to randomly generated lists of 54 genes ( p value<0.00021). The results of siRNA depletion and dominant-negative protein experiments with two CTDGs identified here, CDK11 and Casein kinase 1 gamma 1, suggest that these genes are involved either directly or indirectly in HIV-1 replication. It is likely that the 54 CTDGs identified here include novel HIV-1 co-factors. The presence of CTDGs in the protein space that was available for HIV-1 to sample during its evolution and acquisition of Tat function may provide an explanation for why CTDGs are enriched in viral co-factors.	[Yu, Wendong; Ramakrishnan, Rajesh; Wang, Yan; Chiang, Karen; Sung, Tzu-Ling; Rice, Andrew P.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine	Yu, WD (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	arice@bcm.tmc.edu		Rice, Andrew/0000-0002-1237-4769; Yu, Wendong/0000-0001-8958-6762	NIH [AI35381, AI45374]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI035381, R01AI035381, R21AI045374, R01AI045374] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the NIH (AI35381 and AI45374).	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Barboric M, 2005, J VIROL, V79, P11135, DOI 10.1128/JVI.79.17.11135-11141.2005; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; De Martino MU, 2004, MOL ENDOCRINOL, V18, P820, DOI 10.1210/me.2003-0341; Dufner A, 2006, P NATL ACAD SCI USA, V103, P988, DOI 10.1073/pnas.0510380103; Freedland Eric S, 2004, Nutr Metab (Lond), V1, P12, DOI 10.1186/1743-7075-1-12; Garber ME, 1999, CURR OPIN IMMUNOL, V11, P460, DOI 10.1016/S0952-7915(99)80077-6; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Herrmann CH, 1998, J VIROL, V72, P9881, DOI 10.1128/JVI.72.12.9881-9888.1998; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Hoque M, 2003, MOL CELL BIOL, V23, P1688, DOI 10.1128/MCB.23.5.1688-1702.2003; HUANG Y, 1993, TOUGHENED PLASTICS, V1, P1; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Komano J, 2004, MOL BIOL CELL, V15, P5197, DOI 10.1091/mbc.E04-04-0279; Lam LT, 2001, GENOME BIOL, V2; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Liou LY, 2006, J LEUKOCYTE BIOL, V79, P388, DOI 10.1189/jlb.0805429; Liou LY, 2002, J VIROL, V76, P10579, DOI 10.1128/JVI.76.21.10579-10587.2002; Liou LY, 2004, J VIROL, V78, P8114, DOI 10.1128/JVI.78.15.8114-8119.2004; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Ma XT, 2004, ACTA BIOCH BIOPH SIN, V36, P250, DOI 10.1093/abbs/36.4.250; Meanwell NA, 2007, CURR OPIN INVEST DR, V8, P669; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Moriuchi M, 1998, J CLIN INVEST, V102, P1540, DOI 10.1172/JCI4151; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Rice AP, 2003, CURR HIV RES, V1, P395, DOI 10.2174/1570162033485159; RICE AP, 2007, FUTURE HIV THER, V1, P369; RICH EA, 1992, J CLIN INVEST, V89, P176, DOI 10.1172/JCI115559; RITTNER K, 1995, J MOL BIOL, V248, P562, DOI 10.1006/jmbi.1995.0243; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; SOUTHGATE CD, 1991, GENE DEV, V5, P2496, DOI 10.1101/gad.5.12b.2496; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Sung TL, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-66; Wang Y, 2006, VIROLOGY, V352, P485, DOI 10.1016/j.virol.2006.05.013; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang XZ, 1996, J VIROL, V70, P4576, DOI 10.1128/JVI.70.7.4576-4584.1996; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yu WD, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-32; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	65	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3146	10.1371/journal.pone.0003146	http://dx.doi.org/10.1371/journal.pone.0003146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773076	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420100004
J	Kurisetty, VV; Johnston, PG; Johnston, N; Erwin, P; Crowe, P; Fernig, DG; Campbell, FC; Anderson, IP; Rudland, PS; El-Tanani, MK				Kurisetty, V. V.; Johnston, P. G.; Johnston, N.; Erwin, P.; Crowe, P.; Fernig, D. G.; Campbell, F. C.; Anderson, I. P.; Rudland, P. S.; El-Tanani, M. K.			RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin	ONCOGENE			English	Article						osteopontin; RAN; breast cancer invasion and metastasis	MAMMARY EPITHELIAL-CELLS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; BINDING-PROTEIN; PLASMA OSTEOPONTIN; NUCLEAR-PROTEIN; RAN/TC4 GTPASE; C-MET; EXPRESSION; METASTASIS	Osteopontin (OPN) is a phosphorylated glycoprotein that binds to alpha v-containing integrins and is important in malignant transformation and cancer. Previously, we have utilized suppressive subtractive hybridization between mRNAs isolated from the Rama 37 (R37) rat mammary cell line and a subclone rendered invasive and metastatic by stable transfection with an expression vector for OPN to identify RAN GTPase (RAN) as the most over-expressed gene, in addition to that of OPN. Here we show that transfection of noninvasive R37 cells with an expression vector for RAN resulted in increased anchorage-independent growth, cell attachment and invasion through Matrigel in vitro, and metastasis in syngeneic rats. This induction of a malignant phenotype was induced independently of the expression of OPN, and was reversed by specifically reducing the expression of RAN using small-interfering RNAs. By using a combination of mutant protein and inhibitors, it was found that RAN signal transduction occurred through the c-Met receptor and PI3 kinase. This study therefore identifies RAN as a novel effector of OPN-mediated malignant transformation and some of its downstream signaling events in a mammary epithelial model of cancer invasion/metastasis.	[Johnston, P. G.; Johnston, N.; Erwin, P.; Crowe, P.; Campbell, F. C.; El-Tanani, M. K.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7LB, Antrim, North Ireland; [Fernig, D. G.; Anderson, I. P.; Rudland, P. S.] Univ Liverpool, Canc & Polio Res Fund Labs, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	Queens University Belfast; University of Liverpool	El-Tanani, MK (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, 97 Lisburn Rd, Belfast BT9 7LB, Antrim, North Ireland.	m.el-tanani@qub.ac.uk	Johnston, Nick/C-3028-2008; Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293; Campbell, Frederick/0000-0002-0363-9964; El-Tanani, Mohamed/0000-0002-4735-5445	Research and Development Office, Queen's University Belfast, Northern Ireland, UK; Cancer and Polio Research Fund, Wirral, UK; Northwest Cancer Research Fund, Liverpool, UK	Research and Development Office, Queen's University Belfast, Northern Ireland, UK; Cancer and Polio Research Fund, Wirral, UK; Northwest Cancer Research Fund, Liverpool, UK	This work was supported by grants from Research and Development Office, Queen's University Belfast, Northern Ireland, UK and The Cancer and Polio Research Fund, Wirral, UK. DGF's post is funded by the Northwest Cancer Research Fund, Liverpool, UK.	Abe H, 2008, INT J CANCER, V122, P2391, DOI 10.1002/ijc.23400; Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO;2-E; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bramwell VHC, 2006, CLIN CANCER RES, V12, P3337, DOI 10.1158/1078-0432.CCR-05-2354; Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985; Chen HJ, 1997, ONCOGENE, V14, P1581, DOI 10.1038/sj.onc.1200993; Darzynkiewicz Z, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0804s01; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; DAVIES BR, 1993, ONCOGENE, V8, P999; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; DUNNINGTON DJ, 1983, J NATL CANCER I, V71, P1227; El-Tanani M, 2001, CANCER RES, V61, P5619; El-Tanani M, 2004, J BIOL CHEM, V279, P20794, DOI 10.1074/jbc.M311131200; El-Tanani MK, 2006, J BIOL CHEM, V281, P26587, DOI 10.1074/jbc.M604403200; El-Tanani MK, 2006, CYTOKINE GROWTH F R, V17, P463, DOI 10.1016/j.cytogfr.2006.09.010; Emberley ED, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-28; Furger KA, 2003, MOL CANCER RES, V1, P810; Hafizi S, 2005, INT J BIOCHEM CELL B, V37, P2344, DOI 10.1016/j.biocel.2005.05.006; Hara S, 2008, BIOCHEM BIOPH RES CO, V370, P123, DOI 10.1016/j.bbrc.2008.03.042; Johnston NIF, 2008, FRONT BIOSCI-LANDMRK, V13, P4361, DOI 10.2741/3009; Kilty IC, 1999, J NEUROCHEM, V73, P1859; KURISETTY VV, 2008, BMC RES NOT IN PRESS; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Moye VE, 2004, BRIT J CANCER, V90, P1796, DOI 10.1038/sj.bjc.6601683; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Oates AJ, 1996, ONCOGENE, V13, P97; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Rudland PS, 2002, CANCER RES, V62, P3417; Sakata H, 1997, J BIOL CHEM, V272, P9457; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sazer S, 2000, J CELL SCI, V113, P1111; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Singhal H, 1997, CLIN CANCER RES, V3, P605; SU LC, 1995, ONCOGENE, V10, P2163; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Tuck AB, 2000, J CELL BIOCHEM, V78, P465, DOI 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C; Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Ue T, 1998, INT J CANCER, V79, P127, DOI 10.1002/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059	51	56	56	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	57					7139	7149		10.1038/onc.2008.325	http://dx.doi.org/10.1038/onc.2008.325			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	379GG	18794800				2022-12-25	WOS:000261384100001
J	Davies, KD; Goebel-Goody, SM; Coultrap, SJ; Browning, MD				Davies, Kurtis D.; Goebel-Goody, Susan M.; Coultrap, Steven J.; Browning, Michael D.			Long Term Synaptic Depression That Is Associated with GluR1 Dephosphorylation but Not alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; D-ASPARTATE RECEPTOR; GLUTAMATE RECEPTORS; SURFACE EXPRESSION; REGULATORY PHOSPHORYLATION; MEDIATED ENDOCYTOSIS; RAPID REDISTRIBUTION; RAT HIPPOCAMPUS; CA1 REGION; AREA CA1	Long lasting changes in the strength of synaptic transmission in the hippocampus are thought to underlie certain forms of learning and memory. Accordingly, the molecular mechanisms that account for these changes are heavily studied. Postsynaptically, changes in synaptic strength can occur by altering the amount of neurotransmitter receptors at the synapse or by altering the functional properties of synaptic receptors. In this study, we examined the biochemical changes produced following chemically induced long term depression in acute hippocampal CA1 minislices. Using three independent methods, we found that this treatment did not lead to an internalization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid ( AMPA) receptors. Furthermore, when the plasma membrane was separated into synaptic membrane-enriched and extrasynaptic membrane-enriched fractions, we actually observed a significant increase in the concentration of AMPA receptors at the synapse. However, phosphorylation of Ser-845 on the AMPA receptor subunit GluR1 was significantly decreased throughout the neuron, including in the synaptic membrane-enriched fraction. In addition, phosphorylation of Ser-831 on GluR1 was decreased specifically in the synaptic membrane-enriched fraction. Phosphorylation of these residues has been demonstrated to control AMPA receptor function. From these data, we conclude that the decrease in synaptic strength is likely the result of a change in the functional properties of AMPA receptors at the synapse and not a decrease in the amount of synaptic receptors.	[Davies, Kurtis D.; Coultrap, Steven J.; Browning, Michael D.] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA; [Goebel-Goody, Susan M.; Browning, Michael D.] Univ Colorado, Hlth Sci Ctr, Program Neurosci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Browning, MD (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Mail Stop 8303,POB 6511, Aurora, CO 80045 USA.	michael.browning@uchsc.edu			National Institutes of Health Research [AA014691, AA09675]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014691, R01AA009675] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Research Grants AA014691 and AA09675. M. D. B. has a financial interest in PhosphoSolutions, a company that provided several of the antibodies used in this study. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COTMAN CW, 1972, J CELL BIOL, V55, P696, DOI 10.1083/jcb.55.3.696; CRAIN B, 1973, BRAIN RES, V63, P195, DOI 10.1016/0006-8993(73)90088-7; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Davies KD, 2007, BRAIN RES, V1158, P39, DOI 10.1016/j.brainres.2007.05.008; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Goebel SM, 2005, MOL BRAIN RES, V142, P65, DOI 10.1016/j.molbrainres.2005.09.012; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hall RA, 1997, NEUROSCIENCE, V78, P361, DOI 10.1016/S0306-4522(96)00525-8; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Holman D, 2007, NEUROPHARMACOLOGY, V52, P92, DOI 10.1016/j.neuropharm.2006.05.022; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Huang CC, 2004, J NEUROCHEM, V89, P217, DOI 10.1111/j.1471-4159.2003.02307.x; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; MATUS AI, 1978, PROC R SOC SER B-BIO, V203, P135, DOI 10.1098/rspb.1978.0097; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4	52	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33138	33146		10.1074/jbc.M803431200	http://dx.doi.org/10.1074/jbc.M803431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18819923	Green Published, hybrid			2022-12-25	WOS:000261183700015
J	Duser, MG; Bi, YM; Zarrabi, N; Dunn, SD; Borsch, M				Dueser, Monika G.; Bi, Yumin; Zarrabi, Nawid; Dunn, Stanley D.; Boersch, Michael			The Proton-translocating a Subunit of F0F1-ATP Synthase Is Allocated Asymmetrically to the Peripheral Stalk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ATP SYNTHASE; GREEN FLUORESCENT PROTEIN; SINGLE-MOLECULE SPECTROSCOPY; RESONANCE ENERGY-TRANSFER; ESCHERICHIA-COLI; EPSILON-SUBUNIT; CONFORMATIONAL DYNAMICS; GAMMA-SUBUNIT; B-SUBUNIT; MEMBRANE	The position of the a subunit of the membrane-integral F-0 sector of Escherichia coli ATP synthase was investigated by single molecule fluorescence resonance energy transfer studies utilizing a fusion of enhanced green fluorescent protein to the C terminus of the a subunit and fluorescent labels attached to specific positions of the epsilon or gamma subunits. Three fluorescence resonance energy transfer levels were observed during rotation driven by ATP hydrolysis corresponding to the three resting positions of the rotor subunits, gamma or epsilon, relative to the a subunit of the stator. Comparison of these positions of the rotor sites with those previously determined relative to the b subunit dimer indicates the position of a as adjacent to the b dimer on its counterclockwise side when the enzyme is viewed from the cytoplasm. This relationship provides stability to the membrane interface between a and b(2), allowing it to withstand the torque imparted by the rotor during ATP synthesis as well as ATP hydrolysis.	[Dueser, Monika G.; Zarrabi, Nawid; Boersch, Michael] Univ Stuttgart, Inst Phys 3, D-70550 Stuttgart, Germany; [Bi, Yumin; Dunn, Stanley D.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	University of Stuttgart; Western University (University of Western Ontario)	Borsch, M (corresponding author), Univ Stuttgart, Inst Phys 3, Pfaffenwaldring 57, D-70550 Stuttgart, Germany.	m.boersch@physik.uni-stuttgart.de	Dunn, Stanley/D-3418-2013	Borsch, Michael/0000-0002-0634-2963	Deutsche Forschungsgemeinschaft [BO 1891/8-1]; Canadian Institutes of Health Research [MT-10237]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant BO 1891/8-1 (to M. B.) and by Canadian Institutes of Health Research Grant MT-10237 (to S. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGGELER R, 1992, J BIOL CHEM, V267, P21355; Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; Alemdaroglu FE, 2008, ANGEW CHEM INT EDIT, V47, P974, DOI 10.1002/anie.200703466; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Borsch M, 2002, FEBS LETT, V527, P147, DOI 10.1016/S0014-5793(02)03198-8; Bottcher B, 2000, J MOL BIOL, V296, P449, DOI 10.1006/jmbi.1999.3435; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cotlet M, 2006, CHEMPHYSCHEM, V7, P250, DOI 10.1002/cphc.200500247; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; Deniz AA, 2001, ANNU REV PHYS CHEM, V52, P233, DOI 10.1146/annurev.physchem.52.1.233; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Ding K, 2007, ANGEW CHEM INT EDIT, V46, P1172, DOI 10.1002/anie.200603064; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dmitriev OY, 2008, BBA-BIOENERGETICS, V1777, P227, DOI 10.1016/j.bbabio.2007.11.011; DUSER MG, 2006, P SOC PHOTOOPT INSTR, V6092; Fillingame RH, 2000, J EXP BIOL, V203, P9; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GOGOL EP, 1989, BIOCHEMISTRY-US, V28, P4709, DOI 10.1021/bi00437a030; Ha T, 1999, BIOPHYS J, V76, pA386; Heitkamp T, 2008, BIOCHEMISTRY-US, V47, P3564, DOI 10.1021/bi702038e; Krebstakies T, 2005, J BIOL CHEM, V280, P33338, DOI 10.1074/jbc.M506251200; KUMAMOTO CA, 1987, J BIOL CHEM, V262, P3060; KUMAMOTO CA, 1986, J BIOL CHEM, V261, P37; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; McLachlin DT, 2000, J BIOL CHEM, V275, P17571, DOI 10.1074/jbc.M000375200; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Mellwig C, 2003, J BIOL CHEM, V278, P18544, DOI 10.1074/jbc.M212852200; Myong S, 2006, STRUCTURE, V14, P633, DOI 10.1016/j.str.2006.02.005; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Panke O, 1999, BBA-BIOENERGETICS, V1412, P118, DOI 10.1016/S0005-2728(99)00059-6; Peneva K, 2008, J AM CHEM SOC, V130, P5398, DOI 10.1021/ja711322g; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Rubinstein JL, 2002, J MOL BIOL, V321, P613, DOI 10.1016/S0022-2836(02)00671-X; Stalz WD, 2003, J BIOL CHEM, V278, P27068, DOI 10.1074/jbc.M302027200; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zarrabi N, 2005, PROC SPIE, V5699, P175, DOI 10.1117/12.597967; ZARRABI N, 2007, P SOC PHOTOOPT INSTR, V6771; ZARRABI N, 2007, P SOC PHOTOOPT INSTR, V6444; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682; Zimmermann B, 2006, BBA-BIOENERGETICS, V1757, P311, DOI 10.1016/j.bbabio.2006.03.020	52	54	54	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33602	33610		10.1074/jbc.M805170200	http://dx.doi.org/10.1074/jbc.M805170200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18786919	hybrid, Green Published			2022-12-25	WOS:000261183700066
J	Sweet, L; Zhang, WH; Torres-Fewell, H; Serianni, A; Boggess, W; Schorey, J				Sweet, Lindsay; Zhang, Wenhui; Torres-Fewell, Heidi; Serianni, Anthony; Boggess, William; Schorey, Jeffrey			Mycobacterium avium Glycopeptidolipids Require Specific Acetylation and Methylation Patterns for Signaling through Toll-like Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROVAR-SPECIFIC GLYCOPEPTIDOLIPIDS; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; IMMUNE-RESPONSES; NONTUBERCULOUS MYCOBACTERIA; MICROBIAL LIPOPROTEINS; PSEUDOMONAS-AERUGINOSA; CUTTING EDGE; SMEGMATIS; MACROPHAGES; MICE	Toll-like receptors (TLRs) recognize pathogen- associated molecules and play a vital role in promoting an immune response against invading microbes. TLR2, one of the key members of the TLR family, recognizes a wide variety of microbial products, including lipoproteins and lipopeptides, from a number of pathogens. Recent studies from our laboratory indicate that glycopeptidolipids (GPLs), a major surface component of Mycobacterium avium and other non-tuberculosis mycobacteria, are ligands for TLR2. However, the molecular requirements necessary for the GPL-TLR2 interaction were not defined in this report. In the present study we isolated different GPL species from M. avium, and using mass spectrometry and NMR analyses, characterized the molecular requirements of the GPL-TLR2 interaction. Interestingly, the extent of the respective acetylation and methylation of the 6-deoxytalose and rhamnose contained within the core GPL structure dictated whether the GPL signaled through TLR2. These experiments illustrate how subtle changes in a complex TLR2 ligand can alter its affinity for this important receptor, and suggest that M. avium could potentially modify its GPL structure to limit its interaction with TLR2.	[Schorey, Jeffrey] Univ Notre Dame, Dept Biol Sci, Eck Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA; [Zhang, Wenhui; Serianni, Anthony; Boggess, William] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Schorey, J (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Ctr Global Hlth & Infect Dis, 130 Galvin Life Sci Ctr, Notre Dame, IN 46556 USA.	schorey.1@nd.edu	Zhang, Wenhui/B-1695-2013		National Institutes of Health; NIAID [AI056979, AI052439]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052439, R01AI056979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI056979 and AI052439 from NIAID. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or NIH. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bernardo J, 1998, INFECT IMMUN, V66, P28, DOI 10.1128/IAI.66.1.28-35.1998; BRENNAN PJ, 1982, J CLIN MICROBIOL, V15, P447, DOI 10.1128/JCM.15.3.447-455.1982; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Eckstein TM, 2003, MICROBIOL-SGM, V149, P2797, DOI 10.1099/mic.0.26528-0; Ernst RK, 1999, J INFECT DIS, V179, pS326, DOI 10.1086/513850; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gomes MS, 2004, IMMUNOLOGY, V111, P179, DOI 10.1111/j.0019-2805.2003.01807.x; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hilborn ED, 2006, APPL ENVIRON MICROB, V72, P5864, DOI 10.1128/AEM.00759-06; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Horgen L, 2000, MICROB PATHOGENESIS, V29, P9, DOI 10.1006/mpat.2000.0358; HORSBURGH CR, 1991, AM REV RESPIR DIS, V144, P557, DOI 10.1164/ajrccm/144.3_Pt_1.557; HORSBURGH CR, 1986, ANTIMICROB AGENTS CH, V30, P955, DOI 10.1128/AAC.30.6.955; Horsburgh CR, 1999, J INFECT DIS, V179, pS461; Kang BK, 1998, INFECT IMMUN, V66, P2769, DOI 10.1128/IAI.66.6.2769-2777.1998; Kano H, 2005, BIOL PHARM BULL, V28, P335, DOI 10.1248/bpb.28.335; Krzywinska E, 2005, MOL MICROBIOL, V56, P1262, DOI 10.1111/j.1365-2958.2005.04608.x; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Means TK, 1999, J IMMUNOL, V163, P3920; Mukherjee R, 2005, MICROBIOL-SGM, V151, P2385, DOI 10.1099/mic.0.27908-0; Ojha AK, 2002, MICROBIOL-SGM, V148, P3039, DOI 10.1099/00221287-148-10-3039; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Sweet L, 2006, J LEUKOCYTE BIOL, V80, P415, DOI 10.1189/jlb.1205702; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Villeneuve C, 2003, J BIOL CHEM, V278, P51291, DOI 10.1074/jbc.M306554200; Wieland CW, 2004, AM J RESP CRIT CARE, V170, P1367, DOI 10.1164/rccm.200404-525OC; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; YAKRUS MA, 1990, J CLIN MICROBIOL, V28, P926, DOI 10.1128/JCM.28.5.926-929.1990; Yamazaki Y, 2006, CELL MICROBIOL, V8, P806, DOI 10.1111/j.1462-5822.2005.00667.x	49	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33221	33231		10.1074/jbc.M805539200	http://dx.doi.org/10.1074/jbc.M805539200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824550	hybrid, Green Published			2022-12-25	WOS:000261183700025
J	Duriez, M; Rossignol, JM; Sitterlin, D				Duriez, Marion; Rossignol, Jean-Michel; Sitterlin, Delphine			The Hepatitis B Virus Precore Protein Is Retrotransported from Endoplasmic Reticulum (ER) to Cytosol through the ER-associated Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE ENVELOPE PROTEIN; E-ANTIGEN; MISFOLDED PROTEINS; IN-VITRO; VERTICAL TRANSMISSION; MOLECULAR CHAPERONES; VIRAL REPLICATION; MESSENGER-RNA; CHOLERA-TOXIN; CELL-DEATH	The hepatitis B virus precore protein is closely related to the nucleocapsid core protein but is processed distinctly in the cell and plays a different role in the viral cycle. Precore is addressed to the endoplasmic reticulum (ER) through a signal peptide, and the form present in the ER is the P22 protein. P22 is then cleaved in its C-terminal part to be secreted as HBe antigen. In addition, a cytosolic form of 22 kDa less characterized has been observed. Precore gene was shown to be implicated in viral persistence, but until now, the actual protein species involved has not been determined. Our work focuses on the cytosolic form of precore. Using human cells expressing precore and a convenient fractionation assay, we demonstrated that the cytosolic form is identical to the ER form and retrotransported in the cytoplasm through the ER-associated degradation pathway. This cellular machinery translocates misfolded proteins to the cytoplasm, where they are ubiquitinated on lysine residues and degraded by proteasome. We showed that precore escapes proteasome due to its low lysine content and accumulates in the cytosol. The role of this retrotransport was investigated. In the presence of precore, we found a specific redistribution of the Grp78/BiP chaperone protein to cytosol and demonstrated a specific interaction between precore and Grp78/BiP. Altogether, these data support the idea that the hepatitis B virus develops a strategy to take advantage of the ER-associated degradation pathway, allowing distinct subcellular localization and probably distinct roles for the viral precore protein.			Sitterlin, D (corresponding author), Univ Versailles St Quentin, CNRS, Lab Genet & Biol Cellulaire, Ecole Prat Hautes Etud,UMR 8159, 45 Ave Etats Unis, F-7803 Versailles, France.	delphine.sitterlin@uvsq.fr			Agence Nationale de Recherches sur le SIDA et les Hepatites virales [07309]; Association pour la Recherche sur le Cancer [3404]	Agence Nationale de Recherches sur le SIDA et les Hepatites virales(ANRSFrench National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by Agence Nationale de Recherches sur le SIDA et les Hepatites virales, Grant 07309 and Association pour la Recherche sur le Cancer, Grant 3404. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Awe K, 2008, FEBS LETT, V582, P3179, DOI 10.1016/j.febslet.2008.07.062; BEASLEY RP, 1977, AM J EPIDEMIOL, V105, P94, DOI 10.1093/oxfordjournals.aje.a112370; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHANG C, 1987, J VIROL, V61, P3322, DOI 10.1128/JVI.61.10.3322-3325.1987; CHEN HS, 1992, J VIROL, V66, P5682, DOI 10.1128/JVI.66.9.5682-5684.1992; Chen YY, 2006, CELL MOL IMMUNOL, V3, P373; Cho DY, 2003, J VIROL, V77, P2784, DOI 10.1128/JVI.77.4.2784-2788.2003; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Friedt M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-11; Guidotti LG, 1996, J VIROL, V70, P7056, DOI 10.1128/JVI.70.10.7056-7061.1996; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Huang ZM, 2005, MOL CELL BIOL, V25, P7522, DOI 10.1128/MCB.25.17.7522-7533.2005; Kimura T, 2005, J BIOL CHEM, V280, P21713, DOI 10.1074/jbc.M501564200; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Laine S, 2003, J VIROL, V77, P12875, DOI 10.1128/JVI.77.23.12875-12880.2003; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; LAMBERTS C, 1993, J VIROL, V67, P3756, DOI 10.1128/JVI.67.7.3756-3762.1993; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu H, 1998, J BIOL CHEM, V273, P12858, DOI 10.1074/jbc.273.21.12858; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Messageot F, 2003, J BIOL CHEM, V278, P891, DOI 10.1074/jbc.M207634200; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Milich DR, 1998, J IMMUNOL, V160, P2013; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; OU JH, 1986, P NATL ACAD SCI USA, V83, P1578, DOI 10.1073/pnas.83.6.1578; OU JH, 1989, J VIROL, V63, P5238, DOI 10.1128/JVI.63.12.5238-5243.1989; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; Scaglioni PP, 1997, VIROLOGY, V233, P374, DOI 10.1006/viro.1997.8594; SCHLICHT HJ, 1987, J VIROL, V61, P3701, DOI 10.1128/JVI.61.12.3701-3709.1987; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; STEVENS CE, 1979, J MED VIROL, V3, P237, DOI 10.1002/jmv.1890030310; Uetrecht C, 2008, P NATL ACAD SCI USA, V105, P9216, DOI 10.1073/pnas.0800406105; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Wang XL, 2006, J BIOL CHEM, V281, P8636, DOI 10.1074/jbc.M513920200; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002	51	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32352	32360		10.1074/jbc.M807178200	http://dx.doi.org/10.1074/jbc.M807178200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805786	hybrid			2022-12-25	WOS:000260893700022
J	Li, GD; Zhang, X; Li, R; Wang, YD; Wang, YL; Han, KJ; Qian, XP; Yang, CG; Liu, P; Wei, Q; Chen, WF; Zhang, J; Zhang, Y				Li, Guo-Dong; Zhang, Xi; Li, Rong; Wang, Yue-Dan; Wang, Yan-Li; Han, Ke-Jun; Qian, Xiao-Ping; Yang, Cheng-Gang; Liu, Ping; Wei, Qun; Chen, Wei-Feng; Zhang, Jun; Zhang, Yu			CHP2 Activates the Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway and Enhances the Oncogenic Potential of HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER; PHOSPHATASE-ACTIVITY; TRANSCRIPTION FACTOR; HOMOLOGOUS PROTEIN; B-SUBUNIT; NFAT; EXPRESSION; OVEREXPRESSION; CALMODULIN; INHIBITOR	CHP2 (calcineurin B homologous protein 2) was initially identified as a tumor-associated antigen highly expressed in hepatocellular carcinoma. Its biological function remains largely unknown except for a potential role in transmembrane Na+/H+ exchange. In the present study, we observed that ectopic expression of CHP2 promoted the proliferation of HEK293 cells, whereas knockdown of endogenous CHP2 expression in HepG2 inhibited cell proliferation. When inoculated into nude mice, CHP2 transfected HEK293 cells displayed markedly increased oncogenic potential. In analysis of the underlying molecular mechanisms, we found that like calcineurin B, CHP2 was able to bind to and stimulate the phosphatase activity of calcineurin A. In accord with this, CHP2-transfected cells showed increased nuclear presence of NFATc3 (nuclear factor of activated T cells) and enhanced NFAT activity. Finally, both accelerated cell proliferation and NFAT activation following CHP2 transfection could be suppressed by the calcineurin inhibitor cyclosporine A, suggesting an intrinsic connection between these events. Taken together, our results highlighted a potential role of CHP2 in tumorigenesis and revealed a novel function of CHP2 as an activator of the calcineurin/NFAT signaling pathway.	[Li, Guo-Dong; Zhang, Xi; Li, Rong; Wang, Yue-Dan; Han, Ke-Jun; Qian, Xiao-Ping; Chen, Wei-Feng; Zhang, Jun; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100191, Peoples R China; [Wang, Yan-Li; Yang, Cheng-Gang; Liu, Ping; Wei, Qun] Beijing Normal Univ, Dept Biochem & Mol Biol, Sch Life Sci, Beijing 100875, Peoples R China	Peking University; Beijing Normal University	Zhang, J (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	junzhang@bjmu.edu.cn; zhangyu007@hsc.pku.edu.cn	Chen, Wei/GZK-7348-2022		National Basic Research Program of China [2006CB504307, 2006CB910101]; Ludwig Institute for Cancer Research [KSP 003]; National Natural Science Foundation of China [30300309, 30525044]; Beijing Natural Science Foundation [7061003]	National Basic Research Program of China(National Basic Research Program of China); Ludwig Institute for Cancer Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Basic Research Program of China Grants 2006CB504307 and 2006CB910101, James R. Kerr Program, Ludwig Institute for Cancer Research Grant KSP 003, National Natural Science Foundation of China Grants 30300309 and 30525044, and Beijing Natural Science Foundation Grant 7061003.	Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Glud SZ, 2005, BLOOD, V106, P3546, DOI 10.1182/blood-2005-02-0493; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jin Q, 2007, IN VIVO, V21, P593; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; KINCAID RL, 1986, P NATL ACAD SCI USA, V83, P1193, DOI 10.1073/pnas.83.5.1193; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Kuwahara H, 2003, J BIOCHEM, V134, P245, DOI 10.1093/jb/mvg137; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Lakshmikuttyamma A, 2005, J CELL BIOCHEM, V95, P731, DOI 10.1002/jcb.20437; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Liu P, 2005, BIOCHIMIE, V87, P215, DOI 10.1016/j.biochi.2004.10.009; Lu HT, 2007, CURR CANCER DRUG TAR, V7, P343, DOI 10.2174/156800907780809750; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marafiot T, 2005, BRIT J HAEMATOL, V128, P333, DOI 10.1111/j.1365-2141.2004.05313.x; Matsumoto M, 2001, J BIOCHEM, V130, P217, DOI 10.1093/oxfordjournals.jbchem.a002975; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Qin YL, 2005, BBA-PROTEINS PROTEOM, V1747, P171, DOI 10.1016/j.bbapap.2004.11.002; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; RYOEM S, 2008, CANCER CELL, V13, P420; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Wang YL, 2008, CANCER SCI, V99, P1100, DOI 10.1111/j.1349-7006.2008.00799.x; Wei Q, 1997, BIOCHEM MOL BIOL INT, V41, P169; Zaun HC, 2008, J BIOL CHEM, V283, P12456, DOI 10.1074/jbc.M800267200; 韩克军, 2003, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V19, P31	40	17	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32660	32668		10.1074/jbc.M806684200	http://dx.doi.org/10.1074/jbc.M806684200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815128	hybrid			2022-12-25	WOS:000260893700056
J	Caines, MEC; Zhu, HZ; Vuckovic, M; Willis, LM; Withers, SG; Wakarchuk, WW; Strynadka, NCJ				Caines, Matthew E. C.; Zhu, Haizhong; Vuckovic, Marija; Willis, Lisa M.; Withers, Stephen G.; Wakarchuk, Warren W.; Strynadka, Natalie C. J.			The Structural Basis for T-antigen Hydrolysis by Streptococcus pneumoniae A TARGET FOR STRUCTURE-BASED VACCINE DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; ALPHA-AMYLASE; PROTEIN; IDENTIFICATION; CRYSTALLOGRAPHY; RECOGNITION; MECHANISM; REVEALS	Streptococcus pneumoniae endo-alpha-N-acetylgalactosaminidase is a cell surface-anchored glycoside hydrolase from family GH101 involved in the breakdown of mucin type O-linked glycans. The 189-kDa mature enzyme specifically hydrolyzes the T-antigen disaccharide from extracellular host glycoproteins and is representative of a broadly important class of virulence factors that have remained structurally uncharacterized due to their large size and highly modular nature. Here we report a 2.9 angstrom resolution crystal structure that remarkably captures the multidomain architecture and characterizes a catalytic center unexpectedly resembling that of alpha-amylases. Our analysis presents a complete model of glycoprotein recognition and provides a basis for the structure-based design of novel Streptococcus vaccines and therapeutics.	[Caines, Matthew E. C.; Zhu, Haizhong; Vuckovic, Marija; Withers, Stephen G.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Caines, Matthew E. C.; Zhu, Haizhong; Vuckovic, Marija; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Willis, Lisa M.; Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; National Research Council Canada	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Willis, Lisa/0000-0001-6204-033X	Howard Hughes Medical Institute; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Canada Foundation for Innovation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was funded by the Howard Hughes Medical Institute, Canadian Institutes of Health Research, Michael Smith Foundation for Health Research, and Canada Foundation for Innovation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe A, 2005, FEBS J, V272, P6145, DOI 10.1111/j.1742-4658.2005.05013.x; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adam D, 2002, J ANTIMICROB CHEMOTH, V50, P1, DOI 10.1093/jac/dkf801; Afonine P., 2005, CCP4 NEWSLETTER, V42; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, VACCINE, V22, P2209, DOI 10.1016/j.vaccine.2003.11.038; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Carlson CB, 2008, J BIOL CHEM, V283, P20069, DOI 10.1074/jbc.M800223200; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; GLASGOW LR, 1977, J BIOL CHEM, V252, P8615; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Moreno FBMB, 2008, J STRUCT BIOL, V161, P133, DOI 10.1016/j.jsb.2007.10.002; Mizuno M, 2004, EUR J BIOCHEM, V271, P2530, DOI 10.1111/j.1432-1033.2004.04183.x; Mizushima T, 2007, P NATL ACAD SCI USA, V104, P5777, DOI 10.1073/pnas.0610312104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nahoum V, 1999, ACTA CRYSTALLOGR D, V55, P360, DOI 10.1107/S0907444998010701; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simpson PJ, 2002, BIOCHEMISTRY-US, V41, P5712, DOI 10.1021/bi012093i; Song JH, 2005, MOL CELLS, V19, P365; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Thoden JB, 2004, J BIOL CHEM, V279, P23431, DOI 10.1074/jbc.M402347200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; Xie HF, 2001, BIOCHEMISTRY-US, V40, P9167, DOI 10.1021/bi0106742; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	48	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31279	31283		10.1074/jbc.C800150200	http://dx.doi.org/10.1074/jbc.C800150200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784084	hybrid			2022-12-25	WOS:000260760800003
J	Ishikawa, Y; Vranka, J; Wirz, J; Nagata, K; Bachinger, HP				Ishikawa, Yoshihiro; Vranka, Janice; Wirz, Jackie; Nagata, Kazuhiro; Baechinger, Hans Peter			The Rough Endoplasmic Reticulum-resident FK506-binding Protein FKBP65 Is a Molecular Chaperone That Interacts with Collagens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; OSTEOGENESIS IMPERFECTA; TRIPLE-HELIX; IN-VITRO; DISULFIDE-ISOMERASE; THERMAL-STABILITY; NEUROSPORA-CRASSA; BINDING-PROTEIN; MUTATIONS; HSP47	The rough endoplasmic reticulum-resident FK-506-binding protein FKBP65 can be isolated from chick embryos on a gelatin-Sepharose column, indicating some involvement in the biosynthesis of procollagens. The peptidylprolyl cis-trans-isomerase activity of FKBP65 was previously shown to have only marginal effects on the rate of triple helix formation (Zeng, B., MacDonald, J. R., Bann, J. G., Beck, K., Gambee, J. E., Boswell, B. A., and Bachinger, H. P. (1998) Biochem. J. 330, 109 - 114). Here we show that FKBP65 is a monomer in solution and acts as a chaperone molecule when tested with two classic chaperone assays: FKBP65 inhibits the thermal aggregation of citrate synthase and is active in the denatured rhodanese refolding and aggregation assay. The chaperone activity is comparable to that of protein-disulfide isomerase, a well characterized chaperone. FKBP65 delays the in vitro fibril formation of type I collagen, indicating that FKBP65 is also able to interact with triple helical collagen, and acts as a collagen chaperone.	[Ishikawa, Yoshihiro; Vranka, Janice; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Wirz, Jackie; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan	Oregon Health & Science University; Kyoto University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Ishikawa, Yoshihiro/0000-0003-2013-0518; Wirz, Jacqueline/0000-0003-2046-610X	Shriners Hospitals for Children	Shriners Hospitals for Children	This work was supported by a grant from the Shriners Hospitals for Children (to H. P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; BUSH KT, 1994, BIOCHEM J, V303, P705, DOI 10.1042/bj3030705; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; COSS MC, 1995, J BIOL CHEM, V270, P29336, DOI 10.1074/jbc.270.49.29336; Coss MC, 1998, CELL GROWTH DIFFER, V9, P41; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; Main ERG, 1999, J MOL BIOL, V291, P429, DOI 10.1006/jmbi.1999.2941; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; PARTALEDIS JA, 1993, P NATL ACAD SCI USA, V90, P5450, DOI 10.1073/pnas.90.12.5450; Patterson CE, 2000, MOL BIOL CELL, V11, P3925, DOI 10.1091/mbc.11.11.3925; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; Tremmel D, 2007, J MOL BIOL, V369, P55, DOI 10.1016/j.jmb.2007.01.092; Tremmel D, 2007, FEBS LETT, V581, P2036, DOI 10.1016/j.febslet.2007.04.042; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	34	91	95	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31584	31590		10.1074/jbc.M802535200	http://dx.doi.org/10.1074/jbc.M802535200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786928	hybrid			2022-12-25	WOS:000260760800038
J	Ng, SW; Di Capite, J; Singaravelu, K; Parekh, AB				Ng, Siaw Wei; Di Capite, Joseph; Singaravelu, Karthika; Parekh, Anant B.			Sustained Activation of the Tyrosine Kinase Syk by Antigen in Mast Cells Requires Local Ca2+ Influx through Ca2+ Release-activated Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; BASOPHILIC LEUKEMIA-CELLS; LEUKOTRIENE C-4 SECRETION; CRAC CHANNEL; CALCIUM-CHANNELS; PORE SUBUNIT; PHOSPHORYLATION; MICRODOMAINS; DOMAINS	Mast cell activation involves cross-linking of IgE receptors followed by phosphorylation of the non-receptor tyrosine kinase Syk. This results in activation of the plasma membrane-bound enzyme phospholipase C gamma 1, which hydrolyzes the minor membrane phospholipid phosphatidylinositol 4,5-bisphosphate to generate diacylglycerol and inositol trisphosphate. Inositol trisphosphate raises cytoplasmic Ca2+ concentration by releasing Ca2+ from intracellular stores. This Ca2+ release phase is accompanied by sustained Ca2+ influx through store-operated Ca2+ release-activated Ca2+ (CRAC) channels. Here, we find that engagement of IgE receptors activates Syk, and this leads to Ca2+ release from stores followed by Ca2+ influx. The Ca2+ influx phase then sustains Syk activity. The Ca2+ influx pathway activated by these receptors was identified as the CRAC channel, because pharmacological block of the channels with either a low concentration of Gd3+ or exposure to the novel CRAC channel blocker 3-fluoropyridine-4-carboxylic acid (2', 5'-dimethoxybiphenyl-4-yl) amide or RNA interference knockdown of Orai1, which encodes the CRAC channel pore, all prevented the increase in Syk activity triggered by Ca2+ entry. CRAC channels and Syk are spatially close together, because increasing cytoplasmic Ca2+ buffering with the fast Ca2+ chelator 1,2-bis(2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid tetrakis failed to prevent activation of Syk by Ca2+ entry. Our results reveal a positive feedback step in mast cell activation where receptor-triggered Syk activation and subsequent Ca2+ release opens CRAC channels, and the ensuing local Ca2+ entry then maintains Syk activity. Ca2+ entry through CRAC channels therefore provides a means whereby the Ca2+ and tyrosine kinase signaling pathways can interact with one another.	[Ng, Siaw Wei; Di Capite, Joseph; Singaravelu, Karthika; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council; MRC [G0601485] Funding Source: UKRI; Medical Research Council [G0601485] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Medical Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Dauvillier S, 2002, J IMMUNOL, V169, P2274, DOI 10.4049/jimmunol.169.5.2274; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fierro L, 1999, J PHYSIOL-LONDON, V520, P407, DOI 10.1111/j.1469-7793.1999.00407.x; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kuehn HS, 2007, IMMUNOL LETT, V113, P59, DOI 10.1016/j.imlet.2007.08.007; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; MINOGUCHI K, 1994, J BIOL CHEM, V269, P16902; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; PAREKH AB, 1995, P NATL ACAD SCI USA, V92, P7907, DOI 10.1073/pnas.92.17.7907; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 1997, CELL, V89, P973, DOI 10.1016/S0092-8674(00)80282-2; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney J W Jr, 2001, Mol Interv, V1, P84; Rezaul K, 1997, BIOCHEM BIOPH RES CO, V239, P23, DOI 10.1006/bbrc.1997.7419; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SEGAL DM, 1977, P NATL ACAD SCI USA, V74, P2993, DOI 10.1073/pnas.74.7.2993; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Stenton GR, 2002, J IMMUNOL, V169, P1028, DOI 10.4049/jimmunol.169.2.1028; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; Xu DZ, 2006, MOL CELL BIOL, V26, P5043, DOI 10.1128/MCB.02387-05; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoon E, 2004, BIOCHEM BIOPH RES CO, V325, P117, DOI 10.1016/j.bbrc.2004.09.216; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	48	96	97	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31348	31355		10.1074/jbc.M804942200	http://dx.doi.org/10.1074/jbc.M804942200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18806259	hybrid			2022-12-25	WOS:000260760800012
J	Hopper, ED; Pittman, AMC; Fitzgerald, MC; Tucker, CL				Hopper, Erin D.; Pittman, Adrianne M. C.; Fitzgerald, Michael C.; Tucker, Chandra L.			In Vivo and in Vitro Examination of Stability of Primary Hyperoxaluria-associated Human Alanine: Glyoxylate Aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROUGHPUT SCREENING ASSAY; PROMOTE PROTEIN STABILITY; THERMAL SHIFT ASSAYS; ESCHERICHIA-COLI; PYRIDOXAL 5'-PHOSPHATE; SERINE HYDROXYMETHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-DISTRIBUTION; TRAFFICKING DEFECT; DRUG DISCOVERY	Primary hyperoxaluria type I is a severe kidney stone disease caused by mutations in the protein alanine: glyoxylate aminotransferase (AGT). Many patients have mutations in AGT that are not deleterious alone but act synergistically with a common minor allele polymorphic variant to impair protein folding, dimerization, or localization. Although studies suggest that the minor allele variant itself is destabilized, no direct stability studies have been carried out. In this report, we analyze AGT function and stability using three approaches. First, we describe a yeast complementation growth assay for AGT, in which we show that human AGT can substitute for function of yeast Agx1 and that mutations associated with disease in humans show reduced growth in yeast. The reduced growth of minor allele mutants reflects reduced protein levels, indicating that these proteins are less stable than wild-type AGT in yeast. We further examine stability of AGT alleles in vitro using two direct methods, a mass spectrometry-based technique (stability of unpurified proteins from rates of H/D exchange) and differential scanning fluorimetry. We also examine the effect of known ligands pyridoxal 5'-phosphate and aminooxyacetic acid on stability. Our work establishes that the minor allele is destabilized and that pyridoxal 5'-phosphate and aminooxyacetic acid binding significantly stabilizes both alleles. To our knowledge, this is the first work that directly measures relative stabilities of AGT variants and ligand complexes. Because previous studies suggest that stabilizing compounds (i.e. pharmacological chaperones) may be effective for treatment of primary hyperoxaluria, we propose that the methods described here can be used in high throughput screens for compounds that stabilize AGT mutants.	[Pittman, Adrianne M. C.; Tucker, Chandra L.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Hopper, Erin D.; Fitzgerald, Michael C.] Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Duke University	Tucker, CL (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	chandra@duke.edu	Fitzgerald, Michael/E-3392-2010; Tucker, Chandra/F-6842-2011	Tucker, Chandra/0000-0003-3033-1786	National Institutes of Health [R21 DK075291-01A1]; Oxalosis and Hyperoxaluria Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081584, R21DK075291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxalosis and Hyperoxaluria Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 DK075291-01A1 (to C. L. T.). This work was also supported by a grant from the Oxalosis and Hyperoxaluria Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baum EZ, 2007, ANTIMICROB AGENTS CH, V51, P4420, DOI 10.1128/AAC.00845-07; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; BEELER T, 1976, J BIOL CHEM, V251, P5267; Bettati S, 2000, J BIOL CHEM, V275, P40244, DOI 10.1074/jbc.M007015200; CAI K, 1995, J BIOL CHEM, V270, P19294, DOI 10.1074/jbc.270.33.19294; Cellini B, 2008, PROTEIN PEPTIDE LETT, V15, P153; Chen CH, 1998, ARCH BIOCHEM BIOPHYS, V349, P175, DOI 10.1006/abbi.1997.0457; Coulter-Mackie MB, 2006, MOL GENET METAB, V89, P349, DOI 10.1016/j.ymgme.2006.07.013; Coulter-Mackie MB, 2005, PROTEIN EXPRES PURIF, V41, P18, DOI 10.1016/j.pep.2004.11.004; Coulter-Mackie MB, 2004, MOL GENET METAB, V83, P38, DOI 10.1016/j.ymgme.2004.08.009; Danpure CJ, 2006, BBA-MOL CELL RES, V1763, P1776, DOI 10.1016/j.bbamcr.2006.08.021; DANPURE CJ, 1994, EUR J CELL BIOL, V64, P295; Danpure CJ, 2005, AM J NEPHROL, V25, P303, DOI 10.1159/000086362; DANPURE CJ, 1990, J CELL SCI, V97, P669; DOMINICI P, 1993, BIOCHEM J, V295, P493, DOI 10.1042/bj2950493; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Epps DE, 2001, ANAL BIOCHEM, V292, P40, DOI 10.1006/abio.2001.5047; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Ghaemmaghami S, 2000, P NATL ACAD SCI USA, V97, P8296, DOI 10.1073/pnas.140111397; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Liu WS, 2004, BIOCHEMISTRY-US, V43, P10896, DOI 10.1021/bi049218e; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; Lumb MJ, 1999, J BIOL CHEM, V274, P20587, DOI 10.1074/jbc.274.29.20587; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; Monico CG, 2005, AM J NEPHROL, V25, P183, DOI 10.1159/000085411; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NISHIYAMA K, 1991, BIOCHEM BIOPH RES CO, V176, P1093, DOI 10.1016/0006-291X(91)90396-O; Nozaki Y, 1972, Methods Enzymol, V26, P43; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Poklar N, 1997, BIOCHEMISTRY-US, V36, P14345, DOI 10.1021/bi971719v; Powell KD, 2004, J COMB CHEM, V6, P262, DOI 10.1021/cc034051e; Powell KD, 2003, BIOCHEMISTRY-US, V42, P4962, DOI 10.1021/bi034096w; Powell KD, 2002, PROTEIN SCI, V11, P841, DOI 10.1110/ps.3820102; Powell KD, 2002, J AM CHEM SOC, V124, P10256, DOI 10.1021/ja026574g; PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Rumsby G, 1997, ANN CLIN BIOCHEM, V34, P400, DOI 10.1177/000456329703400411; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; Schlosser T, 2004, YEAST, V21, P63, DOI 10.1002/yea.1058; SEIFERT T, 1985, BIOCHEMISTRY-US, V24, P339, DOI 10.1021/bi00323a016; Stolz J, 2003, J BIOL CHEM, V278, P18990, DOI 10.1074/jbc.M300949200; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Venkatesha B, 1998, BBA-PROTEIN STRUCT M, V1384, P141, DOI 10.1016/S0167-4838(98)00013-2; Williams E, 2007, CLIN CHEM, V53, P1216, DOI 10.1373/clinchem.2006.084434; Wu TH, 2003, BBA-PROTEINS PROTEOM, V1647, P315, DOI 10.1016/S1570-9639(03)00081-5; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com; ZETINA CR, 1980, J BIOL CHEM, V255, P4381; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5; ZOLLNER H, 1989, HDB ENZYME INHIBITOR	55	45	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30493	30502		10.1074/jbc.M803525200	http://dx.doi.org/10.1074/jbc.M803525200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782763	Green Published, hybrid			2022-12-25	WOS:000260544800007
J	Musso, T; Scutera, S; Vermi, W; Daniele, R; Fornaro, M; Castagnoli, C; Alotto, D; Ravanini, M; Cambieri, I; Salogni, L; Elia, AR; Giovarelli, M; Facchetti, F; Girolomoni, G; Sozzani, S				Musso, Tiziana; Scutera, Sara; Vermi, William; Daniele, Roberta; Fornaro, Michele; Castagnoli, Carlotta; Alotto, Daniela; Ravanini, Maria; Cambieri, Irene; Salogni, Laura; Elia, Angela Rita; Giovarelli, Mirella; Facchetti, Fabio; Girolomoni, Giampiero; Sozzani, Silvano			Activin A Induces Langerhans Cell Differentiation In Vitro and in Human Skin Explants	PLOS ONE			English	Article								Langerhans cells (LC) represent a well characterized subset of dendritic cells located in the epidermis of skin and mucosae. In vivo, they originate from resident and blood-borne precursors in the presence of keratinocyte-derived TGF beta. In vitro, LC can be generated from monocytes in the presence of GM-CSF, IL-4 and TGF beta. However, the signals that induce LC during an inflammatory reaction are not fully investigated. Here we report that Activin A, a TGF beta family member induced by proinflammatory cytokines and involved in skin morphogenesis and wound healing, induces the differentiation of human monocytes into LC in the absence of TGF beta. Activin A-induced LC are Langerin(+), Birbeck granules(+), E-cadherin(+), CLA(+) and CCR6(+) and possess typical APC functions. In human skin explants, intradermal injection of Activin A increased the number of CD1a(+) and Langerin(+) cells in both the epidermis and dermis by promoting the differentiation of resident precursor cells. High levels of Activin A were present in the upper epidermal layers and in the dermis of Lichen Planus biopsies in association with a marked infiltration of CD1a(+) and Langerin(+) cells. This study reports that Activin A induces the differentiation of circulating CD14(+) cells into LC. Since Activin A is abundantly produced during inflammatory conditions which are also characterized by increased numbers of LC, we propose that this cytokine represents a new pathway, alternative to TGF beta, responsible for LC differentiation during inflammatory/autoimmune conditions.	[Musso, Tiziana; Scutera, Sara] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy; [Vermi, William; Ravanini, Maria; Facchetti, Fabio] Univ Brescia, Dept Pathol, I-25121 Brescia, Italy; [Daniele, Roberta; Salogni, Laura; Sozzani, Silvano] Univ Brescia, Dept Biomed Sci & Biotecnol, Sect Gen Pathol & Immunol, I-25121 Brescia, Italy; [Daniele, Roberta; Girolomoni, Giampiero] Univ Verona, Dept Dermatol, I-37100 Verona, Italy; [Fornaro, Michele] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, I-10124 Turin, Italy; [Castagnoli, Carlotta; Alotto, Daniela; Cambieri, Irene] CTO Hosp, Dept Plastic Surg, Burn Unit Skin Bank, Turin, Italy; [Elia, Angela Rita; Giovarelli, Mirella] Univ Turin, S Giovanni Battista Hosp, Ctr Expt Res & Med Stud CERMS, I-10124 Turin, Italy	University of Turin; University of Brescia; University of Brescia; University of Verona; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Musso, T (corresponding author), Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy.	sozzani@med.unibs.it	GIROLOMONI, Giampiero/AAC-3405-2022; Facchetti, Fabio/E-7190-2010; SCUTERA, SARA AGATA CATERINA/AAU-6455-2020; Sozzani, Silvano/C-1447-2009	Facchetti, Fabio/0000-0003-4975-2388; SCUTERA, SARA AGATA CATERINA/0000-0002-7431-0875; Fornaro, Michele/0000-0003-1852-9167; Giovarelli, Mirella/0000-0002-7397-3466; Sozzani, Silvano/0000-0002-3144-8743; VERMI, WILLIAM/0000-0002-2291-2997; MUSSO, Tiziana/0000-0002-7487-6078	AIRC (Associazione Italiana per la Ricerca sul Cancro); MIUR (Ministero dell'Istruzione Universita e Ricerca); Istituto Superiore di Sanita; NOBEL Project Cariplo; Fondazione Piemontese per gli Studi e le Ricerche sulle Ustioni; Compagnia di San Paolo, Fondazione CRT; Ricerca Sanitaria Finalizzata Regione Piemonte	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); MIUR (Ministero dell'Istruzione Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; NOBEL Project Cariplo; Fondazione Piemontese per gli Studi e le Ricerche sulle Ustioni; Compagnia di San Paolo, Fondazione CRT(Compagnia di San Paolo); Ricerca Sanitaria Finalizzata Regione Piemonte(Regione Piemonte)	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro); MIUR (Ministero dell'Istruzione Universita e Ricerca; Cofin); Istituto Superiore di Sanita; NOBEL Project Cariplo "Genetic and functional genomics of myelomonocytic cells"; Fondazione Piemontese per gli Studi e le Ricerche sulle Ustioni; Compagnia di San Paolo, Fondazione CRT; Ricerca Sanitaria Finalizzata Regione Piemonte.	Arora DS, 1997, J PATHOL, V181, P413, DOI 10.1002/(SICI)1096-9896(199704)181:4<413::AID-PATH789>3.0.CO;2-U; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Bamberger C, 2005, AM J PATHOL, V167, P733, DOI 10.1016/S0002-9440(10)62047-0; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bell D, 1999, ADV IMMUNOL, V72, P255, DOI 10.1016/S0065-2776(08)60023-1; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CERIO R, 1989, BRIT J DERMATOL, V121, P421, DOI 10.1111/j.1365-2133.1989.tb15509.x; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Cumberbatch M, 2000, CLIN EXP DERMATOL, V25, P413, DOI 10.1046/j.1365-2230.2000.00678.x; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; de Gruijl TD, 2006, J IMMUNOL, V176, P7232, DOI 10.4049/jimmunol.176.12.7232; de Gruijl TD, 2002, J IMMUNOL, V169, P5322, DOI 10.4049/jimmunol.169.9.5322; FIVENSON DP, 1995, J CUTAN PATHOL, V22, P223, DOI 10.1111/j.1600-0560.1995.tb00742.x; Fumagalli M, 2007, EXP DERMATOL, V16, P600, DOI 10.1111/j.1600-0625.2007.00571.x; Gatti E, 2000, J IMMUNOL, V164, P3600, DOI 10.4049/jimmunol.164.7.3600; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gustafson J, 2007, ACTA ODONTOL SCAND, V65, P156, DOI 10.1080/00016350601137251; Hasseus B, 2001, SCAND J IMMUNOL, V54, P516, DOI 10.1046/j.1365-3083.2001.00988.x; Herbst B, 1996, BLOOD, V88, P2541, DOI 10.1182/blood.V88.7.2541.bloodjournal8872541; Hubner G, 1996, EXP CELL RES, V228, P106, DOI 10.1006/excr.1996.0305; Hubner G, 1996, DEV BIOL, V173, P490, DOI 10.1006/dbio.1996.0042; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; KASHIHARA M, 1986, J INVEST DERMATOL, V87, P602, DOI 10.1111/1523-1747.ep12455849; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Larregina AT, 2001, NAT IMMUNOL, V2, P1151, DOI 10.1038/ni731; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Mc Dermott R, 2002, MOL BIOL CELL, V13, P317, DOI 10.1091/mbc.01-06-0300; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; MEUNIER L, 1993, J IMMUNOL, V151, P4067; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Palucka AK, 2006, NAT IMMUNOL, V7, P223, DOI 10.1038/ni0306-223; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Phillips DJ, 2005, VET IMMUNOL IMMUNOP, V108, P23, DOI 10.1016/j.vetimm.2005.08.011; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Power CA, 1997, J EXP MED, V186, P825, DOI 10.1084/jem.186.6.825; RANDOLPH GJ, 2007, ANN REV IMMUNOL; Santoro A, 2005, J PATHOL, V205, P426, DOI 10.1002/path.1699; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; SOUSA CRE, 1993, J EXP MED, V178, P509, DOI 10.1084/jem.178.2.509; Sozzani S, 2005, CYTOKINE GROWTH F R, V16, P581, DOI 10.1016/j.cytogfr.2005.04.008; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; STINGL G, 1978, J INVEST DERMATOL, V71, P59, DOI 10.1111/1523-1747.ep12544055; Stoitzner P, 2005, EUR J CELL BIOL, V84, P733, DOI 10.1016/j.ejcb.2005.04.003; Strobl H, 1998, IMMUNOBIOLOGY, V198, P588, DOI 10.1016/S0171-2985(98)80080-6; Strobl H, 1996, J IMMUNOL, V157, P1499; Sugerman PB, 2002, CRIT REV ORAL BIOL M, V13, P350, DOI 10.1177/154411130201300405; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Sulyok S, 2004, MOL CELL ENDOCRINOL, V225, P127, DOI 10.1016/j.mce.2004.07.011; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Vermi W, 2006, BLOOD, V107, P454, DOI 10.1182/blood-2005-04-1342; Vulcano M, 2003, J IMMUNOL, V170, P3843, DOI 10.4049/jimmunol.170.7.3843; Wankell M, 2001, EMBO J, V20, P5361, DOI 10.1093/emboj/20.19.5361; Yang D, 1999, J IMMUNOL, V163, P1737; Yasaka N, 1996, J DERMATOL SCI, V11, P19, DOI 10.1016/0923-1811(95)00411-4	63	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3271	10.1371/journal.pone.0003271	http://dx.doi.org/10.1371/journal.pone.0003271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813341	Green Submitted, Green Published, gold			2022-12-25	WOS:000264431800009
J	Calcott, B; Balcan, D; Hohenlohe, PA				Calcott, Brett; Balcan, Duygu; Hohenlohe, Paul A.			A Publish-Subscribe Model of Genetic Networks	PLOS ONE			English	Article							REGULATORY NETWORKS; TRANSCRIPTIONAL REGULATION; BOOLEAN DYNAMICS; EVOLUTION; EXPRESSION; CONSTRUCTION; ROBUSTNESS; ELEMENTS; MOTIFS	We present a simple model of genetic regulatory networks in which regulatory connections among genes are mediated by a limited number of signaling molecules. Each gene in our model produces ( publishes) a single gene product, which regulates the expression of other genes by binding to regulatory regions that correspond ( subscribe) to that product. We explore the consequences of this publish-subscribe model of regulation for the properties of single networks and for the evolution of populations of networks. Degree distributions of randomly constructed networks, particularly multimodal in-degree distributions, which depend on the length of the regulatory sequences and the number of possible gene products, differed from simpler Boolean NK models. In simulated evolution of populations of networks, single mutations in regulatory or coding regions resulted in multiple changes in regulatory connections among genes, or alternatively in neutral change that had no effect on phenotype. This resulted in remarkable evolvability in both number and length of attractors, leading to evolved networks far beyond the expectation of these measures based on random distributions. Surprisingly, this rapid evolution was not accompanied by changes in degree distribution; degree distribution in the evolved networks was not substantially different from that of randomly generated networks. The publish-subscribe model also allows exogenous gene products to create an environment, which may be noisy or stable, in which dynamic behavior occurs. In simulations, networks were able to evolve moderate levels of both mutational and environmental robustness.	[Calcott, Brett] Australian Natl Univ, RSSS, Philosophy Program, Canberra, ACT, Australia; [Calcott, Brett] Australian Natl Univ, Ctr Macroevol & Macroecol, Canberra, ACT, Australia; [Balcan, Duygu] Indiana Univ, Sch Informat, Bloomington, IN 47405 USA; [Hohenlohe, Paul A.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Hohenlohe, Paul A.] Univ Oregon, Ctr Ecol & Evol Biol, Eugene, OR 97403 USA	Australian National University; Australian National University; Indiana University System; Indiana University Bloomington; Oregon State University; University of Oregon	Calcott, B (corresponding author), Australian Natl Univ, RSSS, Philosophy Program, Canberra, ACT, Australia.	hohenlop@science.oregonstate.edu	Hohenlohe, Paul/AAE-7744-2019	Hohenlohe, Paul/0000-0002-7616-0161	Santa Fe Institute [Complex Systems Summer School Fellowship]; Cambridge-Templeton Consortium; National Institutes of Health [National Research Service Award Ruth L. Kirschstein Postdoctoral Fellowship]	Santa Fe Institute; Cambridge-Templeton Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All 3 authors: Santa Fe Institute Complex Systems Summer School Fellowship. BC: Cambridge-Templeton Consortium Research Grant. PH: National Institutes of Health National Research Service Award Ruth L. Kirschstein Postdoctoral Fellowship. Funders had no direct role in any part of the study or manuscript preparation, review, or approval.	Adams MD, 2005, CURR OPIN GENET DEV, V15, P628, DOI 10.1016/j.gde.2005.09.004; Akutsu T, 2000, BIOINFORMATICS, V16, P727, DOI 10.1093/bioinformatics/16.8.727; Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; Aldana M, 2003, P NATL ACAD SCI USA, V100, P8710, DOI 10.1073/pnas.1536783100; ALDANA M, 2002, Patent No. 0204062; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Balcan D, 2004, EUR PHYS J B, V38, P253, DOI 10.1140/epjb/e2004-00055-7; Balcan D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000501; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bilke S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.016129; CILIBERTI S, 2007, PLOS COMP BIOL, V3; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Dorogovtsev SN, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066122; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Enemark J, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/11/P11007; Eugster PT, 2003, ACM COMPUT SURV, V35, P114, DOI 10.1145/857076.857078; Fenster CB, 1997, TRENDS ECOL EVOL, V12, P282, DOI 10.1016/S0169-5347(97)81027-0; Gamma E., 1994, DESIGN PATTERNS ELEM; Gavrilets S, 1997, TRENDS ECOL EVOL, V12, P307, DOI 10.1016/S0169-5347(97)01098-7; Gavrilets S., 2004, FITNESS LANDSCAPES O, pxviii; GEARD N, 2003, P 2003 C EV COMP CAN, P1493; Goutsias J, 2004, BIOPHYS J, V86, P1922, DOI 10.1016/S0006-3495(04)74257-5; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Haag ES, 2007, GENETICA, V129, P45, DOI 10.1007/s10709-006-0032-3; HANSEN TF, 2003, BIOSYSTEMS, V2189, P1; Harrelson GL, 2002, ATHLET THER TODAY, V7, P23, DOI 10.1123/att.7.5.23; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; KANEKO K, 2003, ORIGINATION ORG FORM; Kauffman S, 2004, J THEOR BIOL, V230, P581, DOI 10.1016/j.jtbi.2003.12.017; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KAUFFMAN SA, 1993, ORIDINS ORDER SELF O; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Mungan M, 2005, J PHYS A-MATH GEN, V38, P9599, DOI 10.1088/0305-4470/38/44/001; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Quayle AP, 2006, J THEOR BIOL, V238, P737, DOI 10.1016/j.jtbi.2005.06.020; REIL T, 1999, P 5 EUR C ART LIF, P457; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Schlichting CD, 2003, EVOL DEV, V5, P98, DOI 10.1046/j.1525-142X.2003.03015.x; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serra R, 2007, J THEOR BIOL, V246, P449, DOI 10.1016/j.jtbi.2007.01.012; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Valentine JW, 2000, PALEOBIOLOGY, V26, P513, DOI 10.1666/0094-8373(2000)026<0513:TGPTTE>2.0.CO;2; van Steensel B, 2005, NAT GENET, V37, pS18, DOI 10.1038/ng1559; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; von Dassow G, 1999, J EXP ZOOL, V285, P307, DOI 10.1002/(SICI)1097-010X(19991215)285:4<307::AID-JEZ2>3.3.CO;2-M; Von Dassow G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P244; Von Dassow G, 2002, J EXP ZOOL, V294, P179, DOI 10.1002/jez.10144; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2007, BIOSYSTEMS, V88, P163, DOI 10.1016/j.biosystems.2006.06.002; Watson J, 2004, BIOSYSTEMS, V76, P239, DOI 10.1016/j.biosystems.2004.05.016; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; ZHONG W, 2006, SCIENCE, V311	62	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3245	10.1371/journal.pone.0003245	http://dx.doi.org/10.1371/journal.pone.0003245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802467	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428600005
J	Dreher, JC; Koechlin, E; Tierney, M; Grafman, J				Dreher, Jean-Claude; Koechlin, Etienne; Tierney, Michael; Grafman, Jordan			Damage to the Fronto-Polar Cortex Is Associated with Impaired Multitasking	PLOS ONE			English	Article							HUMAN PREFRONTAL CORTEX; DUAL-TASK PERFORMANCE; HUMAN COGNITION; WORKING-MEMORY; HUMANS; FMRI; INFORMATION; INTEGRATION; RETRIEVAL; ACTIVATION	Background: A major question in understanding the functional organization of the brain is to delineate the functional divisions of the prefrontal cortex. Of particular importance to the cognitive capacities that are uniquely human is the fronto-polar cortex (Brodmann's area 10), which is disproportionally larger in humans relative to the rest of the brain than it is in the ape's brain. The specific function of this brain region remains poorly understood, but recent neuroimaging studies have proposed that it may hold goals in mind while exploring and processing secondary goals. Principal Findings: Here we show that the extent of damage to the fronto-polar cortex predicts impairment in the management of multiple goals. This result reveals that the integrity of the fronto-polar cortex is necessary to perform tasks that require subjects to maintain a primary goal in mind while processing secondary goals, an ability which is crucial for complex human cognitive abilities. Conclusion/Significance: These results provide important new insights concerning the cerebral basis of complex human cognition such as planning and multitasking.			Dreher, JC (corresponding author), CNRS, Cognit Neurosci Ctr, Reward & Decis Making Team, UMR 5229, Lyon, France.	dreher@isc.cnrs.fr; grafmanj@ninds.nih.gov	Koechlin, Etienne/AAF-5717-2021; Koechlin, Etienne/E-5061-2016; Dreher, Jean-Claude/H-8949-2017	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Dreher, Jean-Claude/0000-0002-2157-1529; Grafman, Jordan H./0000-0001-8645-4457	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003024, ZIANS003024] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Burgess CP, 2003, J HIGH ENERGY PHYS; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; DAMASIO AR, 1995, BRAIN ANATOMY COMPUT; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Dreher JC, 2002, P NATL ACAD SCI USA, V99, P14595, DOI 10.1073/pnas.222193299; Dreher JC, 2002, NEUROIMAGE, V17, P95, DOI 10.1006/nimg.2002.1169; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Green AE, 2006, BRAIN RES, V1096, P125, DOI 10.1016/j.brainres.2006.04.024; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Stelzel C, 2006, PSYCHOL RES-PSYCH FO, V70, P514, DOI 10.1007/s00426-005-0013-7; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2012, DOI 10.1073/pnas.91.6.2012; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Wylie GR, 2006, CEREB CORTEX, V16, P394, DOI 10.1093/cercor/bhi118	35	74	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3227	10.1371/journal.pone.0003227	http://dx.doi.org/10.1371/journal.pone.0003227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422LA	18795100	Green Submitted, gold, Green Published			2022-12-25	WOS:000264428000009
J	Paterson, DM; Aspden, RJ; Visscher, PT; Consalvey, M; Andres, MS; Decho, AW; Stolz, J; Reid, RP				Paterson, David M.; Aspden, Rebecca J.; Visscher, Pieter T.; Consalvey, Mireille; Andres, Miriam S.; Decho, Alan W.; Stolz, John; Reid, R. Pamela			Light-Dependant Biostabilisation of Sediments by Stromatolite Assemblages	PLOS ONE			English	Article								For the first time we have investigated the natural ecosystem engineering capacity of stromatolitic microbial assemblages. Stromatolites are laminated sedimentary structures formed by microbial activity and are considered to have dominated the shallows of the Precambrian oceans. Their fossilised remains are the most ancient unambiguous record of early life on earth. Stromatolites can therefore be considered as the first recognisable ecosystems on the planet. However, while many discussions have taken place over their structure and form, we have very little information on their functional ecology and how such assemblages persisted despite strong eternal forcing from wind and waves. The capture and binding of sediment is clearly a critical feature for the formation and persistence of stromatolite assemblages. Here, we investigated the ecosystem engineering capacity of stromatolitic microbial assemblages with respect to their ability to stabilise sediment using material from one of the few remaining living stromatolite systems (Highborne Cay, Bahamas). It was shown that the most effective assemblages could produce a rapid (12-24 h) and significant increase in sediment stability that continued in a linear fashion over the period of the experimentation (228 h). Importantly, it was also found that light was required for the assemblages to produce this stabilisation effect and that removal of assemblage into darkness could lead to a partial reversal of the stabilisation. This was attributed to the breakdown of extracellular polymeric substances under anaerobic conditions. These data were supported by microelectrode profiling of oxygen and calcium. The structure of the assemblages as they formed was visualised by low-temperature scanning electron microscopy and confocal laser microscopy. These results have implications for the understanding of early stromatolite development and highlight the potential importance of the evolution of photosynthesis in the mat forming process. The evolution of photosynthesis may have provided an important advance for the niche construction activity of microbial systems and the formation and persistence of the stromatolites which came to dominate shallow coastal environments for 80% of the biotic history of the earth.	[Paterson, David M.; Aspden, Rebecca J.] Univ St Andrews, Sediment Ecol Res Grp, Gatty Marine Lab, Sch Biol, St Andrews, Fife, Scotland; [Visscher, Pieter T.] Univ Connecticut, Dept Marine Sci, Storrs, CT 06269 USA; [Consalvey, Mireille] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Andres, Miriam S.; Reid, R. Pamela] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Geol & Geophys, Coral Gables, FL 33124 USA; [Decho, Alan W.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Environm Hlth Sci, Columbia, SC USA; [Stolz, John] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA USA	University of St Andrews; University of Connecticut; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Miami; University of South Carolina System; University of South Carolina Columbia; Duquesne University	Paterson, DM (corresponding author), Univ St Andrews, Sediment Ecol Res Grp, Gatty Marine Lab, Sch Biol, St Andrews, Fife, Scotland.	dp1@st-andrews.ac.uk	Paterson, David M/D-5202-2013; Decho, Alan W/F-9510-2010; Visscher, Pieter/T-7464-2017	Paterson, David M/0000-0003-1174-6476; Visscher, Pieter/0000-0001-6911-1532	NSF Biocomplexity award	NSF Biocomplexity award	Funding was provided by the NSF Biocomplexity award to the RIBS programme under Dr. P. Reid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres MS, 2006, SEDIMENT GEOL, V185, P319, DOI 10.1016/j.sedgeo.2005.12.020; ASPDEN RJ, 2004, SALT MARSH MICROBIAL; AWRAMIK SM, 1988, P NATL ACAD SCI USA, V85, P1327, DOI 10.1073/pnas.85.5.1327; Casillas-Martinez L, 2005, GEOMICROBIOL J, V22, P269, DOI 10.1080/01490450500182672; CHAFETZ HS, 1986, J SEDIMENT PETROL, V56, P812; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; DADE WB, 1990, GEOMICROBIOL J, V8, P1, DOI 10.1080/01490459009377874; Decho AW, 1999, BIOTECHNIQUES, V27, P1246; Decho AW, 2005, PALAEOGEOGR PALAEOCL, V219, P71, DOI 10.1016/j.palaeo.2004.10.015; DRAVIS JJ, 1983, SCIENCE, V219, P385, DOI 10.1126/science.219.4583.385; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; GRANT J, 1987, NATURE, V330, P244, DOI 10.1038/330244a0; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; LAWTON J, 1995, LINKING SPECIES ECOS; LOREAU M, 2004, BIODIVERSITY ECOSYST; PATERSON DM, 1989, LIMNOL OCEANOGR, V34, P223, DOI 10.4319/lo.1989.34.1.0223; PATERSON DM, 1995, J GEOL SOC LONDON, V152, P131, DOI 10.1144/gsjgs.152.1.0131; Paterson DM, 2000, MICROBIAL SEDIMENTS, P217; Pringault O, 2005, MICROB ECOL, V49, P604, DOI 10.1007/s00248-004-0102-y; Reid P, 2003, FOSSIL AND RECENT BIOFILMS, P103; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; Sergeev VN, 2002, MICROBIOLOGY+, V71, P623, DOI 10.1023/A:1021415503436; Stal L.J., 2000, ECOLOGY CYANOBACTERI, P61; STAL LJ, 1985, FEMS MICROBIOL ECOL, V31, P111, DOI 10.1111/j.1574-6968.1985.tb01138.x; Tolhurst TJ, 1999, ESTUAR COAST SHELF S, V49, P281, DOI 10.1006/ecss.1999.0512; Underwood GJC, 2003, ADV BOT RES, V40, P183, DOI 10.1016/S0065-2296(05)40005-1; VASCONCELOS C, 1995, NATURE, V377, P220, DOI 10.1038/377220a0; Visscher PT, 2000, GEOLOGY, V28, P919, DOI 10.1130/0091-7613(2000)028<0919:MOOSRC>2.3.CO;2; Visscher PT, 1998, AM MINERAL, V83, P1482, DOI 10.2138/am-1998-11-1236; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; VISSCHER PT, 2002, ENV ELECTROCHEMISTRY, P265; Wright DT, 2005, GEOMICROBIOL J, V22, P27, DOI 10.1080/01490450590922532; Zar JH., 1999, BIOSTAT ANAL	33	39	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3176	10.1371/journal.pone.0003176	http://dx.doi.org/10.1371/journal.pone.0003176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781202	Green Published, gold			2022-12-25	WOS:000264425700008
J	Vikman, J; Jimenez-Feltstrom, J; Nyman, P; Thelin, J; Eliasson, L				Vikman, Jenny; Jimenez-Feltstrom, Javier; Nyman, Per; Thelin, Johan; Eliasson, Lena			Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol	FASEB JOURNAL			English	Article						Ca2+; exocytosis; SNAP-25; methyl-beta-cyclodextrin	LIPID RAFTS; CA2+ CHANNELS; SNARE PROTEINS; ALPHA-CELLS; FUSION PORE; PC12 CELLS; EXOCYTOSIS; GRANULES; RELEASE; SNAP-25	Cholesterol-rich clusters of SNARE (soluble NSF attachment protein receptor) proteins have been implicated as being important for exocytosis. Here we demonstrate the significance of cholesterol for normal biphasic insulin secretion in mouse beta cells by removal of cholesterol from the plasma membrane using methyl-beta-cyclodextrin (MBCD). Maximal inhibition of insulin secretion in static incubations was achieved using 0.1 mM MBCD. In in situ pancreatic perfusion measurements, both first and second phase insulin secretions were reduced by similar to 50% (P<0.05). This was accompanied by a reduced number of docked large dense core vesicles (LDCVs) (similar to 40%; P<0.01) and a reduced exocytotic response (>50%; P<0.01). Further, subcellular fractionations demonstrated movement of the synaptosomal protein of 25 kDa (SNAP-25) from the plasma membrane to the cytosol after MBCD treatment. The inhibitory actions of MBCD were counteracted by subsequent addition of cholesterol. We hypothesize that desorption of cholesterol leads to the disturbance of a basic exocytotic mechanism partly due to migration of SNAP-25, and we conclude that insulin secretion is highly sensitive to changes in plasma membrane cholesterol.-Vikman, J., Jimenez-Feltstrom, J., Nyman, P., Thelin, J., Eliasson, L. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB J. 23, 58-67 (2009)	[Vikman, Jenny; Jimenez-Feltstrom, Javier; Nyman, Per; Thelin, Johan; Eliasson, Lena] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Unit Islet Cell Exocytosis,Clin Res Ctr, S-20502 Malmo, Sweden	Lund University	Vikman, J (corresponding author), Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Unit Islet Cell Exocytosis,Clin Res Ctr, CRC 91-11,UMAS Entrance 72, S-20502 Malmo, Sweden.	jenny.vikman@med.lu.se	Eliasson, Lena/E-9294-2012	Eliasson, Lena/0000-0002-6467-5029; Thelin, Johan/0000-0002-6101-4946; Vikman, Jenny/0000-0001-5082-8867	Swedish Research Council [13147]; EU-Biosim; European Foundation for the Study of Diabetes; Novo Nordisk Foundation; Albert Pahlssons Foundation; Svenska Sallskapet for Medicinsk Forskning; Swedish Diabetes Association; Diabetes Program at Lund University; Thurings Foundation; Royal Physiografic Society in Lund; Crafoord Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU-Biosim; European Foundation for the Study of Diabetes; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Albert Pahlssons Foundation; Svenska Sallskapet for Medicinsk Forskning; Swedish Diabetes Association; Diabetes Program at Lund University; Thurings Foundation; Royal Physiografic Society in Lund(Royal Society of London); Crafoord Foundation	We thank Kristina Borglid and Britt-Marie Nilsson for expert technical assistance and Dr. Dina Speidel for valuable discussion. This work was supported by the Swedish Research Council (13147), EU-Biosim, the European Foundation for the Study of Diabetes, the Novo Nordisk Foundation, the Albert Pahlssons Foundation, the Svenska Sallskapet for Medicinsk Forskning, the Swedish Diabetes Association, the Diabetes Program at Lund University, the Thurings Foundation, the Royal Physiografic Society in Lund, and the Crafoord Foundation. L.E. is employed by the Lund University Diabetes Centre.	AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; BONNEVIENIELSEN V, 1981, DIABETES, V30, P424, DOI 10.2337/diabetes.30.5.424; Braun M, 2007, J GEN PHYSIOL, V129, P221, DOI 10.1085/jgp.200609658; CERASI E, 1992, INSULIN MOL BIOL PAT; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Cho WJ, 2007, CELL BIOL INT, V31, P1301, DOI 10.1016/j.cellbi.2007.06.011; Churchward MA, 2005, J CELL SCI, V118, P4833, DOI 10.1242/jcs.02601; Dotta F, 1998, ENDOCRINOLOGY, V139, P316, DOI 10.1210/en.139.1.316; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gonelle-Gispert C, 2000, J CELL SCI, V113, P3197; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Haynes MP, 2000, BIOCHEMISTRY-US, V39, P4508, DOI 10.1021/bi992125q; HOSKER JP, 1989, METABOLISM, V38, P767, DOI 10.1016/0026-0495(89)90064-4; Ji JZ, 2002, DIABETES, V51, P1425, DOI 10.2337/diabetes.51.5.1425; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lang T, 2007, J PHYSIOL-LONDON, V585, P693, DOI 10.1113/jphysiol.2007.134346; MacDonald PE, 2006, CELL METAB, V4, P283, DOI 10.1016/j.cmet.2006.08.011; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Ohara-Imaizumi M, 2004, DIABETOLOGIA, V47, P2200, DOI 10.1007/s00125-004-1579-0; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P8403, DOI 10.1074/jbc.M308954200; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Takahashi N, 2004, J CELL BIOL, V165, P255, DOI 10.1083/jcb.200312033; Vikman J, 2003, BIOCHEM SOC T, V31, P842, DOI 10.1042/BST0310842; Vikman J, 2006, J MOL ENDOCRINOL, V36, P503, DOI 10.1677/jme.1.01978; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; Xia FZ, 2007, ENDOCRINOLOGY, V148, P2157, DOI 10.1210/en.2006-1296; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200	42	63	65	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					58	67		10.1096/fj.08-105734	http://dx.doi.org/10.1096/fj.08-105734			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18806218				2022-12-25	WOS:000262095500008
J	Janumyan, Y; Cui, QH; Yan, L; Sansam, CG; Valentin, M; Yang, E				Janumyan, Yelena; Cui, Qinghua; Yan, Ling; Sansam, Courtney G.; Valentin, Mayda; Yang, Elizabeth			G(0) Function of BCL2 and BCL-x(L) Requires BAX, BAK, and p27 Phosphorylation by Mirk, Revealing a Novel Role of BAX and BAK in Quiescence Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ENTRY; TRANSGENIC MICE; DEPENDENT KINASE; UBIQUITIN LIGASE; INHIBITOR P27; B-CELLS; P27(KIP1); PROGRESSION; SURVIVAL; DEATH	BCL2 and BCL-x(L) facilitate G(0) quiescence by decreasing RNA content and cell size and up-regulating p27 protein, but the precise mechanism is not understood. We investigated the relationship between cell cycle regulation and the anti-apoptosis function of BCL2 and BCL-x(L). Neither caspase inhibition nor abrogation of mitochondria-dependent apoptosis by BAX and BAK deletion fully recapitulated the G(0) effects of BCL2 or BCL-x(L), suggesting that mechanisms in addition to anti-apoptosis are involved in the cell cycle arrest function of BCL2 or BCL-x(L). We found that BCL2 and BCL-x(L) expression in bax(-/-) bak(-/-) cells did not confer cell cycle effects, consistent with the G(0) function of BCL2 and BCL-x(L) being mediated through BAX or BAK. Stabilization of p27 in G(0) in BCL2 or BCL-x(L) cells was due to phosphorylation of p27 at Ser(10) by the kinase Mirk. In bax(-/-) bak(-/-) cells, total p27 and p27 phosphorylated at Ser(10) were elevated. Re-expression of BAX in bax(-/-) bak(-/-) cells and silencing of BAX and BAK in wild type cells confirmed that endogenous BAX and BAK modulated p27. These data revealed a novel role for BAX and BAK in the regulation of G(0) quiescence.	[Yang, Elizabeth] Vanderbilt Univ, Med Ctr, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Yang, E (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Dept Pediat, 397 PRB, Nashville, TN 37232 USA.	elizabeth.yang@vanderbilt.edu		Janumyan, Yelena/0000-0001-9860-6366; Sansam, Courtney/0000-0002-0253-8643	National Institutes of Health [RO1CA78443]; NATIONAL CANCER INSTITUTE [R01CA078443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA78443. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Bartek J, 2001, NAT CELL BIOL, V3, pE95, DOI 10.1038/35070160; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cepero E, 2005, ONCOGENE, V24, P6354, DOI 10.1038/sj.onc.1208793; Cheng NL, 2004, ONCOGENE, V23, P3770, DOI 10.1038/sj.onc.1207478; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P401; de la Coste A, 1999, CANCER RES, V59, P5017; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Furth PA, 1999, ONCOGENE, V18, P6589, DOI 10.1038/sj.onc.1203073; Greider C, 2002, ONCOGENE, V21, P7765, DOI 10.1038/sj.onc.1205928; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Lim S, 2002, J BIOL CHEM, V277, P25040, DOI 10.1074/jbc.M203257200; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LINETTE GP, 1995, BLOOD, V86, P1255, DOI 10.1182/blood.V86.4.1255.bloodjournal8641255; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; MARVEL J, 1994, ONCOGENE, V9, P1117; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Murphy KL, 1999, ONCOGENE, V18, P6597, DOI 10.1038/sj.onc.1203099; Olson NE, 2003, J IMMUNOL, V170, P6065, DOI 10.4049/jimmunol.170.12.6065; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pierce RH, 2002, AM J PATHOL, V160, P1555, DOI 10.1016/S0002-9440(10)61101-7; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Vail ME, 2001, CANCER RES, V61, P594; Vairo G, 2000, MOL CELL BIOL, V20, P4745, DOI 10.1128/MCB.20.13.4745-4753.2000; Vairo G, 1996, ONCOGENE, V13, P1511; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976	45	46	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34108	34120		10.1074/jbc.M806294200	http://dx.doi.org/10.1074/jbc.M806294200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818203	Green Published, hybrid			2022-12-25	WOS:000261277700039
J	Shinomura, T; Nakamura, S; Ito, K; Shirasawa, S; Hook, M; Kimura, JH				Shinomura, Tamayuki; Nakamura, Sayaka; Ito, Kazuo; Shirasawa, Shin-ichi; Hook, Magnus; Kimura, James H.			Adsorption of Follicular Dendritic Cell-secreted Protein (FDC-SP) onto Mineral Deposits APPLICATION OF A NEW STABLE GENE EXPRESSION SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; SALIVARY STATHERIN; CHONDROGENESIS; HYDROXYAPATITE; LINE	Follicular dendritic cell-secreted protein (FDC-SP) is a small secretory protein having structural similarities to statherin, a protein in saliva thought to play a role in calcium retention in saliva. In contrast, FDC-SP is thought to play a role in the immune system associated with germinal centers. We report here the very specific expression of FDC-SP in junctional epithelium at the gingival crevice. This region is very important for the host defense against pathogens and for periodontal protection. To be able to better understand the function of FDC-SP, we developed a novel gene expression system that exploited gene trapping and site-specific gene integration to introduce the protein into a mammalian cell culture system. Using this system we were able to express FDC-SP as a fusion protein with green fluorescent protein in an osteogenic progenitor cell line with long term stability, which we then used to find that the fusion protein specifically adsorbs onto mineral deposits and the surface of hydroxyapatite particles exogenously added to the culture. This adsorption was highly dependent on the structural integrity of FDC-SP. These results suggest that FDC-SP may play an important role, adsorbing onto the surface of cementum and alveolar bone adjacent to periodontal ligament and onto tooth surface at the gingival crevice.	[Shinomura, Tamayuki; Nakamura, Sayaka; Shirasawa, Shin-ichi] Tokyo Med & Dent Univ, Dept Hard Tissue Engn, Tokyo 1138549, Japan; [Ito, Kazuo] Yamagata Univ, Sch Med, Dept Orthopaed Surg, Yamagata 9909585, Japan; [Hook, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Kimura, James H.] Univ Hawaii, John A Burns Sch Med, Dept Surg, Manoa, HI 96822 USA	Tokyo Medical & Dental University (TMDU); Yamagata University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Hawaii System; University of Hawaii Manoa	Shinomura, T (corresponding author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138549, Japan.	t.shinomura.trg@tmd.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [19659485]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 19659485 from the Ministry of Education, Science, Sports and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBank (TM)/EBI Data Bank with accession number( s) AB375112, AB375113, and AB375115.	Al-Alwan M, 2007, J IMMUNOL, V178, P7859, DOI 10.4049/jimmunol.178.12.7859; Amano A, 1996, INFECT IMMUN, V64, P4249, DOI 10.1128/IAI.64.10.4249-4254.1996; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009; Goobes G, 2006, P NATL ACAD SCI USA, V103, P16083, DOI 10.1073/pnas.0607193103; Isogai Z, 1996, CANCER RES, V56, P3902; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kawashima N, 2005, J BONE MINER METAB, V23, P123, DOI 10.1007/s00774-004-0550-y; King KB, 2003, J CELL BIOCHEM, V89, P992, DOI 10.1002/jcb.10571; Marshall AJ, 2002, J IMMUNOL, V169, P2381, DOI 10.4049/jimmunol.169.5.2381; Nakamura S, 2005, BIOCHEM BIOPH RES CO, V338, P1197, DOI 10.1016/j.bbrc.2005.10.076; Niemi LD, 2004, INFECT IMMUN, V72, P782, DOI 10.1128/IAI.72.2.782-787.2004; RAJ PA, 1992, J BIOL CHEM, V267, P5968; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Schroeder HE, 1997, PERIODONTOL 2000, V13, P91, DOI 10.1111/j.1600-0757.1997.tb00097.x; Shinomura T, 2006, BIOCHEM BIOPH RES CO, V341, P167, DOI 10.1016/j.bbrc.2005.12.169; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Shirasawa S, 2005, J BIOCHEM, V137, P79, DOI 10.1093/jb/mvi013; UMEZAWA A, 1992, J CELL PHYSIOL, V151, P197, DOI 10.1002/jcp.1041510125	20	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33658	33664		10.1074/jbc.M800719200	http://dx.doi.org/10.1074/jbc.M800719200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18806264	Green Published, hybrid			2022-12-25	WOS:000261183700072
J	Smith, AJ; Sanders, MA; Juhlmann, BE; Hertzel, AV; Bernlohr, DA				Smith, Anne J.; Sanders, Mark A.; Juhlmann, Brittany E.; Hertzel, Ann V.; Bernlohr, David A.			Mapping of the Hormone-sensitive Lipase Binding Site on the Adipocyte Fatty Acid-binding Protein (AFABP) IDENTIFICATION OF THE CHARGE QUARTET ON THE AFABP/aP2 HELIX-TURN-HELIX DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMAGEJ PLUG-IN; LIPID-BINDING; PERILIPIN; MICE; LIPOLYSIS; DROPLETS; PHOSPHORYLATION; MECHANISMS; FAMILY; ADRP	The hormone-sensitive lipase (HSL) and adipocyte fatty acid-binding protein (AFABP/aP2) form a physical complex that affects basal and hormone-stimulated adipocyte fatty acid efflux. Previous work has established that AFABP/aP2-HSL complex formation requires that HSL be in its activated, phosphorylated form and AFABP/aP2 have a bound fatty acid. To identify the HSL binding site of AFABP/aP2 a combination of alanine-scanning mutagenesis and fluorescence resonance energy transfer was used. Mutation of Asp(17), Asp(18), Lys(21), or Arg(30) (but not other amino acids in the helix-turn-helix region) to alanine inhibited interaction with HSL without affecting fatty acid binding. The cluster of residues on the helical domain of AFABP/aP2 form two ion pairs (Asp(17)-Arg(30) and Asp(18)-Lys(21)) and identifies the region we have termed the charge quartet as the HSL interaction site. To demonstrate direct association, the non-interacting AFABP/aP2-D18K mutant was rescued by complementary mutation of HSL(K196E). The charge quartet is conserved on other FABPs that interact with HSL such as the heart and epithelial FABPs but not on non-interacting proteins from the liver or intestine and may be a general protein interaction domain utilized by fatty acid-binding proteins in regulatory control of lipid metabolism.	[Smith, Anne J.; Juhlmann, Brittany E.; Hertzel, Ann V.; Bernlohr, David A.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sanders, Mark A.] Univ Minnesota Twin Cities, Imaging Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	Bernl001@umn.edu		Juhlmann, Brittany/0000-0002-9000-6179	National Institutes of Health [DK053189, P30 DK050456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053189, R01DK053189, P30DK050456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK053189 (to D. A. B.) and P30 DK050456 (to the Minnesota Obesity Center). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baar RA, 2005, AM J PHYSIOL-ENDOC M, V288, pE187, DOI 10.1152/ajpendo.00256.2004; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Helledie T, 2000, J LIPID RES, V41, P1740; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; LiCata VJ, 1998, PROTEINS, V33, P577, DOI 10.1002/(SICI)1097-0134(19981201)33:4<577::AID-PROT10>3.0.CO;2-2; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Shen WJ, 2001, J BIOL CHEM, V276, P49443, DOI 10.1074/jbc.M104095200; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; XU ZH, 1991, J BIOL CHEM, V266, P14367; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; YOUVAN DC, 1997, BIOTECHNOLOGY ALIA, V1, P1	28	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33536	33543		10.1074/jbc.M806732200	http://dx.doi.org/10.1074/jbc.M806732200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18820256	Green Published, hybrid			2022-12-25	WOS:000261183700058
J	Hoffmann, A; Funkner, A; Neumann, P; Juhnke, S; Walther, M; Schierhorn, A; Weininger, U; Balbach, J; Reuter, G; Stubbs, MT				Hoffmann, Anita; Funkner, Andreas; Neumann, Piotr; Juhnke, Susanne; Walther, Matthias; Schierhorn, Angelika; Weininger, Ulrich; Balbach, Jochen; Reuter, Gunter; Stubbs, Milton T.			Biophysical Characterization of Refolded Drosophila Spatzle, a Cystine Knot Protein, Reveals Distinct Properties of Three Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; TOLL RECEPTOR-LIGAND; PRO-PEPTIDE; DORSOVENTRAL AXIS; INNATE IMMUNITY; ACTIVATION; EMBRYO; COMPLEX; BINDING; NGF	The Drosophila Spatzle protein, involved in the embryonic development of the dorsal-ventral axis and in the adult immune response, is expressed as a proprotein and is activated by the serine proteinases Easter or Spatzle-processing enzyme. Proteolytic cleavage generates a 106-amino acid COOH-terminal fragment, C106, homologous to the mature form of nerve growth factor NGF, a cystine knot protein. Through alternative splicing, the Spatzle gene encodes for several isoforms that ( with one exception, the "propeptide isoform") share C106 but differ in the prosequence. Three isoforms have been expressed recombinantly in Escherichia coli strains. The propeptide isoform could be expressed in soluble form and is unstructured according to CD and NMR measurements. Dimeric full-length Spatzle isoforms have been refolded from insoluble inclusion bodies and are able to rescue Spatzle-deficient embryos. Although the two full-length isoforms exhibit similar far-UV CD spectra, large differences in tryptophan fluorescence quenching by the respective pro-parts are observed. Both full-length isoforms exhibited highly cooperative folding transitions. Proteolytic digestion using trypsin resulted in C106, whose unfolding exhibits lower thermodynamic stability and cooperativity compared with the full-length proteins. The structure of C106 reveals a T-shaped dimer with significant differences to NGF and a deep internal cavity. Substantial beta-sheet formation is observed between the two monomers, whereas a long loop containing the single tryptophan residue is disordered in the crystals. Our results suggest that the propeptides stabilize the tertiary structure of the "mature" Spatzle cystine knot.	[Hoffmann, Anita; Funkner, Andreas; Neumann, Piotr; Juhnke, Susanne; Stubbs, Milton T.] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Walther, Matthias; Reuter, Gunter] Univ Halle Wittenberg, Inst Genet, D-06120 Halle, Germany; [Weininger, Ulrich; Balbach, Jochen] Univ Halle Wittenberg, Inst Phys, D-06120 Halle, Germany; [Balbach, Jochen; Stubbs, Milton T.] Univ Halle Wittenberg, Mitteldeutsch Zentrum Struktur & Dynam Prot, D-06120 Halle, Germany; [Schierhorn, Angelika] Max Planck Forsch Sstelle Enzymol Prot Faltung, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Max Planck Society	Stubbs, MT (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	stubbs@biochemtech.uni-halle.de	Stubbs, Milton/ABC-7585-2020	Stubbs, Milton/0000-0003-1278-9013; Weininger, Ulrich/0000-0003-0841-8332	Deutsche Forschungsgemeinschaft [SFB610, GRK1026]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB610 "Protein-Zustande mit Zellbiologischer und Medizinischer Relevanz" and GRK1026 "Conformational Transitions in Macromolecular Interactions." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bax B, 1997, STRUCTURE, V5, P1275, DOI 10.1016/S0969-2126(97)00280-3; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W, 2002, PYMOL 0 99; DeLotto Y, 2001, MOL GEN GENET, V264, P643, DOI 10.1007/s004380000350; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Hillger F, 2005, J BIOL CHEM, V280, P14974, DOI 10.1074/jbc.M414413200; Hoffmann A, 2008, ACTA CRYSTALLOGR F, V64, P707, DOI 10.1107/S1744309108018812; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HOLLAND DR, 1994, J MOL BIOL, V239, P385, DOI 10.1006/jmbi.1994.1380; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kliemannel M, 2004, FEBS LETT, V566, P207, DOI 10.1016/j.febslet.2004.04.034; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Muller YA, 2002, J BIOL CHEM, V277, P43410, DOI 10.1074/jbc.M206438200; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; Rehm T, 2002, STRUCTURE, V10, P1613, DOI 10.1016/S0969-2126(02)00894-8; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955	49	32	34	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32598	32609		10.1074/jbc.M801815200	http://dx.doi.org/10.1074/jbc.M801815200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790733	hybrid			2022-12-25	WOS:000260893700049
J	Ono, K; Condron, MM; Ho, L; Wang, J; Zhao, W; Pasinetti, GM; Teplow, DB				Ono, Kenjiro; Condron, Margaret M.; Ho, Lap; Wang, Jun; Zhao, Wei; Pasinetti, Giulio M.; Teplow, David B.			Effects of Grape Seed-derived Polyphenols on Amyloid beta-Protein Self-assembly and Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILS IN-VITRO; ALZHEIMERS-DISEASE; CROSS-LINKING; SYNAPTIC PLASTICITY; WINE CONSUMPTION; APOLIPOPROTEIN-E; TRANSGENIC MICE; ALPHA-SYNUCLEIN; FRENCH PARADOX; MOUSE MODEL	Epidemiological evidence suggests that moderate consumption of red wine reduces the incidence of Alzheimer disease (AD). To study the protective effects of red wine, experiments recently were executed in the Tg2576 mouse model of AD. These studies showed that a commercially available grape seed polyphenolic extract, MegaNatural-AZ (MN), significantly attenuated AD-type cognitive deterioration and reduced cerebral amyloid deposition (Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., Chen, L., Humala, N., Teplow, D. B., and Pasinetti, G. M. (2008) J. Neurosci. 28, 6388-6392). To elucidate the mechanistic bases for these observations, here we used CD spectroscopy, photo-induced cross-linking of unmodified proteins, thioflavin T fluorescence, size exclusion chromatography, and electron microscopy to examine the effects of MN on the assembly of the two predominant disease-related amyloid beta-protein alloforms, A beta 40 and A beta 42. We also examined the effects of MN on A beta-induced cytotoxicity by assaying 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide metabolism and lactate dehydrogenase activity in A beta-treated, differentiated pheochromocytoma (PC12) cells. Initial studies revealed that MN blocked A beta fibril formation. Subsequent evaluation of the assembly stage specificity of the effect showed thatMNwas able to inhibit protofibril formation, pre-protofibrillar oligomerization, and initial coil -> alpha-helix/beta-sheet secondary structure transitions. Importantly, MN had protective effects in assays of cytotoxicity in which MN was mixed with A beta prior to peptide assembly or following assembly and just prior to peptide addition to cells. These data suggest that MN is worthy of consideration as a therapeutic agent for AD.	[Ho, Lap; Wang, Jun; Zhao, Wei; Pasinetti, Giulio M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Ono, Kenjiro] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol, Kanazawa, Ishikawa 9208640, Japan; [Ho, Lap; Wang, Jun; Zhao, Wei; Pasinetti, Giulio M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Ho, Lap; Pasinetti, Giulio M.] Bronx Vet Adm Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Kanazawa University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Dept Psychiat, 1468 Madison Ave,Rm 14-94C, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu; dteplow@ucla.edu		Zhao, Wei/0000-0002-3449-2395; Pasinetti, Giulio/0000-0002-1524-5196	National Institutes of Health [PO1 AT004511]; NCCAM; Department of Veterans Affairs Merit Review; James J. Peters Veterans Affairs Medical Center Geriatric Research Education Clinical Center Program, and Polyphenolics; Japan Human Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research; Alzheimer's Association; Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers at UCLA;  [AG027818]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); James J. Peters Veterans Affairs Medical Center Geriatric Research Education Clinical Center Program, and Polyphenolics; Japan Human Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research; Alzheimer's Association(Alzheimer's Association); Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers at UCLA; ; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AT004511 through the NCCAM (to L. H., G. M. P., and D. B. T.) and Grant AG027818(to (D. B. T.). This work also was supported by the Department of Veterans Affairs Merit Review grant and a grant from the James J. Peters Veterans Affairs Medical Center Geriatric Research Education Clinical Center Program, and Polyphenolics (to G. M. P.); grants from the Japan Human Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to K. O.); and grants from the Alzheimer's Association, and the Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers at UCLA (to D. B. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dorozynski A, 1997, BRIT MED J, V314, P997; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Ferrieres J, 2004, HEART, V90, P107, DOI 10.1136/heart.90.1.107; Flamini R, 2003, MASS SPECTROM REV, V22, P218, DOI 10.1002/mas.10052; Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hirohata M, 2007, BIOCHEMISTRY-US, V46, P1888, DOI 10.1021/bi061540x; HO L, 2008, J ALZHEIMER IN PRESS; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Le Bars PL, 2002, NEUROPSYCHOBIOLOGY, V45, P19, DOI 10.1159/000048668; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LETENNEUR L, 1993, ANN INTERN MED, V118, P317, DOI 10.7326/0003-4819-118-4-199302150-00028; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naiki H, 1996, LAB INVEST, V74, P374; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	53	153	173	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32176	32187		10.1074/jbc.M806154200	http://dx.doi.org/10.1074/jbc.M806154200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815129	Green Published, hybrid			2022-12-25	WOS:000260893700004
J	Wang, JZ; Sen, J; Rong, LJ; Caffrey, M				Wang, Jizhen; Sen, Jayita; Rong, Lijun; Caffrey, Michael			Role of the HIV gp120 Conserved Domain 1 in Processing and Viral Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; MUTATIONAL ANALYSIS; GP41; CLEAVAGE; ECTODOMAIN; FURIN; USAGE	The importance of the N-terminal region of HIV gp120 conserved domain 1 (gp120-C1) to envelope function has been examined by alanine-scanning mutagenesis and subsequent characterization of the mutagenic effects on viral entry; envelope expression, processing, and incorporation; and gp120 association with gp41. With respect to the wild-type gp120, mutational effects on viral entry fall into two classes: functional, as defined by > 20% entry with respect to wild type, and impaired, as defined by < 20% entry with respect to wild type. Based on Western blot analyses of cell lysates and virions, the entry impairment of W35A, V38A, Y39A, Y40A, G41A, V42A, and I52A is due primarily to disruption of envelope processing. The entry impairment of P43A and W45A is apparently due to a combination of effects on processing and incorporation into virions. In contrast, the entry impairment of V44A and F53A is primarily due to disruption of the gp120-gp41 interaction, which results in dissociation of gp120 from the virion. We present a model for gp120-C1 interactions with gp120-C5 and the gp41 disulfide loop in unprocessed gp160 and processed gp120/gp41.	[Wang, Jizhen; Sen, Jayita; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Rong, Lijun] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Caffrey, M (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	caffrey@uic.edu			National Institutes of Health [RO1 AI47674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI47674 ( to M. C.).	Bazan HA, 1998, J VIROL, V72, P4485, DOI 10.1128/JVI.72.5.4485-4491.1998; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BIRD C, 1990, J BIOL CHEM, V265, P19151; Bjorndal A, 1997, J VIROL, V71, P7478; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Douglas NW, 1997, J MOL BIOL, V273, P122, DOI 10.1006/jmbi.1997.1277; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Guilhaudis L, 2002, EUR J BIOCHEM, V269, P4860, DOI 10.1046/j.1432-1033.2002.03187.x; Hansen JE, 1996, PROTEINS, V25, P1, DOI 10.1002/(SICI)1097-0134(199605)25:1<1::AID-PROT1>3.0.CO;2-N; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; IVEYHOYLE M, 1991, J VIROL, V65, P2682, DOI 10.1128/JVI.65.5.2682-2685.1991; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Moulard M, 1999, VIRUS RES, V60, P55, DOI 10.1016/S0168-1702(99)00002-7; Otteken A, 1996, J VIROL, V70, P3407, DOI 10.1128/JVI.70.6.3407-3415.1996; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Sen J, 2007, PROTEIN SCI, V16, P1236, DOI 10.1110/ps.072771407; Wyatt R, 1997, J VIROL, V71, P9722, DOI 10.1128/JVI.71.12.9722-9731.1997	31	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32644	32649		10.1074/jbc.M806099200	http://dx.doi.org/10.1074/jbc.M806099200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815131	Green Published, hybrid			2022-12-25	WOS:000260893700054
J	Zhang, Q; Hong, M; Duan, P; Pan, Z; Ma, JJ; You, GF				Zhang, Qiang; Hong, Mei; Duan, Peng; Pan, Zui; Ma, Jianjie; You, Guofeng			Organic Anion Transporter OAT1 Undergoes Constitutive and Protein Kinase C-regulated Trafficking through a Dynamin- and Clathrin-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; EXPRESSION CLONING; ENDOCYTOSIS; PHOSPHORYLATION; IDENTIFICATION; INHIBITION; MEMBRANE; INTERNALIZATION; GLYCOSYLATION	Organic anion transporter 1 (OAT1) mediates the body disposition of a diverse array of environmental toxins and clinically important drugs. Therefore, understanding the regulation of this transporter has profound clinical significance. We previously demonstrate that OAT1 activity was down-regulated by activation of protein kinase C (PKC), kinetically revealed as a decrease in the maximum transport velocity V-max without significant change in the substrate affinity K-m of the transporter. In the current study, we showed that OAT1 constitutively internalized from and recycled back to the plasma membrane, and PKC activation accelerated OAT1 internalization without affecting OAT1 recycling. We further showed that treatment of OAT1expressing cells with concanavalin A, depletion of K+ from the cells, or transfection of dominant negative mutants of dynamin-2 or Eps15 into the cells, all of which block the clathrin-dependent endocytotic pathway, significantly blocked constitutive and PKC-regulated OAT1 internalization. We finally showed that OAT1 colocalized with transferrin, a marker for clathrin-dependent endocytosis, at the cell surface and in the EEA1-positive early endosomes. Together, our findings demonstrated for the first time that (i) OAT1 constitutively traffics between plasma membrane and recycling endosomes, (ii) PKC activation down-regulates OAT1 activity by altering already existent OAT1 trafficking, and (iii) OAT1 internalization occurs partly through a dynamin- and clathrin-dependent pathway.	[Zhang, Qiang; Hong, Mei; Duan, Peng; You, Guofeng] Rutgers State Univ, Dept Pharmaceut, Piscataway, NJ 08854 USA; [You, Guofeng] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Pan, Zui; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	You, GF (corresponding author), Rutgers State Univ, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	gyou@rci.rutgers.edu		Pan, Zui/0000-0003-4105-901X	National Institutes of Health [R01-DK 60034, R01-GM 079123]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK 60034 and R01-GM 079123 ( to G.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benmerah A, 1999, J CELL SCI, V112, P1303; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Cihlar T, 1999, MOL PHARMACOL, V56, P570, DOI 10.1124/mol.56.3.570; Cobb BR, 2002, AM J PHYSIOL-LUNG C, V282, pL12, DOI 10.1152/ajplung.2002.282.1.L12; Ekaratanawong S, 2004, J PHARMACOL SCI, V94, P297, DOI 10.1254/jphs.94.297; Gekle M, 1999, AM J PHYSIOL-RENAL, V277, pF251, DOI 10.1152/ajprenal.1999.277.2.F251; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Halpin PA, 1996, AM J PHYSIOL-REG I, V271, pR1372, DOI 10.1152/ajpregu.1996.271.5.R1372; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hong M, 2005, J BIOL CHEM, V280, P32285, DOI 10.1074/jbc.M501447200; HORI R, 1993, AM J PHYSIOL, V264, pF975, DOI 10.1152/ajprenal.1993.264.6.F975; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kazanietz MG, 2001, ARCH BIOCHEM BIOPHYS, V388, P74, DOI 10.1006/abbi.2000.2264; Klahr S, 1998, KIDNEY INT, V54, P286; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Klahr S, 2000, KIDNEY PHYSL PATHOPH, P2473; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; Li DL, 1998, AM J PHYSIOL-RENAL, V275, pF863, DOI 10.1152/ajprenal.1998.275.6.F863; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lu R, 1999, AM J PHYSIOL-RENAL, V276, pF295, DOI 10.1152/ajprenal.1999.276.2.F295; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Miller DS, 1998, AM J PHYSIOL-RENAL, V274, pF156, DOI 10.1152/ajprenal.1998.274.1.F156; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nagai K, 2006, ARCH BIOCHEM BIOPHYS, V452, P29, DOI 10.1016/j.abb.2006.06.006; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Rangel LBA, 2002, BBA-BIOMEMBRANES, V1564, P310, DOI 10.1016/S0005-2736(02)00472-8; Sekine T, 1998, FEBS LETT, V429, P179, DOI 10.1016/S0014-5793(98)00585-7; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Shin HJ, 2007, HEPATOLOGY, V45, P1046, DOI 10.1002/hep.21596; Shuprisha A, 2000, AM J PHYSIOL-RENAL, V278, pF104, DOI 10.1152/ajprenal.2000.278.1.F104; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; Takano M, 1996, AM J PHYSIOL-RENAL, V271, pF469, DOI 10.1152/ajprenal.1996.271.2.F469; Tanaka K, 2004, J BIOL CHEM, V279, P14961, DOI 10.1074/jbc.M400197200; Teter K, 1998, J BIOL CHEM, V273, P19625, DOI 10.1074/jbc.273.31.19625; Tremblay F, 2003, FRONT BIOSCI-LANDMRK, V8, pD1072, DOI 10.2741/1137; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Villar SR, 2005, KIDNEY INT, V68, P2704, DOI 10.1111/j.1523-1755.2005.00741.x; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wolff NA, 2003, J AM SOC NEPHROL, V14, P1959, DOI 10.1097/01.ASN.0000079040.55124.25; Wolff NA, 1997, FEBS LETT, V417, P287, DOI 10.1016/S0014-5793(97)01304-5; You GF, 2004, MED RES REV, V24, P762, DOI 10.1002/med.20014; You GF, 2004, CURR DRUG METAB, V5, P55, DOI 10.2174/1389200043489207; You GF, 2000, J BIOL CHEM, V275, P10278, DOI 10.1074/jbc.275.14.10278; You GF, 2002, MED RES REV, V22, P602, DOI 10.1002/med.10019; Youngblood GL, 2004, AM J PHYSIOL-RENAL, V287, pF236, DOI 10.1152/ajprenal.00012.2004; Zhang XH, 2002, AM J PHYSIOL-RENAL, V283, pF124, DOI 10.1152/ajprenal.00367.2001; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200; Zhou FF, 2007, AM J PHYSIOL-ENDOC M, V293, pE57, DOI 10.1152/ajpendo.00696.2006; Zhou FF, 2006, EUR J PHARM SCI, V27, P518, DOI 10.1016/j.ejps.2005.09.008; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	59	78	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32570	32579		10.1074/jbc.M800298200	http://dx.doi.org/10.1074/jbc.M800298200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818201	hybrid, Green Published			2022-12-25	WOS:000260893700046
J	Kosloff, M; Alexov, E; Arshavsky, VY; Honig, B				Kosloff, Mickey; Alexov, Emil; Arshavsky, Vadim Y.; Honig, Barry			Electrostatic and Lipid Anchor Contributions to the Interaction of Transducin with Membranes MECHANISTIC IMPLICATIONS FOR ACTIVATION AND TRANSLOCATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LIGHT-DRIVEN TRANSLOCATION; BETA-GAMMA; ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; FATTY ACYLATION; AMINO-TERMINUS; BASIC PEPTIDES; ACIDIC LIPIDS; ROD	The heterotrimeric G protein transducin is a key component of the vertebrate phototransduction cascade. Transducin is peripherally attached to membranes of the rod outer segment, where it interacts with other proteins at the membrane-cytosol interface. However, upon sustained activation by light, the dissociated G(t)alpha and G beta(1)gamma(1) subunits of transducin translocate from the outer segment to other parts of the rod cell. Here we used a computational approach to analyze the interaction strength of transducin and its subunits with acidic lipid bilayers, as well as the range of orientations that they are allowed to occupy on the membrane surface. Our results suggest that the combined constraints of electrostatics and lipid anchors substantially limit the rotational degrees of freedom of the membrane-bound transducin heterotrimer. This may contribute to a faster transducin activation rate by accelerating transducin-rhodopsin complex formation. Notably, the membrane interactions of the dissociated transducin subunits are very different from those of the heterotrimer. As shown previously, G beta(1)gamma(1) experiences significant attractive interactions with negatively charged membranes, whereas our new results suggest that G(t)alpha is electrostatically repelled by such membranes. We suggest that this repulsion could facilitate the membrane dissociation and intracellular translocation of G(t)alpha. Moreover, based on similarities in sequence and electrostatic properties, we propose that the properties described for transducin are common to its homologs within the G(i) subfamily. In a broader view, this work exemplifies how the activity-dependent association and dissociation of a G protein can change both the affinity for membranes and the range of allowed orientations, thereby modulating G protein function.	[Arshavsky, Vadim Y.] Duke Univ, Med Ctr, AERI, Durham, NC 27710 USA; [Kosloff, Mickey; Alexov, Emil; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Alexov, Emil; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Duke University; Columbia University; Columbia University; Howard Hughes Medical Institute	Arshavsky, VY (corresponding author), Duke Univ, Med Ctr, AERI, 2351 Erwin Rd,Box 3802, Durham, NC 27710 USA.	vadim.arshavsky@duke.edu; bh6@columbia.edu	Kosloff, Mickey/B-5962-2008	Kosloff, Mickey/0000-0003-1807-4000	National Institutes of Health [EY10336]; National Science Foundation [MCB-0416708]; Human Frontier Science Program; NATIONAL EYE INSTITUTE [R01EY010336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY10336 (to V.Y.A.). This work was also supported by National Science Foundation Grant MCB-0416708 (to B.H.) and a long term postdoctoral fellowship from the Human Frontier Science Program (to M.K.).	ANDERSON RE, 1970, BIOCHEMISTRY-US, V9, P3624, DOI 10.1021/bi00820a019; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; ARSHAVSKY VY, 1987, RETINAL PROTEINS, P497; Artemyev NO, 2008, MOL NEUROBIOL, V37, P44, DOI 10.1007/s12035-008-8015-2; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BenTal N, 1997, BIOPHYS J, V73, P1717, DOI 10.1016/S0006-3495(97)78203-1; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; BIGAY J, 1994, METHOD ENZYMOL, V237, P139; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; BOESZEBATTAGLIA K, 1994, EXP EYE RES, V58, P293, DOI 10.1006/exer.1994.1020; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; BORGGREVEN JM, 1970, BIOCHIM BIOPHYS ACTA, V202, P374, DOI 10.1016/0005-2760(70)90201-8; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Crouthamel M, 2008, CELL SIGNAL, V20, P1900, DOI 10.1016/j.cellsig.2008.06.019; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hessel E, 2003, J BIOL CHEM, V278, P22853, DOI 10.1074/jbc.M302747200; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HUBBELL WL, 1990, BIOPHYS J, V57, P99, DOI 10.1016/S0006-3495(90)82510-8; JOHNSON RS, 1994, J BIOL CHEM, V269, P21067; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Kerov V, 2007, J NEUROSCI, V27, P10270, DOI 10.1523/JNEUROSCI.2494-07.2007; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Kosloff M, 2002, BIOCHEMISTRY-US, V41, P14518, DOI 10.1021/bi026729x; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; MATSUDA T, 1994, J BIOL CHEM, V269, P30358; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; Murray D, 2001, J BIOL CHEM, V276, P45153, DOI 10.1074/jbc.M101784200; Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; Neubert TA, 1998, FEBS LETT, V422, P343, DOI 10.1016/S0014-5793(98)00037-4; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Pedone KH, 2007, J BIOL CHEM, V282, P25199, DOI 10.1074/jbc.M610297200; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; PEITZSCH RM, 1995, BIOPHYS J, V68, P729, DOI 10.1016/S0006-3495(95)80253-5; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Seitz HR, 1999, BIOCHEMISTRY-US, V38, P7950, DOI 10.1021/bi990298+; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; TSUI FC, 1990, BIOPHYS J, V57, P85, DOI 10.1016/S0006-3495(90)82509-1; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Wang JY, 2004, BIOPHYS J, V86, P1969, DOI 10.1016/S0006-3495(04)74260-5; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Zhang ZX, 2004, J BIOL CHEM, V279, P33937, DOI 10.1074/jbc.M403404200	83	30	30	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31197	31207		10.1074/jbc.M803799200	http://dx.doi.org/10.1074/jbc.M803799200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782760	Green Published, hybrid			2022-12-25	WOS:000260544800073
J	Barnes, P; Thomas, KL				Barnes, Philip; Thomas, Kerrie L.			Proteolysis of proBDNF Is a Key Regulator in the Formation of Memory	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RANDOMIZED CONTROLLED-TRIAL; NEUROTROPHIC FACTOR; FEAR MEMORY; BASOLATERAL AMYGDALA; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; AVERSIVE MEMORIES; RAT HIPPOCAMPUS; IN-VITRO	It is essential to understand the molecular processes underlying long-term memory to provide therapeutic targets of aberrant memory that produce pathological behaviour in humans. Under conditions of recall, fully-consolidated memories can undergo reconsolidation or extinction. These retrieval-mediated memory processes may rely on distinct molecular processes. The cellular mechanisms initiating the signature molecular events are not known. Using infusions of protein synthesis inhibitors, antisense oligonucleotide targeting brain-derived neurotrophic factor (BDNF) mRNA or tPA-STOP (an inhibitor of the proteolysis of BDNF protein) into the hippocampus of the awake rat, we show that acquisition and extinction of contextual fear memory depended on the increased and decreased proteolysis of proBDNF (precursor BDNF) in the hippocampus, respectively. Conditions of retrieval that are known to initiate the reconsolidation of contextual fear memory, a BDNF-independent memory process, were not correlated with altered proBDNF cleavage. Thus, the processing of BDNF was associated with the acquisition of new information and the updating of information about a salient stimulus. Furthermore, the differential requirement for the processing of proBDNF by tPA in distinct memory processes suggest that the molecular events actively engaged to support the storage and/or the successful retrieval of memory depends on the integration of ongoing experience with past learning.	[Barnes, Philip; Thomas, Kerrie L.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	Cardiff University	Barnes, P (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.	ThomasKL5@cf.ac.uk	Thomas, Kerrie L/A-6509-2010	Thomas, Kerrie L/0000-0003-3355-9583	The Royal Society; BBSRC [BB/C00583X]	The Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a research grant from The Royal Society. P.B. was supported by a BBSRC project grant (BB/C00583X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Berlau DJ, 2006, NEUROBIOL LEARN MEM, V86, P123, DOI 10.1016/j.nlm.2005.12.008; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bisson JI, 1997, BRIT J PSYCHIAT, V171, P78, DOI 10.1192/bjp.171.1.78; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; FALLS WA, 1992, J NEUROSCI, V12, P854; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Horwood JM, 2004, BEHAV BRAIN RES, V150, P127, DOI 10.1016/S0166-4328(03)00248-1; LaLumiere RT, 2005, LEARN MEMORY, V12, P296, DOI 10.1101/lm.93205; Lee H, 1998, J NEUROSCI, V18, P8444; Lee I, 2003, BEHAV NEUROSCI, V117, P1044, DOI 10.1037/0735-7044.117.5.1044; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; Lin CH, 2005, LEARN MEMORY, V12, P130, DOI 10.1101/lm.85304; Lin CH, 2003, J NEUROSCI, V23, P8310; Lin CH, 2003, J NEUROSCI, V23, P1574; Liot G, 2004, J CEREBR BLOOD F MET, V24, P1153, DOI 10.1097/01.WCB.0000134476.93809.75; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Mayou RA, 2000, BRIT J PSYCHIAT, V176, P589, DOI 10.1192/bjp.176.6.589; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; McCloskey M., 1989, PSYCHOL LEARNING MOT, V24, P109, DOI [10.1016/S0079-7421(08)60536-8, DOI 10.1016/S0079-7421(08)60536-8]; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Raymond CR, 2007, TRENDS NEUROSCI, V30, P167, DOI 10.1016/j.tins.2007.01.007; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Routtenberg A, 2005, TRENDS NEUROSCI, V28, P12, DOI 10.1016/j.tins.2004.11.006; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Ullal GR, 2007, NEUROCHEM INT, V50, P866, DOI 10.1016/j.neuint.2007.02.009; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	60	89	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3248	10.1371/journal.pone.0003248	http://dx.doi.org/10.1371/journal.pone.0003248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422MG	18813339	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000264431800002
J	Chatterjee, DK; Sitaraman, K; Baptista, C; Hartley, J; Hill, TM; Munroe, DJ				Chatterjee, Deb K.; Sitaraman, Kalavathy; Baptista, Cassio; Hartley, James; Hill, Thomas M.; Munroe, David J.			Protein Microarray On-Demand: A Novel Protein Microarray System	PLOS ONE			English	Article								We describe a novel, simple and low-cost protein microarray strategy wherein the microarrays are generated by printing expression ready plasmid DNAs onto slides that can be converted into protein arrays on-demand. The printed expression plasmids serve dual purposes as they not only direct the synthesis of the protein of interest; they also serve to capture the newly synthesized proteins through a high affinity DNA-protein interaction. To accomplish this we have exploited the high-affinity binding (similar to 3-7 x 10(-13) M) of E. coli Tus protein to Ter, a 20 bp DNA sequence involved in the regulation of E. coli DNA replication. In our system, each protein of interest is synthesized as a Tus fusion protein and each expression construct directing the protein synthesis contains embedded Ter DNA sequence. The embedded Ter sequence functions as a capture reagent for the newly synthesized Tus fusion protein. This "all DNA'' microarray can be converted to a protein microarray on-demand without need for any additional capture reagent..	[Chatterjee, Deb K.; Sitaraman, Kalavathy; Hartley, James] NCI, Prot Express Lab, SAIC Frederick Inc, Frederick, MD USA; [Baptista, Cassio] NCI, Lab Mol Technol, SAIC Frederick Inc, Frederick, MD USA; [Chatterjee, Deb K.; Sitaraman, Kalavathy; Baptista, Cassio; Hartley, James; Munroe, David J.] NCI, Advanced Technol Program, SAIC Frederick Inc, Frederick, MD USA; [Hill, Thomas M.] Univ North Dakota, Sch Med & Hlth Sci, Dept Microbiol & Immunol, Grand Forks, ND USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of North Dakota Grand Forks	Chatterjee, DK (corresponding author), NCI, Prot Express Lab, SAIC Frederick Inc, Frederick, MD USA.	chatterjee@mail.ncifcrf.gov			National Cancer Institute, National Institutes of Health [N01-CO-12400]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; BAPTISTA C, 2006, PROTEOMICS BIOL DISC, P189; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Dietrich HRC, 2004, ANAL CHEM, V76, P4112, DOI 10.1021/ac049737n; Ge H, 2000, Nucleic Acids Res, V28, pe3, DOI 10.1093/nar/28.2.e3; Henderson TA, 2001, MOL GENET GENOMICS, V265, P941; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; MacBeath G, 2000, SCIENCE, V289, P1760; Nord O, 2003, J BIOTECHNOL, V106, P1, DOI 10.1016/j.jbiotec.2003.09.002; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	13	22	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3265	10.1371/journal.pone.0003265	http://dx.doi.org/10.1371/journal.pone.0003265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813342	Green Published, gold, Green Submitted			2022-12-25	WOS:000264431800005
J	Richards, J; McNally, B; Fang, XF; Caligiuri, MA; Zheng, P; Liu, Y				Richards, John; McNally, Beth; Fang, Xianfeng; Caligiuri, Michael A.; Zheng, Pan; Liu, Yang			Tumor Growth Decreases NK and B Cells as well as Common Lymphoid Progenitor	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMATURE MYELOID CELLS; FLT3 LIGAND; INTRAEPITHELIAL LYMPHOCYTES; MICE LACKING; GENERATION; SURVIVAL; LEUKEMIA; INTERLEUKIN-15; IDENTIFICATION	Background: It is well established that chronic tumor growth results in functional inactivation of T cells and NK cells. It is less clear, however, whether lymphopoeisis is affected by tumor growth. Principal Findings: In our efforts of analyzing the impact of tumor growth on NK cell development, we observed a major reduction of NK cell numbers in mice bearing multiple lineages of tumor cells. The decrease in NK cell numbers was not due to increased apoptosis or decreased proliferation in the NK compartment. In addition, transgenic expression of IL-15 also failed to rescue the defective production of NK cells. Our systematic characterization of lymphopoeisis in tumor-bearing mice indicated that the number of the common lymphoid progenitor was significantly reduced in tumor-bearing mice. The number of B cells also decreased substantially in tumor bearing mice. Conclusions and Significance: Our data reveal a novel mechanism for tumor evasion of host immunity and suggest a new interpretation for the altered myeloid and lymphoid ratio in tumor bearing hosts.	[Richards, John; McNally, Beth] Ohio State Univ, Med Ctr, Div Canc Immunol, Dept Pathol, Columbus, OH 43210 USA; [Caligiuri, Michael A.] Ohio State Univ, Med Ctr, Comprehensive Canc Ctr, Dept Med, Div Hematol & Oncol, Columbus, OH USA; [McNally, Beth; Fang, Xianfeng; Zheng, Pan; Liu, Yang] Univ Michigan, Comprehensive Canc Ctr, Dept Surg Internal Med Pathol, Div Immunotherapy, Ann Arbor, MI USA; [Fang, Xianfeng] Chinese Acad Sci, Inst Biophys, Beijing, Peoples R China	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Institute of Biophysics, CAS	Richards, J (corresponding author), Ohio State Univ, Med Ctr, Div Canc Immunol, Dept Pathol, Columbus, OH 43210 USA.	panz@umich.edu; yangl@umich.edu	fang, xianfeng/E-6301-2012; Zheng, Pan/E-8691-2011	fang, xianfeng/0000-0003-0161-0209; Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	 [P01CA9542];  [R01 CA112001]; NATIONAL CANCER INSTITUTE [R01CA112001, T32CA009542, R01CA058033] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by P01CA9542 and R01 CA112001. The sponsors have no role in study design, collection, analysis, and interpretation of data, writing of the paper, and decision to submit it for publication.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bauernhofer T, 2003, EUR J IMMUNOL, V33, P119, DOI 10.1002/immu.200390014; Bronte V, 2001, J IMMUNOTHER, V24, P431, DOI 10.1097/00002371-200111000-00001; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; de Jonge WJ, 2002, J CLIN INVEST, V110, P1539, DOI [10.1172/JCI200216143, 10.1172/JCI0216143]; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Geldhof Anja B, 2003, Clin Dev Immunol, V10, P71, DOI 10.1080/10446670310001626580; HACKETT J, 1986, P NATL ACAD SCI USA, V83, P3427, DOI 10.1073/pnas.83.10.3427; HALLER O, 1977, J EXP MED, V145, P1411, DOI 10.1084/jem.145.5.1411; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; Kennedy P, 2000, LAT TRADE, V8, P15; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mellqvist UH, 2000, BLOOD, V96, P1961, DOI 10.1182/blood.V96.5.1961.h8001961_1961_1968; Minagawa M, 2002, J IMMUNOL, V169, P4153, DOI 10.4049/jimmunol.169.8.4153; Pierson BA, 1996, BLOOD, V88, P2279, DOI 10.1182/blood.V88.6.2279.bloodjournal8862279; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; RICHARDS J, 2006, BLOOD; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; SEAMAN WE, 1981, EXP HEMATOL, V9, P691; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Williams NS, 1999, J IMMUNOL, V163, P2648; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; Yu HX, 1998, BLOOD, V92, P3647, DOI 10.1182/blood.V92.10.3647.422k43_3647_3657; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	33	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3180	10.1371/journal.pone.0003180	http://dx.doi.org/10.1371/journal.pone.0003180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784839	Green Published, Green Submitted, gold			2022-12-25	WOS:000264425900002
J	Datta, S; Sarvetnick, NE				Datta, Shrimati; Sarvetnick, Nora E.			IL-21 Limits Peripheral Lymphocyte Numbers through T Cell Homeostatic Mechanisms	PLOS ONE			English	Article								Background: IL-21, a member of the common gamma-chain utilizing family of cytokines, participates in immune and inflammatory processes. In addition, the cytokine has been linked to autoimmunity in humans and rodents. Methodology/Principal Findings: To investigate the mechanism whereby IL-21 affects the immune system, we investigated its role in T cell homeostasis and autoimmunity in both non-autoimmune C57BL/6 and autoimmune NOD mice. Our data indicate that IL-21R knockout C57BL/6 and NOD mice show increased size of their lymphocyte population and decreased homeostatic proliferation. In addition, our experimental results demonstrate that IL-21 inhibits T cell survival. These data suggest that IL-21 acts to limit the size of the T cell pool. Furthermore, our data suggest IL-21 may contribute to the development of autoimmunity. Conclusions/Significance: Taken together, our results suggest that IL-21 plays a global role in regulating T cell homeostasis, promoting the continuous adaptation of the T cell lymphoid space.	[Datta, Shrimati; Sarvetnick, Nora E.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Datta, S (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	noras@scripps.edu			NIH [A1064325]; The Larry L. Hillblom Foundation [postdoctoral fellowship]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Larry L. Hillblom Foundation	The work was supported by NIH grant A1064325 (to NS). SD was supported by a postdoctoral fellowship from The Larry L. Hillblom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Alves NL, 2005, J IMMUNOL, V175, P755, DOI 10.4049/jimmunol.175.2.755; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Baccala R, 2005, TRENDS IMMUNOL, V26, P5, DOI 10.1016/j.it.2004.11.006; Barker BR, 2007, J IMMUNOL, V179, P3596, DOI 10.4049/jimmunol.179.6.3596; Berzins SP, 2003, DIABETES, V52, P327, DOI 10.2337/diabetes.52.2.327; Bour-Jordan H, 2007, J CLIN INVEST, V117, P3642, DOI 10.1172/JCI34236; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; Cantor J, 2005, J IMMUNOL, V175, P7738, DOI 10.4049/jimmunol.175.11.7738; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Davis ID, 2007, CLIN CANCER RES, V13, P6926, DOI 10.1158/1078-0432.CCR-07-1238; Falcone M, 1998, J IMMUNOL, V161, P1163; Ge Q, 2002, P NATL ACAD SCI USA, V99, P2989, DOI 10.1073/pnas.052714099; Georgescu L, 1997, J CLIN INVEST, V100, P2622, DOI 10.1172/JCI119806; GIORDANO C, 1995, DIABETOLOGIA, V38, P953, DOI 10.1007/BF00400585; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Goronzy JJ, 2001, TRENDS IMMUNOL, V22, P251, DOI 10.1016/S1471-4906(00)01841-X; Gurlo T, 1999, J IMMUNOL, V163, P5770; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Haskins K, 2005, ADV IMMUNOL, V87, P123, DOI 10.1016/S0065-2776(05)87004-X; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Li J, 2006, SCAND J IMMUNOL, V64, P515, DOI 10.1111/j.1365-3083.2006.01795.x; Li WQ, 2004, J BIOL CHEM, V279, P29160, DOI 10.1074/jbc.M401656200; Li YQ, 2005, J IMMUNOL, V175, P2261, DOI 10.4049/jimmunol.175.4.2261; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mehta DS, 2003, J IMMUNOL, V170, P4111, DOI 10.4049/jimmunol.170.8.4111; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Ostiguy V, 2007, J LEUKOCYTE BIOL, V82, P645, DOI 10.1189/jlb.0806494; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Peluso I, 2007, J IMMUNOL, V178, P732, DOI 10.4049/jimmunol.178.2.732; Qin JZ, 2001, BLOOD, V98, P2778, DOI 10.1182/blood.V98.9.2778; Rietz C, 2003, SCAND J IMMUNOL, V57, P342, DOI 10.1046/j.1365-3083.2003.01244.x; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; Schulze-Koops H, 2004, ARTHRITIS RES THER, V6, P178, DOI 10.1186/ar1208; Serreze DV, 2000, DIABETES, V49, P2007, DOI 10.2337/diabetes.49.12.2007; Smyth MJ, 2008, CANCER RES, V68, P3019, DOI 10.1158/0008-5472.CAN-07-6019; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Theofilopoulos AN, 2001, J CLIN INVEST, V108, P335, DOI 10.1172/JCI12173; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Vollmer TL, 2005, J IMMUNOL, V174, P2696, DOI 10.4049/jimmunol.174.5.2696; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Yadav D, 2004, J IMMUNOL, V173, P3631, DOI 10.4049/jimmunol.173.6.3631; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	63	45	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3118	10.1371/journal.pone.0003118	http://dx.doi.org/10.1371/journal.pone.0003118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773086	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420100001
J	Attur, MG; Palmer, GD; Al-Mussawir, HE; Dave, M; Teixeira, CC; Rifkin, DB; Appleton, CTG; Beier, F; Abramson, SB				Attur, Mukundan G.; Palmer, Glyn D.; Al-Mussawir, Hayf E.; Dave, Mandar; Teixeira, Cristina C.; Rifkin, Daniel B.; Appleton, C. Thomas G.; Beier, Frank; Abramson, Steven B.			F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activation	FASEB JOURNAL			English	Article						extracellular matrix; chondrocyte regulation; prostaglandin	GROWTH-FACTOR-BETA; CHONDROCYTE DIFFERENTIATION; ARTICULAR-CARTILAGE; GENE-EXPRESSION; THROMBOSPONDIN-1; DEGRADATION; MECHANISMS; RECEPTOR; CELLS; MODEL	In osteoarthritis (OA) articular chondrocytes undergo phenotypic changes culminating in the progressive loss of cartilage from the joint surface. The molecular mechanisms underlying these changes are poorly understood. Here we report enhanced (similar to 7-fold) expression of F-spondin, a neuronal extracellular matrix glycoprotein, in human OA cartilage (P<0.005). OA-specific up-regulation of F-spondin was also demonstrated in rat knee cartilage following surgical menisectomy. F-spondin treatment of OA cartilage explants caused a 2-fold increase in levels of the active form of TGF-beta 1 (P<0.01) and a 10-fold induction of PGE2 (P<0.005) in culture supernatants. PGE2 induction was found to be dependent on TGF-beta and the thrombospondin domain of the F-spondin molecule. F-spondin addition to cartilage explant cultures also caused a 4-fold increase in collagen degradation (P<0.05) and a modest reduction in proteoglycan synthesis (similar to 20%; P<0.05), which were both TGF-beta and PGE2 dependent. F-spondin treatment also led to increased secretion and activation of MMP-13 (P<0.05). Together these studies identify F-spondin as a novel protein in OA cartilage, where it may act in situ at lesional areas to activate latent TGF-beta and induce cartilage degradation via pathways that involve production of PGE2.-Attur, M. G., Palmer, G. D., Al-Mussawir, H. E., Dave, M., Teixeira, C. C., Rifkin, D. B., Appleton, C. T. G., Beier, F., Abramson, S. B. F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activation. FASEB J. 23, 79-89 (2009)	[Attur, Mukundan G.; Palmer, Glyn D.; Al-Mussawir, Hayf E.; Dave, Mandar; Abramson, Steven B.] NYU, Hosp Joint Dis, Div Rheumatol, Sch Med, New York, NY 10003 USA; [Teixeira, Cristina C.] NYU, Dept Basic Sci & Craniofacial Biol, Coll Dent, New York, NY 10003 USA; [Rifkin, Daniel B.] NYU, Dept Cell Biol, Sch Med, New York, NY 10003 USA; [Appleton, C. Thomas G.; Beier, Frank] Univ Western Ontario, CIHR Grp Skeletal Dev & Remodeling, Schulich Sch Med & Dent, London, ON, Canada	New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; New York University; New York University; Western University (University of Western Ontario)	Abramson, SB (corresponding author), NYU, Hosp Joint Dis, Div Rheumatol, Sch Med, 301 E 17th St, New York, NY 10003 USA.	stevenb.abramson@nyumc.org	Appleton, Tom/E-3145-2016; Beier, Frank/T-4734-2019; Beier, Frank/G-4595-2013; Attur, Mukundan/O-1578-2019	Appleton, Tom/0000-0001-7148-0767; Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537; Attur, Mukundan/0000-0001-7080-8118; Abramson, Steven/0000-0002-0668-6344	U.S. National Institutes of Health [CA034282]; William and Linda Steere Foundation; Joseph and Sophia Abeles Foundation; NATIONAL CANCER INSTITUTE [R01CA034282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054817, T32AR007176] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William and Linda Steere Foundation; Joseph and Sophia Abeles Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Jyoti Patel (Division of Rheumatology, Hospital for Joint Diseases, New York, NY, USA) for her help with harvesting cartilage. This work is supported in part by U.S. National Institutes of Health grant CA034282 (D.B.R.). The authors also thank the William and Linda Steere Foundation and the Joseph and Sophia Abeles Foundation for their generous support.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aigner T, 1999, ARTHRITIS RHEUM, V42, P1443, DOI 10.1002/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO;2-A; Aigner T, 2007, CURR DRUG TARGETS, V8, P377, DOI 10.2174/138945007779940052; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; AMIN AR, 1995, J EXP MED, V182, P2097, DOI 10.1084/jem.182.6.2097; Appleton CTG, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2120; Attur M. G., 2002, Current Issues in Molecular Biology, V4, P129; Attur MG, 2001, ARTHRITIS RHEUM-US, V44, P578, DOI 10.1002/1529-0131(200103)44:3<578::AID-ANR106>3.3.CO;2-Z; Attur M, 2006, ARTHRITIS RHEUM, V54, pS93; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Dabovic B, 2002, J CELL BIOL, V156, P227, DOI 10.1083/jcb.200111080; Davidson ENB, 2007, OSTEOARTHR CARTILAGE, V15, P597, DOI 10.1016/j.joca.2007.02.005; Debby-Brafman A, 1999, NEURON, V22, P475, DOI 10.1016/S0896-6273(00)80703-5; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; LAFEBER FPJG, 1993, BRIT J RHEUMATOL, V32, P281; LIPPIELLO L, 1977, J CLIN INVEST, V59, P593, DOI 10.1172/JCI108676; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeser RF, 2006, ARTHRITIS RHEUM-US, V54, P1357, DOI 10.1002/art.21813; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Martel-Pelletier Johanne, 1999, Frontiers in Bioscience, V4, pd694, DOI 10.2741/Martel; Mi Z, 2003, ARTHRITIS RES THER, V5, pR132, DOI 10.1186/ar745; Mix KS, 2007, J BIOL CHEM, V282, P9492, DOI 10.1074/jbc.M608327200; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Orito Keisuke, 2003, J Orthop Sci, V8, P294, DOI 10.1007/s10776-003-0647-6; PALMER GD, 2007, OSTEOARTHR CARTILAGE, V15, pC95; Quintavalla J, 2005, J CELL PHYSIOL, V204, P560, DOI 10.1002/jcp.20345; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Tardif G, 2001, J RHEUMATOL, V28, P1631; Tchetina EV, 2006, AM J PATHOL, V168, P131, DOI 10.2353/ajpath.2006.050369; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Tzarfati-Majar V, 2001, P NATL ACAD SCI USA, V98, P4722, DOI 10.1073/pnas.081062398; Uchino M, 2000, CLIN ORTHOP RELAT R, P119; van Beuningen HM, 2000, OSTEOARTHR CARTILAGE, V8, P25, DOI 10.1053/joca.1999.0267; Verdier MP, 2005, RHEUMATOL INT, V25, P118, DOI 10.1007/s00296-003-0409-x; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	40	43	46	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					79	89		10.1096/fj.08-114363	http://dx.doi.org/10.1096/fj.08-114363			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18780763	Green Published			2022-12-25	WOS:000262095500010
J	Canugovi, C; Samaranayake, M; Bhagwat, AS				Canugovi, Chandrika; Samaranayake, Mala; Bhagwat, Ashok S.			Transcriptional pausing and stalling causes multiple clustered mutations by human activation-induced deaminase	FASEB JOURNAL			English	Article						hypermutations; antibody maturation; cytosine deamination; uracils in DNA	INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; T7 RNA-POLYMERASE; CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; ESCHERICHIA-COLI; R-LOOPS; NONTRANSCRIBED STRAND; CYTOSINE DEAMINATION; ELONGATION COMPLEX	Transcription of the rearranged immunoglobulin gene and expression of the enzyme activation-induced deaminase (AID) are essential for somatic hypermutations of this gene during antibody maturation. While AID acts as a single-strand DNA-cytosine deaminase creating U . G mispairs that lead to mutations, the role played by transcription in this process is less clear. We have used in vitro transcription of the kan gene by the T7 RNA polymerase (RNAP) in the presence of AID and a genetic reversion assay for kanamycin-resistance to investigate the causes of multiple clustered mutations (MCMs) during somatic hypermutations. We find that, depending on transcription conditions, AID can cause single-base substitutions or MCMs. When wild-type RNAP is used for transcription at physiologically relevant concentrations of ribonucleoside triphosphates (NTPs), few MCMs are found. In contrast, slowing the rate of elongation by reducing the NTP concentration or using a mutant RNAP increases several-fold the percent of revertants containing MCMs. Arresting the elongation complexes by a quick removal of NTPs leads to formation of RNA-DNA hybrids (R-loops). Treatment of these structures with AID results in a high percentage of Kan(R) revertants with MCMs. Furthermore, selecting for transcription elongation complexes stalled near the codon that suffers mutations during acquisition of kanamycin-resistance results in an overwhelming majority of revertants with MCMs. These results show that if RNAP II pauses or stalls during transcription of immunoglobulin gene, AID is likely to promote MCMs. As changes in physiological conditions such as occurrence of certain DNA primary or secondary structures or DNA adducts are known to cause transcriptional pausing and stalling in mammalian cells, this process may cause MCMs during somatic hypermutation.-Canugovi, C., Samaranayake, M., Bhagwat, A. S. Transcriptional pausing and stalling causes multiple clustered mutations by human activation-induced deaminase. FASEB J. 23, 34-44 (2009)	[Canugovi, Chandrika; Samaranayake, Mala; Bhagwat, Ashok S.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Wayne State University	Bhagwat, AS (corresponding author), Wayne State Univ, Dept Chem, 443 Chem, Detroit, MI 48202 USA.	axb@chem.wayne.edu	Bhagwat, Ashok/ABA-3861-2020; Bhagwat, Ashok/AAU-4186-2021	Bhagwat, Ashok/0000-0003-1188-0579	U.S. National Institutes of Health [GM 57200, CA 97899]; NATIONAL CANCER INSTITUTE [R21CA097899, R33CA097899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057200] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the U.S. National Institutes of Health (GM 57200 and CA 97899).	Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; Beletskii A, 2000, J MOL BIOL, V300, P1057, DOI 10.1006/jmbi.2000.3944; Besmer E, 2006, MOL CELL BIOL, V26, P4378, DOI 10.1128/MCB.02375-05; Bhagwat AS, 2004, DNA REPAIR, V3, P85, DOI 10.1016/j.dnarep.2003.09.008; BONNER G, 1994, J BIOL CHEM, V269, P25120; BONNER G, 1992, EMBO J, V11, P3767, DOI 10.1002/j.1460-2075.1992.tb05462.x; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; GALLANT J, 1969, J BIOL CHEM, V244, P3125; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Guajardo R, 1998, J MOL BIOL, V281, P777, DOI 10.1006/jmbi.1998.1988; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; Huang FT, 2007, MOL CELL BIOL, V27, P5921, DOI 10.1128/MCB.00702-07; Klix N, 1998, EUR J IMMUNOL, V28, P317, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;317::AID-IMMU317&gt;3.0.CO;2-S; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Lutsenko E, 1999, J BIOL CHEM, V274, P31034, DOI 10.1074/jbc.274.43.31034; Martomo SA, 2005, J IMMUNOL, V174, P7787, DOI 10.4049/jimmunol.174.12.7787; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; Mizuta R, 2003, J BIOL CHEM, V278, P4431, DOI 10.1074/jbc.M209262200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Perlot T, 2008, P NATL ACAD SCI USA, V105, P3843, DOI 10.1073/pnas.0712291105; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2007, DNA REPAIR, V6, P689, DOI 10.1016/j.dnarep.2007.01.001; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; REABAN ME, 1994, J BIOL CHEM, V269, P21850; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Ronai D, 2007, J EXP MED, V204, P181, DOI 10.1084/jem.20062032; Samaranayake M, 2006, CHEM REV, V106, P700, DOI 10.1021/cr040496t; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shilatifard A, 2004, BBA-GENE STRUCT EXPR, V1677, P79, DOI 10.1016/j.bbaexp.2003.11.013; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Sohn YH, 2005, P NATL ACAD SCI USA, V102, P75, DOI 10.1073/pnas.0406581101; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689; Storb U, 1998, IMMUNOL REV, V162, P153; Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953; WYSZYNSKI M, 1994, P NATL ACAD SCI USA, V91, P1574, DOI 10.1073/pnas.91.4.1574; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Yu KF, 2005, MOL CELL BIOL, V25, P1730, DOI 10.1128/MCB.25.5.1730-1736.2005; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	54	34	35	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					34	44		10.1096/fj.08-115352	http://dx.doi.org/10.1096/fj.08-115352			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18772346	Green Published			2022-12-25	WOS:000262095500006
J	Schaeffer, EM; Marchionni, L; Huang, Z; Simons, B; Blackman, A; Yu, W; Parmigiani, G; Berman, DM				Schaeffer, E. M.; Marchionni, L.; Huang, Z.; Simons, B.; Blackman, A.; Yu, W.; Parmigiani, G.; Berman, D. M.			Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer	ONCOGENE			English	Article						prostate organogenesis; androgen signaling; prostate cancer; microarray	INTRAEPITHELIAL NEOPLASIA; GENE-EXPRESSION; MURINE PROSTATE; MOUSE PROSTATE; BETA-CATENIN; STEM-CELLS; RECEPTOR; ADENOCARCINOMA; TUMORIGENESIS; GENOME	Cancer cells differentiate along specific lineages that largely determine their clinical and biologic behavior. Distinct cancer phenotypes from different cells and organs likely result from unique gene expression repertoires established in the embryo and maintained after malignant transformation. We used comprehensive gene expression analysis to examine this concept in the prostate, an organ with a tractable developmental program and a high propensity for cancer. We focused on gene expression in the murine prostate rudiment at three time points during the first 48 h of exposure to androgen, which initiates proliferation and invasion of prostate epithelial buds into surrounding urogenital sinus mesenchyme. Here, we show that androgen exposure regulates genes previously implicated in prostate carcinogenesis comprising pathways for the phosphatase and tensin homolog (PTEN), fibroblast growth factor (FGF)/mitogen-activated protein kinase (MAPK), and Wnt signaling along with cellular programs regulating such 'hallmarks' of cancer as angiogenesis, apoptosis, migration and proliferation. We found statistically significant evidence for novel androgen-induced gene regulation events that establish and/or maintain prostate cell fate. These include modulation of gene expression through microRNAs, expression of specific transcription factors, and regulation of their predicted targets. By querying public gene expression databases from other tissues, we found that rather than generally characterizing androgen exposure or epithelial budding, the early prostate development program more closely resembles the program for human prostate cancer. Most importantly, early androgen-regulated genes and functional themes associated with prostate development were highly enriched in contrasts between increasingly lethal forms of prostate cancer, confirming a 'reactivation' of embryonic pathways for proliferation and invasion in prostate cancer progression. Among the genes with the most significant links to the development and cancer, we highlight coordinate induction of the transcription factor Sox9 and suppression of the proapoptotic phospholipid-binding protein Annexin A1 that link early prostate development to early prostate carcinogenesis. These results credential early prostate development as a reliable and valid model system for the investigation of genes and pathways that drive prostate cancer.	[Schaeffer, E. M.; Huang, Z.; Simons, B.; Parmigiani, G.; Berman, D. M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Schaeffer, E. M.; Huang, Z.; Berman, D. M.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21231 USA; [Schaeffer, E. M.; Marchionni, L.; Blackman, A.; Yu, W.; Parmigiani, G.; Berman, D. M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Parmigiani, G.] Johns Hopkins Univ, Sch Med, Dept Biostat, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Berman, DM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, CRB2 Room 545,1550 Orleans St, Baltimore, MD 21231 USA.	berman@jhmi.edu	Thomson, Axel/A-7893-2013; Simons, Brian W./G-7352-2015; Marchionni, Luigi/S-6774-2017	Simons, Brian W./0000-0003-0644-211X; Marchionni, Luigi/0000-0002-7336-8071; berman, david/0000-0001-5985-3698	Evensen Family; Evensen Family, Passano and Patrick C Walsh Prostate Cancer Foundations;  [NIH5K08DK059375];  [NIHK08 DK081019];  [NIH5P30CA06973-39];  [NSF034211]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081019, K08DK059375] Funding Source: NIH RePORTER	Evensen Family; Evensen Family, Passano and Patrick C Walsh Prostate Cancer Foundations; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W Matsui and N Watkins for comments on the manuscript, A DeMarzo and J Epstein for TMAs and YQ Chen for prostate regeneration data. These studies were funded by the Evensen Family, Passano and Patrick C Walsh Prostate Cancer Foundations, and NIH5K08DK059375 (DB) NIHK08 DK081019 (EMS), NIH5P30CA06973-39 (GP) and NSF034211 (GPand LM).	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Ashburner M, 2003, COLD SPRING HARB SYM, V68, P227, DOI 10.1101/sqb.2003.68.227; Bailey P, 1925, ARCH NEURO PSYCHIATR, V14, P192, DOI 10.1001/archneurpsyc.1925.02200140055002; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berman DM, 2004, DEV BIOL, V267, P387, DOI 10.1016/j.ydbio.2003.11.018; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1278, DOI 10.1152/ajpheart.00685.2006; Bostwick DG, 2004, MODERN PATHOL, V17, P360, DOI 10.1038/modpathol.3800053; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Donjacour AA, 2003, DEV BIOL, V261, P39, DOI 10.1016/S0012-1606(03)00250-1; Drews U, 2001, HISTOCHEM CELL BIOL, V116, P427, DOI 10.1007/s00418-001-0335-5; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ii M, 2006, EXP BIOL MED, V231, P20; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; JOST A, 1968, PERSPECT BIOL MED, V11, P371; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang JS, 2002, CLIN CANCER RES, V8, P117; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lu J, 2004, DEV BIOL, V273, P418, DOI 10.1016/j.ydbio.2004.05.035; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; McMenamin ME, 1999, CANCER RES, V59, P4291; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ornstein DK, 2006, UROL ONCOL-SEMIN ORI, V24, P231, DOI 10.1016/j.urolonc.2005.11.035; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shen MM, 2007, CANCER RES, V67, P6535, DOI 10.1158/0008-5472.CAN-07-1271; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomson AA, 2001, REPRODUCTION, V121, P187, DOI 10.1530/rep.0.1210187; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Treister NS, 2005, J DENT RES, V84, P160, DOI 10.1177/154405910508400210; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; WILSON JD, 1980, BIOL REPROD, V22, P9, DOI 10.1095/biolreprod22.1.9; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xu JF, 2005, CANCER EPIDEM BIOMAR, V14, P2563, DOI 10.1158/1055-9965.EPI-05-0356; Yeager N, 2008, CANCER RES, V68, P444, DOI 10.1158/0008-5472.CAN-07-3030; Zeng L, 2005, PROSTATE CANCER P D, V8, P7, DOI 10.1038/sj.pcan.4500757; Zhang TJ, 2006, GENE EXPR PATTERNS, V6, P310, DOI 10.1016/j.modgep.2005.07.005; Zwick E, 2002, TRENDS MOL MED, V8, P17, DOI 10.1016/S1471-4914(01)02217-1	63	128	137	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	57					7180	7191		10.1038/onc.2008.327	http://dx.doi.org/10.1038/onc.2008.327			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	379GG	18794802	Green Accepted			2022-12-25	WOS:000261384100005
J	McLean, KJ; Carroll, P; Lewis, DG; Dunford, AJ; Seward, HE; Neeli, R; Cheesman, MR; Marsollier, L; Douglas, P; Smith, WE; Rosenkrands, I; Cole, ST; Leys, D; Parish, T; Munro, AW				McLean, Kirsty J.; Carroll, Paul; Lewis, D. Geraint; Dunford, Adrian J.; Seward, Harriet E.; Neeli, Rajasekhar; Cheesman, Myles R.; Marsollier, Laurent; Douglas, Philip; Smith, W. Ewen; Rosenkrands, Ida; Cole, Stewart T.; Leys, David; Parish, Tanya; Munro, Andrew W.			Characterization of Active Site Structure in CYP121 A CYTOCHROME P450 ESSENTIAL FOR VIABILITY OF MYCOBACTERIUM TUBERCULOSIS H37Rv	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOPHYSICAL CHARACTERIZATION; CRYSTAL-STRUCTURE; AZOLE ANTIFUNGALS; ESSENTIAL GENES; HEME-PROTEINS; IN-VITRO; EXPRESSION; P450BM3; AGENTS; IDENTIFICATION	Mycobacterium tuberculosis (Mtb) cytochrome P450 gene CYP121 is shown to be essential for viability of the bacterium in vitro by gene knock-out with complementation. Production of CYP121 protein in Mtb cells is demonstrated. Minimum inhibitory concentration values for azole drugs against Mtb H37Rv were determined, the rank order of which correlated well with K-d values for their binding to CYP121. Solution-state spectroscopic, kinetic, and thermodynamic studies and crystal structure determination for a series of CYP121 active site mutants provide further insights into structure and biophysical features of the enzyme. Pro(346) was shown to control heme cofactor conformation, whereas Arg(386) is a critical determinant of heme potential, with an unprecedented 280-mV increase in heme iron redox potential in a R386L mutant. A homologous Mtb redox partner system was reconstituted and transported electrons faster to CYP121 R386L than to wild type CYP121. Hemepotential was not perturbed in a F338H mutant, suggesting that a proposed P450 superfamily-wide role for the phylogenetically conserved phenylalanine in heme thermodynamic regulation is unlikely. Collectively, data point to an important cellular role for CYP121 and highlight its potential as a novel Mtb drug target.	[McLean, Kirsty J.; Lewis, D. Geraint; Dunford, Adrian J.; Neeli, Rajasekhar; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Carroll, Paul; Parish, Tanya] Ctr Infect Dis, Inst Cell & Mol Sci, London E1 2AT, England; [Seward, Harriet E.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Cheesman, Myles R.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England; [Marsollier, Laurent] Inst Pasteur, Unite Genet Mol Bacterienne, Paris, France; [Douglas, Philip; Smith, W. Ewen] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland; [Rosenkrands, Ida] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark; [Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Stn 15, CH-1015 Lausanne, Switzerland	University of Manchester; University of London; Queen Mary University London; University of Leicester; University of East Anglia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Strathclyde; Statens Serum Institut; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	McLean, KJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	Kirsty.McLean@Manchester.ac.uk; Andrew.Munro@Manchester.ac.uk	Marsollier, Laurent/P-6178-2015; Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044; Laurent, Marsollier/0000-0001-5497-5995	United Kingdom Biotechnology and Biological Sciences Research Council [BBS/B/06288/2, C19757/2]; European Union [NM4TB]; Royal Society Leverhulme Trust Research Fellowship; Biotechnology and Biological Sciences Research Council [C19757/2, BBS/B/06288/2] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Royal Society Leverhulme Trust Research Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Grants BBS/B/06288/2 and C19757/2 and by European Union FP6 Project NM4TB. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a Royal Society Leverhulme Trust Research Fellowship. To whom correspondence may be addressed. Tel.: 44-161-3065151; Fax: 44-161-3068918; E-mail: Andrew. Munro@Manchester.ac.uk.	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Aoyama Y, 1998, J BIOCHEM-TOKYO, V124, P694; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Burguiere A, 2005, MICROBIOL-SGM, V151, P2087, DOI 10.1099/mic.0.27938-0; Byrne ST, 2007, J MED MICROBIOL, V56, P1047, DOI 10.1099/jmm.0.47058-0; Chen ZC, 2004, BIOCHEMISTRY-US, V43, P1798, DOI 10.1021/bi034920g; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Dunford AJ, 2007, J BIOL CHEM, V282, P24816, DOI 10.1074/jbc.M702958200; Dutton P L, 1978, Methods Enzymol, V54, P411; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer F, 2002, EUR J BIOCHEM, V269, P3005, DOI 10.1046/j.1432-1033.2002.02989.x; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gao Q, 2005, MICROBIOL-SGM, V151, P5, DOI 10.1099/mic.0.27539-0; Guardiola-Diaz HM, 2001, BIOCHEM PHARMACOL, V61, P1463, DOI 10.1016/S0006-2952(01)00571-8; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; HILDEBRANDT P, 1989, EUR J BIOCHEM, V186, P291, DOI 10.1111/j.1432-1033.1989.tb15208.x; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Jackson CJ, 2000, FEMS MICROBIOL LETT, V192, P159, DOI 10.1111/j.1574-6968.2000.tb09375.x; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Matsumoto M, 2007, CURR TOP MED CHEM, V7, P499, DOI 10.2174/156802607780059727; Matsuura K, 2005, J BIOL CHEM, V280, P9088, DOI 10.1074/jbc.M413042200; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2003, BIOCHEM J, V372, P317, DOI 10.1042/BJ20021692; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Parish T, 2000, J BACTERIOL, V182, P5715, DOI 10.1128/JB.182.20.5715-5720.2000; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Podust LM, 2004, STRUCTURE, V12, P1937, DOI 10.1016/j.str.2004.08.009; POULOS TL, 1987, BIOCHEMISTRY-US, V26, P8165, DOI 10.1021/bi00399a022; Rosenkrands I, 2008, TUBERCULOSIS, V88, P335, DOI 10.1016/j.tube.2007.12.001; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Smith SJ, 2003, BIOPOLYMERS, V70, P620, DOI 10.1002/bip.10502; Spigelman MK, 2007, J INFECT DIS, V196, pS28, DOI 10.1086/518663; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101	54	98	104	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33406	33416		10.1074/jbc.M802115200	http://dx.doi.org/10.1074/jbc.M802115200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18818197	hybrid, Green Published			2022-12-25	WOS:000261183700045
J	Basu, S; Pathak, SK; Chatterjee, G; Pathak, S; Basu, J; Kundu, M				Basu, Sanchita; Pathak, Sushil Kumar; Chatterjee, Gargi; Pathak, Shresh; Basu, Joyoti; Kundu, Manikuntala			Helicobacter pylori Protein HP0175 Transactivates Epidermal Growth Factor Receptor through TLR4 in Gastric Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; TYROSINE PHOSPHORYLATION; GASTROINTESTINAL-TRACT; SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; FACTOR EXPRESSION; CANCER-CELLS; LIPID RAFTS; PROLIFERATION; INFECTION	The pathophysiology of Helicobacter pylori-associated gastroduodenal diseases, ulcerogenesis, and carcinogenesis is intimately linked to activation of epidermal growth factor receptor (EGFR) and production of vascular endothelial growth factor (VEGF). Extracellular virulence factors, such as CagA and VacA, have been proposed to regulate EGFR activation and VEGF production in gastric epithelial cells. We demonstrate that the H. pylori secretory protein, HP0175, by virtue of its ability to bind TLR4, transactivates EGFR and stimulates EGFR-dependent VEGF production in the gastric cancer cell line AGS. Knock-out of the hp0175 gene attenuates the ability of the resultant H. pylori strain to activate EGFR or to induce VEGF production. HP0175-induced activation of EGFR is preceded by translocation of TLR4 into lipid rafts. In lipid rafts, the Src kinase family member Lyn interacts with TLR4, leading to tyrosine phosphorylation of TLR4. Knockdown of Lyn prevents HP0175-induced activation of EGFR and VEGF production. Tyrosine-phosphorylated TLR4 interacts with EGFR. This interaction is necessary for the activation of EGFR. Disruption of lipid rafts with methyl beta-cyclodextrin prevents HP0175-induced tyrosine phosphorylation of TLR4 and activation of EGFR. This mechanism of transactivation of EGFR is novel and distinct from that of metalloprotease-dependent shedding of EGF-like ligands, leading to autocrine activation of EGFR. It provides new insight into our understanding of the receptor cross-talk network.	[Basu, Sanchita; Pathak, Sushil Kumar; Chatterjee, Gargi; Pathak, Shresh; Basu, Joyoti; Kundu, Manikuntala] Bose Inst, Dept Chem, Kolkata 700009, W Bengal, India	Department of Science & Technology (India); Bose Institute	Kundu, M (corresponding author), Bose Inst, Dept Chem, 93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, W Bengal, India.	manikuntala@vsnl.net	PATHAK, SHRESH/I-6938-2012; Bhattacharyya, Asima/J-7423-2012	Bhattacharyya, Asima/0000-0001-7292-6644; PATHAK, SHRESH/0000-0001-5275-1816	Department of Atomic Energy, Government of India; Indian Council of Medical Research	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported in part by grants from the Department of Atomic Energy, Government of India, and the Indian Council of Medical Research (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Basak C, 2005, J IMMUNOL, V174, P5672, DOI 10.4049/jimmunol.174.9.5672; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Bhattacharyya A, 2002, BIOCHEM J, V368, P121, DOI 10.1042/BJ20020555; BLASER MJ, 1995, CANCER RES, V55, P2111; BROWN LF, 1993, CANCER RES, V53, P4727; Caputo R, 2003, CLIN CANCER RES, V9, P2015; Caruso R, 2006, AM J PATHOL, V169, P268, DOI 10.2353/ajpath.2006.050841; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; de Bono JS, 2002, TRENDS MOL MED, V8, pS19, DOI 10.1016/S1471-4914(02)02306-7; Eriksson U, 1999, CURR TOP MICROBIOL, V237, P41; Evdonin AL, 2006, FEBS LETT, V580, P6674, DOI 10.1016/j.febslet.2006.11.024; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121, DOI 10.1091/mbc.4.1.121; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Johns TG, 2003, P NATL ACAD SCI USA, V100, P15871, DOI 10.1073/pnas.2036503100; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Keates S, 2007, J INFECT DIS, V196, P95, DOI 10.1086/518440; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Maity A, 2000, CANCER RES, V60, P5879; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Romano M, 2006, NAT CLIN PRACT GASTR, V3, P622, DOI 10.1038/ncpgasthep0634; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slichenmyer WJ, 2001, SEMIN ONCOL, V28, P67, DOI 10.1053/sonc.2001.28557; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Strowski MZ, 2004, FASEB J, V18, P218, DOI 10.1096/fj.03-0055fje; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Yoshimura T, 2002, J INFECT DIS, V185, P332, DOI 10.1086/338191; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	45	42	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32369	32376		10.1074/jbc.M805053200	http://dx.doi.org/10.1074/jbc.M805053200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806258	hybrid			2022-12-25	WOS:000260893700024
J	Legan, SK; Rebrin, I; Mockett, RJ; Radyuk, SN; Klichko, VI; Sohal, RS; Orr, WC				Legan, Susan K.; Rebrin, Igor; Mockett, Robin J.; Radyuk, Svetlana N.; Klichko, Vladimir I.; Sohal, Rajindar S.; Orr, William C.			Overexpression of Glucose-6-phosphate Dehydrogenase Extends the Life Span of Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE REDOX STATE; SUPEROXIDE-DISMUTASE; TRANSGENIC DROSOPHILA; MECHANISMS; EXPRESSION; EXTENSION; REDUCTASE; CATALASE; OXIDANT; STRESS	The redox state of tissues tends to become progressively more prooxidizing during the aging process. The hypothesis tested in this study was that enhancement of reductive capacity by overexpression of glucose-6-phosphate dehydrogenase (G6PD), a key enzyme for NADPH biosynthesis, could protect against oxidative stress and extend the life span of transgenic Drosophila melanogaster. Overexpression of G6PD was achieved by combining a UAS-G6PD responder transgene at one of four independent loci with either a broad expression (armadillo-GAL4, Tubulin-GAL4, C23-GAL4, and da-GAL4) or a neuronal driver (D42-GAL4 and Appl-GAL4). The mean life spans of G6PD overexpressor flies were extended, in comparison with driver and responder controls, as follows: armadillo-GAL4 (up to 38%), Tubulin-GAL4 (up to 29%), C23-GAL4 (up to 27%), da-GAL4 (up to 24%), D42-GAL4 (up to 18%), and Appl-GAL4 (up to 16%). The G6PD enzymatic activity was increased, as were the levels of NADPH, NADH, and the GSH/GSSG ratio. Resistance to experimental oxidative stress was enhanced. Furthermore, metabolic rates and fertility were essentially the same in G6PD overexpressors and control flies. Collectively, the results demonstrate that enhancement of the NADPH biosynthetic capability can extend the life span of a relatively long-lived strain of flies, which supports the oxidative stress hypothesis of aging.	[Legan, Susan K.; Radyuk, Svetlana N.; Klichko, Vladimir I.; Orr, William C.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Rebrin, Igor; Mockett, Robin J.; Sohal, Rajindar S.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	Southern Methodist University; University of Southern California	Orr, WC (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	borr@smu.edu		Radyuk, Svetlana/0000-0002-3467-5255	National Institutes of Health, NIA [RO1 AG15122]; NATIONAL INSTITUTE ON AGING [R01AG015122] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grant RO1 AG15122. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bayne ACV, 2005, BIOCHEM J, V391, P277, DOI 10.1042/BJ20041872; Beutler E, 1971, RED CELL METABOLISM, P62; CLARK AG, 1988, GENETICS, V119, P565; Corcoran CM, 1996, GENE, V173, P241, DOI 10.1016/0378-1119(96)00094-7; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; LUZZATTO L, 1967, BIOCHIM BIOPHYS ACTA, V146, P18, DOI 10.1016/0005-2744(67)90069-1; Mockett RJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P260, DOI 10.1006/abbi.1999.1460; Mockett RJ, 2002, METHOD ENZYMOL, V349, P213, DOI 10.1016/S0076-6879(02)49336-6; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Rebrin I, 2004, BIOCHEM J, V382, P131, DOI 10.1042/BJ20040506; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STANTON RC, 1991, J BIOL CHEM, V266, P12442; Sun JT, 1999, MOL CELL BIOL, V19, P216; Tatar M, 1999, AM NAT, V154, pS67, DOI 10.1086/303284; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005	28	86	90	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32492	32499		10.1074/jbc.M805832200	http://dx.doi.org/10.1074/jbc.M805832200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809674	Green Published, hybrid			2022-12-25	WOS:000260893700037
J	Tsang, E; Giannetti, AM; Shaw, D; Dinh, M; Tse, JKY; Gandhi, S; Ho, HD; Wang, S; Papp, E; Bradshaw, JM				Tsang, Emily; Giannetti, Anthony M.; Shaw, David; Dinh, Marie; Tse, Joyce K. Y.; Gandhi, Shaan; Ho, Hoangdung; Wang, Sandra; Papp, Eva; Bradshaw, J. Michael			Molecular Mechanism of the Syk Activation Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; PROTEIN-TYROSINE KINASE; PHOSPHOTYROSINE-BINDING DOMAIN; PHOSPHORYLATED ITAM PEPTIDE; STEADY-STATE KINETICS; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; LOOP TYROSINES; ZAP-70; INHIBITION	Many immune signaling pathways require activation of the Syk tyrosine kinase to link ligation of surface receptors to changes in gene expression. Despite the central role of Syk in these pathways, the Syk activation process remains poorly understood. In this work we quantitatively characterized the molecular mechanism of Syk activation in vitro using a real time fluorescence kinase assay, mutagenesis, and other biochemical techniques. We found that dephosphorylated full-length Syk demonstrates a low initial rate of substrate phosphorylation that increases during the kinase reaction due to autophosphorylation. The initial rate of Syk activity was strongly increased by either pre-autophosphorylation or binding of phosphorylated immune tyrosine activation motif peptides, and each of these factors independently fully activated Syk. Deletion mutagenesis was used to identify regions of Syk important for regulation, and residues 340-356 of the SH2 kinase linker region were identified to be important for suppression of activity before activation. Comparison of the activation processes of Syk and Zap-70 revealed that Syk is more readily activated by autophosphorylation than Zap-70, although both kinases are rapidly activated by Src family kinases. We also studied Syk activity in B cell lysates and found endogenous Syk is also activated by phosphorylation and immune tyrosine activation motif binding. Together these experiments show that Syk functions as an "OR-gate" type of molecular switch. This mechanism of switch-like activation helps explain how Syk is both rapidly activated after receptor binding but also sustains activity over time to facilitate longer term changes in gene expression.	[Tsang, Emily; Dinh, Marie; Tse, Joyce K. Y.; Gandhi, Shaan; Papp, Eva; Bradshaw, J. Michael] Roche Palo Alto LLC, Dept Inflammat Discovery, Palo Alto, CA 94304 USA; [Giannetti, Anthony M.] Roche Palo Alto LLC, Dept Biophys & Crystallog, Palo Alto, CA 94304 USA; [Shaw, David; Ho, Hoangdung; Wang, Sandra] Roche Palo Alto LLC, Dept Mol & Prot Sci, Palo Alto, CA 94304 USA	Roche Holding; Roche Holding; Roche Holding	Bradshaw, JM (corresponding author), 3431 Hillview Ave,Mailstop R2-101, Palo Alto, CA 94304 USA.	Michael.bradshaw@roche.com		Gandhi, Shaan-Chirag/0000-0001-6272-5531				Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Arias-Palomo E, 2007, BBA-PROTEINS PROTEOM, V1774, P1493, DOI 10.1016/j.bbapap.2007.10.008; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Bajpai M, 2008, EXPERT OPIN INV DRUG, V17, P641, DOI [10.1517/13543784.17.5.641, 10.1517/13543784.17.5.641 ]; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dinh M, 2007, J BIOL CHEM, V282, P8768, DOI 10.1074/jbc.M609920200; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Flaswinkel H, 1995, Semin Immunol, V7, P21, DOI 10.1016/1044-5323(95)90004-7; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Grucza RA, 1999, BIOCHEMISTRY-US, V38, P5024, DOI 10.1021/bi9829938; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kappes DJ, 2007, IMMUNITY, V27, P691, DOI 10.1016/j.immuni.2007.11.002; Kimura T, 1996, MOL CELL BIOL, V16, P1471; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kumaran S, 2003, P NATL ACAD SCI USA, V100, P14828, DOI 10.1073/pnas.2432867100; LI M, 2008, ANAL BIOCH IN PRESS; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; MALMQVIST M, 1993, NATURE, V361, P186, DOI 10.1038/361186a0; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Oh H, 2007, J BIOL CHEM, V282, P33760, DOI 10.1074/jbc.M704846200; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; Prehoda KE, 2002, CURR OPIN CELL BIOL, V14, P149, DOI 10.1016/S0955-0674(02)00307-1; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Shults MD, 2005, NAT METHODS, V2, P277, DOI 10.1038/NMETH747; Shults MD, 2006, ANAL BIOCHEM, V352, P198, DOI 10.1016/j.ab.2006.03.003; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Ulanova M, 2005, EXPERT OPIN THER TAR, V9, P901, DOI 10.1517/14728222.9.5.901; Visco C, 2000, BIOCHEMISTRY-US, V39, P2784, DOI 10.1021/bi991840x; Wong BR, 2004, EXPERT OPIN INV DRUG, V13, P743, DOI 10.1517/13543784.13.7.743; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 1998, J IMMUNOL, V161, P4366	43	103	106	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32650	32659		10.1074/jbc.M806340200	http://dx.doi.org/10.1074/jbc.M806340200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818202	hybrid			2022-12-25	WOS:000260893700055
J	Cyr, JL; Heinen, CD				Cyr, Jennifer L.; Heinen, Christopher D.			Hereditary Cancer-associated Missense Mutations in hMSH6 Uncouple ATP Hydrolysis from DNA Mismatch Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MSH6 GERMLINE MUTATIONS; REPAIR GENES; RECOGNITION COMPLEX; FUNCTIONAL-ANALYSIS; MOLECULAR SWITCH; LYNCH-SYNDROME; HNPCC; MALIGNANCIES; INSTABILITY	Hereditary nonpolyposis colorectal cancer is caused by germline mutations in DNA mismatch repair genes. The majority of cases are associated with mutations in hMSH2 or hMLH1; however, about 12% of cases are associated with alterations in hMSH6. The hMSH6 protein forms a heterodimer with hMSH2 that is capable of recognizing a DNA mismatch. The heterodimer then utilizes its adenosine nucleotide processing ability in an, as of yet, unclear mechanism to facilitate communication between the mismatch and a distant strand discrimination site. The majority of reported mutations in hMSH6 are deletions or truncations that entirely eliminate the function of the protein; however, nearly a third of the reported variations are missense mutations whose functional significance is unclear. We analyzed seven cancer-associated single amino acid alterations in hMSH6 distributed throughout the functional domains of the protein to determine their effect on the biochemical activity of the hMSH2-hMSH6 heterodimer. Five alterations affect mismatch-stimulated ATP hydrolysis activity providing functional evidence that missense variants of hMSH6 can disrupt mismatch repair function and may contribute to disease. Of the five mutants that affect mismatch-stimulated ATP hydrolysis, only two (R976H and H1248D) affect mismatch recognition. Thus, three of the mutants (G566R, V878A, and D803G) appear to uncouple the mismatch binding and ATP-hydrolysis activities of the heterodimer. We also demonstrate that these three mutations alter ATP-dependent conformation changes of hMSH2-hMSH6, suggesting that cancer-associated mutations in hMSH6 can disrupt the intramolecular signaling that coordinates mismatch binding with adenosine nucleotide processing.	[Cyr, Jennifer L.; Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA	University of Connecticut	Heinen, CD (corresponding author), Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, 263 Farmington Ave,ML3101, Farmington, CT 06030 USA.	cheinen@uchc.edu			National Institutes of Health [CA115783]; Wendy Will Case Cancer Foundation; American Cancer Society [RSG-07-145-01-CCG]; NATIONAL CANCER INSTITUTE [R01CA115783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wendy Will Case Cancer Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115783 (NCI). This work was also supported by the Wendy Will Case Cancer Foundation, Grant RSG-07-145-01-CCG from the American Cancer Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Bandipalliam P, 2005, FAM CANCER, V4, P323, DOI 10.1007/s10689-005-8351-6; Berends MJW, 2002, AM J HUM GENET, V70, P26, DOI 10.1086/337944; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Drotschmann K, 1999, CURR BIOL, V9, P907, DOI 10.1016/S0960-9822(99)80396-0; Duval A, 2002, CANCER RES, V62, P2447; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Guerrette S, 1998, MOL CELL BIOL, V18, P6616, DOI 10.1128/MCB.18.11.6616; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Heinen CD, 2002, CANCER CELL, V1, P469, DOI 10.1016/S1535-6108(02)00073-9; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kariola R, 2002, HUM MOL GENET, V11, P1303, DOI 10.1093/hmg/11.11.1303; Kolodner RD, 1999, CANCER RES, V59, P5068; Laguri C, 2008, BIOCHEMISTRY-US, V47, P6199, DOI 10.1021/bi7024639; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lynch HT, 1997, CANCER GENET CYTOGEN, V93, P84, DOI 10.1016/S0165-4608(96)00290-7; Martik D, 2004, J BIOL CHEM, V279, P28402, DOI 10.1074/jbc.M312108200; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ou J, 2007, HUM MUTAT, V28, P1047, DOI 10.1002/humu.20580; Plaschke J, 2002, INT J CANCER, V97, P643, DOI 10.1002/ijc.10097; Poley JW, 2007, CANCER-AM CANCER SOC, V109, P2349, DOI 10.1002/cncr.22697; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Woods MO, 2007, HUM MUTAT, V28, P669, DOI 10.1002/humu.20502; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	39	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31641	31648		10.1074/jbc.M806018200	http://dx.doi.org/10.1074/jbc.M806018200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18790734	hybrid, Green Published			2022-12-25	WOS:000260760800045
J	Haaning, S; Radutoiu, S; Hoffmann, SV; Dittmer, J; Giehm, L; Otzen, DE; Stougaard, J				Haaning, Svend; Radutoiu, Simona; Hoffmann, Soren V.; Dittmer, Jens; Giehm, Lise; Otzen, Daniel E.; Stougaard, Jens			An Unusual Intrinsically Disordered Protein from the Model Legume Lotus japonicus Stabilizes Proteins in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; NATIVELY UNFOLDED PROTEINS; SECONDARY STRUCTURE; STRUCTURAL DISORDER; REACTIVE OXYGEN; TERMINAL DOMAIN; CHAPERONE; EXPRESSION; STRESS; GENE	Intrinsic structural disorder is a prevalent feature of proteins with chaperone activity. Using a complementary set of techniques, we have structurally characterized LjIDP1 (intrinsically disordered protein 1) from the model legume Lotus japonicus, and our results provide the first structural characterization of a member of the Lea5 protein family (PF03242). Contrary to in silico predictions, we show that LjIDP1 is intrinsically disordered and probably exists as an ensemble of conformations with limited residual beta-sheet, turn/loop, and polyproline II secondary structure. Furthermore, we show that LjIDP1 has an inherent propensity to undergo a large conformational shift, adopting a largely alpha-helical structure when it is dehydrated and in the presence of different detergents and alcohols. This is consistent with an overrepresentation of order-promoting residues in LjIDP1 compared with the average of intrinsically disordered proteins. In line with functioning as a chaperone, we show that LjIDP1 effectively prevents inactivation of two model enzymes under conditions that promote protein misfolding and aggregation. The LjIdp1 gene is expressed in all L. japonicus tissues tested. A higher expression level was found in the root tip proximal zone, in roots inoculated with compatible endosymbiotic M. loti, and in functional nitrogen-fixing root nodules. We suggest that the ability of LjIDP1 to prevent protein misfolding and aggregation may play a significant role in tissues, such as symbiotic root nodules, which are characterized by high metabolic activity.	[Haaning, Svend; Radutoiu, Simona; Stougaard, Jens] Univ Aarhus, Ctr Carbohydrate Recognit & Signalling, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Hoffmann, Soren V.] Univ Aarhus, Inst Storage Ring Facil, DK-8000 Aarhus, Denmark; [Dittmer, Jens] Univ Aarhus, Dept Chem, DK-8000 Aarhus, Denmark; [Giehm, Lise; Otzen, Daniel E.] Univ Aarhus, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Stougaard, J (corresponding author), Gustav Wieds Vej 10, DK-8000 Aarhus, Denmark.	stougaard@mb.au.dk	Dittmer, Jens/B-2020-2014	Dittmer, Jens/0000-0001-5038-6077; Hoffmann, Soren Vronning/0000-0002-8018-5433; Stougaard, Jens/0000-0002-9312-2685; Haaning, Svend/0000-0001-8417-2579; Otzen, Daniel/0000-0002-2918-8989	Danish Biotech Research Academy (DBRA); Danish National Research Foundation (Research Centre CARB); Danish Research Science Foundation; Villum Kann Rasmussen Foundation; Danish National Research Foundation	Danish Biotech Research Academy (DBRA); Danish National Research Foundation (Research Centre CARB)(Danmarks Grundforskningsfond); Danish Research Science Foundation; Villum Kann Rasmussen Foundation(Villum Fonden); Danish National Research Foundation(Danmarks Grundforskningsfond)	Supported by the Danish Biotech Research Academy (DBRA) and the Danish National Research Foundation (Research Centre CARB).; Supported by the Danish National Research Foundation (Research Centre CARB).; Supported by the Danish Research Science Foundation (Research Centre in SPIN) and the Villum Kann Rasmussen Foundation (Research Centre BioNET).; Supported by the Danish National Research Foundation (Research Centre CARB).	Alesandrini F, 2003, NEW PHYTOL, V158, P131, DOI 10.1046/j.1469-8137.2003.00720.x; Bhattacharyya J, 1999, J BIOL CHEM, V274, P15505, DOI 10.1074/jbc.274.22.15505; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Chatellier J, 1998, P NATL ACAD SCI USA, V95, P9861, DOI 10.1073/pnas.95.17.9861; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; GALAU GA, 1993, PLANT PHYSIOL, V101, P695, DOI 10.1104/pp.101.2.695; GOSTI F, 1995, MOL GEN GENET, V246, P10, DOI 10.1007/BF00290128; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Jewett AI, 2006, J MOL BIOL, V363, P945, DOI 10.1016/j.jmb.2006.08.040; JIRGENSON B, 1961, ARCH BIOCHEM BIOPHYS, V94, P59, DOI 10.1016/0003-9861(61)90011-X; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; Mohan A, 2008, MOL BIOSYST, V4, P328, DOI 10.1039/b719168e; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; NAOT D, 1995, PLANT MOL BIOL, V27, P619, DOI 10.1007/BF00019327; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Otzen DE, 2005, PROTEIN SCI, V14, P1396, DOI 10.1110/ps.041285605; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; PLADYS D, 1993, PLANT PHYSIOL, V103, P379, DOI 10.1104/pp.103.2.379; Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.3.CO;2-5; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Santarius KA, 1998, CRYO-LETT, V19, P37; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; SRERE PA, 1966, J BIOL CHEM, V241, P2157; Stacey G, 2006, PLANT PHYSIOL, V141, P1473, DOI 10.1104/pp.106.080986; Stan G, 2005, J MOL BIOL, V350, P817, DOI 10.1016/j.jmb.2005.05.012; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; TAMIYA T, 1985, CRYOBIOLOGY, V22, P446, DOI 10.1016/0011-2240(85)90156-7; Tian R, 2004, NEUROCHEM RES, V29, P1863, DOI 10.1023/B:NERE.0000042213.68600.65; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tsai CJ, 2002, PROTEIN SCI, V11, P1753, DOI 10.1110/ps.4100102; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; WALSH KB, 1987, PLANT PHYSIOL, V85, P137, DOI 10.1104/pp.85.1.137; Wang YC, 2006, PLANT SCI, V171, P655, DOI 10.1016/j.plantsci.2006.06.011; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Whitehead A, 2004, ATLA-ALTERN LAB ANIM, V32, P73, DOI 10.1177/026119290403202s15; Zhang XF, 2005, INT J BIOCHEM CELL B, V37, P1232, DOI 10.1016/j.biocel.2004.12.004	73	34	35	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31142	31152		10.1074/jbc.M805024200	http://dx.doi.org/10.1074/jbc.M805024200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18779323	Green Published, hybrid			2022-12-25	WOS:000260544800068
J	Lancellotti, S; Rutella, S; De Filippis, V; Pozzi, N; Rocca, B; De Cristofaro, R				Lancellotti, Stefano; Rutella, Sergio; De Filippis, Vincenzo; Pozzi, Nicola; Rocca, Bianca; De Cristofaro, Raimondo			Fibrinogen-elongated gamma Chain Inhibits Thrombin-induced Platelet Response, Hindering the Interaction with Different Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN IB-ALPHA; VON-WILLEBRAND-FACTOR; BLOOD-COAGULATION PROTEINASES; PEPTIDE CHLOROMETHYL KETONES; II-BINDING INHIBITOR; CRYSTAL-STRUCTURE; EXOSITE-II; FRAGMENT-D; MYOCARDIAL-INFARCTION; PROTHROMBIN FRAGMENT-2	The expression of the elongated fibrinogen gamma chain, termed gamma', derives from alternative splicing of mRNA and causes an insertion sequence of 20 amino acids. This insertion domain interacts with the anion-binding exosite (ABE)-II of thrombin. This study investigated whether and how gamma' chain binding to ABE-II affects thrombin interaction with its platelet receptors, i.e. glycoprotein Ib alpha (GpIb alpha), protease-activated receptor (PAR) 1, and PAR4. Both synthetic gamma' peptide and fibrinogen fragment D*, containing the elongated gamma' chain, inhibited thrombin-induced platelet aggregation up to 70%, with IC50 values of 42 +/- 3.5 and 0.47 +/- 0.03 mu M, respectively. Solid-phase binding and spectrofluorimetric assays showed that both fragment D* and the synthetic gamma' peptide specifically bind to thrombin ABE-II and competitively inhibit the thrombin binding to GpIb alpha with a mean K-i approximate to 0.5 and approximate to 35 mu M, respectively. Both these gamma' chain-containing ligands allosterically inhibited thrombin cleavage of a synthetic PAR1 peptide, of native PAR1 molecules on intact platelets, and of the synthetic chromogenic peptide D-Phe-pipecolyl-Arg-p-nitroanilide. PAR4 cleavage was unaffected. In summary, fibrinogen gamma' chain binds with high affinity to thrombin and inhibits with combined mechanisms the platelet response to thrombin. Thus, its variations in vivo may affect the hemostatic balance in arterial circulation.	[Lancellotti, Stefano; De Cristofaro, Raimondo] Catholic Univ, Sch Med, Haemostasis Res Ctr, Inst Internal Med & Geriatr, I-00168 Rome, Italy; [Rutella, Sergio] Catholic Univ, Sch Med, Immunol Lab, Dept Hematol, I-00168 Rome, Italy; [De Filippis, Vincenzo; Pozzi, Nicola] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy; [Rocca, Bianca] Catholic Univ, Sch Med, Inst Pharmacol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Cristofaro, R (corresponding author), Catholic Univ, Sch Med, Haemostasis Res Ctr, Inst Internal Med & Geriatr, Largo F Vito 1, I-00168 Rome, Italy.	rdecristofaro@rm.unicatt.it	LANCELLOTTI, Stefano/AAA-2950-2022; Pozzi, Nicola/AAV-4876-2021; De Cristofaro, Raimondo/K-3942-2018; Rutella, Sergio/AAF-9187-2020; Lancellotti, Stefano/K-3939-2018; Pozzi, Nicola/AAE-4910-2020; Rutella, Sergio/AAF-9210-2020; rocca, bianca/K-3922-2018	LANCELLOTTI, Stefano/0000-0002-8090-9040; Pozzi, Nicola/0000-0003-2309-7100; De Cristofaro, Raimondo/0000-0002-8066-8849; Rutella, Sergio/0000-0003-1970-7375; 	Italian Ministry of University [PRIN-2005]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	This work was supported by Italian Ministry of University "PRIN-2005." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Atherton E., 1990, SOLID PHASE PEPTIDE; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Cheung EYL, 2008, STROKE, V39, P1033, DOI 10.1161/STROKEAHA.107.495499; Chung DW, 2002, BIOCHEMISTRY-US, V41, P11065, DOI 10.1021/bi0204692; Cleary DB, 2002, ARCH BIOCHEM BIOPHYS, V403, P179, DOI 10.1016/S0003-9861(02)00220-5; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; De Cristofaro R, 2000, J BIOL CHEM, V275, P3887, DOI 10.1074/jbc.275.6.3887; De Cristofaro R, 2005, J BIOL CHEM, V280, P23295, DOI 10.1074/jbc.M501143200; De Cristofaro R, 2003, BIOCHEM J, V373, P593, DOI 10.1042/BJ20030167; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; DECRISTOFARO R, 1993, BIOCHEM J, V289, P475, DOI 10.1042/bj2890475; Drouet L, 1999, Blood Coagul Fibrinolysis, V10 Suppl 1, pS35; Duan HO, 2003, J BIOL CHEM, V278, P41270, DOI 10.1074/jbc.M304210200; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; EVERSE SJ, 1995, PROTEIN SCI, V4, P1013; Falls LA, 1997, J BIOL CHEM, V272, P14251, DOI 10.1074/jbc.272.22.14251; FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P9414, DOI 10.1021/bi00103a004; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Henry BL, 2007, J BIOL CHEM, V282, P31891, DOI 10.1074/jbc.M704257200; Jacques SL, 2003, BIOCHEM J, V376, P733, DOI 10.1042/BJ20030954; Jacques SL, 2000, J BIOL CHEM, V275, P40671, DOI 10.1074/jbc.M004544200; JANDROTPERRUS M, 1992, BLOOD, V80, P2781; KIRSCHBAUM NE, 1992, BLOOD, V79, P2643; Kostelansky MS, 2002, BIOCHEMISTRY-US, V41, P12124, DOI 10.1021/bi0261894; KUYAS C, 1982, J BIOL CHEM, V257, P1107; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LANCELLOTTI S, 2008, CARDIOVASCU IN PRESS; LIU LW, 1991, J BIOL CHEM, V266, P16977; Lovely RS, 2007, BRIT J HAEMATOL, V139, P494, DOI 10.1111/j.1365-2141.2007.06825.x; Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26; Mannila MN, 2007, J THROMB HAEMOST, V5, P766, DOI 10.1111/j.1538-7836.2007.02406.x; Mannila MN, 2007, J INTERN MED, V261, P138, DOI 10.1111/j.1365-2796.2006.01749.x; Mannila MN, 2005, THROMB HAEMOSTASIS, V93, P570, DOI 10.1160/TH04-10-0698; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; MAYO KH, 1990, BIOCHEMISTRY-US, V29, P3277, DOI 10.1021/bi00465a019; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Mosesson MW, 2003, J THROMB HAEMOST, V1, P231, DOI 10.1046/j.1538-7836.2003.00063.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pineda AO, 2007, BIOPHYS CHEM, V125, P556, DOI 10.1016/j.bpc.2006.08.005; Richardson JL, 2000, EMBO J, V19, P5650, DOI 10.1093/emboj/19.21.5650; Richardson JL, 2002, BIOCHEMISTRY-US, V41, P2535, DOI 10.1021/bi011605q; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sabo TM, 2006, BIOCHEMISTRY-US, V45, P7434, DOI 10.1021/bi060360k; SEEGERS WH, 1945, SCIENCE, V101, P520, DOI 10.1126/science.101.2629.520; Soslau G, 2001, J BIOL CHEM, V276, P21173, DOI 10.1074/jbc.M008249200; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Thomas DP, 1997, ANN INTERN MED, V126, P638, DOI 10.7326/0003-4819-126-8-199704150-00009; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; WYMAN J, 1990, BINDING LINKAGE FUNC, P33; Yee VC, 1997, STRUCTURE, V5, P125, DOI 10.1016/S0969-2126(97)00171-8	61	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30193	30204		10.1074/jbc.M803659200	http://dx.doi.org/10.1074/jbc.M803659200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18779330	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000260366900064
J	Chen, Y; Pan, XJ; Tang, Y; Quan, S; Tai, PC; Sui, SF				Chen, Yong; Pan, Xijiang; Tang, Ying; Quan, Shu; Tai, Phang C.; Sui, Sen-Fang			Full-length Escherichia coli SecA Dimerizes in a Closed Conformation in Solution as Determined by Cryo-electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATION ATPASE SECA; BACILLUS-SUBTILIS SECA; PLASMA-MEMBRANE; PROTEIN TRANSLOCATION; PRECURSOR PROTEIN; CRYSTAL-STRUCTURE; BINDING; VESICLES; COMPLEX; EXISTS	SecA is an obligatory component of the Escherichia coli general secretion pathway. However, the oligomeric structure of SecA and SecA conformational changes during translocation processes are still unclear. Here we obtained the three-dimensional structure of E. coli wild-type full-length SecA in solution by single particle cryo-electron microscopy and determined its oligomeric organization. In this structure, SecA occurs as a dimer in which the two protomers are arranged in an antiparallel mode, with a novel electrostatic interface, and both protomers are in closed conformation. The system developed here may provide a promising technique for studying dynamic structural changes in SecA.	[Chen, Yong; Pan, Xijiang; Tang, Ying; Quan, Shu; Sui, Sen-Fang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Tai, Phang C.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	Tsinghua University; University System of Georgia; Georgia State University	Sui, SF (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Chen, Yong/AAF-9915-2020; Quan, Shu/O-4562-2015; chen, Yong/F-3938-2010	Chen, Yong/0000-0001-5857-6086; Quan, Shu/0000-0002-6672-4947; Sui, Sen-Fang/0000-0001-5253-2592	National Nature Science Foundation of China; National Basic Research Program 973 of China [2004 CB720005]; National Institutes of Health [34766]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program 973 of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by research grants from the National Nature Science Foundation of China and the National Basic Research Program 973 of China (Grant 2004 CB720005). This work was also supported in part by National Institutes of Health Grant 34766 (to P. C. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Chen Y, 2007, J STRUCT BIOL, V159, P149, DOI 10.1016/j.jsb.2007.01.015; CUNNINGHAM K, 1989, EMBO J, V8, P955, DOI 10.1002/j.1460-2075.1989.tb03457.x; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; Ding HY, 2003, BIOCHEMISTRY-US, V42, P8729, DOI 10.1021/bi0342057; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; PAN XJ, 2005, TSINGHUA SCI TECHNOL, V10, P445; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; WATANABE M, 1993, P NATL ACAD SCI USA, V90, P9011, DOI 10.1073/pnas.90.19.9011; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514; Woodbury RL, 2000, J BIOL CHEM, V275, P24191, DOI 10.1074/jbc.M002885200; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Zimmer J, 2006, J MOL BIOL, V364, P259, DOI 10.1016/j.jmb.2006.08.044	32	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28783	28787		10.1074/jbc.C800160200	http://dx.doi.org/10.1074/jbc.C800160200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18772144	Green Published, hybrid			2022-12-25	WOS:000260179900002
J	Yoshiike, Y; Minai, R; Matsuo, Y; Chen, YR; Kimura, T; Takashima, A				Yoshiike, Yuji; Minai, Ryoichi; Matsuo, Yo; Chen, Yun-Ru; Kimura, Tetsuya; Takashima, Akihiko			Amyloid Oligomer Conformation in a Group of Natively Folded Proteins	PLOS ONE			English	Article								Recent in vitro and in vivo studies suggest that destabilized proteins with defective folding induce aggregation and toxicity in protein-misfolding diseases. One such unstable protein state is called amyloid oligomer, a precursor of fully aggregated forms of amyloid. Detection of various amyloid oligomers with A11, an anti-amyloid oligomer conformation-specific antibody, revealed that the amyloid oligomer represents a generic conformation and suggested that toxic beta-aggregation processes possess a common mechanism. By using A11 antibody as a probe in combination with mass spectrometric analysis, we identified GroEL in bacterial lysates as a protein that may potentially have an amyloid oligomer conformation. Surprisingly, A11 reacted not only with purified GroEL but also with several purified heat shock proteins, including human Hsp27, 40, 70, 90; yeast Hsp104; and bovine Hsc70. The native folds of A11-reactive proteins in purified samples were characterized by their anti-beta-aggregation activity in terms of both functionality and in contrast to the beta-aggregation promoting activity of misfolded pathogenic amyloid oligomers. The conformation-dependent binding of A11 with natively folded Hsp27 was supported by the concurrent loss of A11 reactivity and anti-beta-aggregation activity of heat-treated Hsp27 samples. Moreover, we observed consistent anti-beta-aggregation activity not only by chaperones containing an amyloid oligomer conformation but also by several A11-immunoreactive non-chaperone proteins. From these results, we suggest that the amyloid oligomer conformation is present in a group of natively folded proteins. The inhibitory effects of A11 antibody on both GroEL/ES-assisted luciferase refolding and Hsp70-mediated decelerated nucleation of A beta aggregation suggested that the A11-binding sites on these chaperones might be functionally important. Finally, we employed a computational approach to uncover possible A11-binding sites on these targets. Since the beta-sheet edge was a common structural motif having the most similar physicochemical properties in the A11-reactive proteins we analyzed, we propose that the beta-sheet edge in some natively folded amyloid oligomers is designed positively to prevent beta aggregation.	[Yoshiike, Yuji; Kimura, Tetsuya; Takashima, Akihiko] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan; [Minai, Ryoichi; Matsuo, Yo] RIKEN, Genom Sci Ctr, Computat Proteom Team, Yokohama, Kanagawa, Japan; [Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei, Taiwan	RIKEN; RIKEN; Academia Sinica - Taiwan	Yoshiike, Y (corresponding author), RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan.	kenneth@brain.riken.jp	Chen, Yun-Ru/C-9304-2014	Chen, Yun-Ru/0000-0002-6596-6338	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid for Scientific Research on Priority Areas]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ashcroft AE, 2002, J BIOL CHEM, V277, P33115, DOI 10.1074/jbc.M203398200; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; BLAKE CCF, 1977, NATURE, V268, P115, DOI 10.1038/268115a0; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BUSH BL, 1993, J CHEM INF COMP SCI, V33, P756, DOI 10.1021/ci00015a015; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Du YS, 1998, J NEUROCHEM, V70, P1182; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Ermolenko DN, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1233, DOI 10.1007/s10541-005-0069-4; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Jenner L, 1998, STRUCTURE, V6, P595, DOI 10.1016/S0969-2126(98)00061-6; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kameda A, 2005, J MOL BIOL, V348, P383, DOI 10.1016/j.jmb.2005.02.050; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimura T, 2002, J AM CHEM SOC, V124, P11596, DOI 10.1021/ja026639f; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Schwarzman AL, 1996, CIBA F SYMP, V199, P146; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; Stein TD, 2002, J NEUROSCI, V22, P7380; Stockel J, 2001, J MOL BIOL, V313, P861, DOI 10.1006/jmbi.2001.5085; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Xu Q, 2004, PROTEIN SCI, V13, P1851, DOI 10.1110/ps.04699904; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	50	56	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3235	10.1371/journal.pone.0003235	http://dx.doi.org/10.1371/journal.pone.0003235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800165	Green Published, gold, Green Submitted			2022-12-25	WOS:000264428400005
J	Van den Stock, J; van de Riet, WAC; Righart, R; de Gelder, B				Van den Stock, Jan; van de Riet, Wim A. C.; Righart, Ruthger; de Gelder, Beatrice			Neural Correlates of Perceiving Emotional Faces and Bodies in Developmental Prosopagnosia: An Event-Related fMRI-Study	PLOS ONE			English	Article								Many people experience transient difficulties in recognizing faces but only a small number of them cannot recognize their family members when meeting them unexpectedly. Such face blindness is associated with serious problems in everyday life. A better understanding of the neuro-functional basis of impaired face recognition may be achieved by a careful comparison with an equally unique object category and by a adding a more realistic setting involving neutral faces as well facial expressions. We used event-related functional magnetic resonance imaging (fMRI) to investigate the neuro-functional basis of perceiving faces and bodies in three developmental prosopagnosics (DP) and matched healthy controls. Our approach involved materials consisting of neutral faces and bodies as well as faces and bodies expressing fear or happiness. The first main result is that the presence of emotional information has a different effect in the patient vs. the control group in the fusiform face area (FFA). Neutral faces trigger lower activation in the DP group, compared to the control group, while activation for facial expressions is the same in both groups. The second main result is that compared to controls, DPs have increased activation for bodies in the inferior occipital gyrus (IOG) and for neutral faces in the extrastriate body area (EBA), indicating that body and face sensitive processes are less categorically segregated in DP. Taken together our study shows the importance of using naturalistic emotional stimuli for a better understanding of developmental face deficits.	[Van den Stock, Jan; van de Riet, Wim A. C.; Righart, Ruthger; de Gelder, Beatrice] Tilburg Univ, Lab Cognit & Affect Neurosci, NL-5000 LE Tilburg, Netherlands; [Van den Stock, Jan] Univ Hosp Leuven, Old Age Psychiat Dept, Louvain, Belgium; [de Gelder, Beatrice] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA	Tilburg University; KU Leuven; University Hospital Leuven; Harvard University; Massachusetts General Hospital	Van den Stock, J (corresponding author), Tilburg Univ, Lab Cognit & Affect Neurosci, NL-5000 LE Tilburg, Netherlands.	degelder@nmr.mgh.harvard.edu	Van den Stock, J./F-1906-2014	Van den Stock, J./0000-0001-5756-3195	Human Frontiers Science Program [RGP0054/2004-C]; European Commission [FP6-2005-NEST-Path Imp 043403-COBOL]; NWO, Dutch Science Foundation	Human Frontiers Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); NWO, Dutch Science Foundation(Netherlands Organization for Scientific Research (NWO))	The research was partly funded by a Human Frontiers Science Program grant (RGP0054/2004-C), a European Commission grant (FP6-2005-NEST-Path Imp 043403-COBOL) and a NWO grant (Dutch Science Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Baker CI, 2007, NAT NEUROSCI, V10, P3, DOI 10.1038/nn0107-3; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Bentin S, 2007, J COGNITIVE NEUROSCI, V19, P132, DOI 10.1162/jocn.2007.19.1.132; Benton A., 1983, CONTRIBUTION NEUROPS; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; de Gelder B, 2000, COGN NEUROPSYCHOL, V17, P89, DOI 10.1080/026432900380508; de Gelder B, 2000, NEUROPSYCHOLOGIA, V38, P1271, DOI 10.1016/S0028-3932(00)00039-7; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 1998, VISION RES, V38, P2855, DOI 10.1016/S0042-6989(97)00458-6; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder B, 2000, NEUROREPORT, V11, P3145, DOI 10.1097/00001756-200009280-00021; DEGELDER B, 2003, P NATL ACAD SCI US; DeGutis JM, 2007, J COGNITIVE NEUROSCI, V19, P1790, DOI 10.1162/jocn.2007.19.11.1790; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duchaine BC, 2003, PERCEPTION, V32, P827, DOI 10.1068/p5067; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Eastwood JD, 2003, PERCEPT PSYCHOPHYS, V65, P352, DOI 10.3758/BF03194566; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah M.J., 1990, VISUAL AGNOSIA DISOR; Fodor J. A, 1983, MODULARITY MIND; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2008, TRENDS COGN SCI, V12, P152, DOI 10.1016/j.tics.2008.01.009; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; GUYER AE, 2008, J COGN NEUROSCI; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Jones RD, 2001, J CLIN EXP NEUROPSYC, V23, P265, DOI 10.1076/jcen.23.3.265.1183; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lundqvist D., 1998, KAROLINSKA DIRECTED; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Nunn JA, 2001, NEUROCASE, V7, P15, DOI 10.1093/neucas/7.1.15; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Puce A, 1996, J NEUROSCI, V16, P5205; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Riddoch MJ., 1993, BORB BIRMINGHAM OBJE; RIGHART R, 2007, P NATL ACAD SCI US; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Russell, 1974, APPROACH ENV PSYCHOL; Sorger B, 2007, NEUROIMAGE, V35, P836, DOI 10.1016/j.neuroimage.2006.09.051; Steeves JKE, 2006, NEUROPSYCHOLOGIA, V44, P594, DOI 10.1016/j.neuropsychologia.2005.06.013; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Surguladze SA, 2003, NEUROIMAGE, V19, P1317, DOI 10.1016/S1053-8119(03)00085-5; Talairach J., 1988, COPLANAR STEREOTAXIC; VANDERIET WAC, SOC NEUROSC IN PRESS; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Warrington EK., 1984, RECOGNITION MEMORY T; Williams MA, 2007, CURR BIOL, V17, P1259, DOI 10.1016/j.cub.2007.06.042; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	77	51	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3195	10.1371/journal.pone.0003195	http://dx.doi.org/10.1371/journal.pone.0003195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797499	Green Submitted, Green Published, gold			2022-12-25	WOS:000264428200002
J	Chang, HCH; Dimlich, DN; Yokokura, T; Mukherjee, A; Kankel, MW; Sen, A; Sridhar, V; Fulga, TA; Hart, AC; Van Vactor, D; Artavanis-Tsakonas, S				Chang, Howard Chia-Hao; Dimlich, Douglas N.; Yokokura, Takakazu; Mukherjee, Ashim; Kankel, Mark W.; Sen, Anindya; Sridhar, Vasanthi; Fulga, Tudor A.; Hart, Anne C.; Van Vactor, David; Artavanis-Tsakonas, Spyros			Modeling Spinal Muscular Atrophy in Drosophila	PLOS ONE			English	Article							REGULATES SYNAPTIC GROWTH; MOTOR-NEURONS; SMN COMPLEX; MOUSE MODEL; SINGLE NUCLEOTIDE; II RECEPTOR; GENE SMN1; EXPRESSION; SURVIVAL; PROTEIN	Spinal Muscular Atrophy (SMA), a recessive hereditary neurodegenerative disease in humans, has been linked to mutations in the survival motor neuron (SMN) gene. SMA patients display early onset lethality coupled with motor neuron loss and skeletal muscle atrophy. We used Drosophila, which encodes a single SMN ortholog, survival motor neuron (Smn), to model SMA, since reduction of Smn function leads to defects that mimic the SMA pathology in humans. Here we show that a normal neuromuscular junction (NMJ) structure depends on SMN expression and that SMN concentrates in the postsynaptic NMJ regions. We conducted a screen for genetic modifiers of an Smn phenotype using the Exelixis collection of transposon-induced mutations, which affects approximately 50% of the Drosophila genome. This screen resulted in the recovery of 27 modifiers, thereby expanding the genetic circuitry of Smn to include several genes not previously known to be associated with this locus. Among the identified modifiers was wishful thinking (wit), a type II BMP receptor, which was shown to alter the Smn NMJ phenotype. Further characterization of two additional members of the BMP signaling pathway, Mothers against dpp (Mad) and Daughters against dpp (Dad), also modify the Smn NMJ phenotype. The NMJ defects caused by loss of Smn function can be ameliorated by increasing BMP signals, suggesting that increased BMP activity in SMA patients may help to alleviate symptoms of the disease. These results confirm that our genetic approach is likely to identify bona fide modulators of SMN activity, especially regarding its role at the neuromuscular junction, and as a consequence, may identify putative SMA therapeutic targets.	[Chang, Howard Chia-Hao; Dimlich, Douglas N.; Yokokura, Takakazu; Kankel, Mark W.; Sen, Anindya; Sridhar, Vasanthi; Fulga, Tudor A.; Van Vactor, David; Artavanis-Tsakonas, Spyros] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02163 USA; [Mukherjee, Ashim] Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India; [Hart, Anne C.] Harvard Univ, Sch Med, Canc Ctr, Massachusetts Gen Hosp, Dept Pathol, Cambridge, MA 02138 USA; [Artavanis-Tsakonas, Spyros] Coll France, Paris, France	Harvard University; Harvard Medical School; Banaras Hindu University (BHU); Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; PSL Research University Paris; College de France	Chang, HCH (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02163 USA.	artavanis@hms.harvard.edu		Chang, Howard/0000-0003-4310-8890; Viswanathan, Vasanthi/0000-0001-9878-3629; Fulga, Tudor/0000-0002-1056-0082; Van Vactor, Jr., David L./0000-0001-8156-9482	SMA foundation; NIH	SMA foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SMA foundation, NIH	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Frugier T, 2002, CURR OPIN GENET DEV, V12, P294, DOI 10.1016/S0959-437X(02)00301-5; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; Jablonka S, 2006, HUM MOL GENET, V15, P511, DOI 10.1093/hmg/ddi467; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; KARIYA S, 2008, HUM MOL GENET; Khalsa O, 1998, DEVELOPMENT, V125, P2723; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lee S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001404; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; MICHELSON AM, 1994, DEVELOPMENT, V120, P755; Miguel-Aliaga I, 2000, FEBS LETT, V486, P99, DOI 10.1016/S0014-5793(00)02243-2; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	66	133	134	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3209	10.1371/journal.pone.0003209	http://dx.doi.org/10.1371/journal.pone.0003209			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791638	Green Published, gold, Green Submitted			2022-12-25	WOS:000264427700004
J	Sohi, MK; Veselkov, DA; Laponogov, I; Pan, XS; Fisher, LM; Sanderson, MR				Sohi, Maninder K.; Veselkov, Dennis A.; Laponogov, Ivan; Pan, Xiao-Su; Fisher, L. Mark; Sanderson, Mark R.			The Difficult Case of Crystallization and Structure Solution for the ParC55 Breakage-Reunion Domain of Topoisomerase IV from Streptococcus pneumoniae	PLOS ONE			English	Article								Background: Streptococcus pneumoniae is the major cause of community-acquired pneumonia and is also associated with bronchitis, meningitis, otitis and sinusitis. The emergence and increasing prevalence of resistance to penicillin and other antibiotics has led to interest in other anti-pneumonococcal drugs such as quinolones that target the enzymes DNA gyrase and topoisomerase IV. During crystallization and in the avenues to finding a method to determine phases for the structure of the ParC55 breakage-reunion domain of topoisomerase IV from Streptococcus pneumoniae, obstacles were faced at each stage of the process. These problems included: majority of the crystals being twinned, either non-diffracting or exhibiting a high mosaic spread. The crystals, which were grown under conditions that favoured diffraction, were difficult to flash-freeze without loosing diffraction. The initial structure solution by molecular replacement failed and the approach proved to be unviable due to the complexity of the problem. In the end the successful structure solution required an in-depth data analysis and a very detailed molecular replacement search. Methodology/Principal Findings: Crystal anti-twinning agents have been tested and two different methods of flash freezing have been compared. The fragility of the crystals did not allow the usual method of transferring the crystals into the heavy atom solution. Consequently, it was necessary to co-crystallize in the presence of the heavy atom compound. The multiple isomorphous replacement approach was unsuccessful because the 7 cysteine mutants which were engineered could not be successfully derivatized. Ultimately, molecular replacement was used to solve the structure by sorting through a large number of solutions in space group P1 using CNS. Conclusions/Significance: The main objective of this paper is to describe the obstacles which were faced and overcome in order to acquire data sets on such difficult crystals and determine phases for successful structure solution.	[Sohi, Maninder K.; Veselkov, Dennis A.; Laponogov, Ivan; Sanderson, Mark R.] Kings Coll London, Sch Biomed & Hlth Sci, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Pan, Xiao-Su; Fisher, L. Mark] Univ London, Div Basic Med Sci, Mol & Metabol Signalling Ctr, Mol Genet Grp, London WC1E 7HU, England	University of London; King's College London; University of London	Sohi, MK (corresponding author), Kings Coll London, Sch Biomed & Hlth Sci, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	lfisher@sgul.ac.uk; mark.sanderson@kcl.ac.uk		Fisher, Larry Mark/0000-0002-2172-3369	Biothechnology and Biological Sciences Research Council [C16747]; BBSRC [BB/D01882X/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01882X/1] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish	Biothechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Project Grant C16747 from the Biothechnology and Biological Sciences Research Council to L.M. Fisher and M.R. Sanderson.	[Anonymous], ACTA CRYSTALLOGR D, V50, P760; Bates A.D., 2005, DNA TOPOLOGY; Berger JM, 1998, BBA-GENE STRUCT EXPR, V1400, P3, DOI 10.1016/S0167-4781(98)00124-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carr SB, 2006, ACTA CRYSTALLOGR F, V62, P1164, DOI 10.1107/S1744309106044150; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; HATFULL GF, 1989, J MOL BIOL, V208, P661, DOI 10.1016/0022-2836(89)90156-3; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kabsch W, 1993, P CCP4 STUD WEEK WAR, P63; Laponogov I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000301; Leo E, 2005, J BIOL CHEM, V280, P14252, DOI 10.1074/jbc.M500156200; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; Maxwell A, 1996, NAT STRUCT BIOL, V3, P109, DOI 10.1038/nsb0296-109; Maxwell A, 2005, BIOCHEM SOC T, V33, P1460, DOI 10.1042/BST0331460; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan XS, 1999, ANTIMICROB AGENTS CH, V43, P1129, DOI 10.1128/AAC.43.5.1129; Pan XS, 1997, ANTIMICROB AGENTS CH, V41, P471, DOI 10.1128/AAC.41.2.471; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Sohi M, 2000, FEBS LETT, V465, P161, DOI 10.1016/S0014-5793(99)01690-7; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	28	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3201	10.1371/journal.pone.0003201	http://dx.doi.org/10.1371/journal.pone.0003201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787651	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000264426200006
J	Kim, HJ; Kim, YM; Lim, S; Nam, YK; Jeong, J; Kim, HJ; Lee, KJ				Kim, H. J.; Kim, Y. M.; Lim, S.; Nam, Y. K.; Jeong, J.; Kim, H-J; Lee, K-J			Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis	ONCOGENE			English	Article						UCH-L1; deubiquitinating enzyme; metastasis; tumor invasion; lung cancer; Akt activation; proteomics	LUNG-CANCER; ENDOTHELIAL-CELLS; PGP9.5; PROTEIN; PATHWAY; KINASE; GENE; INHIBITOR; P27(KIP1); MOTILITY	Ubiquitin C-terminal hydrolase-L1 (UCH-L1) catalyses the hydrolysis of ubiquitin ester and amide mainly in neuronal cells. Recently it was proposed as a marker with a potential role in carcinogenesis. However, the molecular mechanism underlying the biological function of UCH-L1 in tumor cells is poorly understood. We found that UCH-L1 is highly expressed in non-small lung cancer cell line H157, having high invasive potential, and that the expression of UCH-L1 in tumor cells enhances their invasive potential in vitro and in vivo. UCH-L1 changes cell morphology by regulating cell adhesion through Akt-mediated pathway. Suppressing UCH-L1 expression by RNAi significantly suppressed the invasion in vitro and in vivo, and the activation of Akt and downstream mitogen activated protein kinases c-Jun N-terminal kinases and p38, but not ERK. In Akt-negative mutants, overexpression of UCH-L1 does not affect the invasion and migration capability of H157 cells. These results suggest that UCH-L1 is a key molecule to regulate tumor-cell invasion by upstream activation of Akt.	[Lee, K-J] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Coll Pharm, Seoul 120750, South Korea; Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University	Lee, KJ (corresponding author), Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Coll Pharm, Seoul 120750, South Korea.	kjl@ewha.ac.kr			KOSEF [R15-2006-002, FPR05A2-480]	KOSEF(Korea Science and Engineering Foundation)	This study was supported by SK Corp. Korea, KOSEF through the Center for Cell Signaling & Drug Discovery Research (CCS & DDR, R15-2006-002) at Ewha Womans University, by KOSEF Grant FPR05A2-480. Kim HJ, Nam YK, Kim YM, Kim HJ and Lim S were supported by the Brain Korea 21 project.	Brichory F, 2001, CANCER RES, V61, P7908; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Diebold BA, 2004, J BIOL CHEM, V279, P28136, DOI 10.1074/jbc.M313891200; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Huang C, 2004, CELL CYCLE, V3, P4, DOI 10.4161/cc.3.1.601; Kim YM, 2007, J PROTEOME RES, V6, P3278, DOI 10.1021/pr070168k; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Rosas SLB, 2001, CANCER LETT, V170, P73, DOI 10.1016/S0304-3835(01)00449-9; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Tezel E, 2000, CLIN CANCER RES, V6, P4764; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamazaki T, 2002, CLIN CANCER RES, V8, P192; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561	24	119	125	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					117	127		10.1038/onc.2008.364	http://dx.doi.org/10.1038/onc.2008.364			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18820707				2022-12-25	WOS:000262294100012
J	Palm-Apergi, C; Lorents, A; Padari, K; Pooga, M; Hallbrink, M				Palm-Apergi, Caroline; Lorents, Annely; Padari, Kart; Pooga, Margus; Hallbrink, Mattias			The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake	FASEB JOURNAL			English	Article						protein transduction domains; perforin; granzyme B; granulysin; cellular wound healing	TAT PEPTIDE; MECHANISM; EXOCYTOSIS; PLASMA; LYSOSOMES; CALCIUM; MODEL; MACROPINOCYTOSIS; TRANSLOCATION; DEGRADATION	Although cell-penetrating peptides are able to deliver cargo into cells, their uptake mechanism is still not fully understood and needs to be elucidated to improve their delivery efficiency. Herein, we present evidence of a new mechanism involved in uptake, the membrane repair response. Recent studies have suggested that there might be a direct penetration of peptides in parallel with different forms of endocytosis. The direct penetration of hydrophilic peptides through the hydrophobic plasma membrane, however, is highly controversial. Three proteins involved in target cell apoptosis-perforin, granulysin, and granzymes-share many features common in uptake of cell-penetrating peptides (e. g., they bind proteoglycans). During perforin uptake, the protein activates the membrane repair response, a resealing mechanism triggered in cells with injured plasma membrane, because of extracellular calcium influx. On activation of the membrane repair response, internal vesicles are mobilized to the site of the disrupted plasma membrane, resealing it within seconds. In this study, we have used flow cytometry, fluorescence, and electron microscopy, together with high-performance liquid chromatography and mass spectrometry, to present evidence that the membrane repair response is able to mask damages caused during cell-penetrating peptide uptake, thus preventing leakage of endogenous molecules out of the cell.-Palm-Apergi, C., Lorents, A., Padari, K., Pooga, M., and Hallbrink, M. The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake. FASEB J. 23, 214-223 (2009)	[Palm-Apergi, Caroline; Hallbrink, Mattias] Stockholm Univ, Dept Neurochem, Arrhenius Labs, S-10691 Stockholm, Sweden; [Lorents, Annely; Padari, Kart; Pooga, Margus] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Lorents, Annely; Padari, Kart; Pooga, Margus] Estonian Bioctr, Tartu, Estonia	Stockholm University; University of Tartu; Estonian Biocentre	Palm-Apergi, C (corresponding author), Stockholm Univ, Dept Neurochem, Arrhenius Labs, S-10691 Stockholm, Sweden.	caroline@neurochem.su.se	Pooga, Margus/A-8575-2011	Pooga, Margus/0000-0003-4532-4087; Lorents, Annely/0000-0002-2823-5202; Palm Apergi, Caroline/0000-0003-2236-2099	Jeansson foundation; Estonian Science Foundation [ETF7058]	Jeansson foundation; Estonian Science Foundation	This work was supported by the Jeansson foundation and Estonian Science Foundation (ETF7058). We thank M. Kure for the expert help in electron microscopy experiments.	Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bird CH, 2005, MOL CELL BIOL, V25, P7854, DOI 10.1128/MCB.25.17.7854-7867.2005; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P7698, DOI 10.1021/bi049298m; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Gerbal-Chaloin S, 2007, BIOL CELL, V99, P223, DOI 10.1042/BC20060123; Hallbrink M, 2001, BBA-BIOMEMBRANES, V1515, P101, DOI 10.1016/S0005-2736(01)00398-4; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Howl J, 2003, CHEMBIOCHEM, V4, P1312, DOI 10.1002/cbic.200300694; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Johansson HJ, 2008, MOL THER, V16, P115, DOI 10.1038/sj.mt.6300346; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Kim JS, 1999, TRANSPLANTATION, V68, P938, DOI 10.1097/00007890-199910150-00007; Li Q, 2005, ANTIMICROB AGENTS CH, V49, P388, DOI 10.1128/AAC.49.1.388-397.2005; LIU CC, 1995, IMMUNOL TODAY, V16, P194, DOI 10.1016/0167-5699(95)80121-9; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2002, J CELL SCI, V115, P873; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Palm C, 2007, BBA-BIOMEMBRANES, V1768, P1769, DOI 10.1016/j.bbamem.2007.03.029; Palm C, 2006, PEPTIDES, V27, P1710, DOI 10.1016/j.peptides.2006.01.006; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Saar K, 2005, ANAL BIOCHEM, V345, P55, DOI 10.1016/j.ab.2005.07.033; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Togo T, 1999, J CELL SCI, V112, P719; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	35	89	100	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2009	23	1					214	223		10.1096/fj.08-110254	http://dx.doi.org/10.1096/fj.08-110254			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18787109				2022-12-25	WOS:000262095500024
J	Marrichi, M; Camacho, L; Russell, DG; DeLisa, MP				Marrichi, Matthew; Camacho, Luis; Russell, David G.; DeLisa, Matthew P.			Genetic Toggling of Alkaline Phosphatase Folding Reveals Signal Peptides for All Major Modes of Transport across the Inner Membrane of Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE TRANSLOCATION PATHWAY; AERUGINOSA VIRULENCE FACTORS; MALTOSE-BINDING PROTEIN; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; RECOGNITION PARTICLE; EXPORTED PROTEINS; TOPOLOGY ANALYSIS; BETA-LACTAMASES; DISULFIDE BONDS	Prediction of export pathway specificity in prokaryotes is a challenging endeavor due to the similar overall architecture of N-terminal signal peptides for the Sec-, SRP- (signal recognition particle), and Tat (twin arginine translocation)-dependent pathways. Thus, we sought to create a facile experimental strategy for unbiased discovery of pathway specificity conferred by N-terminal signals. Using a limited collection of Escherichia coli strains that allow protein oxidation in the cytoplasm or, conversely, disable protein oxidation in the periplasm, we were able to discriminate the specific mode of export for PhoA (alkaline phosphatase) fusions to signal peptides for all of the major modes of transport across the inner membrane (Sec, SRP, or Tat). Based on these findings, we developed a mini-Tn5 phoA approach to isolate pathway-specific export signals from libraries of random fusions between exported proteins and the phoA gene. Interestingly, we observed that reduced PhoA was exported in a Tat-independent manner when targeted for Tat export in the absence of the essential translocon component TatC. This suggests that initial docking to TatC serves as a key specificity determinant for Tat-specific routing of PhoA, and in its absence, substrates can be rerouted to the Sec pathway, provided they remain compatible with the Sec export mechanism. Finally, the utility of our approach was demonstrated by experimental verification that four secreted proteins from Mycobacterium tuberculosis carrying putative Tat signals are bona fide Tat substrates and thus represent potential Tat-dependent virulence factors in this important human pathogen.	[Marrichi, Matthew; DeLisa, Matthew P.] Cornell Univ, Dept Microbiol & Immunol, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Camacho, Luis; Russell, David G.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	DeLisa, MP (corresponding author), 254 Olin Hall, Ithaca, NY 14853 USA.	md255@cornell.edu	Russell, David G/D-4533-2009; DeLisa, Matthew/AAE-7361-2019; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation Career Award [BES 0449080]; NYSTAR James D. Watson Award	National Science Foundation Career Award(National Science Foundation (NSF)); NYSTAR James D. Watson Award	This work was supported by National Science Foundation Career Award BES 0449080 and a NYSTAR James D. Watson Award (both to M. P. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; ALLARD JD, 1992, J BIOL CHEM, V267, P17809; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailey J, 2002, NAT BIOTECHNOL, V20, P839, DOI 10.1038/nbt715; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERG DE, 1983, GENETICS, V105, P813; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Braunstein M, 2000, J BACTERIOL, V182, P2732, DOI 10.1128/JB.182.10.2732-2740.2000; Bronstein P, 2004, RES MICROBIOL, V155, P803, DOI 10.1016/j.resmic.2004.06.013; Bronstein PA, 2005, J BACTERIOL, V187, P8450, DOI 10.1128/JB.187.24.8450-8461.2005; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chan CS, 2006, BIOCHEM BIOPH RES CO, V343, P244, DOI 10.1016/j.bbrc.2006.02.133; Chen G, 2001, NAT BIOTECHNOL, V19, P537, DOI 10.1038/89281; Cho DH, 2006, PROTEOMICS, V6, P5785, DOI 10.1002/pmic.200600207; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; DONNENBERG MS, 1990, INFECT IMMUN, V58, P1565, DOI 10.1128/IAI.58.6.1565-1571.1990; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FINLAY BB, 1988, MOL MICROBIOL, V2, P757, DOI 10.1111/j.1365-2958.1988.tb00087.x; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Froderberg L, 2003, MOL MICROBIOL, V47, P1015, DOI 10.1046/j.1365-2958.2003.03346.x; GILADI M, 1993, J BACTERIOL, V175, P4129, DOI 10.1128/JB.175.13.4129-4136.1993; GOTT P, 1988, MOL MICROBIOL, V2, P655, DOI 10.1111/j.1365-2958.1988.tb00074.x; GUTIERREZ C, 1987, J MOL BIOL, V195, P289, DOI 10.1016/0022-2836(87)90650-4; HERRERO M, 1988, J BACTERIOL, V170, P56, DOI 10.1128/jb.170.1.56-64.1988; HUANG HC, 1988, J BACTERIOL, V170, P4748, DOI 10.1128/jb.170.10.4748-4756.1988; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Kim J, 1998, J BACTERIOL, V180, P1396, DOI 10.1128/JB.180.6.1396-1401.1998; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; Kumar P, 2003, INFECT IMMUN, V71, P1929, DOI 10.1128/IAI.71.4.1929-1937.2003; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; LODGE JK, 1988, GENETICS, V120, P645; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; Lutz S, 2002, PROTEIN ENG, V15, P1025, DOI 10.1093/protein/15.12.1025; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Manoil C, 1997, J MOL BIOL, V267, P250, DOI 10.1006/jmbi.1996.0881; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Posey JE, 2006, J BACTERIOL, V188, P1332, DOI 10.1128/JB.188.4.1332-1340.2006; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; SARTHY A, 1981, J BACTERIOL, V145, P288, DOI 10.1128/JB.145.1.288-292.1981; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; WEBER RF, 1988, J MOL BIOL, V203, P467, DOI 10.1016/0022-2836(88)90013-7; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WEISS JB, 1988, P NATL ACAD SCI USA, V85, P8978, DOI 10.1073/pnas.85.23.8978	80	37	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35223	35235		10.1074/jbc.M802660200	http://dx.doi.org/10.1074/jbc.M802660200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18819916	Green Published, hybrid			2022-12-25	WOS:000261469100078
J	Chaineau, M; Danglot, L; Proux-Gillardeaux, V; Galli, T				Chaineau, Mathilde; Danglot, Lydia; Proux-Gillardeaux, Veronique; Galli, Thierry			Role of HRB in Clathrin-dependent Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; SYNAPTIC VESICLE; PLASMA-MEMBRANE; CELLULAR COFACTOR; SNARE COMPLEXES; COATED VESICLES; EH DOMAIN; TI-VAMP; IDENTIFICATION; EPS15	Human immunodeficiency virus Rev-binding protein (HRB), also called human Rev-interacting protein (hRIP) or Rev/Rex activation domain binding (RAB) is a partner of the tyrosine kinase substrate EPS15, and it has been recovered in the AP-2 interactome. EPS15 and AP-2 are involved in endocytosis, but the function of HRB in this process is still unknown. Here we identified HRB as a partner of the vesicular SNARE tetanus neurotoxin-insensitive vesicle-associated membrane protein (TI-VAMP, also called VAMP7) in yeast two-hybrid screens and using biochemical assays. In HeLa cells, HRB localized both in the nucleus and in the cytoplasm. In the cytoplasm, HRB colocalized with clathrin-, AP-2-, EPS15-, and transferrin receptor-containing vesicles. We did not see significant colocalization between HRB and TI-VAMP in HeLa cells, and we saw partial colocalization with green fluorescent protein-TI-VAMP in stably expressing Madin-Darby canine kidney cells. Nevertheless using a pHLuorin-tagged TI-VAMP construct, we found that HRB and TI-VAMP colocalize close to the plasma membrane after 5 min of anti-green fluorescent protein antibody uptake. These results suggest that TI-VAMP and HRB may interact only during the early stages of endocytosis. Furthermore uptake experiments followed by fluorescence-activated cell sorting showed that the endocytosis of fluorescent transferrin and pHLuorin-TI-VAMP is strongly reduced in HRB knockdown cells. Altogether these results suggest that HRB is involved in clathrin-dependent endocytosis and recruits TI-VAMP in this process.	Univ Paris 06, INSERM, Avenir Team, F-75005 Paris, France; Univ Paris 07, INSERM, Avenir Team, F-75005 Paris, France; Univ Paris 07, Inst Jacques Monod, CNRS, UMR7592, F-75005 Paris, France; Univ Paris 06, Inst Jacques Monod, CNRS, UMR7592, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Galli, T (corresponding author), Inst Jacques Monod, 2 Pl Jussieu, F-75251 Paris 05, France.	thierry@tgalli.net	DANGLOT, Lydia/G-5684-2013; Galli, Thierry/Q-2249-2019; Galli, Thierry/G-8842-2011	DANGLOT, Lydia/0000-0001-6190-6605; Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455	INSERM; European Commission [503229]; Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche ("PolarHiCell"); Mairie de Paris Medical Research and Health Program; Fondation pour la Recherche Medicale; Ministry of Research and la Ligue Contre le Cancer (Paris committee)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale pour la Recherche ("PolarHiCell")(French National Research Agency (ANR)); Mairie de Paris Medical Research and Health Program; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ministry of Research and la Ligue Contre le Cancer (Paris committee)	This work was supported in part by grants from INSERM (Avenir Program), the European Commission ("Signalling and Traffic" Specific Targeted Research Project Grant 503229), the Association pour la Recherche sur le Cancer, the Agence Nationale pour la Recherche ("PolarHiCell"), the Mairie de Paris Medical Research and Health Program, and the Fondation pour la Recherche Medicale (to T. G.). The CyAn ADP analyzer was bought with funds from the Ministry of Research and la Ligue Contre le Cancer (Paris committee). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alberts P, 2003, BIOL CELL, V95, P419, DOI 10.1016/S0248-4900(03)00074-1; Alberts P, 2003, MOL BIOL CELL, V14, P4207, DOI 10.1091/mbc.e03-03-0147; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; Doria M, 1999, J CELL BIOL, V147, P1379, DOI 10.1083/jcb.147.7.1379; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; GALLI T, 2004, SCI STKE, pRE19; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Juneja SC, 2005, HUM REPROD, V20, P881, DOI 10.1093/humrep/deh719; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; MIESENBOCK G, 2000, IMAGING NEURONS LAB; Mitsunari T, 2005, MOL CELL BIOL, V25, P9318, DOI 10.1128/MCB.25.21.9318-9323.2005; Morgan JR, 2003, J BIOL CHEM, V278, P33583, DOI 10.1074/jbc.M304346200; Morgan JR, 2002, NEUROMOL MED, V2, P101, DOI 10.1385/NMM:2:2:101; Muzerelle A, 2003, NEUROSCIENCE, V122, P59, DOI 10.1016/S0306-4522(03)00567-0; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; Proux-Gillardeaux V, 2007, BIOL CELL, V99, P261, DOI 10.1042/BC20060097; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sanchez-Velar N, 2004, GENE DEV, V18, P23, DOI 10.1101/gad.1149704; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STUTZ F, 1995, CELL, V82, P495, DOI 10.1016/0092-8674(95)90438-7; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417	45	48	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34365	34373		10.1074/jbc.M804587200	http://dx.doi.org/10.1074/jbc.M804587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819912	Green Published, hybrid			2022-12-25	WOS:000261277700064
J	Chien, J; Narita, K; Rattan, R; Giri, S; Shridhar, R; Staub, J; Beleford, D; Lai, J; Roberts, LR; Molina, J; Kaufmann, SH; Prendergast, GC; Shridhar, V				Chien, J.; Narita, K.; Rattan, R.; Giri, S.; Shridhar, R.; Staub, J.; Beleford, D.; Lai, J.; Roberts, L. R.; Molina, J.; Kaufmann, S. H.; Prendergast, G. C.; Shridhar, V.			A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation	ONCOGENE			English	Article						TCEAL7; Myc; cyclin D1; tumor suppressor; transformation	OVARIAN-CARCINOMA CELLS; RNA-POLYMERASE-II; BURKITT-LYMPHOMA; CANCER CELLS; EARLY-STAGE; NETWORK; PROTEIN; FIDELITY; SCREEN; HTRA1	The pathophysiological mechanisms that drive the development and progression of epithelial ovarian cancer remain obscure. Recently, we identified TCEAL7 as a transcriptional regulatory protein often downregulated in epithelial ovarian cancer. However, the biological significance of such downregulation in cancer is not currently known. Here, we show that TCEAL7 is downregulated frequently in many human cancers and that in immortalized human ovarian epithelial cells this event promotes anchorage-independent cell growth. Mechanistic investigations revealed that TCEAL7 associates with cyclin D1 promoter containing Myc E-box sequence and transcriptionally represses cyclin D1 expression. Moreover, downregulation of TCEAL7 promotes DNA-binding activity of Myc-Max, and upregulates the promoter activity of c-Myc-target gene, ornithine decarboxylase (ODC), whereas enhanced expression of TCEAL7 inhibits Myc-induced promoter activity of ODC. Our findings suggest that TCEAL7 may restrict ovarian epithelial cell transformation by limiting Myc activity. These results also suggest a potential, alternative mechanism by which c-Myc activity may be deregulated in cancer by the downregulation of TCEAL7.	[Chien, J.; Rattan, R.; Staub, J.; Beleford, D.; Shridhar, V.] Mayo Clin, Coll Med, Div Expt Pathol, Rochester, MN USA; [Narita, K.] Univ Yamanashi, Fac Med, Dept Anat & Cell Biol, Chuo Yamanashi, Japan; [Giri, S.] Med Univ S Carolina, Children Res Inst, Dept Pediat, Charleston, SC 29425 USA; [Shridhar, R.] Wayne State Univ, Dept Radiat Oncol, Sch Med, Detroit, MI 48202 USA; [Lai, J.; Roberts, L. R.] Mayo Clin, Coll Med, Dept Gastroenterol & Hepatol, Rochester, MN USA; [Molina, J.] Mayo Clin, Coll Med, Dept Med Oncol, Rochester, MN USA; [Kaufmann, S. H.] Mayo Clin, Coll Med, Dept Oncol Res, Rochester, MN USA; [Prendergast, G. C.] Lankenau Inst Med Res, Wynnewood, PA USA	Mayo Clinic; University of Yamanashi; Medical University of South Carolina; Wayne State University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Lankenau Medical Center; Lankenau Institute for Medical Research	Shridhar, V (corresponding author), Mayo Coll Med, Div Expt Pathol, 200 1st St SW,2-46 Stabile, Rochester, MN 55905 USA.	shridhar.vijayalakshmi@mayo.edu	Seal, Sudipta/A-7698-2012; Lai, Jinping/AAZ-6861-2021; Narita, Keishi/E-3539-2010; Chien, Jeremy/AID-8939-2022	Narita, Keishi/0000-0002-7602-8523; Kaufmann, Scott/0000-0002-4900-7145; Roberts, Lewis/0000-0001-7885-8574; Chien, Jeremy/0000-0003-4744-8374	Department of Defense OCRP [W81XWH-04-1-0085]; NATIONAL CANCER INSTITUTE [K12CA090628] Funding Source: NIH RePORTER	Department of Defense OCRP(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Fraternal Order of Eagle to VS, by Department of Defense OCRP W81XWH-04-1-0085 to VS, and by Edith and Bernie Waterman Foundation and the Mayo Foundation to VS.	Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Budhram-Mahadeo VS, 2006, EXPERT OPIN THER TAR, V10, P15, DOI 10.1517/14728222.10.1.15; Chien J, 1999, ONCOGENE, V18, P3376, DOI 10.1038/sj.onc.1202690; Chien J, 2005, ONCOGENE, V24, P5089, DOI 10.1038/sj.onc.1208700; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Conover CA, 1998, EXP CELL RES, V238, P439, DOI 10.1006/excr.1997.3861; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Elliott K, 1999, ONCOGENE, V18, P3564, DOI 10.1038/sj.onc.1202670; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fukumoto M, 2006, PATHOL INT, V56, P233, DOI 10.1111/J.1440-1827.2006.01960.x; GILLETT C, 1994, CANCER RES, V54, P1812; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kalli KR, 2002, ENDOCRINOLOGY, V143, P3259, DOI 10.1210/en.2001-211408; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Shridhar V, 2002, CANCER RES, V62, P262; Shridhar V, 2001, CANCER RES, V61, P5895; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; YEH CH, 1995, J BIOL CHEM, V270, P15815, DOI 10.1074/jbc.270.26.15815	32	32	34	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	58					7223	7234		10.1038/onc.2008.360	http://dx.doi.org/10.1038/onc.2008.360			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	382FI	18806825	Green Accepted			2022-12-25	WOS:000261590300001
J	Meyerkord, CL; Takahashi, Y; Araya, R; Takada, N; Weiss, RS; Wang, HG				Meyerkord, C. L.; Takahashi, Y.; Araya, R.; Takada, N.; Weiss, R. S.; Wang, H-G			Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins	ONCOGENE			English	Article						Hus1; Rad9; Bim; Puma; DNA damage; apoptosis	DNA-DAMAGE CHECKPOINT; HUMAN RAD9; GENOMIC INSTABILITY; IONIZING-RADIATION; CYCLE CHECKPOINT; BCL-2 FAMILY; MOUSE HUS1; COMPLEX; INTERACTS; RESPONSES	The Rad9-Rad1-Hus1 (9-1-1) cell cycle checkpoint complex plays a key role in the DNA damage response. Cells with a defective 9-1-1 complex have been shown to be sensitive to apoptosis induced by certain types of genotoxic stress. However, the mechanism linking the loss of a functional 9-1-1 complex to the cell death machinery has yet to be determined. Here, we report that etoposide treatment dramatically upregulates the BH3-only proteins, Bim and Puma, in Hus1-deficient cells. Inhibition of either Bim or Puma expression in Hus1-knockout cells confers significant resistance to etoposide-induced apoptosis, whereas knockdown of both proteins results in further resistance, suggesting that Bim and Puma cooperate in sensitizing Hus1-deficient cells to etoposide treatment. Moreover, we found that Rad9 collaborates with Bim and Puma to sensitize Hus1-deficient cells to etoposide-induced apoptosis. In response to DNA damage, Rad9 localizes to chromatin in Hus1-wild-type cells, whereas in Hus1-deficient cells, it is predominantly located in the cytoplasm where it binds to Bcl-2. Taken together, these results suggest that loss of Hus1 sensitizes cells to etoposide-induced apoptosis not only by inducing Bim and Puma expressions but also by releasing Rad9 into the cytosol to augment mitochondrial apoptosis.	[Meyerkord, C. L.; Takahashi, Y.; Araya, R.; Takada, N.; Wang, H-G] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL 33612 USA; [Meyerkord, C. L.; Wang, H-G] Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Canc Biol PhD Program, Tampa, FL 33612 USA; [Weiss, R. S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Cornell University	Wang, HG (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, SRB-2,12902 Magnolia Dr, Tampa, FL 33612 USA.	Hong-Gang.Wang@Moffitt.org	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817	National Institutes of Health [CA90315, CA108773]; Department of Defense Breast Cancer [BC050563]; NATIONAL CANCER INSTITUTE [R01CA090315, R01CA108773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Analytical Microscopy Core facility at the H Lee Moffitt Cancer Center and Research Institute for their technical assistance. This work was supported by grants from the National Institutes of Health (CA90315 to H-GW and CA108773 to RSW) and the Department of Defense Breast Cancer Research Program (BC050563 to CLM).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Brandt PD, 2006, BIOCHEM BIOPH RES CO, V347, P232, DOI 10.1016/j.bbrc.2006.06.064; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Burtelow MA, 2001, J BIOL CHEM, V276, P25903, DOI 10.1074/jbc.M102946200; Chen MJ, 2001, J BIOL CHEM, V276, P16580, DOI 10.1074/jbc.M008871200; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Dang TY, 2005, GENES CELLS, V10, P287, DOI 10.1111/j.1365-2443.2005.00840.x; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Ishii H, 2005, P NATL ACAD SCI USA, V102, P9655, DOI 10.1073/pnas.0504222102; Kinzel B, 2002, CANCER, V94, P1808, DOI 10.1002/cncr.10383; Komatsu K, 2000, FEBS LETT, V481, P122, DOI 10.1016/S0014-5793(00)01975-X; Komatsu K, 2000, NAT CELL BIOL, V2, P1, DOI 10.1038/71316; Lee MW, 2003, ONCOGENE, V22, P6340, DOI 10.1038/sj.onc.1206729; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Loegering D, 2004, J BIOL CHEM, V279, P18641, DOI 10.1074/jbc.M313536200; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Weiss RS, 2000, GENE DEV, V14, P1886; Weiss RS, 2003, MOL CELL BIOL, V23, P791, DOI 10.1128/MCB.23.3.791-803.2003; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wong HK, 2005, MOL CELL BIOL, V25, P8732, DOI 10.1128/MCB.25.19.8732-8747.2005; Yang JY, 2006, INT J ONCOL, V29, P643; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	50	9	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	58					7248	7259		10.1038/onc.2008.336	http://dx.doi.org/10.1038/onc.2008.336			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	382FI	18794804	Green Accepted			2022-12-25	WOS:000261590300003
J	Kariya, Y; Kato, R; Itoh, S; Fukuda, T; Shibukawa, Y; Sanzen, N; Sekiguchi, K; Wada, Y; Kawasaki, N; Gu, JG				Kariya, Yoshinobu; Kato, Rika; Itoh, Satsuki; Fukuda, Tomohiko; Shibukawa, Yukinao; Sanzen, Noriko; Sekiguchi, Kiyotoshi; Wada, Yoshinao; Kawasaki, Nana; Gu, Jianguo			N-Glycosylation of Laminin-332 Regulates Its Biological Functions A NOVEL FUNCTION OF THE BISECTING GlcNAc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; ACETYLGLUCOSAMINYLTRANSFERASE-V; CELL-MIGRATION; MATRIX METALLOPROTEASE-2; ALPHA-3-BETA-1 INTEGRIN; LIQUID-CHROMATOGRAPHY; PHASEOLUS-VULGARIS; MASS-SPECTROMETRY; TUMOR-GROWTH; HUMAN-BREAST	Laminin-332 (Lm332) is a large heterotrimeric glycoprotein that has been identified as a scattering factor, a regulator of cancer invasion as well as a prominent basement membrane component of the skin. Past studies have identified the functional domains of Lm332 and revealed the relationships between its activities and the processing of its subunits. However, there is little information available concerning the effects of N-glycosylation on Lm332 activities. In some cancer cells, an increase of beta 1,6-GlcNAc catalyzed by N-acetylglucosaminyltransferase V (GnT-V) is related to the promotion of cancer cell motility. By contrast, bisecting GlcNAc catalyzed by N-acetylglucosaminyltransferase III (GnT-III) suppresses the further processing with branching enzymes, such as GnT-V, and the elongation of N-glycans. To examine the effects of those N-glycosylations to Lm332 on its activities, we purified Lm332s from the conditioned media of GnT-III- and GnT-V-overexpressing MKN45 cells. Lectin blotting and mass spectrometry analyses revealed that N-glycans containing the bisecting GlcNAc and beta 1,6-GlcNAc structures were strongly expressed on Lm332 purified from GnT-III-overexpressing (GnT-III-Lm332) and GnT-V-overexpressing (GnT-V-Lm332) cells, respectively. Interestingly, the cell adhesion activity of GnT-III-Lm332 was apparently decreased compared with those of control Lm332 and GnT-V-Lm332. In addition, the introduction of bisecting GlcNAc to Lm332 resulted in a decrease in its cell scattering and migration activities. The weakened activities were most likely derived from the impaired alpha 3 beta 1 integrin clustering and resultant focal adhesion formation. Taken together, our results clearly demonstrate for the first time that N-glycosylation may regulate the biological function of Lm332. This finding could introduce a new therapeutic strategy for cancer.	[Kariya, Yoshinobu; Kato, Rika; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Itoh, Satsuki; Kawasaki, Nana] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Shibukawa, Yukinao; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Izumi Ku, Osaka 5941101, Japan; [Shibukawa, Yukinao; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Sanzen, Noriko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Div Prot Chem, Suita, Osaka 5650871, Japan	Tohoku Medical & Pharmaceutical University; National Institute of Health Sciences - Japan; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020	Sanzen, Noriko/0000-0001-6518-403X	Core Research for Evolutional Science and Technology (CREST); apan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); apan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (JST), and the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; CARTER BZ, 1991, LAB INVEST, V65, P610; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DEAN JW, 1990, J BIOL CHEM, V265, P12553; DENNIS JW, 1989, CANCER RES, V49, P945; FERNANDES B, 1991, CANCER RES, V51, P718; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Granovsky M, 2000, NAT MED, V6, P306; GREEN TL, 1992, J BIOL CHEM, V267, P2014; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Handerson T, 2003, CANCER RES, V63, P5363; Hirosaki T, 2002, J BIOL CHEM, V277, P49287, DOI 10.1074/jbc.M111096200; HOWE CC, 1984, MOL CELL BIOL, V4, P1; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Itoh S, 2006, J CHROMATOGR A, V1103, P296, DOI 10.1016/j.chroma.2005.11.043; Kariya Y, 2003, J CELL BIOCHEM, V88, P506, DOI 10.1002/jcb.10350; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kunneken K, 2004, J BIOL CHEM, V279, P5184, DOI 10.1074/jbc.M310424200; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; MATSUI C, 1995, J BIOL CHEM, V270, P23496, DOI 10.1074/jbc.270.40.23496; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Murata K, 2000, CLIN CANCER RES, V6, P1772; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Paret C, 2005, INT J CANCER, V115, P724, DOI 10.1002/ijc.20977; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; Ryan MC, 1996, MATRIX BIOL, V15, P369, DOI 10.1016/S0945-053X(96)90157-2; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; Tsubota Y, 2005, J BIOL CHEM, V280, P14370, DOI 10.1074/jbc.M413051200; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	44	36	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33036	33045		10.1074/jbc.M804526200	http://dx.doi.org/10.1074/jbc.M804526200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18812317	Green Published, hybrid			2022-12-25	WOS:000261183700003
J	Tejero, JS; Biswas, A; Wang, ZQ; Page, RC; Haque, MM; Hemann, C; Zweier, JL; Misra, S; Stuehr, DJ				Tejero, Jesu S.; Biswas, Ashis; Wang, Zhi-Qiang; Page, Richard C.; Haque, Mohammad Mahfuzul; Hemann, Craig; Zweier, Jay L.; Misra, Saurav; Stuehr, Dennis J.			Stabilization and Characterization of a Heme-Oxy Reaction Intermediate in Inducible Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPOUND-I FORMATION; S HYDROGEN-BOND; ELECTRON-TRANSFER; OXYGENASE DOMAIN; L-ARGININE; CYTOCHROME P450CAM; SINGLE-TURNOVER; KINETIC CHARACTERIZATION; SUBUNIT DIMERIZATION; DIOXYGEN COMPLEX	Nitric-oxide synthases ( NOS) are heme-thiolate enzymes that N-hydroxylate L-arginine (L-Arg) to make NO. NOS contain a unique Trp residue whose side chain stacks with the heme and hydrogen bonds with the heme thiolate. To understand its importance we substituted His for Trp(188) in the inducible NOS oxygenase domain (iNOSoxy) and characterized enzyme spectral, thermodynamic, structural, kinetic, and catalytic properties. The W188H mutation had relatively small effects on L-Arg binding and on enzyme heme-CO and heme-NO absorbance spectra, but increased the heme midpoint potential by 88 mV relative to wildtype iNOSoxy, indicating it decreased heme-thiolate electronegativity. The protein crystal structure showed that the His(188) imidazole still stacked with the heme and was positioned to hydrogen bond with the heme thiolate. Analysis of a single turnover L-Arg hydroxylation reaction revealed that a new heme species formed during the reaction. Its build up coincided kinetically with the disappearance of the enzyme heme-dioxy species and with the formation of a tetrahydrobiopterin (H4B) radical in the enzyme, whereas its subsequent disappearance coincided with the rate of L-Arg hydroxylation and formation of ferric enzyme. We conclude: (i) W188H iNOSoxy stabilizes a heme-oxy species that forms upon reduction of the heme-dioxy species by H4B.(ii) The W188H mutation hinders either the processing or reactivity of the heme-oxy species and makes these steps become rate-limiting for L-Arg hydroxylation. Thus, the conserved Trp residue in NOS may facilitate formation and/or reactivity of the ultimate hydroxylating species by tuning heme-thiolate electronegativity.	[Tejero, Jesu S.; Biswas, Ashis; Wang, Zhi-Qiang; Haque, Mohammad Mahfuzul; Stuehr, Dennis J.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Page, Richard C.; Misra, Saurav] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Wang, Zhi-Qiang] Kent State Univ Tuscarawas, Dept Chem, New Philadelphia, OH 44663 USA; [Hemann, Craig; Zweier, Jay L.] Ohio State Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med,Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Tuscarawas; University System of Ohio; Ohio State University	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; HAQUE, MOHAMMAD/0000-0003-0852-6368; Misra, Saurav/0000-0002-1385-8554; Page, Richard/0000-0002-3006-3171; Hemann, Craig/0000-0002-7380-4072	National Institutes of Health [CA53914, GM51491, HL76491, GM080271, HL63744, HL65608, HL38324]; American Heart Association [0565297B]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL063744, R01HL038324, R29HL038324, P01HL065608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491, R01GM080271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53914, GM51491, HL76491 (to D. J. S.), GM080271 (to S. M.), HL63744, HL65608, and HL38324 (to J. L. Z.). This work was also supported by American Heart Association Beginning Grant-in-Aid 0565297B (to Z.-Q. W.). The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AbuSoud HM, 1997, J BIOL CHEM, V272, P17349, DOI 10.1074/jbc.272.28.17349; AbuSoud HM, 1997, BIOCHEMISTRY-US, V36, P10811, DOI 10.1021/bi971414g; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Barbato JE, 2004, J VASC SURG, V40, P187, DOI 10.1016/j.jvs.2004.03.043; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; Benson DE, 1997, BIOCHEMISTRY-US, V36, P5104, DOI 10.1021/bi963170q; Berka V, 2008, BIOCHEMISTRY-US, V47, P405, DOI 10.1021/bi701677r; Boggs S, 2000, BIOCHEMISTRY-US, V39, P2332, DOI 10.1021/bi9920228; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Cho KB, 2007, J AM CHEM SOC, V129, P3182, DOI 10.1021/ja066662r; Clark JP, 2006, J INORG BIOCHEM, V100, P1075, DOI 10.1016/j.jinorgbio.2005.11.020; Couture M, 2000, J BIOL CHEM, V275, P3201, DOI 10.1074/jbc.275.5.3201; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Davydov R, 2002, BIOCHEMISTRY-US, V41, P10375, DOI 10.1021/bi0260637; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; de Visser SP, 2008, J AM CHEM SOC, V130, P12961, DOI 10.1021/ja8010995; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denisov IG, 2007, BIOCHEM BIOPH RES CO, V363, P954, DOI 10.1016/j.bbrc.2007.09.085; Efimov I, 2007, BIOCHEMISTRY-US, V46, P8017, DOI 10.1021/bi7006492; EGAWA T, 1994, BIOCHEM BIOPH RES CO, V201, P1464, DOI 10.1006/bbrc.1994.1868; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Glascock MC, 2005, J BIOL CHEM, V280, P42134, DOI 10.1074/jbc.M505426200; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Groves JT, 2000, CURR OPIN CHEM BIOL, V4, P687, DOI 10.1016/S1367-5931(00)00146-0; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Jung C, 2005, MAGN RESON CHEM, V43, pS84, DOI 10.1002/mrc.1694; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; Ledbetter AP, 1999, BIOCHEMISTRY-US, V38, P8014, DOI 10.1021/bi990619h; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Li HY, 2001, BIOCHEMISTRY-US, V40, P5399, DOI 10.1021/bi002658v; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Makris TM, 2006, J INORG BIOCHEM, V100, P507, DOI 10.1016/j.jinorgbio.2006.01.025; Mansuy Daniel, 1995, P537; Marchal S, 2004, J BIOL CHEM, V279, P19824, DOI 10.1074/jbc.M313587200; Matsumura H, 2008, BIOCHEMISTRY-US, V47, P4834, DOI 10.1021/bi800142v; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCMILLAN K, 1993, BIOCHEMISTRY-US, V32, P9875, DOI 10.1021/bi00089a001; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Ogliaro F, 2002, J INORG BIOCHEM, V91, P554, DOI 10.1016/S0162-0134(02)00437-3; Ogliaro F, 2000, J AM CHEM SOC, V122, P12892, DOI 10.1021/ja005619f; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; PAPALE D, 2007, J BIOL INORG CHEM, V12, pS199; Pfeiffer S, 1999, ANGEW CHEM INT EDIT, V38, P1715, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1714::AID-ANIE1714>3.0.CO;2-3; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Poulos TL, 2005, PHILOS T R SOC A, V363, P793, DOI 10.1098/rsta.2004.1537; Poulos TL, 1996, J BIOL INORG CHEM, V1, P356, DOI 10.1007/s007750050064; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Raner GM, 2006, J INORG BIOCHEM, V100, P2045, DOI 10.1016/j.jinorgbio.2006.09.025; Scheiner S, 2002, J AM CHEM SOC, V124, P13257, DOI 10.1021/ja027200q; Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; Shikama K, 2006, PROG BIOPHYS MOL BIO, V91, P83, DOI 10.1016/j.pbiomolbio.2005.04.001; Sligar SG, 2005, BIOCHEM BIOPH RES CO, V338, P346, DOI 10.1016/j.bbrc.2005.08.094; Song YF, 2006, BIOCHEMISTRY-US, V45, P7949, DOI 10.1021/bi052182l; SONO M, 1995, J BIOL CHEM, V270, P19943, DOI 10.1074/jbc.270.34.19943; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sorlie M, 2003, J BIOL CHEM, V278, P48602, DOI 10.1074/jbc.M305682200; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Suzuki N, 1999, J AM CHEM SOC, V121, P11571, DOI 10.1021/ja992511v; Ueyama N, 1996, INORG CHEM, V35, P6473, DOI 10.1021/ic9604324; Ueyama N, 1998, INORG CHEM, V37, P2415, DOI 10.1021/ic971140l; Voigt P, 2003, J BIOL CHEM, V278, P51993, DOI 10.1074/jbc.M307560200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang ZQ, 2002, J BIOL CHEM, V277, P12830, DOI 10.1074/jbc.M111967200; Wang ZQ, 2001, BIOCHEMISTRY-US, V40, P12819, DOI 10.1021/bi011182s; Wei CC, 2003, BIOCHEMISTRY-US, V42, P1969, DOI 10.1021/bi026898h; Wei CC, 2001, J BIOL CHEM, V276, P315, DOI 10.1074/jbc.M008441200; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; Whitwam RE, 1999, BIOCHEMISTRY-US, V38, P9608, DOI 10.1021/bi982568e; Wilson DJ, 2001, BIOCHEM BIOPH RES CO, V287, P126, DOI 10.1006/bbrc.2001.5559; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763; Yoshioka S, 2002, J AM CHEM SOC, V124, P14571, DOI 10.1021/ja0265409; Yoshioka S, 2000, J INORG BIOCHEM, V81, P141, DOI 10.1016/S0162-0134(00)00097-0; Yun HY, 1997, MOL PSYCHIATR, V2, P300, DOI 10.1038/sj.mp.4000272; Zhu YQ, 2008, BIOCHEMISTRY-US, V47, P2231, DOI 10.1021/bi7023817	96	45	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33498	33507		10.1074/jbc.M806122200	http://dx.doi.org/10.1074/jbc.M806122200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18815130	hybrid, Green Published			2022-12-25	WOS:000261183700054
J	Metzger, MB; Maurer, MJ; Dancy, BM; Michaelis, S				Metzger, Meredith Boyle; Maurer, Matthew J.; Dancy, Beverley M.; Michaelis, Susan			Degradation of a Cytosolic Protein Requires Endoplasmic Reticulum-associated Degradation Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER QUALITY-CONTROL; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN-PROTEASOME PATHWAY; HEAT-SHOCK PROTEINS; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; IN-VIVO; TRANSCRIPTIONAL REGULATOR; MAT-ALPHA-2 REPRESSOR; MISFOLDED PROTEINS	Protein misfolding is monitored by a variety of cellular "quality control" systems. Endoplasmic reticulum (ER) quality control handles misfolded secretory and membrane proteins and is well characterized. However, less is known about the quality control of misfolded cytosolic proteins (CytoQC). To study CytoQC, we have employed a genetic system in Saccharomyces cerevisiae using a transplantable degron, CL1 (1). Attachment of CL1 to the cytosolic protein Ura3p destabilizes Ura3p, targeting it for rapid proteasomal degradation. We have performed a comprehensive analysis of Ura3p-CL1 degradation requirements. As shown previously, we observe that the ER-localized ubiquitin E2 (Ubc6p, Ubc7p, and Cue1p) and E3 (Doa10p) machinery involved in ER-associated degradation (ERAD) are also responsible for the degradation of the cytosolic substrate Ura3p-CL1. Importantly, we find that the cytosol/ER membrane-localized chaperones Ydj1p and Ssa1p, known to be necessary for the ERAD of membrane proteins with misfolded cytosolic domains, are also required for the ubiquitination and degradation of Ura3p-CL1. In addition, we show a role for the Cdc48p-Npl4p-Ufd1p complex in the degradation of Ura3p-CL1. When ubiquitination is blocked, a portion of Ura3p-CL1 is ER membrane-localized. Furthermore, access to the cytosolic face of the ER is required for the degradation of CL1 degron-containing proteins. The ER is distributed throughout the cytosol, and our data, together with previous studies, suggest that the cytosolic face of the ER membrane serves as a "platform" for the degradation of Ura3p-CL1, which may also be the case for other CytoQC substrates.	[Metzger, Meredith Boyle; Maurer, Matthew J.; Dancy, Beverley M.; Michaelis, Susan] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Michaelis, S (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	michaelis@jhmi.edu	Rabbitts, Beverley M./W-1376-2019	Rabbitts, Beverley M./0000-0002-0896-6024; Maurer, Matthew/0000-0002-9150-0240; Metzger, Meredith/0000-0002-6248-0009	National Institutes of Health [GM51508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51508 (to S. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1992, J BIOL CHEM, V267, P20927; den Boon JA, 2001, J VIROL, V75, P12370, DOI 10.1128/JVI.75.24.12370-12381.2001; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; GAIGG B, 1995, BBA-BIOMEMBRANES, V1234, P214, DOI 10.1016/0005-2736(94)00287-Y; Gandre S, 2002, BIOCHEM BIOPH RES CO, V293, P139, DOI 10.1016/S0006-291X(02)00194-8; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; HEINEMEYER W, 1991, BIOCHEM SOC T, V19, P724, DOI 10.1042/bst0190724; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JARIELENCONTRE I, 2008, BIOCH BIOPHYS ACTA; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Lenk U, 2000, J BIOL CHEM, V275, P39403, DOI 10.1074/jbc.M006949200; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; MICHAELIS S, 1988, MOL CELL BIOL, V8, P1309, DOI 10.1128/MCB.8.3.1309; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; SIKORSKI RS, 1989, GENETICS, V122, P19; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	77	103	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32302	32316		10.1074/jbc.M806424200	http://dx.doi.org/10.1074/jbc.M806424200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18812321	Green Published, hybrid			2022-12-25	WOS:000260893700017
J	Pioszak, AA; Parker, NR; Suino-Powell, K; Xu, HE				Pioszak, Augen A.; Parker, Naomi R.; Suino-Powell, Kelly; Xu, H. Eric			Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST EXTRACELLULAR DOMAIN; N-TERMINAL DOMAIN; COMPETITIVE ANTAGONISTS; LIGAND-BINDING; CRYSTAL-STRUCTURE; HIGH-AFFINITY; SOLUBLE FORM; PEPTIDE; UROCORTIN; IDENTIFICATION	The bimolecular interaction between corticotropin-releasing factor (CRF), a neuropeptide, and its type 1 receptor (CRFR1), a class B G-protein-coupled receptor (GPCR), is crucial for activation of the hypothalamic-pituitary-adrenal axis in response to stress, and has been a target of intense drug design for the treatment of anxiety, depression, and related disorders. As a class B GPCR, CRFR1 contains an N-terminal extracellular domain (ECD) that provides the primary ligand binding determinants. Here we present three crystal structures of the human CRFR1 ECD, one in a ligand-free form and two in distinct CRF-bound states. The CRFR1 ECD adopts the alpha-beta-beta alpha fold observed for other class B GPCR ECDs, but the N-terminal alpha-helix is significantly shorter and does not contact CRF. CRF adopts a continuous alpha-helix that docks in a hydrophobic surface of the ECD that is distinct from the peptide-binding site of other class B GPCRs, thereby providing a basis for the specificity of ligand recognition between CRFR1 and other class B GPCRs. The binding of CRF is accompanied by clamp-like conformational changes of two loops of the receptor that anchor the CRF C terminus, including the C-terminal amide group. These structural studies provide a molecular framework for understanding peptide binding and specificity by the CRF receptors as well as a template for designing potent and selective CRFR1 antagonists for therapeutic applications.	[Pioszak, Augen A.; Parker, Naomi R.; Suino-Powell, Kelly; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	Van Andel Institute	Pioszak, AA (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	augie.pioszak@vai.org; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301]; The Jay and Betty Van Andel Foundation; Michigan Economic Development Corporation [085P1000817]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Jay and Betty Van Andel Foundation; Michigan Economic Development Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662, DK066202, and HL089301. This work was also supported by The Jay and Betty Van Andel Foundation and Michigan Economic Development Corporation Grant 085P1000817. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Dautzenberg FM, 1998, P NATL ACAD SCI USA, V95, P4941, DOI 10.1073/pnas.95.9.4941; Dautzenberg FM, 1999, J NEUROCHEM, V73, P821, DOI 10.1046/j.1471-4159.1999.0730821.x; De Lano W.L., 2002, PY MOL MOL GRAPHICS; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; HERNANDEZ JF, 1993, J MED CHEM, V36, P2860, DOI 10.1021/jm00072a004; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Klose J, 2005, BIOCHEMISTRY-US, V44, P1614, DOI 10.1021/bi049022e; KORNREICH WD, 1992, J MED CHEM, V35, P1870, DOI 10.1021/jm00088a024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; Liaw CW, 1997, MOL ENDOCRINOL, V11, P2048, DOI 10.1210/me.11.13.2048; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesleh MF, 2007, J BIOL CHEM, V282, P6338, DOI 10.1074/jbc.M609816200; MIRANDA A, 1994, J MED CHEM, V37, P1450, DOI 10.1021/jm00036a010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2007, J BIOL CHEM, V282, P37529, DOI 10.1074/jbc.M703748200; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rijkers DTS, 2004, CHEMBIOCHEM, V5, P340, DOI 10.1002/cbic.200300769; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; Ruhmann A, 1998, P NATL ACAD SCI USA, V95, P15264, DOI 10.1073/pnas.95.26.15264; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Wille S, 1999, J NEUROCHEM, V72, P388, DOI 10.1046/j.1471-4159.1999.0720388.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamada Y, 2004, J MED CHEM, V47, P1075, DOI 10.1021/jm034180+	52	132	139	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32900	32912		10.1074/jbc.M805749200	http://dx.doi.org/10.1074/jbc.M805749200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801728	hybrid, Green Published			2022-12-25	WOS:000260893700079
J	Ujvari, A; Hsieh, FK; Luse, SW; Studitsky, VM; Luse, DS				Ujvari, Andrea; Hsieh, Fu-Kai; Luse, Susan W.; Studitsky, Vasily M.; Luse, Donal S.			Histone N-terminal Tails Interfere with Nucleosome Traversal by RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE PARTICLES; RECOMBINANT HISTONES; CHIRAL TRANSITION; DNA INTERACTIONS; TRANSCRIPTION; CHROMATIN; ELONGATION; ACETYLATION; STABILITY; H2A/H2B	We determined the effect of the N-terminal histone tails on nucleosome traversal by yeast and human RNA polymerase II (pol II). Removal of H2A/H2B tails, H3/H4 tails, or all tails increased complete traversal of the nucleosome by human pol II, although the increase varied considerably depending on the template and on which tails were removed. Human pol II achieved >80% traversal of one nucleosomal template lacking the H2A/H2B tails, but even in those reactions, the transcript elongation rate was lower than the rate on pure DNA templates. For yeast pol II, transcription proceeded much farther into the nucleosome in the absence of tails, but complete read-through was not substantially increased by tail removal. Transcription factor IIS provided roughly the same level of read-through stimulation for transcript elongation in the presence or absence of tails. FACT also stimulated elongation on nucleosomal templates, and this effect was similar regardless of the presence of tails. For both polymerases, removal of the H2A/H2B tails reduced pausing throughout the nucleosome, suggesting that histone tails affect a common step at most points during nucleosome traversal. We conclude that histone tails provide a significant part of the nucleosomal barrier to pol II transcript elongation.	[Ujvari, Andrea; Luse, Susan W.; Luse, Donal S.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Hsieh, Fu-Kai; Studitsky, Vasily M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Cleveland Clinic Foundation; Rutgers State University New Brunswick; Rutgers State University Medical Center	Luse, DS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Genet, NE20,9500 Euclid Ave, Cleveland, OH 44195 USA.	lused@ccf.org	Studitsky, Vasily/A-9382-2014		National Institutes of Health [GM58650]; National Science Foundation [0646019, 0743298]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58650 (to V. M. S.). This work was also supported by National Science Foundation Grants 0646019 and 0743298 (to D. S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bertin A, 2007, EUR BIOPHYS J BIOPHY, V36, P1083, DOI 10.1007/s00249-007-0212-9; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Carruthers LM, 2000, J BIOL CHEM, V275, P37285, DOI 10.1074/jbc.M006801200; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; HILL CS, 1990, EUR J BIOCHEM, V187, P145, DOI 10.1111/j.1432-1033.1990.tb15288.x; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KM, 1997, P NATL ACAD SCI USA, V94, P8959, DOI 10.1073/pnas.94.17.8959; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; MORSE RH, 1986, NUCLEIC ACIDS RES, V14, P3293, DOI 10.1093/nar/14.8.3293; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sivolob A, 2000, J MOL BIOL, V295, P55, DOI 10.1006/jmbi.1999.3302; Studitsky VM, 1999, METH MOL B, V119, P17; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Widlund HR, 2000, BIOCHEMISTRY-US, V39, P3835, DOI 10.1021/bi991957l; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200	37	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32236	32243		10.1074/jbc.M806636200	http://dx.doi.org/10.1074/jbc.M806636200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815126	Green Published, hybrid			2022-12-25	WOS:000260893700010
J	Anderka, O; Boyken, J; Aschenbach, U; Batzer, A; Boscheinen, O; Schmoll, D				Anderka, Oliver; Boyken, Janina; Aschenbach, Ursula; Batzer, Andreas; Boscheinen, Oliver; Schmoll, Dieter			Biophysical Characterization of the Interaction between Hepatic Glucokinase and Its Regulatory Protein IMPACT OF PHYSIOLOGICAL AND PHARMACOLOGICAL EFFECTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; LIVER GLUCOKINASE; LIGAND INTERACTIONS; GLUCOSE-METABOLISM; BINDING ENERGETICS; DIABETES THERAPY; HEAT-CAPACITY; THERMODYNAMICS; TRANSLOCATION; FRUCTOSE	Glucokinase (GK) is a key enzyme of glucose metabolism in liver and pancreatic beta-cells, and small molecule activators of GK (GKAs) are under evaluation for the treatment of type 2 diabetes. In liver, GK activity is controlled by the GK regulatory protein (GKRP), which forms an inhibitory complex with the enzyme. Here, we performed isothermal titration calorimetry and surface plasmon resonance experiments to characterize GK-GKRP binding and to study the influence that physiological and pharmacological effectors of GK have on the protein-protein interaction. In the presence of fructose-6-phosphate, GK-GKRP complex formation displayed a strong entropic driving force opposed by a large positive enthalpy; a negative change in heat capacity was observed (K-d = 45 nM, Delta H = 15.6 kcal/mol, T Delta S = 25.7 kcal/mol, Delta C-p = -354 cal mol(-1) K-1). With k(off) = 1.3 x 10(-2) s(-1), the complex dissociated quickly. The thermodynamic profile suggested a largely hydrophobic interaction. In addition, effects of pH and buffer demonstrated the coupled uptake of one proton and indicated an ionic contribution to binding. Glucose decreased the binding affinity between GK and GKRP. This decrease was potentiated by an ATP analogue. Prototypical GKAs of the amino-heteroaryl-amide type bound to GK in a glucose-dependent manner and impaired the association of GK with GKRP. This mechanism might contribute to the antidiabetic effects of GKAs.	[Anderka, Oliver; Boyken, Janina; Aschenbach, Ursula; Batzer, Andreas; Boscheinen, Oliver; Schmoll, Dieter] Sanofi Aventis Deutschland GmbH, Res & Dev, D-65926 Frankfurt, Germany; [Boyken, Janina] Ernst Moritz Arndt Univ Greifswald, Inst Med Biochem & Mol Biol, D-17487 Greifswald, Germany	Sanofi-Aventis; Ernst Moritz Arndt Universitat Greifswald	Anderka, O (corresponding author), Sanofi Aventis Deutschland GmbH, Res & Dev, D-65926 Frankfurt, Germany.	oliver.anderka@sanofi-aventis.com		Schmoll, Dieter/0000-0003-2578-3366				Agius L, 1998, ADV ENZYME REGUL, V38, P303, DOI 10.1016/S0065-2571(97)00001-0; Agius L, 1997, BIOCHEM SOC T, V25, P145, DOI 10.1042/bst0250145; AGIUS L, 1993, BIOCHEM J, V296, P785, DOI 10.1042/bj2960785; Anderka O, 2008, BIOCHEMISTRY-US, V47, P4683, DOI 10.1021/bi702397d; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Baltrusch S, 2006, DIABETES, V55, pS55, DOI 10.2337/db06-S008; Brocklehurst KJ, 2004, BIOCHEM J, V378, P693, DOI 10.1042/BJ20031414; Brocklehurst KJ, 2004, DIABETES, V53, P535, DOI 10.2337/diabetes.53.3.535; Chu CA, 2004, AM J PHYSIOL-GASTR L, V286, pG627, DOI 10.1152/ajpgi.00218.2003; DETHEUX M, 1991, EUR J BIOCHEM, V200, P553, DOI 10.1111/j.1432-1033.1991.tb16218.x; Doyle ML, 1995, METHOD ENZYMOL, V259, P183; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.3.CO;2-F; Futamura M, 2006, J BIOL CHEM, V281, P37668, DOI 10.1074/jbc.M605186200; Gakamsky DM, 2004, P NATL ACAD SCI USA, V101, P9063, DOI 10.1073/pnas.0402840101; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x; Holdgate GA, 2001, BIOTECHNIQUES, V31, P164; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kim YB, 2007, BIOCHEMISTRY-US, V46, P1423, DOI 10.1021/bi0617308; Ladbury JE, 2004, CURR OPIN STRUC BIOL, V14, P562, DOI 10.1016/j.sbi.2004.08.001; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; LUTHER MA, 1986, BIOCHEMISTRY-US, V25, P7931, DOI 10.1021/bi00372a022; Mackay JP, 2007, TRENDS BIOCHEM SCI, V32, P530, DOI 10.1016/j.tibs.2007.09.006; Matschinsky FM, 2006, DIABETES, V55, P1; Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470; Mookhtiar KA, 1996, DIABETES, V45, P1670, DOI 10.2337/diabetes.45.12.1670; Moukil MA, 2000, DIABETES, V49, P195, DOI 10.2337/diabetes.49.2.195; MURPHY KP, 1993, PROTEINS, V15, P113, DOI 10.1002/prot.340150203; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; O'Brien R, 2004, BIOCALORIMETRY, P1; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Ralph EC, 2008, BIOCHEMISTRY-US, V47, P5028, DOI 10.1021/bi702516y; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Shin JS, 2007, AM J PHYSIOL-REG I, V292, pR1381, DOI 10.1152/ajpregu.00260.2006; Shiota M, 1998, DIABETES, V47, P867, DOI 10.2337/diabetes.47.6.867; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Thomson J.A., 2004, BIOCALORIMETRY, P37; VANDERCAMMEN A, 1991, EUR J BIOCHEM, V200, P545, DOI 10.1111/j.1432-1033.1991.tb16217.x; VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; Veiga-da-Cunha M, 2003, DIABETOLOGIA, V46, P704, DOI 10.1007/s00125-003-1083-y; Veiga-da-Cunha M, 2002, J BIOL CHEM, V277, P8466, DOI 10.1074/jbc.M105984200; VeigadaCunha M, 1996, DIABETOLOGIA, V39, P1173, DOI 10.1007/BF02658503; VeigadaCunha M, 1996, J BIOL CHEM, V271, P6292, DOI 10.1074/jbc.271.11.6292; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; XIE D, 1994, PROTEINS, V19, P291, DOI 10.1002/prot.340190404; 1997, KINETIC AFFINITY ANA	53	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31333	31340		10.1074/jbc.M805434200	http://dx.doi.org/10.1074/jbc.M805434200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18809676	hybrid			2022-12-25	WOS:000260760800010
J	Gillette, TG; Kumar, B; Thompson, D; Slaughter, CA; DeMartino, GN				Gillette, Thomas G.; Kumar, Brajesh; Thompson, David; Slaughter, Clive A.; DeMartino, George N.			Differential Roles of the COOH Termini of AAA Subunits of PA700 (19 S Regulator) in Asymmetric Assembly and Activation of the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; ATP-DEPENDENT ACTIVATOR; 20S PROTEASOME; MULTICATALYTIC PROTEINASE; CROSS-LINKING; PURIFICATION; PARTICLE; ATPASES; IDENTIFICATION; BINDING	The 26 S proteasome is an energy-dependent protease that degrades proteins modified with polyubiquitin chains. It is assembled from two multi-protein subcomplexes: a protease (20 S proteasome) and an ATPase regulatory complex (PA700 or 19 S regulatory particle) that contains six different AAA family subunits (Rpt1 to -6). Here we show that binding of PA700 to the 20 S proteasome is mediated by the COOH termini of two (Rpt2 and Rpt5) of the six Rpt subunits that constitute the interaction surface between the subcomplexes. COOH-terminal peptides of either Rpt2 or Rpt5 bind to the 20 S proteasome and activate hydrolysis of short peptide substrates. Simultaneous binding of both COOH-terminal peptides had additive effects on peptide substrate hydrolysis, suggesting that they bind to distinct sites on the proteasome. In contrast, only the Rpt5 peptide activated hydrolysis of protein substrates. Nevertheless, the COOH-terminal peptide of Rpt2 greatly enhanced this effect, suggesting that proteasome activation is a multistate process. Rpt2 and Rpt5 COOH-terminal peptides cross-linked to different but specific subunits of the 20 S proteasome. These results reveal critical roles of COOH termini of Rpt subunits of PA700 in the assembly and activation of eukaryotic 26 S proteasome. Moreover, they support a model in which Rpt subunits bind to dedicated sites on the proteasome and play specific, nonequivalent roles in the asymmetric assembly and activation of the 26 S proteasome.	[Gillette, Thomas G.; Kumar, Brajesh; Thompson, David; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Slaughter, Clive A.] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu			National Institutes of Health [R01 DK46181]; Welch Foundation [I-500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK46181. This work was also supported by Welch Foundation Grant I-500 (to G.N.D.).	Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beyer A, 1997, PROTEIN SCI, V6, P2043; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Burdine L, 2004, J AM CHEM SOC, V126, P11442, DOI 10.1021/ja045982c; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; MA CP, 1994, J BIOL CHEM, V269, P3539; MA CP, 1992, J BIOL CHEM, V267, P10515; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; MYKLES DL, 1991, ARCH BIOCHEM BIOPHYS, V288, P543, DOI 10.1016/0003-9861(91)90233-9; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Song XL, 1997, J BIOL CHEM, V272, P27994, DOI 10.1074/jbc.272.44.27994; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807	42	119	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31813	31822		10.1074/jbc.M805935200	http://dx.doi.org/10.1074/jbc.M805935200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18796432	Green Published, hybrid			2022-12-25	WOS:000260760800064
J	Kim, IY; Li, CX; Liang, D; Chen, XZ; Coffy, RJ; Ma, J; Zhao, P; Wu, GQ				Kim, Ingyu; Li, Cunxi; Liang, Dan; Chen, Xing-Zhen; Coffy, Robert J.; Ma, Jie; Zhao, Ping; Wu, Guanqing			Polycystin-2 Expression Is Regulated by a PC2-binding Domain in the Intracellular Portion of Fibrocystin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE ARPKD; AUTOSOMAL-DOMINANT; PRIMARY CILIA; TRP CHANNELS; PROTEIN; GENE; PKHD1; ENCODES; PKD2; INACTIVATION	Autosomal dominant (ADPKD) and autosomal recessive (ARPKD) polycystic kidney disease are caused by mutations in Pkd1/Pkd2 and Pkhd1, which encode polycystins (PCs) and fibrocystin/ polyductin (FPC). Our recent study reported that a deficiency in FPC increases the severity of cystic disease in Pkd2 mutantsanddown-regulates PC2 in vivo, buttheprecisemolecular mechanism of these effects is unknown (Kim, I., Fu, Y., Hui, K., Moeckel, G., Mai, W., Li, C., Liang, D., Zhao, P., Ma, J., Chen, X.-Z., George, A. L., Jr., Coffey, R. J., Feng, Z. P., and Wu, G. (2008) J. Am. Soc. Nephrol. 19, 455 - 468). In this study, through the use of deletion and mutagenesis strategies, we identified a PC2-binding domain in the intracellular C terminus of FPC and an FPC-binding domain in the intracellular N terminus of PC2. These binding domains provide a molecular basis for the physical interaction between PC2 and FPC. In addition, we also found that physical interaction between the binding domains of PC2 and FPC is able to prevent down-regulation of PC2 induced by loss of FPC. In vivo, we generated a mouse model of ADPKD with hypomorphic Pkd2 alleles (Pkd2(nf3/nf3)) and show that PC2 down-regulation is accompanied by a phenotype similar to that of Pkhd1(-/)-mice. These findings demonstrate a common mechanism underlying cystogenesis in ADPKD and ARPKD and provide insight into the molecular relationship between PC2 and FPC.	[Kim, Ingyu; Li, Cunxi; Liang, Dan; Coffy, Robert J.; Wu, Guanqing] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Kim, Ingyu; Li, Cunxi; Liang, Dan; Coffy, Robert J.; Wu, Guanqing] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Ma, Jie; Zhao, Ping; Wu, Guanqing] Chinese Acad Med Sci, Canc Hosp & Inst, Div Translat Canc Res & Therapy, Beijing 100021, Peoples R China	Vanderbilt University; University of Alberta; Vanderbilt University; Chinese Academy of Medical Sciences - Peking Union Medical College	Wu, GQ (corresponding author), Vanderbilt Univ, Dept Med, 539 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	guanqing.wu@vanderbilt.edu			National Institutes of Health [DK062373, DK071090]; Yangzhi scholarship, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062373, R01DK071090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yangzhi scholarship, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062373 and DK071090. This work was also supported by a Yangzhi scholarship, China (to G. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; Capisonda R, 2003, PEDIATR NEPHROL, V18, P119, DOI 10.1007/s00467-002-1021-0; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Garcia-Gonzalez MA, 2007, HUM MOL GENET, V16, P1940, DOI 10.1093/hmg/ddm141; Guay-Woodford LM, 2003, PEDIATRICS, V111, P1072, DOI 10.1542/peds.111.5.1072; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Kaimori JY, 2008, J AM SOC NEPHROL, V19, P416, DOI 10.1681/ASN.2008010033; Kaimori JY, 2007, HUM MOL GENET, V16, P942, DOI 10.1093/hmg/ddm039; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lilova MI, 2001, PEDIATR NEPHROL, V16, P1030, DOI 10.1007/s004670100019; Losekoot M, 2005, HUM GENET, V118, P185, DOI 10.1007/s00439-005-0027-7; Mai WY, 2005, MOL BIOL CELL, V16, P4398, DOI 10.1091/mbc.E04-11-1019; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Qamar S, 2007, BIOCHEM SOC T, V35, P124, DOI 10.1042/BST0350124; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Rodova M, 2002, J BIOL CHEM, V277, P29577, DOI 10.1074/jbc.M203570200; Rossetti S, 2003, KIDNEY INT, V64, P391, DOI 10.1046/j.1523-1755.2003.00111.x; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Sharp AM, 2005, J MED GENET, V42, P336, DOI 10.1136/jmg.2004.024489; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; WARD CJ, 1994, CELL, V77, P881; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; Xiong HQ, 2002, GENOMICS, V80, P96, DOI 10.1006/geno.2002.6802; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104; Zerres K, 1996, Adv Nephrol Necker Hosp, V25, P147; Zerres K, 2003, J NEPHROL, V16, P453; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101	42	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31559	31566		10.1074/jbc.M805452200	http://dx.doi.org/10.1074/jbc.M805452200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782757	Green Published, hybrid			2022-12-25	WOS:000260760800035
J	Lu, LY; Wood, JL; Ye, L; Minter-Dykhouse, K; Saunders, TL; Yu, XC; Chen, JJ				Lu, Lin-Yu; Wood, Jamie L.; Ye, Lin; Minter-Dykhouse, Katherine; Saunders, Thomas L.; Yu, Xiaochun; Chen, Junjie			Aurora A Is Essential for Early Embryonic Development and Tumor Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; A KINASE; D-TACC; CHROMOSOMAL PASSENGERS; PROTEIN-KINASE; CANCER-THERAPY; ABL KINASE; PHOSPHORYLATION; CENTROSOME; TARGETS	Aurora A is a serine/threonine kinase that functions in various stages of mitosis. Accumulating evidence has demonstrated that gene amplification and overexpression of Aurora A are linked to tumorigenesis, suggesting that Aurora A is an oncogene. In addition, Aurora A overexpression has been used as a negative prognostic marker, because it is associated with resistance to anti-mitotic agents commonly used for cancer therapy. To understand the physiological functions of Aurora A, we generated Aurora A knock-out mice. Aurora A null mice die early during embryonic development before the 16-cell stage. These Aurora A null embryos have defects in mitosis, particularly in spindle assembly, supporting critical functions of Aurora A during mitotic transitions. Interestingly, Aurora A heterozygosity results in a significantly increased tumor incidence in mice, suggesting that Aurora A may also act as a haploinsufficient tumor suppressor. Consistently, Aurora A heterozygous mouse embryonic fibroblasts have higher rates of aneuploidy. We further discovered that VX-680, an Aurora kinase inhibitor currently in phase II clinical trials for cancer treatment, could induce aneuploidy in wild type mouse embryonic fibroblasts. We conclude that a balanced Aurora A level is critical for maintaining genomic stability and one needs to be fully aware of the potential side effects of anti-cancer therapy based on the use of Aurora A-specific inhibitors.	[Lu, Lin-Yu; Ye, Lin; Yu, Xiaochun] Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Sch Med, Transgen Anim Model Core, Ann Arbor, MI 48109 USA; [Wood, Jamie L.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Wood, Jamie L.; Minter-Dykhouse, Katherine] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Mayo Clinic	Yu, XC (corresponding author), Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, BSRB 1520, Ann Arbor, MI 48109 USA.	xiayu@umich.edu; junjie.chen@yale.edu	Minter Dykhouse, Katherine/L-4573-2013	Minter Dykhouse, Katherine/0000-0003-4363-5826; Saunders, Thom/0000-0003-2015-101X	National Institutes of Health [CA113381]; American Cancer Society [RSG-08-125-01-CCG]; NATIONAL CANCER INSTITUTE [R01CA113381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113381 ( to J. C.). This work was also supported American Cancer Society Grant RSG-08-125-01-CCG ( to X. Y.).	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Cazales M, 2005, CELL CYCLE, V4, P1233, DOI 10.4161/cc.4.9.1964; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheetham GMT, 2007, CANCER LETT, V251, P323, DOI 10.1016/j.canlet.2006.12.004; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Kimmins S, 2007, MOL ENDOCRINOL, V21, P726, DOI 10.1210/me.2006-0332; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sasai K, 2008, ONCOGENE, V27, P4122, DOI 10.1038/onc.2008.47; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	37	75	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31785	31790		10.1074/jbc.M805880200	http://dx.doi.org/10.1074/jbc.M805880200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801727	hybrid, Green Published			2022-12-25	WOS:000260760800061
J	Lukiw, WJ; Zhao, YH; Cui, JG				Lukiw, Walter J.; Zhao, Yuhai; Cui, Jian Guo			An NF-kappa B-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)	APR 30, 2008	Ft Lauderdale, FL	Assoc Res Vis & Ophthalmol (ARVO)			GENE-EXPRESSION; SMALL RNAS; MIRNAS; TRANSCRIPTION; INDUCTION; SURVIVAL; FETAL	Human brains retain discrete populations of micro RNA (miRNA) species that support homeostatic brain gene expression functions; however, specific miRNA abundance is significantly altered in neurological disorders such as Alzheimer disease (AD) when compared with age-matched controls. Here we provide evidence in AD brains of a specific up-regulation of an NF-kappa B-sensitive miRNA-146a highly complementary to the 3'-untranslated region of complement factor H (CFH), an important repressor of the inflammatory response of the brain. Up-regulation of miRNA-146a coupled to down-regulation of CFH was observed in AD brain and in interleukin-1 beta, A beta 42, and/or oxidatively stressed human neural (HN) cells in primary culture. Transfection of HN cells using an NF-kappa B-containing pre-miRNA-146a promoter-luciferase reporter construct in stressed HN cells showed significant up-regulation of luciferase activity that paralleled decreases in CFH gene expression. Treatment of stressed HN cells with the NF-kappa B inhibitor pyrollidine dithiocarbamate or the resveratrol analog CAY10512 abrogated this response. Incubation of an antisense oligonucleotide to miRNA-146a (anti-miRNA-146a; AM-146a) was found to restore CFH expression levels. These data indicate that NF-kappa B-sensitive miRNA-146a-mediated modulation of CFH gene expression may in part regulate an inflammatory response in AD brain and in stressed HN cell models of AD and illustrate the potential for anti-miRNAs as an effective therapeutic strategy against pathogenic inflammatory signaling.	Louisiana State Univ, Ctr Neurosci, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, 2020 Gravier St,Suite 8B8, New Orleans, LA 70112 USA.	wlukiw@lsuhsc.edu	ZHAO, YUHAI/A-1167-2010		NATIONAL INSTITUTE ON AGING [R01AG018031] Funding Source: NIH RePORTER; NIA NIH HHS [AG18031] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bazan NG, 2002, J BIOL CHEM, V277, P30359, DOI 10.1074/jbc.M203201200; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Cui JG, 2007, NEUROREPORT, V18, P115, DOI 10.1097/WNR.0b013e32801198bc; DeLegge MH, 2008, NUTR CLIN PRACT, V23, P35, DOI 10.1177/011542650802300135; Gustincich S, 2006, J PHYSIOL-LONDON, V575, P321, DOI 10.1113/jphysiol.2006.115568; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Ho Gilbert J., 2005, Current Drug Targets - Inflammation and Allergy, V4, P247, DOI 10.2174/1568010053586237; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hudder A, 2008, TOXICOL SCI, V103, P228, DOI 10.1093/toxsci/kfn033; Infante-Duarte C, 2008, J MOL MED, V86, P975, DOI 10.1007/s00109-007-0292-0; Jellinger KA, 2006, J ALZHEIMERS DIS, V9, P61; Kim VN, 2005, MOL CELLS, V19, P1; Letiembre M, 2007, NEUROSCIENCE, V146, P248, DOI 10.1016/j.neuroscience.2007.01.004; Lio D, 2006, AGING CLIN EXP RES, V18, P163, DOI 10.1007/BF03327434; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lukiw WJ, 2006, BIOCHEM SOC T, V34, P1277, DOI 10.1042/BST0341277; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw WJ, 2000, ALZHEIMERS REP, V3, P233; Lukiw WJ, 2004, NEUROCHEM RES, V29, P1287, DOI 10.1023/B:NERE.0000023615.89699.63; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Minghetti Luisa, 2007, Subcell Biochem, V42, P127; Mufson EJ, 2006, PROG BRAIN RES, V158, P197, DOI 10.1016/S0079-6123(06)58010-0; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; Niwa R, 2008, DEV BIOL, V315, P418, DOI 10.1016/j.ydbio.2007.12.044; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Rogaev EI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1404, DOI 10.1007/s10541-005-0276-z; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Singh SK, 2007, PHARMACOGENOMICS, V8, P971, DOI 10.2217/14622416.8.8.971; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Vasto S, 2007, PHARMACOGENOMICS, V8, P1735, DOI 10.2217/14622416.8.12.1735; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Zhao YH, 2006, MOL NEUROBIOL, V34, P181, DOI 10.1385/MN:34:3:181	38	351	375	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31315	31322		10.1074/jbc.M805371200	http://dx.doi.org/10.1074/jbc.M805371200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	370KJ	18801740	Green Published, hybrid			2022-12-25	WOS:000260760800008
J	Prasad, V; Bodi, I; Meyer, JW; Wang, YG; Ashraf, M; Engle, SJ; Doetschman, T; Sisco, K; Nieman, ML; Miller, ML; Lorenz, JN; Shull, GE				Prasad, Vikram; Bodi, Ilona; Meyer, Jamie W.; Wang, Yigang; Ashraf, Muhammad; Engle, Sandra J.; Doetschman, Thomas; Sisco, Karena; Nieman, Michelle L.; Miller, Marian L.; Lorenz, John N.; Shull, Gary E.			Impaired Cardiac Contractility in Mice Lacking Both the AE3 Cl-/HCO3- Exchanger and the NKCC1 Na+-K+-2Cl(-) Cotransporter EFFECTS ON Ca2+ HANDLING AND PROTEIN PHOSPHATASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2A CATALYTIC SUBUNIT; NA+-H+ EXCHANGER; TARGETED DISRUPTION; SARCOPLASMIC-RETICULUM; CARBOXYL METHYLATION; NA+-CA2+ EXCHANGE; ANGIOTENSIN-II; NULL MUTATION; BRUSH-BORDER; HEART	To analyze the cardiac functions of AE3, we disrupted its gene (Slc4a3) in mice. Cl-/HCO3- exchange coupled with Na+-dependent acid extrusion can mediate pH-neutral Na+ uptake, potentially affecting Ca2+ handling via effects on Na+/Ca2+ exchange. AE3 null mice appeared normal, however, and AE3 ablation had no effect on ischemia-reperfusion injury in isolated hearts or cardiac performance in vivo. The NKCC1 Na+-K+-2Cl(-) cotransporter also mediates Na+ uptake, and loss of NKCC1 alone does not impair contractility. To further stress the AE3-deficient myocardium, we combined the AE3 and NKCC1 knock-outs. Double knock-outs had impaired contraction and relaxation both in vivo and in isolated ventricular myocytes. Ca2+ transients revealed an apparent increase in Ca2+ clearance in double null cells. This was unlikely to result from increased Ca2+ sequestration, since the ratio of phosphorylated phospholamban to total phospholamban was sharply reduced in all three mutant hearts. Instead, Na+/Ca2+ exchanger activity was found to be enhanced in double null cells. Systolic Ca2+ was unaltered, however, suggesting more direct effects on the contractile apparatus of double null myocytes. Expression of the catalytic subunit of protein phosphatase 1 was increased in all mutant hearts. There was also a dramatic reversal, between single null and double null hearts, in the carboxymethylation and localization to the myofibrillar fraction, of the catalytic subunit of protein phosphatase 2A, which corresponded to the loss of normal contractility in double null hearts. These data show that AE3 and NKCC1 affect Ca2+ handling, PLN regulation, and expression and localization of major cardiac phosphatases and that their combined loss impairs cardiac function.	[Prasad, Vikram; Meyer, Jamie W.; Engle, Sandra J.; Doetschman, Thomas; Shull, Gary E.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Wang, Yigang; Ashraf, Muhammad] Univ Cincinnati, Coll Med, Dept Lab Med, Cincinnati, OH 45267 USA; [Sisco, Karena; Nieman, Michelle L.; Lorenz, John N.] Univ Cincinnati, Coll Med, Dept Mol & Cellular Biol, Cincinnati, OH 45267 USA; [Miller, Marian L.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Bodi, Ilona] Univ Cincinnati, Coll Med, Inst Mol Pharmacol & Biophys, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Shull, GE (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	shullge@ucmail.uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health [HL61974, DK50594, DK57552, HL081859, HL080686]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007382, R01HL092508, R01HL081859, R01HL061974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057552, R37DK050594, R01DK050594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL61974, DK50594, DK57552, HL081859, and HL080686. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AdachiAkahane S, 1997, J GEN PHYSIOL, V109, P717, DOI 10.1085/jgp.109.6.717; Alvarez BV, 2004, J PHYSIOL-LONDON, V561, P721, DOI 10.1113/jphysiol.2004.077339; Alvarez BV, 2001, CIRC RES, V89, P1246, DOI 10.1161/hh2401.101907; Baartscheer A, 2003, CARDIOVASC RES, V57, P1015, DOI 10.1016/S0008-6363(02)00809-X; Baartscheer A, 2003, CARDIOVASC RES, V57, P986, DOI 10.1016/S0008-6363(02)00848-9; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Cingolani HE, 2002, CIRC RES, V90, P751, DOI 10.1161/01.RES.0000016836.24179.AE; de Hurtado MCC, 1998, CIRC RES, V82, P473, DOI 10.1161/01.RES.82.4.473; Ennis IL, 1998, HYPERTENSION, V31, P961, DOI 10.1161/01.HYP.31.4.961; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; FRELIN C, 1986, BIOCHEM BIOPH RES CO, V134, P326, DOI 10.1016/0006-291X(86)90566-8; Gawenis LR, 2005, GASTROENTEROLOGY, V128, pA44; Gawenis LR, 2005, J BIOL CHEM, V280, P12781, DOI 10.1074/jbc.M414118200; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Golenhofen N, 1998, AM J PHYSIOL-HEART C, V274, pH1457, DOI 10.1152/ajpheart.1998.274.5.H1457; Grubb BR, 2000, AM J PHYSIOL-GASTR L, V279, pG707, DOI 10.1152/ajpgi.2000.279.4.G707; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Ji Y, 2006, AM J PHYSIOL-HEART C, V290, pH599, DOI 10.1152/ajpheart.00214.2005; Jiang LW, 1997, AM J PHYSIOL-CELL PH, V272, pC191, DOI 10.1152/ajpcell.1997.272.1.C191; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Kawasaki H, 2001, EUR J PHARMACOL, V411, P35, DOI 10.1016/S0014-2999(00)00893-1; Khandoudi N, 2001, CARDIOVASC RES, V52, P387, DOI 10.1016/S0008-6363(01)00430-8; Kirchhefer U, 2005, CARDIOVASC RES, V68, P98, DOI 10.1016/j.cardiores.2005.05.019; Knauf F, 2001, P NATL ACAD SCI USA, V98, P9425, DOI 10.1073/pnas.141241098; KNICKELBEIN R, 1985, AM J PHYSIOL, V249, pG236, DOI 10.1152/ajpgi.1985.249.2.G236; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; KUDRYCKI KE, 1990, J BIOL CHEM, V265, P462; Lai ZF, 1998, AM J PHYSIOL-HEART C, V275, pH1613, DOI 10.1152/ajpheart.1998.275.5.H1613; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; LINN SC, 1992, J BIOL CHEM, V267, P7927; LINN SC, 1995, CIRC RES, V76, P584, DOI 10.1161/01.RES.76.4.584; Liu QH, 2003, AM J PHYSIOL-HEART C, V285, pH97, DOI 10.1152/ajpheart.00956.2002; Liu QH, 2002, AM J PHYSIOL-HEART C, V283, pH1314, DOI 10.1152/ajpheart.00343.2002; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; MACDOUGALL LK, 1991, EUR J BIOCHEM, V196, P725, DOI 10.1111/j.1432-1033.1991.tb15871.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mattiazzi A, 1997, AM J PHYSIOL-HEART C, V272, pH1131, DOI 10.1152/ajpheart.1997.272.3.H1131; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Meyer JW, 2002, AM J PHYSIOL-HEART C, V283, pH1846, DOI 10.1152/ajpheart.00083.2002; Mihailidou AS, 1998, AM J PHYSIOL-CELL PH, V274, pC175, DOI 10.1152/ajpcell.1998.274.1.C175; Mumby M., 2001, SCI STKE, pe1; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Perez NG, 2001, CIRC RES, V88, P376; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; Pieske B, 2003, CARDIOVASC RES, V57, P874, DOI 10.1016/S0008-6363(02)00841-6; Pieske B, 2003, CARDIOVASC RES, V57, P871, DOI 10.1016/S0008-6363(02)00849-0; Pushkin A, 2000, IUBMB LIFE, V50, P13; Richards SM, 1999, J CELL SCI, V112, P1519; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Schafer C, 2000, AM J PHYSIOL-HEART C, V278, pH1457, DOI 10.1152/ajpheart.2000.278.5.H1457; Sheehan KA, 2007, AM J PHYSIOL-REG I, V293, pR963, DOI 10.1152/ajpregu.00253.2007; SOLARO RJ, 2001, HDB PHYSL 2, V1, P264; STEENAART NAE, 1992, ARCH BIOCHEM BIOPHYS, V293, P17, DOI 10.1016/0003-9861(92)90359-5; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Terracciano CMN, 1998, J PHYSIOL-LONDON, V512, P651, DOI 10.1111/j.1469-7793.1998.651bd.x; Tikh EI, 2008, J CELL PHYSIOL, V216, P83, DOI 10.1002/jcp.21375; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Walker NM, 2002, GASTROENTEROLOGY, V123, P531, DOI 10.1053/gast.2002.34757; Wang YG, 2003, CIRC RES, V93, P776, DOI 10.1161/01.RES.0000094746.24774.DC; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yamamoto T, 2007, AM J PHYSIOL-HEART C, V293, pH1254, DOI 10.1152/ajpheart.00964.2006; Yao AS, 1998, CIRC RES, V82, P657, DOI 10.1161/01.RES.82.6.657; Yoo SJS, 2007, ARCH BIOCHEM BIOPHYS, V461, P186, DOI 10.1016/j.abb.2007.02.019; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	73	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31303	31314		10.1074/jbc.M803706200	http://dx.doi.org/10.1074/jbc.M803706200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779325	Green Published			2022-12-25	WOS:000260760800007
J	Kartsogiannis, V; Sims, NA; Quinn, JMW; Ly, C; Cipetic, M; Poulton, IJ; Walker, EC; Saleh, H; McGregor, NE; Wallace, ME; Smyth, MJ; Martin, TJ; Zhou, H; Ng, KW; Gillespie, MT				Kartsogiannis, Vicky; Sims, Natalie A.; Quinn, Julian M. W.; Ly, Chi; Cipetic, Mirijana; Poulton, Ingrid J.; Walker, Emma C.; Saleh, Hasnawati; McGregor, Narelle E.; Wallace, Morgan E.; Smyth, Mark J.; Martin, T. John; Zhou, Hong; Ng, Kong Wah; Gillespie, Matthew T.			Osteoclast Inhibitory Lectin, an Immune Cell Product That Is Required for Normal Bone Physiology in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; FAMILY; DIFFERENTIATION; RECEPTORS; GENE; OSTEOIMMUNOLOGY; EXPRESSION; VITRO; LINE	Osteoclast inhibitory lectin (OCIL or clrb) is a member of the natural killer cell C-type lectins that have a described role mostly in autoimmune cell function. OCIL was originally identified as an osteoblast-derived inhibitor of osteoclast formation in vitro. To determine the physiological function(s) of OCIL, we generated ocil(-/-) mice. These mice appeared healthy and were fertile, with no apparent immune function defect, and phenotypic abnormalities were limited to bone. Histomorphometric analysis revealed a significantly lower tibial trabecular bone volume and trabecular number in the 10- and 16-week-old male ocil(-/-) mice compared with wild type mice. Furthermore, ocil(-/-) mice showed reduced bone formation rate in the 10-week-old females and 16-week-old males while Static markers of bone formation showed no significant changes in male or female ocil(-/-) mice. Examination of bone resorption markers in the long bones of ocil(-/-) mice indicated a transient increase in osteoclast number per unit bone perimeter. Enhanced osteoclast formation was also observed when either bone marrow or splenic cultures were generated in vitro from ocil(-/-) mice relative to wild type control cultures. Loss of ocil therefore resulted in osteopenia in adult mice primarily as a result of increased osteoclast formation and/or decreased bone formation. The enhanced osteoclastic activity led to elevated serum calcium levels, which resulted in the suppression of circulating parathyroid hormone in 10-week-old ocil(-/-) mice compared with wild type control mice. Collectively, our data suggest that OCIL is a physiological negative regulator of bone.	[Kartsogiannis, Vicky; Sims, Natalie A.; Quinn, Julian M. W.; Ly, Chi; Cipetic, Mirijana; Poulton, Ingrid J.; Walker, Emma C.; Saleh, Hasnawati; McGregor, Narelle E.; Martin, T. John; Zhou, Hong; Gillespie, Matthew T.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Sims, Natalie A.; Quinn, Julian M. W.; Saleh, Hasnawati; Martin, T. John; Gillespie, Matthew T.] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Wallace, Morgan E.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 8006, Australia; [Ng, Kong Wah] Univ Melbourne, St Vincents Hosp, Dept Endocrinol & Diabet, Fitzroy, Vic 3065, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne	Gillespie, MT (corresponding author), Prince Henrys Inst, POB 5152, Clayton, Vic 3168, Australia.	Matthew.Gillespie@princehenrys.org	Sims, Natalie Ann/A-7192-2012; Wallace, Morgan/AAG-5451-2019; Smyth, Mark J/H-8709-2014	Sims, Natalie Ann/0000-0003-1421-8468; Wallace, Morgan/0000-0002-0744-6895; Smyth, Mark J/0000-0001-7098-7240; Gillespie, Matthew/0000-0001-6543-8909; Zhou, Hong/0000-0001-5899-9660	National Health and Medical Research Council of Australia [345401, 454569]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Program Grant 345401 (to M.T.G., T.J.M., N. A.S., and K.W.N.) and Program Grant 454569 (to M.J.S.) from the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Gange CT, 2004, J BIOL CHEM, V279, P29043, DOI 10.1074/jbc.M312518200; Gillespie MT, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2141; Horwood NJ, 1998, J CLIN INVEST, V101, P595, DOI 10.1172/JCI1333; Horwood NJ, 2001, J IMMUNOL, V166, P4915, DOI 10.4049/jimmunol.166.8.4915; Hu YS, 2004, J BONE MINER RES, V19, P89, DOI 10.1359/JBMR.0301215; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Katsu Y, 2003, ENDOCRINOLOGY, V144, P2597, DOI 10.1210/en.2002-220980; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; LEARY NO, 1992, CLIN CHEM, V38, P904; Nakamura A, 2007, BONE, V40, P305, DOI 10.1016/j.bone.2006.09.001; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PARKINSON IH, 1991, J HISTOTECHNOL, V14, P81, DOI 10.1179/his.1991.14.2.81; Pineda B, 2008, CALCIFIED TISSUE INT, V82, P348, DOI 10.1007/s00223-008-9135-4; Plougastel B, 2001, IMMUNOGENETICS, V53, P209, DOI 10.1007/s002510100319; Quinn JMW, 2005, BIOCHEM BIOPH RES CO, V328, P739, DOI 10.1016/j.bbrc.2004.11.076; Schmidt C, 2003, J BONE MINER RES, V18, P1486, DOI 10.1359/jbmr.2003.18.8.1486; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; UMEZAWA A, 1992, J CELL PHYSIOL, V151, P197, DOI 10.1002/jcp.1041510125; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zhou H, 2001, J BIOL CHEM, V276, P14916, DOI 10.1074/jbc.M011554200; Zhou H, 2002, J BIOL CHEM, V277, P48808, DOI 10.1074/jbc.M209059200	29	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30850	30860		10.1074/jbc.M801761200	http://dx.doi.org/10.1074/jbc.M801761200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782774	Green Published, hybrid			2022-12-25	WOS:000260544800040
J	Pyo, JO; Nah, J; Kim, HJ; Chang, JW; Song, YW; Yang, DK; Jo, DG; Kim, HR; Chae, HJ; Chae, SW; Hwang, SY; Kim, SJ; Kim, HJ; Cho, C; Oh, CG; Park, WJ; Jung, YK				Pyo, Jong-Ok; Nah, Jihoon; Kim, Hyo-Jin; Chang, Jae-Woong; Song, Young-Wha; Yang, Dong-Kwon; Jo, Dong-Gyu; Kim, Hyung-Ryong; Chae, Han-Jung; Chae, Soo-Wan; Hwang, Seung-Yong; Kim, Seung-Jun; Kim, Hyo-Joon; Cho, Chunghee; Oh, Chang-Gyu; Park, Woo Jin; Jung, Yong-Keun			Protection of Cardiomyocytes from Ischemic/Hypoxic Cell Death via Drbp1 and pMe(2)GlyDH in Cardio-specific ARC Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE RECRUITMENT DOMAIN; APOPTOSIS REPRESSOR; REPERFUSION INJURY; ACTIVATED AKT; KINASE; HEART; CARDIOPROTECTION; CARDIOMYOPATHY; MITOCHONDRIA; EXPRESSION	The ischemic death of cardiomyocytes is associated in heart disease and heart failure. However, the molecular mechanism underlying ischemic cell death is not well defined. To examine the function of apoptosis repressor with a caspase recruitment domain (ARC) in the ischemic/hypoxic damage of cardiomyocytes, we generated cardio-specific ARC transgenic mice using a mouse alpha-myosin heavy chain promoter. Compared with the control, the hearts of ARC transgenic mice showed a 3-fold overexpression of ARC. Langendoff preparation showed that the hearts isolated from ARC transgenic mice exhibited improved recovery of contractile performance during reperfusion. The cardiomyocytes cultured from neonatal ARC transgenic mice were significantly resistant to hypoxic cell death. Furthermore, the ARC C-terminal calcium-binding domain was as potent to protect cardiomyocytes from hypoxic cell death as ARC. Genome-wide RNA expression profiling uncovered a list of genes whose expression was changed (>2-fold) in ARC transgenic mice. Among them, expressional regulation of developmentally regulated RNA-binding protein 1 (Drbp1) or the dimethylglycine dehydrogenase precursor (pMe(2)GlyDH) affected hypoxic death of cardiomyocytes. These results suggest that ARC may protect cardiomyocytes from hypoxic cell death by regulating its downstream, Drbp1 and pMe2GlyDH, shedding new insights into the protection of heart from hypoxic damages.	[Pyo, Jong-Ok; Nah, Jihoon; Kim, Hyo-Jin; Chang, Jae-Woong; Jung, Yong-Keun] Seoul Natl Univ, Creat Res Initiat Accelerat Res, Seoul 151747, South Korea; [Song, Young-Wha; Yang, Dong-Kwon; Cho, Chunghee; Park, Woo Jin; Jung, Yong-Keun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Jo, Dong-Gyu] Sungkyunkwan Univ, Coll Pharm, Seoul 440746, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Chonbuk 570749, South Korea; [Chae, Han-Jung; Chae, Soo-Wan] Chonbuk Natl Univ, Sch Med, Dept Pharmacol, Jeonju 560180, Chonbuk, South Korea; [Hwang, Seung-Yong; Kim, Seung-Jun; Kim, Hyo-Joon] Hanyang Univ, Dept Biochem, Ansan 428791, South Korea; [Hwang, Seung-Yong; Kim, Seung-Jun; Kim, Hyo-Joon] Genocheck Co Ltd, Ansan 428791, South Korea; [Oh, Chang-Gyu] Macrogen Inc, World Merdian Venture Ctr, Seoul 153023, South Korea	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Sungkyunkwan University (SKKU); Wonkwang University; Jeonbuk National University; Hanyang University; GenoCheck Co. Ltd; Macrogen, Inc.	Jung, YK (corresponding author), Seoul Natl Univ, Creat Res Initiat Accelerat Res, Shillim Dong, Seoul 151747, South Korea.	ykjung@snu.ac.kr	Nah, Jihoon/ABC-5145-2020; Nah, Jihoon/ABB-4363-2021; Kim, Seung Jun/N-5248-2019; Jo, Dong-Gyu/AAN-9278-2021	Nah, Jihoon/0000-0003-2254-2233; Nah, Jihoon/0000-0003-2254-2233; Kim, Seung Jun/0000-0002-6913-6358; Jo, Dong-Gyu/0000-0003-2271-1076; Jung, Yong-Keun/0000-0002-9686-3120; Chae, Han-Jung/0000-0003-4190-9889	Brain Research Center; Korea Science and Engineering Foundation	Brain Research Center; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported in part by the Brain Research Center of 21C Frontier, Ubiquitome, CRI of the Korea Science and Engineering Foundation, and a Basic Science grant of the Korean Research Foundation (to Y. K. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abmayr S, 2004, HUM MOL GENET, V13, P213, DOI 10.1093/hmg/ddh018; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Brar BK, 2001, CYTOKINE, V16, P93, DOI 10.1006/cyto.2001.0951; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Chatterjee S, 2003, J THORAC CARDIOV SUR, V125, P1461, DOI 10.1016/S0022-5223(02)73229-7; Dawn B, 2002, ANN NY ACAD SCI, V962, P18, DOI 10.1111/j.1749-6632.2002.tb04053.x; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Ekhterae D, 1999, CIRC RES, V85, pE70; GULICK J, 1991, J BIOL CHEM, V266, P9180; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hofer T, 2003, BLOOD, V101, P348, DOI 10.1182/blood-2002-03-0773; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jo DG, 2004, MOL CELL BIOL, V24, P9763, DOI 10.1128/MCB.24.22.9763-9770.2004; Jo DG, 2004, J NEUROCHEM, V88, P604, DOI 10.1046/j.1471-4159.2003.02159.x; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; MEGURO K, 1995, BLOOD, V86, P940; Miao WF, 2000, J MOL CELL CARDIOL, V32, P2397, DOI 10.1006/jmcc.2000.1283; NAKAMURA TY, 1993, CIRC RES, V73, P758, DOI 10.1161/01.RES.73.4.758; Otto A, 1998, CLIN EXP IMMUNOL, V111, P541; Serviddio G, 2005, FASEB J, V19, P354, DOI 10.1096/fj.04-2338com; Tamada H, 2002, BIOCHEM BIOPH RES CO, V297, P96, DOI 10.1016/S0006-291X(02)02132-0; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tian R, 1999, P NATL ACAD SCI USA, V96, P13536, DOI 10.1073/pnas.96.23.13536; Yamashita K, 2001, CIRC RES, V88, P609, DOI 10.1161/01.RES.88.6.609; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070	30	20	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30707	30714		10.1074/jbc.M804209200	http://dx.doi.org/10.1074/jbc.M804209200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782777	Green Published, hybrid			2022-12-25	WOS:000260544800026
J	Ideses, Y; Brill-Karniely, Y; Haviv, L; Ben-Shaul, A; Bernheim-Groswasser, A				Ideses, Yaron; Brill-Karniely, Yifat; Haviv, Lior; Ben-Shaul, Avinoam; Bernheim-Groswasser, Anne			Arp2/3 Branched Actin Network Mediates Filopodia-Like Bundles Formation In Vitro	PLOS ONE			English	Article								During cellular migration, regulated actin assembly takes place at the cell leading edge, with continuous disassembly deeper in the cell interior. Actin polymerization at the plasma membrane results in the extension of cellular protrusions in the form of lamellipodia and filopodia. To understand how cells regulate the transformation of lamellipodia into filopodia, and to determine the major factors that control their transition, we studied actin self-assembly in the presence of Arp2/3 complex, WASp-VCA and fascin, the major proteins participating in the assembly of lamellipodia and filopodia. We show that in the early stages of actin polymerization fascin is passive while Arp2/3 mediates the formation of dense and highly branched aster-like networks of actin. Once filaments in the periphery of an aster get long enough, fascin becomes active, linking the filaments into bundles which emanate radially from the aster's surface, resulting in the formation of star-like structures. We show that the number of bundles nucleated per star, as well as their thickness and length, is controlled by the initial concentration of Arp2/3 complex ([Arp2/3]). Specifically, we tested several values of [Arp2/3] and found that for given initial concentrations of actin and fascin, the number of bundles per star, as well as their length and thickness are larger when [Arp2/3] is lower. Our experimental findings can be interpreted and explained using a theoretical scheme which combines Kinetic Monte Carlo simulations for aster growth, with a simple mechanistic model for bundles' formation and growth. According to this model, bundles emerge from the aster's (sparsely branched) surface layer. Bundles begin to form when the bending energy associated with bringing two filaments into contact is compensated by the energetic gain resulting from their fascin linking energy. As time evolves the initially thin and short bundles elongate, thus reducing their bending energy and allowing them to further associate and create thicker bundles, until all actin monomers are consumed. This process is essentially irreversible on the time scale of actin polymerization. Two structural parameters, L, which is proportional to the length of filament tips at the aster periphery and b, the spacing between their origins, dictate the onset of bundling; both depending on [Arp2/3]. Cells may use a similar mechanism to regulate filopodia formation along the cell leading edge. Such a mechanism may allow cells to have control over the localization of filopodia by recruiting specific proteins that regulate filaments length (e. g., Dia2) to specific sites along lamellipodia.	[Ideses, Yaron; Haviv, Lior; Bernheim-Groswasser, Anne] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Brill-Karniely, Yifat; Ben-Shaul, Avinoam] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel	Ben Gurion University; Hebrew University of Jerusalem	Ideses, Y (corresponding author), Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.	bernheim@bgu.ac.il	Brill-Karniely, Yifat/GSO-2750-2022; Bernheim, Anne/AAM-5969-2020	Bernheim-Groswasser, Anne/0000-0003-3999-6098; Brill-Karniely, Yifat/0000-0002-8842-9105	Joseph and May Winston Foundation Career Development Chair in Chemical Engineering; Israel Cancer Association [20070020B]; Israel Science Foundation [551/04, 659/06]; US-Israel Binational Science Foundation [2006-401]	Joseph and May Winston Foundation Career Development Chair in Chemical Engineering; Israel Cancer Association; Israel Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	A.B.G. wishes to thank the Joseph and May Winston Foundation Career Development Chair in Chemical Engineering, the Israel Cancer Association (grant No. 20070020B) and the Israel Science Foundation (grant No. 551/04) for financial support. A.B.S. thanks the US-Israel Binational Science Foundation (BSF grant 2006-401), and the Israel Science Foundation (ISF grant 659/06) for financial support. The Fritz Haber research center, where the calculations were carried out, is supported by the Minerva foundation, Germany.	Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Haviv L, 2008, EUR BIOPHYS J BIOPHY, V37, P447, DOI 10.1007/s00249-007-0236-1; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Le Y, 2006, BIOPHYS J, V90, P4295, DOI 10.1529/biophysj.105.076968; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Ono S, 1997, J BIOL CHEM, V272, P2527; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Resch GP, 2002, J CELL SCI, V115, P1877; Schafer DA, 2004, NATURE, V430, P734, DOI 10.1038/430734a; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Takenawa T, 2001, J CELL SCI, V114, P1801; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yang L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021911	34	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3297	10.1371/journal.pone.0003297	http://dx.doi.org/10.1371/journal.pone.0003297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820726	Green Published, Green Submitted, gold			2022-12-25	WOS:000264432500007
J	Kacherovsky, N; Tachibana, C; Amos, E; Fox, D; Young, ET				Kacherovsky, Nataly; Tachibana, Christine; Amos, Emily; Fox, David, III; Young, Elton T.			Promoter Binding by the Adr1 Transcriptional Activator May Be Regulated by Phosphorylation in the DNA-Binding Region	PLOS ONE			English	Article								Background: Post-translational modification regulates promoter-binding by Adr1, a Zn-finger transcriptional activator of glucose-regulated genes. Support for this model includes the activation of an Adr1-dependent gene in the absence of Adr1 protein synthesis, and a requirement for the kinase Snf1 for Adr1 DNA-binding. A fusion protein with the Adr1 DNA-binding domain and a heterologous activation domain is glucose-regulated, suggesting that the DNA binding region is the target of regulation. Methodology/Principal Findings: Peptide mapping identified serine 98 adjacent to the Zn-fingers as a phosphorylation site. An antibody specific for phosphorylated serine 98 on Adr1 showed that the level of phosphorylated Adr1 relative to the level of total Adr1 decreased with glucose derepression, in a Snf1-dependent manner. Relative phosphorylation decreased in a PHO85 mutant, and this mutant constitutively expressed an Adr1-dependent reporter. Pho85 did not phosphorylate Adr1 in vitro, suggesting that it affects Adr1 indirectly. Mutation of serine 98 to the phosphomimetic amino acid aspartate reduced in vitro DNA-binding of the recombinant Adr1 DNA-binding domain. Mutation to aspartate or alanine affected activation of a reporter by full-length Adr1, and in vivo promoter binding. Conclusions/Significance: Mutation of Adr1 serine 98 affects in vitro and in vivo DNA binding, and phosphorylation of serine 98 in vivo correlates with glucose availability, suggesting that Adr1 promoter-binding is regulated in part by serine 98 phosphorylation.	[Kacherovsky, Nataly; Tachibana, Christine; Amos, Emily; Fox, David, III; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kacherovsky, N (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	ety@u.washington.edu			NIGMS [26079]; NIDDK [67276]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIGMS 26079 and NIDDK67276.	Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; BLUMBERG H, 1987, NATURE, V328, P443, DOI 10.1038/328443a0; Bowers PW, 1999, NAT STRUCT BIOL, V6, P478; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brachmann CB, 1998, YEAST, V14, P115; CAMIER S, 1992, MOL CELL BIOL, V12, P5758, DOI 10.1128/MCB.12.12.5758; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; COOK WJ, 1994, J BIOL CHEM, V269, P9374; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; DENIS CL, 1991, J BIOL CHEM, V266, P17932; DENIS CL, 1987, MOL GEN GENET, V208, P101, DOI 10.1007/BF00330429; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DOMBEK KM, 1993, MOL CELL BIOL, V13, P4391, DOI 10.1128/MCB.13.7.4391; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Huang DQ, 1996, MOL CELL BIOL, V16, P4357; Huang DQ, 1998, MOL CELL BIOL, V18, P3289, DOI 10.1128/MCB.18.6.3289; IRANI M, 1987, MOL CELL BIOL, V7, P1233, DOI 10.1128/MCB.7.3.1233; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Nishizawa M, 2004, YEAST, V21, P903, DOI 10.1002/yea.1138; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Schaufler LE, 2003, J MOL BIOL, V329, P931, DOI 10.1016/S0022-2836(03)00550-3; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sloan JS, 1999, J BIOL CHEM, V274, P37575, DOI 10.1074/jbc.274.53.37575; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; THUKRAL SK, 1989, MOL CELL BIOL, V9, P2360, DOI 10.1128/MCB.9.6.2360; Timblin BK, 1996, GENETICS, V143, P57; Voronkova V, 2006, GENETICS, V172, P2123, DOI 10.1534/genetics.105.048231; WILLIAMSON VM, 1980, NATURE, V283, P214, DOI 10.1038/283214a0; Young ET, 2008, MOL CELL BIOL, V28, P2509, DOI 10.1128/MCB.00658-07; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Young ET, 2002, J BIOL CHEM, V277, P38095, DOI 10.1074/jbc.M206158200; Young ET, 2000, BIOCHEMISTRY-US, V39, P567, DOI 10.1021/bi992049r; Yuzyuk T, 2002, MOL BIOL CELL, V13, P2869, DOI 10.1091/mbc.02-01-0004; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	43	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3213	10.1371/journal.pone.0003213	http://dx.doi.org/10.1371/journal.pone.0003213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791642	Green Submitted, gold, Green Published			2022-12-25	WOS:000264427700008
J	Livny, J; Teonadi, H; Livny, M; Waldor, MK				Livny, Jonathan; Teonadi, Hidayat; Livny, Miron; Waldor, Matthew K.			High-Throughput, Kingdom-Wide Prediction and Annotation of Bacterial Non-Coding RNAs	PLOS ONE			English	Article								Background: Diverse bacterial genomes encode numerous small non-coding RNAs (sRNAs) that regulate myriad biological processes. While bioinformatic algorithms have proven effective in identifying sRNA-encoding loci, the lack of tools and infrastructure with which to execute these computationally demanding algorithms has limited their utilization. Genome-wide predictions of sRNA-encoding genes have been conducted in less than 3% of all sequenced bacterial strains, leading to critical gaps in current annotations. The relative paucity of genome-wide sRNA prediction represents a critical gap in current annotations of bacterial genomes and has limited examination of larger issues in sRNA biology, such as sRNA evolution. Methodology/Principal Findings: We have developed and deployed SIPHT, a high throughput computational tool that utilizes workflow management and distributed computing to effectively conduct kingdom-wide predictions and annotations of intergenic sRNA-encoding genes. Candidate sRNA-encoding loci are identified based on the presence of putative Rho-independent terminators downstream of conserved intergenic sequences, and each locus is annotated for several features, including conservation in other species, association with one of several transcription factor binding sites and homology to any of over 300 previously identified sRNAs and cis-regulatory RNA elements. Using SIPHT, we conducted searches for putative sRNA-encoding genes in all 932 bacterial replicons in the NCBI database. These searches yielded nearly 60% of previously confirmed sRNAs, hundreds of previously annotated cis-encoded regulatory RNA elements such as riboswitches, and over 45,000 novel candidate intergenic loci. Conclusions/Significance: Candidate loci were identified across all branches of the bacterial evolutionary tree, suggesting a central and ubiquitous role for RNA-mediated regulation among bacterial species. Annotation of candidate loci by SIPHT provides clues into the potential biological function of thousands of previously confirmed and candidate regulatory RNAs and affords new insights into the evolution of bacterial riboregulation.	[Livny, Jonathan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Labs, Boston, MA 02115 USA; [Teonadi, Hidayat; Livny, Miron] Univ Wisconsin, Comput Sci Dept, Madison, WI 53706 USA; [Waldor, Matthew K.] Harvard Univ, Brigham & Womens Hosp, Harvard Med Sch, Howard Hughes Med Inst, Channing Lab, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Livny, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Labs, Boston, MA 02115 USA.	jlivny@rics.bwh.harvard.edu		Waldor, Matthew/0000-0003-1843-7000	National Institutes of Health [AI-42347]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347, R01AI042347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health (AI-42347); Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06; Davis BM, 2005, J BACTERIOL, V187, P4005, DOI 10.1128/JB.187.12.4005-4014.2005; De Gregorio E, 2005, J BACTERIOL, V187, P7945, DOI 10.1128/JB.187.23.7945-7954.2005; del Val C, 2007, MOL MICROBIOL, V66, P1080, DOI 10.1111/j.1365-2958.2007.05978.x; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; HULTON CSJ, 1991, MOL MICROBIOL, V5, P825, DOI 10.1111/j.1365-2958.1991.tb00755.x; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Liu X, 2001, Pac Symp Biocomput, P127; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Makita Y, 2004, NUCLEIC ACIDS RES, V32, pD75, DOI 10.1093/nar/gkh074; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; McArthur SD, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-52; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pichon C, 2003, BIOINFORMATICS, V19, P1707, DOI 10.1093/bioinformatics/btg235; RHODIUS VA, 2005, PLOS BIOL, V4, P757; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Saetrom P, 2005, NUCLEIC ACIDS RES, V33, P3263, DOI 10.1093/nar/gki644; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; SITTKA A, 2008, PLOS GENETI IN PRESS; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vogel J, 2004, CURR BIOL, V14, P2271, DOI 10.1016/j.cub.2004.12.003; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilson LA, 2006, MOL BIOL EVOL, V23, P1156, DOI 10.1093/molbev/msj125; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhang Y, 2004, BIOINFORMATICS, V20, P599, DOI 10.1093/bioinformatics/btg457; Zhou DS, 2006, FEMS MICROBIOL LETT, V258, P9, DOI 10.1111/j.1574-6968.2006.00208.x	60	158	167	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3197	10.1371/journal.pone.0003197	http://dx.doi.org/10.1371/journal.pone.0003197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787707	gold, Green Published, Green Submitted			2022-12-25	WOS:000264426200003
J	McDevitt, JJ; Milton, DK; Rudnick, SN; First, MW				McDevitt, James J.; Milton, Donald K.; Rudnick, Stephen N.; First, Melvin W.			Inactivation of Poxviruses by Upper-Room UVC Light in a Simulated Hospital Room Environment	PLOS ONE			English	Article							ULTRAVIOLET GERMICIDAL IRRADIATION; SERRATIA-MARCESCENS; RELATIVE-HUMIDITY; TRANSMISSION; SENSITIVITY; SMALLPOX; EFFICACY; AIR; BCG	In the event of a smallpox outbreak due to bioterrorism, delays in vaccination programs may lead to significant secondary transmission. In the early phases of such an outbreak, transmission of smallpox will take place especially in locations where infected persons may congregate, such as hospital emergency rooms. Air disinfection using upper-room 254 nm (UVC) light can lower the airborne concentrations of infective viruses in the lower part of the room, and thereby control the spread of airborne infections among room occupants without exposing occupants to a significant amount of UVC. Using vaccinia virus aerosols as a surrogate for smallpox we report on the effectiveness of air disinfection, via upper-room UVC light, under simulated real world conditions including the effects of convection, mechanical mixing, temperature and relative humidity. In decay experiments, upper-room UVC fixtures used with mixing by a conventional ceiling fan produced decreases in airborne virus concentrations that would require additional ventilation of more than 87 air changes per hour. Under steady state conditions the effective air changes per hour associated with upper-room UVC ranged from 18 to 1000. The surprisingly high end of the observed range resulted from the extreme susceptibility of vaccinia virus to UVC at low relative humidity and use of 4 UVC fixtures in a small room with efficient air mixing. Increasing the number of UVC fixtures or mechanical ventilation rates resulted in greater fractional reduction in virus aerosol and UVC effectiveness was higher in winter compared to summer for each scenario tested. These data demonstrate that upper-room UVC has the potential to greatly reduce exposure to susceptible viral aerosols. The greater survival at baseline and greater UVC susceptibility of vaccinia under winter conditions suggest that while risk from an aerosol attack with smallpox would be greatest in winter, protective measures using UVC may also be most efficient at this time. These data may also be relevant to influenza, which also has improved aerosol survival at low RH and somewhat similar sensitivity to UVC.	[McDevitt, James J.; Milton, Donald K.; Rudnick, Stephen N.; First, Melvin W.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Milton, Donald K.] Univ Massachusetts, Dept Work Environm, Lowell, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Lowell	McDevitt, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	Donald_Milton@uml.edu	Milton, Donald K/G-3286-2010	Milton, Donald K/0000-0002-0550-7834	NIH [R21AI053522]; NIEHS Center [P30ES000002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant R21AI053522 "Prevention of airborne smallpox transmission" and by NIEHS Center grant P30ES000002.	Brickner PW, 2003, PUBLIC HEALTH REP, V118, P99, DOI 10.1016/S0033-3549(04)50225-X; CINCINNATI OH, 2008, THRESHOLD LIMIT VALU, P144; First M. W, 1999, ASHRAE T, V105, P877; First M, 2007, J OCCUP ENVIRON HYG, V4, P321, DOI 10.1080/15459620701271693; First MW, 2005, J OCCUP ENVIRON HYG, V2, P285, DOI 10.1080/15459620590952224; First MW N.E., 1999, T AM SOC HEAT REFRIG, V105, P869; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Ko G, 2000, TUBERCLE LUNG DIS, V80, P217, DOI 10.1054/tuld.2000.0249; McDevitt JJ, 2007, APPL ENVIRON MICROB, V73, P5760, DOI 10.1128/AEM.00110-07; Nicas M, 1999, Appl Occup Environ Hyg, V14, P317; RILEY RL, 1972, APPL MICROBIOL, V23, P1113, DOI 10.1128/AEM.23.6.1113-1120.1972; RILEY RL, 1976, AM REV RESPIR DIS, V113, P413; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; Rudnick SN, 2007, J OCCUP ENVIRON HYG, V4, P352, DOI 10.1080/15459620701298167; SATTAR AS, 1987, CRC CRIT R ENVIRON, V17, P88; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; WEHRLE PF, 1970, B WORLD HEALTH ORGAN, V43, P669; Xu P, 2005, ENVIRON SCI TECHNOL, V39, P9656, DOI 10.1021/es0504892; Xu P, 2003, ATMOS ENVIRON, V37, P405, DOI 10.1016/S1352-2310(02)00825-7	20	35	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3186	10.1371/journal.pone.0003186	http://dx.doi.org/10.1371/journal.pone.0003186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781204	Green Published, Green Submitted, gold			2022-12-25	WOS:000264425700012
J	O'Riordan, P; Schwab, U; Logan, S; Cooke, G; Wilkinson, RJ; Davidson, RN; Bassett, P; Wall, R; Pasvol, G; Flanagan, KL				O'Riordan, Philly; Schwab, Uli; Logan, Sarah; Cooke, Graham; Wilkinson, Robert J.; Davidson, Robert N.; Bassett, Paul; Wall, Robert; Pasvol, Geoffrey; Flanagan, Katie L.			Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study	PLOS ONE			English	Article							SURVEILLANCE; SITUATION; RISK	Background: Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often delayed, increasing the risk of spread to the community and health care workers. Treatment is prolonged, and the total cost of treating a single case is high. Diagnosis has traditionally relied upon clinical suspicion, based on risk factors and culture with sensitivity testing, a process that can take weeks or months. Rapid diagnostic molecular techniques have the potential to shorten the time to commencing appropriate therapy, but have not been put to the test under field conditions. Methodology/Principal Findings: This retrospective case-control study aimed to identify risk factors for MDR-TB, and analyse the impact of testing for rifampicin resistance using RNA polymerase B (rpoB) mutations as a surrogate for MDR-TB. Forty two MDR-TB cases and 84 fully sensitive TB controls were matched by date of diagnosis; and factors including demographics, clinical presentation, microbiology findings, management and outcome were analysed using their medical records. Conventionally recognised risk factors for MDR-TB were absent in almost half (43%) of the cases, and 15% of cases were asymptomatic. A significant number of MDR-TB cases were identified in new entrants to the country. Using rpoB mutation testing, the time to diagnosis of MDR-TB was dramatically shortened by a median of 6 weeks, allowing patients to be commenced on appropriate therapy a median of 51 days earlier than those diagnosed by conventional culture and sensitivity testing. Conclusions/Significance: MDR-TB is frequently an unexpected finding, may be asymptomatic, and is particularly prevalent among TB infected new entrants to the country. Molecular resistance testing of all acid fast bacilli positive specimens has the potential to rapidly identify MDR-TB patients and commence them on appropriate therapy significantly earlier than by conventional methods.	[O'Riordan, Philly; Schwab, Uli; Logan, Sarah; Cooke, Graham; Wilkinson, Robert J.; Davidson, Robert N.; Bassett, Paul; Pasvol, Geoffrey; Flanagan, Katie L.] Northwick Pk Hosp & Clin Res Ctr, Lister Unit, Dept Infect & Trop Med, Harrow HA1 3UJ, Middx, England; [Wilkinson, Robert J.; Pasvol, Geoffrey] Imperial Coll London, Wellcome Ctr Clin Trop Med, Div Med, London, England; [Wall, Robert] Northwick Park Hosp, Dept Med Microbiol, Harrow, Middx, England	Imperial College London; Imperial College London	O'Riordan, P (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Lister Unit, Dept Infect & Trop Med, Harrow HA1 3UJ, Middx, England.	kflanagan@mrc.gm		Cooke, Graham/0000-0001-6475-5056; Bassett, Paul/0000-0001-7830-4563; Wilkinson, Robert/0000-0002-2753-1800; Flanagan, Katie/0000-0002-1575-1953	MRC [MC_U117588499] Funding Source: UKRI; Medical Research Council [MC_U117588499] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Callister MEJ, 2002, THORAX, V57, P152, DOI 10.1136/thorax.57.2.152; Caws M, 2001, ANN NY ACAD SCI, V953, P138, DOI 10.1111/j.1749-6632.2001.tb11371.x; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; DEBEENHOUWER H, 1995, J CLIN MICROBIOL, V33, P2994, DOI 10.1128/JCM.33.11.2994-2998.1995; Drobniewski F, 2002, THORAX, V57, P810, DOI 10.1136/thorax.57.9.810; El Sahly HM, 2006, J INFECTION, V53, P5, DOI 10.1016/j.jinf.2005.10.002; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; HARDIE RM, 1993, BRIT MED J, V307, P1539, DOI 10.1136/bmj.307.6918.1539; HAYWARD A, 1996, THORAX S, V3, pS31; *HLTH PROT AG LOND, 2005, UK MYC SURV NETW REP; *HLTH PROT AG LOND, 2006, FOC TUB ANN SURV REP; Ormerod LP, 1998, J INFECTION, V37, P39, DOI 10.1016/S0163-4453(98)90432-7; Ormerod P, 2001, ANN NY ACAD SCI, V953, P185, DOI 10.1111/j.1749-6632.2001.tb11376.x; Rajbhandary SS, 2004, INT J TUBERC LUNG D, V8, P1012; Sam IC, 2006, EMERG INFECT DIS, V12, P752, DOI 10.3201/eid1205.041339; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Watterson SA, 1998, J CLIN MICROBIOL, V36, P1969, DOI 10.1128/JCM.36.7.1969-1973.1998; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2003, TREATM TUB GUID NAT	23	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3173	10.1371/journal.pone.0003173	http://dx.doi.org/10.1371/journal.pone.0003173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779863	gold, Green Submitted, Green Published			2022-12-25	WOS:000264425100009
J	Bernatavichute, YV; Zhang, XY; Cokus, S; Pellegrini, M; Jacobsen, SE				Bernatavichute, Yana V.; Zhang, Xiaoyu; Cokus, Shawn; Pellegrini, Matteo; Jacobsen, Steven E.			Genome-Wide Association of Histone H3 Lysine Nine Methylation with CHG DNA Methylation in Arabidopsis thaliana	PLOS ONE			English	Article								Methylation of histone H3 lysine 9 (H3K9) is a hallmark of transcriptional silencing in many organisms. In Arabidopsis thaliana, dimethylation of H3K9 (H3K9m2) is important in the silencing of transposons and in the control of DNA methylation. We constructed a high-resolution genome-wide map of H3K9m2 methylation by using chromatin immunoprecipitation coupled with whole genome Roche Nimblegen microarrays (ChIP-chip). We observed a very high coincidence between H3K9m2 and CHG methylation (where H is either A, T or C) throughout the genome. The coding regions of genes that are associated exclusively with methylation in a CG context did not contain H3K9m2. In addition, we observed two distinct patterns of H3K9m2. Transposons and other repeat elements present in the euchromatic arms contained small islands of H3K9m2 present at relatively low levels. In contrast, pericentromeric/centromeric regions of Arabidopsis chromosomes contained long, rarely interrupted blocks of H3K9m2 present at much higher average levels than seen in the chromosome arms. These results suggest a complex interplay between H3K9m2 and different types of DNA methylation and suggest that distinct mechanisms control H3K9m2 in different compartments of the genome.	[Bernatavichute, Yana V.; Jacobsen, Steven E.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Bernatavichute, Yana V.; Cokus, Shawn; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol, Cell & Dev Biol, Los Angeles, CA 90024 USA; [Zhang, Xiaoyu] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University System of Georgia; University of Georgia; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Pellegrini, M (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	matteop@mcdb.ucla.edu; jacobsen@ucla.edu	Zhang, xiaoyu/GXA-3206-2022	Pellegrini, Matteo/0000-0001-9355-9564	USPHS National Research Sevice Award [GM07104]; Jonsson Cancer Center Foundation [fellowship]; NIH [GM60398]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R37GM060398] Funding Source: NIH RePORTER	USPHS National Research Sevice Award; Jonsson Cancer Center Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Y.V.B. was supported by USPHS National Research Sevice Award GM07104. X.Z. was supported by a fellowship from the Jonsson Cancer Center Foundation. Jacobsen lab research was supported by NIH grant GM60398. S.E.J. is an investigator of the Howard Hughes Medical Institute.	Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Ebbs ML, 2005, MOL CELL BIOL, V25, P10507, DOI 10.1128/MCB.25.23.10507-10515.2005; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jasencakova Z, 2003, PLANT J, V33, P471, DOI 10.1046/j.1365-313X.2003.01638.x; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kankel MW, 2003, GENETICS, V163, P1109; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; TURCK F, 2007, IN PRESS PLOS GENET, DOI DOI 10.1371/JOURNAL.PGEN.0030086.EOR; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	51	238	246	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3156	10.1371/journal.pone.0003156	http://dx.doi.org/10.1371/journal.pone.0003156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776934	Green Published, gold			2022-12-25	WOS:000264424300003
J	Buijs, RM; van der Vliet, J; Garidou, ML; Huitinga, I; Escobar, C				Buijs, Ruud M.; van der Vliet, Jan; Garidou, Mari-Laure; Huitinga, Inge; Escobar, Carolina			Spleen Vagal Denervation Inhibits the Production of Antibodies to Circulating Antigens	PLOS ONE			English	Article								Background: Recently the vagal output of the central nervous system has been shown to suppress the innate immune defense to pathogens. Here we investigated by anatomical and physiological techniques the communication of the brain with the spleen and provided evidence that the brain has the capacity to stimulate the production of antigen specific antibodies by its parasympathetic autonomic output. Methodology/Principal Findings: This conclusion was reached by successively demonstrating that: 1. The spleen receives not only sympathetic input but also parasympathetic input. 2. Intravenous trinitrophenyl-ovalbumin (TNP-OVA) does not activate the brain and does not induce an immune response. 3. Intravenous TNP-OVA with an inducer of inflammation; lipopolysaccharide (LPS), activates the brain and induces TNP-specific IgM. 4. LPS activated neurons are in the same areas of the brain as those that provide parasympathetic autonomic information to the spleen, suggesting a feed back circuit between brain and immune system. Consequently we investigated the interaction of the brain with the spleen and observed that specific parasympathetic denervation but not sympathetic denervation of the spleen eliminates the LPS-induced antibody response to TNP-OVA. Conclusions/Significance: These findings not only show that the brain can stimulate antibody production by its autonomic output, it also suggests that the power of LPS as adjuvant to stimulate antibody production may also depend on its capacity to activate the brain. The role of the autonomic nervous system in the stimulation of the adaptive immune response may explain why mood and sleep have an influence on antibody production.	[Buijs, Ruud M.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [van der Vliet, Jan; Garidou, Mari-Laure; Huitinga, Inge] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Escobar, Carolina] Univ Nacl Autonoma Mexico, Fac Med, Dept Anat, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Universidad Nacional Autonoma de Mexico	Buijs, RM (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	ruudbuijs@gmail.com	Escobar, Carolina/AAX-2354-2020; Buijs, Rudolf/AAD-5707-2020	Escobar, Carolina/0000-0002-2974-7875; 	DGAPA PAPIIT [IN215308-3]	DGAPA PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This study was supported in part by DGAPA PAPIIT IN215308-3.	Batocchi AP, 2003, J NEUROIMMUNOL, V139, P150, DOI 10.1016/S0165-5728(03)00154-1; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Buijs RM, 2001, J COMP NEUROL, V431, P405, DOI 10.1002/1096-9861(20010319)431:4<405::AID-CNE1079>3.0.CO;2-D; Cottrell GT, 2004, REGUL PEPTIDES, V117, P11, DOI 10.1016/j.regpep.2003.09.004; COVERT JB, 1971, INFECT IMMUN, V4, P452, DOI 10.1128/IAI.4.4.452-455.1971; DELREY A, 2006, P NATL ACAD SCI US; ENQUIST LW, 1994, SEMIN VIROL, V5, P221, DOI 10.1006/smvy.1994.1024; Fry M, 2007, EXP BIOL MED, V232, P14; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Goehler LE, 2006, NEUROSCIENCE, V140, P1415, DOI 10.1016/j.neuroscience.2006.03.048; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Hansen MK, 2000, AUTON NEUROSCI-BASIC, V85, P83, DOI 10.1016/S1566-0702(00)00224-1; Hopkins Stephen J, 2007, Acta Biomed, V78 Suppl 1, P231; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kalsbeek A, 1996, J NEUROENDOCRINOL, V8, P299, DOI 10.1046/j.1365-2826.1996.04597.x; Kreier F, 2002, J CLIN INVEST, V110, P1243, DOI 10.1172/JCI200215736; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; LANG CH, 1995, AM J PHYSIOL-REG I, V269, pR437, DOI 10.1152/ajpregu.1995.269.2.R437; LIND RW, 1985, NEUROENDOCRINOLOGY, V40, P2; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Rivest S, 2001, PSYCHONEUROENDOCRINO, V26, P761, DOI 10.1016/S0306-4530(01)00064-6; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosenkranz MA, 2005, P NATL ACAD SCI USA, V102, P13319, DOI 10.1073/pnas.0504365102; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Ruggiero DA, 1996, J COMP NEUROL, V364, P51; Sakaguchi T, 2002, AUTON NEUROSCI-BASIC, V99, P54, DOI 10.1016/S1566-0702(02)00060-7; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Schafer MKH, 1998, NEUROSCIENCE, V84, P361, DOI 10.1016/S0306-4522(97)80196-0; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Straub RH, 2004, TRENDS PHARMACOL SCI, V25, P640, DOI 10.1016/j.tips.2004.10.007; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Turek VF, 2005, PHARMACOL BIOCHEM BE, V80, P115, DOI 10.1016/j.pbb.2004.10.013; VANDERKOOY D, 1983, J COMP NEUROL, V219, P328, DOI 10.1002/cne.902190307; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339	36	78	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3152	10.1371/journal.pone.0003152	http://dx.doi.org/10.1371/journal.pone.0003152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773078	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420100009
J	Vallerie, SN; Furuhashi, M; Fucho, R; Hotamisligil, GS				Vallerie, Sara N.; Furuhashi, Masato; Fucho, Raquel; Hotamisligil, Goekhan S.			A Predominant Role for Parenchymal c-Jun Amino Terminal Kinase (JNK) in the Regulation of Systemic Insulin Sensitivity	PLOS ONE			English	Article								It has been established that c-Jun N-terminal kinase 1 (JNK1) is essential to the pathogenesis of insulin resistance and type 2 diabetes. Although JNK influences inflammatory signaling pathways, it remains unclear whether its activity in macrophages contributes to adipose tissue inflammation and ultimately to the regulation of systemic metabolism. To address whether the action of this critical inflammatory kinase in bone marrow-derived elements regulates inflammatory responses in obesity and is sufficient and necessary for the deterioration of insulin sensitivity, we performed bone marrow transplantation studies with wild type and JNK1-deficient mice. These studies illustrated that JNK1-deficiency in the bone marrow-derived elements (BMDE) was insufficient to impact macrophage infiltration or insulin sensitivity despite modest changes in the inflammatory profile of adipose tissue. Only when the parenchymal elements lacked JNK1 could we demonstrate a significant increase in systemic insulin sensitivity. These data indicate that while the JNK1 activity in BMDE is involved in metabolic regulation and adipose milieu, it is epistatic to JNK1 activity in the parenchymal tissue for regulation of metabolic homeostasis.	[Vallerie, Sara N.; Furuhashi, Masato; Fucho, Raquel; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Vallerie, SN (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Furuhashi, Masato/AAT-5518-2021; Fucho, Raquel/A-6684-2016	Furuhashi, Masato/0000-0002-0145-3541; Fucho, Raquel/0000-0002-1774-9099	National Institutes of Health, USA [DK52539]; Irene M. and Frederick J. Stare Nutrition Education Fund; Japan Society for the Promotion of Science and American Diabetes Association [postdoctoral fellowships];  [T90 DK70078];  [F31 DK072556]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539, F31DK072556, T90DK070078] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene M. and Frederick J. Stare Nutrition Education Fund; Japan Society for the Promotion of Science and American Diabetes Association; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from the National Institutes of Health, USA, to GSH (DK52539). SNV received support from the Irene M. and Frederick J. Stare Nutrition Education Fund and the T90 DK70078 Interdisciplinary Training Grant in Genetics & Complex Diseases. SNV is currently supported by a F31 DK072556 Predoctoral Fellowship to Promote Diversity in Health-Related Research. MF is supported by postdoctoral fellowships from the Japan Society for the Promotion of Science and American Diabetes Association.	Ablamunits V, 2007, OBESITY, V15, P1419, DOI 10.1038/oby.2007.170; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; COUSE JF, 1994, BIOTECHNIQUES, V17, P1030; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fujii N, 2004, AM J PHYSIOL-CELL PH, V287, pC200, DOI 10.1152/ajpcell.00415.2003; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Witczak CA, 2006, BIOCHEM BIOPH RES CO, V350, P1063, DOI 10.1016/j.bbrc.2006.09.158; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang R, 2007, J BIOL CHEM, V282, P22765, DOI 10.1074/jbc.M700790200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	41	83	87	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3151	10.1371/journal.pone.0003151	http://dx.doi.org/10.1371/journal.pone.0003151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773087	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420100008
J	Nakanishi, M; Kurisaki, A; Hayashi, Y; Warashina, M; Ishiura, S; Kusuda-Furue, M; Asashima, M				Nakanishi, Mio; Kurisaki, Akira; Hayashi, Yohei; Warashina, Masaki; Ishiura, Shoichi; Kusuda-Furue, Miho; Asashima, Makoto			Directed induction of anterior and posterior primitive streak by Wnt from embryonic stem cells cultured in a chemically defined serum-free medium	FASEB JOURNAL			English	Article						mesendoderm; endoderm; regenerative medicine; brachyury; sox17	MOUSE EMBRYO; DEFINITIVE ENDODERM; MESODERM FORMATION; GENE; DIFFERENTIATION; GASTRULATION; EXPRESSION; BODIES; MICE; REQUIREMENT	Formation of the primitive streak (PS) is the initial specification step that generates all the mesodermal and endodermal tissue lineages during early differentiation. Thus, a therapeutically compatible and efficient method for differentiation of the PS is crucial for regenerative medicine. In this study, we developed chemically defined serum-free culture conditions for the differentiation of embryonic stem (ES) cells into the PS-like cells. Cultures supplemented with Wnt showed induction of expression of a PS marker, the brachyury gene, followed by induction of the anterior PS markers goosecoid and foxa2, a posterior PS marker, evx1, and the endoderm marker sox17. Similar differentiation of PS by Wnt was also observed in human ES cells. Moreover, we revealed that the activation of the Wnt canonical pathway is essential for PS differentiation in mouse ES cells. These results demonstrated that Wnt is an essential and sufficient factor for the induction of the PS-like cells in vitro. These conditions of induction could constitute the initial step in generating therapeutically useful cells of the definitive endoderm lineage, such as hepatocytes and pancreatic endocrine cells, under chemically defined conditions. Nakanishi, M., Kurisaki, A., Hayashi, Y., Warashina, M., Ishiura, S., Kusuda-Furue, M., Asashima, M. Directed induction of anterior and posterior primitive streak by Wnt from embryonic stem cells cultured in a chemically defined serum-free medium. FASEB J. 23, 114-122 (2009)	[Nakanishi, Mio; Hayashi, Yohei; Ishiura, Shoichi; Asashima, Makoto] Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Kurisaki, Akira; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Tsukuba, Japan; [Warashina, Masaki] Wako Pure Chem Ind Ltd, Genome Res Labs, Kobe, Hyogo, Japan; [Kusuda-Furue, Miho] Natl Inst Biomed Innovat, Div Bioresources, Osaka, Japan; [Kusuda-Furue, Miho; Asashima, Makoto] Japan Sci & Technol Agcy, Int Cooperat Res Project ICORP, Tokyo, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST)	Asashima, M (corresponding author), Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	asashi@bio.c.u-tokyo.ac.jp	Hayashi, Yohei/AAF-6059-2020; Asashima, Makoto/O-8389-2018; Hayashi, Yohei/L-8190-2019	Hayashi, Yohei/0000-0001-5490-7052; Asashima, Makoto/0000-0002-0012-026X; Furue, Miho/0000-0001-5032-9953	Takeda Pharmaceuticals Company, Inc; Ministry of Health, Labor and Welfare of Japan; Naito Foundation,; Wako Pure Chemical Industries, Ltd	Takeda Pharmaceuticals Company, Inc(Takeda Pharmaceutical Company Ltd); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Naito Foundation,; Wako Pure Chemical Industries, Ltd	We thank Drs. N. Nakatsuji and H. Suemori (Kyoto University, Kyoto, Japan) for providing human KhES-1 cell line. We thank Drs. T. Michiue and H. Danno for discussion. We also gratefully acknowledge Takeda Pharmaceuticals Company, Inc. for its generous support of this study. This work was supported in part by a grant-in-aid for scientific research from the Ministry of Health, Labor and Welfare of Japan, by a grant from the Naito Foundation, and by Wako Pure Chemical Industries, Ltd.	Aumailley M, 2000, J CELL SCI, V113, P259; Bader A, 2001, DIFFERENTIATION, V68, P31, DOI 10.1046/j.1432-0436.2001.068001031.x; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; CONLON FL, 1994, DEVELOPMENT, V120, P1919; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; DUSH MK, 1992, DEV BIOL, V151, P273, DOI 10.1016/0012-1606(92)90232-6; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Inman KE, 2006, GENE EXPR PATTERNS, V6, P783, DOI 10.1016/j.modgep.2006.01.010; KAESTNER KH, 1994, GENOMICS, V20, P377, DOI 10.1006/geno.1994.1191; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Liu Y, 2004, DEV BIOL, V270, P411, DOI 10.1016/j.ydbio.2004.03.017; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Stemmler MP, 2003, DEV DYNAM, V227, P238, DOI 10.1002/dvdy.10301; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	36	67	70	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					114	122		10.1096/fj.08-111203	http://dx.doi.org/10.1096/fj.08-111203			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18809738				2022-12-25	WOS:000262095500014
J	Monje, PV; Athauda, G; Wood, PM				Monje, Paula V.; Athauda, Gagani; Wood, Patrick M.			Protein Kinase A-mediated Gating of Neuregulin-dependent ErbB2-ErbB3 Activation Underlies the Synergistic Action of cAMP on Schwann Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CYCLIC-AMP; MAP KINASE; SIGNALING PATHWAYS; FACTOR RECEPTOR; HEREGULIN; AKT; EPAC; PHOSPHORYLATION; ERBB3	In Schwann cells (SCs), cyclic adenosine monophosphate (cAMP) enhances the action of neuregulin, the most potent known mitogen for SCs, by synergistically increasing the activation of two crucial signaling pathways: ERK and Akt. However, the underlying mechanism of cross-talk between neuregulin and cAMP signaling remains mostly undefined. Here, we report that the activation of protein kinase A (PKA), but not that of exchange protein activated by cAMP (EPAC), enhances S-phase entry of SCs by synergistically enhancing the ligand-dependent tyrosine phosphorylation/activation of the neuregulin co-receptor, ErbB2-ErbB3. The role of PKA in neuregulin-ErbB signaling was confirmed using PKA inhibitors, pathway-selective cAMP analogs, and natural ligands stimulating PKA activity in SCs, such as adenosine and epinephrine. Two basic observations defined the synergistic action of PKA as "gating" for neuregulin-ErbB signaling: 1) the activation of PKA was not sufficient to induce S-phase entry or the activation of either ErbB2 or ErbB3; and 2) the presence of neuregulin was strictly required to ignite ErbB activation and thereby ERK and Akt signaling. However, PKA directly phosphorylated ErbB2 on Thr-686, a highly conserved intracellular regulatory site that was required for the PKA-mediated synergistic enhancement of neuregulin-induced ErbB2-ErbB3 activation and proliferation in SCs. The gating action of PKA on neuregulin-induced ErbB2-ErbB3 activation has important biological significance, because it insures signal amplification into the ERK and Akt pathways without compromising either the neuregulin dependence or the high specificity of ErbB signaling pathways.	[Monje, Paula V.; Athauda, Gagani] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Wood, Patrick M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA	University of Miami; University of Miami	Monje, PV (corresponding author), 1095 NW 14th Terrace, Miami, FL 33136 USA.	MPaula@miamiproject.med.miami.edu	Monje, Paula/AAB-9099-2020		National Institutes of Grant [NS009923]; NINDS; The Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923] Funding Source: NIH RePORTER	National Institutes of Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); The Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Grant NS009923 from NINDS. This work was also supported by The Project to Cure Paralysis. The costs of publication of this article defrayed in part by the payment of page charges. This article must be hereby marked "advertisement" in accordance with 18 U. S. C. 1734 solely to indicate this fact.	ALIMANDI M, 1995, ONCOGENE, V10, P1813; Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; CARRAWAY KL, 1995, J BIOL CHEM, V270, P7111, DOI 10.1074/jbc.270.13.7111; CHENG L, 1995, J CELL BIOL, V129, P789, DOI 10.1083/jcb.129.3.789; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fink T, 1999, CAN J PHYSIOL PHARM, V77, P204, DOI 10.1139/cjpp-77-3-204; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gulliford T, 1999, CELL SIGNAL, V11, P245, DOI 10.1016/S0898-6568(98)00058-8; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Kim HA, 1997, J NEUROSCI RES, V49, P236; Kim HA, 2001, J NEUROSCI, V21, P1110; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Piiper A, 2004, CURR PHARM DESIGN, V10, P3539, DOI 10.2174/1381612043382936; Piiper A, 2003, BIOCHEM BIOPH RES CO, V301, P848, DOI 10.1016/S0006-291X(03)00055-X; Piiper A, 2002, J BIOL CHEM, V277, P43623, DOI 10.1074/jbc.M203926200; RAFF MC, 1978, CELL, V15, P813, DOI 10.1016/0092-8674(78)90266-0; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; REHMANN H, 2005, EXPT PROCEDURES ENZY, V407, P159; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; Stevens B, 2004, NEURON GLIA BIOL, V1, P23, DOI 10.1017/s1740925x04000055; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; WOOD PM, 1975, NATURE, V256, P662, DOI 10.1038/256662a0; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366	47	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34087	34100		10.1074/jbc.M802318200	http://dx.doi.org/10.1074/jbc.M802318200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18799465	Green Published, hybrid			2022-12-25	WOS:000261277700037
J	Casagrande, F; Ratera, M; Schenk, AD; Chami, M; Valencia, E; Lopez, JM; Torrents, D; Engel, A; Palacin, M; Fotiadis, D				Casagrande, Fabio; Ratera, Merce; Schenk, Andreas D.; Chami, Mohamed; Valencia, Eva; Maria Lopez, Jesus; Torrents, David; Engel, Andreas; Palacin, Manuel; Fotiadis, Dimitrios			Projection Structure of a Member of the Amino Acid/Polyamine/Organocation Transporter Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINURIC PROTEIN INTOLERANCE; IMAGE-PROCESSING LIBRARY; EXTREME ACID RESISTANCE; ESCHERICHIA-COLI; PYROCOCCUS-HORIKOSHII; AGMATINE ANTIPORTER; MEMBRANE TOPOLOGY; APC SUPERFAMILY; ARGININE; PERMEASE	The L-arginine/agmatine antiporter AdiC is a key component of the arginine-dependent extreme acid resistance system of Escherichia coli. Phylogenetic analysis indicated that AdiC belongs to the amino acid/polyamine/organocation (APC) transporter superfamily having sequence identities of 15-17% to eukaryotic and human APC transporters. For functional and structural characterization, we cloned, overexpressed, and purified wild-type AdiC and the point mutant AdiC-W293L, which is unable to bind and consequently transport L-arginine. Purified detergent-solubilized AdiC particles were dimeric. Reconstitution experiments yielded two-dimensional crystals of AdiC-W293L diffracting beyond 6 angstrom resolution from which we determined the projection structure at 6.5 angstrom resolution. The projection map showed 10-12 density peaks per monomer and suggested mainly tilted helices with the exception of one distinct perpendicular membrane spanning alpha-helix. Comparison of AdiC-W293L with the projection map of the oxalate/formate antiporter from Oxalobacter formigenes, a member from the major facilitator superfamily, indicated different structures. Thus, two-dimensional crystals of AdiC-W293L yielded the first detailed view of a transport protein from the APC superfamily at sub-nanometer resolution.	[Casagrande, Fabio; Schenk, Andreas D.; Chami, Mohamed; Engel, Andreas; Fotiadis, Dimitrios] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; [Ratera, Merce; Valencia, Eva; Palacin, Manuel] Ctr Invest Biomed Red Enfermedades Raras, E-08028 Barcelona, Spain; [Maria Lopez, Jesus; Torrents, David] Barcelona Supercomp Ctr, Life Sci Program, E-08034 Barcelona, Spain; [Maria Lopez, Jesus] Natl Inst Bioinformat, E-08034 Barcelona, Spain; [Torrents, David] Inst Catalana Recerca & Estudis Avancats, E-08034 Barcelona, Spain; [Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Ratera, Merce; Valencia, Eva; Palacin, Manuel] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Inst Biomed Res, E-08028 Barcelona, Spain	University of Basel; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); ICREA; University of Bern; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Palacin, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Inst Biomed Res, Barcelona Sci Pk,Josep Samitier 1-5, E-08028 Barcelona, Spain.	manuel.palacin@irbbarcelona.org; dimitrios.fotiadis@mci.unibe.ch	Torrents, David/G-5785-2015	Torrents, David/0000-0002-6086-9037; Lopez Marti, Jesus Maria/0000-0002-3006-1360; Schenk, Andreas/0000-0001-9214-2505; Ratera, Merce/0000-0001-5224-9172; Palacin, Manuel/0000-0002-8670-293X	European Community Project [502802]; Berne University Research Foundation; Spanish Ministry of Science and Education [BFU2006-14600]; Swiss National Center of Competence in Research for Structural Biology; Maurice E. Muller Foundation of Switzerland; Fondo Social Europeo; ICREA Funding Source: Custom	European Community Project(European Commission); Berne University Research Foundation; Spanish Ministry of Science and Education(Spanish Government); Swiss National Center of Competence in Research for Structural Biology(Swiss National Science Foundation (SNSF)); Maurice E. Muller Foundation of Switzerland; Fondo Social Europeo(European Social Fund (ESF)European Commission); ICREA(ICREA)	This work was supported by the European Community Project Grant 502802 EUGINDAT (to D. F. and M. P.), by the Berne University Research Foundation (to D. F. and Matthias Hediger), by the Spanish Ministry of Science and Education Grant BFU2006-14600 (to M. P.), by the Swiss National Center of Competence in Research for Structural Biology (to A. E.), and by the Maurice E. Muller Foundation of Switzerland (to A. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a pre-doctoral fellowship from the Spanish Ministry of Science and Education.; Recipient of a Juan de La Cierva contract from the Spanish Ministry of Science and Education with support from the Fondo Social Europeo.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Cosgriff AJ, 1997, J BACTERIOL, V179, P3317, DOI 10.1128/jb.179.10.3317-3323.1997; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; ELLIS J, 1995, MICROBIOL-UK, V141, P1927, DOI 10.1099/13500872-141-8-1927; Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Heymann JAW, 2001, EMBO J, V20, P4408, DOI 10.1093/emboj/20.16.4408; Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731; Hu LA, 1998, BIOCHEM J, V336, P69, DOI 10.1042/bj3360069; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Jimenez-Vidal M, 2004, J BIOL CHEM, V279, P11214, DOI 10.1074/jbc.M309866200; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032; Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Stahlberg H, 2001, FEBS LETT, V504, P166, DOI 10.1016/S0014-5793(01)02746-6; Subramaniam S, 2002, PHILOS T ROY SOC A, V360, P859, DOI 10.1098/rsta.2001.0971; Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445; Xie H, 2004, MOL MEMBR BIOL, V21, P323, DOI 10.1080/09687860400003941; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yeramian A, 2006, J IMMUNOL, V176, P5918, DOI 10.4049/jimmunol.176.10.5918; Yeramian A, 2006, EUR J IMMUNOL, V36, P1516, DOI 10.1002/eji.200535694; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	42	34	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33240	33248		10.1074/jbc.M806917200	http://dx.doi.org/10.1074/jbc.M806917200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18819925	Green Published, hybrid			2022-12-25	WOS:000261183700027
J	Hirota, K; Sakamaki, J; Ishida, J; Shimamoto, Y; Nishihara, S; Kodama, N; Ohta, K; Yamamoto, M; Tanimoto, K; Fukamizu, A				Hirota, Keiko; Sakamaki, Jun-ichi; Ishida, Junji; Shimamoto, Yoko; Nishihara, Shigeki; Kodama, Norio; Ohta, Kazuhide; Yamamoto, Masayuki; Tanimoto, Keiji; Fukamizu, Akiyoshi			A Combination of HNF-4 and Foxo1 Is Required for Reciprocal Transcriptional Regulation of Glucokinase and Glucose-6-phosphatase Genes in Response to Fasting and Feeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR 4-ALPHA; FACTOR FKHR; PROMOTER ACTIVITY; CYCLIC-AMP; IN-VIVO; INSULIN; EXPRESSION; LIVER; RECEPTOR; PROTEIN	Glucokinase (GK) and glucose-6-phosphatase (G6Pase) regulate rate-limiting reactions in the physiologically opposed metabolic cascades, glycolysis and gluconeogenesis, respectively. Expression of these genes is conversely regulated in the liver in response to fasting and feeding. We explored the mechanism of transcriptional regulation of these genes by nutritional condition and found that reciprocal function of HNF-4 and Foxo1 plays an important role in this process. In the GK gene regulation, Foxo1 represses HNF-4-potentiated transcription of the gene, whereas it synergizes with HNF-4 in activating the G6Pase gene transcription. These opposite actions of Foxo1 concomitantly take place in the cells under no insulin stimulus, and such gene-specific action was promoter context-dependent. Interestingly, HNF-4-binding elements (HBEs) in the GK and G6Pase promoters were required both for the insulin-stimulated GK gene activation and insulin-mediated G6Pase gene repression. Indeed, mouse in vivo imaging showed that mutating the HBEs in the GK and G6Pase promoters significantly impaired their reactivity to the nutritional states, even in the presence of intact Foxo1-binding sites (insulin response sequences). Thus, in the physiological response of the GK and G6Pase genes to fasting/feeding conditions, Foxo1 distinctly decodes the promoter context of these genes and differently modulates the function of HBE, which then leads to opposite outcomes of gene transcription.	[Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Nishihara, Shigeki; Kodama, Norio; Ohta, Kazuhide] Otsuka Pharmaceut Co Ltd, Otsuka GEN Res Inst, Tokushima 7710192, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan	University of Tsukuba; Otsuka Pharmaceutical; Tohoku University	Fukamizu, A (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ctr Tsukuba Adv Res Alliance, Tennoudai 1-1-1, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp	Tanimoto, Keiji/B-2600-2014; Yamamoto, Masayuki/A-4873-2010; fukamizu, akiyoshi/J-5350-2012	Yamamoto, Masayuki/0000-0002-9073-9436; fukamizu, akiyoshi/0000-0002-8786-6020; Tanimoto, Keiji/0000-0003-1971-6546; Sakamaki, Jun-ichi/0000-0003-3361-6314	Ministry of Education, Culture, Sports, Science and Technology of Japan; Fumi Yamamura Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fumi Yamamura Memorial Foundation	This work was supported by a grant-in-aid for scientific research on priority areas and a grant-in-aid for young scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Fumi Yamamura Memorial Foundation for Female Natural Scientists. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Chatelain F, 1998, DIABETES, V47, P882, DOI 10.2337/diabetes.47.6.882; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Drewes T, 1996, MOL CELL BIOL, V16, P925; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gautier-Stein A, 2005, MOL ENDOCRINOL, V19, P163, DOI 10.1210/me.2004-0105; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hirota K, 2005, INT J MOL MED, V15, P487; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; HROMAS R, 1995, CRIT REV ONCOL HEMAT, V20, P129, DOI 10.1016/1040-8428(94)00151-I; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Rajas F, 2002, J BIOL CHEM, V277, P15736, DOI 10.1074/jbc.M200971200; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Roth U, 2002, BIOCHEM J, V365, P223, DOI 10.1042/BJ20020340; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taylor DG, 1996, NUCLEIC ACIDS RES, V24, P2930, DOI 10.1093/nar/24.15.2930; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Yoshida E, 1997, BIOCHEM BIOPH RES CO, V241, P664, DOI 10.1006/bbrc.1997.7871; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	44	95	98	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32432	32441		10.1074/jbc.M806179200	http://dx.doi.org/10.1074/jbc.M806179200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805788	hybrid			2022-12-25	WOS:000260893700031
J	Kaeser, MD; Aslanian, A; Dong, MQ; Yates, JR; Emerson, BM				Kaeser, Matthias D.; Aslanian, Aaron; Dong, Meng-Qiu; Yates, John R., III; Emerson, Beverly M.			BRD7, a Novel PBAF-specific SWI/SNF Subunit, Is Required for Target Gene Activation and Repression in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTIONAL REGULATION; LENTIVIRAL VECTORS; CYCLE CONTROL; HORMONE GENE; SNF COMPLEX; DIFFERENTIATION; BINDING; BRG1; PLURIPOTENCY	The composition of chromatin-remodeling complexes dictates how these enzymes control transcriptional programs and cellular identity. In the present study we investigated the composition of SWI/SNF complexes in embryonic stem cells (ESCs). In contrast to differentiated cells, ESCs have a biased incorporation of certain paralogous SWI/SNF subunits with low levels of BRM, BAF170, and ARID1B. Upon differentiation, the expression of these subunits increases, resulting in a higher diversity of compositionally distinct SWI/SNF enzymes. We also identified BRD7 as a novel component of the Polybromo-associated BRG1-associated factor (PBAF) complex in both ESCs and differentiated cells. Using short hairpin RNA-mediated depletion of BRG1, we showed that SWI/SNF can function as both a repressor and an activator in pluripotent cells, regulating expression of developmental modifiers and signaling components such as Nodal, ADAMTS1, BMI-1, CRABP1, and thyroid releasing hormone. Knockdown studies of PBAF-specific BRD7 and of a signature subunit within the BAF complex, ARID1A, showed that these two subcomplexes affect SWI/SNF target genes differentially, in some cases even antagonistically. This may be due to their different biochemical properties. Finally we examined the role of SWI/SNF in regulating its target genes during differentiation. We found that SWI/SNF affects recruitment of components of the preinitiation complex in a promoter-specific manner to modulate transcription positively or negatively. Taken together, our results provide insight into the function of compositionally diverse SWI/SNF enzymes that underlie their inherent gene-specific mode of action.	[Kaeser, Matthias D.; Emerson, Beverly M.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Aslanian, Aaron; Dong, Meng-Qiu; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Emerson, BM (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	emerson@salk.edu		Kaeser, Matthias/0000-0003-0050-9408	National Institutes of Health [GM038760]; Swiss National Science Foundation; European Molecular Biology Organization; Roche Research Foundation; Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Roche Research Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM038760 (to B. M. E.). This work was also supported by fellowships from the Swiss National Science Foundation, European Molecular Biology Organization, and Roche Research Foundation (to M. D. K.) and by the Ruth L. Kirschstein National Research Service Award (to A. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; D Kaeser M, 2006, CURR OPIN GENET DEV, V16, P508, DOI 10.1016/j.gde.2006.08.001; Dauvillier S, 2001, MECH DEVELOP, V101, P221, DOI 10.1016/S0925-4773(00)00560-8; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gunawardena RW, 2007, J BIOL CHEM, V282, P20116, DOI 10.1074/jbc.M701406200; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Logie C, 1999, METHOD ENZYMOL, V304, P726; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitra D, 2006, MOL CELL BIOL, V26, P4095, DOI 10.1128/MCB.01849-05; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Moreira JMA, 1999, EMBO J, V18, P2836, DOI 10.1093/emboj/18.10.2836; Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06; Motoyama A, 2007, ANAL CHEM, V79, P3623, DOI 10.1021/ac062292d; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Peng C, 2006, J CELL BIOCHEM, V97, P882, DOI 10.1002/jcb.20645; Ren Y, 1998, ENDOCRINOLOGY, V139, P195, DOI 10.1210/en.139.1.195; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Staal A, 2000, J CELL PHYSIOL, V185, P269, DOI 10.1002/1097-4652(200011)185:2<269::AID-JCP12>3.0.CO;2-L; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zani VJ, 1996, BLOOD, V87, P3124, DOI 10.1182/blood.V87.8.3124.bloodjournal8783124	59	160	162	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32254	32263		10.1074/jbc.M806061200	http://dx.doi.org/10.1074/jbc.M806061200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809673	Green Published, hybrid			2022-12-25	WOS:000260893700012
J	Sudhamsu, J; Lee, GI; Klessig, DF; Crane, BR				Sudhamsu, Jawahar; Lee, Gyu In; Klessig, Daniel F.; Crane, Brian R.			The Structure of YqeH AN AtNOS1/AtNOA1 ORTHOLOG THAT COUPLES GTP HYDROLYSIS TO MOLECULAR RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NUCLEAR EXPORT RECEPTOR; MESSENGER-RNA STABILITY; HIPPEL-LINDAU PROTEIN; BACILLUS-SUBTILIS; BINDING-PROTEINS; ARABIDOPSIS-THALIANA; ATTENUATION PROTEIN; RIBOSOMAL-SUBUNIT; CELL-DIVISION	AtNOS1/AtNOA1 was identified as a nitric oxide-generating enzyme in plants, but that function has recently been questioned. To resolve issues surrounding AtNOA1 activity, we report the biochemical properties and a 2.36 angstrom resolution crystal structure of a bacterial AtNOA1 ortholog (YqeH). Geobacillus YqeH fused to a putative AtNOA1 leader peptide complements growth and morphological defects of Atnoa1 mutant plants. YqeH does not synthesize nitric oxide from L-arginine but rather hydrolyzes GTP. The YqeH structure reveals a circularly permuted GTPase domain and an unusual C-terminal beta-domain. A small N-terminal domain, disordered in the structure, binds zinc. Structural homology among the C-terminal domain, the RNA-binding regulator TRAP, and the hypoxia factor pVHL define a recognition module for peptides and nucleic acids. TRAP residues important for RNA binding are conserved by the YqeH C-terminal domain, whose positioning is coupled to GTP hydrolysis. YqeH and AtNOA1 probably act as G-proteins that regulate nucleic acid recognition and not as nitric-oxide synthases.	[Sudhamsu, Jawahar; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Lee, Gyu In; Klessig, Daniel F.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Cornell University; Boyce Thompson Institute for Plant Research	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, G60 ST OLIN, Ithaca, NY 14853 USA.	bc69@cornell.edu	Sudhamsu, Jawahar/A-8751-2012		National Institutes of Health [5R01GM067011]; National Science Foundation [CHE-0749996]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM067011 ( to D. F. K.). This work was also supported by National Science Foundation Grant CHE-0749996 ( to B. R. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; Cheng G, 2005, NUCLEIC ACIDS RES, V33, P5861, DOI 10.1093/nar/gki894; Cohen HT, 1999, BIOCHEM BIOPH RES CO, V266, P43, DOI 10.1006/bbrc.1999.1767; Comartin DJ, 2006, CURR OPIN PHARMACOL, V6, P453, DOI 10.1016/j.coph.2006.05.005; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Crawford NM, 2006, J EXP BOT, V57, P471, DOI 10.1093/jxb/erj050; Crawford NM, 2005, TRENDS PLANT SCI, V10, P195, DOI 10.1016/j.tplants.2005.02.008; Cueto M, 1996, FEBS LETT, V398, P159, DOI 10.1016/S0014-5793(96)01232-X; Datta K, 2005, ONCOGENE, V24, P7850, DOI 10.1038/sj.onc.1208912; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; FLORESPEREZ U, 2008, PLANT CELL IN PRESS; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fridell RA, 1997, J CELL SCI, V110, P1325; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P1703, DOI 10.1093/nar/29.8.1703; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang S, 1997, J NEUROCHEM, V69, P2516; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kaiser WM, 2004, NITRIC OXIDE-BIOL CH, V11, P37; Kent HM, 1999, J MOL BIOL, V289, P565, DOI 10.1006/jmbi.1999.2775; Klessig Daniel F, 2004, Proc Natl Acad Sci U S A, V101, P16081, DOI 10.1073/pnas.0406996101; Klessig DF, 2004, CELL, V119, P445, DOI 10.1016/j.cell.2004.10.007; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Lamotte O, 2004, PLANT PHYSIOL, V135, P516, DOI 10.1104/pp.104.038968; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Mur LAJ, 2006, J EXP BOT, V57, P489, DOI 10.1093/jxb/erj052; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen C, 2000, J BIOL CHEM, V275, P4081, DOI 10.1074/jbc.275.6.4081; Pioli PA, 2001, J BIOL CHEM, V276, P40346, DOI 10.1074/jbc.M105391200; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Reynaud EG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-21; Ribeiro EA, 1999, FEBS LETT, V445, P283, DOI 10.1016/S0014-5793(99)00138-6; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3; Yang M, 1997, J MOL BIOL, V270, P696, DOI 10.1006/jmbi.1997.1149; Yona G, 2005, J COMPUT BIOL, V12, P12, DOI 10.1089/cmb.2005.12.12; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zemojtel T, 2006, FEBS LETT, V580, P455, DOI 10.1016/j.febslet.2005.12.038; Zemojtel T, 2004, TRENDS BIOCHEM SCI, V29, P224, DOI 10.1016/j.tibs.2004.03.005; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	85	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32968	32976		10.1074/jbc.M804837200	http://dx.doi.org/10.1074/jbc.M804837200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801747	Green Published, hybrid			2022-12-25	WOS:000260893700085
J	Hemmati, PG; Normand, G; Gillissen, B; Wendt, J; Doerken, B; Daniel, PT				Hemmati, P. G.; Normand, G.; Gillissen, B.; Wendt, J.; Doerken, B.; Daniel, P. T.			Cooperative effect of p21(Cip1/WAF-1) and 14-3-3 sigma on cell cycle arrest and apoptosis induction by p14(ARF)	ONCOGENE			English	Article						p14(ARF); 14-3-3 sigma; p21; cell cycle; apoptosis; mitotic catastrophe	ARF TUMOR-SUPPRESSOR; NF-KAPPA-B; HUMAN CARCINOMA-CELLS; HUMAN CANCER-CELLS; DNA-DAMAGE; G(2) ARREST; P53-DEPENDENT APOPTOSIS; PROTEIN-BINDING; G2 ARREST; P21	P14(ARF) (p19(ARF) in the mouse) plays a central role in the regulation of cellular proliferation. Although the capacity of p14(ARF) to induce a cell cycle arrest in G1 phase depends on a functional p53/p21-signaling axis, the G2 arrest triggered by p14(ARF) is p53/p21-independent. Using isogeneic HCT116 cells either wild-type or homozygously deleted for p21, 14-3-3 sigma or both, we further investigated the cooperative effect of p21 and 14-3-3 sigma on cell cycle regulation and apoptosis induction by p14(ARF). In contrast to DNA damage, which induces mitotic catastrophe in 14-3-3 sigma-deficient cells, we show here that the expression of p14(ARF) triggers apoptotic cell death, as evidenced by nuclear DNA fragmentation and induction of pan-caspase activities, irrespective of the presence or absence of 14-3-3 sigma. The activation of the intrinsic mitochondrial apoptosis pathway by p14(ARF) was confirmed by cytochrome c release from mitochondria and induction of caspase-9- (LEHDase) and caspase-3/7-like (DEVDase) activities. Moreover, 14-3-3 sigma/p21 double-deficient cells were exceedingly sensitive to apoptosis induction by p14(ARF) as compared to wild-type cells or cells lacking either gene alone. Notably, p14(ARF)-induced apoptosis was preceded by an arrest in the G2 phase of cell cycle, which coincided with downregulation of cdc2 (cdk1) protein expression and lack of its nuclear localization. This indicates that p14(ARF) impairs mitotic entry by targeting the distal DNA damage-signaling pathway and induces apoptotic cell death, rather than mitotic catastrophe, out of a transient G2 arrest. Furthermore, our data delineate that the disruption of G2/M cell cycle checkpoint control critically determines the sensitivity of the cell toward p14(ARF)-induced mitochondrial apoptosis.	[Hemmati, P. G.; Gillissen, B.; Doerken, B.; Daniel, P. T.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Hemmati, P. G.; Normand, G.; Gillissen, B.; Wendt, J.; Doerken, B.; Daniel, P. T.] Univ Med Ctr Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Daniel, PT (corresponding author), Max Delbruck Ctr Mol Med, Campus Berlin Buch,Lindenberger Weg 80, D-13125 Berlin, Germany.	pdaniel@mdc-berlin.de	Normand, Guillaume/A-1975-2010	Gillissen, Bernhard/0000-0002-1815-2091; Normand, Guillaume/0000-0003-1228-3813	Deutsche Krebshilfe [10-2088-Da3]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe Grant 10-2088-Da3 to PTD and PGH. We would like to thank Ms Antje and Anja Richter for expert technical assistance.	Bhonde MR, 2006, J BIOL CHEM, V281, P8675, DOI 10.1074/jbc.M511333200; Bhonde MR, 2006, ONCOGENE, V25, P165, DOI 10.1038/sj.onc.1209017; Blagosklonny MV, 2002, CELL CYCLE, V1, P67, DOI 10.4161/cc.1.1.102; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chan TA, 2000, GENE DEV, V14, P1584; Daniel PT, 1999, ANAL BIOCHEM, V266, P110, DOI 10.1006/abio.1998.2929; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DURO D, 1995, ONCOGENE, V11, P21; Eymin B, 2006, CELL CYCLE, V5, P759, DOI 10.4161/cc.5.7.2625; Eymin B, 2001, ONCOGENE, V20, P1033, DOI 10.1038/sj.onc.1204220; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Eymin B, 2006, MOL CELL BIOL, V26, P4339, DOI 10.1128/MCB.02240-05; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Gorospe M, 1996, MOL CELL BIOL, V16, P6654; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; Hemmati PG, 2006, ONCOGENE, V25, P6582, DOI 10.1038/sj.onc.1209668; Hemmati PG, 2005, ONCOGENE, V24, P4114, DOI 10.1038/sj.onc.1208579; Hemmati PG, 2002, ONCOGENE, V21, P3149, DOI 10.1038/sj.onc.1205458; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Janicke RU, 2007, CELL CYCLE, V6, P407; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Li YX, 2004, ONCOGENE, V23, P7355, DOI 10.1038/sj.onc.1207957; MAO L, 1995, CANCER RES, V55, P2995; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; Martinez LA, 2002, CARCINOGENESIS, V23, P1289, DOI 10.1093/carcin/23.8.1289; Morgan DO, 1998, CANCER J SCI AM, V4, pS77; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; QUELLE DE, 1995, CELL, V83, P993; Radfar A, 1998, P NATL ACAD SCI USA, V95, P13194, DOI 10.1073/pnas.95.22.13194; Rocha S, 2005, CELL CYCLE, V4, P756, DOI 10.4161/cc.4.6.1739; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; TAAGEPERA S, 1993, P NATL ACAD SCI USA, V90, P8407, DOI 10.1073/pnas.90.18.8407; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; WALDMAN T, 1995, CANCER RES, V55, P5187; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wendt J, 2006, ONCOGENE, V25, P972, DOI 10.1038/sj.onc.1209031; Zeng Y, 1999, MOL CELL BIOL, V19, P7410; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	50	19	19	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV 13	2008	27	53					6707	6719		10.1038/onc.2008.193	http://dx.doi.org/10.1038/onc.2008.193			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	371XO	18806827				2022-12-25	WOS:000260866200001
J	Lin, WW; Wu, J; Dong, HQ; Bouck, D; Zeng, FY; Chen, TS				Lin, Wenwei; Wu, Jing; Dong, Hanqing; Bouck, David; Zeng, Fu-Yue; Chen, Taosheng			Cyclin-dependent Kinase 2 Negatively Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; XENOBIOTIC RECEPTOR; HUMAN HEPATOCYTES; DRUG-METABOLISM; PXR; ACTIVATION; INDUCTION; PHOSPHORYLATION; REPRESSION; RESISTANCE	The human pregnane X receptor (hPXR) regulates the expression of critical drug metabolism enzymes. One of such enzymes, cytochrome P450 3A4 (CYP3A4), plays critical roles in drug metabolism in hepatocytes that are either quiescent or passing through the cell cycle. It has been well established that the expression of P450, such as CYP3A4, is markedly reduced during liver development or regeneration. Numerous studies have implicated cellular signaling pathways in modulating the functions of nuclear receptors, including hPXR. Here we report that inhibition of cyclin-dependent kinases (Cdks) by kenpaullone and roscovitine (two small molecule inhibitors of Cdks that we identified in a screen for compounds that activate hPXR) leads to activation of hPXR-mediated CYP3A4 gene expression in HepG2 human liver carcinoma cells. Consistent with this finding, activation of Cdk2 attenuates the activation of CYP3A4 gene expression. In vitro kinase assays revealed that Cdk2 directly phosphorylates hPXR. A phosphomimetic mutation of a putative Cdk phosphorylation site, Ser(350), significantly impairs the function of hPXR, whereas a phosphorylation-deficient mutation confers resistance to Cdk2. Using HepG2 that has been stably transfected with hPXR and the CYP3A4-luciferase reporter, enriched in different phases of the cell cycle, we found that hPXR-mediated CYP3A4 expression is greatly reduced in the S phase. Our results indicate for the first time that Cdk2 negatively regulates the activity of hPXR, and suggest an important role for Cdk2 in regulating hPXR activity and CYP3A4 expression in hepatocytes passing through the cell cycle, such as those in fetal or regenerating adult liver.	[Lin, Wenwei; Wu, Jing; Dong, Hanqing; Bouck, David; Zeng, Fu-Yue; Chen, Taosheng] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Chen, TS (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	taosheng.chen@stjude.org	Chen, Taosheng/I-6351-2013; Lin, Wenwei/D-9241-2018; Dong, Hanqing/F-6075-2013	Chen, Taosheng/0000-0001-6420-3809; Lin, Wenwei/0000-0001-8754-6150; Bouck, David/0000-0002-6281-2544	American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital	This work was supported by the American Lebanese Syrian Associated Charities and St. Jude Children's Research Hospital. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; Berthet C, 2007, ONCOGENE, V26, P4469, DOI 10.1038/sj.onc.1210243; Blake MJ, 2007, CLIN PHARMACOL THER, V81, P510, DOI 10.1038/sj.clpt.6100101; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Boylan JM, 2005, BIOCHEM BIOPH RES CO, V330, P722, DOI 10.1016/j.bbrc.2005.03.042; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Chen TS, 1999, CANCER RES, V59, P213; Chen TS, 2000, CANCER RES, V60, P2132; Chen Y, 2007, CANCER RES, V67, P10361, DOI 10.1158/0008-5472.CAN-06-4758; Ding XS, 2005, BIOCHEM PHARMACOL, V69, P867, DOI 10.1016/j.bcp.2004.11.025; Ding XS, 2005, J PHARMACOL EXP THER, V312, P849, DOI 10.1124/jpet.104.076331; Donato MT, 1998, J PHARMACOL EXP THER, V284, P760; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Favre C, 1998, J HEPATOL, V28, P700, DOI 10.1016/S0168-8278(98)80295-X; Gong HB, 2005, METHOD ENZYMOL, V400, P598, DOI 10.1016/S0076-6879(05)00034-0; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Hines RN, 2007, J BIOCHEM MOL TOXIC, V21, P169, DOI 10.1002/jbt.20179; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Luo G, 2002, DRUG METAB DISPOS, V30, P795, DOI 10.1124/dmd.30.7.795; Martinez ED, 2002, J BIOL CHEM, V277, P29719, DOI 10.1074/jbc.M112134200; Masuyama H, 2007, MOL PHARMACOL, V72, P1045, DOI 10.1124/mol.107.037937; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mensah-Osman EJ, 2007, CANCER-AM CANCER SOC, V109, P957, DOI 10.1002/cncr.22479; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Moore NL, 2007, STEROIDS, V72, P202, DOI 10.1016/j.steroids.2006.11.025; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Narayanan R, 2005, MOL CELL BIOL, V25, P2885, DOI 10.1128/MCB.25.8.2885-2898.2005; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Saradhi M, 2005, BBA-MOL CELL RES, V1746, P85, DOI 10.1016/j.bbamcr.2005.10.004; Saradhi M, 2005, CELL RES, V15, P785, DOI 10.1038/sj.cr.7290348; Sinz M, 2006, CURR DRUG METAB, V7, P375, DOI 10.2174/138920006776873535; Thasler WE, 2006, J PHARMACOL EXP THER, V316, P822, DOI 10.1124/jpet.105.094201; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664; Zhu ZR, 2004, J BIOMOL SCREEN, V9, P533, DOI 10.1177/1087057104264902	41	74	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30650	30657		10.1074/jbc.M806132200	http://dx.doi.org/10.1074/jbc.M806132200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784074	hybrid, Green Published			2022-12-25	WOS:000260544800022
J	Naganawa, S; Yokoyama, M; Shiino, T; Suzuki, T; Ishigatsubo, Y; Ueda, A; Shirai, A; Takeno, M; Hayakawa, S; Sato, S; Tochikubo, O; Kiyoura, S; Sawada, K; Ikegami, T; Kanda, T; Kitamura, K; Sato, H				Naganawa, Satoshi; Yokoyama, Masaru; Shiino, Teiichiro; Suzuki, Takeyuki; Ishigatsubo, Yoshiaki; Ueda, Atsuhisa; Shirai, Akira; Takeno, Mitsuhiro; Hayakawa, Satoshi; Sato, Shigehiro; Tochikubo, Osamu; Kiyoura, Shingo; Sawada, Kaori; Ikegami, Takashi; Kanda, Tadahito; Kitamura, Katsuhiko; Sato, Hironori			Net Positive Charge of HIV-1 CRF01_AE V3 Sequence Regulates Viral Sensitivity to Humoral Immunity	PLOS ONE			English	Article								The third variable region (V3) of the human immunodeficiency virus type 1 (HIV-1) envelope gp120 subunit participates in determination of viral infection coreceptor tropism and host humoral immune responses. Positive charge of the V3 plays a key role in determining viral coreceptor tropism. Here, we examined by bioinformatics, experimental, and protein modelling approaches whether the net positive charge of V3 sequence regulates viral sensitivity to humoral immunity. We chose HIV-1 CRF01_AE strain as a model virus to address the question. Diversity analyses using CRF01_AE V3 sequences from 37 countries during 1984 and 2005 (n=1361) revealed that reduction in the V3's net positive charge makes V3 less variable due to limited positive selection. Consistently, neutralization assay using CRF01_AE V3 recombinant viruses (n=30) showed that the reduction in the V3's net positive charge rendered HIV-1 less sensitive to neutralization by the blood anti-V3 antibodies. The especially neutralization resistant V3 sequences were the particular subset of the CCR5-tropic V3 sequences with net positive charges of +2 to +4. Molecular dynamics simulation of the gp120 monomers showed that the V3's net positive charge regulates the V3 configuration. This and reported gp120 structural data predict a less-exposed V3 with a reduced net positive charge in the native gp120 trimer context. Taken together, these data suggest a key role of the V3's net positive charge in the immunological escape and coreceptor tropism evolution of HIV-1 CRF01_AE in vivo. The findings have molecular implications for the adaptive evolution and vaccine design of HIV-1.	[Naganawa, Satoshi; Tochikubo, Osamu; Kitamura, Katsuhiko] Yokohama City Univ, Sch Med, Dept Publ Hlth, Kanagawa, Japan; [Yokoyama, Masaru; Kanda, Tadahito; Sato, Hironori] Natl Inst Infect Dis, Ctr Pathogen Genom, Tokyo, Japan; [Shiino, Teiichiro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Suzuki, Takeyuki; Ishigatsubo, Yoshiaki; Ueda, Atsuhisa; Takeno, Mitsuhiro] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanagawa, Japan; [Shirai, Akira] Yokohama City Univ, Sch Med, Coll Nursing, Kanagawa, Japan; [Naganawa, Satoshi; Hayakawa, Satoshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Tokyo, Japan; [Sato, Shigehiro] Iwate Med Univ, Dept Bacteriol, Iwate, Japan; [Kiyoura, Shingo] SGI Japan Ltd, Tokyo, Japan; [Sawada, Kaori; Ikegami, Takashi] Ryoka Syst Inc, Tokyo, Japan	Yokohama City University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Yokohama City University; Yokohama City University; Nihon University; Iwate Medical University	Naganawa, S (corresponding author), Yokohama City Univ, Sch Med, Dept Publ Hlth, Kanagawa, Japan.				Ministry of Health, Labor and Welfare for HIV/AIDS research; IMAI Memorial Trust for AIDS Research, Japan	Ministry of Health, Labor and Welfare for HIV/AIDS research; IMAI Memorial Trust for AIDS Research, Japan	This work was supported by grants from the Ministry of Health, Labor and Welfare for HIV/AIDS research, and the IMAI Memorial Trust for AIDS Research, Japan.	Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; BONHOEFFER S, 1995, NATURE, V376, P125, DOI 10.1038/376125a0; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavacini LA, 2002, AIDS, V16, P2409, DOI 10.1097/00002030-200212060-00005; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; CORNELISSEN M, 1995, J VIROL, V69, P1810, DOI 10.1128/JVI.69.3.1810-1818.1995; Desrosiers RC, 1999, NAT MED, V5, P723, DOI 10.1038/10439; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Ida S, 1997, AIDS RES HUM RETROV, V13, P1597, DOI 10.1089/aid.1997.13.1597; Kato K, 1999, J VIROL, V73, P5520, DOI 10.1128/JVI.73.7.5520-5526.1999; Kusagawa S, 2002, AIDS RES HUM RETROV, V18, P115, DOI 10.1089/08892220252779656; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; MILICH L, 1993, J VIROL, V67, P5623, DOI 10.1128/JVI.67.9.5623-5634.1993; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oka T, 2007, J VIROL, V81, P6798, DOI 10.1128/JVI.02840-06; OTA T, 1994, MOL BIOL EVOL, V11, P613; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; PAU CP, 1993, AIDS, V7, P337, DOI 10.1097/00002030-199303000-00005; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; PRATT RD, 1995, J INFECT DIS, V172, P851, DOI 10.1093/infdis/172.3.851; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sato H, 1999, VIROLOGY, V257, P491, DOI 10.1006/viro.1999.9670; Sato H, 1999, J VIROL, V73, P3551, DOI 10.1128/JVI.73.5.3551-3559.1999; Sato H, 2001, J VIROL, V75, P5604, DOI 10.1128/JVI.75.12.5604-5613.2001; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Shannon CE, 1997, M D COMPUT, V14, P306; Shiino T, 2000, J VIROL, V74, P1069, DOI 10.1128/JVI.74.3.1069-1078.2000; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; STAMATATOS L, 1995, J VIROL, V69, P6191, DOI 10.1128/JVI.69.10.6191-6198.1995; TAJIMA F, 1989, GENETICS, V123, P585; Yamaguchi Y, 1997, P NATL ACAD SCI USA, V94, P1264, DOI 10.1073/pnas.94.4.1264; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	48	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3206	10.1371/journal.pone.0003206	http://dx.doi.org/10.1371/journal.pone.0003206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787705	Green Published, gold, Green Submitted			2022-12-25	WOS:000264426200011
J	Hadchouel, A; Decobert, F; Franco-Montoya, ML; Halphen, I; Jarreau, PH; Boucherat, O; Martin, E; Benachi, A; Amselem, S; Bourbon, J; Danan, C; Delacourt, C				Hadchouel, Alice; Decobert, Fabrice; Franco-Montoya, Marie-Laure; Halphen, Isabelle; Jarreau, Pierre-Henri; Boucherat, Olivier; Martin, Emmanuel; Benachi, Alexandra; Amselem, Serge; Bourbon, Jacques; Danan, Claude; Delacourt, Christophe			Matrix Metalloproteinase Gene Polymorphisms and Bronchopulmonary Dysplasia: Identification of MMP16 as a New Player in Lung Development	PLOS ONE			English	Article							PREMATURE-INFANTS; EXPRESSION; ACTIVATION; INHIBITORS; PROMOTER; MT1-MMP; PRETERM; AIRWAYS	Backgound: Alveolarization requires coordinated extracellular matrix remodeling, a process in which matrix metalloproteinases (MMPs) play an important role. We postulated that polymorphisms in MMP genes might affect MMP function in preterm lungs and thus influence the risk of bronchopulmonary dysplasia (BPD). Methods and Findings: Two hundred and eighty-four consecutive neonates with a gestational age of,28 weeks were included in this prospective study. Forty-five neonates developed BPD. Nine single-nucleotide polymorphisms (SNPs) were sought in the MMP2, MMP14 and MMP16 genes. After adjustment for birth weight and ethnic origin, the TT genotype of MMP16 C/T (rs2664352) and the GG genotype of MMP16 A/G (rs2664349) were found to protect from BPD. These genotypes were also associated with a smaller active fraction of MMP2 and with a 3-fold-lower MMP16 protein level in tracheal aspirates collected within 3 days after birth. Further evaluation of MMP16 expression during the course of normal human and rat lung development showed relatively low expression during the canalicular and saccular stages and a clear increase in both mRNA and protein levels during the alveolar stage. In two newborn rat models of arrested alveolarization the lung MMP16 mRNA level was less than 50% of normal. Conclusions: MMP16 may be involved in the development of lung alveoli. MMP16 polymorphisms appear to influence not only the pulmonary expression and function of MMP16 but also the risk of BPD in premature infants.	[Hadchouel, Alice; Decobert, Fabrice; Franco-Montoya, Marie-Laure; Halphen, Isabelle; Boucherat, Olivier; Benachi, Alexandra; Bourbon, Jacques; Danan, Claude; Delacourt, Christophe] IMRB, INSERM, U841, Equipe 06, Creteil, France; [Hadchouel, Alice; Decobert, Fabrice; Franco-Montoya, Marie-Laure; Halphen, Isabelle; Jarreau, Pierre-Henri; Boucherat, Olivier; Benachi, Alexandra; Bourbon, Jacques; Danan, Claude; Delacourt, Christophe] PremUp, Paris, France; [Decobert, Fabrice; Danan, Claude] Ctr Hosp Intercommunal, Creteil, France; [Jarreau, Pierre-Henri] Hop Cochin, AP HP, Serv Med Neonatale Port Royal, Paris, France; [Martin, Emmanuel] IntegraGen, Evry, France; [Benachi, Alexandra] Hop Necker Enfants Malad, AP HP, Serv Obstet Gynecol, Paris, France; [Amselem, Serge] GH Armand Trousseau, INSERM, U654, Paris, France; [Danan, Claude] Ctr Hosp Intercommunal, Unite Fonctionnelle Rech Clin, Creteil, France; [Delacourt, Christophe] Univ Paris 12, Fac Med, IFR10, Creteil, France; [Jarreau, Pierre-Henri] Univ Paris 05, Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite	Hadchouel, A (corresponding author), IMRB, INSERM, U841, Equipe 06, Creteil, France.	christophe.delacourt@chicreteil.fr	Delacourt, Christophe/K-6161-2019		INSERM Programme Hospitalier de Recherche Clinique AOR03 - Assistance Publique - Hopitaux de Paris; Association des Juniors en Pediatrie	INSERM Programme Hospitalier de Recherche Clinique AOR03 - Assistance Publique - Hopitaux de Paris; Association des Juniors en Pediatrie	INSERM Programme Hospitalier de Recherche Clinique AOR03 - Assistance Publique - Hopitaux de Paris. AH was founded by a grant from Association des Juniors en Pediatrie.	Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; Bhandari V, 2006, PEDIATRICS, V117, P1901, DOI 10.1542/peds.2005-1414; Boucherat O, 2007, PHYSIOL GENOMICS, V32, P128, DOI 10.1152/physiolgenomics.00108.2007; Boucherat O, 2007, PEDIATR RES, V62, P20, DOI 10.1203/PDR.0b013e3180686cc5; Boucherat O, 2007, AM J RESP CRIT CARE, V175, P1066, DOI 10.1164/rccm.200601-050OC; Boucherat O, 2007, PLOS MED, V4, P1205, DOI 10.1371/journal.pmed.0040237; Buckley S, 2002, AM J PHYSIOL-LUNG C, V283, pL747, DOI 10.1152/ajplung.00415.2001; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Danan C, 2002, AM J RESP CRIT CARE, V165, P1384, DOI 10.1164/rccm.200112-134BC; Danan C, 2002, AM J PHYSIOL-LUNG C, V283, pL1086, DOI 10.1152/ajplung.00066.2002; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Garcia-Alvarez J, 2006, SARCOIDOSIS VASC DIF, V23, P13; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Jiang AX, 2003, J BIOL CHEM, V278, P38765, DOI 10.1074/jbc.M306618200; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kazzi S Nadya J, 2004, Pediatrics, V114, pe243, DOI 10.1542/peds.114.2.e243; Kheradmand F, 2002, J CELL SCI, V115, P839; Manar Martha H, 2004, J Perinatol, V24, P30, DOI 10.1038/sj.jp.7211020; Matsumoto SI, 1997, BBA-GENE STRUCT EXPR, V1354, P159, DOI 10.1016/S0167-4781(97)00120-6; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Rova M, 2004, HUM MOL GENET, V13, P1095, DOI 10.1093/hmg/ddh132; Saitoh W, 2006, INT J MOL MED, V17, P621; Schulz CG, 2004, PEDIATR RES, V55, P794, DOI 10.1203/01.PDR.0000120683.68630.FB; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Walsh LA, 2007, INT J DEV BIOL, V51, P389, DOI 10.1387/ijdb.062253lw; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Yu CY, 2002, CANCER RES, V62, P6430; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou YF, 2005, CARCINOGENESIS, V26, P1117, DOI 10.1093/carcin/bgi057	31	44	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3188	10.1371/journal.pone.0003188	http://dx.doi.org/10.1371/journal.pone.0003188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784838	Green Submitted, gold, Green Published			2022-12-25	WOS:000264425900008
J	Jin, Y; Kim, HP; Cao, JF; Zhang, M; Ifedigbo, E; Choi, AMK				Jin, Yang; Kim, Hong Pyo; Cao, Jiaofei; Zhang, Meng; Ifedigbo, Emeka; Choi, Augustine M. K.			Caveolin-1 regulates the secretion and cytoprotection of Cyr61 in hyperoxic cell death	FASEB JOURNAL			English	Article						CNN; exocytosis; signaling	VEIN ENDOTHELIAL-CELLS; IMMEDIATE-EARLY GENE; CCN FAMILY; BREAST-CANCER; AKT PATHWAY; ACTIVATION; EXPRESSION; INTEGRINS; MEMBRANE; RECEPTOR	Cysteine-rich 61 (Cyr61) belongs to the CCN family and mediates cell proliferation, survival, and apoptosis. Our previous studies showed that Cyr61 protected against hyperoxia-induced lung cell death via Akt phosphorylation. Caveolin-1 (cav-1), a 22-kDa trans-membrane scaffolding protein, is the principal structural component of caveolae. Emerging data show that cav-1 regulates signal transduction-associated proteins that reside in the caveolae. Numerous integrin-related pathways, including PI3K/Akt-induced cell survival are controlled by cav-1-mediated signaling. Our data showed that recombinant Cyr61 promoted cell proliferation and resistance to hyperoxia-induced cell death in vitro. Neutralizing antibodies reversed the above effects, indicating functional role of secreted Cyr61 in response to hyperoxic stress. While deletion of cav-1 protected cells from hyperoxia-induced cell death, Cyr61-neutralizing antibodies abolished this protective effect. Furthermore, Cyr61 and cav-1 colocalized and physically interacted via integrins in bronchial epithelial cells. Deletion of cav-1 increased extracellular and decreased cytosolic Cyr61, both in vitro and in vivo. Pretreatment with Brefeldin A increased intracellular Cyr61 in cav-1(-/-) cells, while decreasing extracellular Cyr61. Taken together, Cav-1/Cyr61 interaction via integrins represents a novel pathway of Cyr61 signaling involving cav-1-dependent processes, which play a critical role in regulating hyperoxia-induced cell death. - Jin, Y., Kim, H. P., Cao, J., Zhang, M., Ifedigbo, E., Choi, A. M. K. Caveolin-1 regulates the secretion and cytoprotection of Cyr61 in hyperoxic cell death. FASEB J. 23, 341-350 (2009)	[Kim, Hong Pyo; Cao, Jiaofei; Ifedigbo, Emeka; Choi, Augustine M. K.] Harvard Univ, Sch Med, Div Pulm & Crit Care Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Jin, Yang; Zhang, Meng] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Choi, AMK (corresponding author), Harvard Univ, Sch Med, Div Pulm & Crit Care Med, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	amchoi@rics.bwh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085601] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL085601] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Desnoyers L, 2004, CURR PHARM DESIGN, V10, P3913, DOI 10.2174/1381612043382567; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Echarri A, 2006, CELL CYCLE, V5, P2179, DOI 10.4161/cc.5.19.3264; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Jin Y, 2005, AM J RESP CELL MOL, V33, P297, DOI 10.1165/rcmb.2005-0144OC; Kim SM, 2004, J VIROL, V78, P13479, DOI 10.1128/JVI.78.24.13479-13488.2004; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kolesnikova TV, 1998, ONCOGENE, V16, P747, DOI 10.1038/sj.onc.1201572; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lechner A, 2000, BONE, V27, P53, DOI 10.1016/S8756-3282(00)00294-5; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Lin BR, 2007, MOL CANCER RES, V5, P1111, DOI 10.1158/1541-7786.MCR-06-0289; LISANTI MP, 1995, MOL MEMBR BIOL, V12, P121, DOI 10.3109/09687689509038506; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Planque N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-15; Salanueva IJ, 2007, J CELL MOL MED, V11, P969, DOI 10.1111/j.1582-4934.2007.00109.x; Sampath D, 2001, ENDOCRINOLOGY, V142, P2540, DOI 10.1210/en.142.6.2540; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yoshida Y, 2007, BIOCHEM BIOPH RES CO, V355, P611, DOI 10.1016/j.bbrc.2007.01.195	36	29	29	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					341	350		10.1096/fj.08-108423	http://dx.doi.org/10.1096/fj.08-108423			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18801924	Green Published			2022-12-25	WOS:000262892900006
J	Smalley, KSM; Xiao, M; Villanueva, J; Nguyen, TK; Flaherty, KT; Letrero, R; Van Belle, P; Elder, DE; Wang, Y; Nathanson, KL; Herlyn, M				Smalley, K. S. M.; Xiao, M.; Villanueva, J.; Nguyen, T. K.; Flaherty, K. T.; Letrero, R.; Van Belle, P.; Elder, D. E.; Wang, Y.; Nathanson, K. L.; Herlyn, M.			CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations	ONCOGENE			English	Article						melanoma; BRAF; CRAF; targeted therapy; sorafenib	MALIGNANT-MELANOMA; KINASE-KINASE; B-RAF; ERK; SURVIVAL; PROTEIN; PHOSPHORYLATION; SUPPRESSION; EXPRESSION; SORAFENIB	Here, we identify a panel of melanoma lines with non-V600E mutations in BRAF. These G469E- and D594G-mutated melanomas were found to exhibit constitutive levels of phospho-extracellular signal-regulated kinase (pERK) and low levels of phospho-mitogen-activated protein kinase/ERKkinase (pMEK) and were resistant to MEK inhibition. Upon treatment with the CRAF inhibitor sorafenib, these lines underwent apoptosis and associated with mitochondrial depolarization and relocalization of apoptosis-inducing factor, whereas the BRAF-V600-Emutated melanomas did not. Studies have shown low-activity mutants of BRAF (G469E/D594G) instead signal through CRAF. Unlike BRAF, CRAF directly regulates apoptosis through mitochondrial localization where it binds to Bcl-2 and phosphorylates BAD. The CRAF inhibitor sorafenib was found to induce a time-dependent reduction in both BAD phosphorylation and Bcl-2 expression in the D594G/G469E lines only. Knockdown of CRAF using a lentiviral shRNA suppressed both Bcl-2 expression and induced apoptosis in the D594G melanoma line but not in a V600E-mutated line. Finally, we showed in a series of xenograft studies that sorafenib was more potent at reducing the growth of tumors with the D594G mutation than those with the V600E mutation. In summary, we have identified a group of melanomas with low-activity BRAF mutations that are reliant upon CRAF-mediated survival activity.	[Smalley, K. S. M.; Xiao, M.; Villanueva, J.; Nguyen, T. K.; Herlyn, M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Flaherty, K. T.] Univ Penn, Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Letrero, R.; Nathanson, K. L.] Univ Penn, Sch Med, Div Med Genet, Philadelphia, PA 19104 USA; [Van Belle, P.; Elder, D. E.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Y.] Univ Penn, Sch Med, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA; [Flaherty, K. T.; Nathanson, K. L.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Smalley, KSM (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	k.smalley@mac.com; herlynm@wistar.org	Smalley, Keiran S/A-1320-2007	Smalley, Keiran S/0000-0002-4121-8335; Nathanson, Katherine/0000-0002-6740-0901; Smalley, Keiran/0000-0003-1089-9307	Bayer Corporation [BAY 43-9006]; NATIONAL CANCER INSTITUTE [R01CA047159, P50CA093372, R01CA080999, P01CA114046, R01CA076674, P01CA025874] Funding Source: NIH RePORTER	Bayer Corporation(Bayer AG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Bayer Corporation for providing the BAY 43-9006 (sorafenib).	Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; Houben R, 2008, J INVEST DERMATOL, V128, P2003, DOI 10.1038/jid.2008.30; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Rapp UR, 2004, BBA-MOL CELL RES, V1644, P149, DOI 10.1016/j.bbamcr.2003.10.015; Smalley KM, 2007, BRIT J CANCER, V96, P445, DOI 10.1038/sj.bjc.6603596; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Smalley KSM, 2003, INT J CANCER, V104, P527, DOI 10.1002/ijc.10978; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Spittle C, 2007, J MOL DIAGN, V9, P464, DOI 10.2353/jmoldx.2007.060191; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	27	164	173	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 8	2009	28	1					85	94		10.1038/onc.2008.362	http://dx.doi.org/10.1038/onc.2008.362			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18794803	Green Accepted			2022-12-25	WOS:000262294100009
J	Kato, S; Ding, JX; Pisck, E; Jhala, US; Du, KY				Kato, Satomi; Ding, Jixin; Pisck, Evan; Jhala, Ulupi S.; Du, Keyong			COP1 Functions as a FoxO1 Ubiquitin E3 Ligase to Regulate FoxO1-mediated Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; PHOSPHOENOLPYRUVATE CARBOXYKINASE; HEPATIC GLUCONEOGENESIS; INSULIN SENSITIVITY; GLUCOSE-PRODUCTION; NUCLEAR EXCLUSION; MAMMALIAN HOMOLOG; TUMOR SUPPRESSION; AKT ACTIVATION; C-JUN	COP1 is a Ring-Finger E3 ubiquitin ligase that is involved in plant development, mammalian cell survival, growth, and metabolism. Here we report that COP1, whose expression is enhanced by insulin, regulates FoxO1 protein stability. We found that in Fao hepatoma cells, ectopic expression of COP1 decreased, whereas knockdown of COP1 expression increased the level of endogenous FoxO1 protein without impacting other factors such as C/EBP alpha and CREB (cAMP-response element-binding protein). We further showed that COP1 binds FoxO1, enhances its ubiquitination, and promotes its degradation via the ubiquitin-proteasome pathway. To determine the biological significance of COP1-mediated FoxO1 protein degradation, we have examined the impact of COP1 on FoxO1-mediated gene expression and found that COP1 suppressed FoxO1 reporter gene as well as FoxO1 target genes such as glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, two key targets for FoxO1 in the regulation of gluconeogenesis, with corresponding changes of hepatic glucose production in Fao cells. We suggest that by functioning as a FoxO1 E3 ligase, COP1 may play a role in the regulation of hepatic glucose metabolism.	[Kato, Satomi; Ding, Jixin; Pisck, Evan; Du, Keyong] Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Jhala, Ulupi S.] Univ Calif San Diego, Whittier Inst, Islet Res Lab, La Jolla, CA 92037 USA	Tufts Medical Center; University of California System; University of California San Diego	Du, KY (corresponding author), Tufts Univ New England Med Ctr, Mol Oncol Res Inst, 750 Washington St, Boston, MA 02111 USA.	kdu@tufts-nemc.org			National Institutes of Health [DK08147]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK08147 ( to U. S. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Cho CY, 2006, CELL METAB, V3, P367, DOI 10.1016/j.cmet.2006.03.006; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; FEHLMANN M, 1983, BIOCHEM J, V214, P845, DOI 10.1042/bj2140845; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; KAHN CR, 1981, NATURE, V290, P717, DOI 10.1038/290717a0; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; SASAKI K, 1984, J BIOL CHEM, V259, P5242; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Subramanian C, 2004, P NATL ACAD SCI USA, V101, P6798, DOI 10.1073/pnas.0307964101; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; VINITSKY A, 1992, BIOCHEMISTRY-US, V31, P9421, DOI 10.1021/bi00154a014; Wang HY, 1999, CURR BIOL, V9, P711, DOI 10.1016/S0960-9822(99)80314-5; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yamamoto N, 1999, GENES CELLS, V4, P489, DOI 10.1046/j.1365-2443.1999.00282.x; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Yi CL, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-30	51	71	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35464	35473		10.1074/jbc.M801011200	http://dx.doi.org/10.1074/jbc.M801011200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18815134	hybrid, Green Published			2022-12-25	WOS:000261687900018
J	Sangwan, V; Paliouras, GN; Abella, JV; Dube, N; Monast, A; Tremblay, ML; Park, M				Sangwan, Veena; Paliouras, Grigorios N.; Abella, Jasmine V.; Dube, Nadia; Monast, Anie; Tremblay, Michel L.; Park, Morag			Regulation of the Met Receptor-tyrosine Kinase by the Protein-tyrosine Phosphatase 1B and T-cell Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SCATTER FACTOR-RECEPTOR; INSULIN-RECEPTOR; ENDOPLASMIC-RETICULUM; SELECTIVE REGULATION; SIGNAL-TRANSDUCTION; LIVER-REGENERATION; NEGATIVE REGULATOR; TERMINAL SEQUENCE; TPR-MET	The non-receptor protein-tyrosine phosphatases (PTPs) 1B and T-cell phosphatase ( TCPTP) have been implicated as negative regulators of multiple signaling pathways including receptor-tyrosine kinases. We have identified PTP1B and TCPTP as negative regulators of the hepatocyte growth factor receptor, the Met receptor-tyrosine kinase. In vivo, loss of PTP1B or TCPTP enhances hepatocyte growth factor-mediated phosphorylation of Met. Using substrate trapping mutants of PTP1B or TCPTP, we have demonstrated that both phosphatases interact with Met and that these interactions require phosphorylation of twin tyrosines (Tyr-1234/1235) in the activation loop of the Met kinase domain. Using confocal microscopy, we show that trapping mutants of both PTP1B and the endoplasmic reticulum-targeted TCPTP isoform, TC48, colocalize with Met and that activation of Met enables the nuclear-localized isoform of TCPTP, TC45, to exit the nucleus. Using small interfering RNA against PTP1B and TCPTP, we demonstrate that phosphorylation of Tyr-1234/1235 in the activation loop of the Met receptor is elevated in the absence of either PTP1B or TCPTP and further elevated upon loss of both phosphatases. This enhanced phosphorylation of Met corresponds to enhanced biological activity and cellular invasion. Our data demonstrate that PTP1B and TCPTP play distinct and non-redundant roles in the regulation of the Met receptor-tyrosine kinase.	[Sangwan, Veena; Paliouras, Grigorios N.; Abella, Jasmine V.; Monast, Anie; Park, Morag] McGill Univ, Ctr Hlth, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; [Abella, Jasmine V.; Dube, Nadia; Tremblay, Michel L.; Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Sangwan, Veena; Paliouras, Grigorios N.; Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; [Dube, Nadia; Tremblay, Michel L.] McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Park, M (corresponding author), McGill Univ, Ctr Hlth, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada.	morag.park@mcgill.ca			Cancer Research Society, Inc.; Terry Fox Foundation (National Cancer Institute of Canada); McGill University Health Center and Faculty of Medicine, McGill University; United States Department of Defense Breast Cancer Research Initiative [AMD17-99-1-9284]; Canadian Institutes of Health Research Doctoral Award and Alexander McFee Memorial Fellowship; Cancer Research Society, Inc. and Canadian Institutes of Health Research Operating [MOP-62887]; Canadian Institutes of Health Research [MOP-1154]	Cancer Research Society, Inc.; Terry Fox Foundation (National Cancer Institute of Canada); McGill University Health Center and Faculty of Medicine, McGill University; United States Department of Defense Breast Cancer Research Initiative(United States Department of Defense); Canadian Institutes of Health Research Doctoral Award and Alexander McFee Memorial Fellowship(Canadian Institutes of Health Research (CIHR)); Cancer Research Society, Inc. and Canadian Institutes of Health Research Operating; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a fellowship from Cancer Research Society, Inc. and the Terry Fox Foundation (National Cancer Institute of Canada) (to V. S.), by the McGill University Health Center and Faculty of Medicine, McGill University (to G. P.), by United States Department of Defense Breast Cancer Research Initiative Grant DAMD17-99-1-9284 (to J. A.), and by a Canadian Institutes of Health Research Doctoral Award and Alexander McFee Memorial Fellowship (to N. D.). This work was also supported by the Cancer Research Society, Inc. and Canadian Institutes of Health Research Operating Grant MOP-62887 (to M. L. T.) and by Canadian Institutes of Health Research operating Grant MOP-1154 (to M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cook WS, 2002, DEV CELL, V2, P385, DOI 10.1016/S1534-5807(02)00158-2; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FIXMAN ED, 1995, ONCOGENE, V10, P237; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Iversen LF, 2002, J BIOL CHEM, V277, P19982, DOI 10.1074/jbc.M200567200; Kakazu A, 2008, INVEST OPHTH VIS SCI, V49, P2927, DOI 10.1167/iovs.07-0709; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kulas DT, 1996, J BIOL CHEM, V271, P748, DOI 10.1074/jbc.271.2.748; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; Li SQ, 2005, STRUCTURE, V13, P1643, DOI 10.1016/j.str.2005.07.019; Liu F, 1998, MOL CELL BIOL, V18, P250, DOI 10.1128/MCB.18.1.250; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakagawa Y, 2005, ZOOL SCI, V22, P169, DOI 10.2108/zsj.22.169; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Pestana ES, 1999, ONCOGENE, V18, P4069, DOI 10.1038/sj.onc.1202794; PONZETTO C, 1993, MOL CELL BIOL, V13, P4600, DOI 10.1128/MCB.13.8.4600; RODRIGUES GA, 1994, ONCOGENE, V9, P2019; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Sangwan V, 2006, J BIOL CHEM, V281, P221, DOI 10.1074/jbc.M507858200; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Villa-Moruzzi E, 1998, BIOCHEM J, V336, P235, DOI 10.1042/bj3360235; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Xu JF, 2007, CELL BIOL INT, V31, P88, DOI 10.1016/j.cellbi.2006.09.010; Yang HP, 2007, J CELL PHYSIOL, V210, P766, DOI 10.1002/jcp.20891; YANG XM, 1993, DEV BIOL, V157, P308, DOI 10.1006/dbio.1993.1137; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; ZHU H, 1994, CELL GROWTH DIFFER, V5, P359	68	77	81	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34374	34383		10.1074/jbc.M805916200	http://dx.doi.org/10.1074/jbc.M805916200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819921	hybrid, Green Published			2022-12-25	WOS:000261277700065
J	Lawrence, R; Olson, SK; Steele, RE; Wang, LC; Warrior, R; Cummings, RD; Esko, JD				Lawrence, Roger; Olson, Sara K.; Steele, Robert E.; Wang, Lianchun; Warrior, Rahul; Cummings, Richard D.; Esko, Jeffrey D.			Evolutionary Differences in Glycosaminoglycan Fine Structure Detected by Quantitative Glycan Reductive Isotope Labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-UNSUBSTITUTED GLUCOSAMINE; TANDEM MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; CHONDROITIN-SULFATE-E; HEPARAN-SULFATE; CAENORHABDITIS-ELEGANS; GLUCURONIC-ACID; AMINO-GROUPS; TOUT-VELU; OLIGOSACCHARIDES	To facilitate qualitative and quantitative analysis of glycosaminoglycans, we tagged the reducing end of lyase-generated disaccharides with aniline-containing stable isotopes (C-12(6) and C-13(6)). Because different isotope tags have no effect on chromatographic retention times but can be discriminated by a mass detector, differentially isotope-tagged samples can be compared simultaneously by liquid chromatography/mass spectrometry and quantified by admixture with known amounts of standards. The technique is adaptable to all types of glycosaminoglycans, and its sensitivity is only limited by the type of mass spectrometer available. We validated the method using commercial heparin and keratan sulfate as well as heparan sulfate isolated from mutant and wild-type Chinese hamster ovary cells, and select tissues from mutant and wild-type mice. This new method provides more robust, reliable, and sensitive means of quantitative evaluation of glycosaminoglycan disaccharide compositions than existing techniques allowing us to compare the chondroitin and heparan sulfate compositions of Hydra vulgaris, Drosophila melanogaster, Caenorhabditis elegans, and mammalian cells. Our results demonstrate significant differences in glycosaminoglycan structure among these organisms that might represent evolutionarily distinct functional motifs.	[Lawrence, Roger; Olson, Sara K.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Steele, Robert E.; Warrior, Rahul] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Steele, Robert E.; Warrior, Rahul] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; [Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Cummings, Richard D.] Emory Univ, Sch Med Ctr, Dept Biochem, Atlanta, GA 30322 USA	University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine; University System of Georgia; University of Georgia; Emory University	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu			National Institutes of Health [GM33063, HL57345]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33063 and HL57345 ( to J. D. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Barroso B, 2005, J CHROMATOGR A, V1080, P43, DOI 10.1016/j.chroma.2005.03.020; Behr JR, 2005, RAPID COMMUN MASS SP, V19, P2553, DOI 10.1002/rcm.2079; Bowman MJ, 2007, ANAL CHEM, V79, P5777, DOI 10.1021/ac070581b; Cesaretti M, 2004, GLYCOBIOLOGY, V14, P1275, DOI 10.1093/glycob/cwh128; Desaire H, 2000, J AM SOC MASS SPECTR, V11, P916, DOI 10.1016/S1044-0305(00)00168-9; Ding K, 2001, J BIOL CHEM, V276, P3885, DOI 10.1074/jbc.M005238200; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; GUO YC, 1988, ANAL BIOCHEM, V168, P54, DOI 10.1016/0003-2697(88)90009-7; Hitchcock AM, 2007, GLYCOBIOLOGY, V17, P25, DOI 10.1093/glycob/cwl046; Hitchcock AM, 2008, PROTEOMICS, V8, P1384, DOI 10.1002/pmic.200700787; Hitchcock AM, 2006, BIOCHEMISTRY-US, V45, P2350, DOI 10.1021/bi052100t; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Karlsson NG, 2005, J CHROMATOGR B, V824, P139, DOI 10.1016/j.jchromb.2005.07.014; Kim YS, 1998, GLYCOBIOLOGY, V8, P869, DOI 10.1093/glycob/8.9.869; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita-Toyoda A, 2004, BIOCHEMISTRY-US, V43, P11063, DOI 10.1021/bi049622d; Korir AK, 2008, ANAL CHEM, V80, P1297, DOI 10.1021/ac702235u; Kuberan B, 2002, J AM CHEM SOC, V124, P8707, DOI 10.1021/ja0178867; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; Manzi AE, 2000, GLYCOBIOLOGY, V10, P669, DOI 10.1093/glycob/10.7.669; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; NADER HB, 1984, J BIOL CHEM, V259, P1431; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; Saad OM, 2005, ANAL CHEM, V77, P5902, DOI 10.1021/ac050793d; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Saad OM, 2004, J AM SOC MASS SPECTR, V15, P1274, DOI 10.1016/j.jasms.2004.05.008; Saad OM, 2003, ANAL CHEM, V75, P2985, DOI 10.1021/ac0340455; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Tai GH, 1996, J BIOL CHEM, V271, P23535, DOI 10.1074/jbc.271.38.23535; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; Toyoda H, 1997, J CHROMATOGR B, V704, P19, DOI 10.1016/S0378-4347(97)00478-7; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Wilson VA, 2002, GLYCOCONJUGATE J, V19, P347, DOI 10.1023/A:1025325222530; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Yang HO, 2000, GLYCOBIOLOGY, V10, P1033, DOI 10.1093/glycob/10.10.1033; Yuan J, 2005, J CHROMATOGR A, V1067, P145, DOI 10.1016/j.chroma.2004.11.070; Zhang YT, 2005, INVEST OPHTH VIS SCI, V46, P1604, DOI 10.1167/iovs.04-1453	49	149	157	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33674	33684		10.1074/jbc.M804288200	http://dx.doi.org/10.1074/jbc.M804288200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18818196	Green Published, hybrid			2022-12-25	WOS:000261183700074
J	Kalie, E; Jaitin, DA; Podoplelova, Y; Piehler, J; Schreiber, G				Kalie, Eyal; Jaitin, Diego A.; Podoplelova, Yulia; Piehler, Jacob; Schreiber, Gideon			The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-BETA; LIGAND-BINDING; ALPHA RECEPTOR; MUTATIONAL ANALYSIS; DOWN-REGULATION; PHAGE DISPLAY; CELLS; MUTANT; IFN-ALPHA-2; ACTIVATION	Type I interferons (IFNs) signal for their diverse biological effects by binding a common receptor on target cells, composed of the two transmembrane IFNAR1 and IFNAR2 proteins. We have previously differentially enhanced the antiproliferative activity of IFN by increasing the weak binding affinity of IFN to IFNAR1. In this study, we further explored the affinity interdependencies between the two receptor subunits and the role of IFNAR1 in differential IFN activity. For this purpose, we generated a panel of mutations targeting the IFNAR2 binding site on the background of the IFN alpha 2 YNS mutant, which increases the affinity to IFNAR1 by 60-fold, resulting in IFNAR2-to-IFNAR1 binding affinity ratios ranging from 1000:1 to 1:1000. Both the antiproliferative and antiviral potencies of the interferon mutants clearly correlated to the in situ binding IC50 values, independently of the relative contributions of the individual receptors, thus relating to the integral lifetime of the complex. However, the antiproliferative potency correlated throughout the entire range of affinities, as well as with prolonged IFNAR1 receptor down-regulation, whereas the antiviral potency reached a maximum at binding affinities equivalent to that of wild-type IFN alpha 2. Our data suggest that (i) the specific activity of interferon is related to the ternary complex binding affinity and not to affinity toward individual receptor components and (ii) although the antiviral pathway is strongly dependent on pSTAT1 activity, the cytostatic effect requires additional mechanisms that may involve IFNAR1 down-regulation. This differential interferon response is ultimately mediated through distinct gene expression profiling.	[Kalie, Eyal; Jaitin, Diego A.; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Podoplelova, Yulia; Piehler, Jacob] Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Podoplelova, Yulia; Piehler, Jacob] Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany	Weizmann Institute of Science; Goethe University Frankfurt; Goethe University Frankfurt	Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	gideon.schreiber@weizmann.ac.il	Schreiber, Gideon/C-7332-2008		Israel Science Foundation [633/06]; Deutsche Forschungsgemeinschaft [PI 405/4, EXC 115]	Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Israel Science Foundation (founded by the Israel Academy of Sciences and Humanities) Grant 633/06 (to G. S.) and Deutsche Forschungsgemeinschaft Grants PI 405/4 and EXC 115 (to J.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed CMI, 2006, J IMMUNOL, V177, P315, DOI 10.4049/jimmunol.177.1.315; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Cajean-Feroldi C, 2004, BIOCHEMISTRY-US, V43, P12498, DOI 10.1021/bi049111r; Chill JH, 2003, STRUCTURE, V11, P791, DOI 10.1016/S0969-2126(03)00120-5; Claudinon J, 2007, BIOCHIMIE, V89, P735, DOI 10.1016/j.biochi.2007.03.014; Damdinsuren B, 2007, HEPATOL RES, V37, P77, DOI 10.1111/j.1872-034X.2007.00007.x; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Gakovic M, 2008, J BIOL CHEM, V283, P18522, DOI 10.1074/jbc.M801427200; Gavutis M, 2006, BIOPHYS J, V90, P3345, DOI 10.1529/biophysj.105.072546; Gavutis M, 2005, BIOPHYS J, V88, P4289, DOI 10.1529/biophysj.104.055855; Grumbach IM, 1999, J INTERF CYTOK RES, V19, P797, DOI 10.1089/107999099313659; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Ito K, 2004, EUR J HAEMATOL, V73, P191, DOI 10.1111/j.1600-0609.2004.00275.x; JACOBS S, 1979, P NATL ACAD SCI USA, V76, P4918, DOI 10.1073/pnas.76.10.4918; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaitin DA, 2007, J INTERF CYTOK RES, V27, P653, DOI 10.1089/jir.2006.0162; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; Lata S, 2006, J AM CHEM SOC, V128, P6, DOI 10.1021/ja054700l; Li ZL, 2008, J MOL BIOL, V377, P715, DOI 10.1016/j.jmb.2007.12.005; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; LUTFALLA G, 1995, EMBO J, V14, P5100, DOI 10.1002/j.1460-2075.1995.tb00192.x; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Piehler J, 1999, J MOL BIOL, V289, P57, DOI 10.1006/jmbi.1999.2726; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rani MRS, 1996, J BIOL CHEM, V271, P22878, DOI 10.1074/jbc.271.37.22878; Reichel A, 2007, ANAL CHEM, V79, P8590, DOI 10.1021/ac0714922; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Roisman LC, 2001, P NATL ACAD SCI USA, V98, P13231, DOI 10.1073/pnas.221290398; ROSENBLUM MG, 1990, J INTERFERON RES, V10, P141, DOI 10.1089/jir.1990.10.141; Rubinstein M, 1981, Methods Enzymol, V78, P464; Saleh AZM, 2004, ONCOGENE, V23, P7076, DOI 10.1038/sj.onc.1207955; Severa M, 2006, J LEUKOCYTE BIOL, V79, P1286, DOI 10.1189/jlb.1205742; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Subramaniam PS, 2004, FEBS LETT, V578, P207, DOI 10.1016/j.febslet.2004.10.085; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Wagner TC, 2004, INT J CANCER, V111, P32, DOI 10.1002/ijc.20236	51	86	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32925	32936		10.1074/jbc.M806019200	http://dx.doi.org/10.1074/jbc.M806019200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801736	hybrid			2022-12-25	WOS:000260893700081
J	McMahon, MA; Siliciano, JD; Lai, J; Liu, JO; Stivers, JT; Siliciano, RF; Kohli, RM				McMahon, Moira A.; Siliciano, Janet D.; Lai, Jun; Liu, Jun O.; Stivers, James T.; Siliciano, Robert F.; Kohli, Rahul M.			The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX-VIRUS; NUCLEOSIDE ANALOGS; DNA-POLYMERASE; DOUBLE-BLIND; TYPE-1; SUPPRESSION; INFECTION; THERAPY; PLASMA	The antiviral drug acyclovir is a guanosine nucleoside analog that potently inhibits herpes simplex virus (HSV) replication. Acyclovir treatment in patients coinfected with HSV and human immunodeficiency virus (HIV) has been observed to alter disease course and decrease HIV viral load, a finding that has been attributed to indirect effects of HSV suppression on HIV replication. Based on this hypothesis, several clinical studies have recently investigated the use of acyclovir for treatment of patients coinfected with HSV and HIV or for prophylaxis against HIV transmission. In this report, we use a single round HIV infectivity assay to show that acyclovir directly inhibits HIV infection with an IC50 of similar to 5 mu M. The target of acyclovir in HIV-infected cells is validated as HIV reverse transcriptase (RT) by the emergence of the RT variant V75I under the selective pressure of acyclovir. The V75I mutation is part of the multidrug resistance pathway that enhances viral resistance to many of the best RT inhibitors approved for the treatment of HIV. Biochemical analyses demonstrate that acyclovir triphosphate is a chain terminator substrate for HIV RT and can compete with dGTP for incorporation into DNA. Although acyclovir may prove a useful lead for development of new HIV treatments, the selection of resistant mutants raises a cautionary note to the use of acyclovir monotherapy in patients coinfected with HSV and HIV.	[Kohli, Rahul M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [McMahon, Moira A.; Liu, Jun O.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Lai, Jun; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Kohli, RM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, 1830 Monument St, Baltimore, MD 21205 USA.	rkohli2@jhmi.edu		Kohli, Rahul/0000-0002-7689-5678; McMahon, Moira/0000-0001-9810-8623	National Institutes of Health [AI43222, GM56834-12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI43222 (to R. F. S.) and GM56834-12 (to J. T. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Ferguson NM, 2001, TRENDS PHARMACOL SCI, V22, P97, DOI 10.1016/S0165-6147(00)01615-1; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; GAO Q, 1993, ANTIMICROB AGENTS CH, V37, P1390, DOI 10.1128/AAC.37.6.1390; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBSON MA, 1993, J MED VIROL, P150; Johnson Victoria A, 2008, Top HIV Med, V16, P62; KELLER PM, 1981, BIOCHEM PHARMACOL, V30, P3071, DOI 10.1016/0006-2952(81)90495-0; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Krone MR, 2000, CLIN INFECT DIS, V30, P261, DOI 10.1086/313647; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; Lisco A, 2008, NEW ENGL J MED, V359, P535, DOI 10.1056/NEJMc081075; MARGOLIS DM, 1992, VIROLOGY, V186, P788, DOI 10.1016/0042-6822(92)90048-T; Matamoros T, 2008, J MOL BIOL, V375, P1234, DOI 10.1016/j.jmb.2007.11.021; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MOSCA JD, 1987, P NATL ACAD SCI USA, V84, P7408, DOI 10.1073/pnas.84.21.7408; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; REARDON JE, 1989, J BIOL CHEM, V264, P19039; REARDON JE, 1989, J BIOL CHEM, V264, P7405; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Schacker T, 1998, ANN INTERN MED, V128, P21, DOI 10.7326/0003-4819-128-1-199801010-00004; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Winters MA, 2001, ANTIMICROB AGENTS CH, V45, P2276, DOI 10.1128/AAC.45.8.2276-2279.2001; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	37	68	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31289	31293		10.1074/jbc.C800188200	http://dx.doi.org/10.1074/jbc.C800188200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18818198	Green Published, hybrid			2022-12-25	WOS:000260760800005
J	Ha, UH; Lim, JH; Kim, HJ; Wu, WH; Jin, SG; Xu, HD; Li, JD				Ha, Un-Hwan; Lim, Jae Hyang; Kim, Hyun-Joong; Wu, Weihui; Jin, Shouguang; Xu, Haidong; Li, Jian-Dong			MKP1 Regulates the Induction of MUC5AC Mucin by Streptococcus pneumoniae Pneumolysin by Inhibiting the PAK4-JNK Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AIRWAY EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSES; P38 MAPK; NEGATIVE MUTANT; GENE-REGULATION; UP-REGULATION; IKK-BETA; ALPHA; TRANSCRIPTION	Mucosal epithelial cells in the respiratory tract act as the first line of host innate defense against inhaled microbes by producing a range of molecules for clearance. In particular, epithelial mucins facilitate the mucociliary clearance by physically trapping the inhaled microbes. Up-regulation of mucin production thus represents an important host innate defense response against invading microbes. Excess mucin production, however, overwhelms the mucociliary clearance, resulting in defective mucosal defenses. Thus, tight regulation of mucin production is critical for maintaining an appropriate balance between beneficial and detrimental outcomes. Among various mechanisms, negative regulation plays an important role in tightly regulating mucin production. Here we show that the PAK4-JNK signaling pathway acted as a negative regulator for Streptococcus pneumoniae pneumolysin-induced MUC5AC mucin transcription. Moreover pneumolysin also selectively induced expression of MKP1 via a TLR4-dependent MyD88-TRAF6-ERK signaling pathway, which inhibited the PAK4-JNK signaling pathway, thereby leading to up-regulation of MUC5AC mucin production to maintain effective mucosal protection against S. pneumoniae infection. These studies provide novel insights into the molecular mechanisms underlying the tight regulation of mucin overproduction in the pathogenesis of airway infectious diseases and may lead to development of new therapeutic strategies.	[Ha, Un-Hwan; Lim, Jae Hyang; Kim, Hyun-Joong; Xu, Haidong; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Wu, Weihui; Jin, Shouguang] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	University of Rochester; State University System of Florida; University of Florida	Li, JD (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Box 672,601 Elmwood Ave, Rochester, NY 14642 USA.	Jian-Dong_Li@urmc.rochester.edu	Ha, Un-Hwan/ABH-8017-2020; Jin, Shouguang/N-5548-2016	Li, Jian-Dong/0000-0002-5593-050X; Ha, Un-Hwan/0000-0001-9182-7000; Lim, Jae Hyang/0000-0003-0972-9271	National Institutes of Health [DC004562, DC005843, DC008703]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC005843, F32DC008703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC004562 and DC005843 (to J.-D. L.) and Training Grant DC008703 (to U.-H. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Ahn DH, 2005, CELL PHYSIOL BIOCHEM, V15, P29, DOI 10.1159/000083636; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BENTON KA, 1995, INFECT IMMUN, V63, P448, DOI 10.1128/IAI.63.2.448-455.1995; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Borchers MT, 1999, AM J PHYSIOL-LUNG C, V276, pL549, DOI 10.1152/ajplung.1999.276.4.L549; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Burgel PR, 2001, J IMMUNOL, V167, P5948, DOI 10.4049/jimmunol.167.10.5948; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Cockeran R, 2001, J INFECT DIS, V183, P604, DOI 10.1086/318536; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gensch E, 2004, J BIOL CHEM, V279, P39085, DOI 10.1074/jbc.M406866200; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Huang YX, 2007, BIOCHEM BIOPH RES CO, V359, P691, DOI 10.1016/j.bbrc.2007.05.170; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Kato S, 2006, INT J ONCOL, V29, P33; Klugman KP, 2001, CURR OPIN INFECT DIS, V14, P173, DOI 10.1097/00001432-200104000-00011; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Li QT, 2000, GENE DEV, V14, P1729; Li XF, 2005, J BIOL CHEM, V280, P41192, DOI 10.1074/jbc.M506884200; MAJIMA Y, 1988, ANN OTO RHINOL LARYN, V97, P272, DOI 10.1177/000348948809700311; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; MITCHELL TJ, 1991, MOL MICROBIOL, V5, P1883, DOI 10.1111/j.1365-2958.1991.tb00812.x; Mitchell TJ, 1997, MICROB DRUG RESIST, V3, P19, DOI 10.1089/mdr.1997.3.19; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Perez A, 2003, J BIOL CHEM, V278, P36942, DOI 10.1074/jbc.M300264200; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	48	35	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30624	30631		10.1074/jbc.M802519200	http://dx.doi.org/10.1074/jbc.M802519200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782768	Green Published, hybrid			2022-12-25	WOS:000260544800019
J	Webb, N; Connolly, G; Tellam, J; Yap, AS; Khanna, R				Webb, Natasha; Connolly, Geoff; Tellam, Judy; Yap, Alpha S.; Khanna, Rajiv			Epstein-Barr Virus Associated Modulation of Wnt Pathway Is Not Dependent on Latent Membrane Protein-1	PLOS ONE			English	Article								Previous studies have indicated that Epstein-Barr virus (EBV) can modulate the Wnt pathway in virus-infected cells and this effect is mediated by EBV-encoded oncogene latent membrane protein 1 (LMP1). Here we have reassessed the role of LMP1 in regulating the expression of various mediators of the canonical Wnt cascade. Contradicting the previous finding, we found that the levels of E-cadherin, beta-catenin, Glycogen Synthase Kinase 3 beta (GSK3 beta), axin and a-catenin were not affected by the expression of LMP1 sequences from normal B cells or nasopharyngeal carcinoma. Moreover, we also show that LMP1 expression had no detectable effect on the E-cadherin and alpha-catenin interaction and did not induce transcriptional activation of beta-catenin. Taken together these studies demonstrate that EBV-mediated activation of Wnt pathway is not dependent on the expression of LMP1.	[Webb, Natasha; Connolly, Geoff; Tellam, Judy; Khanna, Rajiv] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia; [Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Webb, N (corresponding author), Queensland Inst Med Res, Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia.	rajiv.khanna@qimr.edu.au	Yap, Alpha S./J-1554-2014; Khanna, Rajiv/A-7691-2008	Yap, Alpha S./0000-0002-1038-8956; Khanna, Rajiv/0000-0003-2241-0353	Queensland Cancer Fund; National Health and Medical Research Council (Australia)	Queensland Cancer Fund; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by research funding from the Queensland Cancer Fund and the National Health and Medical Research Council (Australia).	Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Everly DN, 2004, J VIROL, V78, P11648, DOI 10.1128/JVI.78.21.11648-11655.2004; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P1447, DOI 10.1073/pnas.94.4.1447; Kao RH, 2002, ANTICANCER RES, V22, P4109; Khanna R, 2005, NAT CLIN PRACT ONCOL, V2, P138, DOI 10.1038/ncponc0107; Khanna R, 2000, ANNU REV MICROBIOL, V54, P19, DOI 10.1146/annurev.micro.54.1.19; Kieff E., 1996, EPSTEINBARR VIRUS IT, P2343; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284; Lo AKF, 2004, INT J CANCER, V109, P919, DOI 10.1002/ijc.20051; Miller WE, 1998, ONCOGENE, V16, P1869, DOI 10.1038/sj.onc.1201696; Miller WE, 1997, J VIROL, V71, P586, DOI 10.1128/JVI.71.1.586-594.1997; Morrison JA, 2005, J VIROL, V79, P2375, DOI 10.1128/JVI.79.4.2375-2382.2005; Morrison JA, 2004, CANCER RES, V64, P5251, DOI 10.1158/0008-5472.CAN-04-0538; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Shackelford J, 2003, P NATL ACAD SCI USA, V100, P15572, DOI 10.1073/pnas.2636947100; Tan E-L, 2007, Exp Oncol, V29, P166; Tellam J, 2003, BLOOD, V102, P4535, DOI 10.1182/blood-2003-03-0870; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsai CN, 2002, P NATL ACAD SCI USA, V99, P10084, DOI 10.1073/pnas.152059399; Tsao SW, 2003, EUR J CANCER, V39, P524, DOI 10.1016/S0959-8049(02)00494-X	23	19	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3254	10.1371/journal.pone.0003254	http://dx.doi.org/10.1371/journal.pone.0003254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806872	gold, Green Published			2022-12-25	WOS:000264430800004
J	Ejima, A; Griffith, LC				Ejima, Aki; Griffith, Leslie C.			Courtship Initiation Is Stimulated by Acoustic Signals in Drosophila melanogaster	PLOS ONE			English	Article								Finding a mating partner is a critical task for many organisms. It is in the interest of males to employ multiple sensory modalities to search for females. In Drosophila melanogaster, vision is thought to be the most important courtship stimulating cue at long distance, while chemosensory cues are used at relatively short distance. In this report, we show that when visual cues are not available, sounds produced by the female allow the male to detect her presence in a large arena. When the target female was artificially immobilized, the male spent a prolonged time searching before starting courtship. This delay in courtship initiation was completely rescued by playing either white noise or recorded fly movement sounds to the male, indicating that the acoustic and/or seismic stimulus produced by movement stimulates courtship initiation, most likely by increasing the general arousal state of the male. Mutant males expressing tetanus toxin ( TNT) under the control of Gr68a-GAL4 had a defect in finding active females and a delay in courtship initiation in a large arena, but not in a small arena. Gr68a-GAL4 was found to be expressed pleiotropically not only in putative gustatory pheromone receptor neurons but also in mechanosensory neurons, suggesting that Gr68a-positive mechanosensory neurons, not gustatory neurons, provide motion detection necessary for courtship initiation. TNT/Gr68a males were capable of discriminating the copulation status and age of target females in courtship conditioning, indicating that female discrimination and formation of olfactory courtship memory are independent of the Gr68a-expressing neurons that subserve gustation and mechanosensation. This study suggests for the first time that mechanical signals generated by a female fly have a prominent effect on males' courtship in the dark and leads the way to studying how multimodal sensory information and arousal are integrated in behavioral decision making.	[Ejima, Aki; Griffith, Leslie C.] Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Ejima, A (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA.	aki@brandeis.edu		Griffith, Leslie/0000-0003-3164-9876	NIH [R01 GM54408, P30 NS045713, S10 RR16780]; NIMH [R25 MH059472]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH059472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232, P30NS045713] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant R01 GM54408 to LCG. The Brandeis confocal imaging facility is supported by NIH grants P30 NS045713 and S10 RR16780. The sound recording room was provided by MBL Neural Systems and Behavior course supported by NIMH R25 MH059472.	Barth FG, 2004, CURR OPIN NEUROBIOL, V14, P415, DOI 10.1016/j.conb.2004.07.005; BURNET B, 1971, ANIM BEHAV, V19, P409, DOI 10.1016/S0003-3472(71)80025-8; CROSSLEY SA, 1995, ANIM BEHAV, V50, P827, DOI 10.1016/0003-3472(95)80142-1; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Joiner MA, 2000, LEARN MEMORY, V7, P32, DOI 10.1101/lm.7.1.32; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; PAILLETTE M, 1991, Bioacoustics, V3, P247; PECHINE JM, 1988, J CHEM ECOL, V14, P1071, DOI 10.1007/BF01019336; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P565; SPIETH HT, 1966, ANIM BEHAV, V14, P226, DOI 10.1016/S0003-3472(66)80076-3; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Tauber E, 2001, J COMP PHYSIOL A, V187, P341, DOI 10.1007/s003590100206; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	30	66	66	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3246	10.1371/journal.pone.0003246	http://dx.doi.org/10.1371/journal.pone.0003246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802468	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428600006
J	Sentandreu, V; Jimenez-Hernandez, N; Torres-Puente, M; Bracho, MA; Valero, A; Gosalbes, MJ; Ortega, E; Moya, A; Gonzalez-Candelas, F				Sentandreu, Vicente; Jimenez-Hernandez, Nuria; Torres-Puente, Manuela; Alma Bracho, Maria; Valero, Ana; Jose Gosalbes, Maria; Ortega, Enrique; Moya, Andres; Gonzalez-Candelas, Fernando			Evidence of Recombination in Intrapatient Populations of Hepatitis C Virus	PLOS ONE			English	Article							SENSITIVITY-DETERMINING REGION; RIBAVIRIN COMBINATION THERAPY; QUASI-SPECIES HETEROGENEITY; PCR-MEDIATED RECOMBINATION; E2 ENVELOPE GLYCOPROTEIN; AMINO-ACID SUBSTITUTIONS; NONSTRUCTURAL 5A REGION; OPEN READING FRAME; INTERFERON SENSITIVITY; GENOTYPE 1B	Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future. HCV is characterized by a high level of genetic heterogeneity. Although homologous recombination has been demonstrated in many members of the family Flaviviridae, to which HCV belongs, there are only a few studies reporting recombination on natural populations of HCV, suggesting that these events are rare in vivo. Furthermore, these few studies have focused on recombination between different HCV genotypes/subtypes but there are no reports on the extent of intra-genotype or intra-subtype recombination between viral strains infecting the same patient. Given the important implications of recombination for RNA virus evolution, our aim in this study has been to assess the existence and eventually the frequency of intragenic recombination on HCV. For this, we retrospectively have analyzed two regions of the HCV genome (NS5A and E1-E2) in samples from two different groups: (i) patients infected only with HCV (either treated with interferon plus ribavirin or treatment naive), and (ii) HCV-HIV co-infected patients (with and without treatment against HIV). The complete data set comprised 17712 sequences from 136 serum samples derived from 111 patients. Recombination analyses were performed using 6 different methods implemented in the program RDP3. Recombination events were considered when detected by at least 3 of the 6 methods used and were identified in 10.7% of the amplified samples, distributed throughout all the groups described and the two genomic regions studied. The resulting recombination events were further verified by detailed phylogenetic analyses. The complete experimental procedure was applied to an artificial mixture of relatively closely viral populations and the ensuing analyses failed to reveal artifactual recombination. From these results we conclude that recombination should be considered as a potentially relevant mechanism generating genetic variation in HCV and with important implications for the treatment of this infection.	[Sentandreu, Vicente; Jimenez-Hernandez, Nuria; Torres-Puente, Manuela; Alma Bracho, Maria; Valero, Ana; Jose Gosalbes, Maria; Moya, Andres; Gonzalez-Candelas, Fernando] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain; [Jimenez-Hernandez, Nuria; Alma Bracho, Maria; Jose Gosalbes, Maria; Moya, Andres; Gonzalez-Candelas, Fernando] CIBER Epidemiol Salud Publ CIBERESP, Barcelona, Spain; [Ortega, Enrique] Hosp Gen Univ, Unidad Enfermedades Infecciosas, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinic Universitari de Valencia	Sentandreu, V (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	fernando.gonzalez@uv.es	Rello, Ana Valero/J-9479-2015; Sentandreu, Vicente/AAH-5972-2020; Bracho, Maria/K-6018-2014; Torres-Puente, Manuela/P-1791-2016; Hernández, Nuria Jiménez/H-1982-2015; Gosalbes, Maria Jose/C-7194-2011; Moya, Andrés/A-8190-2008; Candelas, Fernando Gonzalez/G-5681-2010	Rello, Ana Valero/0000-0002-0126-1128; Bracho, Maria/0000-0002-9204-5526; Torres-Puente, Manuela/0000-0002-8352-180X; Hernández, Nuria Jiménez/0000-0002-9107-056X; Gosalbes, Maria Jose/0000-0003-0460-1105; Moya, Andrés/0000-0002-2867-1119; Candelas, Fernando Gonzalez/0000-0002-0879-5798	Conselleria de Sanitat i Consum Generalitat Valenciana (Spain); Ministerio de Educacion y Ciencia [BFU2005 00503]	Conselleria de Sanitat i Consum Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF)); Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by the Conselleria de Sanitat i Consum Generalitat Valenciana (Spain) and project BFU2005 00503 from Ministerio de Educacion y Ciencia.	Accapezzato D, 2002, EUR J GASTROEN HEPAT, V14, P879, DOI 10.1097/00042737-200208000-00012; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bracho MA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-13; Becher P, 2001, J VIROL, V75, P6256, DOI 10.1128/JVI.75.14.6256-6264.2001; Bernardin F, 2006, J VIRAL HEPATITIS, V13, P532, DOI 10.1111/j.1365-2893.2006.00722.x; Blackard JT, 2007, J INFECT DIS, V195, P1765, DOI 10.1086/518251; Blackard JT, 2007, J INFECT DIS, V195, P519, DOI 10.1086/510858; Carvajal-Rodriguez A, 2007, INFECT GENET EVOL, V7, P476, DOI 10.1016/j.meegid.2007.02.001; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; Chayama K, 1997, HEPATOLOGY, V25, P745, DOI 10.1002/hep.510250342; Chung RT, 1999, J MED VIROL, V58, P353, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;353::AID-JMV6&gt;3.0.CO;2-C; Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0; *CTR NAC EP, 2006, VIG EP SIDA ESP; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Di Liberto G, 2006, GASTROENTEROLOGY, V131, P76, DOI 10.1053/j.gastro.2006.04.016; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; DURANTE ME, 2003, J MED VIROL, V70, P62; Duverlie G, 1998, J GEN VIROL, V79, P1373, DOI 10.1099/0022-1317-79-6-1373; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Fleury HJ, 2006, AIDS RES HUM RETROV, V22, P357, DOI 10.1089/aid.2006.22.357; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guettouche T, 2005, ANTIVIR THER, V10, P593; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Herring BL, 2004, J INFECT DIS, V190, P1396, DOI 10.1086/424491; Hofgartner WT, 1997, J MED VIROL, V53, P118, DOI 10.1002/(SICI)1096-9071(199710)53:2<118::AID-JMV3>3.0.CO;2-C; Ibarrola N, 1999, AM J GASTROENTEROL, V94, P2487; Jimenez-Hernandez N, 2007, J GEN VIROL, V88, P123, DOI 10.1099/vir.0.82277-0; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kageyama S, 2006, J MED VIROL, V78, P1423, DOI 10.1002/jmv.20714; Kalinina O, 2004, J GEN VIROL, V85, P1853, DOI 10.1099/vir.0.79984-0; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; Khorsi H, 1997, J HEPATOL, V27, P72, DOI 10.1016/S0168-8278(97)80282-6; KOIZUMI K, 1995, HEPATOLOGY, V22, P30, DOI 10.1002/hep.1840220106; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06; LeGuen B, 1997, HEPATOLOGY, V25, P1250, DOI 10.1002/hep.510250531; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Minosse C, 2006, J INFECT DIS, V194, P1529, DOI 10.1086/508889; Moreau I, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-95; Moreno MP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-87; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Murayama M, 2007, J MED VIROL, V79, P35, DOI 10.1002/jmv.20766; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; OKADA S, 1992, HEPATOLOGY, V16, P619, DOI 10.1002/hep.1840160302; OKAMOTO H, 1992, VIROLOGY, V188, P331, DOI 10.1016/0042-6822(92)90762-E; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Peeters M, 2001, AIDS REV, V3, P3; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Polyak SJ, 1997, J INFECT DIS, V175, P1101, DOI 10.1086/516448; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Rispeter K, 1998, J HEPATOL, V29, P352, DOI 10.1016/S0168-8278(98)80051-2; Roque-Afonso AM, 2005, J VIROL, V79, P6349, DOI 10.1128/JVI.79.10.6349-6357.2005; Saiz JC, 1998, J INFECT DIS, V177, P839, DOI 10.1086/515243; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; SCHINKEL J, 2001, 8 INT S HEP C VIR RE, P266; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shafikhani S, 2002, ENVIRON MICROBIOL, V4, P482, DOI 10.1046/j.1462-2920.2002.00326.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; SMITH JM, 1992, J MOL EVOL, V34, P126; Squadrito G, 1999, J HEPATOL, V30, P1023, DOI 10.1016/S0168-8278(99)80255-4; Squadrito G, 1997, GASTROENTEROLOGY, V113, P567, DOI 10.1053/gast.1997.v113.pm9247477; STADEN R, 1999, COMPUTER METHODS MOL, P115; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TANIGUCHI S, 1993, VIROLOGY, V195, P297, DOI 10.1006/viro.1993.1378; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson BJ, 2005, CLIN MICROBIOL INFEC, V11, P86, DOI 10.1111/j.1469-0691.2004.01061.x; Torres-Puente M, 2008, J VIRAL HEPATITIS, V15, P188, DOI 10.1111/j.1365-2893.2007.00929.x; Torres-Puente M, 2007, J GEN VIROL, V88, P2198, DOI 10.1099/vir.0.82855-0; Troesch M, 2006, VIROLOGY, V352, P357, DOI 10.1016/j.virol.2006.05.015; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0; Viazov S, 2000, INFECTION, V28, P21, DOI 10.1007/s150100050005; Watanabe H, 2001, J INFECT DIS, V183, P1195, DOI 10.1086/319674; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; Witherell GW, 2001, J MED VIROL, V63, P8, DOI 10.1002/1096-9071(200101)63:1&lt;8::AID-JMV1001&gt;3.0.CO;2-K; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352; Worobey M, 2001, MOL BIOL EVOL, V18, P254, DOI 10.1093/oxfordjournals.molbev.a003799; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Yun AB, 1996, J MED VIROL, V49, P155, DOI 10.1002/(SICI)1096-9071(199607)49:3<155::AID-JMV1>3.0.CO;2-3; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Zeuzem S, 1997, HEPATOLOGY, V25, P740, DOI 10.1002/hep.510250341; zur Wiesch JS, 2003, ARCH VIROL, V148, P1247, DOI 10.1007/s00705-003-0115-8	103	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3239	10.1371/journal.pone.0003239	http://dx.doi.org/10.1371/journal.pone.0003239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800167	gold, Green Published, Green Submitted			2022-12-25	WOS:000264428400008
J	Sugiura, Y; Shimma, S; Konishi, Y; Yamada, MK; Setou, M				Sugiura, Yuki; Shimma, Shuichi; Konishi, Yoshiyuki; Yamada, Maki K.; Setou, Mitsutoshi			Imaging Mass Spectrometry Technology and Application on Ganglioside Study; Visualization of Age-Dependent Accumulation of C20-Ganglioside Molecular Species in the Mouse Hippocampus	PLOS ONE			English	Article								Gangliosides are particularly abundant in the central nervous system (CNS) and thought to play important roles in memory formation, neuritogenesis, synaptic transmission, and other neural functions. Although several molecular species of gangliosides have been characterized and their individual functions elucidated, their differential distribution in the CNS are not well understood. In particular, whether the different molecular species show different distribution patterns in the brain remains unclear. We report the distinct and characteristic distributions of ganglioside molecular species, as revealed by imaging mass spectrometry (IMS). This technique can discriminate the molecular species, raised from both oligosaccharide and ceramide structure by determining the difference of the mass-to-charge ratio, and structural analysis by tandem mass spectrometry. Gangliosides in the CNS are characterized by the structure of the long-chain base (LCB) in the ceramide moiety. The LCB of the main ganglioside species has either 18 or 20 carbons (i.e., C18- or C20-sphingosine); we found that these 2 types of gangliosides are differentially distributed in the mouse brain. While the C18- species was widely distributed throughout the frontal brain, the C20-species selectively localized along the entorhinal-hippocampus projections, especially in the molecular layer (ML) of the dentate gyrus (DG). We revealed development- and aging-related accumulation of the C20 species in the ML-DG. Thus it is possible to consider that this brain-region specific regulation of LCB chain length is particularly important for the distinct function in cells of CNS.	[Sugiura, Yuki; Setou, Mitsutoshi] Tokyo Inst Technol, Dept Biosci & Biotechnol, Kanagawa, Japan; [Sugiura, Yuki; Konishi, Yoshiyuki; Yamada, Maki K.; Setou, Mitsutoshi] Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo, Japan; [Shimma, Shuichi; Setou, Mitsutoshi] Natl Inst Physiol Sci, Okazaki, Aichi, Japan; [Setou, Mitsutoshi] Hamamatsu Med Sch, Dept Mol Anat, Hamamatsu, Shizuoka, Japan	Tokyo Institute of Technology; Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Hamamatsu University School of Medicine	Sugiura, Y (corresponding author), Tokyo Inst Technol, Dept Biosci & Biotechnol, Kanagawa, Japan.	setou@hama-med.ac.jp	Yamada, Maki K./A-1573-2015; Yamada, Maki/U-5251-2019; Shimma, Shuichi/L-5975-2019	Yamada, Maki K./0000-0002-1956-6069; Sugiura, Yuki/0000-0002-6983-8958	SENTAN program of the Japan Science and Technology Agency; Japan Society for the Promotion of Science [WAKATE S]	SENTAN program of the Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the SENTAN program of the Japan Science and Technology Agency, and a WAKATE S grant from the Japan Society for the Promotion of Science to M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CALDERON RO, 1995, J NEUROCHEM, V64, P424; Chaurand P, 2008, MOL CELL PROTEOMICS, V7, P411, DOI 10.1074/mcp.M700190-MCP200; GARRETT TJ, 2006, INT J MASS SPECTROM, V260, P11; GLASIER MM, 1995, NEUROBIOL LEARN MEM, V64, P203, DOI 10.1006/nlme.1995.0003; GomezIsla T, 1996, J NEUROSCI, V16, P4491; HANDA S, 1984, J BIOCHEM-TOKYO, V95, P1323, DOI 10.1093/oxfordjournals.jbchem.a134738; Harvey DJ, 1996, J CHROMATOGR A, V720, P429, DOI 10.1016/0021-9673(95)00307-X; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V146, P219, DOI 10.1002/cne.901460206; Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; JUNGALWALA FB, 1979, J LIPID RES, V20, P579; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; KOTANI M, 1995, BRAIN RES, V700, P40, DOI 10.1016/0006-8993(95)00923-E; KOTANI M, 1993, GLYCOBIOLOGY, V3, P137, DOI 10.1093/glycob/3.2.137; MANSSON JE, 1978, J NEUROCHEM, V30, P273, DOI 10.1111/j.1471-4159.1978.tb07064.x; MASCO D, 1990, BRAIN RES, V514, P84, DOI 10.1016/0006-8993(90)90438-H; MASSERINI M, 1990, BIOCHEM J, V271, P107, DOI 10.1042/bj2710107; PALESTINI P, 1991, J NEUROCHEM, V56, P2048, DOI 10.1111/j.1471-4159.1991.tb03465.x; PALESTINI P, 1990, J NEUROCHEM, V54, P230, DOI 10.1111/j.1471-4159.1990.tb13305.x; Powell AK, 1996, RAPID COMMUN MASS SP, V10, P1027; Prinetti A, 1999, J BIOL CHEM, V274, P20916, DOI 10.1074/jbc.274.30.20916; RAHMANN H, 1995, BEHAV BRAIN RES, V66, P105, DOI 10.1016/0166-4328(94)00131-X; Ramirez JJ, 1998, RESTOR NEUROL NEUROS, V12, P203; RAMIREZ OA, 1990, BRAIN RES, V506, P291, DOI 10.1016/0006-8993(90)91264-H; Rubakhin SS, 2007, CURR PHARM DESIGN, V13, P3325, DOI 10.2174/138161207782360708; SAMBASIVARAO K, 1964, J LIPID RES, V15, P103; Schwartz SA, 2003, J MASS SPECTROM, V38, P699, DOI 10.1002/jms.505; SCHWARZ HP, 1967, J NEUROCHEM, V14, P91, DOI 10.1111/j.1471-4159.1967.tb09497.x; Sekiya S, 2005, ANAL CHEM, V77, P4962, DOI 10.1021/ac050287o; SHIMMA S, 2007, J MASS SPECTROM SOC, V55; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; Shimma S, 2007, J CHROMATOGR B, V855, P98, DOI 10.1016/j.jchromb.2007.02.037; Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; SUGIURA Y, 2006, J MASS SPECTROM SOC, V54, P4; Sugiura Y, 2006, ANAL CHEM, V78, P8227, DOI 10.1021/ac060974v; Sugiyama E, 1997, GLYCOBIOLOGY, V7, P719, DOI 10.1093/glycob/7.5.719; VALSECCHI M, 1993, J NEUROCHEM, V60, P193, DOI 10.1111/j.1471-4159.1993.tb05837.x; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; VANECHTEN G, 1993, J BIOL CHEM, V268, P5341; YU RK, 1988, J NEUROCHEM, V50, P1825, DOI 10.1111/j.1471-4159.1988.tb02484.x	42	113	118	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3232	10.1371/journal.pone.0003232	http://dx.doi.org/10.1371/journal.pone.0003232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800170	Green Submitted, Green Published, gold			2022-12-25	WOS:000264428400003
J	Fagundes, NJR; Kanitz, R; Bonatto, SL				Fagundes, Nelson J. R.; Kanitz, Ricardo; Bonatto, Sandro L.			A Reevaluation of the Native American MtDNA Genome Diversity and Its Bearing on the Models of Early Colonization of Beringia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; TIME DEPENDENCY; REGION; ORIGIN; SINGLE; HAPLOGROUPS; EVOLUTION; MIGRATION; SEQUENCES; SELECTION	The Americas were the last continents to be populated by humans, and their colonization represents a very interesting chapter in our species' evolution in which important issues are still contentious or largely unknown. One difficult topic concerns the details of the early peopling of Beringia, such as for how long it was colonized before people moved into the Americas and the demography of this occupation. A recent work using mitochondrial genome ( mtDNA) data presented evidence for a so called "three-stage model'' consisting of a very early expansion into Beringia followed by,20,000 years of population stability before the final entry into the Americas. However, these results are in disagreement with other recent studies using similar data and methods. Here, we reanalyze their data to check the robustness of this model and test the ability of Native American mtDNA to discriminate details of the early colonization of Beringia. We apply the Bayesian Skyline Plot approach to recover the past demographic dynamic underpinning these events using different mtDNA data sets. Our results refute the specific details of the "three-stage model'', since the early stage of expansion into Beringia followed by a long period of stasis could not be reproduced in any mtDNA data set cleaned from non-Native American haplotypes. Nevertheless, they are consistent with a moderate population bottleneck in Beringia associated with the Last Glacial Maximum followed by a strong population growth around 18,000 years ago as suggested by other recent studies. We suggest that this bottleneck erased the signals of ancient demographic history from recent Native American mtDNA pool, and conclude that the proposed early expansion and occupation of Beringia is an artifact caused by the misincorporation of non-Native American haplotypes.	[Fagundes, Nelson J. R.; Kanitz, Ricardo; Bonatto, Sandro L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Fagundes, Nelson J. R.] Univ Fed Rio Grande do Sul, Dept Genet Inst Biociencias, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul	Fagundes, NJR (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.	slbonatto@pucrs.br	Kanitz, Ricardo/F-4177-2012; Bonatto, Sandro L/A-1240-2010; Fagundes, Nelson/F-7490-2014	Kanitz, Ricardo/0000-0003-4759-0207; Bonatto, Sandro L/0000-0002-0064-467X; Fagundes, Nelson/0000-0003-0456-0323	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grants to SLB, and by CNPq scholarships to RK and NJRF.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 2008, INT J LEGAL MED, V122, P11, DOI 10.1007/s00414-006-0151-5; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Battilana J, 2007, ANN HUM GENET, V71, P64, DOI 10.1111/j.1469-1809.2006.00296.x; Battilana J, 2006, ANN HUM BIOL, V33, P142, DOI 10.1080/03014460500487347; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dixon E.J., 1993, QUEST ORIGINS 1 AM; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ellis N, 2002, GENOME RES, V12, P339; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fagundes NJR, 2005, ANN HUM GENET, V69, P389, DOI 10.1046/j.1529-8817.2005.00163.x; FLADMARK KR, 1979, AM ANTIQUITY, V44, P55, DOI 10.2307/279189; Forster P, 1996, AM J HUM GENET, V59, P935; GIBERT MTP, 2008, SCIENCE, V320, P786; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; GONZALESJOSE R, 2008, AM J PHYS A IN PRESS; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kitchen A, 2008, MOL PHYLOGENET EVOL, V46, P673, DOI 10.1016/j.ympev.2007.09.005; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Salzano FM, 2007, ANTHROPOLOGICAL GENETICS: THEORY, METHODS AND APPLICATIONS, P433; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185	40	54	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3157	10.1371/journal.pone.0003157	http://dx.doi.org/10.1371/journal.pone.0003157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797501	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428200001
J	Larsson, O; Diebold, D; Fan, DH; Peterson, M; Nho, RS; Bitterman, PB; Henke, CA				Larsson, Ola; Diebold, Deanna; Fan, Danhua; Peterson, Mark; Nho, Richard Seonghun; Bitterman, Peter B.; Henke, Craig A.			Fibrotic Myofibroblasts Manifest Genome-Wide Derangements of Translational Control	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HUMAN LUNG FIBROBLASTS; I COLLAGEN MATRICES; GENE-EXPRESSION; MESENCHYMAL TRANSITION; EPITHELIAL-CELLS; MESSENGER-RNAS; APOPTOSIS; CONTRACTION; VIABILITY	Background: As a group, fibroproliferative disorders of the lung, liver, kidney, heart, vasculature and integument are common, progressive and refractory to therapy. They can emerge following toxic insults, but are frequently idiopathic. Their enigmatic propensity to resist therapy and progress to organ failure has focused attention on the myofibroblast-the primary effector of the fibroproliferative response. We have recently shown that aberrant beta 1 integrin signaling in fibrotic fibroblasts results in defective PTEN function, unrestrained Akt signaling and subsequent activation of the translation initiation machinery. How this pathological integrin signaling alters the gene expression pathway has not been elucidated. Results: Using a systems approach to study this question in a prototype fibrotic disease, Idiopathic Pulmonary Fibrosis (IPF); here we show organized changes in the gene expression pathway of primary lung myofibroblasts that persist for up to 9 sub-cultivations in vitro. When comparing IPF and control myofibroblasts in a 3-dimensional type I collagen matrix, more genes differed at the level of ribosome recruitment than at the level of transcript abundance, indicating pathological translational control as a major characteristic of IPF myofibroblasts. To determine the effect of matrix state on translational control, myofibroblasts were permitted to contract the matrix. Ribosome recruitment in control myofibroblasts was relatively stable. In contrast, IPF cells manifested large alterations in the ribosome recruitment pattern. Pathological studies suggest an epithelial origin for IPF myofibroblasts through the epithelial to mesenchymal transition (EMT). In accord with this, we found systems-level indications for TGF-beta-driven EMT as one source of IPF myofibroblasts. Conclusions: These findings establish the power of systems level genome-wide analysis to provide mechanistic insights into fibrotic disorders such as IPF. Our data point to derangements of translational control downstream of aberrant beta 1 integrin signaling as a fundamental component of IPF pathobiology and indicates that TGF-beta-driven EMT is one source for IPF myofibroblasts.	[Larsson, Ola; Diebold, Deanna; Fan, Danhua; Peterson, Mark; Nho, Richard Seonghun; Bitterman, Peter B.; Henke, Craig A.] Univ Minnesota, Dept Med, Div Pulm, Minneapolis, MN 55455 USA; [Larsson, Ola] McGill Univ, Dept Biochem, Montreal, PQ H3A 2T5, Canada; [Fan, Danhua] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; McGill University; University of Minnesota System; University of Minnesota Twin Cities	Larsson, O (corresponding author), Univ Minnesota, Dept Med, Div Pulm, Box 736 UMHC, Minneapolis, MN 55455 USA.	ola.larsson@mail.mcgill.ca	Larsson, Ola/F-8151-2013	BITTERMAN, PETER/0000-0002-7995-7117; Larsson, Ola/0000-0003-1412-1308	ALA [RT-10053N, HL073719, HL076779, HL 074882]; Swedish Research Council [post-doctoral fellowship]; Knut and Alice Wallenberg foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073719, R01HL076779, R01HL074882] Funding Source: NIH RePORTER	ALA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by ALA grant RT-10053N (to D. Diebold), HL073719, HL076779 (P.B.), and HL 074882 (C.H.). O.L. was supported by a post-doctoral fellowship from the Swedish Research Council during the majority of the study and a fellowship from the Knut and Alice Wallenberg foundation during the completion of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2005, BIOINFORMATICS, V21, P2988, DOI 10.1093/bioinformatics/bti457; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Aono Y, 2005, AM J RESP CRIT CARE, V171, P1279, DOI 10.1164/rccm.200404-531OC; BITTERMAN PB, 1991, FIBROPROLIFERATIVE D, pS81; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chilosi M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-95; Choi ES, 2004, AM J RESP CRIT CARE, V170, P508, DOI 10.1164/rccm.200401-002OC; Cosgrove GP, 2004, AM J RESP CRIT CARE, V170, P242, DOI 10.1164/rccm.200308-1151OC; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Enomoto N, 2006, CHEST, V130, P22, DOI 10.1378/chest.130.1.22; Fluck J, 1998, J INVEST DERMATOL, V110, P153, DOI 10.1046/j.1523-1747.1998.00095.x; Frankel SK, 2006, AM J RESP CELL MOL, V34, P293, DOI 10.1165/rcmb.2005-0155OC; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Gruber MP, 2006, AM J RESP CELL MOL, V35, P65, DOI 10.1165/rcmb.2004-0261OC; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Kaminski Naftali, 2006, Proc Am Thorac Soc, V3, P339, DOI 10.1513/pats.200601-011TK; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; LADIN DA, 1998, WOUND REPAIR REGEN, P28; Larsson O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-129; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; Larsson O, 2006, OMICS, V10, P381, DOI 10.1089/omi.2006.10.381; Li S, 2003, J BIOL CHEM, V278, P3015, DOI 10.1074/jbc.M208821200; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Moodley YP, 2004, J PATHOL, V202, P486, DOI 10.1002/path.1531; Moodley YP, 2003, AM J PATHOL, V163, P345, DOI 10.1016/S0002-9440(10)63658-9; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Norman JT, 1999, EXP NEPHROL, V7, P167; Oostendorp RAJ, 1999, LEUKEMIA, V13, P499, DOI 10.1038/sj.leu.2401373; Pacanowski MA, 2005, ANN PHARMACOTHER, V39, P1678, DOI 10.1345/aph.1E672; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Santiago B, 2001, ARTHRITIS RHEUM-US, V44, P1667, DOI 10.1002/1529-0131(200107)44:7<1667::AID-ART291>3.0.CO;2-Y; SCHUTTERT JB, 2003, PFLUGERS ARCH, P387; SELMAN M, 1986, THORAX, V41, P355, DOI 10.1136/thx.41.5.355; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; TORRY DJ, 1994, J CLIN INVEST, V93, P1525, DOI 10.1172/JCI117131; Tsujita-Kyutoku M, 2005, IN VIVO, V19, P959; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wennmalm K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r109; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; WYNN TA, 2004, FIBROTIC DIS T H1 TH, P583; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	56	81	84	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3220	10.1371/journal.pone.0003220	http://dx.doi.org/10.1371/journal.pone.0003220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795102	Green Published, gold, Green Submitted			2022-12-25	WOS:000264428000004
J	Bonde, S; Chan, KM; Zavazava, N				Bonde, Sabrina; Chan, Kun-Ming; Zavazava, Nicholas			ES-Cell Derived Hematopoietic Cells Induce Transplantation Tolerance	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HOXB4; ENGRAFTMENT; EXPRESSION; EXPANSION; PROMOTES; CONFERS	Background: Bone marrow cells induce stable mixed chimerism under appropriate conditioning of the host, mediating the induction of transplantation tolerance. However, their strong immunogenicity precludes routine use in clinical transplantation due to the need for harsh preconditioning and the requirement for toxic immunosuppression to prevent rejection and graft-versus-host disease. Alternatively, embryonic stem (ES) cells have emerged as a potential source of less immunogenic hematopoietic progenitor cells (HPCs). Up till now, however, it has been difficult to generate stable hematopoietic cells from ES cells. Methodology/Principal Findings: Here, we derived CD45(+) HPCs from HOXB4-transduced ES cells and showed that they poorly express MHC antigens. This property allowed their long-term engraftment in sublethally irradiated recipients across MHC barriers without the need for immunosuppressive agents. Although donor cells declined in peripheral blood over 2 months, low level chimerism was maintained in the bone marrow of these mice over 100 days. More importantly, chimeric animals were protected from rejection of donor-type cardiac allografts. Conclusions: Our data show, for the first time, the efficacy of ES-derived CD45(+) HPCs to engraft in allogenic recipients without the use of immunosuppressive agents, there by protecting cardiac allografts from rejection.	[Bonde, Sabrina; Chan, Kun-Ming; Zavazava, Nicholas] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Chan, Kun-Ming] Chang Gung Univ, Coll Med, Chang Gung Memorial Hosp, Dept Gen Surg, Tao Yuan, Taiwan	University of Iowa; Chang Gung Memorial Hospital; Chang Gung University	Bonde, S (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	nicholas-zavazava@uiowa.edu			NIH/NHLBI; Department of Veterans Affairs; ROTRF	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); ROTRF	Grant Support: NIH/NHLBI; Department of Veterans Affairs; ROTRF. None of the sponsors were involved in the conducting, analysis or publication of the data.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BILLINGHAM RE, 1956, NATURE, V178, P514, DOI 10.1038/178514a0; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Bowles KM, 2006, STEM CELLS, V24, P1359, DOI 10.1634/stemcells.2005-0210; Burt RK, 2004, J EXP MED, V199, P895, DOI 10.1084/jem.20031916; Chan KM, 2008, BLOOD, V111, P2953, DOI 10.1182/blood-2007-10-117366; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Haanstra KG, 2007, AM J TRANSPLANT, V7, P2236, DOI 10.1111/j.1600-6143.2007.01917.x; Honig GR, 2004, BLOOD CELL MOL DIS, V32, P5, DOI 10.1016/j.bcmd.2003.09.008; JUST U, 1991, CELL, V64, P1163, DOI 10.1016/0092-8674(91)90271-Y; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Pilat S, 2005, P NATL ACAD SCI USA, V102, P12101, DOI 10.1073/pnas.0505624102; Potocnik AJ, 1997, P NATL ACAD SCI USA, V94, P10295, DOI 10.1073/pnas.94.19.10295; Potocnik AJ, 1997, IMMUNOL LETT, V57, P131, DOI 10.1016/S0165-2478(97)00089-8; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Schiedlmeier B, 2003, BLOOD, V101, P1759, DOI 10.1182/blood-2002-03-0767; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SYKES M, 1999, HEMATOPOETIC CELL TR, P300; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; WEISSMANN A, 1889, ESSAYS HEREDITARY KI, V25; Zavazava N, 1996, NAT MED, V2, P1005, DOI 10.1038/nm0996-1005; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173	27	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3212	10.1371/journal.pone.0003212	http://dx.doi.org/10.1371/journal.pone.0003212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791641	Green Published, gold, Green Submitted			2022-12-25	WOS:000264427700007
J	Huang, YX; Krasnitz, M; Rabadan, R; Witten, DM; Song, Y; Levine, AJ; Ho, DD; Robins, H				Huang, Yaoxing; Krasnitz, Michael; Rabadan, Raul; Witten, Daniela M.; Song, Yang; Levine, Arnold J.; Ho, David D.; Robins, Harlan			A Recoding Method to Improve the Humoral Immune Response to an HIV DNA Vaccine	PLOS ONE			English	Article								This manuscript describes a novel strategy to improve HIV DNA vaccine design. Employing a new information theory based bioinformatic algorithm, we identify a set of nucleotide motifs which are common in the coding region of HIV, but are under-represented in genes that are highly expressed in the human genome. We hypothesize that these motifs contribute to the poor protein expression of gag, pol, and env genes from the c-DNAs of HIV clinical isolates. Using this approach and beginning with a codon optimized consensus gag gene, we recode the nucleotide sequence so as to remove these motifs without modifying the amino acid sequence. Transfecting the recoded DNA sequence into a human kidney cell line results in doubling the gag protein expression level compared to the codon optimized version. We then turn both sequences into DNA vaccines and compare induced antibody response in a murine model. Our sequence, which has the motifs removed, induces a five-fold increase in gag antibody response compared to the codon optimized vaccine.	[Huang, Yaoxing; Song, Yang; Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Krasnitz, Michael; Rabadan, Raul; Levine, Arnold J.] Inst Advanced Study, Princeton, NJ USA; [Witten, Daniela M.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Robins, Harlan] Fred Hutchinson Canc Res Ctr, Computat Biol Grp, Seattle, WA USA	Rockefeller University; Institute for Advanced Study - USA; Stanford University; Fred Hutchinson Cancer Center	Huang, YX (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA.	hrobins@fhcrc.org	Rabadan, Raul/AAZ-7367-2020	Rabadan, Raul/0000-0001-7946-9255	Simons Foundation; Ambrose Monell Foundation; Leon Levy Foundation; Irene Diamond Fund	Simons Foundation; Ambrose Monell Foundation; Leon Levy Foundation; Irene Diamond Fund	This work was supported in part by the Simons Foundation, the Ambrose Monell Foundation, and the Leon Levy Foundation. YH, YS, and DH are supported in part by the Irene Diamond Fund.	Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; Laddy DJ, 2006, INT REV IMMUNOL, V25, P99, DOI 10.1080/08830180600785827; Liu MA, 2006, HUM GENE THER, V17, P1051, DOI 10.1089/hum.2006.17.1051; Robins H, 2005, J BACTERIOL, V187, P8370, DOI 10.1128/JB.187.24.8370-8374.2005; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997	6	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3214	10.1371/journal.pone.0003214	http://dx.doi.org/10.1371/journal.pone.0003214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791646	Green Published, gold, Green Submitted			2022-12-25	WOS:000264427700009
J	Allsopp, MH; de Lange, WJ; Veldtman, R				Allsopp, Mike H.; de Lange, Willem J.; Veldtman, Ruan			Valuing Insect Pollination Services with Cost of Replacement	PLOS ONE			English	Article							ECOSYSTEM SERVICES; BEE POLLINATION; ECONOMIC VALUE; CROP POLLINATION; APIS-MELLIFERA; HONEY-BEES; FRUIT-SET; CONSERVATION; BIODIVERSITY; MCINTOSH	Value estimates of ecosystem goods and services are useful to justify the allocation of resources towards conservation, but inconclusive estimates risk unsustainable resource allocations. Here we present replacement costs as a more accurate value estimate of insect pollination as an ecosystem service, although this method could also be applied to other services. The importance of insect pollination to agriculture is unequivocal. However, whether this service is largely provided by wild pollinators (genuine ecosystem service) or managed pollinators (commercial service), and which of these requires immediate action amidst reports of pollinator decline, remains contested. If crop pollination is used to argue for biodiversity conservation, clear distinction should be made between values of managed- and wild pollination services. Current methods either under-estimate or over-estimate the pollination service value, and make use of criticised general insect and managed pollinator dependence factors. We apply the theoretical concept of ascribing a value to a service by calculating the cost to replace it, as a novel way of valuing wild and managed pollination services. Adjusted insect and managed pollinator dependence factors were used to estimate the cost of replacing insect- and managed pollination services for the Western Cape deciduous fruit industry of South Africa. Using pollen dusting and hand pollination as suitable replacements, we value pollination services significantly higher than current market prices for commercial pollination, although lower than traditional proportional estimates. The complexity associated with inclusive value estimation of pollination services required several defendable assumptions, but made estimates more inclusive than previous attempts. Consequently this study provides the basis for continued improvement in context specific pollination service value estimates.	[Allsopp, Mike H.] Plant Protect Res Inst, Agr Res Council, ZA-0001 Pretoria, South Africa; [de Lange, Willem J.] Council Sci & Industrial Res, Environm & Resource Econ Grp, Stellenbosch, South Africa; [Veldtman, Ruan] Kirstenbosch Res Ctr, S African Natl Biodivers Inst, Cape Town, South Africa	Agricultural Research Council of South Africa; South African National Biodiversity Institute	Allsopp, MH (corresponding author), Plant Protect Res Inst, Agr Res Council, Private Bag X134, ZA-0001 Pretoria, South Africa.	Veldtman@sanbi.org	Veldtman, Ruan/I-1131-2019; De Lange, Willem/GYU-4982-2022	De Lange, Willem/0000-0001-5369-7049				Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Allsopp M.H., 2004, ASSESSMENT IMPACT BE; Benedek P, 2003, FLORAL BIOLOGY : POLLINATION AND FERTILISATION IN TEMPERATE ZONE FRUIT SPECIES AND GRAPE, P531; Bos MM, 2007, ECOL APPL, V17, P1841, DOI 10.1890/06-1763.1; Buchmann SL, 1996, FORGOTTEN POLLINATOR; Burgett M, 2004, AM BEE J, V144, P269; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; CALDERONE NW, 2006, BEE CULT, V134, P31; Calzoni GL, 1998, SCI HORTIC-AMSTERDAM, V72, P227, DOI 10.1016/S0304-4238(97)00132-5; CHAGNON M, 1993, J ECON ENTOMOL, V86, P416, DOI 10.1093/jee/86.2.416; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Curtis IA, 2004, ECOL ECON, V50, P163, DOI 10.1016/j.ecolecon.2004.02.003; Dag A, 2001, ACTA HORTIC, P61, DOI 10.17660/ActaHortic.2001.561.8; DEGRANDI H, 2000, AM BEE J, V137, P565; *DFPT, 2005, KEY DEC FRUIT STAT; *FIRM POLL CO, 2007, PRIC; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gill R. A., 1991, The Sixth International Symposium on Pollination, Tilburg, Netherlands, 27-31 August 1990., P62; Gill RA, 1985, 371 IND ASS COMM; Goodstein E., 2008, EC ENV; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hassan RM, 2005, MILLENNIUM ECOSYSTEM; Heazlewood JE, 2004, VITIS, V43, P65; Howpage D, 2001, NEW ZEAL J CROP HORT, V29, P51, DOI 10.1080/01140671.2001.9514160; JOHANNSMEIER MF, 2001, PLANT PROTECTION RES, V14, P232; JOHNSON DB, 1973, J LAW ECON, V16, P35, DOI 10.1086/466754; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, AM J BOT, V90, P153, DOI 10.3732/ajb.90.1.153; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; KUBERSKY U, 2001, APIDOLOGIE, V32, P463; Lange W. J. de, 2007, Agrekon, V46, P371; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; McGregor, 1976, USDA AGR HDB, V496; McLaren GF, 1996, NEW ZEAL J CROP HORT, V24, P55, DOI 10.1080/01140671.1996.9513935; Moritz RFA, 2007, J INSECT CONSERV, V11, P391, DOI 10.1007/s10841-006-9054-5; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; OLMSTEAD AL, 1987, AM J AGR ECON, V69, P56, DOI 10.2307/1241306; PEARCE DW, 1993, EC VALUES ENV; Pritchard KD, 2006, J HORTIC SCI BIOTECH, V81, P78, DOI 10.1080/14620316.2006.11512032; RANDALL A, 1983, NAT RESOUR J, V23, P131; Razeto B, 2005, INT J FRUIT SCI, V5, P37, DOI 10.1300/J492v05n02_05; Richards AJ, 2001, ANN BOT-LONDON, V88, P165, DOI 10.1006/anbo.2001.1463; RICHARDS KW, 1993, REV SUISSE ZOOL, V100, P807, DOI 10.5962/bhl.part.79885; ROBINSON WS, 1989, AM BEE J, V129, P477; Schupp JR, 1997, HORTSCIENCE, V32, P742, DOI 10.21273/HORTSCI.32.4.742; Sheffield CS, 2005, ANN BOT-LONDON, V95, P583, DOI 10.1093/aob/mci058; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Turpie JK, 2003, BIOL CONSERV, V112, P233, DOI 10.1016/S0006-3207(02)00398-1; van Wilgen BW, 1997, S AFR J SCI, V93, P404; Williams Ingrid H., 1996, Linnean Society Symposium Series, V18, P63; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Ya T., 2003, HAND POLLINATION PEA	58	165	171	3	212	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3128	10.1371/journal.pone.0003128	http://dx.doi.org/10.1371/journal.pone.0003128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KD	18781196	Green Published, gold, Green Submitted			2022-12-25	WOS:000264425700001
J	Vyleta, NP; Smith, SM				Vyleta, Nicholas P.; Smith, Stephen M.			Fast Inhibition of Glutamate-Activated Currents by Caffeine	PLOS ONE			English	Article							RECEPTORS; RELEASE; CHANNEL	Background: Caffeine stimulates calcium-induced calcium release (CICR) in many cell types. In neurons, caffeine stimulates CICR presynaptically and thus modulates neurotransmitter release. Methodology/Principal Findings: Using the whole-cell patch-clamp technique we found that caffeine ( 20 mM) reversibly increased the frequency and decreased the amplitude of miniature excitatory postsynaptic currents (mEPSCs) in neocortical neurons. The increase in mEPSC frequency is consistent with a presynaptic mechanism. Caffeine also reduced exogenously applied glutamate-activated currents, confirming a separate postsynaptic action. This inhibition developed in tens of milliseconds, consistent with block of channel currents. Caffeine ( 20 mM) did not reduce currents activated by exogenous NMDA, indicating that caffeine block is specific to non-NMDA type glutamate receptors. Conclusions/Significance: Caffeine-induced inhibition of mEPSC amplitude occurs through postsynaptic block of non-NMDA type ionotropic glutamate receptors. Caffeine thus has both pre and postsynaptic sites of action at excitatory synapses.	[Vyleta, Nicholas P.; Smith, Stephen M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, Portland, OR 97201 USA	Oregon Health & Science University	Vyleta, NP (corresponding author), Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	smisteph@ohsu.edu		Smith, Stephen/0000-0002-0331-7615	NINDS [R01-NS 43444]; Multidisciplinary Research Training in Pulmonary Medicine [1T32 HL083808]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043444] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Multidisciplinary Research Training in Pulmonary Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS (R01-NS 43444) and Multidisciplinary Research Training in Pulmonary Medicine Training Grant (1T32 HL083808).	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; BEZPROZVANNY I, 1994, MOL BIOL CELL, V5, P97, DOI 10.1091/mbc.5.1.97; Cysneiros RM, 2007, CLIN PHARMACOL THER, V82, P54, DOI 10.1038/sj.clpt.6100211; DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; EHRLICH BE, 1994, TRENDS PHARM SCI, V15; Gundlfinger A, 2007, J PHYSIOL-LONDON, V582, P263, DOI 10.1113/jphysiol.2007.132613; Liu XR, 2006, DRUG METAB DISPOS, V34, P1443, DOI 10.1124/dmd.105.008201; Martin ED, 2003, J NEUROPHYSIOL, V89, P3029, DOI 10.1152/jn.00601.2002; Morton-Jones RT, 2008, CELL CALCIUM, V43, P356, DOI 10.1016/j.ceca.2007.07.003; MRVOS RM, 1989, VET HUM TOXICOL, V31, P571; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P521, DOI 10.1113/jphysiol.2002.022103; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007	17	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3155	10.1371/journal.pone.0003155	http://dx.doi.org/10.1371/journal.pone.0003155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781199	gold, Green Published, Green Submitted			2022-12-25	WOS:000264425700006
J	Aharonowiz, M; Einstein, O; Fainstein, N; Lassmann, H; Reubinoff, B; Ben-Hur, T				Aharonowiz, Michal; Einstein, Ofira; Fainstein, Nina; Lassmann, Hans; Reubinoff, Benjamin; Ben-Hur, Tamir			Neuroprotective Effect of Transplanted Human Embryonic Stem Cell-Derived Neural Precursors in an Animal Model of Multiple Sclerosis	PLOS ONE			English	Article								Background: Multiple sclerosis (MS) is an immune mediated demyelinating disease of the central nervous system (CNS). A potential new therapeutic approach for MS is cell transplantation which may promote remyelination and suppress the inflammatory process. Methods: We transplanted human embryonic stem cells (hESC)-derived early multipotent neural precursors (NPs) into the brain ventricles of mice induced with experimental autoimmune encephalomyelitis (EAE), the animal model of MS. We studied the effect of the transplanted NPs on the functional and pathological manifestations of the disease. Results: Transplanted hESC-derived NPs significantly reduced the clinical signs of EAE. Histological examination showed migration of the transplanted NPs to the host white matter, however, differentiation to mature oligodendrocytes and remyelination were negligible. Time course analysis of the evolution and progression of CNS inflammation and tissue injury showed an attenuation of the inflammatory process in transplanted animals, which was correlated with the reduction of both axonal damage and demyelination. Co-culture experiments showed that hESC-derived NPs inhibited the activation and proliferation of lymph node-derived T cells in response to nonspecific polyclonal stimuli. Conclusions: The therapeutic effect of transplantation was not related to graft or host remyelination but was mediated by an immunosuppressive neuroprotective mechanism. The attenuation of EAE by hESC-derived NPs, demonstrated here, may serve as the first step towards further developments of hESC for cell therapy in MS.	[Aharonowiz, Michal; Reubinoff, Benjamin] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cells Res Ctr, Jerusalem, Israel; [Aharonowiz, Michal; Einstein, Ofira; Fainstein, Nina; Ben-Hur, Tamir] Hadassah Hebrew Univ, Med Ctr, Agnes Ginges Ctr Human Neurogenesis, Dept Neurol, Jerusalem, Israel; [Reubinoff, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Gynecol, Jerusalem, Israel; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Medical University of Vienna	Aharonowiz, M (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cells Res Ctr, Jerusalem, Israel.	benjaminr@ekmd.huji.ac.il; TAMIR@hadassah.org.il	Einstein, Ofira/AAE-2869-2019; Lassmann, Hans/Z-2269-2019	Einstein, Ofira/0000-0003-0819-3057; Lassmann, Hans/0000-0001-8617-5052; Reubinoff, Benjamin/0000-0003-0353-1299	Israel Science Foundation [140/05]; Legacy Heritage Fund	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund	This work was supported in part by the Israel Science Foundation (Grant 140/05) and by the Legacy Heritage Fund. Both funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Ben-Hur T, 2007, MAGN RESON MED, V57, P164, DOI 10.1002/mrm.21116; Bronstein-Sitton N, 2003, NAT IMMUNOL, V4, P957, DOI 10.1038/ni975; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Einstein O, 2006, GLIA, V53, P449, DOI 10.1002/glia.20305; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gironi M., 2000, Neurological Sciences, V21, pS871, DOI 10.1007/s100720070029; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hemmer B, 2002, CURR OPIN NEUROL, V15, P227, DOI 10.1097/00019052-200206000-00001; HILDEBRAND C, 1978, J NEUROL SCI, V38, P421, DOI 10.1016/0022-510X(78)90147-8; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Joannides AJ, 2007, BRAIN, V130, P1263, DOI 10.1093/brain/awm070; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lassmann H, 2002, CLIN NEUROL NEUROSUR, V104, P168, DOI 10.1016/S0303-8467(02)00033-1; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Lu F, 2005, RADIAT RES, V163, P63, DOI 10.1667/RR3285; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wang QY, 2007, IUTAM BOOKSER, V2, P323, DOI 10.1007/978-1-4020-6332-9_33; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	31	156	157	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3145	10.1371/journal.pone.0003145	http://dx.doi.org/10.1371/journal.pone.0003145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773082	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420100003
J	Gilad, S; Meiri, E; Yogev, Y; Benjamin, S; Lebanony, D; Yerushalmi, N; Benjamin, H; Kushnir, M; Cholakh, H; Melamed, N; Bentwich, Z; Hod, M; Goren, Y; Chajut, A				Gilad, Shlomit; Meiri, Eti; Yogev, Yariv; Benjamin, Sima; Lebanony, Danit; Yerushalmi, Noga; Benjamin, Hila; Kushnir, Michal; Cholakh, Hila; Melamed, Nir; Bentwich, Zvi; Hod, Moshe; Goren, Yaron; Chajut, Ayelet			Serum MicroRNAs Are Promising Novel Biomarkers	PLOS ONE			English	Article							EXPRESSION PROFILES; NUCLEIC-ACIDS; CANCER; IDENTIFICATION; RNA	Background: Circulating nucleic acids (CNAs) offer unique opportunities for early diagnosis of clinical conditions. Here we show that microRNAs, a family of small non-coding regulatory RNAs involved in human development and pathology, are present in bodily fluids and represent new effective biomarkers. Methods and Results: After developing protocols for extracting and quantifying microRNAs in serum and other body fluids, the serum microRNA profiles of several healthy individuals were determined and found to be similar, validating the robustness of our methods. To address the possibility that the abundance of specific microRNAs might change during physiological or pathological conditions, serum microRNA levels in pregnant and non pregnant women were compared. In sera from pregnant women, microRNAs associated with human placenta were significantly elevated and their levels correlated with pregnancy stage. Conclusions and Significance: Considering the central role of microRNAs in development and disease, our results highlight the medically relevant potential of determining microRNA levels in serum and other body fluids. Thus, microRNAs are a new class of CNAs that promise to serve as useful clinical biomarkers.	[Gilad, Shlomit; Meiri, Eti; Benjamin, Sima; Lebanony, Danit; Yerushalmi, Noga; Benjamin, Hila; Kushnir, Michal; Cholakh, Hila; Bentwich, Zvi; Goren, Yaron; Chajut, Ayelet] Rosetta Genom Ltd, Rehovot, Israel; [Yogev, Yariv; Melamed, Nir; Hod, Moshe] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Div Maternal Fetal Med, IL-49100 Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Gilad, S (corresponding author), Rosetta Genom Ltd, Rehovot, Israel.	zbentwich@rosettagenomics.com; ayelet_ch@rosettagenomics.com			Rosetta Genomics	Rosetta Genomics	Rosetta Genomics is a commercial for-profit company, which provided funding for the study. Most key investigators are employees of the company.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Koonin L M, 1997, MMWR CDC Surveill Summ, V46, P17; Kopreski MS, 2001, ANN NY ACAD SCI, V945, P172; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; SOIFER HS, 2007, MOL THER; Swaminathan R, 2006, ANN NY ACAD SCI, V1075, P1, DOI 10.1196/annals.1368.001; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103	24	1088	1212	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3148	10.1371/journal.pone.0003148	http://dx.doi.org/10.1371/journal.pone.0003148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773077	gold, Green Published			2022-12-25	WOS:000264420100006
J	Tomaic, V; Gardiol, D; Massimi, P; Ozbun, M; Myers, M; Banks, L				Tomaic, V.; Gardiol, D.; Massimi, P.; Ozbun, M.; Myers, M.; Banks, L.			Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators	ONCOGENE			English	Article						papillomavirus; oncoproteins; PDZ domains; Par3	PAPILLOMAVIRUS E6 PROTEINS; MEDIATED DEGRADATION; ACTIVATED RAS; ONCOPROTEIN; SCRIBBLE; SUPPRESSOR; SEQUENCE; RHPV-1; DOMAIN; MOTIF	A unique feature of the cancer-causing mucosotropic human papillomaviruses (HPVs) is the ability of their E6 proteins to interact with a number of PDZ domain-containing cellular substrates, including the cell polarity regulators hDlg and hScrib. These interactions are essential for the ability of these viruses to induce malignant progression. Rhesus papillomaviruses (RhPV) are similar to their human counterparts in that they also cause anogenital malignancy in their host, the Rhesus Macaque. However, unlike HPV E6, the RhPV E6 has no PDZ-binding motif. We now show that such a motif is present on the RhPV E7 oncoprotein. This motif specifically confers PDZ-binding activity and directs the interaction of RhPV E7 with the cell polarity regulator Par3, which it targets for proteasome-mediated degradation. These results demonstrate an amazing evolutionary conservation of function between the RhPV and the HPV oncoproteins, where both target proteins of the same cell polarity control network, although through different components and pathways.	[Tomaic, V.; Gardiol, D.; Massimi, P.; Myers, M.; Banks, L.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, TS, Italy; [Ozbun, M.] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	International Center for Genetic Engineering & Biotechnology (ICGEB); University of New Mexico	Banks, L (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, TS, Italy.	banks@icgeb.org	Ozbun, Michelle/AAN-2922-2021; Ozbun, Michelle Adair/Q-4158-2017	Ozbun, Michelle/0000-0001-8551-4606; Ozbun, Michelle Adair/0000-0001-8551-4606	NIH [CA103645]; NATIONAL CANCER INSTITUTE [R21CA103645] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by a research grant from the Associazione Italiana per la Ricerca sul Cancro to LB and from a Public Health Service Grant from the NIH CA103645 (MAO) to MO.	Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Lee CH, 2004, J VIROL, V78, P12366, DOI 10.1128/JVI.78.22.12366-12377.2004; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; MATLASHEWSKI G, 1987, EMBO J, V6, P1741, DOI 10.1002/j.1460-2075.1987.tb02426.x; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nguyen ML, 2003, J VIROL, V77, P6957, DOI 10.1128/JVI.77.12.6957-6964.2003; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; OSTROW RS, 1991, VIROLOGY, V181, P424; OSTROW RS, 1993, VIROLOGY, V196, P861, DOI 10.1006/viro.1993.1547; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Song S, 2000, VIROLOGY, V267, P141, DOI 10.1006/viro.1999.0106; Thomas M, 2002, ONCOGENE, V21, P5088, DOI 10.1038/sj.onc.1205668; Thomas M, 1996, ONCOGENE, V13, P471; Watson RA, 2003, J CELL SCI, V116, P4925, DOI 10.1242/jcs.00809; Wood CE, 2007, J VIROL, V81, P6339, DOI 10.1128/JVI.00233-07; Zhang Y, 2007, J VIROL, V81, P3618, DOI 10.1128/JVI.02044-06; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	23	53	53	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					1	8		10.1038/onc.2008.365	http://dx.doi.org/10.1038/onc.2008.365			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18820705	Green Accepted			2022-12-25	WOS:000262294100001
J	Goldman, D; Lavid, N; Schwartz, A; Shoham, G; Danino, D; Shoham, Y				Goldman, Dan; Lavid, Noa; Schwartz, Alon; Shoham, Gil; Danino, Dganit; Shoham, Yuval			Two Active Forms of Zymomonas mobilis Levansucrase AN ORDERED MICROFIBRIL STRUCTURE OF THE ENZYME PROMOTES LEVAN POLYMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS LEVANSUCRASE; EXTRACELLULAR LEVANSUCRASE; ACID; PURIFICATION; FRUCTOSYLTRANSFERASE; RESIDUES; IDENTIFICATION; DIAZOTROPHICUS; INVERTASE; SEQUENCE	Fructansucrases, members of glycoside hydrolase family 68, catalyze both sucrose hydrolysis and the polymerization of fructose to beta-D-fructofuranose polymers. The resulting fructan polymers are distinguished by the nature of the glycosidic bond: inulin (beta-(2-1)-fructofuranose) and levan (beta-(2-6)-fructofuranose). In this study we demonstrate that Zymomonas mobilis levansucrase exists in two active forms, depending on the pH and ionic strength. At pH values above 7.0, the enzyme is mainly a dimer, whereas at pH values below 6.0, the protein forms well ordered microfibrils that precipitate out of the solution. These two forms are readily interchangeable simply by changing the pH. Surprisingly the manner in which the enzyme is arranged strongly affects its product specificity and kinetic properties. At pH values above 7.0, the activity of the enzyme as a dimer is mainly sucrose hydrolysis and the synthesis of short fructosaccharides (degree of polymerization, 3). At pH values below 6.0, in its microfibril form, the enzyme catalyzes almost exclusively the synthesis of levan (a degree of polymerization greater than 20,000). This difference in product specificity appears to depend on the form of the enzyme, dimer versus microfibril, and not directly on the pH. Images made by negative stain transmission electron microscopy reveal that the enzyme forms a very ordered structure of long fibrils that appear to be composed of repeating rings of six to eight protein units. A single amino acid replacement of H296R abolished the ability of the enzyme to form microfibrils with organized fibril networks and to synthesize levan at pH 6.0.	[Goldman, Dan; Lavid, Noa; Schwartz, Alon; Danino, Dganit; Shoham, Yuval] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel; [Shoham, Gil] Hebrew Univ Jerusalem, Dept Inorgan Chem, IL-91904 Jerusalem, Israel; [Shoham, Gil] Hebrew Univ Jerusalem, Lab Struct Chem & Biol, IL-91904 Jerusalem, Israel	Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shoham, Y (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel.	yshoham@tx.technion.ac.il	Danino, Dganit/D-6832-2016; Shoham, Yuval/M-4409-2013	Danino, Dganit/0000-0002-9782-4940; 	Otto Meyerhof Center for Biotechnology, Technion	Otto Meyerhof Center for Biotechnology, Technion	This work was supported in part by the Otto Meyerhof Center for Biotechnology, Technion, established by the Minerva Foundation (Munich, Germany). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albenne C, 2007, PROTEINS, V66, P118, DOI 10.1002/prot.21083; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arrieta JG, 2004, J BACTERIOL, V186, P5031, DOI 10.1128/jb.186.15.5031-5039.2004; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; BARROW KD, 1984, EUR J BIOCHEM, V145, P173, DOI 10.1111/j.1432-1033.1984.tb08537.x; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; CHAMBERT R, 1974, EUR J BIOCHEM, V41, P285, DOI 10.1111/j.1432-1033.1974.tb03269.x; CHAMBERT R, 1991, BIOCHEM J, V279, P35, DOI 10.1042/bj2790035; CRITTENDEN RG, 1994, APPL MICROBIOL BIOT, V41, P302, DOI [10.1007/s002530050148, 10.1007/BF00221223]; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Johnson JL, 1981, MANUAL METHODS GENER, P450; KYONO K, 1995, BIOSCI BIOTECH BIOCH, V59, P289, DOI 10.1271/bbb.59.289; L'Hocine L, 2000, J BIOTECHNOL, V81, P73, DOI 10.1016/S0168-1656(00)00277-7; Li SY, 2008, ACTA BIOCHIM POL, V55, P201, DOI 10.18388/abp.2008_3217; LYNESS EW, 1983, BIOTECHNOL LETT, V5, P345, DOI 10.1007/BF01141136; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Meng G, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-16; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Seibel J, 2006, CARBOHYD RES, V341, P2335, DOI 10.1016/j.carres.2006.07.001; Seo JS, 2005, NAT BIOTECHNOL, V23, P63, DOI 10.1038/nbt1045; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SONG KB, 1994, BIOTECHNOL LETT, V16, P1305; SWINGS J, 1977, BACTERIOL REV, V41, P1; TANRISEVEN A, 1993, CARBOHYD RES, V245, P97, DOI 10.1016/0008-6215(93)80062-J; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Hijum SAFT, 2003, FEBS LETT, V534, P207, DOI 10.1016/S0014-5793(02)03841-3; Vigants A, 2003, CURR MICROBIOL, V47, P198, DOI 10.1007/s00284-002-3984-2; Vigants A, 2001, CURR MICROBIOL, V42, P415, DOI 10.1007/s002840010239; Vigants A, 1998, BIOTECHNOL LETT, V20, P1017, DOI 10.1023/A:1005454921301; YANASE H, 1992, BIOSCI BIOTECH BIOCH, V56, P1335, DOI 10.1271/bbb.56.1335; Yanase H, 2002, J BIOCHEM, V132, P565, DOI 10.1093/oxfordjournals.jbchem.a003258	35	48	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32209	32217		10.1074/jbc.M805985200	http://dx.doi.org/10.1074/jbc.M805985200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809687	hybrid			2022-12-25	WOS:000260893700007
J	Kanters, E; van Rijssel, J; Hensbergen, PJ; Hondius, D; Mul, FPJ; Deelder, AM; Sonnenberg, A; van Buul, JD; Hordijk, PL				Kanters, Edwin; van Rijssel, Jos; Hensbergen, Paul J.; Hondius, David; Mul, Frederik P. J.; Deelder, Andre M.; Sonnenberg, Arnoud; van Buul, Jaap D.; Hordijk, Peter L.			Filamin B Mediates ICAM-1-driven Leukocyte Transendothelial Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; BRAIN ENDOTHELIAL-CELLS; INTRACELLULAR DOMAIN; ACTIN CYTOSKELETON; ALPHA-ACTININ; IN-VITRO; T-CELLS; ICAM-1; TRANSMIGRATION; ACTIVATION	During inflammation, the endothelium mediates rolling and firm adhesion of activated leukocytes. Integrin-mediated adhesion to endothelial ligands of the Ig-superfamily induces intracellular signaling in endothelial cells, which promotes leukocyte transendothelial migration. We identified the actin cross-linking molecule filamin B as a novel binding partner for intracellular adhesion molecule-1 (ICAM-1). Immune precipitation as well as laser scanning confocal microscopy confirmed the specific interaction and co-localization of endogenous filamin B with ICAM-1. Importantly, clustering of ICAM-1 promotes the ICAM-1-filamin B interaction. To investigate the functional consequences of filamin B binding to ICAM-1, we used small interfering RNA to reduce filamin B expression in ICAM-1-GFP expressing HeLa cells. We found that filamin B is required for the lateral mobility of ICAM-1 and for ICAM-1-induced transmigration of leukocytes. Reducing filamin B expression in primary human endothelial cells resulted in reduced recruitment of ICAM-1 to endothelial docking structures, reduced firm adhesion of the leukocytes to the endothelium, and inhibition of transendothelial migration. In conclusion, this study identifies filamin B as a molecular linker that mediates ICAM-1-driven transendothelial migration.	[Kanters, Edwin; van Rijssel, Jos; Hondius, David; Mul, Frederik P. J.; van Buul, Jaap D.; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Hensbergen, Paul J.; Deelder, Andre M.] Leiden Univ, Biomol Mass Spectrometry Unit, Dept Parasitol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	Hordijk, PL (corresponding author), Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	p.hordijk@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021	van Buul, Jaap D/0000-0003-0054-7949; Hordijk, Peter/0000-0002-3348-078X; van Rijssel, Jos/0000-0001-8077-1371; Hensbergen, Paul/0000-0002-3193-5445; Mul, FPJ/0000-0002-8234-9972	Dutch Heart Foundation [2003B012]	Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported in part by Dutch Heart Foundation Grant 2003B012.	Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Celli L, 2006, J IMMUNOL, V177, P4113, DOI 10.4049/jimmunol.177.6.4113; Cunningham CC, 1997, J CELL BIOL, V136, P845, DOI 10.1083/jcb.136.4.845; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Etienne S, 1998, J IMMUNOL, V161, P5755; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; GREENWOOD J, 1995, IMMUNOLOGY, V86, P408; Greenwood J, 2003, J IMMUNOL, V171, P2099, DOI 10.4049/jimmunol.171.4.2099; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Nyman-Huttunen H, 2006, J CELL SCI, V119, P3057, DOI 10.1242/jcs.03045; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; Rauch BH, 2007, EUR J PHARMACOL, V577, P54, DOI 10.1016/j.ejphar.2007.08.041; Reiss Y, 1998, EUR J IMMUNOL, V28, P3086, DOI 10.1002/(SICI)1521-4141(199810)28:10<3086::AID-IMMU3086>3.3.CO;2-Q; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Romero IA, 2002, MOL BRAIN RES, V105, P47, DOI 10.1016/S0169-328X(02)00392-3; Sans E, 2001, J IMMUNOL, V166, P544, DOI 10.4049/jimmunol.166.1.544; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; STEEN H, 2002, SCI STKE, pL16, DOI DOI 10.1126/STKE.2002.154.PL16; STEMME S, 1994, ANN MED, V26, P141, DOI 10.3109/07853899409147881; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; van Buul JD, 2007, ARTERIOSCL THROM VAS, V27, P1870, DOI 10.1161/ATVBAHA.107.145821; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Yang L, 2006, J IMMUNOL, V177, P6440, DOI 10.4049/jimmunol.177.9.6440	42	67	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31830	31839		10.1074/jbc.M804888200	http://dx.doi.org/10.1074/jbc.M804888200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18809679	hybrid			2022-12-25	WOS:000260760800066
J	Samanta, U; Bahnson, BJ				Samanta, Uttamkumar; Bahnson, Brian J.			Crystal Structure of Human Plasma Platelet-activating Factor Acetylhydrolase STRUCTURAL IMPLICATION TO LIPOPROTEIN BINDING AND CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE A(2); MOLECULAR-BASIS; ATHEROSCLEROSIS; SUBSTRATE; MEMBRANE; RISK; LYSOPHOSPHATIDYLCHOLINE; IDENTIFICATION; ASSOCIATION; DARAPLADIB	Human plasma platelet-activating factor ( PAF) acetylhydrolase functions by reducing PAF levels as a general anti-inflammatory scavenger and is linked to anaphylactic shock, asthma, and allergic reactions. The enzyme has also been implicated in hydrolytic activities of other pro-inflammatory agents, such as sn-2 oxidatively fragmented phospholipids. This plasma enzyme is tightly bound to low and high density lipoprotein particles and is also referred to as lipoprotein-associated phospholipase A(2). The crystal structure of this enzyme has been solved from x- ray diffraction data collected to a resolution of 1.5 A. It has a classic lipase alpha/beta-hydrolase fold, and it contains a catalytic triad of Ser(273), His(351), and Asp(296). Two clusters of hydrophobic residues define the probable interface-binding region, and a prediction is given of how the enzyme is bound to lipoproteins. Additionally, an acidic patch of 10 carboxylate residues and a neighboring basic patch of three residues are suggested to play a role in high density lipoprotein/low density lipoprotein partitioning. A crystal structure is also presented of PAF acetylhydrolase reacted with the organophosphate compound paraoxon via its active site Ser273. The resulting diethyl phosphoryl complex was used to model the tetrahedral intermediate of the substrate PAF to the active site. The model of interface binding begins to explain the known specificity of lipoprotein-bound substrates and how the active site can be both close to the hydrophobic-hydrophobic interface and at the same time be accessible to the aqueous phase.	[Samanta, Uttamkumar; Bahnson, Brian J.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	University of Delaware	Bahnson, BJ (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	bahnson@udel.edu			National Institutes of Health [2P20RR015588, 1R01HL084366-A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants 2P20RR015588 and 1R01HL084366-A1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abuzeid AM, 2003, ATHEROSCLEROSIS, V168, P283, DOI 10.1016/S0021-9150(03)00086-8; Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Arai H, 2002, PROSTAG OTH LIPID M, V68-9, P83, DOI 10.1016/S0090-6980(02)00023-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blackie JA, 2003, BIOORG MED CHEM LETT, V13, P1067, DOI 10.1016/S0960-894X(03)00058-1; Davis B, 2008, J BIOL CHEM, V283, P6428, DOI 10.1074/jbc.M709970200; DeLano WL, 2002, PYMOL USERS MANUAL; Derewenda ZS, 2002, COLLOID SURFACE B, V26, P31, DOI 10.1016/S0927-7765(01)00314-9; Derewenda ZS, 1998, CELL MOL LIFE SCI, V54, P446, DOI 10.1007/s000180050172; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPSTEIN TM, 2005, THESIS U DELAWARE NE; Gardner AA, 2008, J BIOL CHEM, V283, P17099, DOI 10.1074/jbc.M802394200; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruse S, 2000, AM J HUM GENET, V66, P1522, DOI 10.1086/302901; Lomize AL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-44; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Macphee CH, 2006, CURR OPIN PHARMACOL, V6, P154, DOI 10.1016/j.coph.2005.11.008; Macphee CH, 2005, CURR OPIN LIPIDOL, V16, P442, DOI 10.1097/01.mol.0000174155.61307.5f; Macphee CH, 2005, EUR HEART J, V26, P107, DOI 10.1093/eurheartj/ehi042; MacRitchie AN, 2007, FASEB J, V21, P1164, DOI 10.1096/fj.06-6743com; Mannheim D, 2008, STROKE, V39, P1448, DOI 10.1161/STROKEAHA.107.503193; Min JH, 1999, BIOCHEMISTRY-US, V38, P12935, DOI 10.1021/bi991149u; Min JH, 2001, BIOCHEMISTRY-US, V40, P4539, DOI 10.1021/bi002600g; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Ninio E, 2004, HUM MOL GENET, V13, P1341, DOI 10.1093/hmg/ddh145; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Samanta U, 2002, PROTEIN ENG, V15, P659, DOI 10.1093/protein/15.8.659; SAMANTA U, 2008, PROTEIN PEP IN PRESS; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sharikov Y, 2008, NAT METHODS, V5, P119, DOI 10.1038/nmeth0208-119; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Stafforini DM, 1999, J CLIN INVEST, V103, P989, DOI 10.1172/JCI5574; Stafforini DM, 1999, J BIOL CHEM, V274, P7018, DOI 10.1074/jbc.274.11.7018; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; TJOELKER LW, 1995, J BIOL CHEM, V270, P25481, DOI 10.1074/jbc.270.43.25481; Wei YY, 1998, STRUCTURE, V6, P511, DOI 10.1016/S0969-2126(98)00052-5; Wilensky RL, 2007, CIRCULATION, V116, P33	51	65	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31617	31624		10.1074/jbc.M804750200	http://dx.doi.org/10.1074/jbc.M804750200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784071	Green Published, hybrid			2022-12-25	WOS:000260760800042
J	Campbell, GR; Spector, SA				Campbell, Grant R.; Spector, Stephen A.			CCL2 Increases X4-tropic HIV-1 Entry into Resting CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CORECEPTOR USAGE; DISEASE PROGRESSION; SURFACE EXPRESSION; TYPE-1; CXCR4; CHEMOKINE; INFECTION; RECEPTOR; CHEMOTAXIS	During human immunodeficiency virus type 1 (HIV-1) infection, there is a strong positive correlation between CCL2 levels and HIV viral load. To determine whether CCL2 alters HIV-1 infection of resting CD4(+) T cells, we infected purified resting CD4(+) T cells after incubation with CCL2. We show that CCL2 up-regulates CXCR4 on resting CD4(+) T cells in a CCR2-dependent mechanism, and that this augmentation of CXCR4 expression by CCL2 increases the ability of these cells to be chemoattracted to CXCR4 using gp 120 and renders them more permissive to X4-tropic HIV-1 infection. Thus, CCL2 has the capacity to render a large population of lymphocytes more susceptible to HIV-1 late in the course of infection.	[Campbell, Grant R.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	National Institutes of Health [AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068632, UM1AI068632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI068632 (NIAID). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abebe A, 1999, AIDS, V13, P1305, DOI 10.1097/00002030-199907300-00006; Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Ansari AW, 2006, INT IMMUNOL, V18, P1443, DOI 10.1093/intimm/dxl078; Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Batra M, 2000, AIDS RES HUM RETROV, V16, P973, DOI 10.1089/08892220050058399; Berger EA, 1997, AIDS, V11, pS3; Bjorndal A, 1997, J VIROL, V71, P7478; Campbell GR, 2007, J VIROL, V81, P5919, DOI 10.1128/JVI.01938-06; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Cole SW, 1999, J IMMUNOL, V162, P1392; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Fantuzzi L, 2001, J IMMUNOL, V166, P5381, DOI 10.4049/jimmunol.166.9.5381; Futahashi Y, 2007, CANCER SCI, V98, P373, DOI 10.1111/j.1349-7006.2007.00388.x; Glushakova S, 1997, AIDS RES HUM RETROV, V13, P461, DOI 10.1089/aid.1997.13.461; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Johnston ER, 2003, J VIROL, V77, P7682, DOI 10.1128/JVI.77.13.7682-7688.2003; Jourdan P, 1998, J IMMUNOL, V160, P4153; Kinter A, 1998, P NATL ACAD SCI USA, V95, P11880, DOI 10.1073/pnas.95.20.11880; Kinter AL, 2003, J IMMUNOL, V170, P2449, DOI 10.4049/jimmunol.170.5.2449; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Lee B, 1998, J VIROL, V72, P7450, DOI 10.1128/JVI.72.9.7450-7458.1998; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Mengozzi M, 1999, BLOOD, V93, P1851, DOI 10.1182/blood.V93.6.1851.406k12_1851_1857; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Peacock JW, 1999, J IMMUNOL, V162, P215; PELCHENMATTHEWS A, 1989, EMBO J, V8, P3641, DOI 10.1002/j.1460-2075.1989.tb08538.x; Philpott SM, 2003, CURR HIV RES, V1, P217, DOI 10.2174/1570162033485357; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; Stanners J, 1995, J BIOL CHEM, V270, P30635, DOI 10.1074/jbc.270.51.30635; WAINHOBSON S, 1991, SCIENCE, V252, P961, DOI 10.1126/science.2035026; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0	45	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30745	30753		10.1074/jbc.M804112200	http://dx.doi.org/10.1074/jbc.M804112200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784079	hybrid, Green Published			2022-12-25	WOS:000260544800029
J	Fukami, H; Chen, CA; Budd, AF; Collins, A; Wallace, C; Chuang, YY; Chen, C; Dai, CF; Iwao, K; Sheppard, C; Knowlton, N				Fukami, Hironobu; Chen, Chaolun Allen; Budd, Ann F.; Collins, Allen; Wallace, Carden; Chuang, Yao-Yang; Chen, Chienhsun; Dai, Chang-Feng; Iwao, Kenji; Sheppard, Charles; Knowlton, Nancy			Mitochondrial and Nuclear Genes Suggest that Stony Corals Are Monophyletic but Most Families of Stony Corals Are Not (Order Scleractinia, Class Anthozoa, Phylum Cnidaria)	PLOS ONE			English	Article							EVOLUTION; TREE; SYSTEMATICS; PHYLOGENY; GENOME; MODEL	Modern hard corals (Class Hexacorallia; Order Scleractinia) are widely studied because of their fundamental role in reef building and their superb fossil record extending back to the Triassic. Nevertheless, interpretations of their evolutionary relationships have been in flux for over a decade. Recent analyses undermine the legitimacy of traditional suborders, families and genera, and suggest that a non-skeletal sister clade (Order Corallimorpharia) might be imbedded within the stony corals. However, these studies either sampled a relatively limited array of taxa or assembled trees from heterogeneous data sets. Here we provide a more comprehensive analysis of Scleractinia (127 species, 75 genera, 17 families) and various outgroups, based on two mitochondrial genes (cytochrome oxidase I, cytochrome b), with analyses of nuclear genes (beta-tubulin, ribosomal DNA) of a subset of taxa to test unexpected relationships. Eleven of 16 families were found to be polyphyletic. Strikingly, over one third of all families as conventionally defined contain representatives from the highly divergent "robust'' and "complex'' clades. However, the recent suggestion that corallimorpharians are true corals that have lost their skeletons was not upheld. Relationships were supported not only by mitochondrial and nuclear genes, but also often by morphological characters which had been ignored or never noted previously. The concordance of molecular characters and more carefully examined morphological characters suggests a future of greater taxonomic stability, as well as the potential to trace the evolutionary history of this ecologically important group using fossils.	[Fukami, Hironobu] Kyoto Univ, Seto Marine Biol Lab, Field Sci Educ & Res Ctr, Wakayama, Japan; [Chen, Chaolun Allen; Chuang, Yao-Yang; Chen, Chienhsun] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Chen, Chaolun Allen; Chuang, Yao-Yang; Chen, Chienhsun; Dai, Chang-Feng] Natl Taiwan Univ, Inst Oceanography, Taipei, Taiwan; [Budd, Ann F.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; [Collins, Allen] Smithsonian Inst, MRC 153, Natl Museum Nat Hist, NOAA Fisheries Serv, Natl Syst Lab, Washington, DC USA; [Wallace, Carden] Museum Trop Queensland, Townsville, Qld, Australia; [Iwao, Kenji] Akajima Marine Sci Lab, Okinawa, Japan; [Sheppard, Charles] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Knowlton, Nancy] Univ Calif San Diego, Scripps Inst Oceanography, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Knowlton, Nancy] Smithsonian Inst, MRC 163, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA	Kyoto University; Academia Sinica - Taiwan; National Taiwan University; University of Iowa; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Warwick; University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian National Museum of Natural History	Fukami, H (corresponding author), Kyoto Univ, Seto Marine Biol Lab, Field Sci Educ & Res Ctr, Wakayama, Japan.	knowlton@si.edu	Collins, Allen G/A-7944-2008	Collins, Allen G/0000-0002-3664-9691; DAI, CHANG-FENG/0000-0003-2242-5643; sheppard, charles/0000-0002-2579-5124	US NSF [DEB0344310, 0343208, 0531779]; Academia Sinica [PhD fellowships]; Genomics and Proteinomics; Grant-in-Aid for Young Scientists [18770013]	US NSF(National Science Foundation (NSF)); Academia Sinica(Academia Sinica - Taiwan); Genomics and Proteinomics; Grant-in-Aid for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported through funding by US NSF grants to Nancy Knowlton and Ann Budd (DEB0344310, 0343208), by Academia Sinica Thematic grants (2002 2004, 2005 2007) and a Genomics and Proteinomics grant (2006 2007) to Chaolun Allen Chen, by a Grant-in-Aid for Young Scientists (B) (No. 18770013) to Hironobu Fukami, and by a US NSF Assembling the Tree of Life grant (0531779) to Allen Collins, Daphne Fautin, and Paulyn Cartwright. Yao-Yang Chuang and Chien-Hsun Chen received PhD fellowships from the Biodiversity Research Centre, Academia Sinica.	ALLOITEAU J, 1957, CONTRIBUTION SYSTEMA, P1; Beagley CT, 1998, GENETICS, V148, P1091; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Benzoni F, 2007, CONTRIB ZOOL, V76, P35, DOI 10.1163/18759866-07601004; Boury-Esnault N, 2006, CAN J ZOOL, V84, P205, DOI 10.1139/Z06-003; Brugler MR, 2007, MOL PHYLOGENET EVOL, V42, P776, DOI 10.1016/j.ympev.2006.08.016; Buckley TR, 2002, SYST BIOL, V51, P509, DOI 10.1080/10635150290069922; BUDD AF, 2008, ACTA ZOOL IN PRESS, V89; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chase MW, 2000, TAXON, V49, P685, DOI 10.2307/1223971; Chen CA, 2004, ZOOL STUD, V43, P759; Chen L, 2002, BIOORG MED CHEM LETT, V12, P137, DOI 10.1016/S0960-894X(01)00711-9; Cuif JP, 2003, ZOOL SCR, V32, P459, DOI 10.1046/j.1463-6409.2003.00133.x; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; DENHARTOG JC, 1980, ZOOL VERH-LEIDEN, V176, P1; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; GOLOBOFF P, 2000, TNT TREE ANAL USING; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; VAUGHAN TW, 1943, SPEC PAP GEOL SOC AM, V44, P1; Veron JEN, 1996, CORAL REEFS, V15, P1; Wei NWV, 2006, ZOOL STUD, V45, P404; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	37	230	240	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3222	10.1371/journal.pone.0003222	http://dx.doi.org/10.1371/journal.pone.0003222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795098	Green Published, gold, Green Submitted			2022-12-25	WOS:000264428000005
J	Tamura, Y; Simizu, S; Muroi, M; Takagi, S; Kawatani, M; Watanabe, N; Osada, H				Tamura, Y.; Simizu, S.; Muroi, M.; Takagi, S.; Kawatani, M.; Watanabe, N.; Osada, H.			Polo-like kinase 1 phosphorylates and regulates Bcl-x(L) during pironetin-induced apoptosis	ONCOGENE			English	Article						apoptosis; Bcl-x(L); phosphorylation; Plk1; pironetin	BCL-2 FAMILY; SOMATIC WEE1; PROTEIN; IDENTIFICATION; INHIBITOR; DOMAIN; DEATH; GENE; ALPHA; PLK1	Bcl-x(L), an anti-apoptotic Bcl-2 family member protein, contributes to the resistance against chemotherapies such as tubulin-binder treatment in many human tumors. Although Bcl-x(L) is phosphorylated after tubulin-binder treatment, the role of the phosphorylation and its responsible kinase(s) are poorly understood. Here, we identified Plk1 (polo-like kinase 1) as a Bcl-x(L) kinase. Same location of Bcl-x(L) and Plk1 was revealed by immunocytochemical analyses at M-phase in situ. Plk1 phosphorylates Bcl-x(L) in vitro, and we identified Plk1 phosphorylation sites in Bcl-x(L). When all of these phosphorylation sites were substituted to alanines, the anti-apoptotic activity of the Bcl-x(L) mutant against the apoptosis induced by pironetin, but not against ultraviolet-induced apoptosis, was increased. These observations suggest that Plk1 is a regulator of Bcl-x(L) phosphorylation and controls the anti-apoptotic activity of Bcl-x(L) during pironetin-induced apoptosis.	[Tamura, Y.; Simizu, S.; Muroi, M.; Takagi, S.; Kawatani, M.; Watanabe, N.; Osada, H.] RIKEN, Antibiot Lab, Wako, Saitama 3510198, Japan; [Tamura, Y.; Simizu, S.; Muroi, M.; Takagi, S.; Kawatani, M.; Watanabe, N.; Osada, H.] RIKEN, Dept Biol Chem, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Tamura, Y.; Takagi, S.; Osada, H.] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	RIKEN; RIKEN; Saitama University	Osada, H (corresponding author), RIKEN, Antibiot Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hisyo@riken.jp	Watanabe, Nobumoto/N-6959-2015; Muroi, Makoto/C-7430-2017; Osada, Hiroyuki/N-4305-2014; Osada, Hiroyuki/AAY-6254-2020	Watanabe, Nobumoto/0000-0002-2130-1334; Simizu, Siro/0000-0003-2949-2427; Kawatani, Makoto/0000-0002-9571-4916; MUROI, Makoto/0000-0002-4323-9527				Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen J, 2006, FEBS LETT, V580, P3624, DOI 10.1016/j.febslet.2006.05.047; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cittelly DM, 2007, J NEUROSCI RES, V85, P1894, DOI 10.1002/jnr.21313; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kawatani M, 2003, J BIOL CHEM, V278, P19732, DOI 10.1074/jbc.M213038200; Kondoh M, 1999, BIOCHEM J, V340, P411, DOI 10.1042/0264-6021:3400411; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Ree AH, 2003, ONCOGENE, V22, P8952, DOI 10.1038/sj.onc.1207000; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Schinzel A, 2004, BBA-MOL CELL RES, V1644, P95, DOI 10.1016/j.bbamcr.2003.09.006; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Simizu S, 2005, CANCER RES, V65, P7455, DOI 10.1158/0008-5472.CAN-04-4446; Simizu S, 2004, CANCER SCI, V95, P266, DOI 10.1111/j.1349-7006.2004.tb02214.x; Tamura Y, 2004, FEBS LETT, V569, P249, DOI 10.1016/j.febslet.2004.06.003; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; Usui T, 2004, CHEM BIOL, V11, P799, DOI 10.1016/j.chembiol.2004.03.028; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zheng JY, 2008, BIOPHYS J, V94, P286, DOI 10.1529/biophysj.107.104323	37	34	34	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					107	116		10.1038/onc.2008.368	http://dx.doi.org/10.1038/onc.2008.368			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18820703				2022-12-25	WOS:000262294100011
J	Ischenko, I; Camaj, P; Seeliger, H; Kleespies, A; Guba, M; De Toni, EN; Schwarz, B; Graeb, C; Eichhorn, ME; Jauch, KW; Bruns, CJ				Ischenko, I.; Camaj, P.; Seeliger, H.; Kleespies, A.; Guba, M.; De Toni, E. N.; Schwarz, B.; Graeb, C.; Eichhorn, M. E.; Jauch, K-W; Bruns, C. J.			Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling	ONCOGENE			English	Article						5-fluorouracil; acquired resistance; thymidylate synthase; Src kinase inhibition; mouse xenograft pancreatic tumor model; epidermal growth factor receptor	THYMIDYLATE SYNTHASE INHIBITORS; COLORECTAL-CANCER CELLS; DIHYDROPYRIMIDINE DEHYDROGENASE; FAMILY KINASES; TUMOR-CELLS; STEM-CELLS; EXPRESSION; RESISTANCE; PROTEIN; DNA	Resistance to chemotherapy is believed to be a major cause of treatment failure in pancreatic cancer. Thus, it is necessary to explore alternative therapeutic modalities to overcome drug resistance in pancreatic cancer treatment. We tested the hypothesis that Src tyrosine kinase inhibition could augment the chemosensitivity of 5-fluorouracil (5-FU)-resistant human pancreatic cancer cells to 5-FU. As detected by MTT proliferation assay, propidium iodide and annexin V staining, a combination of 5-FU_Src kinase inhibitor PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d] pyrimidine) reflected the chemotherapeutic sensitivity and restored the 5-FU-induced apoptosis in 5-FU-resistant cells. Furthermore, when small-interfering RNA approach to silence Src gene expression was applied, the degree of 5-FU-induced apoptosis was increased in all cell lines independently of the chemoresistance status. Western blotting and RT-PCR analysis revealed that the expression of thymidylate synthase (TS) was higher in 5-FU-resistant cells, however, decreased significantly after pretreatment with PP2. Furthermore, the combination of 5-FU_PP2 decreased the 5-FU-induced activation of epidermal growth factor receptor (EGFR)-AKT pathway. Finally, PP2 in combination with 5-FU substantially decreased the in vivo tumor growth and inhibited distant metastases. Taken together, 5-FU chemoresistance can be reversed through indirect TS regulation by inhibiting Src tyrosine kinase. A potential mechanism of action of Src kinase inhibitors on 5-FU chemosensitivity might be linked to the inhibition of 5-FU-induced EGFR-AKT activation.	[Ischenko, I.; Camaj, P.; Seeliger, H.; Kleespies, A.; Guba, M.; Schwarz, B.; Graeb, C.; Eichhorn, M. E.; Jauch, K-W; Bruns, C. J.] Univ Munich, Dept Surg, D-81377 Munich, Germany; [De Toni, E. N.] Univ Munich, Dept Gastroenterol, D-81377 Munich, Germany	University of Munich; University of Munich	Ischenko, I (corresponding author), Univ Munich, Dept Surg, Grosshadern Campus,Marchioninistr 15, D-81377 Munich, Germany.	Ivan.Ischenko@med.uni-muenchen.de	Eichhorn, Martin/AAU-7204-2020; Guba, Markus/M-4309-2019; Ischenko, Ivan/A-4591-2011; Eichhorn, Martin/GRE-9126-2022; De Toni, Enrico N/C-6496-2008	Eichhorn, Martin/0000-0002-0362-0374; 	Deutsche Forschungsgemeinschaft (DFG) [KFO 128/1-3]; Deutsche Forschungsgemeinschaft (DFG) of the Schwerpunktprogramm [GU 489/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG) of the Schwerpunktprogramm(German Research Foundation (DFG))	We thank AstraZeneca for providing with AZM475271. This research was supported by the grant of the clinical research group KFO 128/1-3 of the Deutsche Forschungsgemeinschaft (DFG) and the research grant GU 489/3-1 of the Deutsche Forschungsgemeinschaft (DFG) of the Schwerpunktprogramm 'The tumor-vessel interface'. This report includes data that were generated during the doctoral thesis of Bettina Schwarz at the Medical School of the Ludwig-Maximilians-University, Munich.	BECK A, 1994, EUR J CANCER, V30A, P1517, DOI 10.1016/0959-8049(94)00216-R; Blaszkowsky Lawrence, 1998, Frontiers in Bioscience, V3, pE214; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Chu E, 1996, BIOESSAYS, V18, P191, DOI 10.1002/bies.950180306; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; CHU E, 1993, P NATL ACAD SCI USA, V90, P517, DOI 10.1073/pnas.90.2.517; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; DECAPRIO JA, 1991, J CLIN ONCOL, V9, P2128, DOI 10.1200/JCO.1991.9.12.2128; Duxbury MS, 2004, CLIN CANCER RES, V10, P2307, DOI 10.1158/1078-0432.CCR-1183-3; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Ghoshal K, 1997, BIOCHEM PHARMACOL, V53, P1569, DOI 10.1016/S0006-2952(97)00040-3; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Hamaji Masayasu, 2002, Gan To Kagaku Ryoho, V29, P889; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Karni R, 1999, ONCOGENE, V18, P4654, DOI 10.1038/sj.onc.1202835; Kleespies A, 2006, DRUG RESIST UPDATE, V9, P1, DOI 10.1016/j.drup.2006.02.002; Koizumi F, 2004, INT J CANCER, V108, P464, DOI 10.1002/ijc.11539; KOLLMANNSBERGER C, 1996, CANCER, V78, P654; LONN U, 1984, CANCER RES, V44, P3414; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; MAJOR PP, 1982, CANCER RES, V42, P3005; Masumoto N, 1997, Gan To Kagaku Ryoho, V24, P424; Miyazaki Y, 2001, GASTROENTEROLOGY, V120, P108, DOI 10.1053/gast.2001.20950; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Nam JS, 2002, CLIN CANCER RES, V8, P2430; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Paul Manash K, 2004, Int J Med Sci, V1, P101; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; Salonga D, 2000, CLIN CANCER RES, V6, P1322; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Summy JM, 2005, PANCREAS, V31, P263, DOI 10.1097/01.mpa.0000178280.50534.0c; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Van Schaeybroeck S, 2005, CLIN CANCER RES, V11, P7480, DOI 10.1158/1078-0432.CCR-05-0328; Voboril R, 2004, J SURG RES, V120, P178, DOI 10.1016/j.jss.2003.11.023; Wang W, 2003, BRIT J CANCER, V88, P624, DOI 10.1038/sj.bjc.6600753; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Wang WG, 2001, CANCER RES, V61, P5505; Wu YP, 1998, INT J ONCOL, V13, P1241; Yezhelyev MV, 2004, CLIN CANCER RES, V10, P8028, DOI 10.1158/1078-0432.CCR-04-0621; Zhao YP, 2006, J SURG RES, V136, P325, DOI 10.1016/j.jss.2006.06.031	47	59	62	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	57					7212	7222		10.1038/onc.2008.326	http://dx.doi.org/10.1038/onc.2008.326			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	379GG	18794807				2022-12-25	WOS:000261384100008
J	Erb, TJ; Retey, J; Fuchs, G; Alber, BE				Erb, Tobias J.; Retey, Janos; Fuchs, Georg; Alber, Birgit E.			Ethylmalonyl-CoA Mutase from Rhodobacter sphaeroides Defines a New Subclade of Coenzyme B-12-dependent Acyl-CoA Mutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSERTIONAL INACTIVATION; ABSOLUTE-CONFIGURATION; MICROBIAL-METABOLISM; ACETATE ASSIMILATION; GLYOXYLATE CYCLE; C2 COMPOUNDS; PATHWAY; ETHANOL; GENE; PURIFICATION	Coenzyme B-12-dependent mutases are radical enzymes that catalyze reversible carbon skeleton rearrangement reactions. Here we describe Rhodobacter sphaeroides ethylmalonyl-CoA mutase (Ecm), a novel member of the family of coenzyme B-12-dependent acyl-CoA mutases, that operates in the recently discovered ethylmalonyl-CoA pathway for acetate assimilation. Ecm is involved in the central reaction sequence of this novel pathway and catalyzes the transformation of ethylmalonyl-CoA to methylsuccinyl-CoA in combination with a second enzyme that was further identified as promiscuous ethylmalonyl-CoA/methylmalonyl-CoA epimerase. In contrast to the epimerase, Ecm is highly specific for its substrate, ethylmalonyl-CoA, and accepts methylmalonyl-CoA only at 0.2% relative activity. Sequence analysis revealed that Ecm is distinct from (2R)-methylmalonylCoA mutase as well as isobutyryl-CoA mutase and defines a new subfamily of coenzyme B-12-dependent acyl-CoA mutases. In combination with molecular modeling, two signature sequences were identified that presumably contribute to the substrate specificity of these enzymes.	[Alber, Birgit E.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Erb, Tobias J.; Fuchs, Georg] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Retey, Janos] Univ Karlsruhe TH, Inst Organ Chem, D-76131 Karlsruhe, Germany	University System of Ohio; Ohio State University; University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology	Alber, BE (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	alber.8@osu.edu	Erb, Tobias/J-5214-2013	Erb, Tobias/0000-0003-3685-0894	Deutsche Forschungsgemeinschaft [AL677/1-1]; Evonik-Degussa GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evonik-Degussa GmbH	This work was supported by Deutsche Forschungsgemeinschaft Grant AL677/1-1 and by Evonik-Degussa GmbH. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABEND A, 1995, THESIS U KARLSRUHE; Alber BE, 2006, MOL MICROBIOL, V61, P297, DOI 10.1111/j.1365-2958.2006.05238.x; ALLEN SHG, 1963, J BIOL CHEM, V238, P1637; ANTHONY C, 1982, BIOCH METHYLOTROPHS, P103; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckel W, 2006, CHEM-EUR J, V12, P352, DOI 10.1002/chem.200501074; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova LV, 1996, MICROBIOL-UK, V142, P1459, DOI 10.1099/13500872-142-6-1459; DECKER K, 1959, AKTIVIERTE ESSIGSAUR, P84; DUNSTAN PM, 1973, BIOCHEM J, V132, P797, DOI 10.1042/bj1320797; DUNSTAN PM, 1972, BIOCHEM J, V128, P107, DOI 10.1042/bj1280107; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Han L, 1997, J BACTERIOL, V179, P5157, DOI 10.1128/jb.179.16.5157-5164.1997; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; KELLERMEYER RW, 1964, J BIOL CHEM, V239, P2562; KORNBERG HL, 1965, ANGEW CHEM INT EDIT, V4, P558, DOI 10.1002/anie.196505581; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEADLAY PF, 1981, BIOCHEM J, V197, P413, DOI 10.1042/bj1970413; Liu HB, 1999, J BACTERIOL, V181, P6806, DOI 10.1128/JB.181.21.6806-6813.1999; Mancia F, 1999, BIOCHEMISTRY-US, V38, P7999, DOI 10.1021/bi9903852; McCarthy AA, 2001, STRUCTURE, V9, P637, DOI 10.1016/S0969-2126(01)00622-0; Meister M, 2005, J BACTERIOL, V187, P1415, DOI 10.1128/JB.187.4.1415-1425.2005; Miyamoto E, 2003, ARCH MICROBIOL, V180, P151, DOI 10.1007/s00203-003-0570-3; PFENNIG N, 1978, INT J SYST BACTERIOL, V28, P283, DOI 10.1099/00207713-28-2-283; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; RETEY J, 1978, EUR J BIOCHEM, V83, P437, DOI 10.1111/j.1432-1033.1978.tb12110.x; RETEY J, 1964, BIOCHEM BIOPH RES CO, V16, P358, DOI 10.1016/0006-291X(64)90040-3; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Rutey J., 1990, ANGEW CHEM, V102, P373, DOI DOI 10.1039/C4EE03271C; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Smith LM, 1996, MICROBIOL-UK, V142, P675, DOI 10.1099/13500872-142-3-675; SPRECHER M, 1966, J BIOL CHEM, V241, P872; STABLER SP, 1985, ARCH BIOCHEM BIOPHYS, V241, P252, DOI 10.1016/0003-9861(85)90381-9; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; TAOKA S, 1994, J BIOL CHEM, V269, P31630; Thoma NH, 2000, BIOCHEMISTRY-US, V39, P9213, DOI 10.1021/bi0004302; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q; Vrijbloed JW, 1999, J BACTERIOL, V181, P5600, DOI 10.1128/JB.181.18.5600-5605.1999; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2; Xue Q, 1999, P NATL ACAD SCI USA, V96, P11740, DOI 10.1073/pnas.96.21.11740; ZAGALAK B, 1974, EUR J BIOCHEM, V44, P529, DOI 10.1111/j.1432-1033.1974.tb03512.x; Zarzycki J, 2008, J BACTERIOL, V190, P1366, DOI 10.1128/JB.01621-07; Zerbe-Burkhardt K, 1998, J BIOL CHEM, V273, P6508, DOI 10.1074/jbc.273.11.6508	48	78	83	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32283	32293		10.1074/jbc.M805527200	http://dx.doi.org/10.1074/jbc.M805527200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819910	hybrid			2022-12-25	WOS:000260893700015
J	Friedrichs, J; Manninen, A; Muller, DJ; Helenius, J				Friedrichs, Jens; Manninen, Aki; Muller, Daniel J.; Helenius, Jonne			Galectin-3 Regulates Integrin alpha(2)beta(1)-mediated Adhesion to Collagen-I and -IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED EPITHELIAL-CELLS; FORCE SPECTROSCOPY; ENDOTHELIAL-CELLS; BINDING PROTEINS; MDCK CELLS; SINGLE; RECEPTOR; LAMININ; MATRIX; LECTIN	Galectins are a taxonomically widespread family of galactose-binding proteins of which galectin-3 is known to modulate cell adhesion. Using single cell force spectroscopy, the contribution of galectin-3 to the adhesion of Madin-Darby canine kidney (MDCK) cells to different extracellular matrix proteins was investigated. When adhering to collagen-I or-IV, some cells rapidly entered an enhanced adhesion state, marked by a significant increase in the force required for cell detachment. Galectin-3-depleted cells had an increased probability of entering the enhanced adhesion state. Adhesion enhancement was specific to integrin alpha(2)beta(1), as it was not observed when cells adhered to extracellular matrix substrates by other integrins. The adhesion phenotype of galectin-3-depleted cells was mimicked in a galactoside-deficient MDCK cell line and could be complemented by the addition of recombinant galectin-3. We propose that galectin-3 influences integrin alpha(2)beta(1)-mediated adhesion complex formation by altering receptor clustering.	[Friedrichs, Jens; Muller, Daniel J.; Helenius, Jonne] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Manninen, Aki] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Dept Med Biochem & Mol Biol, SF-90220 Oulu, Finland	Technische Universitat Dresden; University of Oulu	Helenius, J (corresponding author), Tatzberg 47-49, D-01307 Dresden, Germany.	jonne.helenius@biotec.tu-dresden.de	Müller, Daniel J./A-5967-2010; Manninen, Aki/AAC-8067-2019; Friedrichs, Jens/D-4833-2015	Müller, Daniel J./0000-0003-3075-0665; Manninen, Aki/0000-0002-6263-8101; 	Volkswagenstiftung; AO Research Fund; Deutsche Forschungsgemeinschaft (DFG); Sigrid Juselius Foundation; Academy of Finland	Volkswagenstiftung(Volkswagen); AO Research Fund; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work was supported by the Volkswagenstiftung, the AO Research Fund, the Deutsche Forschungsgemeinschaft (DFG), the Sigrid Juselius Foundation, and the Academy of Finland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; AUMAILLEY M, 1990, EXP CELL RES, V188, P55, DOI 10.1016/0014-4827(90)90277-H; Bao Q, 1999, GLYCOBIOLOGY, V9, P489, DOI 10.1093/glycob/9.5.489; BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; CARTER BZ, 1991, LAB INVEST, V65, P610; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; Cisneros DA, 2006, J STRUCT BIOL, V154, P232, DOI 10.1016/j.jsb.2006.02.006; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; HSU DK, 1992, J BIOL CHEM, V267, P14167; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Hughes RC, 2002, GLYCOCONJUGATE J, V19, P621, DOI 10.1023/B:GLYC.0000014094.39168.fd; Hughes RC, 2001, BIOCHIMIE, V83, P667; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Mak GZ, 2006, MOL BIOL CELL, V17, P3664, DOI 10.1091/mbc.E05-11-1070; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; MEISS HK, 1982, MOL CELL BIOL, V2, P1287, DOI 10.1128/MCB.2.10.1287; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; VANDEWIELVANKEMENADE E, 1992, J CELL BIOL, V117, P461, DOI 10.1083/jcb.117.2.461; Weisel JW, 2003, CURR OPIN STRUC BIOL, V13, P227, DOI 10.1016/S0959-440X(03)00039-3; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zuk A, 1996, J CELL SCI, V109, P1875	45	74	76	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32264	32272		10.1074/jbc.M803634200	http://dx.doi.org/10.1074/jbc.M803634200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806266	hybrid			2022-12-25	WOS:000260893700013
J	Gozgit, JM; Bebernitz, G; Patil, P; Ye, MW; Parmentier, J; Wu, JQ; Su, N; Wang, T; Ioannidis, S; Davies, A; Huszar, D; Zinda, M				Gozgit, Joseph M.; Bebernitz, Geraldine; Patil, Pankaj; Ye, Minwei; Parmentier, Julie; Wu, Jiaquan; Su, Nancy; Wang, Tao; Ioannidis, Stephanos; Davies, Audrey; Huszar, Dennis; Zinda, Michael			Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE KINASE-ACTIVITY; CONSTITUTIVELY ACTIVATED FLT3; BAD-MEDIATED APOPTOSIS; MYELOPROLIFERATIVE DISORDERS; PHOSPHORYLATES BAD; BCL-X; MOLECULAR TARGETS; PIM-1; DEATH; MEGAKARYOCYTES	The Janus-associated kinase 2 (JAK2) V617F mutation is believed to play a critical role in the pathogenesis of polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis. We have characterized a novel small molecule JAK2 inhibitor, AZ960, and used it as a tool to investigate the consequences of JAK2 V617F inhibition in the SET-2 cell line. AZ960 inhibits JAK2 kinase with a K-i of 0.00045 mu M in vitro and treatment of TEL-JAK2 driven Ba/F3 cells with AZ960 blocked STAT5 phosphorylation and potently inhibited cell proliferation (GI(50) = 0.025 mu M). AZ960 demonstrated selectivity for TEL-JAK2-driven STAT5 phosphorylation and cell proliferation when compared with cell lines driven by similar fusions of the other JAK kinase family members. In the SET-2 human megakaryoblastic cell line, heterozygous for the JAK2 V617F allele, inhibition of JAK2 resulted in decreased STAT3/5 phosphorylation and inhibition of cell proliferation (GI(50) = 0.033 mu M) predominately through the induction of mitochondrial-mediated apoptosis. We provide evidence that JAK2 inhibition induces apoptosis by direct and indirect regulation of the antiapoptotic protein BCL-xL. Inhibition of JAK2 blocked BCL-XL mRNA expression resulting in a reduction of BCL-xL protein levels. Additionally, inhibition of JAK2 resulted in decreased PIM1 and PIM2 mRNA expression. Decreased PIM1 mRNA corresponded with a decrease in Pim1 protein levels and inhibition of BAD phosphorylation at Ser(112). Finally, small interfering RNA-mediated suppression of BCL-xL resulted in apoptotic cell death similar to the phenotype observed following JAK2 inhibition. These results suggest a model in which JAK2 promotes cell survival by signaling through the Pim/BAD/BCL-xL pathway.	[Gozgit, Joseph M.; Bebernitz, Geraldine; Patil, Pankaj; Ye, Minwei; Parmentier, Julie; Wu, Jiaquan; Su, Nancy; Wang, Tao; Ioannidis, Stephanos; Davies, Audrey; Huszar, Dennis; Zinda, Michael] AstraZeneca R&D Boston, Canc Biosci, Waltham, MA 02451 USA	AstraZeneca	Zinda, M (corresponding author), 35 Gatehouse Dr, Waltham, MA 02451 USA.	michael.zinda@astrazeneca.com						Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Buettner R, 2002, CLIN CANCER RES, V8, P945; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Castedo M, 1996, J IMMUNOL, V157, P512; Ciurea SO, 2007, BLOOD, V110, P986, DOI 10.1182/blood-2006-12-064626; Delhommeau F, 2006, CELL MOL LIFE SCI, V63, P2939, DOI 10.1007/s00018-006-6272-7; Ferrajoli A, 2006, CURR CANCER DRUG TAR, V6, P671, DOI 10.2174/156800906779010227; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Hexner EO, 2007, CURR OPIN HEMATOL, V14, P450, DOI 10.1097/MOH.0b013e3282861d1b; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kim KT, 2006, BRIT J HAEMATOL, V134, P500, DOI 10.1111/j.1365-2141.2006.06225.x; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Li YY, 2006, CANCER RES, V66, P6741, DOI 10.1158/0008-5472.CAN-05-4272; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Popivanova BK, 2007, CANCER SCI, V98, P321, DOI 10.1111/j.1349-7006.2007.00390.x; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Sanz C, 2001, EXP HEMATOL, V29, P728, DOI 10.1016/S0301-472X(01)00635-X; Schwernmers S, 2007, EXP HEMATOL, V35, P1695, DOI 10.1016/j.exphem.2007.07.004; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Tenedini E, 2004, BLOOD, V104, P3126, DOI 10.1182/blood-2003-07-2597; Teofili L, 2007, BLOOD, V110, P354, DOI 10.1182/blood-2007-01-069237; Uozumi K, 2000, LEUKEMIA, V14, P142, DOI 10.1038/sj.leu.2401608; Vainchenker William, 2005, Hematology Am Soc Hematol Educ Program, P195; Walters DK, 2006, LEUKEMIA RES, V30, P1097, DOI 10.1016/j.leukres.2006.01.001; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; Wang Z, 2001, J Vet Sci, V2, P167; White E, 2003, GENE DEV, V17, P1813, DOI 10.1101/gad.1123103; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	43	78	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32334	32343		10.1074/jbc.M803813200	http://dx.doi.org/10.1074/jbc.M803813200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18775810	hybrid			2022-12-25	WOS:000260893700020
J	Huang, YC; Misquitta, S; Blond, SY; Adams, E; Colman, RF				Huang, Yu-chu; Misquitta, Stephanie; Blond, Sylvie Y.; Adams, Elizabeth; Colman, Roberta F.			Catalytically Active Monomer of Glutathione S-Transferase pi and Key Residues Involved in the Electrostatic Interaction between Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING SITE; 3-DIMENSIONAL STRUCTURE; INTERFACE; STABILITY; COMPLEX; P1-1; HEXYLGLUTATHIONE; IDENTIFICATION; TYROSINE-7; ENZYME	Human glutathione transferase pi (GST pi) has been crystallized as a homodimer, with a subunit molecular mass of similar to 23 kDa; however, in solution the average molecular mass depends on protein concentration, approaching that of monomer at < 0.03 mg/ml, concentrations typically used to measure catalytic activity of the enzyme. Electrostatic interaction at the subunit interface greatly influences the dimer-monomer equilibrium of the enzyme and is an important force for holding subunits together. Arg-70, Arg-74, Asp-90, Asp-94, and Thr-67 were selected as target sites for mutagenesis, because they are at the subunit interface. R70Q, R74Q, D90N, D94N, and T67A mutant enzymes were constructed, expressed in Escherichia coli, and purified. The construct of N-terminal His tag enzyme facilitates the purification of GST pi, resulting in a high yield of enzyme, but does not alter the kinetic parameters or secondary structure of the enzyme. Our results indicate that these mutant enzymes show no appreciable changes in K-m for 1-chloro-2,4-dinitrobenzene and have similar CD spectra to that of wild-type enzyme. However, elimination of the charges of either Arg-70, Arg-74, Asp-90, or Asp-94 shifts the dimer-monomer equilibrium toward monomer. In addition, replacement of Asp-94 or Arg-70 causes a large increase in the K-m(GSH), whereas substitution for Asp-90 or Arg-74 primarily results in a marked decrease in V-max. The GST pi retains substantial catalytic activity as a monomer probably because the glutathione and electrophilic substrate sites (such as for 1-chloro-2,4-dinitrobenzene) are predominantly located within each subunit.	[Huang, Yu-chu; Misquitta, Stephanie; Colman, Roberta F.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Blond, Sylvie Y.] Univ Illinois, Coll Pharm, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA; [Adams, Elizabeth] Delaware Biotechnol Inst, Newark, DE 19711 USA	University of Delaware; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colman, RF (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	rfcolman@udel.edu			National Institutes of Health [R01-CA66561]; NATIONAL CANCER INSTITUTE [R01CA066561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA66561 ( to R. F. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this work.	Abdalla AM, 2002, PROTEIN ENG, V15, P827, DOI 10.1093/protein/15.10.827; Adams EL, 2004, CARBOHYD RES, V339, P579, DOI 10.1016/j.carres.2003.11.023; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carey J, 2007, PROTEIN SCI, V16, P2317, DOI 10.1110/ps.072985007; Chang MS, 1999, PROTEIN EXPRES PURIF, V17, P443, DOI 10.1006/prep.1999.1149; DIRR H, 1994, J MOL BIOL, V243, P72, DOI 10.1006/jmbi.1994.1631; Erhardt J, 1996, FEBS LETT, V391, P313, DOI 10.1016/0014-5793(96)00768-5; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hearne JL, 2006, BIOCHEMISTRY-US, V45, P5974, DOI 10.1021/bi060249e; Hegazy UM, 2004, J BIOL CHEM, V279, P9586, DOI 10.1074/jbc.M312320200; Hornby JAT, 2002, BIOCHEMISTRY-US, V41, P14238, DOI 10.1021/bi020548d; Ji XH, 1997, BIOCHEMISTRY-US, V36, P9690, DOI 10.1021/bi970805s; Ji XH, 1999, BIOCHEMISTRY-US, V38, P10231, DOI 10.1021/bi990668u; KONG KH, 1992, BIOCHEM BIOPH RES CO, V184, P194, DOI 10.1016/0006-291X(92)91177-R; KONG KH, 1993, PROTEIN ENG, V6, P93, DOI 10.1093/protein/6.1.93; KONG KH, 1992, BIOCHEM BIOPH RES CO, V182, P1122, DOI 10.1016/0006-291X(92)91848-K; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357; MANOHARAN TH, 1992, J BIOL CHEM, V267, P18940; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Parraga A, 1998, BIOCHEM J, V333, P811, DOI 10.1042/bj3330811; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Ralat LA, 2004, J BIOL CHEM, V279, P50204, DOI 10.1074/jbc.M407445200; Ralat LA, 2003, PROTEIN SCI, V12, P2575, DOI 10.1110/ps.03249303; Ralat LA, 2008, ARCH BIOCHEM BIOPHYS, V474, P109, DOI 10.1016/j.abb.2008.02.043; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P12491, DOI 10.1021/bi061330k; Ramos CHI, 2002, PROTEIN SCI, V11, P1771, DOI 10.1110/ps.0205902; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; SOUNDAR S, 1993, J BIOL CHEM, V268, P5264; Stenberg G, 2000, BIOCHEM BIOPH RES CO, V271, P59, DOI 10.1006/bbrc.2000.2579; Stevens JM, 2000, BIOCHEM J, V347, P193, DOI 10.1042/0264-6021:3470193; Thompson LC, 2006, BIOCHEMISTRY-US, V45, P2267, DOI 10.1021/bi0519506; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vararattanavech A, 2006, BIOCHEM J, V393, P89, DOI 10.1042/BJ20050555; Vargo MA, 2004, BIOCHEMISTRY-US, V43, P3327, DOI 10.1021/bi030245z; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Winayanuwattikun P, 2007, BIOCHEM J, V402, P339, DOI 10.1042/BJ20061253	43	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32880	32888		10.1074/jbc.M805484200	http://dx.doi.org/10.1074/jbc.M805484200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18796433	Green Published, hybrid			2022-12-25	WOS:000260893700077
J	Jang, MS; Sul, JW; Choi, BJ; Lee, SJ; Suh, JH; Kim, NS; Kim, WH; Lim, DS; Lee, CW; Kim, E				Jang, Moon-Sun; Sul, Jee-Won; Choi, Byung-Jung; Lee, Su-Jin; Suh, Jee-Hee; Kim, Nam-Soon; Kim, Woo Ho; Lim, Dae-Sik; Lee, Chang-Woo; Kim, Eunhee			Negative Feedback Regulation of Aurora-A via Phosphorylation of Fas-associated Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; CENTROSOME AMPLIFICATION; INDUCED APOPTOSIS; FACTOR FAF1; KAPPA-B; OVEREXPRESSION; DEGRADATION; INTERACTS; PATHWAY; COMPLEX	This study reports that Aurora-A (Aur-A) phosphorylates Fas-associated factor-1 (FAF1) at Ser-289 and Ser-291. Forced expression of a FAF1 mutant mimicking phosphorylation at Ser-289 and Ser-291 (FAF1 DD), but not phosphorylation-deficient FAF1 (FAF1 AA), reduced Aur-A expression. However, transfection of FAF1 DD failed to reduce Aur-A expression in the presence of MG132 and MG115, indicating that this decrease is proteasome-mediated. Additionally, transfection of FAF1 DD suppressed the expression of Aur-A in ts20-BALB cells lacking E1 ubiquitin (Ub) activating enzyme activity at restrictive temperatures and also reduced the expression of Aur-A S51D, a mutant resistant to Ub-dependent degradation. Our data indicate that phosphorylated FAF1 mediates the ubiquitin-independent, proteasome-dependent degradation of Aur-A. Overexpression of FAF1 DD blocked Aur-A-induced centrosome amplification and accumulated cells in G(2)/M phase, representing cellular phenotypes consistent with the anticipated loss of Aur-A. Collectively, our findings support the negative feedback regulation of Aur-A via phosphorylation of the death-promoting protein, FAF1, and disclose the presence of molecular cross-talk between constituents of the cell cycle and cell death machinery.	[Jang, Moon-Sun; Sul, Jee-Won; Choi, Byung-Jung; Lee, Su-Jin; Kim, Eunhee] Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea; [Suh, Jee-Hee] Korea Res Inst Chem Technol, Ctr Metab Syndrome Therapeut, Taejon 305600, South Korea; [Kim, Nam-Soon] Korea Res Inst Biosci & Biotechnol, Lab Human Genom, Taejon 305806, South Korea; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Chang-Woo] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea	Chungnam National University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU)	Kim, E (corresponding author), Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea.	eunhee@cnu.ac.kr	Kim, Wooho/G-3703-2011; Lim, Dae-Sik/C-1599-2011; LEE, CHANG WOO/AAK-7567-2020	Lim, Dae-Sik/0000-0003-2356-7555; 	Ministry of Education, Science, and Technology in Korea and the Brain Korea 21 Project Fellowship [FG08-21-02]	Ministry of Education, Science, and Technology in Korea and the Brain Korea 21 Project Fellowship	This work was supported by FG08-21-02 of the 21C Frontier Functional Human Genome Project from the Ministry of Education, Science, and Technology in Korea and the Brain Korea 21 Project Fellowship. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bjorling-Poulsen M, 2003, INT J ONCOL, V23, P1015; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Goepfert TM, 2002, CANCER RES, V62, P4115; Guerra B, 2001, INT J ONCOL, V19, P1117; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Jensen HH, 2001, INT J BIOCHEM CELL B, V33, P577, DOI 10.1016/S1357-2725(01)00039-5; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Kamada K, 2004, ONCOL REP, V12, P593; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Katayama H, 2007, J CELL BIOCHEM, V102, P1318, DOI 10.1002/jcb.21421; Kim HJ, 2005, J BIOL CHEM, V280, P8125, DOI 10.1074/jbc.M406297200; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Lim SK, 2007, BIOCHEM J, V403, P119, DOI 10.1042/BJ20061272; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Olsen BB, 2003, FEBS LETT, V546, P218, DOI 10.1016/S0014-5793(03)00575-1; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Park MY, 2005, INT J CANCER, V115, P412, DOI 10.1002/ijc.20857; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Ryu SW, 2001, BIOCHEM BIOPH RES CO, V286, P1027, DOI 10.1006/bbrc.2001.5505; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	33	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32344	32351		10.1074/jbc.M804199200	http://dx.doi.org/10.1074/jbc.M804199200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790738	hybrid			2022-12-25	WOS:000260893700021
J	Kim, TY; Healy, KD; Der, CJ; Sciaky, N; Bang, YJ; Juliano, RL				Kim, Tai Young; Healy, Kevin D.; Der, Channing J.; Sciaky, Noah; Bang, Yung-Jue; Juliano, Rudy L.			Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell Morphology and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; P190 RHOGAP; PLC-DELTA(1)-BINDING PROTEIN; TUMOR-SUPPRESSOR; FOCAL ADHESIONS; CANCER CELLS; GROWTH; DOMAIN; GENE; BINDING	DLC-1 encodes a Rho GTPase-activating protein (RhoGAP) and negative regulator of specific Rho family proteins (RhoA-C and Cdc42). DLC-1 is a multi-domain protein, with the RhoGAP catalytic domain flanked by an amino-terminal sterile alpha motif (SAM) and a carboxyl-terminal START domain. The roles of these domains in the regulation of DLC-1 function remain to be determined. We undertook a structure-function analysis involving truncation and missense mutants of DLC-1. We determined that the amino-terminal SAM domain functions as an autoinhibitory domain of intrinsic RhoGAP activity. Additionally, we determined that the SAM and START domains are dispensable for DLC-1 association with focal adhesions. We then characterized several mutants for their ability to regulate cell migration and identified constitutively activated and dominant negative mutants of DLC-1. We report that DLC-1 activation profoundly alters cell morphology, enhances protrusive activity, and can increase the velocity but reduce directionality of cell migration. Conversely, the expression of the amino-terminal domain of DLC-1 acts as a dominant negative and profoundly inhibits cell migration by displacing endogenous DLC-1 from focal adhesions.	[Kim, Tai Young; Healy, Kevin D.; Der, Channing J.; Sciaky, Noah; Juliano, Rudy L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Healy, Kevin D.; Der, Channing J.; Juliano, Rudy L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110744, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU)	Der, CJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu; arjay@med.unc.edu	Bang, Yung Jue/J-2759-2012	Bang, Yung Jue/0000-0001-6000-4597; KIM, TAI YOUNG/0000-0001-8086-2476; Der, Channing/0000-0002-7751-2747	National Institutes of Health [PO1 HL4500, CA063071, CA129610, CA67771]; NATIONAL CANCER INSTITUTE [R01CA129610, R01CA063071, U19CA067771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL4500 (to R.L.J.) and CA063071, CA129610, and CA67771 (to C.J.D.).	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Durkin ME, 2007, ONCOGENE, V26, P4580, DOI 10.1038/sj.onc.1210244; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawai K, 2004, BIOCHEM SOC T, V32, P1107, DOI 10.1042/BST0321107; Kawai K, 2007, BIOCHEM BIOPH RES CO, V364, P783, DOI 10.1016/j.bbrc.2007.10.052; Kim TY, 2003, ONCOGENE, V22, P3943, DOI 10.1038/sj.onc.1206573; Kwan JJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-34; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Li HY, 2007, PROTEINS, V67, P1154, DOI 10.1002/prot.21361; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Ng IOL, 2000, CANCER RES, V60, P6581; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sekimata M, 1999, J BIOL CHEM, V274, P17757, DOI 10.1074/jbc.274.25.17757; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yamaga M, 2004, GENES CELLS, V9, P25, DOI 10.1111/j.1356-9597.2004.00698.x; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	36	48	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32762	32770		10.1074/jbc.M800617200	http://dx.doi.org/10.1074/jbc.M800617200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18786931	Green Published, hybrid			2022-12-25	WOS:000260893700065
J	Stuck, BJ; Lenski, M; Bohm, M; Laufs, U				Stuck, Bettina Johanna; Lenski, Matthias; Boehm, Michael; Laufs, Ulrich			Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID OXIDATION; CARDIAC-HYPERTROPHY; GLUCOSE-UPTAKE; PRESSURE-OVERLOAD; RAT-HEART; MUSCLE; OVEREXPRESSION; ISCHEMIA; GLUT4	Angiotensin II induces cardiomyocyte hypertrophy, but its consequences on cardiomyocyte metabolism and energy supply are not completely understood. Here we investigate the effect of angiotensin II on glucose and fatty acid utilization and the modifying role of AMP-activated protein kinase (AMPK), a key regulator of metabolism and proliferation. Treatment of H9C2 cardiomyocytes with angiotensin II (Ang II, 1 mu M, 4 h) increased [H-3] leucine incorporation, up-regulated the mRNA expression of the hypertrophy marker genes MLC, ANF, BNP, and beta-MHC, and decreased the phosphorylation of the negative mTOR-regulator tuberin (TSC-2). Rat neonatal cardiomyocytes showed similar results. Western blot analysis revealed a time-and concentration-dependent down-regulation of AMPK-phosphorylation in the presence of angiotensin II, whereas the protein expression of the catalytic alpha-subunit remained unchanged. This was paralleled by membrane translocation of glucose-transporter type 4 (GLUT4), increased uptake of [H-3] glucose and transient down-regulation of phosphorylation of acetyl-CoA carboxylase (ACC), whereas fatty acid uptake remained unchanged. Similarly, short-term transaortic constriction in mice resulted in down-regulation of P-AMPK and P-ACC but up-regulation of GLUT4 membrane translocation in the heart. Preincubation of cardiomyocytes with the AMPK stimulator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR; 1mM, 4 h) completely prevented the angiotensin II-induced cardiomyocytes hypertrophy. In addition, AICAR reversed the metabolic effects of angiotensin II: GLUT4 translocation was reduced, but ACC phosphorylation and TSC phosphorylation were elevated. In summary, angiotensin II-induced hypertrophy of cardiomyocytes is accompanied by decreased activation of AMPK, increased glucose uptake, and decreased mTOR inhibition. Stimulation with the AMPK activator AICAR reverses these metabolic changes, increases fatty acid utilization, and inhibits cardiomyocyte hypertrophy.	[Stuck, Bettina Johanna; Lenski, Matthias; Boehm, Michael; Laufs, Ulrich] Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, D-66421 Homburg, Germany	Universitatsklinikum des Saarlandes	Stuck, BJ (corresponding author), Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Kirrberger Str, D-66421 Homburg, Germany.	bettina.stuck@web.de	Böhm, Michael/C-3638-2011		Ernst und Berta Grimmke-Foundation; Universitat des Saarlandes (HOMFOR); Deutsche Forschungsgemeinschaft [KFO 196]	Ernst und Berta Grimmke-Foundation; Universitat des Saarlandes (HOMFOR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Ernst und Berta Grimmke-Foundation, the Universitat des Saarlandes (HOMFOR), and Deutsche Forschungsgemeinschaft KFO 196. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; BAYESGENIS A, 1995, AM J CARDIOL, V76, pD54, DOI 10.1016/S0002-9149(99)80493-7; Custodis F, 2006, CARDIOVASC RES, V71, P342, DOI 10.1016/j.cardiores.2006.04.005; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Frederich M, 2002, J BIOL CHEM, V277, P1928, DOI 10.1074/jbc.M107128200; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Grynberg A, 1996, J CARDIOVASC PHARM, V28, pS11; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; KRAEGEN EW, 1993, BIOCHEM J, V295, P287, DOI 10.1042/bj2950287; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Malhotra R, 1999, CIRC RES, V85, P137, DOI 10.1161/01.RES.85.2.137; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; NEELY JR, 1973, AM J PHYSIOL, V225, P651; Omar MA, 2008, AM J PHYSIOL-HEART C, V294, pH1266, DOI 10.1152/ajpheart.01087.2007; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Pellieux C, 2006, J MOL CELL CARDIOL, V41, P459, DOI 10.1016/j.yjmcc.2006.06.004; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Ritchie RH, 2006, CLIN EXP PHARMACOL P, V33, P159, DOI 10.1111/j.1440-1681.2006.04342.x; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; SADDIK M, 1993, J BIOL CHEM, V268, P25836; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; Serneri GGN, 2001, CIRC RES, V89, P977, DOI 10.1161/hh2301.100982; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; SUN DQ, 1994, CIRCULATION, V89, P793, DOI 10.1161/01.CIR.89.2.793; SUZUKI J, 1993, CIRC RES, V73, P439, DOI 10.1161/01.RES.73.3.439; Tomita T, 1990, Am J Cardiovasc Pathol, V3, P81; WEBER KT, 1993, BASIC RES CARDIOL, V88, P107; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	37	98	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32562	32569		10.1074/jbc.M801904200	http://dx.doi.org/10.1074/jbc.M801904200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790741	hybrid			2022-12-25	WOS:000260893700045
J	Wohlgemuth, I; Brenne, S; Beringer, M; Rodnina, MV				Wohlgemuth, Ingo; Brenne, Sibylle; Beringer, Malte; Rodnina, Marina V.			Modulation of the Rate of Peptidyl Transfer on the Ribosome by the Nature of Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; ACID SIDE-CHAIN; AMINOACYL-TRANSFER-RNA; PROLYL-TRANSFER-RNA; BOND FORMATION; STRUCTURAL BASIS; UNIFORM BINDING; IONIC-STRENGTH; A-SITE; MECHANISM	The ribosome catalyzes peptide bond formation between peptidyl-tRNA in the P site and aminoacyl-tRNA in the A site. Here, we show that the nature of the C-terminal amino acid residue in the P-site peptidyl-tRNA strongly affects the rate of peptidyl transfer. Depending on the C-terminal amino acid of the peptidyl-tRNA, the rate of reaction with the small A-site substrate puromycin varied between 100 and 0.14 s(-1), regardless of the tRNA identity. The reactivity decreased in the order Lys = Arg > Ala > Ser > Phe = Val > Asp >> Pro, with Pro being by far the slowest. However, when Phe-tRNAPhe was used as A-site substrate, the rate of peptide bond formation with any peptidyl-tRNA was similar to 7 s(-1), which corresponds to the rate of binding of Phe-tRNA(Phe) to the A site (accommodation). Because accommodation is rate-limiting for peptide bond formation, the reaction rate is uniform for all peptidyl-tRNAs, regardless of the variations of the intrinsic chemical reactivities. On the other hand, the 50-fold increase in the reaction rate for peptidyl-tRNA ending with Pro suggests that full-length aminoacyl-tRNA in the A site greatly accelerates peptide bond formation.	[Wohlgemuth, Ingo; Brenne, Sibylle; Beringer, Malte; Rodnina, Marina V.] Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany; [Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Witten Herdecke University; Max Planck Society	Rodnina, MV (corresponding author), Univ Witten Herdecke, Inst Phys Biochem, Stockumer Str 10, D-58448 Witten, Germany.	rodnina@uni-wh.de	Rodnina, Marina V./AAD-4667-2019; Beringer, Malte/AAC-5734-2020; Beringer, Malte/N-3766-2015	Rodnina, Marina V./0000-0003-0105-3879; Beringer, Malte/0000-0003-1958-9786; Wohlgemuth, Ingo/0000-0001-9121-7675	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Present address: Manchester Interdisciplinary Biocentre and Faculty of Life Sciences, University of Manchester, Manchester M1 7DN, UK.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Beringer M, 2005, J BIOL CHEM, V280, P36065, DOI 10.1074/jbc.M507961200; Beringer M, 2008, RNA, V14, P795, DOI 10.1261/rna.980308; Beringer M, 2007, BIOL CHEM, V388, P687, DOI 10.1515/BC.2007.077; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; BHUTA A, 1981, BIOCHEMISTRY-US, V20, P8, DOI 10.1021/bi00504a002; Bieling P, 2006, NAT STRUCT MOL BIOL, V13, P423, DOI 10.1038/nsmb1091; BRUICE TC, 1970, J AM CHEM SOC, V92, P1370; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; BURGI HB, 1995, STRUCTURE CORRELATIO; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Che Y, 2006, BIOPOLYMERS, V81, P392, DOI 10.1002/bip.20431; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2007, J BACTERIOL, V189, P3140, DOI 10.1128/JB.01869-06; Daviter T, 2006, BIOCHIMIE, V88, P1001, DOI 10.1016/j.biochi.2006.04.013; DETAR DF, 1983, J AM CHEM SOC, V105, P2734, DOI 10.1021/ja00347a036; DMITRIEVA MG, 1965, RUSS CHEM B, V14, P1141; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Dwyer Donard S, 2005, BMC Chem Biol, V5, P2, DOI 10.1186/1472-6769-5-2; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; HENTZEN D, 1972, BIOCHIM BIOPHYS ACTA, V281, P228, DOI 10.1016/0005-2787(72)90174-8; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; KEMP DS, 1974, J ORG CHEM, V39, P3841, DOI 10.1021/jo00940a009; KEMP DS, 1986, J ORG CHEM, V51, P3320, DOI 10.1021/jo00367a013; KIER LB, 1987, QUANT STRUCT-ACT REL, V6, P117, DOI 10.1002/qsar.19870060305; Kingery DA, 2008, CHEM BIOL, V15, P493, DOI 10.1016/j.chembiol.2008.04.005; Kothe U, 2007, MOL CELL, V25, P167, DOI 10.1016/j.molcel.2006.11.014; Kothe U, 2006, ANAL BIOCHEM, V356, P148, DOI 10.1016/j.ab.2006.04.038; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; MONRO RE, 1968, P NATL ACAD SCI USA, V61, P1042, DOI 10.1073/pnas.61.3.1042; MottaguiTabar S, 1996, BIOCHIMIE, V78, P953, DOI 10.1016/S0300-9084(97)86717-X; Murakami H, 2003, CHEM BIOL, V10, P1077, DOI 10.1016/j.chembiol.2003.10.010; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; NADASDI L, 1983, PEPTIDES, V4, P137, DOI 10.1016/0196-9781(83)90103-1; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOVOGRODSKY A, 1971, BIOCHIM BIOPHYS ACTA, V228, P688, DOI 10.1016/0005-2787(71)90733-7; PANET A, 1970, EUR J BIOCHEM, V15, P222, DOI 10.1111/j.1432-1033.1970.tb00998.x; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; ROBERTSON SA, 1991, J AM CHEM SOC, V113, P2722, DOI 10.1021/ja00007a055; RODNINA MV, 1995, EMBO J, V14, P2613, DOI 10.1002/j.1460-2075.1995.tb07259.x; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; RYCHLIK I, 1970, EUR J BIOCHEM, V16, P136, DOI 10.1111/j.1432-1033.1970.tb01064.x; Saito H, 2001, EMBO J, V20, P1797, DOI 10.1093/emboj/20.7.1797; Saito H, 2001, J AM CHEM SOC, V123, P7178, DOI 10.1021/ja015756s; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Sardesai NY, 1999, BIOCHEMISTRY-US, V38, P12080, DOI 10.1021/bi991126f; SATTERTH.AC, 1974, J AM CHEM SOC, V96, P7018, DOI 10.1021/ja00829a034; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P4037, DOI 10.1021/bi602600p; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Starck SR, 2003, J AM CHEM SOC, V125, P8090, DOI 10.1021/ja034817e; Steitz TA, 2005, FEBS LETT, V579, P955, DOI 10.1016/j.febslet.2004.11.053; STRICKLAND JE, 1972, BIOCHEMISTRY-US, V11, P2321, DOI 10.1021/bi00762a017; TAFT RW, 1952, J AM CHEM SOC, V74, P3120, DOI 10.1021/ja01132a049; Trobro S, 2005, P NATL ACAD SCI USA, V102, P12395, DOI 10.1073/pnas.0504043102; Trobro S, 2006, BIOCHEMISTRY-US, V45, P7049, DOI 10.1021/bi0605383; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Wohlgemuth I, 2006, EMBO REP, V7, P699, DOI 10.1038/sj.embor.7400732; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; ZACHAU HG, 1960, CHEM BER-RECL, V93, P1822, DOI 10.1002/cber.19600930820; [No title captured]	74	107	110	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32229	32235		10.1074/jbc.M805316200	http://dx.doi.org/10.1074/jbc.M805316200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809677	Green Published, hybrid			2022-12-25	WOS:000260893700009
J	Samways, DSK; Khakh, BS; Egan, TM				Samways, Damien S. K.; Khakh, Baljit S.; Egan, Terrance M.			Tunable Calcium Current through TRPV1 Receptor Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; CA2+ PERMEABILITY; CATION CHANNELS; SELECTIVITY; RESIDUE; DETERMINANTS; PERMEATION; ACTIVATION	TRPV1 receptors are polymodal cation channels that open in response to diverse stimuli including noxious heat, capsaicin, and protons. Because Ca2+ is vital for TRPV1 signaling, we sought to precisely measure its contribution to TRPV1 responses and discovered that the Ca2+ current was tuned by the mode of activation. Using patch clamp photometry, we found that the fraction of the total current carried by Ca2+ (called the Pf%) was significantly smaller for TRPV1 currents evoked by protons than for those evoked by capsaicin. Using site-directed mutagenesis, we discovered that the smaller Pf% was due to protonation of three acidic amino acids (Asp(646), Glu(648), and Glu(651)) that are located in the mouth of the pore. Thus, in keeping with recent reports of time-dependent changes in the ionic permeability of some ligand gated ion channels, we now show for the first time that the physiologically important Ca2+ current of the TRPV1 receptor is also dynamic and depends on the mode of activation. This current is significantly smaller when the receptor is activated by a change in pH, owing to atomic scale interactions of H+ and Ca2+ with the fixed negative charge of side chains in the pore.	[Samways, Damien S. K.; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Samways, Damien S. K.; Egan, Terrance M.] St Louis Univ, Sch Med, Ctr Excellence Neurosci, St Louis, MO 63104 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	Saint Louis University; Saint Louis University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Samways, DSK (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	samwaysds@slu.edu		Egan, Terrance/0000-0002-7249-3161	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health grants (to T. M. E. and B. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Dorostkar M. M., 2008, V184, P479; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Frings S, 2000, METHOD ENZYMOL, V315, P797; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; HILLE B, 2004, IONIC CHANNELS EXCIT, P445; Jatzke C, 2003, J PHYSIOL-LONDON, V549, P439, DOI 10.1113/jphysiol.2002.034413; Jatzke C, 2002, J PHYSIOL-LONDON, V538, P25, DOI 10.1113/jphysiol.2001.012897; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oh U, 1996, J NEUROSCI, V16, P1659; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Premkumar LS, 2002, J PHYSIOL-LONDON, V545, P107, DOI 10.1113/jphysiol.2002.016352; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; VERNINO S, 1994, J NEUROSCI, V14, P5514; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Wu ZZ, 2005, J BIOL CHEM, V280, P18142, DOI 10.1074/jbc.M501229200; Zeilhofer HU, 1997, J PHYSIOL-LONDON, V503, P67, DOI 10.1111/j.1469-7793.1997.067bi.x	35	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31274	31278		10.1074/jbc.C800131200	http://dx.doi.org/10.1074/jbc.C800131200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18775990	Green Published, hybrid			2022-12-25	WOS:000260760800002
J	Yeung, BHY; Kwan, BWY; He, QY; Lee, AS; Liu, J; Wong, AST				Yeung, B. H. Y.; Kwan, B. W. Y.; He, Q. Y.; Lee, A. S.; Liu, J.; Wong, A. S. T.			Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis	ONCOGENE			English	Article						GRP78; unfolded protein response; BRCA1; ovarian cancer; breast cancer; apoptosis	CANCER; BREAST; CHAPERONE; CELLS; GRP78	The tumor suppressor BRCA1 is mutated in a high percentage of familial breast and ovarian cancer, but our understanding of its mechanisms of action remains incomplete. We report here that glucose-regulated protein (GRP)-78, a critical regulator of the unfolded protein response (UPR), is a novel downstream target of BRCA1. We showed that overexpression of wild-type BRCA1 suppressed the expression of GRP78, whereas expression of mutant BRCA1 gene or targeted inhibition of endogenous BRCA1 using small-interfering RNA (siRNA) enhanced GRP78 expression. Knockdown of BRCA1 also led to induction of other components of UPR, such as GRP94 and CHOP. Consistent with a role of BRCA1 knockdown in mediating cell survival, forced expression of GRP78 stimulated cell proliferation and prevented apoptosis, including that induced by endoplasmic reticulum stress and chemotherapy, in ovarian OVCAR-3 and breast MCF-7 cancer cells. Overexpression of wild-type BRCA1 could increase the apoptosis of GRP78-over-expressing cells. Conversely, knockdown GRP78 by siRNA sensitized ovarian and breast cancer cells to apoptosis. This effect was reduced when the expression of BRCA1 was simultaneously knockdown by siRNA, indicating that BRCA1 also negatively regulates GRP78mediated cell survival and resistance to apoptosis.	[Yeung, B. H. Y.; Kwan, B. W. Y.; Wong, A. S. T.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China; [He, Q. Y.] Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Peoples R China; [Lee, A. S.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Liu, J.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	University of Hong Kong; Jinan University; University of Southern California; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Wong, AST (corresponding author), Univ Hong Kong, Sch Biol Sci, 4S-14 Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Peoples R China.	awong1@hku.hk	He, Qing-Yu/H-7078-2014; Wong, Alice/AFJ-4595-2022	He, Qing-Yu/0000-0003-0503-9492; Wong, Alice/0000-0002-0676-6475; Lee, Amy/0000-0002-0378-5443	Hong Kong Research Grants Council [7484/04M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The present work was supported by Hong Kong Research Grants Council Grant (7484/04M) (AST Wong).	Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; He QY, 2005, GYNECOL ONCOL, V98, P68, DOI 10.1016/j.ygyno.2005.04.002; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee K, 2003, J BIOL CHEM, V278, P11818, DOI 10.1074/jbc.M210475200; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Ma YX, 2003, ONCOGENE, V22, P10, DOI 10.1038/sj.onc.1206061; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Thangaraju M, 2000, J BIOL CHEM, V275, P33487, DOI 10.1074/jbc.M005824200; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106; Zheng WX, 2000, GYNECOL ONCOL, V76, P294, DOI 10.1006/gyno.1999.5664; Zhou CY, 2003, ONCOGENE, V22, P2396, DOI 10.1038/sj.onc.1206319	20	39	43	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2008	27	53					6782	6789		10.1038/onc.2008.290	http://dx.doi.org/10.1038/onc.2008.290			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	371XO	18776923				2022-12-25	WOS:000260866200008
J	Calvanese, V; Horrillo, A; Hmadcha, A; Suarez-Alvarez, B; Fernandez, AF; Lara, E; Casado, S; Menendez, P; Bueno, C; Garcia-Castro, J; Rubio, R; Lapunzina, P; Alaminos, M; Borghese, L; Terstegge, S; Harrison, NJ; Moore, HD; Brustle, O; Lopez-Larrea, C; Andrews, PW; Soria, B; Esteller, M; Fraga, MF				Calvanese, Vincenzo; Horrillo, Angelica; Hmadcha, Abdelkrim; Suarez-Alvarez, Beatriz; Fernandez, Agustin F.; Lara, Ester; Casado, Sara; Menendez, Pablo; Bueno, Clara; Garcia-Castro, Javier; Rubio, Ruth; Lapunzina, Pablo; Alaminos, Miguel; Borghese, Lodovica; Terstegge, Stefanie; Harrison, Neil J.; Moore, Harry D.; Bruestle, Oliver; Lopez-Larrea, Carlos; Andrews, Peter W.; Soria, Bernat; Esteller, Manel; Fraga, Mario F.			Cancer Genes Hypermethylated in Human Embryonic Stem Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CPG METHYLATION; DIFFERENTIATION; RUNX3; INACTIVATION; POLYCOMB; PROTEIN; DLC-1	Developmental genes are silenced in embryonic stem cells by a bivalent histone-based chromatin mark. It has been proposed that this mark also confers a predisposition to aberrant DNA promoter hypermethylation of tumor suppressor genes (TSGs) in cancer. We report here that silencing of a significant proportion of these TSGs in human embryonic and adult stem cells is associated with promoter DNA hypermethylation. Our results indicate a role for DNA methylation in the control of gene expression in human stem cells and suggest that, for genes repressed by promoter hypermethylation in stem cells in vivo, the aberrant process in cancer could be understood as a defect in establishing an unmethylated promoter during differentiation, rather than as an anomalous process of de novo hypermethylation.	[Calvanese, Vincenzo; Fernandez, Agustin F.; Lara, Ester; Casado, Sara; Esteller, Manel; Fraga, Mario F.] Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid, Spain; [Horrillo, Angelica; Hmadcha, Abdelkrim] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Suarez-Alvarez, Beatriz; Lopez-Larrea, Carlos; Soria, Bernat] HUCA, Unidad Histocompatibil, Oviedo, Spain; [Fernandez, Agustin F.; Esteller, Manel] Catalan Inst Oncol ICO, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Menendez, Pablo; Bueno, Clara; Garcia-Castro, Javier; Rubio, Ruth] Univ Granada, Inst Investigaciones Biomed, Parque Tecnol Salud, Andalusian Stem Cell Bank BACM, E-18071 Granada, Spain; [Lapunzina, Pablo] Ctr Investigacion Biomed Red Enfermedades Raras, Hosp Univ La Paz, Madrid CIBERER, Madrid, Spain; [Alaminos, Miguel] Univ Granada, Dept Histol, E-18071 Granada, Spain; [Borghese, Lodovica; Terstegge, Stefanie; Bruestle, Oliver] Univ Bonn, Hertie Fdn, LIFE & BRAIN Ctr, Inst Reconstruct Neurobiol, D-5300 Bonn, Germany; [Harrison, Neil J.; Moore, Harry D.; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Fraga, Mario F.] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Central University Hospital Asturias; Catalan Institute of Oncology; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University of Granada; University of Bonn; University of Sheffield; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Calvanese, V (corresponding author), Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid, Spain.	mesteller@cnio.es; mffraga@cnio.es	Garcia-Castro, Javier/ABC-9741-2021; Calvanese, Vincenzo/AAO-4311-2020; Bujan, Pablo Menendez/W-3736-2017; Fraga, Mario F/H-7824-2017; , Bernat/AAL-6470-2021; Hmadcha, Abdelkrim/T-1173-2019; Esteller, Manel/L-5956-2014; Garcia-Castro, Javier/H-5274-2011; Fernandez, Agustin F./N-7302-2014; Calvanese, Vincenzo/E-1145-2016; ALAMINOS, MIGUEL/N-9960-2016; Lapunzina, Pablo/L-7075-2014	Garcia-Castro, Javier/0000-0001-7604-1640; Calvanese, Vincenzo/0000-0002-7937-1511; Bujan, Pablo Menendez/0000-0001-9372-1007; Fraga, Mario F/0000-0001-8450-2603; Hmadcha, Abdelkrim/0000-0002-4105-3702; Esteller, Manel/0000-0003-4490-6093; Garcia-Castro, Javier/0000-0001-7604-1640; Fernandez, Agustin F./0000-0002-3792-4085; Calvanese, Vincenzo/0000-0002-7937-1511; ALAMINOS, MIGUEL/0000-0003-4876-2672; Lapunzina, Pablo/0000-0002-6324-4825; Rubio Amador, Ruth/0000-0003-3263-0819; Andrews, Peter/0000-0001-7215-4410; Lopez-Larrea, Carlos/0000-0001-9988-1730; Soria, Bernat/0000-0002-2356-0380	European Union [LSHG-CT-2006-018739]; Spanish Ramon & Cajal Programme; Health Department of the Spanish Government [PI061267, PI051707]; Health and Education and Science Departments of the Spanish Government [FIS01-04, MCYT08-03, FU2004-02073, MEC09-05]; TRANSFOG [LSHC-CT-2004-503438]; Spanish Association Against Cancer (AECC); FPU Spanish Research Programme [Fellowship]; Consejeria de Salud de la Junta de Andalucia [0029, 0030/2006]; Spanish Ministry of Health [FIS PI070026]; International Jose Carreras Foundation against Leukemia [EDThomas-05]; ISCIII; DFG; Hertie Foundation; Fundacion Progreso y Salud; Instituto de Salud Carlos III-Red Espanola de Terapia Celular [RD06/0010/0025]; MRC; MRC [G0801059, G0700785, G0300268] Funding Source: UKRI; Medical Research Council [G0801059, G0300268, G0700785] Funding Source: researchfish	European Union(European Commission); Spanish Ramon & Cajal Programme(Spanish Government); Health Department of the Spanish Government; Health and Education and Science Departments of the Spanish Government; TRANSFOG; Spanish Association Against Cancer (AECC); FPU Spanish Research Programme; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); International Jose Carreras Foundation against Leukemia; ISCIII(Instituto de Salud Carlos III); DFG(German Research Foundation (DFG)); Hertie Foundation; Fundacion Progreso y Salud; Instituto de Salud Carlos III-Red Espanola de Terapia Celular; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was primarily supported by the European Union (LSHG-CT-2006-018739; ESTOOLS). MFF is funded by the Spanish Ramon & Cajal Programme and the Health Department of the Spanish Government (PI061267). The Cancer Epigenetics group at the CNIO is supported by the Health (FIS01-04) and Education and Science (I+D+I MCYT08-03, FU2004-02073/BMC and Consolider MEC09-05) Departments of the Spanish Government, the European Grant TRANSFOG LSHC-CT-2004-503438, and the Spanish Association Against Cancer (AECC). VC is a recipient of a Fellowship from the FPU Spanish Research Programme. CLL and BSA are supported by the Health Department of the Spanish Government (PI051707). The BACM is supported by the Consejeria de Salud de la Junta de Andalucia (0029 and, 0030/2006 to PM) and, the Spanish Ministry of Health to PM (FIS PI070026). CB is supported by the International Jose Carreras Foundation against Leukemia (EDThomas-05) and the ISCIII (FIS 3+3 contract). The Institute of Reconstructive Neurobiology received additional funding from the DFG and the Hertie Foundation. BS, AbH and AnH are supported by the Fundacion Progreso y Salud and Instituto de Salud Carlos III-Red Espanola de Terapia Celular (RD06/0010/0025 ). PWA, NH and HDM are also supported by the MRC.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Choi SC, 2004, EXP MOL MED, V36, P515, DOI 10.1038/emm.2004.66; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Conway KE, 2000, CANCER RES, V60, P6236; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kang MI, 2007, J CELL BIOCHEM, V102, P224, DOI 10.1002/jcb.21291; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levanon D, 2003, EMBO REP, V4, P560, DOI 10.1038/sj.embor.embor868; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Woerner SM, 2007, GENE CHROMOSOME CANC, V46, P1080, DOI 10.1002/gcc.20493; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Ying JM, 2007, EPIGENETICS-US, V2, P15, DOI 10.4161/epi.2.1.3883; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	39	66	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3294	10.1371/journal.pone.0003294	http://dx.doi.org/10.1371/journal.pone.0003294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820729	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000264432500004
J	Berg, RW; Ditlevsen, S; Hounsgaard, J				Berg, Rune W.; Ditlevsen, Susanne; Hounsgaard, Jorn			Intense Synaptic Activity Enhances Temporal Resolution in Spinal Motoneurons	PLOS ONE			English	Article							LUMBAR MOTONEURONS; NETWORK ACTIVITY; IN-VIVO; BALANCED INHIBITION; BACKGROUND ACTIVITY; FICTIVE LOCOMOTION; CORTICAL-NEURONS; PYRAMIDAL CELLS; SCRATCH REFLEX; EXCITATION	In neurons, spike timing is determined by integration of synaptic potentials in delicate concert with intrinsic properties. Although the integration time is functionally crucial, it remains elusive during network activity. While mechanisms of rapid processing are well documented in sensory systems, agility in motor systems has received little attention. Here we analyze how intense synaptic activity affects integration time in spinal motoneurons during functional motor activity and report a 10-fold decrease. As a result, action potentials can only be predicted from the membrane potential within 10 ms of their occurrence and detected for less than 10 ms after their occurrence. Being shorter than the average inter-spike interval, the AHP has little effect on integration time and spike timing, which instead is entirely determined by fluctuations in membrane potential caused by the barrage of inhibitory and excitatory synaptic activity. By shortening the effective integration time, this intense synaptic input may serve to facilitate the generation of rapid changes in movements.	[Berg, Rune W.; Hounsgaard, Jorn] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Ditlevsen, Susanne] Univ Copenhagen, Dept Math Sci, DK-1168 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Berg, RW (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	rune2earth@gmail.com	Berg, Rune W/C-9717-2014; Ditlevsen, Susanne/F-6708-2012; Berg, Rune W./X-7293-2019	Berg, Rune W/0000-0001-6376-9368; Ditlevsen, Susanne/0000-0002-1998-2783; Berg, Rune W./0000-0001-6376-9368; hounsgaard, jorn/0000-0003-1523-0485	Carlsberg foundation; Novo Nordisk foundation; Lundbeck foundation	Carlsberg foundation(Carlsberg Foundation); Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck foundation(Lundbeckfonden)	This work was funded by the Carlsberg foundation (RB), the Novo Nordisk foundation (RB), the Lundbeck foundation (SD and JH) and FIST (JH). Role of sponsors: None.	Alaburda A, 2005, J NEUROSCI, V25, P6316, DOI 10.1523/JNEUROSCI.0843-05.2005; Alaburda A, 2003, J NEUROSCI, V23, P8625; Baca SM, 2008, NEURON, V57, P276, DOI 10.1016/j.neuron.2007.11.028; BARRETT JN, 1975, FED PROC, V34, P1398; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Berg RW, 2007, SCIENCE, V315, P390, DOI 10.1126/science.1134960; Berkowitz A, 2001, J NEUROPHYSIOL, V86, P1017, DOI 10.1152/jn.2001.86.2.1017; BERNANDER OJD, 1991, PNAS, V88; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BorgGraham L, 1996, J PHYSIOLOGY-PARIS, V90, P185, DOI 10.1016/S0928-4257(97)81421-0; BROWNSTONE RM, 1992, EXP BRAIN RES, V90, P441; Brownstone RM, 2006, PROG NEUROBIOL, V78, P156, DOI 10.1016/j.pneurobio.2006.04.002; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chmykhova NM, 2005, BRAIN RES BULL, V66, P381, DOI 10.1016/j.brainresbull.2004.08.008; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Del Negro CA, 2002, NEURON, V34, P821, DOI 10.1016/S0896-6273(02)00712-2; Delgado-Lezama R, 1999, PROG BRAIN RES, V123, P57, DOI 10.1016/S0079-6123(08)62844-7; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Ditlevsen S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011907; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; GRANIT R, 1966, J PHYSIOL-LONDON, V187, P379, DOI 10.1113/jphysiol.1966.sp008097; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Guillamon A, 2006, J PHYSIOL-PARIS, V100, P31, DOI 10.1016/j.jphysparis.2006.09.010; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; Hyngstrom AS, 2007, NAT NEUROSCI, V10, P363, DOI 10.1038/nn1852; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; KEIFER J, 1983, BRAIN RES, V266, P148, DOI 10.1016/0006-8993(83)91318-5; Kernell D., 2006, MOTONEURONE ITS MUSC; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Parkis MA, 1999, J NEUROSCI, V19, P2368; Perreault MC, 2002, J NEUROSCI, V22, P8259; Powers RK, 2000, J NEUROPHYSIOL, V83, P483, DOI 10.1152/jn.2000.83.1.483; Press W., 1992, NUMERICAL RECIPES FO; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; RAPP M, 1992, NEURAL COMPUT, V4, P518, DOI 10.1162/neco.1992.4.4.518; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; ROBERTSON GA, 1988, J PHYSIOL-LONDON, V404, P101, DOI 10.1113/jphysiol.1988.sp017281; RODIECK RW, 1962, BIOPHYS J, V2, P351, DOI 10.1016/S0006-3495(62)86860-X; RUIGROK TJH, 1984, J COMP NEUROL, V230, P413, DOI 10.1002/cne.902300309; SCHMIDT BJ, 1994, EXP BRAIN RES, V99, P214; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHEFCHYK SJ, 1985, J NEUROPHYSIOL, V54, P1101, DOI 10.1152/jn.1985.54.5.1101; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; STEIN RB, 2005, NAT REV NEUROSCI, V25, P4985; Taylor J. R., 1982, INTRO ERROR ANAL STU; Tiesinga PHE, 2000, PHYS REV E, V62, P8413, DOI 10.1103/PhysRevE.62.8413; Toledo-Rodriguez M, 2005, TRENDS NEUROSCI, V28, P534, DOI 10.1016/j.tins.2005.08.001; TUCKWELL HC, INTRO THEORETICAL TH; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591	61	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3218	10.1371/journal.pone.0003218	http://dx.doi.org/10.1371/journal.pone.0003218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795101	Green Published, gold, Green Submitted			2022-12-25	WOS:000264428000002
J	Chevalier, J; Mulfinger, C; Garnotel, E; Nicolas, P; Davin-Regli, A; Pages, JM				Chevalier, Jacqueline; Mulfinger, Celine; Garnotel, Eric; Nicolas, Pierre; Davin-Regli, Anne; Pages, Jean-Marie			Identification and Evolution of Drug Efflux Pump in Clinical Enterobacter aerogenes Strains Isolated in 1995 and 2003	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; MULTIDRUG-RESISTANCE; PSEUDOMONAS-AERUGINOSA; MOLECULAR EPIDEMIOLOGY; ANTIBIOTIC-RESISTANCE; PORIN ALTERATION; INHIBITORS; CHLORAMPHENICOL; IMIPENEM	Background: The high mortality impact of infectious diseases will increase due to accelerated evolution of antibiotic resistance in important human pathogens. Development of antibiotic resistance is a evolutionary process inducing the erosion of the effectiveness of our arsenal of antibiotics. Resistance is not necessarily limited to a single class of antibacterial agents but may affect many unrelated compounds; this is termed 'multidrug resistance' (MDR). The major mechanism of MDR is the active expulsion of drugs by bacterial pumps; the treatment of Gram negative bacterial infections is compromised due to resistance mechanisms including the expression of efflux pumps that actively expel various usual antibiotics (beta-lactams, quinolones, ... ). Methodology/Principal Findings: Enterobacter aerogenes has emerged among Enterobacteriaceae associated hospital infections during the last twenty years due to its faculty of adaptation to antibiotic stresses. Clinical isolates of E. aerogenes belonging to two strain collections isolated in 1995 and 2003 respectively, were screened to assess the involvement of efflux pumps in antibiotic resistance. Drug susceptibility assays were performed on all bacterial isolates and an efflux pump inhibitor (PA beta N) previously characterized allowed to decipher the role of efflux in the resistance. Accumulation of labelled chloramphenicol was monitored in the presence of an energy poison to determine the involvement of active efflux on the antibiotic intracellular concentrations. The presence of the PA beta N-susceptible efflux system was also identified in resistant E. aerogenes strains. Conclusions/Significance: For the first time a noticeable increase in clinical isolates containing an efflux mechanism susceptible to pump inhibitor is report within an 8 year period. After the emergence of extended spectrum beta-lactamases in E. aerogenes and the recent characterisation of porin mutations in clinical isolates, this study describing an increase in inhibitor-susceptible efflux throws light on a new step in the evolution of mechanism in E. aerogenes.	[Chevalier, Jacqueline; Mulfinger, Celine; Garnotel, Eric; Nicolas, Pierre; Davin-Regli, Anne; Pages, Jean-Marie] Fac Med & Pharm, UMR MD1, IFR 48, Marseille, France; [Garnotel, Eric] HIA Laveran, Serv Biol, Marseille, France; [Nicolas, Pierre] IMTSSA, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Chevalier, J (corresponding author), Fac Med & Pharm, UMR MD1, IFR 48, Marseille, France.	Jean-Marie.PAGES@univmed.fr	PAGES, jean-marie/F-2555-2013	PAGES, jean-marie/0000-0001-7092-7977	Service de Sante des Armees [2004RC16]; Universite de la Mediterranee; Eloi Collery prize: Academie Nationale de Medecine	Service de Sante des Armees; Universite de la Mediterranee; Eloi Collery prize: Academie Nationale de Medecine	This study was supported by the Service de Sante des Armees (contrat recherche clinique n 2004RC16 and livre rouge operation 23e), by the Universite de la Mediterranee and from Eloi Collery prize: Academie Nationale de Medecine (J.-M. Pages).	Aeschlimann JR, 2003, PHARMACOTHERAPY, V23, P916, DOI 10.1592/phco.23.7.916.32722; Arpin C, 2003, ANTIMICROB AGENTS CH, V47, P3506, DOI 10.1128/AAC.47.11.3506-3514.2003; Arpin C, 1996, J CLIN MICROBIOL, V34, P2163, DOI 10.1128/JCM.34.9.2163-2169.1996; Bernstein C, 1999, CURR MICROBIOL, V39, P68, DOI 10.1007/s002849900420; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; Bornet C, 2000, J CLIN MICROBIOL, V38, P1048, DOI 10.1128/JCM.38.3.1048-1052.2000; Bosi C, 1999, J CLIN MICROBIOL, V37, P2165, DOI 10.1128/JCM.37.7.2165-2169.1999; Braibant M, 2005, ANTIMICROB AGENTS CH, V49, P2965, DOI 10.1128/AAC.49.7.2965-2971.2005; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Canton R, 2002, J CLIN MICROBIOL, V40, P1237, DOI 10.1128/JCM.40.4.1237-1243.2002; Charrel RN, 1996, ANTIMICROB AGENTS CH, V40, P2854, DOI 10.1128/AAC.40.12.2854; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P3621, DOI 10.1128/AAC.48.9.3621-3624.2004; DavinRegli A, 1996, J CLIN MICROBIOL, V34, P1474, DOI 10.1128/JCM.34.6.1474-1480.1996; DAVINREGLI A, 2006, REGULATION EFFLUX PU; De Gheldre Y, 2001, J CLIN MICROBIOL, V39, P889, DOI 10.1128/JCM.39.3.889-896.2001; Dumarche P, 2002, ANTIMICROB AGENTS CH, V46, P1128, DOI 10.1128/AAC.46.4.1128-1131.2002; Elkins CA, 2003, DRUG RESIST UPDATE, V6, P9, DOI 10.1016/S1368-7646(03)00004-9; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P423, DOI 10.1093/jac/dkl183; Gayet S, 2003, ANTIMICROB AGENTS CH, V47, P1555, DOI 10.1128/AAC.47.5.1555-1559.2003; George AM, 1996, FEMS MICROBIOL LETT, V139, P1, DOI 10.1016/0378-1097(96)00127-9; Ghisalberti D, 2005, BIOCHEM BIOPH RES CO, V328, P1113, DOI 10.1016/j.bbrc.2005.01.069; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Goshi S, 2002, J HOSP INFECT, V51, P221, DOI 10.1053/jhin.2002.1255; Hasdemir UO, 2004, J CLIN MICROBIOL, V42, P2701, DOI 10.1128/JCM.42.6.2701-2706.2004; Lavigne JP, 2004, J CLIN MICROBIOL, V42, P3805, DOI 10.1128/JCM.42.8.3805-3808.2004; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Machado E, 2007, J ANTIMICROB CHEMOTH, V60, P1370, DOI 10.1093/jac/dkm381; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; Mallea M, 2002, BIOCHEM BIOPH RES CO, V293, P1370, DOI 10.1016/S0006-291X(02)00404-7; Masi M, 2006, J ANTIMICROB CHEMOTH, V57, P1223, DOI 10.1093/jac/dkl139; Mazzariol A, 2002, ANTIMICROB AGENTS CH, V46, P3984, DOI 10.1128/AAC.46.12.3984-3986.2002; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K., 2008, MICROBE, V3, P179, DOI DOI 10.1128/MICR0BE.3.179.1; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Ricci V, 2006, ANTIMICROB AGENTS CH, V50, P38, DOI 10.1128/AAC.50.1.38-42.2006; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Saenz Y, 2004, J ANTIMICROB CHEMOTH, V53, P544, DOI 10.1093/jac/dkh117; Saito R, 2006, J ANTIMICROB CHEMOTH, V58, P673, DOI 10.1093/jac/dkl297; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thiolas A, 2005, ANTIMICROB AGENTS CH, V49, P1354, DOI 10.1128/AAC.49.4.1354-1358.2005; Thiolas A, 2004, BIOCHEM BIOPH RES CO, V317, P851, DOI 10.1016/j.bbrc.2004.03.130; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Vonberg RP, 2007, J HOSP INFECT, V65, P372, DOI 10.1016/j.jhin.2006.12.010; Warner DM, 2007, J INFECT DIS, V196, P1804, DOI 10.1086/522964; Wenzel RP, 2003, ANTIMICROB AGENTS CH, V47, P3089, DOI 10.1128/AAC.47.10.3089-3098.2003; Yan MG, 2006, J ANTIMICROB CHEMOTH, V58, P1154, DOI 10.1093/jac/dkl412; 2006, EARSS ANN REPORTS	53	36	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3203	10.1371/journal.pone.0003203	http://dx.doi.org/10.1371/journal.pone.0003203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787654	Green Submitted, gold, Green Published			2022-12-25	WOS:000264426200008
J	Pickar, D; Vinik, J; Bartko, JJ				Pickar, David; Vinik, Jessie; Bartko, John J.			Pharmacotherapy of Schizophrenic Patients: Preponderance of Off-Label Drug Use	PLOS ONE			English	Article							LATEST ANTIPSYCHOTIC-DRUGS; COST-UTILITY; POLYPHARMACY; MEDICATIONS; 2ND-GENERATION; DEPRESSION; OLANZAPINE; PROMOTION; GUIDANCE; AGENTS	Multiple drug class combinations are often prescribed for the treatment of schizophrenia, although antipsychotic monotherapy reflects FDA labeling and scientific justification for combinations is highly variable. This study was performed to gain current data regarding drug treatment of schizophrenia as practiced in the community and to assess the frequencies of off-label drug class combinations. 200 DSM IV-diagnosed schizophrenic patients recruited from community treatment sources participated in this cross-sectional study of community based schizophrenic patients. Drug class categories include First and Second Generation Antipsychotic drugs (FGA and SGA, respectively), mood stabilizers, antidepressants and anti-anxiety drugs. 25.5% of patients received antipsychotic monotherapy; 70% of patients received an antipsychotic and another drug class. A total of 42.5% of patients received more than one antipsychotic drug. The most common drug class combination was antipsychotic and a mood stabilizer. Stepwise linear discriminant function analysis identified the diagnosis of schizoaffective schizophrenia, history of having physically hurt someone and high scores on the General Portion of the PANSS rating scale predicted the combined use of an antipsychotic drug and a mood stabilizer. "Real world'' pharmacotherapy of schizophrenia has developed its own established practice that is predominantly off-label and may have outstripped current data support. The economic implications for public sector payers are substantial as well as for the revenue of the pharmaceutical industry, whose promotion of off-label drug use is an increasingly problematic. These data are consistent with the recognition of the therapeutic limitations of both first and second generation antipsychotic drugs.	[Pickar, David; Vinik, Jessie] Gabriel Sci LLC, Cabin John, MD USA; [Pickar, David] Johns Hopkins Med Sch, Dept Psychiat, Baltimore, MD 21287 USA; [Pickar, David] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Bartko, John J.] Univ Maryland, Sch Med, Dept Stat, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Medicine; Uniformed Services University of the Health Sciences - USA; University System of Maryland; University of Maryland Baltimore	Pickar, D (corresponding author), Gabriel Sci LLC, Cabin John, MD USA.	dpickar@gabrielpharma.com		Pickar, David/0000-0002-8596-3687	NIH SBIR [R44MH67351-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R44MH067351] Funding Source: NIH RePORTER	NIH SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH SBIR Grant # R44MH67351-02. This funding source had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, DIAGN STAT MAN MENT; Barbui C, 2006, INT CLIN PSYCHOPHARM, V21, P355, DOI 10.1097/01.yic.0000224785.68040.43; Buchanan RW, 2002, AM J PSYCHIAT, V159, P1035, DOI 10.1176/appi.ajp.159.6.1035; Casey DE, 2003, NEUROPSYCHOPHARMACOL, V28, P182, DOI 10.1038/sj.npp.1300023; Centorrino F, 2004, AM J PSYCHIAT, V161, P700, DOI 10.1176/appi.ajp.161.4.700; Chakos MH, 2006, PSYCHIAT SERV, V57, P1094, DOI 10.1176/appi.ps.57.8.1094; Clark RE, 2002, SCHIZOPHRENIA BULL, V28, P75, DOI 10.1093/oxfordjournals.schbul.a006928; Correll CU, 2007, SCHIZOPHR RES, V89, P91, DOI 10.1016/j.schres.2006.08.017; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; DeMonaco HJ, 2006, PHARMACOTHERAPY, V26, P323, DOI 10.1592/phco.26.3.323; Glick ID, 2004, J CLIN PSYCHIAT, V65, P679, DOI 10.4088/jcp.v65n0513; Glick ID, 2006, J CLIN PSYCHIAT, V67, P1261, DOI 10.4088/JCP.v67n0813; Henney JE, 2006, ANN INTERN MED, V145, P305, DOI 10.7326/0003-4819-145-4-200608150-00013; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kreyenbuhl J, 2006, SCHIZOPHR RES, V84, P90, DOI 10.1016/j.schres.2006.02.023; Levinson DF, 1999, AM J PSYCHIAT, V156, P1138; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lieberman JA, 2006, ARCH GEN PSYCHIAT, V63, P1069, DOI 10.1001/archpsyc.63.10.1069; *MICR, 2002, MICR HEALTHC SER; Mitka M, 2008, JAMA-J AM MED ASSOC, V299, P1759, DOI 10.1001/jama.299.15.1759; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; PATICK V, 2006, PSYCHIAT SERV, V57, P21; PICKAR D, 1995, LANCET, V345, P557, DOI 10.1016/S0140-6736(95)90469-7; Procyshyn RM, 2001, CAN J PSYCHIAT, V46, P334, DOI 10.1177/070674370104600404; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1949, DOI 10.1001/jama.299.16.1949; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Rosenheck RA, 2006, ARCH GEN PSYCHIAT, V63, P1074, DOI 10.1001/archpsyc.63.10.1074; Rosenheck RA, 2006, PSYCHIAT SERV, V57, P1093, DOI 10.1176/appi.ps.57.8.1093; Siris SG, 2000, AM J PSYCHIAT, V157, P1379, DOI 10.1176/appi.ajp.157.9.1379; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Stahl SM, 1999, J CLIN PSYCHIAT, V60, P425, DOI 10.4088/JCP.v60n0701; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Swartz MS, 2007, AM J PSYCHIAT, V164, P428, DOI 10.1176/appi.ajp.164.3.428; TAPP A, 1999, PSYCHIAT SERV, V54, P55; Tempier RP, 2003, J CLIN PSYCHIAT, V64, P673, DOI 10.4088/JCP.v64n0609; THOMSON PDR, 2007, PHYS DESK REFERENCE, P2184; THOMSON PDR, 2007, PHYS DESK REFERENCE; Wassef AA, 2000, J CLIN PSYCHOPHARM, V20, P357, DOI 10.1097/00004714-200006000-00011; WOLKOWITZ OM, 1991, AM J PSYCHIAT, V148, P714; 2004, FDA CONSUM, V4, P36; 2008, FED REG, V74, P9342; 2006, WALL STREET J   1123	43	45	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3150	10.1371/journal.pone.0003150	http://dx.doi.org/10.1371/journal.pone.0003150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KD	18781198	Green Submitted, gold, Green Published			2022-12-25	WOS:000264425700005
J	Fulurija, A; Lutz, TA; Sladko, K; Osto, M; Wielinga, PY; Bachmann, MF; Saudan, P				Fulurija, Alma; Lutz, Thomas A.; Sladko, Katja; Osto, Melania; Wielinga, Peter Y.; Bachmann, Martin F.; Saudan, Philippe			Vaccination against GIP for the Treatment of Obesity	PLOS ONE			English	Article								Background: According to the WHO, more than 1 billion people worldwide are overweight and at risk of developing chronic illnesses, including cardiovascular disease, type 2 diabetes, hypertension and stroke. Current therapies show limited efficacy and are often associated with unpleasant side-effect profiles, hence there is a medical need for new therapeutic interventions in the field of obesity. Gastric inhibitory peptide (GIP, also known as glucose-dependent insulinotropic polypeptide) has recently been postulated to link over-nutrition with obesity. In fact GIP receptor-deficient mice (GIPR(-/-)) were shown to be completely protected from diet-induced obesity. Thus, disrupting GIP signaling represents a promising novel therapeutic strategy for the treatment of obesity. Methodology/Principal Findings: In order to block GIP signaling we chose an active vaccination approach using GIP peptides covalently attached to virus-like particles (VLP-GIP). Vaccination of mice with VLP-GIP induced high titers of specific antibodies and efficiently reduced body weight gain in animals fed a high fat diet. The reduction in body weight gain could be attributed to reduced accumulation of fat. Moreover, increased weight loss was observed in obese mice vaccinated with VLP-GIP. Importantly, despite the incretin action of GIP, VLP-GIP-treated mice did not show signs of glucose intolerance. Conclusions/Significance: This study shows that vaccination against GIP was safe and effective. Thus active vaccination may represent a novel, long-lasting treatment for obesity. However further preclinical safety/ toxicology studies will be required before the therapeutic concept can be addressed in humans.	[Fulurija, Alma; Sladko, Katja; Bachmann, Martin F.; Saudan, Philippe] Cytos Biotechnol AG, Schlieren, Switzerland; [Lutz, Thomas A.; Osto, Melania; Wielinga, Peter Y.] Univ Zurich, Vetsuisse Fac, Ctr Integrat Human Physiol, Inst Vet Physiol, Zurich, Switzerland	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Fulurija, A (corresponding author), Cytos Biotechnol AG, Schlieren, Switzerland.	philippe.saudan@cytos.com		Fulurija, Alma/0000-0003-1776-785X	Cytos Biotechnology AG	Cytos Biotechnology AG	Most of the work was carried out and financed by Cytos Biotechnology AG.	Ahren B, 2002, DIABETES CARE, V25, P869, DOI 10.2337/diacare.25.5.869; Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; ANDERSEN DK, 1978, J CLIN INVEST, V62, P152, DOI 10.1172/JCI109100; Bachmann MF, 2004, NAT REV DRUG DISCOV, V3, P81, DOI 10.1038/nrd1284; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Blackburn G., 1995, OBES RES S2, V3, P211; Bosello O, 1997, INT J OBESITY, V21, pS10; Chackerian B, 1999, P NATL ACAD SCI USA, V96, P2373, DOI 10.1073/pnas.96.5.2373; Cielens I, 2000, FEBS LETT, V482, P261, DOI 10.1016/S0014-5793(00)02061-5; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; EBERT R, 1991, HORM METAB RES, V23, P517, DOI 10.1055/s-2007-1003745; ECKEL RH, 1979, DIABETES, V28, P1141, DOI 10.2337/diabetes.28.12.1141; ELAHI D, 1994, REGUL PEPTIDES, V51, P63, DOI 10.1016/0167-0115(94)90136-8; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Gault VA, 2007, DIABETOLOGIA, V50, P1752, DOI 10.1007/s00125-007-0710-4; Gault VA, 2002, J ENDOCRINOL, V175, P525, DOI 10.1677/joe.0.1750525; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Greenway Frank L, 2005, Expert Opin Drug Saf, V4, P1083, DOI 10.1517/14740338.4.6.1083; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Heijboer AC, 2006, J NEUROENDOCRINOL, V18, P883, DOI 10.1111/j.1365-2826.2006.01492.x; Huda MSB, 2006, OBES REV, V7, P163, DOI 10.1111/j.1467-789X.2006.00245.x; Ioannides-Demos LL, 2005, DRUGS, V65, P1391, DOI 10.2165/00003495-200565100-00006; Irwin N, 2007, DIABETOLOGIA, V50, P1532, DOI 10.1007/s00125-007-0692-2; Irwin N, 2004, BIOL CHEM, V385, P845, DOI 10.1515/BC.2004.110; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kieffer TJ, 2003, TRENDS PHARMACOL SCI, V24, P110, DOI 10.1016/S0165-6147(03)00031-2; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KOZLOVSKA TM, 1993, GENE, V137, P133, DOI 10.1016/0378-1119(93)90261-Z; Leung WYS, 2003, CLIN THER, V25, P58, DOI 10.1016/S0149-2918(03)90009-9; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497; Mest HJ, 2005, DIABETOLOGIA, V48, P616, DOI 10.1007/s00125-005-1707-5; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Spohn G, 2005, J IMMUNOL, V175, P6211, DOI 10.4049/jimmunol.175.9.6211; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; WASADA T, 1981, J CLIN INVEST, V68, P1106, DOI 10.1172/JCI110335; Yamada Y, 2004, HORM METAB RES, V36, P771, DOI 10.1055/s-2004-826162; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yip RGC, 1999, LIFE SCI, V66, P91, DOI 10.1016/S0024-3205(99)00314-8; YUE DK, 1980, DIABETES, V29, P296, DOI 10.2337/diab.29.4.296	48	77	95	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3163	10.1371/journal.pone.0003163	http://dx.doi.org/10.1371/journal.pone.0003163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779862	Green Submitted, Green Published, gold			2022-12-25	WOS:000264425100002
J	Isono, O; Ohshima, T; Saeki, Y; Matsumoto, J; Hijikata, M; Tanaka, K; Shimotohno, K				Isono, Osamu; Ohshima, Takayuki; Saeki, Yasushi; Matsumoto, Jun; Hijikata, Makoto; Tanaka, Keiji; Shimotohno, Kunitada			Human T-cell Leukemia Virus Type 1 HBZ Protein Bypasses the Targeting Function of Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; TRANSCRIPTIONAL ACTIVITY; ORNITHINE-DECARBOXYLASE; INDEPENDENT DEGRADATION; RETINOBLASTOMA PROTEIN; PROTEASOMAL TURNOVER; NEGATIVE REGULATOR; 20S PROTEASOME; IN-VIVO; P53	Human T-cell leukemia virus type 1 (HTLV-1) encodes an antisense viral gene product termed HTLV-1 basic leucine-zipper factor (HBZ). HBZ forms heterodimers with c-Jun, a member of the AP-1 family, and promotes its proteasomal degradation. Although most proteasomal substrates are targeted for degradation via conjugation of polyubiquitin chains, we show that ubiquitination is not required for HBZ-mediated proteasomal degradation of c-Jun. We demonstrate that HBZ directly interacts with both the 26 S proteasome and c-Jun and facilitates the delivery of c-Jun to the proteasome without ubiquitination. HBZ acts as a tethering factor between the 26 S proteasome and its substrate, thereby bypassing the targeting function of ubiquitination. These findings disclose a novel viral strategy to utilize the cellular proteolytic system for viral propagation.	[Isono, Osamu; Ohshima, Takayuki; Matsumoto, Jun; Hijikata, Makoto; Shimotohno, Kunitada] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Human Tumor Viruses,Sakyo Ku, Kyoto 6068507, Japan; [Ohshima, Takayuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa 7692193, Japan; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Shimotohno, Kunitada] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Chiba 2750016, Japan	Kyoto University; Tokushima Bunri University; Tokyo Metropolitan Institute of Medical Science; Keio University; Chiba Institute of Technology	Shimotohno, K (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Human Tumor Viruses,Sakyo Ku, Kyoto 6068507, Japan.	shimkuni@z8.keio.jp	Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; OHSHIMA, Takayuki/0000-0002-1501-6430	Ministry of Health, Labour and Welfare; Takeda Science Foundation; Suzuken Memorial Foundation; Japanese Leukemia Research Foundation	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Japanese Leukemia Research Foundation	This work was supported by grants-in-aid for cancer research and for the second-term comprehensive 10-year strategy for cancer control from the Ministry of Health, Labour and Welfare as well as by grants-in-aid for Scientific Research on Priority Areas "Integrative Research Toward the Conquest of Cancer" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. In addition, this work was supported by research funds from the Takeda Science Foundation, the Suzuken Memorial Foundation, and the Japanese Leukemia Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; FUJII M, 1991, ONCOGENE, V6, P1023; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; INOUE J, 1987, P NATL ACAD SCI USA, V84, P3653, DOI 10.1073/pnas.84.11.3653; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; KANNAGI M, 1991, INT IMMUNOL, V3, P761, DOI 10.1093/intimm/3.8.761; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Lemasson I, 2007, J VIROL, V81, P1543, DOI 10.1128/JVI.00480-06; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; Mori N, 2000, BLOOD, V95, P3915; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murata K, 2006, J VIROL, V80, P2495, DOI 10.1128/JVI.80.5.2495-2505.2006; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nicot C, 2004, NAT MED, V10, P197, DOI 10.1038/nm984; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shackelford J, 2005, ESSAYS BIOCHEM, V41, P139, DOI 10.1042/EB0410139; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	46	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34273	34282		10.1074/jbc.M802527200	http://dx.doi.org/10.1074/jbc.M802527200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18805793	Green Published, hybrid			2022-12-25	WOS:000261277700055
J	Nihira, K; Taira, N; Miki, Y; Yoshida, K				Nihira, K.; Taira, N.; Miki, Y.; Yoshida, K.			TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress	ONCOGENE			English	Article						c-Abl; TTK; oxidative stress; phosphorylation	LYN TYROSINE KINASE; DNA-DAMAGE; BCR-ABL; APOPTOTIC RESPONSE; SUBCELLULAR-LOCALIZATION; CELL-DEATH; PROTEIN; DELTA; ACTIVATION; MECHANISMS	Upon exposure to genotoxic stress, the c-Abl tyrosine kinase is released from cytoplasmic 14-3-3 proteins and then is targeted to the nucleus. Phosphorylation of Thr735 in c-Abl is critical for binding to 14-3-3; however, kinases responsible for this phosphorylation are unknown. Here, we identify CLK1, CLK4, MST1, MST2 and TTK (also known as Mps1) as novel Thr735 kinases in vitro by expression cloning strategy using phosphospeci. c antibody. We also demonstrate that ectopic expression of these kinases is capable for phosphorylation of Thr735 in cells. Importantly, upon exposure to oxidative stress, phosphorylation of Thr735 is transiently upregulated, and the status of this phosphorylation remains unchanged in cells silenced for CLK1, CLK4, MST1 or MST2. By contrast, knockdown of TTK attenuates phosphorylation of Thr735, suggesting that TTK is a physiological kinase that phosphorylates Thr735. In concert with these results, we show that, in cells silenced for TTK, c-Abl is accumulated in the nucleus even in unstressed condition and no further targeting into the nucleus occurs after oxidative stress. Moreover, nuclear entrapment of c-Abl by knocking down TTK enhances oxidative stress-induced apoptosis. These findings provide evidence that TTK phosphorylates c-Abl at Thr735 and that this phosphorylation is of importance to the cytoplasmic sequestration of c-Abl.	[Nihira, K.; Taira, N.; Miki, Y.; Yoshida, K.] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Yoshida, K (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	yos.mgen@mri.tmd.ac.jp		Nihira, Keishi/0000-0002-3797-9289	Ministry of Education, Science and Culture of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sumitomo Foundation; Yasuda Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Sagawa Foundation for Promotion of Cancer Research; Osaka Cancer Research Foundation; Kato Memorial Bioscience Foundation; Uehara Memorial Foundation	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sumitomo Foundation; Yasuda Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Sagawa Foundation for Promotion of Cancer Research; Osaka Cancer Research Foundation; Kato Memorial Bioscience Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	We thank Dr Xuebiao Yao for the GFP-TTK. This work was supported by grants from the Ministry of Education, Science and Culture of Japan (to KY and YM), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to KY), the Sumitomo Foundation (to KY), the Yasuda Memorial Foundation (to KY), Astellas Foundation for Research on Metabolic Disorders (to KY), the Sagawa Foundation for Promotion of Cancer Research (to KY), Osaka Cancer Research Foundation (to KY), Kato Memorial Bioscience Foundation (to KY) and Uehara Memorial Foundation (to KY).	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Cao C, 2003, J BIOL CHEM, V278, P29667, DOI 10.1074/jbc.M301292200; Castillo AR, 2002, J CELL BIOL, V156, P453, DOI 10.1083/jcb.200111025; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Dierov J, 2004, CANCER CELL, V5, P275, DOI 10.1016/S1535-6108(04)00056-X; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Jones MH, 1999, MOL BIOL CELL, V10, P2377, DOI 10.1091/mbc.10.7.2377; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; REUTHER GW, 1994, SCIENCE, V266, P129, DOI 10.1126/science.7939633; Straight PD, 2000, MOL BIOL CELL, V11, P3525, DOI 10.1091/mbc.11.10.3525; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; WETZLER M, 1993, J CLIN INVEST, V92, P1925, DOI 10.1172/JCI116786; Yoshida K, 2006, MOL CELL BIOL, V26, P3414, DOI 10.1128/MCB.26.9.3414-3431.2006; Yoshida K, 1999, J BIOL CHEM, V274, P34663, DOI 10.1074/jbc.274.49.34663; Yoshida K, 2000, MOL CELL BIOL, V20, P5370, DOI 10.1128/MCB.20.15.5370-5380.2000; Yoshida K, 2005, CELL CYCLE, V4, P777, DOI 10.4161/cc.4.6.1746; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, J BIOL CHEM, V277, P48372, DOI 10.1074/jbc.M205485200; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Yoshida K, 2001, MOL PHARMACOL, V60, P1431, DOI 10.1124/mol.60.6.1431; Yoshida K, 2008, TRENDS MOL MED, V14, P305, DOI 10.1016/j.molmed.2008.05.003; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027; Yoshikawa S, 2006, J JPN SOC FOOD SCI, V53, P281, DOI 10.3136/nskkk.53.281; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5	40	33	34	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	58					7285	7295		10.1038/onc.2008.334	http://dx.doi.org/10.1038/onc.2008.334			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	382FI	18794806				2022-12-25	WOS:000261590300006
J	Sato, H; Kato, R; Isogai, Y; Saka, G; Ohtsuki, M; Taketomi, Y; Yamamoto, K; Tsutsumi, K; Yamada, J; Masuda, S; Ishikawa, Y; Ishii, T; Kobayashi, T; Ikeda, K; Taguchi, R; Hatakeyama, S; Hara, S; Kudo, I; Itabe, H; Murakami, M				Sato, Hiroyasu; Kato, Rina; Isogai, Yuki; Saka, Go-ichi; Ohtsuki, Mitsuhiro; Taketomi, Yoshitaka; Yamamoto, Kei; Tsutsumi, Kae; Yamada, Joe; Masuda, Seiko; Ishikawa, Yukio; Ishii, Toshiharu; Kobayashi, Tetsuyuki; Ikeda, Kazutaka; Taguchi, Ryo; Hatakeyama, Shinji; Hara, Shuntaro; Kudo, Ichiro; Itabe, Hiroyuki; Murakami, Makoto			Analyses of Group III Secreted Phospholipase A(2) Transgenic Mice Reveal Potential Participation of This Enzyme in Plasma Lipoprotein Modification, Macrophage Foam Cell Formation, and Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ARACHIDONATE-RELEASING FUNCTION; MOUSE PERITONEAL-MACROPHAGES; GROUP-V; GROUP-X; EXPRESSION; GENE; ACID; ACTIVATION; LYSOPHOSPHATIDYLCHOLINE	Among the many mammalian secreted phospholipase A(2) (sPLA(2)) enzymes, PLA2G3 ( group III secreted phospholipase A2) is unique in that it possesses unusual N- and C-terminal domains and in that its central sPLA(2) domain is homologous to bee venom PLA(2) rather than to other mammalian sPLA(2)s. To elucidate the in vivo actions of this atypical sPLA(2), we generated transgenic (Tg) mice overexpressing human PLA2G3. Despite marked increases in PLA(2) activity and mature 18-kDa PLA2G3 protein in the circulation and tissues, PLA2G3 Tg mice displayed no apparent abnormality up to 9 months of age. However, alterations in plasma lipoproteins were observed in PLA2G3 Tg mice compared with control mice. In vitro incubation of low density (LDL) and high density (HDL) lipoproteins with several sPLA(2)s showed that phosphatidylcholine was efficiently converted to lysophosphatidylcholine by PLA2G3 as well as by PLA2G5 and PLA2G10, to a lesser extent by PLA2G2F, and only minimally by PLA2G2A and PLA2G2E. PLA2G3-modified LDL, like PLA2G5- or PLA2G10-treated LDL, facilitated the formation of foam cells from macrophages ex vivo. Accumulation of PLA2G3 was detected in the atherosclerotic lesions of humans and apoE-deficient mice. Furthermore, following an atherogenic diet, aortic atherosclerotic lesions were more severe in PLA2G3 Tg mice than in control mice on the apoE-null background, in combination with elevated plasma lysophosphatidylcholine and thromboxane A(2) levels. These results collectively suggest a potential functional link between PLA2G3 and atherosclerosis, as has recently been proposed for PLA2G5 and PLA2G10.	[Sato, Hiroyasu; Isogai, Yuki; Yamamoto, Kei; Masuda, Seiko; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Biomembrane Signaling Project, Bunkyo Ku, Tokyo 1138613, Japan; [Sato, Hiroyasu; Ohtsuki, Mitsuhiro; Taketomi, Yoshitaka; Masuda, Seiko; Kudo, Ichiro; Murakami, Makoto] Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Kato, Rina; Saka, Go-ichi; Itabe, Hiroyuki] Showa Univ, Sch Pharmaceut Sci, Dept Biol Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Taketomi, Yoshitaka] Showa Univ, Ctr Biotechnol, Shinagawa Ku, Tokyo 1428555, Japan; [Isogai, Yuki; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo 1128610, Japan; [Tsutsumi, Kae; Yamada, Joe; Hatakeyama, Shinji] Novartis Inst BioMed Res, Tsukuba, Ibaraki 3002611, Japan; [Ishikawa, Yukio; Ishii, Toshiharu] Toho Univ, Sch Med, Dept Pathol, Ohta Ku, Tokyo 1438540, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Fac Med, Dept Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Murakami, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Showa University; Showa University; Showa University; Ochanomizu University; Novartis; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Biomembrane Signaling Project, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	murakami-mk@igakuken.or.jp	Hatakeyama, Shinji/I-8873-2019; 板部板部, 洋之/ABC-7746-2020; Kobayashi, Tetsuyuki/AAH-2985-2020	Hatakeyama, Shinji/0000-0002-0166-2773; Kobayashi, Tetsuyuki/0000-0002-9285-0859	Ministry of Education, Science, Culture, Sports and Technology of Japan	Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, Sports and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Boyanovsky BB, 2005, J BIOL CHEM, V280, P32746, DOI 10.1074/jbc.M502067200; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Chen YJ, 1998, BBA-LIPID LIPID MET, V1394, P57, DOI 10.1016/S0005-2760(98)00098-8; Curfs DMJ, 2008, J BIOL CHEM, V283, P21640, DOI 10.1074/jbc.M710584200; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Deregnaucourt C, 2000, J BIOL CHEM, V275, P39973, DOI 10.1074/jbc.M006712200; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Fox N, 1996, EUR J PHARMACOL, V308, P195, DOI 10.1016/0014-2999(96)00257-9; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; HEIDER JG, 1978, J LIPID RES, V19, P514; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Houjou T, 2004, RAPID COMMUN MASS SP, V18, P3123, DOI 10.1002/rcm.1737; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Hurt-Camejo E, 2001, CIRC RES, V89, P298, DOI 10.1161/hh1601.095598; Hurt-Camejo E, 2001, ARTHRITIS RHEUM, V44, P2761, DOI 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5; Ishimoto Y, 2003, BBA-MOL CELL RES, V1642, P129, DOI 10.1016/S0167-4889(03)00120-4; ITABE H, 1994, J BIOL CHEM, V269, P15274; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Kimura-Matsumoto M, 2008, ATHEROSCLEROSIS, V196, P81, DOI 10.1016/j.atherosclerosis.2006.08.062; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Masuda S, 2008, BIOCHEM J, V409, P429, DOI 10.1042/BJ20070844; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Mitsuishi M, 2007, BBA-MOL CELL BIOL L, V1771, P1389, DOI 10.1016/j.bbalip.2007.09.006; Mounier CM, 2008, BRIT J CANCER, V98, P587, DOI 10.1038/sj.bjc.6604184; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Murakami M, 2005, J BIOL CHEM, V280, P24987, DOI 10.1074/jbc.M502088200; Murakami M, 2003, J BIOL CHEM, V278, P10657, DOI 10.1074/jbc.M211325200; Murakami M, 2002, J BIOL CHEM, V277, P19145, DOI 10.1074/jbc.M112385200; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Neuzil J, 1998, BIOCHEMISTRY-US, V37, P9203, DOI 10.1021/bi9730745; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; POSTON RN, 1992, AM J PATHOL, V140, P665; Pruzanski W, 2005, BBA-MOL CELL BIOL L, V1736, P38, DOI 10.1016/j.bbalip.2005.07.005; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Romano M, 1998, ARTERIOSCL THROM VAS, V18, P519, DOI 10.1161/01.ATV.18.4.519; Rosengren B, 2006, ARTERIOSCL THROM VAS, V26, P1579, DOI 10.1161/01.ATV.0000221231.56617.67; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sartipy P, 1996, J BIOL CHEM, V271, P26307, DOI 10.1074/jbc.271.42.26307; Sartipy P, 2000, CIRC RES, V86, P707, DOI 10.1161/01.RES.86.6.707; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492; VANZANTEN GH, 1994, J CLIN INVEST, V93, P615, DOI 10.1172/JCI117014; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1439, P1, DOI 10.1016/S1388-1981(99)00063-3; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5; Weinrauch Y, 1996, J CLIN INVEST, V97, P250, DOI 10.1172/JCI118399; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Wootton PTE, 2007, HUM MOL GENET, V16, P1437, DOI 10.1093/hmg/ddm094; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Yanaru-Fujisawa R, 2007, DIS COLON RECTUM, V50, P223, DOI 10.1007/s10350-006-0780-2; YOKODE M, 1988, J CLIN INVEST, V81, P720, DOI 10.1172/JCI113377; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	77	92	100	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33483	33497		10.1074/jbc.M804628200	http://dx.doi.org/10.1074/jbc.M804628200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18801741	Green Published, hybrid			2022-12-25	WOS:000261183700053
J	Abu-Elneel, K; Ochiishi, T; Medina, M; Remedi, M; Gastaldi, L; Caceres, A; Kosik, KS				Abu-Elneel, Kawther; Ochiishi, Tomoyo; Medina, Miguel; Remedi, Monica; Gastaldi, Laura; Caceres, Alfredo; Kosik, Kenneth S.			A delta-Catenin Signaling Pathway Leading to Dendritic Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; REGULATES SPINE MORPHOGENESIS; CULTURED HIPPOCAMPAL-NEURONS; X MENTAL-RETARDATION; P120 CATENIN; E-CADHERIN; DESMOSOMAL PLAQUE; COFILIN PHOSPHORYLATION; SYNAPTIC PLASTICITY; CONTACT FORMATION	delta-Catenin is a synaptic adherens junction protein pivotally positioned to serve as a signaling sensor and integrator. Expression of delta-catenin induces filopodia-like protrusions in neurons. Here we show that the small GTPases of the Rho family act coordinately as downstream effectors of delta-catenin. A dominant negative Rac prevented delta-catenin-induced protrusions, and Cdc42 activity was dramatically increased by delta-catenin expression. A kinase dead LIMK (LIM kinase) and a mutant Cofilin also prevented delta-catenin-induced protrusions. To link the effects of delta-catenin to a physiological pathway, we noted that (S)-3,5-dihydroxyphenylglycine (DHPG) activation of metabotropic glutamate receptors induced dendritic protrusions that are very similar to those induced by delta-catenin. Furthermore, delta-catenin RNA-mediated interference can block the induction of dendritic protrusions by DHPG. Interestingly, DHPG dissociated PSD-95 and N-cadherin from the delta-catenin complex, increased the association of delta-catenin with Cortactin, and induced the phosphorylation of delta-catenin within the sites that bind to these protein partners.	[Ochiishi, Tomoyo] Natl Inst Adv Ind Sci & Technol, Mol Neurobiol Grp, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Abu-Elneel, Kawther; Medina, Miguel; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Abu-Elneel, Kawther; Medina, Miguel; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Remedi, Monica; Gastaldi, Laura; Caceres, Alfredo] Consejo Nacl Invest Cient & Tecn, Inst Invest Med Mercedes & Martin Ferreya, RA-5000 Cordoba, Argentina	National Institute of Advanced Industrial Science & Technology (AIST); University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Ochiishi, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Mol Neurobiol Grp, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan.	tomoyo.ochiishi@aist.go.jp; kosik@lifesci.ucsb.edu	Ochiishi, Tomoyo/L-7041-2018; Medina, Miguel/I-7135-2019; Medina, Miguel/J-1642-2019; Medina, Miguel/H-5676-2012	Ochiishi, Tomoyo/0000-0001-6290-6471; Medina, Miguel/0000-0002-7016-5340	W.M. Keck Foundation	W.M. Keck Foundation(W.M. Keck Foundation)	Support for this work was provided by the W.M. Keck Foundation.	Ahmed SH, 2005, P NATL ACAD SCI USA, V102, P11533, DOI 10.1073/pnas.0504438102; Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fiala JC, 1998, J NEUROSCI, V18, P8900; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Grosheva I, 2001, J CELL SCI, V114, P695; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; HEID HW, 1994, DIFFERENTIATION, V58, P113; Hering H, 2003, J NEUROSCI, V23, P11759; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hoogenraad SC, 2004, BIOESSAYS, V26, P141, DOI 10.1002/bies.10402; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; KAPPRELL HP, 1988, J CELL BIOL, V106, P1679, DOI 10.1083/jcb.106.5.1679; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; PAPA M, 1995, J NEUROSCI, V15, P1; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Sirotkin H, 1997, GENOMICS, V41, P75, DOI 10.1006/geno.1997.4627; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	65	52	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32781	32791		10.1074/jbc.M804688200	http://dx.doi.org/10.1074/jbc.M804688200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809680	hybrid			2022-12-25	WOS:000260893700067
J	Shen, H; Walters, DE; Mueller, DM				Shen, Hong; Walters, D. Eric; Mueller, David M.			Introduction of the Chloroplast Redox Regulatory Region in the Yeast ATP Synthase Impairs Cytochrome c Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL CRISTAE MORPHOLOGY; BOVINE HEART-MITOCHONDRIA; SACCHAROMYCES-CEREVISIAE; GAMMA-SUBUNIT; F1F0-ATP SYNTHASE; PERIPHERAL STALK; EPSILON-SUBUNIT; DISULFIDE BOND; P-I; F-1-ATPASE	The ATP synthase is under a number of mechanisms of regulation. The chloroplast ATPase has a unique mode of regulation in which activity is controlled by the redox state in the organelle. This mode of regulation is determined by a small unique region within the gamma-subunit and this region contains two cysteine residues. Introduction of this region within the yeast gamma-subunit causes a defect in oxidative phosphorylation. Oxidative phosphorylation is restored if the cysteine residues are replaced with serine. Biochemical analysis of the chimeric mitochondrial ATPase indicates that the ATP synthase is not largely altered with the cysteine residues in either the oxidized or reduced states. However, the level and activity of cytochrome c oxidase are decreased by about 90%, whereas that of NADH dehydrogenase and cytochrome c reductase are unchanged as compared with the wild-type enzymes. The level and activity of cytochrome c oxidase are restored with replacement of the cysteine residues with serine in the regulatory region. These results indicate that the chimeric ATP synthase containing cysteine, but not serine, decreases the expression or assembly of cytochrome c oxidase with little effect on the activity of the ATP synthase.	[Shen, Hong; Walters, D. Eric; Mueller, David M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Mueller, DM (corresponding author), 3333 Green Bay Rd, N Chicago, IL 60064 USA.	david.mueller@RosalindFranklin.edu	Walters, D. Eric/C-9626-2010	Walters, D. Eric/0000-0002-1513-3522	National Institutes of Health [R01-GM067091, R01-GM066223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067091, R01GM066223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM067091 and R01-GM066223 (to D. M. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact..	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Bakhtiari N, 1999, J BIOL CHEM, V274, P16363, DOI 10.1074/jbc.274.23.16363; Bald D, 2000, J BIOL CHEM, V275, P12757, DOI 10.1074/jbc.275.17.12757; Boyle GM, 1999, EUR J BIOCHEM, V262, P315, DOI 10.1046/j.1432-1327.1999.00345.x; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Chiadmi M, 1999, EMBO J, V18, P6809, DOI 10.1093/emboj/18.23.6809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Jie LZ, 1999, EMBO J, V18, P58, DOI 10.1093/emboj/18.1.58; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Knowles AF, 1997, BBA-BIOMEMBRANES, V1329, P311, DOI 10.1016/S0005-2736(97)00123-5; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Krenn BE, 1995, BIOCHEM SOC T, V23, P757, DOI 10.1042/bst0230757; KUKI M, 1988, J BIOL CHEM, V263, P17437; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai-Zhang J, 2000, EUR J BIOCHEM, V267, P2409, DOI 10.1046/j.1432-1327.2000.01253.x; MACKLER B, 1967, METHOD ENZYMOL, V10, P295; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; MUELLER DM, 1988, J BIOL CHEM, V263, P5634; MUKHOPADHYAY A, 1994, FEBS LETT, V343, P160, DOI 10.1016/0014-5793(94)80310-2; NALIN CM, 1984, J BIOL CHEM, V259, P7275; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pedersen PL, 1996, J BIOENERG BIOMEMBR, V28, P389, DOI 10.1007/BF02113979; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; QIU ZH, 1992, BIOCHEMISTRY-US, V31, P3297, DOI 10.1021/bi00127a036; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; Samra HS, 2006, J BIOL CHEM, V281, P31041, DOI 10.1074/jbc.M603315200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, J BIOL CHEM, V276, P37861; Silvester JA, 2006, ACTA CRYSTALLOGR F, V62, P530, DOI 10.1107/S1744309106015338; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i	44	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32937	32943		10.1074/jbc.M805310200	http://dx.doi.org/10.1074/jbc.M805310200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819926	hybrid, Green Published			2022-12-25	WOS:000260893700082
J	Thelen, K; Georg, T; Bertuch, S; Zelina, P; Pollerberg, GE				Thelen, Karsten; Georg, Tanja; Bertuch, Stefanie; Zelina, Pavol; Pollerberg, G. Elisabeth			Ubiquitination and Endocytosis of Cell Adhesion Molecule DM-GRASP Regulate Its Cell Surface Presence and Affect Its Role for Axon Navigation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; GROWTH CONE; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR TRAFFICKING; CYTOPLASMIC DOMAIN; NERVOUS-SYSTEM; PROTEIN-KINASE; GANGLION-CELLS; COATED PITS	DM-GRASP, cell adhesion molecule of the immunoglobulin superfamily, has been shown to promote growth and navigation of axons. We here demonstrate that clustering of DM-GRASP in the plasma membrane induces its rapid internalization via dynamin-and clathrin-dependent endocytosis, which is controlled by phosphatidylinositol 3-kinase and mitogen-activated protein kinase ERK. The clustering of DM-GRASP activates ERK; the intensity and duration of ERK activation by DM-GRASP do not depend on rapid clathrin-mediated internalization of DM-GRASP. Moreover, the preference of retinal ganglion cell axons for DM-GRASP-coated micro-lanes requires clathrin-mediated endocytosis for the appropriate axonal turning reactions at substrate borders. Because the intracellular domain of DM-GRASP does not contain motifs for direct interactions with the endocytosis machinery, we performed a yeast two-hybrid screen to identify intracellular proteins mediating the uptake of DM-GRASP and isolated ubiquitin. Immunoprecipitation of DM-GRASP coexpressed with ubiquitin revealed that one or two ubiquitin(s) are attached to the intracellular domain of cell surface-resident DM-GRASP. Furthermore, elevated ubiquitination levels result in a decrease of cell surface-resident DM-GRASP as well as in the amount of total DM-GRASP. The endocytosis rate is not affected, but the delivery to multivesicular bodies is increased, indicating that DM-GRASP ubiquitination enhances its sorting into the degradation pathway. Together, our data show that ubiquitination and endocytosis of DM-GRASP in concert regulate its cell surface concentration, which is crucial for its function in axon navigation.	[Thelen, Karsten; Georg, Tanja; Bertuch, Stefanie; Zelina, Pavol; Pollerberg, G. Elisabeth] Univ Heidelberg, Dept Dev Neurobiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Pollerberg, GE (corresponding author), Neuenheimer Feld 232, D-69120 Heidelberg, Germany.	G.E.Pollerberg@urz.uni-heidelberg.de	Zelina, Pavol/AAO-7851-2021		 [SFB488];  [GRK484];  [GRK791]	; ; 	The work was supported by Grants SFB488, GRK484, and GRK791.	Aguilar RC, 2003, J BIOL CHEM, V278, P10737, DOI 10.1074/jbc.M211622200; Avci HX, 2004, DEV BIOL, V271, P291, DOI 10.1016/j.ydbio.2004.03.035; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; Chedotal A, 1996, J NEUROSCI, V16, P3296; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; DEBERNARDO AP, 1995, DEV BIOL, V169, P65, DOI 10.1006/dbio.1995.1127; DeBernardo AP, 1996, J CELL BIOL, V133, P657, DOI 10.1083/jcb.133.3.657; ELDEEB S, 1992, DEV BIOL, V149, P213, DOI 10.1016/0012-1606(92)90278-O; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gommerman JL, 1997, J BIOL CHEM, V272, P30519, DOI 10.1074/jbc.272.48.30519; Gu F, 1999, FEBS LETT, V452, P61, DOI 10.1016/S0014-5793(99)00561-X; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Heffron DS, 2000, J NEUROSCI, V20, P2287; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Holbrook MR, 1999, BIOCHEMISTRY-US, V38, P9348, DOI 10.1021/bi990195r; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; KANKI JP, 1994, J NEUROBIOL, V25, P831, DOI 10.1002/neu.480250708; KAYYEM JF, 1992, EUR J BIOCHEM, V208, P1, DOI 10.1111/j.1432-1033.1992.tb17152.x; Khundmiri SJ, 2004, J BIOL CHEM, V279, P17418, DOI 10.1074/jbc.M311715200; Konno A, 2001, J LEUKOCYTE BIOL, V69, P944; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; LAMAZE C, 1995, J CELL BIOL, V129, P47, DOI 10.1083/jcb.129.1.47; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Long KE, 2001, J BIOL CHEM, V276, P1285, DOI 10.1074/jbc.M006658200; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Minana R, 2001, EUR J NEUROSCI, V13, P749, DOI 10.1046/j.0953-816x.2000.01439.x; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; POLLERBERG EG, 1985, J CELL BIOL, V101, P1921, DOI 10.1083/jcb.101.5.1921; POLLERBERG GE, 1994, DEV BIOL, V165, P670, DOI 10.1006/dbio.1994.1284; POURQUIE O, 1990, DEVELOPMENT, V109, P743; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schmid RS, 2000, J NEUROSCI, V20, P4177; Sekine-Aizawa Y, 1998, EUR J NEUROSCI, V10, P2810, DOI 10.1111/j.1460-9568.1998.00288.x; Stephan JP, 1999, DEV BIOL, V212, P264, DOI 10.1006/dbio.1999.9348; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; Thelen K, 2007, SOFT MATTER, V3, P1486, DOI 10.1039/b707250c; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; VOJTEK AB, 1997, YEAST 2 HYBRID SYSTE, P29; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yang PZ, 2002, INVEST OPHTH VIS SCI, V43, P1488; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zelina P, 2005, DEVELOPMENT, V132, P3609, DOI 10.1242/dev.01934; Zimmerman AW, 2004, J CELL SCI, V117, P2841, DOI 10.1242/jcs.01139	67	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32792	32801		10.1074/jbc.M805896200	http://dx.doi.org/10.1074/jbc.M805896200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790729	hybrid			2022-12-25	WOS:000260893700068
J	Ohne, Y; Takahara, T; Hatakeyama, R; Matsuzaki, T; Noda, M; Mizushima, N; Maeda, T				Ohne, Yoichiro; Takahara, Terunao; Hatakeyama, Riko; Matsuzaki, Tomoko; Noda, Makoto; Mizushima, Noboru; Maeda, Tatsuya			Isolation of Hyperactive Mutants of Mammalian Target of Rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICTOR-MTOR COMPLEX; CELL-GROWTH CONTROL; SIGNALING PATHWAYS; BINDING PARTNER; KINASE; TOR; YEAST; NUTRIENT; RAPTOR; PHOSPHORYLATION	The mammalian target of rapamycin(mTOR) is a Ser/Thr kinase that plays essential roles in the regulation of a wide array of growth-related processes such as protein synthesis, cell sizing, and autophagy. mTOR forms two functionally distinct complexes, termed the mTOR complex 1(mTORC1) and 2 (mTORC2); only the former of which is inhibited by rapamycin. Based on the similarity between the cellular responses caused by rapamycin treatment and by nutrient starvation, it has been widely accepted that modulation in the mTORC1 activity in response to nutrient status directs these cellular responses, although direct evidence has been scarce. Here we report isolation of hyperactive mutants of mTOR. The isolated mTOR mutants exhibited enhanced kinase activity in vitro and rendered cells refractory to the dephosphorylation of the mTORC1 substrates upon amino acid starvation. Cells expressing the hyperactive mTOR mutant displayed larger cell size in a normal growing condition and were resistant to cell size reduction and autophagy induction in an amino acid-starved condition. These results indicate that the activity of mTORC1 actually directs these cellular processes in response to nutrient status and confirm the biological functions of mTORC1, which had been proposed solely from loss-of-function analyses using rapamycin and(molecular) genetic techniques. Additionally, the hyperactive mTOR mutant did not induce cellular transformation of NIH/3T3 cells, suggesting that concomitant activation of additional pathways is required for tumorigenesis. This hyperactive mTOR mutant will be a valuable tool for establishing physiological consequences of mTOR activation in cells as well as in organisms.	[Ohne, Yoichiro; Takahara, Terunao; Hatakeyama, Riko; Maeda, Tatsuya] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Matsuzaki, Tomoko; Noda, Makoto] Kyoto Univ, Dept Mol Oncol, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan	University of Tokyo; Kyoto University; Tokyo Medical & Dental University (TMDU)	Maeda, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	maeda@iam.u-tokyo.ac.jp	Ohne, Yoichiro/AGE-6061-2022; Mizushima, Noboru/C-3635-2009; Maeda, Tatsuya/L-5540-2019	Mizushima, Noboru/0000-0002-6258-6444; Hatakeyama, Riko/0000-0002-3065-6639; Matsuzaki, Tomoko/0000-0002-9878-0433	Japan Society for the Promotion of Science [KAKENHI 20658027]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Welfide Medicinal Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Welfide Medicinal Research Foundation	This work was supported in part by a Grant-in-aid for Exploratory Research KAKENHI 20658027 from the Japan Society for the Promotion of Science and grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Naito Foundation, and the Welfide Medicinal Research Foundation (all to T. Maeda).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Alarcon CM, 1996, GENE DEV, V10, P279, DOI 10.1101/gad.10.3.279; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; SIKORSKI RS, 1989, GENETICS, V122, P19; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979	48	59	59	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31861	31870		10.1074/jbc.M801546200	http://dx.doi.org/10.1074/jbc.M801546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18812319	hybrid			2022-12-25	WOS:000260760800069
J	Papic, N; Hunn, JP; Pawlowski, N; Zerrahn, J; Howard, JC				Papic, Natasa; Hunn, Julia P.; Pawlowski, Nikolaus; Zerrahn, Jens; Howard, Jonathan C.			Inactive and Active States of the Interferon-inducible Resistance GTPase, Irga6, in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-GAMMA; TOXOPLASMA-GONDII; HOST-RESISTANCE; MICE DEFICIENT; INFECTION; LRG-47; MOUSE; PROTEINS; IRGB10; IIGP1	Irga6, a myristoylated, interferon-inducible member of the immunity-related GTPase family, contributes to disease resistance against Toxoplasma gondii in mice. Accumulation of Irga6 on the T. gondii parasitophorous vacuole membrane is associated with vesiculation and ultimately disruption of the vacuolar membrane in a process that requires an intact GTP-binding domain. The role of the GTP-binding domain of Irga6 in pathogen resistance is, however, unclear. We provide evidence that Irga6 in interferon-induced, uninfected cells is predominantly in a GDP-bound state that is maintained by other interferon-induced proteins. However, Irga6 that accumulates on the parasitophorous vacuole membrane after Toxoplasma infection is in the GTP-bound form. We demonstrate that a monoclonal antibody, 10D7, specifically detects GTP-bound Irga6, and we show that the formation of the 10D7 epitope follows from a GTP-dependent conformational transition of the N terminus of Irga6, anticipating an important role of the myristoyl group on Irga6 function in vivo.	[Papic, Natasa; Hunn, Julia P.; Pawlowski, Nikolaus; Howard, Jonathan C.] Univ Cologne, Inst Genet, Dept Cell Genet, D-50674 Cologne, Germany; [Zerrahn, Jens] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	University of Cologne; Max Planck Society	Howard, JC (corresponding author), Univ Cologne, Inst Genet, Dept Cell Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	j.howard@uni-koeln.de		Howard, Jonathan/0000-0003-2756-5143	Deutsche Forschungsgemeinschaft [SPP1110, SFB635, SFB670]; University of Cologne	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Cologne	This study was supported by Deutsche Forschungsgemeinschaft Grants SPP1110, SFB635, and SFB670 and by the University of Cologne. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; BEKPEN C, 2005, GENOME BIOL, V92, pR1; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Boehm U, 1998, J IMMUNOL, V161, P6715; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; FAZEKAS SDS, 1963, BIOCHIM BIOPHYS ACTA, V71, P377; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; GILLINGHAM AK, 2007, ANN REV CELL DEV BIO; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GORINI G, 1969, J IMMUNOL, V103, P1132; Halonen SK, 2001, INFECT IMMUN, V69, P5573, DOI 10.1128/IAI.69.9.5573-5576.2001; HARLOW E, 1988, ANTIBODIES LAB MANUA, P516; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; KLEINECKE J, 1979, FEBS LETT, V107, P1255; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Santiago HC, 2005, J IMMUNOL, V175, P8165, DOI 10.4049/jimmunol.175.12.8165; TAINER JA, 1985, ANNU REV IMMUNOL, V3, P501, DOI 10.1146/annurev.iy.03.040185.002441; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; TUMA PL, 1995, J BIOL CHEM, V270, P26707, DOI 10.1074/jbc.270.44.26707; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200	33	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32143	32151		10.1074/jbc.M804846200	http://dx.doi.org/10.1074/jbc.M804846200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784077	hybrid, Green Published			2022-12-25	WOS:000260760800095
J	Paredes-Gamero, EJ; Leon, CMMP; Borojevic, R; Oshiro, MEM; Ferreira, AT				Paredes-Gamero, Edgar J.; Leon, Carlos M. M. P.; Borojevic, Radovan; Oshiro, Maria E. M.; Ferreira, Alice T.			Changes in Intracellular Ca2+ Levels Induced by Cytokines and P2 Agonists Differentially Modulate Proliferation or Commitment with Macrophage Differentiation in Murine Hematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BONE-MARROW; SIGNALING PATHWAYS; GAP-JUNCTIONS; STEM-CELLS; IN-VITRO; RECEPTOR; CONNEXIN-43; PROGENITORS; ACTIVATION	The role of intracellular Ca2+ (Ca-i(2+)) on hematopoiesis was investigated in long term bone marrow cultures using cytokines and agonists of P2 receptors. Cytokines interleukin 3 and granulocyte/macrophage colony stimulator factor promoted a modest increase in Ca-i(2+) concentration ([Ca2+](i)) with activation of phospholipase C gamma, MEK1/2, and Ca2+/calmodulin kinase II. Involvement of protein kinase C was restricted to stimulation with interleukin 3. In addition, these cytokines promoted proliferation (20 times) and an increase in the Gr-1(-)Mac-1(+) population with participation of gap junctions (GJ). Nevertheless ATP, ADP, and UTP promoted a large increase in [Ca2+](i), moderate proliferation (6 times), a reduction in the primitive Gr-1(-)Mac-1(-)c-Kit(+) population, and differentiation into macrophages without participation of GJ. It is likely that Ca-i(2+) participates as a regulator of hematopoietic signaling: moderate increases in [Ca2+](i) would be related to cytokine-dependent proliferation with participation of GJ, whereas high increases in [Ca2+](i) would be related to macrophage differentiation without maintenance of the primitive population.	[Paredes-Gamero, Edgar J.; Leon, Carlos M. M. P.; Oshiro, Maria E. M.; Ferreira, Alice T.] Univ Fed Sao Paulo, Dept Biophys, BR-04023062 Sao Paulo, Brazil; [Borojevic, Radovan] Univ Fed Rio de Janeiro, Dept Histol & Embryol, BR-21941970 Rio De Janeiro, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Paredes-Gamero, EJ (corresponding author), Univ Fed Sao Paulo, Dept Biophys, Rua Botucatu 862, BR-04023062 Sao Paulo, Brazil.	jean@biofis.epm.br	Borojevic, Radovan/V-8500-2019; Paredes-Gamero, Edgar J/C-4791-2012	Borojevic, Radovan/0000-0002-2393-7280; Paredes-Gamero, Edgar J/0000-0003-3686-8402	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo."	Adrian K, 2000, BBA-GENE STRUCT EXPR, V1492, P127, DOI 10.1016/S0167-4781(00)00094-4; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bradley HL, 2002, BLOOD, V100, P3983, DOI 10.1182/blood-2002-05-1602; Cancelas JA, 2000, BLOOD, V96, P498; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; Clifford EE, 1998, BLOOD, V91, P3172, DOI 10.1182/blood.V91.9.3172.3172_3172_3181; Collison K, 1998, J IMMUNOL, V161, P3737; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Durig J, 2000, BRIT J HAEMATOL, V111, P416, DOI 10.1046/j.1365-2141.2000.02385.x; Dutt P, 1998, J IMMUNOL, V161, P3652; Engels FHC, 1999, P NATL ACAD SCI USA, V96, P10332, DOI 10.1073/pnas.96.18.10332; Frimberger AE, 2001, BRIT J HAEMATOL, V112, P644, DOI 10.1046/j.1365-2141.2001.02542.x; Hoebertz A, 2003, TRENDS PHARMACOL SCI, V24, P290, DOI 10.1016/S0165-6147(03)00123-8; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200; Koski GK, 1999, J IMMUNOL, V163, P82; Krenacs T, 1998, AM J PATHOL, V152, P993; Lemaire I, 2006, J IMMUNOL, V177, P7257, DOI 10.4049/jimmunol.177.10.7257; Lemoli RM, 2004, BLOOD, V104, P1662, DOI 10.1182/blood-2004-03-0834; Montecino-Rodriguez E, 2000, BLOOD, V96, P917, DOI 10.1182/blood.V96.3.917.015k45_917_924; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Paraguassu-Braga FH, 2003, CELL DEATH DIFFER, V10, P1101, DOI 10.1038/sj.cdd.4401279; Paredes-Gamero EJ, 2007, EXP GERONTOL, V42, P320, DOI 10.1016/j.exger.2006.11.011; Paredes-Gamero EJ, 2006, EUR J PHARMACOL, V534, P30, DOI 10.1016/j.ejphar.2006.01.010; QUESENBERRY PJ, 1994, BLOOD CELLS, V20, P97; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; ROSENDAAL M, 1994, J CELL SCI, V107, P29; Rossi F, 1996, EMBO J, V15, P1894, DOI 10.1002/j.1460-2075.1996.tb00540.x; Rossi L, 2007, BLOOD, V109, P533, DOI 10.1182/blood-2006-01-035634; Rothermel Annette L., 2004, BMC Immunology, V5, P1; Thrower EC, 2001, TRENDS PHARMACOL SCI, V22, P580, DOI 10.1016/S0165-6147(00)01809-5; Thuringer D, 2004, ANN NY ACAD SCI, V1030, P14, DOI 10.1196/annals.1329.003; Tonon R, 2002, BIORHEOLOGY, V39, P153; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; Wandzioch E, 2004, BLOOD, V104, P51, DOI 10.1182/blood-2003-07-2554; WHETTON AD, 1988, BIOCHEM J, V256, P585, DOI 10.1042/bj2560585	40	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31909	31919		10.1074/jbc.M801990200	http://dx.doi.org/10.1074/jbc.M801990200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18775989	hybrid			2022-12-25	WOS:000260760800073
J	Hakobyan, S; Harris, CL; van den Berg, CW; Fernandez-Alonso, MC; de Jorge, EG; de Cordoba, SR; Rivas, G; Mangione, P; Pepys, MB; Morgan, BP				Hakobyan, Svetlana; Harris, Claire L.; van den Berg, Carmen W.; Carmen Fernandez-Alonso, Maria; Goicoechea de Jorge, Elena; Rodriguez de Cordoba, Santiago; Rivas, German; Mangione, Palma; Pepys, Mark B.; Morgan, B. Paul			Complement Factor H Binds to Denatured Rather than to Native Pentameric C-reactive Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED FORM; MACULAR DEGENERATION; ALTERNATIVE PATHWAY; POLYMORPHISM; ACTIVATION; VARIANT; COMPONENT; SITE; CRP; INDIVIDUALS	Binding of the complement regulatory protein, factor H, to C-reactive protein has been reported and implicated as the biological basis for association of the H402 polymorphic variant of factor H with macular degeneration. Published studies utilize solid-phase or fluid-phase binding assays to show that the factor H Y402 variant binds C-reactive protein more strongly than H402. Diminished binding of H402 variant to C-reactive protein in retinal drusen is posited to permit increased complement activation, driving inflammation and pathology. We used well validated native human C-reactive protein and pure factor H Y402H variants to test interactions. When factor H variants were incubated with C-reactive protein in the fluid phase at physiological concentrations, no association occurred. When C-reactive protein was immobilized on plastic, either non-specifically by adsorption in the presence of Ca2+ to maintain its native fold and pentameric subunit assembly or by specific Ca2+-dependent binding to immobilized natural ligands, no specific binding of either factor H variant from the fluid phase was observed. In contrast, both factor H variants reproducibly bound to C-reactive protein immobilized in the absence of Ca2+, conditions that destabilize the native fold and pentameric assembly. Both factor H variants strongly bound C-reactive protein that was denatured by heat treatment before immobilization, confirming interaction with denatured but not native C-reactive protein. We conclude that the reported binding of factor H to C-reactive protein results from denaturation of the C-reactive protein during immobilization. Differential binding to C-reactive protein, thus, does not explain association of the Y402H polymorphism with macular degeneration.	[Hakobyan, Svetlana; Harris, Claire L.; Morgan, B. Paul] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, Wales; [van den Berg, Carmen W.] Cardiff Univ, Sch Med, Dept Pharmacol, Cardiff CF14 4XN, Wales; [Carmen Fernandez-Alonso, Maria; Goicoechea de Jorge, Elena; Rodriguez de Cordoba, Santiago; Rivas, German] Ctr Invest Biol & Ciber Enfermedades Raras, Dept Mol & Cellular Physiopathol, Madrid 28040, Spain; [Carmen Fernandez-Alonso, Maria; Goicoechea de Jorge, Elena; Rodriguez de Cordoba, Santiago; Rivas, German] Ctr Invest Biol & Ciber Enfermedades Raras, Dept Prot Sci, Madrid 28040, Spain; [Mangione, Palma] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy; [Mangione, Palma; Pepys, Mark B.] Royal Free & Univ Coll Med Sch, Div Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	Cardiff University; Cardiff University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Pavia; University of London; University College London	Morgan, BP (corresponding author), Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, Wales.	morganbp@cardiff.ac.uk	Rivas, German/AAG-7458-2022; de Jorge, Elena Goicoechea/L-4580-2016; Rivas, German/AFL-7528-2022; de Cordoba, Santiago Rodriguez/K-6727-2014	Rivas, German/0000-0003-3450-7478; de Jorge, Elena Goicoechea/0000-0002-4978-2483; Rivas, German/0000-0003-3450-7478; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Mangione, Palma/0000-0003-0260-1400; Morgan, Paul/0000-0003-4075-7676	Wellcome Trust Programme [068590]; Wellcome Trust University [068823]; Spanish Ministerio de Educacion y Cultura [SAF2005-00913]; Medical Research Council [G7900510] Funding Source: researchfish; MRC [G7900510] Funding Source: UKRI	Wellcome Trust Programme(Wellcome Trust); Wellcome Trust University(Wellcome Trust); Spanish Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by Wellcome Trust Programme Grant 068590 (to B. P. M.), Wellcome Trust University Award 068823 (to C. L. H.), and Spanish Ministerio de Educacion y Cultura Grant SAF2005-00913 (to S. R. d.-C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Boguslawski G, 2007, J HEART LUNG TRANSPL, V26, P705, DOI 10.1016/j.healun.2007.04.006; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; DEBEER FC, 1982, IMMUNOLOGY, V45, P55; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gasque P, 2002, MOL NEUROBIOL, V25, P1, DOI 10.1385/MN:25:1:001; Gerl VB, 2002, INVEST OPHTH VIS SCI, V43, P1104; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; HAAPASALO K, 2008, MOL MICROBI IN PRESS; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Jarva H, 1999, J IMMUNOL, V163, P3957; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Kemp P A, 1992, J Clin Lab Immunol, V37, P147; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; MOLD C, 1984, J IMMUNOL, V133, P882; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Prosser BE, 2007, ACTA CRYSTALLOGR F, V63, P480, DOI 10.1107/S1744309107020052; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; SANCHEZCORRAL P, 1989, J IMMUNOL METHODS, V122, P105, DOI 10.1016/0022-1759(89)90340-2; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; VIGUSHIN DM, 1993, J CLIN INVEST, V91, P1351, DOI 10.1172/JCI116336; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; VOLANAKIS JE, 1974, J IMMUNOL, V113, P9; WHO Expert Committee on Biological Standardization, 1987, WHO TECHN REP SER, V760, P21; YING SC, 1989, J IMMUNOL, V143, P221; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	44	78	80	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30451	30460		10.1074/jbc.M803648200	http://dx.doi.org/10.1074/jbc.M803648200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18786923	Green Published, hybrid			2022-12-25	WOS:000260544800003
J	Tsutsui, Y; Kuri, B; Sengupta, T; Wintrode, PL				Tsutsui, Yuko; Kuri, Barbara; Sengupta, Tanusree; Wintrode, Patrick L.			The Structural Basis of Serpin Polymerization Studied by Hydrogen/Deuterium Exchange and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-EXCHANGE; CONFORMATIONAL-CHANGES; METASTABLE SERPIN; REACTIVE LOOP; BETA-SHEET; ALPHA(1)-ANTITRYPSIN; MECHANISM; POLYMERS; INHIBITOR; DYNAMICS	The serpinopathies are a group of inherited disorders that share as their molecular basis the misfolding and polymerization of serpins, an important class of protease inhibitors. Depending on the identity of the serpin, conditions arising from polymerization include emphysema, thrombosis, and dementia. The structure of serpin polymers is thus of considerable medical interest. Wild-type alpha(1)-antitrypsin will form polymers upon incubation at moderate temperatures and has been widely used as a model system for studying serpin polymerization. Using hydrogen/deuterium exchange and mass spectrometry, we have obtained molecular level structural information on the alpha(1)-antitrypsin polymer. We found that the flexible reactive center loop becomes strongly protected upon polymerization. We also found significant increases in protection in the center of beta-sheet A and in helix F. These results support a model in which linkage between serpins is achieved through insertion of the reactive center loop of one serpin into beta-sheet A of another. We have also examined the heat-induced conformational changes preceding polymerization. We found that polymerization is preceded by significant destabilization of beta-sheet C. On the basis of our results, we propose a mechanism for polymerization in which beta-strand 1C is displaced from the rest of beta-sheet C through a binary serpin/serpin interaction. Displacement of strand 1C triggers further conformational changes, including the opening of beta-sheet A, and allows for subsequent polymerization.	[Tsutsui, Yuko; Kuri, Barbara; Sengupta, Tanusree; Wintrode, Patrick L.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Wintrode, PL (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	patrick.wintrode@case.edu	S, Tanusree/AAI-8680-2021	S, Tanusree/0000-0002-6828-667X	National Institutes of Health [RO1-HL085469]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-HL085469. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cabrita LD, 2004, BIOCHEMISTRY-US, V43, P9834, DOI 10.1021/bi0491346; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Chang WSW, 1997, PROTEIN SCI, V6, P89; Crowther DC, 2003, BIOCHEMISTRY-US, V42, P2355, DOI 10.1021/bi0259305; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Deng YZ, 1999, ANAL BIOCHEM, V276, P150, DOI 10.1006/abio.1999.4347; Dunstone MA, 2000, PROTEIN SCI, V9, P417; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Kheterpal I, 2006, METHOD ENZYMOL, V413, P140, DOI 10.1016/S0076-6879(06)13008-6; Koloczek H, 1996, J PROTEIN CHEM, V15, P447, DOI 10.1007/BF01886851; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; LOMAS DA, 1995, J BIOL CHEM, V270, P16864, DOI 10.1074/jbc.270.28.16864; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Marszal E, 2003, J BIOL CHEM, V278, P19611, DOI 10.1074/jbc.M210720200; Purkayastha P, 2005, BIOCHEMISTRY-US, V44, P2642, DOI 10.1021/bi048662e; Redeker V, 2007, J MOL BIOL, V369, P1113, DOI 10.1016/j.jmb.2007.04.018; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; Tsutsui Y, 2006, BIOCHEMISTRY-US, V45, P6561, DOI 10.1021/bi060431f; Tsutsui Y, 2007, J MOL BIOL, V371, P245, DOI 10.1016/j.jmb.2007.05.039; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Zhang QW, 2008, J MOL BIOL, V376, P1348, DOI 10.1016/j.jmb.2007.12.050; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055; Zhou AW, 2003, J BIOL CHEM, V278, P15116, DOI 10.1074/jbc.M211663200	29	34	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30804	30811		10.1074/jbc.M804048200	http://dx.doi.org/10.1074/jbc.M804048200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18794298	Green Published, hybrid			2022-12-25	WOS:000260544800035
J	Zhang, YH; Shu, LM; Chen, XB				Zhang, Yanhong; Shu, Limin; Chen, Xinbin			Syntaxin 6, a Regulator of the Protein Trafficking Machinery and a Target of the p53 Family, Is Required for Cell Adhesion and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; FUNCTIONAL DOMAINS; APOPTOSIS; KINASE; ACTIVATION; GENE; EXPRESSION; PATHWAY; P21; P63	The p53 family consists of p53, p63, and p73. It has been well characterized that all of the p53 family proteins are transcription factors and capable of regulating cell cycle and apoptosis. To determine whether the p53 family exerts tumor suppression by other mechanisms, we set to identify novel p53 family target genes. Here, we found that the gene encoding STX6 (syntaxin 6), a vesicle transporter protein, is directly regulated by each of the p53 family proteins. In addition, STX6 can be induced by DNA damage and Mdm2 inhibitor Nutlin-3 in a p53-dependent manner. To examine how STX6 mediates the activity of the p53 family, STX6 is inducibly overexpressed or knocked down in various cell lines. We found that overexpression of STX6 alone has limited effect on cell proliferation. In contrast, we found that knockdown of STX6 inhibits cell proliferation and survival. We also found that knockdown of STX6 leads to cell cycle arrest and apoptosis. Interestingly, we found that p53 is necessary for STX6 knockdown-induced cell cycle arrest and apoptosis. Furthermore, we found that STX6 is necessary for proper expression of focal adhesion kinase and integrin alpha 5 adhesion receptor. Consistent with this observation, STX6 knockdown inhibits cell adhesion. Together, we postulate that STX6 is an effector and a modulator of the p53 family in the regulation of cell adhesion and survival.	[Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, VM Surg & Radiol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, VM Surg & Radiol Sci, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA121137, CA081237, CA076069]; NATIONAL CANCER INSTITUTE [R29CA076069, R01CA121137, R01CA076069, R01CA081237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA121137, CA081237, and CA076069. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Bock JB, 1996, J BIOL CHEM, V271, P17961, DOI 10.1074/jbc.271.30.17961; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; CHEN XB, 1995, CANCER RES, V55, P4257; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Dohn Michael, 2003, Methods Mol Biol, V223, P221; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ilic D, 1998, J CELL BIOL, V143, P547; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; Kabayama H, 2008, NEUROSCI LETT, V436, P340, DOI 10.1016/j.neulet.2008.03.061; Kim B, 2002, J BIOL CHEM, V277, P27393, DOI 10.1074/jbc.M201963200; Kuliawat R, 2004, MOL BIOL CELL, V15, P1690, DOI 10.1091/mbc.E03-08-0554; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Nozell S, 2003, ONCOGENE, V22, P4333, DOI 10.1038/sj.onc.1206470; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade N, 2001, J BIOL CHEM, V276, P19820, DOI 10.1074/jbc.M010838200; WALDMAN T, 1995, CANCER RES, V55, P5187; Watson RT, 2008, J CELL SCI, V121, P1243, DOI 10.1242/jcs.017517; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Xu LH, 1996, CELL GROWTH DIFFER, V7, P413; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200	43	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30689	30698		10.1074/jbc.M801711200	http://dx.doi.org/10.1074/jbc.M801711200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18779328	hybrid, Green Published			2022-12-25	WOS:000260544800025
J	Munshi-South, J				Munshi-South, Jason			Female-Biased Dispersal and Gene Flow in a Behaviorally Monogamous Mammal, the Large Treeshrew (Tupaia tana)	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; EFFECTIVE POPULATION-SIZE; TAILED DWARF LEMUR; MICROSATELLITE ANALYSIS; RELATEDNESS; EVOLUTION; CONSEQUENCES; STRATEGIES; COALESCENT; PHILOPATRY	Background: Female-biased dispersal (FBD) is predicted to occur in monogamous species due to local resource competition among females, but evidence for this association in mammals is scarce. The predicted relationship between FBD and monogamy may also be too simplistic, given that many pair-living mammals exhibit substantial extra-pair paternity. Methodology/Principal Findings: I examined whether dispersal and gene flow are female-biased in the large treeshrew (Tupaia tana) in Borneo, a behaviorally monogamous species with a genetic mating system characterized by high rates (50%) of extra-pair paternity. Genetic analyses provided evidence of FBD in this species. As predicted for FBD, I found lower mean values for the corrected assignment index for adult females than for males using seven microsatellite loci, indicating that female individuals were more likely to be immigrants. Adult female pairs were also less related than adult male pairs. Furthermore, comparison of Bayesian coalescent-based estimates of migration rates using maternally and bi-parentally inherited genetic markers suggested that gene flow is female-biased in T. tana. The effective number of migrants between populations estimated from mitochondrial DNA sequence was three times higher than the number estimated using autosomal microsatellites. Conclusions/Significance: These results provide the first evidence of FBD in a behaviorally monogamous species without mating fidelity. I argue that competition among females for feeding territories creates a sexual asymmetry in the costs and benefits of dispersal in treeshrews.	[Munshi-South, Jason] Univ Maryland, Dept Biol, Behavior, Ecol, Evolut & Syst Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Munshi-South, J (corresponding author), CUNY, Dept Nat Sci, Baruch Coll, New York, NY 10021 USA.	Jason.Munshi-South@baruch.cuny.edu	Munshi-South, Jason/A-3385-2009	Munshi-South, Jason/0000-0002-8067-4341	Institute of Tropical Biology and Conservation; University of Malaysia, Sabah; Danum Valley Management Committee; Royal Society Southeast Asian Rainforest Research Programme; Animal Behavior Society; University of Maryland; Cleveland Zoological Society; Sigma Xi; American Society of Mammalogists; Explorers Club	Institute of Tropical Biology and Conservation; University of Malaysia, Sabah; Danum Valley Management Committee; Royal Society Southeast Asian Rainforest Research Programme; Animal Behavior Society; University of Maryland; Cleveland Zoological Society; Sigma Xi; American Society of Mammalogists; Explorers Club	Institute of Tropical Biology and Conservation, University of Malaysia, Sabah, Danum Valley Management Committee, Royal Society Southeast Asian Rainforest Research Programme, Animal Behavior Society, University of Maryland, Cleveland Zoological Society, Sigma Xi, American Society of Mammalogists, and Explorers Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo ZAID, 2004, MOL ECOL, V13, P837, DOI 10.1111/j.1365-294X.2004.02132.x; Banks SC, 2002, J ZOOL, V256, P389, DOI 10.1017/S0952836902000432; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Biek R, 2006, BIOL LETT-UK, V2, P312, DOI 10.1098/rsbl.2005.0437; Blundell GM, 2002, MOL ECOL, V11, P289, DOI 10.1046/j.0962-1083.2001.01440.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bradley BJ, 2004, CURR BIOL, V14, P510, DOI 10.1016/j.cub.2004.02.062; Brookfield H.C., 1995, PLACE FOREST ENV SOC; Brotherton Peter N. M., 2003, P42; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Cutrera AP, 2005, MOL ECOL, V14, P2511, DOI 10.1111/j.1365-294X.2005.02551.x; DIETZ JM, 1993, ANIM BEHAV, V46, P1067, DOI 10.1006/anbe.1993.1297; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; Douadi MI, 2007, MOL ECOL, V16, P2247, DOI 10.1111/j.1365-294X.2007.03286.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Emmons L.H., 2000, TUPAI FIELD STUDY BO; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Fietz J, 2000, BEHAV ECOL SOCIOBIOL, V49, P8, DOI 10.1007/s002650000269; Fontanillas P, 2004, EVOLUTION, V58, P886; Fredsted T, 2007, BEHAV ECOL SOCIOBIOL, V61, P943, DOI 10.1007/s00265-006-0323-9; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Gerlach G, 2001, MOL ECOL, V10, P2307, DOI 10.1046/j.0962-1083.2001.01369.x; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; Goossens B, 2001, MOL ECOL, V10, P41, DOI 10.1046/j.1365-294X.2001.01192.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammond RL, 2006, P ROY SOC B-BIOL SCI, V273, P479, DOI 10.1098/rspb.2005.3257; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hazlitt SL, 2004, MOL ECOL, V13, P3621, DOI 10.1111/j.1365-294X.2004.02342.x; HOOD G, 2005, POPTOOLS VERSION 2 6; Hudson RR, 2000, GENETICS, V155, P2011; Ji W, 2001, MOL ECOL, V10, P1527, DOI 10.1046/j.1365-294X.2001.01287.x; Johns AG., 1997, TIMBER PRODUCTION BI; Kays RW, 2000, MOL ECOL, V9, P743, DOI 10.1046/j.1365-294x.2000.00921.x; Kitchen AM, 2006, ANIM BEHAV, V71, P1029, DOI 10.1016/j.anbehav.2005.06.015; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Ligon JD, 1999, EVOLUTION AVIAN BREE; Lynch M, 1999, GENETICS, V152, P1753; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Martin JK, 2007, BEHAVIOUR, V144, P1419, DOI 10.1163/156853907782418240; MCCRACKEN GF, 1984, Z TIERPSYCHOL, V66, P55; Mossman CA, 1999, MOL ECOL, V8, P1063, DOI 10.1046/j.1365-294x.1999.00652.x; Muller AE, 2000, BIOL REV, V75, P405, DOI 10.1017/S0006323100005533; Munshi-South J, 2006, MOL ECOL NOTES, V6, P698, DOI 10.1111/j.1471-8286.2006.01314.x; Munshi-South J, 2007, J MAMMAL, V88, P1427, DOI 10.1644/06-MAMM-A-295R1.1; Munshi-South J, 2007, BEHAV ECOL SOCIOBIOL, V62, P201, DOI 10.1007/s00265-007-0454-7; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols J., 2001, DISPERSAL; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Pusey A.E., 1987, P250; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Reichard Ulrich H., 2003, P3; Ritland K, 2004, FOREST ECOL MANAG, V197, P171, DOI 10.1016/j.foreco.2004.05.012; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schulke O, 2005, INT J PRIMATOL, V26, P903, DOI 10.1007/s10764-005-5328-0; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sun LX, 2000, CAN J ZOOL, V78, P393, DOI 10.1139/cjz-78-3-393; Thomas SC, 2005, PHILOS T R SOC B, V360, P1457, DOI 10.1098/rstb.2005.1675; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; Whitmore T.C., 1984, TROPICAL RAM FORESTS; WOLFF JO, 1994, OIKOS, V71, P349, DOI 10.2307/3546284; WOLFF JO, 1993, OIKOS, V68, P173, DOI 10.2307/3545324; Wright TF, 2005, MOL ECOL, V14, P1197, DOI 10.1111/j.1365-294X.2005.02466.x	73	12	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3228	10.1371/journal.pone.0003228	http://dx.doi.org/10.1371/journal.pone.0003228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797506	Green Submitted, Green Published, gold			2022-12-25	WOS:000264428200007
J	Turner, TL; Von Wettberg, EJ; Nuzhdin, SV				Turner, Thomas L.; Von Wettberg, Eric J.; Nuzhdin, Sergey V.			Genomic Analysis of Differentiation between Soil Types Reveals Candidate Genes for Local Adaptation in Arabidopsis lyrata	PLOS ONE			English	Article							SERPENTINE SOILS; SELECTION; EVOLUTION; IDENTIFICATION; POLYMORPHISMS; NEUTRALITY; FREQUENCY	Serpentine soil, which is naturally high in heavy metal content and has low calcium to magnesium ratios, comprises a difficult environment for most plants. An impressive number of species are endemic to serpentine, and a wide range of non-endemic plant taxa have been shown to be locally adapted to these soils. Locating genomic polymorphisms which are differentiated between serpentine and non-serpentine populations would provide candidate loci for serpentine adaptation. We have used the Arabidopsis thaliana tiling array, which has 2.85 million probes throughout the genome, to measure genetic differentiation between populations of Arabidopsis lyrata growing on granitic soils and those growing on serpentinic soils. The significant overrepresentation of genes involved in ion transport and other functions provides a starting point for investigating the molecular basis of adaptation to soil ion content, water retention, and other ecologically and economically important variables. One gene in particular, calcium-exchanger 7, appears to be an excellent candidate gene for adaptation to low Ca: Mg ratio in A. lyrata.	[Turner, Thomas L.; Von Wettberg, Eric J.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Turner, Thomas L.; Nuzhdin, Sergey V.] Univ Southern Calif, Los Angeles, CA USA	University of California System; University of California Davis; University of Southern California	Turner, TL (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	habarimbu@gmail.com	von Wettberg, Eric/C-1115-2016	von Wettberg, Eric/0000-0002-2724-0317	NSF [Predoctoral Fellowship, DEB0548991]; Center for Population Biology at UC Davis; NIH [NRSA Postdoctoral Fellowship, RGM076643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076643] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Center for Population Biology at UC Davis; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF Predoctoral Fellowship and the Center for Population Biology at UC Davis (TLT), an NIH NRSA Postdoctoral Fellowship (EVW), NIH grant RGM076643 (SVN), and NSF grant DEB0548991 (SVN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; [Anonymous], 2002, GEOLOGY PLANT LIFE E; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Berglund ABN, 2004, NEW PHYTOL, V161, P199, DOI 10.1046/j.1469-8137.2003.00934.x; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; FU YX, 1993, GENETICS, V133, P693; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Hahn MW, 2008, EVOLUTION, V62, P255, DOI 10.1111/j.1558-5646.2007.00308.x; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kruckeberg A.R., 1984, CALIFORNIA SERPENTIN; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; LATHAM RE, 1993, BARTONIA S, V57, P61; LEWONTIN RC, 1973, GENETICS, V74, P175; Lynch M, 2007, ORIGINS GENOME ARCHI; Nuzhdin SV, 2007, HEREDITY, V99, P313, DOI 10.1038/sj.hdy.6801003; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Rhoads A. F., 1993, VASCULAR FLORA PENNS; ROBERTSON A, 1975, GENETICS, V81, P775; Ronald J, 2005, GENOME RES, V15, P284, DOI 10.1101/gr.2850605; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Safford H. D., 2005, Madrono, V52, P222, DOI 10.3120/0024-9637(2005)52[222:SEITCF]2.0.CO;2; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TAJIMA F, 1989, GENETICS, V123, P585; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Turner TL, 2008, GENETICS, V179, P455, DOI 10.1534/genetics.107.083659; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wright JW, 2007, PLANT SOIL, V293, P209, DOI 10.1007/s11104-006-9181-5; Wright JW, 2006, EVOL ECOL RES, V8, P1	40	41	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3183	10.1371/journal.pone.0003183	http://dx.doi.org/10.1371/journal.pone.0003183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784841	Green Submitted, Green Published, gold			2022-12-25	WOS:000264425900005
J	Wong, GW; Krawczyk, SA; Kitidis-Mitrokostas, C; Ge, GT; Spooner, E; Hug, C; Gimeno, R; Lodish, HF				Wong, G. William; Krawczyk, Sarah A.; Kitidis-Mitrokostas, Claire; Ge, Guangtao; Spooner, Eric; Hug, Christopher; Gimeno, Ruth; Lodish, Harvey F.			Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin	FASEB JOURNAL			English	Article						C1q/TNF family; adipokine; diabetes; obesity	COMPLEMENT-RELATED PROTEIN; CONSERVED LYSINE RESIDUES; TYPE-2 DIABETIC-PATIENTS; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; COLLAGENOUS DOMAIN; HORMONE ADIPONECTIN; POSTTRANSLATIONAL MODIFICATIONS; PLASMA-CONCENTRATIONS; LIPID-METABOLISM	Adiponectin is a major insulin-sensitizing, multimeric hormone derived from adipose tissue that acts on muscle and liver to regulate whole-body glucose and lipid metabolism. Here, we describe a novel and highly conserved paralog of adiponectin designated as C1q/TNF-related protein (CTRP) 9. Of all the CTRP paralogs, CTRP9 shows the highest degree of amino acid identity to adiponectin in its globular C1q domain. CTRP9 is expressed predominantly in adipose tissue and females expresses higher levels of the transcript than males. Moreover, its expression levels in ob/ob mice changed in an age-dependent manner, with significant up-regulation in younger mice. CTRP9 is a secreted glycoprotein with multiple post-translational modifications in its collagen domain that include hydroxylated prolines and hydroxylated and glycosylated lysines. It is secreted as multimers (predominantly trimers) from transfected cells and circulates in the mouse serum with levels varying according to sex and metabolic state of mice. Furthermore, CTRP9 and adiponectin can be secreted as heterooligomers when cotransfected into mammalian cells, and in vivo, adiponectin/CTRP9 complexes can be reciprocally coimmunoprecipitated from the serum of adiponectin and CTRP9 transgenic mice. Biochemical analysis demonstrates that adiponectin and CTRP9 associate via their globular C1q domain, and this interaction does not require their conserved N-terminal cysteines or their collagen domains. Furthermore, we show that adiponectin and CTRP9 form heterotrimers. In cultured myotubes, CTRP9 specifically activates AMPK, Akt, and p44/42 MAPK signaling pathways. Adenovirus-mediated overexpression of CTRP9 in obese (ob/ob) mice significantly lowered serum glucose levels. Collectively, these results suggest that CTRP9 is a novel adipokine, and further study of CTRP9 will yield novel mechanistic insights into its physiological and metabolic function. Wong, G. W., Krawczyk, S. A., Kitidis-Mitrokostas, C., Ge, G., Spooner, E., Hug, C., Gimeno, R., Lodish, H. F. Identification and characterization of CTRP9, a novel secreted glycoprotein from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J. 23, 241-258 (2009)	[Wong, G. William; Krawczyk, Sarah A.; Kitidis-Mitrokostas, Claire; Ge, Guangtao; Spooner, Eric; Hug, Christopher; Lodish, Harvey F.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gimeno, Ruth] Wyeth Res, Cardiovasc & Metab Dis, Cambridge, MA USA; [Hug, Christopher] Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA; [Hug, Christopher] Harvard Univ, Sch Med, Boston, MA USA; [Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Pfizer; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gwwong@jhmi.edu; gwwong@jhmi.edu		Wong, G. William/0000-0002-5286-6506	U. S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R37 DK47618 - 19]; NIH [HL077499 - 01, F32DK067835]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL077499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK067835, R37DK047618] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Prakash Rao, Joseph Marszalek, Alec Cheng Cheng Zhang, and Kelly Wong for helpful comments during the course of this work. This work was supported in part by U. S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R37 DK47618 - 19 (to H. F. L.), NIH KO8 grant HL077499 - 01 (to C. H.), and NIH National Research Service Award postdoctoral fellowship F32DK067835 (to G. W. W.)	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Aso Y, 2006, DIABETES, V55, P1954, DOI 10.2337/db05-1525; Bao DS, 2006, MOL CELL BIOL, V26, P9327, DOI 10.1128/MCB.01161-06; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bobbert T, 2005, DIABETES, V54, P2712, DOI 10.2337/diabetes.54.9.2712; Cai GW, 2004, DIABETES, V53, P1369, DOI 10.2337/diabetes.53.5.1369; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325; KONDO N, 1992, J BIOL CHEM, V267, P473; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pang Z, 2000, J NEUROSCI, V20, P6333, DOI 10.1523/JNEUROSCI.20-17-06333.2000; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Satoh H, 2005, DIABETES, V54, P1304, DOI 10.2337/diabetes.54.5.1304; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; STOKES DG, 1991, J BIOL CHEM, V266, P8626; Suzuki S, 2007, FEBS LETT, V581, P809, DOI 10.1016/j.febslet.2007.01.046; TAKAMATSU N, 1993, MOL CELL BIOL, V13, P1516, DOI 10.1128/MCB.13.3.1516; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tonelli J, 2004, DIABETES, V53, P1621, DOI 10.2337/diabetes.53.6.1621; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2006, PROTEOMICS, V6, P3862, DOI 10.1002/pmic.200500840; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi Toshimasa, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P243, DOI 10.2174/1568008033340090; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829	66	215	231	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					241	258		10.1096/fj.08-114991	http://dx.doi.org/10.1096/fj.08-114991			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18787108	Green Published			2022-12-25	WOS:000262095500027
J	Siegel, C; Schreiber, J; Haupt, K; Skerka, C; Brade, V; Simon, MM; Stevenson, B; Wallich, R; Zipfel, PF; Kraiczy, P				Siegel, Corinna; Schreiber, Johanna; Haupt, Katrin; Skerka, Christine; Brade, Volker; Simon, Markus M.; Stevenson, Brian; Wallich, Reinhard; Zipfel, Peter F.; Kraiczy, Peter			Deciphering the Ligand-binding Sites in the Borrelia burgdorferi Complement Regulator-acquiring Surface Protein 2 Required for Interactions with the Human Immune Regulators Factor H and Factor H-like Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR FACTOR-H; SERUM RESISTANCE; FUNCTIONAL-CHARACTERIZATION; VIRULENCE FACTOR; RELAPSING FEVER; HERMSII FHBA; EXPRESSION; EVASION; IDENTIFICATION; INFECTION	Borrelia burgdorferi, the etiologic agent of Lyme disease, employs sophisticated means to evade killing by its mammalian hosts. One important immune escape mechanism is the inhibition of complement activation mediated by interactions of the host-derived immune regulators factor H (CFH) and factor H-like protein 1 (CFHL1) with borrelial complement regulator-acquiring surface proteins (BbCRASPs). BbCRASP-2 is a distinctive CFH- and CFHL1-binding protein that is produced by serum-resistant B. burgdorferi strains. Here we show that binding of CFH by BbCRASP-2 is due to electrostatic as well as hydrophobic forces. In addition, 14 individual amino acid residues of BbCRASP-2 were identified as being involved in CFH and CFHL1 binding. Alanine substitutions of most of those residues significantly inhibited binding of CFH and/or CFHL1 by recombinant BbCRASP-2 proteins. To conclusively define the effects of BbCRASP-2 residue substitutions on serum sensitivity in the bacterial context, a serum-sensitive Borrelia garinii strain was transformed with plasmids that directed production of either wildtype or mutated BbCRASP-2 proteins. Critical amino acid residues within BbCRASP-2 were identified, with bacteria producing distinct mutant proteins being unable to bind either CFH or CFHL1, showing high levels of complement components C3, C6, and C5b-9 deposited on their surfaces and being highly sensitive to killing by normal serum. Collectively, we mapped a structurally sensitive CFH/CFHL1 binding site within borrelial BbCRASP-2 and identified single amino acid residues potentially involved in the interaction with both complement regulators.	[Siegel, Corinna; Schreiber, Johanna; Brade, Volker; Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, D-60596 Frankfurt, Germany; [Haupt, Katrin; Skerka, Christine; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, D-79108 Freiburg, Germany; [Stevenson, Brian] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany; [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hans Knoll Institute (HKI); Max Planck Society; University of Kentucky; Ruprecht Karls University Heidelberg; Friedrich Schiller University of Jena	Kraiczy, P (corresponding author), Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	Kraiczy@em.uni-frankfurt.de			Deutsche Forschungsgemeinschaft [Kr3383/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft ( Grant Kr3383/1-1 to P. K.). This work forms part of the doctoral theses of C. S. and J. S. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alitalo A, 2004, J IMMUNOL, V172, P6195, DOI 10.4049/jimmunol.172.10.6195; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; BRADE V, 1992, IMMUNOBIOLOGY, V185, P453, DOI 10.1016/S0171-2985(11)80087-2; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Bykowski T, 2008, INT J MED MICROBIOL, V298, P249, DOI 10.1016/j.ijmm.2007.10.002; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Coleman AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003010; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Embers ME, 2004, MICROBES INFECT, V6, P312, DOI 10.1016/j.micinf.2003.11.014; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Hauser U, 1999, J CLIN MICROBIOL, V37, P2241, DOI 10.1128/JCM.37.7.2241-2247.1999; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Herzberger P, 2007, INFECT IMMUN, V75, P4817, DOI 10.1128/IAI.00532-07; Hovis KM, 2008, INFECT IMMUN, V76, P2113, DOI 10.1128/IAI.01266-07; Hovis KM, 2006, INFECT IMMUN, V74, P2007, DOI 10.1128/IAI.74.4.2007-2014.2006; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001; Jarva H, 2004, J IMMUNOL, V172, P3111, DOI 10.4049/jimmunol.172.5.3111; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Johnsson E, 1998, J IMMUNOL, V161, P4894; KOLLMAN PA, 1994, CURR OPIN STRUC BIOL, V4, P240, DOI 10.1016/S0959-440X(94)90315-8; Kotarsky H, 1998, J IMMUNOL, V160, P3349; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; Kraiczy P, 2000, IMMUNOBIOLOGY, V201, P406, DOI 10.1016/S0171-2985(00)80094-7; Kraiczy P, 2008, CLIN VACCINE IMMUNOL, V15, P484, DOI 10.1128/CVI.00415-07; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; Kuhn S, 1996, EUR J IMMUNOL, V26, P2383, DOI 10.1002/eji.1830261017; KUHN S, 1995, J IMMUNOL, V155, P5663; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lu L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/jbc.M602404200; McDowell JV, 2003, J CLIN MICROBIOL, V41, P3905, DOI 10.1128/JCM.41.8.3905-3910.2003; Metts MS, 2003, INFECT IMMUN, V71, P3587, DOI 10.1128/IAI.71.6.3587-3596.2003; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Miller JC, 2006, INT J MED MICROBIOL, V296, P185, DOI 10.1016/j.ijmm.2006.01.010; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Prodinger WM, 1998, BIOCHEM J, V331, P41, DOI 10.1042/bj3310041; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; Rogers EA, 2007, INFECT IMMUN, V75, P5272, DOI 10.1128/IAI.00850-07; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; SAMUELS SD, 1995, ELECTROPORATION PROT, V47; Siegel C, 2008, INT J MED MICROBIOL, V298, P292, DOI 10.1016/j.ijmm.2007.12.007; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; VanDam AP, 1997, INFECT IMMUN, V65, P1228, DOI 10.1128/IAI.65.4.1228-1236.1997; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; von Lackum K, 2005, INFECT IMMUN, V73, P7398, DOI 10.1128/IAI.73.11.7398-7405.2005; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Zipfel PF, 1999, IMMUNOL TODAY, V20, P135, DOI 10.1016/S0167-5699(98)01432-7	63	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34855	34863		10.1074/jbc.M805844200	http://dx.doi.org/10.1074/jbc.M805844200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18824548	Green Published, hybrid			2022-12-25	WOS:000261469100041
J	Muller, M; Essin, K; Hill, K; Beschmann, H; Rubant, S; Schempp, CM; Gollasch, M; Boehncke, WH; Harteneck, C; Muller, WE; Leuner, K				Mueller, Margarethe; Essin, Kirill; Hill, Kerstin; Beschmann, Heike; Rubant, Simone; Schempp, Christoph M.; Gollasch, Maik; Boehncke, W. Henning; Harteneck, Christian; Mueller, Walter E.; Leuner, Kristina			Specific TRPC6 Channel Activation, a Novel Approach to Stimulate Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ST-JOHNS-WORT; CALCIUM-INDUCED DIFFERENTIATION; HUMAN GINGIVAL KERATINOCYTES; ATOPIC-DERMATITIS; EPIDERMAL DIFFERENTIATION; ULTRASTRUCTURAL-LOCALIZATION; SENSING RECEPTOR; HYPERFORIN; PSORIASIS; BARRIER	The protective epithelial barrier in our skin undergoes constant regulation, whereby the balance between differentiation and proliferation of keratinocytes plays a major role. Impaired keratinocyte differentiation and proliferation are key elements in the pathophysiology of several important dermatological diseases, including atopic dermatitis and psoriasis. Ca2+ influx plays an essential role in this process presumably mediated by different transient receptor potential (TRP) channels. However, investigating their individual role was hampered by the lack of specific stimulators or inhibitors. Because we have recently identified hyperforin as a specific TRPC6 activator, we investigated the contribution of TRPC6 to keratinocyte differentiation and proliferation. Like the endogenous differentiation stimulus high extracellular Ca2+ concentration ([Ca2+](o)), hyperforin triggers differentiation in HaCaT cells and in primary cultures of human keratinocytes by inducing Ca2+ influx via TRPC6 channels and additional inhibition of proliferation. Knocking down TRPC6 channels prevents the induction of Ca2+- and hyperforin-induced differentiation. Importantly, TRPC6 activation is sufficient to induce keratinocyte differentiation similar to the physiological stimulus [Ca2+](o). Therefore, TRPC6 activation by hyperforin may represent a new innovative therapeutic strategy in skin disorders characterized by altered keratinocyte differentiation.	[Mueller, Margarethe; Mueller, Walter E.; Leuner, Kristina] Univ Frankfurt, Bioctr Niederursel, Inst Pharmacol, D-60439 Frankfurt, Germany; [Essin, Kirill; Gollasch, Maik] Charite Univ Med Berlin, Sect Nephrol Intens Care, D-13353 Berlin, Germany; [Essin, Kirill; Gollasch, Maik] Max Delbruck Ctr Berlin Buch, Franz Volhard Clin, D-13353 Berlin, Germany; [Hill, Kerstin; Harteneck, Christian] Charite Univ Med Berlin, D-14195 Berlin, Germany; [Beschmann, Heike; Rubant, Simone; Boehncke, W. Henning] Univ Frankfurt, Dept Dermatol, D-60590 Frankfurt, Germany; [Schempp, Christoph M.] Univ Med Ctr Freiburg, Dept Dermatol, D-79104 Freiburg, Germany	Goethe University Frankfurt; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Franz-Volhard Clinical Research Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; University of Freiburg	Leuner, K (corresponding author), Univ Frankfurt, Bioctr Niederursel, Inst Pharmacol, Max Von Laue Str 9, D-60439 Frankfurt, Germany.	Leuner@em.uni-frankfurt.de	Friedland, Kristina/G-4651-2015	Friedland, Kristina/0000-0001-8603-5957; Muller, Werner E.G./0000-0002-8223-3689	Casella Med GmbH & Co. KG(Cologne, Germany); German Research Foundation	Casella Med GmbH & Co. KG(Cologne, Germany); German Research Foundation(German Research Foundation (DFG))	This work was supported by a research grant from Casella Med GmbH & Co. KG(Cologne, Germany) and the German Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck B, 2008, CELL CALCIUM, V43, P492, DOI 10.1016/j.ceca.2007.08.005; Beck B, 2006, J INVEST DERMATOL, V126, P1982, DOI 10.1038/sj.jid.5700352; Bikle DD, 1996, J CLIN INVEST, V97, P1085, DOI 10.1172/JCI118501; Bovenschen HJ, 2005, BRIT J DERMATOL, V153, P72, DOI 10.1111/j.1365-2133.2005.06538.x; Cai SW, 2006, PFLUG ARCH EUR J PHY, V452, P43, DOI 10.1007/s00424-005-0001-1; Cai SW, 2005, J DERMATOL SCI, V40, P21, DOI 10.1016/j.jdermsci.2005.06.005; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; Fatherazi S, 2007, PFLUG ARCH EUR J PHY, V453, P879, DOI 10.1007/s00424-006-0156-4; Forslind B, 1987, Acta Derm Venereol Suppl (Stockh), V134, P1; GERDES J, 1984, J IMMUNOL, V133, P1710; GUREVICH AI, 1971, ANTIBIOT MED BIOTEK, V16, P510; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hwang SM, 2001, INT J DERMATOL, V40, P223, DOI 10.1046/j.1365-4362.2001.01158.x; Jensen JM, 2004, J INVEST DERMATOL, V122, P1423, DOI 10.1111/j.0022-202X.2004.22621.x; Lehen'kyi V, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611398200; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MAISENBACHER P, 1992, PLANTA MED, V58, P351, DOI 10.1055/s-2006-961483; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Muller WE, 2003, PHARMACOL RES, V47, P101, DOI 10.1016/S1043-6618(02)00266-9; Pallon J, 1996, CELL MOL BIOL, V42, P111; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; Schempp CA, 2003, PHYTOMEDICINE, V10, P31, DOI 10.1078/1433-187X-00306; Schempp CM, 2005, PLANTA MED, V71, P999, DOI 10.1055/s-2005-871303; Schempp CM, 1999, LANCET, V353, P2129, DOI 10.1016/S0140-6736(99)00214-7; Schempp CM, 2000, BRIT J DERMATOL, V142, P979, DOI 10.1046/j.1365-2133.2000.03482.x; SHARPE GR, 1989, FEBS LETT, V254, P25, DOI 10.1016/0014-5793(89)81002-6; Treiber K, 2005, BRIT J PHARMACOL, V145, P75, DOI 10.1038/sj.bjp.0706155; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	39	82	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33942	33954		10.1074/jbc.M801844200	http://dx.doi.org/10.1074/jbc.M801844200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818211	hybrid, Green Published			2022-12-25	WOS:000261277700021
J	Rigoni, M; Paoli, M; Milanesi, E; Caccin, P; Rasola, A; Bernardi, P; Montecucco, C				Rigoni, Michela; Paoli, Marco; Milanesi, Eva; Caccin, Paola; Rasola, Andrea; Bernardi, Paolo; Montecucco, Cesare			Snake Phospholipase A(2) Neurotoxins Enter Neurons, Bind Specifically to Mitochondria, and Open Their Transition Pores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BUNGAROTOXIN; PERMEABILITY TRANSITION; NEUROMUSCULAR-JUNCTION; PRESYNAPTIC NEUROTOXINS; SYNAPTIC VESICLES; CELL-DEATH; TAIPOXIN; VENOM; NERVE; INHIBITION	Snake presynaptic neurotoxins with phospholipase A(2) activity are potent inducers of paralysis through inhibition of the neuromuscular junction. These neurotoxins were recently shown to induce exocytosis of synaptic vesicles following the production of lysophospholipids and fatty acids and a sustained influx of Ca2+ from the medium. Here, we show that these toxins are able to penetrate spinal cord motor neurons and cerebellar granule neurons and selectively bind to mitochondria. As a result of this interaction, mitochondria depolarize and undergo a profound shape change from elongated and spaghetti-like to round and swollen. We show that snake presynaptic phospholipase A(2) neurotoxins facilitate opening of the mitochondrial permeability transition pore, an inner membrane high-conductance channel. The relative potency of the snake neurotoxins was similar for the permeability transition pore opening and for the phospholipid hydrolysis activities, suggesting a causal relationship, which is also supported by the effect of phospholipid hydrolysis products, lysophospholipids and fatty acids, on mitochondrial pore opening. These findings contribute to define the cellular events that lead to intoxication of nerve terminals by these snake neurotoxins and suggest that mitochondrial impairment is an important determinant of their toxicity.	[Rigoni, Michela; Paoli, Marco; Caccin, Paola; Rasola, Andrea; Bernardi, Paolo; Montecucco, Cesare] Univ Padua, Dipartimento Sci Biomed Sperimentali, I-35121 Padua, Italy; [Rigoni, Michela; Paoli, Marco; Caccin, Paola; Rasola, Andrea; Bernardi, Paolo; Montecucco, Cesare] CNR, Ist Neurosci, I-35121 Padua, Italy; [Milanesi, Eva] Congenia Srl, I-20139 Milan, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Montecucco, C (corresponding author), Univ Padua, Dipartimento Sci Biomed Sperimentali, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	cesare.montecucco@unipd.it	Paoli, Marco/HDO-6474-2022; Bernardi, Paolo/C-3656-2008	Bernardi, Paolo/0000-0001-9187-3736; Paoli, Marco/0000-0001-5672-1403; Rasola, Andrea/0000-0003-4522-3008	Telethon [GGP06133, GGP04113]; Fondazione Cariparo Progetto "Physiopathology of the Synapse: Neurotransmitters, Neurotoxins and Novel Therapies; Ministero dell' Universita e della Ricerca	Telethon(Fondazione Telethon); Fondazione Cariparo Progetto "Physiopathology of the Synapse: Neurotransmitters, Neurotoxins and Novel Therapies(Fondazione Cariparo); Ministero dell' Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by Telethon Grants GGP06133 and GGP04113, the Fondazione Cariparo Progetto "Physiopathology of the Synapse: Neurotransmitters, Neurotoxins and Novel Therapies" (to C. M.), and by the Ministero dell' Universita e della Ricerca (to P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Bonanomi D, 2005, MOL PHARMACOL, V67, P1901, DOI 10.1124/mol.104.005678; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; CHEN I, 1970, VIRCHOWS ARCH B, V6, P318; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Connolly S, 1995, ANN NEUROL, V38, P916, DOI 10.1002/ana.410380612; CULLCANDY SG, 1976, NEUROSCIENCE, V1, P175, DOI 10.1016/0306-4522(76)90074-9; Dixon RW, 1999, AM J PATHOL, V154, P447, DOI 10.1016/S0002-9440(10)65291-1; DODDS D, 1995, J NEUROCHEM, V64, P2339; FOHLMAN J, 1979, EUR J BIOCHEM, V94, P531, DOI 10.1111/j.1432-1033.1979.tb12922.x; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; GOPALAKRISHNAKONE P, 1984, TOXICON, V22, P791, DOI 10.1016/0041-0101(84)90162-4; HALPERT J, 1976, FEBS LETT, V61, P72, DOI 10.1016/0014-5793(76)80174-3; Herkert M, 2001, EUR J NEUROSCI, V14, P821, DOI 10.1046/j.0953-816x.2001.01699.x; LEE CY, 1984, ARCH INT PHARMACOD T, V268, P313; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; Means G.E., 1971, CHEM MODIFICATION PR, P214; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Neco P, 2003, J NEUROCHEM, V85, P329, DOI 10.1046/j.1471-4159.2003.01682.x; NG RH, 1980, P NATL ACAD SCI-BIOL, V77, P1346, DOI 10.1073/pnas.77.3.1346; PAPINI E, 1989, J BIOL CHEM, V264, P12385; Petrovic U, 2004, BIOCHEM BIOPH RES CO, V324, P981, DOI 10.1016/j.bbrc.2004.09.144; Prasarnpun S, 2005, BRAIN, V128, P2987, DOI 10.1093/brain/awh642; Prasarnpun S, 2004, NEUROPHARMACOLOGY, V47, P304, DOI 10.1016/j.neuropharm.2004.04.012; Praznikar ZJ, 2008, BBA-MOL CELL RES, V1783, P1129, DOI 10.1016/j.bbamcr.2008.01.011; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Rigoni M, 2004, J CELL SCI, V117, P3561, DOI 10.1242/jcs.01218; Rigoni M, 2007, J BIOL CHEM, V282, P11238, DOI 10.1074/jbc.M610176200; Rossetto Ornella, 2008, V184, P129; Rossetto O, 2006, J NEUROCHEM, V97, P1534, DOI 10.1111/j.1471-4159.2006.03965.x; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; SIMPSON LL, 1994, J PHARMACOL EXP THER, V269, P256; Sribar J, 2003, FEBS LETT, V553, P309, DOI 10.1016/S0014-5793(03)01035-4; Sribar J, 2003, BIOCHEM BIOPH RES CO, V302, P691, DOI 10.1016/S0006-291X(03)00228-6; Sribar J, 2001, J BIOL CHEM, V276, P12493, DOI 10.1074/jbc.C100048200; WAGNER GM, 1974, BIOCHEM BIOPH RES CO, V58, P475, DOI 10.1016/0006-291X(74)90389-1; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	42	74	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34013	34020		10.1074/jbc.M803243200	http://dx.doi.org/10.1074/jbc.M803243200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18809685	Green Published, hybrid			2022-12-25	WOS:000261277700028
J	Stoddart, CA; Nault, G; Galkina, SA; Thibaudeau, K; Bakis, P; Bousquet-Gagnon, N; Robitaille, M; Bellomo, M; Paradis, V; Liscourt, P; Lobach, A; Rivard, ME; Ptak, RG; Mankowski, MK; Bridon, D; Quraishi, O				Stoddart, Cheryl A.; Nault, Genevieve; Galkina, Sofiya A.; Thibaudeau, Karen; Bakis, Peter; Bousquet-Gagnon, Nathalie; Robitaille, Martin; Bellomo, Maryanne; Paradis, Veronique; Liscourt, Patricia; Lobach, Alexandra; Rivard, Marie-Eve; Ptak, Roger G.; Mankowski, Marie K.; Bridon, Dominique; Quraishi, Omar			Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor EQUIPOTENT TO C34 AND T-20 IN VITRO WITH SUSTAINED ACTIVITY IN SCID-HU THY/LIV MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INJECTION SITE REACTIONS; HUMAN SERUM ALBUMINS; ENVELOPE GLYCOPROTEIN; ENFUVIRTIDE T-20; COILED-COIL; HTLV-III; GP41; POTENT; ENTRY	Entry inhibitors of human immunodeficiency virus, type 1 (HIV-1) have been the focus of much recent research. C34, a potent fusion inhibitor derived from the HR2 region of gp41, was engineered into a 1:1 human serum albumin conjugate through stable covalent attachment of a maleimido-C34 analog onto cysteine 34 of albumin. This bioconjugate, PC-1505, was designed to require less frequent dosing and less peptide than T-20 and was assessed for its antifusogenic activity both in vitro and in vivo in the SCID-hu Thy/Liv mouse model. PC-1505 was essentially equipotent to the original C34 peptide and to T-20 in vitro. In HIV-1-infected SCID-hu Thy/Liv mice, T-20 lost activity with infrequent dosing, whereas the antiviral potency of PC-1505 was sustained, and PC-1505 was active against T-20-resistant ("DIV") virus with a G36D substitution in gp41. The in vivo results are the direct result of a significantly improved pharmacokinetic profile for the C34 peptide following albumin conjugation. Contrary to previous reports that the gp41 NHR trimer is poorly accessible to C34 fused to protein cargoes of increasing size (Hamburger, A. E., Kim, S., Welch, B. D., and Kay, M. S. (2005) J. Biol. Chem. 280, 12567-12572), these results are the first demonstration of the capacity for a large, endogenous serum protein to gain unobstructed access to the transient gp41 intermediates that exist during the HIV fusion process, and it supports further development of albumin conjugation as a promising approach to inhibit HIV-1 entry.	[Stoddart, Cheryl A.; Galkina, Sofiya A.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Expt Med, Dept Med, San Francisco, CA 94110 USA; [Nault, Genevieve; Thibaudeau, Karen; Bakis, Peter; Bousquet-Gagnon, Nathalie; Robitaille, Martin; Bellomo, Maryanne; Paradis, Veronique; Liscourt, Patricia; Lobach, Alexandra; Rivard, Marie-Eve; Bridon, Dominique; Quraishi, Omar] Conjuchem Biotechnol Inc, Montreal, PQ H2X 3Y8, Canada; [Ptak, Roger G.; Mankowski, Marie K.] So Res Inst, Infect Dis Res Dept, Frederick, MD 21701 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Stoddart, CA (corresponding author), Box 1234, San Francisco, CA 94143 USA.	cheryl.stoddart@.ucsf.edu; quraishi@conjuchem.com			National Institutes of Health [N01-AI-05418, N01-AI-70002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Contracts N01-AI-05418 and N01-AI-70002. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ball RA, 2003, J AM ACAD DERMATOL, V49, P826, DOI 10.1016/S0190-9622(03)02099-1; BENTHANSEN L, 1991, ACTA PHYSIOL SCAND, V143, P5; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gilden D, 1998, GMHC Treat Issues, V12, P6; Golding H, 2002, J VIROL, V76, P6780, DOI 10.1128/JVI.76.13.6780-6790.2002; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Groenink M, 1997, AIDS RES HUM RETROV, V13, P179, DOI 10.1089/aid.1997.13.179; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; Holmes DL, 2000, BIOCONJUGATE CHEM, V11, P439, DOI 10.1021/bc0000233; Jacobs A, 2007, J BIOL CHEM, V282, P32406, DOI 10.1074/jbc.M705577200; JANSEN RW, 1993, MOL PHARMACOL, V44, P1003; Jette L, 2005, ENDOCRINOLOGY, V146, P3052, DOI 10.1210/en.2004-1286; Kliger Y, 2000, J MOL BIOL, V295, P163, DOI 10.1006/jmbi.1999.3368; Kliger Y, 2001, J BIOL CHEM, V276, P1391, DOI 10.1074/jbc.M004113200; Leger R, 2004, BIOORG MED CHEM LETT, V14, P4395, DOI 10.1016/j.bmcl.2004.06.066; Leger R, 2004, BIOORG MED CHEM LETT, V14, P841, DOI 10.1016/j.bmcl.2003.12.025; Leger R, 2003, BIOORG MED CHEM LETT, V13, P3571, DOI 10.1016/S0960-894X(03)00790-X; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Maggi P, 2004, J ANTIMICROB CHEMOTH, V53, P678, DOI 10.1093/jac/dkh141; Manfredi R, 2006, CURR MED CHEM, V13, P2369, DOI 10.2174/092986706777935069; Meanwell NA, 2003, CURR OPIN DRUG DISC, V6, P451; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Olson W. C., 2003, Current Drug Targets - Infectious Disorders, V3, P283, DOI 10.2174/1568005033481015; Opalka D, 2004, J IMMUNOL METHODS, V287, P49, DOI 10.1016/j.jim.2004.01.016; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Petersen S, 1996, J CONSTR PSYCHOL, V9, P75; POPOVIC M, 1984, LANCET, V2, P1472; Porter CJH, 2000, J PHARM SCI-US, V89, P297, DOI 10.1002/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Rabin L, 1996, ANTIMICROB AGENTS CH, V40, P755, DOI 10.1128/AAC.40.3.755; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Roman F, 2003, JAIDS-J ACQ IMM DEF, V33, P134, DOI 10.1097/00126334-200306010-00003; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Stoddart CA, 2000, ANTIMICROB AGENTS CH, V44, P783, DOI 10.1128/AAC.44.3.783-786.2000; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001251; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000655; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Swart PJ, 1996, J DRUG TARGET, V4, P109, DOI 10.3109/10611869609046269; TAKAMI M, 1992, BIOCHIM BIOPHYS ACTA, V1180, P180, DOI 10.1016/0925-4439(92)90066-V; Thibaudeau K, 2005, BIOCONJUGATE CHEM, V16, P1000, DOI 10.1021/bc050102k; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weiss Carol D, 2003, AIDS Rev, V5, P214	47	60	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34045	34052		10.1074/jbc.M805536200	http://dx.doi.org/10.1074/jbc.M805536200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18809675	hybrid, Green Published			2022-12-25	WOS:000261277700032
J	van den Bogaart, G; Guzman, JV; Mika, JT; Poolman, B				van den Bogaart, Geert; Guzman, Jeanette Velasquez; Mika, Jacek T.; Poolman, Bert			On the Mechanism of Pore Formation by Melittin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE-BURST ANALYSIS; ANTIMICROBIAL PEPTIDES; PHOSPHOLIPID-BILAYERS; ELECTRON-MICROSCOPY; LIPID-BILAYERS; MEMBRANE PORES; BEE VENOM; VESICLES; BINDING; PROTEIN	The mechanism of pore formation of lytic peptides, such as melittin from bee venom, is thought to involve binding to the membrane surface, followed by insertion at threshold levels of bound peptide. We show that in membranes composed of zwitterionic lipids, i.e. phosphatidylcholine, melittin not only forms pores but also inhibits pore formation. We propose that these two modes of action are the result of two competing reactions: direct insertion into the membrane and binding parallel to the membrane surface. The direct insertion of melittin leads to pore formation, whereas the parallel conformation is inactive and prevents other melittin molecules from inserting, hence preventing pore formation.	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Poolman, B (corresponding author), Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Institute, Zernike/W-7033-2019; Poolman, Bert/D-1882-2012; van den Bogaart, Geert/A-1089-2014; van den Bogaart, Geert/GLV-3283-2022	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735	Dutch Science Foundation (NWO) [ALW-814.02.002]; Zernike Institute for Advanced Materials	Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO)); Zernike Institute for Advanced Materials	This work was supported by the Dutch Science Foundation (NWO, Grant ALW-814.02.002) and the Zernike Institute for Advanced Materials. The costs of publication of this article were defrayed in part by the payment of page charges.	ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; BENACHIR T, 1995, BBA-BIOMEMBRANES, V1235, P452, DOI 10.1016/0005-2736(95)80035-E; BESCHIASCHVILI G, 1991, BIOCHIM BIOPHYS ACTA, V1068, P195, DOI 10.1016/0005-2736(91)90210-Y; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BROWN LR, 1980, BIOCHIM BIOPHYS ACTA, V622, P231, DOI 10.1016/0005-2795(80)90034-3; DUFOURCQ J, 1977, BIOCHIM BIOPHYS ACTA, V467, P1, DOI 10.1016/0005-2736(77)90236-X; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j; GOTO Y, 1992, BIOCHEMISTRY-US, V31, P732, DOI 10.1021/bi00118a014; He K, 1996, BIOPHYS J, V71, P2669, DOI 10.1016/S0006-3495(96)79458-4; Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; HUANG HW, 1995, J PHYS II, V5, P1427, DOI 10.1051/jp2:1995103; Kleinschmidt JH, 1997, BIOPHYS J, V72, P767, DOI 10.1016/S0006-3495(97)78711-3; Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760; KUBOTA S, 1986, BIOPOLYMERS, V25, P1493, DOI 10.1002/bip.360250808; Ladokhin AS, 1997, BIOPHYS J, V72, P1762, DOI 10.1016/S0006-3495(97)78822-2; Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Lee TH, 2001, J PEPT RES, V58, P464, DOI 10.1034/j.1399-3011.2001.10974.x; Lin JJ, 2007, ANAL BIOCHEM, V367, P49, DOI 10.1016/j.ab.2007.04.039; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Park SC, 2006, BIOCHEM BIOPH RES CO, V343, P222, DOI 10.1016/j.bbrc.2006.02.090; Popplewell JF, 2007, BBA-BIOMEMBRANES, V1768, P13, DOI 10.1016/j.bbamem.2006.05.016; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Schumann M, 1997, BIOCHEMISTRY-US, V36, P4345, DOI 10.1021/bi962304x; SCHWARZ G, 1989, BIOCHIM BIOPHYS ACTA, V979, P82, DOI 10.1016/0005-2736(89)90526-9; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; STEINER H, 1988, BIOCHIM BIOPHYS ACTA, V939, P260, DOI 10.1016/0005-2736(88)90069-7; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; van den Bogaart G, 2007, BIOPHYS J, V93, P154, DOI 10.1529/biophysj.107.106005; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X	35	133	137	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33854	33857		10.1074/jbc.M805171200	http://dx.doi.org/10.1074/jbc.M805171200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819911	Green Published, hybrid			2022-12-25	WOS:000261277700009
J	Yegneswaran, S; Hackeng, TM; Dawson, PE; Griffin, JH				Yegneswaran, Subramanian; Hackeng, Tilman M.; Dawson, Philip E.; Griffin, John H.			The Thrombin-sensitive Region of Protein S Mediates Phospholipid-dependent Interaction with Factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT ANTICOAGULANT ACTIVITY; FACTOR V-A; ACTIVE-SITE; MEMBRANE-SURFACE; TISSUE FACTOR; PROTHROMBINASE COMPLEX; STRUCTURAL-CHANGES; CHEMICAL-SYNTHESIS; PATHWAY INHIBITOR; ENERGY-TRANSFER	To test the hypothesis that factor Xa (fXa) interacts with protein S, fXa was labeled active-site specifically with a dansyl (D) dye via a Glu-Gly-Arg (EGR) tether to yield DEGR-fXa(i). When protein S was added to phosphatidylcholine/phosphatidylserine (PC/PS, 4:1) vesicle-bound DEGR-fXa(i), the anisotropy of the dansyl moiety was altered from 0.219 +/- 0.002 to 0.245 +/- 0.003. This change in dansyl anisotropy was not observed when DEGR-Xa(i) was titrated with protein S in the absence of PC/PS vesicles, or in the presence of 100% PC vesicles, or when PC/PS vesicle-bound DEGR-fXa(i) was titrated with thrombin-cleaved protein S. The protein S-dependent dansyl fluorescence change was specific for fXa because it was not observed for two homologous and similarly labeled DEGR-fIXa(i) and DEGR-fVIIa(i). Furthermore, protein S specifically and saturably altered the fluorescence anisotropy of PC/PS-bound active site-labeled LWB-FPR-fXa(i) (K-d = 33 nM) and was photocross-linked to PC/PS-bound LWB-FPR-fXa(i) analog, independently confirming the above results. Chemically synthesized microprotein S, comprising residues 1-116 of protein S and including the gamma-carboxyglutamic-rich domain, the thrombin-sensitive region (TSR), and the first epidermal growth factor-like domain (EGF1) of protein S, altered the anisotropy of PC/PS-bound DEGR-fXa(i) from 0.219 to 0.242, similar to the effect of the protein S titration (K-d = 303 nM), suggesting that microprotein S binds to DEGR-fXa(i). To identify individual protein S domain(s) that binds DEGR-fXa(i), the EGF1 and TSR domains were chemically synthesized and studied. The TSR altered the anisotropy of DEGR-fXa(i) by similar to 16%(K-d = 3.9 mu M), but the EGF1 domain had no effect on the signal. In controls, the TSR domain did not alter the anisotropy of DEGR-fIXa(i) and DEGR-fVIIa(i), respectively. These data demonstrate that membrane-bound fXa binding to protein S involves the TSR of protein S.	[Yegneswaran, Subramanian; Griffin, John H.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Dawson, Philip E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Dawson, Philip E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Hackeng, Tilman M.] Univ Maastricht, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Maastricht University	Griffin, JH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jgriffin@scripps.edu		Griffin, John/0000-0002-4302-2547; Hackeng, Tilman/0000-0003-0142-0843	National Institutes of Health [R01 HL21544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL21544 (to J.H.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; Hackeng TM, 2000, BIOCHEM J, V349, P757, DOI 10.1042/bj3490757; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; Hackeng TM, 1998, BIOPOLYMERS, V46, P53, DOI 10.1002/(SICI)1097-0282(199808)46:2<53::AID-BIP1>3.0.CO;2-W; Hackeng TM, 2000, P NATL ACAD SCI USA, V97, P14074, DOI 10.1073/pnas.260239797; Hayashi T, 1995, BBA-MOL BASIS DIS, V1272, P159, DOI 10.1016/0925-4439(95)00081-X; Heeb MJ, 2006, J THROMB HAEMOST, V4, P2215, DOI 10.1111/j.1538-7836.2006.02117.x; Heeb MJ, 2006, J THROMB HAEMOST, V4, P385, DOI 10.1111/j.1538-7836.2006.01743.x; HEEB MJ, 1994, P NATL ACAD SCI USA, V91, P2728, DOI 10.1073/pnas.91.7.2728; HOLBROOK JJ, 1973, BIOCHEM J, V131, P739, DOI 10.1042/bj1310739; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; Koppaka V, 1997, BIOPHYS J, V73, P2638, DOI 10.1016/S0006-3495(97)78293-6; Koppaka V, 1996, BIOPHYS J, V70, P2930, DOI 10.1016/S0006-3495(96)79863-6; Long GL, 1998, J BIOL CHEM, V273, P11521, DOI 10.1074/jbc.273.19.11521; Majumder R, 2003, BIOPHYS J, V84, P1238, DOI 10.1016/S0006-3495(03)74939-X; Mann KG, 2005, BLOOD, V106, P1884, DOI 10.1182/blood-2004-12-4706; McCallum CD, 1996, J BIOL CHEM, V271, P28168, DOI 10.1074/jbc.271.45.28168; MUTUCUMARANA VP, 1992, J BIOL CHEM, V267, P17012; Ndonwi M, 2008, J THROMB HAEMOST, V6, P1044, DOI 10.1111/j.1538-7836.2008.02980.x; Pauls JED, 2000, BIOCHEMISTRY-US, V39, P5468, DOI 10.1021/bi992747b; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Sere KM, 2001, BIOCHEMISTRY-US, V40, P8852; Stenberg Y, 1999, J MOL BIOL, V293, P653, DOI 10.1006/jmbi.1999.3139; STINSON RA, 1973, BIOCHEM J, V131, P719, DOI 10.1042/bj1310719; van Wijnen M, 1998, THROMB HAEMOSTASIS, V80, P930; van't Veer C, 1999, THROMB HAEMOSTASIS, V82, P80; vanWijnen M, 1996, THROMB HAEMOSTASIS, V76, P397; YE J, 1991, J BIOL CHEM, V266, P23016; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013; Yegneswaran S, 2002, CHEM BIOL, V9, P485, DOI 10.1016/S1074-5521(02)00132-1	32	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33046	33052		10.1074/jbc.M806527200	http://dx.doi.org/10.1074/jbc.M806527200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18784085	hybrid, Green Published			2022-12-25	WOS:000261183700004
J	Lund, IK; Jogi, A; Rono, B; Rasch, MG; Lund, LR; Almholt, K; Gardsvoll, H; Behrendt, N; Romer, J; Hoyer-Hansen, G				Lund, Ida K.; Joegi, Annika; Rono, Birgitte; Rasch, Morten G.; Lund, Leif R.; Almholt, Kasper; Gardsvoll, Henrik; Behrendt, Niels; Romer, John; Hoyer-Hansen, Gunilla			Antibody-mediated Targeting of the Urokinase-type Plasminogen Activator Proteolytic Function Neutralizes Fibrinolysis in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-DEFICIENT MICE; MONOCLONAL-ANTIBODIES; BREAST-CANCER; TUMOR-GROWTH; BINDING REGION; U937 MONOCYTES; ANTHRAX TOXIN; RECEPTOR; METASTASIS; SYSTEM	Urokinase-type plasminogen activator (uPA) plays a central role in tissue remodeling processes. Most of our understanding of the role of uPA in vivo is derived from studies using gene-targeted uPA-deficient mice. To enable in vivo studies on the specific interference with uPA functionality in mouse models, we have now developed murine monoclonal antibodies (mAbs) directed against murine uPA by immunization of uPA-deficient mice with the recombinant protein. Guided by enzyme-linked immunosorbent assay, Western blotting, surface plasmon resonance, and enzyme kinetic analyses, we have selected two highly potent and inhibitory anti-uPA mAbs (mU1 and mU3). Both mAbs recognize epitopes located on the B-chain of uPA that encompasses the catalytic site. In enzyme activity assays in vitro, mU1 blocked uPA-catalyzed plasminogen activation as well as plasmin-mediated pro-uPA activation, whereas mU3 only was directed against the first of these reactions. We additionally provide evidence that mU1, but not mU3, successfully targets uPA-dependent processes in vivo. Hence, systemic administration of mU1 (i) rescued mice treated with a uPA-activable anthrax protoxin and (ii) impaired uPA-mediated hepatic fibrinolysis in tissue-type plasminogen activator (tPA)-deficient mice, resulting in a phenotype mimicking that of uPA; tPA double deficient mice. Importantly, this is the first report demonstrating specific antagonist-directed targeting of mouse uPA at the enzyme activity level in a normal physiological process in vivo.	[Lund, Ida K.; Joegi, Annika; Rono, Birgitte; Rasch, Morten G.; Lund, Leif R.; Almholt, Kasper; Gardsvoll, Henrik; Behrendt, Niels; Romer, John; Hoyer-Hansen, Gunilla] Rigshosp, Finsen Lab, Copenhagen BioCtr, DK-2200 Copenhagen N, Denmark	Rigshospitalet	Lund, IK (corresponding author), Rigshosp, Finsen Lab, Copenhagen BioCtr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	ikl@finsenlab.dk	Almholt, Kasper/D-6133-2013	Almholt, Kasper/0000-0002-9250-514X; Behrendt, Niels/0000-0003-1833-3922; Jogi, Annika/0000-0003-1697-8030	H:S Copenhagen Hospital Corpation; European Union [LSHC-CT-2003-503297, 201279]; MICROENVIMET; Danish Cancer Society; Danish Cancer Research Foundation; Dagmar Marshall's Foundation; Fru Astrid Thaysen's Legat for Laegevidenskabelig Grundforskning; Swedish Society for Medical Research	H:S Copenhagen Hospital Corpation; European Union(European Commission); MICROENVIMET; Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; Dagmar Marshall's Foundation; Fru Astrid Thaysen's Legat for Laegevidenskabelig Grundforskning; Swedish Society for Medical Research	This work was supported by the H:S Copenhagen Hospital Corpation, European Union Grants LSHC-CT-2003-503297 and Grant 201279, MICROENVIMET, the Danish Cancer Society, the Danish Cancer Research Foundation, Dagmar Marshall's Foundation, Fru Astrid Thaysen's Legat for Laegevidenskabelig Grundforskning, and the Swedish Society for Medical Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Almholt K, 2005, INT J CANCER, V113, P525, DOI 10.1002/ijc.20631; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Behrendt N, 2003, BIOCHEM J, V371, P277, DOI 10.1042/BJ20021508; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Carmeliet P, 1998, J CELL BIOL, V140, P233, DOI 10.1083/jcb.140.1.233; Collen D, 2005, THROMB HAEMOSTASIS, V93, P627, DOI 10.1160/TH04-11-0724; DANO K, 1980, BIOCHIM BIOPHYS ACTA, V613, P542, DOI 10.1016/0005-2744(80)90110-2; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DECLERCK PJ, 1995, J BIOL CHEM, V270, P8397, DOI 10.1074/jbc.270.15.8397; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; ELLIS V, 1991, J BIOL CHEM, V266, P12752; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Green KA, 2005, BIOESSAYS, V27, P894, DOI 10.1002/bies.20281; Groner B, 2004, CURR MOL MED, V4, P539, DOI 10.2174/1566524043360483; Guo YJ, 2002, CANCER RES, V62, P4678; Guo YJ, 2000, FASEB J, V14, P1400, DOI 10.1096/fj.14.10.1400; Harbeck N, 2004, THROMB HAEMOSTASIS, V91, P450, DOI 10.1160/TH03-12-0798; Jogi A, 2007, J THROMB HAEMOST, V5, P1936, DOI 10.1111/j.1538-7836.2007.02653.x; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Mishima K, 2000, P NATL ACAD SCI USA, V97, P8484, DOI 10.1073/pnas.150239497; Pass J, 2007, THROMB HAEMOSTASIS, V97, P1013, DOI 10.1160/TH06-11-0644; PETERSEN LC, 1988, J BIOL CHEM, V263, P11189; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Schmitt M, 1997, THROMB HAEMOSTASIS, V78, P285; Scott KA, 2003, MOL CANCER THER, V2, P445; Setyono-Han B, 2005, THROMB HAEMOSTASIS, V93, P779, DOI 10.1160/TH04-11-0712; Shanmukhappa K, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-40; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939	40	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32506	32515		10.1074/jbc.M801924200	http://dx.doi.org/10.1074/jbc.M801924200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18799467	hybrid			2022-12-25	WOS:000260893700039
J	Moreau, M; Lee, GI; Wang, Y; Crane, BR; Klessig, DF				Moreau, Magali; Lee, Gyu In; Wang, Yongzeng; Crane, Brian R.; Klessig, Daniel F.			AtNOS/AtNOA1 Is a Functional Arabidopsis thaliana cGTPase and Not a Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; PLANT NITRATE REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; RNA-BINDING; PROTEIN; NO; SUBUNIT; GTPASES	AtNOS1 was previously identified as a potential nitric-oxide synthase (NOS) in Arabidopsis thaliana, despite lack of sequence similarity to animal NOSs. Although the dwarf and yellowish leaf phenotype of Atnos1 knock-out mutant plants can be rescued by treatment with exogenous NO, doubts have recently been raised as to whether AtNOS1 is a true NOS. Moreover, depending on the type of physiological responses studied, Atnos1 is not always deficient in NO induction and/or detection, as previously reported. Here, we present experimental evidence showing that AtNOS1 is unable to bind and oxidize arginine to NO. These results support the argument that AtNOS1 is not a NOS. We also show that the renamed NO-associated protein 1 (AtNOA1) is a member of the circularly permuted GTPase family (cGTPase). AtNOA1 specifically binds GTP and hydrolyzes it. Complementation experiments of Atnoa1 mutant plants with different constructs of AtNOA1 show that GTP hydrolysis is necessary but not sufficient for the physiological function of AtNOA1. Mutant AtNOA1 lacking the C-terminal domain, although retaining GTPase activity, failed to complement Atnoa1, suggesting that this domain plays a crucial role in planta. cGTPases appear to be RNA-binding proteins, and the closest homolog of AtNOA1, the Bacillus subtilis YqeH, has been shown to participate in ribosome assembly and stability. We propose a similar function for AtNOA1 and discuss it in the light of its potential role in NO accumulation and plant development.	[Moreau, Magali; Lee, Gyu In; Wang, Yongzeng; Klessig, Daniel F.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Moreau, Magali; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Klessig, DF (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	dfk8@cornell.edu			National Institutes of Health [5R01GM067011]; National Science Foundation [CHE-0749996]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM067011 (to D. F. K.). This work was also supported by National Science Foundation Grant CHE-0749996 (to B. R. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Bassler J, 2006, J BIOL CHEM, V281, P24737, DOI 10.1074/jbc.M604261200; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bethke PC, 2006, J EXP BOT, V57, P517, DOI 10.1093/jxb/erj060; Bethke PC, 2004, PLANT CELL, V16, P332, DOI 10.1105/tpc.017822; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Campbell TL, 2008, J BACTERIOL, V190, P2537, DOI 10.1128/JB.01744-07; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; Cladiere L, 2006, MOL GENET GENOMICS, V275, P409, DOI 10.1007/s00438-006-0097-9; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Cueto M, 1996, FEBS LETT, V398, P159, DOI 10.1016/S0014-5793(96)01232-X; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Daigle DM, 2002, BIOCHEMISTRY-US, V41, P11109, DOI 10.1021/bi020355q; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; Flores-Perez U, 2008, PLANT CELL, V20, P1303, DOI 10.1105/tpc.108.058768; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P1703, DOI 10.1093/nar/29.8.1703; Guo FG, 2006, TRENDS PLANT SCI, V11, P527, DOI 10.1016/j.tplants.2006.09.006; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; HALL A, 1986, J BIOL CHEM, V261, P963; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; HEVEL JM, 1994, METHOD ENZYMOL, V233, P250; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Huang S, 1997, J NEUROCHEM, V69, P2516; KILBY NJ, 1992, PLANT MOL BIOL, V20, P103, DOI 10.1007/BF00029153; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kolbert Z, 2008, J PLANT PHYSIOL, V165, P967, DOI 10.1016/j.jplph.2007.07.019; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lamotte O, 2004, PLANT PHYSIOL, V135, P516, DOI 10.1104/pp.104.038968; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Levdikov VM, 2004, J MOL BIOL, V340, P767, DOI 10.1016/j.jmb.2004.05.029; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; Majumdar S, 2004, J BIOL CHEM, V279, P40137, DOI 10.1074/jbc.M405420200; Martinez-Vicente M, 2005, J BIOL CHEM, V280, P30660, DOI 10.1074/jbc.M503223200; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Mishra R, 2005, PROTEINS, V59, P332, DOI 10.1002/prot.20413; Moreau M, 2004, J INORG BIOCHEM, V98, P1200, DOI 10.1016/j.jinorgbio.2004.03.015; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Mur LAJ, 2006, J EXP BOT, V57, P489, DOI 10.1093/jxb/erj052; MURPHY ME, 1994, METHOD ENZYMOL, V233, P240; Neill SJ, 2002, PLANT PHYSIOL, V128, P13, DOI 10.1104/pp.010707; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Pan JY, 1998, BIOESSAYS, V20, P516, DOI 10.1002/(SICI)1521-1878(199806)20:6<516::AID-BIES11>3.0.CO;2-3; Planchet E, 2005, PLANT J, V41, P732, DOI 10.1111/j.1365-313X.2005.02335.x; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Rockel P, 2002, J EXP BOT, V53, P103, DOI 10.1093/jexbot/53.366.103; Rutthard H, 2001, J BIOL CHEM, V276, P18728, DOI 10.1074/jbc.M102122200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Shi FM, 2008, BMB REP, V41, P79, DOI 10.5483/BMBRep.2008.41.1.079; Shin DH, 2004, P NATL ACAD SCI USA, V101, P13198, DOI 10.1073/pnas.0405202101; Stohr C, 2006, J EXP BOT, V57, P463, DOI 10.1093/jxb/erj058; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Travis J, 2004, SCIENCE, V306, P960; Tun NN, 2008, NEW PHYTOL, V178, P515, DOI 10.1111/j.1469-8137.2008.02383.x; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Wink DA, 2001, ANTIOXID REDOX SIGN, V3, P203, DOI 10.1089/152308601300185179; Yamasaki H, 2000, FEBS LETT, V468, P89, DOI 10.1016/S0014-5793(00)01203-5; Yang M, 1997, J MOL BIOL, V270, P696, DOI 10.1006/jmbi.1997.1149; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zemojtel T, 2006, FEBS LETT, V580, P455, DOI 10.1016/j.febslet.2005.12.038; Zemojtel T, 2004, TRENDS BIOCHEM SCI, V29, P224, DOI 10.1016/j.tibs.2004.03.005; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao MG, 2007, PLANT PHYSIOL, V144, P206, DOI 10.1104/pp.107.096842; Zhao MG, 2007, J PLANT PHYSIOL, V164, P737, DOI 10.1016/j.jplph.2006.03.002; Zottini M, 2007, J EXP BOT, V58, P1397, DOI 10.1093/jxb/erm001	82	227	249	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32957	32967		10.1074/jbc.M804838200	http://dx.doi.org/10.1074/jbc.M804838200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801746	hybrid, Green Published			2022-12-25	WOS:000260893700084
J	Stoddart, LA; Smith, NJ; Jenkins, L; Brown, AJ; Milligan, G				Stoddart, Leigh A.; Smith, Nicola J.; Jenkins, Laura; Brown, Andrew J.; Milligan, Graeme			Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; G-ALPHA PROTEINS; DRUG DISCOVERY; INSULIN-SECRETION; CONSTITUTIVE ACTIVITY; AGONIST RECOGNITION; LIGAND-BINDING; C-TERMINUS; GPR40; ACTIVATION	FFA2 and FFA3 are closely related G protein-coupled receptors that bind and respond to short chain fatty acids. (FFA2 and FFA3 are the provisional International Union of Pharmacology designations for the receptors previously called GPR43 and GPR41, respectively.) Sequence comparisons between these two receptors and alignments with the related G protein-coupled receptor FFA1, linked to homology modeling based on the atomic level structure of bovine rhodopsin, indicated the potential for polar residues within the transmembrane helix bundle to play important roles in ligand recognition and function. In both FFA2 and FFA3, mutation of either an arginine at the top of transmembrane domain V or a second arginine at the top of transmembrane domain VII eliminated the function of a range of short chain fatty acids. Mutation of a histidine in transmembrane domain VI, predicted to be in proximity to both the arginine residues, also eliminated function in many but not all assay formats. By contrast, mutation of a histidine in transmembrane domain IV, predicted to be lower in the binding pocket, modulated function in some assays of FFA3 function but had limited effects on the function of acetate and propionate at FFA2. Interestingly, wild type FFA3 responded to caproate, whereas FFA2 did not. Mutation of the transmembrane domain IV histidine eliminated responses of FFA3 to caproate but resulted in a gain of function of FFA2 to this six-carbon fatty acid. These data demonstrate the importance of positively charged residues in the recognition and/or function of short chain fatty acids in both FFA2 and FFA3. The development of small molecule ligands that interact selectively with these receptors will allow further details of the binding pockets to be elucidated.	[Stoddart, Leigh A.; Smith, Nicola J.; Jenkins, Laura; Milligan, Graeme] Univ Glasgow, Fac Biomed & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Brown, Andrew J.] GlaxoSmithKline, Dept Screening & Compound Profiling, Harlow CM19 5AW, Essex, England	University of Glasgow; GlaxoSmithKline	Milligan, G (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Mol Pharmacol Grp, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	g.milligan@bio.gla.ac.uk	Brown, Andrew J/G-6403-2013; Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519; Stoddart, Leigh/0000-0002-4469-0600; Brown, Andrew James/0000-0002-5616-3664; Smith, Nicola J/0000-0002-7247-9562	Biotechnology and Biosciences Research Council [BB/E019455/1]; BBSRC [BB/E019455/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E019455/1] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biosciences Research Council Grant BB/E019455/1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berkhout TA, 2003, J MED CHEM, V46, P4070, DOI 10.1021/jm030862l; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2005, DNA CELL BIOL, V24, P54, DOI 10.1089/dna.2005.24.54; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; Covington DK, 2006, BIOCHEM SOC T, V34, P770, DOI 10.1042/BST0340770; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Garrido DM, 2006, BIOORG MED CHEM LETT, V16, P1840, DOI 10.1016/j.bmcl.2006.01.007; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kenakin T, 2008, J RECEPT SIG TRANSD, V28, P109, DOI 10.1080/10799890801946318 ; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; Kostenis E, 2005, J PHARMACOL EXP THER, V313, P78, DOI 10.1124/jpet.104.080424; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Liu S, 2002, J BIOL CHEM, V277, P25707, DOI 10.1074/jbc.M201015200; MCCLUE SJ, 1992, BIOCHEM J, V284, P565, DOI 10.1042/bj2840565; Milasta S, 2006, MOL PHARMACOL, V69, P479, DOI 10.1124/mol.105.018788; Milligan G, 1999, TRENDS PHARMACOL SCI, V20, P118, DOI 10.1016/S0165-6147(99)01320-6; Milligan G, 2006, CELL SIGNAL, V18, P1360, DOI 10.1016/j.cellsig.2006.03.011; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Sabirsh A, 2006, BIOCHEMISTRY-US, V45, P5733, DOI 10.1021/bi060076t; Song FB, 2007, J MED CHEM, V50, P2807, DOI 10.1021/jm070130j; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stitham J, 2003, J BIOL CHEM, V278, P4250, DOI 10.1074/jbc.M207420200; STODDART LA, 2008, PHARM REV IN PRESS; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Wise A, 1999, BIOCHEMISTRY-US, V38, P2272, DOI 10.1021/bi982054f	39	82	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32913	32924		10.1074/jbc.M805601200	http://dx.doi.org/10.1074/jbc.M805601200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801738	hybrid			2022-12-25	WOS:000260893700080
J	Cunha, SR; Mohler, PJ				Cunha, Shane R.; Mohler, Peter J.			Obscurin Targets Ankyrin-B and Protein Phosphatase 2A to the Cardiac M-line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROCYTE ANKYRIN; AXON INITIAL SEGMENTS; C-TERMINAL DOMAIN; SARCOPLASMIC-RETICULUM; NEONATAL CARDIOMYOCYTES; SKELETAL-MUSCLE; INOSITOL 1,4,5-TRISPHOSPHATE; SPECTRIN CYTOSKELETON; ISOFORM SPECIFICITY; RYANODINE RECEPTOR	Ankyrin-B targets ion channels and transporters in excitable cells. Dysfunction in ankyrin-B-based pathways results in defects in cardiac physiology. Despite a wealth of knowledge regarding the role of ankyrin-B for cardiac function, little is known regarding the mechanisms underlying ankyrin-B regulation. Moreover, the pathways underlying ankyrin-B targeting in heart are unclear. We report that alternative splicing regulates ankyrin-B localization and function in cardiomyocytes. Specifically, we identify a novel exon (exon 43') in the ankyrin-B regulatory domain that mediates interaction with the Rho-GEF obscurin. Ankyrin-B transcripts harboring exon 43' represent the primary cardiac isoform in human and mouse. We demonstrate that ankyrin-B and obscurin are co-localized at the M-line of myocytes and co-immunoprecipitate from heart. We define the structural requirements for ankyrin-B/obscurin interaction to two motifs in the ankyrin-B regulatory domain and demonstrate that both are critical for obscurin/ankyrin-B interaction. In addition, we demonstrate that interaction with obscurin is required for ankyrin-B M-line targeting. Specifically, both obscurin-binding motifs are required for the M-line targeting of a GFP-ankyrin-B regulatory domain. Moreover, this construct acts as a dominant-negative by competing with endogenous ankyrin-B for obscurin-binding at the M-line, thus providing a powerful new tool to evaluate the function of obscurin/ankyrin-B interactions. With this new tool, we demonstrate that the obscurin/ankyrin-B interaction is critical for recruitment of PP2A to the cardiac M-line. Together, these data provide the first evidence for the molecular basis of ankyrin-B and PP2A targeting and function at the cardiac M-line. Finally, we report that ankyrin-B R1788W is localized adjacent to the ankyrin-B obscurin-binding motif and increases binding activity for obscurin. In summary, our new findings demonstrate that ANK2 is subject to alternative splicing that gives rise to unique polypeptides with diverse roles in cardiac function.	[Cunha, Shane R.; Mohler, Peter J.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Mohler, Peter J.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Cunha, SR (corresponding author), 285 Newton Rd,CBRB 2283, Iowa City, IA 52242 USA.	shane-cunha@uiowa.edu			National Institutes of Health [HL084583, HL083422]; Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422, R01HL084583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583 and HL083422 (to P. J. M.). This work was also supported by Pew Scholars Trust (to P. J. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Beck KA, 1997, J CELL SCI, V110, P1239; Benian GM, 1996, J CELL BIOL, V132, P835, DOI 10.1083/jcb.132.5.835; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Birkenmeier CS, 1998, GENOMICS, V50, P79, DOI 10.1006/geno.1998.5305; BIRKENMEIER CS, 1993, J BIOL CHEM, V268, P9533; Borisov AB, 2006, HISTOCHEM CELL BIOL, V125, P227, DOI 10.1007/s00418-005-0069-x; Borisov AB, 2004, J HISTOCHEM CYTOCHEM, V52, P1117, DOI 10.1369/jhc.3A6183.2004; Borzok MA, 2007, J BIOL CHEM, V282, P32384, DOI 10.1074/jbc.M704089200; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; Brewis N, 2000, AM J PHYSIOL-HEART C, V279, pH1307, DOI 10.1152/ajpheart.2000.279.3.H1307; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Das A, 2006, J CELL BIOL, V175, P325, DOI 10.1083/jcb.200602095; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; DAVIS LH, 1992, J BIOL CHEM, V267, P18966; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; DRENCKHAHN D, 1987, EUR J CELL BIOL, V43, P479; Dubreuil RR, 2006, J MEMBRANE BIOL, V211, P151, DOI 10.1007/s00232-006-0863-y; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Fukuzawa A, 2005, J MUSCLE RES CELL M, V26, P427, DOI 10.1007/s10974-005-9025-6; Gagelin C, 2002, J BIOL CHEM, V277, P12978, DOI 10.1074/jbc.M111299200; Gallagher PG, 1998, J BIOL CHEM, V273, P1339, DOI 10.1074/jbc.273.3.1339; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Gotthardt M, 2003, J BIOL CHEM, V278, P6059, DOI 10.1074/jbc.M211723200; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; HALL TG, 1987, J BIOL CHEM, V262, P10537; Hopitzan AA, 2006, MOL BIOL EVOL, V23, P46, DOI 10.1093/molbev/msj004; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; LAMBERT S, 1990, P NATL ACAD SCI USA, V87, P1730, DOI 10.1073/pnas.87.5.1730; LAMBERT S, 1993, J NEUROSCI, V13, P3725; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2004, J BIOL CHEM, V279, P25798, DOI 10.1074/jbc.M401296200; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Musa H, 2006, J CELL SCI, V119, P4322, DOI 10.1242/jcs.03198; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Peng J, 2007, CIRCULATION, V115, P743, DOI 10.1161/CIRCULATIONAHA.106.645499; PETERS LL, 1991, J CELL BIOL, V114, P1233, DOI 10.1083/jcb.114.6.1233; Raeker MO, 2006, DEV DYNAM, V235, P2018, DOI 10.1002/dvdy.20812; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sherman J, 2005, HEART RHYTHM, V2, P1218, DOI 10.1016/j.hrthm.2005.07.026; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; Weinert S, 2006, J CELL BIOL, V173, P559, DOI 10.1083/jcb.200601014; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621	73	63	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31968	31980		10.1074/jbc.M806050200	http://dx.doi.org/10.1074/jbc.M806050200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782775	Green Published, hybrid			2022-12-25	WOS:000260760800079
J	Hasan, MR; Tosha, T; Theil, EC				Hasan, Mohammad R.; Tosha, Takehiko; Theil, Elizabeth C.			Ferritin Contains Less Iron (Fe-59) in Cells When the Protein Pores Are Unfolded by Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL; RELEASE; MOBILIZATION; MECHANISM; STORAGE	Ferric minerals in ferritins are protected from cytoplasmic reductants and Fe2+ release by the protein nanocage until iron need is signaled. Deletion of ferritin genes is lethal; two critical ferritin functions are concentrating iron and oxidant protection (consuming cytoplasmic iron and oxygen in the mineral). In solution, opening/closing (gating) of eight ferritin protein pores controls reactions between external reductant and the ferritin mineral; pore gating is altered by mutation, low heat, and physiological urea (1 mM) and monitored by CD spectroscopy, protein crystallography, and Fe2+ release rates. To study the effects of a ferritin pore gating mutation in living cells, we cloned/expressed human ferritin H and H L138P, homologous to the frog open pore model that was unexpressable in human cells. Human ferritin H L138P behaved like the open pore ferritin model in vitro as follows: (i) normal protein cage assembly and mineralization, (ii) increased iron release (t(1/2) decreased 17-fold), and (iii) decreased alpha-helix (8%). Overexpression (>4-fold), in HeLa cells, showed for ferritin H L138P equal protein expression and total cell Fe-59 but increased chelatable iron, 16%, p < 0.01 (Fe-59 in the deferoxamine-containing medium), and decreased Fe-59 in ferritin, 28%, p < 0.01, compared with wild type. The coincidence of decreased Fe-59 in open pore ferritin with increased chelatable Fe-59 in cells expressing the ferritin open pore mutation suggests that ferritin pore gating influences to the amount of iron (Fe-59) in ferritin in vivo.	[Theil, Elizabeth C.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94609 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Theil, EC (corresponding author), Childrens Hosp, Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	etheil@chori.org	Hasan, Mohammad/AAR-2093-2020; Tosha, Takehiko/AAR-2404-2020	Hasan, Mohammad/0000-0002-4658-7949; Tosha, Takehiko/0000-0002-8971-0759	National Institutes of Health [DK20251]; Children's Hospital Oakland Research Institute Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK020251, R37DK020251, R01DK020251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Oakland Research Institute Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK20251 (to E. C. T., M. R. H., and T. T.). This work was also supported by Children's Hospital Oakland Research Institute Foundation (to E. C. T.) and Japan Society for the Promotion of Science fellowship for research abroad (to T. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BOTHWELL TH, 1979, IRON BIOCH MED, P564; BRADY MC, 1989, J INORG BIOCHEM, V35, P9, DOI 10.1016/0162-0134(89)84002-4; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; CRICHTON RR, 1980, J INORG BIOCHEM, V13, P305, DOI 10.1016/S0162-0134(00)80251-2; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Harrison P.M., 1989, IRON CARRIERS IRON P, P123; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; IHARA K, 1984, J BIOL CHEM, V259, P278; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Kurz T, 2007, ARCH BIOCHEM BIOPHYS, V462, P220, DOI 10.1016/j.abb.2007.01.013; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; LIPSCHITZ DA, 1971, BRIT J HAEMATOL, V21, P289, DOI 10.1111/j.1365-2141.1971.tb03441.x; LISTOWSKY I, 1972, BIOCHEMISTRY-US, V11, P2176, DOI 10.1021/bi00761a026; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XS, 2007, J BIOL CHEM, V282, P31821, DOI 10.1074/jbc.C700153200; McDonough SI, 2007, TOXICON, V49, P202, DOI 10.1016/j.toxicon.2006.09.018; MERTZ JR, 1983, J BIOL CHEM, V258, P1719; Porter JB, 2007, AM J HEMATOL, V82, P1136, DOI 10.1002/ajh.21100; SCHLABACH MR, 1975, J BIOL CHEM, V250, P2182; Schwartz JK, 2008, J AM CHEM SOC, V130, P9441, DOI 10.1021/ja801251q; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; Theil EC, 2008, INORG CHIM ACTA, V361, P868, DOI 10.1016/j.ica.2007.08.025; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; WALDO GS, 1993, BIOCHEMISTRY-US, V32, P13262, DOI 10.1021/bi00211a039	36	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31394	31400		10.1074/jbc.M806025200	http://dx.doi.org/10.1074/jbc.M806025200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18805796	Green Published, hybrid			2022-12-25	WOS:000260760800018
J	Lima, CD; Reverter, D				Lima, Christopher D.; Reverter, David			Structure of the Human SENP7 Catalytic Domain and Poly-SUMO Deconjugation Activities for SENP6 and SENP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEASE; UBIQUITIN; PROTEINS; COMPLEX; NEDD8; PML; STABILIZATION; LOCALIZATION; SUMOYLATION	Small ubiquitin-like modifier (SUMO) proteases regulate the abundance and lifetime of SUMO-conjugated substrates by antagonizing reactions catalyzed by SUMO-conjugating enzymes. Six SUMO proteases constitute the human SENP/ULP protease family (SENP1-3 and SENP5-7). SENP6 and SENP7 include the most divergent class of SUMO proteases, which also includes the yeast enzyme ULP2. We present the crystal structure of the SENP7 catalytic domain at a resolution of 2.4 angstrom. Comparison with structures of human SENP1 and SENP2 reveals unique elements that differ from previously characterized structures of SUMO-deconjugating enzymes. Biochemical assays show that SENP6 and SENP7 prefer SUMO2 or SUMO3 in deconjugation reactions with rates comparable with those catalyzed by SENP2, particularly during cleavage of di-SUMO2, di-SUMO3, and poly-SUMO chains composed of SUMO2 or SUMO3. In contrast, SENP6 and SENP7 exhibit lower rates for processing pre-SUMO1, pre-SUMO2, or pre-SUMO3 in comparison with SENP2. Structure-guided mutational analysis reveals elements unique to the SENP6 and SENP7 subclass of SENP/ULP proteases that contribute to protease function during deconjugation of poly-SUMO chains.	[Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain	Memorial Sloan Kettering Cancer Center; Autonomous University of Barcelona	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	limac@mskcc.org; david.reverter@uab.cat	Reverter, David/H-5360-2015	Reverter, David/0000-0002-5347-0992; Lima, Christopher/0000-0002-9163-6092	National Institutes of Health [GM65872]; European Community [MIRG-CT-2007-200346]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65872 (to C. D. L.). This work was also supported by European Community Grant MIRG-CT-2007-200346 (to D. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L, 2002, PYMOL VERSION 0 99RC; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li YH, 2003, P NATL ACAD SCI USA, V100, P259, DOI 10.1073/pnas.0235361100; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Reverter D, 2005, J MOL BIOL, V345, P141, DOI 10.1016/j.jmb.2004.10.022; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Xu Z, 2006, BIOCHEM J, V398, P345, DOI 10.1042/BJ20060526; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	48	95	101	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32045	32055		10.1074/jbc.M805655200	http://dx.doi.org/10.1074/jbc.M805655200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799455	Green Published, hybrid			2022-12-25	WOS:000260760800086
J	Takechi, M; Seno, S; Kawamura, S				Takechi, Masaki; Seno, Sadayoshi; Kawamura, Shoji			Identification of cis-Acting Elements Repressing Blue Opsin Expression in Zebrafish UV Cones and Pineal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; VISUAL PIGMENTS; PHOTORECEPTOR DEVELOPMENT; TRANSGENIC ZEBRAFISH; GENE-EXPRESSION; SENSITIVE OPSIN; HOMEOBOX GENE; HUMAN RED; ROD; RECEPTOR	Opsin genes are expressed in a cell type-specific manner in the retina and the pineal organ for visual and nonvisual photoreceptive purposes, but the regulatory mechanism behind the tissue and cell selectivity is not well understood. In this study, we focus on the expression regulation of the blue-sensitive opsin gene SWS2 of zebrafish by taking a transgenic approach using the green fluorescence protein as an expression reporter. The zebrafish SWS2 is a single-copy gene and is expressed specifically in the "long single cones" in the retina. We found the following. 1)A0.3-kb region between 0.6 and 0.3 kb 5' of the SWS2 initiation codon, encompassing four cone-rod homeobox-binding sites (OTX sequences), contains the region necessary and sufficient to drive gene expression in long single cones. 2) A 15-bp portion (-341 to -327) in the 0.3-kb region represses the gene expression in the "short single cones," which are dedicated to the UV-sensitive opsin gene SWS1. 3) An 11-bp sequence TAACTGCCAGT (-441 to -431) in the 0.3-kb region, with its adjacent OTX element, also works as a repressor for gene expression in the pineal cells. 4) Finally, this OTX site is necessary for expression repression in the bipolar cells in the retina. These findings open a way for understanding the complex interaction of positive and negative regulatory factors that govern the cell type specificity of the opsin gene expression in the photoreceptive cells in the retina and the pineal organ. We termed the novel 11-bp sequence as the pineal negative regulatory element, PINE.	[Takechi, Masaki; Seno, Sadayoshi; Kawamura, Shoji] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	University of Tokyo	Kawamura, S (corresponding author), Seimeitou 502,5-1-5 Kashiwanoha, Chiba 2778562, Japan.	Kawamura@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20017008]; Japan Society for the Promotion of Science (JSPS) [19207018, 16-11736]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research on Priority Areas "Comparative Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan 20017008 (to S. K.), Grant-in-Aid for Scientific Research A from Japan Society for the Promotion of Science (JSPS) 19207018 (to S. K.), and JSPS Fellowship 16-11736 (to M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Appelbaum L, 2005, J BIOL CHEM, V280, P11544, DOI 10.1074/jbc.M412935200; Asaoka Y, 2002, P NATL ACAD SCI USA, V99, P15456, DOI 10.1073/pnas.232444199; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng CL, 2007, J EXP BIOL, V210, P4123, DOI 10.1242/jeb.009217; Chinen A, 2003, GENETICS, V163, P663; Davies WL, 2007, CURR BIOL, V17, pR161, DOI 10.1016/j.cub.2007.01.037; Forsell J, 2001, J EXP BIOL, V204, P2517; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Kawamura S, 1997, VISION RES, V37, P1867, DOI 10.1016/S0042-6989(96)00309-4; Kawamura S, 1999, GENETICS, V153, P1839; Kennedy BN, 2001, J BIOL CHEM, V276, P14037, DOI 10.1074/jbc.M010490200; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Luo WQ, 2004, J BIOL CHEM, V279, P19286, DOI 10.1074/jbc.M400161200; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Meissl H, 1997, BIOL CELL, V89, P549, DOI 10.1016/S0248-4900(98)80158-5; Muller F, 1997, MOL REPROD DEV, V47, P404, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;404::AID-MRD6&gt;3.0.CO;2-O; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Okano T, 1997, MOL BRAIN RES, V50, P190, DOI 10.1016/S0169-328X(97)00184-8; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; OKSCHE A, 1984, OPHTHALMIC RES, V16, P88, DOI 10.1159/000265300; Prabhudesai SN, 2005, DEV BIOL, V287, P157, DOI 10.1016/j.ydbio.2005.08.045; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Smallwood PM, 2002, P NATL ACAD SCI USA, V99, P1008, DOI 10.1073/pnas.022629799; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; TAKAHASHI JS, 1993, CURR OPIN GENET DEV, V3, P301, DOI 10.1016/0959-437X(93)90038-Q; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Tsujimura T, 2007, P NATL ACAD SCI USA, V104, P12813, DOI 10.1073/pnas.0704061104; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Wakefield MJ, 2008, VISUAL NEUROSCI, V25, P257, DOI 10.1017/S0952523808080255; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; YOKOYAMA R, 1993, FEBS LETT, V334, P27, DOI 10.1016/0014-5793(93)81673-N; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Ziv L, 2007, EXP EYE RES, V84, P92, DOI 10.1016/j.exer.2006.09.004	41	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31625	31632		10.1074/jbc.M806226200	http://dx.doi.org/10.1074/jbc.M806226200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18796431	hybrid			2022-12-25	WOS:000260760800043
J	Azam, S; Jouvet, N; Jilani, A; Vongsamphanh, R; Yang, XM; Yang, S; Ramotar, D				Azam, Sonish; Jouvet, Nathalie; Jilani, Arshad; Vongsamphanh, Ratsavarinh; Yang, Xiaoming; Yang, Stephen; Ramotar, Dindial			Human Glyceraldehyde-3-phosphate Dehydrogenase Plays a Direct Role in Reactivating Oxidized Forms of the DNA Repair Enzyme APE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSLOCATION; OXIDATIVE STRESS; APURINIC/APYRIMIDINIC ENDONUCLEASE; REDOX REGULATION; BINDING ACTIVITY; CELL-DEATH; PROTEIN; GAPDH; IDENTIFICATION; APOPTOSIS	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has diverse biological functions including its nuclear translocation in response to oxidative stress. We show that GAPDH physically associates with APE1, an essential enzyme involved in the repair of abasic sites in damaged DNA, as well as in the redox regulation of several transcription factors. This interaction allows GAPDH to convert the oxidized species of APE1 to the reduced form, thereby reactivating its endonuclease activity to cleave abasic sites. The GAPDH variants C152G and C156G retain the ability to interact with but are unable to reactivate APE1, implicating these cysteines in catalyzing the reduction of APE1. Interestingly, GAPDH-small interfering RNA knockdown sensitized the cells to methyl methane sulfonate and bleomycin, which generate lesions that are repaired by APE1, but showed normal sensitivity to 254-nm UV. Moreover, the GAPDH knockdown cells exhibited an increased level of spontaneous abasic sites in the genomic DNA as a result of diminished APE1 endonuclease activity. Thus, the nuclear translocation of GAPDH during oxidative stress constitutes a protective mechanism to safeguard the genome by preventing structural inactivation of APE1.	[Azam, Sonish; Jouvet, Nathalie; Jilani, Arshad; Vongsamphanh, Ratsavarinh; Yang, Xiaoming; Yang, Stephen; Ramotar, Dindial] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada	Universite de Montreal	Ramotar, D (corresponding author), 5415 Assompt, Montreal, PQ H1T 2M4, Canada.	dramotar.hmr@ssss.gouv.qc.ca	Yang, Stephen/M-8177-2019	Yang, Stephen/0000-0003-3859-5110	Natural Sciences and Engineering Research Council of Canada [202432-01]; Canadian Institute of Health Research [MOP-13152]; Maisonneuve-Rosemont Hospital	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Maisonneuve-Rosemont Hospital	This work was supported partially by Natural Sciences and Engineering Research Council of Canada Grant 202432-01 and Canadian Institute of Health Research Grant MOP-13152 (to D. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a fellowship from Maisonneuve-Rosemont Hospital.	Azam S, 2007, APOPTOSIS, V12, P1243, DOI 10.1007/s10495-006-0050-8; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; BRODIE AE, 1990, ARCH BIOCHEM BIOPHYS, V276, P212, DOI 10.1016/0003-9861(90)90028-W; Brown VM, 2004, J BIOL CHEM, V279, P5984, DOI 10.1074/jbc.M307071200; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Dastoor Z, 2001, J CELL SCI, V114, P1643; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; GEORGIADIS MM, 2008, MUTAT RES IN PRESS; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Jilani A, 2003, BIOCHEMISTRY-US, V42, P6436, DOI 10.1021/bi034163m; Kelley MR, 2001, ANTIOXID REDOX SIGN, V3, P671, DOI 10.1089/15230860152543014; Krynetski EY, 2001, MOL PHARMACOL, V59, P367, DOI 10.1124/mol.59.2.367; Mathonnet R, 2003, P NATL ACAD SCI USA, V100, P7219, DOI 10.1073/pnas.123216100; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Patterson RL, 2005, P NATL ACAD SCI USA, V102, P1357, DOI 10.1073/pnas.0409657102; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; SCHULZE H, 1993, J NEUROCHEM, V60, P1915, DOI 10.1111/j.1471-4159.1993.tb13420.x; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Shatilla A, 2002, BIOCHEM J, V365, P547, DOI 10.1042/BJ20020375; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Xing CG, 2004, P NATL ACAD SCI USA, V101, P5862, DOI 10.1073/pnas.0307476101; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	39	104	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30632	30641		10.1074/jbc.M801401200	http://dx.doi.org/10.1074/jbc.M801401200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18776186	hybrid, Green Published			2022-12-25	WOS:000260544800020
J	Dugan, AS; Maginnis, MS; Jordan, JA; Gasparovic, ML; Manley, K; Page, R; Williams, G; Porter, E; O'Hara, BA; Atwood, WJ				Dugan, Aisling S.; Maginnis, Melissa S.; Jordan, Joslynn A.; Gasparovic, Megan L.; Manley, Kate; Page, Rebecca; Williams, Geoffrey; Porter, Edith; O'Hara, Bethany A.; Atwood, Walter J.			Human alpha-Defensins Inhibit BK Virus Infection by Aggregating Virions and Blocking Binding to Host Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-TRANSPLANT RECIPIENTS; HUMAN NEUTROPHIL PEPTIDES; HERPES-SIMPLEX-VIRUS; JC-VIRUS; THETA-DEFENSINS; IN-VITRO; POLYOMAVIRUS-NEPHROPATHY; IMMUNOSUPPRESSIVE DRUGS; INTERSTITIAL NEPHRITIS; NEISSERIA-GONORRHOEAE	BK virus (BKV) is a polyomavirus that establishes a lifelong persistence in most humans and is a major impediment to success of kidney grafts. The function of the innate immune system in BKV infection and pathology has not been investigated. Here we examine the role of antimicrobial defensins in BKV infection of Vero cells. Our data show that alpha-defensin human neutrophil protein 1 (HNP1) and human alpha-defensin 5 (HD5) inhibit BKV infection by targeting an early event in the viral lifecycle. HD5 treatment of BKV reduced viral attachment to cells, whereas cellular treatment with HD5 did not. Colocalization studies indicated that HD5 interacts directly with BKV. Ultrastructural analysis revealed HD5-induced aggregation of virions. HD5 also inhibited infection of cells by other related polyomaviruses. This is the first study to demonstrate polyomavirus sensitivity to defensins. We also show a novel mechanism whereby HD5 binds to BKV leading to aggregation of virion particles preventing normal virus binding to the cell surface and uptake into cells.	[Dugan, Aisling S.; Maginnis, Melissa S.; Manley, Kate; Page, Rebecca; Williams, Geoffrey; O'Hara, Bethany A.; Atwood, Walter J.] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA; [Jordan, Joslynn A.] Brown Univ, Grad Program Pathobiol, Providence, RI 02912 USA; [Gasparovic, Megan L.] Brown Univ, Grad Program Mol & Cell Biol & Biochem, Providence, RI 02912 USA; [Porter, Edith] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	Brown University; Brown University; Brown University; California State University System; California State University Los Angeles	Atwood, WJ (corresponding author), Box G-E434,70 Ship St, Providence, RI 02903 USA.	Walter_Atwood@Brown.edu	Stanifer, Megan/ABB-4254-2020	Stanifer, Megan/0000-0002-5606-1297	National Institutes of Health [R01 CA71878]; NCI [R01 NS43097]; NATIONAL CANCER INSTITUTE [R01CA071878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA71878 from the NCI and R01 NS43097 from the NINDS (to W.J.A.).	Aceti A, 2006, J VIRAL HEPATITIS, V13, P821, DOI 10.1111/j.1365-2893.2006.00762.x; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; ARTHUR RR, 1988, J INFECT DIS, V158, P563, DOI 10.1093/infdis/158.3.563; Bdeir K, 1999, BLOOD, V94, P2007; Binet I, 1999, TRANSPLANTATION, V67, P918, DOI 10.1097/00007890-199903270-00022; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Bofill-Mas S, 2000, APPL ENVIRON MICROB, V66, P238, DOI 10.1128/AEM.66.1.238-245.2000; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chen BJ, 2002, VIROLOGY, V300, P282, DOI 10.1006/viro.2002.1522; Chen YP, 2006, J VIROL, V80, P3495, DOI 10.1128/JVI.80.7.3495-3505.2006; COLEMAN DV, 1980, J INFECT DIS, V142, P1, DOI 10.1093/infdis/142.1.1; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Dhaliwal W, 2003, MOL IMMUNOL, V40, P469, DOI 10.1016/S0161-5890(03)00156-1; Drachenberg CB, 2007, TRANSPLANTATION, V84, P323, DOI 10.1097/01.tp.0000269706.59977.a5; Dugan AS, 2008, J VIROL, V82, P2560, DOI 10.1128/JVI.02123-07; Dugan AS, 2005, J VIROL, V79, P14442, DOI 10.1128/JVI.79.22.14442-14445.2005; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; EISENHAUER PB, 1989, INFECT IMMUN, V57, P2021, DOI 10.1128/IAI.57.7.2021-2027.1989; Falco A, 2007, ANTIVIR RES, V76, P111, DOI 10.1016/j.antiviral.2007.06.006; Frye M, 2000, EUR J CLIN INVEST, V30, P695; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Hein M, 2002, AM J OBSTET GYNECOL, V187, P137, DOI 10.1067/mob.2002.123034; HERITAGE J, 1981, J MED VIROL, V8, P143, DOI 10.1002/jmv.1890080208; Hirsch HH, 2002, NEW ENGL J MED, V347, P488, DOI 10.1056/NEJMoa020439; Howell MD, 2007, J ALLERGY CLIN IMMUN, V119, P1022, DOI 10.1016/j.jaci.2007.01.044; Ihi T, 1997, CLIN INFECT DIS, V25, P1134, DOI 10.1086/516075; JIN L, 1995, CLIN DIAGN VIROL, V3, P285, DOI 10.1016/S0928-0197(94)00044-1; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; Koo SP, 1997, INFECT IMMUN, V65, P4795, DOI 10.1128/IAI.65.11.4795-4800.1997; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; Lehrer RI, 1997, CLIN INFECT DIS, V25, P1141, DOI 10.1086/516082; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Lin PL, 2001, PEDIATR TRANSPLANT, V5, P398, DOI 10.1034/j.1399-3046.2001.00037.x; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Manley K, 2008, VIROLOGY, V372, P48, DOI 10.1016/j.virol.2007.10.029; Manley K, 2006, J VIROL, V80, P12079, DOI 10.1128/JVI.01456-06; Mengel M, 2003, NEPHROL DIAL TRANSPL, V18, P1190, DOI 10.1093/ndt/gfg072; NAKASHIMA H, 1993, AIDS, V7, P1129, DOI 10.1097/00002030-199308000-00019; Niyonsaba Francois, 2003, Current Drug Targets - Inflammation and Allergy, V2, P224, DOI 10.2174/1568010033484115; PANYUTICH AV, 1993, J LAB CLIN MED, V122, P202; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Ramos E, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023435.07320.81; Randhawa PS, 1999, TRANSPLANTATION, V67, P103, DOI 10.1097/00007890-199901150-00018; RAPTIS L, 2001, SV40 PROTOCOLS; ROSEN S, 1983, NEW ENGL J MED, V308, P1192, DOI 10.1056/NEJM198305193082004; SHAH KV, 1975, J NATL CANCER I, V54, P945; SHIOMI K, 1993, BIOCHEM BIOPH RES CO, V195, P1336, DOI 10.1006/bbrc.1993.2190; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Sundbom M, 2007, J CLIN PATHOL, V60, P1029, DOI 10.1136/jcp.2006.041871; Sundsfjord A, 1999, J INFECT DIS, V180, P1, DOI 10.1086/314830; SUNDSFJORD A, 1994, J CLIN MICROBIOL, V32, P1390, DOI 10.1128/JCM.32.5.1390-1394.1994; Svenson J, 2007, J MED CHEM, V50, P3334, DOI 10.1021/jm0703542; Svinarich DM, 1997, AM J OBSTET GYNECOL, V176, P470, DOI 10.1016/S0002-9378(97)70517-9; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076; Vanchiere JA, 2005, J MED VIROL, V75, P447, DOI 10.1002/jmv.20287; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yasin B, 2000, EUR J CLIN MICROBIOL, V19, P187, DOI 10.1007/s100960050457	76	59	70	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31125	31132		10.1074/jbc.M805902200	http://dx.doi.org/10.1074/jbc.M805902200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782756	hybrid, Green Published			2022-12-25	WOS:000260544800067
J	Mayanagi, T; Morita, T; Hayashi, K; Fukumoto, K; Sobue, K				Mayanagi, Taira; Morita, Tsuyoshi; Hayashi, Ken'ichiro; Fukumoto, Kentaro; Sobue, Kenji			Glucocorticoid Receptor-mediated Expression of Caldesmon Regulates Cell Migration via the Reorganization of the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING PROTEIN; PITUITARY-ADRENAL AXIS; SMOOTH-MUSCLE; STRESS FIBERS; TRANSCRIPTIONAL REGULATION; PROSTATE-CANCER; GENE-EXPRESSION; RHO-KINASE; TROPOMYOSIN; ACTIVATION	Glucocorticoids (GCs) play important roles in numerous cellular processes, including growth, development, homeostasis, inhibition of inflammation, and immunosuppression. Here we found that GC-treated human lung carcinoma A549 cells exhibited the enhanced formation of the thick stress fibers and focal adhesions, resulting in suppression of cell migration. In a screen for GC-responsive genes encoding actin-interacting proteins, we identified caldesmon (CaD), which is specifically up-regulated in response to GCs. CaD is a regulatory protein involved in actomyosin-based contraction and the stability of actin filaments. We further demonstrated that the up-regulation of CaD expression was controlled by glucocorticoid receptor (GR). An activated form of GR directly bound to the two glucocorticoid-response element-like sequences in the human CALD1 promoter and transactivated the CALD1 gene, thereby up-regulating the CaD protein. Forced expression of CaD, without GC treatment, also enhanced the formation of thick stress fibers and focal adhesions and suppressed cell migration. Conversely, depletion of CaD abrogated the GC-induced phenotypes. The results of this study suggest that the GR-dependent up-regulation of CaD plays a pivotal role in regulating cell migration via the reorganization of the actin cytoskeleton.	[Sobue, Kenji] Osaka Univ, Grad Sch Med, Dept Neurosci D13, Res Ctr Child Mental Dev, Suita, Osaka 5650871, Japan; [Morita, Tsuyoshi; Hayashi, Ken'ichiro; Fukumoto, Kentaro; Sobue, Kenji] Osaka Univ, Grad Sch Med, Dept Neurosci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Sobue, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, Res Ctr Child Mental Dev, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	sobue@nbiochem.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15GS0312]; Japan Society [20240038]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research 15GS0312 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.S.) and Grant-in-aid for Scientific Research 20240038 from the Japan Society for the Promotion of Science (to K.S.).	Abe M, 2007, J CELL BIOCHEM, V102, P1290, DOI 10.1002/jcb.21359; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BODIN P, 1991, AM J PHYSIOL, V260, pC151, DOI 10.1152/ajpcell.1991.260.1.C151; BRETSCHER A, 1985, J CELL BIOL, V100, P1656, DOI 10.1083/jcb.100.5.1656; CASTELLINO F, 1992, P NATL ACAD SCI USA, V89, P3775, DOI 10.1073/pnas.89.9.3775; CASTELLINO F, 1995, J CELL BIOL, V131, P1223, DOI 10.1083/jcb.131.5.1223; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Eppinga RD, 2006, CELL MOTIL CYTOSKEL, V63, P543, DOI 10.1002/cm.20144; Fakih M, 2002, UROLOGY, V60, P553, DOI 10.1016/S0090-4295(02)01741-7; FAY FS, 1973, P NATL ACAD SCI USA, V70, P641, DOI 10.1073/pnas.70.3.641; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; HAYASHI K, 1992, P NATL ACAD SCI USA, V89, P12122, DOI 10.1073/pnas.89.24.12122; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; KREIS TE, 1980, CELL, V22, P555, DOI 10.1016/0092-8674(80)90365-7; Li Y, 2004, J CELL SCI, V117, P3593, DOI 10.1242/jcs.01216; LYNCH WP, 1987, J BIOL CHEM, V262, P7429; Meijsing SH, 2007, MOL CELL BIOL, V27, P2442, DOI 10.1128/MCB.01570-06; Mirzapoiazova T, 2005, J CELL PHYSIOL, V203, P520, DOI 10.1002/jcp.20244; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Morita T, 2007, J BIOL CHEM, V282, P8454, DOI 10.1074/jbc.M609983200; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; MUNCK A, 1976, J STEROID BIOCHEM, V7, P1117, DOI 10.1016/0022-4731(76)90042-X; NGAI PK, 1984, J BIOL CHEM, V259, P3656; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OWADA MK, 1984, P NATL ACAD SCI-BIOL, V81, P3133, DOI 10.1073/pnas.81.10.3133; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Planey SL, 2000, BIOCHEM BIOPH RES CO, V279, P307, DOI 10.1006/bbrc.2000.3922; REINER GCA, 1984, CANCER RES, V44, P2302; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOBUE K, 1982, BIOMED RES-TOKYO, V3, P188, DOI 10.2220/biomedres.3.188; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; TANAKA J, 1993, J CELL SCI, V104, P595; Tronche F, 2004, GENE DEV, V18, P492, DOI 10.1101/gad.284704; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; UEKI N, 1987, P NATL ACAD SCI USA, V84, P9049, DOI 10.1073/pnas.84.24.9049; VAN AL, 1997, GENE DEV, V11, P2295; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; WARREN KS, 1994, J CELL BIOL, V125, P359, DOI 10.1083/jcb.125.2.359; WICK G, 1993, ENDOCR REV, V14, P539, DOI 10.1210/edrv-14-5-539; YANO H, 1995, J BIOL CHEM, V270, P23661, DOI 10.1074/jbc.270.40.23661; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; YONEZAWA N, 1988, BIOCHEM J, V251, P121, DOI 10.1042/bj2510121; Yoshio T, 2007, FEBS LETT, V581, P3777, DOI 10.1016/j.febslet.2007.06.073; Zheng R, 2006, ONCOGENE, V25, P5942, DOI 10.1038/sj.onc.1209586; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	63	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31183	31196		10.1074/jbc.M801606200	http://dx.doi.org/10.1074/jbc.M801606200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18772142	hybrid, Green Published			2022-12-25	WOS:000260544800072
J	Savolainen, L; Pusa, L; Kim, HJ; Sillanpaa, H; Seppala, I; Tuuminen, T				Savolainen, Laura; Pusa, Liana; Kim, Hwa-Jung; Sillanpaa, Heidi; Seppala, Ilkka; Tuuminen, Tamara			Pilot Study of Diagnostic Potential of the Mycobacterium tuberculosis Recombinant HBHA Protein in a Vaccinated Population in Finland	PLOS ONE			English	Article								Background: In recent years T cell based interferon gamma release assays (IGRA) have been developed for immunodiagnosis of M. tuberculosis infection. At present these assays do not discriminate between disease and latency. Therefore, more promising antigens and diagnostic tools are continuously being searched for tuberculosis immunodiagnostics. The heparin binding hemagglutinin (HBHA) is a surface protein of M. tuberculosis which promotes bacterial aggregation and adhesion to non-phagocytic cells. It has been previously assumed that native, methylated form of this protein would be a promising antigen to discriminate latent from active infection. Methodology and Principal Findings: We performed a pilot investigation to study humoral and T-cell mediated immunological responses to recombinant HBHA produced in M. smegmatis or to synthetic peptides in patients with recent or past tuberculosis, with atypical mycobacteriosis, or in healthy vaccinated individuals. The T cell reactivities to HBHA were compared to the respective reactivities towards Purified Protein Derivative (PPD) and two surface secreted proteins, ie. Early Secretory Antigen Target-6 (ESAT-6) and Culture Filtrate Protein-10 (CFP-10). Our pilot results indicate that methylated recombinant HBHA induced a strong T cell mediated immune response and the production of IgG and IgM-class antibodies in all patient groups, most surprisingly in young Finnish vaccinees, as well. We observed a positive correlation between the reactivities to HBHA and non-specific PPD among all studied subjects. As expected, ESAT-6 and CFP-10 were the most powerful antigens to discriminate disease from immunity caused by vaccination. Conclusions: On the basis of results of this exploratory investigation we raise concerns that in countries like Finland, where BCG vaccination was routinely used, HBHA utility might not be sufficient for diagnostics because of inability to explicitly discriminate tuberculosis infection from immunoreactivity caused by previous BCG vaccination.	[Savolainen, Laura; Sillanpaa, Heidi; Seppala, Ilkka; Tuuminen, Tamara] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland; [Pusa, Liana] Lansi Uusimaa Hosp, Tammisaari, Finland; [Kim, Hwa-Jung] Chungnam Natl Univ, Coll Med, Dept Microbiol, Taejon, South Korea; [Seppala, Ilkka; Tuuminen, Tamara] Helsinki Univ Hosp, HUSLAB, Div Clin Microbiol, Helsinki, Finland	University of Helsinki; Chungnam National University; University of Helsinki; Helsinki University Central Hospital	Savolainen, L (corresponding author), Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland.	tamara.tuuminen@helsinki.fi		Kim, Hwa-Jung/0000-0002-1127-0909; Sillanpaa, Heidi/0000-0001-6649-6828; Savolainen, Laura/0000-0003-2527-4211	Finnish Lung Health Association; Pulmonary Association Heli; Tuberculosis Association of the University of Tampere	Finnish Lung Health Association; Pulmonary Association Heli; Tuberculosis Association of the University of Tampere	We wish to thank the following private Finnish foundations for financial support: Finnish Lung Health Association (Filha ry), Pulmonary Association Heli, and the Tuberculosis Association of the University of Tampere. MD Raimo Tuuminen is acknowledged for help in data analysis.	Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Dheda K, 2005, CURR OPIN PULM MED, V11, P195, DOI 10.1097/01.mcp.0000158726.13159.5e; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; LABARGA A, 2007, WEB SERVICE EUROPEAN; Locht C, 2006, TUBERCULOSIS, V86, P303, DOI 10.1016/j.tube.2006.01.016; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; National Public Health Institute, 2008, INF DIS FINL 2007, V9; Pethe K, 2002, P NATL ACAD SCI USA, V99, P10759, DOI 10.1073/pnas.162246899; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Shin AR, 2006, CLIN VACCINE IMMUNOL, V13, P869, DOI 10.1128/CVI.00103-06; Sillanpaa H, 2007, INT J MED MICROBIOL, V297, P45, DOI 10.1016/j.ijmm.2006.09.001; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Tuuminen T, 2007, J IMMUNOL, V179, P1988, DOI 10.4049/jimmunol.179.3.1988; Van Epps HL, 2002, J EXP MED, V196, P579, DOI 10.1084/jem.20011255; Zanetti S, 2005, CLIN DIAGN LAB IMMUN, V12, P1135, DOI 10.1128/CDLI.12.9.1135-1138.2005	17	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3272	10.1371/journal.pone.0003272	http://dx.doi.org/10.1371/journal.pone.0003272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815611	Green Published, gold, Green Submitted			2022-12-25	WOS:000264431900002
J	Ruiz, L; Traskine, M; Ferrer, I; Castro, E; Leal, JFM; Kaufman, M; Carnero, A				Ruiz, Lidia; Traskine, Magali; Ferrer, Irene; Castro, Estrella; Leal, Juan F. M.; Kaufman, Marcelline; Carnero, Amancio			Characterization of the p53 Response to Oncogene-Induced Senescence	PLOS ONE			English	Article								Background: P53 activation can trigger various outcomes, among them reversible growth arrest or cellular senescence. It is a live debate whether these outcomes are influenced by quantitative or qualitative mechanisms. Furthermore, the relative contribution of p53 to Ras-induced senescence is also matter of controversy. Methodology/Principal Findings: This study compared situations in which different signals drove senescence with increasing levels of p53 activation. The study revealed that the levels of p53 activation do not determine the outcome of the response. This is further confirmed by the clustering of transcriptional patterns into two broad groups: p53-activated or p53-inactivated, i.e., growth and cellular arrest/senescence. Furthermore, while p53-dependent transcription decreases after 24 hrs in the presence of active p53, senescence continues. Maintaining cells in the arrested state for long periods does not switch reversible arrest to cellular senescence. Together, these data suggest that a Ras-dependent, p53-independent, second signal is necessary to induce senescence. This study tested whether PPP1CA (the catalytic subunit of PP1 alpha), recently identified as contributing to Ras-induced senescence, might be this second signal. PPP1CA is induced by Ras; its inactivation inhibits Ras-induced senescence, presumably by inhibiting pRb dephosphorylation. Finally, PPP1CA seems to strongly colocalize with pRb only during senescence. Conclusions: The levels of p53 activation do not determine the outcome of the response. Rather, p53 activity seems to act as a necessary but not sufficient condition for senescence to arise. Maintaining cells in the arrested state for long periods does not switch reversible arrest to cellular senescence. PPP1CA is induced by Ras; its inactivation inhibits Ras-induced senescence, presumably by inhibiting pRb dephosphorylation. Finally, PPP1CA seems to strongly co-localize with pRb only during senescence, suggesting that PP1 alpha activation during senescence may be the second signal contributing to the irreversibility of the senescent phenotype.	[Ruiz, Lidia; Ferrer, Irene; Castro, Estrella; Leal, Juan F. M.; Carnero, Amancio] CNIO, Expt Therapeut Programme, Madrid, Spain; [Traskine, Magali; Kaufman, Marcelline] Free Univ Brussels, Fac Sci, Unit Theoretical & Computat Biol, B-1050 Brussels, Belgium	Centro Nacional de Investigaciones Oncologicas (CNIO); Universite Libre de Bruxelles; Vrije Universiteit Brussel	Ruiz, L (corresponding author), CNIO, Expt Therapeut Programme, Madrid, Spain.	acarnero@cnio.es	Leal, Juan F Martinez/N-6328-2013; Ferrer, Irene/C-9418-2015; Ruiz, Lidia/L-1620-2014; IBIS, CANCER/P-3323-2015	Leal, Juan F Martinez/0000-0002-7538-0875; Ferrer, Irene/0000-0002-2748-2607; Ruiz, Lidia/0000-0003-1430-9618; Carnero, Amancio/0000-0003-4357-3979	Ministerio de Educacion y Ciencia [SAF2005-00944, fellowship]; Fundacion Mutua Madrilena; EU	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); EU(European Commission)	This work has been supported by grants from the Ministerio de Educacion y Ciencia (SAF2005-00944), Fundacion Mutua Madrilena and the EU (from VI framework, Project COMBIO, Project NETSENSOR). IF is supported by a fellowship from the Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Castro ME, 2008, CARCINOGENESIS, V29, P491, DOI 10.1093/carcin/bgm246; Castro ME, 2004, J CELL BIOCHEM, V92, P514, DOI 10.1002/jcb.20079; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Evan GI, 2005, COLD SH Q B, V70, P263, DOI 10.1101/sqb.2005.70.054; Ferbeyre G, 2000, GENE DEV, V14, P2015; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Goodrich DW, 2006, ONCOGENE, V25, P5233, DOI 10.1038/sj.onc.1209616; Insinga A, 2004, EMBO J, V23, P1144, DOI 10.1038/sj.emboj.7600109; Jimenez-Velasco A, 2005, LEUKEMIA, V19, P2347, DOI 10.1038/sj.leu.2403974; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Lohrum MAE, 2000, TRENDS CELL BIOL, V10, P197, DOI 10.1016/S0962-8924(00)01736-0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nakano H, 2007, INT J RADIAT ONCOL, V68, P883, DOI 10.1016/j.ijrobp.2007.03.007; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nelson DA, 1997, J BIOL CHEM, V272, P4528, DOI 10.1074/jbc.272.7.4528; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Rajesh D, 1999, MOL PHARMACOL, V56, P515, DOI 10.1124/mol.56.3.515; Rubin Ethel, 1998, Frontiers in Bioscience, V3, pD1209; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Vidal A, 2007, FRONT BIOSCI-LANDMRK, V12, P4483, DOI 10.2741/2403; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Zhao RB, 2000, GENE DEV, V14, P981; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	57	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3230	10.1371/journal.pone.0003230	http://dx.doi.org/10.1371/journal.pone.0003230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800172	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428400001
J	Mankar, M; Joshi, RS; Belsare, PV; Jog, MM; Watve, MG				Mankar, Manasee; Joshi, Radhika S.; Belsare, Prajakta V.; Jog, Maithili M.; Watve, Milind G.			Obesity as a Perceived Social Signal	PLOS ONE			English	Article							INSULIN; EXPERIENCE	Fat accumulation has been classically considered as a means of energy storage. Obese people are theorized as metabolically 'thrifty', saving energy during times of food abundance. However, recent research has highlighted many neuro-behavioral and social aspects of obesity, with a suggestion that obesity, abdominal obesity in particular, may have evolved as a social signal. We tested here whether body proportions, and abdominal obesity in particular, are perceived as signals revealing personality traits. Faceless drawings of three male body forms namely lean, muscular and feminine, each with and without abdominal obesity were shown in a randomized order to a group of 222 respondents. A list of 30 different adjectives or short descriptions of personality traits was given to each respondent and they were asked to allocate the most appropriate figure to each of them independently. The traits included those directly related to physique, those related to nature, attitude and moral character and also those related to social status. For 29 out of the 30 adjectives people consistently attributed specific body forms. Based on common choices, the 30 traits could be clustered into distinct 'personalities' which were strongly associated with particular body forms. A centrally obese figure was perceived as "lethargic, greedy, political, money-minded, selfish and rich''. The results show that body proportions are perceived to reflect personality traits and this raises the possibility that in addition to energy storage, social selection may have played some role in shaping the biology of obesity.	[Mankar, Manasee; Joshi, Radhika S.; Belsare, Prajakta V.; Watve, Milind G.] Abasaheb Garware Coll, Dept Microbiol, Pune, Maharashtra, India; [Jog, Maithili M.] Abasaheb Garware Coll, Dept Biotechnol, Pune, Maharashtra, India; [Watve, Milind G.] Anujeeva Biosci Pvt Ltd, Pune, Maharashtra, India		Mankar, M (corresponding author), Abasaheb Garware Coll, Dept Microbiol, Pune, Maharashtra, India.	milind_watve@yahoo.com		JOSHI, RADHIKA/0000-0002-4313-2586				Black AE, 1996, EUR J CLIN NUTR, V50, P72; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Briers B, 2006, PSYCHOL SCI, V17, P939, DOI 10.1111/j.1467-9280.2006.01808.x; Chang VW, 2002, SOCIOL HEALTH ILL, V24, P151, DOI 10.1111/1467-9566.00289; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Elliott R, 2003, J NEUROSCI, V23, P303; Esposito K, 2005, INT J IMPOT RES, V17, P391, DOI 10.1038/sj.ijir.3901333; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; NEEL JV, 1962, AM J HUM GENET, V14, P353; Norman RJ, 1998, REPROD FERT DEVELOP, V10, P55, DOI 10.1071/R98010; O'Rahilly S, 2006, PHILOS T R SOC B, V361, P1095, DOI 10.1098/rstb.2006.1850; Pond CM, 2001, P NUTR SOC, V60, P365, DOI 10.1079/PNS200198; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Speakman John R, 2006, Diab Vasc Dis Res, V3, P7, DOI 10.3132/dvdr.2006.010; Stoger R, 2008, BIOESSAYS, V30, P156, DOI 10.1002/bies.20700; Watve MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-61; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Zahavi Amotz, 1997, HANDICAP PRINCIPLE M; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	29	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3187	10.1371/journal.pone.0003187	http://dx.doi.org/10.1371/journal.pone.0003187			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KF	18784836	Green Submitted, gold, Green Published			2022-12-25	WOS:000264425900007
J	Taube, R; Zhu, Q; Xu, C; Diaz-Griffero, F; Sui, J; Kamau, E; Dwyer, M; Aird, D; Marasco, WA				Taube, Ran; Zhu, Quan; Xu, Chen; Diaz-Griffero, Felipe; Sui, Jianhua; Kamau, Erick; Dwyer, Markryan; Aird, Daniel; Marasco, Wayne A.			Lentivirus Display: Stable Expression of Human Antibodies on the Surface of Human Cells and Virus Particles	PLOS ONE			English	Article								Background: Isolation of human antibodies using current display technologies can be limited by constraints on protein expression, folding and post-translational modifications. Here we describe a discovery platform that utilizes self-inactivating (SIN) lentiviral vectors for the surface display of high-affinity single-chain variable region (scFv) antibody fragments on human cells and lentivirus particles. Methodology/Principal Findings: Bivalent scFvFc human antibodies were fused in frame with different transmembrane (TM) anchoring moieties to allow efficient high- level expression on human cells and the optimal TM was identified. The addition of an eight amino acid HIV-1 gp41 envelope incorporation motif further increased scFvFc expression on human cells and incorporation into lentiviral particles. Both antibody-displaying human cells and virus particles bound antigen specifically. Sulfation of CDR tyrosine residues, a property recently shown to broaden antibody binding affinity and antigen recognition was also demonstrated. High level scFvFc expression and stable integration was achieved in human cells following transduction with IRES containing bicistronic SIN lentivectors encoding ZsGreen when scFvFc fusion proteins were expressed from the first cassette. Up to 10(6)-fold enrichment of antibody expressing cells was achieved with one round of antigen coupled magnetic bead pre-selection followed by FACS sorting. Finally, the scFvFc displaying human cells could be used directly in functional biological screens with remarkable sensitivity. Conclusions/Significance: This antibody display platform will complement existing technologies by virtue of providing properties unique to lentiviruses and antibody expression in human cells, which, in turn, may aid the discovery of novel therapeutic human mAbs.	[Taube, Ran; Zhu, Quan; Xu, Chen; Diaz-Griffero, Felipe; Sui, Jianhua; Kamau, Erick; Dwyer, Markryan; Aird, Daniel; Marasco, Wayne A.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA USA; [Taube, Ran; Zhu, Quan; Xu, Chen; Sui, Jianhua; Marasco, Wayne A.] Harvard Med Sch, Dept Med, Boston, MA USA; [Diaz-Griffero, Felipe] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Taube, R (corresponding author), Ben Gurion Univ Negev, Dept Virol, IL-84105 Beer Sheva, Israel.	Wayne_Marasco@dfci.harvard.edu	TAUBE, RAN/F-2029-2012	TAUBE, RAN/0000-0002-2062-4537; SUI, JIANHUA/0000-0002-1272-9662	National Institutes of Health [AI061318, AI58804]; Israeli government [Bikura fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058804, U01AI061318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the National Institutes of Health grants, AI061318 (W. A. Marasco) and AI58804 (Q. Zhu). RT was supported by the Israeli government "Bikura" fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Bai JR, 2003, J BIOL CHEM, V278, P1433, DOI 10.1074/jbc.M208297200; Brown C, 2007, PULM PHARMACOL THER, V20, P90, DOI 10.1016/j.pupt.2005.12.009; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; Daugherty PS, 2000, J IMMUNOL METHODS, V243, P211, DOI 10.1016/S0022-1759(00)00236-2; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Gura T, 2002, NATURE, V417, P584, DOI 10.1038/417584a; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Ikeda Y, 2003, NAT BIOTECHNOL, V21, P569, DOI 10.1038/nbt815; Klages N, 2000, MOL THER, V2, P170, DOI 10.1006/mthe.2000.0103; Lin AH, 2001, HUM GENE THER, V12, P323, DOI 10.1089/10430340150503957; MINTZ KP, 1994, J BIOL CHEM, V269, P4845; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Ogueta SB, 2001, MOL MED, V7, P569, DOI 10.1007/BF03401863; Reichert J, 2004, NAT REV DRUG DISCOV, V3, P383, DOI 10.1038/nrd1386; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Souriau C, 2003, EXPERT OPIN BIOL TH, V3, P305, DOI 10.1517/eobt.3.2.305.21159; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Sui JH, 2005, J VIROL, V79, P5900, DOI 10.1128/JVI.79.10.5900-5906.2005; Urban JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni033; VanAntwerp JJ, 2000, BIOTECHNOL PROGR, V16, P31, DOI 10.1021/bp990133s; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Weiner LM, 2005, NAT BIOTECHNOL, V23, P556, DOI 10.1038/nbt0505-556; Xu C, 2007, J IMMUNOL, V179, P2408, DOI 10.4049/jimmunol.179.4.2408; Yang L, 2006, P NATL ACAD SCI USA, V103, P11479, DOI 10.1073/pnas.0604993103; Yuan QA, 2006, MOL CANCER THER, V5, P2096, DOI 10.1158/1535-7163.MCT-06-0115; ZHU Q, 2004, GENE THERAPY MOL BIO, V8, P91	34	23	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3181	10.1371/journal.pone.0003181	http://dx.doi.org/10.1371/journal.pone.0003181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784843	gold, Green Submitted, Green Published			2022-12-25	WOS:000264425900003
J	Zheng, W; Kuhlicke, J; Jaeckel, K; Eltzschig, HK; Singh, A; Sjoeblom, M; Riederer, B; Weinhold, C; Seidler, U; Colgan, SP; Karhausen, J				Zheng, Wen; Kuhlicke, Johannes; Jaeckel, Kristian; Eltzschig, Holger K.; Singh, Anurag; Sjoeblom, Markus; Riederer, Brigitte; Weinhold, Cornelia; Seidler, Ursula; Colgan, Sean P.; Karhausen, Joern			Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium	FASEB JOURNAL			English	Article						anion transporter; ion movement; fluid secretion; mucosa	CAMP RESPONSE ELEMENT; DUODENAL BICARBONATE SECRETION; ACTIVATED PROTEIN-KINASE; ION-TRANSPORT; NA-K-2CL COTRANSPORTER; EXPERIMENTAL COLITIS; CHLORIDE SECRETION; BINDING PROTEIN; CHOLERA-TOXIN; CL-SECRETION	Diarrhea is widespread in intestinal diseases involving ischemia and/or hypoxia. Since hypoxia alters stimulated Cl- and water flux, we investigated the influence of such a physiologically and pathophysiologically important signal on expression of the cystic fibrosis transmembrane conductance regulator (CFTR). Located on the apical membrane, this cAMP-activated Cl- channel determines salt and fluid transport across mucosal surfaces. Our studies revealed depression of CFTR mRNA, protein, and function in hypoxic epithelia. Chromatin immunoprecipitation identified a previously unappreciated binding site for the hypoxia inducible factor-1 (HIF-1), and promoter studies established its relevance by loss of repression following point mutation. Consequently, HIF-1 overexpressing cells exhibited significantly reduced transport capacity in colorimetric Cl- efflux studies, altered short circuit measurements, and changes in transepithelial fluid movement. Whole-body hypoxia in wild-type mice resulted in significantly reduced small intestinal fluid and HCO3- secretory responses to forskolin. Experiments performed in Cftr(-/-) and Nkcc1(-/-) mice underlined the role of altered CFTR expression for these functional changes, and work in conditional Hif1a mutant mice verified HIF-1-dependent CFTR regulation in vivo. In summary, our study clarifies CFTR regulation and introduces the concept of a HIF-1-orchestrated response designed to regulate ion and fluid movement across hypoxic intestinal epithelia.-Zheng, W., Kuhlicke, J., Jackel, K., Eltzschig, H. K., Singh, A., Sjoblom, M., Riederer, B., Weinhold, C., Seidler, U., Colgan, S. P., Karhausen, J. Hypoxia inducible factor-1 (HIF-1) -mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J. 23, 204-213 (2009)	[Kuhlicke, Johannes; Jaeckel, Kristian; Eltzschig, Holger K.; Karhausen, Joern] Univ Tubingen, Univ Klin Anasthesiol & Intensivmed, D-72076 Tubingen, Germany; [Zheng, Wen; Singh, Anurag; Sjoeblom, Markus; Riederer, Brigitte; Weinhold, Cornelia; Seidler, Ursula] Hannover Med Sch, Abt Gastroenterol Hepatol & Endokirnol, D-30623 Hannover, Germany; [Eltzschig, Holger K.; Colgan, Sean P.] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol, Mucosal Inflammat Program, Denver, CO USA	Eberhard Karls University of Tubingen; Hannover Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Karhausen, J (corresponding author), Univ Tubingen, Univ Klin Anasthesiol & Intensivmed, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	joern.karhausen@medizin.uni-tuebingen.de	Seidler, Ursula/HII-8049-2022; karhausen, jorn/X-8813-2019; Colgan, Sean P./B-4573-2009	Seidler, Ursula/0000-0002-9600-2769; karhausen, jorn/0000-0002-4240-229X; Singh, Anurag Kumar/0000-0003-0818-0993	Deutsche Forschungsgemeinschaft [KA2330/ 1-2, Se460/13-4]; SFB621 [C9]; European Community [LSHM-CT-2005-018932]; U.S. National Institutes of Health [HL60569, DK50189]; Interdisziplinares Zentrum fur Klinische Forschung, University of Tubingen; Lower Saxony Ministry of Science; Hannover Biomedical Research School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SFB621(German Research Foundation (DFG)); European Community(European Commission); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisziplinares Zentrum fur Klinische Forschung, University of Tubingen; Lower Saxony Ministry of Science; Hannover Biomedical Research School	Support came from grants KA2330/ 1-2 (J. Karhausen) and Se460/13-4 (U.S.) of the Deutsche Forschungsgemeinschaft, SFB621 grant C9 (U.S.), a training grant of EuroCareCF (to J. Karhausen; EuroCareCF is supported by the European Community's Sixth Framework Programme for Research, contract LSHM-CT-2005-018932), and U.S. National Institutes of Health grants HL60569 and DK50189 (S.P.C.). The Interdisziplinares Zentrum fur Klinische Forschung, University of Tubingen, gave support through a Verbundprojekt (J. Karhausen and H.K.E.) and within the Promotionskolleg (K.J.). M. S. was supported by an exchange scientists grant from the Lower Saxony Ministry of Science, and A.S. by a Ph.D. grant from the Hannover Biomedical Research School. The authors thank Dr. B. Scholte and Prof. K. Unertl for exceedingly helpful discussions and support and Michaela Hoch-Gutbrot and Irene Vollmer for technical assistance.	BEBOCK Z, 1999, AM J PHYSIOL-CELL PH, V280, pC135; Broere N, 2007, J BIOL CHEM, V282, P37575, DOI 10.1074/jbc.M704878200; Cafferata EGA, 2001, J BIOL CHEM, V276, P15441, DOI 10.1074/jbc.M010061200; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Comerford KM, 2002, CANCER RES, V62, P3387; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; CUTHBERT AW, 1995, J PHYSIOL-LONDON, V482, P449, DOI 10.1113/jphysiol.1995.sp020531; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; DEJONGE HR, 2006, PED PULMONOL S, V29, P148; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Fouassier L, 2007, AM J PHYSIOL-GASTR L, V293, pG25, DOI 10.1152/ajpgi.00175.2006; Frede S, 2007, METHOD ENZYMOL, V435, P405, DOI 10.1016/S0076-6879(07)35021-0; Furuta GT, 2000, J LEUKOCYTE BIOL, V68, P251; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; HAUSER CJ, 1988, J LAB CLIN MED, V112, P68; Hogan DL, 1997, GASTROENTEROLOGY, V113, P533, DOI 10.1053/gast.1997.v113.pm9247473; Ibla JC, 2006, AM J PHYSIOL-CELL PH, V291, pC282, DOI 10.1152/ajpcell.00564.2005; Karhausen J, 2005, J CELL BIOCHEM, V95, P1264, DOI 10.1002/jcb.20489; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kles KA, 2002, AM J PHYSIOL-GASTR L, V283, pG1336, DOI 10.1152/ajpgi.00055.2002; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kunzelmann K, 2001, NEWS PHYSIOL SCI, V16, P167; Li J, 2008, EXP EYE RES, V86, P684, DOI 10.1016/j.exer.2008.01.017; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MacVinish LJ, 2007, BRIT J PHARMACOL, V150, P1055, DOI 10.1038/sj.bjp.0707175; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Mairbaurl H, 1997, AM J PHYSIOL-LUNG C, V273, pL797, DOI 10.1152/ajplung.1997.273.4.L797; MATTHEWS JB, 1995, J CLIN INVEST, V96, P117, DOI 10.1172/JCI118010; Matthews RP, 1996, J BIOL CHEM, V271, P31869, DOI 10.1074/jbc.271.50.31869; Papen M, 2001, CELL PHYSIOL BIOCHEM, V11, P187, DOI 10.1159/000047805; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROBINSON JWL, 1981, GUT, V22, P512, DOI 10.1136/gut.22.6.512; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; SEIDLER U, 2007, EUR J PHYSL, V455, P757; Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972; Sjoblom M, 2007, AM J PHYSIOL-GASTR L, V292, pG899, DOI 10.1152/ajpgi.00398.2006; Sreenarasimhaiah Jayaprakash, 2005, Curr Gastroenterol Rep, V7, P421, DOI 10.1007/s11894-005-0013-1; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Tang WM, 2004, J BIOMOL SCREEN, V9, P607, DOI 10.1177/1087057104266740; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Taylor CT, 1999, J BIOL CHEM, V274, P19447, DOI 10.1074/jbc.274.27.19447; Taylor CT, 1998, J PHARMACOL EXP THER, V284, P568; Uramoto H, 2003, JPN J PHYSIOL, V53, P357, DOI 10.2170/jjphysiol.53.357; Walker J, 2003, AM J PHYSIOL-GASTR L, V285, pG850, DOI 10.1152/ajpgi.00077.2003; Walker NM, 2002, GASTROENTEROLOGY, V123, P531, DOI 10.1053/gast.2002.34757; White NL, 1998, HUM MOL GENET, V7, P363, DOI 10.1093/hmg/7.3.363; Wodopia R, 2000, AM J PHYSIOL-LUNG C, V279, pL1110, DOI 10.1152/ajplung.2000.279.6.L1110; YOSHIMURA K, 1991, J BIOL CHEM, V266, P9140; Zaidi T, 2004, INVEST OPHTH VIS SCI, V45, P4066, DOI 10.1167/iovs.04-0627; Zhou BY, 2007, AM J PHYSIOL-CELL PH, V292, pC1280, DOI 10.1152/ajpcell.00070.2006	62	68	68	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					204	213		10.1096/fj.08-110221	http://dx.doi.org/10.1096/fj.08-110221			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18779379	Green Published			2022-12-25	WOS:000262095500023
J	Parastatidis, I; Thomson, L; Burke, A; Chernysh, I; Nagaswami, C; Visser, J; Stamer, S; Liebler, DC; Koliakos, G; Heijnen, HFG; FitzGerald, GA; Weisel, JW; Ischiropoulos, H				Parastatidis, Ioannis; Thomson, Leonor; Burke, Anne; Chernysh, Irina; Nagaswami, Chandrasekaran; Visser, Jetze; Stamer, Sheryl; Liebler, Daniel C.; Koliakos, George; Heijnen, Harry F. G.; FitzGerald, Garret A.; Weisel, John W.; Ischiropoulos, Harry			Fibrinogen beta-Chain Tyrosine Nitration Is a Prothrombotic Risk Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ARG-PRO-AMIDE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; PLATELET REACTIVITY; VENOUS THROMBOSIS; PLASMA-FIBRINOGEN; DEFICIENT MICE; CLOT STRUCTURE; HEART-DISEASE	Elevated levels of circulating fibrinogen are associated with an increased risk of atherothrombotic diseases although a causative correlation between high levels of fibrinogen and cardiovascular complications has not been established. We hypothesized that a potential mechanism for an increased prothrombotic state is the post-translational modification of fibrinogen by tyrosine nitration. Mass spectrometry identified tyrosine residues 292 and 422 at the carboxyl terminus of the beta-chain as the principal sites of fibrinogen nitration in vivo. Immunoelectron microscopy confirmed the incorporation of nitrated fibrinogen molecules in fibrin fibers. The nitration of fibrinogen in vivo resulted in four distinct functional consequences: increased initial velocity of fibrin clot formation, altered fibrin clot architecture, increased fibrin clot stiffness, and reduced rate of clot lysis. The rate of fibrin clot formation and clot architecture was restored upon depletion of the tyrosine-nitrated fibrinogen molecules. An enhanced response to the knob "B" mimetic peptides Gly-His-Arg-Pro(am) and Ala-His-Arg-Pro(am) suggests that incorporation of nitrated fibrinogen molecules accelerates fibrin lateral aggregation. The data provide a novel biochemical risk factor that could explain epidemiological associations of oxidative stress and inflammation with thrombotic complications.	[Parastatidis, Ioannis; Thomson, Leonor; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Stokes Res Inst, Philadelphia, PA 19104 USA; [Parastatidis, Ioannis; Thomson, Leonor; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Parastatidis, Ioannis; Thomson, Leonor; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA 19104 USA; [Parastatidis, Ioannis; Koliakos, George] Aristotle Univ Thessaloniki, Sch Med, Dept Biol Chem, Thessaloniki 54210, Greece; [Burke, Anne; FitzGerald, Garret A.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Chernysh, Irina; Nagaswami, Chandrasekaran; Visser, Jetze; Weisel, John W.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Stamer, Sheryl; Liebler, Daniel C.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Heijnen, Harry F. G.] Univ Med Ctr Utrecht, Dept Cell Biol, Thrombosis & Haemostasis Lab, NL-3584 CX Utrecht, Netherlands; [Heijnen, Harry F. G.] Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; [Thomson, Leonor] Univ Republica, Fac Ciencias, Montevideo, Uruguay	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Aristotle University of Thessaloniki; University of Pennsylvania; University of Pennsylvania; Vanderbilt University; Utrecht University; Utrecht University Medical Center; Universidad de la Republica, Uruguay	Ischiropoulos, H (corresponding author), 417 Abramson Res Ctr, 34th St,Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ischirop@mail.med.upenn.edu	FitzGerald, Garret A/A-4222-2010; Koliakos, George/AAC-8888-2021; Visser, Jetze/ABE-2738-2021; Thomson, Leonor/C-4684-2008	Thomson, Leonor/0000-0002-2574-8520; Liebler, Daniel/0000-0002-7873-3031	National Institutes of Health [P50 HL70128, RO1 HL54926]; NIEHS Center of Excellence in Environmental Toxicology [ES013508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL070128, R01HL054926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Center of Excellence in Environmental Toxicology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 HL70128 (to G. F. and H. I.), RO1 HL54926 (to H. I.), and ES013508 from the NIEHS Center of Excellence in Environmental Toxicology (to H. I.).	Afeltra A, 2005, ARTHRIT RHEUM-ARTHR, V53, P452, DOI 10.1002/art.21172; ALPERT JS, 1976, JAMA-J AM MED ASSOC, V236, P1477, DOI 10.1001/jama.236.13.1477; Blake GJ, 2001, EUR HEART J, V22, P2262, DOI 10.1053/euhj.2001.2692; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Carter AM, 2000, BLOOD, V96, P1177, DOI 10.1182/blood.V96.3.1177.015k25_1177_1179; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Doolittle RF, 2006, BIOCHEMISTRY-US, V45, P13962, DOI 10.1021/bi061219e; DOTEVALL A, 1987, EUR J HAEMATOL, V38, P55; Everse SJ, 1999, BIOCHEMISTRY-US, V38, P2941, DOI 10.1021/bi982626w; FATAH K, 1992, THROMB HAEMOSTASIS, V68, P130; Fatah K, 1996, THROMB HAEMOSTASIS, V76, P535; Ferro D, 1997, CIRCULATION, V95, P1425; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Heijnen HFG, 2006, FREE RADICAL BIO MED, V40, P1903, DOI 10.1016/j.freeradbiomed.2005.09.006; INADA Y, 1978, BIOCHIM BIOPHYS ACTA, V532, P161, DOI 10.1016/0005-2795(78)90459-2; KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; KAZAL LA, 1963, P SOC EXP BIOL MED, V113, P989; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Parastatidis I, 2007, CIRC RES, V101, P368, DOI 10.1161/CIRCRESAHA.107.157537; Pignatelli B, 2001, CANCER RES, V61, P778; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Reilly M, 1996, CIRCULATION, V94, P19, DOI 10.1161/01.CIR.94.1.19; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; WEISEL JW, 1993, J MOL BIOL, V232, P285, DOI 10.1006/jmbi.1993.1382; WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804	41	65	67	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33846	33853		10.1074/jbc.M805522200	http://dx.doi.org/10.1074/jbc.M805522200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818200	Green Published, hybrid			2022-12-25	WOS:000261277700008
J	Ametzazurra, A; Larrea, E; Civeira, MP; Prieto, J; Aldabe, R				Ametzazurra, A.; Larrea, E.; Civeira, M. P.; Prieto, J.; Aldabe, R.			Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis	ONCOGENE			English	Article						N-alpha-acetyltransferase; hNAT5/hNAT3; cellular proliferation; tumour progression	DIET-DEPENDENT CARCINOGENESIS; STRESS-INDUCED APOPTOSIS; TERMINAL ACETYLTRANSFERASES; RNA INTERFERENCE; TRANSGENIC MICE; P53; IDENTIFICATION; PROTEIN; GENES; YEAST	The N-alpha-acetyltransferase NatB, composed in Saccharomyces cerevisiae by the Nat3p and Mdm20p subunits, is an important factor for yeast growth and resistance to several stress agents. However, the expression and functional role of the mammalian counterpart has not yet been analysed. Here, we report the identification of Nat3p human homologue (hNAT5/hNAT3) and the characterization of its biological function. We found that hNAT5/hNAT3 silencing in HeLa cells results in inhibition of cell proliferation and increased sensitivity to the pro-apoptotic agent MG132. Moreover, inhibition of hNAT5/hNAT3 expression induces p53 activation and upregulation of the antiproliferative protein p21(WAF1/CIP1). The changes of the cellular transcriptome after hNAT5/hNAT3 knockdown confirmed the involvement of this protein in cell growth and survival processes. Among the genes differentially expressed, we observed upregulation of several p53-dependent antiproliferative and pro-apoptotic genes. In the c-myc transgenic mice, which is a model of inducible hepatocarcinoma, we found that hNAT5/hNAT3 was upregulated when the tumour was induced. In accordance with this observation, we noticed increased hNAT5/hNAT3 protein level in neoplastic versus non-neoplastic tissue in a high proportion of patients with hepatocellular carcinoma. Consequently, our results suggest that hNAT5/hNAT3 is required for cellular proliferation and can be implicated in tumour growth.	[Ametzazurra, A.; Larrea, E.; Prieto, J.; Aldabe, R.] Univ Navarra, CIMA, Div Gene Therapy & Hepatol, Pamplona 31008, Spain; [Civeira, M. P.; Prieto, J.] CIBER EHD, Clin Univ, Liver Unit, Pamplona, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra	Aldabe, R (corresponding author), Univ Navarra, CIMA, Div Gene Therapy & Hepatol, Ave Pio 12,55, Pamplona 31008, Spain.	raldabe@unav.es	Aldabe, Rafael/F-3112-2015; Larrea, Esther/L-7586-2014	Aldabe, Rafael/0000-0002-9461-020X; Larrea, Esther/0000-0002-1443-6513; Prieto, Jesus/0000-0002-1091-9593	FPU [AP2001-1567]; FIS; Instituto de Salud Carlos III; Ministerio de Sanidad y Consumo [02/3054]; Departamento de Educacion; Gobierno de Navarra (GNE-Enzima N); UTE	FPU(Spanish Government); FIS(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Departamento de Educacion; Gobierno de Navarra (GNE-Enzima N); UTE	We thank Dr Christine Perret for the transgenic mice, Dr Carmen Berasain and Dr Maider Zabala for providing samples, Dr Francisco Borras-Cuesta and Virginia Belsue for peptides synthesis, Dr Victor Segura for bioinformatics assistance and Sandra Jusue, Maite Corres and Beatriz Carte for excellent technical assistance. AA was supported by an FPU training fellowship (AP2001-1567) and RA was supported by an FIS research contract. CIBEREHD is funded by Instituto de Salud Carlos III, and this research was partially supported by grants from Ministerio de Sanidad y Consumo (02/3054), Departamento de Educacion, Gobierno de Navarra (GNE-Enzima N) and UTE project CIMA.	Agarwal MK, 2006, P NATL ACAD SCI USA, V103, P16278, DOI 10.1073/pnas.0607210103; Arnesen T, 2006, ONCOGENE, V25, P4350, DOI 10.1038/sj.onc.1209469; Arnesen T, 2006, GENE, V371, P291, DOI 10.1016/j.gene.2005.12.008; Arnesen T, 2005, THYROID, V15, P1131, DOI 10.1089/thy.2005.15.1131; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; BORRASCUESTA F, 1991, BIOLOGICALS, V19, P187, DOI 10.1016/1045-1056(91)90033-G; Braun K, 1998, ONCOGENE, V17, P2259, DOI 10.1038/sj.onc.1202145; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Caesar R, 2006, EUKARYOT CELL, V5, P368, DOI 10.1128/EC.5.2.368-378.2006; CARTIER N, 1994, B ACAD NAT MED PARIS, V178, P23; CARTIER N, 1992, ONCOGENE, V7, P1413; CARTIER N, 1994, B ACAD NATL MED, V178, P32; Cheung PK, 2004, CANCER RES, V64, P5929, DOI 10.1158/0008-5472.CAN-04-1216; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Fisher TS, 2005, J BIOL CHEM, V280, P17749, DOI 10.1074/jbc.M412055200; Fluge O, 2002, ONCOGENE, V21, P5056, DOI 10.1038/sj.onc.1205687; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Gendron RL, 2000, DEV DYNAM, V218, P300, DOI 10.1002/(SICI)1097-0177(200006)218:2<300::AID-DVDY5>3.0.CO;2-K; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lim JH, 2007, APOPTOSIS, V12, P411, DOI 10.1007/s10495-006-0576-9; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Line A, 2002, BRIT J CANCER, V86, P1824, DOI 10.1038/sj.bjc.6600321; Liu G, 2005, CANCER CELL, V7, P113, DOI 10.1016/j.ccr.2005.01.019; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sim E, 2008, DRUG METAB REV, V40, P479, DOI [10.1080/03602530802186603, 10.1080/03602530802186603 ]; SIMON HU, 1994, BIOCHEM J, V297, P389, DOI 10.1042/bj2970389; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; STARHEIM KK, 2008, BIOCH J; Sugiura N, 2003, J BIOL CHEM, V278, P40113, DOI 10.1074/jbc.M301218200; Sugiura N, 2001, J BIOL CHEM, V276, P14257, DOI 10.1074/jbc.M100011200; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517	47	34	35	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	58					7296	7306		10.1038/onc.2008.332	http://dx.doi.org/10.1038/onc.2008.332			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	382FI	18794801				2022-12-25	WOS:000261590300007
J	Dweck, D; Hus, N; Potter, JD				Dweck, David; Hus, Nir; Potter, James D.			Challenging Current Paradigms Related to Cardiomyopathies ARE CHANGES IN THE Ca2+ SENSITIVITY OF MYOFILAMENTS CONTAINING CARDIAC TROPONIN C MUTATIONS (G159D AND L29Q) GOOD PREDICTORS OF THE PHENOTYPIC OUTCOMES?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNESIUM BINDING-SITES; DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; ALPHA-TROPOMYOSIN; CALCIUM-BINDING; ATPASE ACTIVITY; FUNCTIONAL CONSEQUENCES; T MUTATIONS; N-TERMINUS; AFFINITY	Two novel mutations (G159D and L29Q) in cardiac troponin C (CTnC) associate their phenotypic outcomes with dilated (DCM) and hypertrophic cardiomyopathy (HCM), respectively. Current paradigms propose that sarcomeric mutations associated with DCM decrease the myofilament Ca2+ sensitivity, whereas those associated with HCM increase it. Therefore, we incorporated the mutant CTnCs into skinned cardiac muscle in order to determine if their effects on the Ca2+ sensitivities of tension and ATPase activity coincide with the current paradigms and phenotypic outcomes. The G159D-CTnC decreases the Ca2+ sensitivity of tension and ATPase activation and reduces the maximal ATPase activity when incorporated into regulated actomyosin filaments. Under the same conditions, the L29Q-CTnC has no effect. Surprisingly, changes in the apparent G159D-CTnC Ca2+ affinity measured by tension in fibers do not occur in the isolated CTnC, and large changes measured in the isolated L29Q-CTnC do not manifest in the fiber. These counterintuitive findings are justified through a transition in Ca2+ affinity occurring at the level of cardiac troponin and higher, implying that the true effects of these mutations become apparent as the hierarchical level of the myofilament increases. Therefore, the contractile apparatus, representing a large cooperative machine, can provide the potential for a change ( G159D) or no change ( L29Q) in the Ca2+ regulation of contraction. In accordance with the clinical outcomes and current paradigms, the desensitization of myofilaments from G159D-CTnC is expected to weaken the contractile force of the myocardium, whereas the lack of myofilament changes from L29Q-CTnC may preserve diastolic and systolic function.	[Dweck, David; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Hus, Nir] Mt Sinai Med Ctr, Dept Surg, Miami Beach, FL 33141 USA	University of Miami; Mount Sinai Medical Center	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave R-189, Miami, FL 33136 USA.	jdpotter@miami.edu			National Institutes of Health [HL67415, HL42325, HL07188]; American Heart Association [AHA 0315164B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R01HL067415, T32HL007188, R37HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67415 and HL42325 (to J.D.P.) and T32-HL07188. This work was also supported by American Heart Association Grant AHA 0315164B (to D. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; de Simone G, 2005, EUR HEART J, V26, P1039, DOI 10.1093/eurheartj/ehi019; de Simone G, 2005, AM J HYPERTENS, V18, P191, DOI 10.1016/j.amjhyper.2004.08.032; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Dweck D, 2005, BIOPHYS J, V88, p317A; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GRIFFIN BP, 2004, MANUAL CARDIOVASCULA, P101; GULATI J, 1991, J PHYSIOL-LONDON, V441, P305, DOI 10.1113/jphysiol.1991.sp018753; GUTH K, 1987, J BIOL CHEM, V262, P13627; Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200; Heller MJ, 2003, J BIOL CHEM, V278, P41742, DOI 10.1074/jbc.M303408200; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Jain M, 1998, CIRCULATION, V98, P179; JAQUET K, 1987, BIOCHEM BIOPH RES CO, V145, P1390, DOI 10.1016/0006-291X(87)91592-0; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; Karibe A, 2001, CIRCULATION, V103, P65; Kaski JP, 2007, CARDIOL YOUNG, V17, P675, DOI 10.1017/S1047951107001291; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Lilly L., 2006, PATHOPHYSIOLOGY HEAR; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; MORIMOTO S, 1987, J BIOCHEM-TOKYO, V101, P291, DOI 10.1093/oxfordjournals.jbchem.a121913; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; MURAKAMI U, 1976, J BIOCHEM, V80, P611, DOI 10.1093/oxfordjournals.jbchem.a131316; Palmieri V, 2001, AM J CARDIOL, V88, P1163, DOI 10.1016/S0002-9149(01)02054-9; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Preston LC, 2007, BIOCHEM BIOPH RES CO, V360, P27, DOI 10.1016/j.bbrc.2007.05.221; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Venkatraman G, 2005, J BIOL CHEM, V280, P17584, DOI 10.1074/jbc.M409337200; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773	61	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33119	33128		10.1074/jbc.M804070200	http://dx.doi.org/10.1074/jbc.M804070200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18820258	Green Published, hybrid			2022-12-25	WOS:000261183700013
J	England, P; Westblade, LF; Karimova, G; Robbe-Saule, V; Norel, F; Kolb, A				England, Patrick; Westblade, Lars F.; Karimova, Gouzel; Robbe-Saule, Veronique; Norel, Francoise; Kolb, Annie			Binding of the Unorthodox Transcription Activator, Crl, to the Components of the Transcription Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE HOLOENZYME; PROTEIN-PROTEIN INTERACTION; ESCHERICHIA-COLI REGULATOR; GENERAL STRESS-RESPONSE; PHASE SIGMA-FACTOR; STATIONARY-PHASE; CRYSTAL-STRUCTURE; CORE ENZYME; SIGMA(S)-DEPENDENT GENES; SIGNAL-TRANSDUCTION	The small regulatory protein Crl binds to sigma(S), the RNA polymerase stationary phase sigma factor. Crl facilitates the formation of the sigma(S)-associated holoenzyme (E sigma(S)) and thereby activates sigma(S)-dependent genes. Using a real time surface plasmon resonance biosensor, we characterized in greater detail the specificity and mode of action of Crl. Crl specifically forms a 1: 1 complex with sigma(S), which results in an increase of the association rate of sigma(S) to core RNA polymerase without any effect on the dissociation rate of E sigma(S). Crl is also able to associate with preformed E sigma(S) with a higher affinity than with sigma(S) alone. Furthermore, even at saturating sigma(S) concentrations, Crl significantly increases E sigma(S) association with the katN promoter and the productive isomerization of the E sigma(S)-katN complex, supporting a direct role of Crl in transcription initiation. Finally, we show that Crl does not bind to sigma(70) itself but is able at high concentrations to form a weak and transient 1:1 complex with both core RNA polymerase and the sigma(70)-associated holoenzyme, leaving open the possibility that Crl might also exert a side regulatory role in the transcriptional activity of additional non-sigma(S) holoenzymes.	[England, Patrick] Inst Pasteur, F-75015 Paris, France; [Karimova, Gouzel] Unite Biochim Interact Macromol, F-75015 Paris, France; [Robbe-Saule, Veronique; Norel, Francoise; Kolb, Annie] Mol Genet Unit, F-75015 Paris, France; [England, Patrick; Karimova, Gouzel] CNRS, URA2185, F-75015 Paris, France; [Robbe-Saule, Veronique; Norel, Francoise; Kolb, Annie] CNRS, URA2172, F-75015 Paris, France; [Westblade, Lars F.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Rockefeller University	England, P (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75724 Paris 15, France.	england@pasteur.fr; akolb@pasteur.fr	, KARIMOVA/W-4225-2018	, KARIMOVA/0000-0003-4279-186X; ENGLAND, Patrick/0000-0001-6410-5918	National Institutes of Health [GM53759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53759 (in support of L. F. W.; awarded to Seth A. Darst). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; ARNQVIST A, 1992, MOL MICROBIOL, V6, P2443; Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439; Bougdour A, 2004, J BIOL CHEM, V279, P19540, DOI 10.1074/jbc.M314145200; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Colland F, 1999, EMBO J, V18, P4049, DOI 10.1093/emboj/18.14.4049; Colland F, 2002, GENES CELLS, V7, P233, DOI 10.1046/j.1365-2443.2002.00517.x; DEHASETH P L, 1978, Biochemistry, V17, P1612, DOI 10.1021/bi00602a006; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; Ferguson AL, 2000, FEBS LETT, V481, P281, DOI 10.1016/S0014-5793(00)02028-7; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gaal T, 2006, J BACTERIOL, V188, P7966, DOI 10.1128/JB.01266-06; Gildehaus N, 2007, NUCLEIC ACIDS RES, V35, P1885, DOI 10.1093/nar/gkm085; Gourse RL, 2006, J BACTERIOL, V188, P4589, DOI 10.1128/JB.00499-06; Gowrishankar J, 2003, J BACTERIOL, V185, P2673, DOI 10.1128/JB.185.8.2673-2679.2003; Greive SJ, 2008, P NATL ACAD SCI USA, V105, P3315, DOI 10.1073/pnas.0712074105; GRIBSKOV M, 1983, GENE, V26, P109, DOI 10.1016/0378-1119(83)90180-4; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gruber TM, 2001, MOL CELL, V8, P21, DOI 10.1016/S1097-2765(01)00292-1; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Klauck Eberhard, 2007, Science Progress, V90, P103, DOI 10.3184/003685007X215922; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; LEDERER H, 1991, J MOL BIOL, V219, P747, DOI 10.1016/0022-2836(91)90669-W; Lee DJ, 2008, J BACTERIOL, V190, P1284, DOI 10.1128/JB.01599-07; Lelong C, 2007, MOL CELL PROTEOMICS, V6, P648, DOI 10.1074/mcp.M600191-MCP200; Lelong C, 2007, MOL CELL PROTEOMICS, V6, P660, DOI 10.1074/mcp.M600192-MCP200; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; MELANCON P, 1983, BIOCHEMISTRY-US, V22, P5169, DOI 10.1021/bi00291a017; Miller JH., 1972, EXPT MOL GENETICS; Mitchell JE, 2007, J BACTERIOL, V189, P3489, DOI 10.1128/JB.00019-07; Mooney RA, 2003, GENE DEV, V17, P2839, DOI 10.1101/gad.1142203; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Patikoglou GA, 2007, J MOL BIOL, V372, P649, DOI 10.1016/j.jmb.2007.06.081; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Pemberton IK, 1999, J MOL RECOGNIT, V12, P322, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<322::AID-JMR471>3.0.CO;2-W; Pratt LA, 1998, MOL MICROBIOL, V29, P1225, DOI 10.1046/j.1365-2958.1998.01007.x; Robbe-Saule V, 2001, MOL MICROBIOL, V39, P1533, DOI 10.1046/j.1365-2958.2001.02340.x; Robbe-Saule V, 2008, J BACTERIOL, V190, P4453, DOI 10.1128/JB.00154-08; Robbe-Saule V, 2007, J BACTERIOL, V189, P2976, DOI 10.1128/JB.01919-06; Robbe-Saule V, 2006, J BACTERIOL, V188, P3983, DOI 10.1128/JB.00033-06; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; Schnetz K, 2002, MICROBIOL-SGM, V148, P2573, DOI 10.1099/00221287-148-8-2573; Sorenson MK, 2006, P NATL ACAD SCI USA, V103, P16722, DOI 10.1073/pnas.0606482103; Sorenson MK, 2004, MOL CELL, V14, P127, DOI 10.1016/S1097-2765(04)00150-9; Stockley PG, 1998, BIOSENS BIOELECTRON, V13, P637, DOI 10.1016/S0956-5663(98)00019-0; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Westblade LF, 2004, J MOL BIOL, V335, P685, DOI 10.1016/j.jmb.2003.11.004; WU FYH, 1976, BIOCHEMISTRY-US, V15, P3254, DOI 10.1021/bi00660a014; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhi HJ, 2003, METHOD ENZYMOL, V370, P174; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	72	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33455	33464		10.1074/jbc.M807380200	http://dx.doi.org/10.1074/jbc.M807380200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18818199	hybrid, Green Published			2022-12-25	WOS:000261183700050
J	Basu, S; Azarova, NA; Font, MD; King, SB; Hogg, N; Gladwin, MT; Shiva, S; Kim-Shapiro, DB				Basu, Swati; Azarova, Natalia A.; Font, Michael D.; King, S. Bruce; Hogg, Neil; Gladwin, Mark T.; Shiva, Sruti; Kim-Shapiro, Daniel B.			Nitrite Reductase Activity of Cytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL TRANSITIONS; TYROSINE NITRATION; HYPOXIC CONDITIONS; S-NITROSATION; OXIDE; OXYGEN; CARDIOLIPIN; SUPEROXIDE; KINETICS; CELL	Small increases in physiological nitrite concentrations have now been shown to mediate a number of biological responses, including hypoxic vasodilation, cytoprotection after ischemia/reperfusion, and regulation of gene and protein expression. Thus, while nitrite was until recently believed to be biologically inert, it is now recognized as a potentially important hypoxic signaling molecule and therapeutic agent. Nitrite mediates signaling through its reduction to nitric oxide, via reactions with several heme-containing proteins. In this report, we show for the first time that the mitochondrial electron carrier cytochrome c can also effectively reduce nitrite to NO. This nitrite reductase activity is highly regulated as it is dependent on pentacoordination of the heme iron in the protein and occurs under anoxic and acidic conditions. Further, we demonstrate that in the presence of nitrite, pentacoordinate cytochrome c generates bioavailable NO that is able to inhibit mitochondrial respiration. These data suggest an additional role for cytochrome c as a nitrite reductase that may play an important role in regulating mitochondrial function and contributing to hypoxic, redox, and apoptotic signaling within the cell.	[Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Gladwin, Mark T.; Shiva, Sruti] Univ Pittsburgh, Hemostasis & Vasc Biol Res Inst, Pittsburgh, PA 15213 USA; [Basu, Swati; Azarova, Natalia A.; Font, Michael D.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [King, S. Bruce] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Hogg, Neil] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Hogg, Neil] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Gladwin, Mark T.] Univ Pittsburgh, Med Ctr, Pulm Allergy & Crit Care Med Div, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Wake Forest University; Medical College of Wisconsin; Medical College of Wisconsin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shiva, S (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	shivas@upmc.edu; shapiro@wfu.edu	Kim-Shapiro, Daniel/HGA-2682-2022		National Institutes of Health [HL058091, HL078706]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058091, R37HL058091, K02HL078706, R01HL058091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058091 and HL078706. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASCENZI P, 1994, J INORG BIOCHEM, V53, P273, DOI 10.1016/0162-0134(94)85114-X; Batthyany C, 2005, BIOCHEMISTRY-US, V44, P8038, DOI 10.1021/bi0474620; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Boyd CS, 2002, BIOL CHEM, V383, P411, DOI 10.1515/BC.2002.045; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; BUTT WD, 1962, PROC R SOC SER B-BIO, V156, P429, DOI 10.1098/rspb.1962.0049; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Castello PR, 2008, P NATL ACAD SCI USA, V105, P8203, DOI 10.1073/pnas.0709461105; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Castro L, 2004, ARCH BIOCHEM BIOPHYS, V421, P99, DOI 10.1016/j.abb.2003.08.033; Chen YR, 2002, J BIOL CHEM, V277, P29781, DOI 10.1074/jbc.M200709200; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Estevam ML, 2004, J BIOL CHEM, V279, P39214, DOI 10.1074/jbc.M402093200; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; Frost MT, 2005, AM J PHYSIOL-REG I, V288, pR394, DOI 10.1152/ajpregu.00504.2004; Galkin A, 2007, ESSAYS BIOCHEM, V43, P29, DOI 10.1042/bse0430029; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Godoy LC, 2007, FREE RADICAL BIO MED, V43, pS31; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; HOGG N, 1993, FEBS LETT, V326, P199, DOI 10.1016/0014-5793(93)81790-7; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lee VY, 2002, J BIOL CHEM, V277, P16067, DOI 10.1074/jbc.M111177200; Li CQ, 2005, CANCER LETT, V226, P1, DOI 10.1016/j.canlet.2004.10.021; Li HT, 2004, J BIOL CHEM, V279, P16939, DOI 10.1074/jbc.M314336200; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Nadtochiy SM, 2007, J MOL CELL CARDIOL, V42, P812, DOI 10.1016/j.yjmcc.2007.01.010; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nantes IL, 2001, J BIOL CHEM, V276, P153, DOI 10.1074/jbc.M006338200; Osipov AN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1491, DOI 10.1134/S0006297907130068; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Schonhoff CM, 2003, J BIOL CHEM, V278, P18265, DOI 10.1074/jbc.M212459200; Shen YH, 1998, FEBS LETT, V433, P125, DOI 10.1016/S0014-5793(98)00844-8; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; SPOONER PJR, 1992, BIOCHEMISTRY-US, V31, P10129, DOI 10.1021/bi00156a037; Thomas DD, 2002, P NATL ACAD SCI USA, V99, P12691, DOI 10.1073/pnas.202312699; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169; Tuominen EKJ, 2002, J BIOL CHEM, V277, P8822, DOI 10.1074/jbc.M200056200; van Beek-Harmsen BJ, 2005, J HISTOCHEM CYTOCHEM, V53, P803, DOI 10.1369/jhc.4C6527.2005; Xu XL, 2002, J BIOL CHEM, V277, P36787, DOI 10.1074/jbc.M205350200; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	60	154	157	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32590	32597		10.1074/jbc.M806934200	http://dx.doi.org/10.1074/jbc.M806934200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18820338	Green Published, hybrid			2022-12-25	WOS:000260893700048
J	Sharma, AK; Zhou, GP; Kupferman, J; Surks, HK; Christensen, EN; Chou, JJ; Mendelsohn, ME; Rigby, AC				Sharma, Alok K.; Zhou, Guo-Ping; Kupferman, Joseph; Surks, Howard K.; Christensen, Eva N.; Chou, James J.; Mendelsohn, Michael E.; Rigby, Alan C.			Probing the Interaction between the Coiled Coil Leucine Zipper of cGMP-dependent Protein Kinase I alpha and the C Terminus of the Myosin Binding Subunit of the Myosin Light Chain Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE RELAXATION; NMR-SPECTROSCOPY; CIRCULAR-DICHROISM; TARGETING SUBUNIT; BLOOD-PRESSURE; PKGI-ALPHA; DOMAIN; RESIDUES; COMPLEX; IDENTIFICATION	Nitric oxide and nitrovasodilators induce vascular smooth muscle cell relaxation in part by cGMP-dependent protein kinase I (PKG-I alpha)-mediated activation of myosin phosphatase (MLCP). Mechanistically it has been proposed that protein-protein interactions between the N-terminal leucine zipper (LZ) domain of PKG-I alpha((PKG-I alpha(1-59)) and the LZ and/or coiled coil (CC) domain of the myosin binding subunit (MBS) of MLCP are localized in the C terminus of MBS. Although recent studies have supported these interactions, the critical amino acids responsible for these interactions have not been identified. Here we present structural and biophysical data identifying that the LZ domain of PKG-I alpha(1-59) interacts with a well defined 42-residue CC motif (MBSCT42) within the C terminus of MBS. Using glutathione S-transferase pulldown experiments, chemical cross-linking, size exclusion chromatography, circular dichroism, and isothermal titration calorimetry we identified a weak dimer-dimer interaction between PKG-I alpha(1-59) and this C-terminal CC domain of MBS. The K-d of this non-covalent complex is 178.0 +/- 1.5 mu M. Furthermore our H-1-N-15 heteronuclear single quantum correlation NMR data illustrate that this interaction is mediated by several PKG-I alpha residues that are on the a, d, e, and g hydrophobic and electrostatic interface of the C-terminal heptad layers 2, 4, and 5 of PKG-I alpha. Taken together these data support a role for the LZ domain of PKG-I alpha and the CC domain of MBS in this requisite contractile complex.	[Sharma, Alok K.; Zhou, Guo-Ping; Kupferman, Joseph; Rigby, Alan C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Mol & Vasc Med, Vasc Biol Res Ctr,Dept Med,Sch Med, Boston, MA 02215 USA; [Surks, Howard K.; Christensen, Eva N.; Mendelsohn, Michael E.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Chou, James J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tufts Medical Center; Harvard University; Harvard Medical School	Rigby, AC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Mol & Vasc Med, Vasc Biol Res Ctr,Dept Med,Sch Med, 330 Brookline Ave, Boston, MA 02215 USA.	arigby@bidmc.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344; Sharma, Alok/0000-0002-7668-3501	National Institutes of Health [1PO1HL077378, 1RO1HL74069]; Atorvastatin Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074069, P01HL077378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Atorvastatin Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1PO1HL077378 ( to M. E. M.) and 1PO1HL077378 and 1RO1HL74069 ( to H. K. S.). This work was also supported by an Atorvastatin Research Award ( to A. C. R.).	Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; ATKINSON RA, 1991, BIOCHEMISTRY-US, V30, P9387, DOI 10.1021/bi00103a001; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Collins BM, 2003, NAT STRUCT BIOL, V10, P607, DOI 10.1038/nsb955; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng YQ, 2007, PROTEIN SCI, V16, P323, DOI 10.1110/ps.062590807; Falls LA, 2001, J BIOL CHEM, V276, P23895, DOI 10.1074/jbc.M008332200; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; Freedman SJ, 2003, J BIOL CHEM, V278, P13462, DOI 10.1074/jbc.M210483200; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; Goto NK, 2000, CURR OPIN STRUC BIOL, V10, P585, DOI 10.1016/S0959-440X(00)00135-4; Grant MA, 2004, J BIOL CHEM, V279, P32464, DOI 10.1074/jbc.M313826200; Green NS, 2005, P NATL ACAD SCI USA, V102, P14545, DOI 10.1073/pnas.0501609102; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Hamilton KS, 2000, J BIOMOL NMR, V18, P319, DOI 10.1023/A:1026773008237; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hartshorne DJ, 1999, MOL CELL BIOCHEM, V190, P79, DOI 10.1023/A:1006917032557; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Ishigaki T, 2007, J BIOCHEM, V141, P855, DOI 10.1093/jb/mvm093; JUNIUS FK, 1995, BIOCHEMISTRY-US, V34, P6164, DOI 10.1021/bi00018a020; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Lamb HK, 2007, PROTEIN SCI, V16, P2391, DOI 10.1110/ps.072900907; Langsetmo K, 2001, J BIOL CHEM, V276, P34318, DOI 10.1074/jbc.M103255200; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; Mendelsohn ME, 2005, NAT MED, V11, P115, DOI 10.1038/nm0205-115; MERELO JJ, 1994, NEUROCOMPUTING, V6, P443, DOI 10.1016/0925-2312(94)90021-3; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; MONERA OD, 1994, BIOCHEMISTRY-US, V33, P3862, DOI 10.1021/bi00179a010; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Shekhtman A, 2001, J MOL BIOL, V314, P129, DOI 10.1006/jmbi.2001.5126; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Soupene E, 2008, J LIPID RES, V49, P1103, DOI 10.1194/jlr.M800007-JLR200; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Surks HK, 2007, CIRC RES, V101, P1078, DOI 10.1161/CIRCRESAHA.107.165779; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Zhang T, 2003, BIOPHYS J, V85, P3279, DOI 10.1016/S0006-3495(03)74746-8; ZHOU NE, 1992, J BIOL CHEM, V267, P2664; [No title captured]	56	79	81	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32860	32869		10.1074/jbc.M804916200	http://dx.doi.org/10.1074/jbc.M804916200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18782776	hybrid, Green Published			2022-12-25	WOS:000260893700075
J	Dermody, JL; Dreyfuss, JM; Villen, J; Ogundipe, B; Gygi, SP; Park, PJ; Ponticelli, AS; Moore, CL; Buratowski, S; Bucheli, ME				Dermody, Jessica L.; Dreyfuss, Jonathan M.; Villen, Judit; Ogundipe, Babatunde; Gygi, Steven P.; Park, Peter J.; Ponticelli, Alfred S.; Moore, Claire L.; Buratowski, Stephen; Bucheli, Miriam E.			Unphosphorylated SR-Like Protein Npl3 Stimulates RNA Polymerase II Elongation	PLOS ONE			English	Article								The production of a functional mRNA is regulated at every step of transcription. An area not well-understood is the transition of RNA polymerase II from elongation to termination. The S. cerevisiae SR-like protein Npl3 functions to negatively regulate transcription termination by antagonizing the binding of polyA/termination proteins to the mRNA. In this study, Npl3 is shown to interact with the CTD and have a direct stimulatory effect on the elongation activity of the polymerase. The interaction is inhibited by phosphorylation of Npl3. In addition, Casein Kinase 2 was found to be required for the phosphorylation of Npl3 and affect its ability to compete against Rna15 (Cleavage Factor I) for binding to polyA signals. Our results suggest that phosphorylation of Npl3 promotes its dissociation from the mRNA/RNAP II, and contributes to the association of the polyA/termination factor Rna15. This work defines a novel role for Npl3 in elongation and its regulation by phosphorylation.	[Dermody, Jessica L.; Buratowski, Stephen; Bucheli, Miriam E.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ogundipe, Babatunde; Moore, Claire L.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Medford, MA 02155 USA; [Villen, Judit; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA; [Ponticelli, Alfred S.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY USA; [Dreyfuss, Jonathan M.; Park, Peter J.] Harvard Partners Ctr Genet & Genom, Boston, MA USA	Harvard University; Harvard Medical School; Tufts University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University	Dermody, JL (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	Miriam_Bucheli@hms.harvard.edu		Dreyfuss, Jonathan/0000-0001-7242-3991; Bucheli, Miriam/0000-0002-3757-8522; Park, Peter/0000-0001-9378-960X; Villen, Judit/0000-0002-1005-1739	NIH [1K01CA115515-01A1, GM51124, GM46498, GM56663, GM68887];  [5F31GM075383-03]; NATIONAL CANCER INSTITUTE [K01CA115515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, F31GM075383, R01GM051124, R29GM046498, R01GM056663, R01GM068887, R29GM051124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants 1K01CA115515-01A1 to M.B., GM51124 to A.S.P., GM46498 and GM56663 to S.B., GM68887 to C.M., and fellowship 5F31GM075383-03 to J.D.	*AFF, 2005, GENECHIP WHOL TRANSC; Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; BUCHELI M, 2007, POLYADENYLATION SITE; Bucheli ME, 2005, EMBO J, V24, P2150, DOI 10.1038/sj.emboj.7600687; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Deka P, 2008, J MOL BIOL, V375, P136, DOI 10.1016/j.jmb.2007.09.029; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FLACH J, 1994, MOL CELL BIOL, V14, P8399, DOI 10.1128/MCB.14.12.8399; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; Grossman MJ, 2001, GEOMORPHOLOGY, V39, P21, DOI 10.1016/S0169-555X(01)00049-6; He XY, 2005, MOL CELL, V19, P619, DOI 10.1016/j.molcel.2005.07.016; Hirose Y, 2000, GENE DEV, V14, P1415; Huang CJ, 2007, FEBS LETT, V581, P223, DOI 10.1016/j.febslet.2006.12.015; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kaneko S, 2005, MOL CELL, V20, P91, DOI 10.1016/j.molcel.2005.08.033; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LUND MK, 2008, MOL CELL BIOL; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Rosonina E, 2006, GENE DEV, V20, P1050, DOI 10.1101/gad.1431606; Ryan K, 2007, RNA BIOL, V4, P26, DOI 10.4161/rna.4.1.4365; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Sarno S, 1997, BIOCHEMISTRY-US, V36, P11717, DOI 10.1021/bi9705772; Sawa C, 2004, MOL CELL BIOL, V24, P4734, DOI 10.1128/MCB.24.11.4734-4742.2004; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; Shen HH, 2004, MOL CELL, V16, P363, DOI 10.1016/j.molcel.2004.10.021; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Tacke R, 1997, P NATL ACAD SCI USA, V94, P1148, DOI 10.1073/pnas.94.4.1148; *TEAM RDC, 2007, LANG ENV STAT COMP; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Velazquez-Dones A, 2005, J BIOL CHEM, V280, P41761, DOI 10.1074/jbc.M504156200; WONG CM, 2007, MOL CELL BIOL; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao J, 1999, MOL CELL BIOL, V19, P7733; Ziegler LM, 2003, J BIOL CHEM, V278, P48950, DOI 10.1074/jbc.M309656200; Zielinski R, 2006, MOL CELL BIOCHEM, V286, P191, DOI 10.1007/s11010-005-9104-4	60	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3273	10.1371/journal.pone.0003273	http://dx.doi.org/10.1371/journal.pone.0003273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818768	Green Submitted, Green Published, gold			2022-12-25	WOS:000264432300001
J	Qin, J; Tsai, MJ; Tsai, SY				Qin, Jun; Tsai, Ming-Jer; Tsai, Sophia Y.			Essential Roles of COUP-TFII in Leydig Cell Differentiation and Male Fertility	PLOS ONE			English	Article								Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII; also known as NR2F2), is an orphan nuclear receptor of the steroid/thyroid hormone receptor superfamily. COUP-TFII-null mice die during the early embryonic development due to angiogenesis and cardiovascular defects. To circumvent the early embryonic lethality and investigate the physiological function of COUP-TFII, we knocked out COUP-TFII gene in a time-specific manner by using a tamoxifen inducible Cre recombinase. The ablation of COUP-TFII during pre-pubertal stages of male development results in infertility, hypogonadism and spermatogenetic arrest. Homozygous adult male mutants are defective in testosterone synthesis, and administration of testosterone could largely rescue the mutant defects. Notably, the rescued results also provide the evidence that the major function of adult Leydig cell is to synthesize testosterone. Further phenotypic analysis reveals that Leydig cell differentiation is arrested at the progenitor cell stage in the testes of null mice. The failure of testosterone to resumption of Leydig cell maturation in the null mice indicates that COUP-TFII itself is essential for this process. In addition, we identify that COUP-TFII plays roles in progenitor Leydig cell formation and early testis organogenesis, as demonstrated by the ablation of COUP-TFII at E18.5. On the other hand, when COUP-TFII is deleted in the adult stage after Leydig cells are well differentiated, there are no obvious defects in reproduction and Leydig cell function. Taken together, these results indicate that COUP-TFII plays a major role in differentiation, but not the maintenance of Leydig cells.	[Qin, Jun; Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Qin, J (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	mtsai@bcm.tmc.edu; stsai@bcm.tmc.edu	Qin, Jun/A-1148-2010	Qin, Jun/0000-0002-2263-128X	NIH [DK45641, HD17379, HL076448, P01DK59820]; National Institute of Child Health and Human Development [U54-HD28934]; University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017379, R37HD017379] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045641, R37DK045641, P01DK059820] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK45641 and HD17379 (MJT), HL076448 (SYT) and P01DK59820 (SYT and MJT). Ligand assay was supported by National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction Research) grant U54-HD28934 to the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core.	Akingbemi BT, 2003, ENDOCRINOLOGY, V144, P84, DOI 10.1210/en.2002-220292; Ariyaratne HBS, 2000, BIOL REPROD, V63, P1115, DOI 10.1095/biolreprod63.4.1115; Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; HARDY MP, 1990, ENDOCRINOLOGY, V127, P488, DOI 10.1210/endo-127-1-488; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hirashima M, 2006, ENDOTHELIUM-J ENDOTH, V13, P137, DOI 10.1080/10623320600698078; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; Lei ZM, 2001, MOL ENDOCRINOL, V15, P184, DOI 10.1210/me.15.1.184; Lui WY, 2003, BIOL REPROD, V68, P1087, DOI 10.1095/biolreprod.102.010371; Lundwall A, 1997, EUR J BIOCHEM, V249, P39, DOI 10.1111/j.1432-1033.1997.t01-2-00039.x; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; Mann DR, 1996, J ENDOCRINOL, V149, P191, DOI 10.1677/joe.0.1490191; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Nakamura T, 2004, NAT GENET, V36, P528, DOI 10.1038/ng1344; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; ODELL WD, 1974, ENDOCRINOLOGY, V95, P1380, DOI 10.1210/endo-95-5-1380; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104; Qian YM, 2001, ENDOCRINOLOGY, V142, P5342, DOI 10.1210/en.142.12.5342; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; STEINBERGER E, 1971, PHYSIOL REV, V51, P1, DOI 10.1152/physrev.1971.51.1.1; Takamoto N, 2005, MOL ENDOCRINOL, V19, P2299, DOI 10.1210/me.2005-0019; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Wang GM, 2003, ENDOCRINOLOGY, V144, P5058, DOI 10.1210/en.2003-0563; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Wolgemuth DJ, 2002, RECENT PROG HORM RES, V57, P75, DOI 10.1210/rp.57.1.75; Yan W, 2000, DEV BIOL, V227, P169, DOI 10.1006/dbio.2000.9885; Yan W, 2003, P NATL ACAD SCI USA, V100, P10546, DOI 10.1073/pnas.1837812100; You LR, 2005, P NATL ACAD SCI USA, V102, P16351, DOI 10.1073/pnas.0507832102; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zhang FP, 2004, ENDOCRINOLOGY, V145, P1453, DOI 10.1210/en.2003-1049	38	80	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3285	10.1371/journal.pone.0003285	http://dx.doi.org/10.1371/journal.pone.0003285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818749	Green Published, gold, Green Submitted			2022-12-25	WOS:000264432300007
J	Logan, DW; Marton, TF; Stowers, L				Logan, Darren W.; Marton, Tobias F.; Stowers, Lisa			Species Specificity in Major Urinary Proteins by Parallel Evolution	PLOS ONE			English	Article								Species-specific chemosignals, pheromones, regulate social behaviors such as aggression, mating, pup-suckling, territory establishment, and dominance. The identity of these cues remains mostly undetermined and few mammalian pheromones have been identified. Genetically-encoded pheromones are expected to exhibit several different mechanisms for coding 1) diversity, to enable the signaling of multiple behaviors, 2) dynamic regulation, to indicate age and dominance, and 3) species-specificity. Recently, the major urinary proteins (Mups) have been shown to function themselves as genetically-encoded pheromones to regulate species-specific behavior. Mups are multiple highly related proteins expressed in combinatorial patterns that differ between individuals, gender, and age; which are sufficient to fulfill the first two criteria. We have now characterized and fully annotated the mouse Mup gene content in detail. This has enabled us to further analyze the extent of Mup coding diversity and determine their potential to encode species-specific cues. Our results show that the mouse Mup gene cluster is composed of two subgroups: an older, more divergent class of genes and pseudogenes, and a second class with high sequence identity formed by recent sequential duplications of a single gene/pseudogene pair. Previous work suggests that truncated Mup pseudogenes may encode a family of functional hexapeptides with the potential for pheromone activity. Sequence comparison, however, reveals that they have limited coding potential. Similar analyses of nine other completed genomes find Mup gene expansions in divergent lineages, including those of rat, horse and grey mouse lemur, occurring independently from a single ancestral Mup present in other placental mammals. Our findings illustrate that increasing genomic complexity of the Mup gene family is not evolutionarily isolated, but is instead a recurring mechanism of generating coding diversity consistent with a species-specific function in mammals.	[Logan, Darren W.; Marton, Tobias F.; Stowers, Lisa] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Logan, DW (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	stowers@scripps.edu	Logan, Darren/D-5629-2009; Stowers, Lisa/K-6137-2015	Logan, Darren/0000-0003-1545-5510; Stowers, Lisa/0000-0002-4403-1269	NIDCD; Pew Charitable Trusts; Skaggs Institute; The Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Pew Charitable Trusts; Skaggs Institute; The Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents	This work was supported by NIDCD, Pew Charitable Trusts, Skaggs Institute, and The Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SD, 2005, BIOCHEM J, V391, P343, DOI 10.1042/BJ20050404; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Beynon RJ, 2002, J CHEM ECOL, V28, P1429, DOI 10.1023/A:1016252703836; Beynon RJ, 2008, CHEM SIGNAL, V11, P37, DOI 10.1007/978-0-387-73945-8_3; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BISHOP JO, 1982, EMBO J, V1, P615, DOI 10.1002/j.1460-2075.1982.tb01217.x; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; CLARE BW, 1985, ADV DYNAMIC STEREOCH, V1, P1; CLARK AJ, 1985, EMBO J, V4, P3159, DOI 10.1002/j.1460-2075.1985.tb04059.x; CLARK AJ, 1984, EMBO J, V3, P2055, DOI 10.1002/j.1460-2075.1984.tb02091.x; CLARK AJ, 1982, GENE, V18, P221, DOI 10.1016/0378-1119(82)90159-7; Demas GE, 1999, PHYSIOL BEHAV, V66, P59, DOI 10.1016/S0031-9384(98)00268-6; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Emes RD, 2004, GENOME RES, V14, P591, DOI 10.1101/gr.1940604; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; Flower DR, 1996, BIOCHEM J, V318, P1; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Gregoire C, 1996, J BIOL CHEM, V271, P32951, DOI 10.1074/jbc.271.51.32951; HARR R, 1982, NUCLEIC ACIDS RES, V10, P365, DOI 10.1093/nar/10.1.365; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Kruczek M, 2007, PHYSIOL BEHAV, V90, P483, DOI 10.1016/j.physbeh.2006.10.012; KUHN NJ, 1984, NUCLEIC ACIDS RES, V12, P6073, DOI 10.1093/nar/12.15.6073; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KURTZ D T, 1981, Journal of Molecular and Applied Genetics, V1, P29; KURTZ DT, 1977, P NATL ACAD SCI USA, V74, P4791, DOI 10.1073/pnas.74.11.4791; Lane RP, 2004, GENOME RES, V14, P603, DOI 10.1101/gr.2117004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-40; Loebel D, 2000, BIOCHEM J, V350, P369, DOI 10.1042/0264-6021:3500369; MACINNES JI, 1986, MOL CELL BIOL, V6, P3563, DOI 10.1128/MCB.6.10.3563; Marchese S, 1998, EUR J BIOCHEM, V252, P563, DOI 10.1046/j.1432-1327.1998.2520563.x; Marchlewska-Koj A, 2000, J CHEM ECOL, V26, P2355, DOI 10.1023/A:1005578911652; McFadyen DA, 1999, MAMM GENOME, V10, P463, DOI 10.1007/s003359901024; More L, 2006, CHEM SENSES, V31, P393, DOI 10.1093/chemse/bjj043; Mucignat-Caretta C, 2006, J NEUROCHEM, V99, P881, DOI 10.1111/j.1471-4159.2006.04127.x; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; NEI M, 1986, MOL BIOL EVOL, V3, P418; PAYNE AP, 1973, PHYSIOL BEHAV, V10, P629, DOI 10.1016/0031-9384(73)90235-7; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; Robertson DHL, 1997, RAPID COMMUN MASS SP, V11, P786, DOI 10.1002/(SICI)1097-0231(19970422)11:7<786::AID-RCM876>3.0.CO;2-8; Robertson DHL, 2007, J CHEM ECOL, V33, P613, DOI 10.1007/s10886-006-9247-0; ROY AK, 1966, P SOC EXP BIOL MED, V121, P894; ROY AK, 1966, BIOCHIM BIOPHYS ACTA, V127, P72, DOI 10.1016/0304-4165(66)90477-6; ROY AK, 1966, BIOCHIM BIOPHYS ACTA, V127, P82, DOI 10.1016/0304-4165(66)90478-8; ROY AK, 1967, NATURE, V214, P618, DOI 10.1038/214618b0; SHAHAN K, 1987, MOL CELL BIOL, V7, P1947, DOI 10.1128/MCB.7.5.1947; SHAHAN K, 1987, MOL CELL BIOL, V7, P1938, DOI 10.1128/MCB.7.5.1938; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Shi P, 2005, J MOL EVOL, V60, P566, DOI 10.1007/s00239-004-0172-y; Storz JF, 2007, GENETICS, V177, P481, DOI 10.1534/genetics.107.078550; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; SZOKA PR, 1978, GENETICS, V90, P597; Thom MD, 2008, CURR BIOL, V18, P619, DOI 10.1016/j.cub.2008.03.056; Wang W, 2005, GENOME RES, V15, P1258, DOI 10.1101/gr.3929705; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012	65	118	124	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3280	10.1371/journal.pone.0003280	http://dx.doi.org/10.1371/journal.pone.0003280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815613	gold, Green Submitted, Green Published			2022-12-25	WOS:000264431900006
J	Temime, L; Boelle, PY; Opatowski, L; Guillemot, D				Temime, Laura; Boelle, Pierre-Yves; Opatowski, Lulla; Guillemot, Didier			Impact of Capsular Switch on Invasive Pneumococcal Disease Incidence in a Vaccinated Population	PLOS ONE			English	Article							PNEUMONIAE SEROTYPE 19A; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CONJUGATE VACCINATION; NONVACCINE SEROTYPES; UNITED-STATES; DAY-CARE; CHILDREN; RESISTANCE; EMERGENCE	Background: Despite the dramatic decline in the incidence of invasive pneumococcal disease (IPD) observed since the introduction of conjugate vaccination, it is feared that several factors may undermine the future effectiveness of the vaccines. In particular, pathogenic pneumococci may switch their capsular types and evade vaccine-conferred immunity. Methodology/Principal Findings: Here, we first review the literature and summarize the available epidemiological data on capsular switch for S. pneumoniae. We estimate the weekly probability that a persistently carried strain may switch its capsule from four studies, totalling 516 children and 6 years of follow-up, at 1.5 x 10(-3)/week [4.6 x 10(-5)-4.8 x 10(-3)/week]. There is not enough power to assess an increase in this frequency in vaccinated individuals. Then, we use a mathematical model of pneumococcal transmission to quantify the impact of capsular switch on the incidence of IPD in a vaccinated population. In this model, we investigate a wide range of values for the frequency of vaccine-selected capsular switch. Predictions show that, with vaccine-independent switching only, IPD incidence in children should be down by 48% 5 years after the introduction of the vaccine with high coverage. Introducing vaccine-selected capsular switch at a frequency up to 0.01/week shows little effect on this decrease; yearly, at most 3 excess cases of IPD per 10 6 children might occur due to switched pneumococcal strains. Conclusions: Based on all available data and model predictions, the existence of capsular switch by itself should not impact significantly the efficacy of pneumococcal conjugate vaccination on IPD incidence. This optimistic result should be tempered by the fact that the selective pressure induced by the vaccine is currently increasing along with vaccine coverage worldwide; continued surveillance of pneumococcal populations remains of the utmost importance, in particular during clinical trials of the new conjugate vaccines.	[Temime, Laura] CNAM, Paris, France; [Boelle, Pierre-Yves] INSERM, UMR S707, Paris, France; [Boelle, Pierre-Yves] Univ Paris 06, F-75252 Paris, France; [Opatowski, Lulla; Guillemot, Didier] PhEMI, Inst Pasteur, Paris, France; [Opatowski, Lulla; Guillemot, Didier] INSERM, U 657, Paris, France; [Opatowski, Lulla; Guillemot, Didier] Univ Versailles St Quentin, Fac Med Paris France Ouest, Versailles, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Temime, L (corresponding author), CNAM, Paris, France.	laura.temime@cnam.fr	Guillemot, Didier/AAN-3051-2020; Opatowski, Lulla/I-3143-2015; Temime, Laura/G-7010-2011	Opatowski, Lulla/0000-0001-8348-700X; Temime, Laura/0000-0002-8850-5403; Guillemot, Didier/0000-0002-8497-1765; Boelle, Pierre-Yves/0000-0002-5367-8232				Aristegui J, 2007, EUR J CLIN MICROBIOL, V26, P303, DOI 10.1007/s10096-007-0294-4; Austrian R, 1999, J INFECT DIS, V179, pS338, DOI 10.1086/513841; BARNES DM, 1995, J INFECT DIS, V171, P890, DOI 10.1093/infdis/171.4.890; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bogaert D, 2005, J CLIN MICROBIOL, V43, P74, DOI 10.1128/JCM.43.1.74-83.2005; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Cauchemez S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-14; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e; Fry AM, 2002, VACCINE, V21, P303, DOI 10.1016/S0264-410X(02)00451-6; GRATTEN M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P501; Hanage WP, 2004, INFECT IMMUN, V72, P76, DOI 10.1128/IAI.72.1.76-81.2004; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Inostroza J, 1998, CLIN DIAGN LAB IMMUN, V5, P176, DOI 10.1128/CDLI.5.2.176-180.1998; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; Kadioglu A, 2002, INFECT IMMUN, V70, P2886, DOI 10.1128/IAI.70.6.2886-2890.2002; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; Lepoutre A., 2007, Bulletin Epidemiologique Hebdomadaire, P37; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Long SS, 2005, CLIN INFECT DIS, V41, P30, DOI 10.1086/430608; Meats E, 2003, J CLIN MICROBIOL, V41, P386, DOI 10.1128/JCM.41.1.386-392.2003; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Nebenzahl YM, 2004, FEMS MICROBIOL LETT, V233, P147, DOI 10.1016/j.femsle.2004.02.003; Nesin M, 1998, J INFECT DIS, V177, P707, DOI 10.1086/514242; O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Porat N, 2004, J INFECT DIS, V190, P2154, DOI 10.1086/425908; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Sleeman K, 2001, J INFECT DIS, V183, P239, DOI 10.1086/317924; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Sluijter M, 1998, J CLIN MICROBIOL, V36, P2248, DOI 10.1128/JCM.36.8.2248-2253.1998; Temime L, 2006, PEDIATR INFECT DIS J, V25, P382, DOI 10.1097/01.inf.0000210460.21966.f1; Temime L, 2005, EPIDEMIOL INFECT, V133, P493, DOI 10.1017/S0950268804003565; Temime L, 2004, ANTIMICROB AGENTS CH, V48, P2206, DOI 10.1128/AAC.48.6.2206-2213.2004; TOMASZ A, 2000, STREPTOCOCCUS PNEUMO, P491; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	48	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3244	10.1371/journal.pone.0003244	http://dx.doi.org/10.1371/journal.pone.0003244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802466	Green Submitted, Green Published, gold			2022-12-25	WOS:000264428600004
J	Carracedo, A; Pandolfi, PP				Carracedo, A.; Pandolfi, P. P.			The PTEN-PI3K pathway: of feedbacks and cross-talks	ONCOGENE			English	Review						feedback; PTEN; PI3K; drug combination; cross-talk	INSULIN-RECEPTOR SUBSTRATE-1; TUMOR-SUPPRESSOR PTEN; ACTIVATED PROTEIN-KINASE; PROSTATE INTRAEPITHELIAL NEOPLASIA; TRANSCRIPTION FACTOR FKHR; HEMATOPOIETIC STEM-CELLS; GROWTH-FACTOR RECEPTOR; B-RAF KINASE; PHOSPHOINOSITIDE 3-KINASE; TUBEROUS SCLEROSIS	The tumor suppressor PTEN was originally identified as a negative regulator of the phosphoinositide 3-kinase (PI3K) signaling, a main regulator of cell growth, metabolism and survival. Yet this function of PTEN is extremely relevant for its tumor-suppressive ability, albeit the recent characterization of many PI3K-independent tumor-suppressive activities. PI3K-mediated PIP3 production leads to the activation of the canonical AKT-mTORC1 pathway. The implications of this signaling cascade in health and disease have been underscored by the high number of regulators within the pathway whose alterations give rise to different malignancies, including familiar syndromes, metabolic dysfunctions and cancer. Moreover, PI3K is tightly buffered at multiple levels by downstream components, which have turned this signaling pathway literally upside down. PI3K and its downstream components in turn cross-talk with a number of other pathways, thereby leading to a complex network of signals that may have dramatic consequences when perturbed. Here, we review the current status of the PTEN-PI3K signaling pathway with special emphasis on the most recent data on targets and regulation of the PTEN-PI3K axis. This provides novel provocative therapeutic implications based on the targeted modulation of PI3K-cross-talking signals.	[Carracedo, A.; Pandolfi, P. P.] Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011	Carracedo, Arkaitz/0000-0001-5957-1260	US National Cancer Institute; European Molecular Biology Organization Long-Term Fellowship Award	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Molecular Biology Organization Long-Term Fellowship Award(European Molecular Biology Organization (EMBO))	We thank all members of the Pandolfi lab who contributed to these ideas. In particular, we are grateful to L Salmena and MS Song for insightful discussions. The work of PPP was supported by the US National Cancer Institute, and AC was supported by a European Molecular Biology Organization Long-Term Fellowship Award.	Ahn Y, 2008, BIOCHEM J, V412, P331, DOI 10.1042/BJ20071403; Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Almind K, 1996, J CLIN INVEST, V97, P2569, DOI 10.1172/JCI118705; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Barber Domingo F, 2006, Sci STKE, V2006, ppe49, DOI 10.1126/stke.3622006pe49; Baselga J, 2008, BIOMARKERS, V13, P217, DOI [10.1080/13547500701676019, 10.1080/13547500701676019 ]; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Beck SE, 2007, CANCER BIOL THER, V6, P1313; Berg CE, 2002, BIOCHEM BIOPH RES CO, V293, P1021, DOI 10.1016/S0006-291X(02)00333-9; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CARRACEDO A, 2008, J CLIN INVE IN PRESS; CARRACEDO A, 2008, CELL, V133; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Culjkovic B, 2008, J CELL BIOL, V181, P51, DOI 10.1083/jcb.200707018; D'Alfonso R, 2003, J CLIN ENDOCR METAB, V88, P317, DOI 10.1210/jc.2002-020807; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; delPeso L, 1997, SCIENCE, V278, P687; Denley A, 2008, ONCOGENE, V27, P2561, DOI 10.1038/sj.onc.1210918; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; ENDERSBY R, 2008, ONCOGENE IN PRESS; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Esposito DL, 2003, J CLIN ENDOCR METAB, V88, P1468, DOI 10.1210/jc.2002-020933; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GARCIAECHEVERRI.C, 2008, ONCOGENE IN PRESS; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Guan KL, 2000, J BIOL CHEM, V275, P27354; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Han SW, 2008, AM J PHYSIOL-LUNG C, V294, pL1238, DOI 10.1152/ajplung.00017.2008; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Harvey R Donald, 2007, Future Oncol, V3, P639, DOI 10.2217/14796694.3.6.639; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; JACOBSEN SN, 2004, J BIOL CHEM, V276, P46912; Jozwiak J, 2008, LANCET ONCOL, V9, P73, DOI 10.1016/S1470-2045(07)70411-4; Karbowniczek M, 2004, J BIOL CHEM, V279, P29930, DOI 10.1074/jbc.M402591200; Karbowniczek M, 2006, J BIOL CHEM, V281, P25447, DOI 10.1074/jbc.M605273200; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kawanishi M, 1997, DIABETES CARE, V20, P1043, DOI 10.2337/diacare.20.6.1043; KIM MS, 2008, BRIT J CANCER, V118, P1700; Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; Lee JT, 2008, CELL CYCLE, V7, P631, DOI 10.4161/cc.7.5.5416; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Luo J, 2005, P NATL ACAD SCI USA, V102, P10238, DOI 10.1073/pnas.0504378102; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Mabuchi S, 2002, J BIOL CHEM, V277, P33490, DOI 10.1074/jbc.M204042200; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Ramjaun AR, 2007, CELL CYCLE, V6, P2902, DOI 10.4161/cc.6.23.4996; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sampaio C, 2008, MOL CELL BIOL, V28, P587, DOI 10.1128/MCB.01318-07; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Sato S, 2004, J BIOL CHEM, V279, P33759, DOI 10.1074/jbc.M402055200; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang YM, 2006, J INFRARED MILLIM W, V25, P50; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Wells V, 2007, ONCOGENE, V26, P7709, DOI 10.1038/sj.onc.1210580; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wu DN, 2006, NEUROSCI LETT, V404, P98, DOI 10.1016/j.neulet.2006.05.018; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Yart A, 2002, BBA-MOL CELL BIOL L, V1582, P107, DOI 10.1016/S1388-1981(02)00144-0; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200; Yee WM, 1997, MOL CELL BIOL, V17, P921, DOI 10.1128/MCB.17.2.921; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; YUAN TL, 2008, ONCOGENE IN PRESS; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhang BH, 2001, J BIOL CHEM, V276, P31620, DOI 10.1074/jbc.M102808200; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; ZHAO L, 2008, ONCOGENE IN PRESS; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	189	653	678	1	62	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2008	27	41					5527	5541		10.1038/onc.2008.247	http://dx.doi.org/10.1038/onc.2008.247			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KW	18794886				2022-12-25	WOS:000259280700013
J	Khoja, S; Ojwang, P; Khan, S; Okinda, N; Harania, R; Ali, S				Khoja, Suhail; Ojwang, Peter; Khan, Saeed; Okinda, Nancy; Harania, Reena; Ali, Syed			Genetic Analysis of HIV-1 Subtypes in Nairobi, Kenya	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; MALE CIRCUMCISION; 4 CITIES; DIVERSITY; VACCINE; INFECTION; IDENTIFICATION; TRANSMISSION; SPREAD	Background: Genetic analysis of a viral infection helps in following its spread in a given population, in tracking the routes of infection and, where applicable, in vaccine design. Additionally, sequence analysis of the viral genome provides information about patterns of genetic divergence that may have occurred during viral evolution. Objective: In this study we have analyzed the subtypes of Human Immunodeficiency Virus -1 (HIV-1) circulating in a diverse sample population of Nairobi, Kenya. Methodology: 69 blood samples were collected from a diverse subject population attending the Aga Khan University Hospital in Nairobi, Kenya. Total DNA was extracted from peripheral blood mononuclear cells (PBMCs), and used in a Polymerase Chain Reaction (PCR) to amplify the HIV gag gene. The PCR amplimers were partially sequenced, and alignment and phylogenetic analysis of these sequences was performed using the Los Alamos HIV Database. Results: Blood samples from 69 HIV-1 infected subjects from varying ethnic backgrounds were analyzed. Sequence alignment and phylogenetic analysis showed 39 isolates to be subtype A, 13 subtype D, 7 subtype C, 3 subtype AD and CRF01_AE, 2 subtype G and 1 subtype AC and 1 AG. Deeper phylogenetic analysis revealed HIV subtype A sequences to be highly divergent as compared to subtypes D and C. Conclusion: Our analysis indicates that HIV-1 subtypes in the Nairobi province of Kenya are dominated by a genetically diverse clade A. Additionally, the prevalence of highly divergent, complex subtypes, intersubtypes, and the recombinant forms indicates viral mixing in Kenyan population, possibly as a result of dual infections.			Khoja, S (corresponding author), Aga Khan Univ Hosp, Dept Biol & Biomed Sci, Karachi, Pakistan.	syed.ali@aku.edu	Abidi, Syed Hani/G-9457-2013; Khan, Saeed/D-5098-2014	Abidi, Syed Hani/0000-0001-9497-0902; OKINDA, NANCY/0000-0003-1373-5607; Khan, Saeed/0000-0003-0910-4095	University Research Council, Aga Khan University, Karachi; Higher Education Commission, Pakistan [20-775]	University Research Council, Aga Khan University, Karachi; Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	This study was partly funded by the University Research Council, Aga Khan University, Karachi, the Higher Education Commission, Pakistan, grant 20-775. The experimental work was performed in the Juma Research Laboratory, Aga Khan University Hospital, Karachi, Pakistan.	Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Belda FJ, 1997, J ACQ IMMUN DEF SYND, V16, P63, DOI 10.1097/00042560-199709010-00010; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Essex M, 1999, ADV VIRUS RES, V53, P71, DOI 10.1016/S0065-3527(08)60343-7; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000; Ho DD, 1995, J BIOL REG HOMEOS AG, V9, P76; Holmes EC, 2001, BIOL REV, V76, P239, DOI 10.1017/S1464793101005668; JANSSENS W, 1994, AIDS RES HUM RETROV, V10, P1577, DOI 10.1089/aid.1994.10.1577; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kandathil AJ, 2005, INDIAN J MED RES, V121, P333; Kato S, 2003, AIDS RES HUM RETROV, V19, P1057, DOI 10.1089/088922203322588431; Khan S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-164; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuiken C, 2000, AM J EPIDEMIOL, V152, P814, DOI 10.1093/aje/152.9.814; Lihana RW, 2006, AIDS RES HUM RETROV, V22, P1172, DOI 10.1089/aid.2006.22.1172; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Luginaah I, 2005, SOC SCI MED, V60, P1219, DOI 10.1016/j.socscimed.2004.07.010; MADDISON DR, 2000, MACCLADE VERSION 4; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; McCutchan FE, 2000, AIDS, V14, pS31; Mertens T E, 1995, AIDS, V9 Suppl A, pS259; Morison L, 2001, AIDS, V15, pS109, DOI 10.1097/00002030-200108004-00012; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Peeters M, 2000, AIDS, V14, pS129; Poss M, 1997, AIDS RES HUM RETROV, V13, P493, DOI 10.1089/aid.1997.13.493; Robbins KE, 1999, AIDS RES HUM RETROV, V15, P329, DOI 10.1089/088922299311295; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHARP PM, 1995, PHILOS T R SOC B, V349, P41, DOI 10.1098/rstb.1995.0089; Songok EM, 2003, AIDS RES HUM RETROV, V19, P161, DOI 10.1089/088922203762688676; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Tatt ID, 2001, AIDS, V15, pS59, DOI 10.1097/00002030-200100005-00009; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P4419, DOI 10.1073/pnas.90.10.4419; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; UNAIDS/WHO, 2006, 2006 REP GLOB AIDS E; Yang CF, 2003, AIDS, V17, P1667, DOI 10.1097/00002030-200307250-00011; Zachar V, 1996, AIDS RES HUM RETROV, V12, P75, DOI 10.1089/aid.1996.12.75	48	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3191	10.1371/journal.pone.0003191	http://dx.doi.org/10.1371/journal.pone.0003191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784834	Green Published, gold, Green Submitted			2022-12-25	WOS:000264425900010
J	Wang, YP; Wang, YE; Cotticelli, MG; Wilson, RB				Wang, Yongping; Wang, Yun E.; Cotticelli, M. Grazia; Wilson, Robert B.			A Random shRNA-Encoding Library for Phenotypic Selection and Hit-Optimization	PLOS ONE			English	Article							SMALL INTERFERING RNA; CAENORHABDITIS-ELEGANS; SIRNA; ACTIVATION; MICRORNAS; POTENCY; SCREEN; GENES	RNA interference (RNAi) is a mechanism for inhibiting gene expression through the action of small, non-coding RNAs. Most existing RNAi libraries target single genes through canonical pathways. Endogenous microRNAs (miRNAs), however, often target multiple genes and can act through non-canonical pathways, including pathways that activate gene expression. To interrogate all possible functions, we designed, synthesized, and validated the first shRNA-encoding library that is completely random at the nucleotide level. Screening in an IL3-dependent cell line, FL5.12, yielded shRNA-encoding sequences that double cell survival upon IL3 withdrawal. Using random mutagenesis and re-screening under more stringent IL3-starvation conditions, we hit-optimized one of the sequences; a specific nucleotide change and the creation of a mismatch between the two halves of the stem both contributed to the improved potency. Our library allows unbiased selection and optimization of shRNA-encoding sequences that confer phenotypes of interest, and could be used for the development of therapeutics and tools in many fields of biology.	[Wang, Yongping; Cotticelli, M. Grazia; Wilson, Robert B.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Yun E.] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wang, YP (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	wilsonr@mail.med.upenn.edu			National Institute for Neurological Disorders and Stroke [R21-NS-053546]; Friedreich's Ataxia Research Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053546] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friedreich's Ataxia Research Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by research grants (to R.B.W.) from the National Institute for Neurological Disorders and Stroke (R21-NS-053546) and the Friedreich's Ataxia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blow N, 2007, NATURE, V450, P1120, DOI 10.1038/4501120a; Blow N, 2007, NATURE, V450, P1117, DOI 10.1038/4501117a; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen MH, 2005, P NATL ACAD SCI USA, V102, P2356, DOI 10.1073/pnas.0401549101; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; HILL DE, 1987, METHOD ENZYMOL, V155, P558; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; JANOWSKI BA, 2007, NAT CHEM BIOL; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; McAnuff MA, 2007, J PHARM SCI-US, V96, P2922, DOI 10.1002/jps.20968; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Vander Heiden MG, 1999, MOL CELL, V3, P159; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	32	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3171	10.1371/journal.pone.0003171	http://dx.doi.org/10.1371/journal.pone.0003171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779859	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000264425100007
J	Bunbury, A; Potolicchio, I; Maitra, R; Santambrogio, L				Bunbury, Allyson; Potolicchio, Ilaria; Maitra, Radhashree; Santambrogio, Laura			Functional analysis of monocyte MHC class II compartments	FASEB JOURNAL			English	Article						MHCII trafficking; calcium flux; MIIC; lysosomes; cathepsins	DENDRITIC CELLS; SECRETORY LYSOSOMES; MULTIVESICULAR BODIES; ANTIGEN PRESENTATION; PLASMA-MEMBRANE; MOLECULES; COMPLEX; GRANULES; NEUTROPHILS; INVOLVEMENT	Circulating monocytes, as dendritic cell and macrophage precursors, exhibit several functions usually associated with antigen-presenting cells, such as phagocytosis and presence of endosomal/lysosomal degradative compartments particularly enriched in Lamp-1, MHC class II molecules, and other proteins related to antigen processing and MHC class II loading [MHC class II compartments (MIICs)]. Ultrastructural analysis of these organelles indicates that, differently from the multivesicular bodies present in dendritic cells, in monocytes the MIICs are characterized by a single perimetral membrane surrounding an electron-dense core. Analysis of their content reveals enrichment in myeloperoxidase, an enzyme classically associated with azurophilic granules in granulocytes and mast cell secretory lysosomes. Elevation in intracellular free calcium levels in monocytes induced secretion of beta-hexosaminidase, cathepsins, and myeloperoxidase in the extracellular milieu; surface up-regulation of MHC class II molecules; and appearance of lysosomal resident proteins. The Ca2+-regulated surface transport mechanism of MHC class II molecules observed in monocytes is different from the tubulovesicular organization of the multivesicular bodies previously reported in dendritic cells and macrophages. Hence, in monocytes, MHC class II-enriched organelles combine degradative functions typical of lysosomes and regulated secretion typical of secretory lysosomes. More important, Ca2+-mediated up-regulation of surface MHC class II molecules is accompanied by extracellular release of lysosomal resident enzymes. Bunbury, A., Potolicchio, I., Maitra, R., Santambrogio, L. Functional analysis of monocyte MHC class II compartments. FASEB J. 23, 164-171 (2009)	[Bunbury, Allyson; Potolicchio, Ilaria; Maitra, Radhashree; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, New York, NY USA	Yeshiva University	Santambrogio, L (corresponding author), Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lsantamb@aecom.yu.edu			U.S. National Institutes of Health; Irene Diamond Professorships in Immunology	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Professorships in Immunology	This work was supported by the U.S. National Institutes of Health (L.S.) and Irene Diamond Professorships in Immunology (L.S.). The authors declare no conflicts of interest.	Barois N, 2002, TRAFFIC, V3, P894, DOI 10.1034/j.1600-0854.2002.31205.x; Calafat J, 1997, BLOOD, V90, P1255, DOI 10.1182/blood.V90.3.1255.1255_1255_1266; CALAFAT J, 1994, J CELL BIOL, V126, P967, DOI 10.1083/jcb.126.4.967; Carven GJ, 2004, J BIOL CHEM, V279, P16561, DOI 10.1074/jbc.M314315200; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; FITTSCHEN C, 1994, J CLIN INVEST, V93, P247, DOI 10.1172/JCI116952; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Griffiths G, 2002, SEMIN CELL DEV BIOL, V13, P279, DOI 10.1016/S1084-9521(02)00057-5; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kleijmeer Monique J., 1996, Methods (Orlando), V10, P191, DOI 10.1006/meth.1996.0095; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; Murk JL, 2002, SEMIN CELL DEV BIOL, V13, P303, DOI 10.1016/S1084952102000605; Murk JLAN, 2004, TRAFFIC, V5, P936, DOI 10.1111/j.1600-0854.2004.00235.x; Murk JLAN, 2003, P NATL ACAD SCI USA, V100, P13332, DOI 10.1073/pnas.2232379100; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; PETERS PJ, 1995, J EXP MED, V182, P325, DOI 10.1084/jem.182.2.325; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Polasek J, 2005, PLATELETS, V16, P500, DOI 10.1080/09537100500169926; Potolicchio H, 2005, J IMMUNOL, V175, P4935, DOI 10.4049/jimmunol.175.8.4935; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Santambrogio L, 2006, IMMUNITY, V25, P857, DOI 10.1016/j.immuni.2006.11.007; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Stinchcombe JC, 2003, SEMIN IMMUNOL, V15, P301, DOI 10.1016/j.smim.2003.09.003; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Tapper H, 1996, J LEUKOCYTE BIOL, V59, P613, DOI 10.1002/jlb.59.5.613; Vaaraniemi J, 2004, J BONE MINER RES, V19, P1432, DOI 10.1359/JBMR.040603; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vincent-Schneider H, 2001, J CELL SCI, V114, P323	36	14	15	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					164	171		10.1096/fj.08-109439	http://dx.doi.org/10.1096/fj.08-109439			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18815360	Green Published			2022-12-25	WOS:000262095500019
J	Fortin, CF; Ear, T; McDonald, PP				Fortin, Carl F.; Ear, Thornin; McDonald, Patrick P.			Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils	FASEB JOURNAL			English	Article						signaling pathways; granulocytes	NF-KAPPA-B; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; ANTIMICROBIAL HOST RESPONSE; MESSENGER-RNA EXPRESSION; IL-18 BINDING-PROTEIN; TUMOR-NECROSIS-FACTOR; INTERFERON-GAMMA; IFN-GAMMA; STIMULATED NEUTROPHILS; GENE-EXPRESSION	Neutrophils are key players of innate immunity and influence inflammatory and immune reactions through the production of numerous cytokines. Interleukin-18 (IL-18) is known to stimulate several neutrophil responses, and recent evidence suggests that neutrophils might represent a source of IL-18. Here, we show that neutrophils constitutively produce both IL-18 and its antagonist, IL-18BP. Cell activation does not affect IL-18BP release but leads to an increased gene expression and secretion of IL-18, a process that depends on NF-kappa B activation. Moreover, endogenous IL-18 feeds back on the neutrophils to augment cytokine generation in lipopolysaccharide-treated cells. Accordingly, exogenous IL-18 can induce the gene expression and release of several inflammatory cytokines in neutrophils, including its own expression. We finally report that IL-18 activates the p38 MAPK, MEK/ERK, and PI3K/Akt pathways in neutrophils. The IKK cascade is also activated by IL-18, resulting in I kappa B-alpha degradation, NF-kappa B activation, and RelA phosphorylation. Accordingly, these pathways contribute to the generation of inflammatory cytokines in IL-18-stimulated neutrophils. By contrast, the phosphorylation and DNA-binding activity of various STAT proteins were not induced by IL-18. Collectively, our results unveil new interactions between IL-18 and neutrophils and further support a role for these cells in influencing both innate and adaptive immunity.-Fortin, C. F., Ear, T., McDonald, P. P. Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils. FASEB J. 23, 194-203 (2009)	[McDonald, Patrick P.] Univ Sherbrooke, Fac Med, Div Pulm, Sherbrooke, PQ J1H 5N4, Canada; CHU Sherbrooke, Ctr Rech, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke	McDonald, PP (corresponding author), Univ Sherbrooke, Fac Med, Div Pulm, 3001 12E Ave Nord,Piece 4849, Sherbrooke, PQ J1H 5N4, Canada.	patrick.mcdonald@usherbrooke.ca		Fortin, Carl/0000-0002-4495-7408	Canadian Arthritis Society; Canadian Foundation for Innovation; Canadian Institutes of Health Research	Canadian Arthritis Society; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	C.F.F. performed the experiments, analyzed the results, drew the figures, and wrote the first draft of the article. T. E. performed the experiments; P.P.M. designed the research and wrote the final version of the article. This work was supported by grants to P.P.M. from the Canadian Arthritis Society, and from the Canadian Foundation for Innovation. C.F.F. is the recipient of a studentship from the Canadian Institutes of Health Research.	BAZZONI F, 1991, J LEUKOCYTE BIOL, V50, P223, DOI 10.1002/jlb.50.3.223; BAZZONI F, 1991, J EXP MED, V173, P771, DOI 10.1084/jem.173.3.771; Cannetti CA, 2003, J IMMUNOL, V171, P1009, DOI 10.4049/jimmunol.171.2.1009; CASSATELLA MA, 1993, J EXP MED, V178, P2207, DOI 10.1084/jem.178.6.2207; Cassatella MA, 1997, EUR J IMMUNOL, V27, P111, DOI 10.1002/eji.1830270117; CASSATELLA MA, 1995, EUR J IMMUNOL, V25, P1, DOI 10.1002/eji.1830250102; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Chandrasekar B, 2004, BIOCHEM BIOPH RES CO, V319, P304, DOI 10.1016/j.bbrc.2004.04.185; Chandrasekar B, 2003, BIOCHEM BIOPH RES CO, V303, P1152, DOI 10.1016/S0006-291X(03)00496-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cloutier A, 2007, J LEUKOCYTE BIOL, V81, P567, DOI 10.1189/jlb.0806536; Conti B, 1999, MOL BRAIN RES, V67, P46, DOI 10.1016/S0169-328X(99)00034-0; Dai SM, 2007, ANN RHEUM DIS, V66, P1411, DOI 10.1136/ard.2006.067793; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Ear T, 2005, J IMMUNOL, V175, P1834, DOI 10.4049/jimmunol.175.3.1834; Elbim C, 2005, CLIN DIAGN LAB IMMUN, V12, P436, DOI 10.1128/CDLI.12.3.436-446.2005; Ethuin F, 2004, LAB INVEST, V84, P1363, DOI 10.1038/labinvest.3700148; GASPERINI S, 1995, J INFLAMM, V45, P143; Grandjean-Laquerriere A, 2007, CYTOKINE, V37, P76, DOI 10.1016/j.cyto.2007.02.020; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Hong TP, 2000, EUR CYTOKINE NETW, V11, P193; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Jablonska E, 2005, CYTOKINE, V30, P93, DOI 10.1016/j.cyto.2004.12.004; Jablonska E, 2002, IMMUNOL INVEST, V31, P159, DOI 10.1081/IMM-120016237; Jablonska E, 2001, IMMUNOL INVEST, V30, P221, DOI 10.1081/IMM-100105066; Kampfer H, 2000, EUR CYTOKINE NETW, V11, P626; KASAMA T, 1994, J IMMUNOL, V152, P3559; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Klein SA, 1999, CYTOKINE, V11, P451, DOI 10.1006/cyto.1998.0424; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; Lee KS, 2006, MOL PHARMACOL, V70, P1184, DOI 10.1124/mol.106.024737; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; Li XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1193, DOI 10.1152/ajplung.00408.2006; LORD PCW, 1991, J CLIN INVEST, V87, P1312, DOI 10.1172/JCI115134; Marshall JD, 1999, CLIN IMMUNOL, V90, P15, DOI 10.1006/clim.1998.4633; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; McDonald PP, 1998, BIOCHEMISTRY-US, V37, P13165, DOI 10.1021/bi972539o; McDonald PP, 1998, CELL IMMUNOL, V184, P45, DOI 10.1006/cimm.1998.1255; McLeish KR, 1998, J LEUKOCYTE BIOL, V64, P537, DOI 10.1002/jlb.64.4.537; MEDA L, 1994, CELL IMMUNOL, V157, P448, DOI 10.1006/cimm.1994.1241; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Robertson SE, 2006, EUR J IMMUNOL, V36, P722, DOI 10.1002/eji.200535402; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Scapini P, 2001, EUR J IMMUNOL, V31, P1981, DOI 10.1002/1521-4141(200107)31:7<1981::AID-IMMU1981>3.0.CO;2-X; Stoll S, 1998, EUR J IMMUNOL, V28, P3231, DOI 10.1002/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q; Tecchio C, 2004, BLOOD, V103, P3837, DOI 10.1182/blood-2003-08-2806; TIKU K, 1986, J IMMUNOL, V136, P3677; Veenstra KG, 2002, J IMMUNOL, V168, P2282, DOI 10.4049/jimmunol.168.5.2282; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; WANG P, 1994, BLOOD, V83, P2678, DOI 10.1182/blood.V83.9.2678.bloodjournal8392678; Weijer S, 2003, INFECT IMMUN, V71, P5488, DOI 10.1128/IAI.71.10.5488-5497.2003; Wyman TH, 2002, J LEUKOCYTE BIOL, V72, P401	60	52	54	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					194	203		10.1096/fj.08-110213	http://dx.doi.org/10.1096/fj.08-110213			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18780764				2022-12-25	WOS:000262095500022
J	Coba, MP; Valor, LM; Kopanitsa, MV; Afinowi, NO; Grant, SGN				Coba, Marcelo P.; Valor, Luis M.; Kopanitsa, Maksym V.; Afinowi, Nurudeen O.; Grant, Seth G. N.			Kinase Networks Integrate Profiles of N-Methyl-D-aspartate Receptor-mediated Gene Expression in Hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR; POSTSYNAPTIC DENSITY-95; SYNAPTIC PLASTICITY; IN-VIVO; PHOSPHORYLATION; NEUROSCIENCE; INDUCTION; PATHWAYS; COMPLEX	The postsynaptic N-methyl-D-aspartate (NMDA) receptor activates multiple kinases and changes the phosphorylation of many postsynaptic proteins organized in signaling networks. Because the NMDA receptor is known to regulate gene expression, it is important to examine whether networks of kinases control signaling to gene expression. We examined the requirement of multiple kinases and NMDA receptor-interacting proteins for gene expression in mouse hippocampal slices. Protocols that induce long-term depression (LTD) and long-term potentiation (LTP) activated common kinases and overlapping gene expression profiles. Combinations of kinases were required for induction of each gene. Distinct combinations of kinases were required to up-regulate Arc, Npas4, Egr2, and Egr4 following either LTP or LTD protocols. Consistent with the combinatorial data, a mouse mutant model of the human cognition disease gene SAP102, which couples ERK kinase to the NMDA receptor, showed deregulated expression of specific genes. These data support a network model of postsynaptic integration where kinase signaling networks are recruited by differential synaptic activity and control both local synaptic events and activity-dependent gene expression.	[Coba, Marcelo P.; Valor, Luis M.; Kopanitsa, Maksym V.; Afinowi, Nurudeen O.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Valor, Luis M.] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante 03550, Spain	Wellcome Trust Sanger Institute; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Grant, SGN (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	sg3@sanger.ac.uk	Kopanitsa, Maksym/I-4668-2019; Kopanitsa, Maksym/G-6266-2011; Valor, Luis/ABG-1754-2020	Grant, Seth/0000-0001-8732-8735; Valor, Luis M./0000-0002-1229-0565				Bloomer WAC, 2008, J BIOL CHEM, V283, P582, DOI 10.1074/jbc.M702451200; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Dadgostar H, 2002, P NATL ACAD SCI USA, V99, P1497, DOI 10.1073/pnas.032665099; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Grant SGN, 2005, HUM MOL GENET, V14, pR225, DOI 10.1093/hmg/ddi330; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kopanitsa MV, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-61; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Opazo P, 2003, J NEUROSCI, V23, P3679; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Watanabe T, 2005, DEV BIOL, V277, P508, DOI 10.1016/j.ydbio.2004.08.051; Winstanley CA, 2007, J NEUROSCI, V27, P10497, DOI 10.1523/JNEUROSCI.2566-07.2007; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	30	34	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34101	34107		10.1074/jbc.M804951200	http://dx.doi.org/10.1074/jbc.M804951200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18815127	Green Published, hybrid			2022-12-25	WOS:000261277700038
J	Willer, M; Forte, GMA; Stirling, CJ				Willer, Martin; Forte, Gabriella M. A.; Stirling, Colin J.			Sec61p Is Required for ERAD-L GENETIC DISSECTION OF THE TRANSLOCATION AND ERAD-L FUNCTIONS OF Sec61P USING NOVEL DERIVATIVES OF CPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN TRANSLOCATION; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; UBIQUITIN-LIGASE; QUALITY-CONTROL; YEAST SEC61P; DEGRADATION; COMPLEX; REVEALS	Misfolded proteins in the endoplasmic reticulum (ER) are exported to the cytosol for degradation by the proteasome in a process known as ER-associated degradation (ERAD). CPY* is a well characterized ERAD substrate whose degradation is dependent upon the Hrd1 complex. However, although the functions of some of the components of this complex are known, the nature of the protein dislocation channel remains obscure. Sec61p has been suggested as an obvious candidate because of its role as a protein-conducting channel through which polypeptides are initially translocated into the ER. However, it has not yet been possible to functionally dissect any role for Sec61p in dislocation from its essential function in translocation. By changing the translocation properties of a series of novel ERAD substrates, we are able to separate these two events and find that functional Sec61p is essential for the ERAD-L pathway.	[Willer, Martin; Forte, Gabriella M. A.; Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk			Wellcome Trust [074149]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant 074149. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hitt R, 2004, FEMS YEAST RES, V4, P815, DOI 10.1016/j.femsyr.2004.04.002; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Robson A, 2006, EMBO REP, V7, P1099, DOI 10.1038/sj.embor.7400832; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; SILBERSTEIN S, 1995, J CELL BIOL, V128, P525, DOI 10.1083/jcb.128.4.525; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Willer M, 2003, YEAST, V20, P133, DOI 10.1002/yea.954; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	31	63	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33883	33888		10.1074/jbc.M803054200	http://dx.doi.org/10.1074/jbc.M803054200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819915	Green Published, hybrid			2022-12-25	WOS:000261277700013
J	Heng, BC; Gribbon, PM; Day, AJ; Hardingham, TE				Heng, Boon Chin; Gribbon, Philip M.; Day, Anthony J.; Hardingham, Timothy E.			Hyaluronan Binding to Link Module of TSG-6 and to G1 Domain of Aggrecan Is Differently Regulated by pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFOCAL FLUORESCENCE RECOVERY; INTER-ALPHA-INHIBITOR; CARTILAGE PROTEOGLYCAN; PROTEIN TSG-6; EXTRACELLULAR-MATRIX; INDUCED ARTHRITIS; STIMULATED GENE-6; MOLECULAR-BASIS; UP-REGULATION; IN-VIVO	The physiological functions of hyaluronan (HA) in the extracellular matrix of vertebrate tissues involve a range of specific protein interactions. In this study, the interaction of HA with the Link module from TSG-6 (Link_TSG6) and G1 domain of aggrecan (G1), were investigated by a biophysical analysis of translational diffusion in dilute solution using confocal fluorescence recovery after photobleaching (confocal FRAP). Both Link_TSG6 and G1 were shown to bind to polymeric HA and these interactions could be competed with HA(8) and HA(10) oligosaccharides, respectively. Equilibrium experiments showed that the binding affinity of Link_TSG6 to HA was maximal at pH 6.0, and reduced dramatically above and below this pH. In contrast, G1 had maximum binding at pH 7.0-8.0 and moderate to strong binding affinity over a much broader pH range (5.5-8.0). The K-D determined for Link_TSG6 binding to HA showed a 100-fold increase in binding affinity between pH 7.4 and 6.0, whereas G1 showed a 75-fold decrease in binding affinity over the same pH range. The sharp difference observed in their pH binding suggests that pH controls the physiological function of TSG-6, with a low affinity for HA at neutral pH, but with increased affinity as the pH falls below pH 7. TSG-6 and aggrecan interact with HA through structurally homologous domains and the difference in pH-dependent binding can be understood in terms of differences in the presence and topographical distribution of key regulatory amino acids in Link_TSG6 and in the related tandem Link domains in aggrecan G1.	[Heng, Boon Chin; Gribbon, Philip M.; Day, Anthony J.; Hardingham, Timothy E.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Heng, Boon Chin] Abbott Vasc Inc, Santa Clara, CA 95054 USA; [Gribbon, Philip M.] GlaxoSmithKline Res & Dev Ltd, Med Res Ctr, Stevenage SG1 2NY, Herts, England	University of Manchester; GlaxoSmithKline	Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk; timothy.e.hardingham@manchester.ac.uk	Heng, Boon Chin/E-5462-2016; Day, Anthony/O-1658-2015; Gribbon, Philip/ABC-7807-2020	Heng, Boon Chin/0000-0003-2541-3699; Day, Anthony/0000-0002-1415-3134; Hardingham, Timothy/0000-0001-8271-6763; Gribbon, Philip/0000-0001-7655-2459	Seikagaku Corporation (Tokyo, Japan); Arthritis Research Campaign [D0540, 16539]; Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK	Seikagaku Corporation (Tokyo, Japan); Arthritis Research Campaign(Versus Arthritis); Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK(Wellcome Trust)	This work was supported by the Seikagaku Corporation (Tokyo, Japan), Arthritis Research Campaign Grants D0540 and 16539 (to A. J. D.), and the Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Blundell C. D., 2002, HYALURONAN, P161; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; BONNET F, 1985, BIOCHEM J, V228, P77, DOI 10.1042/bj2280077; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; COWMAN MK, 1984, ARCH BIOCHEM BIOPHYS, V230, P203, DOI 10.1016/0003-9861(84)90101-2; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Gribbon P, 1999, BIOPHYS J, V77, P2210, DOI 10.1016/S0006-3495(99)77061-X; Gribbon P, 2001, Methods Mol Biol, V171, P487; Gribbon P, 1998, BIOPHYS J, V75, P1032, DOI 10.1016/S0006-3495(98)77592-7; Gribbon P, 2000, BIOCHEM J, V350, P329, DOI 10.1042/0264-6021:3500329; Han L, 2007, BIOPHYS J, V93, pL23, DOI 10.1529/biophysj.107.114025; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; HARDINGHAM TE, 1994, EUR J CLIN CHEM CLIN, V32, P249; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HARDINGHAM TE, 1973, BIOCHEM J, V135, P905, DOI 10.1042/bj1350905; Hardingham T, 1981, BIOCHEM SOC T, V9, P489, DOI 10.1042/bst0090489; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; KUBITSCHECK U, 1994, BIOPHYS J, V67, P948, DOI 10.1016/S0006-3495(94)80596-X; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Maroudas A., 1980, JOINTS SYNOVIAL FLUI, P239; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; MORGELIN M, 1995, BIOCHEM J, V307, P595; NIEDUSZYNSKI IA, 1980, BIOCHEM J, V185, P107, DOI 10.1042/bj1850107; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Rodriguez E, 2006, J BIOL CHEM, V281, P18444, DOI 10.1074/jbc.M512531200; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; SIMKIN PA, 1992, J RHEUMATOL, V19, P1017; SMEDSROD B, 1985, CELL TISSUE RES, V241, P639; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; TENGBLAD A, 1981, BIOCHEM J, V199, P297, DOI 10.1042/bj1990297; Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057; WEISSMANN B, 1954, J AM CHEM SOC, V76, P1753, DOI 10.1021/ja01636a010; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; Wisniewski HG, 1996, J IMMUNOL, V156, P1609	52	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32294	32301		10.1074/jbc.M804155200	http://dx.doi.org/10.1074/jbc.M804155200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806261	hybrid			2022-12-25	WOS:000260893700016
J	Sethi, AA; Stonik, JA; Thomas, F; Demosky, SJ; Amar, M; Neufeld, E; Brewer, HB; Davidson, WS; D'Souza, W; Sviridov, D; Remaley, AT				Sethi, Amar A.; Stonik, John A.; Thomas, Fairwell; Demosky, Steve J.; Amar, Marcelo; Neufeld, Edward; Brewer, H. Bryan; Davidson, W. Sean; D'Souza, Wilissa; Sviridov, Dmitri; Remaley, Alan T.			Asymmetry in the Lipid Affinity of Bihelical Amphipathic Peptides A STRUCTURAL DETERMINANT FOR THE SPECIFICITY OF ABCA1-DEPENDENT CHOLESTEROL EFFLUX BY PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; CASSETTE TRANSPORTER A1; CELLULAR CHOLESTEROL; HELICAL PEPTIDES; APOA-I; MIMETIC PEPTIDES; ALPHA-HELICES; DOMAIN-STRUCTURE; TANGIER DISEASE; BINDING	ApoA-I contains a tandem array of amphipathic helices with varying lipid affinity, which are critical in its ability to bind and remove lipids from cells by the ABCA1 transporter. In this study, the effect of asymmetry in the lipid affinity of amphipathic helices in a bihelical apoA-I mimetic peptide, 37pA, on lipid efflux by the ABCA1 transporter was examined. Seven peptide variants of 37pA were produced by substituting a varying number of hydrophobic amino acids for alanine on either one or both helices. The 5A peptide with five alanine substitutions in the second helix had decreased helical content compared with 37pA (5A, 12 +/- 1% helicity; 37pA, 28 +/- 2% helicity) and showed less self-association but, similar to the parent peptide, was able to readily solubilize phospholipid vesicles. Furthermore, 5A, unlike the parent peptide 37pA, was not hemolytic (37pA, 27 +/- 2% RBC lysis, 2 h, 18 mu M). Finally, the 5A peptide stimulated cholesterol and phospholipid efflux by the ABCA1 transporter with higher specificity (ABCA1-transfected versus untransfected cells) than 37pA(5A, 9.7 +/- 0.77%, 18 h, 18 mu M versus 1.5 +/- 0.27%, 18 h, 18 mu M (p < 0.0001); 37pA, 7.4 +/- 0.85%, 18h, 18 mu M versus 5.8 +/- 0.20%, 18h, 18 mu M(p = 0.03)). In summary, we describe a novel bihelical peptide with asymmetry in the lipid affinity of its helices and properties similar to apoA-I in terms of specificity for cholesterol efflux by the ABCA1 transporter and low cytotoxicity.	[Neufeld, Edward] NHLBI, NIH, Bethesda, MD 20892 USA; [Sethi, Amar A.; Stonik, John A.; Thomas, Fairwell; Demosky, Steve J.; Amar, Marcelo; Remaley, Alan T.] NHLBI, Lipoprot Metab Sect, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Brewer, H. Bryan] Washington Hosp Ctr, Cardiovasc Res Inst, MedStar Res Inst, Washington, DC 20010 USA; [Davidson, W. Sean] Univ Cincinnati, Ctr Lipid & Arteriosclerosis Studies, Cincinnati, OH 45221 USA; [D'Souza, Wilissa; Sviridov, Dmitri] Baker Heart Res Inst, Melbourne, Vic, Australia	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); MedStar Washington Hospital Center; University System of Ohio; University of Cincinnati; Baker Heart and Diabetes Institute	Remaley, AT (corresponding author), NHLBI, NIH, Bldg 10,Rm 7N-115,10 Ctr Dr, Bethesda, MD 20892 USA.	aremaley@cc.nih.gov	Neufeld, Edward/R-3819-2019; Amar, Marcelo/AAD-5599-2019; Sviridov, Dmitri/E-7943-2010	Davidson, William/0000-0003-2756-2989	National Institutes of Health; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062542, R01HL067093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by intramural funds from the National Institutes of Health, NHLBI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Bielicki JK, 2002, BIOCHEMISTRY-US, V41, P2089, DOI 10.1021/bi011716p; Boggs JM, 2001, BBA-BIOMEMBRANES, V1511, P28, DOI 10.1016/S0005-2736(00)00379-5; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; CALABRESI L, 1994, J BIOL CHEM, V269, P32168; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Costet P, 2000, J BIOL CHEM, V275, P28240; Dashti N, 2004, J LIPID RES, V45, P1919, DOI 10.1194/jlr.M400251-JLR200; Datta G, 2004, J BIOL CHEM, V279, P26509, DOI 10.1074/jbc.M314276200; Datta G, 2001, J LIPID RES, V42, P1096; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Gazzara JA, 1997, J LIPID RES, V38, P2134; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Handattu SP, 2007, J BIOL CHEM, V282, P1980, DOI 10.1074/jbc.M606231200; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; MISHRA VK, 1995, J BIOL CHEM, V270, P1602, DOI 10.1074/jbc.270.4.1602; Mukhamedova N, 2007, BIOCHEMISTRY-US, V46, P9388, DOI 10.1021/bi700473t; Natarajan P, 2004, J BIOL CHEM, V279, P24044, DOI 10.1074/jbc.M400561200; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Nicholls SJ, 2006, J AM COLL CARDIOL, V47, P992, DOI 10.1016/j.jacc.2005.11.040; Nofer JR, 2005, CELL MOL LIFE SCI, V62, P2150, DOI 10.1007/s00018-005-5125-0; Oram JF, 1996, J LIPID RES, V37, P2473; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Phoenix DA, 2002, CURR PROTEIN PEPT SC, V3, P201, DOI 10.2174/1389203024605368; Pownall HJ, 2006, CURR OPIN LIPIDOL, V17, P209, DOI 10.1097/01.mol.0000226110.66942.e8; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SEGREST JP, 1992, J LIPID RES, V33, P141; Sethi AA, 2007, CURR OPIN INVEST DR, V8, P201; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sugar IP, 2005, BIOPHYS J, V89, P3997, DOI 10.1529/biophysj.105.061952; Tanaka M, 2005, BIOCHEMISTRY-US, V44, P10689, DOI 10.1021/bi050853+; UEDA M, 2005, J CLIN LIGAND ASSAY, V4, P216; VEDHACHALAM C, 2007, J BIOL CHEM; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Victor K, 1999, BIOCHEMISTRY-US, V38, P12527, DOI 10.1021/bi990847b; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021	49	83	89	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32273	32282		10.1074/jbc.M804461200	http://dx.doi.org/10.1074/jbc.M804461200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805791	Green Published, hybrid			2022-12-25	WOS:000260893700014
J	Courchet, J; Buchet-Poyau, K; Potemski, A; Bres, A; Jariel-Encontre, I; Billaud, M				Courchet, Julien; Buchet-Poyau, Karine; Potemski, Auriane; Bres, Aurelie; Jariel-Encontre, Isabelle; Billaud, Marc			Interaction with 14-3-3 Adaptors Regulates the Sorting of hMex-3B RNA-binding Protein to Distinct Classes of RNA Granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA-DEPENDENT LOCALIZATION; PROCESSING BODIES; STRUCTURAL BASIS; STRESS GRANULES; MESSENGER-RNAS; P-BODIES; PHOSPHORYLATION; DECAY; INHIBITION; MEX-3	Stress granules (SG) and processing bodies (PBs) are cytoplasmic ribonucleoprotein particles whose assembly is induced by different stimuli. SG are the site of storage of untranslated transcripts formed in response to environmental stress, whereas PBs are involved in mRNA turnover. We recently characterized a novel family of four human proteins related to the Caenorhabditis elegans Mex-3, a RNA binding protein involved in the establishment of the anterior-posterior embryonic asymmetry and in the maintenance of germline pluripotency. We now report that the adaptorproteins 14-3-3 bind to hMex-3B but not to the three other hMex-3 family members. Serine 462, when phosphorylated, is the major 14-3-3 docking site on hMex-3B, and manipulation of this interaction reveals that 14-3-3 both stabilizes hMex-3B and modulates its ability to bind RNA. Furthermore, the complex formed between hMex-3B and Argonaute proteins is excluded from PBs when the interaction with 14-3-3 is disrupted, whereas the recruitment to SG is not affected. Thus, 14-3-3 exerts combined effects on hMex-3B and acts as a major regulator of the sorting between distinct classes of RNA granules.	[Courchet, Julien; Buchet-Poyau, Karine; Potemski, Auriane; Bres, Aurelie; Billaud, Marc] CNRS, Lab Genet Mol Signalisat & Canc, UMR5201, F-69008 Lyon, France; Univ Lyon, F-69008 Lyon, France; Univ Lyon 1, F-69008 Lyon, France; [Jariel-Encontre, Isabelle] CNRS, Inst Genet Mol Montpellier, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Billaud, M (corresponding author), CNRS, Lab Genet Mol Signalisat & Canc, UMR5201, F-69008 Lyon, France.	billaud@univ-lyon1.fr	COURCHET, JULIEN/E-9645-2016; Billaud, Marc N/M-6954-2013	COURCHET, JULIEN/0000-0002-1199-9329; 				Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bowerman B, 1997, DEVELOPMENT, V124, P3815; Buchet-Poyau K, 2007, NUCLEIC ACIDS RES, V35, P1289, DOI 10.1093/nar/gkm016; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Donnini M, 2004, J BIOL CHEM, V279, P20154, DOI 10.1074/jbc.M314071200; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; GALLO CM, 2008, DEV BIOL IN PRESS; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; He C, 2006, EMBO J, V25, P3823, DOI 10.1038/sj.emboj.7601264; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hoffmeister M, 2008, J BIOL CHEM, V283, P2297, DOI 10.1074/jbc.M706825200; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Huang NN, 2002, DEVELOPMENT, V129, P747; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Jud MC, 2008, DEV BIOL, V318, P38, DOI 10.1016/j.ydbio.2008.02.059; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Noble SL, 2008, J CELL BIOL, V182, P559, DOI 10.1083/jcb.200802128; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sato M, 2002, CURR BIOL, V12, P141, DOI 10.1016/S0960-9822(01)00654-6; Schmidlin M, 2004, EMBO J, V23, P4760, DOI 10.1038/sj.emboj.7600477; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	61	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32131	32142		10.1074/jbc.M802927200	http://dx.doi.org/10.1074/jbc.M802927200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779327	Green Published, hybrid			2022-12-25	WOS:000260760800094
J	Knowles, LM; Yang, C; Osterman, A; Smith, JW				Knowles, Lynn M.; Yang, Chen; Osterman, Andrei; Smith, Jeffrey W.			Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ATP CITRATE LYASE; PROSTATE-CANCER; SELECTIVE-INHIBITION; SYNTHESIS PATHWAY; NUDE-MICE; EXPRESSION; CARCINOMA; TARGET; GROWTH	Fatty-acid synthase (FAS) is up-regulated in a broad range of cancers, including those of the breast, prostate, and ovaries. In tumor cells, the inhibition of FAS elicits cell cycle arrest and apoptosis, so it is considered a potential drug target for oncology. Results from this study show that inhibition of FAS, by either knockdown with small interfering RNA or inhibition with the small molecule drug orlistat, leads to activation of the receptor-mediated apoptotic cascade (caspase-8-mediated) and ultimately to cell death. However, knockdown of two enzymes upstream of FAS, acetyl-CoA carboxylase-alpha and ATP-citrate lyase, fails to activate caspase-8 or to elicit apoptosis in tumor cells, even though palmitate synthesis was suppressed. Using differential gene analysis, we traced the unique apoptotic effect of FAS inhibition to up-regulation of DDIT4 (DNA damage-inducible transcript 4), a stress-response gene that negatively regulates the mTOR pathway. These findings indicate that suppression of palmitate synthesis is not sufficient for eliciting tumor cell death and suggest that the unique effect of inhibition of FAS results from negative regulation of the mTOR pathway via DDIT4.	[Knowles, Lynn M.] Burnham Inst Med Res, Canc Res Ctr, La Jolla, CA 92037 USA; [Yang, Chen; Osterman, Andrei; Smith, Jeffrey W.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Smith, JW (corresponding author), Burnham Inst Med Res, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jsmith@burnham.org		Knowles, Lynn/0000-0002-6250-9289	National Institutes of Health [CA108959, RR020843, HL080718]; Department of Defense [DAMD17-02-0693]; California Breast Cancer Research Program [CA6982713, CA69306, 8FB-0107]; NATIONAL CANCER INSTITUTE [R01CA069306, R01CA108959] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA108959, RR020843, and HL080718. This work was also supported by Department of Defense Grant DAMD17-02-0693 and California Breast Cancer Research Program Grants CA6982713 and CA69306 (to J. W. S.) and Grant 8FB-0107 (to L. M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Carlo-Stella C, 2007, CLIN CANCER RES, V13, P2313, DOI 10.1158/1078-0432.CCR-06-2774; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; De Schrijver E, 2003, CANCER RES, V63, P3799; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Innocenzi D, 2003, J CUTAN PATHOL, V30, P23, DOI 10.1034/j.1600-0560.2003.300104.x; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Koshida K, 2004, INT J UROL, V11, P1114, DOI 10.1111/j.1442-2042.2004.00961.x; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; KUREBAYASHI J, 1993, CANCER RES, V53, P2178; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Orita H, 2007, CLIN CANCER RES, V13, P7139, DOI 10.1158/1078-0432.CCR-07-1186; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Pizer ES, 1996, CANCER RES, V56, P745; Pizer ES, 1996, CANCER RES, V56, P1189; Pizer ES, 2000, CANCER RES, V60, P213; Pizer ES, 1998, CANCER RES, V58, P4611; PRICE JE, 1990, CANCER RES, V50, P717; Rashid A, 1997, AM J PATHOL, V150, P201; SHAFIE SM, 1980, CANCER LETT, V11, P81, DOI 10.1016/0304-3835(80)90097-X; Siegmund D, 2002, MOL MED, V8, P725, DOI 10.1007/BF03402036; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Swinnen JV, 2000, INT J CANCER, V88, P176, DOI 10.1002/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; SZUTOWICZ A, 1979, BRIT J CANCER, V39, P681, DOI 10.1038/bjc.1979.120; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; Turyn J, 2003, HORM METAB RES, V35, P565, DOI 10.1055/s-2003-43500; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wittmann C, 1999, BIOTECHNOL BIOENG, V62, P739, DOI 10.1002/(SICI)1097-0290(19990320)62:6<739::AID-BIT13>3.0.CO;2-E; Zhou WB, 2003, CANCER RES, V63, P7330	53	79	85	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31378	31384		10.1074/jbc.M803384200	http://dx.doi.org/10.1074/jbc.M803384200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18796435	Green Published, hybrid			2022-12-25	WOS:000260760800016
J	Schoijet, AC; Miranda, K; Girard-Dias, W; de Souza, W; Flawia, MM; Torres, HN; Docampo, R; Alonso, GD				Schoijet, Alejandra C.; Miranda, Kildare; Girard-Dias, Wendell; de Souza, Wanderley; Flawia, Mirtha M.; Torres, Hector N.; Docampo, Roberto; Alonso, Guillermo D.			A Trypanosoma cruzi Phosphatidylinositol 3-Kinase (TcVps34) Is Involved in Osmoregulation and Receptor-mediated Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE VACUOLE COMPLEX; CAMP-SPECIFIC PHOSPHODIESTERASE; PROTON-PUMPING PYROPHOSPHATASE; PHOSPHOINOSITIDE 3-KINASES; H+-ATPASE; CANDIDA-ALBICANS; MEMBRANE TRAFFICKING; DISTINCT CLASSES; PLASMA-MEMBRANE; PROTEIN-KINASE	Trypanosoma cruzi, the etiological agent of Chagas disease, has the ability to respond to a variety of environmental changes during its life cycle both in the insect vector and in the vertebrate host. Because regulation of transcription initiation seems to be nonfunctional in this parasite, it is important to investigate other regulatory mechanisms of adaptation. Regulatory mechanisms at the level of signal transduction pathways involving phosphoinositides are good candidates for this purpose. Here we report the identification of the first phosphatidylinositol 3-kinase (PI3K) in T. cruzi, with similarity with its yeast counterpart, Vps34p. TcVps34 specifically phosphorylates phosphatidylinositol to produce phosphatidylinositol 3-phosphate, thus confirming that it belongs to class III PI3K family. Overexpression of TcVps34 resulted in morphological and functional alterations related to vesicular trafficking. Although inhibition of TcVps34 with specific PI3K inhibitors, such as wortmannin and LY294,000, resulted in reduced regulatory volume decrease after hyposmotic stress, cells overexpressing this enzyme were resistant to these inhibitors. Furthermore, these cells were able to recover their original volume faster than wild type cells when they were submitted to severe hyposmotic stress. In addition, in TcVps34-overexpressing cells, the activities of vacuolar-H+-ATPase and vacuolar H+-pyrophosphatase were altered, suggesting defects in the acidification of intracellular compartments. Furthermore, receptor-mediated endocytosis was partially blocked although fluid phase endocytosis was not affected, confirming a function for TcVps34 in membrane trafficking. Taken together, these results strongly support that TcVps34 plays a prominent role in vital processes for T. cruzi survival such as osmoregulation, acidification, and vesicular trafficking.	[Schoijet, Alejandra C.; Flawia, Mirtha M.; Torres, Hector N.; Alonso, Guillermo D.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina; [Schoijet, Alejandra C.; Flawia, Mirtha M.; Torres, Hector N.; Alonso, Guillermo D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, RA-1428 Buenos Aires, DF, Argentina; [Schoijet, Alejandra C.; Miranda, Kildare; Docampo, Roberto; Alonso, Guillermo D.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Schoijet, Alejandra C.; Miranda, Kildare; Docampo, Roberto; Alonso, Guillermo D.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Miranda, Kildare; Girard-Dias, Wendell; de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Universidade Federal do Rio de Janeiro	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	rdocampo@uga.edu; galonso@dna.uba.ar	Torres, Héctor/GXG-1780-2022; Alonso, Guillermo Daniel/AAI-6674-2020	Alonso, Guillermo Daniel/0000-0001-9386-9431; Schoijet, Alejandra/0000-0002-4999-7169	National Institutes of Health [AI-68647]; Consejo Nacional de Investigaciones CientIficas y Te cnicas (CONICET, Argentina); Departamento de Fisiologia; Biologia Molecular y Celular; Facultad de Ciencias Exactas y Naturales; University of Buenos Aires (Argentina); Agencia Nacional de Promocion Cientifica y Tecnolo gica (Argentina); Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases; MCT-CNPq; FAPERJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones CientIficas y Te cnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Departamento de Fisiologia; Biologia Molecular y Celular; Facultad de Ciencias Exactas y Naturales; University of Buenos Aires (Argentina)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnolo gica (Argentina)(ANPCyT); Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases(Lawrence Ellison Foundation); MCT-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, by National Institutes of Health Grant AI-68647 (to R. D.). This work was also supported by Consejo Nacional de Investigaciones CientIficas y Te cnicas (CONICET, Argentina), Departamento de Fisiologia, Biologia Molecular y Celular, Facultad de Ciencias Exactas y Naturales, University of Buenos Aires (Argentina), and Agencia Nacional de Promocion Cientifica y Tecnolo gica (Argentina). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Fellow of CONICET and supported in part by a training grant of the Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases.; Supported by MCT-CNPq and FAPERJ.	Alonso GD, 2006, MOL BIOCHEM PARASIT, V145, P40, DOI 10.1016/j.molbiopara.2005.09.005; Alonso GD, 2007, MOL BIOCHEM PARASIT, V152, P72, DOI 10.1016/j.molbiopara.2006.12.002; Benchimol M, 1998, BIOCHEM J, V332, P695, DOI 10.1042/bj3320695; Braga MV, 2006, FEMS MICROBIOL LETT, V256, P209, DOI 10.1111/j.1574-6968.2006.00125.x; Brown RA, 2001, BIOCHEM SOC T, V29, P535, DOI 10.1042/BST0290535; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Corvera S, 2001, TRAFFIC, V2, P859, DOI 10.1034/j.1600-0854.2001.21201.x; Eck R, 2000, YEAST, V16, P933, DOI 10.1002/1097-0061(200007)16:10&lt;933::AID-YEA591&gt;3.0.CO;2-C; Eck R, 2005, INT J MED MICROBIOL, V295, P57, DOI 10.1016/j.ijmm.2004.12.007; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; FRY MJ, 1994, BBA-MOL BASIS DIS, V1226, P237, DOI 10.1016/0925-4439(94)90036-1; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; GUHL F, 2007, REPORT SCI WORKING G; Gunther J, 2005, MICROBIOL-SGM, V151, P81, DOI 10.1099/mic.0.27333-0; Hall BS, 2006, J BIOL CHEM, V281, P27600, DOI 10.1074/jbc.M602183200; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kollien AH, 2001, J INSECT PHYSIOL, V47, P739, DOI 10.1016/S0022-1910(00)00170-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Martinez R, 2002, MOL BIOCHEM PARASIT, V120, P205, DOI 10.1016/S0166-6851(01)00456-X; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Ono F, 1998, J BIOL CHEM, V273, P7731, DOI 10.1074/jbc.273.13.7731; Pereira CA, 2000, J BIOL CHEM, V275, P1495, DOI 10.1074/jbc.275.2.1495; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Porto-Carreiro I, 2000, EUR J CELL BIOL, V79, P858, DOI 10.1078/0171-9335-00112; Rog O, 2005, CURR GENET, V47, P18, DOI 10.1007/s00294-004-0548-y; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Rohloff P, 2008, EXP PARASITOL, V118, P17, DOI 10.1016/j.exppara.2007.04.013; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Scott DA, 1998, BIOCHEM J, V331, P583, DOI 10.1042/bj3310583; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Soares MJ, 2006, PARASITOL RES, V99, P321, DOI 10.1007/s00436-006-0189-9; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Vieira M, 2005, BIOCHEM J, V392, P467, DOI 10.1042/BJ20051319; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7	50	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31541	31550		10.1074/jbc.M801367200	http://dx.doi.org/10.1074/jbc.M801367200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801733	Green Published, hybrid			2022-12-25	WOS:000260760800033
J	Pan, HL; Yu, J; Zhang, LH; Carpenter, A; Zhu, H; Li, L; Ma, DW; Yuan, JY				Pan, Heling; Yu, Jia; Zhang, Lihong; Carpenter, Anne; Zhu, Hong; Li, Li; Ma, Dawei; Yuan, Junying			A Novel Small Molecule Regulator of Guanine Nucleotide Exchange Activity of the ADP-ribosylation Factor and Golgi Membrane Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREFELDIN-A; ENDOPLASMIC-RETICULUM; CIS-GOLGI; INTERMEDIATE COMPARTMENT; PROTEIN-TRANSPORT; SEC7 DOMAIN; FACTOR GBF1; MDCK CELLS; ARF; INHIBITION	An image-based phenotypic screen was developed to identify small molecule regulators of intracellular traffic. Using this screen we found that AG1478, a previously known inhibitor of epidermal growth factor receptor, had epidermal growth factor receptor-independent activity in inducing the disassembly of the Golgi in human cells. Similar to brefeldin A (BFA), a known disrupter of the Golgi, AG1478 inhibits the activity of small GTPase ADP-ribosylation factor. Unlike BFA, AG1478 exhibits low cytotoxicity and selectively targets the cis-Golgi without affecting endosomal compartment. We show that AG1478 inhibits GBF1, a large nucleotide exchange factor for the ADP-ribosylation factor, in a Sec7 domain-dependent manner and mimics the phenotype of a GBF1 mutant that has an inactive mutation. The treatment with AG1478 leads to the recruitment of GBF1 to the vesicular-tubular clusters adjacent to the endoplasmic reticulum exit sites, a step only transiently observed previously in the presence of BFA. We propose that the treatment with AG1478 delineates a membrane trafficking intermediate step that depends upon the Sec7 domain.	[Pan, Heling; Yu, Jia; Zhang, Lihong; Li, Li; Ma, Dawei] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Carpenter, Anne] MIT, Cambridge, MA 02142 USA; [Carpenter, Anne] Broad Inst Harvard, Cambridge, MA 02142 USA; [Zhu, Hong; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Ma, DW (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 354 Fenglin Rd, Shanghai 200032, Peoples R China.	madw@pub.sioc.ac.cn; jyuan@hms.harvard.edu	Carpenter, Anne/C-4982-2008	Carpenter, Anne/0000-0003-1555-8261; Zhu, Hong/0000-0002-2575-4031; LI, LI/0000-0003-2064-2177	National Institutes of Health [R37 AG12859]; National Natural Science Foundation of China [20321202]; Chinese Academy of Science [KGCX2-SW-209]; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 AG12859 (to J.Y.). This work was also supported by National Natural Science Foundation of China Grant 20321202 and Chinese Academy of Science Grant KGCX2-SW-209 (to D.M.).	Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; BREWER CB, 1995, J CELL SCI, V108, P789; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; FINAZZI D, 1994, J BIOL CHEM, V269, P13325; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Gleeson PA, 1996, J CELL SCI, V109, P2811; Guo H, 1998, EXP CELL RES, V245, P57, DOI 10.1006/excr.1998.4235; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Hauri HP, 2000, J CELL SCI, V113, P587; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LOW SH, 1991, J BIOL CHEM, V266, P17729; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; ORCI L, 1993, P NATL ACAD SCI USA, V90, P11089, DOI 10.1073/pnas.90.23.11089; Puri S, 2003, MOL BIOL CELL, V14, P5011, DOI 10.1091/mbc.E03-06-0437; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; STEPHEN GM, 1992, J CELL BIOL, V118, P267; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Tang BL, 1997, MOL CELL BIOL, V17, P256, DOI 10.1128/MCB.17.1.256; TSAI SC, 1993, J BIOL CHEM, V268, P10820; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	53	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31087	31096		10.1074/jbc.M806592200	http://dx.doi.org/10.1074/jbc.M806592200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18799457	Green Published, hybrid			2022-12-25	WOS:000260544800063
J	El-Manzalawy, Y; Dobbs, D; Honavar, V				El-Manzalawy, Yasser; Dobbs, Drena; Honavar, Vasant			On Evaluating MHC-II Binding Peptide Prediction Methods	PLOS ONE			English	Article							PROTEIN; MOLECULES; CLASSIFICATION; DATABASE	Choice of one method over another for MHC-II binding peptide prediction is typically based on published reports of their estimated performance on standard benchmark datasets. We show that several standard benchmark datasets of unique peptides used in such studies contain a substantial number of peptides that share a high degree of sequence identity with one or more other peptide sequences in the same dataset. Thus, in a standard cross-validation setup, the test set and the training set are likely to contain sequences that share a high degree of sequence identity with each other, leading to overly optimistic estimates of performance. Hence, to more rigorously assess the relative performance of different prediction methods, we explore the use of similarity-reduced datasets. We introduce three similarity-reduced MHC-II benchmark datasets derived from MHCPEP, MHCBN, and IEDB databases. The results of our comparison of the performance of three MHC-II binding peptide prediction methods estimated using datasets of unique peptides with that obtained using their similarity-reduced counterparts shows that the former can be rather optimistic relative to the performance of the same methods on similarity-reduced counterparts of the same datasets. Furthermore, our results demonstrate that conclusions regarding the superiority of one method over another drawn on the basis of performance estimates obtained using commonly used datasets of unique peptides are often contradicted by the observed performance of the methods on the similarity-reduced versions of the same datasets. These results underscore the importance of using similarity-reduced datasets in rigorously comparing the performance of alternative MHC-II peptide prediction methods.	[El-Manzalawy, Yasser; Honavar, Vasant] Iowa State Univ, Dept Comp Sci, Ctr Computat Intelligence Learning & Discovery, Ames, IA 50011 USA; [Dobbs, Drena] Iowa State Univ, Ctr Computat Intelligence, Learning & Discovery, Bioinformat & Computat Biol Grad Program, Dept Genet, Dev & Cell Biol, Ames, IA 50011 USA	Iowa State University; Iowa State University	El-Manzalawy, Y (corresponding author), Iowa State Univ, Dept Comp Sci, Ctr Computat Intelligence Learning & Discovery, Ames, IA 50011 USA.	yasser@iastate.edu	El-Manzalawy, Yasser/ABE-3489-2020; Honavar, Vasant G/K-9835-2015	Honavar, Vasant G/0000-0001-5399-3489; Dobbs, Drena/0000-0003-4404-9554	Egyptian Government [doctoral fellowship]; National Institutes of Health [GM066387]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM066387, R21GM066387] Funding Source: NIH RePORTER	Egyptian Government; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by a doctoral fellowship from the Egyptian Government to Yasser EL-Manzalawy and a grant from the National Institutes of Health (GM066387) to Vasant Honavar.	Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bhasin M, 2003, BIOINFORMATICS, V19, P665, DOI 10.1093/bioinformatics/btg055; Bhasin M, 2004, BIOINFORMATICS, V20, P421, DOI 10.1093/bioinformatics/btg424; Brusic V, 1998, NUCLEIC ACIDS RES, V26, P368, DOI 10.1093/nar/26.1.368; BURDEN F, 2006, J MOL GRAPH MODEL, P481; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Chinnasamy A, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P387; Cui J, 2007, MOL IMMUNOL, V44, P866, DOI 10.1016/j.molimm.2006.04.001; Demsar J, 2006, J MACH LEARN RES, V7, P1; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; Fisher Ronald A., 1973, STAT METHODS SCI INF; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Garcia JE, 2007, BIOCHEM BIOPH RES CO, V355, P409, DOI 10.1016/j.bbrc.2007.01.167; Gowthaman U, 2008, J PROTEOME RES, V7, P154, DOI 10.1021/pr070527b; Hertz T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S3; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; LESLIE C, 2002, P PSB, V7, P566; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Mallios RR, 2003, HUM IMMUNOL, V64, P852, DOI 10.1016/S0198-8859(03)00142-3; Mamitsuka H, 1998, PROTEINS, V33, P460, DOI 10.1002/(SICI)1097-0134(19981201)33:4<460::AID-PROT2>3.0.CO;2-M; Murugan Naveen, 2005, Immunome Res, V1, P6, DOI 10.1186/1745-7580-1-6; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Noguchi H, 2002, J BIOSCI BIOENG, V94, P264, DOI 10.1263/jbb.94.264; OSULLIVAN D, 1991, J IMMUNOL, V146, P1240; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Platt J., 1999, FAST TRAINING SUPPOR; RAGHAVA G, MHCBENCH EVALUATION; Rajapakse M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-459; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Salomon J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-501; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Witten I. H., 2005, DATA MINING PRACTICA; YU H, 2006, 8 INT C SIGN PROC; Zhang GL, 2007, J IMMUNOL METHODS, V320, P143, DOI 10.1016/j.jim.2006.12.011	42	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3268	10.1371/journal.pone.0003268	http://dx.doi.org/10.1371/journal.pone.0003268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813344	Green Published, gold, Green Submitted			2022-12-25	WOS:000264431800007
J	Thomas, T; Evans, FF; Schleheck, D; Mai-Prochnow, A; Burke, C; Penesyan, A; Dalisay, DS; Stelzer-Braid, S; Saunders, N; Johnson, J; Ferriera, S; Kjelleberg, S; Egan, S				Thomas, Torsten; Evans, Flavia F.; Schleheck, David; Mai-Prochnow, Anne; Burke, Catherine; Penesyan, Anahit; Dalisay, Doralyn S.; Stelzer-Braid, Sacha; Saunders, Neil; Johnson, Justin; Ferriera, Steve; Kjelleberg, Staffan; Egan, Suhelen			Analysis of the Pseudoalteromonas tunicata Genome Reveals Properties of a Surface-Associated Life Style in the Marine Environment	PLOS ONE			English	Article							MERCURY-RESISTANT BACTERIA; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; CHITIN DEGRADATION; PROTEIN; BIOSYNTHESIS; SEQUENCE; GENES; IDENTIFICATION; COLONIZATION	Background: Colonisation of sessile eukaryotic host surfaces (e. g. invertebrates and seaweeds) by bacteria is common in the marine environment and is expected to create significant inter-species competition and other interactions. The bacterium Pseudoalteromonas tunicata is a successful competitor on marine surfaces owing primarily to its ability to produce a number of inhibitory molecules. As such P. tunicata has become a model organism for the studies into processes of surface colonisation and eukaryotic host-bacteria interactions. Methodology/Principal Findings: To gain a broader understanding into the adaptation to a surface-associated life-style, we have sequenced and analysed the genome of P. tunicata and compared it to the genomes of closely related strains. We found that the P. tunicata genome contains several genes and gene clusters that are involved in the production of inhibitory compounds against surface competitors and secondary colonisers. Features of P. tunicata's oxidative stress response, iron scavenging and nutrient acquisition show that the organism is well adapted to high-density communities on surfaces. Variation of the P. tunicata genome is suggested by several landmarks of genetic rearrangements and mobile genetic elements (e. g. transposons, CRISPRs, phage). Surface attachment is likely to be mediated by curli, novel pili, a number of extracellular polymers and potentially other unexpected cell surface proteins. The P. tunicata genome also shows a utilisation pattern of extracellular polymers that would avoid a degradation of its recognised hosts, while potentially causing detrimental effects on other host types. In addition, the prevalence of recognised virulence genes suggests that P. tunicata has the potential for pathogenic interactions. Conclusions/Significance: The genome analysis has revealed several physiological features that would provide P. tunciata with competitive advantage against other members of the surface-associated community. We have also identified properties that could mediate interactions with surfaces other than its currently recognised hosts. This together with the detection of known virulence genes leads to the hypothesis that P. tunicata maintains a carefully regulated balance between beneficial and detrimental interactions with a range of host surfaces.	[Thomas, Torsten; Evans, Flavia F.; Schleheck, David; Mai-Prochnow, Anne; Burke, Catherine; Penesyan, Anahit; Stelzer-Braid, Sacha; Kjelleberg, Staffan; Egan, Suhelen] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Johnson, Justin; Ferriera, Steve] J Craig Venter Inst, Rockville, MD USA; [Schleheck, David] Univ Konstanz, Dept Biol, D-7750 Constance, Germany; [Mai-Prochnow, Anne] Univ Nottingham, Ctr Biomol Sci, Inst Infect, Immun & Inflammat, Nottingham NG7 2RD, England; [Dalisay, Doralyn S.] Unive Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Saunders, Neil] Univ Queensland, Sch Mol & Microb Sci, St Lucia, Qld 4067, Australia; [Stelzer-Braid, Sacha] Prince Wales Hosp, S East Area Lab Serv, Randwick, NSW, Australia	University of New South Wales Sydney; J. Craig Venter Institute; University of Konstanz; University of Nottingham; University of California System; University of California San Diego; University of Queensland	Thomas, T (corresponding author), Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	t.thomas@unsw.edu.au	Burke, Catherine/C-5664-2014; Penesyan, Anahit/A-9442-2012; Kjelleberg, Staffan/AAB-4641-2020; Kjelleberg, Staffan/C-9229-2015; Saunders, Neil/B-5325-2010; Dalisay, Doralyn S/I-7558-2016; Mai-Prochnow, Anne/D-3954-2013; Penesyan, Anahit/Y-6884-2019	Penesyan, Anahit/0000-0002-2502-0740; Kjelleberg, Staffan/0000-0003-4271-6413; Kjelleberg, Staffan/0000-0003-4271-6413; Saunders, Neil/0000-0003-2139-6107; Mai-Prochnow, Anne/0000-0003-0136-9144; Penesyan, Anahit/0000-0002-2502-0740; Thomas, Torsten/0000-0001-9557-3001; Stelzer-Braid, Sacha/0000-0001-6037-9305; Burke, Catherine/0000-0002-8917-0019; Egan, Suhelen/0000-0003-3286-4279; Dalisay, Doralyn/0000-0003-2850-7797	Betty and Gordon Moore Foundation; Australian Research Council Discovery Project	Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); Australian Research Council Discovery Project(Australian Research Council)	Sequencing and assembly were supported by the Betty and Gordon Moore Foundation as part of its Marine Microbial Sequencing Project (www.moore.org/marinemicro). The JCVI software team, under the leadership of Saul A. Kravitz, manages assembly and Web delivery of data for the GBMF-funded project (http://moore.jcvi.org). This research was also supported by funds provided by the Australian Research Council Discovery Project scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; BARTLETT DH, 1989, J BACTERIOL, V171, P1763, DOI 10.1128/jb.171.3.1763-1766.1989; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Baynham PJ, 2006, J BACTERIOL, V188, P132, DOI 10.1128/JB.188.1.132-140.2006; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BERK SG, 2001, INT BIODETERIATION B, V34, P387; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Bowman JP, 2007, MAR DRUGS, V5, P220, DOI 10.3390/md20070017; Braithwaite RA, 2005, ADV MAR BIOL, V47, P215; Burke C, 2007, ENVIRON MICROBIOL, V9, P814, DOI 10.1111/j.1462-2920.2006.01177.x; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; CARSIOTIS M, 1989, INFECT IMMUN, V57, P3276, DOI 10.1128/IAI.57.11.3276-3280.1989; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Chiu HH, 2007, INT J SYST EVOL MICR, V57, P1209, DOI 10.1099/ijs.0.64762-0; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Dalisay DS, 2006, MICROBIOL-SGM, V152, P2875, DOI 10.1099/mic.0.29158-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Egan S, 2002, ENVIRON MICROBIOL, V4, P433, DOI 10.1046/j.1462-2920.2002.00322.x; Egan S, 2001, FEMS MICROBIOL ECOL, V35, P67, DOI 10.1111/j.1574-6941.2001.tb00789.x; Egan S, 2008, CURR OPIN MICROBIOL, V11, P219, DOI 10.1016/j.mib.2008.04.001; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; FONG ST, 1995, MOL MICROBIOL, V15, P1127, DOI 10.1111/j.1365-2958.1995.tb02286.x; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; Franks A, 2006, APPL ENVIRON MICROB, V72, P6079, DOI 10.1128/AEM.00559-06; Franks A, 2005, MOLECULES, V10, P1286, DOI 10.3390/10101286; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haas BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-7; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Higgins BP, 2007, P NATL ACAD SCI USA, V104, P1901, DOI 10.1073/pnas.0608633104; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; HOLMSTROM C, 1992, APPL ENVIRON MICROB, V58, P2111; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Huxley-Jones J, 2007, MATRIX BIOL, V26, P2, DOI 10.1016/j.matbio.2006.09.008; Ivanova EP, 2002, CURR MICROBIOL, V44, P357, DOI 10.1007/s00284-001-0017-5; James SG, 1996, APPL ENVIRON MICROB, V62, P2783, DOI 10.1128/AEM.62.8.2783-2788.1996; Jeter C, 2005, MOL PLANT MICROBE IN, V18, P1235, DOI 10.1094/MPMI-18-1235; Kanamori T, 2004, J BACTERIOL, V186, P2532, DOI 10.1128/JB.186.9.2532-2539.2004; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LeCleir GR, 2004, APPL ENVIRON MICROB, V70, P6977, DOI 10.1128/AEM.70.12.6977-6983.2004; Ling JML, 2006, CAN J MICROBIOL, V52, P831, DOI 10.1139/W06-042; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MAIPROCHNOW A, 2008, J BACTERIOL; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Markowitz Victor M., 2007, V395, P35; Matthysse AG, 2004, P NATL ACAD SCI USA, V101, P986, DOI 10.1073/pnas.0303623101; MATZ C, 2008, PLOS ONE IN PRESS; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Miyamoto K, 2007, ARCH MICROBIOL, V188, P619, DOI 10.1007/s00203-007-0283-0; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Morelle S, 2003, J BACTERIOL, V185, P2618, DOI 10.1128/JB.185.8.2618-2627.2003; Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0; Potin P, 2002, CURR OPIN PLANT BIOL, V5, P308, DOI 10.1016/S1369-5266(02)00273-X; Preston GM, 2005, FEMS MICROBIOL REV, V29, P331, DOI 10.1016/j.femsre.2004.12.004; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Qian PY, 2007, MAR BIOTECHNOL, V9, P399, DOI 10.1007/s10126-007-9001-9; Ramaiah N, 2003, MICROB ECOL, V45, P444, DOI 10.1007/s00248-001-1068-7; Rao D, 2005, APPL ENVIRON MICROB, V71, P1729, DOI 10.1128/AEM.71.4.1729-1736.2005; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Robertus JD, 1999, EXS, V87, P125; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; RUSSELL MA, 1994, MOL MICROBIOL, V13, P973, DOI 10.1111/j.1365-2958.1994.tb00489.x; Rychel AL, 2006, MOL BIOL EVOL, V23, P541, DOI 10.1093/molbev/msj055; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; SPANGENBERG C, 1995, FEMS MICROBIOL LETT, V125, P265; STELZER S, 2006, THESIS U NEW S WALES; Stelzer S, 2006, MICROBIOL-SGM, V152, P1385, DOI 10.1099/mic.0.28740-0; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Suzumura M, 1998, LIMNOL OCEANOGR, V43, P1553, DOI 10.4319/lo.1998.43.7.1553; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Techkarnjanaruk S, 1999, MICROBIOL-SGM, V145, P925, DOI 10.1099/13500872-145-4-925; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Tsujibo H, 1999, J BACTERIOL, V181, P5461, DOI 10.1128/JB.181.17.5461-5466.1999; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vera J, 1998, APPL ENVIRON MICROB, V64, P4378; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Vogan CL, 2002, MICROBIOL-SGM, V148, P743, DOI 10.1099/00221287-148-3-743; Wang Y, 2006, J ENVIRON SCI, V18, P543; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531	96	100	102	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3252	10.1371/journal.pone.0003252	http://dx.doi.org/10.1371/journal.pone.0003252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813346	Green Published, gold, Green Submitted			2022-12-25	WOS:000264431800003
J	Basha, G; Lizee, G; Reinicke, AT; Seipp, RP; Omilusik, KD; Jefferies, WA				Basha, Genc; Lizee, Gregory; Reinicke, Anna T.; Seipp, Robyn P.; Omilusik, Kyla D.; Jefferies, Wilfred A.			MHC Class I Endosomal and Lysosomal Trafficking Coincides with Exogenous Antigen Loading in Dendritic Cells	PLOS ONE			English	Article								Background: Cross-presentation by dendritic cells (DCs) is a crucial prerequisite for effective priming of cytotoxic T-cell responses against bacterial, viral and tumor antigens; however, this antigen presentation pathway remains poorly defined. Methodology/Principal Findings: In order to develop a comprehensive understanding of this process, we tested the hypothesis that the internalization of MHC class I molecules (MHC-I) from the cell surface is directly involved in cross-presentation pathway and the loading of antigenic peptides. Here we provide the first examination of the internalization of MHC-I in DCs and we demonstrate that the cytoplasmic domain of MHC-I appears to act as an addressin domain to route MHC-I to both endosomal and lysosomal compartments of DCs, where it is demonstrated that loading of peptides derived from exogenously-derived proteins occurs. Furthermore, by chasing MHC-I from the cell surface of normal and transgenic DCs expressing mutant forms of MHC-I, we observe that a tyrosine-based endocytic trafficking motif is required for the constitutive internalization of MHC-I molecules from the cell surface into early endosomes and subsequently deep into lysosomal peptide-loading compartments. Finally, our data support the concept that multiple pathways of peptide loading of cross-presented antigens may exist depending on the chemical nature and size of the antigen requiring processing. Conclusions/Significance: We conclude that DCs have 'hijacked' and adapted a common vacuolar/endocytic intracellular trafficking pathway to facilitate MHC I access to the endosomal and lysosomal compartments where antigen processing and loading and antigen cross-presentation takes place.	[Basha, Genc; Lizee, Gregory; Reinicke, Anna T.; Seipp, Robyn P.; Omilusik, Kyla D.; Jefferies, Wilfred A.] Univ British Columbia, Dept Microbiol & Immunol, Michael Smith Labs, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Basha, Genc; Lizee, Gregory; Reinicke, Anna T.; Seipp, Robyn P.; Omilusik, Kyla D.; Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Michael Smith Lab, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Basha, Genc; Lizee, Gregory; Reinicke, Anna T.; Seipp, Robyn P.; Omilusik, Kyla D.; Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Michael Smith Lab, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Basha, G (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Michael Smith Labs, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada.	wilf@brc.ubc.ca		Basha, Genc/0000-0003-0471-2892; Lizee, Gregory/0000-0003-4449-7461; Omilusik, Kyla/0000-0003-3675-048X	Canadian Institute for Health Research (CIHR); BC Transplantation Society; Michael Smith Foundation for Health Research (MSHRF); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Transplantation Society; Michael Smith Foundation for Health Research (MSHRF)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was funded by Canadian Institute for Health Research (CIHR), BC Transplantation Society and the Michael Smith Foundation for Health Research (MSHRF). R.P.S. gratefully acknowledges funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Michael Smith Foundation for Health Research (MSFHR).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; BLANDER JM, 2006, TOLL DEPENDENT SELEC; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; DASGUPTA JD, 1988, J IMMUNOL, V141, P2577; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Liu TM, 1997, J IMMUNOL, V159, P5364; Lizee G, 2005, TRENDS IMMUNOL, V26, P141, DOI 10.1016/j.it.2005.01.005; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; MCCLUSKEY J, 1986, EMBO J, V5, P2477, DOI 10.1002/j.1460-2075.1986.tb04524.x; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Palliser D, 2005, J IMMUNOL, V174, P1879, DOI 10.4049/jimmunol.174.4.1879; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Ramirez MC, 2004, TRENDS MICROBIOL, V12, P204, DOI 10.1016/j.tim.2004.03.008; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3	33	64	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3247	10.1371/journal.pone.0003247	http://dx.doi.org/10.1371/journal.pone.0003247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802471	gold, Green Published, Green Submitted			2022-12-25	WOS:000264428600007
J	Kitazaki, M; Kobiki, H; Maloney, LT				Kitazaki, Michiteru; Kobiki, Hisashi; Maloney, Laurence T.			Effect of Pictorial Depth Cues, Binocular Disparity Cues and Motion Parallax Depth Cues on Lightness Perception in Three-Dimensional Virtual Scenes	PLOS ONE			English	Article							RECOGNIZED VISUAL SPACE; PERCEIVED SPATIAL ARRANGEMENT; SURFACE COLOR-PERCEPTION; VIEWED SCENES; ILLUMINATION; CONSTANCY; SEGMENTATION; REFLECTANCE; BRIGHTNESS; ROUGHNESS	Background: Surface lightness perception is affected by scene interpretation. There is some experimental evidence that perceived lightness under bi-ocular viewing conditions is different from perceived lightness in actual scenes but there are also reports that viewing conditions have little or no effect on perceived color. We investigated how mixes of depth cues affect perception of lightness in three-dimensional rendered scenes containing strong gradients of illumination in depth. Methodology/Principal Findings: Observers viewed a virtual room (4 m width x 5 m height x 17.5 m depth) with checkerboard walls and floor. In four conditions, the room was presented with or without binocular disparity (BD) depth cues and with or without motion parallax (MP) depth cues. In all conditions, observers were asked to adjust the luminance of a comparison surface to match the lightness of test surfaces placed at seven different depths (8.5-17.5 m) in the scene. We estimated lightness versus depth profiles in all four depth cue conditions. Even when observers had only pictorial depth cues (no MP, no BD), they partially but significantly discounted the illumination gradient in judging lightness. Adding either MP or BD led to significantly greater discounting and both cues together produced the greatest discounting. The effects of MP and BD were approximately additive. BD had greater influence at near distances than far. Conclusions/Significance: These results suggest the surface lightness perception is modulated by three-dimensional perception/interpretation using pictorial, binocular-disparity, and motion-parallax cues additively. We propose a two-stage (2D and 3D) processing model for lightness perception.	[Kitazaki, Michiteru] Toyohashi Univ Technol, Res Ctr Future Vehicle, Aichi, Japan; [Kobiki, Hisashi] Toshiba Co Ltd, Corporate Res & Dev Ctr, Kanagawa, Japan; [Maloney, Laurence T.] NYU, Ctr Neural Sci, Dept Psychol, New York, NY USA	Toyohashi University of Technology; Toshiba Corporation; New York University	Kitazaki, M (corresponding author), Toyohashi Univ Technol, Res Ctr Future Vehicle, Tempakucho, Aichi, Japan.	mich@tutkie.tut.ac.jp	Kitazaki, Mitchiteru/AAI-6554-2020	Kitazaki, Mitchiteru/0000-0003-0966-4842	Nissan Science Foundation; MEXT Japan; NIH [EY08266]; NATIONAL EYE INSTITUTE [R01EY008266] Funding Source: NIH RePORTER	Nissan Science Foundation; MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Nissan Science Foundation to MK, for designing and conducting experiments, collecting data, and writing the manuscript. The Global COE Program: Frontiers of Intelligent Sensing by MEXT Japan to HK, for research meetings. NIH EY08266 to LTM, for the design of the study and modeling.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Adelson E.H., 1991, COMPUTATIONAL MODELS, P3; Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; Anderson BL, 2003, PSYCHOL REV, V110, P785, DOI 10.1037/0033-295X.110.4.785; Basri R, 2003, IEEE T PATTERN ANAL, V25, P218, DOI 10.1109/TPAMI.2003.1177153; Bloj MG, 1999, NATURE, V402, P877, DOI 10.1038/47245; Boyaci H, 2003, J VISION, V3, P541, DOI 10.1167/3.8.2; Boyaci H, 2004, J VISION, V4, P664, DOI 10.1167/4.9.1; Boyaci H, 2006, VISUAL NEUROSCI, V23, P311, DOI 10.1017/S0952523806233431; Brunswik E, 1929, Z PSYCHOL PHYSIOL SI, V109, P40; Doerschner K, 2007, VISION RES, V47, P3409, DOI 10.1016/j.visres.2007.09.020; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; FLOCK HR, 1970, PERCEPT PSYCHOPHYS, V8, P251, DOI 10.3758/BF03210216; Gershun A., 1939, J MATH PHYS, V18, P51, DOI [DOI 10.1002/SAPM193918151, 10.1002/sapm193918151]; GILCHRIST AL, 1980, PERCEPT PSYCHOPHYS, V28, P527, DOI 10.3758/BF03198821; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; GOGEL WC, 1969, PERCEPT PSYCHOPHYS, V5, P13, DOI 10.3758/BF03210471; Ho YX, 2006, J VISION, V6, P634, DOI 10.1167/6.5.8; Ho YX, 2007, J VISION, V7, DOI 10.1167/7.1.1; HOCHBERG JE, 1954, J EXP PSYCHOL, V47, P263, DOI 10.1037/h0056283; Ikeda M, 1998, OPT REV, V5, P380, DOI 10.1007/s10043-998-0380-6; Ikeda M, 1998, OPT REV, V5, P200, DOI 10.1007/s10043-998-0200-z; Knill D. C., 1996, PERCEPTION BAYESIAN, P1, DOI [DOI 10.1017/CBO9780511984037, 10.1017/cbo9780511984037, 10.1017/CBO9780511984037]; Kraft JM, 2002, PERCEPTION, V31, P247, DOI 10.1068/p08sp; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Levine M., 2000, FUNDAMENTALS SENSATI; Logvinenko AD, 2002, PERCEPTION, V31, P73, DOI 10.1068/p3171; Logvinenko AD, 2008, PERCEPT PSYCHOPHYS, V70, P828, DOI 10.3758/PP.70.5.828; Mamassian P, 2002, NEU INF PRO, P13; Mamassian P, 2001, VISION RES, V41, P2653, DOI 10.1016/S0042-6989(01)00147-X; MERSHON DH, 1970, AM J PSYCHOL, V83, P55, DOI 10.2307/1420855; Mizokami Y, 1998, OPT REV, V5, P315, DOI 10.1007/s10043-998-0315-2; Mizokami Y, 2004, OPT REV, V11, P288, DOI 10.1007/s10043-004-0288-8; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; NAKAYAMA K, 1992, SCIENCE, V257, P1357, DOI 10.1126/science.1529336; Purves D., 2003, WHY WE SEE WHAT WE E; RAMANATHAN R, 2001, ESSAYS ECONOMETRICS, P497; Ripamonti C, 2004, J VISION, V4, P747, DOI 10.1167/4.9.7; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; SCHIRILLO J, 1990, PERCEPT PSYCHOPHYS, V48, P82, DOI 10.3758/BF03205014; SCHIRILLO JA, 1993, J OPT SOC AM A, V10, P2442, DOI 10.1364/JOSAA.10.002442; Snyder JL, 2005, J VISION, V5, P863, DOI 10.1167/5.10.8; Thouless RH, 1931, B J PSYCHOL-GEN SECT, V21, P339, DOI 10.1111/j.2044-8295.1931.tb00597.x; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Werner A, 2006, PERCEPTION, V35, P1171, DOI 10.1068/p5476; Wolff W, 1933, PSYCHOL FORSCH, V18, P90, DOI 10.1007/BF02409628; Yang JN, 2002, VISION RES, V42, P1979, DOI 10.1016/S0042-6989(02)00098-6	47	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3177	10.1371/journal.pone.0003177	http://dx.doi.org/10.1371/journal.pone.0003177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KD	18781201	Green Published, Green Submitted, gold			2022-12-25	WOS:000264425700009
J	Manukyan, GP; Ghazaryan, KA; Ktsoyan, ZA; Khachatryan, ZA; Arakelova, KA; Kelly, D; Grant, G; Aminov, RI				Manukyan, Gayane P.; Ghazaryan, Karine A.; Ktsoyan, Zhanna A.; Khachatryan, Zaruhi A.; Arakelova, Karine A.; Kelly, Denise; Grant, George; Aminov, Rustam I.			Elevated Systemic Antibodies towards Commensal Gut Microbiota in Autoinflammatory Condition	PLOS ONE			English	Article								Background: Familial Mediterranean fever (FMF) is an autoinflammatory condition, which is characterized by acute, self-limiting episodes of fever and serositis and chronic subclinical inflammation in remission. Here we investigated the consequence of this condition on the level of systemic antibodies directed towards common intestinal bacteria. Methodology/Principal Findings: The level of systemic antibodies towards the antigens of Bacteroides, Parabacteroides, Escherichia, Enteroccocus and Lactobaccilus was measured by ELISA in FMF patients at various stages of the disease and in healthy controls. The difference between remission and attack was not significant. IgG antibodies against the antigens of Bacteroides, Parabacteroides, Escherichia and Enteroccocus were significantly increased in FMF compared to control while IgA levels were not significantly affected. Western blot analyses demonstrated the IgG reactivity against multiple antigens of commensal bacteria in FMF. Serological expression cloning was performed to identify these antigens. No single dominant antigen was identified; the response was generalized and directed against a variety of proteins from Bacteroides, Parabacteroides, Escherichia, and other gut commensals. Conclusions/Significance: This autoinflammatory syndrome is characterized by the increased systemic reactivity against commensal gut microbiota. This is probably the consequence of hypersensitivity of the inflammasome in FMF that triggers the inflammation and contributes to the excessive translocation of bacteria and bacterial antigens through the gut barrier.	[Manukyan, Gayane P.; Ghazaryan, Karine A.; Ktsoyan, Zhanna A.; Khachatryan, Zaruhi A.; Arakelova, Karine A.] Natl Acad Sci, Inst Mol Biol, Yerevan, Armenia; [Kelly, Denise; Grant, George; Aminov, Rustam I.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; University of Aberdeen	Manukyan, GP (corresponding author), Natl Acad Sci, Inst Mol Biol, Yerevan, Armenia.	r.aminov@rowett.ac.uk	Aminov, Rustam/AAF-9052-2019; Aminov, Rustam/C-8764-2016; Manukyan, Gayane/AAR-7421-2020	Aminov, Rustam/0000-0002-5811-8322; Manukyan, Gayane/0000-0001-7541-5743	ISTC [A-1055]; RERAD	ISTC; RERAD	This work was funded by the ISTC (project A-1055). RIA is supported by the RERAD. Funders did not participate in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adams RJ, 2008, AM J GASTROENTEROL, V103, P386, DOI 10.1111/j.1572-0241.2007.01577.x; Aksentijevich I, 1997, CELL, V90, P797; Ben-Chetrit E, 1998, SEMIN ARTHRITIS RHEU, V28, P48, DOI 10.1016/S0049-0172(98)80028-0; Bernot A, 1997, NAT GENET, V17, P25; Brydges S, 2006, CURR TOP MICROBIOL, V305, P127, DOI 10.1007/3-540-29714-6_7; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Davtyan TK, 2006, PATHOBIOLOGY, V73, P26, DOI 10.1159/000093089; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kastner DL, 1998, HOSP PRACT, V33, P131, DOI 10.3810/hp.1998.04.90; Keith MP, 2007, AM J MED, V120, P221, DOI 10.1016/j.amjmed.2006.02.044; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Lodes Michael J, 2004, Methods Mol Med, V94, P91; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Manukyan GP, 2008, CLIN BIOCHEM, V41, P920, DOI 10.1016/j.clinbiochem.2008.03.017; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nadler EP, 2000, PEDIATR SURG INT, V16, P165, DOI 10.1007/s003830050714; Nazli A, 2006, INFECT IMMUN, V74, P192, DOI 10.1128/IAI.74.1.192-201.2006; Notarnicola C, 2002, ARTHRITIS RHEUM-US, V46, P2785, DOI 10.1002/art.10575; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; SEDMAN PC, 1994, GASTROENTEROLOGY, V107, P643, DOI 10.1016/0016-5085(94)90110-4; Sitaraman SV, 2005, AM J PHYSIOL-GASTR L, V288, pG403, DOI 10.1152/ajpgi.00357.2004; Suzuki K, 2007, SEMIN IMMUNOL, V19, P127, DOI 10.1016/j.smim.2006.10.001; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xu DZ, 2002, SHOCK, V17, P139, DOI 10.1097/00024382-200202000-00010; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003	51	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3172	10.1371/journal.pone.0003172	http://dx.doi.org/10.1371/journal.pone.0003172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779861	gold, Green Published, Green Submitted			2022-12-25	WOS:000264425100008
J	Bobashev, G; Morris, RJ; Goedecke, DM				Bobashev, Georgiy; Morris, Robert J.; Goedecke, D. Michael			Sampling for Global Epidemic Models and the Topology of an International Airport Network	PLOS ONE			English	Article								Mathematical models that describe the global spread of infectious diseases such as influenza, severe acute respiratory syndrome (SARS), and tuberculosis (TB) often consider a sample of international airports as a network supporting disease spread. However, there is no consensus on how many cities should be selected or on how to select those cities. Using airport flight data that commercial airlines reported to the Official Airline Guide (OAG) in 2000, we have examined the network characteristics of network samples obtained under different selection rules. In addition, we have examined different size samples based on largest flight volume and largest metropolitan populations. We have shown that although the bias in network characteristics increases with the reduction of the sample size, a relatively small number of areas that includes the largest airports, the largest cities, the most-connected cities, and the most central cities is enough to describe the dynamics of the global spread of influenza. The analysis suggests that a relatively small number of cities ( around 200 or 300 out of almost 3000) can capture enough network information to adequately describe the global spread of a disease such as influenza. Weak traffic flows between small airports can contribute to noise and mask other means of spread such as the ground transportation.	[Bobashev, Georgiy; Morris, Robert J.; Goedecke, D. Michael] RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Bobashev, G (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	bobashev@rti.org			National Institute of General Medical Sciences [U01GM070698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070698] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant Number U01GM070698 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Borgatti S. P., 2006, Computational & Mathematical Organization Theory, V12, P21, DOI 10.1007/s10588-006-7084-x; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Costenbader E, 2003, SOC NETWORKS, V25, P283, DOI 10.1016/S0378-8733(03)00012-1; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ghani AC, 1998, J ROY STAT SOC A STA, V161, P227, DOI 10.1111/1467-985X.00101; Ghani AC, 1998, STAT MED, V17, P2079, DOI 10.1002/(SICI)1097-0258(19980930)17:18&lt;2079::AID-SIM902&gt;3.0.CO;2-H; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Kerneis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001478; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Stumpf MPH, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036118; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Wasserman S., 1994, SOCIAL NETWORK ANAL; Yoon S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046114	22	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3154	10.1371/journal.pone.0003154	http://dx.doi.org/10.1371/journal.pone.0003154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776932	gold, Green Submitted, Green Published			2022-12-25	WOS:000264424300002
J	Kasperczyk, H; Baumann, B; Debatin, KM; Fulda, S				Kasperczyk, Hubert; Baumann, Bernd; Debatin, Klaus-Michael; Fulda, Simone			Characterization of sonic hedgehog as a novel NF-kappa B target gene that promotes NF-kappa B-mediated apoptosis resistance and tumor growth in vivo	FASEB JOURNAL			English	Article						cancer; cell death	PANCREATIC-CARCINOMA CELLS; HUMAN PROSTATE-CANCER; INHIBITION; ACTIVATION; EXPRESSION; PATHWAY; SUFFICIENT; NEOPLASIA; XIAP	To explore mechanisms controlling sonic hedgehog (Shh) expression in human cancers, we investigated regulation of Shh by the transcription factor NF-kappa B. We identify putative NF-kappa B binding sites in the human Shh promoter region that specifically bind NF-kappa B complexes. Further, NF-kappa B activation by tumor necrosis factor alpha (TNF-alpha) or p65 overexpression stimulates Shh promoter activity and p65 binds to Shh promoter in vivo. NF-kappa B-mediated transcriptional activation of Shh is mapped to a minimal NF-kappa B consensus site at position + 139 of Shh promoter. NF-kappa B activation results in increased Shh mRNA and protein expression in vitro and, notably, also in vivo in a genetic mouse model of inducible NF-kappa B activity. Specific NF-kappa B inhibition by inhibitory NF-kappa B alpha (I kappa-B alpha) superrepressor or p65 knockdown inhibits NF-kappa B-induced Shh promoter activation and Shh expression. NF-kappa B-mediated Shh expression promotes proliferation and confers resistance to TRAIL-induced apoptosis. Silencing of Shh prevents NF-kappa B-stimulated proliferation, while the addition of Shh rescues the proliferation defect imposed by NF-kappa B inhibition. Notably, NF-kappa B-stimulated tumor growth is significantly impaired by Shh knockdown in an in vivo model of pancreatic cancer. By demonstrating that NF-kappa B regulates Shh expression, which contributes to NF-kappa B-mediated proliferation and apoptosis resistance in vitro and in vivo, our findings have important implications to target aberrant Shh expression in human cancers.-Kasperczyk, H., Baumann, B., Debatin, K.-M., Fulda, S. Characterization of sonic hedgehog as a novel NF-kappa B target gene that promotes NF-kappa B-mediated apoptosis resistance and tumor growth in vivo. FASEB J. 23, 21-33 (2009)	[Kasperczyk, Hubert; Debatin, Klaus-Michael; Fulda, Simone] Univ Childrens Hosp, D-89075 Ulm, Germany; [Baumann, Bernd] Univ Ulm, Inst Physiol Chem, Ulm, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University	Fulda, S (corresponding author), Univ Childrens Hosp, Eythstr 24, D-89075 Ulm, Germany.	simone.fulda@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014; Fulda, Simone/D-5864-2011	Debatin, Klaus-Michael/0000-0002-8397-1886; Fulda, Simone/0000-0002-0459-6417	Deutsche Forschungsgemeinschaft;  [IAP6/18]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	We thank R. Toftgard (Karolinska Institute, Sweden) for providing the vector encoding the N-terminal fragment of human Shh (PShhHN1-CMV5), M. Jovanovic and A. Dittrich for expert technical assistance, and H. Hahn (University of Goettingen, Germany) for helpful discussions and critical reading of the manuscript. This work has been partially supported by a grant from the Deutsche Forschungsgemeinschaft and by IAP6/18 (to S.F.).	Algul H, 2002, J GASTROINTEST CANC, V31, P71, DOI 10.1385/IJGC:31:1-3:71; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Giagkousiklidis S, 2007, ONCOGENE, V26, P7006, DOI 10.1038/sj.onc.1210502; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kitazawa S, 1998, BBA-GENE STRUCT EXPR, V1443, P358, DOI 10.1016/S0167-4781(98)00243-7; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Kunzi-Rapp K, 2001, J UROLOGY, V166, P1502, DOI 10.1016/S0022-5347(05)65820-X; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; Suhasini M, 1999, ONCOGENE, V18, P7360, DOI 10.1038/sj.onc.1203158; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493	30	110	115	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					21	33		10.1096/fj.08-111096	http://dx.doi.org/10.1096/fj.08-111096			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18772349				2022-12-25	WOS:000262095500005
J	Wilkins, ME; Li, XY; Smart, TG				Wilkins, Megan E.; Li, Xinyan; Smart, Trevor G.			Tracking Cell Surface GABA(B) Receptors Using an alpha-Bungarotoxin Tag	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; INHIBITORY SYNAPSES; BINDING-SITE; A RECEPTORS; TRAFFICKING; PHOSPHORYLATION; SUBUNIT; DESENSITIZATION; ENDOCYTOSIS; MODULATION	GABA(B) receptors mediate slow synaptic inhibition in the central nervous system and are important for synaptic plasticity as well as being implicated in disease. Located at pre- and postsynaptic sites, GABAB receptors will influence cell excitability, but their effectiveness in doing so will be dependent, in part, on their trafficking to, and stability on, the cell surface membrane. To examine the dynamic behavior of GABA(B) receptors in GIRK cells and neurons, we have devised a method that is based on tagging the receptor with the binding site components for the neurotoxin, alpha-bungarotoxin. By using the alpha-bungarotoxin binding site-tagged GABA(B) R1a subunit (R1a(BBS)), co-expressed with the R2 subunit, we can track receptor mobility using the small reporter, alpha-bungarotoxin-conjugated rhodamine. In this way, the rates of internalization and membrane insertion for these receptors could be measured with fixed and live cells. The results indicate that GABAB receptors rapidly turnover in the cell membrane, with the rate of internalization affected by the state of receptor activation. The bungarotoxin-based method of receptor-tagging seems ideally suited to follow the dynamic regulation of other G-protein-coupled receptors.	[Wilkins, Megan E.; Li, Xinyan; Smart, Trevor G.] UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk		Wilkins, Megan/0000-0003-0150-4457	MRC; Wellcome Trust; Medical Research Council [G0601529] Funding Source: researchfish; MRC [G0601529] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MRC and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Caputi L, 2003, SYNAPSE, V47, P236, DOI 10.1002/syn.10164; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Enna SJ, 2004, BIOCHEM PHARMACOL, V68, P1541, DOI 10.1016/j.bcp.2004.06.037; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Fritschy JM, 2004, J COMP NEUROL, V477, P235, DOI 10.1002/cne.20188; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Gonzalez-Maeso J, 2003, EUR J PHARMACOL, V481, P15, DOI 10.1016/j.ejphar.2003.09.002; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pooler AM, 2007, J BIOL CHEM, V282, P25349, DOI 10.1074/jbc.M702358200; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Wilkins ME, 2005, J PHYSIOL-LONDON, V567, P365, DOI 10.1113/jphysiol.2005.088823	33	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34745	34752		10.1074/jbc.M803197200	http://dx.doi.org/10.1074/jbc.M803197200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18812318	Green Published, hybrid			2022-12-25	WOS:000261469100031
J	Ohtani, Y; Harada, T; Funasaka, Y; Nakao, K; Takahara, C; Abdel-Daim, M; Sakai, N; Saito, N; Nishigori, C; Aiba, A				Ohtani, Y.; Harada, T.; Funasaka, Y.; Nakao, K.; Takahara, C.; Abdel-Daim, M.; Sakai, N.; Saito, N.; Nishigori, C.; Aiba, A.			Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma	ONCOGENE			English	Article						mGluR1; melanoma; transgenic; tetracycline	MGLUR1 MUTANT MICE; MALIGNANT-MELANOMA; GENE-EXPRESSION; CELLS; BRAF; MUTATIONS; GLUTAMATE-RECEPTOR-1; STIMULATION; ACTIVATION; PLASTICITY	Ectopic expression of metabotropic glutamate receptor subtype 1 (mGluR1) in mouse melanocytes induces melanoma formation. Although requirement of mGluR1 for development of melanoma in the initial stage has been demonstrated, its role in melanoma growth in vivo remains unclear. In this study, we developed novel transgenic mice that conditionally express mGluR1 in melanocytes, using a tetracycline regulatory system. Pigmented lesions on the ears and tails of the transgenic mice began to appear 29 weeks after activation of the mGluR1 transgene, and the transgenic mice produced melanomas at a frequency of 100% 52 weeks after transgene activation. Subsequent inactivation of the mGluR1 transgene in melanoma-bearing mice inhibited melanoma growth with reduction of immunoreactivity to phosphorylated ERK1/2, whereas mice with persistent expression of mGluR1 developed larger melanoma burdens. mGluR1 expression is thus required not only for melanoma development but also for melanoma growth in vivo. These findings suggest that growth of melanoma can be inhibited in vivo by eliminating only one of the multiple genetic anomalies involved in tumorigenesis.	[Ohtani, Y.; Harada, T.; Takahara, C.; Aiba, A.] Kobe Univ, Div Mol Genet, Dept Physiol & Cell Biol, Grad Sch Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Funasaka, Y.; Abdel-Daim, M.; Nishigori, C.] Kobe Univ, Div Dermatol, Dept Clin Mol Med, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Nakao, K.] RIKEN, Lab Anim Resources & Genet Engn, Ctr Dev Biol, Kobe, Hyogo, Japan; [Sakai, N.] Hiroshima Univ, Dept Mol & Pharmacol Neurosci, Grad Sch Biomed Sci, Hiroshima, Japan; [Saito, N.] Kobe Univ, Mol Pharmacol Lab, Biosignal Res Ctr, Kobe, Hyogo 6500017, Japan	Kobe University; Kobe University; RIKEN; Hiroshima University; Kobe University	Aiba, A (corresponding author), Kobe Univ, Div Mol Genet, Dept Physiol & Cell Biol, Grad Sch Med,Chuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan.	aiba@med.kobe-u.ac.jp	Sakai, Norio/AAM-5822-2021; Abdel-Daim, Mohamed M./B-2545-2013	Sakai, Norio/0000-0002-6648-8761; Abdel-Daim, Mohamed M./0000-0002-4341-2713; zhong wei, he gui/0000-0002-3066-3564	Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Takeda Science Foundation; Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders	We thank Dr S Nakanishi for rat mGluR1a cDNA, Dr Y Ishida for beta-globin insulator and the members of Aiba lab for helpful discussion. This study supported in part by Grant-in-Aid for Scientific Research on Priority Areas Molecular Brain Science, a grant for the 21st Century COE Program 'Center for Excellence for Signal Transduction Disease: Diabetes Mellitus as Model' from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the Naito Foundation, the Takeda Science Foundation, the Uehara Memorial Foundation and the Astellas Foundation for Research on Metabolic Disorders.	AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; Chen S, 1996, J INVEST DERMATOL, V106, P1145, DOI 10.1111/1523-1747.ep12340194; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Handerson T, 2003, CANCER RES, V63, P5363; Huntington JT, 2004, J BIOL CHEM, V279, P33168, DOI 10.1074/jbc.M405102200; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; Marin YE, 2005, NEUROPHARMACOLOGY, V49, P70, DOI 10.1016/j.neuropharm.2005.05.018; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Michaloglou C, 2008, ONCOGENE, V27, P877, DOI 10.1038/sj.onc.1210704; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nambiar S, 2005, ARCH DERMATOL, V141, P165, DOI 10.1001/archderm.141.2.165; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Satyamoorthy K, 2003, CANCER RES, V63, P756; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Stepulak A, 2005, P NATL ACAD SCI USA, V102, P15605, DOI 10.1073/pnas.0507679102; Thandi S, 2002, J NEUROCHEM, V83, P1139, DOI 10.1046/j.1471-4159.2002.01217.x; Thomas NE, 2006, MELANOMA RES, V16, P97, DOI 10.1097/01.cmr.0000215035.38436.87; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Wong CW, 2005, J CLIN PATHOL, V58, P640, DOI 10.1136/jcp.2004.022509	30	60	64	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	57					7162	7170		10.1038/onc.2008.329	http://dx.doi.org/10.1038/onc.2008.329			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	379GG	18776920	Bronze			2022-12-25	WOS:000261384100003
J	Chee, MJS; Morl, K; Lindner, D; Merten, N; Zamponi, GW; Light, PE; Beck-Sickinger, AG; Colmers, WF				Chee, Melissa J. S.; Moerl, Karin; Lindner, Diana; Merten, Nicole; Zamponi, Gerald W.; Light, Peter E.; Beck-Sickinger, Annette G.; Colmers, William F.			The Third Intracellular Loop Stabilizes the Inactive State of the Neuropeptide Y1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; RESONANCE ENERGY-TRANSFER; MU-OPIOID RECEPTOR; CONSTITUTIVE ACTIVATION; ADENYLYL-CYCLASE; INVERSE AGONIST; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSTABILITY; THYROTROPIN RECEPTOR	Constitutively active G-protein-coupled receptors (GPCRs) can signal even in the absence of ligand binding. Most Class I GPCRs are stabilized in the resting conformation by intramolecular interactions involving transmembrane domain (TM) 3 and TM6, particularly at loci 6.30 and 6.34 of TM6. Signaling by G(i)/G(o)-coupled receptors such as the Neuropeptide Y1 receptor decreases already low basal metabolite levels. Thus, we examined constitutive activity using a biochemical assay mediated by a G(i)/G(q) chimeric protein and a more direct electrophysiological assay. Wild-type (WT-Y1) receptors express no measurable, agonist-independent activation, while mu-opioid receptors (MOR) and P2Y(12) purinoceptors showed clear evidence of constitutive activation, especially in the electrophysiological assay. Neither point mutations at TM6 (T(6.30)A or N(6.34)A) nor substitution of the entire TM3 and TM6 regions from the MOR into the Y1 receptor increased basal WT-Y1 activation. By contrast, chimeric substitution of the third intracellular loop (ICL3) generated a constitutively active, Y1-ICL3-MOR chimera. Furthermore, the loss of stabilizing interactions from the native ICL3 enhanced the role of surrounding residues to permit basal receptor activation; because constitutive activity of the Y1-ICL3-MOR chimera was further increased by point mutation at locus 6.34, which did not alter WT-Y1 receptor activity. Our results indicate that the ICL3 stabilizes the Y1 receptor in the inactive state and confers structural properties critical for regulating Y receptor activation and signal transduction. These studies reveal the active participation of the ICL3 in the stabilization and activation of Class I GPCRs.	[Chee, Melissa J. S.; Light, Peter E.; Colmers, William F.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; [Chee, Melissa J. S.; Colmers, William F.] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2H7, Canada; [Moerl, Karin; Lindner, Diana; Merten, Nicole; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, D-041033 Leipzig, Germany; [Zamponi, Gerald W.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada	University of Alberta; University of Alberta; Leipzig University; University of Calgary	Colmers, WF (corresponding author), Univ Alberta, Dept Pharmacol, 9-36 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	william.colmers@ualberta.ca	Colmers, William/C-3106-2013; Lindner, Diana/AAL-9856-2021; Chee, Melissa/G-4150-2014	Colmers, William/0000-0001-7902-3560; Lindner, Diana/0000-0001-5477-769X; Chee, Melissa/0000-0003-3815-9095; Zamponi, Gerald W./0000-0002-0644-9066	Canadian Institutes of Health Research (CIHR) [MT10520]; German Research Foundation [DFG SFB610, TP A1]; Saxonian Ministry for Science and Culture [4-7531.50-02-0361-05/1]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); German Research Foundation(German Research Foundation (DFG)); Saxonian Ministry for Science and Culture	The work was supported by the Canadian Institutes of Health Research (CIHR) Grant MT10520, the German Research Foundation (DFG SFB610, TP A1), and the Saxonian Ministry for Science and Culture (SMWK, Saxonia/Alberta-collaboration 4-7531.50-02-0361-05/1). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Bakker RA, 2004, J BIOL CHEM, V279, P5152, DOI 10.1074/jbc.M309200200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Burford NT, 2000, BIOCHEM J, V348, P531, DOI 10.1042/0264-6021:3480531; Chalmers DT, 2002, NAT REV DRUG DISCOV, V1, P599, DOI 10.1038/nrd872; Chan KYY, 2001, ENDOCRINOLOGY, V142, P3926, DOI 10.1210/en.142.9.3926; Chen G, 2000, MOL PHARMACOL, V57, P125; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conner AC, 2006, BIOCHEMISTRY-US, V45, P12976, DOI 10.1021/bi0615801; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; Couvineau A, 2003, J BIOL CHEM, V278, P24759, DOI 10.1074/jbc.M301916200; Ding ZG, 2006, MOL PHARMACOL, V69, P338, DOI 10.1124/mol.105.014654; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Egan CT, 1998, J PHARMACOL EXP THER, V286, P85; El Bahh B, 2005, EUR J NEUROSCI, V22, P1417, DOI 10.1111/j.1460-9568.2005.04338.x; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fuhrer D, 1997, J CLIN ENDOCR METAB, V82, P4234, DOI 10.1210/jc.82.12.4234; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HillEubanks D, 1996, J BIOL CHEM, V271, P3058, DOI 10.1074/jbc.271.6.3058; HOLST B, 2003, ANN NY ACAD SCI, P9941; Huang P, 2002, BIOCHEMISTRY-US, V41, P11972, DOI 10.1021/bi026067b; Huang P, 2001, BIOCHEMISTRY-US, V40, P13501, DOI 10.1021/bi010917q; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jackson DN, 2005, J PHYSIOL-LONDON, V568, P573, DOI 10.1113/jphysiol.2005.092700; Janovick JA, 2003, J PHARMACOL EXP THER, V305, P608, DOI 10.1124/jpet.102.048454; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kostenis E, 1997, J BIOL CHEM, V272, P19107, DOI 10.1074/jbc.272.31.19107; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; KOSUGI S, 1994, FEBS LETT, V356, P291, DOI 10.1016/0014-5793(94)01286-5; Kosugi S, 1998, MOL PHARMACOL, V53, P894; Larhammar D, 2001, PEPTIDES, V22, P295, DOI 10.1016/S0196-9781(01)00331-X; Larhammar D, 1996, REGUL PEPTIDES, V65, P165, DOI 10.1016/0167-0115(96)00110-3; LATRONICO AC, 1995, J CLIN ENDOCR METAB, V80, P2490, DOI 10.1210/jc.80.8.2490; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Lindner D, 2008, BIOCHEMISTRY-US, V47, P5905, DOI 10.1021/bi800181k; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; Menzaghi F, 2002, CNS NEUROL DISORD-DR, V1, P105, DOI 10.2174/1568007023339508; Miura S, 2000, FEBS LETT, V470, P331, DOI 10.1016/S0014-5793(00)01346-6; NELSON CP, 2002, J PHARMACOL EXP THER, V316, P279; Niswender CM, 2008, MOL PHARMACOL, V73, P1213, DOI 10.1124/mol.107.041053; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pan XH, 1998, MOL PHARMACOL, V54, P1064, DOI 10.1124/mol.54.6.1064; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; Straiker AJ, 2002, J NEUROSCI, V22, P2460, DOI 10.1523/JNEUROSCI.22-07-02460.2002; Takhar S, 1996, ENDOCRINOLOGY, V137, P2175, DOI 10.1210/en.137.5.2175; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timossi C, 2004, MOL CELL ENDOCRINOL, V223, P17, DOI 10.1016/j.mce.2004.06.004; Tu B, 2005, J NEUROSCI, V25, P1718, DOI 10.1523/JNEUROSCI.4835-04.2005; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wonerow P, 1998, J BIOL CHEM, V273, P7900, DOI 10.1074/jbc.273.14.7900; Yao LN, 2002, CELL, V109, P733, DOI 10.1016/S0092-8674(02)00763-8; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang M, 2000, J BIOL CHEM, V275, P15782, DOI 10.1074/jbc.M000198200	70	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33337	33346		10.1074/jbc.M804671200	http://dx.doi.org/10.1074/jbc.M804671200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18812316	Green Published, hybrid			2022-12-25	WOS:000261183700038
J	Frasch, SC; Berry, KZ; Fernandez-Boyanapalli, R; Jin, HS; Leslie, C; Henson, PM; Murphy, RC; Bratton, DL				Frasch, S. Courtney; Berry, Karin Zemski; Fernandez-Boyanapalli, Ruby; Jin, Hyun-Sun; Leslie, Christina; Henson, Peter M.; Murphy, Robert C.; Bratton, Donna L.			NADPH Oxidase-dependent Generation of Lysophosphatidylserine Enhances Clearance of Activated and Dying Neutrophils via G2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); SOLID-PHASE EXTRACTION; APOPTOTIC CELLS INDUCE; PERITONEAL MAST-CELLS; PHOSPHATIDYLSERINE RECEPTOR; IN-VIVO; FACTOR ACETYLHYDROLASE; PROTEIN-KINASE; UNSATURATED PHOSPHATIDYLCHOLINES; BACTERIAL LIPOPOLYSACCHARIDE	Exofacial phosphatidylserine (PS) is an important ligand mediating apoptotic cell clearance by phagocytes. Oxidation of PS fatty acyl groups (oxPS) during apoptosis reportedly mediates recognition through scavenger receptors. Given the oxidative capacity of the neutrophil NADPH oxidase, we sought to identify oxPS signaling species in stimulated neutrophils. Using mass spectrometry analysis, only trace amounts of previously characterized oxPS species were found. Conversely, 18: 1 and 18: 0 lysophosphatidylserine (lysoPS), known bioactive signaling phospholipids, were identified as abundant modified PS species following activation of the neutrophil oxidase. NADPH oxidase inhibitors blocked the production of lyso-PS in vitro, and accordingly, its generation in vivo by activated, murine neutrophils during zymosan-induced peritonitis was absent in mice lacking a functional NADPH oxidase (gp91(phox-/-)). Treatment of macrophages with lyso-PS enhanced the uptake of apoptotic cells in vitro, an effect that was dependent on signaling via the macrophage G2A receptor. Similarly, endogenously produced lyso-PS also enhanced the G2A-mediated uptake of activated PS-exposing (but non-apoptotic) neutrophils, raising the possibility of non-apoptotic mechanisms for removal of inflammatory cells during resolution. Finally, antibody blockade of G2A signaling in vivo prolonged zymosan-induced neutrophilia in wild-type mice, whereas having no effect in gp91(phox-/-) mice where lyso-PS are not generated. Taken together, we show that lyso-PS are modified PS species generated following activation of the NADPH oxidase and lyso-PS signaling through the macrophage G2A functions to enhance existing receptor/ligand systems for optimal resolution of neutrophilic inflammation.	[Berry, Karin Zemski; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby; Jin, Hyun-Sun; Leslie, Christina; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leslie, Christina; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Cell Biol Program, Denver, CO 80206 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; National Jewish Health	Frasch, SC (corresponding author), 1400 Jackson St, Denver, CO 80206 USA.	fraschc@njc.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [AI058228, HL34303, GM61031, HL81151]; Immunodeficiency Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081151, P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058228, R01AI058228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunodeficiency Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058228 (to D. L. B.), HL34303 (to D. L. B., C. C. L., and R. C. M.), and GM61031 and HL81151 (to P. M. H.). This work was also supported by a grant from the Immunodeficiency Foundation (to D. L. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Berry KAZ, 2005, ANTIOXID REDOX SIGN, V7, P157, DOI 10.1089/ars.2005.7.157; Bodennec J, 2003, J LIPID RES, V44, P218, DOI 10.1194/jlr.D200026-JLR200; Bratton DL, 2008, CURR BIOL, V18, pR76, DOI 10.1016/j.cub.2007.11.024; Campbell EL, 2007, FASEB J, V21, P3162, DOI 10.1096/fj.07-8473com; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Elliott JI, 2006, BLOOD, V108, P1611, DOI 10.1182/blood-2005-11-012328; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frasch SC, 2007, J IMMUNOL, V178, P6540, DOI 10.4049/jimmunol.178.10.6540; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; Guzik K, 2008, BIOCHIMIE, V90, P405, DOI 10.1016/j.biochi.2007.09.008; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hallett JM, 2008, TRENDS PHARMACOL SCI, V29, P250, DOI 10.1016/j.tips.2008.03.002; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HASLETT C, 1985, AM J PATHOL, V119, P101; Hazan I, 1997, BIOCHEM J, V326, P867, DOI 10.1042/bj3260867; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; Hosono H, 2001, J BIOL CHEM, V276, P29664, DOI 10.1074/jbc.M104597200; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kawamoto K, 2002, J IMMUNOL, V168, P6412, DOI 10.4049/jimmunol.168.12.6412; KIM HY, 1990, J LIPID RES, V31, P2285; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Kriska T, 2007, J BIOL CHEM, V282, P100, DOI 10.1074/jbc.M608135200; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; MUELLER HW, 1984, J LIPID RES, V25, P383; Panasenko OM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P571, DOI 10.1134/S0006297906050178; Panasenko OM, 2003, FREE RADICAL BIO MED, V34, P553, DOI 10.1016/S0891-5849(02)01358-8; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rossi AG, 2007, BIOCHEM SOC T, V35, P288, DOI 10.1042/BST0350288; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SMITH GA, 1979, FEBS LETT, V105, P58, DOI 10.1016/0014-5793(79)80887-X; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; VANHOEVEN RP, 1975, BIOCHIM BIOPHYS ACTA, V380, P1, DOI 10.1016/0005-2760(75)90039-9; Yamamori T, 2002, BIOCHEM BIOPH RES CO, V293, P1571, DOI 10.1016/S0006-291X(02)00418-7; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Zhao XX, 2002, J BIOL CHEM, V277, P25385, DOI 10.1074/jbc.M203630200	68	76	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33736	33749		10.1074/jbc.M807047200	http://dx.doi.org/10.1074/jbc.M807047200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824544	Green Published, hybrid			2022-12-25	WOS:000261183700080
J	Matsui, C; Kaieda, S; Ikegami, T; Mimori-Kiyosue, Y				Matsui, Chiyuki; Kaieda, Shuji; Ikegami, Takahisa; Mimori-Kiyosue, Yuko			Identification of a Link between the SAMP Repeats of Adenomatous Polyposis Coli Tumor Suppressor and the Src Homology 3 Domain of DDEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; FOCAL ADHESION KINASE; PAXILLIN-BINDING PROTEIN; WNT SIGNALING PATHWAY; CELL-MIGRATION; BETA-CATENIN; SH3 DOMAIN; MICROTUBULE DYNAMICS; NEGATIVE REGULATOR; STRUCTURAL BASIS	The adenomatous polyposis coli (APC) tumor suppressor protein is a multifunctional protein with a well characterized role in the Wnt signal transduction pathway and in cytoskeletal regulation. The SAMP repeats region of APC, an Axin-binding site, is known to be important for tumor suppression and for the developmental function of APC. We performed a yeast two-hybrid screening using the first SAMP motif-containing region of Xenopus APC as bait and obtained several SAMP binding candidates including DDEF2 (development and differentiation enhancing factor 2), which is an ADP-ribosylation factor (Arf) GTPase-activating protein (GAP (ArfGAP)) involved in the regulation of focal adhesions. In vitro and in cells the Src homology 3 (SH3) domain of DDEF2 and its close homolog, DDEF1, are associated with the SAMP motif of APC competitively with Axin1. Moreover, NMR chemical shift perturbation experiments revealed that the SAMP motif interacts at the same surface of the SH3 domain of DDEF as the known SH3 binding motif, PXXP. When fluorescent protein-tagged APC and DDEF are expressed in Xenopus A6 cells, co-localization at microtubule ends is observed. Overexpression and RNA interference experiments indicate that APC and DDEFs cooperatively regulate the distributions of microtubules and focal adhesions. Our findings reveal that the SAMP motif of APC specifically binds to the SH3 domains of DDEFs, providing new insights into the functions of APC in cell migration.	[Matsui, Chiyuki; Mimori-Kiyosue, Yuko] KAN Res Inst Inc, Kobe MI R&D Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kaieda, Shuji; Ikegami, Takahisa] Osaka Univ, Lab Struct Prote, Inst Prot Res, Suita, Osaka 5650871, Japan	KAN Research Institute; Osaka University	Mimori-Kiyosue, Y (corresponding author), KAN Res Inst Inc, Kobe MI R&D Ctr, Chuo Ku, 3F,6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	y-kiyosue@kan.eisai.co.jp	Mimori-Kiyosue, Yuko/K-9158-2015; Ikegami, Takahisa/I-9626-2017	Mimori-Kiyosue, Yuko/0000-0003-3513-9072; Ikegami, Takahisa/0000-0002-1429-1844				Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Hamada F, 1999, GENES CELLS, V4, P465, DOI 10.1046/j.1365-2443.1999.00272.x; Hashimoto S, 2004, J BIOL CHEM, V279, P37677, DOI 10.1074/jbc.M404196200; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Kruljac-Letunic A, 2005, METHOD ENZYMOL, V404, P411, DOI 10.1016/S0076-6879(05)04036-X; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mimori-Kiyosue Y, 2007, GENES CELLS, V12, P219, DOI 10.1111/j.1365-2443.2007.01045.x; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; MUNEMITSU S, 1994, CANCER RES, V54, P3676; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nakamura K, 2000, J BIOL CHEM, V275, P27155; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Oshiro T, 2002, J BIOL CHEM, V277, P38618, DOI 10.1074/jbc.M203453200; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; POLAKIS P, 1995, CURR OPIN GENET DEV, V5, P66, DOI 10.1016/S0959-437X(95)90055-1; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Renner C, 1997, J IMMUNOL, V159, P1276; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; SMITH KJ, 1994, CANCER RES, V54, P3672; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Vaughan KT, 1999, J CELL SCI, V112, P1437; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104	61	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					33006	33020		10.1074/jbc.M800420200	http://dx.doi.org/10.1074/jbc.M800420200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18786926	hybrid			2022-12-25	WOS:000260893700089
J	Agren, D; Schnell, R; Oehlmann, W; Singh, M; Schneider, G				Agren, Daniel; Schnell, Robert; Oehlmann, Wulf; Singh, Mahavir; Schneider, Gunter			Cysteine Synthase (CysM) of Mycobacterium tuberculosis Is an O-Phosphoserine Sulfhydrylase EVIDENCE FOR AN ALTERNATIVE CYSTEINE BIOSYNTHESIS PATHWAY IN MYCOBACTERIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLSERINE SULFHYDRYLASE; 3-DIMENSIONAL STRUCTURE; SALMONELLA-TYPHIMURIUM; MECHANISM; ENZYME; IDENTIFICATION; REQUIREMENTS; MACROPHAGES; ADAPTATION; PERSISTENT	The biosynthesis of cysteine is a crucial metabolic pathway supplying a building block for de novo protein synthesis but also a reduced thiol as a component of the oxidative defense mechanisms that appear particularly vital in the dormant state of Mycobacterium tuberculosis. We here show that the cysteine synthase CysM is, in contrast to previous annotations, an O-phosphoserine-specific cysteine synthase. CysM belongs to the fold type II pyridoxal 5'-phosphate-dependent enzymes, as revealed by the crystal structure determined at 2.1-angstrom resolution. A model of O-phosphoserine bound to the enzyme suggests a hydrogen bonding interaction of the side chain of Arg(220) with the phosphate group as a key feature in substrate selectivity. Replacement of this residue results in a significant loss of specificity for O- phosphoserine. Notably, reactions with sulfur donors are not affected by the amino acid replacement. The specificity of CysM toward O- phosphoserine together with the previously established novel mode of sulfur delivery via thiocar-boxylated CysO (Burns, K. E., Baumgart, S., Dorrestein, P. C., Zhai, H., McLafferty, F. W., and Begley, T. P. (2005) J. Am. Chem. Soc. 127, 11602 - 11603) provide strong evidence for an O-phosphoserine-based cysteine biosynthesis pathway in M. tuberculosis that is independent of both O- acetylserine and the sulfate reduction pathway. The existence of an alternative biosynthetic pathway to cysteine in this pathogen has implications for the design strategy aimed at inhibition of this metabolic route.	[Agren, Daniel; Schnell, Robert; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Oehlmann, Wulf; Singh, Mahavir] LIONEX GmbH, D-38124 Braunschweig, Germany; [Singh, Mahavir] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Karolinska Institutet; Helmholtz Association; Helmholtz-Center for Infection Research	Schneider, G (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	Robert.Schnell@ki.se; Gunter.Schneider@ki.se		Schneider, Gunter/0000-0003-0622-5713; SCHNELL, ROBERT/0000-0001-7530-3629	European Commission [LSHP-CT-2005-018729]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Contract LSHP-CT-2005-018729. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Bornemann C, 1997, BIOCHEM J, V325, P623, DOI 10.1042/bj3250623; Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Chattopadhyay A, 2007, BIOCHEMISTRY-US, V46, P8315, DOI 10.1021/bi602603c; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; *COLL COMP PROJ, 1994, ACTA CRYSTALLOGR D, V53, P760; Cook PF, 1996, J BIOL CHEM, V271, P25842, DOI 10.1074/jbc.271.42.25842; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenton MJ, 1996, INFECT IMMUN, V64, P683, DOI 10.1128/IAI.64.3.683-690.1996; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Hwang CC, 1996, BIOCHEMISTRY-US, V35, P6358, DOI 10.1021/bi9602472; Karsten WE, 2002, METHOD ENZYMOL, V354, P223; Kinsland C, 1998, PROTEIN SCI, V7, P1839, DOI 10.1002/pro.5560070821; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Maier THP, 2003, NAT BIOTECHNOL, V21, P422, DOI 10.1038/nbt807; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mino K, 2003, FEBS LETT, V551, P133, DOI 10.1016/S0014-5793(03)00913-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAMURA T, 1984, J BACTERIOL, V158, P1122, DOI 10.1128/JB.158.3.1122-1127.1984; Oda Y, 2005, J MOL BIOL, V351, P334, DOI 10.1016/j.jmb.2005.05.064; Rabeh WM, 2005, BIOCHEMISTRY-US, V44, P5541, DOI 10.1021/bi047479i; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; White RH, 2003, BBA-GEN SUBJECTS, V1624, P46, DOI 10.1016/j.bbagen.2003.09.005; Williams SJ, 2002, J BIOL CHEM, V277, P32606, DOI 10.1074/jbc.M204613200; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291; Zocher G, 2007, FEBS J, V274, P5382, DOI 10.1111/j.1742-4658.2007.06063.x	44	42	55	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31567	31574		10.1074/jbc.M804877200	http://dx.doi.org/10.1074/jbc.M804877200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799456	hybrid			2022-12-25	WOS:000260760800036
J	Hausmann, S; Zheng, S; Costanzo, M; Brost, RL; Garcin, D; Boone, C; Shuman, S; Schwer, B				Hausmann, Stephane; Zheng, Sushuang; Costanzo, Michael; Brost, Renee L.; Garcin, Dominique; Boone, Charles; Shuman, Stewart; Schwer, Beate			Genetic and Biochemical Analysis of Yeast and Human Cap Trimethylguanosine Synthase FUNCTIONAL OVERLAP OF 2,2,7-TRIMETHYLGUANOSINE CAPS, SMALL NUCLEAR RIBONUCLEOPROTEIN COMPONENTS, PRE-mRNA SPLICING FACTORS, AND RNA DECAY PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U2 SNRNP PROTEIN; SACCHAROMYCES-CEREVISIAE; U1 SNRNP; MUTATIONAL ANALYSIS; ANALYSIS REVEALS; GIARDIA-LAMBLIA; BINDING PROTEIN; RIBOSOMAL-RNA; COMPLEX; METHYLTRANSFERASE	Trimethylguanosine synthase (Tgs1) is the enzyme that converts standard m(7)G caps to the 2,2,7-trimethylguanosine (TMG) caps characteristic of spliceosomal small nuclear RNAs. Fungi and mammalian somatic cells are able to grow in the absence of Tgs1 and TMG caps, suggesting that an essential function of the TMG cap might be obscured by functional redundancy. A systematic screen in budding yeast identified nonessential genes that, when deleted, caused synthetic growth defects with tgs1 Delta. The Tgs1 interaction network embraced proteins implicated in small nuclear ribonucleoprotein function and spliceosome assembly, including Mud2, Nam8, Brr1, Lea1, Ist3, Isy1, Cwc21, and Bud13. Complementation of the synthetic lethality of mud2 Delta tgs1 Delta and nam8 Delta tgs1 Delta strains by wild-type TGS1, but not by catalytically defective mutants, indicated that the TMG cap is essential for mitotic growth when redundant splicing factors are missing. Our genetic analysis also highlighted synthetic interactions of Tgs1 with proteins implicated in RNA end processing and decay (Pat1, Lsm1, and Trf4) and regulation of polymerase II transcription (Rpn4, Spt3, Srb2, Soh1, Swr1, and Htz1). We find that the C-terminal domain of human Tgs1 can function in lieu of the yeast protein in vivo. We present a biochemical characterization of the human Tgs1 guanine-N-2 methyltransferase reaction and identify individual amino acids required for methyltransferase activity in vitro and in vivo.	[Hausmann, Stephane; Garcin, Dominique] Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Zheng, Sushuang; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA; [Costanzo, Michael; Brost, Renee L.; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Schwer, Beate] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	University of Geneva; Memorial Sloan Kettering Cancer Center; University of Toronto; Cornell University	Hausmann, S (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	Stephane.Hausmann@medecine.unige.ch; s-shuman@ski.mkscc.org; bschwer@med.cornell.edu		Schwer, Beate/0000-0002-3824-9819	National Institutes of Health [GM52470]; Genome Canada [2004-OGI-3-01]; Ontario Genomics Institute; Canadian Institutes of Health [GSP-41567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada(Genome Canada); Ontario Genomics Institute; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52470 (to S. S. and B. S.). This work was also supported by Research Agreement 2004-OGI-3-01 from Genome Canada, the Ontario Genomics Institute, and Research Agreement GSP-41567 from Canadian Institutes of Health (to C. B.).	ABOVICH N, 1994, GENE DEV, V8, P843, DOI 10.1101/gad.8.7.843; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; BUSCH H, 1982, ANNU REV BIOCHEM, V51, P617, DOI 10.1146/annurev.bi.51.070182.003153; Caspary F, 1998, EMBO J, V17, P6348, DOI 10.1093/emboj/17.21.6348; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chen CH, 2001, J BIOL CHEM, V276, P488, DOI 10.1074/jbc.M006958200; Colau G, 2004, MOL CELL BIOL, V24, P7976, DOI 10.1128/MCB.24.18.7976-7986.2004; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Demirci H, 2008, J BIOL CHEM, V283, P26548, DOI 10.1074/jbc.M804005200; Dix I, 1999, RNA, V5, P360, DOI 10.1017/S1355838299981396; Dohmen RJ, 2007, BBA-MOL CELL RES, V1773, P1599, DOI 10.1016/j.bbamcr.2007.05.015; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Enyenihi AH, 2003, GENETICS, V163, P47; Fabrega C, 2004, MOL CELL, V13, P77, DOI 10.1016/S1097-2765(03)00522-7; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; FRESCO LD, 1994, P NATL ACAD SCI USA, V91, P6624, DOI 10.1073/pnas.91.14.6624; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Girard C, 2008, J BIOL CHEM, V283, P2060, DOI 10.1074/jbc.M704209200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gottschalk A, 1998, RNA, V4, P374; Gottschalk A, 2001, MOL CELL BIOL, V21, P3037, DOI 10.1128/MCB.21.9.3037-3046.2001; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hausmann S, 2005, J BIOL CHEM, V280, P32101, DOI 10.1074/jbc.M506438200; Hausmann S, 2005, J BIOL CHEM, V280, P4021, DOI 10.1074/jbc.C400554200; Hausmann S, 2007, NUCLEIC ACIDS RES, V35, P1411, DOI 10.1093/nar/gkl1150; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Komonyi O, 2005, J BIOL CHEM, V280, P12397, DOI 10.1074/jbc.M409251200; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; LIAO XLC, 1993, GENE DEV, V7, P419, DOI 10.1101/gad.7.3.419; Linder T, 2004, J BIOL CHEM, V279, P49455, DOI 10.1074/jbc.M409046200; LIOU RF, 1990, MOL CELL BIOL, V10, P1764, DOI 10.1128/MCB.10.4.1764; Mao XD, 1996, MOL CELL BIOL, V16, P475; Misra P, 2002, J BIOL CHEM, V277, P20011, DOI 10.1074/jbc.M201739200; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Mouaikel J, 2003, NUCLEIC ACIDS RES, V31, P4899, DOI 10.1093/nar/gkg656; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Murphy MW, 2004, GENETICS, V166, P53, DOI 10.1534/genetics.166.1.53; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Noble SM, 1996, EMBO J, V15, P4368, DOI 10.1002/j.1460-2075.1996.tb00810.x; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07; Ping Yueh-Hsin, 2004, Retrovirology, V1, P46, DOI 10.1186/1742-4690-1-46; Puig O, 1999, GENE DEV, V13, P569, DOI 10.1101/gad.13.5.569; Rutz B, 1999, RNA, V5, P819, DOI 10.1017/S1355838299982286; Scherrer FW, 2006, RNA, V12, P1361, DOI 10.1261/rna.2276806; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; SCHWER B, 1994, P NATL ACAD SCI USA, V91, P4328, DOI 10.1073/pnas.91.10.4328; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Shuman S, 2001, COLD SPRING HARB SYM, V66, P301, DOI 10.1101/sqb.2001.66.301; Spingola M, 2000, MOL CELL, V6, P329, DOI 10.1016/S1097-2765(00)00033-2; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Srinivasan P, 2003, J BIOL CHEM, V278, P14168, DOI 10.1074/jbc.M212102200; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Takagi T, 2003, J BIOL CHEM, V278, P14174, DOI 10.1074/jbc.M212101200; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	76	55	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31706	31718		10.1074/jbc.M806127200	http://dx.doi.org/10.1074/jbc.M806127200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18775984	Green Published, hybrid			2022-12-25	WOS:000260760800053
J	Maa, MC; Chang, MY; Chen, YJ; Lin, CH; Yu, CJ; Yang, YL; Li, JR; Chen, PR; Tang, CH; Lei, HY; Leu, TH				Maa, Ming-Chei; Chang, Miao Ying; Chen, Yen-Jen; Lin, Chen-Hsuan; Yu, Chih Jen; Yang, Yi Lun; Li, Jiarung; Chen, Pei-Ru; Tang, Chih-Hsin; Lei, Huan-Yao; Leu, Tzeng-Horng			Requirement of Inducible Nitric-oxide Synthase in Lipopolysaccharide-mediated Src Induction and Macrophage Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROTEIN-TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELL MIGRATION; C-SRC; SIGNAL-TRANSDUCTION; GUANYLYL-CYCLASE; FAMILY KINASES; GROWTH-FACTOR; HUMAN CANCER; CYCLIC-GMP	Previously, we have demonstrated the induction of Src in lipopolysaccharide (LPS)-stimulated macrophages. In this study, we observed that pharmacological blockade or knockout of inducible nitric-oxide synthase (iNOS) reduced LPS-mediated Src induction and macrophage migration. Either SNAP (a NO donor) or 8-Br-cGMP (a cGMP analogue) could rescue these defects in iNOS-null macrophages, which indicated the participation of NO/cGMP in LPS-elicited Src expression and mobilization. In addition, Src family kinase (SFK)-specific inhibitor, PP2, inhibited SNAP- and 8-Br-cGMP-evoked motility implicating the involvement of SFKs downstream of NO/cGMP. Analysis of the expression of SFKs indicated LPS dramatically induced Src, which could be attributable to the increased level of the src transcript. Attenuation of Src by src-specific siRNA reduced LPS- and SNAP-evoked mobilization in Raw264.7 macrophages, and reintroduction of avian Src could rescue their motility. Furthermore, LPS- mediated Src induction led to increased FAK Pi-Tyr-397 and Pi-Tyr-861, which was also iNOS-dependent. With these findings, we concluded that iNOS was important for LPS-mediated macrophage locomotion and Src was a critical player in this process.	[Maa, Ming-Chei; Chang, Miao Ying] China Med Univ, Inst Med Sci, Taichung 40402, Taiwan; [Chen, Yen-Jen; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Inst Basic Med Sci, Dept Pharmacol, Coll Med, Tainan 70101, Taiwan; [Chen, Yen-Jen; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan; [Lin, Chen-Hsuan; Yu, Chih Jen; Yang, Yi Lun; Li, Jiarung] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung 40201, Taiwan; [Chen, Pei-Ru] Chung Shan Med Univ, Instrument Ctr, Taichung 40201, Taiwan; [Tang, Chih-Hsin] China Med Univ, Dept Pharmacol, Taichung 40402, Taiwan; [Lei, Huan-Yao] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan	China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University; Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan; National Cheng Kung University	Maa, MC (corresponding author), China Med Univ, Inst Med Sci, Taichung 40402, Taiwan.	mcmaa@mail.cmu.edu.tw; tzengleu@mail.ncku.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council (NSC) [NSC95-2311-B-039-001-MY3, NSC95-2320-B-006-074-MY2, NSC 94-3112-B-001-003, NSC 94-3112-B-001-018-Y]; National Health Research Institute [NHRI-EX-97-9517BI]; China Medical University [CMU95-306, CMU96-134]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); China Medical University(China Medical University)	This work was supported by the National Science Council (NSC) (Grant NSC95-2311-B-039-001-MY3 to M.-C. M. and Grant NSC95-2320-B-006-074-MY2 to T.-H. L.). Additional support came from National Health Research Institute (Grant NHRI-EX-97-9517BI) and China Medical University Grants CMU95-306 and CMU96-134 (to T.-H. L. and M.-C. M., respectively). The DNA construct pLKO.1-msrc (puro) was provided by the National RNAi Core Facility located at the institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by the National Research Program for Genomic Medicine Grants of NSC (Grants NSC 94-3112-B-001-003 and NSC 94-3112-B-001-018-Y). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Ajuebor MN, 1998, IMMUNOLOGY, V95, P625; Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; BELENKY SN, 1993, J LEUKOCYTE BIOL, V53, P498, DOI 10.1002/jlb.53.5.498; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Gerthoffer William T, 2008, Proc Am Thorac Soc, V5, P97, DOI 10.1513/pats.200704-051VS; Haase A, 2003, DEVELOPMENT, V130, P3977, DOI 10.1242/dev.00612; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Iwabuchi K, 1997, EUR J IMMUNOL, V27, P742, DOI 10.1002/eji.1830270324; Kamisato S, 1997, J BIOCHEM-TOKYO, V121, P862; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Korade-Mirnics Z, 2000, J LEUKOCYTE BIOL, V68, P603; Kox M, 2007, VASC PHARMACOL, V46, P195, DOI 10.1016/j.vph.2006.10.004; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; Kuo ML, 1997, MOL PHARMACOL, V52, P535, DOI 10.1124/mol.52.3.535; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lee JC, 2005, MOL CARCINOGEN, V43, P207, DOI 10.1002/mc.20117; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Leu TH, 2004, J BIOL CHEM, V279, P9875, DOI 10.1074/jbc.M309884200; Leu TH, 2003, BIOCHEM PHARMACOL, V66, P2323, DOI 10.1016/j.bcp.2003.08.017; Leu TH, 2002, ONCOGENE, V21, P6992, DOI 10.1038/sj.onc.1205904; Lin WC, 2000, MUTAT RES-GEN TOX EN, V466, P187, DOI 10.1016/S1383-5718(00)00018-8; Lucas KA, 2000, PHARMACOL REV, V52, P375; Maa MC, 1998, BIOCHEM BIOPH RES CO, V251, P344, DOI 10.1006/bbrc.1998.9464; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Obasanjo-Blackshire K, 2006, CARDIOVASC RES, V71, P672, DOI 10.1016/j.cardiores.2006.05.026; Orlicek SL, 1999, SHOCK, V12, P350, DOI 10.1097/00024382-199911000-00004; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Tanno T, 2007, FEBS LETT, V581, P1022, DOI 10.1016/j.febslet.2007.02.001; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Walpen S, 2001, FASEB J, V15, P571; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; WEINSTEIN SL, 1993, J IMMUNOL, V151, P3829; WILSON LK, 1989, MOL CELL BIOL, V9, P1536, DOI 10.1128/MCB.9.4.1536; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Yaroslavskiy BB, 2005, J CELL SCI, V118, P5479, DOI 10.1242/jcs.02655	49	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31408	31416		10.1074/jbc.M801158200	http://dx.doi.org/10.1074/jbc.M801158200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786925	hybrid			2022-12-25	WOS:000260760800020
J	Moore, KJ; Fillingame, RH				Moore, Kyle J.; Fillingame, Robert H.			Structural Interactions between Transmembrane Helices 4 and 5 of Subunit a and the Subunit c Ring of Escherichia coli ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS ACCESS PATHWAYS; CROSS-LINKING; ROTARY MOTOR; MEMBRANE; SECTOR; F-0; REACTIVITY	Subunit a plays a key role in promoting H+ transport and the coupled rotary motion of the subunit c ring in F1F0-ATP synthase. H+ binding and release occur at Asp-61 in the middle of the second transmembrane helix (TMH) of F-0 subunit c. H+ are thought to reach Asp-61 via aqueous pathways mapping to the surfaces of TMHs 2-5 of subunit a. TMH4 of subunit a is thought to pack close to TMH2 of subunit c based upon disulfide cross-link formation between Cys substitutions in both TMHs. Here we substituted Cys into the fifth TMH of subunit a and the second TMH of subunit c and tested for cross-linking using bismethanethiosulfonate (bis-MTS) reagents. A total of 62 Cys pairs were tested and 12 positive cross-links were identified with variable alkyl length linkers. Cross-linking was achieved near the middle of the bilayer for the Cys pairs a248C/c62C, a248C/c63C, a248C/c65C, a251C/c57C, a251C/c59C, a251C/c62C, a252C/c62C, and a252C/c65C. Cross-linking was achieved near the cytoplasmic side of the bilayer for Cys pairs a262C/c53C, a262C/c54C, a262C/c55C, and a263C/c54C. We conclude that both aTMH4 and aTMH5 pack proximately to cTMH2 of the c-ring. In other experiments we demonstrate that aTMH4 and aTMH5 can be simultaneously cross-linked to different subunit c monomers in the c-ring. Five mutants showed pH-dependent cross-linking consistent with a TMH5 changing conformation at lower pH values to facilitate cross-linking. We suggest that the pH-dependent conformational change may be related to the proposed role of a TMH5 in gating H+ access from the periplasm to the cAsp-61 residue in cTMH2.	[Moore, Kyle J.; Fillingame, Robert H.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu			National Institutes of Health [GM23105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23105.	Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Barik S, 1996, Methods Mol Biol, V57, P203; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; Ishmukhametov RR, 2008, BBA-BIOENERGETICS, V1777, P32, DOI 10.1016/j.bbabio.2007.11.004; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	30	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31726	31735		10.1074/jbc.M803848200	http://dx.doi.org/10.1074/jbc.M803848200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786930	hybrid, Green Published			2022-12-25	WOS:000260760800055
J	Kanter, DM; Bruck, I; Kaplan, DL				Kanter, Diane M.; Bruck, Irina; Kaplan, Daniel L.			Mcm Subunits Can Assemble into Two Different Active Unwinding Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; SINGLE-STRANDED-DNA; MINICHROMOSOME MAINTENANCE PROTEINS; HISTONE ACETYLTRANSFERASE HBO1; HELICASE ACTIVITY; HEXAMERIC HELICASE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; SCHIZOSACCHAROMYCES-POMBE; BIOCHEMICAL ACTIVITIES; MCM4/6/7 HELICASE	The replication fork helicase in eukaryotes is a large complex that is composed of Mcm2-7, Cdc45, and GINS. The Mcm2-7 proteins form a heterohexameric ring that hydrolyzes ATP and provide the motor function for this unwinding complex. A comprehensive study of how individual Mcm subunit biochemical activities relate to unwinding function has not been accomplished. We studied the mechanism of the Mcm4-Mcm6-Mcm7 complex, a useful model system because this complex has helicase activity in vitro. We separately purified each of three Mcm subunits until they were each nuclease-free, and we then examined the biochemical properties of different combinations of Mcm subunits. We found that Mcm4 and Mcm7 form an active unwinding assembly. The addition of Mcm6 to Mcm4/Mcm7 results in the formation of an active Mcm4/Mcm6/Mcm7 helicase assembly. The Mcm4-Mcm7 complex forms a ringed-shaped hexamer that unwinds DNA with 3' to 5' polarity by a steric exclusion mechanism, similar to Mcm4/Mcm6/Mcm7. The Mcm4-Mcm7 complex has a high level of ATPase activity that is further stimulated by DNA. The ability of different Mcm mixtures to form rings or exhibit DNA stimulation of ATPase activity correlates with the ability of these complexes to unwind DNA. The Mcm4/Mcm7 and Mcm4/Mcm6/Mcm7 assemblies can open to load onto circular DNA to initiate unwinding. We conclude that the Mcm subunits are surprisingly flexible and dynamic in their ability to interact with one another to form active unwinding complexes.	[Kanter, Diane M.; Bruck, Irina; Kaplan, Daniel L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, DL (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	Daniel.Kaplan@Vanderbilt.Edu		Kaplan, Daniel/0000-0003-2760-7745	Vanderbilt University; Vanderbilt Ingram Cancer Center; American Cancer Society Research Scholar [SG-08-124-01-CCG]	Vanderbilt University; Vanderbilt Ingram Cancer Center; American Cancer Society Research Scholar(American Cancer Society)	This work was supported by Vanderbilt University start-up funds (to D.L.K.), a Vanderbilt University discovery grant (to D.L.K.), a pilot grant from the Vanderbilt Ingram Cancer Center (to D.L.K.), and American Cancer Society Research Scholar Grant SG-08-124-01-CCG (to D.L.K. and I.B.).	Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2007, J BIOL CHEM, V282, P33795, DOI 10.1074/jbc.M703824200; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2006, NUCLEIC ACIDS RES, V34, P5829, DOI 10.1093/nar/gkl708; Coue M, 1998, EXP CELL RES, V245, P282, DOI 10.1006/excr.1998.4271; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; DAVEY MJ, 2003, CURR BIOL; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fitch MJ, 2003, J BIOL CHEM, V278, P25408, DOI 10.1074/jbc.M300699200; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Holthoff HP, 1998, J BIOL CHEM, V273, P7320, DOI 10.1074/jbc.273.13.7320; Honeycutt KA, 2006, ONCOGENE, V25, P4027, DOI 10.1038/sj.onc.1209435; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 2001, J BIOL CHEM, V276, P42744, DOI 10.1074/jbc.M106861200; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Krude T, 1996, J CELL SCI, V109, P309; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lei M, 1996, MOL CELL BIOL, V16, P5081; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MUSAHL C, 1995, EUR J BIOCHEM, V230, P1096, DOI 10.1111/j.1432-1033.1995.tb20660.x; Norcum MT, 2005, P NATL ACAD SCI USA, V102, P3623, DOI 10.1073/pnas.0500713102; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Sherman DA, 1998, NUCLEIC ACIDS RES, V26, P3955, DOI 10.1093/nar/26.17.3955; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Valle M, 2006, J MOL BIOL, V357, P1295, DOI 10.1016/j.jmb.2006.01.021; Yabuta N, 2003, GENES CELLS, V8, P413, DOI 10.1046/j.1365-2443.2003.00645.x; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Ying CY, 2005, EMBO J, V24, P4334, DOI 10.1038/sj.emboj.7600892; You Z, 2005, NUCLEIC ACIDS RES, V33, P3033, DOI 10.1093/nar/gki607; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576; You ZY, 1999, MOL CELL BIOL, V19, P8003; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024	65	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31172	31182		10.1074/jbc.M804686200	http://dx.doi.org/10.1074/jbc.M804686200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18801730	Green Published, hybrid			2022-12-25	WOS:000260544800071
J	Ling, J; Liao, HL; Clark, R; Wong, MSM; Lo, DD				Ling, Jun; Liao, Hailing; Clark, Robin; Wong, Mandy Sze Man; Lo, David D.			Structural Constraints for the Binding of Short Peptides to Claudin-4 Revealed by Surface Plasmon Resonance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; C-TERMINAL FRAGMENT; TIGHT JUNCTION BARRIER; PEYERS PATCH; EXPRESSION; RECEPTOR; PROTEIN; CANCER; MODULATOR; DOMAIN	Claudin family transmembrane proteins play an important role in tight junction structure and function in epithelial cells. Among the 24 isoforms identified in mice and humans, claudin-4 and -3 serve as the receptor for Clostridium perfringens enterotoxin (Cpe). The second extracellular loop (Ecl2) of claudin-4 is responsible for the binding to the C-terminal 30 amino acids of Cpe (Cpe30). To define the structural constraints for the claudin-4/Cpe30 interaction, a surface plasmon resonance (SPR) method was developed. GST fusions with claudin-4 revealed that Ecl2 with the downstream transmembrane domain of claudin-4 reconstituted the basic structural requirement for optimal binding activity to Cpe30, with affinity in the nanomolar range. Two 12-mer peptides selected by phage display against claudin-4-transfected CHO cells and a 12-mer Cpe mutant peptide also showed significant affinity for claudin-4 with this SPR assay, suggesting that a short peptide can establish stable contact with Ecl2 with nanomolar affinity. Alignment of these short peptides unveiled a common Ecl2 binding motif: <XX(Y/W)(X)(3 or 4)Y(Y/X)(L/I)XX>. Whereas the short peptides bound native claudin-4 on transfected CHO cells in pull-down assays, only the larger Cpe30 peptide affected trans-epithelial electrical resistance (TER) in peptide-treated Caco-2BBe monolayers. Importantly, Cpe30 retained its binding to claudin-4 when fused to the C terminus of influenza hemagglutinin, demonstrating that its binding activity can be maintained in a different biochemical context. These studies may help in the design of assays for membrane receptor interactions with soluble ligands, and in applying new targeting ligands to delivering attached "cargo" proteins.	[Ling, Jun; Liao, Hailing; Clark, Robin; Wong, Mandy Sze Man; Lo, David D.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Lo, David D.] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA	University of California System; University of California Riverside; La Jolla Institute for Immunology	Lo, DD (corresponding author), Univ Calif Riverside, Div Biomed Sci, 900 Univ Ave, Riverside, CA 92521 USA.	david.lo@ucr.edu			National Institutes of Health; Bill and Melinda Gates Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported by a Grand Challenges in Global Health grant from the Bill and Melinda Gates Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brayden DJ, 2005, DRUG DISCOV TODAY, V10, P1145, DOI 10.1016/S1359-6446(05)03536-1; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ebihara C, 2007, BIOCHEM PHARMACOL, V73, P824, DOI 10.1016/j.bcp.2006.11.013; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; KokaiKun JF, 1997, CLIN INFECT DIS, V25, pS165, DOI 10.1086/516246; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; Koval M, 2006, CELL COMMUN ADHES, V13, P127, DOI 10.1080/15419060600726209; Kuo WL, 2006, ONCOL REP, V16, P729; Lo D, 2004, INT IMMUNOL, V16, P91, DOI 10.1093/intimm/dxh011; Masuyama A, 2005, J PHARMACOL EXP THER, V314, P789, DOI 10.1124/jpet.105.085399; MEDLEY JG, 2007, INFECT IMMUN, V75, P2381; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Oliveira SS, 2007, CELL MOL LIFE SCI, V64, P17, DOI 10.1007/s00018-006-6314-1; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Van Itallie CM, 2004, J MEMBRANE BIOL, V199, P29, DOI 10.1007/s00232-004-0673-z	23	52	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30585	30595		10.1074/jbc.M803548200	http://dx.doi.org/10.1074/jbc.M803548200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782762	Green Published, hybrid			2022-12-25	WOS:000260544800017
J	Schleinitz, N; March, ME; Long, EO				Schleinitz, Nicolas; March, Michael E.; Long, Eric O.			Recruitment of Activation Receptors at Inhibitory NK Cell Immune Synapses	PLOS ONE			English	Article								Natural killer (NK) cell activation receptors accumulate by an actin-dependent process at cytotoxic immune synapses where they provide synergistic signals that trigger NK cell effector functions. In contrast, NK cell inhibitory receptors, including members of the MHC class I-specific killer cell Ig-like receptor (KIR) family, accumulate at inhibitory immune synapses, block actin dynamics, and prevent actin-dependent phosphorylation of activation receptors. Therefore, one would predict inhibition of actin-dependent accumulation of activation receptors when inhibitory receptors are engaged. By confocal imaging of primary human NK cells in contact with target cells expressing physiological ligands of NK cell receptors, we show here that this prediction is incorrect. Target cells included a human cell line and transfected Drosophila insect cells that expressed ligands of NK cell activation receptors in combination with an MHC class I ligand of inhibitory KIR. The two NK cell activation receptors CD2 and 2B4 accumulated and co-localized with KIR at inhibitory immune synapses. In fact, KIR promoted CD2 and 2B4 clustering, as CD2 and 2B4 accumulated more efficiently at inhibitory synapses. In contrast, accumulation of KIR and of activation receptors at inhibitory synapses correlated with reduced density of the integrin LFA-1. These results imply that inhibitory KIR does not prevent CD2 and 2B4 signaling by blocking their accumulation at NK cell immune synapses, but by blocking their ability to signal within inhibitory synapses.	[Schleinitz, Nicolas; March, Michael E.; Long, Eric O.] NIH, NIAID, Lab Immunogenet, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schleinitz, N (corresponding author), CHU Concept, AP HM, Serv Med Interne, Marseille, France.	eLong@nih.gov	March, Michael/AAB-6502-2019; Long, Eric O/G-5475-2011; schleinitz, nicolas/AAL-6751-2020	March, Michael/0000-0001-9173-6862; Long, Eric O/0000-0002-7793-3728; schleinitz, nicolas/0000-0001-9449-3392	NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000525, ZIAAI001117, ZIAAI000525] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Burshtyn DN, 1999, J IMMUNOL, V162, P897; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Endt J, 2007, J IMMUNOL, V178, P5606, DOI 10.4049/jimmunol.178.9.5606; Fassett MS, 2001, P NATL ACAD SCI USA, V98, P14547, DOI 10.1073/pnas.211563598; Faure M, 2003, J IMMUNOL, V170, P6107, DOI 10.4049/jimmunol.170.12.6107; Guerra N, 2002, BLOOD, V100, P2874, DOI 10.1182/blood-2002-02-0643; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Olcese L, 1996, J IMMUNOL, V156, P4531; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; Roda-Navarro P, 2004, J IMMUNOL, V173, P3640, DOI 10.4049/jimmunol.173.6.3640; Standeven LJ, 2004, J IMMUNOL, V173, P5617, DOI 10.4049/jimmunol.173.9.5617; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Treanor B, 2006, J CELL BIOL, V174, P153, DOI 10.1083/jcb.200601108; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Vyas YM, 2004, J IMMUNOL, V173, P1571, DOI 10.4049/jimmunol.173.3.1571; Watzl C, 2000, J IMMUNOL, V165, P3545, DOI 10.4049/jimmunol.165.7.3545; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Winter CC, 1998, J IMMUNOL, V161, P571; Wulfing C, 2000, P NATL ACAD SCI USA, V97, P10150, DOI 10.1073/pnas.97.18.10150	30	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3278	10.1371/journal.pone.0003278	http://dx.doi.org/10.1371/journal.pone.0003278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818767	Green Submitted, gold, Green Published			2022-12-25	WOS:000264432300003
J	Schmidt, MR; Appel, MC; Giassi, LJ; Greiner, DL; Shultz, LD; Woodland, RT				Schmidt, Madelyn R.; Appel, Michael C.; Giassi, Lisa J.; Greiner, Dale L.; Shultz, Leonard D.; Woodland, Robert T.			Human BLyS Facilitates Engraftment of Human PBL Derived B Cells in Immunodeficient Mice	PLOS ONE			English	Article								The production of fully immunologically competent humanized mice engrafted with peripheral lymphocyte populations provides a model for in vivo testing of new vaccines, the durability of immunological memory and cancer therapies. This approach is limited, however, by the failure to efficiently engraft human B lymphocytes in immunodeficient mice. We hypothesized that this deficiency was due to the failure of the murine microenvironment to support human B cell survival. We report that while the human B lymphocyte survival factor, B lymphocyte stimulator (BLyS/BAFF) enhances the survival of human B cells ex vivo, murine BLyS has no such protective effect. Although human B cells bound both human and murine BLyS, nuclear accumulation of NF-kappa B p52, an indication of the induction of a protective anti-apoptotic response, following stimulation with human BLyS was more robust than that induced with murine BLyS suggesting a fundamental disparity in BLyS receptor signaling. Efficient engraftment of both human B and T lymphocytes in NOD rag1(-/-) Prf1(-/-) immunodeficient mice treated with recombinant human BLyS is observed after adoptive transfer of human PBL relative to PBS treated controls. Human BLyS treated recipients had on average 40-fold higher levels of serum Ig than controls and mounted a de novo antibody response to the thymus-independent antigens in pneumovax vaccine. The data indicate that production of fully immunologically competent humanized mice from PBL can be markedly facilitated by providing human BLyS.	[Schmidt, Madelyn R.; Woodland, Robert T.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Appel, Michael C.] Natl Inst Diabetes & Digest & Kidney Dis NIDDK, NIH, Bethesda, MD USA; [Giassi, Lisa J.; Greiner, Dale L.] Univ Massachusetts, Med Sch, Div Diabetes, Dept Med, Amherst, MA 01003 USA; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Massachusetts System; University of Massachusetts Amherst; Jackson Laboratory	Schmidt, MR (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.	Madelyn.Schmidt@umassmed.edu			National Institutes of Health [AI 041054, AI57463, HL77642, AI46629]; Diabetes Endocrinology Research Center (DERC) [DK32520]; Cancer Center Core [CA34196]; Beta Cell Biology Consortium; Juvenile Diabetes Foundation, International; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI057463, P01AI046629, R01AI041054, R21AI041054, R01AI084800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center (DERC); Cancer Center Core; Beta Cell Biology Consortium; Juvenile Diabetes Foundation, International; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants AI 041054, AI57463, HL77642, AI46629, an institutional Diabetes Endocrinology Research Center (DERC) grant DK32520, a Cancer Center Core grant CA34196, the Beta Cell Biology Consortium, and the Juvenile Diabetes Foundation, International. Human Genome Sciences supplied human recombinant BLyS for some experiments. The contents, study design and interpretation of the data in this publication are solely the responsibility of the authors and do not represent the views of the funding agencies.	Agenes F, 1999, J EXP MED, V189, P319, DOI 10.1084/jem.189.2.319; Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Baker KP, 2004, AUTOIMMUN REV, V3, P368, DOI 10.1016/j.autrev.2004.02.001; Berney T, 2001, TRANSPLANTATION, V72, P133, DOI 10.1097/00007890-200107150-00026; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Cabatingan MS, 2002, J IMMUNOL, V169, P6795, DOI 10.4049/jimmunol.169.12.6795; Cao TH, 2001, J VIROL, V75, P6359, DOI 10.1128/JVI.75.14.6359-6366.2001; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Collins CE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1855; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Depraetere S, 2001, J IMMUNOL, V166, P2929, DOI 10.4049/jimmunol.166.5.2929; Di Ianni M, 2002, CANCER GENE THER, V9, P756, DOI 10.1038/sj.cgt.7700495; Diaz-de-Durana Y, 2006, BLOOD, V107, P594, DOI 10.1182/blood-2004-12-4708; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Gordon NC, 2003, BIOCHEMISTRY-US, V42, P5977, DOI 10.1021/bi034017g; Hase H, 2004, BLOOD, V103, P2257, DOI 10.1182/blood-2003-08-2694; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Huard B, 2001, J IMMUNOL, V167, P6225, DOI 10.4049/jimmunol.167.11.6225; Kanakaraj P, 2001, CYTOKINE, V13, P25, DOI 10.1006/cyto.2000.0793; Kerre TCC, 2002, BLOOD, V99, P1620, DOI 10.1182/blood.V99.5.1620; Kikuchi Kentaro, 2003, Clin Dev Immunol, V10, P197, DOI 10.1080/10446670310001642122; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUMAR CS, 1989, J BIOL CHEM, V264, P17939; Losi CG, 2006, J CLIN IMMUNOL, V26, P396, DOI 10.1007/s10875-006-9026-2; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; MCKENZIE ANJ, 1991, EMBO J, V10, P1193, DOI 10.1002/j.1460-2075.1991.tb08060.x; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Novak AJ, 2004, BLOOD, V103, P689, DOI 10.1182/blood-2003-06-2043; Oren DA, 2002, NAT STRUCT BIOL, V9, P288, DOI 10.1038/nsb769; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Prlic M, 2002, MICROBES INFECT, V4, P531, DOI 10.1016/S1286-4579(02)01569-1; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2003, TRANSPLANTATION, V76, P1036, DOI 10.1097/01.TP.0000083041.44829.2C; Shultz LD, 2000, J IMMUNOL, V164, P2496, DOI 10.4049/jimmunol.164.5.2496; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Smirnova AS, 2008, MOL IMMUNOL, V45, P1179, DOI 10.1016/j.molimm.2007.07.028; Stewart DM, 2003, CLIN IMMUNOL, V109, P137, DOI 10.1016/S1521-6616(03)00215-8; Stohl William, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P351; Stohl William, 2002, Curr Rheumatol Rep, V4, P345, DOI 10.1007/s11926-002-0044-7; Tam WF, 2001, MOL CELL BIOL, V21, P4837, DOI 10.1128/MCB.21.14.4837-4846.2001; TAVERNIER J, 1989, DNA-J MOLEC CELL BIO, V8, P491, DOI 10.1089/dna.1.1989.8.491; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Tournoy KG, 2000, CLIN EXP IMMUNOL, V119, P231, DOI 10.1046/j.1365-2249.2000.01099.x; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Turgeon NA, 2003, EXP BIOL MED, V228, P1096, DOI 10.1177/153537020322800918; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241; Wager EJ, 2000, J IMMUNOL, V165, P518, DOI 10.4049/jimmunol.165.1.518; WILLIAMS IR, 1991, J IMMUNOL, V147, P3752; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001; Woodland RT, 2005, SEMIN IMMUNOL, V17, P209, DOI 10.1016/j.smim.2005.02.006; Woodland RT, 1996, J IMMUNOL, V156, P2143; Ye OR, 2004, EUR J IMMUNOL, V34, P2750, DOI 10.1002/eji.200425198; Yoshioka M, 1999, CYTOKINE, V11, P863, DOI 10.1006/cyto.1998.0499; Zhang X, 2005, INT IMMUNOL, V17, P779, DOI 10.1093/intimm/dxh259	73	44	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3192	10.1371/journal.pone.0003192	http://dx.doi.org/10.1371/journal.pone.0003192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784835	Green Published, gold, Green Submitted			2022-12-25	WOS:000264425900011
J	Jeong, JW; Lee, HS; Franco, HL; Broaddus, RR; Taketo, MM; Tsai, SY; Lydon, JP; DeMayo, FJ				Jeong, J-W; Lee, H. S.; Franco, H. L.; Broaddus, R. R.; Taketo, M. M.; Tsai, S. Y.; Lydon, J. P.; DeMayo, F. J.			beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus	ONCOGENE			English	Article						beta-catenin; uterus; estrogen; hyperplasia	LEUKEMIA INHIBITORY FACTOR; FEMALE REPRODUCTIVE-TRACT; MOUSE UTERUS; ENDOMETRIAL CARCINOMAS; MICROSATELLITE INSTABILITY; TRANSCRIPTIONAL TARGET; NUCLEAR-LOCALIZATION; COLON-CARCINOMA; E-CADHERIN; CYCLIN D1	Endometrioid adenocarcinoma is the most frequent form of endometrial cancer, usually developing in pre- and perimenopausal women. beta-catenin abnormalities are common in endometrioid type endometrial carcinomas with squamous differentiation. To investigate the role of beta-catenin (Ctnnb1) in uterine development and tumorigenesis, mice were generated which expressed a dominant stabilized beta-catenin or had beta-catenin conditionally ablated in the uterus by crossing the PRCre mouse with the Ctnnb1(f(ex3)/+) mouse or Ctnnb1(f/f) mouse, respectively. Both of the beta-catenin mutant mice have fertility defects and the ability of the uterus to undergo a hormonally induced decidual reaction was lost. Expression of the dominant stabilized beta-catenin, PR(cre/+)Ctnnb1(f(ex3)/+), resulted in endometrial glandular hyperplasia, whereas ablation of b-catenin, PR(cre/+)Ctnnb1(f/f), induced squamous cell metaplasia in the murine uterus. Therefore, we have demonstrated that correct regulation of beta-catenin is important for uterine function as well as in the regulation of endometrial epithelial differentiation.	[Jeong, J-W; Franco, H. L.; Tsai, S. Y.; Lydon, J. P.; DeMayo, F. J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lee, H. S.] MizMedi Hosp, Infertil & Reprod Endocrinol Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Broaddus, R. R.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Taketo, M. M.] Kyoto Univ, Dept Pharmacol, Grad Sch Med, Sakyo Ku, Kyoto, Japan	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Kyoto University	DeMayo, FJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	fdemayo@bcm.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336	NICHD; NIH [R01HD042311, U54HD0077495, R01- CA77530, 1P50CA098258-01, R01HD057873]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934, R03HD077495, R01HD042311, U54HD007495, R01HD057873] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077530, P50CA083639, P50CA098258] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jinghua Li and Bryan Ngo for technical assistance; Janet DeMayo, MS for manuscript preparation. This study was supported by the NICHD and, the NIH R01HD042311 and NIH U54HD0077495 (to FJD), NIH R01- CA77530 and the Susan G Komen Award BCTR0503763 (to JPL), NIH 1P50CA098258-01 (to RRB), NIH R01HD057873 and pilot grant from NIH 1P50CA098258-01 (to JWJ), and the NICHD U54HD28934 (to the Universityof Virginia Center for Research in Reproduction Ligand Assayand Analysis Core).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ANDERSON MC, 2002, ENDOMETRITIS METAPLA, P285; Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Brault V, 2001, DEVELOPMENT, V128, P1253; Buchanan DL, 1999, ENDOCRINOLOGY, V140, P484, DOI 10.1210/en.140.1.484; Carta L, 2004, BIOL REPROD, V71, P444, DOI 10.1095/biolreprod.103.026534; Catasus L, 2004, HUM PATHOL, V35, P1360, DOI 10.1016/j.humpath.2004.07.019; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; DELIGDISCH L, 1987, CANCER DETECT PREV, V10, P237; Deutseher E, 2007, DEV BIOL, V307, P227, DOI 10.1016/j.ydbio.2007.04.036; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; FINN CA, 1964, J REPROD FERTIL, V8, P331; Fukuchi T, 1998, CANCER RES, V58, P3526; Garcia-Rostan G, 1999, CANCER RES, V59, P1811; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herington JL, 2007, J HISTOCHEM CYTOCHEM, V55, P963, DOI 10.1369/jhc.7A7199.2007; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Ikeda T, 2000, ONCOL REP, V7, P323; Irving JA, 2005, HUM PATHOL, V36, P605, DOI 10.1016/j.humpath.2005.03.005; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jha RK, 2006, FEBS LETT, V580, P5653, DOI 10.1016/j.febslet.2006.09.014; Kim YT, 2002, YONSEI MED J, V43, P701, DOI 10.3349/ymj.2002.43.6.701; Kobayashi K, 1999, JPN J CANCER RES, V90, P55, DOI 10.1111/j.1349-7006.1999.tb00665.x; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Koster MI, 2007, CELL CYCLE, V6, P269, DOI 10.4161/cc.6.3.3792; Lee KY, 2007, TRENDS ENDOCRIN MET, V18, P234, DOI 10.1016/j.tem.2007.06.002; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Lin ZH, 2006, J CANCER RES CLIN, V132, P811, DOI 10.1007/s00432-006-0130-8; Mao TL, 2001, J PATHOL, V193, P95, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH720>3.0.CO;2-3; MARTIN L, 1973, J ENDOCRINOL, V56, P133, DOI 10.1677/joe.0.0560133; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Miller C, 1998, DEVELOPMENT, V125, P3201; Mirabelli-Primdahl L, 1999, CANCER RES, V59, P3346; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Moreno-Bueno G, 2002, ONCOGENE, V21, P7981, DOI 10.1038/sj.onc.1205924; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nei H, 1999, MOL CARCINOGEN, V25, P207, DOI 10.1002/(SICI)1098-2744(199907)25:3<207::AID-MC7>3.3.CO;2-W; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; PENTECOST BT, 1988, MOL ENDOCRINOL, V2, P1243, DOI 10.1210/mend-2-12-1243; Risinger JI, 1998, CLIN CANCER RES, V4, P3005; Risinger JI, 1997, CANCER RES, V57, P4736; Romano RA, 2007, J INVEST DERMATOL, V127, P1175, DOI 10.1038/sj.jid.5700652; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; Saegusa M, 2001, J PATHOL, V194, P59, DOI 10.1002/path.856; Saegusa M, 2001, BRIT J CANCER, V84, P209, DOI 10.1054/bjoc.2000.1581; Samowitz WS, 1999, CANCER RES, V59, P1442; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; SUNDSTROM SA, 1989, J BIOL CHEM, V264, P16941; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Trink B, 2007, CELL CYCLE, V6, P240, DOI 10.4161/cc.6.3.3803; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wappenschmidt B, 2004, HUM PATHOL, V35, P1260, DOI 10.1016/j.humpath.2004.06.007	64	143	151	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					31	40		10.1038/onc.2008.363	http://dx.doi.org/10.1038/onc.2008.363			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18806829	Green Accepted			2022-12-25	WOS:000262294100004
J	Coutant, J; Yu, HF; Clement, MJ; Alfsen, A; Toma, F; Curmi, PA; Bomsel, M				Coutant, Jerome; Yu, Huifeng; Clement, Marie-Jeanne; Alfsen, Annette; Toma, Flavio; Curmi, Patrick A.; Bomsel, Morgane			Both lipid environment and pH are critical for determining physiological solution structure of 3-D-conserved epitopes of the HIV-1 gp41-MPER peptide P1	FASEB JOURNAL			English	Article						2F5 IgG; 4E10 IgG; glycosphingolipid; mucosa; HIV envelope glycoprotein; NMR	NEUTRALIZING ANTI-GP41 2F5; PROXIMAL EXTERNAL REGION; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; MEMBRANE-FUSION; GP41 ECTODOMAIN; VIRUS; PROTEIN; GLYCOPROTEIN; TRANSCYTOSIS	In terms of background, the solution structure of monomeric peptide P1 (residues 649-683), located in the conserved membrane proximal region (MPER) of HIV-1 envelope glycoprotein gp41, is first reported here in dodecylphosphocholine (DPC) micelles. P1 is the minimal MPER region that permits interaction with the mucosal galactosyl ceramide HIV-receptor; it also contains epitopes recognized by major gp41-specific, broadly neutralizing immunoglobulin Gs (IgGs), 2F5 and 4E10, determinant in HIV fusion/infection. Our principal findings were as follows: the structural stability of P1 is pH dependent, as the alpha-helix comprising Q653 I682, present at pH 3.3, is destabilized at higher pH values. At pH 6, the E-rich N-terminal half of P1 (residues 650 666), partially overlapping the 2F5-specific epitope, becomes fully disordered, while the W-rich C-terminal half conserves two shorter helices (W666-W670 and W672 W680), separated by a well-defined bend overlapped by the 4E10-specific epitope. The two IgGs bind to P1 on DPC micelles with binding parameters (K-d) in the nanomolar range. Next, P1 was derivatized with phosphatidylethanolamine at its C terminal and inserted into liposomes of varied lipid composition, thereby enabling P1 to move laterally. Alternatively, an infectious virus-binding assay was established. The Kd of both 2F5 and 4E10 IgGs measured on viral liposome and virus are similar and much lower than for the binding of the free peptide. In conclusion, P1, in a lipid environment, is an optimized MPER-derived peptide suitable for designing an immunogen inducing broadly neutralizing antibodies to HIV. Coutant, J., Yu, H., Clement, M.- J., Alfsen, A., Toma, F., Curmi, P. A., Bomsel, M. Both lipid environment and pH are critical for determining physiological solution structure of 3-D-conserved epitopes of the HIV-1 gp41-MPER peptide P1. FASEB J. 22, 4338-4351 (2008)	[Yu, Huifeng; Alfsen, Annette; Bomsel, Morgane] Univ Paris 05, CNRS,UMR 8104, Dept Biol Cellulaire,Inst Cochin, Entre Muqueuse VIH & Immun Muqueuse, F-75014 Paris, France; [Coutant, Jerome; Clement, Marie-Jeanne; Toma, Flavio; Curmi, Patrick A.] Univ Evry, INSERM, U829, UEVE, Evry, France; [Yu, Huifeng; Alfsen, Annette; Bomsel, Morgane] INSERM, U567, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bomsel, M (corresponding author), Univ Paris 05, CNRS,UMR 8104, Dept Biol Cellulaire,Inst Cochin, Entre Muqueuse VIH & Immun Muqueuse, 22 Rue Mechain, F-75014 Paris, France.	flavio.toma@univ-evry.fr; pcurmi@univ-evry.fr; morgane.bomsel@inserm.fr	CURMI, Patrick/G-4036-2013; Bomsel, Morgane/GSN-1948-2022	CURMI, Patrick A./0000-0001-5045-8501; Bomsel, Morgane/0000-0002-9577-7474	ANRS; Sidaction-Ensemble contre le SIDA	ANRS(ANRSFrench National Research Agency (ANR)); Sidaction-Ensemble contre le SIDA	We thank B. Weksler for English editing. H.Y. benefited from financial support by Sidaction and Agence Nationale de Recherche sur le SIDA (ANRS), M. B. and P. C. were supported by grants from ANRS, and M. B. was supported by a grant from Sidaction-Ensemble contre le SIDA. We are grateful to S. Fleury (Mymetics, Nyon, Switzerland) for providing P1-PE. We gratefully thank the Conseil Regional d'Ile de France, the Conseil General de l'Essonne, the Genopole, the Commissariat a l'Ennergie Atomique, and the Association Francaise contre les Myopathies for the NMR equipment of INSERM/UEVE U829.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Beswick V, 1996, BIOCHEMISTRY-US, V35, P14717, DOI 10.1021/bi961710d; Biron Z, 2005, BIOCHEMISTRY-US, V44, P13602, DOI 10.1021/bi0509245; Biron Z, 2002, BIOCHEMISTRY-US, V41, P12687, DOI 10.1021/bi026261y; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; BOMSEL M, 2006, PCT IB 2006 000466 I; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; Fantini J, 2000, GLYCOCONJUGATE J, V17, P173, DOI 10.1023/A:1026580905156; GODDARD TD, 1982, SPARKY 3; Killian JA, 2006, CURR OPIN STRUC BIOL, V16, P473, DOI 10.1016/j.sbi.2006.06.007; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V96, P1156, DOI 10.1016/0006-291X(80)90073-X; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Lan C, 2006, FEBS LETT, V580, P5301, DOI 10.1016/j.febslet.2006.08.075; Lenz O, 2005, J BIOL CHEM, V280, P4095, DOI 10.1074/jbc.M411088200; Magerus-Chatinet A, 2007, VIROLOGY, V362, P67, DOI 10.1016/j.virol.2006.11.035; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matoba N, 2004, P NATL ACAD SCI USA, V101, P13584, DOI 10.1073/pnas.0405297101; Matoba N, 2006, VACCINE, V24, P5047, DOI 10.1016/j.vaccine.2006.03.045; Maurin T, 2007, J MOL BIOL, V367, P702, DOI 10.1016/j.jmb.2007.01.031; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Sabado RL, 2007, EUR J IMMUNOL, V37, P1752, DOI 10.1002/eji.200636981; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sanchez-Martinez S, 2006, FEBS LETT, V580, P2395, DOI 10.1016/j.febslet.2006.03.067; Sanchez-Martinez S, 2006, AIDS RES HUM RETROV, V22, P998, DOI 10.1089/aid.2006.22.998; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tamm LK, 2003, CURR OPIN STRUC BIOL, V13, P453, DOI 10.1016/S0959-440X(03)00107-6; TAMM LK, 2007, BIOCHIM BIOPHYS ACTA, V12, P3052; Vidricaire G, 2007, J MOL BIOL, V368, P1267, DOI 10.1016/j.jmb.2007.03.003; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yu HF, 2008, CELL CALCIUM, V43, P73, DOI 10.1016/j.ceca.2007.04.011; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	63	27	29	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4338	4351		10.1096/fj.08-113142	http://dx.doi.org/10.1096/fj.08-113142			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18776068				2022-12-25	WOS:000261254800032
J	Gray, MJ; Dallas, NA; Van Buren, G; Xia, L; Yang, AD; Somcio, RJ; Gaur, P; Mangala, LS; Vivas-Mejia, PE; Fan, F; Sanguino, AM; Gallick, GE; Lopez-Berestein, G; Sood, AK; Ellis, LM				Gray, M. J.; Dallas, N. A.; Van Buren, G.; Xia, L.; Yang, A. D.; Somcio, R. J.; Gaur, P.; Mangala, L. S.; Vivas-Mejia, P. E.; Fan, F.; Sanguino, A. M.; Gallick, G. E.; Lopez-Berestein, G.; Sood, A. K.; Ellis, L. M.			Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver	ONCOGENE			English	Article						Id2; colorectal carcinoma; Inhibitor of DNA-binding; metastasis; siRNA	LOOP-HELIX PROTEINS; RETINOBLASTOMA PROTEIN; PANCREATIC-CANCER; CELL-CYCLE; EXPRESSION; PROLIFERATION; ANGIOGENESIS; GENE; APOPTOSIS; DIFFERENTIATION	During development inhibitor of DNA-bind-2 (Id2) regulates proliferation and differentiation. Id2 expression has been detected in cancer cells, yet its cellular function and validity as a therapeutic target remains largely unknown. Immunohistochemical analysis of colorectal cancer (CRC) specimens revealed that Id2 was undetectable in normal colonic mucosa, but occurs in 40% of primary tumors and in most CRC liver metastases (P<0.0001). Additionally, Id2 was expressed in all CRC cell lines assayed. CRC cells with reduced Id2 expression demonstrated reduced proliferation. Analysis of CRC cell cycle regulatory proteins showed that reducing Id2 levels reduces cyclin D1 levels and increased p21 levels. Reduction of Id2 expression also enhanced tumor cell apoptosis, increasing levels of the pro-apoptotic protein Bim/Bod, and cleavage of caspase-7 and poly (ADP-ribose) polymerase. In vivo studies show tumors derived from cells with decreased Id2 levels formed smaller tumors with fewer metastases compared with tumors with normal levels (P<0.05). Furthermore, intraperitoneal administration of Id2 small interfering RNA (siRNA) conjugated with the neutral liposome 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine decreased tumor burden in mice compared with control treatment (P = 0.006). We conclude that Id2 is upregulated in CRC, and is important in promoting cell survival. In vivo targeting of Id2 by siRNA establishes that it is a valid therapeutic target where its expression occurs.	[Gray, M. J.; Dallas, N. A.; Van Buren, G.; Yang, A. D.; Gaur, P.; Ellis, L. M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Xia, L.; Somcio, R. J.; Fan, F.; Gallick, G. E.; Sood, A. K.; Ellis, L. M.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Mangala, L. S.; Sood, A. K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Vivas-Mejia, P. E.; Sanguino, A. M.; Lopez-Berestein, G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gray, MJ (corresponding author), OSI Pharmaceut, Dept Canc Biol, 1 Biosci Pk Dr, Farmingdale, NY 11735 USA.	mgray@osip.com; lellis@mdanderson.org	Khaitan, Puja/AAQ-6413-2020	Khaitan, Puja/0000-0001-8654-062X	Ovarian Cancer Research Fund, Inc; Zarrow Foundation; William C Liedtke, Jr Chair in Cancer Research (LME);  [NIH-5 T32 CA09599]; NATIONAL CANCER INSTITUTE [T32CA009599] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund, Inc; Zarrow Foundation; William C Liedtke, Jr Chair in Cancer Research (LME); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Rita Hernandez (Department of Surgical Oncology) and Christine Wogan (Department of Scientific Publications) for manuscript editing and preparation. Supported by NIH-5 T32 CA09599 (GVB, NAD, ADY and PG), Program Project Development Grant from the Ovarian Cancer Research Fund, Inc. (AKS), the Zarrow Foundation (AKS) and William C Liedtke, Jr Chair in Cancer Research (LME).	Arumugam T, 2006, J NATL CANCER I, V98, P1806, DOI 10.1093/jnci/djj498; Asirvatharn AJ, 2007, PROSTATE, V67, P1411, DOI 10.1002/pros.20633; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Camp ER, 2006, CLIN CANCER RES, V12, P2628, DOI 10.1158/1078-0432.CCR-05-2257; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Gray MJ, 2005, CANCER RES, V65, P3664, DOI 10.1158/0008-5472.CAN-04-2229; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; Hughes TA, 2005, BIOCHEM BIOPH RES CO, V329, P1267, DOI 10.1016/j.bbrc.2005.02.102; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Jen Y, 1996, DEV DYNAM, V207, P235; Kleeff J, 1998, CANCER RES, V58, P3769; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Langley RR, 2003, CANCER RES, V63, P2971; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lasorella A, 2002, CANCER RES, V62, P301; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; LUKAS J, 1995, MOL CELL BIOL, V15, P2600; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Pagliuca A, 2000, CANCER RES, V60, P1376; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Rothschild G, 2006, MOL CELL BIOL, V26, P4351, DOI 10.1128/MCB.01743-05; Russell RG, 2004, CANCER RES, V64, P7220, DOI 10.1158/0008-5472.CAN-04-2095; Weinberg RA, 1996, CELL, V85, P457, DOI 10.1016/S0092-8674(00)81244-1; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilson JW, 2001, CANCER RES, V61, P8803; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Zhang XM, 2007, CANCER SCI, V98, P308, DOI 10.1111/j.1349-7006.2007.00400.x	35	30	33	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2008	27	57					7192	7200		10.1038/onc.2008.356	http://dx.doi.org/10.1038/onc.2008.356			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	379GG	18806828	Green Accepted			2022-12-25	WOS:000261384100006
J	Yoshioka, H; Kamitani, H; Watanabe, T; Eling, TE				Yoshioka, Hiroki; Kamitani, Hideki; Watanabe, Takashi; Eling, Thomas E.			Nonsteroidal Anti-inflammatory Drug-activated Gene (NAG-1/GDF15) Expression Is Increased by the Histone Deacetylase Inhibitor Trichostatin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER CELLS; SP1 SITES; CYCLOOXYGENASE INHIBITORS; BETA SUPERFAMILY; TUMOR-SUPPRESSOR; ASTROCYTE CELLS; NAG-1; TRANSCRIPTION; APOPTOSIS; P53	Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is a putative tumor suppressor whose expression can be increased by drug treatment. Glioblastoma is the most common central nervous system tumor, is associated with high morbidity and mortality, and responds poorly to surgical, chemical, and radiation therapy. The histone deacetylase inhibitors are under current consideration as therapeutic agents in treating glioblastoma. We investigated whether trichostatin A(TSA) would alter the expression of NAG-1 in glioblastoma cells. The DNA demethylating agent 5-aza-dC did not increase NAG-1 expression, but TSA up-regulated NAG-1 expression and acted synergistically with 5-aza-dC to induce NAG-1 expression. TSA indirectly increases NAG-1 promoter activity and increases NAG-1mRNA and protein expression in the T98G human glioblastoma cell line. TSA also increases the expression of transcription factors Sp-1 and Egr-1. Small interfering RNA experiments link NAG-1 expression to apoptosis induced by TSA. Reporter gene assays, specific inhibition by small interfering RNA transfections, and chromatin immunoprecipitation assays indicate that Egr-1 and Sp-1 mediate TSA-induced NAG-1 expression. TSA also increases the stability of NAG-1 mRNA. TSA-induced NAG-1 expression involves multiple mechanisms at the transcriptional and post-transcriptional levels.	[Yoshioka, Hiroki; Eling, Thomas E.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Yoshioka, Hiroki; Kamitani, Hideki; Watanabe, Takashi] Tottori Univ, Fac Med, Inst Neurol Sci, Div Neurosurg, Tottori 6838504, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tottori University	Eling, TE (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	eling@niehs.nih.gov			National Institutes of Health Intramural Program from the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES010016, ZIAES010016] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program from the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program from the NIEHS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Baek SJ, 2006, PROG LIPID RES, V45, P1, DOI 10.1016/j.plipres.2005.10.001; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Baek SJ, 2004, J BIOL CHEM, V279, P6883, DOI 10.1074/jbc.M305295200; Baek SJ, 2002, J PHARMACOL EXP THER, V301, P1126, DOI 10.1124/jpet.301.3.1126; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baek SJ, 2001, J BIOL CHEM, V276, P33384, DOI 10.1074/jbc.M101814200; Camarero N, 2003, NUCLEIC ACIDS RES, V31, P1693, DOI 10.1093/nar/gkg262; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Condorelli F, 2008, BRIT J PHARMACOL, V153, P657, DOI 10.1038/sj.bjp.0707608; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Eling TE, 2006, J BIOCHEM MOL BIOL, V39, P649; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Habold C, 2008, J CELL MOL MED, V12, P607, DOI 10.1111/j.1582-4934.2007.00136.x; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; KIJIMA M, 1993, J BIOL CHEM, V268, P22429; Kim YB, 1999, ONCOGENE, V18, P2461, DOI 10.1038/sj.onc.1202564; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; Kim YK, 2003, ONCOGENE, V22, P6023, DOI 10.1038/sj.onc.1206875; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kwon HJ, 1998, P NATL ACAD SCI USA, V95, P3356, DOI 10.1073/pnas.95.7.3356; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Maehara K, 2002, BIOCHEM BIOPH RES CO, V295, P187, DOI 10.1016/S0006-291X(02)00646-0; Martinez JM, 2006, J PHARMACOL EXP THER, V318, P899, DOI 10.1124/jpet.105.100081; Moon Y, 2005, MOL CANCER THER, V4, P1551, DOI 10.1158/1535-7163.MCT-05-0213; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; Newman D, 2003, MOL PHARMACOL, V63, P557, DOI 10.1124/mol.63.3.557; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Omotehara F, 2002, BRIT J CANCER, V87, P1042, DOI 10.1038/sj.bjc.6600592; Pan LN, 2007, CANCER, V109, P1676, DOI 10.1002/cncr.22585; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Sasai K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-36; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Strelau J, 2000, J NEUROSCI, V20, P8597; Strelau J, 2008, CANCER LETT, V270, P30, DOI 10.1016/j.canlet.2008.04.042; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Taniura S, 2002, J BIOL CHEM, V277, P16823, DOI 10.1074/jbc.M200527200; Walton TJ, 2008, PROSTATE, V68, P210, DOI 10.1002/pros.20673; Wilson LC, 2003, INT J CANCER, V105, P747, DOI 10.1002/ijc.11173; Yamaguchi K, 2005, J BIOL CHEM, V280, P32569, DOI 10.1074/jbc.M503201200; Yamaguchi K, 2006, MOL CANCER THER, V5, P1352, DOI 10.1158/1535-7163.MCT-05-0528	47	36	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33129	33137		10.1074/jbc.M805248200	http://dx.doi.org/10.1074/jbc.M805248200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18801729	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000261183700014
J	Boudko, SP; Engel, J; Okuyama, K; Mizuno, K; Bachinger, HP; Schumacher, MA				Boudko, Sergei P.; Engel, Juergen; Okuyama, Kenji; Mizuno, Kazunori; Baechinger, Hans Peter; Schumacher, Maria A.			Crystal Structure of Human Type III Collagen Gly(991)-Gly(1032) Cystine Knot-containing Peptide Shows Both 7/2 and 10/3 Triple Helical Symmetries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE SCAVENGER RECEPTORS; AMINO-ACID SEQUENCE; MOLECULAR-STRUCTURE; ANGSTROM RESOLUTION; POLYPEPTIDE (PRO-PRO-GLY)10; ELECTROSTATIC INTERACTIONS; REPEATING SEQUENCE; MODEL PEPTIDES; PROLINE RING; XAA POSITION	Type III collagen is a critical collagen that comprises extensible connective tissue such as skin, lung, and the vascular system. Mutations in the type III collagen gene, COL3A1, are associated with the most severe forms of Ehlers-Danlos syndrome. A characteristic feature of type III collagen is the presence of a stabilizing C-terminal cystine knot. Crystal structures of collagen triple helices reported so far contain artificial sequences like (Gly-Pro-Pro)(n) or (Gly-Pro-Hyp)(n). To gain insight into the structural properties exhibited by the natural type III collagen triple helix, we synthesized, crystallized, and determined the structure of a 12-triplet repeating peptide containing the natural type III collagen sequence from residues 991 to 1032 including the C-terminal cystine knot region, to 2.3 angstrom resolution. This represents the longest collagen triple helical structure determined to date with a native sequence. Strikingly, the Gly(991)-Gly(1032) structure reveals that the central non-imino acid-containing region adopts 10/3 superhelical properties, whereas the imino acid rich N- and C-terminal regions adhere to a 7/2 superhelical conformation. The structure is consistent with two models for the cystine knot; however, the poor density for the majority of this region suggests that multiple conformations may be adopted. The structure shows that the multiple non-imino acids make several types of direct intrahelical as well as interhelical contacts. The looser superhelical structure of the non-imino acid region of collagen triple helices combined with the extra contacts afforded by ionic and polar residues likely play a role in fibrillar assembly and interactions with other extracellular components.	[Boudko, Sergei P.; Mizuno, Kazunori; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Okuyama, Kenji] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Osaka 5600043, Japan; [Schumacher, Maria A.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Basel; Osaka University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.	hbp@shcc.org; maschuma@mdanderson.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Boudko, Sergei/0000-0003-3856-4859	Shriners Hospital; Burroughs Wellcome Career Development Award [992863]; United States Department of Energy [DE-AC03-78SF00098]	Shriners Hospital; Burroughs Wellcome Career Development Award(Burroughs Wellcome Fund); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by a grant from the Shriners Hospital for Children, in part by Burroughs Wellcome Career Development Award 992863 ( to M. A. S.), and in part by United States Department of Energy Contract DE-AC03-78SF00098. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ACTON S, 1993, J BIOL CHEM, V268, P3530; ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; ALLMANN H, 1979, H-S Z PHYSIOL CHEM, V360, P861; Bachmann A, 2005, P NATL ACAD SCI USA, V102, P13897, DOI 10.1073/pnas.0505141102; Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054; Boulegue C, 2008, ANTIOXID REDOX SIGN, V10, P113, DOI 10.1089/ars.2007.1868; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNS RR, 1973, BIOCHEMISTRY-US, V12, P808, DOI 10.1021/bi00729a004; Bulleid NJ, 1996, BIOCHEM J, V317, P195, DOI 10.1042/bj3170195; Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7; COHEN H, 1953, Br J Phys Med, V16, P169; COWAN PM, 1955, NATURE, V176, P1062, DOI 10.1038/1761062a0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOI T, 1993, J BIOL CHEM, V268, P2126; DOYLE BB, 1974, PROC R SOC SER B-BIO, V187, P37, DOI 10.1098/rspb.1974.0059; Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Frankfurter D, 2003, J EARLY CHRISTIAN ST, V11, P339, DOI 10.1353/earl.2003.0043; HAUKIPURO K, 1987, ANN SURG, V206, P752, DOI 10.1097/00000658-198712000-00011; HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X; Hongo C, 2001, POLYM J, V33, P812; HOPPE HJ, 1994, PROTEIN SCI, V3, P1143, DOI 10.1002/pro.5560030801; HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawahara K, 2005, BIOCHEMISTRY-US, V44, P15812, DOI 10.1021/bi051619m; KIELTY ME, 1993, CONNECTIVE TISSUE IT; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI ST, 1975, J MOL BIOL, V98, P835, DOI 10.1016/S0022-2836(75)80015-5; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagarajan V, 1998, J BIOCHEM-TOKYO, V124, P1117, DOI 10.1093/oxfordjournals.jbchem.a022229; Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; Okuyama K, 2004, BIOPOLYMERS, V76, P367, DOI 10.1002/bip.20107; OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7; OKUYAMA K, 1972, J MOL BIOL, V72, P571, DOI 10.1016/0022-2836(72)90175-1; Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; Schumacher M, 2005, J BIOL CHEM, V280, P20397, DOI 10.1074/jbc.M501453200; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; SUGETA H, 1967, BIOPOLYMERS, V5, P673, DOI 10.1002/bip.1967.360050708; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TORCHIA DA, 1976, J MOL BIOL, V104, P315, DOI 10.1016/0022-2836(76)90018-8; TRUS BL, 1976, J MOL BIOL, V108, P705, DOI 10.1016/S0022-2836(76)80113-1; VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023	59	64	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32580	32589		10.1074/jbc.M805394200	http://dx.doi.org/10.1074/jbc.M805394200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805790	hybrid			2022-12-25	WOS:000260893700047
J	Ishii, M; Maeda, N				Ishii, Maki; Maeda, Nobuaki			Oversulfated Chondroitin Sulfate Plays Critical Roles in the Neuronal Migration in the Cerebral Cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-ASSOCIATED MOLECULE; RADIAL MIGRATION; HEPARAN-SULFATE; ZETA/RPTP-BETA; HYBRID CHAINS; NEURITE OUTGROWTH; RNA INTERFERENCE; DERMATAN SULFATE; AXON-GROWTH; BINDING	Chondroitin sulfate (CS) proteoglycans bind with various proteins through CS chains in a CS structure-dependent manner, in which oversulfated structures, such as iB (IdoA(2-O-sulfate) alpha 1-3GalNAc(4-O-sulfate)), D (GlcA(2-O-sulfate) beta 1-3GalNAc(6-O-sulfate)), and E (GlcA beta 1-3GalNAc(4,6-O-disulfate)) units constitute the critical functional module. In this study, we examined the expression and function of three CS sulfotransferases in the developing neocortex: uronyl 2-O-sulfotransferase (UST), N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase (4,6-ST) and dermatan 4-O-sulfotransferase-1 (D4-ST), which are responsible for the synthesis of oversulfated structures. The CS chains of the neocortex of mouse embryos contained significant amounts of D and E units that are generated by UST and 4,6-ST, respectively. UST and 4,6-ST mRNAs were expressed in the ventricular and subventricular zones, and their expression increased during late embryonic development. In utero electroporation experiments indicated that knockdown of UST and 4,6-ST resulted in the disturbed migration of cortical neurons. The neurons electroporated with the short hairpin RNA constructs of UST and 4,6-ST accumulated in the lower intermediate zone and in the subventricular zone, showing a multipolar morphology. The cDNA constructs of UST and 4,6-ST rescued the defects caused by the RNA interference, and the neurons were able to migrate radially. On the other hand, knockdown of D4-ST, which is involved in the biosynthesis of the iB unit, caused no migratory defects. These results revealed that specific oversulfated structures in CS chains play critical roles in the migration of neuronal precursors during cortical development.	[Ishii, Maki; Maeda, Nobuaki] Tokyo Metropolitan Inst Neurosci, Dept Dev Neurosci, Tokyo 1838526, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Maeda, N (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Dev Neurosci, Tokyo 1838526, Japan.	maeda-nb@igakuken.or.jp			Ministry of Education, Sports, and Culture of Japan; Naito Foundation	Ministry of Education, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This work was supported by grants from the Ministry of Education, Sports, and Culture of Japan and the Naito Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Corvetti L, 2005, J NEUROSCI, V25, P7150, DOI 10.1523/JNEUROSCI.0683-05.2005; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Ishii M, 2008, GLYCOBIOLOGY, V18, P602, DOI 10.1093/glycob/cwn040; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MATSUMOTO K, 1994, DEV BRAIN RES, V79, P229, DOI 10.1016/0165-3806(94)90127-9; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Probstmeier R, 2000, BRAIN RES, V863, P42, DOI 10.1016/S0006-8993(00)02075-8; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Shimazaki Y, 2005, J NEUROSCI RES, V82, P172, DOI 10.1002/jnr.20639; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; SNOW DM, 1992, J NEUROBIOL, V23, P322, DOI 10.1002/neu.480230311; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takagaki K, 2002, J BIOL CHEM, V277, P8882, DOI 10.1074/jbc.M106479200; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; YAMAGATA M, 1987, J BIOL CHEM, V262, P4146; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	48	60	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32610	32620		10.1074/jbc.M806331200	http://dx.doi.org/10.1074/jbc.M806331200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819920	hybrid			2022-12-25	WOS:000260893700050
J	Wang, GS				Wang, Guangshun			Structures of Human Host Defense Cathelicidin LL-37 and Its Smallest Antimicrobial Peptide KR-12 in Lipid Micelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; NMR; EXPRESSION; PROTEIN; SYSTEM; DODECYLPHOSPHOCHOLINE; IDENTIFICATION; PURIFICATION; CONFORMATION	As a key component of the innate immunity system, human cathelicidin LL-37 plays an essential role in protecting humans against infectious diseases. To elucidate the structural basis for its targeting bacterial membrane, we have determined the high quality structure of C-13, N-15-labeled LL-37 by three-dimensional triple-resonance NMR spectroscopy, because two-dimensional H-1 NMR did not provide sufficient spectral resolution. The structure of LL-37 in SDS micelles is composed of a curved amphipathic helix-bend-helix motif spanning residues 2-31 followed by a disordered C-terminal tail. The helical bend is located between residues Gly-14 and Glu-16. Similar chemical shifts and N-15 nuclear Overhauser effect (NOE) patterns of the peptide in complex with dioctanoylphosphatidylglycerol (D8PG) micelles indicate a similar structure. The aromatic rings of Phe-5, Phe-6, Phe-17, and Phe-27 of LL-37, as well as arginines, showed intermolecular NOE cross-peaks with D8PG, providing direct evidence for the association of the entire amphipathic helix with anionic lipid micelles. The structure of LL-37 serves as a model for understanding the structure and function relationship of homologous primate cathelicidins. Using synthetic peptides, we also identified the smallest antibacterial peptide KR-12 corresponding to residues 18-29 of LL-37. Importantly, KR-12 displayed a selective toxic effect on bacteria but not human cells. NMR structural analysis revealed a short three-turn amphipathic helix rich in positively charged side chains, allowing for effective competition for anionic phosphatidylglycerols in bacterial membranes. KR-12 may be a useful peptide template for developing novel antimicrobial agents of therapeutic use.	[Wang, Guangshun] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Wang, GS (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, Rm EC13018,986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	gwang@unmc.edu			Nebraska Research Initiative (NRI)	Nebraska Research Initiative (NRI)	This work was supported in part by the Nebraska Research Initiative (NRI) ( to G. W.).	BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Epand RF, 2008, J MOL BIOL, V379, P38, DOI 10.1016/j.jmb.2008.03.047; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hong IP, 2007, BIOTECHNOL LETT, V29, P73, DOI 10.1007/s10529-006-9202-8; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Li X, 2008, AMINO ACIDS, V35, P531, DOI 10.1007/s00726-008-0079-9; Li YF, 2006, PROTEIN EXPRES PURIF, V47, P498, DOI 10.1016/j.pep.2005.10.022; Li YF, 2007, PROTEIN EXPRES PURIF, V54, P157, DOI 10.1016/j.pep.2007.02.003; Lia X, 2003, J BIOMOL NMR, V27, P401; Moon JY, 2006, BBA-BIOMEMBRANES, V1758, P1351, DOI 10.1016/j.bbamem.2006.02.003; Nell MJ, 2006, PEPTIDES, V27, P649, DOI 10.1016/j.peptides.2005.09.016; Neville F, 2006, BIOPHYS J, V90, P1275, DOI 10.1529/biophysj.105.067595; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Sambhara S, 2007, EXPERT REV ANTI-INFE, V5, P1, DOI 10.1586/14787210.5.1.1; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sigurdardottir T, 2006, ANTIMICROB AGENTS CH, V50, P2983, DOI 10.1128/AAC.01583-05; Wang G., 2008, OPEN MAGN RESON J, V1, P9; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Wang GS, 1996, BBA-LIPID LIPID MET, V1301, P174, DOI 10.1016/0005-2760(96)00037-9; Wang GS, 2005, J BIOL CHEM, V280, P5803, DOI 10.1074/jbc.M410116200; Wang GS, 2003, PROTEIN SCI, V12, P1087, DOI 10.1110/ps.0301503; Wang GS, 2008, ANTIMICROB AGENTS CH, V52, P3438, DOI 10.1128/AAC.00452-08; Wang GS, 2007, BBA-BIOMEMBRANES, V1768, P3271, DOI 10.1016/j.bbamem.2007.08.005; Wang GS, 2007, PROTEIN PEPTIDE LETT, V14, P57, DOI 10.2174/092986607779117182; Wang H, 2008, AMYOTROPH LATERAL SC, V9, P50, DOI 10.1080/17482960701791234; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, J BIOL CHEM, V281, P19861, DOI 10.1074/jbc.M511108200	47	310	328	3	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32637	32643		10.1074/jbc.M805533200	http://dx.doi.org/10.1074/jbc.M805533200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818205	hybrid			2022-12-25	WOS:000260893700053
J	Abouzahr-Rifai, S; Hasmim, M; Boukerche, H; Hamelin, J; Janji, B; Jalil, A; Kieda, C; Mami-Chouaib, F; Bertoglio, J; Chouaib, S				Abouzahr-Rifai, Soraya; Hasmim, Meriem; Boukerche, Habib; Hamelin, Jocelyne; Janji, Bassam; Jalil, Abdelali; Kieda, Claudine; Mami-Chouaib, Fathia; Bertoglio, Jacques; Chouaib, Salem			Resistance of Tumor Cells to Cytolytic T Lymphocytes Involves Rho-GTPases and Focal Adhesion Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; STRESS FIBERS; FACTOR-I; ACTIN; EXPRESSION; PROTEINS; BINDING; IMMUNOSURVEILLANCE; IDENTIFICATION; LOCALIZATION	Tumor cells evade adaptive immunity by a variety of mechanisms, including selection of variants that are resistant to specific cytotoxic T lymphocyte (CTL) pressure. Recently, we have reported that the reorganization of the actin cytoskeleton can be used by tumor cells as a strategy to promote their resistance to CTL-mediated lysis. In this study, we further examined the functional features of a CTL-resistant tumor variant and investigated the relationship between cytoskeleton alteration, the acquisition of tumor resistance to CTL-induced cell death, Rho-GTPases, and focal adhesion kinase (FAK) pathways. Our data indicate that although the resistant cells do not display an increased migratory potential, an alteration of adhesion to the extracellular matrix was observed. When Rho-GTPases were activated in cells by the bacterial CNF1 (cytotoxic necrotizing factor 1), striking changes in the cell morphology, including actin cytoskeleton, focal adhesions, and membrane extensions, were observed. More importantly, such activation also resulted in a significant attenuation of resistance to CTL-induced cell death. Furthermore, we demonstrate that FAK signaling pathways were constitutively defective in the resistant cells. Silencing of FAK in the sensitive target cells resulted in the inhibition of immune synapse formation with specific CTLs and their subsequent lysis. Expression of the FAK mutant (Y397F) resulted in an inhibition of IGR-Heu cell adhesion and of their susceptibility to specific lysis. These results suggest that FAK activation plays a role in the control of tumor cell susceptibility to CTL-mediated lysis.	[Abouzahr-Rifai, Soraya; Hasmim, Meriem; Jalil, Abdelali; Mami-Chouaib, Fathia; Chouaib, Salem] Inst Gustave Roussy, INSERM, U753, F-94800 Villejuif, France; [Boukerche, Habib] Univ Lyon 1, INSERM, Lab Hemobiol, EA 4174, F-69372 Lyon, France; [Hamelin, Jocelyne; Bertoglio, Jacques] INSERM, U749, F-92296 Chatenay Malabry, France; [Kieda, Claudine] Ctr Biophys Mol, F-45071 Orleans, France; [Janji, Bassam] Publ Res Ctr Hlth, Lab Expt Hematocancerol, L-1526 Luxembourg, Luxembourg	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chouaib, S (corresponding author), Inst Gustave Roussy, INSERM, U753, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	chouaib@igr.fr	Chouaib, Salem/F-7939-2016; Mami-Chouaib, Fathia/E-5267-2016; HAMELIN, Jocelyne JH/R-4590-2018; Kieda, Claudine/U-1361-2019	HAMELIN, Jocelyne JH/0000-0003-4222-0792; JANJI, Bassam/0000-0002-9763-0943; JALIL, Abdelali/0000-0003-2710-8735; Hasmim, Meriem/0000-0002-7920-2443	INSERM; Association pour la Recherche Contre le Cancer [4744, 3501, 3922]; Canceropole Ile-de-France; Institut National du Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from INSERM, Association pour la Recherche Contre le Cancer Grants 4744, 3501, and 3922, by the Canceropole Ile-de-France, and by the Institut National du Cancer. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this work.	Abouzahr S, 2006, P NATL ACAD SCI USA, V103, P1428, DOI 10.1073/pnas.0510454103; Asselin-Paturel C, 2001, CANCER-AM CANCER SOC, V91, P113, DOI 10.1002/1097-0142(20010101)91:1<113::AID-CNCR15>3.0.CO;2-7; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Chouaib S, 1997, IMMUNOL TODAY, V18, P493, DOI 10.1016/S0167-5699(97)01115-8; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Echchakir H, 1999, INT J CANCER, V81, P205, DOI 10.1002/(SICI)1097-0215(19990412)81:2<205::AID-IJC7>3.0.CO;2-M; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Gabriel B, 2006, CLIN CANCER RES, V12, P2476, DOI 10.1158/1078-0432.CCR-05-1867; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; KRAMER RH, 1989, J BIOL CHEM, V264, P4684; Lacerda HM, 1997, J BIOL CHEM, V272, P9587; LANG P, 1993, BIOCHEM BIOPH RES CO, V196, P1522, DOI 10.1006/bbrc.1993.2424; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Madan R, 2006, HUM PATHOL, V37, P9, DOI 10.1016/j.humpath.2005.09.024; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meslin F, 2007, CANCER RES, V67, P10910, DOI 10.1158/0008-5472.CAN-07-0512; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ohta R, 2006, ONCOLOGY-BASEL, V71, P417, DOI 10.1159/000107109; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Verrills NM, 2006, J NATL CANCER I, V98, P1363, DOI 10.1093/jnci/djj372; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Yasuda M, 2001, CANCER RES, V61, P2022	47	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31665	31672		10.1074/jbc.M800078200	http://dx.doi.org/10.1074/jbc.M800078200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779334	hybrid			2022-12-25	WOS:000260760800048
J	Tripathi, M; Nandana, S; Yamashita, H; Ganesan, R; Kirchhofer, D; Quaranta, V				Tripathi, Manisha; Nandana, Srinivas; Yamashita, Hironobu; Ganesan, Rajkumar; Kirchhofer, Daniel; Quaranta, Vito			Laminin-332 Is a Substrate for Hepsin, a Protease Associated with Prostate Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; TUMOR-SUPPRESSOR GENES; EXTRACELLULAR-MATRIX; CELL-MIGRATION; SERINE-PROTEASE; BETA-3 CHAIN; VII COLLAGEN; CARCINOMA-CELLS; NC1 DOMAIN; EXPRESSION	Hepsin, a cell surface protease, is widely reported to be over-expressed in more than 90% of human prostate tumors. Hepsin expression correlates with tumor progression, making it a significant marker and target for prostate cancer. Recently, it was reported that in a prostate cancer mouse model, hepsin up-regulation in tumor tissue promotes progression and metastasis. The underlying mechanisms, however, remain largely uncharacterized. Hepsin transgenic mice displayed reduced laminin-332 (Ln-332) expression in prostate tumors. This is an intriguing cue, since proteolytic processing of extracellular matrix macromolecules, such as Ln-332, is believed to be involved in cancer progression, and Ln-332 expression is lost during human prostate cancer progression. In this study, we provide the first direct evidence that hepsin cleaves Ln-332. Cleavage is specific, since it is both inhibited in a dose-dependent manner by a hepsin inhibitor (Kunitz domain-1) and does not occur when catalytically inactive hepsin is used. By Western blotting and mass spectrometry, we determined that hepsin cleaves the beta 3 chain of Ln-332. N-terminal sequencing identified the cleavage site at beta 3 Arg(245), in a sequence context (SQLR(245) down arrow LQGSCFC) conserved among species and in remarkable agreement with reported consensus target sequences for hepsin activity. In vitro cell migration assays showed that hepsin-cleaved Ln-332 enhanced motility of DU145 prostate cancer cells, which was inhibited by Kunitz domain-1. Further, hepsin-overexpressing LNCaP prostate cancer cells also exhibited increased migration on Ln-332. Direct cleavage of Ln-332 may be one mechanism by which hepsin promotes prostate tumor progression and metastasis, possibly by up-regulating prostate cancer cell motility.	[Tripathi, Manisha; Nandana, Srinivas; Yamashita, Hironobu; Quaranta, Vito] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Ganesan, Rajkumar; Kirchhofer, Daniel] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Vanderbilt University; Roche Holding; Genentech	Quaranta, V (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 771 Preston Res Bldg,2220 Pierce Ave, Nashville, TN 37232 USA.	vito.quaranta@vanderbilt.edu	Quaranta, Vito/G-6512-2016; Ganesan, Rajkumar/B-1093-2008	Quaranta, Vito/0000-0001-7491-8672; Ganesan, Rajkumar/0000-0002-3431-9664; Yamashita, Hironobu/0000-0003-2587-7100	National Institutes of Health [CA47858-17A2, GM067221-03]; NATIONAL CANCER INSTITUTE [R01CA047858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA47858-17A2 and GM067221-03 (to V. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bair EL, 2005, NEOPLASIA, V7, P380, DOI 10.1593/neo.04619; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Brittingham R, 2006, BIOCHEM BIOPH RES CO, V343, P692, DOI 10.1016/j.bbrc.2006.03.034; Calaluce R, 2006, PROSTATE, V66, P1381, DOI 10.1002/pros.20393; Chen M, 1999, J INVEST DERMATOL, V112, P177, DOI 10.1046/j.1523-1747.1999.00491.x; Chen ZX, 2003, J UROLOGY, V169, P1316, DOI 10.1097/01.ju.0000050648.40164.0d; Davis TL, 2001, PROSTATE, V46, P240; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Falk-Marzillier J, 1998, BIOCHEM BIOPH RES CO, V251, P49, DOI 10.1006/bbrc.1998.9400; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Halvorsen OJ, 2005, INT J ONCOL, V26, P329; Hao JS, 2001, AM J PATHOL, V158, P1129, DOI 10.1016/S0002-9440(10)64060-6; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jenkins RB, 1997, CANCER RES, V57, P524; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; KAZAMA Y, 1995, J BIOL CHEM, V270, P66, DOI 10.1074/jbc.270.1.66; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Koshikawa N, 2003, FASEB J, V17, P364, DOI 10.1096/fj.03-0584fje; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; LI W, 2007, AM ASS CAN RES ANN M; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Luo J, 2001, CANCER RES, V61, P4683; MacGrogan D, 1997, SEMIN CANCER BIOL, V8, P11, DOI 10.1006/scbi.1997.0048; Magee JA, 2001, CANCER RES, V61, P5692; Meneguzzi G, 1992, Exp Dermatol, V1, P221, DOI 10.1111/j.1600-0625.1992.tb00080.x; Moran P, 2006, J BIOL CHEM, V281, P30439, DOI 10.1074/jbc.M605440200; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mydel P, 2008, J BIOL CHEM, V283, P9513, DOI 10.1074/jbc.M706239200; Nagle RB, 2004, J CELL BIOCHEM, V91, P36, DOI 10.1002/jcb.10692; NAGLE RB, 1995, AM J PATHOL, V146, P1498; Nakashima Y, 2005, J BIOCHEM, V138, P539, DOI 10.1093/jb/mvi153; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Noel A, 1997, INVAS METAST, V17, P221; Ortiz-Urda S, 2005, SCIENCE, V307, P1773, DOI 10.1126/science.1106209; Pirila E, 2003, BIOCHEM BIOPH RES CO, V303, P1012, DOI 10.1016/S0006-291X(03)00452-2; Plopper G, 1996, J CELL SCI, V109, P1965; Quaranta V, 2003, TUMORI J, V89, P343, DOI 10.1177/030089160308900401; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Ryan MC, 1996, MATRIX BIOL, V15, P369, DOI 10.1016/S0945-053X(96)90157-2; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5; Stephan C, 2004, J UROLOGY, V171, P187, DOI 10.1097/01.ju.0000101622.74236.94; Turner DP, 2008, EXPERT REV ANTICANC, V8, P33, DOI 10.1586/14737140.8.1.33; Udayakumar TS, 2003, CANCER RES, V63, P2292; Vasioukhin V, 2004, CELL CYCLE, V3, P1394, DOI 10.4161/cc.3.11.1273; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Wang SI, 1998, CLIN CANCER RES, V4, P811; Waterman EA, 2007, CANCER RES, V67, P4264, DOI 10.1158/0008-5472.CAN-06-4141; Woodward JKL, 2007, BONE, V41, P912, DOI 10.1016/j.bone.2007.07.024; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P5052, DOI 10.2741/2447; Xuan JA, 2006, CANCER RES, V66, P3611, DOI 10.1158/0008-5472.CAN-05-2983; Yurchenco PD, 2004, CURR OPIN CELL BIOL, V16, P572, DOI 10.1016/j.ceb.2004.07.013; Zapatka M, 2007, ONCOGENE, V26, P1417, DOI 10.1038/sj.onc.1209918	66	72	91	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30576	30584		10.1074/jbc.M802312200	http://dx.doi.org/10.1074/jbc.M802312200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784072	Green Published, hybrid			2022-12-25	WOS:000260544800016
J	Jetz, W; Freckleton, RP; McKechnie, AE				Jetz, Walter; Freckleton, Robert P.; McKechnie, Andrew E.			Environment, Migratory Tendency, Phylogeny and Basal Metabolic Rate in Birds	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; PHENOTYPIC FLEXIBILITY; ENERGY-EXPENDITURE; BODY-COMPOSITION; SLOW PACE; ADAPTATION; ALLOMETRY; PRODUCTIVITY; TEMPERATURE; ADJUSTMENTS	Basal metabolic rate (BMR) represents the minimum maintenance energy requirement of an endotherm and has far-reaching consequences for interactions between animals and their environments. Avian BMR exhibits considerable variation that is independent of body mass. Some long-distance migrants have been found to exhibit particularly high BMR, traditionally interpreted as being related to the energetic demands of long-distance migration. Here we use a global dataset to evaluate differences in BMR between migrants and non-migrants, and to examine the effects of environmental variables. The BMR of migrant species is significantly higher than that of non-migrants. Intriguingly, while the elevated BMR of migrants on their breeding grounds may reflect the metabolic machinery required for long-distance movements, an alternative (and statistically stronger) explanation is their occupation of predominantly cold high-latitude breeding areas. Among several environmental predictors, average annual temperature has the strongest effect on BMR, with a 50% reduction associated with a 20 degrees C gradient. The negative effects of temperature variables on BMR hold separately for migrants and non-migrants and are not due their different climatic associations. BMR in migrants shows a much lower degree of phylogenetic inertia. Our findings indicate that migratory tendency need not necessarily be invoked to explain the higher BMR of migrants. A weaker phylogenetic signal observed in migrants supports the notion of strong phenotypic flexibility in this group which facilitates migration-related BMR adjustments that occur above and beyond environmental conditions. In contrast to the findings of previous analyses of mammalian BMR, primary productivity, aridity or precipitation variability do not appear to be important environmental correlates of avian BMR. The strong effects of temperature-related variables and varying phylogenetic effects reiterate the importance of addressing both broad-scale and individual-scale variation for understanding the determinants of BMR.	[Jetz, Walter] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Freckleton, Robert P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [McKechnie, Andrew E.] Univ Pretoria, Dept Zool & Entomol, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-0002 Pretoria, South Africa	University of California System; University of California San Diego; University of Sheffield; National Research Foundation - South Africa; University of Pretoria	Jetz, W (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wjetz@ucsd.edu	Freckleton, Rob P/B-6455-2013; McKechnie, Andrew E/E-4398-2010; Jetz, Walter/ABF-1517-2020	McKechnie, Andrew E/0000-0002-1524-1021; Jetz, Walter/0000-0002-1971-7277; Freckleton, Robert/0000-0002-8338-864X	Emmy Noether Program of the Deutsche Forschungsgesellschaft (DFG); National Science Foundation [BCS-0648733]; National Research Foundation; DST/NRF Centre of Excellence at the Percy FitzPatrick Institute; Royal Society University Research Fellow; University of Oxford [Astor Travel Grant]	Emmy Noether Program of the Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); National Research Foundation; DST/NRF Centre of Excellence at the Percy FitzPatrick Institute(Department of Science & Technology (India)); Royal Society University Research Fellow(Royal Society of London); University of Oxford	W.J. was funded by the Emmy Noether Program of the Deutsche Forschungsgesellschaft (DFG) and the National Science Foundation (grant BCS-0648733). A.E.M. received funding from the National Research Foundation and the DST/NRF Centre of Excellence at the Percy FitzPatrick Institute. RPF is a Royal Society University Research Fellow. The study was facilitated by an Astor Travel Grant from the University of Oxford to R.P.F. and W.J.	Ahn C-H, 1994, J JAPANESE SOC PHOTO, V33, P12, DOI DOI 10.4287/JSPRS.33.2_12; Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Battley PF, 2001, CONDOR, V103, P838, DOI 10.1650/0010-5422(2001)103[0838:BMRDDL]2.0.CO;2; Battley PF, 2001, PHYSIOL BIOCHEM ZOOL, V74, P435, DOI 10.1086/320432; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; Broggi J, 2005, EVOLUTION, V59, P1600; Chappell MA, 1999, J EXP BIOL, V202, P2269; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Dawson W.R., 2000, P343, DOI 10.1016/B978-012747605-6/50015-8; Dietz MW, 1999, J EXP BIOL, V202, P2831; Elgar MA, 1987, FUNCT ECOL, V1, P25, DOI 10.2307/2389354; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Jackson S, 1996, EVOLUTION, V50, P1638, DOI [10.2307/2410900, 10.1111/j.1558-5646.1996.tb03936.x]; KERSTEN M, 1987, ARDEA, V75, P175; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Klaassen M, 2004, COMP BIOCHEM PHYS A, V137, P639, DOI 10.1016/j.cbpb.2003.12.004; Kvist A, 2001, FUNCT ECOL, V15, P465, DOI 10.1046/j.0269-8463.2001.00549.x; Liknes ET, 2002, CONDOR, V104, P548, DOI 10.1650/0010-5422(2002)104[0548:SAITAG]2.0.CO;2; Lindstrom A, 2003, CONDOR, V105, P420, DOI 10.1650/7222; LINDSTROM A, 1995, P ROY SOC B-BIOL SCI, V261, P337, DOI 10.1098/rspb.1995.0156; Lindstrom A, 1997, J AVIAN BIOL, V28, P87, DOI 10.2307/3677098; Louw G.N., 1982, ECOLOGY DESERT ORGAN; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Maddocks TA, 2000, J ZOOL, V252, P327; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415; MCKECHNIE AE, 2008, J COMP PHYSL B; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; McKechnie AE, 2007, J EXP BIOL, V210, P97, DOI 10.1242/jeb.02615; MCNAB BK, 1963, ECOL MONOGR, V33, P63, DOI 10.2307/1948477; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PIERSMA T, 1995, J COMP PHYSIOL B, V165, P37, DOI 10.1007/BF00264684; Piersma T, 2002, INTEGR COMP BIOL, V42, P51, DOI 10.1093/icb/42.1.51; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Rezende EL, 2002, J EXP BIOL, V205, P101; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Schmidt-Nielsen K., 1990, ANIMAL PHYSL ADAPTAT; SWANSON DL, 1991, CONDOR, V93, P538, DOI 10.2307/1368185; Tieleman BI, 2003, P ROY SOC B-BIOL SCI, V270, P207, DOI 10.1098/rspb.2002.2205; Tieleman BI, 2000, PHYSIOL BIOCHEM ZOOL, V73, P461, DOI 10.1086/317740; Tieleman BI, 2003, ECOLOGY, V84, P1800, DOI 10.1890/0012-9658(2003)084[1800:PVOLAA]2.0.CO;2; Vezina F, 2003, INTEGR COMP BIOL, V43, P1040; WEATHERS WW, 1979, OECOLOGIA, V42, P81, DOI 10.1007/BF00347620; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P929, DOI 10.1086/425186; White CR, 2007, P ROY SOC B-BIOL SCI, V274, P287, DOI 10.1098/rspb.2006.3727; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; Wikelski M, 2003, P ROY SOC B-BIOL SCI, V270, P2383, DOI 10.1098/rspb.2003.2500; Williams JB, 2000, J EXP BIOL, V203, P3153; WITHERS PC, 1992, COMP ANIMAL PHYSL; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432	59	75	75	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2008	3	9							e3261	10.1371/journal.pone.0003261	http://dx.doi.org/10.1371/journal.pone.0003261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MA	18810267	gold, Green Published, Green Submitted			2022-12-25	WOS:000264431000003
J	Timmerman, SL; Pfingsten, JS; Kieft, JS; Krushel, LA				Timmerman, Stephanie L.; Pfingsten, Jennifer S.; Kieft, Jeffrey S.; Krushel, Les A.			The 5 ' Leader of the mRNA Encoding the Mouse Neurotrophin Receptor TrkB Contains Two Internal Ribosomal Entry Sites that Are Differentially Regulated	PLOS ONE			English	Article								A single internal ribosomal entry site (IRES) in conjunction with IRES transactivating factors (ITAFs) is sufficient to recruit the translational machinery to a eukaryotic mRNA independent of the cap structure. However, we demonstrate that the mouse TrkB mRNA contains two independent IRESes. The mouse TrkB mRNA consists of one of two 59 leaders (1428 nt and 448 nt), both of which include the common 39 exon (Ex2, 344 nt). Dicistronic RNA transfections and in vitro translation of monocistronic RNA demonstrated that both full-length 59 leaders, as well as Ex2, exhibit IRES activity indicating the IRES is located within Ex2. Additional analysis of the upstream sequences demonstrated that the first 260 nt of exon 1 (Ex1a) also contains an IRES. Dicistronic RNA transfections into SH-SY5Y cells showed the Ex1a IRES is constitutively active. However, the Ex2 IRES is only active in response to retinoic acid induced neural differentiation, a state which correlates with the synthesis of the ITAF polypyrimidine tract binding protein (PTB1). Correspondingly, addition or knock-down of PTB1 altered Ex2, but not Ex1a IRES activity in vitro and ex vivo, respectively. These results demonstrate that the two functionally independent IRESes within the mouse TrkB 59 leader are differentially regulated, in part by PTB1.	[Timmerman, Stephanie L.; Pfingsten, Jennifer S.; Kieft, Jeffrey S.; Krushel, Les A.] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Krushel, Les A.] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Timmerman, SL (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA.	Leslie.Krushel@uchsc.edu			NIH [AG028156]; NATIONAL INSTITUTE ON AGING [R01AG028156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH grant AG028156	AHMED S, 1995, J NEUROSCI, V15, P5765; Barettino D, 1999, BBA-GENE STRUCT EXPR, V1446, P24, DOI 10.1016/S0167-4781(99)00056-1; Bastide A, 2008, NUCLEIC ACIDS RES, V36, P2434, DOI 10.1093/nar/gkn093; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Dobson T, 2005, NUCLEIC ACIDS RES, V33, P2929, DOI 10.1093/nar/gki605; Dumas E, 2003, NUCLEIC ACIDS RES, V31, P1275, DOI 10.1093/nar/gkg199; Dyer JR, 2003, NAT NEUROSCI, V6, P219, DOI 10.1038/nn1018; Ferrer I, 1998, J COMP NEUROL, V394, P416; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kingsbury TJ, 2003, J BIOL CHEM, V278, P40744, DOI 10.1074/jbc.M303082200; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LUCARELLI E, 1995, J BIOL CHEM, V270, P24725, DOI 10.1074/jbc.270.42.24725; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Metsis M, 2001, CELL MOL LIFE SCI, V58, P1014, DOI 10.1007/PL00000916; Mitchell SA, 2005, GENE DEV, V19, P1556, DOI 10.1101/gad.339105; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Mitchell SA, 2001, MOL CELL BIOL, V21, P3364, DOI 10.1128/MCB.21.10.3364-3374.2001; Nanbru C, 2001, ONCOGENE, V20, P4270, DOI 10.1038/sj.onc.1204548; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; Perez I, 1997, RNA, V3, P764; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; SONENBERG N, 1981, J BIOL CHEM, V256, P4138; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoilov P, 2002, BIOCHEM BIOPH RES CO, V290, P1054, DOI 10.1006/bbrc.2001.6301; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Tosetti P, 1998, J NEUROPHYSIOL, V79, P648, DOI 10.1152/jn.1998.79.2.648; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Van Eden ME, 2004, RNA, V10, P469, DOI 10.1261/rna.5156804; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3	53	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3242	10.1371/journal.pone.0003242	http://dx.doi.org/10.1371/journal.pone.0003242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18779873	gold, Green Published, Green Submitted			2022-12-25	WOS:000264428600002
J	Allard, JS; Heilbronn, LK; Smith, C; Hunt, ND; Ingram, DK; Ravussin, E; de Cabo, R				Allard, Joanne S.; Heilbronn, Leonie K.; Smith, Carolina; Hunt, Nicole D.; Ingram, Donald K.; Ravussin, Eric; de Cabo, Rafael		Pennington CALERIE Team	In Vitro Cellular Adaptations of Indicators of Longevity in Response to Treatment with Serum Collected from Humans on Calorie Restricted Diets	PLOS ONE			English	Article								Calorie restriction (CR) produces several health benefits and increases lifespan in many species. Studies suggest that alternate-day fasting (ADF) and exercise can also provide these benefits. Whether CR results in lifespan extension in humans is not known and a direct investigation is not feasible. However, phenotypes observed in CR animals when compared to ad libitum fed (AL) animals, including increased stress resistance and changes in protein expression, can be simulated in cells cultured with media supplemented with blood serum from CR and AL animals. Two pilot studies were undertaken to examine the effects of ADF and CR on indicators of health and longevity in humans. In this study, we used sera collected from those studies to culture human hepatoma cells and assessed the effects on growth, stress resistance and gene expression. Cells cultured in serum collected at the end of the dieting period were compared to cells cultured in serum collected at baseline (before the dieting period). Cells cultured in serum from ADF participants, showed a 20% increase in Sirt1 protein which correlated with reduced triglyceride levels. ADF serum also induced a 9% decrease in proliferation and a 25% increase in heat resistance. Cells cultured in serum from CR participants induced an increase in Sirt1 protein levels by 17% and a 30% increase in PGC-1a mRNA levels. This first in vitro study utilizing human serum to examine effects on markers of health and longevity in cultured cells resulted in increased stress resistance and an up-regulation of genes proposed to be indicators of increased longevity. The use of this in vitro technique may be helpful for predicting the potential of CR, ADF and other dietary manipulations to affect markers of longevity in humans.	[Allard, Joanne S.; Smith, Carolina; Hunt, Nicole D.; Ingram, Donald K.; de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; [Heilbronn, Leonie K.; Ingram, Donald K.; Ravussin, Eric] Pennington Biomed Res Ctr, Baton Rouge, LA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Allard, JS (corresponding author), NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA.	decabora@grc.nia.nih.gov	de Cabo, Rafael/E-7996-2010; Heilbronn, Leonie K/H-1874-2013; Ravussin, Eric/N-1985-2017; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; Heilbronn, Leonie K/0000-0003-2106-7303; Ravussin, Eric/0000-0003-2129-547X; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442	Research Program of the NIH, National Institute on Aging [U01 AG20478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000368, U01AG020478] Funding Source: NIH RePORTER	Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging, and also in part by research grant U01 AG20478 from the National Institutes of Health.	ALBANES D, 1988, JNCI-J NATL CANCER I, V80, P772, DOI 10.1093/jnci/80.10.772; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; AUSTAD SN, 1989, EXP GERONTOL, V24, P83, DOI 10.1016/0531-5565(89)90037-5; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colom B, 2007, CARDIOVASC RES, V74, P456, DOI 10.1016/j.cardiores.2007.02.001; Corton JC, 2005, J GERONTOL A-BIOL, V60, P1494, DOI 10.1093/gerona/60.12.1494; de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gomez CR, 2006, MECH AGEING DEV, V127, P257, DOI 10.1016/j.mad.2005.10.002; GOODRICK CL, 1980, GERONTOLOGY, V26, P22, DOI 10.1159/000212390; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Heilbronn LK, 2005, OBES RES, V13, P574, DOI 10.1038/oby.2005.61; Heilbronn LK, 2005, AM J CLIN NUTR, V81, P69; HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Hisahara S, 2005, J PHARMACOL SCI, V98, P200, DOI 10.1254/jphs.FMJ05001X2; HOLLOSZY JO, 1988, J GERONTOL, V43, pB149, DOI 10.1093/geronj/43.6.B149; Ingram DK, 2006, BIOGERONTOLOGY, V7, P143, DOI 10.1007/s10522-006-9013-2; JAMES SJ, 1994, CANCER RES, V54, P5508; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lopez-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Masoro EJ, 2001, AGING-CLIN EXP RES, V13, P261; Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Mulligan JD, 2008, EXP GERONTOL, V43, P146, DOI 10.1016/j.exger.2007.10.011; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P865, DOI 10.1210/jc.2006-2184; RETZLAFF E, 1966, GERIATRICS, V21, P171; RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211; Willcox DC, 2006, BIOGERONTOLOGY, V7, P173, DOI 10.1007/s10522-006-9008-z; Wolkow CA, 2002, TRENDS NEUROSCI, V25, P212, DOI 10.1016/S0166-2236(02)02133-1; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	56	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3211	10.1371/journal.pone.0003211	http://dx.doi.org/10.1371/journal.pone.0003211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791640	Green Submitted, gold, Green Published			2022-12-25	WOS:000264427700006
J	Taylor, BS; Barretina, J; Socci, ND; DeCarolis, P; Ladanyi, M; Meyerson, M; Singer, S; Sander, C				Taylor, Barry S.; Barretina, Jordi; Socci, Nicholas D.; DeCarolis, Penelope; Ladanyi, Marc; Meyerson, Matthew; Singer, Samuel; Sander, Chris			Functional Copy-Number Alterations in Cancer	PLOS ONE			English	Article							RESOLUTION GENOMIC PROFILES; LUNG-CANCER; FINE-SCALE; ADIPOCYTE DIFFERENTIATION; HUMAN-BREAST; MUTATIONS; RECOMBINATION; AMPLIFICATION; ABERRATIONS; EXPRESSION	Understanding the molecular basis of cancer requires characterization of its genetic defects. DNA microarray technologies can provide detailed raw data about chromosomal aberrations in tumor samples. Computational analysis is needed (1) to deduce from raw array data actual amplification or deletion events for chromosomal fragments and (2) to distinguish causal chromosomal alterations from functionally neutral ones. We present a comprehensive computational approach, RAE, designed to robustly map chromosomal alterations in tumor samples and assess their functional importance in cancer. To demonstrate the methodology, we experimentally profile copy number changes in a clinically aggressive subtype of soft-tissue sarcoma, pleomorphic liposarcoma, and computationally derive a portrait of candidate oncogenic alterations and their target genes. Many affected genes are known to be involved in sarcomagenesis; others are novel, including mediators of adipocyte differentiation, and may include valuable therapeutic targets. Taken together, we present a statistically robust methodology applicable to high-resolution genomic data to assess the extent and function of copy-number alterations in cancer.	[Taylor, Barry S.; Socci, Nicholas D.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Taylor, Barry S.] Weill Cornell Grad Sch Med Sci, Dept Physiol & Biophys, New York, NY USA; [Barretina, Jordi; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Barretina, Jordi; Meyerson, Matthew] Massachusetts Inst Technol MIT, Broad Inst Harvard, Cambridge, MA USA; [DeCarolis, Penelope; Singer, Samuel] Memorial Sloan Kettering Canc Ctr, Sarcoma Biol Lab, Sarcoma Dis Management Program, New York, NY USA; [Ladanyi, Marc] Memorial Sloan Kettering Canc Ctr, Dept Pathol & Human Oncol, Pathogenesis Program, New York, NY USA; [Singer, Samuel] Memorial Sloan Kettering Canc Ctr, Dept Surg, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	copy-number@cbio.mskcc.org	Sander, Chris/H-1452-2011; Ladanyi, Marc/AAG-8585-2019; Meyerson, Matthew L/E-7123-2012; Barretina, Jordi/A-7192-2013	Sander, Chris/0000-0001-6059-6270; Singer, Samuel/0000-0001-9713-8230; Barretina, Jordi/0000-0002-3478-4080	The Soft Tissue Sarcoma Program Project [P01 CA047179]; The Sarcoma Genome Project; The Kristen Ann Carr Fund; NATIONAL CANCER INSTITUTE [P01CA047179] Funding Source: NIH RePORTER	The Soft Tissue Sarcoma Program Project; The Sarcoma Genome Project; The Kristen Ann Carr Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by: The Soft Tissue Sarcoma Program Project (P01 CA047179, S.S., N.D.S and C.S.), The Sarcoma Genome Project, and by The Kristen Ann Carr Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; COOP G, 2008, SCIENCE; Dalal KM, 2006, ANN SURG, V244, P381, DOI 10.1097/01.sla.0000234795.98607.00; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Emanuel BS, 2007, NAT REV GENET, V8, P869, DOI 10.1038/nrg2136; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fletcher CDM., 2002, WHO CLASSIFICATION T; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fritz B, 2002, CANCER RES, V62, P2993; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guttman M, 2007, PLOS GENET, V3, P1464, DOI 10.1371/journal.pgen.0030143; HAHN SA, 1995, CANCER RES, V55, P4670; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ida K, 1997, BLOOD, V90, P4699, DOI 10.1182/blood.V90.12.4699.4699_4699_4704; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; King AA, 2000, AM J MED GENET, V93, P388, DOI 10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#; LADANYI M, 2008, ENZINGER WEISSS SOFT; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lupski JR, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-242; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MACK TM, 1995, CANCER-AM CANCER SOC, V75, P211, DOI 10.1002/1097-0142(19950101)75:1+<211::AID-CNCR2820751309>3.0.CO;2-X; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; *NAT CANC I NHGRI, 2007, CANC GEN ATL; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rieker RJ, 2002, INT J CANCER, V99, P68, DOI 10.1002/ijc.10287; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rubin AF, 2007, SCIENCE, V317, DOI 10.1126/science.1138956; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shah SP, 2007, BIOINFORMATICS, V23, pI450, DOI 10.1093/bioinformatics/btm221; Singer S, 2007, CANCER RES, V67, P6626, DOI 10.1158/0008-5472.CAN-07-0584; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Strathdee G, 2002, SEMIN CANCER BIOL, V12, P373, DOI 10.1016/S1044-579X(02)00057-3; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tanaka K, 2006, DNA SEQUENCE, V17, P242, DOI 10.1080/10425170600805433; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; WEIR BA, 2007, NATURE; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wong FL, 1997, JAMA-J AM MED ASSOC, V278, P1262, DOI 10.1001/jama.278.15.1262; Wood LD, 2007, SCIENCE	62	120	127	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3179	10.1371/journal.pone.0003179	http://dx.doi.org/10.1371/journal.pone.0003179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784837	Green Published, gold, Green Submitted			2022-12-25	WOS:000264425900001
J	Kumarasamy, A; Abraham, EC				Kumarasamy, Anbarasu; Abraham, Edathara C.			Interaction of C-Terminal Truncated Human alpha A-Crystallins with Target Proteins	PLOS ONE			English	Article								Background: Significant portion of alpha A-crystallin in human lenses exists as C-terminal residues cleaved at residues 172, 168, and 162. Chaperone activity, determined with alcohol dehydrogenase (ADH) and beta L-crystallin as target proteins, was increased in alpha A(1-172) and decreased in alpha A(1-168) and alpha A(1-162). The purpose of this study was to show whether the absence of the C-terminal residues influences protein-protein interactions with target proteins. Methodology/Principal Findings: Our hypothesis is that the chaperone-target protein binding kinetics, otherwise termed subunit exchange rates, are expected to reflect the changes in chaperone activity. To study this, we have relied on fluorescence resonance energy transfer (FRET) utilizing amine specific and cysteine specific fluorescent probes. The subunit exchange rate (k) for ADH and alpha A(1-172) was nearly the same as that of ADH and alpha A-wt, alpha A(1-168) had lower and alpha A(1-162) had the lowest k values. When beta L-crystallin was used as the target protein, alpha A(1-172) had slightly higher k value than alpha A-wt and alpha A(1-168) and alpha(A1-162) had lower k values. As expected from earlier studies, the chaperone activity of alpha A(1-172) was slightly better than that of alpha A-wt, the chaperone activity of alpha A(1-168) was similar to that of alpha A-wt and alpha A(1-162) had substantially decreased chaperone activity. Conclusions/Significance: Cleavage of eleven C-terminal residues including Arg-163 and the C-terminal flexible arm significantly affects the interaction with target proteins. The predominantly hydrophilic flexible arm appears to be needed to keep the chaperone-target protein complex soluble.	[Kumarasamy, Anbarasu; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Kumarasamy, A (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ecabraham@uams.edu	Kumarasamy, Anbarasu/K-4703-2015	Kumarasamy, Anbarasu/0000-0002-1666-6742	National Institutes of Health [EY11352]; NATIONAL EYE INSTITUTE [R01EY011352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	EY11352 from the National Institutes of Health.	Aziz A, 2007, BIOCHEMISTRY-US, V46, P2510, DOI 10.1021/bi0618722; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; Colvis C, 2002, ARCH BIOCHEM BIOPHYS, V397, P319, DOI 10.1006/abbi.2001.2669; DEJONG WW, 1975, FEBS LETT, V58, P310, DOI 10.1016/0014-5793(75)80286-9; Ghahghaei A, 2007, BBA-PROTEINS PROTEOM, V1774, P102, DOI 10.1016/j.bbapap.2006.10.002; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Kallur LS, 2008, MOL CELL BIOCHEM, V308, P85, DOI 10.1007/s11010-007-9615-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Rajan S, 2006, BIOCHEMISTRY-US, V45, P15684, DOI 10.1021/bi060705z; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Schroff NP, 2001, MOL CELL BIOCHEM, V220, P127, DOI 10.1023/A:1010834107809; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; Takemoto LJ, 1998, EXP EYE RES, V66, P263, DOI 10.1006/exer.1997.0411; TAKEMOTO LJ, 1995, CURR EYE RES, V14, P837, DOI 10.3109/02713689508995806; Thampi P, 2002, INVEST OPHTH VIS SCI, V43, P3265; VANDEROU.FJ, 1974, EUR J BIOCHEM, V49, P157; VANDEROU.FJ, 1973, EUR J BIOCHEM, V39, P207; WANG KY, 1994, J BIOL CHEM, V269, P13601; WISTOW G, 1985, FEBS LETT, V181, P1, DOI 10.1016/0014-5793(85)81102-9	23	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3175	10.1371/journal.pone.0003175	http://dx.doi.org/10.1371/journal.pone.0003175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779867	Green Published, Green Submitted, gold			2022-12-25	WOS:000264425100011
J	Luca, F; Bubba, G; Basile, M; Brdicka, R; Michalodimitrakis, E; Rickards, O; Vershubsky, G; Quintana-Murci, L; Kozlov, AI; Novelletto, A				Luca, Francesca; Bubba, Giuseppina; Basile, Massimo; Brdicka, Radim; Michalodimitrakis, Emmanuel; Rickards, Olga; Vershubsky, Galina; Quintana-Murci, Lluis; Kozlov, Andrey I.; Novelletto, Andrea			Multiple Advantageous Amino Acid Variants in the NAT2 Gene in Human Populations	PLOS ONE			English	Article							ARYLAMINE N-ACETYLTRANSFERASES; SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; POSITIVE SELECTION; NATURAL-SELECTION; BALANCING SELECTION; FREQUENCY-SPECTRUM; STATISTICAL-METHOD; DNA POLYMORPHISM	Background: Genetic variation at NAT2 has been long recognized as the cause of differential ability to metabolize a wide variety of drugs of therapeutic use. Here, we explore the pattern of genetic variation in 12 human populations that significantly extend the geographic range and resolution of previous surveys, to test the hypothesis that different dietary regimens and lifestyles may explain inter-population differences in NAT2 variation. Methodology/Principal Findings: The entire coding region was resequenced in 98 subjects and six polymorphic positions were genotyped in 150 additional subjects. A single previously undescribed variant was found (34T>C; 12Y>H). Several aspects of the data do not fit the expectations of a neutral model, as assessed by coalescent simulations. Tajima's D is positive in all populations, indicating an excess of intermediate alleles. The level of between-population differentiation is low, and is mainly accounted for by the proportion of fast vs. slow acetylators. However, haplotype frequencies significantly differ across groups of populations with different subsistence. Conclusions/Significance: Data on the structure of haplotypes and their frequencies are compatible with a model in which slow-causing variants were present in widely dispersed populations before major shifts to pastoralism and/or agriculture. In this model, slow-causing mutations gained a selective advantage in populations shifting from hunting-gathering to pastoralism/agriculture. We suggest the diminished dietary availability of folates resulting from the nutritional shift, as the possible cause of the fitness increase associated to haplotypes carrying mutations that reduce enzymatic activity.	[Brdicka, Radim] Natl Inst Haematol & Blood Transfus, Prague, Czech Republic; [Michalodimitrakis, Emmanuel] Inst Mol Biol & Biotechnol, Iraklion, Greece; [Rickards, Olga; Novelletto, Andrea] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Vershubsky, Galina; Kozlov, Andrey I.] Arct An C Innovat Lab, Moscow, Russia; [Vershubsky, Galina] Russian Acad Educ, Inst Dev Physiol, Moscow, Russia; [Quintana-Murci, Lluis] Inst Pasteur, CNRS, URA 3012, UP Human Evolutionary Genet, Paris, France; [Luca, Francesca; Bubba, Giuseppina; Basile, Massimo; Novelletto, Andrea] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy	University of Rome Tor Vergata; Institute for Developmental Physiology, Russian Academy of Education; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Calabria	Luca, F (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	novelletto@bio.uniroma2.it	Rickards, Olga/L-7878-2015; Luca, Francesca/B-4850-2019; Kozlov, Andrew/Z-2925-2019; Quintana-Murci, Lluis/AAB-7468-2022	Rickards, Olga/0000-0003-2880-7466; Luca, Francesca/0000-0001-8252-9052; Vershubskaya, Galina/0000-0003-2452-1532; Novelletto, Andrea/0000-0002-1146-7680; Quintana-Murci, Lluis/0000-0003-2429-6320	PRIN-MIUR; RFBR [05-06-80427]; NATO [980469]	PRIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); RFBR(Russian Foundation for Basic Research (RFBR)); NATO(NATO (North Atlantic Treaty Organisation))	Work supported by grants PRIN-MIUR 2005 and 2007 to A.N. and RFBR 05-06-80427 to A.I.K. Russian samples were collected in the frame of an Italian-Russian scientific-technological project (3.RB3 to A.I.K.). A sampling campaign in Eastern Chukotka was supported by NATO Collaborative Linkage Grant Ref. 980469.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bakayev VV, 2004, EUR J CLIN PHARMACOL, V60, P467, DOI 10.1007/s00228-004-0799-z; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Boukouvala S, 2005, DRUG METAB REV, V37, P511, DOI 10.1080/03602530500251204; Bromley, 1988, PEOPLES WORLD; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CASCORBI I, 1995, AM J HUM GENET, V57, P581; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Currat M, 2006, SCIENCE, V313, P172, DOI 10.1126/science.1122712; De Stefano GF, 2002, ANN HUM BIOL, V29, P432, DOI 10.1080/03014460110101440; Deitz AC, 2000, CANCER EPIDEM BIOMAR, V9, P905; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; EXCOFFIER L, 1992, GENETICS, V131, P491; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAO WHO, 2002, REP JOINT FAO WHO EX; Fay JC, 2001, CURR OPIN GENET DEV, V11, P642, DOI 10.1016/S0959-437X(00)00247-1; FERNANDESCOSTA FJ, 1984, AM J CLIN NUTR, V40, P1295, DOI 10.1093/ajcn/40.6.1295; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuselli S, 2007, PHARMACOGENOMICS J, V7, P144, DOI 10.1038/sj.tpj.6500407; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Harding RM, 2004, CURR OPIN GENET DEV, V14, P667, DOI 10.1016/j.gde.2004.08.010; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Hein DW, 2006, ONCOGENE, V25, P1649, DOI 10.1038/sj.onc.1209374; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Husain A, 2007, DRUG METAB DISPOS, V35, P721, DOI 10.1124/dmd.106.014621; Jensen LE, 2006, HUM GENET, V120, P52, DOI 10.1007/s00439-006-0181-6; Kawamura A, 2005, BIOCHEM PHARMACOL, V69, P347, DOI 10.1016/j.bcp.2004.09.014; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Luca F, 2007, AM J PHYS ANTHROPOL, V132, P132, DOI 10.1002/ajpa.20500; Magalon H, 2008, EUR J HUM GENET, V16, P243, DOI 10.1038/sj.ejhg.5201963; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MINCHIN RF, 1995, BIOCHEM J, V307, P1; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Nielsen Rasmus, 2004, Human Genomics, V1, P218; Patin E, 2006, AM J HUM GENET, V78, P423, DOI 10.1086/500614; Patin E, 2006, HUM MUTAT, V27, P720, DOI 10.1002/humu.9438; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schierup MH, 2001, GENETICS, V159, P1833; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Sim E, 2000, HUM MOL GENET, V9, P2435, DOI 10.1093/hmg/9.16.2435; Sim E, 2003, BIOCHEM SOC T, V31, P615, DOI 10.1042/bst0310615; Sim E, 2007, EXPERT OPIN DRUG MET, V3, P169, DOI 10.1517/17425255.3.2.169; Soloway PD, 2006, NUTR REV, V64, pS52, DOI 10.1301/nr.2006.may.S52-S54; Solus JF, 2004, PHARMACOGENOMICS, V5, P895, DOI 10.1517/14622416.5.7.895; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wakeley J, 2001, AM J HUM GENET, V69, P1332, DOI 10.1086/324521; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; WEBER WW, 1985, PHARMACOL REV, V37, P25; WEBER WW, 1987, ACETYLATOR GENES DRU; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wong GKS, 2003, GENOME RES, V13, P1873, DOI 10.1101/gr.1324303; Word Health Organization, 2002, WHO LIB CAT IN PUBL; Zang Y, 2007, CARCINOGENESIS, V28, P1665, DOI 10.1093/carcin/bgm085	73	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3136	10.1371/journal.pone.0003136	http://dx.doi.org/10.1371/journal.pone.0003136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773084	Green Published, gold, Green Submitted			2022-12-25	WOS:000264420100002
J	Young, SL; Wilson, MJ; Miller, D; Hillier, S				Young, Sera L.; Wilson, M. Jeffrey; Miller, Dennis; Hillier, Stephen			Toward a Comprehensive Approach to the Collection and Analysis of Pica Substances, with Emphasis on Geophagic Materials	PLOS ONE			English	Review							RAY-DIFFRACTION PATTERNS; IRON-ABSORPTION; CELL-CULTURE; IN-VITRO; QUANTITATIVE INTERPRETATION; DECREASED BIOAVAILABILITY; EVOLUTIONARY PERSPECTIVE; SOIL CONSUMPTION; POTENTIAL IMPACT; DIETARY TOXINS	Background: Pica, the craving and subsequent consumption of non-food substances such as earth, charcoal, and raw starch, has been an enigma for more than 2000 years. Currently, there are little available data for testing major hypotheses about pica because of methodological limitations and lack of attention to the problem. Methodology: In this paper we critically review procedures and guidelines for interviews and sample collection that are appropriate for a wide variety of pica substances. In addition, we outline methodologies for the physical, mineralogical, and chemical characterization of these substances, with particular focus on geophagic soils and clays. Many of these methods are standard procedures in anthropological, soil, or nutritional sciences, but have rarely or never been applied to the study of pica. Principal Findings: Physical properties of geophagic materials including color, particle size distribution, consistency and dispersion/flocculation (coagulation) should be assessed by appropriate methods. Quantitative mineralogical analyses by Xray diffraction should be made on bulk material as well as on separated clay fractions, and the various clay minerals should be characterized by a variety of supplementary tests. Concentrations of minerals should be determined using X-ray fluorescence for non-food substances and inductively coupled plasma-atomic emission spectroscopy for food-like substances. pH, salt content, cation exchange capacity, organic carbon content and labile forms of iron oxide should also be determined. Finally, analyses relating to biological interactions are recommended, including determination of the bioavailability of nutrients and other bioactive components from pica substances, as well as their detoxification capacities and parasitological profiles. Significance: This is the first review of appropriate methodologies for the study of human pica. The comprehensive and multi-disciplinary approach to the collection and analysis of pica substances detailed here is a necessary preliminary step to understanding the nutritional enigma of non-food consumption.	[Young, Sera L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Young, Sera L.] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA; [Wilson, M. Jeffrey; Hillier, Stephen] Macaulay Land Use Res Inst, Soils Grp, Aberdeen AB9 2QJ, Scotland; [Miller, Dennis] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; James Hutton Institute; Cornell University	Young, SL (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	sera@younglucks.com	Hillier, Stephen/C-6555-2008	Hillier, Stephen/0000-0001-9652-9950; Young, Sera/0000-0002-1763-1218	Einaudi Center for International Studies at Cornell University; National Institutes of Health [5 T32 HD007331]; Macaulay Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007331] Funding Source: NIH RePORTER	Einaudi Center for International Studies at Cornell University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macaulay Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors gratefully acknowledge funding for this research from the Einaudi Center for International Studies at Cornell University, the National Institutes of Health (TG #5 T32 HD007331) and the Macaulay Institute. The funders had no role in the study whatsoever.	Abrahams PW, 2006, APPL GEOCHEM, V21, P98, DOI 10.1016/j.apgeochem.2005.09.015; Adams F., 1849, GENUINE WORKS HIPPOC; ALLEN A, 1985, GASTROEN CLIN BIOL, V9, P9; Anell B, 1958, GEOPHAGICAL CUSTOMS; [Anonymous], 1906, NATURE, V74, P543; [Anonymous], 2000, OXFORD ENGLISH DICT; ARCASOY A, 1978, ACTA HAEMATOL-BASEL, V60, P76, DOI 10.1159/000207700; BATESON EM, 1978, MED J AUSTRALIA, V1, P1; Benito P, 1998, NUTR RES, V18, P581, DOI 10.1016/S0271-5317(98)00044-X; Bernard HR, 2006, RES METHODS ANTHR QU, V4th; BITHONEY WG, 1985, AM J DIS CHILD, V139, P456, DOI 10.1001/archpedi.1985.02140070030023; BLACK DAK, 1956, LANCET, V271, P883; BLUM M, 1968, ANN INTERN MED, V68, P1165, DOI 10.7326/0003-4819-68-5-1165_1; Boyle J S, 1999, J Transcult Nurs, V10, P65, DOI 10.1177/104365969901000116; BROUILLARD MY, 1989, GASTROEN CLIN BIOL, V13, P18; BROUILLARD MY, 1988, ANN GASTROENT HEPATO, V24, P133; BROWN DD, 1976, NEW ENGL J MED, V295, P1034, DOI 10.1056/NEJM197611042951902; Brown G., 1980, CRYSTAL STRUCTURES C, V5, P439; Caius J. F., 1933, J BOMBAY NAT HIST SO, V37, P455; Chisholm J C Jr, 1981, J Natl Med Assoc, V73, P163; CHUNG FH, 1974, J APPL CRYSTALLOGR, V7, P526, DOI 10.1107/S0021889874010387; CHUNG FH, 1974, J APPL CRYSTALLOGR, V7, P519, DOI 10.1107/S0021889874010375; CHURCHMAN GJ, 1984, CLAY CLAY MINER, V32, P241, DOI 10.1346/CCMN.1984.0320401; CLAPP JF, 1988, AM J OBSTET GYNECOL, V159, P1456, DOI 10.1016/0002-9378(88)90574-1; COOKSEY NR, 1995, BIRTH-ISS PERINAT C, V22, P129, DOI 10.1111/j.1523-536X.1995.tb00688.x; Cooney DO, 1997, INT J PRIMATOL, V18, P235, DOI 10.1023/A:1026324703410; Cotting J. R, 1836, S MED SURG J, V1, P288; DANFORD DE, 1982, ANNU REV NUTR, V2, P303, DOI 10.1146/annurev.nu.02.070182.001511; Day P.R., 1965, METHODS SOIL ANAL PA, V9, P545, DOI [10.2134/agronmonogr9.1.c43, DOI 10.2134/AGRONMONOGR9.1.C43]; DE CASTRO J., 1952, Geography of hunger; Diamond J, 1999, IBIS, V141, P181, DOI 10.1111/j.1474-919X.1999.tb07540.x; Dominy NJ, 2004, J EXP BIOL, V207, P319, DOI 10.1242/jeb.00758; DORNAI D, 1993, APPL ENVIRON MICROB, V59, P3123, DOI 10.1128/AEM.59.9.3123-3125.1993; EDWARDS AA, 1983, J NATL MED ASSOC, V75, P895; EDWARDS CECILE HOOVER, 1959, JOUR AMER DIETETIC ASSOC, V35, P810; EDWARDS CH, 1994, J NUTR, V124, pS954, DOI 10.1093/jn/124.suppl_6.954S; FERGUSON RB, 1984, SOIL SCI SOC AM J, V48, P578, DOI 10.2136/sssaj1984.03615995004800030022x; Fessler DMT, 2002, CURR ANTHROPOL, V43, P19, DOI 10.1086/324128; Flaxman SM, 2000, Q REV BIOL, V75, P113, DOI 10.1086/393377; FORMBY B, 1995, ENDOCRIN METAB CLIN, V24, P187, DOI 10.1016/S0889-8529(18)30059-8; FORSYTH CJ, 1989, DEVIANT BEHAV, V10, P61, DOI 10.1080/01639625.1989.9967801; FRATE DA, 1984, SCIENCES, V24, P34, DOI 10.1002/j.2326-1951.1984.tb02752.x; GARDINER KR, 1993, GUT, V34, P51, DOI 10.1136/gut.34.1.51; GARRETSON FD, 1967, P SOC EXP BIOL MED, V126, P304, DOI 10.3181/00379727-126-32431; Geissler PW, 1997, TROP MED INT HEALTH, V2, P624, DOI 10.1046/j.1365-3156.1997.d01-345.x; Geissler PW, 1999, SOC SCI MED, V48, P1069, DOI 10.1016/S0277-9536(98)00409-2; Geissler PW, 2000, AFRICA, V70, P653, DOI 10.3366/afr.2000.70.4.653; Gilardi JD, 1999, J CHEM ECOL, V25, P897, DOI 10.1023/A:1020857120217; GIUDICELLI J, 1992, ARCH FR PEDIATR, V49, P779; Glahn RP, 1998, J NUTR, V128, P1555, DOI 10.1093/jn/128.9.1555; Glickman LT, 1999, INT J EPIDEMIOL, V28, P169, DOI 10.1093/ije/28.1.169; Gonzalez R, 2004, BRIT J PHARMACOL, V141, P951, DOI 10.1038/sj.bjp.0705710; Goodman D, 2007, AM J TROP MED HYG, V76, P725, DOI 10.4269/ajtmh.2007.76.725; Grant W.H., 1962, CLAY CLAY MINER, V11, P65, DOI [10.1346/ccmn.1962.0110106, DOI 10.1346/CCMN.1962.0110106]; Grey G., 1841, J 2 EXPEDITIONS DISC; Grigsby RK, 1999, SOUTHERN MED J, V92, P190, DOI 10.1097/00007611-199902000-00005; HALSTED JA, 1968, AM J CLIN NUTR, V21, P1384, DOI 10.1093/ajcn/21.12.1384; Henry J, 2003, DEVIANT BEHAV, V24, P353, DOI 10.1080/713840222; Hertz H, 1947, SOC FORCES, V25, P343, DOI 10.2307/3005676; Hesse P. R., 1971, TXB SOIL CHEM ANAL; Hillier S, 1999, CLAY MINER, V34, P127, DOI 10.1180/claymin.1999.034.1.14; Hillier S, 2000, CLAY MINER, V35, P291, DOI 10.1180/000985500546666; Hooda PS, 2004, SCI TOTAL ENVIRON, V333, P75, DOI 10.1016/j.scitotenv.2004.04.023; Hooda PS, 2002, ENVIRON GEOCHEM HLTH, V24, P305, DOI 10.1023/A:1020542810334; Houston DC, 2001, MAMMAL REV, V31, P249, DOI 10.1046/j.1365-2907.2001.00091.x; HOWARD L, 1993, NUTR RES, V13, P287, DOI 10.1016/S0271-5317(05)80425-7; Hui YH, 2001, FOODBORNE DIS HDB, V1; HUNTER JM, 1984, GEOGR REV, V74, P157, DOI 10.2307/214097; HUNTER JM, 1989, NATL GEOGR RES, V5, P281; HUNTER JM, 1973, GEOGR REV, V63, P170, DOI 10.2307/213410; Hunter JM, 1993, J CULT GEOGR, V14, P69, DOI [10.1080/08873639309478381, DOI 10.1080/08873639309478381]; JOHNS T, 1991, AM J CLIN NUTR, V53, P448, DOI 10.1093/ajcn/53.2.448; JOHNS T, 1991, ECOL FOOD NUTR, V25, P221, DOI 10.1080/03670244.1991.9991170; JOHNS T, 1986, J CHEM ECOL, V12, P635, DOI 10.1007/BF01012098; KEITH D, 1975, MT SINAI J MED, V42, P410; KEITH L, 1971, EXPERIENTIA, V27, P847, DOI 10.1007/BF02136903; Kohnke H., 1968, SOIL PHYS; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Kraemer S, 2002, SOUTHERN MED J, V95, P1228, DOI 10.1097/00007611-200210000-00030; LA BARRE Weston, 1948, AYMARA INDIANS LAKE; LAYMAN EM, 1963, PSYCHOL REC, V13, P249, DOI 10.1007/BF03393525; LEAKE BE, 1969, CHEM GEOL, V5, P7, DOI 10.1016/0009-2541(69)90002-3; LEONARD A, 1994, GASTROEN CLIN BIOL, V18, P609; LIPSON SM, 1983, APPL ENVIRON MICROB, V46, P673, DOI 10.1128/AEM.46.3.673-682.1983; Livingstone David, 1875, LAST J D LIVINGSTONE; LOTAN N, 1983, INT J ARTIF ORGANS, V6, P207; Luoba AI, 2004, T ROY SOC TROP MED H, V98, P734, DOI 10.1016/j.trstmh.2004.01.009; MacClancy J., 2007, CONSUMING INEDIBLE N, P17; Maekawa AA, 2006, J AGR FOOD CHEM, V54, P8362, DOI 10.1021/jf0615395; Mahaney WC, 2003, J CHEM ECOL, V29, P1503, DOI 10.1023/A:1024263627606; Mahaney WC, 2000, INT J ENVIRON HEAL R, V10, P93, DOI 10.1080/09603120050021100; MCELNAY JC, 1982, J TROP MED HYG, V85, P159; MCGINITY JW, 1975, J PHARM SCI, V64, P1566, DOI 10.1002/jps.2600640935; Miller D, 1998, FOOD CHEM LAB MANUAL; Miller D.D., 2003, FOOD ANAL, P401; MILLER DD, 1981, AM J CLIN NUTR, V34, P2248, DOI 10.1093/ajcn/34.10.2248; MINNICH V, 1968, AM J CLIN NUTR, V21, P78, DOI 10.1093/ajcn/21.1.78; MITCHELL D, 1976, PHYSIOL BEHAV, V17, P691, DOI 10.1016/0031-9384(76)90171-2; Moore D.M., 1997, XRAY DIFFRACTION IDE, Vsecond; MOORE KL, 1998, DEV HUMAN CLINICALLY; MORE J, 1987, HISTOCHEM J, V19, P665, DOI 10.1007/BF01676173; MOUSTAFA MA, 1987, INT J PHARM, V34, P207, DOI 10.1016/0378-5173(87)90181-5; NORRISH K, 1969, GEOCHIM COSMOCHIM AC, V33, P431, DOI 10.1016/0016-7037(69)90126-4; Ofoefule S I, 1999, Boll Chim Farm, V138, P239; OKONEK S, 1983, J TOXICOL-CLIN TOXIC, V19, P807, DOI 10.3109/15563658208992514; OLYNYK F, 1982, NEW ENGL J MED, V306, P1056, DOI 10.1056/NEJM198204293061719; OROURKE DE, 1967, OBSTET GYNECOL, V29, P581; PATTERSON EC, 1977, J NUTR, V107, P2020, DOI 10.1093/jn/107.11.2020; Peech M., 1965, METHODS SOIL ANAL, VVolume 9, P914, DOI DOI 10.2134/AGRONMONOGR9.2.C9; Prasad AS, 2001, NUTRITION, V17, P685, DOI 10.1016/S0899-9007(01)00598-6; PRATHER TA, 1992, J NUTR, V122, P327, DOI 10.1093/jn/122.2.327; Profet M, 1992, ADAPTED MIND EVOLUTI, P327; RATEAU JG, 1982, CURR MED RES OPIN, V8, P233, DOI 10.1185/03007998209109772; Reid R M, 1992, Med Anthropol, V13, P337; Richardson John, 1851, ARCTIC SEARCHING EXP; Schubert ML, 2007, CURR OPIN GASTROEN, V23, P595, DOI 10.1097/MOG.0b013e3282f03462; Schwertmann U., 1989, Minerals in Soil Environments, SSSA Book Series, no. 1., P379; Sherman PW, 2002, AM J OBSTET GYNECOL, V186, pS190, DOI 10.1067/mob.2002.122593; Simpson E, 2000, WESTERN J MED, V173, P20, DOI 10.1136/ewjm.173.1.20; SINGHI S, 1981, CLIN PEDIATR, V20, P783, DOI 10.1177/000992288102001205; Smith B, 1998, J GEOCHEM EXPLOR, V65, P1, DOI 10.1016/S0375-6742(98)00066-1; Smith B, 2000, J GEOL SOC LONDON, V157, P885, DOI 10.1144/jgs.157.4.885; SMITH JC, 1970, J NUTR, V100, P973, DOI 10.1093/jn/100.8.973; SMULIAN JC, 1995, SOUTH MED J, V88, P1236, DOI 10.1097/00007611-199512000-00010; TALKINGTON KM, 1970, AM J OBSTET GYNECOL, V108, P262, DOI 10.1016/0002-9378(70)90308-X; THOMAS FB, 1976, GASTROENTEROLOGY, V71, P1028; TSAKALA M, 1990, J PHARM BELG, V45, P268; VERMEER DE, 1971, ETHNOLOGY, V10, P56, DOI 10.2307/3772799; VERMEER DE, 1979, AM J CLIN NUTR, V32, P2129, DOI 10.1093/ajcn/32.10.2129; von Bonsdorff B, 1977, Br J Haematol, V35, P476, DOI 10.1111/j.1365-2141.1977.tb00611.x; WAI KN, 1966, J PHARM SCI, V55, P1215, DOI 10.1002/jps.2600551110; Ward P, 1999, J Ren Nutr, V9, P14, DOI 10.1016/S1051-2276(99)90017-1; Wiley AS, 1998, CURR ANTHROPOL, V39, P532; Wilson MJ, 2003, J CHEM ECOL, V29, P1525, DOI 10.1023/A:1024262411676; WONG MS, 1993, J TROP PEDIATRICS, V39, P318, DOI 10.1093/tropej/39.5.318; WONG MS, 1988, T ROY SOC TROP MED H, V82, P621, DOI 10.1016/0035-9203(88)90532-9; WOODS SC, 1970, SCIENCE, V169, P1334, DOI 10.1126/science.169.3952.1334; World Health Organisation, 1993, ICD 10 CLASS MENT BE; Yasuda K, 2006, J NUTR, V136, P3033, DOI 10.1093/jn/136.12.3033; YOUDIM MBH, 1977, BRIT J HAEMATOL, V36, P298, DOI 10.1111/j.1365-2141.1977.tb00651.x; Young SL, 2007, T ROY SOC TROP MED H, V101, P766, DOI 10.1016/j.trstmh.2007.04.016; Yun SM, 2004, J NUTR, V134, P2717, DOI 10.1093/jn/134.10.2717; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	170	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3147	10.1371/journal.pone.0003147	http://dx.doi.org/10.1371/journal.pone.0003147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422IE	18773081	Green Published, Green Submitted, gold			2022-12-25	WOS:000264420100005
J	Ivanova, IA; Nakrieko, KA; Dagnino, L				Ivanova, I. A.; Nakrieko, K-A; Dagnino, L.			Phosphorylation by p38 MAP kinase is required for E2F1 degradation and keratinocyte differentiation	ONCOGENE			English	Article						keratinocyte; E2F; differentiation; p38 mitogen-activated kinase	TRANSCRIPTION FACTORS; NUCLEAR IMPORT; SKIN; EXPRESSION; EXPORT; DYNAMICS; REPAIR	The transcription factor E2F1 plays key roles in skin homeostasis, and is essential for normal keratinocyte proliferation and epidermal regeneration after injury. We have previously established that, in differentiating keratinocytes, E2F1 activity is controlled by nuclear export and subsequent degradation. These events are triggered by differentiation-induced stimulation of protein kinase C and p38 mitogen-activated protein kinase ( MAPK). However, the mechanisms that induce E2F1 export from the nucleus and the role of p38 MAPK in this process are poorly understood. We now describe a novel regulatory pathway for E2F1, which involves phosphorylation by p38. We demonstrate that E2F1 forms complexes with active p38 through regions that exclude the N-terminus of this transcription factor, and that p38 activity is a major contributor to the phosphorylation status of E2F1 in keratinocytes. Using in vitro kinase assays, we identified Ser403 and Thr433 as the residues phosphorylated by p38. The biological significance of these observations is underscored by the inability of E2F1 mutants lacking one or both of these residues to be exported from the nucleus and degraded when keratinocytes receive differentiation stimuli, which results in impaired keratinocyte maturation.	[Ivanova, I. A.; Nakrieko, K-A; Dagnino, L.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Dagnino, L.] Univ Western Ontario, Regulatory Biol & Funct Genom Res Grp, Siebens Drake Res Inst, London, ON, Canada; [Ivanova, I. A.] Univ Western Ontario, Dept Paediat, Child Hlth Res Inst, London, ON, Canada; [Ivanova, I. A.] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Dagnino, L (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	ldagnino@uwo.ca		Dagnino, Lina/0000-0003-1483-5159				Apostolova MD, 2002, J BIOL CHEM, V277, P34471, DOI 10.1074/jbc.M205827200; Balasubramanian S, 1999, INT J ONCOL, V15, P387; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; D'Souza SJA, 2002, J BIOL CHEM, V277, P10626, DOI 10.1074/jbc.M111956200; D'Souza SJA, 2001, J BIOL CHEM, V276, P23531, DOI 10.1074/jbc.M100780200; Dagnino L, 1997, CELL GROWTH DIFFER, V8, P553; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; FAGAN R, 1994, CELL, V78, P799, DOI 10.1016/S0092-8674(94)90522-3; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 1994, Princess Takamatsu Symp, V24, P290; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Garcia-Alvarez G, 2007, BBA-MOL CELL RES, V1773, P375, DOI 10.1016/j.bbamcr.2006.09.015; Ivanova IA, 2007, ONCOGENE, V26, P1147, DOI 10.1038/sj.onc.1209894; Ivanova IA, 2006, ONCOGENE, V25, P430, DOI 10.1038/sj.onc.1208999; Ivanova IA, 2007, CELL CYCLE, V6, P2186, DOI 10.4161/cc.6.17.4650; McClellan KA, 2007, CELL CYCLE, V6, P2917, DOI 10.4161/cc.6.23.4997; Pierce AM, 1998, ONCOGENE, V16, P1267, DOI 10.1038/sj.onc.1201666; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vandel L, 1999, EMBO J, V18, P4280, DOI 10.1093/emboj/18.15.4280; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	22	24	24	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					52	62		10.1038/onc.2008.354	http://dx.doi.org/10.1038/onc.2008.354			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18794805				2022-12-25	WOS:000262294100006
J	Wykosky, J; Palma, E; Gibo, DM; Ringler, S; Turner, CP; Debinski, W				Wykosky, J.; Palma, E.; Gibo, D. M.; Ringler, S.; Turner, C. P.; Debinski, W.			Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor	ONCOGENE			English	Article						ephrinA1; EphA2; glioblastoma; monomer; soluble	ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE; IN-VITRO; PANCREATIC ADENOCARCINOMA; INDUCED ANGIOGENESIS; CRYSTAL-STRUCTURE; PROSTATE-CANCER; GLIOMA INVASION; ACTIVATION; EXPRESSION	The ephrinA1 ligand exerts antioncogenic effects in tumor cells through activation and downregulation of the EphA2 receptor and has been described as a membrane-anchored protein requiring clustering for function. However, while investigating the ephrinA1/EphA2 system in the pathobiology of glioblastoma multiforme (GBM), we uncovered that ephrinA1 is released from GBM and breast adenocarcinoma cells as a soluble, monomeric protein and is a functional form of the ligand in this state. Conditioned media containing a soluble monomer of ephrinA1 caused EphA2 internalization and downregulation, dramatic alteration of cell morphology and suppression of the Ras-MAPK pathway. Moreover, soluble monomeric ephrinA1 was functional in a physiological context, eliciting collapse of embryonic neuronal growth cones. We also found that ephrinA1 is cleaved from the plasma membrane of GBM cells, an event which involves the action of a metalloprotease. Thus, the ephrinA1 ligand can, indeed, function as a soluble monomer and may act in a paracrine manner on the EphA2 receptor without the need for juxtacrine interactions. These findings have important implications for further deciphering the function of these proteins in pathology and physiology, as well as for the design of ephrinA1-based EphA2-targeted antitumor therapeutics.	[Wykosky, J.; Palma, E.; Gibo, D. M.; Debinski, W.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Dept Neurosurg,Brain Tumor Ctr Excellence, Winston Salem, NC 27157 USA; [Palma, E.; Debinski, W.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Dept Radiat Oncol,Brain Tumor Ctr Excellence, Winston Salem, NC 27157 USA; [Ringler, S.; Turner, C. P.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Dept Neurobiol & Anat,Brain Tumor Ctr Excellence, Winston Salem, NC 27157 USA; [Debinski, W.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Dept Canc Biol,Brain Tumor Ctr Excellence, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Debinski, W (corresponding author), Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Dept Neurosurg,Brain Tumor Ctr Excellence, Med Ctr Blvd, Winston Salem, NC 27157 USA.	debinski@wfubmc.edu			NIH [1 F31 NSO5553301, 5 T32 CA113267-04]; NATIONAL CANCER INSTITUTE [T32CA113267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS055533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the NIH Grant 1 F31 NSO5553301 to JW, NIH Grant 5 T32 CA113267-04 to Dr Mike Robbins (EP) and Brain Tumor Center of Excellence at Wake Forest University School of Medicine. We thank Dr Hannah Caldas and Ms Amanda Beauchamp for help with real-time PCR and Ms Carla Lema-Tome for preparing cortical neurons.	Aasheim HC, 2000, BLOOD, V95, P221, DOI 10.1182/blood.V95.1.221.001k01_221_230; BECKMANN MP, 1994, EMBO J, V13, P3757, DOI 10.1002/j.1460-2075.1994.tb06685.x; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Carles-Kinch K, 2002, CANCER RES, V62, P2840; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Cheng N, 2002, MOL CANCER RES, V1, P2; Daniel TO, 1996, KIDNEY INT, V50, pS73; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DEBINSKI W, 1992, J CLIN INVEST, V90, P405, DOI 10.1172/JCI115875; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; HOLZMAN LB, 1990, MOL CELL BIOL, V10, P5830, DOI 10.1128/MCB.10.11.5830; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; McBride JL, 1998, MECH DEVELOP, V77, P201, DOI 10.1016/S0925-4773(98)00142-7; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Noblitt LW, 2004, CANCER GENE THER, V11, P757, DOI 10.1038/sj.cgt.7700761; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; SHAO HN, 1995, J BIOL CHEM, V270, P5636, DOI 10.1074/jbc.270.10.5636; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Sweeney P, 2002, CLIN CANCER RES, V8, P2714; Thaker PH, 2004, CLIN CANCER RES, V10, P5145, DOI 10.1158/1078-0432.CCR-03-0589; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Turner CP, 2002, EXP NEUROL, V178, P21, DOI 10.1006/exnr.2002.8027; VanMeter TE, 2001, J NEURO-ONCOL, V53, P213, DOI 10.1023/A:1012280925031; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Xu QL, 1997, J MOL MED-JMM, V75, P576, DOI 10.1007/s001090050142; Zelinski DP, 2001, CANCER RES, V61, P2301; Zeng GY, 2003, AM J PATHOL, V163, P2271, DOI 10.1016/S0002-9440(10)63584-5; Zhang A, 2006, ONCOL REP, V15, P831; Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.3.CO;2-N	57	88	108	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	58					7260	7273		10.1038/onc.2008.328	http://dx.doi.org/10.1038/onc.2008.328			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	382FI	18794797	Green Accepted			2022-12-25	WOS:000261590300004
J	Chan, DI; Stockner, T; Tieleman, DP; Vogel, HJ				Chan, David I.; Stockner, Thomas; Tieleman, D. Peter; Vogel, Hans J.			Molecular Dynamics Simulations of the Apo-, Holo-, and Acyl-forms of Escherichia coli Acyl Carrier Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MACROMOLECULAR STRUCTURES; BINDING; REVEAL; BIOSYNTHESIS; THIOESTERS; REDUCTASE; RESIDUES; PROGRAM; PACKAGE	Acyl carrier protein (ACP) is an essential co-factor protein in fatty acid biosynthesis that shuttles covalently bound fatty acyl intermediates in its hydrophobic pocket to various enzyme partners. To characterize acyl chain-ACP interactions and their influence on enzyme interactions, we performed 19 molecular dynamics(MD) simulations of Escherichia coli apo-, holo-, andacyl-ACPs. The simulations were started with the acyl chain in either a solvent-exposed or a buried conformation. All four short-chain(<= C10) and one long-chain (C16) unbiased acyl-ACP MD simulation show the transition of the solvent-exposed acyl chain into the hydrophobic pocket of ACP, revealing its pathway of acyl chain binding. Although the acyl chain resides inside the pocket, Thr-39 and Glu-60 at the entrance stabilize the phosphopantetheine linker through hydrogen bonding. Comparisons of the different ACP forms indicate that the loop region between helices II and III and the prosthetic linker may aid in substrate recognition by enzymes of fatty acid synthase systems. The MD simulations consistently show that the hydrophobic binding pocket of ACP is best suited to accommodate an octanoyl group and is capable of adjusting in size to accommodate chain lengths as long as decanoic acid. The simulations also reveal a second, novel binding mode of the acyl chains inside the hydrophobic binding pocket directed toward helix I. This study provides a detailed dynamic picture of acyl-ACPs that is in excellent agreement with available experimental data and, thereby, provides a new understanding of enzyme-ACP interactions.	[Chan, David I.; Stockner, Thomas; Tieleman, D. Peter; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca	Tieleman, D. Peter/A-4790-2011; Stockner, Thomas/A-9509-2014	Tieleman, D. Peter/0000-0001-5507-0688; Stockner, Thomas/0000-0002-7071-8283	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants from the Canadian Institute of Health Research ( to H. J. V. and D. P. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDREC M, 1995, PROTEIN SCI, V4, P983; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; CRONAN JE, 1982, J BIOL CHEM, V257, P5013; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Frisch M., 2016, GAUSSIAN 16 REVISION; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Kandt C, 2006, BIOCHEMISTRY-US, V45, P13284, DOI 10.1021/bi061280j; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; ROCK CO, 1979, J BIOL CHEM, V254, P7123; ROCK CO, 1982, J BIOL CHEM, V257, P10759; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Wright HT, 2007, CURR OPIN MICROBIOL, V10, P447, DOI 10.1016/j.mib.2007.07.001; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2004, J BIOL CHEM, V279, P50969, DOI 10.1074/jbc.M409607200; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	44	40	40	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33620	33629		10.1074/jbc.M805323200	http://dx.doi.org/10.1074/jbc.M805323200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18809688	Green Published, hybrid			2022-12-25	WOS:000261183700068
J	Feng, HZ; Chen, M; Weinstein, LS; Jin, JP				Feng, Han-Zhong; Chen, Min; Weinstein, Lee S.; Jin, Jian-Ping			Removal of the N-terminal Extension of Cardiac Troponin I as a Functional Compensation for Impaired Myocardial beta-Adrenergic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE HEART; PHOSPHORYLATION; RECEPTOR; MYOSIN; PROTEIN; TRUNCATION; EXPRESSION; RESPONSES; FAILURE; PHOSPHOLAMBAN	Although beta-adrenergic stimuli are essential for myocardial contractility, beta-blockers have a proven beneficial effect on the treatment of heart failure, but the mechanism is not fully understood. The stimulatory G protein alpha-subunit (G(s)alpha) couples the beta-adrenoreceptor to adenylyl cyclase and the intracellular cAMP response. In a mouse model of conditional G(s)alpha deficiency in the cardiac muscle (G(s)alpha-DF), we demonstrated heart failure phenotypes accompanied by increases in the level of a truncated cardiac troponin I (cTnI-ND) from restricted removal of the cTnI-specific N-terminal extension. To investigate the functional significance of the increase of cTnI-ND in G(s)alpha-DF cardiac muscle, we generated double transgenic mice to overexpress cTnI-ND in G(s)alpha-DF hearts. The overexpression of cTnI-ND in G(s)alpha-DF failing hearts increased relaxation velocity and left ventricular end diastolic volume to produce higher left ventricle maximum pressure and stroke volume. Supporting the hypothesis that up-regulation of cTnI-ND is a compensatory rather than a destructive myocardial response to impaired beta-adrenergic signaling, the aberrant expression of beta-myosin heavy chain in adult G(s)alpha-DF but not control mouse hearts was reversed by cTnI overexpression. These data indicate that the up-regulation of cTnI-ND may partially compensate for the cardiac inefficiency in impaired beta-adrenergic signaling.	[Feng, Han-Zhong; Jin, Jian-Ping] Evanston NW Healthcare & NW Univ, Sect Mol Cardiol, Feinberg Sch Med, Evanston, IL 60201 USA; [Chen, Min; Weinstein, Lee S.] NIDDK, Signal Transduct Sect, Metab Dis Branch, NIH, Bethesda, MD 20892 USA	Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Jin, JP (corresponding author), Evanston NW Healthcare & NW Univ, Sect Mol Cardiol, Feinberg Sch Med, Evanston, IL 60201 USA.	jpjin@northwestern.edu	Jin, Jian-Ping/AAD-1149-2020; Weinstein, Lee S/I-5575-2015	Jin, JP/0000-0001-9932-1063; Weinstein, Lee/0000-0002-1899-5152	National Institutes of Health [HL-078773, AR-048816]; National Institutes of Health, NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-078773 and AR-048816 (to J.-P.J.) and by the Intramural Research Program of the National Institutes of Health, NIDDK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALPERT NR, 1983, MYOCARDIAL HYPERTROP, P619; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRISTOW MR, 1990, CIRCULATION, V82, P12; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; CAPPELLI V, 1989, CIRC RES, V65, P446, DOI 10.1161/01.RES.65.2.446; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; DILISA F, 1995, BIOCHEM J, V308, P57, DOI 10.1042/bj3080057; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Engelhardt Stefan, 2005, Heart Fail Clin, V1, P183, DOI 10.1016/j.hfc.2005.04.005; Feng HZ, 2008, J PHYSIOL-LONDON, V586, P3537, DOI 10.1113/jphysiol.2008.153577; Fitzsimons DP, 1998, J PHYSIOL-LONDON, V513, P171, DOI 10.1111/j.1469-7793.1998.171by.x; Gauthier NS, 1998, J MOL CELL CARDIOL, V30, P453, DOI 10.1006/jmcc.1997.0610; HARTZELL HC, 1984, J BIOL CHEM, V259, P5587; HOMCY CJ, 1991, ANNU REV PHYSIOL, V53, P137, DOI 10.1146/annurev.physiol.53.1.137; How OJ, 2005, AM J PHYSIOL-HEART C, V288, pH2979, DOI 10.1152/ajpheart.00084.2005; Hoyer K, 2007, J MOL CELL CARDIOL, V42, P214, DOI 10.1016/j.yjmcc.2006.08.116; Huang QQ, 2008, AM J PHYSIOL-CELL PH, V294, pC213, DOI 10.1152/ajpcell.00146.2007; JIN JP, 1990, HYBRIDOMA, V9, P597, DOI 10.1089/hyb.1990.9.597; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Kameyama T, 1998, CIRCULATION, V98, P2919, DOI 10.1161/01.CIR.98.25.2919; KATZ AM, 1973, CIRCULATION, V47, P1076, DOI 10.1161/01.CIR.47.5.1076; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; LOMPRE AM, 1981, DEV BIOL, V84, P286, DOI 10.1016/0012-1606(81)90396-1; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McConnell BK, 1998, AM J PHYSIOL-HEART C, V274, pH385, DOI 10.1152/ajpheart.1998.274.2.H385; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; RAPUNDALO ST, 1989, CIRC RES, V64, P104, DOI 10.1161/01.RES.64.1.104; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Sutherland FJ, 2003, CLIN EXP PHARMACOL P, V30, P879, DOI 10.1046/j.1440-1681.2003.03926.x; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; VANBUREN P, 1995, CIRC RES, V77, P439, DOI 10.1161/01.RES.77.2.439; Vatner SF, 2000, CIRC RES, V86, P502, DOI 10.1161/01.RES.86.5.502; Wang QD, 2002, ACTA PHYSIOL SCAND, V175, P279, DOI 10.1046/j.1365-201X.2002.01003.x; Wolska BM, 2002, CIRC RES, V90, P882, DOI 10.1161/01.RES.0000016962.36404.04; Yao A, 2003, CIRC J, V67, P83, DOI 10.1253/circj.67.83; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Yu ZB, 2007, AM J PHYSIOL-CELL PH, V292, pC1192, DOI 10.1152/ajpcell.00462.2006; Yurukova S, 2007, CARDIOVASC RES, V73, P678, DOI 10.1016/j.cardiores.2006.10.003; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773	51	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33384	33393		10.1074/jbc.M803302200	http://dx.doi.org/10.1074/jbc.M803302200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18815135	Green Published, hybrid			2022-12-25	WOS:000261183700043
J	Du, JX; Bialkowska, AB; McConnell, BB; Yang, VW				Du, James X.; Bialkowska, Agnieszka B.; McConnell, Beth B.; Yang, Vincent W.			SUMOylation Regulates Nuclear Localization of Kruppel-like Factor 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-FUNGAL ANTIBIOTICS; PLURIPOTENT STEM-CELLS; NUCLEOCYTOPLASMIC TRANSPORT; CELLULAR-TRANSFORMATION; SUMO-1 MODIFICATION; PROTEIN INHIBITOR; EXPORT SIGNALS; LEPTOMYCIN-B; P53 ACTIVITY; TRANSCRIPTION	SUMOylation is a form of post-translational modification shown to control nuclear transport. Kruppel-like factor 5 (KLF5) is an important mediator of cell proliferation and is primarily localized to the nucleus. Here we show that mouse KLF5 is SUMOylated at lysine residues 151 and 202. Mutation of these two lysines or two conserved nearby glutamates results in the loss of SUMOylation and increased cytoplasmic distribution of KLF5, suggesting that SUMOylation enhances nuclear localization of KLF5. Lysine 151 is adjacent to a nuclear export signal (NES) that resembles a consensus NES. The NES in KLF5 directs a fused green fluorescence protein to the cytoplasm, binds the nuclear export receptor CRM1, and is inhibited by leptomycin and site-directed mutagenesis. SUMOylation facilitates nuclear localization of KLF5 by inhibiting this NES activity, and enhances the ability of KLF5 to stimulate anchorage-independent growth of HCT116 colon cancer cells. A survey of proteins whose nuclear localization is regulated by SUMOylation reveals that SUMOylation sites are frequently located in close proximity to NESs. A relatively common mechanism for SUMOylation to regulate nucleocytoplasmic transport may lie in the interplay between neighboring NES and SUMOylation motifs.	[Du, James X.; Bialkowska, Agnieszka B.; McConnell, Beth B.; Yang, Vincent W.] Emory Univ, Sch Med, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA; [Yang, Vincent W.] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA	Emory University; Emory University	Yang, VW (corresponding author), 615 Michael St, Atlanta, GA 30322 USA.	vyang@emory.edu			National Institutes of Health [DK52230, DK64399, DK77381, CA84197]; NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK077381, R01DK052230, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52230, DK64399, DK77381, and CA84197. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Bialkowska A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-113; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen A, 2006, J CELL BIOCHEM, V98, P895, DOI 10.1002/jcb.20703; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; COX AD, 1994, METHOD ENZYMOL, V238, P277; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Guillemin I, 2005, PROTEOMICS, V5, P35, DOI 10.1002/pmic.200400892; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; HAMAMOTO T, 1983, J ANTIBIOT, V36, P639, DOI 10.7164/antibiotics.36.639; HAMAMOTO T, 1983, J ANTIBIOT, V36, P646, DOI 10.7164/antibiotics.36.646; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kindsmuller K, 2007, P NATL ACAD SCI USA, V104, P6684, DOI 10.1073/pnas.0702158104; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Miyauchi Y, 2002, J BIOL CHEM, V277, P50131, DOI 10.1074/jbc.M208319200; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Rosas-Acosta G, 2008, VIROLOGY, V373, P149, DOI 10.1016/j.virol.2007.12.017; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shields JM, 1997, J BIOL CHEM, V272, P18504, DOI 10.1074/jbc.272.29.18504; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Turpin P, 1999, FEBS LETT, V452, P82, DOI 10.1016/S0014-5793(99)00533-5; Vollert CS, 2004, MOL CELL PROTEOMICS, V3, P1053, DOI 10.1074/mcp.M400081-MCP200; Wilson VG, 2001, EXP CELL RES, V271, P57, DOI 10.1006/excr.2001.5366; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yaseen NR, 1999, P NATL ACAD SCI USA, V96, P5516, DOI 10.1073/pnas.96.10.5516; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005	67	69	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31991	32002		10.1074/jbc.M803612200	http://dx.doi.org/10.1074/jbc.M803612200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782761	hybrid, Green Published			2022-12-25	WOS:000260760800081
J	Finn, RD; McLaughlin, LA; Ronseaux, S; Rosewell, I; Houston, JB; Henderson, CJ; Wolf, CR				Finn, Robert D.; McLaughlin, Lesley A.; Ronseaux, Sebastien; Rosewell, Ian; Houston, J. Brian; Henderson, Colin J.; Wolf, C. Roland			Defining the in Vivo Role for Cytochrome b(5) in Cytochrome P450 Function through the Conditional Hepatic Deletion of Microsomal Cytochrome b(5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIVER-MICROSOMES; ELECTRON-TRANSFER; ESCHERICHIA-COLI; NADPH-CYTOCHROME-P450 REDUCTASE; NADPH-P450 REDUCTASE; HEME OXYGENASE; P450 REDUCTASE; RAT-LIVER; MOUSE; EXPRESSION	In vitro, cytochrome b(5) modulates the rate of cytochrome P450-dependent mono-oxygenation reactions. However, the role of this enzyme in determining drug pharmacokinetics in vivo and the consequential effects on drug absorption distribution, metabolism, excretion, and toxicity are unclear. In order to resolve this issue, we have carried out the conditional deletion of microsomal cytochrome b(5) in the liver to create the hepatic microsomal cytochrome b(5) null mouse. These mice develop and breed normally and have no overt phenotype. In vitro studies using a range of substrates for different P450 enzymes showed that in hepatic microsomal cytochrome b(5) null NADH-mediated metabolism was essentially abolished for most substrates, and the NADPH-dependent metabolism of many substrates was reduced by 50-90%. This reduction in metabolism was also reflected in the in vivo elimination profiles of several drugs, including midazolam, metoprolol, and tolbutamide. In the case of chlorzoxazone, elimination was essentially unchanged. For some drugs, the pharmacokinetics were also markedly altered; for example, when administered orally, the maximum plasma concentration for midazolam was increased by 2.5-fold, and the clearance decreased by 3.6-fold in hepatic microsomal cytochrome b(5) null mice. These data indicate that microsomal cytochrome b(5) can play a major role in the in vivo metabolism of certain drugs and chemicals but in a P450- and substrate-dependent manner.	[Finn, Robert D.; McLaughlin, Lesley A.; Ronseaux, Sebastien; Henderson, Colin J.; Wolf, C. Roland] Ninewells Hosp, Canc Res UK Mol Pharmacol Unit, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Finn, Robert D.; McLaughlin, Lesley A.; Ronseaux, Sebastien; Henderson, Colin J.; Wolf, C. Roland] Sch Med, Dundee DD1 9SY, Scotland; [Rosewell, Ian] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK Transgen Serv, Potters Bar EN6 3LD, Herts, England; [Houston, J. Brian] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England	University of Dundee; University of Dundee; University of Manchester	Wolf, CR (corresponding author), Ninewells Hosp, Canc Res UK Mol Pharmacol Unit, Biomed Res Inst, Level 5, Dundee DD1 9SY, Scotland.	c.r.wolf@dundee.ac.uk	Henderson, Colin/AAE-7141-2019; Henderson, Colin J/A-6347-2009	Henderson, Colin/0000-0002-4764-639X; Wolf, Charles Roland/0000-0002-6969-0113	Cancer Research UK Programme [C4639/A5661]	Cancer Research UK Programme(Cancer Research UK)	This work was supported by Cancer Research UK Programme Grant C4639/A5661 (to C. R. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altuve A, 2001, BIOCHEMISTRY-US, V40, P9469, DOI 10.1021/bi010636i; Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; AOYAMA T, 1990, P NATL ACAD SCI USA, V87, P5425, DOI 10.1073/pnas.87.14.5425; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8; Cannady EA, 2003, TOXICOL SCI, V73, P423, DOI 10.1093/toxsci/kfg077; Cooper MT, 2001, MUTAT RES-FUND MOL M, V484, P61, DOI 10.1016/S0027-5107(01)00236-6; Court MH, 1997, BIOPHARM DRUG DISPOS, V18, P213, DOI 10.1002/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO;2-0; DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; EBERHART DC, 1991, ARCH BIOCHEM BIOPHYS, V291, P231, DOI 10.1016/0003-9861(91)90128-6; Emoto C, 2007, XENOBIOTICA, V37, P986, DOI 10.1080/00498250701620692; FORRESTER LM, 1992, BIOCHEM J, V281, P359, DOI 10.1042/bj2810359; Goosen TC, 2001, J PHARMACOL EXP THER, V296, P198; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Guryev OL, 2001, BIOCHEMISTRY-US, V40, P5018, DOI 10.1021/bi002305w; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; Hlavica P, 2001, EUR J BIOCHEM, V268, P4817, DOI 10.1046/j.1432-1327.2001.02412.x; Li L, 2007, ARCH BIOCHEM BIOPHYS, V461, P76, DOI 10.1016/j.abb.2007.02.010; Lofgren S, 2004, XENOBIOTICA, V34, P811, DOI 10.1080/00498250412331285463; Loughran PA, 2001, ARCH BIOCHEM BIOPHYS, V385, P311, DOI 10.1006/abbi.2000.2136; Masubuchi Y, 1997, J PHARMACOL EXP THER, V282, P1435; McLaughlin LA, 2008, DRUG METAB DISPOS, V36, P1322, DOI 10.1124/dmd.108.021261; MEEHAN RR, 1988, BIOCHEM J, V254, P789, DOI 10.1042/bj2540789; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Mokashi V, 2003, ARCH BIOCHEM BIOPHYS, V412, P147, DOI 10.1016/S0003-9861(03)00040-7; NERURKAR PV, 1993, BIOCHEM PHARMACOL, V46, P933, DOI 10.1016/0006-2952(93)90504-P; Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Pritchard MP, 1998, PHARMACOGENETICS, V8, P33, DOI 10.1097/00008571-199802000-00005; Pritchard MP, 1997, ARCH BIOCHEM BIOPHYS, V345, P342, DOI 10.1006/abbi.1997.0265; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; SHET MS, 1995, ARCH BIOCHEM BIOPHYS, V318, P314, DOI 10.1006/abbi.1995.1235; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Strobel H W, 1978, Methods Enzymol, V52, P89; Ueng YF, 2002, DRUG METAB DISPOS, V30, P349, DOI 10.1124/dmd.30.3.349; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Voice MW, 1999, ARCH BIOCHEM BIOPHYS, V366, P116, DOI 10.1006/abbi.1999.1192; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200; Yang MX, 1995, ARCH BIOCHEM BIOPHYS, V324, P282, DOI 10.1006/abbi.1995.0041; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P11594, DOI 10.1021/bi034968u; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200	49	70	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31385	31393		10.1074/jbc.M803496200	http://dx.doi.org/10.1074/jbc.M803496200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18805792	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000260760800017
J	Krasel, C; Zabel, U; Lorenz, K; Reiner, S; Al-Sabah, S; Lohse, MJ				Krasel, Cornelius; Zabel, Ulrike; Lorenz, Kristina; Reiner, Susanne; Al-Sabah, Suleiman; Lohse, Martin J.			Dual Role of the beta(2)-Adrenergic Receptor C Terminus for the Binding of beta-Arrestin and Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-2-ADRENERGIC RECEPTOR; INTRACELLULAR DOMAINS; ALPHA(2)-ADRENERGIC RECEPTORS; PHOSPHORYLATION SITES; ADRENERGIC-RECEPTOR; OPIOID RECEPTORS; DESENSITIZATION; BETA-ARRESTIN2; SPECIFICITY	Homologous desensitization of beta(2)-adrenergic and other G-protein-coupled receptors is a two-step process. After phosphorylation of agonist-occupied receptors by G-protein-coupled receptor kinases, they bind beta-arrestins, which triggers desensitization and internalization of the receptors. Because it is not known which regions of the receptor are recognized by beta-arrestins, we have investigated beta-arrestin interaction and internalization of a set of mutants of the human beta(2)-adrenergic receptor. Mutation of the four serine/threonine residues between residues 355 and 364 led to the loss of agonist-induced receptor-beta-arrestin2 interaction as revealed by fluorescence resonance energy transfer (FRET), translocation of beta-arrestin2 to the plasma membrane, and receptor internalization. Mutation of all seven serine/threonine residues distal to residue 381 did not affect agonist-induced receptor internalization and beta-arrestin2 translocation. A beta(2)-adrenergic receptor truncated distal to residue 381 interacted normally with beta-arrestin2, whereas its ability to internalize in an agonist-dependent manner was compromised. A similar impairment of internalization was observed when only the last eight residues of the C terminus were deleted. Our experiments show that the C terminus distal to residue 381 does not affect the initial interaction between receptor and beta-arrestin, but its last eight amino acids facilitate receptor internalization in concert with beta-arrestin2.	[Krasel, Cornelius; Al-Sabah, Suleiman] Univ Reading, Sch Pharm, Reading RG6 6AJ, Berks, England; [Krasel, Cornelius; Zabel, Ulrike; Lorenz, Kristina; Reiner, Susanne; Lohse, Martin J.] Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany	University of Reading	Krasel, C (corresponding author), Univ Reading, Sch Pharm, POB 228, Reading RG6 6AJ, Berks, England.	c.krasel@reading.ac.uk	Krasel, Cornelius/AAH-7074-2019; Lohse, Martin J/A-7160-2012; Lorenz, Kristina/F-3522-2016	Lohse, Martin J/0000-0002-0599-3510; Krasel, Cornelius/0000-0001-8309-8696; Al-Sabah, Suleiman/0000-0002-9808-7866; Lorenz, Kristina/0000-0002-5747-2207	DFG [SFB487]; Fonds der Chemischen Industrie; Biotechnology and Biological Sciences Research Council [BB/D012902/1] Funding Source: researchfish; BBSRC [BB/D012902/1] Funding Source: UKRI	DFG(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by SFB487 "Regulatory Membrane Proteins," by a Leibniz grant from the DFG, and by the Fonds der Chemischen Industrie.	BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cen B, 2001, MOL PHARMACOL, V59, P758, DOI 10.1124/mol.59.4.758; Cen B, 2001, J NEUROCHEM, V76, P1887, DOI 10.1046/j.1471-4159.2001.00204.x; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Gabilondo AM, 1996, EUR J PHARMACOL, V307, P243, DOI 10.1016/0014-2999(96)00247-6; Gelber EI, 1999, J NEUROCHEM, V72, P2206, DOI 10.1046/j.1471-4159.1999.0722206.x; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; McDonald PH, 1999, J BIOL CHEM, V274, P10677, DOI 10.1074/jbc.274.16.10677; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu N, 2006, MOL PHARMACOL, V70, P249, DOI 10.1124/mol.105.018804; Zhang X, 2005, J NEUROCHEM, V95, P169, DOI 10.1111/j.1471-4159.2005.03352.x	35	37	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31840	31848		10.1074/jbc.M806086200	http://dx.doi.org/10.1074/jbc.M806086200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801735	hybrid			2022-12-25	WOS:000260760800067
J	Mayer, G; Poirier, S; Seidah, NG				Mayer, Gaetan; Poirier, Steve; Seidah, Nabil G.			Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PLASMINOGEN ACTIVATION; PROPROTEIN CONVERTASE PCSK9; CELL-SURFACE; LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; LIVER-REGENERATION; SECRETED PCSK9; II TETRAMER; MOUSE-LIVER; T-PA	The proprotein convertase subtilisin/kexin-type 9 (PCSK9), which promotes degradation of the hepatic low density lipoprotein receptor (LDLR), is now recognized as a major player in plasma cholesterol metabolism. Several gain-of-function mutations in PCSK9 cause hypercholesterolemia and premature atherosclerosis, and thus, inhibition of PCSK9-induced degradation of the LDLR may be used to treat this deadly disease. Herein, we discovered an endogenous PCSK9 binding partner by Far Western blotting, co-immunoprecipitation, and pull-down assays. Following two-dimensional gel electrophoresis and mass spectrometry analysis, we demonstrated that PCSK9 binds to a similar to 33-kDa protein identified as annexin A2 (AnxA2) but not to the closely related annexin A1. Furthermore, our functional LDLR assays and small hairpin RNA studies show that AnxA2 and the AnxA2.p11 complex could prevent PCSK9-directed LDLR degradation in HuH7, HepG2, and Chinese hamster ovary cells. Immunocytochemistry revealed that PCSK9 and AnxA2 co-localize at the cell surface, indicating a possible competition with the LDLR. Structure-function analyses demonstrated that the C-terminal cysteine-histidine-rich domain of PCSK9 interacts specifically with the N-terminal repeat R1 of AnxA2. Mutational analysis of this 70-amino acid-long repeat indicated that the RRTKK81 sequence of AnxA2 is implicated in this binding because its mutation to AATAA(81) prevents its interaction with PCSK9. To our knowledge, this work constitutes the first to show that PCSK9 activity on LDLR can be regulated by an endogenous inhibitor. The identification of the minimal inhibitory sequence of AnxA2 should pave the way toward the development of PCSK9 inhibitory lead molecules for the treatment of hypercholesterolemia.	[Mayer, Gaetan; Poirier, Steve; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research [MOP-36496, CTP-82946]; Canada Chair [201652]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Chair	This work was supported by Canadian Institutes of Health Research Grants MOP-36496 and CTP-82946 and Canada Chair 201652.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; CHUNG CY, 1994, J CELL BIOL, V126, P539, DOI 10.1083/jcb.126.2.539; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Kassam G, 1998, BIOCHEMISTRY-US, V37, P16958, DOI 10.1021/bi981713l; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; MA ASP, 1994, J CELL SCI, V107, P1973; Mai JX, 2000, BBA-PROTEIN STRUCT M, V1477, P215, DOI 10.1016/S0167-4838(99)00274-5; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Patchell BJ, 2007, AM J PHYSIOL-LUNG C, V293, pL354, DOI 10.1152/ajplung.00412.2006; Peterson AS, 2008, J LIPID RES, V49, P1152, DOI 10.1194/jlr.E800008-JLR200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Sagot I, 1997, FEBS LETT, V410, P229, DOI 10.1016/S0014-5793(97)00594-2; Satish L, 2006, WOUND REPAIR REGEN, V14, P463, DOI 10.1111/j.1743-6109.2006.00135.x; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Siever DA, 1997, INT J BIOCHEM CELL B, V29, P1219, DOI 10.1016/S1357-2725(97)00057-5; Stahlhut M, 2000, EXP CELL RES, V261, P111, DOI 10.1006/excr.2000.4960; THIEL C, 1992, J CELL SCI, V103, P733; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; YEATMAN TJ, 1993, CLIN EXP METASTAS, V11, P37, DOI 10.1007/BF00880064; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zibouche M, 2008, J BIOL CHEM, V283, P22121, DOI 10.1074/jbc.M801000200	52	117	128	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31791	31801		10.1074/jbc.M805971200	http://dx.doi.org/10.1074/jbc.M805971200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799458	hybrid			2022-12-25	WOS:000260760800062
J	Mckee, CJ; Kessl, JJ; Shkriabai, N; Dar, MJ; Engelman, A; Kvaratskhelia, M				McKee, Christopher J.; Kessl, Jacques J.; Shkriabai, Nikolozi; Dar, Mohd Jamal; Engelman, Alan; Kvaratskhelia, Mamuka			Dynamic Modulation of HIV-1 Integrase Structure and Function by Cellular Lens Epithelium-derived Growth Factor (LEDGF) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-BINDING-DOMAIN; IN-VITRO; TYPE-1 INTEGRASE; PREINTEGRATION COMPLEXES; ENZYMATIC-ACTIVITY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; TERMINAL DOMAINS; CDNA INTEGRATION	The mandatory integration of the reverse-transcribed HIV-1 genome into host chromatin is catalyzed by the viral protein integrase (IN), and IN activity can be regulated by numerous viral and cellular proteins. Among these, LEDGF has been identified as a cellular cofactor critical for effective HIV-1 integration. The x-ray crystal structure of the catalytic core domain (CCD) of IN in complex with the IN binding domain (IBD) of LEDGF has furthermore revealed essential protein-protein contacts. However, mutagenic studies indicated that interactions between the full-length proteins were more extensive than the contacts observed in the co-crystal structure of the isolated domains. Therefore, we have conducted detailed biochemical characterization of the interactions between full-length IN and LEDGF. Our results reveal a highly dynamic nature of IN subunit-subunit interactions. LEDGF strongly stabilized these interactions and promoted IN tetramerization. Mass spectrometric protein footprinting and molecular modeling experiments uncovered novel intra- and inter-protein-protein contacts in the full-length IN-LEDGF complex that lay outside of the observable IBD-CCD structure. In particular, our studies defined the IN tetramer interface important for enzymatic activities and high affinity LEDGF binding. These findings provide new insight into how LEDGF modulates HIV-1 IN structure and function, and highlight the potential for exploiting the highly dynamic structure of multimeric IN as a novel therapeutic target.	[McKee, Christopher J.; Kessl, Jacques J.; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Retrovirus Res, Coll Pharm, Columbus, OH 43210 USA; [McKee, Christopher J.; Kessl, Jacques J.; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Comprehens Canc, Coll Pharm, Columbus, OH 43210 USA; [Dar, Mohd Jamal; Engelman, Alan] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; [Dar, Mohd Jamal; Engelman, Alan] Harvard Univ, Sch Med, Div Aids, Boston, MA 02115 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Kvaratskhelia, M (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Coll Pharm, 500 W 12th Ave,238 LM Pk Hall, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Kessl, Jacques/J-6073-2015; Kessl, Jacques/AAV-2526-2021		National Institutes of Health AIDS Research [118-D-24]; Reference Reagent Program; Division of AIDS; NIAID; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039394, R01AI039394] Funding Source: NIH RePORTER	National Institutes of Health AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reference Reagent Program; Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Jocelyn Norris for help with purifying LEDGF proteins. The integrase strand transfer inhibitor (118-D-24) was obtained through the National Institutes of Health AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health.	Al-Mawsawi LQ, 2008, FEBS LETT, V582, P1425, DOI 10.1016/j.febslet.2008.02.076; Al-Mawsawi LQ, 2006, P NATL ACAD SCI USA, V103, P10080, DOI 10.1073/pnas.0511254103; ANDRAKE MD, 1995, J BIOL CHEM, V270, P29299, DOI 10.1074/jbc.270.49.29299; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Berthoux L, 2007, VIROLOGY, V364, P227, DOI 10.1016/j.virol.2007.02.029; Bosserman MA, 2007, BIOCHEMISTRY-US, V46, P11231, DOI 10.1021/bi700197a; Brown P. O., 1997, P161; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; CANNON PM, 1994, J VIROL, V68, P4768, DOI 10.1128/JVI.68.8.4768-4775.1994; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 1999, NUCLEIC ACIDS RES, V27, P2202, DOI 10.1093/nar/27.10.2202; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Kvaratskhelia M, 2002, P NATL ACAD SCI USA, V99, P15988, DOI 10.1073/pnas.252550199; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; Petit C, 2000, J VIROL, V74, P7119, DOI 10.1128/JVI.74.15.7119-7126.2000; Raghavendra NK, 2007, VIROLOGY, V360, P1, DOI 10.1016/j.virol.2006.12.022; Rahman S, 2007, VIROLOGY, V357, P79, DOI 10.1016/j.virol.2006.08.011; Shell SM, 2005, BIOCHEMISTRY-US, V44, P971, DOI 10.1021/bi048208a; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Shkriabai N, 2004, P NATL ACAD SCI USA, V101, P6894, DOI 10.1073/pnas.0400873101; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Svarovskaia ES, 2004, J VIROL, V78, P3210, DOI 10.1128/JVI.78.7.3210-3222.2004; Tsurutani N, 2000, J VIROL, V74, P4795, DOI 10.1128/JVI.74.10.4795-4806.2000; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; VANGENT DC, 1991, NUCLEIC ACIDS RES, V19, P3821, DOI 10.1093/nar/19.14.3821; VINCENT KA, 1993, J VIROL, V67, P425, DOI 10.1128/JVI.67.1.425-437.1993; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Yu F, 2007, BIOCHEMISTRY-US, V46, P2899, DOI 10.1021/bi602387u; Zhang XC, 2003, BIOORG MED CHEM LETT, V13, P1215, DOI 10.1016/S0960-894X(03)00059-3; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	76	105	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31802	31812		10.1074/jbc.M805843200	http://dx.doi.org/10.1074/jbc.M805843200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801737	Green Published, hybrid			2022-12-25	WOS:000260760800063
J	Sawicki, A; Willows, RD				Sawicki, Artur; Willows, Robert D.			Kinetic Analyses of the Magnesium Chelatase Provide Insights into the Mechanism, Structure, and Formation of the Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRIN-IX METHYLTRANSFERASE; PHOSPHATE EXCHANGE ACTIVITIES; ADENOSYL-L-METHIONINE; MG-CHELATASE; RHODOBACTER-CAPSULATUS; ATPASE ACTIVITY; CHLOROPHYLL BIOSYNTHESIS; SYNECHOCYSTIS PCC6803; BARLEY MUTANTS; H-SUBUNIT	The metabolic pathway known as (bacterio) chlorophyll biosynthesis is initiated by magnesium chelatase (BchI, BchD, BchH). This first step involves insertion of magnesium into protoporphyrin IX (proto), a process requiring ATP hydrolysis. Structural information shows that the BchI and BchD subunits form a double hexameric enzyme complex, whereas BchH binds proto and can be purified as BchH-proto. We utilized the Rhodobacter capsulatus magnesium chelatase subunits using continuous magnesium chelatase assays and treated the BchD subunit as the enzyme with both BchI and BchH-proto as substrates. Michaelis-Menten kinetics was observed with the BchI subunit, whereas the BchH subunit exhibited sigmoidal kinetics (Hill coefficient of 1.85). The BchI.BchD complex had intrinsic ATPase activity, and addition of BchH greatly increased ATPase activity. This was concentration-dependent and gave sigmoidal kinetics, indicating there is more than one binding site for the BchH subunit on the BchI.BchD complex. ATPase activity was similar to 40-fold higher than magnesium chelatase activity and continued despite cessation of magnesium chelation, implying one or more secondary roles for ATP hydrolysis and possibly an as yet unknown switch required to terminate ATPase activity. One of the secondary roles for BchH-stimulated ATP hydrolysis by a BchI.BchD complex is priming of BchH to facilitate correct binding of proto to BchH in a form capable of participating in magnesium chelation. This porphyrin binding is the rate-limiting step in catalysis. These data suggest that ATP hydrolysis by the BchI.BchD complex causes a series of conformational changes in BchH to effect substrate binding, magnesium chelation, and product release.	[Sawicki, Artur; Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	Macquarie University	Willows, RD (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	rwillows@rna.bio.mq.edu.au	Willows, Robert/C-1537-2010; Sawicki, Artur/G-7984-2016	Willows, Robert/0000-0002-0731-2950; Sawicki, Artur/0000-0001-6187-042X; Sawicki, Artur/0000-0002-1469-0845				Alawady A, 2005, PLANT MOL BIOL, V57, P679, DOI 10.1007/s11103-005-1427-8; Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; GORCHEIN A, 1972, BIOCHEM J, V127, P97, DOI 10.1042/bj1270097; Grafe S, 1999, P NATL ACAD SCI USA, V96, P1941, DOI 10.1073/pnas.96.5.1941; Guo RB, 1998, PLANT PHYSIOL, V116, P605, DOI 10.1104/pp.116.2.605; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hansson A, 2002, P NATL ACAD SCI USA, V99, P13944, DOI 10.1073/pnas.212504499; Hansson M, 1997, P NATL ACAD SCI USA, V94, P13351, DOI 10.1073/pnas.94.24.13351; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Lake V, 2004, EUR J BIOCHEM, V271, P2182, DOI 10.1111/j.1432-1033.2004.04143.x; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Petersen BL, 1999, ARCH MICROBIOL, V171, P146, DOI 10.1007/s002030050692; Reid JD, 2003, BIOCHEMISTRY-US, V42, P6912, DOI 10.1021/bi034082q; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Reid JD, 2002, BIOCHEM SOC T, V30, P643, DOI 10.1042/bst0300643; RICHTER ML, 1982, BIOCHIM BIOPHYS ACTA, V717, P255, DOI 10.1016/0304-4165(82)90177-5; Sawicki A, 2007, BIOCHEM J, V406, P469, DOI 10.1042/BJ20070284; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Sirijovski N, 2006, BIOCHEM J, V400, P477, DOI 10.1042/BJ20061103; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; Walker CJ, 1997, BIOCHEM J, V327, P321; Willows R.D., 2003, PORPHYRIN HDB CHLORO, V13, P1, DOI [10.1016/B978-0-08-092387-1.50007-2, DOI 10.1016/B978-0-08-092387-1.50007-2]; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019; Willows RD, 1998, J BIOL CHEM, V273, P34206, DOI 10.1074/jbc.273.51.34206; Willows RD, 1996, EUR J BIOCHEM, V235, P438, DOI 10.1111/j.1432-1033.1996.00438.x; Willows RD, 2003, J BACTERIOL, V185, P3249, DOI 10.1128/JB.185.11.3249-3258.2003; Willows RD, 1999, ACTA CRYSTALLOGR D, V55, P689, DOI 10.1107/S0907444998014759	44	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31294	31302		10.1074/jbc.M805792200	http://dx.doi.org/10.1074/jbc.M805792200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18790730	hybrid			2022-12-25	WOS:000260760800006
J	Cho, T; Jung, Y; Koschinsky, ML				Cho, Taewoo; Jung, Yoojin; Koschinsky, Marlys L.			Apolipoprotein(a), through Its Strong Lysine-binding Site in KIV10, Mediates Increased Endothelial Cell Contraction and Permeability via a Rho/Rho Kinase/MYPT1-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; RHO-KINASE; CARDIOVASCULAR-DISEASE; LIPOPROTEIN(A) LEVELS; MYOSIN PHOSPHATASE; ISOMETRIC TENSION; RECOMBINANT FORM; IN-VIVO; PLASMINOGEN; EXPRESSION	Substantial evidence indicates that endothelial dysfunction plays a critical role in atherogenesis. We previously demonstrated that apolipoprotein(a) (apo(a); the distinguishing protein component of the atherothrombotic risk factor lipoprotein(a)) elicits rearrangement of the actin cytoskeleton in human umbilical vein endothelial cells, characterized by increased myosin light chain (MLC) phosphorylation via a Rho/Rho kinase-dependent signaling pathway. Apo(a) contains kringle (K)IV and KV domains similar to those in plasminogen: apo(a) contains 10 types of plasminogen KIV-like sequences, followed by sequences homologous to the plasminogen KV and protease domains. Several of the apo(a) kringles contain lysine-binding sites (LBS) that have been proposed to contribute to the pathogenicity of Lp(a). Here we demonstrate that apo(a)-induced endothelial barrier dysfunction is mediated via a Rho/Rho kinase-dependent signaling pathway that results in increased MYPT1 phosphorylation and hence decreased MLC phosphatase activity, thus leading to an increase in MLC phosphorylation, stress fiber formation, cell contraction, and permeability. In addition, studies using recombinant apo(a) variants indicated that these effects of apo(a) are dependent on sequences within the C-terminal half of the apo(a) molecule, specifically, the strong LBS in KIV10. In parallel experiments, the apo(a)-induced effects were completely abolished by treatment of the cells with the lysine analogue epsilon-aminocaproic acid and the Rho kinase inhibitor Y27632. Taken together, our findings indicate that the strong LBS in apo(a) KIV10 mediates all of our observed effects of apo(a) on human umbilical vein endothelial cell barrier dysfunction. Studies are ongoing to further dissect the molecular basis of these findings.	[Cho, Taewoo; Jung, Yoojin; Koschinsky, Marlys L.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Koschinsky, ML (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	mk11@queensu.ca		Koschinsky, Marlys/0000-0002-2643-2288	Heart and Stroke Foundation of Ontario [T-5916]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by the Heart and Stroke Foundation of Ontario (Grant T-5916 to M. L. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen S, 1998, FASEB J, V12, P1765, DOI 10.1096/fasebj.12.15.1765; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Angelin B, 1997, CURR OPIN LIPIDOL, V8, P337, DOI 10.1097/00041433-199712000-00003; Anuurad E, 2006, CLIN LAB MED, V26, P751, DOI 10.1016/j.cll.2006.07.002; Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Becker L, 2004, BIOCHEMISTRY-US, V43, P9978, DOI 10.1021/bi049536d; Becker L, 2001, J BIOL CHEM, V276, P36155, DOI 10.1074/jbc.M104789200; Belczewski AR, 2005, BIOCHEMISTRY-US, V44, P555, DOI 10.1021/bi048156p; Bodmer JE, 1997, MICROVASC RES, V53, P261, DOI 10.1006/mvre.1997.2011; Boonmark NW, 1997, J CLIN INVEST, V100, P558, DOI 10.1172/JCI119565; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Essler M, 1999, J BIOL CHEM, V274, P30361, DOI 10.1074/jbc.274.43.30361; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; GABEL BR, 1995, BIOCHEMISTRY-US, V34, P15777, DOI 10.1021/bi00048a023; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Gunduz D, 2003, CARDIOVASC RES, V59, P470, DOI 10.1016/S0008-6363(03)00427-9; Hancock MA, 2003, J BIOL CHEM, V278, P23260, DOI 10.1074/jbc.M302780200; Haque NS, 2000, CIRCULATION, V102, P786, DOI 10.1161/01.CIR.102.7.786; Hughes SD, 1997, J CLIN INVEST, V100, P1493, DOI 10.1172/JCI119671; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Koschinsky Marlys L., 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P267; KOSCHINSKY ML, 1991, BIOCHEMISTRY-US, V30, P5044, DOI 10.1021/bi00234a029; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LUM H, 1992, AM J PHYSIOL, V263, pL219, DOI 10.1152/ajplung.1992.263.2.L219; Marcovina SM, 2003, CLIN CHEM, V49, P1785, DOI 10.1373/clinchem.2003.023689; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pellegrino M, 2004, J BIOL CHEM, V279, P6526, DOI 10.1074/jbc.M309705200; REDLITZ A, 1995, BAILLIERE CLIN HAEM, V8, P313, DOI 10.1016/S0950-3536(05)80270-7; Sangrar W, 2000, BIOCHEM CELL BIOL, V78, P519, DOI 10.1139/bcb-78-4-519; Sangrar W, 1997, BIOCHEMISTRY-US, V36, P10353, DOI 10.1021/bi962433d; Schachinger V, 1997, J AM COLL CARDIOL, V30, P927, DOI 10.1016/S0735-1097(97)00237-4; SCHNITTLER HJ, 1990, J PHYSIOL-LONDON, V431, P379, DOI 10.1113/jphysiol.1990.sp018335; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SORENSEN KE, 1994, J CLIN INVEST, V93, P50, DOI 10.1172/JCI116983; Takami S, 1998, CIRCULATION, V97, P721, DOI 10.1161/01.CIR.97.8.721; TSURUMI Y, 1995, J AM COLL CARDIOL, V26, P1242, DOI 10.1016/0735-1097(95)00321-5; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Zhao S, 2000, THROMB RES, V100, P501, DOI 10.1016/S0049-3848(00)00363-7	46	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30503	30512		10.1074/jbc.M802648200	http://dx.doi.org/10.1074/jbc.M802648200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18776185	hybrid, Green Published			2022-12-25	WOS:000260544800008
J	Ho, KM; Knuiman, M; Finn, J; Webb, SA				Ho, Kwok M.; Knuiman, Matthew; Finn, Judith; Webb, Steven A.			Estimating Long-Term Survival of Critically Ill Patients: The PREDICT Model	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; EVALUATION (APACHE)-II SCORE; ACUTE PHYSIOLOGY; HOSPITAL MORTALITY; PROGNOSTIC MODEL; DECISIONS; DETERMINANTS; PHYSICIANS; ADMISSION; OUTCOMES	Background: Long-term survival outcome of critically ill patients is important in assessing effectiveness of new treatments and making treatment decisions. We developed a prognostic model for estimation of long-term survival of critically ill patients. Methodology and Principal Findings: This was a retrospective linked data cohort study involving 11,930 critically ill patients who survived more than 5 days in a university teaching hospital in Western Australia. Older age, male gender, comorbidities, severe acute illness as measured by Acute Physiology and Chronic Health Evaluation II predicted mortality, and more days of vasopressor or inotropic support, mechanical ventilation, and hemofiltration within the first 5 days of intensive care unit admission were associated with a worse long-term survival up to 15 years after the onset of critical illness. Among these seven pre-selected predictors, age (explained 50% of the variability of the model, hazard ratio [HR] between 80 and 60 years old = 1.95) and co-morbidity (explained 27% of the variability, HR between Charlson co-morbidity index 5 and 0 = 2.15) were the most important determinants. A nomogram based on the pre-selected predictors is provided to allow estimation of the median survival time and also the 1-year, 3-year, 5-year, 10-year, and 15-year survival probabilities for a patient. The discrimination (adjusted c-index = 0.757, 95% confidence interval 0.745-0.769) and calibration of this prognostic model were acceptable. Significance: Age, gender, co-morbidities, severity of acute illness, and the intensity and duration of intensive care therapy can be used to estimate long-term survival of critically ill patients. Age and co-morbidity are the most important determinants of long-term prognosis of critically ill patients.	[Ho, Kwok M.; Webb, Steven A.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Ho, Kwok M.; Webb, Steven A.] Univ Western Australia, Sch Med, Royal Perth Hosp, Perth, WA 6009, Australia; [Knuiman, Matthew; Finn, Judith] Univ Western Australia, Sch Populat Hlth, Crawley, WA 6009, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Ho, KM (corresponding author), Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia.	kwok.ho@health.wa.gov.au	Finn, Judith C/B-2678-2010; Knuiman, Matthew W/I-5549-2013; Ho, Kwok M./E-3546-2010	Finn, Judith C/0000-0002-7307-7944; Ho, Kwok M./0000-0002-6705-6004; Knuiman, Matthew/0000-0001-8874-2305	BUPA	BUPA	A grant was received from BUPA to provide support for the cost of linking the databases used in this study. The funding agency has no involvement in the study design, collection of data, analysis and interpretation of data, writing of the report, or in the decision to submit the article for publication.	*AC HLTH DIV DOHS, 1997, REV INT CAR VICT PHA; *AUD COMM, 1999, PLAC EFF EFF CRIT CA; Cabre L, 2005, INTENS CARE MED, V31, P927, DOI 10.1007/s00134-005-2640-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Connors AF, 1999, CRIT CARE MED, V27, P5, DOI 10.1097/00003246-199901000-00004; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; COX DR, 1972, J R STAT SOC B, V34, P187; Efron B., 1994, INTRO BOOTSTRAP; Elstein AS, 1999, CRIT CARE MED, V27, P58, DOI 10.1097/00003246-199901000-00027; Feringa HHH, 2007, ARCH INTERN MED, V167, P2482, DOI 10.1001/archinte.167.22.2482; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Garland A, 2007, J PALLIAT MED, V10, P1298, DOI 10.1089/jpm.2007.0061; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; HALPERN NA, 1994, CRIT CARE MED, V22, P2001; Hamel MB, 1997, ANN INTERN MED, V127, P195, DOI 10.7326/0003-4819-127-3-199708010-00003; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 2001, REGRESSION MODELING; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Ho KM, 2007, ANAESTHESIA, V62, P1095, DOI 10.1111/j.1365-2044.2007.05231.x; Ho KM, 2007, ANAESTH INTENS CARE, V35, P515, DOI 10.1177/0310057X0703500409; Ho KM, 2007, ANAESTHESIA, V62, P466, DOI 10.1111/j.1365-2044.2007.04999.x; Ho KM, 2005, INTENS CARE MED, V31, P668, DOI 10.1007/s00134-005-2613-5; Ho KM, 2004, ANAESTH INTENS CARE, V32, P781, DOI 10.1177/0310057X0403200609; Ho KM, 2006, CRIT CARE, V10, DOI 10.1186/cc3913; Ho KM, 2007, J CLIN EPIDEMIOL, V60, P746, DOI 10.1016/j.jclinepi.2006.10.017; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Kvale R, 2002, INTENS CARE MED, V28, P1110, DOI 10.1007/s00134-002-1378-3; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; Poisal JA, 2007, HEALTH AFFAIR, V26, pW242, DOI 10.1377/hlthaff.26.2.w242; POMPEI P, 1991, J CLIN EPIDEMIOL, V44, P1063, DOI 10.1016/0895-4356(91)90008-W; Sinuff T, 2006, CRIT CARE MED, V34, P878, DOI 10.1097/01.CCM.0000201881.58644.41; Williams TA, 2006, ANAESTH INTENS CARE, V34, P307, DOI 10.1177/0310057X0603400316; Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405; Wright JC, 2003, ANAESTHESIA, V58, P637, DOI 10.1046/j.1365-2044.2003.03205.x; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	41	83	84	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3226	10.1371/journal.pone.0003226	http://dx.doi.org/10.1371/journal.pone.0003226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797505	Green Submitted, Green Published, gold			2022-12-25	WOS:000264428200006
J	Li, RX; Chen, HB; Tu, K; Zhao, SL; Zhou, H; Li, SJ; Dai, J; Li, QR; Nie, S; Li, YX; Jia, WP; Zeng, R; Wu, JR				Li, Rong-Xia; Chen, Hai-Bing; Tu, Kang; Zhao, Shi-Lin; Zhou, Hu; Li, Su-Jun; Dai, Jie; Li, Qing-Run; Nie, Song; Li, Yi-Xue; Jia, Wei-Ping; Zeng, Rong; Wu, Jia-Rui			Localized-Statistical Quantification of Human Serum Proteome Associated with Type 2 Diabetes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HUMAN PLASMA PROTEOME; CORONARY-ARTERY-DISEASE; MANNOSE-BINDING LECTIN; METABOLIC SYNDROME; COMPLEMENT ACTIVATION; ATHEROSCLEROSIS RISK; IDENTIFICATION; MELLITUS; LIPOPROTEINS	Background: Recent advances in proteomics have shed light to discover serum proteins or peptides as biomarkers for tracking the progression of diabetes as well as understanding molecular mechanisms of the disease. Results: In this work, human serum of non-diabetic and diabetic cohorts was analyzed by proteomic approach. To analyze total 1377 high-confident serum-proteins, we developed a computing strategy called localized statistics of protein abundance distribution (LSPAD) to calculate a significant bias of a particular protein-abundance between these two cohorts. As a result, 68 proteins were found significantly over-represented in the diabetic serum (p < 0.01). In addition, a pathway-associated analysis was developed to obtain the overall pathway bias associated with type 2 diabetes, from which the significant over-representation of complement system associated with type 2 diabetes was uncovered. Moreover, an upstream activator of complement pathway, ficolin-3, was observed over-represented in the serum of type 2 diabetic patients, which was further validated with statistic significance (p=0.012) with more clinical samples. Conclusions: The developed LSPAD approach is well fit for analyzing proteomic data derived from biological complex systems such as plasma proteome. With LSPAD, we disclosed the comprehensive distribution of the proteins associated with diabetes in different abundance levels and the involvement of ficolin-related complement activation in diabetes.	[Li, Rong-Xia; Tu, Kang; Zhao, Shi-Lin; Zhou, Hu; Li, Su-Jun; Dai, Jie; Li, Qing-Run; Nie, Song; Li, Yi-Xue; Zeng, Rong; Wu, Jia-Rui] Chinese Acad Sci, Key Lab Syst Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Chen, Hai-Bing; Jia, Wei-Ping] Jiaotong Univ, Shanghai Peoples Hosp 6, Dept Endocrinol & Metabolism, Shanghai Diabetes Inst, Shanghai, Peoples R China; [Wu, Jia-Rui] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, RX (corresponding author), Chinese Acad Sci, Key Lab Syst Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	wpjia@yahoo.com; zr@sibs.ac.cn; wujr@sibs.ac.cn	Li, Qing-Run/C-7362-2011; Nie, Song/E-9027-2014; nie, song/E-6904-2015	Li, Qing-Run/0000-0002-1644-0508; Nie, Song/0000-0001-5035-1827; 	973 Program [2006CB503900]; Chinese Academy of Sciences [KSCX1-YW-02]; National Natural Science Foundation of China [30521005, 30425021]; National Basic Research Program of China [2006CB910700, 2007AA02Z334]	973 Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by 973 Program #2006CB503900 to JR. Wu and WP Jia; a grant of Knowledge Innovation Program of the Chinese Academy of Sciences KSCX1-YW-02 to JR. Wu; the grants of National Natural Science Foundation of China 30521005 to JR. Wu and R. Zeng, #30425021 to R. Zeng; and National Basic Research Program of China #2006CB910700 to R. Zeng, and High-technology Project # 2007AA02Z334 to R. Zeng.	ANDERSON NL, 2002, HUMAN PLASMA PROTEOM, P845; Barraviera B., 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P479, DOI 10.1590/S0036-46651994000500015; Bolstad B, 2005, BIOINFORMATICS COMPU; Cheng Xi, 2004, World J Surg Oncol, V2, P47, DOI 10.1186/1477-7819-2-47; Dayal B, 2002, J PROTEOME RES, V1, P375, DOI 10.1021/pr010008n; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Duncan BB, 1999, DIABETES CARE, V22, P767, DOI 10.2337/diacare.22.5.767; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Georgiou HM, 2001, PROTEOMICS, V1, P1503, DOI 10.1002/1615-9861(200111)1:12<1503::AID-PROT1503>3.0.CO;2-M; Getz GS, 2004, CURR OPIN LIPIDOL, V15, P261, DOI 10.1097/00041433-200406000-00005; Hansen TK, 2005, HORM METAB RES, V37, pS95, DOI 10.1055/s-2005-8613272; Hansen TK, 2004, DIABETES, V53, P1570, DOI 10.2337/diabetes.53.6.1570; Hansen TK, 2006, ARCH INTERN MED, V166, P2007, DOI 10.1001/archinte.166.18.2007; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Heller M, 2005, PROTEOMICS, V5, P2619, DOI 10.1002/pmic.200401233; Horikawa Y, 2003, HORM METAB RES, V35, P308; Jin WH, 2005, J PROTEOME RES, V4, P613, DOI 10.1021/pr049761h; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson H, 2005, PROTEOMICS, V5, P1431, DOI 10.1002/pmic.200401010; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Kim CH, 2002, METABOLISM, V51, P838, DOI 10.1053/meta.2002.33348; Kim EY, 2003, AUTOIMMUNITY, V36, P177, DOI 10.1080/0891693031000101279; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; Korc M, 2003, MOL CELL PROTEOMICS, V2, P399, DOI 10.1074/mcp.R300005-MCP200; Kotite L, 2003, J LIPID RES, V44, P1387, DOI 10.1194/jlr.M300087-JLR200; KUNITAKE ST, 1994, BIOCHEMISTRY-US, V33, P1988, DOI 10.1021/bi00174a003; Lindgren CM, 2002, DIABETES, V51, P1609, DOI 10.2337/diabetes.51.5.1609; Mackness B, 2006, ATHEROSCLEROSIS, V186, P396, DOI 10.1016/j.atherosclerosis.2005.07.028; MCMILLAN DE, 1989, METABOLISM, V38, P1042, DOI 10.1016/0026-0495(89)90038-3; MCVICAR JP, 1984, P NATL ACAD SCI-BIOL, V81, P1356, DOI 10.1073/pnas.81.5.1356; Mirzaei H, 2008, PROTEOMICS, V8, P1516, DOI 10.1002/pmic.200700363; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; O'Brien PJ, 2005, CLIN CHEM, V51, P351, DOI 10.1373/clinchem.2004.040824; On YK, 2007, CIRC J, V71, P868, DOI 10.1253/circj.71.868; Ostergaard J, 2005, CLIN CHIM ACTA, V361, P10, DOI 10.1016/j.cccn.2005.04.028; PASCUAL M, 1995, IMMUNOL TODAY, V16, P58, DOI 10.1016/0167-5699(95)80088-3; Patrick L, 2001, Altern Med Rev, V6, P248; PEETERS A, 2007, MOL GENET METAB; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; RAO AA, 2007, MED HYPOTHESES; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Rothem L, 2007, FREE RADICAL BIO MED, V43, P730, DOI 10.1016/j.freeradbiomed.2007.05.003; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Scott Eleanor M, 2005, Diab Vasc Dis Res, V2, P54, DOI 10.3132/dvdr.2005.009; SPRECHER DL, 1988, J LIPID RES, V29, P273; Sundsten T, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-22; SYVANNE M, 1994, ATHEROSCLEROSIS, V105, P25, DOI 10.1016/0021-9150(94)90004-3; Takahashi M, 2007, ADV EXP MED BIOL, V598, P93; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; Tu CJ, 2005, J PROTEOME RES, V4, P1265, DOI 10.1021/pr0497529; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vendrell J, 2003, ATHEROSCLEROSIS, V167, P257, DOI 10.1016/S0021-9150(02)00429-X; Virella G, 2008, CLIN IMMUNOL, V127, P394, DOI 10.1016/j.clim.2008.02.005; Vorup-Jensen T, 1998, IMMUNOBIOLOGY, V199, P348, DOI 10.1016/S0171-2985(98)80039-9; Whaley K, 1997, SEMIN LIVER DIS, V17, P297, DOI 10.1055/s-2007-1007206; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Zhang LH, 1996, J BIOL CHEM, V271, P1776, DOI 10.1074/jbc.271.3.1776; Zhang RL, 2004, PROTEOMICS, V4, P244, DOI 10.1002/pmic.200300495; Zimmet P, 2003, DIABETES METAB, V29, pS9	66	56	60	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3224	10.1371/journal.pone.0003224	http://dx.doi.org/10.1371/journal.pone.0003224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795103	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428000007
J	Agger, EM; Rosenkrands, I; Hansen, J; Brahimi, K; Vandahl, BS; Aagaard, C; Werninghaus, K; Kirschning, C; Lang, R; Christensen, D; Theisen, M; Follmann, F; Andersen, P				Agger, Else Marie; Rosenkrands, Ida; Hansen, Jon; Brahimi, Karima; Vandahl, Brian S.; Aagaard, Claus; Werninghaus, Kerstin; Kirschning, Carsten; Lang, Roland; Christensen, Dennis; Theisen, Michael; Follmann, Frank; Andersen, Peter			Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; MEROZOITE SURFACE PROTEIN-1; TUBERCULOSIS SUBUNIT VACCINE; BACILLUS-CALMETTE-GUERIN; T-CELL EPITOPES; PROTECTIVE IMMUNITY; CORD FACTOR; IMMUNIZATION; RESPONSES; IMMUNOGENICITY	Background: It is now emerging that for vaccines against a range of diseases including influenza, malaria and HIV, the induction of a humoral response is insufficient and a substantial complementary cell-mediated immune response is necessary for adequate protection. Furthermore, for some diseases such as tuberculosis, a cellular response seems to be the sole effector mechanism required for protection. The development of new adjuvants capable of inducing highly complex immune responses with strong antigen-specific T-cell responses in addition to antibodies is therefore urgently needed. Methods and Findings: Herein, we describe a cationic adjuvant formulation (CAF01) consisting of DDA as a delivery vehicle and synthetic mycobacterial cordfactor as immunomodulator. CAF01 primes strong and complex immune responses and using ovalbumin as a model vaccine antigen in mice, antigen specific cell-mediated-and humoral responses were obtained at a level clearly above a range of currently used adjuvants (Aluminium, monophosphoryl lipid A, CFA/IFA, Montanide). This response occurs through Toll-like receptor 2, 3, 4 and 7-independent pathways whereas the response is partly reduced in MyD88-deficient mice. In three animal models of diseases with markedly different immunological requirement; Mycobacterium tuberculosis (cell-mediated), Chlamydia trachomatis (cell-mediated/humoral) and malaria (humoral) immunization with CAF01-based vaccines elicited significant protective immunity against challenge. Conclusion: CAF01 is potentially a suitable adjuvant for a wide range of diseases including targets requiring both CMI and humoral immune responses for protection.	[Agger, Else Marie; Rosenkrands, Ida; Hansen, Jon; Brahimi, Karima; Vandahl, Brian S.; Aagaard, Claus; Christensen, Dennis; Theisen, Michael; Follmann, Frank; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Werninghaus, Kerstin; Kirschning, Carsten; Lang, Roland] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-8000 Munich, Germany	Statens Serum Institut; Technical University of Munich	Agger, EM (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	eag@ssi.dk	Lang, Roland/C-3287-2011; Christensen, Dennis/C-6378-2008	Christensen, Dennis/0000-0003-2382-8639; Andersen, Peter/0000-0002-5869-2551; Lang, Roland/0000-0003-0502-3677; Hansen, Jon Ulf/0000-0002-6410-5755; Follmann, Frank/0000-0002-8373-7774	European Commission [LSHP-CT-2003-503367]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was in part funded by the European Commission contract no. LSHP-CT-2003-503367.	Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Ahlborg N, 2000, INFECT IMMUN, V68, P2102, DOI 10.1128/IAI.68.4.2102-2109.2000; Bennekov T, 2006, EUR J IMMUNOL, V36, P3346, DOI 10.1002/eji.200636128; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; da Fonseca DM, 2007, IMMUNOLOGY, V121, P508, DOI 10.1111/j.1365-2567.2007.02597.x; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dietrich J, 2007, J IMMUNOL, V178, P3721, DOI 10.4049/jimmunol.178.6.3721; Gabizon AA, 2001, CANCER INVEST, V19, P424, DOI 10.1081/CNV-100103136; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Gluck R, 2004, EXPERT OPIN BIOL TH, V4, P1139, DOI 10.1517/14712598.4.7.1139; Gramzinski RA, 2001, INFECT IMMUN, V69, P1643, DOI 10.1128/IAI.69.3.1643-1649.2001; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hansen J, 2008, J INFECT DIS, V198, P758, DOI 10.1086/590670; Heit A, 2007, EUR J IMMUNOL, V37, P2063, DOI 10.1002/eji.200737169; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; Hu JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001952; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V29, P92, DOI 10.1007/BF00395856; Kamath AT, 2008, EUR J IMMUNOL, V38, P1247, DOI 10.1002/eji.200737889; Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010; Kim SK, 2000, J IMMUNOL, V165, P7285, DOI 10.4049/jimmunol.165.12.7285; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Korsholm KS, 2007, IMMUNOLOGY, V121, P216, DOI 10.1111/j.1365-2567.2007.02560.x; Lee EAM, 2002, INFECT IMMUN, V70, P1417, DOI 10.1128/IAI.70.3.1417-1421.2002; Lipford GB, 1997, EUR J IMMUNOL, V27, P3420, DOI 10.1002/eji.1830271242; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; Olsen AW, 2006, J INFECT DIS, V194, P1258, DOI 10.1086/508203; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Ortiz L, 2000, INFECT IMMUN, V68, P1719, DOI 10.1128/IAI.68.3.1719-1723.2000; Pal S, 1997, INFECT IMMUN, V65, P3361, DOI 10.1128/IAI.65.8.3361-3369.1997; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; PIMM MV, 1979, INT J CANCER, V24, P780, DOI 10.1002/ijc.2910240614; Rafati S, 2005, VACCINE, V23, P3716, DOI 10.1016/j.vaccine.2005.02.009; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Rosenkrands I, 2005, INFECT IMMUN, V73, P5817, DOI 10.1128/IAI.73.9.5817-5826.2005; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; SU H, 1995, VACCINE, V13, P1023, DOI 10.1016/0264-410X(95)00017-U; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Suzuki Y, 2004, CANCER RES, V64, P8754, DOI 10.1158/0008-5472.CAN-04-1691; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; THEISEN M, 1994, INFECT IMMUN, V62, P3270, DOI 10.1128/IAI.62.8.3270-3275.1994; Tian JH, 1997, INFECT IMMUN, V65, P3032, DOI 10.1128/IAI.65.8.3032-3036.1997; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; VANDISSEL JT, LANCET UNPUB; Vangala A, 2006, J PHARM PHARMACOL, V58, P787, DOI 10.1211/jpp.58.6.0009; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335	53	222	230	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3116	10.1371/journal.pone.0003116	http://dx.doi.org/10.1371/journal.pone.0003116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776936	Green Submitted, Green Published, gold			2022-12-25	WOS:000264424300001
J	Zhu, SY; Gao, B				Zhu, Shunyi; Gao, Bin			A fossil antibacterial peptide gives clues to structural diversity of cathelicidin-derived host defense peptides	FASEB JOURNAL			English	Article						functional divergence; gene duplication; innate immunity; exon shuffling; Cetartiodactyla; sequence remodeling	ANTIMICROBIAL PEPTIDES; EVOLUTION; DIVERGENCE; PROTEINS; SEQUENCE; FAMILY; GENES; DUPLICATION; MECHANISMS; MEMBRANE	Cathelicidins, a group of vertebrate-specific immune effector molecules, developed into a multigene family through gene duplication in the Cetartiodactyla lineage, in which structural changes of the antimicrobial domains (AMDs) among paralogs during evolution are clearly associated with functional diversification of cathelicidins. However, the evolutionary mechanism for such structural diversity remains largely unsolved. Although at the genomic level, the 3'-exon alone encoding the variable AMD repertoire would favor a role of exon shuffling, the observation that two structurally unrelated subfamilies of AMDs (protegrins and prophenins) display high similarity in some nucleotide regions of the 3'-exons of their genes provides evidence for postduplication sequence remodeling. This opinion is further strengthened by finding a proline-arginine-rich antibacterial peptide of 38 residues (named PR-38) encoded by an open reading frame located in the 3' untranslated region of protegrins, which is in frame with prophenins. The latter appears to have undergone internal motif repeats in the region corresponding to PR-38. PR-38 exhibits similar amino acid sequence and carboxyl-terminal amidation feature to PR-39s, a subfamily of cathelicidin peptides conserved across Cetartiodactyla. Functional assays of the chemically synthesized PR-38 confirmed its antibacterial activity with a similar action mode to PR-39 against both gram-positive and gram-negative bacteria at micromolar concentrations, supporting an ancient functional link among cathelicidin members belonging to different subfamilies. Resurrecting the fossil peptide highlights the evolutionary position of PR-39 in generating structurally variable subfamilies of porcine cathelicidins through postduplication sequence remodeling.-Zhu, S., Gao, B. A fossil antibacterial peptide gives clues to structural diversity of cathelicidin-derived host defense peptides. FASEB J. 23, 13-20 (2009)	[Zhu, Shunyi; Gao, Bin] Chinese Acad Sci, Inst Zool, Grp Anim Innate Immun, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Zhu, SY (corresponding author), Datun Rd, Beijing 100101, Peoples R China.	zhusy@ioz.ac.cn			Chinese Academy of Sciences	Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Bairen Plan from the Chinese Academy of Sciences to S.Z.	AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Amino R, 2002, J BIOL CHEM, V277, P6207, DOI 10.1074/jbc.M109874200; Arguello J. R., 2007, V3, P131, DOI 10.1159/000107608; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chan YR, 2001, J INVEST DERMATOL, V116, P230, DOI 10.1046/j.1523-1747.2001.01231.x; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; de la Vega RCR, 2005, TRENDS GENET, V21, P330, DOI 10.1016/j.tig.2005.03.009; Froy O, 2003, TRENDS GENET, V19, P684, DOI 10.1016/j.tig.2003.10.010; GUDMUNDSSON GH, 1995, P NATL ACAD SCI USA, V92, P7085, DOI 10.1073/pnas.92.15.7085; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Lai JR, 2002, BIOCHEMISTRY-US, V41, P12835, DOI 10.1021/bi026127d; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lynn DJ, 2004, MOL BIOL EVOL, V21, P819, DOI 10.1093/molbev/msh084; Maxwell AI, 2003, MOL IMMUNOL, V40, P413, DOI 10.1016/S0161-5890(03)00160-3; NICOLAS M, 2002, EUR J BIOCHEM, V269, P1190; Nizet V, 2003, SCAND J INFECT DIS, V35, P670, DOI 10.1080/00365540310015629; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Otvos L, 2002, CELL MOL LIFE SCI, V59, P1138, DOI 10.1007/s00018-002-8493-8; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Raes J, 2005, TRENDS GENET, V21, P428, DOI 10.1016/j.tig.2005.05.013; SHAFER WM, 1997, ANTIBACTERIAL PEPTID; SKERLAVAJ B, 1990, INFECT IMMUN, V58, P3724, DOI 10.1128/IAI.58.11.3724-3730.1990; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Yamakawa M., 1998, TECHNIQUES INSECT IM, P103; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; ZHAO CQ, 1994, FEBS LETT, V346, P285, DOI 10.1016/0014-5793(94)00493-5; Zhu S, 2008, CELL MOL LIFE SCI, V65, P1285, DOI 10.1007/s00018-008-8070-x; Zhu SY, 2008, TRENDS MICROBIOL, V16, P353, DOI 10.1016/j.tim.2008.05.007; Zhu SY, 2008, MOL IMMUNOL, V45, P2531, DOI 10.1016/j.molimm.2008.01.007	41	21	22	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					13	20		10.1096/fj.08-114579	http://dx.doi.org/10.1096/fj.08-114579			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18796560				2022-12-25	WOS:000262095500004
J	Becerra, SP; Perez-Mediavilla, LA; Weldon, JE; Locatelli-Hoops, S; Senanayake, P; Notari, L; Notario, V; Hollyfield, JG				Becerra, S. Patricia; Perez-Mediavilla, L. Alberto; Weldon, John E.; Locatelli-Hoops, Silvia; Senanayake, Preenie; Notari, Luigi; Notario, Vicente; Hollyfield, Joe G.			Pigment Epithelium-derived Factor Binds to Hyaluronan MAPPING OF A HYALURONAN BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERPHOTORECEPTOR MATRIX; FACTOR PEDF; TUMOR-GROWTH; RETINOBLASTOMA CELLS; EXTRACELLULAR-MATRIX; CHONDROITIN SULFATE; GENE; ANGIOGENESIS; GLYCOSAMINOGLYCANS; DIFFERENTIATION	Pigment epithelium-derived factor (PEDF) is a multifunctional serpin with antitumorigenic, antimetastatic, and differentiating activities. PEDF is found within tissues rich in the glycosaminoglycan hyaluronan (HA), and its amino acid sequence contains putative HA-binding motifs. We show that PEDF coprecipitation with glycosaminoglycans in media conditioned by human retinoblastoma Y-79 cells decreased after pretreatments with hyaluronidase, implying an association between HA and PEDF. Direct binding of human recombinant PEDF to highly purified HA was demonstrated by coprecipitation in the presence of cetylpyridinium chloride. Binding of PEDF to HA was concentration-dependent and saturable. The PEDF-HA interactions were sensitive to increasing NaCl concentrations, indicating an ionic nature of these interactions and having affinity higher than PEDF-heparin. Competition assays showed that PEDF can bind heparin and HA simultaneously. PEDF chemically modified with fluorescein retained the capacity for interacting with HA but lacked heparin affinity, suggesting one or more distinct HA-binding regions on PEDF. The HA-binding region was examined by site-directed mutagenesis. Single-point and cumulative alterations at basic residues within the putative HA-binding motif K189A/K191A/R194A/K197A drastically reduced the HA-binding activity without affecting heparin-or collagen I binding of PEDF. Cumulative alterations at sites critical for heparin binding (K146A/K147A/R149A) decreased HA affinity but not collagen I binding. Thus these clusters of basic residues (BXBXXBXXB and BX(3)AB(2)XB motifs) in PEDF are functional regions for binding HA. In the spatial PEDF structure they are located in distinct areas away from the collagen-binding site. The HA-binding activity of PEDF may contribute to deposition in the extracellular matrix and to its reported antitumor/antimetastatic effects.	[Becerra, S. Patricia; Perez-Mediavilla, L. Alberto; Weldon, John E.; Locatelli-Hoops, Silvia; Notari, Luigi] NEI, NIH, Bethesda, MD 20892 USA; [Perez-Mediavilla, L. Alberto] Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Senanayake, Preenie; Hollyfield, Joe G.] Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44195 USA; [Notario, Vicente] Georgetown Univ, Med Ctr, Dept Radiat Med, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Navarra; Case Western Reserve University; Cleveland Clinic Foundation; Georgetown University	Becerra, SP (corresponding author), NEI, NIH, Bldg 7,Rm 304,7 Mem Dr, Bethesda, MD 20892 USA.	becerrap@nei.nih.gov	/AFP-0764-2022; /AAB-6461-2022; Perez-Mediavilla, Alberto/A-5246-2011	Perez-Mediavilla, Alberto/0000-0003-1926-0972; Weldon, John/0000-0002-6516-9064	National Institutes of Health NEI Intramural Research Program; Educational and Cultural Department of the "Gobierno de Navarra," Spain; Foundation for Fighting Blindness; Research to Prevent Blindness to the Department of Ophthalmology; Cleveland Clinic Lerner College of Medicine;  [EY14240-1];  [EY 15638];  [RO1 CA64472]; NATIONAL CANCER INSTITUTE [R01CA064472] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000306, R24EY015638, R01EY014240, R56EY014240] Funding Source: NIH RePORTER	National Institutes of Health NEI Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Educational and Cultural Department of the "Gobierno de Navarra," Spain; Foundation for Fighting Blindness; Research to Prevent Blindness to the Department of Ophthalmology(Research to Prevent Blindness (RPB)); Cleveland Clinic Lerner College of Medicine; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health NEI Intramural Research Program. This work was also supported by the Educational and Cultural Department of the "Gobierno de Navarra," Spain (to A. P.-M.); by Grants EY14240-1 and EY 15638, Foundation for Fighting Blindness, and a Challenge Grant from Research to Prevent Blindness to the Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine (to J. G. H.); and by Grant RO1 CA64472 (to V. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acharya S, 1998, J BIOL CHEM, V273, P31599, DOI 10.1074/jbc.273.47.31599; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Alberdi Elena M, 2003, BMC Biochem, V4, P1, DOI 10.1186/1471-2091-4-1; Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Chen QY, 2004, J BIOL CHEM, V279, P23142, DOI 10.1074/jbc.M401584200; Crawford SE, 2001, J CELL SCI, V114, P4421; des Senanayake P, 2001, J CELL SCI, V114, P199; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Fernandez-Garcia NI, 2007, J MOL MED-JMM, V85, P15, DOI 10.1007/s00109-006-0111; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Goodstone NJ, 1998, ARCH BIOCHEM BIOPHYS, V350, P26, DOI 10.1006/abbi.1997.0472; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; GUO YJ, 1994, CANCER RES, V54, P422; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Hollyfield JG, 1997, EXP EYE RES, V65, P603, DOI 10.1006/exer.1997.0369; Hollyfield JG, 1998, EXP EYE RES, V66, P241, DOI 10.1006/exer.1997.0422; Hosomichi J, 2005, BIOCHEM BIOPH RES CO, V335, P756, DOI 10.1016/j.bbrc.2005.07.140; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Knudson W, 1996, AM J PATHOL, V148, P1721; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; McDonald J, 2002, J BIOL CHEM, V277, P4575, DOI 10.1074/jbc.R100064200; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Mohapatra S, 1996, J EXP MED, V183, P1663, DOI 10.1084/jem.183.4.1663; Normand G, 1998, GLYCOBIOLOGY, V8, P1227, DOI 10.1093/glycob/8.12.1227; Ortego J, 1996, INVEST OPHTH VIS SCI, V37, P2759; Perez-Mediavilla LA, 1998, BBA-GENE STRUCT EXPR, V1398, P203, DOI 10.1016/S0167-4781(98)00055-4; SEIGEL GM, 1994, GROWTH FACTORS, V10, P289, DOI 10.3109/08977199409010995; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stratikos E, 1996, PROTEIN SCI, V5, P2575, DOI 10.1002/pro.5560051220; Streck CJ, 2005, J PEDIATR SURG, V40, P236, DOI 10.1016/j.jpedsurg.2004.09.049; SY MS, 1992, J EXP MED, V176, P623, DOI 10.1084/jem.176.2.623; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Valnickova Z, 2007, J BIOL CHEM, V282, P6661, DOI 10.1074/jbc.M610471200; Wang L, 2003, MOL THER, V8, P72, DOI 10.1016/S1525-0016(03)00128-X; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Wu YQ, 1996, INVEST OPHTH VIS SCI, V37, P1984; WU YQ, 1995, PROTEIN EXPRES PURIF, V6, P447, DOI 10.1006/prep.1995.1060; Xu XM, 2003, CANCER RES, V63, P5685; Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558	50	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33310	33320		10.1074/jbc.M801287200	http://dx.doi.org/10.1074/jbc.M801287200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18805795	hybrid, Green Published			2022-12-25	WOS:000261183700035
J	Konrad, S; Ali, SR; Wiege, K; Syed, SN; Engling, L; Piekorz, RP; Hirsch, E; Nurnberg, B; Schmidt, RE; Gessner, JE				Konrad, Stephanie; Ali, Syed R.; Wiege, Kristina; Syed, Shahzad N.; Engling, Linda; Piekorz, Roland P.; Hirsch, Emilio; Nuernberg, Bernd; Schmidt, Reinhold E.; Gessner, J. Engelbert			Phosphoinositide 3-Kinases gamma and delta, Linkers of Coordinate C5a Receptor-Fc gamma Receptor Activation and Immune Complex-induced Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; T-CELL; AIRWAY INFLAMMATION; ARTHUS REACTION; LUNG-DISEASE; P110-DELTA; PI3K-GAMMA; MICE; AUTOIMMUNITY; GENERATION	Fc gamma receptors (Fc gamma R) and the C5a receptor (C5aR) are key effectors of the acute inflammatory response to IgG immune complexes (IC). Their coordinated activation is critical in IC-induced diseases, although the significance of combined signaling by these two different receptor classes in tissue injury is unclear. Here we used the mouse model of the passive reverse lung Arthus reaction to define their requirements for distinct phosphoinositide 3-kinase (PI3K) activities in vivo. We show that genetic deletion of class IB PI3K gamma abrogates C5aR signaling that is crucial for Fc gamma R-mediated activation of lung macrophages. Thus, in PI3K gamma(-/-) mice, IgG IC-induced Fc gamma R regulation, cytokine release, and neutrophil recruitment were blunted. Notably, however, C5a production occurred normally in PI3K gamma(-/-) mice but was impaired in PI3K gamma(-/-) mice. Consequently, class IA PI3K delta deficiency caused resistance to acute IC lung injury. These results demonstrate that PI3K gamma and PI3K delta coordinate the inflammatory effects of C5aR and Fc gamma R and define PI3K delta as a novel and essential element of Fc gamma R signaling in the generation of C5a in IC disease.	[Konrad, Stephanie; Ali, Syed R.; Wiege, Kristina; Syed, Shahzad N.; Engling, Linda; Schmidt, Reinhold E.; Gessner, J. Engelbert] Hannover Med Sch, Clin Immunol & Rheumatol, Mol Immunol Res Unit, D-30625 Hannover, Germany; [Gessner, J. Engelbert] Hannover Med Sch, Collaborat Res Program Deutsch Forschungsgemeinsc, D-30625 Hannover, Germany; [Piekorz, Roland P.; Nuernberg, Bernd] Univ Dusseldorf, Dept Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Hirsch, Emilio] Univ Turin, Dept Genet Biol & Biochem, I-10124 Turin, Italy	Hannover Medical School; Hannover Medical School; Heinrich Heine University Dusseldorf; University of Turin	Gessner, JE (corresponding author), Hannover Med Sch, Clin Immunol & Rheumatol, Mol Immunol Res Unit, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gessner.johannes@mh-hannover.de	Hirsch, Emilio/F-4848-2013; ali, syed/J-6124-2014; Ali, Syed/M-7418-2013	Hirsch, Emilio/0000-0002-9073-6024; Syed, Shahzad Nawaz/0000-0002-6660-6561; Nurnberg, Bernd/0000-0002-5995-6555	Deutsche Forschungsgemeinschaft [SFB 587, FOR 729]; Fonds der Chemischen Industrie; Freundesgesellschaft der Medizinische Hochschule Hannover	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Freundesgesellschaft der Medizinische Hochschule Hannover	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB 587 (to J. E. G.) and FOR 729 (to B. N.) and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a fellowship of the international M.D./Ph.D. program provided by the Freundesgesellschaft der Medizinische Hochschule Hannover. Present address: Dept. of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636.	Al-Alwan MM, 2007, J IMMUNOL, V178, P2328, DOI 10.4049/jimmunol.178.4.2328; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Barberis L, 2008, THROMB HAEMOSTASIS, V99, P279, DOI 10.1160/TH07-10-0632; Canetti C, 2007, J IMMUNOL, V179, P8350, DOI 10.4049/jimmunol.179.12.8350; Chouchakova N, 2001, J IMMUNOL, V166, P5193, DOI 10.4049/jimmunol.166.8.5193; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kim N, 2007, BLOOD, V110, P3202, DOI 10.1182/blood-2007-02-075366; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Konrad S, 2007, J BIOL CHEM, V282, P37906, DOI 10.1074/jbc.M707937200; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Medina-Tato DA, 2007, IMMUNOLOGY, V121, P448, DOI 10.1111/j.1365-2567.2007.02663.x; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Okkenhaug K, 2003, BIOCHEM SOC T, V31, P270, DOI 10.1042/bst0310270; Okkenhaug K, 2002, SCIENCE, V297, P1031; PIEKORZ RP, 2004, PHOSPHOLIPID KINASES; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Radeke HH, 2002, J BIOL CHEM, V277, P27535, DOI 10.1074/jbc.M200419200; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schiller C, 2000, EUR J IMMUNOL, V30, P481; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; STEVENS JH, 1986, J CLIN INVEST, V77, P1812, DOI 10.1172/JCI112506; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Thomas MJ, 2005, EUR J IMMUNOL, V35, P1283, DOI 10.1002/eji.200425634; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Volanakis J. E., 1998, HUMAN COMPLEMENT SYS; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8	51	37	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33296	33303		10.1074/jbc.M804617200	http://dx.doi.org/10.1074/jbc.M804617200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18786920	hybrid, Green Published			2022-12-25	WOS:000261183700033
J	Bravo, R; Arimon, M; Valle-Delgado, JJ; Garcia, R; Durany, N; Castel, S; Cruz, M; Ventura, S; Fernandez-Busquets, X				Bravo, Ramona; Arimon, Muriel; Valle-Delgado, Juan Jose; Garcia, Raquel; Durany, Nuria; Castel, Susanna; Cruz, Montserrat; Ventura, Salvador; Fernandez-Busquets, Xavier			Sulfated Polysaccharides Promote the Assembly of Amyloid beta(1-42) Peptide into Stable Fibrils of Reduced Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; CHONDROITIN SULFATE; ALZHEIMERS-DISEASE; HEPARAN-SULFATE; LIPID-BILAYERS; BETA PEPTIDES; PROTEIN-TAU; CALCIUM; GLYCOSAMINOGLYCANS; PROTEOGLYCANS	The histopathological hallmarks of Alzheimer disease are the self-aggregation of the amyloid beta peptide (A beta) in extracellular amyloid fibrils and the formation of intraneuronal Tau filaments, but a convincing mechanism connecting both processes has yet to be provided. Here we show that the endogenous polysaccharide chondroitin sulfate B (CSB) promotes the formation of fibrillar structures of the 42-residue fragment, A beta(1-42). Atomic force microscopy visualization, thioflavin T fluorescence, CD measurements, and cell viability assays indicate that CSB-induced fibrils are highly stable entities with abundant beta-sheet structure that have little toxicity for neuroblastoma cells. We propose a wedged cylinder model for A beta(1-42) fibrils that is consistent with the majority of available data, it is an energetically favorable assembly that minimizes the exposure of hydrophobic areas, and it explains why fibrils do not grow in thickness. Fluorescence measurements of the effect of different A beta(1-42) species on Ca2+ homeostasis show that weakly structured nodular fibrils, but not CSB-induced smooth fibrils, trigger a rise in cytosolic Ca2+ that depends on the presence of both extracellular and intracellular stocks. In vitro assays indicate that such transient, local Ca2+ increases can have a direct effect in promoting the formation of Tau filaments similar to those isolated from Alzheimer disease brains.	[Fernandez-Busquets, Xavier] Univ Barcelona, Nanobioengn Grp, Biomol Interact Team, Inst Bioengn Catalonia, E-08028 Barcelona, Spain; Univ Barcelona, Nanosci & Nanotechnol Inst, E-08028 Barcelona, Spain; [Garcia, Raquel; Castel, Susanna; Cruz, Montserrat] Univ Barcelona, Scientif & Tech Serv, E-08028 Barcelona, Spain; [Durany, Nuria] Univ Int Catalunya, Fac Ciencies Salut, E-08195 Sant Cugat Del Valles, Spain; [Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; University of Barcelona; Universitat Internacional de Catalunya (UIC); Autonomous University of Barcelona; Autonomous University of Barcelona	Fernandez-Busquets, X (corresponding author), Univ Barcelona, Nanobioengn Grp, Biomol Interact Team, Inst Bioengn Catalonia, Barcelona Sci Pk,Baldiri Reixac 10, E-08028 Barcelona, Spain.	xfernandez_busquets@ub.edu	Ventura, Salvador/C-7021-2008; Fernàndez-Busquets, Xavier/K-1323-2014; Arimon, Muriel/I-4054-2015; Ventura, Salvador/AAY-3170-2021; Castel, Susana/D-4642-2014; Valle-Delgado, Juan Jose/H-8857-2013	Ventura, Salvador/0000-0002-9652-6351; Fernàndez-Busquets, Xavier/0000-0002-4622-9631; Arimon, Muriel/0000-0002-0894-3324; Ventura, Salvador/0000-0002-9652-6351; Castel, Susana/0000-0002-4551-8204; Valle-Delgado, Juan Jose/0000-0002-4808-1730	Generalitat de Catalunya, Spain [2005-SGR00037]; Ministerio de Ciencia e Innovacion (MCI), Spain [BIO2002-00128, BIO2005-01591, CSD2006-00012]; Juan de la Cierva Programme	Generalitat de Catalunya, Spain(Generalitat de Catalunya); Ministerio de Ciencia e Innovacion (MCI), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva Programme	This work was supported in part by the Generalitat de Catalunya, Spain (Grant 2005-SGR00037) and the Ministerio de Ciencia e Innovacion (MCI), Spain (Grants BIO2002-00128, BIO2005-01591, and CSD2006-00012), which included Fondo Europeo de Desarrollo Regional funds. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Juan de la Cierva Programme (MCI).	Adamec E, 2002, ACTA NEUROPATHOL, V104, P92, DOI 10.1007/s00401-002-0528-6; Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Cecchi C, 2005, J CELL SCI, V118, P3459, DOI 10.1242/jcs.02473; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Christensen RA, 2004, J BIOL CHEM, V279, P53524, DOI 10.1074/jbc.M408473200; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DeGroot J, 2004, CURR OPIN PHARMACOL, V4, P301, DOI 10.1016/j.coph.2004.01.007; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Garcia-Manyes S, 2005, BIOPHYS J, V89, P1812, DOI 10.1529/biophysj.105.064030; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Green JD, 2004, J MOL BIOL, V342, P877, DOI 10.1016/j.jmb.2004.07.052; GRUETTER R, 1992, P NATL ACAD SCI USA, V89, P1109, DOI 10.1073/pnas.89.3.1109; GUPTABANSAL R, 1995, J BIOL CHEM, V270, P18666, DOI 10.1074/jbc.270.31.18666; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Hirschfield GM, 2003, INT J BIOCHEM CELL B, V35, P1608, DOI 10.1016/S1357-2725(03)00169-9; Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8; Kawahara M, 2000, BRAIN RES BULL, V53, P389, DOI 10.1016/S0361-9230(00)00370-1; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin MCA, 2002, PEPTIDES, V23, P1215, DOI 10.1016/S0196-9781(02)00057-8; Losic D, 2006, BIOPOLYMERS, V84, P519, DOI 10.1002/bip.20549; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Malinchik SB, 1998, BIOPHYS J, V74, P537, DOI 10.1016/S0006-3495(98)77812-9; Mandavilli A, 2006, NAT MED, V12, P747, DOI 10.1038/nm0706-747; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; McLaurin J, 2000, EUR J BIOCHEM, V267, P6353, DOI 10.1046/j.1432-1327.2000.01725.x; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; MEYERPUTTLITZ B, 1995, J NEUROCHEM, V65, P2327; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Naito A, 2007, BBA-BIOMEMBRANES, V1768, P1900, DOI 10.1016/j.bbamem.2007.03.025; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Roher AE, 2000, BBA-MOL BASIS DIS, V1502, P31, DOI 10.1016/S0925-4439(00)00030-2; Ruben GC, 2005, MICROSC RES TECHNIQ, V67, P175, DOI 10.1002/jemt.20197; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; SERPELL LC, 1995, J MOL BIOL, V254, P113, DOI 10.1006/jmbi.1995.0604; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Widenbrant MJO, 2006, BIOPHYS J, V91, P4071, DOI 10.1529/biophysj.106.085944; Wolfe MS, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0506-72; WOODS AG, 1995, BRAIN RES, V697, P53, DOI 10.1016/0006-8993(95)00775-L; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yang LS, 1999, J NEUROSCI RES, V55, P36, DOI 10.1002/(SICI)1097-4547(19990101)55:1<36::AID-JNR5>3.3.CO;2-5; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	81	67	74	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32471	32483		10.1074/jbc.M709870200	http://dx.doi.org/10.1074/jbc.M709870200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819917	hybrid			2022-12-25	WOS:000260893700035
J	Cassera, MB; Hazleton, KZ; Riegelhaupt, PM; Merino, EF; Luo, MK; Akabas, MH; Schramm, VL				Cassera, Maria B.; Hazleton, Keith Z.; Riegelhaupt, Paul M.; Merino, Emilio F.; Luo, Minkui; Akabas, Myles H.; Schramm, Vern L.			Erythrocytic Adenosine Monophosphate as an Alternative Purine Source in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PFNT1 NUCLEOSIDE TRANSPORTER; PARASITE PLASMA-MEMBRANE; TRANSITION-STATE ANALOG; DRUG-RESISTANT MALARIA; XENOPUS-LAEVIS OOCYTES; PYRIMIDINE METABOLISM; ADENYLATE KINASE; IN-VITRO; INHIBITORS; PHOSPHORYLASE	Plasmodium falciparum is a purine auxotroph, salvaging purines from erythrocytes for synthesis of RNA and DNA. Hypoxanthine is the key precursor for purine metabolism in Plasmodium. Inhibition of hypoxanthine-forming reactions in both erythrocytes and parasites is lethal to cultured P. falciparum. We observed that high concentrations of adenosine can rescue cultured parasites from purine nucleoside phosphorylase and adenosine deaminase blockade but not when erythrocyte adenosine kinase is also inhibited. P. falciparum lacks adenosine kinase but can salvage AMP synthesized in the erythrocyte cytoplasm to provide purines when both human and Plasmodium purine nucleoside phosphorylases and adenosine deaminases are inhibited. Transport studies in Xenopus laevis oocytes expressing the P. falciparum nucleoside transporter PfNT1 established that this transporter does not transport AMP. These metabolic patterns establish the existence of a novel nucleoside monophosphate transport pathway in P. falciparum.	[Cassera, Maria B.; Hazleton, Keith Z.; Luo, Minkui; Schramm, Vern L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Riegelhaupt, Paul M.; Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Merino, Emilio F.] New York Univ, Langone Med Ctr, Dept Med Parasitol, New York, NY 10010 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University; NYU Langone Medical Center	Schramm, VL (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	vern@aecom.yu.edu	Cassera, Maria/L-1572-2013; Hazleton, Keith Z./AAD-3979-2019	Hazleton, Keith Z./0000-0003-4098-3411; Akabas, Myles/0000-0001-8781-7846	National Institutes of Health [AI49512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant Al49512. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; BERMAN PA, 1991, J CLIN INVEST, V88, P1848, DOI 10.1172/JCI115506; BEUTLER E, 1983, J CLIN INVEST, V72, P648, DOI 10.1172/JCI111014; Boison D, 2008, PROG NEUROBIOL, V84, P249, DOI 10.1016/j.pneurobio.2007.12.002; Boison D, 2008, CURR OPIN PHARMACOL, V8, P2, DOI 10.1016/j.coph.2007.09.002; BRUNS RF, 1980, N-S ARCH PHARMACOL, V315, P5, DOI 10.1007/BF00504224; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; CHOI I, 1990, EXP PARASITOL, V71, P452, DOI 10.1016/0014-4894(90)90071-J; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hyde JE, 2005, TRENDS PARASITOL, V21, P494, DOI 10.1016/j.pt.2005.08.020; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; KANAANI J, 1989, J BIOL CHEM, V264, P3194; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Kimura EA, 1996, J BIOL CHEM, V271, P14452, DOI 10.1074/jbc.271.24.14452; Komarova SV, 1999, BLOOD CELL MOL DIS, V25, P171, DOI 10.1006/bcmd.1999.0243; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Luo M, 2008, J AM CHEM SOC, V130, P2649, DOI 10.1021/ja078008x; Luo MK, 2007, J AM CHEM SOC, V129, P8008, DOI 10.1021/ja072122y; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Matsuoka I, 2002, MOL PHARMACOL, V61, P606, DOI 10.1124/mol.61.3.606; McGaraughty S, 2005, CURR TOP MED CHEM, V5, P43, DOI 10.2174/1568026053386845; MOHRENWEISER HW, 1981, AM J HEMATOL, V11, P125, DOI 10.1002/ajh.2830110203; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Quashie NB, 2008, BIOCHEM J, V411, P287, DOI 10.1042/BJ20071460; Quashie NB, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-95; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Razakantoanina V, 2008, EXP PARASITOL, V118, P181, DOI 10.1016/j.exppara.2007.07.015; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Saliba KJ, 2006, NATURE, V443, P582, DOI 10.1038/nature05149; SANCHEZ G, 1976, COMP BIOCHEM PHYS B, V53, P419, DOI 10.1016/0305-0491(76)90351-5; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; SIMMONDS HA, 1989, BIOSCIENCE REP, V9, P75, DOI 10.1007/BF01117513; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stein A, 2003, J BIOL CHEM, V278, P35127, DOI 10.1074/jbc.M306188200; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tyler PC, 2007, J AM CHEM SOC, V129, P6872, DOI 10.1021/ja0708363; Webster H K, 1984, Adv Exp Med Biol, V165 Pt A, P225; ZIGANSHIN AU, 1995, PFLUG ARCH EUR J PHY, V429, P412, DOI 10.1007/BF00374157	49	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32889	32899		10.1074/jbc.M804497200	http://dx.doi.org/10.1074/jbc.M804497200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18799466	Green Published, hybrid			2022-12-25	WOS:000260893700078
J	Gao, XD; Moriyama, S; Miura, N; Dean, N; Nishimura, SI				Gao, Xiao-Dong; Moriyama, Satoru; Miura, Nobuaki; Dean, Neta; Nishimura, Shin-Ichiro			Interaction between the C Termini of Alg13 and Alg14 Mediates Formation of the Active UDP-N-acetylglucosamine Transferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN GLYCOSYLATION; TRANSCRIPT HETEROGENEITY; CRYSTAL-STRUCTURE; YEAST; MURG; GLYCOSYLTRANSFERASE; GENE; BIOSYNTHESIS	The second step of eukaryotic N-linked glycosylation in endoplasmic reticulum is catalyzed by an UDP-N-acetylglucosamine transferase that is comprised of two subunits, Alg13 and Alg14. The interaction between Alg13 and 14 is crucial for UDP-Glc-NAc transferase activity, so formation of the Alg13/14 complex is likely to play a key role in the regulation of N-glycosylation. Using a combination of bioinformatics and molecular biological methods, we have undertaken a functional analysis of yeast Alg13 and Alg14 proteins to elucidate the mechanism of their interaction. Our mutational studies demonstrated that a short C-terminal alpha-helix of Alg13 is required for interaction with Alg14 and for enzyme activity. Electrostatic surface views of the modeled Alg13/14 complex suggest the presence of a hydrophobic cleft in Alg14 that provides a pocket for the Alg13 C-terminal alpha-helix. Co-immunoprecipitation assays confirmed the C-terminal three amino acids of Alg14 are required for maintaining the integrity of Alg13/Alg14 complex, and this depends on their hydrophobicity. Modeling studies place these three Alg14 residues at the entrance of the hydrophobic-binding pocket, suggesting their role in the stabilization of the interaction between the C termini of Alg13 and Alg14. Together, these results demonstrate that formation of this hetero-oligomeric complex is mediated by a short C-terminal alpha-helix of Alg13 in cooperation with the last three amino acids of Alg14. In addition, deletion of the N-terminal beta-strand of Alg13 caused the destruction of protein, indicating the structural importance of this region in protein stability.	[Gao, Xiao-Dong; Moriyama, Satoru; Miura, Nobuaki; Nishimura, Shin-Ichiro] Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Dean, Neta; Nishimura, Shin-Ichiro] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Hokkaido University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Nishimura, SI (corresponding author), Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Adv Life Sci, Kita Ku, N21,W11, Sapporo, Hokkaido 0010021, Japan.	shin@glyco.sci.hokudai.ac.jp			Ministry of Education, Culture, Science, Sports and Technology of Japan; National Institutes of Health [R01-GM048467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048467] Funding Source: NIH RePORTER	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was mainly supported by funding from the Ministry of Education, Culture, Science, Sports and Technology of Japan for "Innovation COE Program for Future Drug Discovery and Medical Care." This work was also supported, in part, by National Institutes of Health Grant R01-GM048467 (to N.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBRIGHT CF, 1990, J BIOL CHEM, V265, P7042; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Averbeck N, 2008, MOL BIOL CELL, V19, P2169, DOI 10.1091/mbc.E07-10-1077; Bickel T, 2005, J BIOL CHEM, V280, P34500, DOI 10.1074/jbc.M506358200; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Chantret I, 2005, J BIOL CHEM, V280, P9236, DOI 10.1074/jbc.M413941200; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gao XD, 2005, J BIOL CHEM, V280, P36254, DOI 10.1074/jbc.M507569200; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Guharoy M, 2005, P NATL ACAD SCI USA, V102, P15447, DOI 10.1073/pnas.0505425102; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Ha S., 2001, Current Drug Targets - Infectious Disorders, V1, P201, DOI 10.2174/1568005014606116; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KUKURUZINSKA MA, 1987, P NATL ACAD SCI USA, V84, P2145, DOI 10.1073/pnas.84.8.2145; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; SIKORSKI RS, 1989, GENETICS, V122, P19; Wang X, 2008, STRUCTURE, V16, P965, DOI 10.1016/j.str.2008.03.010; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Zawadzke LE, 2003, ANAL BIOCHEM, V314, P243, DOI 10.1016/S0003-2697(02)00622-X	27	32	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32534	32541		10.1074/jbc.M804060200	http://dx.doi.org/10.1074/jbc.M804060200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809682	Green Published, hybrid			2022-12-25	WOS:000260893700042
J	Langel, FD; Jain, NA; Rossman, JS; Kingeter, LM; Kashyap, AK; Schaefer, BC				Langel, Felicia D.; Jain, Nidhi A.; Rossman, Jeremy S.; Kingeter, Lara M.; Kashyap, Anuj K.; Schaefer, Brian C.			Multiple Protein Domains Mediate Interaction between Bcl10 and MALT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL-ACTIVATION; ANTIGEN-RECEPTOR; FLUORESCENT PROTEIN; LYMPHOCYTE-ACTIVATION; CYTOKINE PRODUCTION; SIGNALING PATHWAY; CARMA1; REQUIREMENT; PARACASPASE	Bcl10 and MALT1 are essential mediators of NF-kappa B activation in response to the triggering of a diverse array of transmembrane receptors, including antigen receptors. Additionally, both proteins are translocation targets in MALT lymphoma. Thus, a detailed understanding of the interaction between these mediators is of considerable biological importance. Previous studies have indicated that a 13-amino acid region downstream of the Bcl10 caspase recruitment domain ( CARD) is responsible for interacting with the immunoglobulin-like domains of MALT1. We now provide evidence that the death domain of MALT1 and the CARD of Bcl10 also contribute to Bcl10-MALT1 interactions. Although a direct interaction between the MALT1 death domain and Bcl10 cannot be detected via immunoprecipitation, FRET data strongly suggest that the death domain of MALT1 contributes significantly to the association between Bcl10 and MALT1 in T cells in vivo. Furthermore, analysis of point mutants of conserved residues of Bcl10 shows that the Bcl10 CARD is essential for interaction with the MALT1 N terminus. Mutations that disrupt proper folding of the Bcl10 CARD strongly impair Bcl10-MALT1 interactions. Molecular modeling and functional analyses of Bcl10 point mutants suggest that residues Asp(80) and Glu(84) of helix 5 of the Bcl10 CARD directly contact MALT1. Together, these data demonstrate that the association between Bcl10 and MALT1 involves a complex interaction between multiple protein domains. Moreover, the Bcl10-MALT1 interaction is the second reported example of interactions between a CARD and a non-CARD protein region, which suggests that many signaling cascades may utilize CARD interactions with non-CARD domains.	[Langel, Felicia D.; Jain, Nidhi A.; Rossman, Jeremy S.; Kingeter, Lara M.; Kashyap, Anuj K.; Schaefer, Brian C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Schaefer, BC (corresponding author), 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	bschaefer@usuhs.mil		Schaefer, Brian C/0000-0001-8877-3507; Rossman, Jeremy/0000-0001-6124-4103	National Institutes of Health [AI057481]; Sidney Kimmel Society for Cancer Research; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Society for Cancer Research; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI057481 (to B. C. S.). This work was also supported by a Kimmel Scholar Award from the Sidney Kimmel Society for Cancer Research (to B. C. S.) and a grant from the Dana Foundation Program in Brain and Immunoimaging (to B. C. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guiet C, 2000, J CELL BIOL, V148, P1131, DOI 10.1083/jcb.148.6.1131; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li T, 2000, J VIROL, V74, P7646, DOI 10.1128/JVI.74.16.7646-7650.2000; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Malarkannan S, 2007, J IMMUNOL, V179, P3752, DOI 10.4049/jimmunol.179.6.3752; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rossman JS, 2006, MOL BIOL CELL, V17, P2166, DOI 10.1091/mbc.E05-10-0985; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez R, 2000, METH MOL B, V143, P97; Schaefer BC, 2004, P NATL ACAD SCI USA, V101, P1004, DOI 10.1073/pnas.0307858100; Schaefer BC, 2001, ANAL BIOCHEM, V297, P86, DOI 10.1006/abio.2001.5327; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; SIEGEL RM, 2000, SCI STKE, pPL1; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; WEGENER E, 2007, SCI STKE, pPE21; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	53	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32419	32431		10.1074/jbc.M800670200	http://dx.doi.org/10.1074/jbc.M800670200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806265	hybrid, Green Published			2022-12-25	WOS:000260893700030
J	Berchner-Pfannschmidt, U; Tug, S; Trinidad, B; Oehme, F; Yamac, H; Wotzlaw, C; Flamme, I; Fandrey, J				Berchner-Pfannschmidt, Utta; Tug, Suzan; Trinidad, Buena; Oehme, Felix; Yamac, Hatice; Wotzlaw, Christoph; Flamme, Ingo; Fandrey, Joachim			Nuclear Oxygen Sensing: Induction of Endogenous Prolyl-hydroxylase 2 Activity by Hypoxia and Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR 1-ALPHA; HIF-ALPHA; FACTOR-I; DEGRADATION; HIF-1-ALPHA; PROTEIN; FACTOR-1-ALPHA; EXPRESSION; DOMAIN; PHD2	The abundance of the transcription factor hypoxia-inducible factor is regulated through hydroxylation of its alpha-subunits by a family of prolyl-hydroxylases (PHD1-3). Enzymatic activity of these PHDs is O-2-dependent, which enables PHDs to act as cellular O-2 sensor enzymes. Herein we studied endogenous PHD activity that was induced in cells grown under hypoxia or in the presence of nitric oxide. Under such conditions nuclear extracts contained much higher PHD activity than the respective cytoplasmic extracts. Although PHD1-3 were abundant in both compartments, knockdown experiments for each isoenzyme revealed that nuclear PHD activity was only due to PHD2. Maximal PHD2 activity was found between 120 and 210 mu M O-2. PHD2 activity was strongly decreased below 100 mu M O-2 with a half-maximum activity at 53 +/- 13 mu M O-2 for the cytosolic and 54 +/- 10 mu M O-2 for nuclear PHD2 matching the physiological O-2 concentration within most cells. Our data suggest a role for PHD2 as a decisive oxygen sensor of the hypoxia-inducible factor degradation pathway within the cell nucleus.	[Berchner-Pfannschmidt, Utta; Tug, Suzan; Trinidad, Buena; Yamac, Hatice; Wotzlaw, Christoph; Fandrey, Joachim] Univ Duisburg Essen, Inst Physiol, D-45122 Essen, Germany; [Oehme, Felix; Flamme, Ingo] Bayer HealthCare, Inst Cardiovasc Res, D-42096 Wuppertal, Germany	University of Duisburg Essen; Bayer AG; Bayer Healthcare Pharmaceuticals	Fandrey, J (corresponding author), Univ Duisburg Essen, Inst Physiol, Hufelandstr 55, D-45122 Essen, Germany.	joachim.fandrey@uni-due.de	Fandrey, Joachim/AAA-3524-2021	Fandrey, Joachim/0000-0001-9585-0531	Deutsche Forschungsgemeinschaft [FA225/19-3]; European Commission [LSHM-CT-2005-018725]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Deutsche Forschungsgemeinschaft Grant FA225/19-3 and by the European Commission under 6th Framework Programme Contract LSHM-CT-2005-018725, PULMOTENSION.	ACKER H, 2003, OXYGEN SENSING RESPO, P507; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berchner-Pfannschmidt U, 2004, BIOL CHEM, V385, P231, DOI 10.1515/BC.2004.017; Berchner-Pfannschmidt U, 2007, J BIOL CHEM, V282, P1788, DOI 10.1074/jbc.M607065200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; METZEN E, 1995, RESP PHYSIOL, V100, P101, DOI 10.1016/0034-5687(94)00125-J; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Oehme F, 2004, ANAL BIOCHEM, V330, P74, DOI 10.1016/j.ab.2004.03.066; Pereira T, 2006, CELL CYCLE, V5, P2720, DOI 10.4161/cc.5.23.3536; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Soilleux EJ, 2005, HISTOPATHOLOGY, V47, P602, DOI 10.1111/j.1365-2559.2005.02280.x; Sonnenschein K, 2004, J BIOL CHEM, V279, P45433, DOI 10.1074/jbc.M405987200; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; VAUPEL P, 1991, CANCER RES, V51, P3316; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05	45	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31745	31753		10.1074/jbc.M804390200	http://dx.doi.org/10.1074/jbc.M804390200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18776187	hybrid			2022-12-25	WOS:000260760800057
J	Matsushita, H; Nakajima, H; Nakamura, Y; Tsukamoto, H; Tanaka, Y; Jin, G; Yabe, M; Asai, S; Ono, R; Nosaka, T; Sugita, K; Morimoto, A; Hayashi, Y; Hotta, T; Ando, K; Miyachi, H				Matsushita, H.; Nakajima, H.; Nakamura, Y.; Tsukamoto, H.; Tanaka, Y.; Jin, G.; Yabe, M.; Asai, S.; Ono, R.; Nosaka, T.; Sugita, K.; Morimoto, A.; Hayashi, Y.; Hotta, T.; Ando, K.; Miyachi, H.			C/EBP alpha and C/EBP epsilon induce the monocytic differentiation of myelomonocytic cells with the MLL-chimeric fusion gene	ONCOGENE			English	Article						acute myeloid leukemia; mixed lineage leukemia gene; monocytic differentiation; CCAAT/enhancer binding protein-alpha; CCAAT/enhancer binding protein-epsilon	COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; BINDING-PROTEIN-ALPHA; TRANS-RETINOIC ACID; GRANULOCYTIC DIFFERENTIATION; DEFICIENT MICE; PU.1 GENE; EXPRESSION; PROGENITORS; MACROPHAGE	CCAAT/enhancer binding proteins (C/EBPs) have an important function in granulocytic differentiation, and are also involved in the leukemogenesis of acute myeloid leukemia (AML). Their involvement in myelomonocytic leukemia, however, is still unclear. Therefore, the expression and function of C/EBPs in myelomonocytic cells with MLL-fusion genes were investigated. Retinoic acid (RA) induced monocytic differentiation in the myelomonocytic cell lines with MLL-fusion genes, THP-1, MOLM-14 and HF-6 cells, accompanied by monocytic differentiation with the upregulation of C/EBP alpha and C/EBP epsilon. Monocytic differentiation by RA treatment was confirmed in primary AML cells using a clonogenic assay. When the activity of C/EBP alpha or C/EBP epsilon was introduced into HF-6 cells, their cellular growth was arrested through differentiation into monocytes with the concomitant marked downregulation of Myc. Cebpe mRNA was upregulated by the induction of C/EBP alpha-ER, but not vice versa, thus suggesting that C/EBP epsilon may have an important function in the differentiation process. Introduction of Myc isoforms into HF-6 cells partially antagonized the C/EBP alpha effects. These findings suggest that the ectopic expression of C/EBP epsilon, as well as C/EBP alpha, can induce the monocytic differentiation of myelomonocytic leukemic cells with MLL-fusion gene through the downregulation of Myc, thus providing insight into the development of novel therapeutic approaches.	[Matsushita, H.; Tanaka, Y.; Jin, G.; Yabe, M.; Asai, S.; Miyachi, H.] Tokai Univ, Sch Med, Dept Lab Med, Kanagawa 2591193, Japan; [Nakajima, H.] Univ Tokyo, Inst Med Sci, Ctr Excellence, Tokyo, Japan; [Nakamura, Y.; Tsukamoto, H.] Tokai Univ, Sch Med, Teaching & Res Support Ctr, Kanagawa 2591193, Japan; [Ono, R.; Nosaka, T.] Mie Univ, Grad Sch Med, Dept Microbiol, Tsu, Mie, Japan; [Sugita, K.] Univ Yamanashi, Sch Med, Dept Pediat, Yamanashi, Japan; [Morimoto, A.] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto 602, Japan; [Hayashi, Y.] Gunma Childrens Med Ctr, Dept Hematol Oncol, Gunma, Japan; [Hotta, T.; Ando, K.] Tokai Univ, Sch Med, Dept Hematol, Kanagawa 2591193, Japan	Tokai University; University of Tokyo; Tokai University; Mie University; University of Yamanashi; Kyoto Prefectural University of Medicine; Gunma Children's Medical Centre; Tokai University	Matsushita, H (corresponding author), Tokai Univ, Sch Med, Dept Lab Med, 143 Shimokasuya, Kanagawa 2591193, Japan.	hmatsu@is.icc.u-tokai.ac.jp	松下, 弘道/AEX-6164-2022	松下, 弘道/0000-0002-1629-6630	Ministry of Education, Culture, Sports, Science and Technology of Japan [19591139]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr Toshio Kitamura (Institute of Medical Science, University of Tokyo, Tokyo, Japan) for providing PLAT-E cells. This study was supported in part by Research and Study Program of Tokai University Educational System General Research Organization and a Grant-in Aid for Scientific Research (C) No. 19591139 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; De Braekeleer M, 2005, ANTICANCER RES, V25, P1931; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; Fukuchi Y, 2006, EMBO J, V25, P3398, DOI 10.1038/sj.emboj.7601199; Gery S, 2004, BLOOD, V103, P828, DOI 10.1182/blood-2003-01-0159; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; HEMMI H, 1985, JPN J CANCER RES, V76, P345; Iijima K, 2004, LEUKEMIA LYMPHOMA, V45, P1017, DOI 10.1080/1042819031000163887; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Kawada H, 1999, EXP HEMATOL, V27, P904, DOI 10.1016/S0301-472X(99)00012-0; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kubota T, 2000, BLOOD, V96, P3953, DOI 10.1182/blood.V96.12.3953.h8003953_3953_3957; Kummalue T, 2003, J LEUKOCYTE BIOL, V74, P464, DOI 10.1189/jlb.1202622; Lee IH, 2002, BIOCHEM BIOPH RES CO, V294, P956, DOI 10.1016/S0006-291X(02)00581-8; Lee YJ, 2006, BLOOD, V108, P2416, DOI 10.1182/blood-2006-02-003582; Li ZY, 2005, LEUKEMIA, V19, P183, DOI 10.1038/sj.leu.2403602; Mueller BU, 2006, BLOOD, V107, P3330, DOI 10.1182/blood-2005-07-3068; Nakajima H, 2001, BLOOD, V98, P897, DOI 10.1182/blood.V98.4.897; Nakajima H, 2006, J BIOL CHEM, V281, P14494, DOI 10.1074/jbc.M600575200; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Ono R, 2005, J CLIN INVEST, V115, P919, DOI 10.1172/JCI200522725; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Schoch C, 2003, BLOOD, V102, P2395, DOI 10.1182/blood-2003-02-0434; Schreiner S, 2001, CANCER RES, V61, P6480; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Tavor S, 2002, BLOOD, V99, P1794, DOI 10.1182/blood.V99.5.1794; Truong BTH, 2003, BLOOD, V101, P1141, DOI 10.1182/blood-2002-05-1374; Walkley CR, 2004, BLOOD, V103, P1286, DOI 10.1182/blood-2003-07-2391; Wang D, 2006, BLOOD, V108, P1223, DOI 10.1182/blood-2005-12-008763; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Williams SC, 1998, J BIOL CHEM, V273, P13493, DOI 10.1074/jbc.273.22.13493; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zheng R, 2004, BLOOD, V103, P1883, DOI 10.1182/blood-2003-06-1978	41	16	16	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2008	27	53					6749	6760		10.1038/onc.2008.285	http://dx.doi.org/10.1038/onc.2008.285			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	371XO	18776924	Bronze			2022-12-25	WOS:000260866200005
J	Leikam, C; Hufnagel, A; Schartl, M; Meierjohann, S				Leikam, C.; Hufnagel, A.; Schartl, M.; Meierjohann, S.			Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence	ONCOGENE			English	Article						ROS; melanoma; senescence; oncogene; N-RAS; melanocyte	RECEPTOR TYROSINE KINASE; CELL-CYCLE ARREST; GROWTH-FACTOR; MALIGNANT-MELANOMA; RAS; EXPRESSION; PROTEIN; MUTATIONS; P53; PHOSPHORYLATION	Contrary to malignant melanoma, nevi are a benign form of melanocytic hyperproliferation. They are frequently observed as precursor lesions of melanoma, but they also feature biochemical markers of senescence. In particular, evidence for oncogene-induced melanocyte senescence as natural means to prevent tumorigenesis has been obtained in nevi with mutated B-Raf(V600E). Here, we demonstrate that strong oncogenic growth factor receptor signalling drives melanocytes into senescence, whereas weaker signals keep them in the proliferative state. Activation of oncogene-induced senescence also produces multinucleated giant cells, a long known histological feature of nevus cells. The protein levels of the senescence mediators, p53 and pRB, and their upstream activators do not correlate with senescence. However, strong oncogene signalling leads to pronounced reactive oxygen stress, and scavenging of reactive oxygen species (ROS) efficiently prevents the formation of multinucleated cells and senescence. Similarly, expression of oncogenic N-RAS results in ROS generation, DNA damage and the same multinuclear senescent phenotype. Hence, we identified oncogenic signalling-dependent ROS production as critical mediator of the melanocytic multinuclear phenotype and senescence, both of them being hallmarks of human nevus cells.	[Leikam, C.; Hufnagel, A.; Schartl, M.; Meierjohann, S.] Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Germany	University of Wurzburg	Meierjohann, S (corresponding author), Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Germany.	svenja.meierjohann@biozentrum.uni-wuerzburg.de		Schartl, Manfred/0000-0001-9882-5948	Deutsche Forschungsgesellschaft; German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg	Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg	We thank Dr Thorsten Stiewe for kindly providing the PAB 122 hybridoma supernatant and Professor Jurgen Hoppe for his help with the time lapse experiment. In addition, we thank Johannes Haydn for generating the melan a pWHE459 cell lines and Toni Wagner for great technical support. This work was supported by the Deutsche Forschungsgesellschaft, Transregio 17 ('RAS-dependent pathways in human cancer'). CL was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bardeesy N, 2005, MOL CELL BIOL, V25, P4176, DOI 10.1128/MCB.25.10.4176-4188.2005; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; BENNETT DC, 1989, DEVELOPMENT, V105, P379; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806; Chang DLF, 2007, ONCOGENE, V26, P4627, DOI 10.1038/sj.onc.1210254; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Chen CR, 2005, CANCER RES, V65, P6017, DOI 10.1158/0008-5472.CAN-05-0677; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Debidda M, 2006, J BIOL CHEM, V281, P38519, DOI 10.1074/jbc.M604607200; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Finkel T, 2006, ANTIOXID REDOX SIGN, V8, P1857, DOI 10.1089/ars.2006.8.1857; Geissinger E, 2002, CANCER RES, V62, P4820; Goding C R, 2000, Forum (Genova), V10, P176; Gorla GR, 2001, J CELL SCI, V114, P2943; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Haluska FG, 2006, CLIN CANCER RES, V12, p2301S, DOI 10.1158/1078-0432.CCR-05-2518; Hayashi C, 2007, J CELL BIOCHEM, V101, P979, DOI 10.1002/jcb.21298; Hirose Y, 2005, CANCER RES, V65, P4861, DOI 10.1158/0008-5472.CAN-04-2633; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Itahana K, 2002, J BIOL CHEM, V277, P18206, DOI 10.1074/jbc.M201028200; Jones CJ, 2000, MOL CELL BIOL, V20, P5690, DOI 10.1128/MCB.20.15.5690-5699.2000; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Krueger C, 2006, J GENE MED, V8, P1037, DOI 10.1002/jgm.932; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; Lachat Y, 2004, ONCOGENE, V23, P6854, DOI 10.1038/sj.onc.1207872; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; LEOPOLD JG, 1967, J PATHOL BACTERIOL, V94, P247, DOI 10.1002/path.1700940203; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; Meierjohann S, 2006, CANCER RES, V66, P3145, DOI 10.1158/0008-5472.CAN-05-2667; Meierjohann S, 2006, TRENDS GENET, V22, P654, DOI 10.1016/j.tig.2006.09.013; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mirmohammadsadegh A, 2006, J INVEST DERMATOL, V126, P2272, DOI 10.1038/sj.jid.5700385; NATALI PG, 1993, BRIT J CANCER, V68, P746, DOI 10.1038/bjc.1993.422; Nuciforo PG, 2007, CARCINOGENESIS, V28, P2082, DOI 10.1093/carcin/bgm108; Passos JF, 2006, FREE RADICAL RES, V40, P1277, DOI 10.1080/10715760600917151; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rangel J, 2008, CANCER-AM CANCER SOC, V112, P144, DOI 10.1002/cncr.23147; Rincheval V, 2002, BIOCHEM BIOPH RES CO, V298, P282, DOI 10.1016/S0006-291X(02)02454-3; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Satyamoorthy K, 2003, CANCER RES, V63, P756; SAVCHENKO YY, 1988, TSITOL GENET+, V22, P20; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Spyridopoulos I, 2002, BASIC RES CARDIOL, V97, P117, DOI 10.1007/s003950200001; Straume O, 2000, CLIN CANCER RES, V6, P1845; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Wellbrock C, 1999, EUR J BIOCHEM, V260, P275, DOI 10.1046/j.1432-1327.1999.00180.x; Wellbrock C, 1998, ONCOGENE, V16, P3047, DOI 10.1038/sj.onc.1201844; Wellbrock C, 2005, CURR BIOL, V15, P1629, DOI 10.1016/j.cub.2005.08.036; Wellbrock C, 2002, J BIOL CHEM, V277, P6443, DOI 10.1074/jbc.M110684200; WITTBRODT J, 1992, EMBO J, V11, P4239, DOI 10.1002/j.1460-2075.1992.tb05518.x; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598	70	60	60	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2008	27	56					7070	7082		10.1038/onc.2008.323	http://dx.doi.org/10.1038/onc.2008.323			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	376PQ	18806824				2022-12-25	WOS:000261195900002
J	Sen, D; Deerinck, TJ; Ellisman, MH; Parker, I; Cahalan, MD				Sen, Debasish; Deerinck, Thomas J.; Ellisman, Mark H.; Parker, Ian; Cahalan, Michael D.			Quantum Dots for Tracking Dendritic Cells and Priming an Immune Response In Vitro and In Vivo	PLOS ONE			English	Article								Dendritic cells (DCs) play a key role in initiating adaptive immune response by presenting antigen to T cells in lymphoid organs. Here, we investigate the potential of quantum dots (QDs) as fluorescent nanoparticles for in vitro and in vivo imaging of DCs, and as a particle-based antigen-delivery system to enhance DC-mediated immune responses. We used confocal, two-photon, and electron microscopies to visualize QD uptake into DCs and compared CD69 expression, T cell proliferation, and IFN-gamma production by DO11.10 and OT-II T cells in vivo in response to free antigen or antigen-conjugated to QDs. CD11c(+) DCs avidly and preferentially endocytosed QDs, initially into small vesicles near the plasma membrane by an actin-dependent mechanism. Within 10 min DCs contained vesicles of varying size, motion, and brightness distributed throughout the cytoplasm. At later times, endocytosed QDs were compartmentalized inside lysosomes. LPS-induced maturation of DCs reduced the rate of endocytosis and the proportion of cells taking up QDs. Following subcutaneous injection of QDs in an adjuvant depot, DCs that had endocytosed QDs were visualized up to 400 mm deep within draining lymph nodes. When antigen-conjugated QDs were used, T cells formed stable clusters in contact with DCs. Antigen-conjugated QDs induced CD69 expression, T cell proliferation, and IFN-gamma production in vivo with greater efficiency than equivalent amounts of free antigen. These results establish QDs as a versatile platform for immunoimaging of dendritic cells and as an efficient nanoparticle-based antigen delivery system for priming an immune response.	[Sen, Debasish; Parker, Ian; Cahalan, Michael D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behavior, Irvine, CA 92717 USA; [Deerinck, Thomas J.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Deerinck, Thomas J.; Ellisman, Mark H.] Ctr Res Biol Structure, Natl Ctr Microscopy & Imag Res, La Jolla, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Diego	Sen, D (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	mcahalan@uci.edu		Sen, Debasish/0000-0001-9879-8345	Graduate Research and Education in Adaptive bioTechnology (GREAT) Training Program of the UC Systemwide Biotechnology Research and Education Program [2004-11]; National Institutes of Health [GM-41514, GM-48071, N01-AI-50019]; National Center for Microscopy and Imaging Research; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514, R37GM048071, R01GM048071] Funding Source: NIH RePORTER	Graduate Research and Education in Adaptive bioTechnology (GREAT) Training Program of the UC Systemwide Biotechnology Research and Education Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Microscopy and Imaging Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Graduate Research and Education in Adaptive bioTechnology (GREAT) Training Program of the UC Systemwide Biotechnology Research and Education Program, (grant 2004-11), and by National Institutes of Health grants GM-41514 (to M.D.C.), GM-48071 (to I.P.), biodefense subcontract N01-AI-50019 (to M.D.C), and the National Center for Microscopy and Imaging Research.	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Brewer JM, 2004, J IMMUNOL, V173, P6143, DOI 10.4049/jimmunol.173.10.6143; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; CAHALAN MD, 2008, ANN REV IMMUNOL; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; Geiser M, 2005, ENVIRON HEALTH PERSP, V113, P1555, DOI 10.1289/ehp.8006; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Jaiswal Jyoti K, 2007, Methods Mol Biol, V374, P93; Kuhn M, 1998, FEMS MICROBIOL LETT, V160, P87, DOI 10.1016/S0378-1097(98)00017-2; Lidke Diane S, 2007, Methods Mol Biol, V374, P69; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Luhrmann A, 2000, Methods Cell Sci, V22, P329, DOI 10.1023/A:1017963401560; Manolova V., 2008, EUR J IMMUNOL; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102; Peek L, 2008, ADV DRUG DELIV REV; Pierre P, 1997, ADV EXP MED BIOL, V417, P179; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; REYNOLDS DJ, 1990, INFECT IMMUN, V58, P3208, DOI 10.1128/IAI.58.10.3208-3216.1990; Smith AM, 2006, EXPERT REV MOL DIAGN, V6, P231, DOI 10.1586/14737159.6.2.231; Steinman RM, 1999, HUM IMMUNOL, V60, P562, DOI 10.1016/S0198-8859(99)00030-0; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tanaka S, 2003, AM J PHYSIOL-CELL PH, V285, pC592, DOI 10.1152/ajpcell.00470.2002; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538	41	63	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3290	10.1371/journal.pone.0003290	http://dx.doi.org/10.1371/journal.pone.0003290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820727	gold, Green Published			2022-12-25	WOS:000264432500001
J	Hirokawa, J; Watakabe, A; Ohsawa, S; Yamamori, T				Hirokawa, Junya; Watakabe, Akiya; Ohsawa, Sonoko; Yamamori, Tetsuo			Analysis of Area-Specific Expression Patterns of RORbeta, ER81 and Nurr1 mRNAs in Rat Neocortex by Double In Situ Hybridization and Cortical Box Method	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; PRIMARY VISUAL-CORTEX; CYTOCHROME-OXIDASE; QUANTITATIVE APPROACH; CORTICOCORTICAL CONNECTIONS; DIFFERENTIAL EXPRESSION; SOMATOSENSORY CORTEX; MACAQUE MONKEY; NEURONS; SYSTEM	Background: The mammalian neocortex is subdivided into many areas, each of which exhibits distinctive lamina architecture. To investigate such area differences in detail, we chose three genes for comparative analyses, namely, RORbeta, ER81 and Nurr1, mRNAs of which have been reported to be mainly expressed in layers 4, 5 and 6, respectively. To analyze their qualitative and quantitative coexpression profiles in the rat neocortex, we used double in situ hybridization (ISH) histochemistry and cortical box method which we previously developed to integrate the data of different staining and individuals in a standard three-dimensional space. Principal Findings: Our new approach resulted in three main observations. First, the three genes showed unique area distribution patterns that are mostly complementary to one another. The patterns revealed by cortical box method matched well with the cytoarchitectonic areas defined by Nissl staining. Second, at single cell level, RORbeta and ER81 mRNAs were coexpressed in a subpopulation of layer 5 neurons, whereas Nurr1 and ER81 mRNAs were not colocalized. Third, principal component analysis showed that the order of hierarchical processing in the cortex correlates well with the expression profiles of these three genes. Based on this analysis, the dysgranular zone (DZ) in the somatosensory area was considered to exhibit a profile of a higher order area, which is consistent with previous proposal. Conclusions/Significance: The tight relationship between the expression of the three layer specific genes and functional areas were revealed, demonstrating the usefulness of cortical box method in the study on the cerebral cortex. In particular, it allowed us to perform statistical evaluation and pattern matching, which would become important in interpreting the ever-increasing data of gene expression in the cortex.	[Hirokawa, Junya; Watakabe, Akiya; Ohsawa, Sonoko; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan; [Hirokawa, Junya; Watakabe, Akiya; Yamamori, Tetsuo] Grad Univ Advanced Stud, Dept Basic Biol, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Hirokawa, J (corresponding author), Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan.	yamamori@nibb.ac.jp	Yamamori, Tetsuo/N-6536-2015; Hirokawa, Junya/GSE-5964-2022	Yamamori, Tetsuo/0000-0001-5016-0078; Hirokawa, Junya/0000-0003-1238-5713	KAKENHI [17024055, 19500304]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) 17024055 (to T.Y.) and 19500304 (to A. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu Y, 1999, CEREB CORTEX, V9, P569, DOI 10.1093/cercor/9.6.569; Arimatsu Y, 2003, J COMP NEUROL, V466, P180, DOI 10.1002/cne.10875; ARNAULT P, 1990, J COMP NEUROL, V302, P110, DOI 10.1002/cne.903020109; Bayer S.A., 1991, NEOCORTICAL DEV; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bjaalie JG, 2002, NAT REV NEUROSCI, V3, P322, DOI 10.1038/nrn790; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Brodmann, 1909, VERGLEICHENDE LOKALI; Casagrande Vivien A., 1994, Cerebral Cortex, V10, P201; CHAPIN JK, 1987, J COMP NEUROL, V263, P326, DOI 10.1002/cne.902630303; Ding Y, 1998, J COMP NEUROL, V391, P429, DOI 10.1002/(SICI)1096-9861(19980222)391:4<429::AID-CNE2>3.0.CO;2-2; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; Eickhoff SB, 2007, NEUROIMAGE, V34, P1317, DOI 10.1016/j.neuroimage.2006.11.016; FABRI M, 1991, J COMP NEUROL, V311, P405, DOI 10.1002/cne.903110310; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Geyer S, 1998, J COMP NEUROL, V397, P231, DOI 10.1002/(SICI)1096-9861(19980727)397:2<231::AID-CNE6>3.0.CO;2-1; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hatanaka Y, 1999, CEREB CORTEX, V9, P577, DOI 10.1093/cercor/9.6.577; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; HOF PR, 1995, J COMP NEUROL, V362, P109, DOI 10.1002/cne.903620107; Killackey HP, 2003, J NEUROSCI, V23, P7381; Komatsu Y, 2005, CEREB CORTEX, V15, P96, DOI 10.1093/cercor/bhh112; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liang FY, 2000, J COMP NEUROL, V416, P475, DOI 10.1002/(SICI)1096-9861(20000124)416:4<475::AID-CNE5>3.0.CO;2-V; LIDOW MS, 1989, NEUROSCIENCE, V32, P609, DOI 10.1016/0306-4522(89)90283-2; Liu Q, 2000, J NEUROSCI, V20, P7682; LIVINGSTONE MS, 1982, P NATL ACAD SCI-BIOL, V79, P6098, DOI 10.1073/pnas.79.19.6098; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; MacKenzie-Graham A, 2004, J ANAT, V204, P93, DOI 10.1111/j.1469-7580.2004.00264.x; Mataga N, 2001, J NEUROSCI, V21, P9724, DOI 10.1523/JNEUROSCI.21-24-09724.2001; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Palomero-Gallagher N, 2004, RAT NERVOUS SYSTEM, P729; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pierret T, 2000, J NEUROSCI, V20, P7455; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Schleicher A, 1999, NEUROIMAGE, V9, P165, DOI 10.1006/nimg.1998.0385; SCHLEICHER A, 1990, J MICROSC-OXFORD, V157, P367, DOI 10.1111/j.1365-2818.1990.tb02971.x; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tochitani S, 2001, EUR J NEUROSCI, V13, P297, DOI 10.1046/j.0953-816X.2000.01390.x; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; von Bonin G., 1947, NEOCORTEX MACACA MUL; Wada M, 2006, NEUROSCI RES, V56, P96, DOI 10.1016/j.neures.2006.05.013; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Xing GQ, 1997, MOL BRAIN RES, V47, P251, DOI 10.1016/S0169-328X(97)00056-9; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075; Zhong Y, 2004, CEREB CORTEX, V14, P1144, DOI 10.1093/cercor/bhh074; Zilles K, 2002, EUR NEUROPSYCHOPHARM, V12, P587, DOI 10.1016/S0924-977X(02)00108-6; ZILLES K, 1980, ANAT EMBRYOL, V159, P335, DOI 10.1007/BF00317655; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	65	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3266	10.1371/journal.pone.0003266	http://dx.doi.org/10.1371/journal.pone.0003266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815614	gold, Green Published, Green Submitted			2022-12-25	WOS:000264431900001
J	Zhong, J; Rist, M; Cooper, L; Smith, C; Khanna, R				Zhong, Jie; Rist, Michael; Cooper, Leanne; Smith, Corey; Khanna, Rajiv			Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus	PLOS ONE			English	Article								Based on the life-time cost to the health care system, the Institute of Medicine has assigned the highest priority for a vaccine to control human cytomegalovirus (HCMV) disease in transplant patients and new born babies. In spite of numerous attempts successful licensure of a HCMV vaccine formulation remains elusive. Here we have developed a novel chimeric vaccine strategy based on a replication-deficient adenovirus which encodes the extracellular domain of gB protein and multiple HLA class I & II-restricted CTL epitopes from HCMV as a contiguous polypeptide. Immunisation with this chimeric vaccine consistently generated strong HCMV-specific CD8(+) and CD4(+) T-cells which co-expressed IFN-gamma and TNF-alpha, while the humoral response induced by this vaccine showed strong virus neutralizing capacity. More importantly, immunization with adenoviral chimeric vaccine also afforded protection against challenge with recombinant vaccinia virus encoding HCMV antigens and this protection was associated with the induction of a pluripotent antigen-specific cellular and antibody response. Furthermore, in vitro stimulation with this adenoviral chimeric vaccine rapidly expanded multiple antigen-specific human CD8(+) and CD4(+) T-cells from healthy virus carriers. These studies demonstrate that the adenovirus chimeric HCMV vaccine provides an excellent platform for reconstituting protective immunity to prevent HCMV diseases in different clinical settings.	[Zhong, Jie; Rist, Michael; Cooper, Leanne; Smith, Corey; Khanna, Rajiv] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Tumour Immunol Lab, Div Immunol, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Zhong, J (corresponding author), Queensland Inst Med Res, Australian Ctr Vaccine Dev, Tumour Immunol Lab, Div Immunol, Brisbane, Qld 4006, Australia.	rajiv.khanna@qimr.edu.au	Smith, Corey/L-1357-2017; Khanna, Rajiv/A-7691-2008	Smith, Corey/0000-0002-7550-9595; Khanna, Rajiv/0000-0003-2241-0353	National Health and Medical Research Council (Australia)	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by the National Health and Medical Research Council (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; BenMohamed L, 2000, HUM IMMUNOL, V61, P764, DOI 10.1016/S0198-8859(00)00139-7; BenMohamed L, 2002, IMMUNOLOGY, V106, P113, DOI 10.1046/j.1365-2567.2002.01396.x; Berencsi K, 2001, J INFECT DIS, V183, P1171, DOI 10.1086/319680; Bitmansour AD, 2002, J IMMUNOL, V169, P1207, DOI 10.4049/jimmunol.169.3.1207; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Boeckh Michael, 2003, Herpes, V10, P12; Crough T, 2007, J VIROL, V81, P11538, DOI 10.1128/JVI.00581-07; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davignon JL, 1996, J VIROL, V70, P2162, DOI 10.1128/JVI.70.4.2162-2169.1996; Diamond DJ, 1997, BLOOD, V90, P1751, DOI 10.1182/blood.V90.5.1751; Elkington R, 2005, BLOOD, V105, P1362, DOI 10.1182/blood-2004-07-2602; Elkington R, 2004, EUR J IMMUNOL, V34, P3216, DOI 10.1002/eji.200425203; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; Engstrand M, 2000, TRANSPLANTATION, V69, P2243, DOI 10.1097/00007890-200006150-00005; Furebring C, 2002, MOL IMMUNOL, V38, P833, DOI 10.1016/S0161-5890(01)00119-5; Gallez-Hawkins G, 2002, SCAND J IMMUNOL, V55, P592, DOI 10.1046/j.1365-3083.2002.01099.x; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; GAVIN MA, 1993, J IMMUNOL, V151, P3971; Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024; GONCZOL E, 1995, VACCINE, V13, P1080, DOI 10.1016/0264-410X(95)00048-6; Hebart H, 2002, BLOOD, V99, P3830, DOI 10.1182/blood.V99.10.3830; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Kern F, 2002, J INFECT DIS, V185, P1709, DOI 10.1086/340637; Khanna R, 2006, TRENDS MOL MED, V12, P26, DOI 10.1016/j.molmed.2005.11.006; Kondo E, 2004, BLOOD, V103, P630, DOI 10.1182/blood-2003-03-0824; LI CR, 1994, BLOOD, V83, P1971, DOI 10.1182/blood.V83.7.1971.1971; Longmate J, 2001, IMMUNOGENETICS, V52, P165, DOI 10.1007/s002510000271; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Marshall BC, 2003, VIRAL IMMUNOL, V16, P491, DOI 10.1089/088282403771926319; Marshall GS, 2000, VIRAL IMMUNOL, V13, P329, DOI 10.1089/08828240050144653; Masuoka M, 2001, VIRAL IMMUNOL, V14, P369, DOI 10.1089/08828240152716619; McKay PF, 2002, J IMMUNOL, V168, P332, DOI 10.4049/jimmunol.168.1.332; Morello CS, 2005, J VIROL, V79, P159, DOI 10.1128/JVI.79.1.159-175.2005; Ophorst OJAE, 2004, VACCINE, V22, P3035, DOI 10.1016/j.vaccine.2004.02.011; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pass RF, 1996, INFECT AGENT DIS, V5, P240; Pass RF, 1999, J INFECT DIS, V180, P970, DOI 10.1086/315022; Plotkin SA, 1999, PEDIATR INFECT DIS J, V18, P313, DOI 10.1097/00006454-199904000-00002; Plotkin SA, 2002, J CLIN VIROL, V25, pS13; Plotkin SA, 2001, ARCH VIR S, V17, P121; Plotkin SA, 1999, AM HEART J, V138, pS484, DOI 10.1016/S0002-8703(99)70281-4; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Riddell S R, 1995, Cancer Treat Res, V76, P337; Rist M, 2005, EUR J IMMUNOL, V35, P996, DOI 10.1002/eji.200425746; SACHS G W, 1984, Vaccine, V2, P215, DOI 10.1016/0264-410X(84)90088-4; Schleiss Mark, 2005, Herpes, V12, P66; Schlfiss MR, 2007, J PEDIATR-US, V151, P564, DOI 10.1016/j.jpeds.2007.07.015; STRATTON K, 2001, VACCINES 21 CENTURY, P476; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; THOMSON SA, 1995, P NATL ACAD SCI USA, V92, P5845, DOI 10.1073/pnas.92.13.5845; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wang ZD, 2004, J VIROL, V78, P3965, DOI 10.1128/JVI.78.8.3965-3976.2004; Wang ZD, 2007, VACCINE, V25, P1132, DOI 10.1016/j.vaccine.2006.09.067; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Yao ZQ, 2001, VACCINE, V19, P1628, DOI 10.1016/S0264-410X(00)00423-0; Zhong J, 2007, EXPERT REV ANTI-INFE, V5, P449, DOI 10.1586/14787210.5.3.449; Zhong L, 2004, PROTEOMICS, V4, P1216, DOI 10.1002/pmic.200200679	62	35	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3256	10.1371/journal.pone.0003256	http://dx.doi.org/10.1371/journal.pone.0003256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806877	Green Submitted, gold, Green Published			2022-12-25	WOS:000264430800006
J	Kalsbeek, A; Foppen, E; Schalij, I; Van Heijningen, C; van der Vliet, J; Fliers, E; Buijs, RM				Kalsbeek, Andries; Foppen, Ewout; Schalij, Ingrid; Van Heijningen, Caroline; van der Vliet, Jan; Fliers, Eric; Buijs, Ruud M.			Circadian Control of the Daily Plasma Glucose Rhythm: An Interplay of GABA and Glutamate	PLOS ONE			English	Article							PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; SUPRACHIASMATIC NUCLEUS; PARAVENTRICULAR NUCLEUS; HYPOTHALAMIC INTEGRATION; MELATONIN SYNTHESIS; AUTONOMIC OUTPUT; GENE-EXPRESSION; DIURNAL RHYTHMS; MESSENGER-RNA; LIVER	The mammalian biological clock, located in the hypothalamic suprachiasmatic nuclei (SCN), imposes its temporal structure on the organism via neural and endocrine outputs. To further investigate SCN control of the autonomic nervous system we focused in the present study on the daily rhythm in plasma glucose concentrations. The hypothalamic paraventricular nucleus (PVN) is an important target area of biological clock output and harbors the pre-autonomic neurons that control peripheral sympathetic and parasympathetic activity. Using local administration of GABA and glutamate receptor (ant)agonists in the PVN at different times of the light/dark-cycle we investigated whether daily changes in the activity of autonomic nervous system contribute to the control of plasma glucose and plasma insulin concentrations. Activation of neuronal activity in the PVN of non-feeding animals, either by administering a glutamatergic agonist or a GABAergic antagonist, induced hyperglycemia. The effect of the GABA-antagonist was time dependent, causing increased plasma glucose concentrations only when administered during the light period. The absence of a hyperglycemic effect of the GABA-antagonist in SCN-ablated animals provided further evidence for a daily change in GABAergic input from the SCN to the PVN. On the other hand, feeding-induced plasma glucose and insulin responses were suppressed by inhibition of PVN neuronal activity only during the dark period. These results indicate that the pre-autonomic neurons in the PVN are controlled by an interplay of inhibitory and excitatory inputs. Liver-dedicated sympathetic pre-autonomic neurons (responsible for hepatic glucose production) and pancreas-dedicated pre-autonomic parasympathetic neurons (responsible for insulin release) are controlled by inhibitory GABAergic contacts that are mainly active during the light period. Both sympathetic and parasympathetic pre-autonomic PVN neurons also receive excitatory inputs, either from the biological clock (sympathetic pre-autonomic neurons) or from non-clock areas (para-sympathetic pre-autonomic neurons), but the timing information is mainly provided by the GABAergic outputs of the biological clock.	[Kalsbeek, Andries; Foppen, Ewout; Schalij, Ingrid; Van Heijningen, Caroline; van der Vliet, Jan; Buijs, Ruud M.] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Kalsbeek, Andries; Foppen, Ewout; Fliers, Eric] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metabolism, NL-1012 WX Amsterdam, Netherlands; [Buijs, Ruud M.] Ciudad Univ, Inst Investigac Biomed UNAM, Mexico City, DF, Mexico	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Universidad Nacional Autonoma de Mexico	Kalsbeek, A (corresponding author), Netherlands Inst Neurosci, Amsterdam, Netherlands.	A.Kalsbeek@amc.uva.nl	Buijs, Rudolf/AAD-5707-2020; Kalsbeek, Andries/H-3076-2019; Jansen, Heiko T./A-5770-2008	Kalsbeek, Andries/0000-0001-9606-8453; Jansen, Heiko T./0000-0003-0178-396X; Fliers, Eric/0000-0001-8048-9050				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Alquier T, 2004, ENDOCRINOLOGY, V145, P4022, DOI 10.1210/en.2004-0861; ARMSTRONG S, 1980, NEUROSCI BIOBEHAV R, V4, P27, DOI 10.1016/0149-7634(80)90024-X; Bando H, 2007, J NEUROSCI, V27, P4359, DOI 10.1523/JNEUROSCI.4131-06.2007; BELLINGER LL, 1975, HORM METAB RES, V7, P132, DOI 10.1055/s-0028-1093763; Benavides A, 1998, AM J PHYSIOL-REG I, V275, pR811, DOI 10.1152/ajpregu.1998.275.3.R811; Bester H, 1997, J COMP NEUROL, V383, P245, DOI 10.1002/(SICI)1096-9861(19970707)383:3<245::AID-CNE1>3.0.CO;2-3; Boden G, 1996, DIABETES, V45, P1044, DOI 10.2337/diabetes.45.8.1044; BOLLI GB, 1984, NEW ENGL J MED, V310, P746, DOI 10.1056/NEJM198403223101203; BUIJS RM, 1993, AM J PHYSIOL, V264, pR1186, DOI 10.1152/ajpregu.1993.264.6.R1186; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; BUIJS RM, 1995, J COMP NEUROL, V358, P343, DOI 10.1002/cne.903580304; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Cailotto C, 2008, ENDOCRINOLOGY, V149, P1914, DOI 10.1210/en.2007-0816; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Cole RAL, 2002, J NEUROSCI, V22, P959, DOI 10.1523/JNEUROSCI.22-03-00959.2002; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Corssmit EPM, 2001, METABOLISM, V50, P742, DOI 10.1053/meta.2001.24195; Csaki A, 2000, NEUROSCIENCE, V101, P637, DOI 10.1016/S0306-4522(00)00411-5; DECAVEL C, 1992, J COMP NEUROL, V316, P104, DOI 10.1002/cne.903160109; DRIJFHOUT WJ, 1995, J NEUROSCI METH, V61, P191, DOI 10.1016/0165-0270(94)00041-E; GALE EA, 1985, NETH J MED S, V1, P50; GARDEMANN A, 1992, BIOL CHEM H-S, V373, P195, DOI 10.1515/bchm3.1992.373.1.195; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hernandez LF, 2003, NEUROCHEM RES, V28, P1819, DOI 10.1023/A:1026115607216; Houghton SG, 2006, SURGERY, V139, P542, DOI 10.1016/j.surg.2005.09.002; JOLIN T, 1973, HORM RES, V4, P153, DOI 10.1159/000178303; Kalsbeek A, 1996, NEUROENDOCRINOLOGY, V63, P69, DOI 10.1159/000126937; Kalsbeek A, 1998, PHYSIOL BEHAV, V63, P553, DOI 10.1016/S0031-9384(97)00493-9; Kalsbeek A, 2006, PROG BRAIN RES, V153, P283, DOI 10.1016/S0079-6123(06)53017-1; Kalsbeek A, 2002, CELL TISSUE RES, V309, P109, DOI 10.1007/s00441-002-0577-0; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kalsbeek A, 2000, ENDOCRINOLOGY, V141, P3832, DOI 10.1210/en.141.10.3832; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Kalsbeek A, 2008, EUR J NEUROSCI, V27, P818, DOI 10.1111/j.1460-9568.2008.06057.x; KAMINSKY YG, 1987, COMP BIOCHEM PHYS B, V86, P763, DOI 10.1016/0305-0491(87)90224-0; Kita Y, 2002, PHARMACOGENETICS, V12, P55, DOI 10.1097/00008571-200201000-00008; Kreier F, 2006, ENDOCRINOLOGY, V147, P1140, DOI 10.1210/en.2005-0667; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; la Fleur SE, 2003, J NEUROENDOCRINOL, V15, P315, DOI 10.1046/j.1365-2826.2003.01019.x; LANG CH, 1995, BRAIN RES BULL, V37, P611, DOI 10.1016/0361-9230(95)00052-G; LUITEN PGM, 1987, PROG NEUROBIOL, V28, P1, DOI 10.1016/0301-0082(87)90004-9; MARTIN DS, 1991, HYPERTENSION, V18, P48, DOI 10.1161/01.HYP.18.1.48; Matsuhisa M, 2000, METABOLISM, V49, P11, DOI 10.1016/S0026-0495(00)90538-9; MIKKELSEN JD, 1992, BRAIN RES BULL, V28, P619, DOI 10.1016/0361-9230(92)90112-B; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; NONOGAKI K, 1994, J NEUROENDOCRINOL, V6, P443, DOI 10.1111/j.1365-2826.1994.tb00605.x; OGAWA H, 1995, ARCH BIOCHEM BIOPHYS, V321, P115, DOI 10.1006/abbi.1995.1375; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PERET J, 1973, J NUTR, V103, P866, DOI 10.1093/jn/103.6.866; Perreau-Lenz S, 2004, CHRONOBIOL INT, V21, P1, DOI 10.1081/CBI-120027984; Perreau-Lenz S, 2004, EUR J NEUROSCI, V19, P318, DOI 10.1111/j.0953-816X.2003.03132.x; Perreau-Lenz S, 2003, EUR J NEUROSCI, V17, P221, DOI 10.1046/j.1460-9568.2003.02442.x; Puschel GP, 2004, ANAT REC PART A, V280A, P854, DOI 10.1002/ar.a.20091; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Saper CB, 2006, PROG BRAIN RES, V153, P243, DOI 10.1016/S0079-6123(06)53014-6; Scheving LA, 2000, GASTROENTEROLOGY, V119, P536, DOI 10.1053/gast.2000.9305; SHIMAZU T, 1987, Diabetes Metabolism Reviews, V3, P185; SHIMAZU T, 1967, SCIENCE, V156, P1256, DOI 10.1126/science.156.3779.1256; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; STRUBBE JH, 1987, J AUTONOM NERV SYST, V20, P113, DOI 10.1016/0165-1838(87)90108-1; Takahashi A, 1997, METABOLISM, V46, P897, DOI 10.1016/S0026-0495(97)90076-7; Tanaka M, 1996, NEUROSCI LETT, V215, P119, DOI 10.1016/0304-3940(96)12965-7; Tebbe JJ, 2001, BRAIN RES, V913, P10, DOI 10.1016/S0006-8993(01)02746-9; TERHORST GJ, 1989, NEUROSCIENCE, V31, P785; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; VANDENHOEK AM, 2008, DIABETES IN PRESS; Westerink BHC, 1998, J PHARMACOL EXP THER, V285, P143; YAMAMOTO H, 1984, BIOMED RES-TOKYO, V5, P47, DOI 10.2220/biomedres.5.47	76	77	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3194	10.1371/journal.pone.0003194	http://dx.doi.org/10.1371/journal.pone.0003194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791643	Green Published, Green Submitted, gold			2022-12-25	WOS:000264427700001
J	Cohen, KB; Palmer, M; Hunter, L				Cohen, K. Bretonnel; Palmer, Martha; Hunter, Lawrence			Nominalization and Alternations in Biomedical Language	PLOS ONE			English	Article							EXTRACTION; INFORMATION	Background: This paper presents data on alternations in the argument structure of common domain-specific verbs and their associated verbal nominalizations in the PennBioIE corpus. Alternation is the term in theoretical linguistics for variations in the surface syntactic form of verbs, e. g. the different forms of stimulate in FSH stimulates follicular development and follicular development is stimulated by FSH. The data is used to assess the implications of alternations for biomedical text mining systems and to test the fit of the sublanguage model to biomedical texts. Methodology/Principal Findings: We examined 1,872 tokens of the ten most common domain-specific verbs or their zero-related nouns in the PennBioIE corpus and labelled them for the presence or absence of three alternations. We then annotated the arguments of 746 tokens of the nominalizations related to these verbs and counted alternations related to the presence or absence of arguments and to the syntactic position of non-absent arguments. We found that alternations are quite common both for verbs and for nominalizations. We also found a previously undescribed alternation involving an adjectival present participle. Conclusions/Significance: We found that even in this semantically restricted domain, alternations are quite common, and alternations involving nominalizations are exceptionally diverse. Nonetheless, the sublanguage model applies to biomedical language. We also report on a previously undescribed alternation involving an adjectival present participle.	[Cohen, K. Bretonnel; Hunter, Lawrence] Univ Colorado, Sch Med, Ctr Computat Pharmacol, Aurora, CO USA; [Cohen, K. Bretonnel; Palmer, Martha] Univ Colorado, Dept Linguist, Boulder, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Cohen, KB (corresponding author), Univ Colorado, Sch Med, Ctr Computat Pharmacol, Aurora, CO USA.	kevin.cohen@gmail.com		Hunter, Lawrence/0000-0003-1455-3370; PALMER, MARTHA/0000-0001-9864-6974	NSF [CISE-CRI 0551615];  [G08LM009639];  [R01LM009254];  [R01LM008111];  [T15LM009451]; NATIONAL LIBRARY OF MEDICINE [G08LM009639, T15LM009451, R01LM008111, R01LM009254] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); ; ; ; ; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	K. Bretonnel Cohen's and Lawrence Hunter's work was supported by grants G08LM009639, R01LM009254, and R01LM008111. Martha Palmer's work was supported by NSF grant CISE-CRI 0551615. J. Gregory Caporaso is supported by training grant fellowship T15LM009451. No sponsors or funders were involved in the design or conduct of the study; in the collection, analysis, or interpretation of the data; or in the preparation, review, or approval of the manuscript.	ADAM M, 2004, P 2 ACL WORKSH MULT, P96; ADAM M, ANNOTATION GUI UNPUB; ADAM M, 2004, P LREC 2004, P803; ADAM M, 2004, NOMBANK PROJECT INTE, P24; BARBARA HP, 1993, MATH METHODS LINGUIS; BENGOERTZEL, 2006, P BIONLP 06 WORKSH L, P104; BETH L, 1993, ENGLISH VERB CLASSES; BRETONNEL CK, 2006, BMC BIOINFORMATIC S3, V7, pS5; Chou W.C., 2006, P WORKSH FRONT LING, P5; Christiane F., 1998, WORDNET ELECT LEXICA; Cohen KB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040020; DEBORAH AD, 1987, P ASS COMP LING, P131; Douglas Biber, 1999, LONGMAN GRAMMAR SPOK; Fillmore CJ, 2003, INT J LEXICOGR, V16, P235, DOI 10.1093/ijl/16.3.235; Friedman C, 2002, J BIOMED INFORM, V35, P222, DOI 10.1016/S1532-0464(03)00012-1; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Hu ZZ, 2005, BIOINFORMATICS, V21, P2759, DOI 10.1093/bioinformatics/bti390; JONATHAN S, 2006, P BIONLP 06 WORKSH L, P82; KARIN V, 2006, INTRO BIONLP 06 LINK, pR3; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Ko JMY, 1998, CANCER LETT, V134, P169, DOI 10.1016/S0304-3835(98)00257-2; LAURIE B, 2002, CAMBRIDGE GRAMMAR EN, P1621; Leroy G, 2005, J AM SOC INF SCI TEC, V56, P457, DOI 10.1002/asi.20135; Leroy G, 2003, J BIOMED INFORM, V36, P145, DOI 10.1016/S1532-0464(03)00039-X; Leroy G., 2002, PACIFIC S BIOCOMPUTI, P350; LYNETTE H, 1982, AUTOMATIC INFORM FOR, P27; MARIA KT, 1993, NOMINALIZATIONS; MARTHA P, 1986, P ASS COMP LING, P10; MICHAEL J, 1995, AAAI SPRING S REPR A; MICHAEL J, 1996, P ACL SIGLEX WORKSH; MIRIAM B, 1998, PROJECTION ARGUMENTS; NAOMI S, 1972, AFIPS C P, V41, P9; Narayanaswamy M, 2005, BIOINFORMATICS, V21, pI319, DOI 10.1093/bioinformatics/bti1011; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; Palmer M, 2005, COMPUT LINGUIST, V31, P71, DOI 10.1162/0891201053630264; PHILIP VO, 2006, P 9 INT PROT C, P73; PHILIP VO, 2006, P HLT NAACL 2006 COM, P273; PING JZ, 2006, P 2006 C EMP METH NA, P138; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Pustejovsky J, 2002, Pac Symp Biocomput, P362; Quirk Randolph, 1985, COMPREHENSIVE GRAMMA; RALPH G, 1986, ANAL LANGUAGE RESTRI; Rappaport Hovav M., 1998, PROJECTION ARGUMENTS, P97, DOI DOI 10.1093/J0S/FFQ007; RICHARD K, 1982, SUBLANGUAGE STUDIES; ROBERT BL, 1968, GRAMMAR ENGLISH NOMI; RON A, 2007, AGREEMENT MEASURES N; SAMEER P, 2004, PARSING ARGUMENTS NO, P141; SETH K, 2004, P BIOLINK 2004 LINK, P61; Shah PK, 2005, PLOS COMPUT BIOL, V1, P67, DOI 10.1371/journal.pcbi.0010010; THOMAS CR, 2000, P ANLP NAACL 2000 AS, P188; THOMAS H, 2004, VALENCY DICT ENGLISH; THOMAS R, 2006, P SAABR C NOM QUANT; TONY M, 2001, CORPUS LINGUISTICS; TSAI RTH, 2005, P BIONLP 06 WORKSH L, P57; Wattarujeekrit T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-155; YACOV K, 2005, AMIA 2005 S P, P410; Yuan X, 2006, BIOINFORMATICS, V22, P1668, DOI 10.1093/bioinformatics/btl159; YUKA T, 2004, ANNOTATION PREDICATE; ZELLIG H, 1989, FORM INFORM SCI ANAL; Zweigenbaum P, 2007, BRIEF BIOINFORM, V8, P358, DOI 10.1093/bib/bbm045	60	32	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3158	10.1371/journal.pone.0003158	http://dx.doi.org/10.1371/journal.pone.0003158			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779866	Green Submitted, gold, Green Published			2022-12-25	WOS:000264425100001
J	Liu, YZ; Wilson, SG; Wang, L; Liu, XG; Guo, YF; Li, J; Yan, H; Deloukas, P; Soranzo, N; Chinnapen-Horsley, U; Cervino, A; Williams, FM; Xiong, DH; Zhang, YP; Jin, TB; Levy, S; Papasian, CJ; Drees, BM; Hamilton, JJ; Recker, RR; Spector, TD; Deng, HW				Liu, Yao-Zhong; Wilson, Scott G.; Wang, Liang; Liu, Xiao-Gang; Guo, Yan-Fang; Li, Jian; Yan, Han; Deloukas, Panos; Soranzo, Nicole; Chinnapen-Horsley, Usha; Cervino, Alesandra; Williams, Frances M.; Xiong, Dong-Hai; Zhang, Yin-Ping; Jin, Tian-Bo; Levy, Shawn; Papasian, Christopher J.; Drees, Betty M.; Hamilton, James J.; Recker, Robert R.; Spector, Tim D.; Deng, Hong-Wen			Identification of PLCL1 Gene for Hip Bone Size Variation in Females in a Genome-Wide Association Study	PLOS ONE			English	Article								Osteoporosis, the most prevalent metabolic bone disease among older people, increases risk for low trauma hip fractures (HF) that are associated with high morbidity and mortality. Hip bone size (BS) has been identified as one of the key measurable risk factors for HF. Although hip BS is highly genetically determined, genetic factors underlying the trait are still poorly defined. Here, we performed the first genome-wide association study (GWAS) of hip BS interrogating,380,000 SNPs on the Affymetrix platform in 1,000 homogeneous unrelated Caucasian subjects, including 501 females and 499 males. We identified a gene, PLCL1 (phospholipase c-like 1), that had four SNPs associated with hip BS at, or approaching, a genome-wide significance level in our female subjects; the most significant SNP, rs7595412, achieved a p value of 3.72 x 10(-7). The gene's importance to hip BS was replicated using the Illumina genotyping platform in an independent UK cohort containing 1,216 Caucasian females. Two SNPs of the PLCL1 gene, rs892515 and rs9789480, surrounded by the four SNPs identified in our GWAS, achieved p values of 8.62x10(-3) and 2.44x10(-3), respectively, for association with hip BS. Imputation analyses on our GWAS and the UK samples further confirmed the replication signals; eight SNPs of the gene achieved combined imputed p values, 10 25 in the two samples. The PLCL1 gene's relevance to HF was also observed in a Chinese sample containing 403 females, including 266 with HF and 177 control subjects. A SNP of the PLCL1 gene, rs3771362 that is only similar to 0.6 kb apart from the most significant SNP detected in our GWAS (rs7595412), achieved a p value of 7.66x10(-3) (odds ratio = 0.26) for association with HF. Additional biological support for the role of PLCL1 in BS comes from previous demonstrations that the PLCL1 protein inhibits IP3 (inositol 1,4,5-trisphosphate)-mediated calcium signaling, an important pathway regulating mechanical sensing of bone cells. Our findings suggest that PLCL1 is a novel gene associated with variation in hip BS, and provide new insights into the pathogenesis of HF.	[Liu, Yao-Zhong; Wang, Liang; Liu, Xiao-Gang; Guo, Yan-Fang; Li, Jian; Yan, Han; Zhang, Yin-Ping; Jin, Tian-Bo; Papasian, Christopher J.; Drees, Betty M.; Hamilton, James J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Wilson, Scott G.] Univ Western Australia, Sch Med Pharmacol, Nedlands, WA, Australia; [Wilson, Scott G.] Sir Charles Gairder Hosp, Dept Endocrinol Diabetes, Nedlands, WA, Australia; [Wilson, Scott G.; Deloukas, Panos; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London WC2R 2LS, England; [Wang, Liang; Liu, Xiao-Gang; Guo, Yan-Fang; Yan, Han; Zhang, Yin-Ping; Jin, Tian-Bo; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Key Lab Biomed Informat Engn Minist Ed, Xian, Peoples R China; [Soranzo, Nicole; Chinnapen-Horsley, Usha; Cervino, Alesandra; Williams, Frances M.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Xiong, Dong-Hai; Recker, Robert R.; Deng, Hong-Wen] Creighton Univ, Osteoporosis Res, Omaha, NE 68178 USA; [Levy, Shawn] Vanderbilt Univ, Vanderbilt Microarray Shared Resource, Nashville, TN USA; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Peoples R China	University of Missouri System; University of Missouri Kansas City; University of Western Australia; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Xi'an Jiaotong University; Wellcome Trust Sanger Institute; Creighton University; Vanderbilt University; Hunan Normal University	Liu, YZ (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	dengh@umkc.edu	Deloukas, Panos/B-2922-2013; Liu, Yaozhong/ABD-5544-2020; XIONG, DONGHAI/A-3691-2010; Li, Jian/G-4445-2015	Deloukas, Panos/0000-0001-9251-070X; Williams, Frances/0000-0002-2998-2744; Wilson, Scott/0000-0002-0357-1373; Deng, Hong-Wen/0000-0002-0387-8818; Soranzo, Nicole/0000-0003-1095-3852; Levy, Shawn/0000-0002-1369-5740	NIH [R01 AR050496-01, R21 AG027110, R01 AG026564, R21 AA015973, P50 AR055081]; National Science Foundation of China; Huo Ying Dong Education Foundation; HuNan Province; Xi'an Jiaotong University; Ministry of Education of China; Wellcome Trust; European Commission [QLK6-CT-2002-02629]; Arthritis Research Campaign; Chronic Disease Research Foundation; European Union FP-5 GenomEUtwin Project [QLG2-CT-2002-01254]; Australian National Health and Medical Research Council [294402, 343603]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation; HuNan Province; Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China(Ministry of Education, China); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Arthritis Research Campaign(Versus Arthritis); Chronic Disease Research Foundation; European Union FP-5 GenomEUtwin Project; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work (Deng HW, Liu YZ, Wang L, Guo YF, Li J, Liu XG, Yan H, Xiong DH, Zhang YP, and Jing TB) were partially supported by grants from NIH (R01 AR050496-01, R21 AG027110, R01 AG026564, R21 AA015973 and P50 AR055081). The study also benefited from grants from National Science Foundation of China, Huo Ying Dong Education Foundation, HuNan Province, Xi'an Jiaotong University, and the Ministry of Education of China. Investigators from UK and Australia (Spector TD, Wilson SG, Deloukas P, Soranzo N, Chinnapen-Horsley U, Williams FM and Cervino A) were supported by Wellcome Trust; European Commission (QLK6-CT-2002-02629, GEFOS); the Arthritis Research Campaign; the Chronic Disease Research Foundation and the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254) and the Australian National Health and Medical Research Council (Project Grants 294402 and 343603).	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Deng HW, 2002, J BONE MINER METAB, V20, P358, DOI 10.1007/s007740200052; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; EASTON DF, 2007, NATURE; Fang Y, 2007, J CLIN ENDOCR METAB, V92, P1491, DOI 10.1210/jc.2006-1134; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Genant HK, 1996, J BONE MINER RES, V11, P707; Havill LM, 2007, J BONE MINER RES, V22, P737, DOI 10.1359/JBMR.070213; HUNTER DJ, 2007, NAT GENET; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; KALENDER WA, 1992, OSTEOPOROSIS INT, V2, P82, DOI 10.1007/BF01623841; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lei SF, 2005, BONE, V36, P533, DOI 10.1016/j.bone.2004.11.002; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; LIn XN, 2005, J BIOL CHEM, V280, P12820, DOI 10.1074/jbc.M411591200; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MAZESS RB, 1994, J BONE MINER RES, V9, P541; MORIN S, 2008, OSTEOPOROS INT; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; REICH KM, 1991, AM J PHYSIOL, V261, pC428, DOI 10.1152/ajpcell.1991.261.3.C428; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; Shen H, 2006, J MED GENET, V43, P873, DOI 10.1136/jmg.2006.041251; Vega E, 1998, CALCIFIED TISSUE INT, V62, P465, DOI 10.1007/s002239900462; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Xiong DH, 2006, J BONE MINER RES, V21, P424, DOI 10.1359/JBMR.051202; Yang RS, 1998, CALCIFIED TISSUE INT, V63, P86, DOI 10.1007/s002239900494; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zmuda JM, 2001, J BONE MINER RES, V16, P911, DOI 10.1359/jbmr.2001.16.5.911	37	50	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3160	10.1371/journal.pone.0003160	http://dx.doi.org/10.1371/journal.pone.0003160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776929	Green Submitted, Green Published, gold			2022-12-25	WOS:000264424300005
J	Goytain, A; Hines, RM; Quamme, GA				Goytain, Angela; Hines, Rochelle M.; Quamme, Gary A.			Huntingtin-interacting Proteins, HIP14 and HIP14L, Mediate Dual Functions, Palmitoyl Acyltransferase and Mg2+ Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; WILD-TYPE; CHANNEL; TRAFFICKING; SUBUNIT; DISEASE; IRON; IDENTIFICATION; FERRITIN; KINASE	Polyglutamine expansions of huntingtin protein are responsible for the Huntington neurological disorder. HIP14 protein has been shown to interact with huntingtin. HIP14 and a HIP14-like protein, HIP14L, with a 69% similarity reside in the Golgi and possess palmitoyl acyltransferase activity through innate cysteine-rich domains, DHHC. Here, we used microarray analysis to show that reduced extracellular magnesium concentration increases HIP14L mRNA suggesting a role in cellular magnesium metabolism. Because HIP14 was not on the microarray platform, we used real-time reverse transcriptase-PCR to show that HIP14 and HIP14L transcripts were up-regulated 3-fold with low magnesium. Western analysis with a specific HIP14 antibody also showed that endogenous HIP14 protein increased with diminished magnesium. Furthermore, we demonstrate that when expressed in Xenopus oocytes, HIP14 and HIP14L mediate Mg2+ uptake that is electrogenic, voltage-dependent, and saturable with Michaelis constants of 0.87 +/- 0.02 and 0.74 +/- 0.07 mM, respectively. Diminished magnesium leads to an apparent increase in HIP14-green fluorescent protein and HIP14L-green fluorescent fusion proteins in the Golgi complex and subplasma membrane post-Golgi vesicles of transfected epithelial cells. We also show that inhibition of palmitoylation with 2-bromopalmitate, or deletion of the DHHC motif HIP14 Delta DHHC, diminishes HIP14-mediated Mg2+ transport by about 50%. Coexpression of an independent protein acyltransferase, GODZ, with the deleted HIP14 Delta DHHC mutant restored Mg2+ transport to values observed with wild-type HIP14. Although we did not directly measure palmitoylation of HIP14 in these studies, the data are consistent with a regulatory role of autopalmitoylation in HIP14-mediated Mg2+ transport. We conclude that the huntingtin interacting protein genes, HIP14 and HIP14L, encode Mg2+ transport proteins that are regulated by their innate palmitoyl acyltransferases thus fulfilling the characteristics of "chanzymes."	[Goytain, Angela; Quamme, Gary A.] Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada; [Hines, Rochelle M.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Quamme, GA (corresponding author), Vancouver Hosp, Koerner Pavil,2211 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	quamme@interchange.ubc.ca	Hines, Rochelle/AAE-3784-2020	Hines, Rochelle/0000-0002-0459-7911	Canadian Institutes of Health Research (CIHR) [MOP-53288]; CIHR; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by Canadian Institutes of Health Research (CIHR) Grant MOP-53288 (to G. A. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by studentships from CIHR and the Michael Smith Foundation for Health Research. To whom correspondence should be addressed: Vancouver Hospital, Koerner Pavilion, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada. Tel.: 604-822-7156; Fax: 604-822-7897; E-mail: quamme@interchange.ubc.ca.	Bartzokis G, 2000, CELL MOL BIOL, V46, P821; BONILLA E, 1991, NEUROSCI LETT, V129, P22, DOI 10.1016/0304-3940(91)90711-2; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; CHEN JC, 1993, AM J NEURORADIOL, V14, P275; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Draper JM, 2007, J LIPID RES, V48, P1873, DOI 10.1194/jlr.M700179-JLR200; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Goytain A, 2007, J BIOL CHEM, V282, P8060, DOI 10.1074/jbc.M610314200; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Hoffner G, 2002, J CELL SCI, V115, P941; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lumsden AL, 2007, HUM MOL GENET, V16, P1905, DOI 10.1093/hmg/ddm138; Metzler M, 2000, HUM MOL GENET, V9, P387, DOI 10.1093/hmg/9.3.387; Mies F, 2007, J BIOL CHEM, V282, P18339, DOI 10.1074/jbc.M611160200; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Truant R, 2006, BIOCHEM CELL BIOL, V84, P912, DOI 10.1139/O06-181; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Varner AS, 2003, BIOCHEM J, V373, P91, DOI 10.1042/BJ20021598; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	49	63	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33365	33374		10.1074/jbc.M801469200	http://dx.doi.org/10.1074/jbc.M801469200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18794299	hybrid, Green Published			2022-12-25	WOS:000261183700041
J	Kamdar, K; Maemoto, A; Qu, XQ; Young, SK; Ouellette, AJ				Kamdar, Karishma; Maemoto, Atsuo; Qu, Xiaoqing; Young, Steven K.; Ouellette, Andre J.			In Vitro Activation of the Rhesus Macaque Myeloid alpha-Defensin Precursor proRMAD-4 by Neutrophil Serine Proteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE CRYPTDIN-4; MATRIX METALLOPROTEINASE-7; DISULFIDE ARRAY; INNATE IMMUNITY; SMALL-INTESTINE; SALT BRIDGE; GRANULES; CELLS; DETERMINANTS; LEUKOCYTES	alpha-Defensins are mammalian antimicrobial peptides expressed mainly by cells of myeloid lineage or small intestinal Paneth cells. The peptides are converted from inactive 8.5-kDa precursors to membrane-disruptive forms by post-translational proteolytic events. Because rhesus myeloid pro-alpha-defensin-4 (proRMAD-4((20-94))) lacks bactericidal peptide activity in vitro, we tested whether neutrophil azurophil granule serine proteinases, human neutrophil elastase (NE), cathepsin G (CG), and proteinase-3 (P3) have in vitro convertase activity. Only NE cleaved proRMAD-4((20-94)) at the native RMAD-4Nterminus to produce fully processed, bactericidal RMAD-4((62-94)). The final CG cleavage product was RMAD-4((55-94)), and P3 produced both RMAD-4((55-94)) and RMAD-4((57-94)). Nevertheless, NE, CG, and P3 digests of proRMAD4 and purified RMAD-4((62-94)), RMAD-4((55-94)), and RMAD-4((57-94)) peptides had equivalent in vitro bactericidal activities. Bactericidal peptide activity assays of proRMAD-4((20-94)) variants containing complete charge-neutralizing D/E to N/Q or D/E to A substitutions showed that (DE/NQ)-proRMAD-4((20-94)) and (DE/A)-proRMAD-4((20-94)) were as active as mature RMAD-4((62-94)). Therefore, proregion Asp and Glu side chains inhibit the RMAD-4 component of full-length proRMAD-4((20-94)), perhaps by a combination of charge-neutralizing and hydrogen-bonding interactions. Although native RMAD-4((62-94)) resists NE, CG, and P3 proteolysis completely, RMAD-4((62-94)) variants with disulfide pairing disruptions or lacking disulfide bonds were degraded extensively, evidence that the disulfide array protects the alpha-defensin moiety from degradation by the myeloid converting enzymes. These in vitro analyses support the conclusion that rhesus macaque myeloid pro-alpha-defensins are converted to active forms by serine proteinases that co-localize in azurophil granules.	[Kamdar, Karishma; Maemoto, Atsuo; Qu, Xiaoqing; Young, Steven K.; Ouellette, Andre J.] Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Ouellette, Andre J.] Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ouellette, AJ (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Pathol & Lab Med, Med Sci D440, Irvine, CA 92697 USA.	aouellet@uci.edu		Young, Steven/0000-0002-1586-5651	National Institutes of Health [AI059346, DK044632]; Human Frontiers Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044632, R01DK044632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059346 and DK044632 and the Human Frontiers Science Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167; Arnljots K, 1998, LEUKEMIA, V12, P1789, DOI 10.1038/sj.leu.2401202; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1993, BLOOD, V82, P641; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; LEHRER RI, 1991, CELL, V64, P229, DOI 10.1016/0092-8674(91)90632-9; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Selsted M E, 1993, Genet Eng (N Y), V15, P131; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Tanabe H, 2004, J VIROL, V78, P11622, DOI 10.1128/JVI.78.21.11622-11631.2004; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tanabe H, 2004, INFECT IMMUN, V72, P1470, DOI 10.1128/IAI.72.3.1470-1478.2004; Tang YQ, 1999, INFECT IMMUN, V67, P6139, DOI 10.1128/IAI.67.11.6139-6144.1999; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200	33	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32361	32368		10.1074/jbc.M805296200	http://dx.doi.org/10.1074/jbc.M805296200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18775986	hybrid, Green Published			2022-12-25	WOS:000260893700023
J	Trowitzsch, S; Weber, G; Luhrmann, R; Wahl, MC				Trowitzsch, Simon; Weber, Gert; Luehrmann, Reinhard; Wahl, Markus C.			An Unusual RNA Recognition Motif Acts as a Scaffold for Multiple Proteins in the Pre-mRNA Retention and Splicing Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U2 SNRNP PROTEIN; NUCLEAR RETENTION; GENE-EXPRESSION; CATALYTIC STEP; SPLICEOSOME; CORE; ACTIVATION; COMPONENTS; U2AF(65); SEQUENCE	The yeast pre-mRNA retention and splicing complex counteracts the escape of unspliced pre-mRNAs from the nucleus and activates splicing of a subset of Mer1p-dependent genes. A homologous complex is present in activated human spliceosomes. In many components of the spliceosome, RNA recognition motifs (RRMs) serve as versatile protein-RNA or protein-protein interaction platforms. Here, we show that in the retention and splicing complex, an atypical RRM of the Snu17p (small nuclear ribonucleoprotein-associated protein 17) subunit acts as a scaffold that organizes the other two constituents, Bud13p (bud site selection 13) and Pml1p (pre-mRNA leakage 1). GST pull-down experiments and size exclusion chromatography revealed that Snu17p constitutes the central platform of the complex, whereas Bud13p and Pml1p do not interact with each other. Fluorimetric structure probing showed the entire Bud13p and the N-terminal third of Pml1p to be natively disordered in isolation. Mutational analysis and tryptophan fluorescence confirmed that a conserved tryptophan-containing motif in the C terminus of Bud13p binds to the core RRM of Snu17p, whereas a different interaction surface encompassing a C-terminal extension of the Snu17p RRM is required to bind an N-terminal peptide of Pml1p. Isothermal titration calorimetry revealed 1: 1 interaction stoichiometries, large negative binding entropies, and dissociation constants in the low nanomolar and micromolar ranges for the Snu17p-Bud13p and the Snu17p-Pml1p interactions, respectively. Our results demonstrate that the noncanonical Snu17p RRM concomitantly binds multiple ligand proteins via short, intrinsically unstructured peptide epitopes and thereby acts as a platform that displays functional modules of the ligands, such as a forkhead-associated domain of Pml1p and a conserved polylysine motif of Bud13p.	[Trowitzsch, Simon; Weber, Gert; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Wahl, Markus C.] Univ Gottingen, Univ Med, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen	Wahl, MC (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	mwahl@gwdg.de	Wahl, Markus C./D-6365-2017; Trowitzsch, Simon/O-4957-2016; Weber, Gert/I-1800-2013	Wahl, Markus C./0000-0002-2811-5307; Trowitzsch, Simon/0000-0001-9143-766X; Weber, Gert/0000-0003-3624-1060	Max-Planck-Society	Max-Planck-Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max-Planck-Society (to R. L. and M. C. W.). The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Gottschalk A, 2001, MOL CELL BIOL, V21, P3037, DOI 10.1128/MCB.21.9.3037-3046.2001; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; Schellenberg MJ, 2006, P NATL ACAD SCI USA, V103, P1266, DOI 10.1073/pnas.0508048103; Scherrer FW, 2006, RNA, V12, P1361, DOI 10.1261/rna.2276806; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sommer P, 2005, CURR OPIN CELL BIOL, V17, P294, DOI 10.1016/j.ceb.2005.04.007; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Taniguchi I, 2007, P NATL ACAD SCI USA, V104, P13684, DOI 10.1073/pnas.0704922104; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vincent K, 2003, GENETICS, V164, P895; Wang Q, 2005, MOL CELL BIOL, V25, P10745, DOI 10.1128/MCB.25.24.10745-10754.2005; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; WILL CL, 2006, RNA WORLD, V3, P369	41	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32317	32327		10.1074/jbc.M804977200	http://dx.doi.org/10.1074/jbc.M804977200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809678	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000260893700018
J	Urbach, C; Fastrez, J; Soumillion, P				Urbach, Carole; Fastrez, Jacques; Soumillion, Patrice			A New Family of Cyanobacterial Penicillin-binding Proteins A MISSING LINK IN THE EVOLUTION OF CLASS A beta-LACTAMASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; COMPLETE GENOME STRUCTURE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; BACTERIAL-RESISTANCE; STREPTOMYCES R61; ACYL-ENZYME; OMEGA-LOOP; SUBSTRATE-SPECIFICITY	It is largely accepted that serine beta-lactamases evolved from some ancestral DD-peptidases involved in the biosynthesis and maintenance of the bacterial peptidoglycan. DD-peptidases are also called penicillin-binding proteins (PBPs), since they form stable acyl-enzymes with beta-lactam antibiotics, such as penicillins. On the other hand, beta-lactamases react similarly with these antibiotics, but the acyl-enzymes are unstable and rapidly hydrolyzed. Besides, all known PBPs and beta-lactamases share very low sequence similarities, thus rendering it difficult to understand how a PBP could evolve into a beta-lactamase. In this study, we identified a new family of cyanobacterial PBPs featuring the highest sequence similarity with the most widespread class A beta-lactamases. Interestingly, the Omega-loop, which, in the beta-lactamases, carries an essential glutamate involved in the deacylation process, is six amino acids shorter and does not contain any glutamate residue. From this new family of proteins, we characterized PBP-A from Thermosynechococcus elongatus and discovered hydrolytic activity with synthetic thiolesters that are usually good substrates of DD-peptidases. Penicillin degradation pathways as well as acylation and deacylation rates are characteristic of PBPs. In a first attempt to generate beta-lactamase activity, a 90-fold increase in deacylation rate was obtained by introducing a glutamate in the shorter Omega-loop.	[Urbach, Carole; Fastrez, Jacques; Soumillion, Patrice] Catholic Univ Louvain, Inst Sci Vie, Lab Ingn Prot & Peptides, B-1348 Louvain, Belgium	Universite Catholique Louvain	Soumillion, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Lab Ingn Prot & Peptides, Pl Croix Sud 4-5,Bte3, B-1348 Louvain, Belgium.	patrice.soumillion@uclouvain.be			Belgian Program on Interuniversity Poles of Attraction [PAI 5/33]; Fonds National de la Recherche Scientifique of Belgium	Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Fonds National de la Recherche Scientifique of Belgium(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by Belgian Program on Interuniversity Poles of Attraction Grant PAI 5/33 and the Fonds National de la Recherche Scientifique of Belgium. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADACHI H, 1991, J BIOL CHEM, V266, P3186; ADAM M, 1990, BIOCHEM J, V270, P525, DOI 10.1042/bj2700525; AMANUMA H, 1984, J BACTERIOL, V160, P822, DOI 10.1128/JB.160.2.822-823.1984; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Arpin C, 2001, ANTIMICROB AGENTS CH, V45, P2480, DOI 10.1128/AAC.45.9.2480-2485.2001; ASANO Y, 1989, J BIOL CHEM, V264, P14233; Banerjee S, 1998, BIOCHEMISTRY-US, V37, P3286, DOI 10.1021/bi972127f; Chesnel L, 2002, EUR J BIOCHEM, V269, P1678, DOI 10.1046/j.1432-1327.2002.02815.x; DAMBLON C, 1995, BIOCHEM J, V309, P431, DOI 10.1042/bj3090431; Davies C, 2001, J BIOL CHEM, V276, P616, DOI 10.1074/jbc.M004471200; Deghorain M, 2007, J BACTERIOL, V189, P4332, DOI 10.1128/JB.01829-06; Domanski TL, 1995, GENE, V167, P111, DOI 10.1016/0378-1119(96)82965-9; DUBOIS SK, 1995, J ANTIMICROB CHEMOTH, V35, P7; DUBUS A, 1994, BIOCHEM J, V301, P485, DOI 10.1042/bj3010485; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; Ferain T, 1996, J BACTERIOL, V178, P5431, DOI 10.1128/JB.178.18.5431-5437.1996; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Frere J M, 1976, Methods Enzymol, V45, P610; FRERE JM, 1975, NATURE, V258, P168, DOI 10.1038/258168a0; FRERE JM, 1976, NATURE, V260, P451, DOI 10.1038/260451a0; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; FRERE JM, 1992, CHEM BETA LACTAMS, P149; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Ghuysen JM, 1997, INT J ANTIMICROB AG, V8, P45, DOI 10.1016/S0924-8579(96)00358-5; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; GOODELL EW, 1985, J BACTERIOL, V163, P305, DOI 10.1128/JB.163.1.305-310.1985; Guillaume G, 1997, J BIOL CHEM, V272, P5438, DOI 10.1074/jbc.272.9.5438; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; HAMMARSTROM S, 1975, P NATL ACAD SCI USA, V72, P3463, DOI 10.1073/pnas.72.9.3463; Harris F, 2002, EUR J BIOCHEM, V269, P5821, DOI 10.1046/j.1432-1033.2002.03295.x; Hayes F, 1997, J BIOL CHEM, V272, P28833, DOI 10.1074/jbc.272.46.28833; Hoiczyk E, 2000, J BACTERIOL, V182, P1191, DOI 10.1128/JB.182.5.1191-1199.2000; JAMIN M, 1991, BIOCHEM J, V280, P499, DOI 10.1042/bj2800499; JAMIN M, 1995, ESSAYS BIOCHEM, V29, P1; JORIS B, 1988, BIOCHEM J, V250, P313, DOI 10.1042/bj2500313; KELLY JA, 1986, SCIENCE, V231, P1429, DOI 10.1126/science.3082007; Leganes F, 2005, ARCH MICROBIOL, V184, P234, DOI 10.1007/s00203-005-0046-8; Lewis ER, 1997, P NATL ACAD SCI USA, V94, P443, DOI 10.1073/pnas.94.2.443; LOBKOVSKY E, 1994, BIOCHEMISTRY-US, V33, P6762, DOI 10.1021/bi00188a004; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; MATAGNE A, 1995, BBA-PROTEIN STRUCT M, V1246, P109, DOI 10.1016/0167-4838(94)00177-I; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Morlot C, 2005, J BIOL CHEM, V280, P15984, DOI 10.1074/jbc.M408446200; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Nakamura Y, 2002, DNA RES, V9, P135, DOI 10.1093/dnares/9.4.135; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; NICHOLAS RA, 1988, J BIOL CHEM, V263, P2034; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; Osuna J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh135; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; PRATT RF, 2002, J CHEM SOC P2, V5, P851; Rhazi N, 2003, BIOCHEMISTRY-US, V42, P2895, DOI 10.1021/bi027256x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schrader-Fischer G, 2001, ANTIMICROB AGENTS CH, V45, P407, DOI 10.1128/AAC.45.2.407-412.2001; SHIBATA KI, 1987, J BACTERIOL, V169, P3409, DOI 10.1128/jb.169.8.3409-3413.1987; SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0; VANDERLINDEN MPG, 1992, J BACTERIOL, V174, P7572, DOI 10.1128/JB.174.23.7572-7578.1992; Vanwetswinkel S, 2000, J MOL BIOL, V295, P527, DOI 10.1006/jmbi.1999.3376; WAXMAN DJ, 1979, J BIOL CHEM, V254, P2056; WILKIN JM, 1993, BIOCHEM J, V293, P195, DOI 10.1042/bj2930195; ZHU YF, 1990, J BACTERIOL, V172, P1137, DOI 10.1128/jb.172.2.1137-1141.1990	67	17	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32516	32526		10.1074/jbc.M805375200	http://dx.doi.org/10.1074/jbc.M805375200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801739	hybrid			2022-12-25	WOS:000260893700040
J	Banerjee, S; Bond, JS				Banerjee, Sanjita; Bond, Judith S.			Prointerleukin-18 Is Activated by Meprin beta in Vitro and in Vivo in Intestinal Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BOND SPECIFICITY; ALPHA-SUBUNIT; CONVERTING-ENZYME; EPITHELIAL-CELLS; EXPRESSION; SUBSTRATE; MATRIX; INTERLEUKIN-1-BETA; METALLOPROTEASES; SECRETION	Interleukin-18 (IL-18), a pro-inflammatory cytokine, is a key factor in inflammatory bowel disease (IBD). Caspase-1 activates this cytokine, but other proteases are likely involved in maturation. Because meprin metalloproteinases have been implicated in IBD, the interaction of these proteases with proIL-18 was studied. The results demonstrate that the meprin beta subunit of meprins A and B cleaves proIL-18 into a smaller 17-kDa product. The cleavage is at the Asn(51)-Asp(52) bond, a site C-terminal to caspase-1 cleavage. The cleavage occurred in vitro with a K-m of 1.3 mu M and in Madin-Darby canine kidney cells transfected with meprin beta when proIL-18 was added to the culture medium. The product of meprin B cleavage of proIL-18 activated NF-kappa B in EL-4 cells, indicating that it was biologically active. To determine the physiological significance of the interactions of meprins with proIL-18, an experimental model of IBD was produced by administering dextran sulfate sodium (DSS) to wildtype and meprin beta knock-out (beta KO) mice, and the serum levels of active IL-18 were determined. DSS-treated meprin beta KO mice had lower levels of the active cytokine in the serum compared with wild-type mice. Furthermore, in meprin alpha KO mice, which express meprin beta but not alpha, active IL-18 was elevated in the serum of DSS-treated mice compared with wild-type mice, indicating that the meprin isoforms have opposing effects on the IL-18 levels in vivo. This study identifies proIL-18 as a biologically important substrate for meprin beta and implicates meprins in the modulation of inflammation.	[Banerjee, Sanjita; Bond, Judith S.] Penn State Univ Hosp, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bond, JS (corresponding author), Penn State Univ Hosp, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr,H171, Hershey, PA 17033 USA.	jbond@psu.edu			National Institutes of Health [DK19691]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK019691, R01DK019691, R37DK019691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK19691 (to J. S. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambort D, 2008, FEBS J, V275, P4490, DOI 10.1111/j.1742-4658.2008.06592.x; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Bankus JM, 1996, ARCH BIOCHEM BIOPHYS, V331, P87, DOI 10.1006/abbi.1996.0286; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2002, BIOL CHEM, V383, P1175, DOI 10.1515/BC.2002.129; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; DUMERMUTH E, 1993, FEBS LETT, V335, P367, DOI 10.1016/0014-5793(93)80421-P; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Garrigue-Antar L, 2001, J BIOL CHEM, V276, P26237, DOI 10.1074/jbc.M010814200; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hengst JA, 2004, J BIOL CHEM, V279, P34856, DOI 10.1074/jbc.M405774200; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Ishmael FT, 2005, J BIOL CHEM, V280, P13895, DOI 10.1074/jbc.M414218200; Johnson DE, 2000, LEUKEMIA, V14, P1695, DOI 10.1038/sj.leu.2401879; Kanai T, 2001, GASTROENTEROLOGY, V121, P875, DOI 10.1053/gast.2001.28021; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Mohan MJ, 2002, BIOCHEMISTRY-US, V41, P9462, DOI 10.1021/bi0260132; Monteleone G, 1999, J IMMUNOL, V163, P143; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Reuter BK, 2004, EUR J IMMUNOL, V34, P2347, DOI 10.1002/eji.200425351; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568; Villa JP, 2003, J BIOL CHEM, V278, P42545, DOI 10.1074/jbc.M303718200; Wiercinska-Drapalo A, 2005, WORLD J GASTROENTERO, V11, P605, DOI 10.3748/wjg.v11.i4.605	34	79	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31371	31377		10.1074/jbc.M802814200	http://dx.doi.org/10.1074/jbc.M802814200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786924	Green Published, hybrid			2022-12-25	WOS:000260760800015
J	Montoya-Durango, DE; Velu, CS; Kazanjian, A; Rojas, MEB; Jay, CM; Longmore, GD; Grimes, HL				Montoya-Durango, Diego E.; Velu, Chinavenmeni S.; Kazanjian, Avedis; Rojas, Meghan E. B.; Jay, Chris M.; Longmore, Gregory D.; Grimes, H. Leighton			Ajuba Functions as a Histone Deacetylase-dependent Co-repressor for Autoregulation of the Growth Factor-independent-1 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIM PROTEIN AJUBA; SEVERE CONGENITAL NEUTROPENIA; ZINC-FINGER PROTEIN; FACTOR INDEPENDENCE-1; DOMAIN PROTEIN; ONLY PROTEIN; COMPLEX; GFI-1; DNA; COREPRESSOR	Growth factor independent-1 (Gfi1) is a zinc finger protein with a SNAG-transcriptional repressor domain. Ajuba is a LIM domain protein that shuttles between the cytoplasm and the nucleus. Ajuba functions as a co-repressor for synthetic Gfi1 SNAG-repressor domain-containing constructs, but a role for Ajuba co-repression of the cognate DNA bound Gfi1 protein has not been defined. Co-immunoprecipitation of synthetic and endogenous proteins and co-elution with gel filtration suggest that an endogenous Ajuba.Gfi1.HDAC multiprotein complex is possible. Active histone deacetylase activity co-immunoprecipitates with Ajuba or Gfi1, and both proteins depend upon histone deacetylases for full transcriptional repression activity. Ajuba LIM domains directly bind to Gfi1, but the association is not SNAG domain-dependent. ChIP analysis and reciprocal knockdown experiments suggest that Ajuba selectively functions as a co-repressor for Gfi1 autoregulation. The data suggest that Ajuba is utilized as a corepressor selectively on Gfi1 target genes.	[Montoya-Durango, Diego E.; Kazanjian, Avedis; Jay, Chris M.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Velu, Chinavenmeni S.; Rojas, Meghan E. B.; Grimes, H. Leighton] Cincinnati Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Longmore, Gregory D.] Washington Univ, Dept Med, St Louis, MO 63130 USA	University of Louisville; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Washington University (WUSTL)	Grimes, HL (corresponding author), 3333 Burnet Ave,MLC 7038, Cincinnati, OH 45229 USA.	lee.grimes@cchmc.org		Grimes, H. Leighton/0000-0001-8162-6758	National Institutes of Health [R01 HL079574, CA105152]; Leukemia Lymphoma Society Scholar; NATIONAL CANCER INSTITUTE [R01CA105152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Lymphoma Society Scholar(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079574 and CA105152 (to H. L. G.). This work was also supported by a Leukemia Lymphoma Society Scholar award (to H. L. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doan LL, 2004, NUCLEIC ACIDS RES, V32, P2508, DOI 10.1093/nar/gkh570; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Feng YF, 2007, J BIOL CHEM, V282, P39, DOI 10.1074/jbc.M607399200; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; GILKS C, 1993, MOL CELL BIOL, V113, P1759; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Howard PW, 2001, J BIOL CHEM, V276, P19020, DOI 10.1074/jbc.M101782200; Kanungo J, 2000, MOL BIOL CELL, V11, P3299, DOI 10.1091/mbc.11.10.3299; Kazanjian A, 2004, CANCER RES, V64, P6874, DOI 10.1158/0008-5472.CAN-04-0633; Kazanjian A, 2006, CRIT REV ONCOL HEMAT, V59, P85, DOI 10.1016/j.critrevonc.2006.02.002; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; McLoughlin P, 2002, J BIOL CHEM, V277, P37045, DOI 10.1074/jbc.M203336200; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Retaux S, 2002, MOL NEUROBIOL, V26, P269, DOI 10.1385/MN:26:2-3:269; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang Y, 2001, BBA-MOL CELL RES, V1538, P260, DOI 10.1016/S0167-4889(01)00077-5; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zarebski A, 2008, IMMUNITY, V28, P370, DOI 10.1016/j.immuni.2007.12.020; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	42	48	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32056	32065		10.1074/jbc.M802320200	http://dx.doi.org/10.1074/jbc.M802320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18805794	Green Published, hybrid			2022-12-25	WOS:000260760800087
J	Tateishi, K; He, J; Taranova, O; Liang, GY; D'Alessio, AC; Zhang, Y				Tateishi, Keisuke; He, Jin; Taranova, Olena; Liang, Gaoyang; D'Alessio, Ana C.; Zhang, Yi			Generation of Insulin-secreting Islet-like Clusters from Human Skin Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; DIFFERENTIATION; ADULT; TISSUE	Increasing evidence suggests that islet cell transplantation for patients with type I diabetes holds great promise for achieving insulin independence. However, the extreme shortage of matched organ donors and the necessity for chronic immunosuppression has made it impossible for this treatment to be used for the general diabetic population. Recent success in generating insulin-secreting islet-like cells from human embryonic stem (ES) cells, in combination with the success in deriving human ES cell-like induced pluripotent stem (iPS) cells from human fibroblasts by defined factors, have raised the possibility that patient-specific insulin-secreting islet-like cells might be derived from somatic cells through cell fate reprogramming using defined factors. Here we confirm that human ES-like iPS cells can be derived from human skin cells by retroviral expression of OCT4, SOX2, c-MYC, and KLF4. Importantly, using a serum-free protocol, we successfully generated insulin-producing islet-like clusters (ILCs) from the iPS cells under feeder-free conditions. We demonstrate that, like human ES cells, skin fibroblast-derived iPS cells have the potential to be differentiated into islet-like clusters through definitive and pancreatic endoderm. The iPS-derived ILCs not only contain C-peptidepositive and glucagon-positive cells but also release C-peptide upon glucose stimulation. Thus, our study provides evidence that insulin-secreting ILCs can be generated from skin fibroblasts, raising the possibility that patient-specific iPS cells could potentially provide a treatment for diabetes in the future.	[Tateishi, Keisuke; He, Jin; Taranova, Olena; Liang, Gaoyang; D'Alessio, Ana C.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Tateishi, Keisuke; He, Jin; Taranova, Olena; Liang, Gaoyang; D'Alessio, Ana C.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Liang, Gaoyang/L-2087-2013; liang, gaoyang/A-8059-2010	Liang, Gaoyang/0000-0002-2157-974X; Zhang, Yi/0000-0002-2789-0811	Leukemia and Lymphoma Society	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	A fellow of the Leukemia and Lymphoma Society.	Campbell PM, 2007, AM J TRANSPLANT, V7, P2311, DOI 10.1111/j.1600-6143.2007.01923.x; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Eftat S, 2008, ADV DRUG DELIVER REV, V60, P114, DOI 10.1016/j.addr.2007.08.033; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Gangemi A, 2008, AM J TRANSPLANT, V8, P1250, DOI 10.1111/j.1600-6143.2008.02234.x; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lakey JRT, 2006, METH MOL B, V333, P47; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Suzuki A, 2003, P NATL ACAD SCI USA, V100, P5034, DOI 10.1073/pnas.0936260100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568	25	274	318	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31601	31607		10.1074/jbc.M806597200	http://dx.doi.org/10.1074/jbc.M806597200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782754	hybrid, Green Published			2022-12-25	WOS:000260760800040
J	Delille, HK; Schrader, M				Delille, Hannah K.; Schrader, Michael			Targeting of hFis1 to Peroxisomes Is Mediated by Pex19p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; TAIL-ANCHORED PROTEINS; DYNAMIN-LIKE PROTEIN-1; ASCORBATE PEROXIDASE; FISSION; FIS1; IMPORT; DIVISION; SIGNALS; PROLIFERATION	The processes of peroxisome formation and proliferation are still a matter of debate. We have previously shown that peroxisomes share some components of their division machinery with mitochondria. hFis1, a tail-anchored membrane protein, regulates the membrane fission of both organelles by DLP1/Drp1 recruitment, but nothing is known about the mechanisms of the dual targeting of hFis1. Here we demonstrate for the first time that peroxisomal targeting of hFis1 depends on Pex19p, a peroxisomal membrane protein import factor. hFis1/Pex19p binding was demonstrated by expression and co-immunoprecipitation studies. Using mutated versions of hFis1 an essential binding region for Pex19p was located within the last 26 C-terminal amino acids of hFis1, which are required for proper targeting to both mitochondria and peroxisomes. The basic amino acids in the very C terminus are not essential for Pex19p binding and peroxisomal targeting, but are instead required for mitochondrial targeting. Silencing of Pex19p by small interference RNA reduced the targeting of hFis1 to peroxisomes, but not to mitochondria. In contrast, overexpression of Pex19p alone was not sufficient to shift the targeting of hFis1 to peroxisomes. Our findings indicate that targeting of hFis1 to peroxisomes and mitochondria are independent events and support a direct, Pex19p-dependent targeting of peroxisomal tail-anchored proteins.	[Delille, Hannah K.; Schrader, Michael] Univ Aveiro, Ctr Cell Biol, P-3810193 Aveiro, Portugal; [Delille, Hannah K.; Schrader, Michael] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Delille, Hannah K.] Univ Marburg, Dept Cell Biol & Cell Pathol, D-35037 Marburg, Germany	Universidade de Aveiro; Universidade de Aveiro; Philipps University Marburg	Schrader, M (corresponding author), Univ Aveiro, Ctr Cell Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal.	mschrader@ua.pt			German Research Foundation [SCHR 518/6-1,2]; Portuguese Foundation for Science and Technology [PTDC/BIA-BCM/71932/2006]; University of Aveiro	German Research Foundation(German Research Foundation (DFG)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); University of Aveiro(European Commission)	This work was supported by the German Research Foundation (Grant SCHR 518/6-1,2), the Portuguese Foundation for Science and Technology (Grant PTDC/BIA-BCM/71932/2006), and the University of Aveiro.	Abe I, 1998, FEBS LETT, V431, P468, DOI 10.1016/S0014-5793(98)00815-1; Boll A, 2005, J HISTOCHEM CYTOCHEM, V53, P1037, DOI 10.1369/jhc.5B6681.2005; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; GANDREBABBE S, 2008, MOL BIOL CELL; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Herzig S, 2008, CURR MOL MED, V8, P131, DOI 10.2174/156652408783769625; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Mullen RT, 1999, PLANT CELL, V11, P2167, DOI 10.1105/tpc.11.11.2167; Mullen RT, 2000, J BIOL CHEM, V275, P16337, DOI 10.1074/jbc.M001266200; Muntau AC, 2003, EUR J CELL BIOL, V82, P333, DOI 10.1078/0171-9335-00325; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Nito K, 2001, PLANT CELL PHYSIOL, V42, P20, DOI 10.1093/pcp/pce003; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Schliebs W, 2004, CURR BIOL, V14, pR397, DOI 10.1016/j.cub.2004.05.017; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; Schrader M, 2000, J CELL SCI, V113, P3663; Schrader M, 1996, EUR J CELL BIOL, V69, P24; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2007, BIOESSAYS, V29, P1105, DOI 10.1002/bies.20659; Schrader M, 2006, BBA-MOL CELL RES, V1763, P531, DOI 10.1016/j.bbamcr.2006.01.004; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Van Ael E, 2006, BBA-MOL CELL RES, V1763, P1629, DOI 10.1016/j.bbamcr.2006.08.020; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	55	59	59	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31107	31115		10.1074/jbc.M803332200	http://dx.doi.org/10.1074/jbc.M803332200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782765	Green Published, hybrid			2022-12-25	WOS:000260544800065
J	Maciel, C; de Oliveira, VX; Fazio, MA; Nacif-Pimenta, R; Miranda, A; Pimenta, PFP; Capurro, ML				Maciel, Ceres; de Oliveira Junior, Vani Xavier; Fazio, Marcos Antonio; Nacif-Pimenta, Rafael; Miranda, Antonio; Pimenta, Paulo F. P.; Capurro, Margareth Lara			Anti-Plasmodium Activity of Angiotensin II and Related Synthetic Peptides	PLOS ONE			English	Article								Plasmodium species are the causative agents of malaria, the most devastating insect-borne parasite of human populations. Finding and developing new drugs for malaria treatment and prevention is the goal of much research. Angiotensins I and II (ang I and ang II) and six synthetic related peptides designated Vaniceres 1-6 (VC1-VC6) were assayed in vivo and in vitro for their effects on the development of the avian parasite, Plasmodium gallinaceum. Ang II and VC5 injected into the thoraces of the insects reduced mean intensities of infection in the mosquito salivary glands by 88% and 76%, respectively. Although the mechanism(s) of action is not completely understood, we have demonstrated that these peptides disrupt selectively the P. gallinaceum cell membrane. Additionally, incubation in vitro of sporozoites with VC5 reduced the infectivity of the parasites to their vertebrate host. VC5 has no observable agonist effects on vertebrates, and this makes it a promising drug for malaria prevention and chemotherapy.	[Maciel, Ceres; Capurro, Margareth Lara] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [de Oliveira Junior, Vani Xavier] Fed Univ ABC, Nat & Human Sci Ctr, Santo Andre, Brazil; [Fazio, Marcos Antonio; Miranda, Antonio] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Nacif-Pimenta, Rafael; Pimenta, Paulo F. P.] Fundacao Oswaldo Cruz, FIOCRUZ, Rene Rachou Inst Res, Lab Med Entomol, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz	Maciel, C (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.	mcapurro@icb.usp.br	Miranda, Antonio/C-8855-2012; Capurro, Margareth L/F-8679-2012; Pimenta, Paulo/AAH-1502-2020; Oliveira, Vani X/E-4645-2012; Fazio, Marcos A/P-9993-2015; Capurro, Margareth/M-5286-2019	Capurro, Margareth L/0000-0002-7480-2116; Oliveira, Vani X/0000-0002-9420-0956; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CNPq [fellows]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work is supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). A.M., C.M. and M.L.C. are fellows from CNPq.	BARANY G, 1980, PEPTIDES ANAL SYNTHE, V2, P1; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Dagan A, 2002, ANTIMICROB AGENTS CH, V46, P1059, DOI 10.1128/AAC.46.4.1059-1066.2002; Oliveira VX, 2008, J PEPT SCI, V14, P617, DOI 10.1002/pse.957; Efron L, 2002, J BIOL CHEM, V277, P24067, DOI 10.1074/jbc.M202089200; Fazio MA, 2006, BIOPOLYMERS, V84, P205, DOI 10.1002/bip.20396; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghosh JK, 1997, J BIOL CHEM, V272, P31609, DOI 10.1074/jbc.272.50.31609; GWADZ RW, 1989, INFECT IMMUN, V57, P2628, DOI 10.1128/IAI.57.9.2628-2633.1989; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jubilut GN, 1997, J BRAZIL CHEM SOC, V8, P65; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Leung PS, 2005, INT J BIOCHEM CELL B, V37, P237, DOI 10.1016/j.biocel.2004.07.004; Moreira CK, 2007, EXP PARASITOL, V116, P346, DOI 10.1016/j.exppara.2007.01.022; Munstermann LE, 1997, ANNU REV ENTOMOL, V42, P351, DOI 10.1146/annurev.ento.42.1.351; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; Oliveira VX, 2005, REGUL PEPTIDES, V127, P123, DOI 10.1016/j.regpep.2004.11.001; Oliveira VX, 2003, BIOPOLYMERS, V71, P372; Schneider DS, 2006, EMBO REP, V7, P259, DOI 10.1038/sj.embor.7400643; Shahabuddin M, 1998, EXP PARASITOL, V89, P103, DOI 10.1006/expr.1998.4212; THATHY V, 1994, J PARASITOL, V80, P705, DOI 10.2307/3283249; VIAL HJ, 1998, MALARIA PARASITE BIO, V11, P159; WHO UNICEF, 2005, WORLD MALARIA REPORT; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	25	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3296	10.1371/journal.pone.0003296	http://dx.doi.org/10.1371/journal.pone.0003296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820728	Green Published, Green Submitted, gold			2022-12-25	WOS:000264432500006
J	Tomovic, A; Oakeley, EJ				Tomovic, Andrija; Oakeley, Edward J.			Computational Structural Analysis: Multiple Proteins Bound to DNA	PLOS ONE			English	Article							NUCLEIC ACID RECOGNITION; TRANSCRIPTION FACTORS; STATISTICAL-ANALYSIS; REGULATORY MODULES; IDENTIFICATION; COOPERATIVITY; INTERFACES; IDENTIFY; READOUT; PISCES	Background: With increasing numbers of crystal structures of protein: DNA and protein: protein: DNA complexes publically available, it is now possible to extract sufficient structural, physical-chemical and thermodynamic parameters to make general observations and predictions about their interactions. In particular, the properties of macromolecular assemblies of multiple proteins bound to DNA have not previously been investigated in detail. Methodology/Principal Findings: We have performed computational structural analyses on macromolecular assemblies of multiple proteins bound to DNA using a variety of different computational tools: PISA; PROMOTIF; X3DNA; ReadOut; DDNA and DCOMPLEX. Additionally, we have developed and employed an algorithm for approximate collision detection and overlapping volume estimation of two macromolecules. An implementation of this algorithm is available at http://promoterplot.fmi.ch/Collision1/. The results obtained are compared with structural, physical-chemical and thermodynamic parameters from protein: protein and single protein: DNA complexes. Many of interface properties of multiple protein: DNA complexes were found to be very similar to those observed in binary protein: DNA and protein: protein complexes. However, the conformational change of the DNA upon protein binding is significantly higher when multiple proteins bind to it than is observed when single proteins bind. The water mediated contacts are less important (found in less quantity) between the interfaces of components in ternary (protein: protein: DNA) complexes than in those of binary complexes (protein: protein and protein: DNA). The thermodynamic stability of ternary complexes is also higher than in the binary interactions. Greater specificity and affinity of multiple proteins binding to DNA in comparison with binary protein-DNA interactions were observed. However, protein-protein binding affinities are stronger in complexes without the presence of DNA. Conclusions/Significance: Our results indicate that the interface properties: interface area; number of interface residues/atoms and hydrogen bonds; and the distribution of interface residues, hydrogen bonds, van der Walls contacts and secondary structure motifs are independent of whether or not a protein is in a binary or ternary complex with DNA. However, changes in the shape of the DNA reduce the off-rate of the proteins which greatly enhances the stability and specificity of ternary complexes compared to binary ones.	[Tomovic, Andrija; Oakeley, Edward J.] Novo Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Tomovic, A (corresponding author), Novo Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	andrija.tomovic@fmi.ch			Novartis Research Foundation	Novartis Research Foundation	This work was supported by the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2006, NUCLEIC ACIDS RES, V34, pW124, DOI 10.1093/nar/gkl104; Banerjee N, 2003, NUCLEIC ACIDS RES, V31, P7024, DOI 10.1093/nar/gkg894; BAREQUET G, 1996, BOXTREE HIERARCHICAL; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Cho KI, 2006, PROTEINS, V65, P593, DOI 10.1002/prot.21056; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; GOTTSCHALK S, 1996, OBB TREE HIERARCHICA; Gromiha MM, 2004, J MOL BIOL, V337, P285, DOI 10.1016/j.jmb.2004.01.033; GUHAROY M, 2007, BIOINFORMATICS; Hubbard PM, 1996, ACM T GRAPHIC, V15, P179, DOI 10.1145/231731.231732; HUGHES M, 1996, EFFICIENT ACCURATE I; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Janin J, 1999, STRUCT FOLD DES, V7, pR277, DOI 10.1016/S0969-2126(00)88333-1; Jayaram B, 2004, ANNU REV BIOPH BIOM, V33, P343, DOI 10.1146/annurev.biophys.33.110502.140414; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; KRISSINEL E, 2002, COMPUTATIONAL LIFE S, P163; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Luscombe NM, 2000, GENOME BIOL, V1; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MANDELGUTFREUND Y, 1995, J MOL BIOL, V253, P370, DOI 10.1006/jmbi.1995.0559; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Mirny LA, 2002, NUCLEIC ACIDS RES, V30, P1704, DOI 10.1093/nar/30.7.1704; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; Pabo CO, 2000, J MOL BIOL, V301, P597, DOI 10.1006/jmbi.2000.3918; Reddy CK, 2001, J MOL BIOL, V314, P619, DOI 10.1006/jmbi.2001.5154; Sarai A, 2005, ANNU REV BIOPH BIOM, V34, P379, DOI 10.1146/annurev.biophys.34.040204.144537; Sinha S, 2008, GENOME RES, V18, P477, DOI 10.1101/gr.6828808; Teschner M, 2003, OPTIMIZED SPATIAL HA; Treger M, 2001, J MOL RECOGNIT, V14, P199, DOI 10.1002/jmr.534; TURK G, 1989, INTERACTIVE COLLISIO; van den Bergen G., 1997, J GRAPH TOOLS, V2, P1, DOI [10.1080/10867651.1997.10487480, DOI 10.1080/10867651.1997.10487480]; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Williamson JR, 2008, NAT CHEM BIOL, V4, P458, DOI 10.1038/nchembio.102; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d; Zhao GY, 2007, GENOME RES, V17, P348, DOI 10.1101/gr.5989907	51	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3243	10.1371/journal.pone.0003243	http://dx.doi.org/10.1371/journal.pone.0003243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802470	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428600003
J	Huang, TH; Zhu, MJ; Li, XY; Zhao, SH				Huang, Ting-Hua; Zhu, Meng-Jin; Li, Xin-Yun; Zhao, Shu-Hong			Discovery of Porcine microRNAs and Profiling from Skeletal Muscle Tissues during Development	PLOS ONE			English	Article							GENE-EXPRESSION; ANIMAL MICRORNAS; TARGETS; PIG; DIFFERENTIATION; MICROARRAY; PROTEIN; GROWTH; ZBP-89; IDENTIFICATION	MiRNAs (microRNAs) play critical roles in many important biological processes such as growth and development in mammals. In this study, we identified hundreds of porcine miRNA candidates through in silico prediction and analyzed their expression in developing skeletal muscle using microarray. Microarray screening using RNA samples prepared from a 33-day whole embryo and an extra embryo membrane validated 296 of the predicted candidates. Comparative expression profiling across samples of longissimus muscle collected from 33-day and 65-day post-gestation fetuses, as well as adult pigs, identified 140 differentially expressed miRNAs amongst the age groups investigated. The differentially expressed miRNAs showed seven distinctive types of expression patterns, suggesting possible involvement in certain biological processes. Five of the differentially expressed miRNAs were validated using real-time PCR. In silico analysis of the miRNA-mRNA interaction sites suggested that the potential mRNA targets of the differentially expressed miRNAs may play important roles in muscle growth and development.	[Huang, Ting-Hua; Zhu, Meng-Jin; Li, Xin-Yun; Zhao, Shu-Hong] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University	Huang, TH (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China.	shzhao@mail.hzau.edu.cn			Key Project of National Basic Research and Developmental Plan [2006CB102105]; National Natural Science Foundation of China [30671138]	Key Project of National Basic Research and Developmental Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the Key Project of National Basic Research and Developmental Plan (2006CB102105) and the National Natural Science Foundation (30671138) of China.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang TH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-341; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Law DJ, 2006, NUCLEIC ACIDS RES, V34, P1342, DOI 10.1093/nar/gkl022; Law DJ, 1998, MAMM GENOME, V9, P165, DOI 10.1007/s003359900711; LEFAUCHEUR L, 1995, DEV DYNAM, V203, P27, DOI 10.1002/aja.1002030104; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Luo MY, 2007, PROG BIOCHEM BIOPHYS, V34, P31; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Merchant JL, 1996, MOL CELL BIOL, V16, P6644; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Sawera M, 2005, MAMM GENOME, V16, P594, DOI 10.1007/s00335-005-0013-3; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; WIGMORE PMC, 1983, J ANAT, V137, P235; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhao SH, 2003, J ANIM SCI, V81, P2179; Zhao SH, 2006, MAMM GENOME, V17, P777, DOI 10.1007/s00335-005-0155-3	36	119	134	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3225	10.1371/journal.pone.0003225	http://dx.doi.org/10.1371/journal.pone.0003225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795099	Green Published, gold, Green Submitted			2022-12-25	WOS:000264428000008
J	Benit, P; Goncalves, S; Dassa, EP; Briere, JJ; Rustin, P				Benit, Paule; Goncalves, Sergio; Dassa, Emmanuel Philippe; Briere, Jean-Jacques; Rustin, Pierre			The Variability of the Harlequin Mouse Phenotype Resembles that of Human Mitochondrial-Complex I-Deficiency Syndromes	PLOS ONE			English	Article								Background: Despite the considerable progress made in understanding the molecular bases of mitochondrial diseases, no effective treatments have been developed to date. Faithful animal models would be extremely helpful for designing such treatments. We showed previously that the Harlequin mouse phenotype was due to a specific mitochondrial complex I deficiency resulting from the loss of the Apoptosis Inducing Factor (Aif) protein. Methodology/Principal Findings: Here, we conducted a detailed evaluation of the Harlequin mouse phenotype, including the biochemical abnormalities in various tissues. We observed highly variable disease expression considering both severity and time course progression. In each tissue, abnormalities correlated with the residual amount of the respiratory chain complex I 20 kDa subunit, rather than with residual Aif protein. Antioxidant enzyme activities were normal except in skeletal muscle, where they were moderately elevated. Conclusions/Significance: Thus, the Harlequin mouse phenotype appears to result from mitochondrial respiratory chain complex I deficiency. Its features resemble those of human complex I deficiency syndromes. The Harlequin mouse holds promise as a model for developing treatments for complex I deficiency syndromes.	[Benit, Paule; Goncalves, Sergio; Dassa, Emmanuel Philippe; Briere, Jean-Jacques; Rustin, Pierre] Hop Robert Debre, INSERM, U676, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benit, P (corresponding author), Hop Robert Debre, INSERM, U676, F-75019 Paris, France.	pierre.rustin@inserm.fr			Association Francaise contre les Myopathies (AFM) [11639]; Association contre les Maladies Mitochondriales (Ammi); Association Francaise contre l'Ataxie de Friedreich (AFAF); Leducq foundation; ANR MitOxy; European Union	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association contre les Maladies Mitochondriales (Ammi); Association Francaise contre l'Ataxie de Friedreich (AFAF); Leducq foundation(Leducq Foundation); ANR MitOxy(French National Research Agency (ANR)); European Union(European Commission)	This work was supported by the Association Francaise contre les Myopathies (AFM) Project No. 11639), the Association contre les Maladies Mitochondriales (Ammi), the Association Francaise contre l'Ataxie de Friedreich (AFAF), the Leducq foundation, the ANR MitOxy, and the European Union (EUMITOCOMBAT project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova N, 2006, CELL DEATH DIFFER, V13, P354, DOI 10.1038/sj.cdd.4401776; Barber BR, 1971, MOUSE NEWS LETT, V45, P34; BENIT P, 2006, CLIN CHIM ACTA; BENIT P, 2007, COMPLEX ALTERNATIVE, P157; Benit P, 2008, MOL CELL BIOCHEM, V314, P45, DOI 10.1007/s11010-008-9763-z; Benit Paule, 2004, Current Genomics, V5, P137, DOI 10.2174/1389202043489971; Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briere JJ, 2004, BBA-BIOENERGETICS, V1659, P172, DOI 10.1016/j.bbabio.2004.07.002; BROWN D, 2006, P NATL ACAD IN PRESS; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Claiborne A., 1985, CATALASE ACTIVITY; Delettre C, 2006, J BIOL CHEM, V281, P18507, DOI 10.1074/jbc.M601751200; DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598; Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; JOZA N, 2008, CELL DEATH DIFFER; KATZ BJ, 2006, AM J MED GENET A; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Larsson NG, 2001, TRENDS MOL MED, V7, P578, DOI 10.1016/S1471-4914(01)02167-0; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; QIU XZ, 2008, CELL BIOCH FUNCT; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Tzagoloff A, 1982, MITOCHONDRIA; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; van Empel VPM, 2006, J AM COLL CARDIOL, V48, P824, DOI 10.1016/j.jacc.2006.02.075; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	40	63	63	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3208	10.1371/journal.pone.0003208	http://dx.doi.org/10.1371/journal.pone.0003208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791645	Green Submitted, Green Published, gold			2022-12-25	WOS:000264427700003
J	Kimura, H; Kwan, KM; Zhang, Z; Deng, JM; Darnay, BG; Behringer, RR; Nakamura, T; de Crombrugghe, B; Akiyama, H				Kimura, Hiroaki; Kwan, Kin Ming; Zhang, Zhaoping; Deng, Jian Min; Darnay, Bryant G.; Behringer, Richard R.; Nakamura, Takashi; de Crombrugghe, Benoit; Akiyama, Haruhiko			Cthrc1 Is a Positive Regulator of Osteoblastic Bone Formation	PLOS ONE			English	Article								Background: Bone mass is maintained by continuous remodeling through repeated cycles of bone resorption by osteoclasts and bone formation by osteoblasts. This remodeling process is regulated by many systemic and local factors. Methodology/Principal Findings: We identified collagen triple helix repeat containing-1 (Cthrc1) as a downstream target of bone morphogenetic protein-2 (BMP2) in osteochondroprogenitor-like cells by PCR-based suppression subtractive hybridization followed by differential hybridization, and found that Cthrc1 was expressed in bone tissues in vivo. To investigate the role of Cthrc1 in bone, we generated Cthrc1-null mice and transgenic mice which overexpress Cthrc1 in osteoblasts (Cthrc1 transgenic mice). Microcomputed tomography (micro-CT) and bone histomorphometry analyses showed that Cthrc1-null mice displayed low bone mass as a result of decreased osteoblastic bone formation, whereas Cthrc1 transgenic mice displayed high bone mass by increase in osteoblastic bone formation. Osteoblast number was decreased in Cthrc1-null mice, and increased in Cthrc1 transgenic mice, respectively, while osteoclast number had no change in both mutant mice. In vitro, colony-forming unit (CFU) assays in bone marrow cells harvested from Cthrc1-null mice or Cthrc1 transgenic mice revealed that Cthrc1 stimulated differentiation and mineralization of osteoprogenitor cells. Expression levels of osteoblast specific genes, ALP, Col1a1, and Osteocalcin, in primary osteoblasts were decreased in Cthrc1-null mice and increased in Cthrc1 transgenic mice, respectively. Furthermore, BrdU incorporation assays showed that Cthrc1 accelerated osteoblast proliferation in vitro and in vivo. In addition, overexpression of Cthrc1 in the transgenic mice attenuated ovariectomy-induced bone loss. Conclusions/Significance: Our results indicate that Cthrc1 increases bone mass as a positive regulator of osteoblastic bone formation and offers an anabolic approach for the treatment of osteoporosis.	[Kimura, Hiroaki; Nakamura, Takashi; Akiyama, Haruhiko] Kyoto Univ, Dept Orthopaed, Kyoto, Japan; [Kwan, Kin Ming; Zhang, Zhaoping; Deng, Jian Min; Behringer, Richard R.; de Crombrugghe, Benoit] Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX USA; [Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Kwan, Kin Ming] Chinese Univ Hong Kong, Dept Biol, Shatin, Peoples R China	Kyoto University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Chinese University of Hong Kong	Kimura, H (corresponding author), Kyoto Univ, Dept Orthopaed, Kyoto, Japan.	hakiyama@kuhp.kyoto-u.ac.jp		Kwan, Kin Ming/0000-0002-1246-2398	Japanese Ministry of Education, Culture, Sports, Science, and Technology [18390413]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049072] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#18390413).	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Abe E, 2006, ANN NY ACAD SCI, V1068, P41, DOI 10.1196/annals.1346.007; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; DEMPSTER DW, 1995, BONE, V16, P157, DOI 10.1016/S8756-3282(94)00024-7; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Durmus T, 2006, GENE EXPR PATTERNS, V6, P935, DOI 10.1016/j.modgep.2006.03.008; Garrett IR, 2007, CURR TOP DEV BIOL, V78, P127, DOI 10.1016/S0070-2153(06)78004-8; HAHN M, 1991, VIRCHOWS ARCH A, V418, P1, DOI 10.1007/BF01600238; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kimura H, 2007, BIOCHEM BIOPH RES CO, V356, P935, DOI 10.1016/j.bbrc.2007.03.071; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LeClair RJ, 2007, CIRC RES, V100, P826, DOI 10.1161/01.RES.0000260806.99307.72; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakanishi R, 2006, J BONE MINER RES, V21, P1713, DOI 10.1359/JBMR.060719; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PARFITT AM, 2002, DISORDERS BONE MINER, P469; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; TURNER RT, 1987, J BONE MINER RES, V2, P115; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; ZHAO M, 2002, BONE MORPHOGENETIC P, P1049	33	70	76	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3174	10.1371/journal.pone.0003174	http://dx.doi.org/10.1371/journal.pone.0003174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779865	Green Submitted, gold, Green Published			2022-12-25	WOS:000264425100010
J	Melzer, N; Meuth, SG; Torres-Salazar, D; Bittner, S; Zozulya, AL; Weidenfeller, C; Kotsiari, A; Stangel, M; Fahlke, C; Wiendl, H				Melzer, Nico; Meuth, Sven G.; Torres-Salazar, Delany; Bittner, Stefan; Zozulya, Alla L.; Weidenfeller, Christian; Kotsiari, Alexandra; Stangel, Martin; Fahlke, Christoph; Wiendl, Heinz			A beta-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article								In multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE), impairment of glial "Excitatory Amino Acid Transporters'' (EAATs) together with an excess glutamate-release by invading immune cells causes excitotoxic damage of the central nervous system (CNS). In order to identify pathways to dampen excitotoxic inflammatory CNS damage, we assessed the effects of a beta-lactam antibiotic, ceftriaxone, reported to enhance expression of glial EAAT2, in "Myelin Oligodendrocyte Glycoprotein'' (MOG)-induced EAE. Ceftriaxone profoundly ameliorated the clinical course of murine MOG-induced EAE both under preventive and therapeutic regimens. However, ceftriaxone had impact neither on EAAT2 protein expression levels in several brain areas, nor on the radioactive glutamate uptake capacity in a mixed primary glial cell-culture and the glutamate-induced uptake currents in a mammalian cell line mediated by EAAT2. Moreover, the clinical effect of ceftriaxone was preserved in the presence of the EAAT2-specific transport inhibitor, dihydrokainate, while dihydrokainate alone caused an aggravated EAE course. This demonstrates the need for sufficient glial glutamate uptake upon an excitotoxic autoimmune inflammatory challenge of the CNS and a molecular target of ceftriaxone other than the glutamate transporter. Ceftriaxone treatment indirectly hampered T cell proliferation and proinflammatory INF gamma and IL17 secretion through modulation of myelin-antigen presentation by antigen-presenting cells (APCs) e. g. dendritic cells (DCs) and reduced T cell migration into the CNS in vivo. Taken together, we demonstrate, that a beta-lactam antibiotic attenuates disease course and severity in a model of autoimmune CNS inflammation. The mechanisms are reduction of T cell activation by modulation of cellular antigen-presentation and impairment of antigen-specific T cell migration into the CNS rather than or modulation of central glutamate homeostasis.	[Melzer, Nico; Meuth, Sven G.; Bittner, Stefan; Zozulya, Alla L.; Weidenfeller, Christian; Wiendl, Heinz] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Torres-Salazar, Delany; Fahlke, Christoph] Hannover Med Sch, Dept Neurophysiol, D-30623 Hannover, Germany; [Kotsiari, Alexandra; Stangel, Martin] Hannover Med Sch, Dept Neurol, D-30623 Hannover, Germany; [Torres-Salazar, Delany] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA	University of Wurzburg; Hannover Medical School; Hannover Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Melzer, N (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	melzer_n1@klinik.uni-wuerzburg.de; heinz.wiendl@klinik.uni-wuerzburg.de	Stangel, Martin/AAH-5345-2020; Fahlke, Christoph/G-3635-2013; Melzer, Nico/HGE-2991-2022; Wiendl, Heinz/AAX-6041-2021; Meuth, Sven G/HHM-8941-2022	Fahlke, Christoph/0000-0001-8602-9952; Melzer, Nico/0000-0002-2420-701X; Meuth, Sven G/0000-0003-2571-3501; Torres-Salazar, Delany/0000-0002-6789-9810; Bittner, Stefan/0000-0003-2179-3655; Wiendl, Heinz/0000-0003-4310-3432	IZKF [Z-3/4, A54/1]	IZKF	This study was supported by university grants (IZKF Z-3/4) to NM and HW and (IZKF A54/1) to SGM and HW. All authors report no conflict of interest.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BASSO AS, 2008, J CLIN INVEST; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Brooks BM, 2005, J ANTIMICROB CHEMOTH, V56, P1122, DOI 10.1093/jac/dki373; Brooks BM, 2003, CLIN EXP IMMUNOL, V131, P268, DOI 10.1046/j.1365-2249.2003.02069.x; Brooks BM, 2001, BIOCHEM BIOPH RES CO, V288, P1175, DOI 10.1006/bbrc.2001.5896; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Canton T, 2001, J PHARMACOL EXP THER, V299, P314; CHANDRASEKAR PH, 1984, J ANTIMICROB CHEMOTH, V14, P427, DOI 10.1093/jac/14.4.427; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dixon W. J., 1969, INTRO STAT ANAL; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Furuta A, 1997, J NEUROSCI, V17, P8363; Garg SK, 2008, J IMMUNOL, V180, P3866, DOI 10.4049/jimmunol.180.6.3866; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Heine S, 2006, J NEUROIMMUNOL, V177, P173, DOI 10.1016/j.jneuroim.2006.04.016; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HERREROHERRANZ E, 2008, NEUROBIOL DIS; Kleinschnitz C., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P35; LEE SG, 2008, J BIOL CHEM; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lipski J, 2007, NEUROSCIENCE, V146, P617, DOI 10.1016/j.neuroscience.2007.02.003; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Meuth SG, 2008, J NEUROIMMUNOL, V194, P62, DOI 10.1016/j.jneuroim.2007.11.013; MILLER BR, 2008, NEUROSCIENCE; NAU R, 1993, ANTIMICROB AGENTS CH, V37, P1518, DOI 10.1128/AAC.37.7.1518; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; ORTLER S, 2008, EUR J IMMUNOL; Otis TS, 2000, J NEUROSCI, V20, P2749; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Padovan E, 1999, J IMMUNOL, V162, P1171; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spalloni A, 2004, NEUROBIOL DIS, V15, P340, DOI 10.1016/j.nbd.2003.11.012; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tian GL, 2007, J BIOL CHEM, V282, P1727, DOI 10.1074/jbc.M609822200; WEISS ME, 1988, CLIN ALLERGY, V18, P515, DOI 10.1111/j.1365-2222.1988.tb02904.x; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Zanni MP, 1998, J CLIN INVEST, V102, P1591, DOI 10.1172/JCI3544; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	54	71	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3149	10.1371/journal.pone.0003149	http://dx.doi.org/10.1371/journal.pone.0003149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773080	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000264420100007
J	Neganova, I; Zhang, X; Atkinson, S; Lako, M				Neganova, I.; Zhang, X.; Atkinson, S.; Lako, M.			Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells	ONCOGENE			English	Article						human embryonic stem cell; cell cycle regulation; G1/S transition; CDK2; CYCLIN D1; CYCLIN D2	ES CELLS; DIFFERENTIATION; DERIVATION; ESTABLISHMENT; BLASTOCYSTS; INHIBITION; FEATURES; CULTURE; PHASE; LINES	One of the characteristic features of human embryonic stem cells (hESCs) is the competence for self-renewal and pluripotency. To date, little is known about cell cycle regulation in these cells and how the cell cycle machinery influences hESCs properties. A common feature of human, murine and primate ESCs is the presence of a short G1 phase, which has been viewed as a time window during which stem cells are exposed to differentiation signals. We used the hESCs differentiation model and comparisons to human embryonic carcinoma (EC) cells to study the key regulators of G1 to S transition in hESCs. Our studies show that hESCs express all G1-specific CYCLINs (D1, D2, D3 and E) and cyclin-dependent kinases (CDK) (CDK2, CDK4 and CDK6) at variable levels. In contrast to murine ESCs, most of the cell cycle regulators in hESCs show cell cycle-dependent expression, thus revealing important differences in the expression of cell cycle regulatory components between these two embryonic cell types. Knockdown of CDK2 using RNA interference resulted in hESCs arrest at G1 phase of the cell cycle and differentiation to extraembryonic lineages. This suggests an important role for CDK2 in cell cycle regulation in hESCs that are likely to bear significant impacts on the maintenance of their pluripotent phenotype.	[Neganova, I.; Zhang, X.; Atkinson, S.; Lako, M.] Newcastle Univ, NE Inst Stem Cell Res, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Neganova, I.; Zhang, X.; Atkinson, S.; Lako, M.] Newcastle Univ, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Lako, M (corresponding author), Newcastle Univ, NE Inst Stem Cell Res, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	majlinda.Lako@ncl.ac.uk	Lako, Majlinda/B-6297-2013	lako, majlinda/0000-0003-1327-8573; Atkinson, Stuart P./0000-0002-8218-3730	BBSRC [BBS/B/14779]; Newcastle University; MRC [G0301182]; BBSRC [BB/E012841/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/14779, BB/E012841/1] Funding Source: researchfish; Medical Research Council [G0301182] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Mr I Dimmick and Dr R Stewart for help with the. ow cytometry analysis, Dr A Hampl for useful discussions, A Khnykina for help with. gure preparation, Dr S Pryzborski for providing the EC cells, and Mr G Anyfantis and Mr D Kirk for technical assistance. This study was supported by BBSRC Grant no. BBS/B/14779, MRC Grant G0301182 and Newcastle University.	Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; BLOMEN V, 2007, CELL MOL LIFE SCI, V24, P1789; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Ghule PN, 2007, J CELL PHYSIOL, V213, P9, DOI 10.1002/jcp.21119; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Savatier P, 2004, HDB STEM CELL ELSEVI, P53; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stojkovic M, 2004, REPRODUCTION, V128, P259, DOI 10.1530/rep.1.00243; Stojkovic M, 2004, STEM CELLS, V22, P790, DOI 10.1634/stemcells.22-5-790; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WANG N, 1980, CANCER RES, V40, P796; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	25	132	138	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 8	2009	28	1					20	30		10.1038/onc.2008.358	http://dx.doi.org/10.1038/onc.2008.358			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18806832				2022-12-25	WOS:000262294100003
J	Cohen, TJ; Barrientos, T; Hartman, ZC; Garvey, SM; Cox, GA; Yao, TP				Cohen, Todd J.; Barrientos, Tomasa; Hartman, Zachary C.; Garvey, Sean M.; Cox, Gregory A.; Yao, Tso-Pang			The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity	FASEB JOURNAL			English	Article						neuromuscular disease; remodeling; pathological induction; muscle integrity	AMYOTROPHIC-LATERAL-SCLEROSIS; MUSCULAR-ATROPHY; SKELETAL-MUSCLE; PROMOTER; MEF2; ACTIVATION; MYOTILIN; FIBERS; MICE; BOX	Histone deacetylase 4 (HDAC4) binds and inhibits activation of the critical muscle transcription factor myocyte enhancer factor-2 (MEF2). However, the physiological significance of the HDAC4-MEF2 complex in skeletal muscle has not been established. Here we show that in skeletal muscle, HDAC4 is a critical modulator of MEF2-dependent structural and contractile gene expression in response to neural activity. We present evidence that loss of neural input leads to concomitant nuclear accumulation of HDAC4 and transcriptional reduction of MEF2-regulated gene expression. Cell-based assays show that HDAC4 represses structural gene expression via direct binding to AT-rich MEF2 response elements. Notably, using both surgical denervation and the neuromuscular disease amyotrophic lateral sclerosis (ALS) model, we found that elevated levels of HDAC4 are required for efficient repression of MEF2-dependent structural gene expression, indicating a link between the pathological induction of HDAC4 and subsequent MEF2 target gene suppression. Supporting this supposition, we show that ectopic expression of HDAC4 in muscle fibers is sufficient to induce muscle damage in mice. Our study identifies HDAC4 as an activity-dependent regulator of MEF2 function and suggests that activation of HDAC4 in response to chronically reduced neural activity suppresses MEF2-dependent gene expression and contributes to progressive muscle dysfunction observed in neuromuscular diseases.-Cohen, T. J., Barrientos, T., Hartman, Z. C., Garvey, S. M., Cox, G. A., Yao, T.- P. The deacetylase HDAC4 controls myocyte enhancing factor-2 dependent structural gene expression in response to neural activity. FASEB J. 23, 99-106 (2009)	[Yao, Tso-Pang] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Hartman, Zachary C.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Garvey, Sean M.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA; [Cox, Gregory A.] Jackson Lab, Bar Harbor, ME 04609 USA	Duke University; Duke University; University of Virginia; Jackson Laboratory	Yao, TP (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	yao00001@mc.duke.edu		Garvey, Sean/0000-0003-1013-7871	Leukemia and Lymphoma Society [AR055613]; U.S. National Institutes of Health; ALS Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055613] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Tim Bolger, Xuan Zhao, and Chun Lai for technical assistance. We thank Satoru Noguchi (National Institute of Neuroscience, Tokyo, Japan) and Olli Carpen (University of Helsinki, Helsinki, Finland) for kindly providing mouse gamma-sarcoglycan and mouse myotilin reporter constructs and Mike Hauser (Duke University, Durham, NC, USA) for providing myotilin antibody. This work was supported by the Leukemia and Lymphoma Society and grant AR055613 (to T.-P.Y), and the U.S. National Institutes of Health and the ALS Association (to G.A.C.).	Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brichta L, 2006, ANN NEUROL, V59, P970, DOI 10.1002/ana.20836; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Delgado-Olguin P, 2006, BBA-GENE STRUCT EXPR, V1759, P240, DOI 10.1016/j.bbaexp.2006.04.007; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DRACHMAN DB, 1967, ARCH NEUROL-CHICAGO, V16, P14, DOI 10.1001/archneur.1967.00470190018002; Esser K, 1999, J BIOL CHEM, V274, P12095, DOI 10.1074/jbc.274.17.12095; FIDZIANSKA A, 1976, ACTA NEUROPATHOL, V34, P321, DOI 10.1007/BF00696561; Garvey SM, 2006, HUM MOL GENET, V15, P2348, DOI 10.1093/hmg/ddl160; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Klamut HJ, 1997, NUCLEIC ACIDS RES, V25, P1618, DOI 10.1093/nar/25.8.1618; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Mologni L, 2005, BIOCHEM BIOPH RES CO, V329, P1001, DOI 10.1016/j.bbrc.2005.02.074; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Raffaello A, 2006, PHYSIOL GENOMICS, V25, P60, DOI 10.1152/physiolgenomics.00051.2005; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Wakabayashi-Takai E, 2001, EUR J BIOCHEM, V268, P948, DOI 10.1046/j.1432-1327.2001.01954.x; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	24	63	66	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					99	106		10.1096/fj.08-115931	http://dx.doi.org/10.1096/fj.08-115931			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18780762	Green Published			2022-12-25	WOS:000262095500012
J	Brown, MD; Bry, L; Li, ZG; Sacks, DB				Brown, Matthew D.; Bry, Lynn; Li, Zhigang; Sacks, David B.			Actin Pedestal Formation by Enteropathogenic Escherichia coli Is Regulated by IQGAP1, Calcium, and Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATED INTIMIN RECEPTOR; EPITHELIAL-CELLS; INTEGRATES CA2+/CALMODULIN; TYROSINE PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVITY; SIGNAL-TRANSDUCTION; EFFACING LESIONS; ALPHA-ACTININ; HOST-CELLS; B-RAF	During infection, enteropathogenic Escherichia coli (EPEC) injects effector proteins into the host cell to manipulate the actin cytoskeleton and promote formation of actin pedestals. IQGAP1 is a multidomain protein that participates in numerous cellular functions, including Rac1/Cdc42 and Ca2+/calmodulin signaling and actin polymerization. Here we report that IQGAP1, Ca2+, and calmodulin modulate actin pedestal formation by EPEC. Infection with EPEC promotes both the interaction of IQGAP1 with calmodulin and the localization of IQGAP1 and calmodulin to actin pedestals while reducing the interaction of IQGAP1 with Rac1 and Cdc42. IQGAP1-null fibroblasts display a reduced polymerization of actin in response to EPEC. In addition, antagonism of calmodulin or chelation of intracellular Ca2+ reduces EPEC-dependent actin polymerization. Furthermore, IQGAP1 specifically interacts with Tir in vitro and in cells. Together these data identify IQGAP1, Ca2+, and calmodulin as a novel signaling complex regulating actin pedestal formation by EPEC.	[Sacks, David B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sacks, DB (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Thorn 530,75 Francis St, Boston, MA 02115 USA.	dsacks@rics.bwh.harvard.edu		Bry, Lynn/0000-0002-8792-8527; Sacks, David/0000-0003-3100-0735	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health grants (to D. B. S. and L. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Bain C, 1998, INFECT IMMUN, V66, P3900, DOI 10.1128/IAI.66.8.3900-3908.1998; BALDWIN TJ, 1991, INFECT IMMUN, V59, P1599, DOI 10.1128/IAI.59.5.1599-1604.1991; Ben-Ami G, 1998, INFECT IMMUN, V66, P1755, DOI 10.1128/IAI.66.4.1755-1758.1998; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DYTOC M, 1994, GASTROENTEROLOGY, V106, P1150, DOI 10.1016/0016-5085(94)90004-3; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; FOUBISTER V, 1994, J EXP MED, V179, P993, DOI 10.1084/jem.179.3.993; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; GIULIANO KA, 1995, CURR OPIN CELL BIOL, V7, P4, DOI 10.1016/0955-0674(95)80038-7; Goosney DL, 2000, CURR BIOL, V10, P735, DOI 10.1016/S0960-9822(00)00543-1; Goosney DL, 2000, ANNU REV CELL DEV BI, V16, P173, DOI 10.1146/annurev.cellbio.16.1.173; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Hardwidge PR, 2004, J BIOL CHEM, V279, P20127, DOI 10.1074/jbc.M401228200; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Ide T, 2003, INFECT IMMUN, V71, P1725, DOI 10.1128/IAI.71.4.1725-1732.2003; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; KennedyKalafatis S, 1996, J GEOGR HIGHER EDUC, V20, P323, DOI 10.1080/03098269608709376; Kenny B, 1997, INFECT IMMUN, V65, P2528, DOI 10.1128/IAI.65.7.2528-2536.1997; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Lommel S, 2004, CELL MICROBIOL, V6, P243, DOI 10.1111/j.1462-5822.2004.00364.x; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; Michgehl S, 2006, CELL MICROBIOL, V8, P625, DOI 10.1111/j.1462-5822.2005.00655.x; NORMAN JA, 1987, MOL PHARMACOL, V31, P535; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; Patel A, 2006, CELL MICROBIOL, V8, P55, DOI 10.1111/j.1462-5822.2005.00600.x; Phillips N, 2004, NAT CELL BIOL, V6, P618, DOI 10.1038/ncb1148; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; ROSENSHINE I, 1992, EMBO J, V11, P3551, DOI 10.1002/j.1460-2075.1992.tb05438.x; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; SHELANSKI ML, 1989, ANN NY ACAD SCI, V568, P121; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Unsworth KE, 2007, CELL MICROBIOL, V9, P438, DOI 10.1111/j.1462-5822.2006.00801.x; Zhang HZ, 1996, MOL MICROBIOL, V21, P787, DOI 10.1046/j.1365-2958.1996.431403.x	65	36	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35212	35222		10.1074/jbc.M803477200	http://dx.doi.org/10.1074/jbc.M803477200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18809683	hybrid, Green Published			2022-12-25	WOS:000261469100077
J	Horike, N; Sakoda, H; Kushiyama, A; Ono, H; Fujishiro, M; Kamata, H; Nishiyama, K; Uchijima, Y; Kurihara, Y; Kurihara, H; Asano, T				Horike, Nanao; Sakoda, Hideyuki; Kushiyama, Akifumi; Ono, Hiraku; Fujishiro, Midori; Kamata, Hideaki; Nishiyama, Koichi; Uchijima, Yasunobu; Kurihara, Yukiko; Kurihara, Hiroki; Asano, Tomoichiro			AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3 beta and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; PROMOTER-REGULATORY REGION; ACETYL-COA CARBOXYLASE; LEUCINE-ZIPPER DOMAIN; GTP GENE; GLUCOSE-METABOLISM; HEPATIC GLUCONEOGENESIS; COACTIVATOR TORC2; INSULIN; IDENTIFICATION	AMP-activated protein kinase (AMPK) activation reportedly suppresses transcriptional activity of the cAMP-responsive element (CRE) in the phosphoenolpyruvate carboxykinase C (PEPCK-C) promoter and reduces hepatic PEPCK-C expression. Although a previous study found TORC2 phosphorylation to be involved in the suppression of AMPK-mediated CRE transcriptional activity, we herein present evidence that glycogen synthase kinase 3 beta (GSK3 beta) phosphorylation induced by AMPK also plays an important role. We initially found that injecting fasted mice with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) markedly increased Ser-9 phosphorylation of hepatic GSK3 beta within 15 min. Stimulation with AICAR or the GSK3 beta inhibitor SB-415286 strongly inhibited CRE-containing promoter activity in HepG2 cells. Using the Gal4-based transactivation assay system, the transcriptional activity of cAMP-response element-binding protein (CREB) was suppressed by both AICAR and SB415286, whereas that of TORC2 was repressed significantly by AICAR but very slightly by SB415286. These results show inactivation of GSK3 beta to directly inhibit CREB but not TORC2. Importantly, the AICAR-induced suppression of PEPCK-C expression was shown to be blunted by overexpression of GSK3 beta(S9G) but not wild-type GSK3 beta. In addition, AICAR stimulation decreased, whereas Compound C (AMPK inhibitor) increased CREB phosphorylation (Ser-129) in HepG2 cells. The time-courses of decreased CREB phosphorylation (Ser-129) and increased GSK3 beta phosphorylation were very similar. Furthermore, AMPK-mediated GSK3 beta phosphorylation was inhibited by an Akt-specific inhibitor in HepG2 cells, suggesting involvement of the Akt pathway. In summary, phosphorylation (Ser-9) of GSK3 beta is very likely to be critical for AMPK-mediated PEPCK-C gene suppression. Reduced CREB phosphorylation (Ser- 129) associated with inactivation of GSK3 beta by Ser- 9 phosphorylation may be the major mechanism underlying PEPCK-C gene suppression by AMPK-activating agents such as biguanide.	[Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Horike, Nanao; Nishiyama, Koichi; Uchijima, Yasunobu; Kurihara, Yukiko; Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo, Japan; [Sakoda, Hideyuki; Ono, Hiraku; Fujishiro, Midori] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan	Hiroshima University; University of Tokyo; University of Tokyo; Asahi Life Foundation	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asano-tky@umin.ac.jp	Kushiyama, Akifumi/A-6386-2011; Kamata, Hideaki/N-3907-2017; Nishiyama, Koichi/H-4275-2014; Kushiyama, Akifumi/W-5988-2019	Kushiyama, Akifumi/0000-0003-1385-7487; Nishiyama, Koichi/0000-0003-0529-4207; Kushiyama, Akifumi/0000-0003-1385-7487; Kurihara, Hiroki/0000-0002-6476-5593				Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Boer U, 2007, BIOCHEM J, V408, P69, DOI 10.1042/BJ20070796; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Croniger C, 1998, J BIOL CHEM, V273, P31629, DOI 10.1074/jbc.273.48.31629; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; IZATOS A, 2006, MOL CELL BIOL, V26, P63; Kaidanovich-Beilin O, 2006, J PHARMACOL EXP THER, V316, P17, DOI 10.1124/jpet.105.090266; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; KLEMM DJ, 1990, MOL CELL BIOL, V10, P480, DOI 10.1128/MCB.10.2.480; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Leahy P, 1999, J BIOL CHEM, V274, P8813, DOI 10.1074/jbc.274.13.8813; Lipina C, 2005, BIOCHEM J, V392, P633, DOI 10.1042/BJ20051046; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; Parker D, 1996, MOL CELL BIOL, V16, P694; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SASAKI K, 1984, J BIOL CHEM, V259, P5242; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; SHORT JM, 1986, J BIOL CHEM, V261, P9721; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tyson DR, 2002, ENDOCRINOLOGY, V143, P674, DOI 10.1210/en.143.2.674; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yeagley D, 1998, J BIOL CHEM, V273, P18743, DOI 10.1074/jbc.273.30.18743; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	51	149	153	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33902	33910		10.1074/jbc.M802537200	http://dx.doi.org/10.1074/jbc.M802537200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18801732	Green Published, hybrid			2022-12-25	WOS:000261277700016
J	Zhang, F; Wang, W; Tsuji, Y; Torti, SV; Torti, FM				Zhang, Fan; Wang, Wei; Tsuji, Yoshiaki; Torti, Suzy V.; Torti, Frank M.			Post-transcriptional Modulation of Iron Homeostasis during p53-dependent Growth Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; H-FERRITIN; TUMOR-SUPPRESSOR; MESSENGER-RNA; CANCER CELLS; IN-VITRO; P53; PROTEIN; EXPRESSION; REPRESSION	Iron plays an essential role in cell proliferation and is a required cofactor for a number of critical cellular enzymes. In this report we investigate changes in proteins of iron metabolism during p53-mediated replicative arrest. Following the induction of p53 in H1299 lung cancer cells containing a doxycycline-inducible p53, an increase in both H and L subunits of ferritin protein was observed. To determine the mechanism of this effect, we investigated the ability of p53 to regulate ferritin. Real time reverse transcription-PCR demonstrated no difference in levels of ferritin H mRNA in the presence and absence of p53. Because these results suggested that transcriptional mechanisms were not responsible for the p53-dependent increase in ferritin, we tested whether a post-transcriptional mechanism was involved. RNA bandshift assays revealed that induction of p53 decreased iron regulatory protein binding. Consistent with this observation, Western blot analysis revealed a decline in transferrin receptor 1 protein levels following induction of p53. Collectively, these results suggest that p53 may induce cell cycle arrest not only by well described mechanisms involving the induction of cyclin-dependent kinase inhibitors but also by the recruitment of pathways that reduce the availability of intracellular iron.	[Zhang, Fan; Wang, Wei; Tsuji, Yoshiaki; Torti, Frank M.] Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Torti, Suzy V.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Tsuji, Yoshiaki; Torti, Frank M.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Torti, SV (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	storti@wfubmc.edu			National Institutes of Health [DK42412]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042412, R01DK042412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK42412 (to F. M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bevilacqua MA, 1998, BIOCHEM J, V335, P521, DOI 10.1042/bj3350521; Blish KR, 2008, MOL BIOL CELL, V19, P457, DOI 10.1091/mbc.E07-05-0433; Brown L, 2007, CRIT REV EUKAR GENE, V17, P73, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.50; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Buss JL, 2004, CURR TOP MED CHEM, V4, P1623, DOI 10.2174/1568026043387269; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Chang HC, 1999, CANCER LETT, V145, P1, DOI 10.1016/S0304-3835(99)00209-8; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Epsztejn S, 1999, BLOOD, V94, P3593, DOI 10.1182/blood.V94.10.3593.422k26_3593_3603; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; Faniello MC, 2008, INT J BIOCHEM CELL B, V40, P2110, DOI 10.1016/j.biocel.2008.02.010; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Greene BT, 2002, J BIOL CHEM, V277, P25568, DOI 10.1074/jbc.M110345200; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kakhlon O, 2002, BIOCHEM SOC T, V30, P777, DOI 10.1042/bst0300777; Kakhlon O, 2001, BIOCHEM J, V356, P311, DOI 10.1042/0264-6021:3560311; Kim SW, 2002, P NATL ACAD SCI USA, V99, P12214, DOI 10.1073/pnas.192316099; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Kulp KS, 1996, EXP CELL RES, V229, P60, DOI 10.1006/excr.1996.0343; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Minotti G, 1998, FASEB J, V12, P541, DOI 10.1096/fasebj.12.7.541; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Pahl PMB, 2000, J BIOL CHEM, V275, P17821, DOI 10.1074/jbc.M909918199; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Theil EC, 2006, J INORG BIOCHEM, V100, P2074, DOI 10.1016/j.jinorgbio.2006.09.011; Thornborrow EC, 1999, J BIOL CHEM, V274, P33747, DOI 10.1074/jbc.274.47.33747; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; TSUJI Y, 1995, MOL CELL BIOL, V15, P5152; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2000, NAT CELL BIOL, V2, pE178, DOI 10.1038/35036427; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Weizer-Stern O, 2007, BRIT J HAEMATOL, V138, P253, DOI 10.1111/j.1365-2141.2007.06638.x; Wilkinson J, 2003, ADV ENZYME REGUL, V43, P135, DOI 10.1016/S0065-2571(02)00037-7; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	46	62	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33911	33918		10.1074/jbc.M806432200	http://dx.doi.org/10.1074/jbc.M806432200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819919	hybrid, Green Published			2022-12-25	WOS:000261277700017
J	Okazaki, H; Igarashi, M; Nishi, M; Sekiya, M; Tajima, M; Takase, S; Takanashi, M; Ohta, K; Tamura, Y; Okazaki, S; Yahagi, N; Ohashi, K; Amemiya-Kudo, M; Nakagawa, Y; Nagai, R; Kadowaki, T; Osuga, J; Ishibashi, S				Okazaki, Hiroaki; Igarashi, Masaki; Nishi, Makiko; Sekiya, Motohiro; Tajima, Makiko; Takase, Satoru; Takanashi, Mikio; Ohta, Keisuke; Tamura, Yoshiaki; Okazaki, Sachiko; Yahagi, Naoya; Ohashi, Ken; Amemiya-Kudo, Michiyo; Nakagawa, Yoshimi; Nagai, Ryozo; Kadowaki, Takashi; Osuga, Jun-ichi; Ishibashi, Shun			Identification of Neutral Cholesterol Ester Hydrolase, a Key Enzyme Removing Cholesterol from Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; FOAM CELLS; MESSENGER-RNA; EXPRESSION; HYDROLYSIS; LIPOLYSIS; ATHEROSCLEROSIS; METABOLISM; DISTINCT; ABSENCE	Unstable lipid-rich plaques in atherosclerosis are characterized by the accumulation of macrophage foam cells loaded with cholesterol ester (CE). Although hormone-sensitive lipase and cholesteryl ester hydrolase (CEH) have been proposed to mediate the hydrolysis of CE in macrophages, circumstantial evidence suggests the presence of other enzymes with neutral cholesterol ester hydrolase (nCEH) activity. Here we show that the murine orthologue of KIAA1363, designated as neutral cholesterol ester hydrolase (NCEH), is a microsomal nCEH with high expression in murine and human macrophages. The effect of various concentrations of NaCl on its nCEH activity resembles that on endogenous nCEH activity of macrophages. RNA silencing of NCEH decreases nCEH activity at least by 50%; conversely, its overexpression inhibits the CE formation in macrophages. Immunohistochemistry reveals that NCEH is expressed in macrophage foam cells in atherosclerotic lesions. These data indicate that NCEH is responsible for a major part of nCEH activity in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis.	[Ishibashi, Shun] Jichi Med Univ, Div Endocrinol & Metab, Dept Med, Sch Med, Shimotsuke, Tochigi 3290498, Japan; [Okazaki, Hiroaki; Igarashi, Masaki; Nishi, Makiko; Sekiya, Motohiro; Tajima, Makiko; Takase, Satoru; Takanashi, Mikio; Ohta, Keisuke; Tamura, Yoshiaki; Okazaki, Sachiko; Yahagi, Naoya; Ohashi, Ken; Amemiya-Kudo, Michiyo; Kadowaki, Takashi; Osuga, Jun-ichi; Ishibashi, Shun] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Amemiya-Kudo, Michiyo] Okinaka Mem Inst Med Res, Tokyo 1050001, Japan; [Amemiya-Kudo, Michiyo] Toranomon Gen Hosp, Tokyo 1050001, Japan; [Nakagawa, Yoshimi] Univ Tsukuba, Inst Clin Med, Tsukuba, Ibaraki 3058575, Japan	Jichi Medical University; University of Tokyo; University of Tokyo; Toranomon Hospital; University of Tsukuba	Ishibashi, S (corresponding author), Jichi Med Univ, Div Endocrinol & Metab, Dept Med, Sch Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	ishibash@jichi.ac.jp	Yahagi, Naoya/D-2360-2014	Yahagi, Naoya/0000-0002-1823-1865	Ministry of Education, Science, and Culture; National Institute of Biomedical Innovation; Takeda Science Foundation	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, and Culture and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Takeda Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BROWN MS, 1980, J BIOL CHEM, V255, P9344; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Contreras JA, 2002, BIOCHEM BIOPH RES CO, V292, P900, DOI 10.1006/bbrc.2002.6757; CONTRERAS JA, 1994, ARTERIOSCLER THROMB, V14, P443, DOI 10.1161/01.ATV.14.3.443; Escary JL, 1998, ARTERIOSCL THROM VAS, V18, P991, DOI 10.1161/01.ATV.18.6.991; Faber BCG, 2001, CIRC RES, V89, P547, DOI 10.1161/hh1801.096340; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Ghosh S, 2000, PHYSIOL GENOMICS, V2, P1, DOI 10.1152/physiolgenomics.2000.2.1.1; GOODMAN DS, 1965, PHYSIOL REV, V45, P747, DOI 10.1152/physrev.1965.45.4.747; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; HAJJAR DP, 1983, J BIOL CHEM, V258, P192; Harte RA, 2000, ATHEROSCLEROSIS, V149, P343, DOI 10.1016/S0021-9150(99)00345-7; HEIDER JG, 1978, J LIPID RES, V19, P514; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Jepson CA, 1996, BIOCHEM J, V318, P173, DOI 10.1042/bj3180173; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; KHOO JC, 1993, J LIPID RES, V34, P1969; KHOO JC, 1981, J BIOL CHEM, V256, P2659; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Nomura DK, 2005, P NATL ACAD SCI USA, V102, P6195, DOI 10.1073/pnas.0501915102; Okazaki H, 2002, DIABETES, V51, P3368, DOI 10.2337/diabetes.51.12.3368; Okazaki H, 2002, J BIOL CHEM, V277, P31893, DOI 10.1074/jbc.M204016200; Okazaki H, 2006, DIABETES, V55, P2091, DOI 10.2337/db05-0585; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Osterlund T, 2001, EUR J BIOCHEM, V268, P1899, DOI 10.1046/j.1432-1327.2001.02097.x; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Reue K, 1997, ARTERIOSCL THROM VAS, V17, P3428, DOI 10.1161/01.ATV.17.12.3428; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SMALL CA, 1989, FEBS LETT, V247, P205, DOI 10.1016/0014-5793(89)81335-3; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	34	77	86	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33357	33364		10.1074/jbc.M802686200	http://dx.doi.org/10.1074/jbc.M802686200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18782767	hybrid, Green Published			2022-12-25	WOS:000261183700040
J	Gandhi, R; Manzoor, M; Hudak, KA				Gandhi, Rikesh; Manzoor, Mahira; Hudak, Katalin A.			Depurination of Brome Mosaic Virus RNA3 in Vivo Results in Translation-dependent Accelerated Degradation of the Viral RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POKEWEED ANTIVIRAL PROTEIN; RIBOSOME-INACTIVATING PROTEINS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TERMINATION CODONS; QUALITY-CONTROL; FACTOR ERF1; INHIBITION; CELLS; REPLICATION	Pokeweed antiviral protein (PAP) is a ribosome-inactivating protein isolated from the pokeweed plant (Phytolacca americana) that exhibits antiviral activity against several plant and animal viruses. We have shown previously that PAP depurinates Brome mosaic virus (BMV) RNAs in vitro and that prior incubation of these RNAs with PAP reduced their synthesis in barley protoplasts. To investigate the post-transcriptional effect of PAP on viral RNA in vivo, we transcribed BMV RNA3 and expressed PAP in the yeast, Saccharomyces cerevisiae, which is a surrogate host for BMV. With an inducible transcription system, we show that the half-life of RNA3 in PAP-expressing cells was significantly less than in cells expressing PAPx, its enzymatically inactive form. PAP bound to RNA3 and depurinated the RNA within open reading frames 3 and 4 and within untranslated regions of the RNA. The depurinated RNA was associated with polysomes, caused ribosomes to stall at the point of depurination, and was targeted for accelerated degradation by components of the No-go decay pathway. As a consequence of translation elongation arrest and increased RNA degradation, expression of PAP in yeast also decreased the level of protein 3a, encoded by the 5'-proximal open reading frame 3 of BMV RNA3. These data provide the first evidence of viral RNA depurination in vivo by any ribosome-inactivating protein and support our hypothesis that depurination contributes to the antiviral activity of PAP, by enhancing viral RNA degradation and reducing translation of viral protein product.	[Gandhi, Rikesh; Manzoor, Mahira; Hudak, Katalin A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	York University - Canada	Hudak, KA (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	hudak@yorku.ca			Natural Sciences and Engineering Research Council of Canada and a Premier's Research Excellence Award	Natural Sciences and Engineering Research Council of Canada and a Premier's Research Excellence Award(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada and a Premier's Research Excellence Award ( to K. A. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHLQUIST P, 1981, CELL, V23, P183, DOI 10.1016/0092-8674(81)90283-X; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Ahola T, 2000, J VIROL, V74, P8803, DOI 10.1128/JVI.74.19.8803-8811.2000; ALLISON R, 1990, P NATL ACAD SCI USA, V87, P1820, DOI 10.1073/pnas.87.5.1820; ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; ARON GM, 1980, ANTIMICROB AGENTS CH, V17, P1032, DOI 10.1128/AAC.17.6.1032; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Culbertson MR, 2005, RNA, V11, P1333, DOI 10.1261/rna.2113605; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; ENDO Y, 1988, BIOCHEM BIOPH RES CO, V150, P1032, DOI 10.1016/0006-291X(88)90733-4; FELDEN B, 1994, J MOL BIOL, V235, P508, DOI 10.1006/jmbi.1994.1010; FOATOMASI L, 1982, ARCH VIROL, V71, P323, DOI 10.1007/BF01315062; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GESSNER SL, 1980, J BIOL CHEM, V255, P3251; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; HARTLEY MR, 1991, FEBS LETT, V290, P65, DOI 10.1016/0014-5793(91)81227-Y; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Hudak KA, 2000, RNA, V6, P369, DOI 10.1017/S1355838200991337; HUR Y, 1995, P NATL ACAD SCI USA, V92, P8448, DOI 10.1073/pnas.92.18.8448; Inagaki Y, 2000, MOL BIOL EVOL, V17, P882, DOI 10.1093/oxfordjournals.molbev.a026368; IRVIN JD, 1975, ARCH BIOCHEM BIOPHYS, V169, P522, DOI 10.1016/0003-9861(75)90195-2; IRVIN JD, 1992, PHARMACOL THERAPEUT, V55, P279, DOI 10.1016/0163-7258(92)90053-3; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JANDA M, 1993, CELL, V72, P961, DOI 10.1016/0092-8674(93)90584-D; Kao CC, 2000, MOL PLANT PATHOL, V1, P91, DOI 10.1046/j.1364-3703.2000.00017.x; Kong F, 1999, VIROLOGY, V259, P200, DOI 10.1006/viro.1999.9763; Krol MA, 1999, P NATL ACAD SCI USA, V96, P13650, DOI 10.1073/pnas.96.24.13650; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; LODGE JK, 1993, P NATL ACAD SCI USA, V90, P7089, DOI 10.1073/pnas.90.15.7089; MILLER WA, 1985, NATURE, V313, P68, DOI 10.1038/313068a0; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Noueiry AO, 2003, ANNU REV PHYTOPATHOL, V41, P77, DOI 10.1146/annurev.phyto.41.052002.095717; Parikh BA, 2002, J BIOL CHEM, V277, P41428, DOI 10.1074/jbc.M205463200; Picard D, 2005, J BIOL CHEM, V280, P20069, DOI 10.1074/jbc.M413452200; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V263, P419, DOI 10.1006/bbrc.1999.1335; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; TAYLOR S, 1994, PLANT J, V5, P827, DOI 10.1046/j.1365-313X.1994.5060827.x; Tumer NE, 1997, P NATL ACAD SCI USA, V94, P3866, DOI 10.1073/pnas.94.8.3866; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wagner E, 2002, J CELL SCI, V115, P3033; Wallrapp C, 1998, FEBS LETT, V440, P387, DOI 10.1016/S0014-5793(98)01492-6; ZARLING JM, 1990, NATURE, V347, P92, DOI 10.1038/347092a0; Zoubenko O, 2000, PLANT MOL BIOL, V44, P219, DOI 10.1023/A:1006443626864	50	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32218	32228		10.1074/jbc.M803785200	http://dx.doi.org/10.1074/jbc.M803785200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815133	hybrid			2022-12-25	WOS:000260893700008
J	Guyot, N; Butler, MW; Mcnally, P; Weldon, S; Greene, CM; Levine, RL; O'Neill, SJ; Taggart, CC; McElvaney, NG				Guyot, Nicolas; Butler, Marcus W.; McNally, Paul; Weldon, Sinead; Greene, Catherine M.; Levine, Rodney L.; O'Neill, Shane J.; Taggart, Clifford C.; McElvaney, Noel G.			Elafin, an Elastase-specific Inhibitor, Is Cleaved by Its Cognate Enzyme Neutrophil Elastase in Sputum from Individuals with Cystic Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE PROTEINASE-INHIBITOR; PRE-ELAFIN; HUMAN KERATINOCYTES; EPITHELIAL-CELLS; GENE-EXPRESSION; LIPOPOLYSACCHARIDE; SKALP/ELAFIN; SEQUENCE; INACTIVATION; INFLAMMATION	Elafin is a neutrophil serine protease inhibitor expressed in lung and displaying anti-inflammatory and anti-bacterial properties. Previous studies demonstrated that some innate host defense molecules of the cystic fibrosis (CF) and chronic obstructive pulmonary disease airways are impaired due to increased proteolytic degradation observed during lung inflammation. In light of these findings, we thus focused on the status of elafin in CF lung. We showed in the present study that elafin is cleaved in sputum from individuals with CF. Pseudomonas aeruginosa-positive CF sputum, which was found to contain lower elafin levels and higher neutrophil elastase (NE) activity compared with P. aeruginosa-negative samples, was particularly effective in cleaving recombinant elafin. NE plays a pivotal role in the process as only NE inhibitors are able to inhibit elafin degradation. Further in vitro studies demonstrated that incubation of recombinant elafin with excess of NE leads to the rapid cleavage of the inhibitor. Two cleavage sites were identified at the N-terminal extremity of elafin (Val-5-Lys-6 and Val-9-Ser-10). Interestingly, purified fragments of the inhibitor (Lys-6-Gln-57 and Ser-10-Gln-57) were shown to still be active for inhibiting NE. However, NE in excess was shown to strongly diminish the ability of elafin to bind lipopolysaccharide(LPS) and its capacity to be immobilized by transglutamination. In conclusion, this study provides evidence that elafin is cleaved by its cognate enzyme NE present at excessive concentration in CF sputum and that P. aeruginosa infection promotes this effect. Such cleavage may have repercussions on the innate immune function of elafin.	[Guyot, Nicolas; Butler, Marcus W.; McNally, Paul; Weldon, Sinead; Greene, Catherine M.; O'Neill, Shane J.; Taggart, Clifford C.; McElvaney, Noel G.] Beaumont Hosp, Royal Coll Surg Ireland, Pulm Res Div, Dept Med, Dublin 9, Ireland; [Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Royal College of Surgeons - Ireland; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Taggart, CC (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Pulm Res Div, Dept Med, Dublin 9, Ireland.	c.taggart@qub.ac.uk	Weldon, Sinead/J-5451-2014; McNally, Paul/I-3151-2013; Taggart, Clifford C/G-4492-2014; McElvaney, Noel/A-6809-2010; Levine, Rodney L/D-9885-2011; Greene, Catherine M/D-3513-2012; McNally, Paul/AAL-4407-2021	Weldon, Sinead/0000-0001-5628-6624; McNally, Paul/0000-0001-7102-1712; Greene, Catherine M/0000-0003-2549-2569; McNally, Paul/0000-0001-7102-1712; mcelvaney, Noel/0000-0002-0152-4370; Butler, Marcus/0000-0003-2026-7709; Taggart, Clifford/0000-0002-9930-2978	Health Research Board; Alpha One Foundation; rogram for Research in Third Levels Institutes administered by Higher Education Authority, Science Foundation Ireland; Cystic Fibrosis Hope Source; Cystic Fibrosis Research Trust; Cystic Fibrosis Association of Ireland; Royal College of Surgeons in Ireland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225, Z01HL000225] Funding Source: NIH RePORTER	Health Research Board; Alpha One Foundation; rogram for Research in Third Levels Institutes administered by Higher Education Authority, Science Foundation Ireland(Science Foundation Ireland); Cystic Fibrosis Hope Source; Cystic Fibrosis Research Trust; Cystic Fibrosis Association of Ireland; Royal College of Surgeons in Ireland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was also supported by the Health Research Board, The Alpha One Foundation, The Program for Research in Third Levels Institutes administered by Higher Education Authority, Science Foundation Ireland, Cystic Fibrosis Hope Source, Cystic Fibrosis Research Trust, Cystic Fibrosis Association of Ireland (to C. T.), and the Royal College of Surgeons in Ireland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALKEMADE JAC, 1994, J CELL SCI, V107, P2335; Bingle L, 2001, AM J RESP CELL MOL, V25, P84, DOI 10.1165/ajrcmb.25.1.4341; BLOW AMJ, 1977, BIOCHEM J, V161, P13, DOI 10.1042/bj1610013; Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; BRITIGAN BE, 1993, INFECT IMMUN, V61, P5049, DOI 10.1128/IAI.61.12.5049-5055.1993; Butler MW, 2006, J BIOL CHEM, V281, P34730, DOI 10.1074/jbc.M604844200; Carroll TP, 2005, CURR RESPIR MED REV, V1, P43, DOI 10.2174/1573398052953640; Chaby R, 2004, CELL MOL LIFE SCI, V61, P1697, DOI 10.1007/s00018-004-4020-4; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; Francart C, 1997, J MOL BIOL, V268, P666, DOI 10.1006/jmbi.1997.0983; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; JOHNSON DA, 1982, AM REV RESPIR DIS, V126, P1070; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Laskowski Jr. M., 2000, PROTEIN PROTEIN RECO, P228; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; McMichael JW, 2005, AM J RESP CELL MOL, V32, P443, DOI 10.1165/rcmb.2004-0250OC; Meyer-Hoffert U, 2003, EXP DERMATOL, V12, P418, DOI 10.1034/j.1600-0625.2002.120409.x; Mihaila A, 2001, Z NATURFORSCH C, V56, P291; MOLHUIZEN HOF, 1993, J BIOL CHEM, V268, P12028; Muto J, 2007, J INVEST DERMATOL, V127, P1358, DOI 10.1038/sj.jid.5700647; NARA K, 1994, J BIOCHEM, V115, P441, DOI 10.1093/oxfordjournals.jbchem.a124357; NONOMURA K, 1994, J INVEST DERMATOL, V103, P88, DOI 10.1111/1523-1747.ep12391802; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; Pfundt R, 2000, ARCH DERMATOL RES, V292, P180, DOI 10.1007/s004030050475; Pfundt R, 1996, J CLIN INVEST, V98, P1389, DOI 10.1172/JCI118926; Reid PT, 1999, FEBS LETT, V457, P33, DOI 10.1016/S0014-5793(99)01004-2; Rogan MP, 2004, J INFECT DIS, V190, P1245, DOI 10.1086/423821; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; SALLENAVE JM, 1992, BIOL CHEM H-S, V373, P27, DOI 10.1515/bchm3.1992.373.1.27; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Simpson AJ, 2001, HUM GENE THER, V12, P1395, DOI 10.1089/104303401750298553; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; STREIT V, 1995, J INVEST DERMATOL, V105, P562, DOI 10.1111/1523-1747.ep12323460; Taggart C, 2000, AM J PHYSIOL-LUNG C, V278, pL33, DOI 10.1152/ajplung.2000.278.1.L33; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Tate S, 2002, THORAX, V57, P926, DOI 10.1136/thorax.57.11.926; TSUNEMI M, 1992, BIOCHEM BIOPH RES CO, V185, P967, DOI 10.1016/0006-291X(92)91721-2; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; Vachon E, 2002, BIOL CHEM, V383, P1249, DOI 10.1515/BC.2002.138; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51, DOI 10.1152/ajplung.2000.278.1.L51; YING QL, 1993, BIOCHEMISTRY-US, V32, P1866, DOI 10.1021/bi00058a021; Zani ML, 2004, EUR J BIOCHEM, V271, P2370, DOI 10.1111/j.1432-1033.2004.04156.x	49	63	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32377	32385		10.1074/jbc.M803707200	http://dx.doi.org/10.1074/jbc.M803707200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18799464	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000260893700025
J	Pineau, B; Layoune, O; Danon, A; De Paepe, R				Pineau, Bernard; Layoune, Ouardia; Danon, Antoine; De Paepe, Rosine			L-Galactono-1,4-lactone Dehydrogenase Is Required for the Accumulation of Plant Respiratory Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; NUCLEAR-ENCODED SUBUNITS; NICOTIANA-SYLVESTRIS; ARABIDOPSIS-THALIANA; SUPRAMOLECULAR ORGANIZATION; ASCORBATE BIOSYNTHESIS; POLYACRYLAMIDE GELS; ELECTRON-TRANSPORT; PROTEOMIC APPROACH; LEAF MITOCHONDRIA	Mitochondrial NADH-ubiquinone oxidoreductase (complex I) is the largest enzyme of the oxidative phosphorylation system, with subunits located at the matrix and membrane domains. In plants, holocomplex I is composed of more than 40 subunits, 9 of which are encoded by the mitochondrial genome (NAD subunits). In Nicotiana sylvestris, a minor 800-kDa subcomplex containing subunits of both domains and displaying NADH dehydrogenase activity is detectable. The NMS1 mutant lacking the membrane arm NAD4 subunit and the CMSII mutant lacking the peripheral NAD7 subunit are both devoid of the holoenzyme. In contrast to CMSII, the 800-kDa subcomplex is present in NMS1 mitochondria, indicating that it could represent an assembly intermediate lacking the distal part of the membrane arm. L-galactono-1,4-lactone dehydrogenase (GLDH), the last enzyme in the plant ascorbate biosynthesis pathway, is associated with the 800-kDa subcomplex but not with the holocomplex. To investigate possible relationships between GLDH and complex I assembly, we characterized an Arabidopsis thaliana gldh insertion mutant. Homozygous gldh mutant plants were not viable in the absence of ascorbate supplementation. Analysis of crude membrane extracts by blue native and two-dimensional SDS-PAGE showed that complex I accumulation was strongly prevented in leaves and roots of Atgldh plants, whereas other respiratory complexes were found in normal amounts. Our results demonstrate the role of plant GLDH in both ascorbate biosynthesis and complex I accumulation.	[Pineau, Bernard; Layoune, Ouardia; Danon, Antoine; De Paepe, Rosine] Univ Paris 11, CNRS, Inst Biotechnol Plantes, UMR 8618, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pineau, B (corresponding author), Univ Paris 11, CNRS, Inst Biotechnol Plantes, UMR 8618, F-91405 Orsay, France.	bernard.pineau@u-psud.fr	Danon, Antoine/A-6058-2009; Danon, Antoine/F-7790-2018	Danon, Antoine/0000-0001-6311-6076	CNRS; Universite Paris-Sud 11	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Sud 11	This work was supported by the CNRS and the Universite Paris-Sud 11. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Bartoli CG, 2005, J EXP BOT, V56, P1269, DOI 10.1093/jxb/eri111; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brangeon J, 2000, PLANT J, V21, P269, DOI 10.1046/j.1365-313x.2000.00679.x; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; Cardol P, 2008, BBA-BIOENERGETICS, V1777, P388, DOI 10.1016/j.bbabio.2008.01.001; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; Gutierres S, 1997, P NATL ACAD SCI USA, V94, P3436, DOI 10.1073/pnas.94.7.3436; Heazlewood JL, 2003, BBA-BIOENERGETICS, V1604, P159, DOI 10.1016/S0005-2728(03)00045-8; Heinemeyer J, 2004, PHYTOCHEMISTRY, V65, P1683, DOI 10.1016/j.phytochem.2004.04.022; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Karpova OV, 1999, PLANT J, V17, P511, DOI 10.1046/j.1365-313X.1999.00401.x; Krause F, 2004, J BIOL CHEM, V279, P48369, DOI 10.1074/jbc.M406085200; Kuffner R, 1998, J MOL BIOL, V283, P409, DOI 10.1006/jmbi.1998.2114; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Marques I, 2007, EUKARYOT CELL, V6, P2391, DOI 10.1128/EC.00149-07; Millar AH, 2003, PLANT PHYSIOL, V133, P443, DOI 10.1104/pp.103.028399; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Pineau B, 2005, J BIOL CHEM, V280, P25994, DOI 10.1074/jbc.M500508200; PLA M, 1995, MOL GEN GENET, V248, P79, DOI 10.1007/BF02456616; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	51	108	115	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32500	32505		10.1074/jbc.M805320200	http://dx.doi.org/10.1074/jbc.M805320200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18799460	hybrid, Green Published			2022-12-25	WOS:000260893700038
J	Mace, PD; Linke, K; Feltham, R; Schumacher, FR; Smith, CA; Vaux, DL; Silke, J; Day, CL				Mace, Peter D.; Linke, Katrin; Feltham, Rebecca; Schumacher, Frances-Rose; Smith, Clyde A.; Vaux, David L.; Silke, John; Day, Catherine L.			Structures of the cIAP2 RING Domain Reveal Conformational Changes Associated with Ubiquitin-conjugating Enzyme (E2) Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; PROTEIN LIGASE; APOPTOSIS; INHIBITOR; IAPS; COMPLEX; UBIQUITYLATION; BINDING; SMAC	Inhibitor of apoptosis (IAP) proteins are key negative regulators of cell death that are highly expressed in many cancers. Cell death caused by antagonists that bind to IAP proteins is associated with their ubiquitylation and degradation. The RING domain at the C terminus of IAP proteins is pivotal. Here we report the crystal structures of the cIAP2 RING domain homodimer alone, and bound to the ubiquitin-conjugating (E2) enzyme UbcH5b. These structures show that small changes in the RING domain accompany E2 binding. By mutating residues at the E2-binding surface, we show that autoubiquitylation is required for regulation of IAP abundance. Dimer formation is also critical, and mutation of a single C-terminal residue abrogated dimer formation and E3 ligase activity was diminished. We further demonstrate that disruption of E2 binding, or dimerization, stabilizes IAP proteins against IAP antagonists in vivo.	[Mace, Peter D.; Linke, Katrin; Schumacher, Frances-Rose; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Feltham, Rebecca; Vaux, David L.; Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Smith, Clyde A.] Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	University of Otago; La Trobe University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Day, CL (corresponding author), Univ Otago, Dept Biochem, Dunedin 9054, New Zealand.	catherine.day@stonebow.otago.ac.nz	Vaux, David L/C-7249-2013; Silke, John/B-7622-2008	Vaux, David L/0000-0003-2703-1651; Silke, John/0000-0002-7611-5774; Day, Catherine/0000-0003-1571-4367; Feltham, Rebecca/0000-0001-8376-6869; Mace, Peter/0000-0003-2175-9537	Marsden Fund (New Zealand); National Health and Medical Research Council (Australia); Leukemia and Lymphoma Society; University of Otago	Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); University of Otago	This work was supported by the Marsden Fund (New Zealand), the National Health and Medical Research Council (Australia), and the Leukemia and Lymphoma Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; A recipient of a Health Sciences Career Development Award (University of Otago).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2002, J CELL BIOL, V157, P115, DOI 10.1083/jcb.200108085; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	31	130	130	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31633	31640		10.1074/jbc.M804753200	http://dx.doi.org/10.1074/jbc.M804753200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784070	hybrid			2022-12-25	WOS:000260760800044
J	Zhang, XJ; Cahill, KB; Elfenbein, A; Arshavsky, VY; Cote, RH				Zhang, Xiu-Jun; Cahill, Karyn B.; Elfenbein, Arye; Arshavsky, Vadim Y.; Cote, Rick H.			Direct Allosteric Regulation between the GAF Domain and Catalytic Domain of Photoreceptor Phosphodiesterase PDE6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD CGMP PHOSPHODIESTERASE; CYCLIC-GMP PHOSPHODIESTERASE; INHIBITORY GAMMA-SUBUNIT; STATIONARY NIGHT BLINDNESS; BINDING-SITES; NONCATALYTIC CGMP; NUCLEOTIDE PHOSPHODIESTERASE; STRUCTURAL BASIS; HIGH-AFFINITY; BETA-SUBUNIT	Photoreceptor cGMP phosphodiesterase (PDE6) is the central enzyme in the visual transduction cascade. The PDE6 catalytic subunit contains a catalytic domain and regulatory GAF domains. Unlike most GAF domain-containing cyclic nucleotide phosphodiesterases, little is known about direct allosteric communication of PDE6. In this study, we demonstrate for the first time direct, inter-domain allosteric communication between the GAF and catalytic domains in PDE6. The binding affinity of PDE6 for pharmacological inhibitors or for the C-terminal region of the inhibitory gamma subunit (P gamma), known to directly inhibit PDE6 catalysis, was increased similar to 2-fold by ligands binding to the GAF domain. Binding of the N-terminal half of P gamma to the GAF domains suffices to induce this allosteric effect. Allosteric communication between GAF and catalytic domains is reciprocal, in that drug binding to the catalytic domain slowed cGMP dissociation from the GAF domain. Although cGMP hydrolysis was not affected by binding of P gamma-60, P gamma lacking its last seven amino acids decreased the Michaelis constant of PDE6 by 2.5- fold. P gamma 1-60 binding to the GAF domain increased vardenafil but not cGMP affinity, indicating that substrate- and inhibitor-binding sites do not totally overlap. In addition, prolonged incubation of PDE6 with vardenafil or sildenafil (but not 3-isobutyl-1-methylxanthine and zaprinast) induced a distinct conformational change in the catalytic domain without affecting the binding properties of the GAF domains. We conclude that although P gamma-mediated regulation plays the dominant role in visual excitation, the direct, inter-domain allosteric regulation described in this study may play a feedback role in light adaptational processes during phototransduction.	[Zhang, Xiu-Jun; Cahill, Karyn B.; Cote, Rick H.] Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA; [Elfenbein, Arye; Arshavsky, Vadim Y.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Elfenbein, Arye; Arshavsky, Vadim Y.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA	University System Of New Hampshire; University of New Hampshire; Duke University; Duke University	Cote, RH (corresponding author), Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY-05798]; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-05798. This is Scientific Contribution Number 2361 from the New Hampshire Agricultural Experiment Station. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; Blount MA, 2007, J PHARMACOL EXP THER, V323, P730, DOI 10.1124/jpet.107.126540; CAHILL KB, 2007, INVESTIG OPHTHALMOL, V48; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cote RH, 2000, METHOD ENZYMOL, V315, P646; Cote Rick H., 2005, V307, P141; D'Amours MR, 1999, BIOCHEM J, V340, P863, DOI 10.1042/0264-6021:3400863; Fain G, 2003, SENSORY TRANSDUCTION; FRANCIS SH, 1980, J BIOL CHEM, V255, P620; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Granovsky AE, 2000, J BIOL CHEM, V275, P41258, DOI 10.1074/jbc.M008094200; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; He F, 2000, J BIOL CHEM, V275, P20572, DOI 10.1074/jbc.M000440200; Hebert MC, 1998, J BIOL CHEM, V273, P5557, DOI 10.1074/jbc.273.10.5557; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; Jungbauer A, 2001, J CLIN LIGAND ASSAY, V24, P270; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013; Muradov KG, 2003, BIOCHEMISTRY-US, V42, P3305, DOI 10.1021/bi027095x; Pentia Dana C., 2005, V307, P125; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Rybalkin SD, 2002, J BIOL CHEM, V277, P3310, DOI 10.1074/jbc.M106562200; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; TAKEMOTO DJ, 1992, BIOCHEM J, V281, P637, DOI 10.1042/bj2810637; THOMAS MK, 1990, J BIOL CHEM, V265, P14964; Tsang SH, 2007, HUM MUTAT, V28, P243, DOI 10.1002/humu.20425; Turko IV, 1999, J BIOL CHEM, V274, P29038, DOI 10.1074/jbc.274.41.29038; Turko IV, 1999, MOL PHARMACOL, V56, P124, DOI 10.1124/mol.56.1.124; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wyman J, 1990, BINDING LINKAGE FUNC; YAMAMOTO T, 1983, J BIOL CHEM, V258, P2526; YAMAZAKI A, 1982, P NATL ACAD SCI-BIOL, V79, P3702, DOI 10.1073/pnas.79.12.3702; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	62	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29699	29705		10.1074/jbc.M803948200	http://dx.doi.org/10.1074/jbc.M803948200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18779324	hybrid, Green Published			2022-12-25	WOS:000260366900013
J	Velez, DR; Fortunato, SJ; Thorsen, P; Lombardi, SJ; Williams, SM; Menon, R				Velez, Digna R.; Fortunato, Stephen J.; Thorsen, Poul; Lombardi, Salvatore J.; Williams, Scott M.; Menon, Ramkumar			Preterm Birth in Caucasians Is Associated with Coagulation and Inflammation Pathway Gene Variants	PLOS ONE			English	Article								Spontaneous preterm birth (< 37 weeks gestation-PTB) occurs in similar to 12% of pregnancies in the United States, and is the largest contributor to neonatal morbidity and mortality. PTB is a complex disease, potentially induced by several etiologic factors from multiple pathophysiologic pathways. To dissect the genetic risk factors of PTB a large-scale high-throughput candidate gene association study was performed examining 1536 SNP in 130 candidate genes from hypothesized PTB pathways. Maternal and fetal DNA from 370 US Caucasian birth-events (172 cases and 198 controls) was examined. Single locus, haplotype, and multi-locus association analyses were performed separately on maternal and fetal data. For maternal data the strongest associations were found in genes in the complement-coagulation pathway related to decidual hemorrhage in PTB. In this pathway 3 of 6 genes examined had SNPs significantly associated with PTB. These include factor V (FV) that was previously associated with PTB, factor VII (FVII), and tissue plasminogen activator (tPA). The single strongest effect was observed in tPA marker rs879293 with a significant allelic (p = 2.30 x 10(-3)) and genotypic association (p = 2.0 x 10(-6)) with PTB. The odds ratio (OR) for this SNP was 2.80 [Cl 1.77-4.44] for a recessive model. Given that 6 of 8 markers in tPA were statistically significant, sliding window haplotype analyses were performed and revealed an associating 4 marker haplotype in tPA (p = 6.00 x 10(-3)). The single strongest effect in fetal DNA was observed in the inflammatory pathway at rs17121510 in the interleukin-10 receptor antagonist (IL-10RA) gene for allele (p = 0.01) and genotype (p = 3.34 x 10(-4)). The OR for the IL-10RA genotypic additive model was 1.92 [Cl 1.15-3.19] (p = 2.00 x 10(-3)). Finally, exploratory multi-locus analyses in the complement and coagulation pathway were performed and revealed a potentially significant interaction between a marker in FV (rs2187952) and FVII (rs3211719) (p < 0.001). These results support a role for genes in both the coagulation and inflammation pathways, and potentially different maternal and fetal genetic risks for PTB.	[Velez, Digna R.; Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA; [Fortunato, Stephen J.; Lombardi, Salvatore J.; Menon, Ramkumar] Perinatal Res Ctr, Nashville, TN USA; [Fortunato, Stephen J.] Yale Univ, Dept Obstet & Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Thorsen, Poul; Menon, Ramkumar] Univ Aarhus, N Atlantic Epidemiol Alliance, DK-8000 Aarhus, Denmark	Vanderbilt University; Yale University; Aarhus University	Velez, DR (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA.	fortunat@edge.net; smwilliams@chgr.mc.vanderbilt.edu	Williams, Scott/B-9491-2012; Fortunato, Stephen J/L-7545-2013; Williams, Scott/Q-4812-2019; Velez Edwards, Digna/C-1090-2012	Williams, Scott/0000-0002-4835-9544; 	Elsass Foundation, Denmark; Thrasher Research Fund; Maternal-Fetal Group, LLC, Nashville, TN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	Elsass Foundation, Denmark; Thrasher Research Fund; Maternal-Fetal Group, LLC, Nashville, TN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by grants from Elsass Foundation, Denmark (to RM), the Thrasher Research Fund (to SJF) and funds from Maternal-Fetal Group, LLC, (SJF, SJL) Nashville, TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2000, JAMA-J AM MED ASSOC, V283, P1591, DOI 10.1001/jama.283.12.1591; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bogic LV, 1999, BIOL REPROD, V60, P1006, DOI 10.1095/biolreprod60.4.1006; BRYANTGREENWOOD GD, 1995, AM J OBSTET GYNECOL, V172, P63, DOI 10.1016/0002-9378(95)90085-3; Carlini L, 2002, GYNECOL OBSTET INVES, V53, P174, DOI 10.1159/000058370; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EKWO EE, 1992, OBSTET GYNECOL, V80, P166; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V174, P1618, DOI 10.1016/S0002-9378(96)70617-8; Goldenberg RL, 2001, JAMA-J AM MED ASSOC, V285, P633, DOI 10.1001/jama.285.5.633; Goldenberg RL, 1996, AM J PUBLIC HEALTH, V86, P781, DOI 10.2105/AJPH.86.6.781; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hao K, 2004, HUM MOL GENET, V13, P683, DOI 10.1093/hmg/ddh091; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; HOLLANDER M, 1999, NONPARAMETRIC STAT A; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; JUN Z, 1992, EPIDEMIOLOGY, V3, P428, DOI 10.1097/00001648-199209000-00008; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lockwood CJ, 2002, NEW ENGL J MED, V346, P282, DOI 10.1056/NEJM200201243460412; Lockwood CJ, 2001, ANN NY ACAD SCI, V943, P77, DOI 10.1111/j.1749-6632.2001.tb03793.x; LOCKWOOD CJ, 1993, J CLIN ENDOCR METAB, V76, P231, DOI 10.1210/jc.76.1.231; Lockwood CJ, 2001, PAEDIATR PERINAT EP, V15, P78, DOI 10.1046/j.1365-3016.2001.00010.x; Martin JA, 2005, PEDIATRICS, V115, P619, DOI 10.1542/peds.2004-2695; Mastorakos G, 2003, ANN NY ACAD SCI, V997, P136, DOI 10.1196/annals.1290.016; Mattison DR, 2001, PAEDIATR PERINAT EP, V15, P7, DOI 10.1046/j.1365-3016.2001.00004.x; Matys T, 2004, P NATL ACAD SCI USA, V101, P16345, DOI 10.1073/pnas.0407355101; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; RUSH RW, 1976, BRIT MED J, V2, P965, DOI 10.1136/bmj.2.6042.965; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1065, DOI 10.1016/0002-9378(95)91327-0; StataCorp L, 2007, STAT DAT AN STAT SOF; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Varner MW, 2005, BJOG-INT J OBSTET GY, V112, P28, DOI 10.1111/j.1471-0528.2005.00581.x; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	38	54	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3283	10.1371/journal.pone.0003283	http://dx.doi.org/10.1371/journal.pone.0003283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818748	Green Submitted, gold, Green Published			2022-12-25	WOS:000264432300005
J	Jaspan, HB; Huang, LC; Cotton, MF; Whitelaw, A; Myer, L				Jaspan, Heather B.; Huang, Lyen C.; Cotton, Mark F.; Whitelaw, Andrew; Myer, Landon			Bacterial Disease and Antimicrobial Susceptibility Patterns in HIV-Infected, Hospitalized Children: A Retrospective Cohort Study	PLOS ONE			English	Article								Background: Serious bacterial infections are a major source of morbidity and mortality in HIV-infected children. The spectrum of disease is wide, and responsible organisms vary according to setting. The use of antibiotic prophylaxis and the emergence of multi-drug resistant bacteria necessitate examination of responsible organisms and their antibiotic susceptibility. Methodology/Principal Findings: A retrospective cohort study of all HIV-positive pediatric admissions at an urban public sector hospital in Cape Town between January 2002 and June 2006 was conducted. Children between the ages of one month and nine years with laboratory confirmed HIV status, serious bacterial infection, and a hospital length of stay of 5 days or more, were eligible for inclusion. Organisms isolated from blood, urine, and cerebral spinal fluid cultures and their antimicrobial susceptibility were examined, and compared according to timing of isolation to distinguish nosocomial versus community-acquired. One hundred and forty-one children were identified (median age 1.2 years), 39% of whom were on antiretrovirals started before or during this hospitalization. Bacterial infections involved all organ systems, however pneumonia was most common (67%). S. pneumoniae and S. aureus were the most common gram positive and K. pneumoniae was the most common gram negative organism. K pneumoniae isolates were resistant to many first and second line antibiotics, and were all considered nosocomial. All S. aureus isolates were methicillin resistant, some of which were community-acquired. Conclusions/Significance: Bacterial infections are an important source of co-morbidity in HIV-infected children in resource-limited settings. Clinicians should have a low threshold to initiate antibiotics in children requiring hospitalization. Broad-spectrum antibiotics should be used judiciously. Clinicians caring for HIV-infected children should be cognizant of the most common organisms affecting such children, and of their local antimicrobial susceptibilities, when treating empirically for serious bacterial infections.	[Jaspan, Heather B.] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7700 Rondebosch, South Africa; [Huang, Lyen C.; Whitelaw, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7700 Rondebosch, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Dept Pediat & Child Hlth, Pediat Infect Dis Unit, ZA-7600 Stellenbosch, South Africa; [Whitelaw, Andrew] Univ Cape Town, Div Med Microbiol, Natl Hlth Lab Serv, ZA-7700 Rondebosch, South Africa; [Myer, Landon] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA	University of Cape Town; University of Cape Town; Stellenbosch University; University of Cape Town; Columbia University	Jaspan, HB (corresponding author), Univ Washington, Dept Pediat, Childrens Hosp, Seattle, WA 98195 USA.	heather.jaspan@sbri.org	Cotton, Mark/AAQ-9936-2020; Huang, Lyen/AAM-2144-2021	Cotton, Mark/0000-0003-2559-6034; Huang, Lyen/0000-0002-8605-2631; Whitelaw, Andrew/0000-0001-9070-5247	Palo Alto/University Rotary Club; Waterfront Rotary Club of Cape Town; Rotary Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007233] Funding Source: NIH RePORTER	Palo Alto/University Rotary Club; Waterfront Rotary Club of Cape Town; Rotary Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	LCH was supported in part by the Palo Alto/University Rotary Club, the Waterfront Rotary Club of Cape Town, and the Rotary Foundation, through the Ambassadorial Scholar program, none of whom had any role in the design, conduct, analysis, interpretation and preparation of the research or manuscript.	Abzug MJ, 2006, PEDIATR INFECT DIS J, V25, P920, DOI 10.1097/01.inf.0000237830.33228.c3; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; *CDC, 1987, MMWR-MORBID MORTAL W, V36, P225; COTTON M, 2008, PLOS MED; Franzetti F, 2006, INFECTION, V34, P9, DOI 10.1007/s15010-006-5007-x; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gona P, 2006, JAMA-J AM MED ASSOC, V296, P292, DOI 10.1001/jama.296.3.292; Kapogiannis BG, 2008, PEDIATRICS, V121, pE1229, DOI 10.1542/peds.2007-0871; King J, 1996, PEDIATR RES, V39, P1037; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Madhi SA, 2005, VACCINE, V23, P5517, DOI 10.1016/j.vaccine.2005.07.038; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P315, DOI 10.1097/00006454-200204000-00011; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Meyers TM, 2000, J TROP PEDIATRICS, V46, P224, DOI 10.1093/tropej/46.4.224; MOFENSON LM, 1991, PEDIATR RES, V29, pA179; Mulenga V, 2007, AIDS, V21, P77, DOI 10.1097/QAD.0b013e3280114ed7; Nesheim SR, 2007, PEDIATRICS, V120, P100, DOI 10.1542/peds.2006-2052; PLETZ M, 2008, INT J ANTIMICROBIAL; Puthanakit T, 2007, CLIN INFECT DIS, V44, P599, DOI 10.1086/510489; Robinson A, 2007, S AFR FAM PRACT, V49, DOI 10.1080/20786204.2007.10873589; SPECTOR SA, 1994, NEW ENGL J MED, V331, P1181, DOI 10.1056/NEJM199411033311802; Viani RM, 2004, CLIN INFECT DIS, V39, P725, DOI 10.1086/423178; von Gottberg A, 2006, B WORLD HEALTH ORGAN, V84, P811, DOI 10.2471/BLT.06.030361; Winters M, 2008, CAN J PUBLIC HEALTH, V99, P57, DOI 10.1007/BF03403742; World Health Organisation, 2006, ANT THER HIV INF INF; Zar HJ, 2001, ACTA PAEDIATR, V90, P119, DOI 10.1080/080352501300049163	28	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3260	10.1371/journal.pone.0003260	http://dx.doi.org/10.1371/journal.pone.0003260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813340	Green Published, gold			2022-12-25	WOS:000264431800004
J	Grieder, NC; Caussinus, E; Parker, DS; Cadigan, K; Affolter, M; Luschnig, S				Grieder, Nicole C.; Caussinus, Emmanuel; Parker, David S.; Cadigan, Kenneth; Affolter, Markus; Luschnig, Stefan			gamma COP Is Required for Apical Protein Secretion and Epithelial Morphogenesis in Drosophila melanogaster	PLOS ONE			English	Article							GENETIC-CONTROL; TRACHEAL MORPHOGENESIS; TUBE MORPHOGENESIS; VESICLE TRANSPORT; SALIVARY-GLAND; GTPASE; CHITIN; TRAFFICKING; EXPRESSION; COMPONENTS	Background: There is increasing evidence that tissue-specific modifications of basic cellular functions play an important role in development and disease. To identify the functions of COPI coatomer-mediated membrane trafficking in Drosophila development, we were aiming to create loss-of-function mutations in the gamma COP gene, which encodes a subunit of the COPI coatomer complex. Principal Findings: We found that gamma COP is essential for the viability of the Drosophila embryo. In the absence of zygotic gamma COP activity, embryos die late in embryogenesis and display pronounced defects in morphogenesis of the embryonic epidermis and of tracheal tubes. The coordinated cell rearrangements and cell shape changes during tracheal tube morphogenesis critically depend on apical secretion of certain proteins. Investigation of tracheal morphogenesis in gamma COP loss-of-function mutants revealed that several key proteins required for tracheal morphogenesis are not properly secreted into the apical lumen. As a consequence, gamma COP mutants show defects in cell rearrangements during branch elongation, in tube dilation, as well as in tube fusion. We present genetic evidence that a specific subset of the tracheal defects in gamma COP mutants is due to the reduced secretion of the Zona Pellucida protein Piopio. Thus, we identified a critical target protein of COPI-dependent secretion in epithelial tube morphogenesis. Conclusions/Significance: These studies highlight the role of COPI coatomer-mediated vesicle trafficking in both general and tissue-specific secretion in a multicellular organism. Although COPI coatomer is generally required for protein secretion, we show that the phenotypic effect of gamma COP mutations is surprisingly specific. Importantly, we attribute a distinct aspect of the gamma COP phenotype to the effect on a specific key target protein.	[Grieder, Nicole C.; Caussinus, Emmanuel; Affolter, Markus] Biozentrum Univ Basel, Abt Zellbiol, Basel, Switzerland; [Parker, David S.; Cadigan, Kenneth] Univ Michigan, Dept Mol, Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Luschnig, Stefan] Univ Zurich, Inst Zool, CH-8006 Zurich, Switzerland	University of Basel; University of Michigan System; University of Michigan; University of Zurich	Grieder, NC (corresponding author), NICHD, NIH, Bethesda, MD USA.	nicole.grieder@unibas.ch	Luschnig, Stefan E/A-7253-2010	Luschnig, Stefan E/0000-0002-0634-3368; Cadigan, Ken/0000-0003-2431-1703; Affolter, Markus/0000-0002-5171-0016	Kantons Basel-Stadt; Basel-Land; German Research Foundation; The Swiss National Science Foundation; EMBO [fellowship]; FEBS [fellowship]; Treubel-Fonds, Basel; NIH [RO1 GM082994]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082994] Funding Source: NIH RePORTER	Kantons Basel-Stadt; Basel-Land; German Research Foundation(German Research Foundation (DFG)); The Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); EMBO(European Molecular Biology Organization (EMBO)); FEBS; Treubel-Fonds, Basel; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Kantons Basel-Stadt and Basel-Land (MA), the German Research Foundation (SL), The Swiss National Science Foundation, an EMBO long term fellowship (EC), a FEBS fellowship (EC), the Treubel-Fonds, Basel (NCG) and the NIH grant RO1 GM082994 (KC).	Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; CADIGAN KM, 1994, GENE DEV, V8, P899, DOI 10.1101/gad.8.8.899; CAMPBELL RE, 2002, MONOMETRIC RED FLUOR; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; FARQUHAR MG, 1997, GOLGI APPARATUS, P65; Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; GLOOR GB, 1993, GENETICS, V135, P81; Grieder NC, 2005, GENE EXPR PATTERNS, V6, P11, DOI 10.1016/j.modgep.2005.06.001; Hoffman GR, 2003, MOL CELL, V12, P615, DOI 10.1016/j.molcel.2003.08.002; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Kerman BE, 2006, DIFFERENTIATION, V74, P326, DOI 10.1111/j.1432-0436.2006.00095.x; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01; Lay D, 2006, BBA-MOL CELL RES, V1763, P1678, DOI 10.1016/j.bbamcr.2006.08.036; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee S, 2002, DEVELOPMENT, V129, P1509; Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Miyasaka H, 2002, J MOL EVOL, V55, P52, DOI 10.1007/s00239-001-0090-1; Parker DS, 2002, DEVELOPMENT, V129, P2565; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008; TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697; Thummel CS, 1992, DROS INF SERV, V71, P150; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Wang JB, 2006, APPL MATH COMPUT, V180, P185, DOI 10.1016/j.amc.2005.11.162; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004	55	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3241	10.1371/journal.pone.0003241	http://dx.doi.org/10.1371/journal.pone.0003241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802472	Green Published, Green Submitted, gold			2022-12-25	WOS:000264428600001
J	Yafetto, L; Carroll, L; Cui, YL; Davis, DJ; Fischer, MWF; Henterly, AC; Kessler, JD; Kilroy, HA; Shidler, JB; Stolze-Rybczynski, JL; Sugawara, Z; Money, NP				Yafetto, Levi; Carroll, Loran; Cui, Yunluan; Davis, Diana J.; Fischer, Mark W. F.; Henterly, Andrew C.; Kessler, Jordan D.; Kilroy, Hayley A.; Shidler, Jacob B.; Stolze-Rybczynski, Jessica L.; Sugawara, Zachary; Money, Nicholas P.			The Fastest Flights in Nature: High-Speed Spore Discharge Mechanisms among Fungi	PLOS ONE			English	Article								Background: A variety of spore discharge processes have evolved among the fungi. Those with the longest ranges are powered by hydrostatic pressure and include "squirt guns'' that are most common in the Ascomycota and Zygomycota. In these fungi, fluid-filled stalks that support single spores or spore-filled sporangia, or cells called asci that contain multiple spores, are pressurized by osmosis. Because spores are discharged at such high speeds, most of the information on launch processes from previous studies has been inferred from mathematical models and is subject to a number of errors. Methodology/ Principal Findings: In this study, we have used ultra-high-speed video cameras running at maximum frame rates of 250,000 fps to analyze the entire launch process in four species of fungi that grow on the dung of herbivores. For the first time we have direct measurements of launch speeds and empirical estimates of acceleration in these fungi. Launch speeds ranged from 2 to 25 m s(-1) and corresponding accelerations of 20,000 to 180,000 g propelled spores over distances of up to 2.5 meters. In addition, quantitative spectroscopic methods were used to identify the organic and inorganic osmolytes responsible for generating the turgor pressures that drive spore discharge. Conclusions/Significance: The new video data allowed us to test different models for the effect of viscous drag and identify errors in the previous approaches to modeling spore motion. The spectroscopic data show that high speed spore discharge mechanisms in fungi are powered by the same levels of turgor pressure that are characteristic of fungal hyphae and do not require any special mechanisms of osmolyte accumulation.	[Yafetto, Levi; Cui, Yunluan; Davis, Diana J.; Henterly, Andrew C.; Kessler, Jordan D.; Kilroy, Hayley A.; Shidler, Jacob B.; Stolze-Rybczynski, Jessica L.; Sugawara, Zachary; Money, Nicholas P.] Miami Univ, Dept Bot, Oxford, OH 45056 USA; [Carroll, Loran; Davis, Diana J.; Fischer, Mark W. F.] Coll Mt St Joseph, Dept Chem & Phys Sci, Cincinnati, OH USA	University System of Ohio; Miami University; Mount St. Joseph University	Yafetto, L (corresponding author), Miami Univ, Dept Bot, Oxford, OH 45056 USA.	moneynp@muohio.edu	Yafetto, Levi/Q-7350-2018	Yafetto, Levi/0000-0002-7787-0325	National Science Foundation; National Institutes of Health; Direct For Biological Sciences [0743074] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors' studies on spore discharge are funded by the National Science Foundation and National Institutes of Health.	Buller AHR, 1934, RES FUNGI, V6; Elbert W., 2006, ATMOS CHEM PHYS DISC, V6, P11317; Fischer M, 2004, FUNGAL GENET BIOL, V41, P698, DOI 10.1016/j.fgb.2004.03.005; HIGGINS MK, 1994, ANAL CHEM, V66, P2625; Ingold C., 1971, MYCOLOGIA; INGOLD C. T., 1959, NEW PHYTOL, V58, P46, DOI 10.1111/j.1469-8137.1959.tb05333.x; Lapple CE, 1940, IND ENG CHEM, V32, P605, DOI 10.1021/ie50365a007; Majdalani J., 2006, VISCOUS FLUID FLOW, V3; MICHELI PA, 1729, NOVA PLANTARUM GENER; MONEY NP, 2007, MYCOTA, V8, P237; PAGE RM, 1964, MYCOLOGIA, V56, P363, DOI 10.2307/3756678; Pringle A, 2005, MYCOLOGIA, V97, P866, DOI 10.3852/mycologia.97.4.866; PRINGSHEIM E. G., 1927, JAHRB WISS BOT, V66, P863; ROBINSON J, 1962, NATURE, V193, P353, DOI 10.1038/193353a0; Trail F, 2005, FUNGAL GENET BIOL, V42, P528, DOI 10.1016/j.fgb.2005.03.008; Trail F, 2007, FEMS MICROBIOL LETT, V276, P12, DOI 10.1111/j.1574-6968.2007.00900.x; Tucker K, 2007, FUNGAL GENET BIOL, V44, P641, DOI 10.1016/j.fgb.2006.12.007; van den Berk GEL, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-140; Vogel S, 2005, J BIOSCIENCES, V30, P167, DOI 10.1007/BF02703696; Wakaba L, 2007, THEOR COMP FLUID DYN, V21, P147, DOI 10.1007/s00162-007-0042-5; Webster J., 2007, INTRO FUNGI, V3rd	21	52	55	11	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3237	10.1371/journal.pone.0003237	http://dx.doi.org/10.1371/journal.pone.0003237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797504	Green Published, gold, Green Submitted			2022-12-25	WOS:000264428200009
J	Grod, ON; Budden, AE; Tregenza, T; Koricheva, J; Leimu, R; Aarssen, LW; Lortie, CJ				Grod, Olyana N.; Budden, Amber E.; Tregenza, Tom; Koricheva, Julia; Leimu, Roosa; Aarssen, Lonnie W.; Lortie, Christopher J.			Systematic Variation in Reviewer Practice According to Country and Gender in the Field of Ecology and Evolution	PLOS ONE			English	Article								The characteristics of referees and the potential subsequent effects on the peer-review process are an important consideration for science since the integrity of the system depends on the appropriate evaluation of merit. In 2006, we conducted an online survey of 1334 ecologists and evolutionary biologists pertaining to the review process. Respondents were from Europe, North America and other regions of the world, with the majority from English first language countries. Women comprised a third of all respondents, consistent with their representation in the scientific academic community. Among respondents we found no correlation between the time typically taken over a review and the reported average rejection rate. On average, Europeans took longer over reviewing a manuscript than North Americans, and females took longer than males, but reviewed fewer manuscripts. Males recommended rejection of manuscripts more frequently than females, regardless of region. Hence, editors and potential authors should consider alternative sets of criteria, to what exists now, when selecting a panel of referees to potentially balance different tendencies by gender or region.	[Grod, Olyana N.; Lortie, Christopher J.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Budden, Amber E.] Natl Ctr Ecol Anal & Synthesis NCEAS, Santa Barbara, CA USA; [Tregenza, Tom] Univ Exeter, Ctr Ecol & Conserv, Exeter EX4 4QJ, Devon, England; [Koricheva, Julia] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Leimu, Roosa] Univ Turku, Sect Ecol, SF-20500 Turku, Finland; [Aarssen, Lonnie W.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	York University - Canada; National Center for Ecological Analysis & Synthesis; University of Exeter; University of London; Royal Holloway University London; University of Turku; Queens University - Canada	Grod, ON (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	olyanag@yorku.ca	Budden, Amber/A-2829-2010; Tregenza, Tom/B-1078-2014; Aarssen, Lonnie W./K-5778-2012; lortie, christopher j/F-6241-2014; Koricheva, Julia/G-6754-2011	Budden, Amber/0000-0003-2885-3980; Tregenza, Tom/0000-0003-4182-2222; lortie, christopher j/0000-0002-4291-7023; Koricheva, Julia/0000-0002-9033-0171	National Center for Ecological Analysis and Synthesis, a Center funded by NSF [DEB-0072909]	National Center for Ecological Analysis and Synthesis, a Center funded by NSF	This work was conducted as part of the role of publication-related biases in ecology Working Group supported by the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant no. DEB-0072909).	Benos DJ, 2007, ADV PHYSIOL EDUC, V31, P145, DOI 10.1152/advan.00104.2006; Budden AE, 2008, TRENDS ECOL EVOL, V23, P4, DOI 10.1016/j.tree.2007.07.008; Cassey P, 2004, BIOSCIENCE, V54, P234, DOI 10.1641/0006-3568(2004)054[0234:PARASE]2.0.CO;2; Frank E, 1996, PREV MED, V25, P102, DOI 10.1006/pmed.1996.0035; GARFUNKEL JM, 1994, JAMA-J AM MED ASSOC, V272, P137, DOI 10.1001/jama.272.2.137; GILBERT JR, 1994, JAMA-J AM MED ASSOC, V272, P139, DOI 10.1001/jama.272.2.139; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; KASSIRER JP, 1994, JAMA-J AM MED ASSOC, V272, P96, DOI 10.1001/jama.272.2.96; Kliewer MA, 2005, AM J ROENTGENOL, V184, P1731, DOI 10.2214/ajr.184.6.01841731; Kliewer MA, 2004, AM J ROENTGENOL, V183, P1545, DOI 10.2214/ajr.183.6.01831545; LLOYD ME, 1990, J APPL BEHAV ANAL, V23, P539, DOI 10.1901/jaba.1990.23-539; LOCK S, 1990, JAMA-J AM MED ASSOC, V263, P1341, DOI 10.1001/jama.263.10.1341; Lortie CJ, 2007, OIKOS, V116, P1247, DOI 10.1111/j.0030-1299.2007.15686.x; Millett D, 2006, J ORTHOD, V33, P1, DOI 10.1179/146531205225021321; Moller AP, 2001, TRENDS ECOL EVOL, V16, P580, DOI 10.1016/S0169-5347(01)02235-2; *NAT SCI BOARD, 2006, SCI ENG IND 2006; Neff BD, 2006, BIOSCIENCE, V56, P333, DOI 10.1641/0006-3568(2006)56[333:IPRAGO]2.0.CO;2; NYLENNA M, 1994, JAMA-J AM MED ASSOC, V272, P149, DOI 10.1001/jama.272.2.149; *SAS I INC, 2003, REL 5 1 1; Sokal R. R., 2012, BIOMETRY; Tregenza T, 2002, TRENDS ECOL EVOL, V17, P349, DOI 10.1016/S0169-5347(02)02545-4; *UNESCO, 2000, UNESCO WORLD CULT RE, P312; *UNESCO I STAT COL, 2006, UIS B SCI TECHN STAT; Weller A.C, 2001, EDITORIAL PEER REV I; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; YANKAUER A, 1990, JAMA-J AM MED ASSOC, V263, P1338; Zar J. H., 1996, BIOSTATISTICAL ANAL	27	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3202	10.1371/journal.pone.0003202	http://dx.doi.org/10.1371/journal.pone.0003202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787653	gold, Green Published, Green Submitted			2022-12-25	WOS:000264426200007
J	Penny, MA; Maire, N; Studer, A; Schapira, A; Smith, TA				Penny, Melissa A.; Maire, Nicolas; Studer, Alain; Schapira, Allan; Smith, Thomas A.			What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; AFRICAN CHILDREN; EXPANDED PROGRAM; TRANSMISSION; INFECTION; EFFICACY; IMMUNIZATION; PROTECTION; DURATION; DENSITY	Background: A number of different malaria vaccine candidates are currently in pre-clinical or clinical development. Even though they vary greatly in their characteristics, it is unlikely that any of them will provide long-lasting sterilizing immunity against the malaria parasite. There is great uncertainty about what the minimal vaccine profile should be before registration is worthwhile; how to allocate resources between different candidates with different profiles; which candidates to consider combining; and what deployment strategies to consider. Methods and Findings: We use previously published stochastic simulation models, calibrated against extensive epidemiological data, to make quantitative predictions of the population effects of malaria vaccines on malaria transmission, morbidity and mortality. The models are fitted and simulations obtained via volunteer computing. We consider a range of endemic malaria settings with deployment of vaccines via the Expanded program on immunization (EPI), with and without additional booster doses, and also via 5-yearly mass campaigns for a range of coverages. The simulation scenarios account for the dynamic effects of natural and vaccine induced immunity, for treatment of clinical episodes, and for births, ageing and deaths in the cohort. Simulated pre-erythrocytic vaccines have greatest benefits in low endemic settings (<EIR of 10.5) where between 12% and 14% of all deaths are averted when initial efficacy is 50%. In some high transmission scenarios (>EIR of 84) PEV may lead to increased incidence of severe disease in the long term, if efficacy is moderate to low (<70%). Blood stage vaccines (BSV) are most useful in high transmission settings, and are comparable to PEV for low transmission settings. Combinations of PEV and BSV generally perform little better than the best of the contributing components. A minimum half-life of protection of 2-3 years appears to be a precondition for substantial epidemiological effects. Herd immunity effects can be achieved with even moderately effective (>20%) malaria vaccines (either PEV or BSV) when deployed through mass campaigns targeting all age-groups as well as EPI, and especially if combined with highly efficacious transmission-blocking components. Conclusions: We present for the first time a stochastic simulation approach to compare likely effects on morbidity, mortality and transmission of a range of malaria vaccines and vaccine combinations in realistic epidemiological and health systems settings. The results raise several issues for vaccine clinical development, in particular appropriateness of vaccine types for different transmission settings; the need to assess transmission to the vector and duration of protection; and the importance of deployment additional to the EPI, which again may make the issue of number of doses required more critical. To test the validity and robustness of our conclusions there is a need for further modeling (and, of course, field research) using alternative formulations for both natural and vaccine induced immunity. Evaluation of alternative deployment strategies outside EPI needs to consider the operational implications of different approaches to mass vaccination.	[Penny, Melissa A.; Maire, Nicolas; Studer, Alain; Schapira, Allan; Smith, Thomas A.] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Penny, Melissa A.; Maire, Nicolas; Studer, Alain; Schapira, Allan; Smith, Thomas A.] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Penny, MA (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	Thomas-A.Smith@unibas.ch	Smith, Thomas/B-5569-2015; Penny, Melissa A/N-6838-2015; Schapira, Allan/AAZ-8116-2020	Smith, Thomas/0000-0002-3650-9381; Penny, Melissa A/0000-0002-4972-593X; 	Bill and Melinda Gates Foundation [39777]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by The Bill and Melinda Gates Foundation, project #39777. The funders had no role in study design, development of the model, decision to publish, or preparation of the manuscript.	Alonso PL, 1996, J INFECT DIS, V174, P367, DOI 10.1093/infdis/174.2.367; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ANDERSON RM, 1989, PARASITOLOGY, V99, pS59, DOI 10.1017/S0031182000083426; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Carter R, 2002, INT J PARASITOL, V32, P1617, DOI 10.1016/S0020-7519(02)00190-X; DEZOYSA APK, 1988, T ROY SOC TROP MED H, V82, P548, DOI 10.1016/0035-9203(88)90500-7; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; Goodman C, 2000, EC ANAL MALARIA CONT; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Halloran ME, 1996, AM J EPIDEMIOL, V144, P83, DOI 10.1093/oxfordjournals.aje.a008858; Jensen JLWV, 1906, ACTA MATH-DJURSHOLM, V30, P175, DOI 10.1007/BF02418571; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Maire N, 2006, AM J TROP MED HYG, V75, P104, DOI 10.4269/ajtmh.2006.75.104; MOORTHY VS, 2007, VACCINE IN PRESS; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Saul A, 2007, CURR OPIN INFECT DIS, V20, P476, DOI 10.1097/QCO.0b013e3282a95e12; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; SMITH T, 2008, PARASITOLOG IN PRESS; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STRUCHINER CJ, 1989, MATH BIOSCI, V94, P87, DOI 10.1016/0025-5564(89)90073-4; Tediosi F, 2006, AM J TROP MED HYG, V75, P131, DOI 10.4269/ajtmh.2006.75.131; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	29	55	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3193	10.1371/journal.pone.0003193	http://dx.doi.org/10.1371/journal.pone.0003193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784833	Green Published, gold, Green Submitted			2022-12-25	WOS:000264425900012
J	Grodstein, F; van Oijen, M; Irizarry, MC; Rosas, HD; Hyman, BT; Growdon, JH; De Vivo, I				Grodstein, Francine; van Oijen, Marieke; Irizarry, Michael C.; Rosas, H. Diana; Hyman, Bradley T.; Growdon, John H.; De Vivo, Immaculata			Shorter Telomeres May Mark Early Risk of Dementia: Preliminary Analysis of 62 Participants from the Nurses' Health Study	PLOS ONE			English	Article								Background: Dementia takes decades to develop, and effective prevention will likely require early intervention. Thus, it is critical to identify biomarkers of preclinical disease, allowing targeting of high-risk subjects for preventive efforts. Since telomeres shorten with age and oxidative stress, both of which are important contributors to the onset of dementia, telomere length might be a valuable biomarker. Methodology/Principal Findings: Among 62 participants of the Nurses' Health Study, we conducted neurologic evaluations, including patient and caregiver interviews, physical exam, neurologic exam, and neuropsychologic testing. We also conducted magnetic resonance imaging (MRI) in a sample of 29 of these women. In these preliminary data, after adjustment for numerous health and lifestyle factors, we found that truncated telomeres in peripheral blood leukocytes segregate with preclinical dementia states, including mild cognitive impairment (MCI); the odds of MCI were 12-fold higher (odds ratio = 12.00, 95% confidence interval 1.24-116.5) for those with shorter telomere length compared to longer telomere length. In addition, decreasing telomere length was strongly related to decreasing hippocampal volume (p = 0.038). Conclusions: These preliminary data suggest that telomere length may be a possible early marker of dementia risk, and merits further study in large, prospective investigations.	[Grodstein, Francine; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Grodstein, Francine; De Vivo, Immaculata] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [van Oijen, Marieke] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Oijen, Marieke] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Irizarry, Michael C.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA; [Rosas, H. Diana; Hyman, Bradley T.; Growdon, John H.] Massachusetts Gen Hosp, Harvard Med Sch, Dept Neurol, Massachusetts Alzheimer Dis Res Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; GlaxoSmithKline; Harvard University; Harvard Medical School; Massachusetts General Hospital	Grodstein, F (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 75 Francis St, Boston, MA 02115 USA.	fgrodstein@partners.org			National Institutes of Health [AG15424, AG05134, CA87969]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG015424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by grants AG15424, AG05134, and CA87969 from the National Institutes of Health. The funders had no part in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript	Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Flanary BE, 2007, REJUV RES, V10, P61, DOI 10.1089/rej.2006.9096; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2	12	81	81	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1590	10.1371/journal.pone.0001590	http://dx.doi.org/10.1371/journal.pone.0001590			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18795148	Green Published, gold			2022-12-25	WOS:000260535900024
J	Sanggaard, KW; Sonne-Schmidt, CS; Krogager, TP; Kristensen, T; Wisniewski, HG; Thogersen, IB; Enghild, JJ				Sanggaard, Kristian W.; Sonne-Schmidt, Carsten S.; Krogager, Toke P.; Kristensen, Torsten; Wisniewski, Hans-Georg; Thogersen, Ida B.; Enghild, Jan J.			TSG-6 Transfers Proteins between Glycosaminoglycans via a Ser(28)-mediated Covalent Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; HEAVY-CHAIN TRANSFER; ACYL-ENZYME COMPLEX; STIMULATED GENE-6; LINK MODULE; INDUCED ARTHRITIS; CROSS-LINKS; HYALURONAN; BINDING; SHAP	Studies of the interaction between Bikunin proteins, tumor necrosis factor-stimulated gene-6 protein (TSG-6), and glycos-aminoglycans have revealed a unique catalytic activity where TSG-6/heavy chain 2 transfer heavy chain subunits between glycosaminoglycan chains. The activity is mediated by TSG-6/heavy chain 2 and involves a transient SDS stable interaction between TSG-6 and the heavy chain to be transferred. The focus of this study was to characterize the molecular structure of this cross-link to gain further insight into the catalytic mechanism. The result showed that the C-terminal Asp residue of the heavy chains forms an ester bond to Ser(28) carbon of TSG-6 suggesting that this residue plays a role during catalysis.	[Sanggaard, Kristian W.; Sonne-Schmidt, Carsten S.; Krogager, Toke P.; Kristensen, Torsten; Thogersen, Ida B.; Enghild, Jan J.] Univ Aarhus, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Sanggaard, Kristian W.; Sonne-Schmidt, Carsten S.; Krogager, Toke P.; Kristensen, Torsten; Thogersen, Ida B.; Enghild, Jan J.] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Wisniewski, Hans-Georg] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Aarhus University; Aarhus University; New York University	Enghild, JJ (corresponding author), Gustav Wiedsvej 10C, DK-8000 Aarhus C, Denmark.	jje@inano.dk	; Scavenius, Carsten/Q-5941-2017	Enghild, Jan Johannes/0000-0001-9292-9172; Scavenius, Carsten/0000-0002-4304-0681	Danish National Science Foundation; Carlsberg Foundation	Danish National Science Foundation(Danmarks Grundforskningsfond); Carlsberg Foundation(Carlsberg Foundation)	This work was supported by grants from the Danish National Science Foundation (to J. J. E.) and the Carlsberg Foundation (to K. W. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; HUANG L, 1993, J BIOL CHEM, V268, P26725; Katona G, 2002, J BIOL CHEM, V277, P21962, DOI 10.1074/jbc.M200676200; Keough T, 2002, RAPID COMMUN MASS SP, V16, P1003, DOI 10.1002/rcm.670; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; SANDSON J, 1964, SCIENCE, V146, P70, DOI 10.1126/science.146.3640.70; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; YONEDA M, 1990, J BIOL CHEM, V265, P5247; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	45	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33919	33926		10.1074/jbc.M804240200	http://dx.doi.org/10.1074/jbc.M804240200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18820257	hybrid, Green Published			2022-12-25	WOS:000261277700018
J	Rodriguez-Gonzalez, A; Cyrus, K; Salcius, M; Kim, K; Crews, CM; Deshaies, RJ; Sakamoto, KM				Rodriguez-Gonzalez, A.; Cyrus, K.; Salcius, M.; Kim, K.; Crews, C. M.; Deshaies, R. J.; Sakamoto, K. M.			Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer	ONCOGENE			English	Article						steroid hormone receptors; ubiquitination; degradation; breast cancer; prostate cancer	HUMAN ANDROGEN RECEPTOR; ESTROGEN-RECEPTOR; COMBINATORIAL CHEMISTRY; RESPONSIVE ELEMENT; GROWTH-FACTOR; CELL-LINES; IN-VIVO; ALPHA; GENE; PROTEIN	Proteolysis targeting chimeric molecules (Protacs) target proteins for destruction by exploiting the ubiquitin-dependent proteolytic system of eukaryotic cells. We designed two Protacs that contain the peptide 'degron' from hypoxia-inducible factor-1 alpha, which binds to the Von-Hippel-Lindau (VHL) E3 ubiquitin ligase complex, linked to either dihydroxytestosterone that targets the androgen receptor (AR; Protac-A), or linked to estradiol (E2) that targets the estrogen receptor-alpha (ER alpha; Protac-B). We hypothesized that these Protacs would recruit hormone receptors to the VHL E3 ligase complex, resulting in the degradation of receptors, and decreased proliferation of hormone-dependent cell lines. Treatment of estrogen-dependent breast cancer cells with Protac-B induced the degradation of ER alpha in a proteasome-dependent manner. Protac-B inhibited the proliferation of ER alpha-dependent breast cancer cells by inducing G(1) arrest, inhibition of retinoblastoma phosphorylation and decreasing expression of cyclin D1, progesterone receptors A and B. Protac-B treatment did not affect the proliferation of estrogen-independent breast cancer cells that lacked ERa expression. Similarly, Protac-A treatment of androgen-dependent prostate cancer cells induced G(1) arrest but did not affect cells that do not express AR. Our results suggest that Protacs specifically inhibit the proliferation of hormone-dependent breast and prostate cancer cells through degradation of the ERa and AR, respectively.	[Rodriguez-Gonzalez, A.; Sakamoto, K. M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Gwynne Hazen Cherry Labs,Jonsson Comprehens Canc, Los Angeles, CA 90095 USA; [Rodriguez-Gonzalez, A.; Sakamoto, K. M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Gwynne Hazen Cherry Labs,Jonsson Comprehens Canc, Los Angeles, CA 90095 USA; [Rodriguez-Gonzalez, A.; Deshaies, R. J.; Sakamoto, K. M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Cyrus, K.; Kim, K.] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA; [Salcius, M.; Crews, C. M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Salcius, M.; Crews, C. M.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Salcius, M.; Crews, C. M.] Yale Univ, Dept Chem, New Haven, CT USA; [Deshaies, R. J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Sakamoto, K. M.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology; University of Kentucky; Yale University; Yale University; Yale University; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Sakamoto, KM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Gwynne Hazen Cherry Labs,Jonsson Comprehens Canc, A2-412 MDCC CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	kms@ucla.edu	Deshaies, Raymond/B-8354-2014; Crews, Craig M./ABH-9346-2020	Deshaies, Raymond/0000-0002-3671-9354; Crews, Craig M./0000-0002-8456-2005; Sakamoto, Kathleen/0000-0003-0494-8838	National Institutes of Health [CA-16042, AI-28697]; Jonsson Cancer Center; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; Department of Defense (USA) Prostate Cancer Research [W81XWH-06-1-0192]; Postdoctoral fellowship Ministerio de Educacion y Ciencia (Spain) MEC/Fulbright [EX 2005-0517, NIH R21 R21 CA118631];  [NIH R21 CA108545]; NATIONAL CANCER INSTITUTE [P30CA016042, R21CA108545, R21CA118631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonsson Cancer Center; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); Department of Defense (USA) Prostate Cancer Research(United States Department of Defense); Postdoctoral fellowship Ministerio de Educacion y Ciencia (Spain) MEC/Fulbright(Spanish Government); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Tammy Phung for her kind assistance in the flow cytometry performance in the UCLA Jonsson Comprehensive Cancer Center and Center for AIDS Research FlowCore Facility that is supported by the National Institutes of Health awards CA-16042 and AI-28697, by the Jonsson Cancer Center, the UCLA AIDS Institute and the David Geffen School of Medicine at UCLA. This work was supported by NIH R21 CA108545 (KMS), Department of Defense (USA) Prostate Cancer Research Program W81XWH-06-1-0192 (AR), Postdoctoral fellowship Ministerio de Educacion y Ciencia (Spain) MEC/Fulbright EX 2005-0517 (AR) and NIH R21 R21 CA118631 (CMC). RJD is an Investigator of the Howard Hughes Medical Institute.	Alarid ET, 2003, ENDOCRINOLOGY, V144, P3469, DOI 10.1210/en.2002-0092; Bakin RE, 2003, CANCER RES, V63, P1981; Bargagna-Mohan P, 2005, BIOORG MED CHEM LETT, V15, P2724, DOI 10.1016/j.bmcl.2005.04.008; Blundell TL, 1996, NATURE, V384, P23; Borras M, 1996, J STEROID BIOCHEM, V57, P203, DOI 10.1016/0960-0760(95)00272-3; Broach JR, 1996, NATURE, V384, P14; Bubendorf L, 1999, CANCER RES, V59, P803; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Buzdar AU, 2003, ONCOLOGIST, V8, P335, DOI 10.1634/theoncologist.8-4-335; Clarke R, 1996, Cancer Treat Res, V87, P263; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; CULIG Z, 1994, CANCER RES, V54, P5474; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Duong V, 2007, CANCER RES, V67, P5513, DOI 10.1158/0008-5472.CAN-07-0967; Eder IE, 2002, CANCER GENE THER, V9, P117, DOI 10.1038/sj.cgt.7700416; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Franco OE, 2003, PROSTATE, V56, P319, DOI 10.1002/pros.10258; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Godoy-Tundidor S, 2002, CLIN CANCER RES, V8, P2356; Hogan JC, 1996, NATURE, V384, P17; HUGGINS C, 1967, CANCER RES, V27, P1925; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kirschberg TA, 2003, ORG LETT, V5, P3459, DOI 10.1021/ol035234c; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Linja MJ, 2001, CANCER RES, V61, P3550; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Moul JW, 2000, J UROLOGY, V163, P1632, DOI 10.1016/S0022-5347(05)67511-8; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pink JJ, 1996, CANCER RES, V56, P2321; Preisler-Mashek MT, 2002, AM J PHYSIOL-ENDOC M, V282, pE891, DOI 10.1152/ajpendo.00353.2001; Rau KM, 2005, ENDOCR-RELAT CANCER, V12, P511, DOI 10.1677/erc.1.01026; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Sakamoto KM, 2003, MOL CELL PROTEOMICS, V2, P1350, DOI 10.1074/mcp.T300009-MCP200; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; SANTEN RJ, 1992, J CLIN ENDOCR METAB, V75, P685, DOI 10.1210/jc.75.3.685; Savarese DM, 2001, J CLIN ONCOL, V19, P2509, DOI 10.1200/JCO.2001.19.9.2509; SAVOURET JF, 1991, EMBO J, V10, P1875, DOI 10.1002/j.1460-2075.1991.tb07713.x; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Taplin ME, 1999, CANCER RES, V59, P2511; Thiele B, 1999, J CLIN ENDOCR METAB, V84, P1751, DOI 10.1210/jc.84.5.1751; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Verdine GL, 1996, NATURE, V384, P11; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008	51	125	185	17	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	57					7201	7211		10.1038/onc.2008.320	http://dx.doi.org/10.1038/onc.2008.320			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	379GG	18794799	Green Accepted			2022-12-25	WOS:000261384100007
J	Wickenden, JA; Jin, H; Johnson, M; Gillings, AS; Newson, C; Austin, M; Chell, SD; Balmanno, K; Pritchard, CA; Cook, SJ				Wickenden, J. A.; Jin, H.; Johnson, M.; Gillings, A. S.; Newson, C.; Austin, M.; Chell, S. D.; Balmanno, K.; Pritchard, C. A.; Cook, S. J.			Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM	ONCOGENE			English	Article						apoptosis; BIM; BRAF; colorectal cancer; ERK1/2	B-RAF; BH3-ONLY PROTEIN; BCL-2 PROTEINS; PHOSPHORYLATION; EXPRESSION; APOPTOSIS; GENE; PROMOTES; PROLIFERATION; DEGRADATION	The RAF-mitogen-activated protein kinase kinase 1/2 extracellular signal-regulated kinase 1/2 (RAF-MEK1/2-ERK1/2) pathway is activated in many human tumours and can protect cells against growth factor deprivation; however, most such studies have relied upon overexpression of RAF or MEK constructs that are not found in tumours. Here we show that expression of the endogenous BRAF(V600E) allele in mouse embryonic fibroblasts from conditional knock-in transgenic mice activates ERK1/2, represses the BH3-only protein BIM and protects cells from growth factor withdrawal. Human colorectal cancer (CRC) cell lines harbouring BRAF(V600E) are growth factor independent for the activation of ERK1/2 and survival. However, treatment with the MEK1/2 inhibitors U0126, PD184352 or the novel clinical candidate AZD6244 (ARRY-142886) overcomes growth factor independence, causing CRC cell death. BIM is de-phosphorylated and upregulated following MEK1/2 inhibition in all CRC cell lines studied and knockdown of BIM reduces cell death, indicating that repression of BIM is a major part of the ability of BRAF(V600E) to confer growth factor-independent survival. We conclude that a single endogenous BRAF(V600E) allele is sufficient to repress BIM and prevent death arising from growth factor withdrawal, and CRC cells with BRAF(V600E) mutations are addicted to the ERK1/2 pathway for repression of BIM and growth factor-independent survival.	[Jin, H.; Pritchard, C. A.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Wickenden, J. A.; Johnson, M.; Gillings, A. S.; Newson, C.; Austin, M.; Chell, S. D.; Balmanno, K.; Cook, S. J.] Babraham Inst, Mol Signalling Lab, Cambridge, England	University of Leicester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Pritchard, CA (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	cap8@le.ac.uk; simon.cook@bbsrc.ac.uk		Balmanno, Kathryn/0000-0002-6417-3889; Chell, Simon/0000-0001-5321-9119; Pritchard, Catrin/0000-0003-1859-4487; Austin, Mark/0000-0003-4943-7265	CRUK [C1362/A6969]; Association for International Cancer Research (AICR); AstraZeneca, BBSRC [BB/E02162X/1]; Babraham Institute; BBSRC [BB/E02162X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E02162X/1, BBS/E/B/0000C199, BBS/E/B/0000H151] Funding Source: researchfish	CRUK(Cancer Research UK); Association for International Cancer Research (AICR); AstraZeneca, BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)AstraZeneca); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank members of the SJC and CAPlabs for discussions and Richard Marais for his advice and encouragement. We particularly thank the Division of Biomedical Services at Leicester for help with breeding and Susan Giblett for isolation of MEFs. We are grateful to the Trono lab for provision of lentiviral expression systems, Paul Smith (AstraZeneca) for provision of AZD6244 and discussions and Richard Hamelin for provision of CO115 cells. Work in the CAPlab was funded by a CRUK programme grant number C1362/A6969. Work in the SJC lab was supported by the Association for International Cancer Research (AICR), AstraZeneca, BBSRC (BB/E02162X/1) and the Babraham Institute.	Boisvert-Adamo K, 2008, ONCOGENE, V27, P3301, DOI 10.1038/sj.onc.1211003; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eisenmann KM, 2003, CANCER RES, V63, P8330; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Marani M, 2004, ONCOGENE, V23, P2431, DOI 10.1038/sj.onc.1207364; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Todd DE, 2004, ONCOGENE, V23, P3284, DOI 10.1038/sj.onc.1207467; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wallace EM, 2006, J MED CHEM, V49, P441, DOI 10.1021/jm050834y; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yuen ST, 2002, CANCER RES, V62, P6451; Zantl N, 2007, ONCOGENE, V26, P7038, DOI 10.1038/sj.onc.1210510	45	55	60	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	57					7150	7161		10.1038/onc.2008.335	http://dx.doi.org/10.1038/onc.2008.335			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	379GG	18806830	Green Accepted			2022-12-25	WOS:000261384100002
J	Fletcher, JM; Morton, CJ; Zwar, RA; Murray, SS; O'Leary, PD; Hughes, RA				Fletcher, Jordan M.; Morton, Craig J.; Zwar, Richard A.; Murray, Simon S.; O'Leary, Paul D.; Hughes, Richard A.			Design of a Conformationally Defined and Proteolytically Stable Circular Mimetic of Brain-derived Neurotrophic Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NF-KAPPA-B; CRYSTAL-STRUCTURE; SENSORY NEURONS; TRK RECEPTORS; BINDING; P75; NGF; SURVIVAL; BDNF	Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of neurotrophic factors. BDNF has long been recognized to have potential for the treatment of a variety of human neurodegenerative diseases. However, clinical trials with recombinant BDNF have yet to yield success, leading to the suggestion that alternative means of harnessing BDNF actions for therapeutic use may be required. Here we describe an approach to create low molecular weight peptides that, like BDNF, promote neuronal survival. The peptides were designed to mimic a cationic tripeptide sequence in loop 4 of BDNF shown in previous studies to contribute to the binding of BDNF to the common neurotrophin receptor p75(NTR). The best of these peptides, the cyclic pentapeptide 2 (cyclo(-D-Pro-Ala-Lys-Arg-)), despite being of low molecular weight (M-r 580), was found to be an effective promoter of the survival of embryonic chick dorsal root ganglion sensory neurons in vitro (maximal survival, 68 +/- 3% of neurons supported by BDNF). Pentapeptide 2 did not affect the phosphorylation of either TrkB (the receptor tyrosine kinase for BDNF) or the downstream signaling molecule MAPK, indicating that its mechanism of neuronal survival action is independent of TrkB. NMR studies reveal that pentapeptide 2 adopts a well defined backbone conformation in solution. Furthermore, pentapeptide 2 was found to be effectively resistant to proteolysis when incubated in a solution of rat plasma in vitro. These properties of pentapeptide 2 (low molecular weight, appropriate pharmacological actions, a well defined solution conformation, and proteolytic stability) render it worthy of further investigation, either as a template for the further design of neuronal survival promoting agents or as a lead compound with therapeutic potential in its own right.	[Fletcher, Jordan M.; Zwar, Richard A.; O'Leary, Paul D.; Hughes, Richard A.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Morton, Craig J.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Murray, Simon S.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Hughes, RA (corresponding author), Univ Melbourne, Dept Pharmacol, Grattan St, Melbourne, Vic 3010, Australia.	rahughes@unimelb.edu.au	Morton, Craig/GON-8638-2022	Morton, Craig/0000-0001-5452-5193; Murray, Simon/0000-0001-6671-192X; Fletcher, Jordan/0000-0003-3203-4355; O'Leary, Paul/0000-0003-2717-0790	National Health and Medical Research Council of Australia; Motor Neurone Disease Association of Australia; Calibre Biotechnology Pty. Ltd.; University of Melbourne; Melbourne Research Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Motor Neurone Disease Association of Australia; Calibre Biotechnology Pty. Ltd.; University of Melbourne(University of Melbourne); Melbourne Research Scholarship	This work was supported in part by the National Health and Medical Research Council of Australia, the Motor Neurone Disease Association of Australia, Calibre Biotechnology Pty. Ltd., and a publication grant from the University of Melbourne. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a Melbourne Research Scholarship.	Alberch J, 2004, PROG BRAIN RES, V146, P195, DOI 10.1016/S0079-6123(03)46014-7; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; ASKANAS V, 1995, ADV NEUROL, V68, P241; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; BERGER H, 1979, BIOCHEM PHARMACOL, V28, P3173, DOI 10.1016/0006-2952(79)90058-3; Bhakar AL, 1999, J BIOL CHEM, V274, P21443, DOI 10.1074/jbc.274.30.21443; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Butte MJ, 1998, BIOCHEMISTRY-US, V37, P16846, DOI 10.1021/bi981254o; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chan WC, 2000, PRACT APPROACH SER, V222, P41; Erickson JT, 2001, J NEUROSCI, V21, P581, DOI 10.1523/JNEUROSCI.21-02-00581.2001; Fletcher JM, 2006, J PEPT SCI, V12, P515, DOI 10.1002/psc.760; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hallbook F, 1999, CURR OPIN NEUROBIOL, V9, P616, DOI 10.1016/S0959-4388(99)00011-2; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Heller M, 2006, J AM CHEM SOC, V128, P13806, DOI 10.1021/ja063174a; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Maliartchouk S, 2000, J BIOL CHEM, V275, P9946, DOI 10.1074/jbc.275.14.9946; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; O'Leary PD, 1998, J NEUROCHEM, V70, P1712; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Raguse JD, 2004, ORAL ONCOL, V40, P228, DOI 10.1016/j.oraloncology.2003.08.003; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Robinson RC, 1999, PROTEIN SCI, V8, P2589; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RYDEN M, 1995, EMBO J, V14, P1979, DOI 10.1002/j.1460-2075.1995.tb07190.x; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang XM, 2007, J MED CHEM, V50, P2921, DOI 10.1021/jm070084n	44	40	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33375	33383		10.1074/jbc.M802789200	http://dx.doi.org/10.1074/jbc.M802789200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18809686	Green Published, hybrid			2022-12-25	WOS:000261183700042
J	Tian, G; Kober, FX; Lewandrowski, U; Sickmann, A; Lennarz, WJ; Schindelin, H				Tian, Geng; Kober, Franz-Xaver; Lewandrowski, Urs; Sickmann, Albert; Lennarz, William J.; Schindelin, Hermann			The Catalytic Activity of Protein-disulfide Isomerase Requires a Conformationally Flexible Moleculele	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; FUNCTIONAL-PROPERTIES; CRYSTAL-STRUCTURE; FOLDING CATALYST; PEPTIDE-BINDING; YEAST; SITE; DOMAIN	Protein-disulfide isomerase (PDI) catalyzes the formation of the correct pattern of disulfide bonds in secretory proteins. A low resolution crystal structure of yeast PDI described here reveals large scale conformational changes compared with the initially reported structure, indicating that PDI is a highly flexible molecule with its catalytic domains, a and a', representing two mobile arms connected to a more rigid core composed of the b and b' domains. Limited proteolysis revealed that the linker between the a domain and the core is more susceptible to degradation than that connecting the a' domain to the core. By restricting the two arms with inter-domain disulfide bonds, the molecular flexibility of PDI, especially that of its a domain, was demonstrated to be essential for the enzymatic activity in vitro and in vivo. The crystal structure also featured a PDI dimer, and a propensity to dimerize in solution and in the ER was confirmed by cross-linking experiments and the split green fluorescent protein system. Although sedimentation studies suggested that the self-association of PDI is weak, we hypothesize that PDI exists as an interconvertible mixture of monomers and dimers in the endoplasmic reticulum due to its high abundance in this compartment.	[Tian, Geng; Lennarz, William J.; Schindelin, Hermann] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Kober, Franz-Xaver; Lewandrowski, Urs; Sickmann, Albert; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Schindelin, H (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	hermann.schindelin@virchow.uni-wuerzburg.de	Tian, Geng/G-7374-2011; Schindelin, Hermann/Q-2697-2019; Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265	National Institutes of Health [GM33184, DK54835]; Deutsche Forschungsgemeinschaft [FZ82]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33184 (to W. J. L.) and DK54835 ( to H. S.). This work was also supported by Deutsche Forschungsgemeinschaft Grant FZ82 ( to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brachmann CB, 1998, YEAST, V14, P115; CAI H, 1994, J BIOL CHEM, V269, P24550; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; GALLAGHER SR, 1999, CURRENT PROTOCOLS MO, V2, DOI DOI 10.12B.11-10.12B.15; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Grillo C, 2007, J BIOL CHEM, V282, P10299, DOI 10.1074/jbc.M700966200; Holst B, 1997, J CELL BIOL, V138, P1229, DOI 10.1083/jcb.138.6.1229; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KELLEHER DJ, 1994, J BIOL CHEM, V269, P12908; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LAMANTIA M, 1991, P NATL ACAD SCI USA, V88, P4453, DOI 10.1073/pnas.88.10.4453; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; LAMBERT N, 1983, BIOCHEM J, V213, P225, DOI 10.1042/bj2130225; LEBECHE D, 1994, BIOCHEM BIOPH RES CO, V202, P556, DOI 10.1006/bbrc.1994.1964; LI SJ, 2005, J BIOL CHEM; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Solovyov A, 2004, J BIOL CHEM, V279, P34095, DOI 10.1074/jbc.M405640200; Solovyov A, 2004, PROTEIN SCI, V13, P1902, DOI 10.1110/ps.04716104; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun XX, 2000, J BIOL CHEM, V275, P22743, DOI 10.1074/jbc.M002406200; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Westphal V, 1999, J MOL BIOL, V286, P1229, DOI 10.1006/jmbi.1999.2560; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Yan AX, 2003, J BIOL CHEM, V278, P33078, DOI 10.1074/jbc.M305337200; ZAPUN A, 1992, PROTEINS, V14, P10, DOI 10.1002/prot.340140104	48	64	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33630	33640		10.1074/jbc.M806026200	http://dx.doi.org/10.1074/jbc.M806026200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18815132	hybrid, Green Published			2022-12-25	WOS:000261183700069
J	Yoon, WJ; Cho, YD; Cho, KH; Woo, KM; Baek, JH; Cho, JY; Kim, GS; Ryoo, HM				Yoon, Won-Joon; Cho, Young-Dan; Cho, Kwang-Hwi; Woo, Kyung-Mi; Baek, Jeong-Hwa; Cho, Je-Yoel; Kim, Gwan-Shik; Ryoo, Hyun-Mo			The Boston-type Craniosynostosis Mutation MSX2 (P148H) Results in Enhanced Susceptibility of MSX2 to Ubiquitin-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL SUTURE MORPHOGENESIS; CALVARIAL BONE-DEVELOPMENT; APICAL ECTODERMAL RIDGE; HOMEOBOX GENE; OSTEOBLAST DIFFERENTIATION; HOMEODOMAIN PROTEINS; RETINOBLASTOMA GENE; DEVELOPING LIMB; EXTRA COPY; EXPRESSION	Boston-type craniosynostosis is caused by a single amino acid substitution, P148H, in the transcription factor MSX2. The increased binding affinity of MSX2 (P148H) to the response element has led many to hypothesize that the substitution is a gain-of-function mutation. However, there have been conflicting reports on the function of MSX2, and by extension, the nature of the P148H mutation remains unclear. In this study, we have examined the molecular mechanism of MSX2 function and the nature of the P148H mutation. During cranial suture closure of rodent, Msx2 expression was detected in the suture space. Overexpression of wild type MSX2 in mesenchymal cells stimulated cell proliferation and cyclin D1 expression, whereas P148H mutant did not. These results indicated that MSX2 is involved in maintaining the suture space by stimulating suture mesenchymal cell proliferation and that P148H is defective in this process. The protein levels of P148H were lower than wild type Msx2 (Msx2-WT), and pulse-chase experiments indicated that the mutant protein has a shorter half-life than the Msx2-WT protein. The ubiquitylation level of P148H was greater than that of Msx2-WT. The degradation of Msx2 was mediated by Praja1, and the P148H mutant was degraded more effectively than WT. The ubiquitylation of Msx2-WT was higher in the presence of Msx2 (P148H), which indicated that P148H functions as a dominant-negative mutant. Collectively, the primary function of MSX2 in suture closure is the induction of cell proliferation and suture maintenance, and the mutation results in an increased susceptibility of both wild type and mutant MSX2 to proteasomal degradation.	[Yoon, Won-Joon; Cho, Young-Dan; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Ryoo, Hyun-Mo] Seoul Natl Univ, Dept Cell & Dev Biol, Sch Dent, Seoul 110749, South Korea; [Yoon, Won-Joon; Cho, Young-Dan; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Ryoo, Hyun-Mo] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea; [Cho, Kwang-Hwi] Soongsil Univ, Dept Bioinformat & Life Sci, Seoul 156743, South Korea; [Cho, Je-Yoel] Kyungpook Natl Univ, Dept Biochem, Sch Dent, Taegu 700422, South Korea; [Cho, Je-Yoel] Kyungpook Natl Univ, Dept Biochem, Skeletal Dis Genome Res Ctr, Taegu 700422, South Korea	Seoul National University (SNU); Seoul National University (SNU); Soongsil University; Kyungpook National University; Kyungpook National University	Ryoo, HM (corresponding author), 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Baek, Jeong-Hwa/A-8628-2012; Woo, Kyung Mi/A-2793-2009; Cho, Young-Dan/AAR-4573-2021; Ryoo, Hyun-Mo/D-5839-2012	Woo, Kyung Mi/0000-0002-2782-1189; Ryoo, Hyun-Mo/0000-0001-6769-8341	Basic Research Program of the Korea Science & Engineering Foundation [R01-2005-000-106650]; Korea Health 21 R D Project; Ministry of Health and Welfare Project [A010252]	Basic Research Program of the Korea Science & Engineering Foundation(Korea Science and Engineering Foundation); Korea Health 21 R D Project; Ministry of Health and Welfare Project	This work was supported by Basic Research Program of the Korea Science & Engineering Foundation Grant R01-2005-000-106650 and by Korea Health 21 R & D Project, Ministry of Health and Welfare Project A010252.	Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Dodig M, 1999, DEV BIOL, V209, P298, DOI 10.1006/dbio.1999.9258; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Kim HJ, 1998, DEVELOPMENT, V125, P1241; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Koshiba K, 1998, J EXP ZOOL, V282, P703, DOI 10.1002/(SICI)1097-010X(19981215)282:6<703::AID-JEZ6>3.0.CO;2-P; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; LIU YH, 1994, MECH DEVELOP, V48, P187, DOI 10.1016/0925-4773(94)90059-0; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; LIU YH, 1995, P NATL ACAD SCI USA, V92, P6137, DOI 10.1073/pnas.92.13.6137; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Montanaro L, 2007, CELL PROLIFERAT, V40, P532, DOI 10.1111/j.1365-2184.2007.00448.x; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Newberry EP, 1997, J BIOL CHEM, V272, P29607, DOI 10.1074/jbc.272.47.29607; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; NISHIKAWA K, 1994, BIOCHEM MOL BIOL INT, V32, P763; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; ROMANO JW, 1989, ONCOGENE, V4, P1483; ROS MA, 1994, DEV BIOL, V166, P59, DOI 10.1006/dbio.1994.1296; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; Shiihara T, 2004, AM J MED GENET A, V128A, P214, DOI 10.1002/ajmg.a.20552; SUMOY L, 1995, DEV BIOL, V170, P230, DOI 10.1006/dbio.1995.1210; Towler DA, 2006, ANN NY ACAD SCI, V1068, P327, DOI 10.1196/annals.1346.036; Wang JC, 2007, AM J MED GENET A, V143A, P2931, DOI 10.1002/ajmg.a.31946; Wang WP, 1999, J INVEST DERM SYMP P, V4, P278, DOI 10.1038/sj.jidsp.5640229; WARMAN ML, 1993, AM J MED GENET, V46, P444, DOI 10.1002/ajmg.1320460420; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Yoshizawa T, 2004, MOL CELL BIOL, V24, P3460, DOI 10.1128/MCB.24.8.3460-3472.2004; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	37	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32751	32761		10.1074/jbc.M803183200	http://dx.doi.org/10.1074/jbc.M803183200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18786927	hybrid			2022-12-25	WOS:000260893700064
J	Cao, XQ; Tanis, KQ; Koleske, AJ; Colicelli, J				Cao, Xiaoqing; Tanis, Keith Q.; Koleske, Anthony J.; Colicelli, John			Enhancement of ABL Kinase Catalytic Efficiency by a Direct Binding Regulator Is Independent of Other Regulatory Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; C-ABL; BCR-ABL; FAMILY KINASES; CELL-MIGRATION; DOCKING SITE; MAP KINASE; PHOSPHORYLATION; DOMAIN; ACTIVATION	ABL family tyrosine kinases are tightly regulated by autoinhibition and phosphorylation mechanisms. These kinases maintain an inactive conformation through intramolecular interactions involving SH3 and SH2 domains. RIN1, a downstream effector of RAS, binds to the ABL SH3 and SH2 domains and stimulates ABL tyrosine kinase activity. RIN1 binding to the ABL2 kinase resulted in a large decrease in K-m and a small increase in V-max toward an ABL consensus substrate peptide. The enzyme efficiency (k(cat)/K-m) was increased more than 5-fold by RIN1. In addition, RIN1 strongly enhanced ABL-mediated phosphorylation of CRK, PSTPIP1, and DOK1, all established ABL substrates but with unique protein structures and distinct target sequences. Importantly RIN1-mediated stimulation of ABL kinase activity was independent of activation by SRC-mediated phosphorylation. RIN1 increased the kinase activity of both ABL1 and ABL2, and this occurred in the presence or absence of ABL regulatory domains outside the SH3-SH2-tyrosine kinase domain core. We further demonstrate that a catalytic site mutation associated with broad drug resistance, ABL1(T315I), remains responsive to stimulation by RIN1. These findings are consistent with an allosteric kinase activation mechanism by which RIN1 binding promotes a more accessible ABL catalytic site through relief of autoinhibition. Direct disruption of RIN1 binding may therefore be a useful strategy to suppress the activity of normal and oncogenic ABL, including inhibitor-resistant mutants that confound current therapeutic strategies. Stimulation through derepression may be applicable to many other tyrosine kinases autoinhibited by coupled SH3 and SH2 domains.	[Cao, Xiaoqing; Colicelli, John] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Inst Mol Biol, Los Angeles, CA 90095 USA; [Cao, Xiaoqing; Colicelli, John] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Canc Ctr, Los Angeles, CA 90095 USA; [Tanis, Keith Q.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University	Colicelli, J (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, 615 Charles E Young Dr,34609 BSRB, Los Angeles, CA 90095 USA.	colicelli@mednet.ucla.edu		Tanis, Keith/0000-0001-6744-1183	National Institutes of Health [RO1 NS046787, NS39475, MH77306]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH077306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046787, R01NS039475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS046787 (to J. C.) and NS39475 and MH77306 (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afar DEH, 1997, IMMUNITY, V6, P773, DOI 10.1016/S1074-7613(00)80452-5; Amoui M, 2000, CELL SIGNAL, V12, P637, DOI 10.1016/S0898-6568(00)00107-8; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cujec TP, 2002, CHEM BIOL, V9, P253, DOI 10.1016/S1074-5521(02)00098-4; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Finn AJ, 2003, NAT NEUROSCI, V6, P717, DOI 10.1038/nn1071; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Goss VL, 2006, BLOOD, V107, P4888, DOI 10.1182/blood-2005-08-3399; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Hu HL, 2008, MOL CELL BIOL, V28, P1573, DOI 10.1128/MCB.01087-07; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Huang YP, 2008, BLOOD, V112, P111, DOI 10.1182/blood-2007-10-118232; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jung JH, 2008, BIOCHEMISTRY-US, V47, P1094, DOI 10.1021/bi701533j; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Milstein M, 2007, CANCER RES, V67, P11510, DOI 10.1158/0008-5472.CAN-07-1147; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Wang JYJ, 2005, CELL RES, V15, P43, DOI 10.1038/sj.cr.7290263; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Xiong XL, 2008, BBA-MOL CELL RES, V1783, P737, DOI 10.1016/j.bbamcr.2008.01.028	46	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31401	31407		10.1074/jbc.M804002200	http://dx.doi.org/10.1074/jbc.M804002200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18796434	hybrid, Green Published			2022-12-25	WOS:000260760800019
J	Shi, XR; Burkart, A; Nicoloro, SM; Czech, MP; Straubhaar, J; Corvera, S				Shi, Xiarong; Burkart, Alison; Nicoloro, Sarah M.; Czech, Michael P.; Straubhaar, Juerg; Corvera, Silvia			Paradoxical Effect of Mitochondrial Respiratory Chain Impairment on Insulin Signaling and Glucose Transport in Adipose Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC SYNDROME; STIMULATED PHOSPHORYLATION; OXIDATIVE-PHOSPHORYLATION; TRANSCRIPTION-FACTOR; DIABETES-MELLITUS; MAMMALIAN-CELLS; SKELETAL-MUSCLE; GENE-EXPRESSION; ROS PRODUCTION; TISSUE	Adipocyte function is crucial for the control of whole body energy homeostasis. Pathway analysis of differentiating 3T3-L1 adipocytes reveals that major metabolic pathways induced during differentiation involve mitochondrial function. However, it is not clear why differentiated white adipocytes require enhanced respiratory chain activity relative to pre-adipocytes. To address this question, we used small interference RNA to interfere with the induction of the transcription factor Tfam, which is highly induced between days 2 and 4 of differentiation and is crucial for replication of mitochondrial DNA. Interference with Tfam resulted in cells with decreased respiratory chain capacity, reflected by decreased basal oxygen consumption, and decreased mitochondrial ATP synthesis, but no difference in many other adipocyte functions or expression levels of adipose-specific genes. However, insulin-stimulated GLUT4 translocation to the cell surface and subsequent glucose transport are impaired in Tfam knockdown cells. Paradoxically, insulin-stimulated Akt phosphorylation is significantly enhanced in these cells. These studies reveal independent links between mitochondrial function, insulin signaling, and glucose transport, in which impaired respiratory chain activity enhances insulin signaling to Akt phosphorylation, but impairs GLUT4 translocation. These results indicate that mitochondrial respiratory chain dysfunction in adipocytes can cause impaired insulin responsiveness of GLUT4 translocation by a mechanism downstream of the Akt protein kinase.	[Shi, Xiarong; Burkart, Alison; Nicoloro, Sarah M.; Czech, Michael P.; Straubhaar, Juerg; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	silvia.corvera@umassmed.edu		Nicoloro, Sarah/0000-0002-8638-4556	National Institutes of Health [DK60837]; University of Massachusetts Diabetes and Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK060837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Diabetes and Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK60837. Informatics core services were supported by University of Massachusetts Diabetes and Endocrinology Research Center Grant DK32520. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; BASHAN N, 1993, AM J PHYSIOL, V264, pC430, DOI 10.1152/ajpcell.1993.264.2.C430; Beale EG, 2003, TRENDS BIOCHEM SCI, V28, P402, DOI 10.1016/S0968-0004(03)00163-4; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chavez JA, 2006, BIOCHEM BIOPH RES CO, V342, P1218, DOI 10.1016/j.bbrc.2006.02.091; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Gridley S, 2005, CELL SIGNAL, V17, P59, DOI 10.1016/j.cellsig.2004.05.013; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hresko RC, 1998, J BIOL CHEM, V273, P20658, DOI 10.1074/jbc.273.32.20658; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Imoto K, 2006, DIABETES, V55, P1197, DOI 10.2337/db05-1187; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rasouli N, 2007, DIABETES OBES METAB, V9, P1, DOI 10.1111/j.1463-1326.2006.00590.x; Ravussin E, 2002, ANN NY ACAD SCI, V967, P363; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; SORBRIS R, 1982, METABOLISM, V31, P973, DOI 10.1016/0026-0495(82)90137-8; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	48	50	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30658	30667		10.1074/jbc.M800510200	http://dx.doi.org/10.1074/jbc.M800510200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18779333	Green Published, hybrid			2022-12-25	WOS:000260544800023
J	Singh, JK; Makde, RD; Kumar, V; Panda, D				Singh, Jay Kumar; Makde, Ravindra D.; Kumar, Vinay; Panda, Dulal			SepF Increases the Assembly and Bundling of FtsZ Polymers and Stabilizes FtsZ Protofilaments by Binding along Its Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; INTERACTING PROTEIN; BACTERIAL DIVISION; GTP HYDROLYSIS; Z-RING; MEMBRANE; ZIPA; POLYMERIZATION	SepF (Septum Forming) protein has been recently identified through genetic studies, and it has been suggested to be involved in the division of Bacillus subtilis cells. We have purified functional B. subtilis SepF from the inclusion bodies overexpressed in Escherichia coli. Far-UV circular dichroism and fluorescence spectroscopic analysis involving the extrinsic fluorescent probe 1-anilinonaphthalene-8-sulfonic acid suggested that the purified SepF had characteristics of folded proteins. SepF was found to promote the assembly and bundling of FtsZ protofilaments using three complimentary techniques, namely 90 light scattering, sedimentation, and transmission electron microscopy. SepF also decreased the critical concentration of FtsZ assembly, prevented the dilution-induced disassembly of FtsZ protofilaments, and suppressed the GTPase activity of FtsZ. Further, thick bundles of FtsZ protofilaments were observed using fluorescein isothiocyanate-labeled SepF (FITC-SepF). Interestingly, FITC-SepF was found to be uniformly distributed along the length of the FtsZ protofilaments, suggesting that SepF copolymerizes with FtsZ. SepF formed a stable complex with FtsZ, as evident from the gel filtration analysis. Using a C-terminal tail truncated FtsZ (FtsZ Delta 16) and a C-terminal synthetic peptide of B. subtilis FtsZ (366-382); we provided evidence indicating that SepF binds primarily to the C-terminal tail of FtsZ. The present work in concert with the available in vivo data support a model in which SepF plays an important role in regulating the assembly dynamics of the divisome complex; therefore, it may have an important role in bacterial cell division.	[Singh, Jay Kumar; Panda, Dulal] Indian Inst Technol, Sch Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Makde, Ravindra D.; Kumar, Vinay] Bhabha Atom Res Ctr, High Pressure Phys Div, Bombay 400085, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Bhabha Atomic Research Center (BARC)	Panda, D (corresponding author), Indian Inst Technol, Sch Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Singh, Jaikaran/O-5363-2015	Singh, Jaikaran/0000-0002-9273-6765; Makde, Ravindra D./0000-0001-7020-0065	Dept. of Science and Technology, Government of India; Council of Scientific and Industrial Research	Dept. of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by a grant from the Dept. of Science and Technology, Government of India (to D.P.) and a Council of Scientific and Industrial Research doctoral fellowship (to J.K.S.).	Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Fadda D, 2003, J BACTERIOL, V185, P6209, DOI 10.1128/JB.185.20.6209-6214.2003; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; LEE SY, 1993, MOL MICROBIOL, V7, P601, DOI 10.1111/j.1365-2958.1993.tb01151.x; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2003, CURR BIOL, V13, pR16, DOI 10.1016/S0960-9822(02)01381-7; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Santra MK, 2004, J BIOL CHEM, V279, P25959, DOI 10.1074/jbc.M312473200; Santra MK, 2003, J BIOL CHEM, V278, P21336, DOI 10.1074/jbc.M301303200; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Scheffers DJ, 2002, MOL MICROBIOL, V43, P1517, DOI 10.1046/j.1365-2958.2002.02828.x; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; WOLDRINGH CL, 1990, RES MICROBIOL, V141, P39, DOI 10.1016/0923-2508(90)90096-9; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	39	69	69	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31116	31124		10.1074/jbc.M805910200	http://dx.doi.org/10.1074/jbc.M805910200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782755	Green Published, hybrid			2022-12-25	WOS:000260544800066
J	Braden, WA; McClendon, AK; Knudsen, ES				Braden, W. A.; McClendon, A. K.; Knudsen, E. S.			Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly	ONCOGENE			English	Article						CDK; cyclin; pre-RC; tumor suppressor; cancer	DNA-REPLICATION; S-PHASE; CELL-CYCLE; PREREPLICATION COMPLEX; CHROMOSOME-REPLICATION; CHROMATIN ASSOCIATION; ORIGIN RECOGNITION; EUKARYOTIC CELLS; RE-REPLICATION; HUMAN CANCER	Cyclin-dependent kinases (CDKs) are important in regulating cell cycle transitions, particularly in coordinating DNA replication. Although the role of CDK2 activity on the replication apparatus has been extensively studied, the role of CDK4/6 in DNA replication control is less understood. Through targeted inhibition of CDK4/6 activity, we demonstrate that CDK4/6 kinase activity promotes cdc6 and cdt1 expression, and pre-replication complex (pre-RC) assembly in cycling cells. Conversely, CDK2 inhibition had no effect on the pre-RC assembly. The inhibition of pre-RC assembly is dependent on a functional retinoblastoma (RB) protein, which mediates downstream effects. As such, CDK4/6 inhibition has minimal effect on the replication apparatus in the absence of RB. The requirement of CDK4/6 was further interrogated using cells lacking D-type cyclins, in which replication complexes form normally, and correspondingly CDK4/6 inhibition had no effect on cell cycle or replication control. However, in the absence of D-type cyclins, CDK2 inhibition resulted in the attenuation of cdc6 and cdt1 levels, suggesting overlapping roles for CDK4/6 and CDK2 in regulating replication protein activity. Finally, CDK4/6 inhibition prevented the accumulation of cdc6 and cdt1 as cells progressed from mitosis through the subsequent G(1). Combined, these studies indicate that CDK4/6 activity is important in regulating the expression of these critical mediators of DNA replication.	[Knudsen, E. S.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	eknudsen@kimmalcancercenter.org			NIEHS [T32 ES07250-16];  [NCI CA106471]; NATIONAL CANCER INSTITUTE [R01CA106471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr Karen Knudsen and members of both Knudsen laboratories for critical review of the paper. Critical reagents were provided by Dr Piotr Sicinski and Pfizer Corp. This study was funded by a grant to ESK from the NCI CA106471. WAB and AKM are supported by NIEHS training grant T32 ES07250-16.	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Angus SP, 2004, MOL CELL BIOL, V24, P5404, DOI 10.1128/MCB.24.12.5404-5420.2004; Bartek J, 1997, EXP CELL RES, V237, P1, DOI 10.1006/excr.1997.3776; Bartkova J, 1997, Prog Cell Cycle Res, V3, P211; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Braden WA, 2006, MOL CELL BIOL, V26, P7667, DOI 10.1128/MCB.00045-06; Broceno C, 2002, P NATL ACAD SCI USA, V99, P14200, DOI 10.1073/pnas.212519499; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Diffley JFX, 2002, J CELL SCI, V115, P869; DIFFLEY JFX, 1994, CURR OPIN CELL BIOL, V6, P368, DOI 10.1016/0955-0674(94)90028-0; Dimitrova DS, 2002, J CELL SCI, V115, P51; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Fry DW, 2004, MOL CANCER THER, V3, P1427; Fujita M, 1996, J BIOL CHEM, V271, P4349; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Guo Y, 2002, ONCOGENE, V21, P7545, DOI 10.1038/sj.onc.1205907; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hua XH, 1997, J CELL BIOL, V137, P183, DOI 10.1083/jcb.137.1.183; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Markey MP, 2002, CANCER RES, V62, P6587; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Palmero I, 1996, CANCER SURV, V27, P351; Savio M, 2006, CELL CYCLE, V5, P2153, DOI 10.4161/cc.5.18.3235; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sever-Chroneos Z, 2001, MOL CELL BIOL, V21, P4032, DOI 10.1128/MCB.21.12.4032-4045.2001; Sherr C J, 2000, Harvey Lect, V96, P73; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tanaka S, 2002, GENE DEV, V16, P2639, DOI 10.1101/gad.1011002; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32	58	25	29	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2008	27	56					7083	7093		10.1038/onc.2008.319	http://dx.doi.org/10.1038/onc.2008.319			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	376PQ	18776921				2022-12-25	WOS:000261195900003
J	Kigel, B; Varshavsky, A; Kessler, O; Neufeld, G				Kigel, Boaz; Varshavsky, Asya; Kessler, Ofra; Neufeld, Gera			Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SUPPRESSOR GENE; CANCER CELLS; ANTI-VEGF; IN-VIVO; NEUROPILIN-1; ANGIOGENESIS; FAMILY; 3F; CONVERTASES	The class-3 semaphorins (sema3s) include seven family members. Six of them bind to neuropilin-1 (np1) or neuropilin-2 (np2) receptors or to both, while the seventh, sema3E, binds to the plexin-D1 receptor. Sema3B and sema3F were previously characterized as tumor suppressors and as inhibitors of tumor angiogenesis. To determine if additional class-3 semaphorins such as sema3A, sema3D, sema3E and sema3G possess anti-angiogenic and anti-tumorigenic properties, we expressed the recombinant full length semaphorins in four different tumorigenic cell lines expressing different combinations of class-3 semaphorin receptors. We show for the first time that sema3A, sema3D, sema3E and sema3G can function as potent anti-tumorigenic agents. All the semaphorins we examined were also able to reduce the concentration of tumor associated blood vessels although the potencies of the anti-angiogenic effects varied depending on the tumor cell type. Surprisingly, there was little correlation between the ability to inhibit tumor angiogenesis and their anti-tumorigenic activity. None of the semaphorins inhibited the adhesion of the tumor cells to plastic or fibronectin nor did they modulate the proliferation of tumor cells cultured in cell culture dishes. However, various semaphorins were able to inhibit the formation of soft agar colonies from tumor cells expressing appropriate semaphorin receptors, although in this case too the inhibitory effect was not always correlated with the anti-tumorigenic effect. In contrast, the anti-tumorigenic effect of each of the semaphorins correlated very well with tumor cell expression of specific signal transducing receptors for particular semaphorins. This correlation was not broken even in cases in which the tumor cells expressed significant concentrations of endogenous semaphorins. Our results suggest that combinations of different class-3 semaphorins may be more effective than single semaphorins in cases in which tumor cells express more than one type of semaphorin receptors.	[Kigel, Boaz; Varshavsky, Asya; Kessler, Ofra; Neufeld, Gera] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Kigel, B (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, POB 9649, IL-31096 Haifa, Israel.	gera@tx.technion.ac.il	Neufeld, Gera/F-1524-2019		Israel Science Foundation (ISF); Komen breast cancer foundation; International Union against Cancer (AICR); Rappaport Family Institute for Research in the Medical Sciences of the Faculty of Medicine at the Technion, Israel Institute of Technology	Israel Science Foundation (ISF)(Israel Science Foundation); Komen breast cancer foundation(Susan G. Komen Breast Cancer Foundation); International Union against Cancer (AICR); Rappaport Family Institute for Research in the Medical Sciences of the Faculty of Medicine at the Technion, Israel Institute of Technology	This work was supported by grants from the Israel Science Foundation (ISF), by the Komen breast cancer foundation, by the International Union against Cancer (AICR), and by the by the Rappaport Family Institute for Research in the Medical Sciences of the Faculty of Medicine at the Technion, Israel Institute of Technology (to G. N.). The funding organizations did not take part or affect the design or the conduct of this study.	Acevedo LM, 2008, NAT MED, V14, P372, DOI 10.1038/nm0408-372; Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Akiri G, 2003, CANCER RES, V63, P1657; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bates D, 2003, DEV BIOL, V255, P77, DOI 10.1016/S0012-1606(02)00045-3; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Cifone M A, 1982, Cancer Metastasis Rev, V1, P335, DOI 10.1007/BF00124216; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Futamura M, 2007, CANCER RES, V67, P1451, DOI 10.1158/0008-5472.CAN-06-2485; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; HAMBURGER AW, 1987, INT J CELL CLONING, V5, P89, DOI 10.1002/stem.5530050202; Herman JG, 2007, INT J ONCOL, V30, P1231; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; Nasarre P, 2005, NEOPLASIA, V7, P180, DOI 10.1593/neo.04481; Nasarre P, 2003, NEOPLASIA, V5, P83, DOI 10.1016/S1476-5586(03)80020-9; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Pavelock K, 2001, ENDOCRINOLOGY, V142, P613, DOI 10.1210/en.142.2.613; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 2005, GENES CELLS, V10, P785, DOI 10.1111/j.1365-2443.2005.00877.x; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Tse C, 2002, CANCER RES, V62, P542; Vamesu S, 2007, Rom J Morphol Embryol, V48, P25; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Whitehurst B, 2007, INT J CANCER, V121, P2181, DOI 10.1002/ijc.22937; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Xiang RH, 2002, CANCER RES, V62, P2637; Yu HH, 2005, DEV BIOL, V280, P373, DOI 10.1016/j.ydbio.2005.01.029; Zacchigna S, 2008, J CLIN INVEST, V118, P2062, DOI 10.1172/JCI32832; Zhang Wei, 2002, Angiogenesis, V5, P35, DOI 10.1023/A:1021540120521	47	105	112	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3287	10.1371/journal.pone.0003287	http://dx.doi.org/10.1371/journal.pone.0003287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818766	Green Published, Green Submitted, gold			2022-12-25	WOS:000264432300009
J	Kaittanis, C; Nath, S; Perez, JM				Kaittanis, Charalambos; Nath, Sudip; Perez, J. Manuel			Rapid Nanoparticle-Mediated Monitoring of Bacterial Metabolic Activity and Assessment of Antimicrobial Susceptibility in Blood with Magnetic Relaxation	PLOS ONE			English	Article							SERRATIA-MARCESCENS; GOLD NANOPARTICLES; RESISTANCE; NMR	Considering the increased incidence of bacterial infections and the emergence of multidrug resistant bacteria at the global level, we designed superparamagnetic iron oxide nanoparticles as nanosensors for the assessment of antimicrobial susceptibility through magnetic relaxation. In this report, we demonstrate that iron oxide nanosensors, either dextran-coated supplemented with Con A or silica-coated conjugated directly to Con A, can be used for the fast (1) quantification of polysaccharides, (2) assessment of metabolic activity and (3) determination of antimicrobial susceptibility in blood. The use of these polysaccharide nanosensors in the determination of antimicrobial susceptibility in the clinic or the field, and the utilization of these nanoprobes in pharmaceutical R&D are anticipated.	[Kaittanis, Charalambos; Nath, Sudip; Perez, J. Manuel] Univ Cent Florida, Nanosci Technol Ctr, Orlando, FL 32816 USA; [Kaittanis, Charalambos; Perez, J. Manuel] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Perez, J. Manuel] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Kaittanis, C (corresponding author), Univ Cent Florida, Nanosci Technol Ctr, Orlando, FL 32816 USA.	jmperez@mail.ucf.edu			UCF NSTC; NIH [CA101781]; NATIONAL CANCER INSTITUTE [K01CA101781] Funding Source: NIH RePORTER	UCF NSTC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was partially funded by a UCF NSTC Startup Fund and the NIH CA101781 grant, both awarded to Dr. J. Manuel Perez. Besides funding this work, the sponsors did not have any role in designing or conducting these studies.	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Aslan K, 2004, ANAL BIOCHEM, V330, P145, DOI 10.1016/j.ab.2004.03.032; Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Bennett JW, 2000, ADV APPL MICROBIOL, V47, P1, DOI 10.1016/s0065-2164(00)47000-0; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Choi JH, 2007, NANO LETT, V7, P861, DOI 10.1021/nl062306v; Demas V, 2007, J MAGN RESON, V189, P121, DOI 10.1016/j.jmr.2007.08.011; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Grimm J, 2004, CANCER RES, V64, P639, DOI 10.1158/0008-5472.CAN-03-2798; ITO H, 1995, ANTIMICROB AGENTS CH, V39, P824, DOI 10.1128/AAC.39.4.824; IU CI, 2008, SCIENCE, V319, P1391; Kaittanis C, 2007, NANO LETT, V7, P380, DOI 10.1021/nl062553z; Katneni R, 2007, NAT CLIN PRACT NEPHR, V3, P256, DOI 10.1038/ncpneph0447; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Koh I, 2008, ANGEW CHEM INT EDIT, V47, P4119, DOI 10.1002/anie.200800069; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lee JS, 2008, NANO LETT, V8, P529, DOI 10.1021/nl0727563; Lee JS, 2007, ANGEW CHEM INT EDIT, V46, P4093, DOI 10.1002/anie.200700269; Lowery TJ, 2008, ANAL CHEM, V80, P1118, DOI 10.1021/ac702288r; Ma DL, 2006, CHEM MATER, V18, P1920, DOI 10.1021/cm052067x; Mann TS, 2008, ANAL CHEM, V80, P843, DOI 10.1021/ac701829c; Nath S, 2008, ANAL CHEM, V80, P1033, DOI 10.1021/ac701969u; Perez JM, 2003, J AM CHEM SOC, V125, P10192, DOI 10.1021/ja036409g; Perez JM, 2002, J AM CHEM SOC, V124, P2856, DOI 10.1021/ja017773n; Perez JM, 2002, NAT BIOTECHNOL, V20, P816, DOI 10.1038/nbt720; Perlo J, 2005, SCIENCE, V308, P1279, DOI 10.1126/science.1108944; Phillips RL, 2008, ANGEW CHEM INT EDIT, V47, P2590, DOI 10.1002/anie.200703369; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Sun EY, 2006, SMALL, V2, P1144, DOI 10.1002/smll.200600204; Tapsall JW, 2005, CLIN INFECT DIS, V41, pS263, DOI 10.1086/430787; Tsourkas A, 2004, ANGEW CHEM INT EDIT, V43, P2395, DOI 10.1002/anie.200352998; Yoshizumi A, 1999, LANGMUIR, V15, P482, DOI 10.1021/la980374u	35	34	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2008	3	9							e3253	10.1371/journal.pone.0003253	http://dx.doi.org/10.1371/journal.pone.0003253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MA	18810269	Green Published, gold, Green Submitted			2022-12-25	WOS:000264431000001
J	Geft, D; Schwartzenberg, S; Rogowsky, O; Finkelstein, A; Ablin, J; Maysel-Auslender, S; Wexler, D; Keren, G; George, J				Geft, Dael; Schwartzenberg, Shmuel; Rogowsky, Ori; Finkelstein, Ariel; Ablin, Jacob; Maysel-Auslender, Sofia; Wexler, Dov; Keren, Gad; George, Jacob			Circulating Apoptotic Progenitor Cells in Patients with Congestive Heart Failure	PLOS ONE			English	Article								Background: Circulating CD34+ endothelial progenitor cells (EPCs) are capable of differentiating into mature endothelial cells to assist in angiogenesis and vasculogenesis. We sought to quantify the numbers of apoptotic progenitors in patients with congestive heart failure. Methods and Results: Peripheral blood mononuclear cells were isolated by Ficoll density-gradient from 58 patients with various degrees of heart failure and 23 matched controls. Apoptosis in progenitor CD34+ cells was assessed using the Annexin V-PE/PI detection kit, and FACS analysis was performed with triple staining for CD34, annexin-V and propidium iodide. The percentage of early and late apoptotic progenitor cells was determined in the subject groups and was correlated with clinical characteristics. While there was no significant difference in total CD34 positive cells or early apoptotic progenitors between control subjects and CHF patients (p = 0.42) or between severe and mild/moderate CHF groups (p = 0.544), there was an elevated number of late apoptotic progenitors in the severe CHF group compared with the mild/moderate CHF group (p = 0.03). Late apoptotic progenitors were significantly increased in CHF patients as compared to matched controls. There was also an inverse correlation between late apoptotic progenitors and ejection fraction (r = 20.252, p = 0.028) as well as a positive association with NYHA class (r = 0.223, p = 0.046). Conclusion: Severe heart failure patients exhibited higher numbers of late apoptotic progenitors, and this was positively associated with NYHA class and negatively correlated with ejection fraction. This finding may shed light on the numerous factors governing the pathophysiology of CHF.	[Geft, Dael; Schwartzenberg, Shmuel; Rogowsky, Ori; Finkelstein, Ariel; Ablin, Jacob; Maysel-Auslender, Sofia; Wexler, Dov; Keren, Gad; George, Jacob] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Geft, D (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, IL-69978 Tel Aviv, Israel.	jacobg@post.tau.ac.il	Ablin, Jacob/V-9716-2019	Ablin, Jacob/0000-0003-2523-4850				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Cabezudo E, 1999, TRANSFUSION, V39, P864, DOI 10.1046/j.1537-2995.1999.39080864.x; Chin BSP, 2003, BLOOD COAGUL FIBRIN, V14, P515, DOI 10.1097/00001721-200309000-00001; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Fischer H, 2005, CLIM DYNAM, V25, P65, DOI 10.1007/s00382-005-0011-x; George J, 2006, EUR J HEART FAIL, V8, P58, DOI 10.1016/j.ejheart.2005.04.015; Giannattasio C, 2001, HYPERTENSION, V38, P1451, DOI 10.1161/hy1201.096528; Horstman LL, 2004, FRONT BIOSCI-LANDMRK, V9, P1118, DOI 10.2741/1270; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Imanishi T, 2004, CLIN EXP PHARMACOL P, V31, P407, DOI 10.1111/j.1440-1681.2004.04022.x; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Michowitz Y, 2007, HEART, V93, P1046, DOI 10.1136/hrt.2006.102657; Nonaka-Sarukawa M, 2003, HEART, V89, P871, DOI 10.1136/heart.89.8.871; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Schwartzenberg S, 2007, ARTERIOSCL THROM VAS, V27, pE27, DOI 10.1161/ATVBAHA.107.139626; SIENA S, 1991, BLOOD, V77, P400; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Varin R, 2000, CIRCULATION, V102, P351; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02	32	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3238	10.1371/journal.pone.0003238	http://dx.doi.org/10.1371/journal.pone.0003238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800166	Green Submitted, Green Published, gold			2022-12-25	WOS:000264428400007
J	Woolley, LA; Millspaugh, JJ; Woods, RJ; van Rensburg, SJ; Mackey, RL; Page, B; Slotow, R				Woolley, Leigh-Ann; Millspaugh, Joshua J.; Woods, Rami J.; van Rensburg, Samantha Janse; Mackey, Robin L.; Page, Bruce; Slotow, Rob			Population and Individual Elephant Response to a Catastrophic Fire in Pilanesberg National Park	PLOS ONE			English	Article								In predator-free large herbivore populations, where density-dependent feedbacks occur at the limit where forage resources can no longer support the population, environmental catastrophes may play a significant role in population regulation. The potential role of fire as a stochastic mass-mortality event limiting these populations is poorly understood, so too the behavioural and physiological responses of the affected animals to this type of large disturbance event. During September 2005, a wildfire resulted in mortality of 29 (18% population mortality) and injury to 18, African elephants in Pilanesberg National Park, South Africa. We examined movement and herd association patterns of six GPS-collared breeding herds, and evaluated population physiological response through faecal glucocorticoid metabolite (stress) levels. We investigated population size, structure and projected growth rates using a simulation model. After an initial flight response post-fire, severely injured breeding herds reduced daily displacement with increased daily variability, reduced home range size, spent more time in non-tourist areas and associated less with other herds. Uninjured, or less severely injured, breeding herds also shifted into non-tourist areas post-fire, but in contrast, increased displacement rate (both mean and variability), did not adjust home range size and formed larger herds post-fire. Adult cow stress hormone levels increased significantly post-fire, whereas juvenile and adult bull stress levels did not change significantly. Most mortality occurred to the juvenile age class causing a change in post-fire population age structure. Projected population growth rate remained unchanged at 6.5% p.a., and at current fecundity levels, the population would reach its previous level three to four years post-fire. The natural mortality patterns seen in elephant populations during stochastic events, such as droughts, follows that of the classic mortality pattern seen in predator-free large ungulate populations, i.e. mainly involving juveniles. Fire therefore functions in a similar manner to other environmental catastrophes and may be a natural mechanism contributing to population limitation. Welfare concerns of arson fires, burning during "hot-fire'' conditions and the conservation implications of fire suppression (i.e. removal of a potential contributing factor to natural population regulation) should be integrated into fire management strategies for conservation areas.	[Woolley, Leigh-Ann; van Rensburg, Samantha Janse; Mackey, Robin L.; Page, Bruce; Slotow, Rob] Univ KwaZulu Natal, Amarula Elephant Res Programme, Sch Biol & Conservat Sci, Durban, South Africa; [Millspaugh, Joshua J.; Woods, Rami J.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO USA	University of Kwazulu Natal; University of Missouri System; University of Missouri Columbia	Woolley, LA (corresponding author), Univ KwaZulu Natal, Amarula Elephant Res Programme, Sch Biol & Conservat Sci, Durban, South Africa.	leigh-ann@polka.co.za	Page, Bruce R/G-1245-2010; Slotow, Rob/AAM-9053-2020; Woolley, Leigh-Ann/AAA-6162-2019	Page, Bruce R/0000-0001-7979-5229; Woolley, Leigh-Ann/0000-0002-5295-8734; Slotow, Rob/0000-0001-9469-1508	Amarula (Distell (Pty) Ltd); PPC Cement; National Research Foundation	Amarula (Distell (Pty) Ltd); PPC Cement; National Research Foundation	Funding received from Amarula (Distell (Pty) Ltd), PPC Cement, National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acocks J. P. H., 1988, MEMOIRS BOT SURVEY S; Andersen KF, 1997, AFR J ECOL, V35, P278, DOI 10.1111/j.1365-2028.1997.084-89084.x; BOONZAAIER W. W., 2000, PILANESBERG NATL PAR; Bradshaw GA, 2007, ETHOLOGY, V113, P426, DOI 10.1111/j.1439-0310.2007.01333.x; Brockett BH, 2001, INT J WILDLAND FIRE, V10, P169, DOI 10.1071/WF01024; Burke T, 2005, THESIS U KWAZULU NAT; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Creel S, 1997, CONSERV BIOL, V11, P544, DOI 10.1046/j.1523-1739.1997.95476.x; Dudley JP, 2001, AFR J ECOL, V39, P187, DOI 10.1046/j.0141-6707.2000.00297.x; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; FOWLER CW, 1973, J WILDLIFE MANAGE, V37, P513, DOI 10.2307/3800317; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; HANKS J, 1973, J ZOOL, V169, P29; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; LEGGATT K, 2003, P NORW BONN PROGR WO; LINDEQUE M, 1991, AFR J ECOL, V29, P196, DOI 10.1111/j.1365-2028.1991.tb01002.x; Loveridge AJ, 2006, J ZOOL, V270, P523, DOI 10.1111/j.1469-7998.2006.00181.x; Mackey RL, 2006, S AFR J WILDL RES, V36, P33; MANGEL M, 1994, ECOLOGY, V75, P607, DOI 10.2307/1941719; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; Millspaugh JJ, 2007, J WILDLIFE MANAGE, V71, P1257, DOI 10.2193/2006-015; Morrison TA, 2005, J ZOOL, V266, P89, DOI 10.1017/S0952836905006631; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; OTTICHILO WK, 1986, AFR J ECOL, V24, P53, DOI 10.1111/j.1365-2028.1986.tb00342.x; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith N, 2005, J ANIM ECOL, V74, P762, DOI 10.1111/j.1365-2656.2005.00973.x; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; SCHWARZENBERGER F, 1991, J REPROD FERTIL, P489; Shakespeare A, 2006, J S AFR VET ASSOC, V77, P70; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Slotow R., 2004, Koedoe, V47, P91; Stead SK, 2000, J S AFR VET ASSOC, V71, P192; van Aarde R, 1999, ANIM CONSERV, V2, P287, DOI 10.1017/S1367943099000621; van Wilgen BW, 2000, S AFR J SCI, V96, P167; Van Wilgen BW, 2004, CONSERV BIOL, V18, P1533, DOI 10.1111/j.1523-1739.2004.00362.x; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Whitehouse AM, 2000, ORYX, V34, P46, DOI 10.1046/j.1365-3008.2000.00093.x; Whyte I, 1998, ANIM CONSERV, V1, P77, DOI 10.1111/j.1469-1795.1998.tb00014.x; Whyte IJ, 1993, PACHYDERM, V16, P72; Wittemyer G, 2005, AFR J ECOL, V43, P44, DOI 10.1111/j.1365-2028.2004.00543.x; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Woodd A. M., 1999, Koedoe, V42, P97; Woolley LA, 2008, ORYX, V42, P49, DOI 10.1017/S0030605308000495; WU LSY, 1980, AM NAT, V116, P831, DOI 10.1086/283672	50	28	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3233	10.1371/journal.pone.0003233	http://dx.doi.org/10.1371/journal.pone.0003233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797503	gold, Green Published, Green Submitted			2022-12-25	WOS:000264428200008
J	Kamienkowski, JE; Sigman, M				Kamienkowski, Juan Esteban; Sigman, Mariano			Delays without Mistakes: Response Time and Error Distributions in Dual-Task	PLOS ONE			English	Article							CENTRAL BOTTLENECK; MENTAL PROCESSES; DIFFUSION-MODEL; NUMBER; INTERFERENCE; DISCRIMINATION; JUDGMENTS; REPRESENTATIONS; INFORMATION; NUMEROSITY	Background: When two tasks are presented within a short interval, a delay in the execution of the second task has been systematically observed. Psychological theorizing has argued that while sensory and motor operations can proceed in parallel, the coordination between these modules establishes a processing bottleneck. This model predicts that the timing but not the characteristics (duration, precision, variability.) of each processing stage are affected by interference. Thus, a critical test to this hypothesis is to explore whether the qualitiy of the decision is unaffected by a concurrent task. Methodology/Principal Findings: In number comparison-as in most decision comparison tasks with a scalar measure of the evidence-the extent to which two stimuli can be discriminated is determined by their ratio, referred as the Weber fraction. We investigated performance in a rapid succession of two non-symbolic comparison tasks (number comparison and tone discrimination) in which error rates in both tasks could be manipulated parametrically from chance to almost perfect. We observed that dual-task interference has a massive effect on RT but does not affect the error rates, or the distribution of errors as a function of the evidence. Conclusions/Significance: Our results imply that while the decision process itself is delayed during multiple task execution, its workings are unaffected by task interference, providing strong evidence in favor of a sequential model of task execution.	[Kamienkowski, Juan Esteban; Sigman, Mariano] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Phys, Integrat Neurosci Lab, Buenos Aires, DF, Argentina	University of Buenos Aires	Kamienkowski, JE (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Phys, Integrat Neurosci Lab, Buenos Aires, DF, Argentina.	juank@df.uba.ar		Kamienkowski, Juan Esteban/0000-0002-5725-6539	Human Frontiers Science Program (HFSP); SECYT [38636]; National Research Council of Argentina (CONICET) [fellowship]	Human Frontiers Science Program (HFSP)(Human Frontier Science Program); SECYT(Secretaria de Ciencia y Tecnologia (SECYT)); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	MS is funded by the Human Frontiers Science Program (HFSP) and by the SECYT, PICT 38636. JEK has a fellowship from the National Research Council of Argentina (CONICET).	Arnell KM, 2004, PSYCHON B REV, V11, P77, DOI 10.3758/BF03206464; Arnell KM, 2002, COGNITIVE PSYCHOL, V44, P105, DOI 10.1006/cogp.2001.0762; Barth H, 2006, COGNITION, V98, P199, DOI 10.1016/j.cognition.2004.09.011; Brisson B, 2007, NEUROPSYCHOLOGIA, V45, P3038, DOI 10.1016/j.neuropsychologia.2007.05.022; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; DEHAENE S, 2007, SENSORIMOTOR FDN HIG, V22; DEHAENE S, SYMBOLS QUA IN PRESS; Dell'Acqua R, 2005, EXP BRAIN RES, V165, P54, DOI 10.1007/s00221-005-2281-2; DUNCAN EM, 1980, MEM COGNITION, V8, P612, DOI 10.3758/BF03213781; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Green DM, 1966, SIGNAL DETECTION THE; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; INDOW T, 1977, PERCEPT PSYCHOPHYS, V22, P265, DOI 10.3758/BF03199689; Izard V, 2008, COGNITION, V106, P1221, DOI 10.1016/j.cognition.2007.06.004; Jolicoeur P, 2008, BRAIN RES, V1215, P160, DOI 10.1016/j.brainres.2008.03.059; Kahneman D., 1973, ATTENTION EFFORT; Kantowitz B.H., 1974, HUMAN INFORMATION PR, P41; KRUEGER LE, 1982, PERCEPT PSYCHOPHYS, V31, P175, DOI 10.3758/BF03206218; KRUEGER LE, 1984, PERCEPT PSYCHOPHYS, V35, P536, DOI 10.3758/BF03205949; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Luce R. D., 1986, RESPONSE TIMES; Luck SJ, 1998, PSYCHOL SCI, V9, P223, DOI 10.1111/1467-9280.00043; Macmillan N. A., 2005, DETECTION THEORY USE; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Pashler H, 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Ratcliff R, 2002, PSYCHON B REV, V9, P278, DOI 10.3758/BF03196283; RATCLIFF R, 1988, PSYCHOL REV, V95, P238, DOI 10.1037/0033-295X.95.2.238; Ruthruff E, 2001, PSYCHON B REV, V8, P73, DOI 10.3758/BF03196141; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schwarz W, 2001, BEHAV RES METH INS C, V33, P457, DOI 10.3758/BF03195403; SCHWEICKERT R, 1989, J MATH PSYCHOL, V33, P328, DOI 10.1016/0022-2496(89)90013-8; SCHWEICKERT R, 1980, SCIENCE, V209, P704, DOI 10.1126/science.7394529; Sessa P, 2007, BRAIN RES, V1137, P131, DOI 10.1016/j.brainres.2006.12.066; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; Sigman M, 2005, PLOS BIOL, V3, P334, DOI 10.1371/journal.pbio.0030037; Sigman M, 2008, J NEUROSCI, V28, P7585, DOI 10.1523/JNEUROSCI.0948-08.2008; Sigman M, 2006, PLOS BIOL, V4, P1227, DOI 10.1371/journal.pbio.0040220; SMITH MC, 1967, PSYCHOL BULL, V67, P202, DOI 10.1037/h0020419; Staffen W, 2002, BRAIN, V125, P1275, DOI 10.1093/brain/awf125; STEMBERG S, 1969, ATTENTION PERFORM, V2, P276; Telford CW, 1931, J EXP PSYCHOL, V14, P1, DOI 10.1037/h0073262; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Wagenmakers EJ, 2007, PSYCHOL REV, V114, P830, DOI 10.1037/0033-295X.114.3.830; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P3, DOI 10.3758/BF03194023	61	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3196	10.1371/journal.pone.0003196	http://dx.doi.org/10.1371/journal.pone.0003196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KI	18787706	Green Published, gold, Green Submitted			2022-12-25	WOS:000264426200002
J	Liu, WT; Li, HC; Song, XS; Huang, ZJ; Song, XJ				Liu, Wen-Tao; Li, Hao-Chuan; Song, Xue-Song; Huang, Zhi-Jiang; Song, Xue-Jun			EphB receptor signaling in mouse spinal cord contributes to physical dependence on morphine	FASEB JOURNAL			English	Article						opiate withdrawal; NR2B; ERK; CREB; c-Fos	D-ASPARTATE RECEPTOR; PROTEIN-KINASE-II; PERIPHERAL-NERVE INJURY; NEURAL CREST MIGRATION; DORSAL-ROOT GANGLION; GENE-RELATED PEPTIDE; SYNAPTIC PLASTICITY; NEUROPATHIC PAIN; PRECIPITATED WITHDRAWAL; CELLULAR MECHANISMS	Cellular and molecular mechanisms underlying opioid tolerance and dependence remain elusive. We investigated roles of EphB receptor tyrosine kinases which play important roles in synaptic connection and plasticity during development and in the matured nervous system-in development and maintenance of physical dependence on morphine in the mouse spinal cord (SC). Spinal administration of an EphB receptor blocking reagent EphB2-Fc prevents and/or suppresses behavioral responses to morphine withdrawal and associated induction of c-Fos and depletion of calcitonin gene-related peptide. Western blotting and immunohistochemical fluorescence staining demonstrates that EphB1 receptor protein is significantly up-regulated in the spinal dorsal horn following escalating morphine treatment. Chronic morphine exposure and withdrawal significantly increased phosphorylation of N-methyl-D-aspartate receptor subunit NR2B as well as the activated forms of extracellular signal-regulated kinase and the cAMP response element binding protein in SC. The increased levels of phosphorylation of these molecules, however, are significantly inhibited by the EphB receptor blocker. These findings indicate that EphB receptor signaling, probably by interacting with NR2B in SC, contributes to the development of opioid physical dependence and withdrawal effects. This novel role for EphB receptor signaling suggests that these molecules may be useful therapeutic targets for preventing, minimizing, or reversing the development of opiate dependence.-Liu,W.-T., Li, H.-C., Song, X.-S., Huang, Z.-J., Song, X.-J. EphB receptor signaling in mouse spinal cord contributes to physical dependence on morphine. FASEB J. 23, 90-98 (2009)	[Liu, Wen-Tao; Li, Hao-Chuan; Song, Xue-Song; Huang, Zhi-Jiang; Song, Xue-Jun] Parker Univ, Res Inst, Dept Neurobiol, Dallas, TX 75229 USA; [Song, Xue-Jun] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Song, Xue-Jun] Xuzhou Med Coll, Ctr Pain Res & Treatment, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Song, XJ (corresponding author), Parker Univ, Res Inst, Dept Neurobiol, 2500 Walnut Hill Lane, Dallas, TX 75229 USA.	song@parkercc.edu	HUANG, ZHI-JIANG/F-9443-2010		Parker Research Foundation [PCCRF-BSR0703, PCCRF-BSR0804]; National Natural Science Foundation of China [NSFC-30628027]	Parker Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr. Edgar T. Walters for his helpful comment on the manuscript, Dr. Ronald L. Rupert for his general support as Dean of Research, and Maria Dominguez for her assistance in laboratory management. Supported by grants from Parker Research Foundation (PCCRF-BSR0703 and PCCRF-BSR0804) and National Natural Science Foundation of China (NSFC-30628027).	Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; Bajo M, 2006, J NEUROSCI RES, V83, P532, DOI 10.1002/jnr.20756; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Battaglia AA, 2003, NAT NEUROSCI, V6, P339, DOI 10.1038/nn1034; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Cao JL, 2005, PAIN, V118, P336, DOI 10.1016/j.pain.2005.09.006; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Fan GH, 1999, MOL PHARMACOL, V56, P39, DOI 10.1124/mol.56.1.39; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hamdy MM, 2004, BEHAV BRAIN RES, V152, P263, DOI 10.1016/j.bbr.2003.10.014; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Inoue M, 2003, J NEUROSCI, V23, P6529; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; Jassen AK, 2006, MOL PHARMACOL, V70, P71, DOI 10.1124/mol.105.021998; Jhamandas KH, 1996, J NEUROSCI, V16, P2758; Kerr BJ, 2000, EUR J NEUROSCI, V12, P793, DOI 10.1046/j.1460-9568.2000.00967.x; King M, 2001, NAT NEUROSCI, V4, P268, DOI 10.1038/85115; Kobayashi H, 2007, SPINE, V32, P1592, DOI 10.1097/BRS.0b013e318074d46a; KOLESNIKOV YA, 1993, P NATL ACAD SCI USA, V90, P5162, DOI 10.1073/pnas.90.11.5162; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Liang D, 2004, NEUROSCIENCE, V123, P769, DOI 10.1016/j.neuroscience.2003.10.007; Lu L, 2000, NEUROSCI LETT, V291, P191, DOI 10.1016/S0304-3940(00)01352-5; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; Mao JR, 2002, J NEUROSCI, V22, P8312; Mao JR, 1999, BRAIN RES REV, V30, P289, DOI 10.1016/S0165-0173(99)00020-X; Mao JR, 2001, ANN NY ACAD SCI, V933, P175; MARSHALL DC, 1985, EXPERIENTIA, V41, P1151, DOI 10.1007/BF01951703; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Muscoli C, 2007, J CLIN INVEST, V117, P3530, DOI 10.1172/JCI32420; Nagy GG, 2004, EUR J NEUROSCI, V20, P3301, DOI 10.1111/j.1460-9568.2004.03798.x; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Noda Y, 2004, EUR J PHARMACOL, V500, P121, DOI 10.1016/j.ejphar.2004.07.017; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasternak GW, 2007, J CLIN INVEST, V117, P3185, DOI 10.1172/JCI34035; PASTERNAK GW, 2005, CONT CLIN NEUROSCIEN, P409; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Ren X, 2004, BEHAV BRAIN RES, V152, P243, DOI 10.1016/j.bbr.2003.10.013; Rohde DS, 1998, J NEUROSCI, V18, P4393; Rohde DS, 1997, BRAIN RES, V745, P83, DOI 10.1016/S0006-8993(96)01132-8; Rohde DS, 1996, NEUROSCIENCE, V72, P233, DOI 10.1016/0306-4522(95)00529-3; Shaw-Lutchman TZ, 2002, J NEUROSCI, V22, P3663; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Song XJ, 2008, PAIN, V139, P168, DOI 10.1016/j.pain.2008.03.019; Song XJ, 2008, EUR J PAIN, V12, P1031, DOI 10.1016/j.ejpain.2008.01.011; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Trang T, 2003, BRIT J PHARMACOL, V140, P295, DOI 10.1038/sj.bjp.0705440; Trang T, 2006, PAIN, V126, P256, DOI 10.1016/j.pain.2006.07.008; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; WATSON A, 1995, J BIOL CHEM, V270, P9655, DOI 10.1074/jbc.270.16.9655; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhu HB, 2001, SYNAPSE, V40, P282, DOI 10.1002/syn.1051	65	28	33	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					90	98		10.1096/fj.08-114462	http://dx.doi.org/10.1096/fj.08-114462			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18772347				2022-12-25	WOS:000262095500011
J	Trajkovski, M; Mziaut, H; Schubert, S; Kalaidzidis, Y; Altkruerger, A; Solimena, M				Trajkovski, Mirko; Mziaut, Hassan; Schubert, Sandra; Kalaidzidis, Yannis; Altkruerger, Anke; Solimena, Michele			Regulation of Insulin Granule Turnover in Pancreatic beta-Cells by Cleaved ICA512	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; AUTOANTIGENS IA-2; IN-VIVO; GLUCOSE; EXOCYTOSIS; SECRETION; DYNAMICS; MEMBRANE; BINDING; PHOGRIN	Insulin maintains homeostasis of glucose by promoting its uptake into cells from the blood. Hyperglycemia triggers secretion of insulin from pancreatic beta-cells. This process is mediated by secretory granule exocytosis. However, how beta-cells keep granule stores relatively constant is still unknown. ICA512 is an intrinsic granule membrane protein, whose cytosolic domain binds beta 2-syntrophin, an F-actin-associated protein, and is cleaved upon granule exocytosis. The resulting cleaved cytosolic fragment, ICA512-CCF, reaches the nucleus and up-regulates the transcription of granule genes, including insulin and ICA512. Here, we show that ICA512-CCF also dimerizes with intact ICA512 on granules, thereby displacing it from beta 2-syntrophin. This leads to increased granule mobility and insulin release. Based on these findings, we propose a model whereby the generation of ICA512-CCF first amplifies insulin secretion. The ensuing reduction of granule stores would then increase the probability of newly generated ICA512-CCF to reach the nucleus and enhance granule biogenesis, thus allowing beta-cells to constantly adjust production of granules to their storage size and consumption. Pharmacological modulation of these feedback loops may alleviate deficient insulin release in diabetes.	[Trajkovski, Mirko; Mziaut, Hassan; Schubert, Sandra; Altkruerger, Anke; Solimena, Michele] Tech Univ Dresden, Lab Expt Diabetol, Sch Med, D-01307 Dresden, Germany; [Solimena, Michele] Tech Univ Dresden, Dept Med 3, Sch Med, D-01307 Dresden, Germany; [Solimena, Michele] Tech Univ Dresden, Ctr Regenerat Therapy Dresden, Sch Med, D-01307 Dresden, Germany; [Kalaidzidis, Yannis; Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society; Lomonosov Moscow State University	Solimena, M (corresponding author), Fetscherstr 74, D-01307 Dresden, Germany.	michele.solimena@tu-dresden.de	Solimena, Michele/E-1275-2011; Solimena, Michele/GVS-5990-2022; Kalaidzidis, Yannis/H-3094-2016	Kalaidzidis, Yannis/0000-0002-6137-1193; Trajkovski, Mirko/0000-0002-3152-9551	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung [NBL3]; European Foundation for the Study of Diabetes; Juvenile Diabetes Research Foundation; Max Planck Society; TU Dresden	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Foundation for the Study of Diabetes; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX); TU Dresden(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft SFB655 (Sonderforschungsbereich), Bundesministerium fur Bildung und Forschung Grant NBL3, the European Foundation for the Study of Diabetes, the Juvenile Diabetes Research Foundation, and the Max Planck Society (to M. S.) and a MeDDrive Grant from TU Dresden (to M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Bruun TZ, 2000, EUR J PHARMACOL, V403, P221, DOI 10.1016/S0014-2999(00)00602-6; Cai T, 2004, J NEUROSCI, V24, P3115, DOI 10.1523/JNEUROSCI.0101-04.2004; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cheviet S, 2004, TRENDS CELL BIOL, V14, P525, DOI 10.1016/j.tcb.2004.08.001; Chin CN, 2005, FEBS LETT, V579, P3855, DOI 10.1016/j.febslet.2005.05.071; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Drake PG, 2003, BIOCHEM J, V373, P393, DOI 10.1042/BJ20021851; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Harashima S, 2005, P NATL ACAD SCI USA, V102, P8704, DOI 10.1073/pnas.0408887102; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hermel JM, 1999, EUR J NEUROSCI, V11, P2609, DOI 10.1046/j.1460-9568.1999.00677.x; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kim SJ, 2007, DIABETES, V56, P41, DOI 10.2337/db06-0237; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Magistrelli G, 1996, BIOCHEM BIOPH RES CO, V227, P581, DOI 10.1006/bbrc.1996.1549; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Ort T, 2000, EUR J CELL BIOL, V79, P621, DOI 10.1078/0171-9335-00095; Pouli AE, 1998, BIOCHEM J, V333, P193, DOI 10.1042/bj3330193; RABIN DU, 1994, J IMMUNOL, V152, P3183; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Shibasaki T, 2005, METHOD ENZYMOL, V403, P408, DOI 10.1016/S0076-6879(05)03036-3; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Solimena M, 2003, TRENDS CELL BIOL, V13, P399, DOI 10.1016/S0962-8924(03)00150-8; STEINER DF, 2001, HDB PHYSL ENDOCRINE, V2, P49; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Varadi A, 2002, J CELL SCI, V115, P4177, DOI 10.1242/jcs.00083; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Zahn TR, 2001, J COMP NEUROL, V429, P127, DOI 10.1002/1096-9861(20000101)429:1&lt;127::AID-CNE10&gt;3.0.CO;2-H; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	56	29	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33719	33729		10.1074/jbc.M804928200	http://dx.doi.org/10.1074/jbc.M804928200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824546	Green Published, hybrid			2022-12-25	WOS:000261183700078
J	Bruzzone, S; Bodrato, N; Usai, C; Guida, L; Moreschi, I; Nano, R; Antonioli, B; Fruscione, F; Magnone, M; Scarfi, S; De Flora, A; Zocchi, E				Bruzzone, Santina; Bodrato, Nicoletta; Usai, Cesare; Guida, Lucrezia; Moreschi, Iliana; Nano, Rita; Antonioli, Barbara; Fruscione, Floriana; Magnone, Mirko; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena			Abscisic Acid Is an Endogenous Stimulator of Insulin Release from Human Pancreatic Islets with Cyclic ADP Ribose as Second Messenger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SIGNALING CASCADE; BETA-CELLS; HUMAN GRANULOCYTES; CADP-RIBOSE; IN-VITRO; INFLAMMATION; RESISTANCE; SECRETION; HYPERGLYCEMIA; OBESITY	Abscisic acid (ABA) is a plant stress hormone recently identified as an endogenous pro-inflammatory cytokine in human granulocytes. Because paracrine signaling between pancreatic beta cells and inflammatory cells is increasingly recognized as a pathogenetic mechanism in the metabolic syndrome and type II diabetes, we investigated the effect of ABA on insulin secretion. Nanomolar ABA increases glucose-stimulated insulin secretion from RIN-m and INS-1 cells and from murine and human pancreatic islets. The signaling cascade triggered by ABA in insulin-releasing cells sequentially involves a pertussis toxin-sensitive G protein, cAMP overproduction, protein kinase A-mediated activation of the ADP-ribosyl cyclase CD38, and cyclic ADP-ribose overproduction. ABA is rapidly produced and released from human islets, RIN-m, and INS-1 cells stimulated with high glucose concentrations. In conclusion, ABA is an endogenous stimulator of insulin secretion in human and murine pancreatic beta cells. Autocrine release of ABA by glucose-stimulated pancreatic beta cells, and the paracrine production of the hormone by activated granulocytes and monocytes suggest that ABA may be involved in the physiology of insulin release as well as in its dysregulation under conditions of inflammation.	[Bruzzone, Santina; Bodrato, Nicoletta; Guida, Lucrezia; Moreschi, Iliana; Fruscione, Floriana; Magnone, Mirko; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Bruzzone, Santina; Bodrato, Nicoletta; Guida, Lucrezia; Moreschi, Iliana; Fruscione, Floriana; Magnone, Mirko; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Bruzzone, Santina; Guida, Lucrezia; Fruscione, Floriana; Magnone, Mirko; Scarfi, Sonia; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Usai, Cesare] CNR, Inst Biophys, I-16149 Genoa, Italy; [Nano, Rita; Antonioli, Barbara] Ist Sci San Raffaele, Islet Proc Facil, I-20132 Milan, Italy	University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Zocchi, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto XV 1, I-16132 Genoa, Italy.	ezocchi@unige.it	Bruzzone, Santina/A-4264-2015; Scarfi, Sonia/AAJ-2387-2020; fruscione, floriana/AAA-8747-2020; Nano, Rita/AAC-1934-2019	Bruzzone, Santina/0000-0003-2034-3716; Scarfi, Sonia/0000-0002-7079-6919; Nano, Rita/0000-0003-4520-8481; Usai, Cesare/0000-0001-8863-7759; fruscione, floriana/0000-0002-4054-645X	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Education, University and Scientific Research [MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, MIUR FIRB RBIP06LSS2]; University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia	This work was supported in part by grants from Regione Liguria, from the Associazione Italiana per la Ricerca sul Cancro, from the Italian Ministry of Education, University and Scientific Research Grants MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, and MIUR FIRB RBIP06LSS2, and the University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bacova Z, 2005, CELL PHYSIOL BIOCHEM, V16, P59, DOI 10.1159/000087732; Boittin FX, 2003, J BIOL CHEM, V278, P9602, DOI 10.1074/jbc.M204891200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2006, BIOCHEM J, V393, P697, DOI 10.1042/BJ20051302; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dandona P, 2007, CURR OPIN CLIN NUTR, V10, P511, DOI 10.1097/MCO.0b013e3281e38774; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; DeFlora A, 1996, BIOCHEM J, V320, P665, DOI 10.1042/bj3200665; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Furman B, 2006, CURR OPIN INVEST DR, V7, P898; Gearhart MM, 2006, AACN ADV CRIT CARE, V17, P50, DOI 10.1097/00044067-200601000-00007; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Grill E, 1998, CURR OPIN PLANT BIOL, V1, P412, DOI 10.1016/S1369-5266(98)80265-3; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; LEE HC, 2002, CYCLIC ADP RIBOSE NA, P1; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Melzi R, 2007, TRANSPLANTATION, V83, P167, DOI 10.1097/01.tp.0000250659.24286.43; Miguel JC, 2003, BIOCHEM PHARMACOL, V65, P283, DOI 10.1016/S0006-2952(02)01482-X; Morita K, 1997, J BIOL CHEM, V272, P21002, DOI 10.1074/jbc.272.34.21002; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; SCHUBART UK, 1977, J BIOL CHEM, V252, P92; SHARP GWG, 1979, DIABETOLOGIA, V16, P287, DOI 10.1007/BF01223617; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Verderio C, 2001, J NEUROCHEM, V78, P646, DOI 10.1046/j.1471-4159.2001.00455.x; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114; Zocchi E, 2003, J CELL SCI, V116, P629, DOI 10.1242/jcs.00277; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698; ZOCCHI E, 2006, FLURIDONE ANTIN 1006	42	107	114	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32188	32197		10.1074/jbc.M802603200	http://dx.doi.org/10.1074/jbc.M802603200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18784081	hybrid, Green Published			2022-12-25	WOS:000260893700005
J	Purushothaman, A; Chen, LG; Yang, Y; Sanderson, RD				Purushothaman, Anurag; Chen, Ligong; Yang, Yang; Sanderson, Ralph D.			Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; HEPATOCYTE GROWTH-FACTOR; BREAST-CANCER CELLS; MULTIPLE SIGNALING PATHWAYS; MARROW ENDOTHELIAL-CELLS; UP-REGULATION; MATRIX METALLOPROTEINASES; MAMMALIAN HEPARANASE; MATRIX-METALLOPROTEINASE-9 MMP-9; SULFATE PROTEOGLYCANS	High levels of heparanase are an indicator of poor prognosis in myeloma patients, and up-regulation of the enzyme enhances tumor growth, angiogenesis, and metastasis in animal models. At least part of the impact of heparanase in driving the aggressive tumor phenotype is due to its effect on increasing the expression and shedding of the heparan sulfate proteoglycan syndecan-1, a molecule known to promote myeloma progression. The present work demonstrated that elevation in heparanase expression in myeloma cells stimulates sustained ERK phosphorylation that in turn drives MMP-9 expression. In addition, urokinase-type plasminogen activator (uPA) and uPA receptor expression levels increased, and blocking the proteolytic activation of either MMP-9 or uPA inhibited the heparanase-induced increase in syndecan-1 shedding. Together these data provide a mechanism for heparanase-induced syndecan-1 shedding and, more importantly, demonstrate that heparanase activity in myeloma cells can lead to increased levels of proteases that are known to play important roles in the aggressive behavior of myeloma tumors. This in addition to its other known biological roles, indicates that heparanase acts as a master regulator of the aggressive tumor phenotype by up-regulating protease expression and activity within the tumor microenvironment.	[Purushothaman, Anurag; Chen, Ligong; Yang, Yang; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Ctr Metab Bone Dis, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Chen, Ligong; Yang, Yang; Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Sanderson, Ralph D.] Vet Adm Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, Ctr Metab Bone Dis, 814 SHEL,1530 3rd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu			National Institutes of Health [CA103054, CA055819, CA013148]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P01CA055819, P30CA013148, R01CA103054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103054, CA055819, and CA013148 ( to R. D. S.). This work was also supported by a VISN7 Research Career Development Award from the Department of Veterans Affairs ( to R. D. S.).	Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Barlogie B, 2006, WILLIAMS HEMATOLOGY, P1501; Bartlett AH, 2007, MOL CELLS, V24, P153; Bendre MS, 2002, CANCER RES, V62, P5571; Borset M, 2000, BLOOD, V96, P2528; Breitkreutz I, 2007, BRIT J HAEMATOL, V139, P55, DOI 10.1111/j.1365-2141.2007.06747.x; Broek IV, 2004, LEUKEMIA, V18, P976, DOI 10.1038/sj.leu.2403331; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Cortes-Reynosa P, 2008, MATRIX BIOL, V27, P220, DOI 10.1016/j.matbio.2007.11.003; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Dhodapkar MV, 1997, BRIT J HAEMATOL, V99, P368, DOI 10.1046/j.1365-2141.1997.3893203.x; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Hecht M, 2008, EXP CELL RES, V314, P1082, DOI 10.1016/j.yexcr.2007.10.021; Hecht M, 2007, BRIT J HAEMATOL, V138, P446, DOI 10.1111/j.1365-2141.2007.06665.x; Hideshima T, 2003, BLOOD, V101, P703, DOI 10.1182/blood-2002-06-1874; Hjertner O, 2000, BRIT J HAEMATOL, V109, P815, DOI 10.1046/j.1365-2141.2000.02089.x; Holt RU, 2008, HAEMATOLOGICA, V93, P619, DOI 10.3324/haematol.11867; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Joyce JA, 2005, ONCOGENE, V24, P4037, DOI 10.1038/sj.onc.1208602; Kelly T, 2003, CANCER RES, V63, P8749; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Koliopanos A, 2001, CANCER RES, V61, P4655; Kunigal S, 2007, INT J CANCER, V121, P2307, DOI 10.1002/ijc.22962; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Menu E, 2004, BLOOD CELL MOL DIS, V33, P111, DOI 10.1016/j.bcmd.2004.04.012; Miao HQ, 2002, PROTEIN EXPRES PURIF, V26, P425, DOI 10.1016/S1046-5928(02)00558-2; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Parmo-Cabanas M, 2006, J PATHOL, V208, P108, DOI 10.1002/path.1876; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Reiland J, 2006, NEOPLASIA, V8, P596, DOI 10.1593/neo.06244; RIDLEY RC, 1993, BLOOD, V81, P767; Rigolin GM, 2003, BRIT J HAEMATOL, V120, P953, DOI 10.1046/j.1365-2141.2003.04176.x; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Seidel C, 2000, BLOOD, V95, P388, DOI 10.1182/blood.V95.2.388; Sfiridaki A, 2005, CLIN CHEM LAB MED, V43, P934, DOI 10.1515/CCLM.2005.160; Uno F, 2001, CANCER RES, V61, P7855; Van Valckenborgh E, 2004, AM J PATHOL, V165, P869, DOI 10.1016/S0002-9440(10)63349-4; Van Valckenborgh E, 2002, INT J CANCER, V101, P512, DOI 10.1002/ijc.10642; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yao J, 2001, ONCOGENE, V20, P8066, DOI 10.1038/sj.onc.1204944; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811	65	160	166	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32628	32636		10.1074/jbc.M806266200	http://dx.doi.org/10.1074/jbc.M806266200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18812315	hybrid, Green Published			2022-12-25	WOS:000260893700052
J	Putz, U; Howitt, J; Lackovic, J; Foot, N; Kumar, S; Silke, J; Tan, SS				Putz, Ulrich; Howitt, Jason; Lackovic, Jenny; Foot, Natalie; Kumar, Sharad; Silke, John; Tan, Seong-Seng			Nedd4 Family-interacting Protein 1 (Ndfip1) Is Required for the Exosomal Secretion of Nedd4 Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL DIVERSITY; MULTIVESICULAR BODY; UBIQUITIN LIGASES; MEMBRANE-PROTEIN; WW DOMAINS; IDENTIFICATION; VESICLE; TRAFFICKING; SURVIVAL; CHANNELS	The ability to remove unwanted proteins is an important cellular feature. Classically, this involves the enzymatic addition of ubiquitin moieties followed by degradation in the proteasome. Nedd4 proteins are ubiquitin ligases important not only for protein degradation, but also for protein trafficking. Nedd4 proteins can bind to target proteins either by themselves or through adaptor protein Ndfip1 (Nedd4 family-interacting protein 1). An alternative mechanism for protein removal and trafficking is provided by exosomes, which are small vesicles (50-90-nm diameter) originating from late endosomes and multivesicular bodies (MVBs). Exosomes provide a rapid means of shedding obsolete proteins and also for cell to cell communication. In the present work, we show that Ndfip1 is detectable in exosomes secreted from transfected cells and also from primary neurons. Compared with control, Ndfip1 increases exosome secretion from transfected cells. Furthermore, while Nedd4, Nedd4-2, and Itch are normally absent from exosomes, expression of Ndfip1 results in recruitment of all three Nedd4 proteins into exosomes. Together, these results suggest that Ndfip1 is important for protein trafficking via exosomes, and provides a mechanism for cargoing passenger proteins such as Nedd4 family proteins. Given the positive roles of Ndfip1/Nedd4 in improving neuronal survival during brain injury, it is possible that exosome secretion provides a novel route for rapid sequestration and removal of proteins during stress.	[Putz, Ulrich; Howitt, Jason; Lackovic, Jenny; Tan, Seong-Seng] Univ Melbourne, Howard Florey Inst, Brain Dev Lab, Parkville, Vic 3010, Australia; [Putz, Ulrich; Howitt, Jason; Lackovic, Jenny; Tan, Seong-Seng] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Foot, Natalie; Kumar, Sharad] IMVS, Hanson Ctr, Mol Regulat Lab, Adelaide, SA 5000, Australia; [Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Institute Medical & Veterinary Science Australia; La Trobe University	Tan, SS (corresponding author), Univ Melbourne, Howard Florey Inst, Brain Dev Lab, Parkville, Vic 3010, Australia.	stan@florey.edu.au	Kumar, Sharad/AAX-7787-2020; Foot, Natalie/AAC-4238-2022; Silke, John/B-7622-2008; Foot, Natalie/AAK-8965-2020	Kumar, Sharad/0000-0001-7126-9814; Silke, John/0000-0002-7611-5774; Foot, Natalie/0000-0002-6567-9283; Howitt, Jason/0000-0001-9922-7931	Victorian Neurotrauma Initiative of the TAC; National Health and Medical Research Council (NH and MRC)	Victorian Neurotrauma Initiative of the TAC; National Health and Medical Research Council (NH and MRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants under the Victorian Neurotrauma Initiative of the TAC and the National Health and Medical Research Council (NH and MRC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Buschow SI, 2005, BLOOD CELL MOL DIS, V35, P398, DOI 10.1016/j.bcmd.2005.08.005; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; Denzer K, 2000, J CELL SCI, V113, P3365; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ikeda M, 2007, VIROLOGY, V360, P461, DOI 10.1016/j.virol.2006.10.046; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Putz U, 2005, NAT NEUROSCI, V8, P322, DOI 10.1038/nn1407; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x	36	111	120	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32621	32627		10.1074/jbc.M804120200	http://dx.doi.org/10.1074/jbc.M804120200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819914	hybrid			2022-12-25	WOS:000260893700051
J	Valdramidou, D; Humphries, MJ; Mould, AP				Valdramidou, Dimitra; Humphries, Martin J.; Mould, A. Paul			Distinct Roles of beta 1 Metal Ion-dependent Adhesion Site (MIDAS), Adjacent to MIDAS (ADMIDAS), and Ligand-associated Metal-binding Site (LIMBS) Cation-binding Sites in Ligand Recognition by Integrin alpha 2 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL REGION; I-LIKE DOMAIN; A-DOMAIN; STRUCTURAL BASIS; EXTRACELLULAR SEGMENT; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; PROPELLER DOMAIN; HYBRID DOMAIN; OUTSIDE-IN	Integrin-ligand interactions are regulated in a complex manner by divalent cations, and previous studies have identified ligand-competent, stimulatory, and inhibitory cation-binding sites. In collagen-binding integrins, such as alpha 2 beta 1, ligand recognition takes place exclusively at the alpha subunit I domain. However, activation of the alpha I domain depends on its interaction with a structurally similar domain in the beta subunit known as the I-like or beta I domain. The top face of the beta I domain contains three cation-binding sites: the metal-ion dependent adhesion site (MIDAS), the ADMIDAS (adjacent to MIDAS), and LIMBS (ligand-associated metal-binding site). The role of these sites in controlling ligand binding to the alpha I domain has yet to be elucidated. Mutation of the MIDAS or LIMBS completely blocked collagen binding to alpha 2 beta 1; in contrast mutation of the ADMIDAS reduced ligand recognition but this effect could be overcome by the activating monoclonal antibody TS2/16. Hence, the MIDAS and LIMBS appear to be essential for the interaction between alpha I and beta I, whereas occupancy of the ADMIDAS has an allosteric effect on the conformation of beta I. An activating mutation in the alpha 2 I domain partially restored ligand binding to the MIDAS and LIMBS mutants. Analysis of the effects of Ca2+, Mg2+, and Mn2+ on ligand binding to these mutants showed that the MIDAS is a ligand-competent site through which Mn2+ stimulates ligand binding, whereas the LIMBS is a stimulatory Ca2+-binding site, occupancy of which increases the affinity of Mg2+ for the MIDAS.	[Valdramidou, Dimitra; Humphries, Martin J.; Mould, A. Paul] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Mould, AP (corresponding author), Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	paul.mould@manchester.ac.uk		Humphries, Martin/0000-0002-4331-6967; Mould, Paul/0000-0003-0076-6228	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Wellcome Trust (to M.J.H.).	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Baker EK, 1997, P NATL ACAD SCI USA, V94, P1973, DOI 10.1073/pnas.94.5.1973; Barton SJ, 2004, BIOCHEM J, V380, P401, DOI 10.1042/BJ20031973; Burrows L, 1999, BIOCHEM J, V344, P527, DOI 10.1042/0264-6021:3440527; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Choi S, 2007, J MED CHEM, V50, P5457, DOI 10.1021/jm070252b; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Goodman TG, 1996, J BIOL CHEM, V271, P23729, DOI 10.1074/jbc.271.39.23729; GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644; GRZESIAK JJ, 1992, J CELL BIOL, V117, P1109, DOI 10.1083/jcb.117.5.1109; Grzesiak JJ, 2008, INT J CANCER, V122, P2199, DOI 10.1002/ijc.23368; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kapyla J, 2007, J MED CHEM, V50, P2742, DOI 10.1021/jm070063t; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lu CF, 1998, J BIOL CHEM, V273, P15138, DOI 10.1074/jbc.273.24.15138; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Murcia M, 2008, PROTEINS, V71, P1779, DOI 10.1002/prot.21859; Oxvig C, 1998, P NATL ACAD SCI USA, V95, P4870, DOI 10.1073/pnas.95.9.4870; Park EJ, 2007, J CLIN INVEST, V117, P2526, DOI 10.1172/JCI31570; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Tuckwell DS, 2000, BIOCHEM J, V350, P485, DOI 10.1042/0264-6021:3500485; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamanouchi J, 2002, THROMB HAEMOSTASIS, V87, P756, DOI 10.1055/s-0037-1613076; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101	48	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32704	32714		10.1074/jbc.M802066200	http://dx.doi.org/10.1074/jbc.M802066200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18820259	Green Accepted, hybrid			2022-12-25	WOS:000260893700060
J	Ge, M; Xia, XY; Pan, XM				Ge, Meng; Xia, Xia-Yu; Pan, Xian-Ming			Salt Bridges in the Hyperthermophilic Protein Ssh10b Are Resilient to Temperature Increases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE ELECTROSTATIC INTERACTIONS; DNA-BINDING PROTEIN; GLUTAMATE-DEHYDROGENASE; PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; SIDE-CHAIN; KEY ROLE; STABILITY; THERMOSTABILITY; MUTANT	A double mutant cycle (DMC) approach was employed to estimate the effect of temperature on the contribution of two highly conserved salt bridges to protein stability in the hyperthermophilic protein Ssh10b. The coupling free energy were 2.4 +/- 0.4 kJ/mol at 298 K and 2.2 +/- 0.4 kJ/mol at 353 K for Glu-54/Arg-57, and 6.0 +/- 0.2 kJ/mol at 298 K and 5.9 +/- 0.6 kJ/mol at 353 K for Glu-36/Lys-68. The stability free energy of Ssh10b decrease greatly with increasing temperature, while the direct contribution of these two salt bridges to protein stability remain almost constant, providing evidence supporting the theoretical prediction that salt bridges are extremely resilient to temperature increases and thus are specially suited to improving protein stability at high temperatures. The reason for the difference in coupling free energy between salt bridges Glu-54/Arg-57 and Glu-36/Lys-68 is discussed. Comparing our results with published DMC data for the contribution of salt bridges to stability in other proteins, we found that the energy contribution of a salt bridge formed by two charged residues far apart in the primary sequence is higher than that of those formed between two very close ones. Implications of this finding are useful for engineering proteins with enhanced thermostability.	[Ge, Meng; Xia, Xia-Yu; Pan, Xian-Ming] Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China	Tsinghua University	Pan, XM (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China.	pan-xm@mail.tsinghua.edu.cn			Natural Science Foundation of China [30230100, 30670420]; Program for Changjiang Scholars and Innovative Research Team in University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported in part by grants from the Natural Science Foundation of China (No. 30230100 and No. 30670420) and the Program for Changjiang Scholars and Innovative Research Team in University.	ADAMS MWW, 1993, ANNU REV MICROBIOL, V47, P627, DOI 10.1146/annurev.micro.47.1.627; AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Barril X, 1998, PROTEINS, V32, P67, DOI 10.1002/(SICI)1097-0134(19980701)32:1<67::AID-PROT8>3.0.CO;2-B; Blasie CA, 1997, BIOCHEMISTRY-US, V36, P6218, DOI 10.1021/bi962805i; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; BRITTON KL, 1995, EUR J BIOCHEM, V229, P688, DOI 10.1111/j.1432-1033.1995.tb20515.x; CHEN BL, 1989, BIOCHEMISTRY-US, V28, P685, DOI 10.1021/bi00428a041; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Freire E, 1995, METHOD ENZYMOL, V259, P144; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Ibarra-Molero B, 2004, J MOL BIOL, V336, P989, DOI 10.1016/j.jmb.2003.12.069; Jaenicke R, 1996, ADV PROTEIN CHEM, V48, P181; Kamal JKA, 2002, J BIOL CHEM, V277, P40717, DOI 10.1074/jbc.M208129200; Kawamura S, 1997, J BIOCHEM-TOKYO, V121, P448; KORNDORFER I, 1995, J MOL BIOL, V246, P511, DOI 10.1006/jmbi.1994.0103; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Ladenstein R, 1998, Adv Biochem Eng Biotechnol, V61, P37; Lassila KS, 2002, PROTEIN SCI, V11, P688, DOI 10.1110/ps.23502; Lebbink JHG, 2002, BIOCHEMISTRY-US, V41, P15524, DOI 10.1021/bi020461s; Lounnas V, 1997, BIOCHEMISTRY-US, V36, P5402, DOI 10.1021/bi9622940; Luisi DL, 2003, BIOCHEMISTRY-US, V42, P7050, DOI 10.1021/bi027202n; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; Mao Yong-Jin, 2007, BMC Biochemistry, V8, P28, DOI 10.1186/1471-2091-8-28; MARQUSEE S, 1994, PROTEIN SCI, V3, P2217, DOI 10.1002/pro.5560031207; Marti DN, 2003, J MOL BIOL, V330, P621, DOI 10.1016/S0022-2836(03)00623-5; Merkel JS, 1999, STRUCT FOLD DES, V7, P1333, DOI 10.1016/S0969-2126(00)80023-4; NICHOLSON H, 1991, BIOCHEMISTRY-US, V30, P9816, DOI 10.1021/bi00105a002; NOJIMA H, 1977, J MOL BIOL, V116, P429, DOI 10.1016/0022-2836(77)90078-X; NOJIMA H, 1978, BIOCH THERMOPHILY, P305; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; SALI D, 1991, J MOL BIOL, V220, P779, DOI 10.1016/0022-2836(91)90117-O; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; SCHUMANN J, 1993, PROTEIN SCI, V2, P1612, DOI 10.1002/pro.5560021007; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; SPASSOV VZ, 1995, PROTEIN SCI, V4, P1516, DOI 10.1002/pro.5560040809; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Thomas AS, 2004, J AM CHEM SOC, V126, P2208, DOI 10.1021/ja039159c; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Vaughan CK, 2002, ACTA CRYSTALLOGR D, V58, P591, DOI 10.1107/S0907444902001567; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vieille C, 1996, TRENDS BIOTECHNOL, V14, P183, DOI 10.1016/0167-7799(96)10026-3; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Xu S, 2004, BIOCHEM J, V382, P433, DOI 10.1042/BJ20040191; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9	56	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31690	31696		10.1074/jbc.M805750200	http://dx.doi.org/10.1074/jbc.M805750200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779322	hybrid			2022-12-25	WOS:000260760800051
J	Sela, D; Yaffe, N; Shlomai, J				Sela, Dotan; Yaffe, Nurit; Shlomai, Joseph			Enzymatic Mechanism Controls Redox-mediated Protein-DNA Interactions at the Replication Origin of Kinetoplast DNA Minicircles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; OF-CELLULAR-FUNCTIONS; ZINC-FINGER PROTEIN; UNIVERSAL MINICIRCLE; CRITHIDIA-FASCICULATA; OXIDATIVE STRESS; HYDROPEROXIDE METABOLISM; GLUTATHIONE-REDUCTASE; MITOCHONDRIAL GENOME; TRYPANOSOMA-BRUCEI	Kinetoplast DNA (kDNA) is the mitochondrial DNA of trypanosomatids. Its major components are several thousand topologically interlocked DNA minicircles. Their replication origins are recognized by universal minicircle sequence-binding protein (UMSBP), a CCHC-type zinc finger protein, which has been implicated with minicircle replication initiation and kDNA segregation. Interactions of UMSBP with origin sequences in vitro have been found to be affected by the protein's redox state. Reduction of UMSBP activates its binding to the origin, whereas UMSBP oxidation impairs this activity. The role of redox in the regulation of UMSBP in vivo was studied here in synchronized cell cultures, monitoring both UMSBP origin binding activity and its redox state, throughout the trypanosomatid cell cycle. These studies indicated that UMSBP activity is regulated in vivo through the cell cycle dependent control of the protein's redox state. The hypothesis that UMSBP's redox state is controlled by an enzymatic mechanism, which mediates its direct reduction and oxidation, was challenged in a multienzyme reaction, reconstituted with pure enzymes of the trypanosomal major redox-regulating pathway. Coupling in vitro of this reaction with a UMSBP origin-binding reaction revealed the regulation of UMSBP activity through the opposing effects of tryparedoxin and tryparedoxin peroxidase. In the course of this reaction, tryparedoxin peroxidase directly oxidizes UMSBP, revealing a novel regulatory mechanism for the activation of an origin-binding protein, based on enzyme-mediated reversible modulation of the protein's redox state. This mode of regulation may represent a regulatory mechanism, functioning as an enzyme-mediated, redox-based biological switch.	[Sela, Dotan; Yaffe, Nurit; Shlomai, Joseph] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Parasitol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Shlomai, J (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Parasitol, IL-91120 Jerusalem, Israel.	josephs@ekmd.huji.ac.il			United States-Israel Binational Science Foundation (Jerusalem, Israel) [2005023]; Israel Science Foundation [54/06]	United States-Israel Binational Science Foundation (Jerusalem, Israel)(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This study was supported, in part, by United States-Israel Binational Science Foundation (Jerusalem, Israel) Grant 2005023 and by Israel Science Foundation Grant 54/06. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABELIOVICH H, 1993, MOL CELL BIOL, V13, P7766, DOI 10.1128/MCB.13.12.7766; Abu-Elneel K, 1999, J BIOL CHEM, V274, P13419, DOI 10.1074/jbc.274.19.13419; Abu-Elneel K, 2001, J CELL BIOL, V153, P725, DOI 10.1083/jcb.153.4.725; Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; AVRAHAMI D, 1995, P NATL ACAD SCI USA, V92, P10511, DOI 10.1073/pnas.92.23.10511; Baldwin MA, 2002, METHOD ENZYMOL, V353, P54; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Budde H, 2003, BIOFACTORS, V17, P83, DOI 10.1002/biof.5520170109; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; FAIRLAMB AH, 1985, MOL BIOCHEM PARASIT, V14, P187, DOI 10.1016/0166-6851(85)90037-4; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Hainaut P, 2001, ANTIOXID REDOX SIGN, V3, P611, DOI 10.1089/15230860152542961; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lunec J, 2003, BIOFACTORS, V17, P315, DOI 10.1002/biof.5520170131; Makmura L, 2001, ANTIOXID REDOX SIGN, V3, P1105, DOI 10.1089/152308601317203611; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Milman N, 2007, P NATL ACAD SCI USA, V104, P19250, DOI 10.1073/pnas.0706858104; Motyka SA, 2006, J BIOL CHEM, V281, P18499, DOI 10.1074/jbc.M602880200; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nishinaka Y, 2001, REDOX REP, V6, P289, DOI 10.1179/135100001101536427; Onn I, 2004, EUKARYOT CELL, V3, P277, DOI 10.1128/EC.3.2.277-287.2004; Onn I, 2006, J BIOL CHEM, V281, P37468, DOI 10.1074/jbc.M606374200; Park JS, 1999, J BIOL CHEM, V274, P29075, DOI 10.1074/jbc.274.41.29075; PASION SG, 1994, J CELL SCI, V107, P3515; Roy J, 2007, PROTIST, V158, P385, DOI 10.1016/j.protis.2007.03.002; Sanders CM, 2007, NUCLEIC ACIDS RES, V35, P3504, DOI 10.1093/nar/gkm166; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; SHLOMAI J, 1986, J BIOL CHEM, V261, P6219; Tanaka T, 2000, FREE RADICAL RES, V33, P851, DOI 10.1080/10715760000301361; Tetaud E, 1998, MOL BIOCHEM PARASIT, V96, P111, DOI 10.1016/S0166-6851(98)00120-0; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; TZFATI Y, 1992, P NATL ACAD SCI USA, V89, P6891, DOI 10.1073/pnas.89.15.6891; TZFATI Y, 1995, J BIOL CHEM, V270, P21339, DOI 10.1074/jbc.270.36.21339; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Wang M, 2001, ANTIOXID REDOX SIGN, V3, P657, DOI 10.1089/15230860152543005; Webster KA, 2001, ANTIOXID REDOX SIGN, V3, P535, DOI 10.1089/15230860152542916; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017	51	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32034	32044		10.1074/jbc.M804417200	http://dx.doi.org/10.1074/jbc.M804417200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799461	hybrid			2022-12-25	WOS:000260760800085
J	Stewart, JA; Miller, AS; Campbell, JL; Bambara, RA				Stewart, Jason A.; Miller, Adam S.; Campbell, Judith L.; Bambara, Robert A.			Dynamic Removal of Replication Protein A by Dna2 Facilitates Primer Cleavage during Okazaki Fragment Processing in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; FLAP ENDONUCLEASE-1; IN-VIVO; YEAST; RPA; MATURATION; HELICASE/NUCLEASE; POLYMERASE; PREDICTION; MECHANISM	Eukaryotic Okazaki fragments are initiated by a RNA/DNA primer, which is removed before the fragments are joined. Polymerase delta displaces the primer into a flap for processing. Dna2 nuclease/helicase and flap endonuclease 1 (FEN1) are proposed to cleave the flap. The single-stranded DNA-binding protein, replication protein A (RPA), governs cleavage activity. Flap-bound RPA inhibits FEN1. This necessitates cleavage by Dna2, which is stimulated by RPA. FEN1 then cuts the remaining RPA-free flap to create a nick for ligation. Cleavage by Dna2 requires that it enter the 5'-end and track down the flap. Because Dna2 cleaves the RPA-bound flap, we investigated the mechanism by which Dna2 accesses the protein-coated flap for cleavage. Using a nuclease-defective Dna2 mutant, we showed that just binding of Dna2 dissociates the flap-bound RPA. Facile dissociation is specific to substrates with a genuine flap, and will not occur with an RPA-coated single strand. We also compared the cleavage patterns of Dna2 with and without RPA to better define RPA stimulation of Dna2. Stimulation derived from removal of DNA folding in the flap. Apparently, coordinated with its dissociation, RPA relinquishes the flap to Dna2 for tracking in a way that does not allow flap structure to reform. We also found that RPA strand melting activity promotes excessive flap elongation, but it is suppressed by Dna2-promoted RPA dissociation. Overall, results indicate that Dna2 and RPA coordinate their functions for efficient flap cleavage and preparation for FEN1.	[Stewart, Jason A.; Miller, Adam S.; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_Bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM024441 (to R. A. B.), with additional support from Grant GM087666 (to J. L. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; GEORGAKI A, 1992, FEBS LETT, V308, P240, DOI 10.1016/0014-5793(92)81283-R; GEORGAKI A, 1993, NUCLEIC ACIDS RES, V21, P3659, DOI 10.1093/nar/21.16.3659; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kim DH, 2005, NUCLEIC ACIDS RES, V33, P1372, DOI 10.1093/nar/gki255; KORNBERG A, 1992, DNA REPLICATION, P140; KUO CL, 1983, P NATL ACAD SCI-BIOL, V80, P6465, DOI 10.1073/pnas.80.21.6465; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Maga G, 2001, J BIOL CHEM, V276, P18235, DOI 10.1074/jbc.M009599200; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P8869, DOI 10.1021/bi00027a039; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Smith J, 2000, BIOCHIMIE, V82, P71, DOI 10.1016/S0300-9084(00)00183-8; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	37	37	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31356	31365		10.1074/jbc.M805965200	http://dx.doi.org/10.1074/jbc.M805965200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799459	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000260760800013
J	Pai, VP; Horseman, ND				Pai, Vaibhav P.; Horseman, Nelson D.			Biphasic Regulation of Mammary Epithelial Resistance by Serotonin through Activation of Multiple Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PERMEABILITY; MILK SECRETION; FEEDBACK INHIBITOR; GLAND DEVELOPMENT; 5-HT7 RECEPTOR; PROTEIN; KINASE; CAMP; PHOSPHORYLATION; INVOLUTION	Mammary gland homeostasis and the lactation-to-involution switch are regulated by serotonin (5-hydroxytryptamine (5-HT)). Mammary epithelial tight junctions are physiological targets of 5-HT, and their disruption marks an early stage of mammary gland involution. In these studies, we have identified signal transduction mechanism employed by 5-HT during regulation of mammary gland transepithelial resistance. Transepithelial electrical resistance and tight junction protein architecture were studied in cultures of MCF10A human mammary epithelial cells. Serotonin had biphasic effects on mammary epithelial resistance. At lower concentrations and earlier time points, 5-HT potentiated epithelial transmembrane resistance, whereas at higher concentrations and later time points, 5-HT decreased transepithelial electrical resistance and disrupted tight junctions. Both the early and delayed actions of 5-HT were mediated by the 5-HT7 receptor through activation of G(s)/cAMP. 5-HT induced the activities of both protein kinase A and p38 mitogen-activated protein kinase. Inhibition of p38 mitogen-activated protein kinase abrogated 5-HT-induced disruption of mammary epithelial tight junctions (the delayed effect). In contrast, inhibition of protein kinase A prevented the increased epithelial resistance in response to 5-HT (the transient effect). These studies imply an integrated set of mechanisms whereby transient, modest activation of 5-HT7 promotes tight junction integrity, and sustained 5-HT7 activation drives involution by disrupting tight junctions.	[Pai, Vaibhav P.; Horseman, Nelson D.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Horseman, ND (corresponding author), Univ Cincinnati, Dept Mol & Cellular Physiol, 231 Albert Sabin way,MSB, Cincinnati, OH 45267 USA.	nelson.horseman@uc.edu			National Institutes of HEalth [DK52134]; Department of the Army [BC052576]; National Research Initiative Competitive [2007-35206-17898]; States Department of Agriculture Cooperative State Research, Education, and Extension Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052134] Funding Source: NIH RePORTER	National Institutes of HEalth(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of the Army; National Research Initiative Competitive(United States Department of Agriculture (USDA)); States Department of Agriculture Cooperative State Research, Education, and Extension Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of HEalth Grant DK52134. This work was also supported by Department of the Army Grant BC052576 ( to N. D. H.). This project was also supported by National Research Initiative Competitive Grant 2007-35206-17898 from the States Department of Agriculture Cooperative State Research, Education, and Extension Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; BARD JA, 1993, J BIOL CHEM, V268, P23422; BERGA SE, 1984, AM J PHYSIOL, V247, pC20, DOI 10.1152/ajpcell.1984.247.1.C20; Berle P, 1972, Zentralbl Gynakol, V94, P1081; D'Souza T, 2005, J BIOL CHEM, V280, P26233, DOI 10.1074/jbc.M502003200; DAVIS JW, 1969, ENDOCRINOLOGY, V85, P155, DOI 10.1210/endo-85-1-155; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dhanasekaran N, 1996, CELL SIGNAL, V8, P235, DOI 10.1016/0898-6568(96)00048-4; FAURE M, 1994, J BIOL CHEM, V269, P7851; FLINT DJ, 1994, ENDOCRINOLOGY, V135, P1119, DOI 10.1210/en.135.3.1119; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Grimm SL, 2002, MOL ENDOCRINOL, V16, P2675, DOI 10.1210/me.2002-0239; GROSVENOR CE, 1959, P SOC EXP BIOL MED, V101, P699, DOI 10.3181/00379727-101-25066; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Guthrie CR, 2005, J PHARMACOL EXP THER, V313, P1003, DOI 10.1124/jpet.104.081919; Hendry KAK, 1998, J MOL ENDOCRINOL, V21, P169, DOI 10.1677/jme.0.0210169; Hernandez LL, 2008, J DAIRY SCI, V91, P1834, DOI 10.3168/jds.2007-0766; Hernandez S, 2007, EXP CELL RES, V313, P1533, DOI 10.1016/j.yexcr.2007.01.026; Knight CH, 1998, REV REPROD, V3, P104, DOI 10.1530/ror.0.0030104; Krobert KA, 2002, BRIT J PHARMACOL, V135, P1563, DOI 10.1038/sj.bjp.0704588; Kvachnina E, 2005, J NEUROSCI, V25, P7821, DOI 10.1523/JNEUROSCI.1790-05.2005; Lin SL, 2003, J NEUROCHEM, V87, P1076, DOI 10.1046/j.1471-4159.2003.02076.x; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; Lund LR, 1996, DEVELOPMENT, V122, P181; Mahe C, 2004, BRIT J PHARMACOL, V143, P404, DOI 10.1038/sj.bjp.0705936; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; MORGAN G, 1982, J DAIRY RES, V49, P1, DOI 10.1017/S002202990002207X; Nguyen DA, 2001, J ENDOCRINOL, V170, P347, DOI 10.1677/joe.0.1700347; Nguyen DAD, 1998, J MAMMARY GLAND BIOL, V3, P233, DOI 10.1023/A:1018707309361; PEAKER M, 1980, J PHYSIOL-LONDON, V301, P415, DOI 10.1113/jphysiol.1980.sp013214; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; RENNISON ME, 1993, J CELL SCI, V106, P641; RUAT M, 1993, P NATL ACAD SCI USA, V90, P8547, DOI 10.1073/pnas.90.18.8547; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Seo M, 2002, J BIOL CHEM, V277, P24197, DOI 10.1074/jbc.M201717200; Seo MR, 2004, J BIOL CHEM, V279, P17366, DOI 10.1074/jbc.M312442200; Shimizu M, 1998, BRAIN RES, V784, P57, DOI 10.1016/S0006-8993(97)01185-2; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; SINGER KL, 1994, J BIOL CHEM, V269, P16108; SOULE HD, 1990, CANCER RES, V50, P6075; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; STELWAGEN K, 1995, AM J PHYSIOL-REG I, V269, pR848, DOI 10.1152/ajpregu.1995.269.4.R848; Stelwagen K, 1997, AM J PHYSIOL-REG I, V273, pR379, DOI 10.1152/ajpregu.1997.273.1.R379; Stelwagen K, 1999, MOL CELL ENDOCRINOL, V156, P55, DOI 10.1016/S0303-7207(99)00145-8; STELWAGEN K, 1994, J DAIRY SCI, V77, P426, DOI 10.3168/jds.S0022-0302(94)76969-1; STUCKI JC, 1960, ACTA ENDOCRINOL-COP, V33, P73; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; WILDE CJ, 1987, BIOCHEM J, V242, P285, DOI 10.1042/bj2420285; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31	54	73	76	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30901	30910		10.1074/jbc.M802476200	http://dx.doi.org/10.1074/jbc.M802476200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782769	hybrid, Green Published			2022-12-25	WOS:000260544800045
J	Plesca, D; Mazumder, S; Gama, V; Matsuyama, S; Almasan, A				Plesca, Dragos; Mazumder, Suparna; Gama, Vivian; Matsuyama, Shigemi; Almasan, Alexandru			A C-terminal Fragment of Cyclin E, Generated by Caspase-mediated Cleavage, Is Degraded in the Absence of a Recognizable Phosphodegron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCFFBW7 UBIQUITIN LIGASE; CELL-CYCLE; MULTISITE PHOSPHORYLATION; HEMATOPOIETIC-CELLS; DNA-REPLICATION; APOPTOSIS; CANCER; DEGRADATION; PROTEIN; PROTEASOME	We have previously shown that caspase-mediated cleavage of Cyclin E generates p18-Cyclin E in hematopoietic tumor cells. Its expression can induce apoptosis or sensitize to apoptotic stimuli in many cell types. However, p18-cyclin E has a much shorter halflife than Cyclin E, being more effectively ubiquitinated and degraded by the 26 S proteasome. A two-step process has emerged that regulates accelerated degradation of Cyclin E, with a caspase-mediated cleavage followed by enhanced proteasome- mediated degradation. We show that recognition of p18-Cyclin E by the Skp1-Cul1-Fbw7 (SCF) complex and its interaction with the Fbw7 protein isoforms can take place independently of phosphorylation of p18-Cyclin E at a C-terminal phosphodegron. In addition to the SCFFbw7 pathway, Ku70 binding that facilitates Hdm2 recruitment may also be implicated in p18-Cyclin E ubiquitination. Blocking p18-Cyclin E degradation with proteasome inhibitors increases levels of p18-Cyclin E and enhances its association with Ku70, thus leading to Bax release, its activation, and apoptosis. Moreover, cells expressing p18-Cyclin E are more sensitive to treatment with proteasome inhibitors, such as Bortezomib. By preventing its proteasomal degradation, p18-Cyclin E, but not Cyclin E, may become an effective therapeutic target for Bortezomib and apoptotic effectors in hematopoietic malignancies.	[Plesca, Dragos; Mazumder, Suparna; Almasan, Alexandru] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Almasan, Alexandru] Cleveland Clin, Dept Radiat Oncol, Cleveland, OH 44195 USA; [Plesca, Dragos] Kent State Univ, Sch Biomed Sci, Kent, OH 44240 USA; [Gama, Vivian; Matsuyama, Shigemi] Case Western Reserve Univ, Dept Med, Div Hematol Oncol, Cleveland, OH 44106 USA; [Gama, Vivian; Matsuyama, Shigemi] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Matsuyama, Shigemi] Case Comprehens Canc Ctr, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Almasan, A (corresponding author), 9500 Euclid Ave,NB4, Cleveland, OH 44195 USA.	almasaa@ccf.org	Almasan, Alex/C-2715-2008	Almasan, Alex/0000-0002-8916-6650; Gama, Vivian/0000-0002-1201-1394	National Institutes of Health [CA-81504]; NATIONAL CANCER INSTITUTE [R01CA081504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-81504. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Geisen C, 2002, J BIOL CHEM, V277, P39909, DOI 10.1074/jbc.M205919200; Gong BD, 1999, CELL GROWTH DIFFER, V10, P491; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Mazumder S, 2002, MOL CELL BIOL, V22, P2398, DOI 10.1128/MCB.22.7.2398-2409.2002; Mazumder S, 2000, ONCOGENE, V19, P2828, DOI 10.1038/sj.onc.1203623; Mazumder S, 2007, CELL CYCLE, V6, P1437; Mazumder S, 2007, MOL CELL BIOL, V27, P3511, DOI 10.1128/MCB.01448-06; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Sobol RW, 2008, MOL CELL, V29, P413, DOI 10.1016/j.molcel.2008.02.004; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253	42	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30796	30803		10.1074/jbc.M804642200	http://dx.doi.org/10.1074/jbc.M804642200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784078	hybrid, Green Published			2022-12-25	WOS:000260544800034
J	Hozoji, M; Munehira, Y; Ikeda, Y; Makishima, M; Matsuo, M; Kioka, N; Ueda, K				Hozoji, Masako; Munehira, Youichi; Ikeda, Yuika; Makishima, Makoto; Matsuo, Michinori; Kioka, Noriyuki; Ueda, Kazumitsu			Direct Interaction of Nuclear Liver X Receptor-beta with ABCA1 Modulates Cholesterol Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; TANGIER-DISEASE; CELLULAR CHOLESTEROL; ATP; ALPHA; GENE; DEGRADATION; MUTATIONS; STABILIZATION; MACROPHAGES	Cholesterol is an essential component of eukaryotic cells; at the same time, however, hyperaccumulation of cholesterol is harmful. Therefore, the ABCA1 gene, the product of which mediates secretion of cholesterol, is highly regulated at both the transcriptional and post-transcriptional levels. The transcription of ABCA1 is regulated by intracellular oxysterol concentration via the nuclear liver X receptor (LXR)/retinoid X receptor (RXR); once synthesized, ABCA1 protein turns over rapidly with a half-life of 1-2 h. Here, we show that the LXR beta/RXR complex binds directly to ABCA1 on the plasma membrane of macrophages and modulates cholesterol secretion. When cholesterol does not accumulate, ABCA1-LXR beta/RXR localizes on the plasma membrane, but is inert. When cholesterol accumulates, oxysterols bind to LXR beta, and the LXR beta/RXR complex dissociates from ABCA1, restoring ABCA1 activity and allowing apoA-I-dependent cholesterol secretion. LXR beta can exert an immediate post-translational response, as well as a rather slow transcriptional response, to changes in cellular cholesterol accumulation. Thus, we provide the first demonstration that protein-protein interaction suppresses ABCA1 function. Furthermore, we show that LXR beta is involved in both the transcriptional and post-transcriptional regulation of the ABCA1 transporter.	[Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068502, Japan; [Hozoji, Masako; Munehira, Youichi; Ikeda, Yuika; Matsuo, Michinori; Kioka, Noriyuki; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Cellular Biochem, Kyoto 6068502, Japan; [Makishima, Makoto] Nihon Univ, Sch Med, Dept Biochem, Tokyo 1738610, Japan	Kyoto University; Kyoto University; Nihon University	Ueda, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	uedak@kais.kyoto-u.ac.jp		Kioka, Noriyuki/0000-0002-2708-537X; Ueda, Kazumitsu/0000-0003-2980-6078	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation; World Premier International Research Center Initiative; Grants-in-Aid for Scientific Research [20228001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); World Premier International Research Center Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (S) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by the World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Costet P, 2000, J BIOL CHEM, V275, P28240; Kaneko E, 2003, J BIOL CHEM, V278, P36091, DOI 10.1074/jbc.M304153200; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Yokoyama S, 2000, BBA-MOL CELL BIOL L, V1529, P231, DOI 10.1016/S1388-1981(00)00152-9	22	56	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30057	30063		10.1074/jbc.M804599200	http://dx.doi.org/10.1074/jbc.M804599200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18782758	Green Published, hybrid			2022-12-25	WOS:000260366900050
J	Braquart-Varnier, C; Lachat, M; Herbiniere, J; Johnson, M; Caubet, Y; Bouchon, D; Sicard, M				Braquart-Varnier, Christine; Lachat, Marion; Herbiniere, Juline; Johnson, Monique; Caubet, Yves; Bouchon, Didier; Sicard, Mathieu			Wolbachia Mediate Variation of Host Immunocompetence	PLOS ONE			English	Article								Background: After decades during which endosymbionts were considered as silent in their hosts, in particular concerning the immune system, recent studies have revealed the contrary. In the present paper, we addressed the effect of Wolbachia, the most prevalent endosymbiont in arthropods, on host immunocompetence. To this end, we chose the A. vulgare-Wolbachia symbiosis as a model system because it leads to compare consequences of two Wolbachia strains (wVulC and wVulM) on hosts from the same population. Moreover, A. vulgare is the only host-species in which Wolbachia have been directly observed within haemocytes which are responsible for both humoral and cellular immune responses. Methodology/Principal Findings: We sampled gravid females from the same population that were either asymbiotic, infected with wVulC, or infected with wVulM. The offspring from these females were tested and it was revealed that individuals harbouring wVulC exhibited: (i) lower haemocyte densities, (ii) more intense septicaemia in their haemolymph and (iii) a reduced lifespan as compared to individuals habouring wVulM or asymbiotic ones. Therefore, individuals in this population of A. vulgare appeared to suffer more from wVulC than from wVulM. Symbiotic titer and location in the haemocytes did not differ for the two Wolbachia strains showing that these two parameters were not responsible for differences observed in their extended phenotypes in A. vulgare. Conclusion/Significance: The two Wolbachia strains infecting A. vulgare in the same population induced variation in immunocompetence and survival of their hosts. Such variation should highly influence the dynamics of this host-symbiont system. We propose in accordance with previous population genetic works, that wVulM is a local strain that has attenuated its virulence through a long term adaptation process towards local A. vulgare genotypes whereas wVulC, which is a widespread and invasive strain, is not locally adapted.	[Braquart-Varnier, Christine; Lachat, Marion; Herbiniere, Juline; Johnson, Monique; Caubet, Yves; Bouchon, Didier; Sicard, Mathieu] Univ Poitiers, Ecol Lab, CNRS, UMR 6556, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Braquart-Varnier, C (corresponding author), Univ Poitiers, Ecol Lab, CNRS, UMR 6556, 40 Ave Recteur Pineau, Poitiers, France.	mathieu.sicard@univ-poitiers.fr	Bouchon, Didier/B-2419-2012; Sicard, Mathieu/C-4984-2009; Braquart-Varnier, Christine/C-5217-2009	Bouchon, Didier/0000-0002-4938-408X; Sicard, Mathieu/0000-0003-3692-0039; Braquart-Varnier, Christine/0000-0001-6398-7832; CAUBET, Yves/0000-0001-6716-2942	CNRS; French Ministere de l'Education Nationale; de l'Enseignement superieur et de la Recherche; Agence Nationale de la Recherche [ANR-06-BLAN-0316]	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Education Nationale; de l'Enseignement superieur et de la Recherche; Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was funded by the CNRS, the French Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche, and the Agence Nationale de la Recherche (EndoSymbArt ANR-06-BLAN-0316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzocchi C, 2007, PARASITE IMMUNOL, V29, P73, DOI 10.1111/j.1365-3024.2006.00915.x; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; De Barro PJ, 2001, ENTOMOL EXP APPL, V99, P225, DOI 10.1046/j.1570-7458.2001.00821.x; Dean MD, 2006, P ROY SOC B-BIOL SCI, V273, P1415, DOI 10.1098/rspb.2005.3453; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Dobson SL, 2002, GENETICS, V160, P1087; Dong P, 2007, J ECON ENTOMOL, V100, P1476, DOI 10.1603/0022-0493(2007)100[1476:IOWIOT]2.0.CO;2; Fleury F, 2000, PARASITOLOGY, V121, P493, DOI 10.1017/S0031182099006599; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Herbiniere J, 2005, DEV COMP IMMUNOL, V29, P489, DOI 10.1016/j.dci.2004.11.001; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; HOFFMANN AA, 1988, GENETICS, V119, P435; HOFFMANN AA, 1990, GENETICS, V126, P933; Huigens ME, 2004, ENTOMOL EXP APPL, V110, P115, DOI 10.1111/j.0013-8703.2004.00126.x; Jiggins FM, 2002, MOL BIOL EVOL, V19, P1341, DOI 10.1093/oxfordjournals.molbev.a004195; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; JUCHAULT P, 1974, Annales d'Embryologie et de Morphogenese, V7, P265; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Rigaud T, 2004, P ROY SOC B-BIOL SCI, V271, P1941, DOI 10.1098/rspb.2004.2804; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; Rigaud T, 1999, GENETICS, V152, P1669; Siozios S, 2008, INSECT SCI, V15, P89, DOI 10.1111/j.1744-7917.2008.00189.x; Snook RR, 2000, GENETICS, V155, P167; Tagami Y, 2001, J INVERTEBR PATHOL, V78, P267, DOI 10.1006/jipa.2002.5080; Verne S, 2007, GENE, V397, P58, DOI 10.1016/j.gene.2007.04.006; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	37	62	63	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3286	10.1371/journal.pone.0003286	http://dx.doi.org/10.1371/journal.pone.0003286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818770	Green Submitted, Green Published, gold			2022-12-25	WOS:000264432300008
J	Farrell, J; Ramos, L; Tresguerres, M; Kamenetsky, M; Levin, LR; Buck, J				Farrell, Jeanne; Ramos, Lavoisier; Tresguerres, Martin; Kamenetsky, Margarita; Levin, Lonny R.; Buck, Jochen			Somatic 'Soluble' Adenylyl Cyclase Isoforms Are Unaffected in Sacy(tm1Lex)/Sacy(tm1Lex) 'Knockout' Mice	PLOS ONE			English	Article								Background: Mammalian Soluble adenylyl cyclase (sAC, Adcy10, or Sacy) represents a source of the second messenger cAMP distinct from the widely studied, G protein-regulated transmembrane adenylyl cyclases. Genetic deletion of the second through fourth coding exons in Sacy(tm1Lex)/Sacy(tm1Lex) knockout mice results in a male sterile phenotype. The absence of any major somatic phenotype is inconsistent with the variety of somatic functions identified for sAC using pharmacological inhibitors and RNA interference. Principal Findings: We now use immunological and molecular biological methods to demonstrate that somatic tissues express a previously unknown isoform of sAC, which utilizes a unique start site, and which 'escapes' the design of the Sacy(tm1Lex) knockout allele. Conclusions/Significance: These studies reveal increased complexity at the sAC locus, and they suggest that the known isoforms of sAC play a unique function in male germ cells.	[Farrell, Jeanne; Ramos, Lavoisier; Tresguerres, Martin; Kamenetsky, Margarita; Levin, Lonny R.; Buck, Jochen] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University	Farrell, J (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA.	llevin@med.cornell.edu	Tresguerres, Martin/J-8628-2012	Tresguerres, Martin/0000-0002-7090-9266; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [NS55255, GM62328]; American Diabetes Association; Hirschl Weil-Caulier Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Hirschl Weil-Caulier Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health [NS55255 (LRL) and GM62328 (JB)], American Diabetes Association, and the Hirschl Weil-Caulier Trust (LRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAUN T, 1990, P SOC EXP BIOL MED, V194, P58; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buck J, 2002, METHOD ENZYMOL, V345, P95; Cann MJ, 2003, J BIOL CHEM, V278, P35033, DOI 10.1074/jbc.M303025200; Chaloupka JA, 2006, MOL REPROD DEV, V73, P361, DOI 10.1002/mrd.20409; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; FARRELL J, 2007, THESIS W CORNELL MED; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; HAN H, 2005, J EXP MED; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Johnson LR, 1998, ESSENTIAL MED PHYSL; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kobayashi M, 2004, DEV GENES EVOL, V214, P503, DOI 10.1007/s00427-004-0432-2; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Mogensen EG, 2006, EUKARYOT CELL, V5, P103, DOI 10.1128/EC.5.1.103-111.2006; Moore SW, 2008, J NEUROSCI, V28, P3920, DOI 10.1523/JNEUROSCI.0547-08.2008; NEER EJ, 1978, J BIOL CHEM, V253, P5808; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; PAUNESCU TG, 2007, AM J PHYSL IN PRESS; Pitts RF, 1974, PHYSL KIDNEY BODY FL, V3rd; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; Reed BY, 2002, J CLIN ENDOCR METAB, V87, P1476, DOI 10.1210/jc.87.4.1476; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; STEEGBORN C, 2005, J BIOL CHEM; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Summers BA, 2002, J NEUROPHYSIOL, V88, P604, DOI 10.1152/jn.2002.88.2.604; Sun XC, 2003, AM J PHYSIOL-CELL PH, V284, pC1114, DOI 10.1152/ajpcell.00400.2002; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Xie F, 2004, DEV BIOL, V265, P196, DOI 10.1016/j.ydbio.2003.09.020; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Young JJ, 2008, J NEUROSCI RES, V86, P118, DOI 10.1002/jnr.21458; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	43	47	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3251	10.1371/journal.pone.0003251	http://dx.doi.org/10.1371/journal.pone.0003251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806876	Green Submitted, gold, Green Published			2022-12-25	WOS:000264430800003
J	Wang, YP; Hong, J; Liu, XH; Yang, HL; Liu, R; Wu, J; Wang, AL; Lin, DH; Lai, R				Wang, Yipeng; Hong, Jing; Liu, Xiuhong; Yang, Hailong; Liu, Rui; Wu, Jing; Wang, Aili; Lin, Donghai; Lai, Ren			Snake Cathelicidin from Bungarus fasciatus Is a Potent Peptide Antibiotics	PLOS ONE			English	Article							CYSTEINE PROTEINASE-INHIBITOR; ANTIMICROBIAL PEPTIDES; RAINBOW-TROUT; ANTIBACTERIAL; FAMILY; IDENTIFICATION; BACTENECINS; PURIFICATION; EXPRESSION; DEFENSINS	Background: Cathelicidins are a family of antimicrobial peptides acting as multifunctional effector molecules of innate immunity, which are firstly found in mammalians. Recently, several cathelicidins have also been found from chickens and fishes. No cathelicidins from other non-mammalian vertebrates have been reported. Principal Findings: In this work, a cathelicidin-like antimicrobial peptide named cathelicidin-BF has been purified from the snake venoms of Bungarus fasciatus and its cDNA sequence was cloned from the cDNA library, which confirm the presence of cathelicidin in reptiles. As other cathelicidins, the precursor of cathelicidin-BF has cathelin-like domain at the N terminus and carry the mature cathelicidin-BF at the C terminus, but it has an atypical acidic fragment insertion between the cathelin-like domain and the C-terminus. The acidic fragment is similar to acidic domains of amphibian antimicrobial precursors. Phylogenetic analysis revealed that the snake cathelicidin had the nearest evolution relationship with platypus cathelicidin. The secondary structure of cathelicidin-BF investigated by CD and NMR spectroscopy in the presence of the helicogenic solvent TFE is an amphipathic alpha-helical conformation as many other cathelicidins. The antimicrobial activities of cathelicidin BF against forty strains of microorganisms were tested. Cathelicidin-BF efficiently killed bacteria and some fungal species including clinically isolated drug-resistance microorganisms. It was especially active against Gram-negative bacteria. Furthermore, it could exert antimicrobial activity against some saprophytic fungus. No hemolytic and cytotoxic activity was observed at the dose of up to 400 mg/ml. Cathelicidin-BF could exist stably in the mice plasma for at least 2.5 hours. Conclusion: Discovery of snake cathelicidin with atypical structural and functional characterization offers new insights on the evolution of cathelicidins. Potent, broad spectrum, salt-independent antimicrobial activities make cathelicidin-BF an excellent candidate for clinical or agricultural antibiotics.	[Wang, Yipeng; Yang, Hailong; Wu, Jing; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Biotoxin Units, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Hong, Jing; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China; [Liu, Xiuhong; Liu, Rui; Wang, Aili; Lai, Ren] Nanjing Agr Univ, Life Sci Coll, Minist Agr, Key Lab Microbiol Engn Agr Environm, Nanjing, Peoples R China; [Wang, Yipeng; Hong, Jing; Yang, Hailong; Wu, Jing] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Biotoxin Units, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	dhlin@mail.shcnc.ac.cn; rlai@mail.kiz.ac.cn	Wang, Yipeng/AAA-1499-2020; yang, hailong/GXH-9625-2022	Wang, Yipeng/0000-0003-1385-4470; 	Ministry of Science and Technology of the People's Republic of China [2007AA02Z192, 2007AA100602]; Chinese Academy of Sciences [KSCX2-YW-G-024, KSCX2-YW-R-20]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants of 2007AA02Z192 and 2007AA100602 from the Ministry of Science and Technology of the People's Republic of China, and KSCX2-YW-G-024 and KSCX2-YW-R-20 from Chinese Academy of Sciences.	Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bals R, 2001, CLIN DIAGN LAB IMMUN, V8, P370, DOI 10.1128/CDLI.8.2.370-375.2001; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chang CI, 2006, ANTIMICROB AGENTS CH, V50, P185, DOI 10.1128/AAC.50.1.185-195.2006; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Chattopadhyay S, 2006, PROTEINS, V64, P524, DOI 10.1002/prot.20963; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; FRANK RW, 1990, J BIOL CHEM, V265, P18871; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; GENNARO R, 1989, INFECT IMMUN, V57, P3142, DOI 10.1128/IAI.57.10.3142-3146.1989; Goddard T.D., SPARKY 3; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; Hong YH, 2003, J BIOCHEM, V134, P427, DOI 10.1093/jb/mvg160; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Lakshminarayanan R, 2008, J AM CHEM SOC, V130, P4660, DOI 10.1021/ja075659k; Landon C, 2006, BIOPOLYMERS, V81, P92, DOI 10.1002/bip.20370; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Li JX, 2007, FASEB J, V21, P2466, DOI 10.1096/fj.06-7966com; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Lu Y, 2008, MOL IMMUNOL, V45, P678, DOI 10.1016/j.molimm.2007.07.004; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nagaoka I, 1997, J BIOL CHEM, V272, P22742, DOI 10.1074/jbc.272.36.22742; Nair DG, 2007, BIOCHEM J, V402, P93, DOI 10.1042/BJ20060318; Panyutich A, 1997, INFECT IMMUN, V65, P978, DOI 10.1128/IAI.65.3.978-985.1997; RAISON RL, 1998, HAGFISH IMMUNE SYSTE, P334; RITONJA A, 1989, FEBS LETT, V255, P211, DOI 10.1016/0014-5793(89)81093-2; Santamaria C, 2005, TOXICON, V45, P807, DOI 10.1016/j.toxicon.2004.09.012; Santamaria C, 2005, ANTIMICROB AGENTS CH, V49, P1340, DOI [10.1128/AAC.49.4.1340-1345.2005, 10.1128/AAc.49.4.1340-1345.2005]; SCOCCHI M, 1992, EUR J BIOCHEM, V209, P589, DOI 10.1111/j.1432-1033.1992.tb17324.x; Sorensen OE, 2003, J BIOL CHEM, V278, P28540, DOI 10.1074/jbc.M301608200; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I; Termen S, 2003, CELL MOL LIFE SCI, V60, P536, DOI 10.1007/s000180300045; Uzzell T, 2003, PEPTIDES, V24, P1655, DOI 10.1016/j.peptides.2003.08.024; Wang X, 2007, PEPTIDES, V28, P2069, DOI 10.1016/j.peptides.2007.07.020; Whittington CM, 2008, GENOME RES, V18, P986, DOI 10.1101/gr.7149808; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Xu CH, 2007, PEPTIDES, V28, P969, DOI 10.1016/j.peptides.2007.02.008; Zaiou M, 2002, J MOL MED, V80, P549, DOI 10.1007/s00109-002-0350-6; ZANETTI M, 1990, J CELL BIOL, V111, P1363, DOI 10.1083/jcb.111.4.1363; ZANETTI M, 1993, J BIOL CHEM, V268, P522; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao CQ, 2001, ANTIMICROB AGENTS CH, V45, P2695, DOI 10.1128/AAC.45.10.2695-2702.2001	53	164	180	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3217	10.1371/journal.pone.0003217	http://dx.doi.org/10.1371/journal.pone.0003217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795096	Green Published, gold, Green Submitted			2022-12-25	WOS:000264428000001
J	Ferrante, P; Catalanotti, C; Bonente, G; Giuliano, G				Ferrante, Paola; Catalanotti, Claudia; Bonente, Giulia; Giuliano, Giovanni			An Optimized, Chemically Regulated Gene Expression System for Chlamydomonas	PLOS ONE			English	Article								Background: Chlamydomonas reinhardtii is a model system for algal and cell biology and is used for biotechnological applications, such as molecular farming or biological hydrogen production. The Chlamydomonas metal-responsive CYC6 promoter is repressed by copper and induced by nickel ions. However, induction by nickel is weak in some strains, poorly reversible by chelating agents like EDTA, and causes, at high concentrations, toxicity side effects on Chlamydomonas growth. Removal of these bottlenecks will encourage the wide use of this promoter as a chemically regulated gene expression system. Methodology: Using a codon-optimized Renilla luciferase as a reporter gene, we explored several strategies to improve the strength and reversibility of CYC6 promoter induction. Use of the first intron of the RBCS2 gene or of a modified TAP medium increases the strength of CYC6 induction up to 20-fold. In the modified medium, induction is also obtained after addition of specific copper chelators, like TETA. At low concentrations (up to 10 mu M) TETA is a more efficient inducer than Ni, which becomes a very efficient inducer at higher concentrations (50 mM). Neither TETA nor Ni show toxicity effects at the concentrations used. Unlike induction by Ni, induction by TETA is completely reversible by micromolar copper concentrations, thus resulting in a transient "wave'' in luciferase activity, which can be repeated in subsequent growth cycles. Conclusions: We have worked out a chemically regulated gene expression system that can be finely tuned to produce temporally controlled "waves'' in gene expression. The use of cassettes containing the CYC6 promoter, and of modified growth media, is a reliable and economically sustainable system for the temporally controlled expression of foreign genes in Chlamydomonas.	[Ferrante, Paola; Catalanotti, Claudia; Giuliano, Giovanni] Energy & Environm ENEA, Italian Natl Agcy New Technol, Casaccia Res Ctr, Rome, Italy; [Bonente, Giulia] Univ Verona, Dipartimento Sci Tecnol, I-37100 Verona, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; University of Verona	Ferrante, P (corresponding author), Energy & Environm ENEA, Italian Natl Agcy New Technol, Casaccia Res Ctr, Rome, Italy.	giuliano@casaccia.enea.it	Giuliano, Giovanni/A-2701-2012	Giuliano, Giovanni/0000-0002-2486-0510; Ferrante, Paola/0000-0003-3071-2212	Italian Ministry of Research, Special Fund for Strategic Research (FISR), Idrobio Project	Italian Ministry of Research, Special Fund for Strategic Research (FISR), Idrobio Project	Work supported by the Italian Ministry of Research, Special Fund for Strategic Research (FISR), Idrobio Project.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; BARDSLEY WG, 1974, BIOCHEM J, V137, P61, DOI 10.1042/bj1370061; Bohner S, 2001, MOL GEN GENET, V264, P860, DOI 10.1007/s004380000376; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; COHEN NL, 1983, BIOCHEM BIOPH RES CO, V113, P127, DOI 10.1016/0006-291X(83)90441-2; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Franklin SE, 2004, CURR OPIN PLANT BIOL, V7, P159, DOI 10.1016/j.pbi.2004.01.012; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HUTNER S. H., 1950, PROC AMER PHIL SOC, V94, P152; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; LI YB, 1993, ARCH BIOCHEM BIOPHYS, V300, P346, DOI 10.1006/abbi.1993.1047; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Ma DS, 2002, NUCL MED BIOL, V29, P91, DOI 10.1016/S0969-8051(01)00287-6; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; Melis A, 2007, PLANTA, V226, P1075, DOI 10.1007/s00425-007-0609-9; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Ohresser M, 1997, CURR GENET, V31, P264, DOI 10.1007/s002940050204; Padidam M, 2003, CURR OPIN PLANT BIOL, V6, P169, DOI 10.1016/S1369-5266(03)00005-0; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Quinn JM, 2003, EUKARYOT CELL, V2, P995, DOI 10.1128/EC.2.5.995-1002.2003; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; QUINN JM, 1995, PLANT CELL, V7, P623, DOI 10.1105/tpc.7.5.623; SANCHEZ DJ, 1994, RES COMMUN CHEM PATH, V83, P329; Schroda M, 2006, CURR GENET, V49, P69, DOI 10.1007/s00294-005-0042-1; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; Sprengel R, 2007, Handb Exp Pharmacol, P49; Stevens DR, 1996, MOL GEN GENET, V251, P23; Surzycki R, 2007, P NATL ACAD SCI USA, V104, P17548, DOI 10.1073/pnas.0704205104; UEMASU I, 1982, ANAL CHEM, V54, P835, DOI 10.1021/ac00241a061; Villand P, 1997, BIOCHEM J, V327, P51, DOI 10.1042/bj3270051	36	34	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3200	10.1371/journal.pone.0003200	http://dx.doi.org/10.1371/journal.pone.0003200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787710	Green Submitted, Green Published, gold			2022-12-25	WOS:000264426200005
J	Verhoef, LGGC; Heinen, C; Selivanova, A; Halff, EF; Salomons, FA; Dantuma, NP				Verhoef, Lisette G. G. C.; Heinen, Christian; Selivanova, Alexandra; Halff, Els F.; Salomons, Florian A.; Dantuma, Nico P.			Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates	FASEB JOURNAL			English	Article						ubiquitin fusion degradation; UBB+1; neurodegeneration; conformational diseases; Alzheimer; protein degradation	MUTANT UBIQUITIN; 26S PROTEASOME; AGGREGATE FORMATION; INHIBITION; PROTEINS; ALZHEIMERS; SYSTEM; ACCUMULATION; RAD23; RECOGNITION	An erroneous transcriptional process, known as molecular misreading, gives rise to an alternative transcript of the ubiquitin B (UBB) gene. This transcript encodes the protein UBB+1, which comprises a ubiquitin moiety and a 19-aa C-terminal extension. UBB+1 is found in affected neurons in neurodegenerative diseases and behaves as an atypical ubiquitin fusion degradation (UFD) proteasome substrate that is poorly degraded and impedes the ubiquitin/proteasome system. Here, we show that the limited length of UBB+1 is responsible for its inefficient degradation and inhibitory activity. Designed UFD substrates with an equally short 19-aa or a 20-aa C-terminal extension were also poorly degraded and had a general inhibitory activity on the ubiquitin/proteasome system in two unrelated cell lines. Extending the polypeptide to 25 aa sufficed to convert the protein into an efficiently degraded proteasome substrate that lacked inhibitory activity. A similar length dependency was found for degradation of two UFD substrates in Saccharomyces cerevisiae, which suggests that the mechanisms underlying this length constraint are highly conserved. Extending UBB+1 also converted this protein into an efficient substrate of the proteasome. These observations provide an explanation for the accumulation of UBB+1 in neurodegenerative disorders and offers new insights into the physical constraints determining proteasomal degradation.-Verhoef, L. G. G. C., Heinen, C., Selivanova, A., Halff, E. F., Salomons, F. A., Dantuma, N. P. Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates. FASEB J. 23, 123-133 (2009)	[Verhoef, Lisette G. G. C.; Heinen, Christian; Halff, Els F.; Salomons, Florian A.; Dantuma, Nico P.] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Selivanova, Alexandra] Karolinska Inst, Dept Neurobiol Hlth Care Sci & Soc, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Dantuma, NP (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, Von Eulers Vag 3, S-17177 Stockholm, Sweden.	nico.dantuma@ki.se	Halff, Els F/M-9110-2015	Halff, Els F/0000-0001-5814-0899; Dantuma, Nico/0000-0002-6090-4170	Swedish Research Council; Swedish Cancer Society; Wallenberg foundation; Hereditary Disease Foundation; Nordic Center of Excellence Neurodegeneration; Marie Curie Research Training Network [MRTN-CT-2004-512585]; Karolinska Institute; Prinses Beatrix Fonds	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wallenberg foundation(European Commission); Hereditary Disease Foundation; Nordic Center of Excellence Neurodegeneration; Marie Curie Research Training Network(European Commission); Karolinska Institute(Karolinska Institutet); Prinses Beatrix Fonds	We thank Drs. Michael Glickman and Dasha Krutauz for stimulating discussions and critical reading of the manuscript, Dr. J. Neefjes (Netherlands Cancer Institute, Amsterdam) for the CD8 alpha expression plasmid, Dr. F. van Leeuwen (Maastricht University, Maastricht, The Netherlands) for the UBB<SUP>+1</SUP> antibody, and the members of the Dantuma lab for helpful suggestions. The work in the Dantuma lab was supported by the Swedish Research Council, Swedish Cancer Society, the Wallenberg foundation, the Hereditary Disease Foundation, the Nordic Center of Excellence Neurodegeneration, the Marie Curie Research Training Network (MRTN-CT-2004-512585), and the Karolinska Institute. N.P.D. is supported by the Swedish Research Council. E.F.H. received financial support from the Prinses Beatrix Fonds.	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Dantuma NP, 2002, FEBS LETT, V529, P22, DOI 10.1016/S0014-5793(02)03252-0; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; De Vrij FMS, 2001, FASEB J, V15, P2680, DOI 10.1096/fj.01-0438com; Finney N, 2003, J BIOL CHEM, V278, P16054, DOI 10.1074/jbc.C300051200; Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com; Flick K, 2006, NAT CELL BIOL, V8, P509, DOI 10.1038/ncb1402; Fratta P, 2004, NEUROLOGY, V63, P1114, DOI 10.1212/01.WNL.0000138574.56908.5D; French BA, 2001, EXP MOL PATHOL, V71, P241, DOI 10.1006/exmp.2001.2401; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Hope AD, 2003, J NEUROCHEM, V86, P394, DOI 10.1046/j.1471-4159.2003.01844.x; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lambertson D, 2003, CURR GENET, V42, P199, DOI 10.1007/s00294-002-0350-7; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Shabek N, 2007, BIOCHEM BIOPH RES CO, V363, P425, DOI 10.1016/j.bbrc.2007.08.185; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Stack JH, 2000, NAT BIOTECHNOL, V18, P1298, DOI 10.1038/82422; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; van Leeuwen FW, 2006, BIOCHEM SOC T, V34, P738, DOI 10.1042/BST0340738; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Wu SS, 2002, PEDIATR DEVEL PATHOL, V5, P293, DOI 10.1007/s10024-001-0202-3; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	44	40	40	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					123	133		10.1096/fj.08-115055	http://dx.doi.org/10.1096/fj.08-115055			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18796559				2022-12-25	WOS:000262095500015
J	Umemori, H; Sanes, JR				Umemori, Hisashi; Sanes, Joshua R.			Signal Regulatory Proteins (SIRPS) Are Secreted Presynaptic Organizing Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-ASSOCIATED PROTEIN; CEREBRAL CORTICAL-NEURONS; NEURAL ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR FAMILY; SYNAPTIC DIFFERENTIATION; RECEPTOR SPECIFICITY; NEGATIVE REGULATION; NEURITE OUTGROWTH; CELL-MIGRATION	Formation of chemical synapses requires exchange of organizing signals between the synaptic partners. Using synaptic vesicle aggregation in cultured neurons as a marker of presynaptic differentiation, we purified candidate presynaptic organizers from mouse brain. A major bioactive species was the extracellular domain of signal regulatory protein alpha(SIRP-alpha), a transmembrane immunoglobulin superfamily member concentrated at synapses. Theextracellular domain of SIRP-alpha is cleaved and shed in a developmentally regulated manner. The presynaptic organizing activity of SIRP-alpha is mediated in part by CD47. SIRP-alpha homologues, SIRP-beta and -gamma also have synaptic vesicle clustering activity. The effects of SIRP-alpha are distinct from those of another presynaptic organizer, FGF22: the two proteins induced vesicle clusters of different sizes, differed in their ability to promote neurite branching, and acted through different receptors and signaling pathways. SIRP family proteins may act together with other organizing molecules to pattern synapses.	[Umemori, Hisashi] Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Umemori, Hisashi] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Umemori, Hisashi; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Umemori, Hisashi; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard University	Umemori, H (corresponding author), Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Rm 5065,BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	umemoh@umich.edu		Umemori, Hisashi/0000-0001-7198-2062				AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Araki T, 2000, J NEUROCHEM, V75, P1502, DOI 10.1046/j.1471-4159.2000.0751502.x; Babic I, 2000, J IMMUNOL, V164, P3652, DOI 10.4049/jimmunol.164.7.3652; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; CHUANG W, 1990, DEV BIOL, V137, P219, DOI 10.1016/0012-1606(90)90249-I; Comu S, 1997, J NEUROSCI, V17, P8702; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kato H, 2005, J THROMB HAEMOST, V3, P763, DOI 10.1111/j.1538-7836.2005.01235.x; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kontaridis MI, 2001, J CELL SCI, V114, P2187; Koshimizu H, 2002, J NEUROCHEM, V82, P249, DOI 10.1046/j.1471-4159.2002.00965.x; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Mi ZP, 2000, J COMP NEUROL, V416, P335; Mitsuhashi H, 2005, J BIOCHEM, V137, P495, DOI 10.1093/jb/mvi058; Mitsuhashi H, 2008, J NEUROCHEM, V105, P101, DOI 10.1111/j.1471-4159.2007.05121.x; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Numakawa T, 2004, J BIOL CHEM, V279, P43245, DOI 10.1074/jbc.M406733200; Ohnishi H, 2005, J NEUROSCI, V25, P2702, DOI 10.1523/JNEUROSCI.5173-04.2005; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; RENSDOMIANO S, 1995, FASEB J, V9, P1059, DOI 10.1096/fasebj.9.11.7649405; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; van den Berg TK, 2005, J IMMUNOL, V175, P7788, DOI 10.4049/jimmunol.175.12.7788; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang XXX, 2006, J CELL SCI, V119, P172, DOI 10.1242/jcs.02710; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	56	36	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34053	34061		10.1074/jbc.M805729200	http://dx.doi.org/10.1074/jbc.M805729200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819922	Green Published, hybrid			2022-12-25	WOS:000261277700033
J	Bao, XM; Cai, WL; Deng, H; Zhang, WG; Krencik, R; Girton, J; Johansen, J; Johansen, KM				Bao, Xiaomin; Cai, Weili; Deng, Huai; Zhang, Weiguo; Krencik, Robert; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.			The COOH-terminal Domain of the JIL-1 Histone H3S10 Kinase Interacts with Histone H3 and Is Required for Correct Targeting to Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA POLYTENE CHROMOSOMES; DOSAGE COMPENSATION COMPLEX; POSITION-EFFECT VARIEGATION; CHROMODOMAIN PROTEIN; PHOSPHORYLATION; GENES; HETEROCHROMATIN; ALLELES	The JIL-1 histone H3S10 kinase in Drosophila localizes specifically to euchromatic interband regions of polytene chromosomes and is enriched 2-fold on the male X chromosome. JIL-1 can be divided into four main domains including an NH2-terminal domain, two separate kinase domains, and a COOH-terminal domain. Our results demonstrate that the COOH-terminal domain of JIL-1 is necessary and sufficient for correct chromosome targeting to autosomes but that both COOH-and NH2-terminal sequences are necessary for enrichment on the male X chromosome. We furthermore show that a small 53-amino acid region within the COOH-terminal domain can interact with the tail region of histone H3, suggesting that this interaction is necessary for the correct chromatin targeting of the JIL-1 kinase. Interestingly, our data indicate that the COOH-terminal domain alone is sufficient to rescue JIL-1 null mutant polytene chromosome defects including those of the male X chromosome. Nonetheless, we also found that a truncated JIL-1 protein which was without the COOH-terminal domain but retained histone H3S10 kinase activity was able to rescue autosome as well as partially rescue male X polytene chromosome morphology. Taken together these findings indicate that JIL-1 may participate in regulating chromatin structure by multiple and partially redundant mechanisms.	[Bao, Xiaomin; Cai, Weili; Deng, Huai; Zhang, Weiguo; Krencik, Robert; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Johansen, KM (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 3154 Mol Biol Bldg, Ames, IA 50011 USA.	kristen@iastate.edu	Cai, Weili/B-7691-2013	Zhang, Weiguo/0000-0002-3045-0569; Bao, Xiaomin/0000-0002-8845-5012; Cai, Weili/0000-0002-6781-5322; Krencik, Robert/0000-0002-2968-3162	National Institutes of Health [GM62916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62916 (to K.M.J.).	Bao XM, 2007, GENETICS, V176, P1355, DOI 10.1534/genetics.107.073676; Bao XM, 2005, J CELL SCI, V118, P5079, DOI 10.1242/jcs.02611; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Cai WL, 2008, DEVELOPMENT, V135, P2917, DOI 10.1242/dev.024927; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; DIMARIO P, 2006, DROS INF SERV, V89, P115; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; GORMAN M, 1995, DEVELOPMENT, V121, P463; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; LINDSLEY DL, 1992, GENOME DROSOPHILA ME, P1071; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Rath U, 2006, J CELL SCI, V119, P2332, DOI 10.1242/jcs.02960; Roberts D.B., 1998, DROSOPHILA PRACTICAL, P1; Sambrook J, 2001, MOL CLONING LAB MANU; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhang WG, 2003, GENETICS, V165, P1341; Zhang WG, 2003, J BIOL CHEM, V278, P11696, DOI 10.1074/jbc.M213269200	26	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32741	32750		10.1074/jbc.M806227200	http://dx.doi.org/10.1074/jbc.M806227200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819909	Green Published, hybrid			2022-12-25	WOS:000260893700063
J	Lee, NY; Ray, B; How, T; Blobe, GC				Lee, Nam Y.; Ray, Bridgette; How, Tam; Blobe, Gerard C.			Endoglin Promotes Transforming Growth Factor beta-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; RECEPTOR COMPLEX; ANGIOGENESIS; KINASE; ALK1; PROLIFERATION; ACTIVATION; FAMILY; DOMAIN; TRANSDUCTION	Transforming growth factor beta (TGF-beta) signals through two distinct pathways to regulate endothelial cell proliferation, migration, and angiogenesis, the ALK-1/Smad 1/5/8 and ALK-5/Smad2/3 pathways. Endoglin is a co-receptor predominantly expressed in endothelial cells that participates in TGF beta-mediated signaling with ALK-1 and ALK-5 and regulates critical aspects of cellular and biological responses. The embryonic lethal phenotype of knock-out mice because of defects in angiogenesis and disease-causing mutations resulting in human vascular diseases both support essential roles for endoglin, ALK-1, and ALK-5 in the vasculature. However, the mechanism by which endoglin mediates TGF-beta signaling through ALK-1 and ALK-5 has remained elusive. Here we describe a novel interaction between endoglin and GIPC, a scaffolding protein known to regulate cell surface receptor expression and trafficking. Co-immunoprecipitation and immunofluorescence confocal studies both demonstrate a specific interaction between endoglin and GIPC in endothelial cells, mediated by a class I PDZ binding motif in the cytoplasmic domain of endoglin. Subcellular distribution studies demonstrate that endoglin recruits GIPC to the plasma membrane and co-localizes with GIPC in a TGF beta-independent manner, with GIPC-promoting cell surface retention of endoglin. Endoglin specifically enhanced TGF-beta 1-induced phosphorylation of Smad 1/5/8, increased a Smad 1/5/8 responsive promoter, and inhibited endothelial cell migration in a manner dependent on the ability of endoglin to interact with GIPC. These studies define a novel mechanism for the regulation of endoglin signaling and function in endothelial cells and demonstrate a new role for GIPC in TGF-beta signaling.	[Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Blobe, GC (corresponding author), Duke Univ, Med Ctr, Dept Med, 354 LSRC,Box 91004, Durham, NC 27708 USA.	blobe001@mc.duke.edu	Blobe, Gerard/AAJ-5945-2020; Lee, Nam/H-3073-2016	Blobe, Gerard/0000-0002-4274-8901; 	National Institutes of Health [R01-CA105255]; NCI; NATIONAL CANCER INSTITUTE [R01CA105255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA105255 from the NCI (to G. C. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Katoh M, 2002, INT J MOL MED, V9, P585; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yang X, 1999, DEVELOPMENT, V126, P1571	32	86	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32527	32533		10.1074/jbc.M803059200	http://dx.doi.org/10.1074/jbc.M803059200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18775991	hybrid, Green Published			2022-12-25	WOS:000260893700041
J	Yamazaki, S; Matsuo, S; Muta, T; Yamamoto, M; Akira, S; Takeshige, K				Yamazaki, Soh; Matsuo, Susumu; Muta, Tatsushi; Yamamoto, Masahiro; Akira, Shizuo; Takeshige, Koichiro			Gene-specific Requirement of a Nuclear Protein, I kappa B-zeta, for Promoter Association of Inflammatory Transcription Regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILIZATION; EPITHELIAL-CELLS; INDUCTION; EXPRESSION; RECEPTOR; MACROPHAGES; ROLES; SITES; MICE; LAP	Expression of many inflammatory genes is induced through activation of the transcription factor NF-kappa B. In contrast to the advanced understanding of cytoplasmic control of NF-kappa B activation, its regulation in the nucleus has not been fully understood despite its importance in selective gene expression. We previously identified an inducible nuclear protein, I kappa B-zeta, and demonstrated that this molecule is indispensable for the expression of a group of NF-kappa B-regulated genes. In this study, we established a unique gene induction system, in which I kappa B-zeta is expressed independently of inflammatory stimuli, to specifically investigate the molecular basis underlying I kappa B-zeta-mediated gene activation. We show that in the presence of I kappa B-zeta other primary response genes are dispensable for the expression of the target secondary response genes. ChIP analyses revealed that I kappa B-zeta is required for stimulus-induced recruitment of NF-kappa B onto the target promoter in a gene-specific manner. Surprisingly, I kappa B-zeta is also necessary for the gene-selective promoter recruitment of another inflammatory transcription factor, C/EBP beta, and the chromatin remodeling factor Brg1. We propose a new gene regulatory mechanism underlying the selective expression of inflammatory genes.	[Yamazaki, Soh] Kyushu Univ, Grad Sch Med Sci, Dept Mol & Cellular Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Muta, Tatsushi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan; [Yamamoto, Masahiro; Akira, Shizuo] Osaka Univ, Japan Sci & Technol Agcy, ERATO,Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Kyushu University; Tohoku University; Japan Science & Technology Agency (JST); Osaka University	Yamazaki, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol & Cellular Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	syamaz@mailserver.med.kyushu-u.ac.jp	Akira, Shizuo/C-3134-2009	Yamazaki, Soh/0000-0001-5038-1567	Ministry of Education, Culture, Sports, Science and Technology in Japan; Sankyo Foundation of Life Science	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (to S. Y. and K. T.) and a grant from Sankyo Foundation of Life Science (to S. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Natoli G, 2006, FEBS LETT, V580, P2843, DOI 10.1016/j.febslet.2006.02.072; PETERSON MG, 1986, EUR J BIOCHEM, V160, P579, DOI 10.1111/j.1432-1033.1986.tb10077.x; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; SHANAHAN CM, 1989, MOL CELL BIOL, V9, P5473, DOI 10.1128/MCB.9.12.5473; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yamazaki S, 2008, BBA-GENE REGUL MECH, V1779, P108, DOI 10.1016/j.bbagmi.2007.11.001; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	32	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32404	32411		10.1074/jbc.M802148200	http://dx.doi.org/10.1074/jbc.M802148200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18824552	hybrid			2022-12-25	WOS:000260893700028
J	Zhao, Q; Barakat, BM; Qin, S; Ray, A; El-Mahdy, MA; Wani, G; Arafa, ES; Mir, SN; Wang, QE; Wani, AA				Zhao, Qun; Barakat, Bassant M.; Qin, Song; Ray, Alo; El-Mahdy, Mohamed A.; Wani, Gulzar; Arafa, El-Shaimaa; Mir, Safita N.; Wang, Qi-En; Wani, Altaf A.			The p38 Mitogen-activated Protein Kinase Augments Nucleotide Excision Repair by Mediating DDB2 Degradation and Chromatin Relaxation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGED-DNA-BINDING; GROUP-E CELLS; CYCLOBUTANE PYRIMIDINE DIMERS; GLOBAL GENOMIC REPAIR; UV-IRRADIATION; HISTONE H3; IN-VITRO; C-FOS; DEPENDENT DEGRADATION; MOLECULAR-MECHANISM	The p38 MAPK is a family of serine/threonine protein kinases that play important roles in cellular responses to external stress signals, e. g. UV irradiation. To assess the role of p38 MAPK pathway in nucleotide excision repair (NER), the most versatile DNA repair pathway, we determined the efficiency of NER in cells treated with p38 MAPK inhibitor SB203580 and found that p38 MAPK is required for the prompt repair of UV-induced DNA damage CPD. We further investigated the possible mechanism through which p38 MAPK regulates NER and found that p38 MAPK mediates UV-induced histone H3 acetylation and chromatin relaxation. Moreover, p38 MAPK also regulates UV-induced DDB2 ubiquitylation and degradation via phosphorylation of the target protein. Finally, our results showed that p38 MAPK is required for the recruitment of NER factors XPC and TFIIH to UV-induced DNA damage sites. We conclude that p38 MAPK regulates chromatin remodeling as well as DDB2 degradation for facilitating NER factor assembly.	[Zhao, Qun; Barakat, Bassant M.; Qin, Song; Ray, Alo; El-Mahdy, Mohamed A.; Wani, Gulzar; Arafa, El-Shaimaa; Mir, Safita N.; Wang, Qi-En; Wani, Altaf A.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Wang, QE (corresponding author), Ohio State Univ, Dept Radiol, 460 W 12th Ave, Columbus, OH 43210 USA.	wang.771@osu.edu; wani.2@osu.edu	Arafa, Elshaimaa/Q-1316-2019; Arafa, El-Shaimaa A/C-4777-2013	Arafa, Elshaimaa/0000-0002-9034-6624; Arafa, El-Shaimaa A/0000-0002-9034-6624; Barakat, Bassant/0000-0003-1800-5814	National Institutes of Health [ES2388, ES12991, CA93413]; NATIONAL CANCER INSTITUTE [R01CA093413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002388, R01ES012991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES2388, ES12991, and CA93413. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Andrieux LO, 2007, CANCER RES, V67, P2114, DOI 10.1158/0008-5472.CAN-06-3821; Araujo SJ, 2000, GENE DEV, V14, P349; Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Cheung KJ, 2001, CANCER RES, V61, P4974; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Christmann M, 2007, CARCINOGENESIS, V28, P183, DOI 10.1093/carcin/bgl119; Christmann M, 2006, NUCLEIC ACIDS RES, V34, P6530, DOI 10.1093/nar/gkl895; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; HANAWALT P, 1993, CURR BIOL, V3, P67, DOI 10.1016/0960-9822(93)90156-I; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kulaksiz G, 2005, MOL CELL BIOL, V25, P9784, DOI 10.1128/MCB.25.22.9784-9792.2005; Kuo WHW, 2007, EXP CELL RES, V313, P1628, DOI 10.1016/j.yexcr.2007.02.010; Kusumoto R, 2001, MUTAT RES-DNA REPAIR, V485, P219, DOI 10.1016/S0921-8777(00)00082-3; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Li JP, 2007, J CELL PHYSIOL, V212, P481, DOI 10.1002/jcp.21042; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; RAMANATHAN B, 1989, J BIOL CHEM, V264, P11026; RAMANATHAN B, 1986, CARCINOGENESIS, V7, P1087, DOI 10.1093/carcin/7.7.1087; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rouget R, 2008, J BIOL CHEM, V283, P5533, DOI 10.1074/jbc.M706257200; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; SMERDON MJ, 1982, J BIOL CHEM, V257, P13441; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004; Venkatachalam S, 1997, ONCOGENE, V14, P801, DOI 10.1038/sj.onc.1200890; Wakasugi M, 2001, J BIOL CHEM, V276, P15434, DOI 10.1074/jbc.M011177200; Wang D, 2004, J BIOL CHEM, V279, P20622, DOI 10.1074/jbc.M402547200; Wang J, 2006, CANCER RES, V66, P1906, DOI 10.1158/0008-5472.CAN-05-3444; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wang QE, 2003, DNA REPAIR, V2, P483, DOI 10.1016/S1568-7864(03)00002-8; WANG Z, 1991, J BIOL CHEM, V269, P19034; Wang ZG, 1997, J BIOL CHEM, V272, P24064, DOI 10.1074/jbc.272.38.24064; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199	70	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32553	32561		10.1074/jbc.M803963200	http://dx.doi.org/10.1074/jbc.M803963200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806262	hybrid, Green Published			2022-12-25	WOS:000260893700044
J	Bowling, KM; Huang, ZN; Xu, D; Ferdousy, F; Funderburk, CD; Karnik, N; Neckameyer, W; O'Donnell, JM				Bowling, Kevin M.; Huang, Zhinong; Xu, Dong; Ferdousy, Faiza; Funderburk, Christopher D.; Karnik, Nirmala; Neckameyer, Wendi; O'Donnell, Janis M.			Direct Binding of GTP Cyclohydrolase and Tyrosine Hydroxylase REGULATORY INTERACTIONS BETWEEN KEY ENZYMES IN DOPAMINE BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; AMINO-ACID HYDROXYLASES; DROSOPHILA-MELANOGASTER; TETRAHYDROBIOPTERIN BIOSYNTHESIS; PUNCH LOCUS; RAT-BRAIN; PHOSPHORYLATION; GENE; ISOFORMS; PHENYLKETONURIA	The signaling functions of dopamine require a finely tuned regulatory network for rapid induction and suppression of output. A key target of regulation is the enzyme tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, which is activated by phosphorylation and modulated by the availability of its cofactor, tetrahydrobiopterin. The first enzyme in the cofactor synthesis pathway, GTP cyclohydrolase I, is activated by phosphorylation and inhibited by tetrahydrobiopterin. We previously reported that deficits in GTP cyclohydrolase activity in Drosophila heterozygous for mutant alleles of the gene encoding this enzyme led to tightly corresponding diminution of in vivo tyrosine hydroxylase activity that could not be rescued by exogenous cofactor. We also found that the two enzymes could be coimmunoprecipitated from tissue extracts and proposed functional interactions between the enzymes that extended beyond provision of cofactor by one pathway for another. Here, we confirm the physical association of these enzymes, identifying interacting regions in both, and we demonstrate that their association can be regulated by phosphorylation. The functional consequences of the interaction include an increase in GTP cyclohydrolase activity, with concomitant protection from end-product feedback inhibition. In vivo, this effect would in turn provide sufficient cofactor when demand for catecholamine synthesis is greatest. The activity of tyrosine hydroxylase is also increased by this interaction, in excess of the stimulation resulting from phosphorylation alone. V-max is elevated, with no change in K-m. These results demonstrate that these enzymes engage in mutual positive regulation.	[Bowling, Kevin M.; Huang, Zhinong; Xu, Dong; Ferdousy, Faiza; Funderburk, Christopher D.; Karnik, Nirmala; O'Donnell, Janis M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Neckameyer, Wendi] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Alabama System; University of Alabama Tuscaloosa; Saint Louis University	O'Donnell, JM (corresponding author), Univ Alabama, Dept Biol Sci, Box 870344,411 Hackberry Lane, Tuscaloosa, AL 35487 USA.	jodonnel@bama.ua.edu	Funderburk, Christopher D./R-4092-2019; Funderburk, Christopher D./X-5473-2019	Funderburk, Christopher D./0000-0001-5502-1456	National Institutes of Health [GM62879]; University of Alabama; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62879 (to J. M. O.). This work was also supported by the University of Alabama. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P7713, DOI 10.1073/pnas.81.24.7713; Bencsics C, 1996, J NEUROSCI, V16, P4449; BIRMAN S, 1994, J BIOL CHEM, V269, P26559; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen R, 2003, J BIOMED SCI, V10, P774, DOI 10.1159/000073965; CHEN XY, 1994, J CELL SCI, V107, P3501; DANKS DM, 1975, LANCET, V2, P1043; Dassesse D, 1997, BRAIN RES, V777, P187, DOI 10.1016/S0006-8993(97)01111-6; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; FUNAKOSHI H, 1991, J BIOL CHEM, V266, P15614; Funderburk CD, 2006, J BIOL CHEM, V281, P33302, DOI 10.1074/jbc.M602196200; Furukawa Y, 1996, ANN NEUROL, V39, P609, DOI 10.1002/ana.410390510; GOLDSTEIN F, 1961, J BIOL CHEM, V236, P2656; GOLEMIS E, 2002, PROTEIN PROTEIN INTE, P37; HARADA T, 1993, SCIENCE, V260, P1507, DOI 10.1126/science.8502995; HARLOW E, 1999, USING ANTIBODIES LAB, P323; Hesslinger C, 1998, J BIOL CHEM, V273, P21616, DOI 10.1074/jbc.273.34.21616; Hirayama K, 1998, J NEUROCHEM, V70, P164; Hsouna A, 2007, DEV BIOL, V308, P30, DOI 10.1016/j.ydbio.2007.04.047; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Kapatos G, 1999, J NEUROCHEM, V72, P669, DOI 10.1046/j.1471-4159.1999.0720669.x; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kolinsky MA, 2004, J BIOL CHEM, V279, P40677, DOI 10.1074/jbc.M405370200; Krishnakumar S, 2000, J NEUROGENET, V14, P1, DOI 10.3109/01677060009083474; KUCZENSKI RT, 1972, J BIOL CHEM, V247, P3114; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lapize C, 1998, BIOCHEM BIOPH RES CO, V251, P802, DOI 10.1006/bbrc.1998.9552; LEBOURDELLES B, 1991, J BIOL CHEM, V266, P17124; MACKAY WJ, 1983, GENETICS, V105, P35; MAIER J, 1995, BIOCHEM BIOPH RES CO, V212, P705, DOI 10.1006/bbrc.1995.2026; Maita N, 2001, ACTA CRYSTALLOGR D, V57, P1153, DOI 10.1107/S0907444901005558; Mandel RJ, 1998, J NEUROSCI, V18, P4271; MCLEAN JR, 1993, J BIOL CHEM, V268, P27191; Milstien S, 1996, J BIOL CHEM, V271, P19743, DOI 10.1074/jbc.271.33.19743; Nagatsu I, 1997, NEUROSCI LETT, V224, P185, DOI 10.1016/S0304-3940(97)00159-6; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Neckameyer W, 2001, J NEUROBIOL, V47, P280, DOI 10.1002/neu.1035; Neckameyer WS, 2005, BIOCHEM GENET, V43, P425, DOI 10.1007/s10528-005-6781-3; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; Neckameyer WS, 2000, NEUROBIOL AGING, V21, P145, DOI 10.1016/S0197-4580(99)00109-8; REYNOLDS ER, 1987, DEV BIOL, V123, P430, DOI 10.1016/0012-1606(87)90401-5; Segawa M, 1976, Adv Neurol, V14, P215; Swick L, 2006, J NEUROCHEM, V97, P1447, DOI 10.1111/j.1471-4159.2006.03836.x; Szczypka MS, 1999, NEURON, V22, P167, DOI 10.1016/S0896-6273(00)80688-1; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Vie A, 1999, J BIOL CHEM, V274, P16788, DOI 10.1074/jbc.274.24.16788; Widder JD, 2007, CIRC RES, V101, P830, DOI 10.1161/CIRCRESAHA.107.153809; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	51	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31449	31459		10.1074/jbc.M802552200	http://dx.doi.org/10.1074/jbc.M802552200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801743	Green Published, hybrid			2022-12-25	WOS:000260760800024
J	Romero, A; Cakir, I; Vaslet, CA; Stuart, RC; Lansari, O; Lucero, HA; Nillni, EA				Romero, Amparo; Cakir, Isin; Vaslet, Charles A.; Stuart, Ronald C.; Lansari, Omar; Lucero, Hector A.; Nillni, Eduardo A.			Role of a Pro-sequence in the Secretory Pathway of Prothyrotropin-releasing Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROHORMONE CONVERTASES; PROPROTEIN CONVERTASES; ENDOPLASMIC-RETICULUM; PROLINE RESIDUES; QUALITY-CONTROL; PROTEIN; PEPTIDES; PROINSULIN; PC1; BIOSYNTHESIS	The biogenesis of rat thyrotropin releasing hormone (TRH) involves the processing of its precursor (proTRH) into five biologically active TRH peptides and several non-TRH peptides where two of them had been attributed potential biological functions. This process implicates 1) proper folding of proTRH in the endoplasmic reticulum after its biosynthesis and exit to the Golgi apparatus and beyond, 2) initial processing of proTRH in the trans Golgi network and, 3) sorting of proTRH-derived peptides to the regulated secretory pathway. Previous studies have focused on elucidating the processing and sorting determinants of proTRH. However, the role of protein folding in the sorting of proTRH remains unexplored. Here we have investigated the role in the secretion of proTRH of a sequence comprising 22 amino acid residues, located at the N-terminal region of proTRH, residues 31-52. Complete deletion of these 22 amino acids dramatically compromised the biosynthesis of proTRH, manifested as a severe reduction in the steady state level of proTRH in the endoplasmic reticulum. This effect was largely reproduced by the deletion of only three amino acid residues, (40)PGL(42), within the proTRH(31-52) sequence. The decreased steady state level of the mutant Delta PGL was due to enhanced endoplasmic reticulum-associated protein degradation. However, the remnant of Delta PGL that escaped degradation was properly processed and sorted to secretory granules. Thus, these results suggest that the N-terminal domain within the prohormone sequence does not act as "sorting signal" in late secretion; instead, it seems to play a key role determining the proper folding pathway of the precursor and, thus, its stability.	[Romero, Amparo; Cakir, Isin; Stuart, Ronald C.; Lansari, Omar; Nillni, Eduardo A.] Brown Univ, Warren Alpert Med Sch, Div Endocrinol, Rhode Isl Hosp,Dept Med, Providence, RI 02903 USA; [Vaslet, Charles A.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02903 USA; [Nillni, Eduardo A.] Brown Univ, Dept Mol & Cellular Biol, Providence, RI 02903 USA; [Nillni, Eduardo A.] Brown Univ, Dept Biochem, Providence, RI 02903 USA; [Lucero, Hector A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Brown University; Boston University	Nillni, EA (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Endocrinol, Rhode Isl Hosp,Dept Med, 55 Claverick St,Rm 320, Providence, RI 02903 USA.	Eduardo_Nillni@Brown.edu		cakir, isin/0000-0003-4293-7267; Romero-Pico, Amparo/0000-0001-5104-6998	National Institutes of Health [R01 DK58148 (NIDDK), R01 NS045231 (NINDS)]; National Institutes of Health Public Health Services [HL13262-31]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL013262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Public Health Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK58148 (NIDDK) and R01 NS045231 (NINDS) (to E. A. N.) and National Institutes of Health Public Health Services Grant HL13262-31. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bundgaard JR, 2004, J BIOL CHEM, V279, P5488, DOI 10.1074/jbc.M310547200; delaCruz IP, 1996, J BIOL CHEM, V271, P22736, DOI 10.1074/jbc.271.37.22736; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fisher KE, 2007, BIOCHEMISTRY-US, V46, P640, DOI 10.1021/bi061600z; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; Fricker LD, 2007, ENDOCRINOLOGY, V148, P4185, DOI 10.1210/en.2007-0123; FRIEDMAN TC, 1995, ENDOCRINOLOGY, V136, P4462, DOI 10.1210/en.136.10.4462; FULLERTO.WW, 1970, P NATL ACAD SCI USA, V66, P1213, DOI 10.1073/pnas.66.4.1213; Hagihara Y, 2002, P NATL ACAD SCI USA, V99, P6619, DOI 10.1073/pnas.102172099; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Kjeldsen T, 2002, J BIOL CHEM, V277, P18245, DOI 10.1074/jbc.C200137200; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; Kuliawat R, 2000, MOL BIOL CELL, V11, P1959, DOI 10.1091/mbc.11.6.1959; LEVITT M, 1981, J MOL BIOL, V145, P251, DOI 10.1016/0022-2836(81)90342-9; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Meerovitch K, 1998, J BIOL CHEM, V273, P21025, DOI 10.1074/jbc.273.33.21025; Mulcahy LR, 2006, REGUL PEPTIDES, V133, P123, DOI 10.1016/j.regpep.2005.09.027; Mulcahy LR, 2005, J BIOL CHEM, V280, P39818, DOI 10.1074/jbc.M507193200; Nakagawa K, 2006, BIOCHEMISTRY-US, V45, P15468, DOI 10.1021/bi061420p; NILLNI EA, 1993, ENDOCRINOLOGY, V132, P1260, DOI 10.1210/en.132.3.1260; NILLNI EA, 1993, ENDOCRINOLOGY, V132, P1271, DOI 10.1210/en.132.3.1271; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; NILLNI EA, 1995, J NEUROCHEM, V65, P2462; Nillni EA, 1996, ENDOCRINOLOGY, V137, P5651, DOI 10.1210/en.137.12.5651; Nillni EA, 2002, J BIOL CHEM, V277, P48587, DOI 10.1074/jbc.M206702200; Osvath S, 2003, BIOPHYS J, V85, P1215, DOI 10.1016/S0006-3495(03)74557-3; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Schaner P, 1997, J BIOL CHEM, V272, P19958, DOI 10.1074/jbc.272.32.19958; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SEVARINO KA, 1989, J BIOL CHEM, V264, P21529; SNELL CR, 1975, J BIOL CHEM, V250, P6291; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Truckses DM, 1996, PROTEIN SCI, V5, P1907, DOI 10.1002/pro.5560050917; Varlamov O, 1999, J BIOL CHEM, V274, P14040, DOI 10.1074/jbc.274.20.14040; Wigley WC, 2002, NAT STRUCT BIOL, V9, P381, DOI 10.1038/nsb784; YUTANI K, 1991, PROTEINS, V9, P90, DOI 10.1002/prot.340090203; ZHOU A, 1993, J BIOL CHEM, V268, P1763	40	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31438	31448		10.1074/jbc.M803413200	http://dx.doi.org/10.1074/jbc.M803413200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779326	hybrid, Green Published			2022-12-25	WOS:000260760800023
J	Pene-Dumitrescu, T; Peterson, LF; Donato, NJ; Smithgall, TE				Pene-Dumitrescu, T.; Peterson, L. F.; Donato, N. J.; Smithgall, T. E.			An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259	ONCOGENE			English	Article						Bcr-Abl; CML; Hck; Stat5; pyrrolo-pyrimidine; Src-family kinase inhibitor	CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL ONCOGENE; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; IMATINIB MESYLATE; SH3 DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; PHILADELPHIA-CHROMOSOME; LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC-CELLS	Chronic myelogenous leukemia (CML) is driven by Bcr-Abl, a constitutively active protein-tyrosine kinase that stimulates proliferation and survival of myeloid progenitors. Global inhibition of myeloid Src family kinase (SFK) activity with the broad-spectrum pyrrolo-pyrimidine inhibitor, A-419259, blocks proliferation and induces apoptosis in CML cell lines, suggesting that transformation by Bcr-Abl requires SFK activity. However, the contribution of Hck and other individual SFKs to Bcr-Abl signaling is less clear. Here, we developed an A-419259-resistant mutant of Hck by replacing the gatekeeper residue (Thr-338; c-Src numbering) in the inhibitor-binding site with a bulkier methionine residue (Hck-T338M). This substitution reduced Hck sensitivity to A-419259 by more than 30-fold without significantly affecting kinase activity in vitro. Expression of Hck-T338M protected K-562 CML cells and Bcr-Abl-transformed TF-1 myeloid cells from the apoptotic and antiproliferative effects of A-419259. These effects correlated with persistence of Hck-T338M kinase activity in the presence of the compound, and were accompanied by sustained Erk and Stat5 activation. In contrast, control cells expressing equivalent levels of wild-type Hck retained sensitivity to the inhibitor. We also show for the first time that A-419259 induces cell-cycle arrest and apoptosis in primary CD34(+) CML cells with equal potency to imatinib. These data suggest that Hck has a nonredundant function as a key downstream signaling partner for Bcr-Abl and may represent a potential drug target in CML.	[Pene-Dumitrescu, T.; Smithgall, T. E.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; [Peterson, L. F.; Donato, N. J.] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, E1240 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	tsmithga@pitt.edu			National Institutes of Health [CA101828, GM077629]; NATIONAL CANCER INSTITUTE [R01CA101828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (CA101828 and GM077629 to TES). We thank Dr David Calderwood of the Abbott Bioresearch Center for the generous gift of the Src family kinase inhibitor, A-419259 and Dr Elisabeth Buchdunger of Novartis, Inc. for providing imatinib mesylate.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Blencke S, 2003, J BIOL CHEM, V278, P15435, DOI 10.1074/jbc.M211158200; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; de Groot Rolf P., 2000, Molecular Cell Biology Research Communications, V3, P299, DOI 10.1006/mcbr.2000.0231; Donato NJ, 2004, CANCER RES, V64, P672, DOI 10.1158/0008-5472.CAN-03-1484; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; HARRISONFINDIK D, 1995, ONCOGENE, V10, P1385; Holtz MS, 2005, LEUKEMIA, V19, P1034, DOI 10.1038/sj.leu.2403724; Hoover RR, 2001, ONCOGENE, V20, P5826, DOI 10.1038/sj.onc.1204549; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian HM, 2007, CLIN CANCER RES, V13, P1089, DOI 10.1158/1078-0432.CCR-06-2147; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; Liu Y, 1998, BIOORGAN MED CHEM, V6, P1219, DOI 10.1016/S0968-0896(98)00099-6; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; Martinelli G, 2005, LEUKEMIA, V19, P1872, DOI 10.1038/sj.leu.2403950; Mauro MJ, 2004, LEUKEMIA RES, V28, pS71, DOI 10.1016/j.leukres.2003.10.017; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Million RP, 2000, BLOOD, V96, P664; Nakajima A, 2001, LEUKEMIA, V15, P989, DOI 10.1038/sj.leu.2402137; Neshat MS, 2000, MOL CELL BIOL, V20, P1179, DOI 10.1128/MCB.20.4.1179-1186.2000; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Raffel GD, 1996, J BIOL CHEM, V271, P4640; Ren RB, 2002, ONCOGENE, V21, P8629, DOI 10.1038/sj.onc.1206090; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Sattler M, 1996, ONCOGENE, V12, P839; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Shuai K, 1996, ONCOGENE, V13, P247; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhang XW, 2001, MOL CELL BIOL, V21, P840, DOI 10.1128/MCB.21.3.840-853.2001; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	70	31	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2008	27	56					7055	7069		10.1038/onc.2008.330	http://dx.doi.org/10.1038/onc.2008.330			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	376PQ	18794796	Green Accepted			2022-12-25	WOS:000261195900001
J	Josse, T; Maurel-Zaffran, C; de Vanssay, A; Teysset, L; Todeschini, AL; Delmarre, V; Chaminade, N; Anxolabehere, D; Ronsseray, S				Josse, Thibaut; Maurel-Zaffran, Corinne; de Vanssay, Augustin; Teysset, Laure; Todeschini, Anne-Laure; Delmarre, Valerie; Chaminade, Nicole; Anxolabehere, Dominique; Ronsseray, Stephane			Telomeric Trans-Silencing in Drosophila melanogaster. Tissue Specificity, Development and Functional Interactions between Non-Homologous Telomeres	PLOS ONE			English	Article								Background: The study of P element repression in Drosophila melanogaster led to the discovery of the telomeric Trans-Silencing Effect (TSE), a homology-dependent repression mechanism by which a P-transgene inserted in subtelomeric heterochromatin (Telomeric Associated Sequences, "TAS'') has the capacity to repress in trans, in the female germline, a homologous P-lacZ transgene located in euchromatin. TSE can show variegation in ovaries, displays a maternal effect as well as an epigenetic transmission through meiosis and involves heterochromatin and RNA silencing pathways. Principal Findings: Here, we analyze phenotypic and genetic properties of TSE. We report that TSE does not occur in the soma at the adult stage, but appears restricted to the female germline. It is detectable during development at the third instar larvae where it presents the same tissue specificity and maternal effect as in adults. Transgenes located in TAS at the telomeres of the main chromosomes can be silencers which in each case show the maternal effect. Silencers located at non-homologous telomeres functionally interact since they stimulate each other via the maternally-transmitted component. All germinally-expressed euchromatic transgenes tested, located on all major chromosomes, were found to be repressed by a telomeric silencer: thus we detected no TSE escaper. The presence of the euchromatic target transgene is not necessary to establish the maternal inheritance of TSE, responsible for its epigenetic behavior. A single telomeric silencer locus can simultaneously repress two P-lacZ targets located on different chromosomal arms. Conclusions and Significance: Therefore TSE appears to be a widespread phenomenon which can involve different telomeres and work across the genome. It can explain the P cytotype establishment by telomeric P elements in natural Drosophila populations.	[Josse, Thibaut; Maurel-Zaffran, Corinne; de Vanssay, Augustin; Teysset, Laure; Todeschini, Anne-Laure; Delmarre, Valerie; Anxolabehere, Dominique; Ronsseray, Stephane] Univ Paris 06, CNRS, UMR7592, Inst Jacques Monod, Lab Dynam Genome Evol, F-75252 Paris, France; [Josse, Thibaut; Maurel-Zaffran, Corinne; de Vanssay, Augustin; Teysset, Laure; Todeschini, Anne-Laure; Delmarre, Valerie; Anxolabehere, Dominique; Ronsseray, Stephane] Univ Paris 07, F-75221 Paris, France; [de Vanssay, Augustin; Teysset, Laure; Todeschini, Anne-Laure; Delmarre, Valerie; Ronsseray, Stephane] Univ Paris 06, CNRS, UMR7622, Lab Biol Dev, F-75252 Paris, France; [Chaminade, Nicole] CNRS, Bat 13, UPR 9034, Lab Evol, Genomes, Speciat, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Josse, T (corresponding author), Univ Paris 05, UPR2228, CNRS, UFR Biomed, Paris, France.	stephane.ronsseray@snv.jussieu.fr	Ronsseray, Stephane/AAD-6378-2021; Josse, Thibaut/F-5606-2016	Josse, Thibaut/0000-0002-6607-506X; Teysset, Laure/0000-0002-7413-1850	Centre National de la Recherche Scientifique; Universite Pierre & Marie Curie - Paris 6; Universite Paris-Diderot - Paris 7; Action Concertee Incitative - Biologie Moleculaire et Structurale" programme; Association pour la Recherche sur le Cancer; French government (Ministere de l'Enseignement Superieur et de la Recherche) [graduate student fellowships]; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre & Marie Curie - Paris 6; Universite Paris-Diderot - Paris 7; Action Concertee Incitative - Biologie Moleculaire et Structurale" programme; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); French government (Ministere de l'Enseignement Superieur et de la Recherche); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the "Centre National de la Recherche Scientifique" ("Institut Jacques Monod - Unite Mixte de Recherche 7592" and "Laboratoire de Biologie du developpement - Unite Mixte de Recherche 7622"), by the Universite Pierre & Marie Curie - Paris 6, by the Universite Paris-Diderot - Paris 7, by the "Action Concertee Incitative - Biologie Moleculaire et Structurale" programme and by the "Association pour la Recherche sur le Cancer". T.J and A.V. were supported by graduate student fellowships from the French government (Ministere de l'Enseignement Superieur et de la Recherche). T.J was also supported by the "Association pour la Recherche sur le Cancer". A.L.T. was supported by a post-doctoral position fellowship from the "Fondation pour la Recherche Medicale." We thank these organizations for their funding.	Andreyeva EN, 2005, J CELL SCI, V118, P5465, DOI 10.1242/jcs.02654; ANXOLABEHERE D, 1988, MOL BIOL EVOL, V5, P252; ANXOLABEHERE D, 1987, EVOLUTION, V41, P846, DOI 10.1111/j.1558-5646.1987.tb05857.x; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; BINGHAM PM, 1982, CELL, V29, P995, DOI 10.1016/0092-8674(82)90463-9; BLACK DM, 1987, EMBO J, V6, P4125, DOI 10.1002/j.1460-2075.1987.tb02758.x; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Boivin A, 2003, GENETICS, V164, P195; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Chalvet F, 1999, EMBO J, V18, P2659, DOI 10.1093/emboj/18.9.2659; COEN D, 1994, GENETICA, V93, P61, DOI 10.1007/BF01435240; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; DANIELS SB, 1987, GENETICS, V115, P711; Desset S, 2003, GENETICS, V164, P501; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Dorer DR, 1997, GENETICS, V147, P1181; ENGELS WR, 1979, P NATL ACAD SCI USA, V76, P4011, DOI 10.1073/pnas.76.8.4011; ENGELS WR, 1989, P ELEMENTS DROSOPHIL, P437; Frydrychova RC, 2007, MOL CELL BIOL, V27, P4991, DOI 10.1128/MCB.00515-07; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; GLOOR GB, 1993, GENETICS, V135, P81; Golubovsky MD, 2001, GENETICS, V158, P1111; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; JENSEN PA, 2008, GENETICS; Josse T, 2007, PLOS GENET, V3, P1633, DOI 10.1371/journal.pgen.0030158; KARPEN GH, 1992, GENETICS, V132, P737; KIDWELL MG, 1977, GENETICS, V86, P813; KIDWELL MG, 1983, P NATL ACAD SCI-BIOL, V80, P1655, DOI 10.1073/pnas.80.6.1655; LEMAITRE B, 1993, GENETICS, V135, P149; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; LEVIS RW, 1989, CELL, V58, P791, DOI 10.1016/0092-8674(89)90112-8; LEVIS RW, 1993, CELL, V75, P1083, DOI 10.1016/0092-8674(93)90318-K; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Marin L, 2000, GENETICS, V155, P1841; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; Mason JM, 2003, GENETICS, V163, P917; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; MISRA S, 1993, GENETICS, V135, P785; MISRA S, 1990, CELL, V62, P269, DOI 10.1016/0092-8674(90)90365-L; Niemi JB, 2004, GENETICS, V166, P255, DOI 10.1534/genetics.166.1.255; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; PELISSON A, 2006, J VIROL; PRESTON CR, 1989, PROG NUCLEIC ACID RE, V36, P71; RASMUSSON KE, 1993, GENETICS, V133, P605; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; RIO DC, 1991, TRENDS GENET, V7, P282, DOI 10.1016/0168-9525(91)90176-Q; Rio Donald C., 2002, P484; ROBERTSON HM, 1989, GENETICS, V123, P815; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1996, GENETICS, V143, P1663; RONSSERAY S, 1993, MOL GEN GENET, V241, P115, DOI 10.1007/BF00280208; RONSSERAY S, 1989, CHROMOSOMA, V98, P207, DOI 10.1007/BF00329685; Ronsseray S, 1998, GENETICS, V149, P1857; RONSSERAY S, 1991, GENETICS, V129, P501; Ronsseray S, 2003, GENETICA, V117, P327, DOI 10.1023/A:1022929121828; Ronsseray S, 2001, GENETICS, V159, P1631; ROSEMAN RR, 1995, GENETICS, V141, P1061; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Simmons MJ, 2007, GENETICS, V176, P1945, DOI 10.1534/genetics.106.066746; Simmons MJ, 2004, GENETICS, V166, P243, DOI 10.1534/genetics.166.1.243; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stuart JR, 2002, GENETICS, V162, P1641; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	71	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3249	10.1371/journal.pone.0003249	http://dx.doi.org/10.1371/journal.pone.0003249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18813361	Green Published, Green Submitted, gold			2022-12-25	WOS:000264430800001
J	Hashimoto, K; Nishiyama, S; Ohba, H; Matsuo, M; Kobashi, T; Takahagi, M; Iyo, M; Kitashoji, T; Tsukada, H				Hashimoto, Kenji; Nishiyama, Shingo; Ohba, Hiroyuki; Matsuo, Masaaki; Kobashi, Tatsuhiko; Takahagi, Makoto; Iyo, Masaomi; Kitashoji, Takeru; Tsukada, Hideo			[C-11]CHIBA-1001 as a Novel PET Ligand for alpha 7 Nicotinic Receptors in the Brain: A PET Study in Conscious Monkeys	PLOS ONE			English	Article								Background: The alpha 7 nicotinic acetylcholine receptors (nAChRs) play an important role in the pathophysiology of neuropsychiatric diseases such as schizophrenia and Alzheimer's disease. However, there are currently no suitable positron emission tomography (PET) radioligands for imaging a7 nAChRs in the intact human brain. Here we report the novel PET radioligand [C-11] CHIBA-1001 for in vivo imaging of alpha 7 nAChRs in the non-human primate brain. Methodology/Principal Findings: A receptor binding assay showed that CHIBA-1001 was a highly selective ligand at alpha 7 nAChRs. Using conscious monkeys, we found that the distribution of radioactivity in the monkey brain after intravenous administration of [C-11] CHIBA-1001 was consistent with the regional distribution of alpha 7 nAChRs in the monkey brain. The distribution of radioactivity in the brain regions after intravenous administration of [C-11] CHIBA-1001 was blocked by pretreatment with the selective alpha 7 nAChR agonist SSR180711 (5.0 g/kg). However, the distribution of [C-11] CHIBA-1001 was not altered by pretreatment with the selective alpha 4 beta 2 nAChR agonist A85380 (1.0 mg/kg). Interestingly, the binding of [C-11]CHIBA-1001 in the frontal cortex of the monkey brain was significantly decreased by subchronic administration of the N-methyl-D-aspartate (NMDA) receptor antagonist phencyclidine (0.3 mg/kg, twice a day for 13 days); which is a non-human primate model of schizophrenia. Conclusions/Significance: The present findings suggest that [C-11]CHIBA-1001 could be a novel useful PET ligand for in vivo study of the receptor occupancy and pathophysiology of alpha 7 nAChRs in the intact brain of patients with neuropsychiatric diseases such as schizophrenia and Alzheimer's disease.	[Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan; [Iyo, Masaomi] Chiba Univ, Ctr Forensic Mental Hlth, Div Med Treatment & Rehab, Chiba, Japan; [Nishiyama, Shingo; Ohba, Hiroyuki; Tsukada, Hideo] Hamamatsu Photonics K K, Cent Res Lab, PET Ctr, Hamamatsu, Shizuoka, Japan; [Matsuo, Masaaki; Kobashi, Tatsuhiko; Takahagi, Makoto; Kitashoji, Takeru] Nard Inst Ltd, Amagasaki, Hyogo, Japan; [Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan	Chiba University; Chiba University; Hamamatsu Photonics; Chiba University	Hashimoto, K (corresponding author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015; Waldvogel, Henry/D-6691-2012	Hashimoto, Kenji/0000-0002-8892-0439; Waldvogel, Henry/0000-0003-2165-8568	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan; Research Program on Development of Innovative Technology, Japan Science and Technology Agency (JST); CREST, JST	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); Research Program on Development of Innovative Technology, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported in part by grants from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan (to K.H.), Research Program on Development of Innovative Technology, Japan Science and Technology Agency (JST), and CREST, JST (to H.T.). These funders had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report, and in the decision to submit the paper for publication.	Biton B, 2007, NEUROPSYCHOPHARMACOL, V32, P1, DOI 10.1038/sj.npp.1301189; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Briggs CA, 2008, BRIT J PHARMACOL, V153, P1054, DOI 10.1038/sj.bjp.0707649; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Brody AL, 2006, ARCH GEN PSYCHIAT, V63, P907, DOI 10.1001/archpsyc.63.8.907; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Burghaus L, 2000, MOL BRAIN RES, V76, P385; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Court J, 2001, BIOL PSYCHIAT, V49, P175, DOI 10.1016/S0006-3223(00)01116-1; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; FREEDMAN R, 1994, HARVARD REV PSYCHIAT, V2, P179, DOI 10.3109/10673229409017136; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Gallezot JD, 2005, J NUCL MED, V46, P240; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Han ZY, 2003, J COMP NEUROL, V461, P49, DOI 10.1002/cne.10659; Hashimoto K, 2004, NEUROPSYCHOPHARMACOL, V29, P2018, DOI 10.1038/sj.npp.1300512; Hashimoto K., 2007, NEUROGENETICS PSYCHI, P81; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Hashimoto K, 2007, BIOL PSYCHIAT, V61, P577, DOI 10.1016/j.biopsych.2006.03.019; Hashimoto K, 2005, CURR PSYCHIATRY REV, V1, P151, DOI 10.2174/1573400054065569; Hashimoto Kenji, 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P171, DOI 10.2174/1568015054863828; Hashimoto K, 2006, EUR J PHARMACOL, V553, P191, DOI 10.1016/j.ejphar.2006.09.055; Heiss WD, 2006, J NUCL MED, V47, P302; Hellstrom-Lindahl E, 1999, MOL BRAIN RES, V66, P94, DOI 10.1016/S0169-328X(99)00030-3; Horti AG, 2006, CURR PHARM DESIGN, V12, P3877, DOI 10.2174/138161206778559605; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Jessen F, 2001, AM J PSYCHIAT, V158, P1319, DOI 10.1176/appi.ajp.158.8.1319; Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7; Koike K, 2005, SCHIZOPHR RES, V76, P67, DOI 10.1016/j.schres.2004.12.016; Kulak JM, 2006, EUR J NEUROSCI, V23, P2604, DOI 10.1111/j.1460-9568.2006.04804.x; Kulak JM, 2004, BRAIN RES, V999, P193, DOI 10.1016/j.brainres.2003.10.062; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Martin-Ruiz CM, 2003, BIOL PSYCHIAT, V54, P1222, DOI 10.1016/S0006-3223(03)00348-2; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; Nomikos GG, 2000, BEHAV BRAIN RES, V113, P97, DOI 10.1016/S0166-4328(00)00204-7; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; ONOE H, 1994, BRAIN RES, V663, P191, DOI 10.1016/0006-8993(94)91263-7; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Pichat P, 2007, NEUROPSYCHOPHARMACOL, V32, P17, DOI 10.1038/sj.npp.1301188; Rueter LE, 2006, CNS DRUG REV, V12, P100, DOI 10.1111/j.1527-3458.2006.00100.x; Sihver W, 2000, BEHAV BRAIN RES, V113, P143, DOI 10.1016/S0166-4328(00)00209-6; Sullivan JP, 1996, NEUROPHARMACOLOGY, V35, P725, DOI 10.1016/0028-3908(96)84644-2; TAKECHI H, 1994, NEUROSCI LETT, V182, P279, DOI 10.1016/0304-3940(94)90816-8; Tsukada H, 2005, NEUROPSYCHOPHARMACOL, V30, P1861, DOI 10.1038/sj.npp.1300732; Watanabe M, 1997, IEEE T NUCL SCI, V44, P1277, DOI 10.1109/23.597001	51	51	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3231	10.1371/journal.pone.0003231	http://dx.doi.org/10.1371/journal.pone.0003231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800169	gold, Green Published, Green Submitted			2022-12-25	WOS:000264428400002
J	Yan, RHY; Malisch, JL; Hannon, RM; Hurd, PL; Garland, T				Yan, Reginia H. Y.; Malisch, Jessica L.; Hannon, Robert M.; Hurd, Peter L.; Garland, Theodore, Jr.			Selective Breeding for a Behavioral Trait Changes Digit Ratio	PLOS ONE			English	Article							WHEEL-RUNNING BEHAVIOR; FINGER-LENGTH RATIOS; SEXUAL-DIMORPHISM; POPULATION DIFFERENCES; PHASIANUS-COLCHICUS; FETAL TESTOSTERONE; 4TH-DIGIT RATIO; HOUSE MICE; AGGRESSION; WOMEN	The ratio of the length of the second digit (index finger) divided by the fourth digit (ring finger) tends to be lower in men than in women. This 2D:4D digit ratio is often used as a proxy for prenatal androgen exposure in studies of human health and behavior. For example, 2D:4D ratio is lower (i.e. more "masculinized'') in both men and women of greater physical fitness and/or sporting ability. Lab mice have also shown variation in 2D:4D as a function of uterine environment, and mouse digit ratios seem also to correlate with behavioral traits, including daily activity levels. Selective breeding for increased rates of voluntary exercise (wheel running) in four lines of mice has caused correlated increases in aerobic exercise capacity, circulating corticosterone level, and predatory aggression. Here, we show that this selection regime has also increased 2D:4D. This apparent "feminization'' in mice is opposite to the relationship seen between 2D:4D and physical fitness in human beings. The present results are difficult to reconcile with the notion that 2D: 4D is an effective proxy for prenatal androgen exposure; instead, it may more accurately reflect effects of glucocorticoids, or other factors that regulate any of many genes.	[Yan, Reginia H. Y.; Hurd, Peter L.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Malisch, Jessica L.; Hannon, Robert M.; Garland, Theodore, Jr.] Univ Calif Riverside, Dept Biol, Riverside, CA USA	University of Alberta; University of California System; University of California Riverside	Yan, RHY (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	phurd@ualberta.ca	Hurd, Peter L/A-4342-2009	Hurd, Peter L/0000-0002-4389-0846; Malisch, Jessica/0000-0002-0251-2398; Garland, Theodore/0000-0002-7916-3552	Natural Sciences and Engineering Research Council (NSERC Canada) [249685]; National Science Foundation [IOB-0543429]; University of California Office of the President Dissertation Award	Natural Sciences and Engineering Research Council (NSERC Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); University of California Office of the President Dissertation Award	Supported by Natural Sciences and Engineering Research Council (NSERC Canada) PGS-M scholarship to R.H.Y., NSERC Discovery Grant (249685) to P.L.H., and National Science Foundation grant (IOB-0543429) to T.G. J.L.M was supported by the University of California Office of the President Dissertation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AA, 2005, GENES BRAIN BEHAV, V4, P318, DOI 10.1111/j.1601-183X.2004.00110.x; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; BAKER F, 1888, AM ANTHROPOL, V1, P51, DOI DOI 10.1525/AA.1888.1.1.02A00040; Benderlioglu Z, 2004, HORM BEHAV, V46, P558, DOI 10.1016/j.yhbeh.2004.06.004; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Brown WM, 2002, ANAT RECORD, V267, P231, DOI 10.1002/ar.10108; Burley NT, 2004, P ROY SOC B-BIOL SCI, V271, P239, DOI 10.1098/rspb.2003.2562; Chang JL, 2006, CAN J ZOOL, V84, P1489, DOI 10.1139/Z06-144; Forstmeier W, 2005, P R SOC B, V272, P2641, DOI 10.1098/rspb.2005.3264; Gammie SC, 2003, HORM BEHAV, V44, P209, DOI 10.1016/S0018-506X(03)00140-5; GARLAND T, 2009, EXPT EVOLUT IN PRESS; George R, 1930, ANAT REC, V46, P199, DOI 10.1002/ar.1090460210; Gitau R, 2005, ARCH DIS CHILD-FETAL, V90, P166, DOI 10.1136/adc.2004.049320; Gobrogge KL, 2008, ARCH SEX BEHAV, V37, P112, DOI 10.1007/s10508-007-9272-2; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Hurd PL, 2008, ARCH SEX BEHAV, V37, P9, DOI 10.1007/s10508-007-9259-z; Hurd PL, 2006, GENES BRAIN BEHAV, V5, P300; KLOEPFER HW, 1946, ANN EUGENIC, V13, P35, DOI 10.1111/j.1469-1809.1946.tb02342.x; Loehlin JC, 2006, ARCH SEX BEHAV, V35, P739, DOI 10.1007/s10508-006-9039-1; Lombardo MP, 2008, ANAT REC, V291, P433, DOI 10.1002/ar.20657; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Malisch JL, 2008, GEN COMP ENDOCR, V156, P210, DOI 10.1016/j.ygcen.2008.01.020; MALSICH JL, 2007, PHYS BIOCH ZOOL, V80, P146; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 2003, ANN HUM BIOL, V30, P579, DOI 10.1080/0301446032000112689; Manning JT, 2003, MED HYPOTHESES, V60, P340, DOI 10.1016/S0306-9877(02)00400-0; Manning JT, 2002, J SPORT MED PHYS FIT, V42, P446; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; Manning JT., 2002, DIGIT RATIO POINTER; McIntyre MH, 2007, PERS INDIV DIFFER, V42, P755, DOI 10.1016/j.paid.2006.08.009; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; Okten A, 2002, EARLY HUM DEV, V70, P47, DOI 10.1016/S0378-3782(02)00073-7; Paul SN, 2006, BRIT J SPORT MED, V40, P981, DOI 10.1136/bjsm.2006.027193; Paul SN, 2006, TWIN RES HUM GENET, V9, P215, DOI 10.1375/twin.9.2.215; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Pokrywka L, 2005, AM J HUM BIOL, V17, P796, DOI 10.1002/ajhb.20449; Putz DA, 2004, EVOL HUM BEHAV, V25, P182, DOI 10.1016/j.evolhumbehav.2004.03.005; Rezende EL, 2006, J APPL PHYSIOL, V101, P477, DOI 10.1152/japplphysiol.00042.2006; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, ANAT REC PART A, V288A, P491, DOI 10.1002/ar.a.20323; Saino N, 2007, NATURWISSENSCHAFTEN, V94, P207, DOI 10.1007/s00114-006-0188-9; Sokal RR, 1995, BIOMETRY; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; van Anders SM, 2006, HORM BEHAV, V49, P315, DOI 10.1016/j.yhbeh.2005.08.003; Voracek M, 2006, GENES BRAIN BEHAV, V5, P299, DOI 10.1111/j.1601-183x.2006.00217.x; WILSON GD, 1983, PERS INDIV DIFFER, V4, P111, DOI 10.1016/0191-8869(83)90061-2	47	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3216	10.1371/journal.pone.0003216	http://dx.doi.org/10.1371/journal.pone.0003216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422LB	18797502	Green Published, gold			2022-12-25	WOS:000264428200004
J	Dash, RK; Li, YJ; Kim, J; Beard, DA; Saidel, GM; Cabrera, ME				Dash, Ranjan K.; Li, Yanjun; Kim, Jaeyeon; Beard, Daniel A.; Saidel, Gerald M.; Cabrera, Marco E.			Metabolic Dynamics in Skeletal Muscle during Acute Reduction in Blood Flow and Oxygen Supply to Mitochondria: In-Silico Studies Using a Multi-Scale, Top-Down Integrated Model	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; OXIDATIVE-PHOSPHORYLATION; PROLONGED EXERCISE; GLYCOGEN-PHOSPHORYLASE; CIRCULATORY OCCLUSION; COMPUTATIONAL MODEL; ENERGY-METABOLISM; POOL SIZE; LACTATE; GLYCOLYSIS	Control mechanisms of cellular metabolism and energetics in skeletal muscle that may become evident in response to physiological stresses such as reduction in blood flow and oxygen supply to mitochondria can be quantitatively understood using a multi-scale computational model. The analysis of dynamic responses from such a model can provide insights into mechanisms of metabolic regulation that may not be evident from experimental studies. For the purpose, a physiologically-based, multi-scale computational model of skeletal muscle cellular metabolism and energetics was developed to describe dynamic responses of key chemical species and reaction fluxes to muscle ischemia. The model, which incorporates key transport and metabolic processes and subcellular compartmentalization, is based on dynamic mass balances of 30 chemical species in both capillary blood and tissue cells (cytosol and mitochondria) domains. The reaction fluxes in cytosol and mitochondria are expressed in terms of a general phenomenological Michaelis-Menten equation involving the compartmentalized energy controller ratios ATP/ADP and NADH/NAD(+). The unknown transport and reaction parameters in the model are estimated simultaneously by minimizing the differences between available in vivo experimental data on muscle ischemia and corresponding model outputs in coupled with the resting linear flux balance constraints using a robust, nonlinear, constrained-based, reduced gradient optimization algorithm. With the optimal parameter values, the model is able to simulate dynamic responses to reduced blood flow and oxygen supply to mitochondria associated with muscle ischemia of several key metabolite concentrations and metabolic fluxes in the subcellular cytosolic and mitochondrial compartments, some that can be measured and others that can not be measured with the current experimental techniques. The model can be applied to test complex hypotheses involving dynamic regulation of cellular metabolism and energetics in skeletal muscle during physiological stresses such as ischemia, hypoxia, and exercise.	[Dash, Ranjan K.; Li, Yanjun; Kim, Jaeyeon; Saidel, Gerald M.; Cabrera, Marco E.] Case Western Reserve Univ, Ctr Modeling Integrat Metabol Syst, Cleveland, OH USA; [Li, Yanjun; Kim, Jaeyeon; Saidel, Gerald M.; Cabrera, Marco E.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH USA; [Cabrera, Marco E.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH USA; [Dash, Ranjan K.; Cabrera, Marco E.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH USA; [Beard, Daniel A.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI USA; [Beard, Daniel A.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Medical College of Wisconsin; Medical College of Wisconsin	Dash, RK (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	mec6@cwru.edu		Saidel, Gerald/0000-0003-2159-2343	National Aeronautics and Space Administration [NNJ06HD81G]; National Institute of General Medical Sciences of the National Institute of Health [GM-66309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM066309] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institute of General Medical Sciences of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work presented in this manuscript was supported by grants from the National Aeronautics and Space Administration (NASA Johnson Space Center-NNJ06HD81G) and the National Institute of General Medical Sciences of the National Institute of Health (GM-66309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645; Ainscow EK, 1999, EUR J BIOCHEM, V266, P737, DOI 10.1046/j.1432-1327.1999.00856.x; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Beard DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE633, DOI 10.1152/ajpendo.00239.2004; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; BEARD DA, 2008, MICROCIRCULATION, V1; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; Blomstrand E, 1999, J PHYSIOL-LONDON, V514, P293, DOI 10.1111/j.1469-7793.1999.293af.x; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; Brand MD, 1996, J THEOR BIOL, V182, P351, DOI 10.1006/jtbi.1996.0174; Cabrera ME, 1998, PROG BIOPHYS MOL BIO, V69, P539, DOI 10.1016/S0079-6107(98)00024-8; Cabrera ME, 1998, ANN BIOMED ENG, V26, P1, DOI 10.1114/1.28; Cabrera ME, 1999, AM J PHYSIOL-REG I, V277, pR1522, DOI 10.1152/ajpregu.1999.277.5.R1522; CHASIOTIS D, 1983, J PHYSIOL-LONDON, V345, P167, DOI 10.1113/jphysiol.1983.sp014972; Dash RK, 2008, IEEE T BIO-MED ENG, V55, P1298, DOI 10.1109/TBME.2007.913422; Dash RK, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-14; Dash RK, 2006, ANN BIOMED ENG, V34, P1129, DOI 10.1007/s10439-005-9066-4; Dash RK, 2004, ANN BIOMED ENG, V32, P1676, DOI 10.1007/s10439-004-7821-6; FELL D, 1996, UNDERSTANDING CONTRO; Gibala MJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE235; Gibala MJ, 2002, J PHYSIOL-LONDON, V545, P705, DOI 10.1113/jphysiol.2002.028084; GREEN HJ, 1995, J APPL PHYSIOL, V78, P138, DOI 10.1152/jappl.1995.78.1.138; GUTIERREZ G, 1988, J APPL PHYSIOL, V65, P608, DOI 10.1152/jappl.1988.65.2.608; Howarth KR, 2004, J APPL PHYSIOL, V97, P579, DOI 10.1152/japplphysiol.01344.2003; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; KATZ A, 1988, AM J PHYSIOL, V255, pC140, DOI 10.1152/ajpcell.1988.255.2.C140; KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011; Kushmerick MJ, 1998, COMP BIOCHEM PHYS B, V120, P109, DOI 10.1016/S0305-0491(98)00026-1; Lai N, 2006, EUR J APPL PHYSIOL, V97, P380, DOI 10.1007/s00421-006-0176-y; LAI N, 2007, ANN BIOMED ENG; Lambeth MJ, 2002, ANN BIOMED ENG, V30, P808, DOI 10.1114/1.1492813; Lasdon L. S., 1978, ACM Transactions on Mathematical Software, V4, P34, DOI 10.1145/355769.355773; Nelson DL, 2000, LEHNINGER PRINCIPLES; Parolin ML, 2000, AM J PHYSIOL-ENDOC M, V278, pE522, DOI 10.1152/ajpendo.2000.278.3.E522; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265; Putman CT, 1998, AM J PHYSIOL-ENDOC M, V275, pE132, DOI 10.1152/ajpendo.1998.275.1.E132; Radegran G, 1999, J APPL PHYSIOL, V87, P2375, DOI 10.1152/jappl.1999.87.6.2375; RADHAKRISHNAN K, 1993, RP1327 NASA; Ray CA, 1998, J APPL PHYSIOL, V85, P1194, DOI 10.1152/jappl.1998.85.3.1194; SAHLIN K, 1987, BIOCHEM J, V245, P551, DOI 10.1042/bj2450551; SAHLIN K, 1990, AM J PHYSIOL, V259, pC834, DOI 10.1152/ajpcell.1990.259.5.C834; Sahlin K., 2004, PRINCIPLES EXERCISE, P87; Segel IH., 1993, ENZYME KINETICS BEHA; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Timmons JA, 1996, AM J PHYSIOL-ENDOC M, V270, pE400, DOI 10.1152/ajpendo.1996.270.3.E400; TURCOTTE LP, 1992, AM J PHYSIOL, V262, pE791; van Hall G, 2002, J PHYSIOL-LONDON, V543, P1047, DOI 10.1113/jphysiol.2002.023796; Vinnakota K, 2006, BIOPHYS J, V91, P1264, DOI 10.1529/biophysj.105.073296; WAHREN J, 1971, J CLIN INVEST, V50, P2715, DOI 10.1172/JCI106772; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; Zhou LF, 2005, J PHYSIOL-LONDON, V569, P925, DOI 10.1113/jphysiol.2005.093146; Zhou LF, 2005, AM J PHYSIOL-HEART C, V288, pH2400, DOI 10.1152/ajpheart.01030.2004; Zhou LF, 2006, AM J PHYSIOL-HEART C, V291, pH1036, DOI 10.1152/ajpheart.01382.2005	59	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3168	10.1371/journal.pone.0003168	http://dx.doi.org/10.1371/journal.pone.0003168			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779864	Green Submitted, gold, Green Published			2022-12-25	WOS:000264425100004
J	Hossain, MJ; Hickman, D; Perez, DR				Hossain, Md Jaber; Hickman, Danielle; Perez, Daniel R.			Evidence of Expanded Host Range and Mammalian-Associated Genetic Changes in a Duck H9N2 Influenza Virus Following Adaptation in Quail and Chickens	PLOS ONE			English	Article							A VIRUSES; HUMAN INFECTION; AVIAN H9N2; HONG-KONG; MOLECULAR CHARACTERIZATION; POULTRY; TRANSMISSION; REPLICATION; EVOLUTION; HEMAGGLUTININ	H9N2 avian influenza viruses continue to circulate worldwide; in Asia, H9N2 viruses have caused disease outbreaks and established lineages in land-based poultry. Some H9N2 strains are considered potentially pandemic because they have infected humans causing mild respiratory disease. In addition, some of these H9N2 strains replicate efficiently in mice without prior adaptation suggesting that H9N2 strains are expanding their host range. In order to understand the molecular basis of the interspecies transmission of H9N2 viruses, we adapted in the laboratory a wildtype duck H9N2 virus, influenza A/duck/Hong Kong/702/79 (WT702) virus, in quail and chickens through serial lung passages. We carried out comparative analysis of the replication and transmission in quail and chickens of WT702 and the viruses obtained after 23 serial passages in quail (QA23) followed by 10 serial passages in chickens (QA23CkA10). Although the WT702 virus can replicate and transmit in quail, it replicates poorly and does not transmit in chickens. In contrast, the QA23CkA10 virus was very efficient at replicating and transmitting in quail and chickens. Nucleotide sequence analysis of the QA23 and QA23CkA10 viruses compared to the WT702 virus indicated several nucleotide substitutions resulting in amino acid changes within the surface and internal proteins. In addition, a 21-amino acid deletion was found in the stalk of the NA protein of the QA23 virus and was maintained without further modification in the QA23CkA10 adapted virus. More importantly, both the QA23 and the QA23CkA10 viruses, unlike the WT702 virus, were able to readily infect mice, produce a large-plaque phenotype, showed faster replication kinetics in tissue culture, and resulted in the quick selection of the K627 amino acid mammalian-associated signature in PB2. These results are in agreement with the notion that adaptation of H9 viruses to land-based birds can lead to strains with expanded host range.	[Hossain, Md Jaber; Hickman, Danielle; Perez, Daniel R.] Univ Maryland, Dept Vet Med, College Pk, MD USA; [Hossain, Md Jaber; Hickman, Danielle; Perez, Daniel R.] Virginia Maryland Region Coll Vet Med, College Pk, MD USA	University System of Maryland; University of Maryland College Park	Hossain, MJ (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Mol Virol & Vaccines Branch, Atlanta, GA 30333 USA.	dperez1@umd.edu	Perez, Daniel R./D-5044-2016	Perez, Daniel R./0000-0002-6569-5689	NIAID-NIH [RO1AI052155, HHSN266200700010C]; USDA-CSREES [2005-05523]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052155] Funding Source: NIH RePORTER	NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded in part from the following grants and contracts: NIAID-NIH RO1AI052155, USDA-CSREES 2005-05523, and NIAID-NIH HHSN266200700010C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; BEARE AS, 1991, ARCH VIROL, V119, P37, DOI 10.1007/BF01314321; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kim JA, 2006, VET MICROBIOL, V118, P169, DOI 10.1016/j.vetmic.2006.07.007; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Lee CW, 2000, AVIAN DIS, V44, P527, DOI 10.2307/1593091; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Lipatov AS, 2003, J VIROL, V77, P3816, DOI 10.1128/JVI.77.6.3816-3823.2003; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; Mase M, 2005, VIROLOGY, V339, P101, DOI 10.1016/j.virol.2005.05.010; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; MURPHY BR, 1982, INFECT IMMUN, V37, P1119, DOI 10.1128/IAI.37.3.1119-1126.1982; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Nili H, 2003, AVIAN DIS, V47, P828, DOI 10.1637/0005-2086-47.s3.828; Ninomiya A, 2002, VET MICROBIOL, V88, P107, DOI 10.1016/S0378-1135(02)00105-0; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Peiris M, 1999, J CLIN MICROBIOL, V37, P3426, DOI 10.1128/JCM.37.10.3426-3427.1999; Perez DR, 2003, AVIAN DIS, V47, P1114, DOI 10.1637/0005-2086-47.s3.1114; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Sorrell EM, 2007, AVIAN DIS, V51, P264, DOI 10.1637/7538-032906R.1; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06	52	104	111	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3170	10.1371/journal.pone.0003170	http://dx.doi.org/10.1371/journal.pone.0003170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779858	Green Published, gold, Green Submitted			2022-12-25	WOS:000264425100006
J	Saslowsky, DE; Tanaka, N; Reddy, KP; Lencer, WI				Saslowsky, David E.; Tanaka, Noriyuki; Reddy, Krishna P.; Lencer, Wayne I.			Ceramide activates JNK to inhibit a cAMP-gated K+ conductance and Cl- secretion in intestinal epithelia	FASEB JOURNAL			English	Article						sphingomyelinase; sphingomyelin; potassium channel	POTASSIUM CHANNEL; ALKALINE SPHINGOMYELINASE; NEUTRAL SPHINGOMYELINASE; ACID SPHINGOMYELINASE; STAPHYLOCOCCUS-AUREUS; CHLORIDE SECRETION; PLASMA-MEMBRANE; IN-VIVO; CELLS; MODEL	Sphingomyelinases (SMases) hydrolyze membrane sphingomyelin to ceramide and are expressed by diverse host and microbial cell types populating mucosal surfaces. Exogenous bacterial SMase acts on the basolateral membrane of polarized human intestinal epithelial cells to repress the cAMP-induced Cl- secretory response, but how this occurs is unknown. We show here that SMase acts by down-regulating a cAMP-gated basolateral membrane K+ conductance. Neither phosphocholine, ceramide-1-phosphate, nor sphingosine-1-phosphate recapitulates this effect, indicating that ceramide production is the decisive factor. Basolaterally applied SMase induced the phosphorylation of c-Jun NH2-terminal kinase (JNK), and inhibition of JNK rescued the effect of SMase on cAMP-dependant secretion. SMase secreted by normal human fibroblasts specifically recapitulated the effect on cAMP-induced Cl- secretion, indicating that cell types inhabiting the subepithelial space can provide such an activity to the basolateral membrane of intestinal enterocytes in trans. Thus, conversion of sphingomyelin to ceramide in basolateral membranes of intestinal cells rapidly activates JNK to inhibit a cAMP-gated K+ conductance and thereby attenuates Cl- secretion. These results define a novel lipid-mediated pathway for regulation of salt and water homeostasis at mucosal surfaces.-Saslowsky, D. E., Tanaka, N., Reddy, K. P., Lencer, W. I. Ceramide activates JNK to inhibit a cAMP-gated K+ conductance and Cl- secretion in intestinal epithelia. FASEB J. 23, 259-270 (2009)	[Saslowsky, David E.; Lencer, Wayne I.] Childrens Hosp, GI Cell Biol, Boston, MA 02115 USA; [Saslowsky, David E.; Lencer, Wayne I.] Harvard Digest Dis Ctr, Boston, MA USA; [Saslowsky, David E.; Reddy, Krishna P.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Tanaka, Noriyuki] Teine Keijinkai Hosp, Sapporo, Hokkaido, Japan	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Teine Keijinkai Hospital	Saslowsky, DE (corresponding author), Childrens Hosp, GI Cell Biol, 300 Longwood Ave,Enders 720, Boston, MA 02115 USA.	saslowsky@childrens.harvard.edu		Lencer, Wayne/0000-0001-7346-2730	NIDDK NIH HHS [R01 DK048106, DK48106, P30 DK034854, P30 DK040561, R01 DK084424, P30 DK040561-13, K01 DK073480, R37 DK048106, DK34854] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, P30DK040561, R01DK084424, K01DK073480, R37DK048106, R01DK048106] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ago H, 2006, J BIOL CHEM, V281, P16157, DOI 10.1074/jbc.M601089200; Bajwa PJ, 2007, AM J PHYSIOL-GASTR L, V293, pG1288, DOI 10.1152/ajpgi.00234.2007; BARRETT KE, 1993, AM J PHYSIOL, V265, pC859; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhalla A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-105; Bock J, 2003, BIOCHEM BIOPH RES CO, V305, P890, DOI 10.1016/S0006-291X(03)00763-0; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bourbon NA, 2001, AM J PHYSIOL-CELL PH, V280, pC1403, DOI 10.1152/ajpcell.2001.280.6.C1403; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Chapman H, 2005, J CELL SCI, V118, P5325, DOI 10.1242/jcs.02635; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Chik CL, 2001, J NEUROCHEM, V79, P339, DOI 10.1046/j.1471-4159.2001.00566.x; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Colina C, 2005, ARCH BIOCHEM BIOPHYS, V436, P333, DOI 10.1016/j.abb.2005.02.014; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; De Luca HE, 2006, METH MOL B, V341, P127; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Duan RD, 2003, J LIPID RES, V44, P1241, DOI 10.1194/jlr.M300037-JLR200; Ella KM, 1997, ARCH BIOCHEM BIOPHYS, V340, P101, DOI 10.1006/abbi.1997.9897; Farokhzad OC, 1999, J CELL PHYSIOL, V181, P489, DOI 10.1002/(SICI)1097-4652(199912)181:3<489::AID-JCP13>3.0.CO;2-7; Fink CC, 1999, J CELL BIOL, V147, P929, DOI 10.1083/jcb.147.5.929; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; GILBERT RJ, 1984, BIOCHEM SOC T, V12, P198, DOI 10.1042/bst0120198; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Gonzalez-Zorn B, 1999, MOL MICROBIOL, V33, P510, DOI 10.1046/j.1365-2958.1999.01486.x; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Gulbins E, 1997, P NATL ACAD SCI USA, V94, P7661, DOI 10.1073/pnas.94.14.7661; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Huwiler A, 2000, BBA-MOL CELL BIOL L, V1485, P63, DOI 10.1016/S1388-1981(00)00042-1; Ito Y, 2004, BIOCHEM BIOPH RES CO, V324, P901, DOI 10.1016/j.bbrc.2004.09.134; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Lee CY, 2006, J LIPID RES, V47, P622, DOI 10.1194/jlr.M500487-JLR200; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; LENCER WI, 1995, P NATL ACAD SCI USA, V92, P10094, DOI 10.1073/pnas.92.22.10094; Lepple-Wienhues A, 1999, P NATL ACAD SCI USA, V96, P13795, DOI 10.1073/pnas.96.24.13795; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Martial S, 2008, BIOCHEM BIOPH RES CO, V366, P944, DOI 10.1016/j.bbrc.2007.12.027; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Rawat SS, 2006, GLYCOCONJUGATE J, V23, P189, DOI 10.1007/s10719-006-7924-4; Ray AJ, 2003, CLIN INFECT DIS, V37, P875, DOI 10.1086/377451; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Saslowsky DE, 2008, CELL MICROBIOL, V10, P67, DOI 10.1111/j.1462-5822.2007.01015.x; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Si JM, 2004, WORLD J GASTROENTERO, V10, P1802; Sjoqvist U, 2002, INFLAMM BOWEL DIS, V8, P258; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Subbaiah PV, 2003, J LIPID RES, V44, P1574, DOI 10.1194/jlr.M300103-JLR200; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; Tseng HJ, 2004, BIOCHEM BIOPH RES CO, V314, P513, DOI 10.1016/j.bbrc.2003.12.125; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; VARNUM MD, 1993, P NATL ACAD SCI USA, V90, P11528, DOI 10.1073/pnas.90.24.11528; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wang HT, 2001, CANCER RES, V61, P5102; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Xiao GQ, 2003, BIOCHEM BIOPH RES CO, V306, P1019, DOI 10.1016/S0006-291X(03)01095-7; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	70	7	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					259	270		10.1096/fj.08-116467	http://dx.doi.org/10.1096/fj.08-116467			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18820034	Green Published			2022-12-25	WOS:000262095500028
J	Jadin, L; Wu, XL; Ding, H; Frost, GI; Onclinx, C; Triggs-Raine, B; Flamion, B				Jadin, Laurence; Wu, Xiaoli; Ding, Hao; Frost, Gregory I.; Onclinx, Cecile; Triggs-Raine, Barbara; Flamion, Bruno			Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX?	FASEB JOURNAL			English	Article						hyaluronan; hyaluronidase; sinusoidal endothelial cells; hemolysis; frontonasal suture	JAAGSIEKTE SHEEP RETROVIRUS; HYALURONIC-ACID; CONGENITAL-ANOMALIES; SERUM HYALURONAN; ENDOCYTOSIS HARE; RAT-LIVER; RECEPTOR; GENES; MOUSE; TRANSFORMATION	The metabolism of hyaluronan (HA) relies on HA synthases and hyaluronidases, among which hyaluronidase-1 (HYAL1) and -2 (HYAL2) have been proposed as key actors. Congenital HYAL1 deficiency leads to mucopolysaccharidosis IX (MPS IX), a rare lysosomal storage disorder characterized by joint abnormalities. Knowledge of HYAL2 is limited. This protein displays weak in vitro hyaluronidase activity and acts as a receptor for oncogenic ovine retroviruses. We have generated HYAL2-deficient mice through a conditional Cre-lox system. Hyal2(-/-) mice are viable and fertile. They exhibit localized congenital defects in frontonasal and vertebral bone formation and suffer from mild thrombocytopenia and chronic, possibly intravascular, hemolysis. In addition, Hyal2(-/-) mice display 10-fold increases in plasma levels of HA and 2-fold increases in plasma hyaluronidase activity. Globally, there is no HA accumulation in tissues, including bones, but liver sinusoidal cells seem overloaded with undigested HA. Taken together, these elements demonstrate for the first time that murine HYAL2 has a physiological activity in vivo that is relevant for cranio-vertebral bone formation, maintenance of plasma HA concentrations, and erythrocyte and platelet homeostasis. In addition, the viability of HYAL2-deficient mice raises the possibility that a similar defect, defining a new MPS disorder, exists in humans.-Jadin, L., Wu, X., Ding, H., Frost, G. I., Onclinx, C., Triggs-Raine, B., Flamion, B. Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX? FASEB J. 22, 4316-4326 (2008)	[Jadin, Laurence; Onclinx, Cecile; Flamion, Bruno] Univ Namur, Lab Physiol & Pharmacol, URPhyM, B-5000 Namur, Belgium; [Wu, Xiaoli; Ding, Hao; Triggs-Raine, Barbara] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Frost, Gregory I.] Halozyme Therapeut, San Diego, CA USA	University of Namur; University of Manitoba; Halozyme	Flamion, B (corresponding author), Univ Namur, Lab Physiol & Pharmacol, URPhyM, 61 Rue Bruxelles, B-5000 Namur, Belgium.	bruno.flamion@fundp.ac.be	Triggs-Raine, Barbara/AAF-6209-2021	Triggs-Raine, Barbara/0000-0003-4719-6779	Canadian Institutes of Health Research Innovative Technologies In Multidisciplinary Health Research Training (CIHR ITMHRT) program in Winnipeg	Canadian Institutes of Health Research Innovative Technologies In Multidisciplinary Health Research Training (CIHR ITMHRT) program in Winnipeg(Canadian Institutes of Health Research (CIHR))	During this study, Laurence Jadin was a Research Fellow from the Belgian Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (F.R.S.-FNRS) and a recipient of a short-term training award from the Canadian Institutes of Health Research Innovative Technologies In Multidisciplinary Health Research Training (CIHR ITMHRT) program in Winnipeg. We thank Olivier DeBacker for providing us with ES cells, Thierry VanReeth (BioVallee, Gosselies, Belgium) for PGK-Cre mice, Anirban Kundu for measurement of plasma hyaluronan and hyaluronidase samples, and Catherine Lambert for advice.	Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chajara A, 2000, DIABETOLOGIA, V43, P387; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; DEACIUC IV, 1993, HEPATOLOGY, V17, P266, DOI 10.1002/hep.1840170217; ELLIOTT S, 1988, ARCH DIS CHILD, V63, P1484, DOI 10.1136/adc.63.12.1484; Enomoto Katsuhiko, 2004, Medical Electron Microscopy, V37, P208, DOI 10.1007/s00795-004-0261-4; FRASER JRE, 1985, CELL TISSUE RES, V242, P505; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Frost GI, 1997, ANAL BIOCHEM, V251, P263, DOI 10.1006/abio.1997.2262; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HENSINGER RN, 1978, ORTHOP CLIN N AM, V9, P901; Ikegami-Kawai M, 2004, GLYCOBIOLOGY, V14, P65, DOI 10.1093/glycob/cwh011; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; JOHNSON DR, 1976, J ANAT, V121, P507; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; Mikles M, 1997, Am J Orthop (Belle Mead NJ), V26, P533; Myles DG, 1997, BIOL REPROD, V56, P320, DOI 10.1095/biolreprod56.2.320; Nagy A., 2003, MANIPULATING MOUSE E; Natowicz MR, 1996, NEW ENGL J MED, V335, P1029, DOI 10.1056/NEJM199610033351405; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Ramsden CA, 2000, J PEDIATR-US, V136, P62, DOI 10.1016/S0022-3476(00)90051-9; SHERIDAN O, 1994, J CRAN GENET DEV BIO, V14, P7; SMOKER WRK, 1994, RADIOGRAPHICS, V14, P255, DOI 10.1148/radiographics.14.2.8190952; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Suehiro Y, 2007, EUR J HAEMATOL, V79, P349, DOI 10.1111/j.1600-0609.2007.00909.x; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; TRUSLOVE GM, 1952, J GENET, V51, P115, DOI 10.1007/BF02986709; Vigdorovich V, 2007, J VIROL, V81, P3124, DOI 10.1128/JVI.02177-06; Wadhwa S, 2007, BONE, V40, P861, DOI 10.1016/j.bone.2006.11.003; Weigel JA, 2003, J BIOL CHEM, V278, P9808, DOI 10.1074/jbc.M211462200; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Zhang H, 2005, MOL REPROD DEV, V72, P404, DOI 10.1002/mrd.20360	42	68	71	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2008	22	12					4316	4326		10.1096/fj.08-111997	http://dx.doi.org/10.1096/fj.08-111997			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18772348				2022-12-25	WOS:000261254800030
J	Kanki, T; Klionsky, DJ				Kanki, Tomotake; Klionsky, Daniel J.			Mitophagy in Yeast Occurs through a Selective Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-AUTOPHAGOSOMAL STRUCTURE; VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; MONITORING AUTOPHAGY; ENDOPLASMIC-RETICULUM; CYTOPLASM; MITOCHONDRIA; DEGRADATION; MACHINERY; PROTEINS	The regulation of mitochondrial degradation through autophagy is expected to be a tightly controlled process, considering the significant role of this organelle in many processes ranging from energy production to cell death. However, very little is known about the specific nature of the degradation process. We developed a new method to detect mitochondrial autophagy (mitophagy) by fusing the green fluorescent protein at the C terminus of two endogenous mitochondrial proteins and monitored vacuolar release of green fluorescent protein. Using this method, we screened several atg mutants and found that ATG11, a gene that is essential only for selective autophagy, is also essential for mitophagy. In addition, we found that mitophagy is blocked even under severe starvation conditions, if the carbon source makes mitochondria essential for metabolism. These findings suggest that the degradation of mitochondria is a tightly regulated process and that these organelles are largely protected from nonspecific autophagic degradation.	[Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	klionsky@umich.edu	Kanki, Tomotake/H-7250-2012	Kanki, Tomotake/0000-0001-9646-5379	National Institutes of Health [GM53396]; Japan Society for the Promotion of Science Postdoctoral Fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science Postdoctoral Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53396 (to D.J.K.). This work was also supported by Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (to T.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; Abeliovich H, 2007, AUTOPHAGY, V3, P275, DOI 10.4161/auto.3915; Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; DAMSKY CH, 1976, J CELL BIOL, V71, P123, DOI 10.1083/jcb.71.1.123; Dunn WA, 2005, AUTOPHAGY, V1, P75; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Hutchins MU, 1999, J CELL SCI, V112, P4079; IBRAHIM NG, 1973, EUR J BIOCHEM, V36, P519, DOI 10.1111/j.1432-1033.1973.tb02938.x; Kabeya Y, 2007, BIOCHEM BIOPH RES CO, V356, P405, DOI 10.1016/j.bbrc.2007.02.150; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Keeble JA, 2007, CELL RES, V17, P976, DOI 10.1038/cr.2007.101; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Klionsky Daniel J., 2007, V390, P363; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Reggiori F, 2005, MOL BIOL CELL, V16, P5843, DOI 10.1091/mbc.E05-07-0629; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; Rep M, 1996, CURR GENET, V30, P367, DOI 10.1007/s002940050145; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tucker KA, 2003, J BIOL CHEM, V278, P48445, DOI 10.1074/jbc.M309238200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VISSER W, 1995, ANTON LEEUW INT J G, V67, P243, DOI 10.1007/BF00873688; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	57	260	270	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32386	32393		10.1074/jbc.M802403200	http://dx.doi.org/10.1074/jbc.M802403200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818209	hybrid, Green Published			2022-12-25	WOS:000260893700026
J	Wacker, JL; Feller, DB; Tang, XB; DeFino, MC; Namkung, Y; Lyssand, JS; Mhyre, AJ; Tan, X; Jensen, JB; Hague, C				Wacker, Jennifer L.; Feller, David B.; Tang, Xiao-Bo; DeFino, Mia C.; Namkung, Yuree; Lyssand, John S.; Mhyre, Andrew J.; Tan, Xu; Jensen, Jill B.; Hague, Chris			Disease-causing Mutation in GPR54 Reveals the Importance of the Second Intracellular Loop for Class A G-protein-coupled Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOGONADOTROPIC HYPOGONADISM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; AMINO-ACID; ACTIVATION; TRAFFICKING; RHODOPSIN; G-PROTEIN-COUPLED-RECEPTOR-54; TRANSDUCIN; MEMBRANE	The G-protein-coupled receptor (GPCR) GPR54 is essential for the development and maintenance of reproductive function in mammals. A point mutation (L148S) in the second intracellular loop (IL2) of GPR54 causes idiopathic hypogonadotropic hypogonadism, a disorder characterized by delayed puberty and infertility. Here, we characterize the molecular mechanism by which the L148S mutation causes disease and address the role of IL2 in Class A GPCR function. Biochemical, immunocytochemical, and pharmacological analysis demonstrates that the mutation does not affect the expression, ligand binding properties, or protein interaction network of GPR54. In contrast, diverse GPR54 functional responses are markedly inhibited by the L148S mutation. Importantly, the leucine residue at this position is highly conserved among class A GPCRs. Indeed, mutating the corresponding leucine of the alpha(1A)-AR recapitulates the effects observed with L148S GPR54, suggesting the critical importance of this hydrophobic IL2 residue for Class A GPCR functional coupling. Interestingly, co-immunoprecipitation studies indicate that L148S does not hinder the association of G alpha subunits with GPR54. However, fluorescence resonance energy transfer analysis strongly suggests that L148S impairs the ligand-induced catalytic activation of G alpha. Combining our data with a predictive Class A GPCR/G alpha model suggests that IL2 domains contain a conserved hydrophobic motif that, upon agonist stimulation, might stabilize the switch II region of G alpha. Such an interaction could promote opening of switch II of G alpha to facilitate GDP-GTP exchange and coupling to downstream signaling responses. Importantly, mutations that disrupt this key hydrophobic interface can manifest as human disease.	[Wacker, Jennifer L.; Feller, David B.; Tang, Xiao-Bo; DeFino, Mia C.; Namkung, Yuree; Lyssand, John S.; Tan, Xu; Hague, Chris] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Jensen, Jill B.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Mhyre, Andrew J.] Fred Hutchinson Canc Res Ctr, Clin Div, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Hague, C (corresponding author), 1959 NE Pacific St,Box 357280, Seattle, WA 98195 USA.	chague@u.washington.edu	Tan, Xu/E-7170-2011	Tan, Xu/0000-0003-4861-4573; Jensen, Jill/0000-0002-3527-0911	National Institutes of Health [T32 HD07453]; NIGMS National Research Service Award [T32 GM07270, T32 GM07750, T32 GM07108, RO1 NS08174, U54HD12629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007453, U54HD012629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750, T32GM007270, T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 HD07453 (to J.L.W.); NIGMS National Research Service Award T32 GM07270 (to J.S.L.); T32 GM07750 (to M.C.D.); and T32 GM07108, RO1 NS08174 (BH), and U54HD12629 (to J.B.J.).	ARORA KK, 1995, J BIOL CHEM, V270, P22820, DOI 10.1074/jbc.270.39.22820; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Bhagavath B, 2007, SEMIN REPROD MED, V25, P272, DOI 10.1055/s-2007-980221; BLIN N, 1995, J BIOL CHEM, V270, P17741, DOI 10.1074/jbc.270.30.17741; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Chen HX, 2005, ANAL BIOCHEM, V338, P136, DOI 10.1016/j.ab.2004.11.015; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Conn PM, 2006, J ENDOCRINOL, V190, P13, DOI 10.1677/joe.1.06771; Costa EMF, 2001, J CLIN ENDOCR METAB, V86, P2680, DOI 10.1210/jc.86.6.2680; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Geiser AH, 2006, PROTEIN SCI, V15, P1679, DOI 10.1110/ps.062192306; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Iovane A, 2004, EUR J ENDOCRINOL, V151, pU83, DOI 10.1530/eje.0.151U083; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Kang HT, 2005, BIOCHEM BIOPH RES CO, V329, P684, DOI 10.1016/j.bbrc.2005.02.040; Lyssand JS, 2008, J BIOL CHEM, V283, P18792, DOI 10.1074/jbc.M801860200; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; MORO O, 1993, J BIOL CHEM, V268, P22273; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Navarro VM, 2005, ENDOCRINOLOGY, V146, P156, DOI 10.1210/en.2004-0836; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SCHLIEFENBAUM J, 2008, BIOPH SOC M LONG BEA; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Seminara SB, 2006, NAT CLIN PRACT ENDOC, V2, P328, DOI 10.1038/ncpendmet0139; Semple RK, 2005, J CLIN ENDOCR METAB, V90, P1849, DOI 10.1210/jc.2004-1418; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tao YX, 2006, PHARMACOL THERAPEUT, V111, P949, DOI 10.1016/j.pharmthera.2006.02.008; Tena-Sempere M, 2003, REPROD MED MOL CELLU, P225; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zhou HP, 1999, BIOCHEM BIOPH RES CO, V264, P171, DOI 10.1006/bbrc.1999.1508	47	57	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31068	31078		10.1074/jbc.M805251200	http://dx.doi.org/10.1074/jbc.M805251200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18772143	Green Published, hybrid			2022-12-25	WOS:000260544800061
J	Buelow, B; Scharenberg, AM				Buelow, Ben; Scharenberg, Andrew M.			Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination	PLOS ONE			English	Article								Conditional gene targeting using the Cre-loxp system is a well established technique in numerous in vitro and in vivo systems. Ligand regulated forms of Cre have been increasingly used in these applications in order to gain temporal and spatial control over conditional targeting. The tamoxifen-regulated Cre variant mer-Cre-mer (mCrem) is widely utilized because of its reputation for tight regulation in the absence of its tamoxifen ligand. In the DT40 chicken B cell line, we generated an mCrem-based reversible switch for conditional regulation of a transgene, and in contrast with previous work, observed significant constitutive activity of mCrem. This prompted us to use our system for analysis of the parameters governing tamoxifen-regulated mCrem recombination of a genomic target. We find that robust mCrem expression correlates with a high level of tamoxifen-independent Cre activity, while clones expressing mCrem at the limit of western blot detection exhibit extremely tight regulation. We also observe time and dose-dependent effects on mCrem activity which suggest limitations on the use of conditional targeting approaches for applications which require tight temporal coordination of Cre action within a cell population.	Univ Washington, Seattle Childrens Hosp Res Inst, Dept Pediat, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Buelow, B (corresponding author), Univ Washington, Seattle Childrens Hosp Res Inst, Dept Pediat, Seattle, WA 98195 USA.	andrewms@u.washington.edu			ARCS foundation; NCI; NIH [R01 GM64091]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064091] Funding Source: NIH RePORTER	ARCS foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ARCS foundation, NCI training grant, NIH R01 GM64091	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alinikula Jukka, 2006, Subcell Biochem, V40, P189; [Anonymous], 2007, NATURE, V449, P378; Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Badea TC, 2003, J NEUROSCI, V23, P2314; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Bree RT, 2007, CELL CYCLE, V6, P2310, DOI 10.4161/cc.6.18.4723; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Caldwell Randolph B, 2006, Subcell Biochem, V40, P25; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heidmann D, 2001, DEV GENES EVOL, V211, P458, DOI 10.1007/s004270100167; Kanayama N, 2005, BIOCHEM BIOPH RES CO, V327, P70, DOI 10.1016/j.bbrc.2004.11.143; Lahti JM, 1999, METHODS, V17, P305, DOI 10.1006/meth.1999.0744; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Okada Masahiro, 2006, Subcell Biochem, V40, P91; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Rainey Michael D, 2006, Subcell Biochem, V40, P107; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Semprini S, 2007, NUCLEIC ACIDS RES, V35, P1402, DOI 10.1093/nar/gkl1108; Shinohara Hisaaki, 2006, Subcell Biochem, V40, P145; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	37	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2008	3	9							e3264	10.1371/journal.pone.0003264	http://dx.doi.org/10.1371/journal.pone.0003264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MA	18810268	gold, Green Published, Green Submitted			2022-12-25	WOS:000264431000006
J	Ronicke, R; Klemm, A; Meinhardt, J; Schroder, UH; Fandrich, M; Reymann, KG				Roenicke, Raik; Klemm, Anja; Meinhardt, Jessica; Schroeder, Ulrich H.; Faendrich, Marcus; Reymann, Klaus G.			A beta Mediated Diminution of MTT Reduction-An Artefact of Single Cell Culture?	PLOS ONE			English	Article							HIPPOCAMPAL SLICE CULTURES; MITOCHONDRIAL SUCCINATE-DEHYDROGENASE; ORGANOTYPIC CULTURES; SYNAPTIC PLASTICITY; BIOLOGICAL-ACTIVITY; ALZHEIMERS-DISEASE; NATURAL OLIGOMERS; AMYLOID PEPTIDES; REDOX ACTIVITY; IN-VITRO	The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide (MTT) reduction assay is a frequently used and easily reproducible method to measure beta-amyloid (Ab) toxicity in different types of single cell culture. To our knowledge, the influence of Ab on MTT reduction has never been tested in more complex tissue. Initially, we reproduced the disturbed MTT reduction in neuron and astroglia primary cell cultures from rats as well as in the BV2 microglia cell line, utilizing four different Ab species, namely freshly dissolved Ab (25-35), fibrillar Ab (1-40), oligomeric Ab (1-42) and oligomeric Ab (1-40). In contrast to the findings in single cell cultures, none of these Ab species altered MTT reduction in rat organotypic hippocampal slice cultures (OHC). Moreover, application of Ab to acutely isolated hippocampal slices from adult rats and in vivo intracerebroventricular injection of Ab also did not influence the MTT reduction in the respective tissue. Failure of Ab penetration into the tissue cannot explain the differences between single cells and the more complex brain tissue. Thus electrophysiological investigations disclosed an impairment of long-term potentiation (LTP) in the CA1 region of hippocampal slices from rat by application of oligomeric Ab (1-40), but not by freshly dissolved Ab (25-35) or fibrillar Ab (140). In conclusion, the experiments revealed a glaring discrepancy between single cell cultures and complex brain tissue regarding the effect of different Ab species on MTT reduction. Particularly, the differential effect of oligomeric versus other Ab forms on LTP was not reflected in the MTT reduction assay. This may indicate that the Ab oligomer effect on synaptic function reflected by LTP impairment precedes changes in formazane formation rate or that cells embedded in a more natural environment in the tissue are less susceptible to damage by Ab, raising cautions against the consideration of single cell MTT reduction activity as a reliable assay in Alzheimer's drug discovery studies.	[Roenicke, Raik; Klemm, Anja; Schroeder, Ulrich H.; Reymann, Klaus G.] Leibniz Inst Neurobiol, Project Grp Neuropharmacol, Magdeburg, Germany; [Reymann, Klaus G.] Res Inst Appl Neurosci GmbH, Magdeburg, Germany; [Meinhardt, Jessica] Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany; [Faendrich, Marcus] Max Planck Res Unit Enzymol Protein Fold, Halle, Germany; [Faendrich, Marcus] Martin Luther Univ Halle Wittenberg, Halle, Germany	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Max Planck Society; Martin Luther University Halle Wittenberg	Ronicke, R (corresponding author), Leibniz Inst Neurobiol, Project Grp Neuropharmacol, Magdeburg, Germany.	roenicke@zenit-magdeburg.de	Schröder, Ulrich/ABB-3026-2021; Reymann, Klaus G/J-8507-2013		Leibniz Institute for Neurobiology; Research Institute for Applied Neurosciences gGmbH	Leibniz Institute for Neurobiology; Research Institute for Applied Neurosciences gGmbH	Leibniz Institute for Neurobiology, Research Institute for Applied Neurosciences gGmbH	Abe K, 1997, NEUROSCI RES, V29, P129, DOI 10.1016/S0168-0102(97)00081-3; Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Baldauf K, 2005, BRAIN RES, V1056, P158, DOI 10.1016/j.brainres.2005.07.035; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Baskys A, 2001, BRAIN RES, V907, P188, DOI 10.1016/S0006-8993(01)02517-3; Bieschke J, 2008, BIOCHEMISTRY-US, V47, P50, DOI 10.1021/bi701757v; Boutaud O, 2006, J NEUROCHEM, V96, P917, DOI 10.1111/j.1471-4159.2005.03586.x; Braun H, 2006, J NEUROSCI METH, V157, P32, DOI 10.1016/j.jneumeth.2006.03.019; Breder J, 2000, NEUROPHARMACOLOGY, V39, P1779, DOI 10.1016/S0028-3908(00)00027-7; Choi SJ, 2006, AMYLOID, V13, P6, DOI 10.1080/13506120500535636; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Christopeit T, 2005, PROTEIN SCI, V14, P2125, DOI 10.1110/ps.051470405; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Connelly CA, 2000, J NEUROSCI METH, V99, P1, DOI 10.1016/S0165-0270(00)00205-3; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Gengler S, 2007, EXP BRAIN RES, V179, P621, DOI 10.1007/s00221-006-0819-6; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Gil A, 2001, EUR J NEUROSCI, V13, P1380, DOI 10.1046/j.0953-816x.2001.01509.x; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hayon T, 2003, LEUKEMIA LYMPHOMA, V44, P1957, DOI 10.1080/1042819031000116607; Christian H, 2007, EUR J PHARMACOL, V561, P85, DOI 10.1016/j.ejphar.2007.01.040; Imai T, 2007, NEUROSCIENCE, V147, P639, DOI 10.1016/j.neuroscience.2007.04.057; Ioudina M, 2003, EXP NEUROL, V184, P923, DOI 10.1016/S0014-4886(03)00314-5; Ishige K, 2007, J PHARMACOL SCI, V104, P46, DOI 10.1254/jphs.FP0061533; Ito Y, 2003, BRAIN RES, V985, P98, DOI 10.1016/S0006-8993(03)03173-1; Johansson S, 2006, EXP BRAIN RES, V168, P11, DOI 10.1007/s00221-005-0069-z; KACHADORIAN WA, 1981, J CELL BIOL, V91, P584, DOI 10.1083/jcb.91.2.584; KANEKO I, 1995, J NEUROCHEM, V65, P2585; Kato M, 1997, J NEUROCHEM, V68, P1889; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KIMURA T, 1967, J BIOL CHEM, V242, P4987; KOROTZER AR, 1995, EUR J PHARM-MOLEC PH, V288, P125, DOI 10.1016/0922-4106(95)90006-3; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lane RM, 2005, J LIPID RES, V46, P949, DOI 10.1194/jlr.M400486-JLR200; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; LEE CC, 2007, NEUROBIOL AGING; Liu ML, 2005, EXP MOL MED, V37, P559, DOI 10.1038/emm.2005.69; Liu YB, 1999, PROG NEURO-PSYCHOPH, V23, P377, DOI 10.1016/S0278-5846(99)00003-2; Liu YB, 1997, J NEUROCHEM, V69, P2285; Lushnikova IV, 2004, J CELL MOL MED, V8, P241, DOI 10.1111/j.1582-4934.2004.tb00279.x; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PODLISNY MB, 1993, AM J PATHOL, V142, P17; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Rowan MJ, 2007, BIOCHEM SOC T, V35, P1219, DOI 10.1042/BST0351219; Schroder UH, 2004, EUR J PHARMACOL, V502, P99, DOI 10.1016/j.ejphar.2004.08.046; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Szegedi V, 2006, FASEB J, V20, P1191, DOI 10.1096/fj.05-4891fje; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang X, 2007, EUR J NEUROSCI, V26, P2142, DOI 10.1111/j.1460-9568.2007.05853.x; WILLIAMSON R, 2007, FASEB J; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Xu KX, 1999, GLIA, V25, P390, DOI 10.1002/(SICI)1098-1136(19990215)25:4<390::AID-GLIA8>3.0.CO;2-7; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	62	31	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3236	10.1371/journal.pone.0003236	http://dx.doi.org/10.1371/journal.pone.0003236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800168	Green Submitted, gold, Green Published			2022-12-25	WOS:000264428400006
J	Mulligan, CJ; Kitchen, A; Miyamoto, MM				Mulligan, Connie J.; Kitchen, Andrew; Miyamoto, Michael M.			Updated Three-Stage Model for the Peopling of the Americas	PLOS ONE			English	Article								Background: We re-assess support for our three stage model for the peopling of the Americas in light of a recent report that identified nine non-Native American mitochondrial genome sequences that should not have been included in our initial analysis. Removal of these sequences results in the elimination of an early (i.e.,40,000 years ago) expansion signal we had proposed for the proto-Amerind population. Methodology/Findings: Bayesian skyline plot analysis of a new dataset of Native American mitochondrial coding genomes confirms the absence of an early expansion signal for the proto-Amerind population and allows us to reduce the variation around our estimate of the New World founder population size. In addition, genetic variants that define New World founder haplogroups are used to estimate the amount of time required between divergence of proto-Amerinds from the Asian gene pool and expansion into the New World. Conclusions/Significance: The period of population isolation required for the generation of New World mitochondrial founder haplogroup-defining genetic variants makes the existence of three stages of colonization a logical conclusion. Thus, our three stage model remains an important and useful working hypothesis for researchers interested in the peopling of the Americas and the processes of colonization.	[Mulligan, Connie J.; Kitchen, Andrew] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Miyamoto, Michael M.] Univ Florida, Dept Zool, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mulligan, CJ (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	mulligan@anthro.ufl.edu			National Science Foundation [BSR-0518530]; Department of Zoology, University of Florid	National Science Foundation(National Science Foundation (NSF)); Department of Zoology, University of Florid	This study was supported by a grant from the National Science Foundation to CJM (BSR-0518530) and by funds from the Department of Zoology, University of Florida to MMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Fagundes NJR, 2008, AM J HUM GENET, V83, P146, DOI 10.1016/j.ajhg.2008.06.016; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; FAGUNDES NJR, PLOS ONE IN PRESS; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Goebel T, 2007, SCIENCE, V315, P194, DOI 10.1126/science.1137564; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Ho SYW, 2008, AM J HUM GENET, V83, P142, DOI 10.1016/j.ajhg.2008.06.014; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Hopkins D.M., 1982, PALEOECOLOGY BERINGI, P3, DOI DOI 10.1016/B978-0-12-355860-2.50008-9; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kitchen A, 2008, MOL PHYLOGENET EVOL, V46, P673, DOI 10.1016/j.ympev.2007.09.005; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mulligan CJ, 2004, ANNU REV GENOM HUM G, V5, P295, DOI 10.1146/annurev.genom.5.061903.175920; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; WEST FH, 1996, BERINGIA NEW WORLD O; Zazula GD, 2003, NATURE, V423, P603, DOI 10.1038/423603a	27	96	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3199	10.1371/journal.pone.0003199	http://dx.doi.org/10.1371/journal.pone.0003199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797500	gold, Green Submitted, Green Published			2022-12-25	WOS:000264428200003
J	Cassano, M; Biressi, S; Finan, A; Benedetti, L; Omes, C; Boratto, R; Martin, F; Allegretti, M; Broccoli, V; De Angelis, GC; Comoglio, PM; Basilico, C; Torrente, Y; Michieli, P; Cossu, G; Sampaolesi, M				Cassano, Marco; Biressi, Stefano; Finan, Amanda; Benedetti, Laura; Omes, Claudia; Boratto, Renata; Martin, Frank; Allegretti, Marcello; Broccoli, Vania; De Angelis, Gabriella Cusella; Comoglio, Paolo M.; Basilico, Cristina; Torrente, Yvan; Michieli, Paolo; Cossu, Giulio; Sampaolesi, Maurilio			Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR SCATTER FACTOR; DYSTROPHIN MINIGENE TRANSFER; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; PROTEOLYTIC CLEAVAGE; CELL ACTIVATION; STEM-CELLS; RECEPTOR; EXPRESSION	Background: Hepatocyte Growth Factor (HGF) is a pleiotropic cytokine of mesenchymal origin that mediates a characteristic array of biological activities including cell proliferation, survival, motility and morphogenesis. Its high affinity receptor, the tyrosine kinase Met, is expressed by a wide range of tissues and can be activated by either paracrine or autocrine stimulation. Adult myogenic precursor cells, the so called satellite cells, express both HGF and Met. Following muscle injury, autocrine HGF-Met stimulation plays a key role in promoting activation and early division of satellite cells, but is shut off in a second phase to allow myogenic differentiation. In culture, HGF stimulation promotes proliferation of muscle precursors thereby inhibiting their differentiation. Methodology/Principal Findings: Magic-Factor 1 (Met-Activating Genetically Improved Chimeric Factor-1 or Magic-F1) is an HGF-derived, engineered protein that contains two Met-binding domains repeated in tandem. It has a reduced affinity for Met and, in contrast to HGF it elicits activation of the AKT but not the ERK signaling pathway. As a result, Magic-F1 is not mitogenic but conserves the ability to promote cell survival. Here we show that Magic-F1 protects myogenic precursors against apoptosis, thus increasing their fusion ability and enhancing muscular differentiation. Electrotransfer of Magic-F1 gene into adult mice promoted muscular hypertrophy and decreased myocyte apoptosis. Magic-F1 transgenic mice displayed constitutive muscular hypertrophy, improved running performance and accelerated muscle regeneration following injury. Crossing of Magic-F1 transgenic mice with alpha-sarcoglycan knock-out mice-a mouse model of muscular dystrophy- or adenovirus-mediated Magic-F1 gene delivery resulted in amelioration of the dystrophic phenotype as measured by both anatomical/histological analysis and functional tests. Conclusions/Significance: Because of these features Magic-F1 represents a novel molecular tool to counteract muscle wasting in major muscular diseases such as cachexia or muscular dystrophy.	[Cassano, Marco; Sampaolesi, Maurilio] KULeuven, SCIL, Louvain, Belgium; [Cassano, Marco] Univ Rome Sapienza, Dept Histol & Med Embryol, Rome, Italy; [Biressi, Stefano; Finan, Amanda; Broccoli, Vania; Cossu, Giulio] HS Raffaele, Stem Cell Res Inst, Milan, Italy; [Benedetti, Laura; Omes, Claudia; Boratto, Renata; De Angelis, Gabriella Cusella; Sampaolesi, Maurilio] Univ Pavia, Pavia, Italy; [Martin, Frank; Allegretti, Marcello] Dompe Phrma Res Ctr, Laquila, Italy; [Comoglio, Paolo M.; Basilico, Cristina; Michieli, Paolo] Inst Canc Res & Treatment IRCC, Div Mol Oncol, Turin, Italy; [Torrente, Yvan] Univ Milan, Ospedale Maggiore Policlin, Dept Neurol Sci, Milan, Italy	KU Leuven; Sapienza University Rome; University of Pavia; Dompe; IRCCS Fondazione del Piemonte per l'Oncologia; University of Milan	Cassano, M (corresponding author), KULeuven, SCIL, Louvain, Belgium.	sampa@unipv.it	Cassano, Marco/T-3473-2019; Omes, Claudia/AAO-8280-2020; Michieli, Paolo/A-2588-2011; Biressi, Stefano/AAD-8956-2020; Broccoli, Vania/K-3464-2016; Sampaolesi, Maurilio/H-6509-2013; Basilico, Cristina/A-3253-2011; Omes, Claudia/G-4696-2013; TORRENTE, YVAN/A-2964-2015	Omes, Claudia/0000-0003-0663-6168; Michieli, Paolo/0000-0002-3093-8871; Broccoli, Vania/0000-0003-4050-0926; Sampaolesi, Maurilio/0000-0002-2422-3757; Omes, Claudia/0000-0003-0663-6168; Cassano, Marco/0000-0002-8526-1319; TORRENTE, YVAN/0000-0002-2705-3984; Comoglio, Paolo/0000-0002-7056-5328; Biressi, Stefano Augusto Maria/0000-0001-8631-3419	FWO Odysseus Program [G.0907.08]; Wicka Funds [zkb8720]; Italian Ministry of University and Scientific Research [2005067555_003]; Muscular Dystrophy Association; Telethon; Association Francoise contre les Myopathies; Parent Project Onlus; CARIPLO	FWO Odysseus Program; Wicka Funds; Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Muscular Dystrophy Association(Muscular Dystrophy Association); Telethon(Fondazione Telethon); Association Francoise contre les Myopathies; Parent Project Onlus; CARIPLO(Fondazione Cariplo)	This work was supported in part by: FWO Odysseus Program n. G.0907.08; Wicka Funds n. zkb8720; the Italian Ministry of University and Scientific Research (grant n. 2005067555_003, COFIN 2006 08), the Muscular Dystrophy Association, Telethon, Association Francoise contre les Myopathies, Parent Project Onlus, CARIPLO.	Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Andermarcher E, 1996, DEV GENET, V18, P254, DOI 10.1002/(SICI)1520-6408(1996)18:3<254::AID-DVG6>3.0.CO;2-8; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cioce V, 1996, J BIOL CHEM, V271, P13110, DOI 10.1074/jbc.271.22.13110; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Feero WG, 1997, HUM GENE THER, V8, P371, DOI 10.1089/hum.1997.8.4-371; Fiaccavento R, 2005, J PATHOL, V205, P397, DOI 10.1002/path.1717; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; Kos L, 1999, PIGM CELL RES, V12, P13, DOI 10.1111/j.1600-0749.1999.tb00503.x; Leshem Y, 2000, J CELL PHYSIOL, V184, P101, DOI 10.1002/(SICI)1097-4652(200007)184:1<101::AID-JCP11>3.0.CO;2-D; Li YW, 2003, CIRCULATION, V107, P2499, DOI 10.1161/01.CIR.0000065579.19126.B8; Lochmuller H, 1996, GENE THER, V3, P706; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; MARK MR, 1992, J BIOL CHEM, V267, P26166; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Michieli P, 2002, NAT BIOTECHNOL, V20, P488, DOI 10.1038/nbt0502-488; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schwall RH, 1996, J CELL BIOL, V133, P709, DOI 10.1083/jcb.133.3.709; Sheehan SM, 2000, MUSCLE NERVE, V23, P239, DOI 10.1002/(SICI)1097-4598(200002)23:2<239::AID-MUS15>3.0.CO;2-U; Takahara T, 2008, HEPATOLOGY, V47, P2010, DOI 10.1002/hep.22243; Takayama H, 1996, P NATL ACAD SCI USA, V93, P5866, DOI 10.1073/pnas.93.12.5866; Tamagnone Luca, 1997, Cytokine and Growth Factor Reviews, V8, P129, DOI 10.1016/S1359-6101(97)00007-5; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; VILQUIN JT, 1995, HUM GENE THER, V6, P1391, DOI 10.1089/hum.1995.6.11-1391; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; WOOLF AS, 1995, J CELL BIOL, V128, P171, DOI 10.1083/jcb.128.1.171; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Yang L, 1998, GENE THER, V5, P369, DOI 10.1038/sj.gt.3300600; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177	54	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3223	10.1371/journal.pone.0003223	http://dx.doi.org/10.1371/journal.pone.0003223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795097	Green Published, gold, Green Submitted			2022-12-25	WOS:000264428000006
J	Sheth, BR; Janvelyan, D; Khan, M				Sheth, Bhavin R.; Janvelyan, Davit; Khan, Murtuza			Practice Makes Imperfect: Restorative Effects of Sleep on Motor Learning	PLOS ONE			English	Article							TIME-COURSE; MEMORY CONSOLIDATION; CHUNKING; ACQUISITION; IMPROVEMENT	Emerging evidence suggests that sleep plays a key role in procedural learning, particularly in the continued development of motor skill learning following initial acquisition. We argue that a detailed examination of the time course of performance across sleep on the finger-tapping task, established as the paradigm for studying the effect of sleep on motor learning, will help distinguish a restorative role of sleep in motor skill learning from a proactive one. Healthy subjects rehearsed for 12 trials and, following a night of sleep, were tested. Early training rapidly improved speed as well as accuracy on pre-sleep training. Additional rehearsal caused a marked slow-down in further improvement or partial reversal in performance to observed levels below theoretical upper limits derived on the basis of early pre-sleep rehearsal. This decrement in learning efficacy does not occur always, but if and only if it does, overnight sleep has an effect in fully or partly restoring the efficacy and actual performance to the optimal theoretically achieveable level. Our findings re-interpret the sleep-dependent memory enhancement in motor learning reported in the literature as a restoration of fatigued circuitry specialized for the skill. In providing restitution to the fatigued brain, sleep eliminates the rehearsal-induced synaptic fatigue of the circuitry specialized for the task and restores the benefit of early pre-sleep rehearsal. The present findings lend support to the notion that latent sleep-dependent enhancement of performance is a behavioral expression of the brain's restitution in sleep.	[Sheth, Bhavin R.] Univ Houston, Houston, TX 77004 USA; [Janvelyan, Davit; Khan, Murtuza] California Inst Technol, Pasadena, CA USA	University of Houston System; University of Houston; California Institute of Technology	Sheth, BR (corresponding author), Univ Houston, Houston, TX 77004 USA.	brsheth@uh.edu			University of Houston; UH-PURS [fellowship]; Caltech [SURF fellowship];  [Cline Discovery]	University of Houston; UH-PURS; Caltech; 	This research was supported in part by funds from the University of Houston (BRS) and a Cline Discovery Grant (BRS, Caltech). MZ was supported by a UH-PURS fellowship. DJ was supported by a Caltech-SURF fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Censor N, 2006, VISION RES, V46, P4071, DOI 10.1016/j.visres.2006.07.022; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; ROSENBAUM DA, 1983, J EXP PSYCHOL HUMAN, V9, P86, DOI 10.1037/0096-1523.9.1.86; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Sheth BR, 2005, BEHAV BRAIN SCI, V28, P81, DOI 10.1017/S0140525X05390029; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 1998, J COGNITIVE NEUROSCI, V10, P77; Stocker C, 2004, PSYCHOL RES-PSYCH FO, V68, P126, DOI 10.1007/s00426-003-0150-9; Vertes RP, 2005, BEHAV BRAIN SCI, V28, P86, DOI 10.1017/S0140525X05440029; Verwey WB, 1996, J MOTOR BEHAV, V28, P71, DOI 10.1080/00222895.1996.9941735; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, SLEEP, V26, pA441; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	26	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3190	10.1371/journal.pone.0003190	http://dx.doi.org/10.1371/journal.pone.0003190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KI	18787652	Green Published, gold, Green Accepted			2022-12-25	WOS:000264426200001
J	Kastberger, G; Schmelzer, E; Kranner, I				Kastberger, Gerald; Schmelzer, Evelyn; Kranner, Ilse			Social Waves in Giant Honeybees Repel Hornets	PLOS ONE			English	Article							COLONY DEFENSE; MIGRATION; BEHAVIOR; DORSATA	Giant honeybees (Apis dorsata) nest in the open and have evolved a plethora of defence behaviors. Against predatory wasps, including hornets, they display highly coordinated Mexican wave-like cascades termed 'shimmering'. Shimmering starts at distinct spots on the nest surface and then spreads across the nest within a split second whereby hundreds of individual bees flip their abdomens upwards. However, so far it is not known whether prey and predator interact and if shimmering has anti-predatory significance. This article reports on the complex spatial and temporal patterns of interaction between Giant honeybee and hornet exemplified in 450 filmed episodes of two A. dorsata colonies and hornets (Vespa sp.). Detailed frame-by-frame analysis showed that shimmering elicits an avoidance response from the hornets showing a strong temporal correlation with the time course of shimmering. In turn, the strength and the rate of the bees' shimmering are modulated by the hornets' flight speed and proximity. The findings suggest that shimmering creates a 'shelter zone' of around 50 cm that prevents predatory wasps from foraging bees directly from the nest surface. Thus shimmering appears to be a key defence strategy that supports the Giant honeybees' open-nesting life-style.	[Kastberger, Gerald; Schmelzer, Evelyn] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Kranner, Ilse] Royal Botan Gardens, Seed Conservat Dept, Richmond, Surrey, England	University of Graz; Royal Botanic Gardens, Kew	Kastberger, G (corresponding author), Graz Univ, Inst Zool, A-8010 Graz, Austria.	gerald.kastberger@uni-graz.at	Kranner, Ilse/B-1039-2011	Kranner, Ilse/0000-0003-4959-9109	University Graz; EU [I-SWARM]; Austrian Scientific Foundation	University Graz; EU(European Commission); Austrian Scientific Foundation(Austrian Science Fund (FWF))	The data collection in Nepal was granted by the research funds of the University Graz. The data analysis was partially supported by an EU grant (I-SWARM) and the Austrian Scientific Foundation.	[Anonymous], BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BUTLER CG, 1962, WORLD HONEYBEE; Caro Tim, 2005, pXIII; CREWE RM, 1976, J APICULT RES, V15, P149, DOI 10.1080/00218839.1976.11099850; Das B.P., 1989, ORIENTAL INSECTS MON, V11; EIBLEIBESFELDT J, 1978, GRUNDRISS VERGLEICHE; Farkas I, 2002, NATURE, V419, P131, DOI 10.1038/419131a; Jeschke JM, 2007, ANIM BEHAV, V74, P387, DOI 10.1016/j.anbehav.2006.08.020; Kastberger G, 2003, BEHAV RES METH INS C, V35, P429, DOI 10.3758/BF03195520; Kastberger G, 1996, APIDOLOGIE, V27, P381, DOI 10.1051/apido:19960506; Kastberger G, 1998, ETHOLOGY, V104, P27, DOI 10.1111/j.1439-0310.1998.tb00027.x; Kastberger G, 2000, APIDOLOGIE, V31, P727, DOI 10.1051/apido:2000157; KASTBERGER G, 2001, P DTSCH ZOOLOGISCHE, P7; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; KOENIGER N, 1975, Zeitschrift fuer Tierpsychologie, V37, P99; KOENIGER N, 1980, J APICULT RES, V19, P21, DOI 10.1080/00218839.1980.11099994; Koeniger N, 1996, APIDOLOGIE, V27, P341, DOI 10.1051/apido:19960502; Krause J, 2002, LIVING GROUPS; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LINDAUER M, 1952, Z VERGL PHYSIOL, V38, P521; MORSE RA, 1969, APIS DORSATA PHILLIP; OLDROYD B, 1995, APIDOLOGIE, V26, P119, DOI 10.1051/apido:19950205; OLDROYD BP, 2006, ASIAN HONEY BEES; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Paar J, 2000, NATURE, V406, P475, DOI 10.1038/35020196; Paar J, 2004, J HERED, V95, P119, DOI 10.1093/jhered/esh026; Roepke W, 1930, BEOBACHTUNGEN INDISC; Sakagami S. F., 1960, Acta Hymenopterologica, V1, P171; SCHMELZER E, 2004, P DTSCH ZOOLOGISCHE, P71; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; UNDERWOOD BA, 1990, NATL GEOGR RES, V6, P276; Wickler W., 1968, MIMICRY PLANTS ANIMA	35	73	76	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3141	10.1371/journal.pone.0003141	http://dx.doi.org/10.1371/journal.pone.0003141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781205	Green Published, gold, Green Submitted			2022-12-25	WOS:000264425700004
J	Sethupathy, P; Giang, H; Plotkin, JB; Hannenhalli, S				Sethupathy, Praveen; Giang, Hoa; Plotkin, Joshua B.; Hannenhalli, Sridhar			Genome-Wide Analysis of Natural Selection on Human Cis-Elements	PLOS ONE			English	Article								Background: It has been speculated that the polymorphisms in the non-coding portion of the human genome underlie much of the phenotypic variability among humans and between humans and other primates. If so, these genomic regions may be undergoing rapid evolutionary change, due in part to natural selection. However, the non-coding region is a heterogeneous mix of functional and non-functional regions. Furthermore, the functional regions are comprised of a variety of different types of elements, each under potentially different selection regimes. Findings and Conclusions: Using the HapMap and Perlegen polymorphism data that map to a stringent set of putative binding sites in human proximal promoters, we apply the Derived Allele Frequency distribution test of neutrality to provide evidence that many human-specific and primate-specific binding sites are likely evolving under positive selection. We also discuss inherent limitations of publicly available human SNP datasets that complicate the inference of selection pressures. Finally, we show that the genes whose proximal binding sites contain high frequency derived alleles are enriched for positive regulation of protein metabolism and developmental processes. Thus our genome-scale investigation provides evidence for positive selection on putative transcription factor binding sites in human proximal promoters.	[Sethupathy, Praveen; Hannenhalli, Sridhar] Univ Penn, Dept Genet, Sch Med, Sch Engn & Appl Sci, Philadelphia, PA USA; [Giang, Hoa; Plotkin, Joshua B.] Univ Penn, Sch Engn & Appl Sci, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA; [Hannenhalli, Sridhar] Univ Penn, Sch Engn & Appl Sci, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Sethupathy, P (corresponding author), Univ Penn, Dept Genet, Sch Med, Sch Engn & Appl Sci, Philadelphia, PA USA.	sridharh@pcbi.upenn.edu	Hu, Ruogu/B-2203-2008; Plotkin, Joshua B/E-6947-2013		NIH [R21GM078203, R01GM085226]; Vietnam Education Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078203, R01GM085226] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vietnam Education Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PS was supported by NIH R21GM078203 awarded to SH. SH was supported by NIH grant R01GM085226. HG was supported by Vietnam Education Foundation Fellowship.	BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Bush EC, 2005, PLOS COMPUT BIOL, V1, P593, DOI 10.1371/journal.pcbi.0010073; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Everett L, 2006, BIOINFORMATICS, V22, pE117, DOI 10.1093/bioinformatics/btl260; Fay JC, 2001, GENETICS, V158, P1227; Fay JC, 2000, GENETICS, V155, P1405; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hahn MW, 2007, GENETICA, V129, P7, DOI 10.1007/s10709-006-0029-y; HAYGOOD R, 2007, NAT GENET; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kryukov GV, 2005, HUM MOL GENET, V14, P2221, DOI 10.1093/hmg/ddi226; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; SAWYER SA, 1992, GENETICS, V132, P1161; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Sethupathy Praveen, 2008, Advances in Bioinformatics, V2008, P257864, DOI 10.1155/2008/257864; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	32	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3137	10.1371/journal.pone.0003137	http://dx.doi.org/10.1371/journal.pone.0003137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781197	Green Published, gold, Green Submitted			2022-12-25	WOS:000264425700003
J	Merchant, H; Zarco, W; Bartolo, R; Prado, L				Merchant, Hugo; Zarco, Wilbert; Bartolo, Ramon; Prado, Luis			The Context of Temporal Processing Is Represented in the Multidimensional Relationships between Timing Tasks	PLOS ONE			English	Article							NEURAL MECHANISMS; TIME; PERCEPTION; INTERVALS; VARIABILITY; COGNITION; PREMOTOR	In the present study we determined the performance interrelations of ten different tasks that involved the processing of temporal intervals in the subsecond range, using multidimensional analyses. Twenty human subjects executed the following explicit timing tasks: interval categorization and discrimination (perceptual tasks), and single and multiple interval tapping (production tasks). In addition, the subjects performed a continuous circle-drawing task that has been considered an implicit timing paradigm, since time is an emergent property of the produced spatial trajectory. All tasks could be also classified as single or multiple interval paradigms. Auditory or visual markers were used to define the intervals. Performance variability, a measure that reflects the temporal and non-temporal processes for each task, was used to construct a dissimilarity matrix that quantifies the distances between pairs of tasks. Hierarchical clustering and multidimensional scaling were carried out on the dissimilarity matrix, and the results showed a prominent segregation of explicit and implicit timing tasks, and a clear grouping between single and multiple interval paradigms. In contrast, other variables such as the marker modality were not as crucial to explain the performance between tasks. Thus, using this methodology we revealed a probable functional arrangement of neural systems engaged during different timing behaviors.	[Merchant, Hugo; Zarco, Wilbert; Bartolo, Ramon; Prado, Luis] UNAM, Inst Neurobiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Merchant, H (corresponding author), UNAM, Inst Neurobiol, Queretaro, Mexico.	merchant@inb.unam.mx	Bartolo, Ramon/AAB-6579-2022; Merchant, Hugo/E-8703-2019	Bartolo, Ramon/0000-0003-2165-9747; Merchant, Hugo/0000-0002-3488-9501; Zarco, Wilbert/0000-0002-3599-0476	PAPIIT [IN209305]; FIRCA [TW007224-01A1]; FOGARTY INTERNATIONAL CENTER [R03TW007224] Funding Source: NIH RePORTER	PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); FIRCA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Supported in part by PAPIIT: IN209305 and FIRCA: TW007224-01A1.	Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; GETTY DJ, 1975, PERCEPT PSYCHOPHYS, V18, P1, DOI 10.3758/BF03199358; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GOLDSTONE S, 1959, J EXP PSYCHOL, V57, P243, DOI 10.1037/h0040745; Grondin S, 2001, PERCEPT PSYCHOPHYS, V63, P1214, DOI 10.3758/BF03194535; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Harrington DL, 1999, REV NEUROSCIENCE, V10, P91, DOI 10.1515/REVNEURO.1999.10.2.91; Hazeltine E, 1997, TRENDS COGN SCI, V1, P163, DOI 10.1016/S1364-6613(97)01058-9; Hoshi E, 2004, PROG BRAIN RES, V143, P507, DOI 10.1016/S0079-6123(03)43047-1; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Johnson, 1998, APPL MULTIVARIATE ST; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Merchant H, 2006, J NEUROPHYSIOL, V95, P1, DOI 10.1152/jn.00422.2005; Merchant H, 2003, J NEUROPHYSIOL, V90, P675, DOI 10.1152/jn.00331.2003; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2008, EXP BRAIN RES, V184, P233, DOI 10.1007/s00221-007-1097-7; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Rammsayer TH, 2004, PSYCHOL RES-PSYCH FO, V69, P115, DOI 10.1007/s00426-003-0164-3; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; SCHULZE HH, 1989, PERCEPT PSYCHOPHYS, V45, P291, DOI 10.3758/BF03204943; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; Spencer RMC, 2003, J MOTOR BEHAV, V35, P371, DOI 10.1080/00222890309603157; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Zelaznik HN, 2005, J MOTOR BEHAV, V37, P395, DOI 10.3200/JMBR.37.5.395-403; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	34	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3169	10.1371/journal.pone.0003169	http://dx.doi.org/10.1371/journal.pone.0003169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422JY	18779860	gold, Green Submitted, Green Published			2022-12-25	WOS:000264425100005
J	Kulkarni, H; Agan, BK; Marconi, VC; O'Connell, RJ; Camargo, JF; He, WJ; Delmar, J; Phelps, KR; Crawford, G; Clark, RA; Dolan, MJ; Ahuja, SK				Kulkarni, Hemant; Agan, Brian K.; Marconi, Vincent C.; O'Connell, Robert J.; Camargo, Jose F.; He, Weijing; Delmar, Judith; Phelps, Kenneth R.; Crawford, George; Clark, Robert A.; Dolan, Matthew J.; Ahuja, Sunil K.			CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals	PLOS ONE			English	Article								Background: Whether vexing clinical decision-making dilemmas can be partly addressed by recent advances in genomics is unclear. For example, when to initiate highly active antiretroviral therapy ( HAART) during HIV-1 infection remains a clinical dilemma. This decision relies heavily on assessing AIDS risk based on the CD4(+) T cell count and plasma viral load. However, the trajectories of these two laboratory markers are influenced, in part, by polymorphisms in CCR5, the major HIV coreceptor, and the gene copy number of CCL3L1, a potent CCR5 ligand and HIV-suppressive chemokine. Therefore, we determined whether accounting for both genetic and laboratory markers provided an improved means of assessing AIDS risk. Methods and Findings: In a prospective, single-site, ethnically-mixed cohort of 1,132 HIV-positive subjects, we determined the AIDS risk conveyed by the laboratory and genetic markers separately and in combination. Subjects were assigned to a low, moderate or high genetic risk group (GRG) based on variations in CCL3L1 and CCR5. The predictive value of the CCL3L1-CCR5 GRGs, as estimated by likelihood ratios, was equivalent to that of the laboratory markers. GRG status also predicted AIDS development when the laboratory markers conveyed a contrary risk. Additionally, in two separate and large groups of HIV+ subjects from a natural history cohort, the results from additive risk-scoring systems and classification and regression tree (CART) analysis revealed that the laboratory and CCL3L1-CCR5 genetic markers together provided more prognostic information than either marker alone. Furthermore, GRGs independently predicted the time interval from seroconversion to CD4(+) cell count thresholds used to guide HAART initiation. Conclusions: The combination of the laboratory and genetic markers captures a broader spectrum of AIDS risk than either marker alone. By tracking a unique aspect of AIDS risk distinct from that captured by the laboratory parameters, CCL3L1-CCR5 genotypes may have utility in HIV clinical management. These findings illustrate how genomic information might be applied to achieve practical benefits of personalized medicine.	[Kulkarni, Hemant; Camargo, Jose F.; He, Weijing; Crawford, George; Clark, Robert A.; Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX USA; [Kulkarni, Hemant; Camargo, Jose F.; He, Weijing; Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX USA; [Agan, Brian K.; Marconi, Vincent C.; O'Connell, Robert J.; Delmar, Judith; Dolan, Matthew J.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD USA; [Agan, Brian K.; Marconi, Vincent C.; O'Connell, Robert J.; Delmar, Judith; Dolan, Matthew J.] Wilford Hall United States Air Force Med Ctr, Infect Dis Serv, Lackland AFB, TX USA; [Agan, Brian K.; Dolan, Matthew J.] Wilford Hall United States Air Force Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX USA; [Agan, Brian K.; Marconi, Vincent C.; Delmar, Judith; Dolan, Matthew J.] San Antonio Mil Med Ctr, Ft Sam Houston, TX USA; [Phelps, Kenneth R.] Stratton Veterans Affairs Med Ctr, Albany, NY USA; [Phelps, Kenneth R.] Albany Med Coll, Albany, NY USA; [Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, Dept Microbiol & Immunol & Biochem, San Antonio, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; Albany Medical College; University of Texas System; University of Texas Health San Antonio	Kulkarni, H (corresponding author), S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX USA.	mdolan@idcrp.org; ahujas@uthscsa.edu	Clark, Robert/Q-6764-2019; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Kulkarni, Hemant/AEM-5750-2022	Clark, Robert/0000-0002-4892-3619; Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Agan, Brian/0000-0002-5114-1669	Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System; MERIT [R37046326]; NIH [AI043279, MH069270]; Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research; Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); HHS/NIH/NIAID/DCR [HU0001-05-2-0011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046326, R01AI043279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069270] Funding Source: NIH RePORTER	Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System(US Department of Veterans Affairs); MERIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); HHS/NIH/NIAID/DCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System, and a MERIT (R37046326) and other awards (AI043279 and MH069270) from the NIH to S.K.A. S.K.A. is a recipient of the Elizabeth Glaser Scientist Award and the Burroughs Wellcome Clinical Scientist Award in Translational Research. Support for the Wilford Hall Medical Center cohort was provided by the Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS), of which the Tri-Service AIDS Clinical Consortium (TACC) is a component. The IDCRP is a Department of Defense tri-service program executed through USUHS and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), in collaboration with HHS/NIH/NIAID/DCR through Interagency Agreement HU0001-05-2-0011. The authors have no commercial or other association that might pose a conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Amella CA, 2005, J VIROL, V79, P5625, DOI 10.1128/JVI.79.9.5625-5631.2005; BIRX DL, 1993, J ACQ IMMUN DEF SYND, V6, P1248; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cohen CJ, 2004, CLIN INFECT DIS, V39, P1705, DOI 10.1086/425934; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Department of Health and Human Services (DHHS), 2008, GUID US ANT AG HIV 1; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; DOLAN MJ, 1995, J INFECT DIS, V172, P79, DOI 10.1093/infdis/172.1.79; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Gallagher EJ, 1998, ANN EMERG MED, V31, P391, DOI 10.1016/S0196-0644(98)70352-X; Gervaix A, 2002, J INFECT DIS, V185, P1055, DOI 10.1086/339802; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; GORDIN FM, 1994, J INFECT DIS, V169, P893, DOI 10.1093/infdis/169.4.893; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Hendrickson SL, 2008, JAIDS-J ACQ IMM DEF, V48, P263, DOI 10.1097/QAI.0b013e31816fdc5f; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Hunt PW, 2008, CURR OPIN HIV AIDS, V3, P342, DOI 10.1097/COH.0b013e3282fbaa92; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kalish RS, 1999, J ALLERGY CLIN IMMUN, V103, P192, DOI 10.1016/S0091-6749(99)70489-6; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Ketas TJ, 2007, VIROLOGY, V364, P281, DOI 10.1016/j.virol.2007.02.022; KNIKER WT, 1984, ANN ALLERGY, V52, P75; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Lalezari J, 2008, J INFECT DIS, V197, P721, DOI 10.1086/527327; Langdorf M I, 2002, Eur J Emerg Med, V9, P115, DOI 10.1097/00063110-200206000-00003; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Li L, 2004, STAT MED, V23, P271, DOI 10.1002/sim.1715; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Lillard JW, 2003, BLOOD, V101, P807, DOI 10.1182/blood-2002-07-2305; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Maas JJ, 1998, J INFECT DIS, V178, P1024, DOI 10.1086/515655; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Mayer H., 2006, 16 INT AIDS C; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Menten P, 1999, J CLIN INVEST, V104, pR1, DOI 10.1172/JCI7318; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nakajima T, 2007, IMMUNOGENETICS, V59, P793, DOI 10.1007/s00251-007-0252-4; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; Pinto LA, 2000, EUR J IMMUNOL, V30, P2048, DOI 10.1002/1521-4141(200007)30:7<2048::AID-IMMU2048>3.0.CO;2-I; Podlekareva D, 2006, J INFECT DIS, V194, P633, DOI 10.1086/506366; Province MA, 2001, ADV GENET, V42, P273, DOI 10.1016/S0065-2660(01)42028-1; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Reynes J, 2001, AIDS, V15, P1627, DOI 10.1097/00002030-200109070-00004; Reyues J, 2003, JAIDS-J ACQ IMM DEF, V34, P114, DOI 10.1097/00126334-200309010-00018; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; SADAM M, 2008, 15 C RETR OPP INF; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Shalekoff S, 2008, JAIDS-J ACQ IMM DEF, V48, P245, DOI 10.1097/QAI.0b013e31816fdc77; Silverberg MJ, 2006, AIDS, V20, P1531, DOI 10.1097/01.aids.0000237369.41617.0f; Tarwater PM, 2001, J ACQ IMMUN DEF SYND, V27, P168, DOI 10.1097/00126334-200106010-00012; Taub DD, 1996, J IMMUNOL, V156, P2095; TELENTI A, 2008, CURRENT OPINION HIV, V28, P1; Thomas SM, 2006, AIDS, V20, P1879, DOI 10.1097/01.aids.0000244207.49123.ff; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Valdez H, 1999, JAMA-J AM MED ASSOC, V282, P734, DOI 10.1001/jama.282.8.734; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; Vincent T, 2006, JAIDS-J ACQ IMM DEF, V43, P377, DOI 10.1097/01.qai.0000234088.64655.45; Vlahou Antonia, 2003, Clin Breast Cancer, V4, P203, DOI 10.3816/CBC.2003.n.026; Xin XM, 1999, FEBS LETT, V457, P219, DOI 10.1016/S0014-5793(99)01035-2; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251; Zhang ZQ, 2004, VIROLOGY, V320, P75, DOI 10.1016/j.virol.2003.11.017; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665; Zou WP, 2000, J IMMUNOL, V165, P4388, DOI 10.4049/jimmunol.165.8.4388; AIDS RES HUM RETROVI, V16, P1123; 2005, GUIDELINES USE ANTIR	92	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3165	10.1371/journal.pone.0003165	http://dx.doi.org/10.1371/journal.pone.0003165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776933	gold, Green Published, Green Submitted			2022-12-25	WOS:000264424300009
J	Nordstrom, E; Fisone, G; Kristensson, K				Nordstrom, Elin; Fisone, Gilberto; Kristensson, Krister			Opposing effects of ERK and p38-JNK MAP kinase pathways on formation of prions in GT1-1 cells	FASEB JOURNAL			English	Article						scrapie; neuron; neurodegeneration; protein misfolding; PKA	CREUTZFELDT-JAKOB-DISEASE; HIPPOCAMPAL-NEURONS; OXIDATIVE STRESS; CULTURED-CELLS; HISTONE H3; SCRAPIE; PROTEIN; ACTIVATION; PHOSPHORYLATION; PRPSC	Brain-derived neurotrophic factor, which activates the extracellular regulated kinase (ERK) pathway, increases formation of prions in scrapie-infected gonadotropin-releasing hormone (GT1-1) cells. This indicates that conversion of the cellular prion protein PrPC to its pathogenic isoform, PrPSc, can be regulated by physiological stimuli acting on specific signal transduction pathways. In the present study, we examined the involvement of different mitogen-activated protein (MAP) kinase cascades and the cAMP-PKA pathway in formation of proteinase K-resistant PrPSc (rPrP(Sc)). Long-term depolarization of GT1-1 cells infected with the Rocky Mountain Laboratory strain of scrapie increased the formation of rPrP(Sc). This effect was associated to ERK activation and was blocked by the MAPK/ERK kinase (MEK) inhibitor U0126. Treatment with forskolin caused a similar increase in rPrP(Sc) formation that was prevented by the protein kinase A (PKA) inhibitor H89. Both depolarization and forskolin treatment were accompanied by increased phosphorylation of the S6 ribosomal protein, while phosphorylation of histone H3 occurred only after forskolin treatment. Inhibitors of p38- and c-Jun NH2-terminal kinase (JNK) promoted the formation of rPrP(Sc), in contrast to the clearance of rPrP(Sc) produced by inhibitors of the ERK pathway. Thus, the ERK and the p38- JNK MAP kinase pathways appear to exert opposing effects on rPrP(Sc) formation, suggesting that balances between these intracellular signaling cascades may regulate replication of prions.-Nordstrom, E., Fisone, G., Kristensson, K. Opposing effects of ERK and p38- JNK MAP kinase pathways on formation of prions in GT1-1 cells. FASEB J. 23, 613-622 (2009)	[Nordstrom, Elin; Fisone, Gilberto; Kristensson, Krister] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden	Karolinska Institutet	Nordstrom, E (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, SE-17177 Stockholm, Sweden.	elin.nordstrom@ki.se		Fisone, Gilberto/0000-0002-0719-8000				Ahnert-Hilger G, 1998, EUR J NEUROSCI, V10, P1145, DOI 10.1046/j.1460-9568.1998.00129.x; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; BASSANT MH, 1987, ELECTROEN CLIN NEURO, V66, P307, DOI 10.1016/0013-4694(87)90080-0; BASSANT MH, 1984, ELECTROEN CLIN NEURO, V57, P541, DOI 10.1016/0013-4694(84)90090-7; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Bouzamondo-Bernstein E, 2004, J NEUROPATH EXP NEUR, V63, P882, DOI 10.1093/jnen/63.8.882; Brimacombe DB, 1999, BIOCHEM J, V342, P605, DOI 10.1042/0264-6021:3420605; BROWN P, 1986, ANN NEUROL, V20, P597, DOI 10.1002/ana.410200507; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; Dhingra S, 2007, AM J PHYSIOL-HEART C, V293, pH3524, DOI 10.1152/ajpheart.00919.2007; EHLERS B, 1984, J GEN VIROL, V65, P1325, DOI 10.1099/0022-1317-65-8-1325; Fan YM, 2007, MOL CELLS, V23, P30; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Gomez-Santos C, 2002, BRAIN RES, V935, P32, DOI 10.1016/S0006-8993(02)02422-8; Hans A, 2004, FASEB J, V18, P863, DOI 10.1096/fj.03-0764fje; Hansen TV, 2003, NEUROSCI LETT, V347, P57, DOI 10.1016/S0304-3940(03)00581-0; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jefferys J G, 1994, Neurobiol Dis, V1, P25, DOI 10.1006/nbdi.1994.0004; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Ki MR, 2008, AM J PHYSIOL-GASTR L, V294, pG635, DOI 10.1152/ajpgi.00281.2007; Korth C, 2006, ARCH NEUROL-CHICAGO, V63, P497, DOI 10.1001/archneur.63.4.497; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; LaCasse RA, 2008, J NEUROIMMUNOL, V196, P16, DOI 10.1016/j.jneuroim.2008.02.009; Lee HP, 2005, J NEUROCHEM, V95, P584, DOI 10.1111/j.1471-4159.2005.03429.x; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Luhr KM, 2004, J VIROL, V78, P4776, DOI 10.1128/JVI.78.9.4776-4782.2004; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Nordstrom EK, 2005, J NEUROSCI, V25, P8451, DOI 10.1523/JNEUROSCI.2349-05.2005; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Ostlund P, 2001, MOL BRAIN RES, V97, P161, DOI 10.1016/S0169-328X(01)00316-3; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Planz O, 2001, J VIROL, V75, P4871, DOI 10.1128/JVI.75.10.4871-4877.2001; Rapoport M, 2000, J NEUROCHEM, V74, P125, DOI 10.1046/j.1471-4159.2000.0740125.x; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sandberg MK, 2004, NEUROBIOL DIS, V15, P143, DOI 10.1016/j.nbd.2003.09.006; Schonberger O, 2003, BIOCHEM BIOPH RES CO, V312, P473, DOI 10.1016/j.bbrc.2003.10.150; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; STRAIN GM, 1986, AM J VET RES, V47, P828; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Uppington KM, 2008, J NEUROCHEM, V105, P842, DOI 10.1111/j.1471-4159.2007.05192.x; Weissmann C, 2005, ANNU REV MED, V56, P321, DOI 10.1146/annurev.med.56.062404.172936; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2	53	27	27	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2009	23	2					613	622		10.1096/fj.08-115360	http://dx.doi.org/10.1096/fj.08-115360			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18824519				2022-12-25	WOS:000262892900032
J	Mashima, T; Sato, S; Sugimoto, Y; Tsuruo, T; Seimiya, H				Mashima, T.; Sato, S.; Sugimoto, Y.; Tsuruo, T.; Seimiya, H.			Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions	ONCOGENE			English	Article						low pH; acyl-CoA synthetase; lipid metabolism; microenvironment; midkine	HUMAN HEPATOCELLULAR-CARCINOMA; PROLIFERATOR-ACTIVATED RECEPTOR; HUMAN-MELANOMA CELLS; GENE-EXPRESSION; THERAPEUTIC TARGET; DRUG-RESISTANCE; GROWTH-FACTOR; SOLID TUMORS; MIDKINE; CANCER	Extracellular acidosis (low pH) is a tumor microenvironmental stressor that has a critical function in the malignant progression and met astatic dissemination of tumors. To survive under stress conditions, tumor cells must evolve resistance to stress-induced toxicity. Acyl-CoA synthetase 5 (ACSL5) is a member of the ACS family, which converts fatty acid to acyl-CoA. ACSL5 is frequently overexpressed in malignant glioma, whereas its functional significance is still unknown. Using retrovirus-mediated stable gene transfer ( gain of function) and small interfering RNA-mediated gene silencing ( loss of function), we show here that ACSL5 selectively promotes human glioma cell survival under extracellular acidosis. ACSL5 enhanced cell survival through its ACS catalytic activity. To clarify the genome-wide changes in cell signaling pathways by ACSL5, we performed cDNA microarray analysis and identified an ACSL5-dependent gene expression signature. The analysis revealed that ACSL5 was critical to the expression of tumor-related factors including midkine (MDK), a heparin-binding growth factor frequently overexpressed in cancer. Knockdown of MDK expression significantly attenuated ACSL5-mediated survival under acidic state. These results indicate that ACSL5 is a critical factor for survival of glioma cells under acidic tumor microenvironment, thus providing novel molecular basis for cancer therapy.	[Seimiya, H.] Japanese Fdn Canc Res, Div Mol Biotherapy, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan; [Sato, S.] Japanese Fdn Canc Res, Div Expt Chemotherapy, Ctr Canc Chemotherapy, Tokyo 1358550, Japan; [Sugimoto, Y.] Keio Univ, Dept Chemotherapy, Fac Pharm, Tokyo, Japan; [Sugimoto, Y.] Japanese Fdn Canc Res, Div Gene Therapy, Ctr Canc Chemotherapy, Tokyo 1358550, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Keio University; Japanese Foundation for Cancer Research	Seimiya, H (corresponding author), Japanese Fdn Canc Res, Div Mol Biotherapy, Ctr Canc Chemotherapy, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	hseimiya@jfcr.or.jp		Seimiya, Hiroyuki/0000-0003-3314-9736				BOGAZZI F, 1994, J BIOL CHEM, V269, P11683; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cao Y, 2001, CANCER RES, V61, P8429; Caviglia JM, 2004, J BIOL CHEM, V279, P11163, DOI 10.1074/jbc.M311392200; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Gassler N, 2005, J PATHOL, V207, P295, DOI 10.1002/path.1831; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Ikematsu S, 2000, BRIT J CANCER, V83, P701, DOI 10.1054/bjoc.2000.1339; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Kadomatsu K, 1997, BRIT J CANCER, V75, P354, DOI 10.1038/bjc.1997.58; KADOMATSU K, 2004, CANC LETT, V204, P1391; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Liang YC, 2005, WORLD J GASTROENTERO, V11, P2557, DOI 10.3748/wjg.v11.i17.2557; Maeda S, 2007, BRIT J CANCER, V97, P405, DOI 10.1038/sj.bjc.6603879; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashima T, 2005, DRUG RESIST UPDATE, V8, P339, DOI 10.1016/j.drup.2005.11.001; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mirkin BL, 2005, ONCOGENE, V24, P4965, DOI 10.1038/sj.onc.1208671; Mishima K, 1997, NEUROSCI LETT, V233, P29, DOI 10.1016/S0304-3940(97)00619-8; Mishima K, 2001, CANCER RES, V61, P5349; NAKAGAWARA A, 1995, CANCER RES, V55, P1792; OBrien T, 1996, CANCER RES, V56, P2515; Ohtsubo T, 1997, CANCER RES, V57, P3910; Reichert M, 2002, CANCER, V95, P1113, DOI 10.1002/cncr.10767; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Schoonjans K, 1996, J LIPID RES, V37, P907; Seimiya H, 1999, BIOCHEM BIOPH RES CO, V260, P365, DOI 10.1006/bbrc.1999.0910; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Sung YK, 2003, CANCER SCI, V94, P421, DOI 10.1111/j.1349-7006.2003.tb01458.x; Sung YK, 2007, EXP MOL MED, V39, P477, DOI 10.1038/emm.2007.52; Takei Y, 2001, CANCER RES, V61, P8486; TANNOCK IF, 1989, CANCER RES, V49, P4373; Tao QG, 2007, JNCI-J NATL CANCER I, V99, P1668, DOI 10.1093/jnci/djm208; Tomida A, 1999, ANTI-CANCER DRUG DES, V14, P169; Tong Y, 2007, J NEUROCHEM, V100, P1097, DOI 10.1111/j.1471-4159.2006.04276.x; UEHARA K, 1992, J BIOCHEM-TOKYO, V111, P563, DOI 10.1093/oxfordjournals.jbchem.a123797; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; VAUPEL P, 1989, CANCER RES, V49, P6449; Xie SH, 1997, CANCER RES, V57, P2295; Yamashita Y, 2000, ONCOGENE, V19, P5919, DOI 10.1038/sj.onc.1203981; Ye C, 1999, BRIT J CANCER, V79, P179, DOI 10.1038/sj.bjc.6690030; Yeh CS, 2006, CANCER LETT, V233, P297, DOI 10.1016/j.canlet.2005.03.050	50	52	57	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					9	19		10.1038/onc.2008.355	http://dx.doi.org/10.1038/onc.2008.355			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18806831				2022-12-25	WOS:000262294100002
J	Chan, YW; Chen, Y; Poon, RYC				Chan, Y. W.; Chen, Y.; Poon, R. Y. C.			Generation of an indestructible cyclin B1 by caspase-6-dependent cleavage during mitotic catastrophe	ONCOGENE			English	Article						apoptosis; cell cycle; checkpoint; cyclin; DNA damage; mitotic catastrophe	CELL-CYCLE; DNA-DAMAGE; CHECKPOINT PATHWAY; DEPENDENT KINASES; APOPTOSIS; DEATH; CHK1; PHOSPHORYLATION; ACTIVATION; DISTINCT	Overriding the G(2) DNA damage checkpoint permits precocious entry into mitosis that ultimately leads to mitotic catastrophe. Mitotic catastrophe is manifested by an unscheduled activation of CDK1, caspase activation and apoptotic cell death. We found that although cyclin B1 was required for mitotic catastrophe, it was cleaved into a similar to 35kDa protein by a caspase-dependent mechanism during the process. Cyclin B1 cleavage occurred after Asp123 in the motif ILVD123 down arrow, and mutation of this motif attenuated the cleavage. Cleavage was abolished by a pan-caspase inhibitor as well as by specific inhibitors for the effector caspase-6 and the initiator caspase-8. Cleavage created a truncated cyclin B1 lacking part of the NH2-terminal regulatory domain that included the destruction box sequence. Although cleavage of cyclin B1 itself was not absolutely required for mitotic catastrophe, expression of the truncated product enhanced cell death. In support of this, ectopic expression of this truncated cyclin B1 was not only sufficient to induce mitotic block and apoptosis but also enhanced mitotic catastrophe induced by ionizing radiation and caffeine. These data underscore a possible linkage between mitotic and apoptotic functions by caspase-dependent processing of mitotic activators.	[Chan, Y. W.; Chen, Y.; Poon, R. Y. C.] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	rycpoon@ust.hk	Chan, Gary/P-7347-2019	Chan, Gary/0000-0002-6196-7675; Poon, Randy/0000-0001-5571-6231	Hong Kong Research Grants Council [66207, HKUST6439/06M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	Many thanks are due to members of the Poon Lab for constructive criticism on the manuscript. We thank Julian Gannon, Tim Hunt and Katsumi Yamashita for generous gifts of reagents. We also thank Talha Arooz and Wai Yi Siu for technical assistance and Jeremy PK Chow for the original observation of cyclin B1 cleavage. This work was supported in part by the Hong Kong Research Grants Council Grants 66207 and HKUST6439/06M to RYCP.	Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Baek KH, 2005, ONCOL RES, V15, P161, DOI 10.3727/096504005776367906; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chan YW, 2008, J BIOL CHEM, V283, P15716, DOI 10.1074/jbc.M800629200; Chan YW, 2008, CELL CYCLE, V7, P1449, DOI 10.4161/cc.7.10.5880; Chow JPH, 2003, MOL BIOL CELL, V14, P3989, DOI 10.1091/mbc.E03-03-0168; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fung TK, 2005, CELL CYCLE, V4, P1411, DOI 10.4161/cc.4.10.2046; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Giles N, 2003, J BIOL CHEM, V278, P28580, DOI 10.1074/jbc.M304027200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Ho CC, 2006, CANCER RES, V66, P2233, DOI 10.1158/0008-5472.CAN-05-1790; Ho CC, 2005, EXP CELL RES, V304, P1, DOI 10.1016/j.yexcr.2004.10.016; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lee J, 2001, MOL BIOL CELL, V12, P551, DOI 10.1091/mbc.12.3.551; Li KKW, 2002, LIVER, V22, P259, DOI 10.1046/j.0106-9543.2002.01629.x; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Rothblum-Oviatt CJ, 2001, CELL GROWTH DIFFER, V12, P581; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schmitt E, 2006, J CELL SCI, V119, P4269, DOI 10.1242/jcs.03200; Siu WY, 2004, MOL CANCER THER, V3, P621; Siu WY, 1999, EXP CELL RES, V250, P131, DOI 10.1006/excr.1999.4551; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Stack JH, 1997, DEVELOPMENT, V124, P3185; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Vogel C, 2007, CANCER RES, V67, P339, DOI 10.1158/0008-5472.CAN-06-2548; Yam CH, 1999, CANCER RES, V59, P5075; Yam CH, 1999, MOL CELL BIOL, V19, P635; Yam CH, 2000, J BIOL CHEM, V275, P3158, DOI 10.1074/jbc.275.5.3158; Yanagida M, 2005, PHILOS T R SOC B, V360, P609, DOI 10.1098/rstb.2004.1615; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yim H, 2003, MOL BIOL CELL, V14, P4250, DOI 10.1091/mbc.E03-01-0029; Yim H, 2006, J CELL BIOL, V174, P77, DOI 10.1083/jcb.200509141	52	16	17	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2009	28	2					170	183		10.1038/onc.2008.369	http://dx.doi.org/10.1038/onc.2008.369			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	395CY	18820706				2022-12-25	WOS:000262501100002
J	Klein, J; Gonzalez, J; Duchene, J; Esposito, L; Pradere, JP; Neau, E; Delage, C; Calise, D; Ahluwalia, A; Carayon, P; Pesquero, JB; Bader, M; Schanstra, JP; Bascands, JL				Klein, J.; Gonzalez, J.; Duchene, J.; Esposito, L.; Pradere, J. P.; Neau, E.; Delage, C.; Calise, D.; Ahluwalia, A.; Carayon, P.; Pesquero, J. B.; Bader, M.; Schanstra, J. P.; Bascands, J. L.			Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy	FASEB JOURNAL			English	Article						kidney disease; bradykinin; unilateral ureteral obstruction; chemokine; reversion	NF-KAPPA-B; BRADYKININ B-1 RECEPTOR; IN-VIVO; INVOLVEMENT; PROGRESSION; ACTIVATION; MECHANISMS; MANAGEMENT; INDUCTION; RESPONSES	Renal fibrosis is the common histological feature of advanced glomerular and tubulointerstitial disease leading to end-stage renal disease (ESRD). However, specific antifibrotic therapies to slow down the evolution to ESRD are still absent. Because persistent inflammation is a key event in the development of fibrosis, we hypothesized that the proinflammatory kinin B1 receptor (B1R) could be such a new target. Here we show that, in the unilateral ureteral obstruction model of renal fibrosis, the B1R is overexpressed and that delayed treatment with an orally active non-peptide B1R antagonist blocks macrophage infiltration, leading to a reversal of the level of renal fibrosis. In vivo bone marrow transplantation studies as well as in vitro studies on renal cells show that part of this antifibrotic mechanism of B1R blockade involves a direct effect on resident renal cells by inhibiting chemokine CCL2 and CCL7 expression. These findings suggest that blocking the B1R is a promising antifibrotic therapy.-Klein, J., Gonzalez, J., Duchene, J., Esposito, L., Pradere, J. P., Neau, E., Delage, C., Calise, D., Ahluwalia, A., Carayon, P., Pesquero, J. B., Bader, M., Schanstra, J. P., Bascands, J. L. Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J. 23, 134-142 (2009)	[Klein, J.; Gonzalez, J.; Duchene, J.; Pradere, J. P.; Neau, E.; Delage, C.; Schanstra, J. P.; Bascands, J. L.] INSERM, Dept Renal, F-31432 Toulouse, France; [Klein, J.; Gonzalez, J.; Duchene, J.; Pradere, J. P.; Neau, E.; Delage, C.; Schanstra, J. P.; Bascands, J. L.] INSERM, Cardiac Remodeling Team 5, F-31432 Toulouse, France; [Klein, J.; Gonzalez, J.; Pradere, J. P.; Neau, E.; Delage, C.; Schanstra, J. P.; Bascands, J. L.] Univ Toulouse 3, F-31062 Toulouse, France; [Duchene, J.; Ahluwalia, A.] Barts & London Med Sch, William Harvey Res Inst, London, England; [Esposito, L.] Toulouse Univ Hosp, Nephrol & Kidney Transplantat Dept, CHU Rangueil, Toulouse, France; [Calise, D.] INSERM, Zootechny Dept Expt Microsurg, Toulouse, France; [Carayon, P.] Sanofi Aventis R&D, Montpellier, France; [Pesquero, J. B.] Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, Sao Paulo, Brazil; [Bader, M.] Max Delbruck Ctr Mol Med, Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of London; Queen Mary University London; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Sanofi-Aventis; Sanofi France; Universidade Federal de Sao Paulo (UNIFESP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Schanstra, JP (corresponding author), INSERM, Dept Renal, 1 Jean Poulhes, F-31432 Toulouse, France.	joost-peter.schanstra@inserm.fr; jean-loup.bascands@inserm.fr	Bascands, Jean-loup/G-3260-2013; Duchene, Johan/Q-9472-2019; Bader, Michael/K-2124-2013; Klein, Julie/M-7088-2017; Pesquero, Joao/C-1470-2012; Klein, Julie/ABE-2622-2020; Schanstra, Joost P/X-7724-2018	Duchene, Johan/0000-0002-3973-0022; Klein, Julie/0000-0002-3279-0559; Pesquero, Joao/0000-0002-4507-632X; Klein, Julie/0000-0002-3279-0559; Schanstra, Joost P/0000-0002-7471-372X; Pradere, Jean-Philippe/0000-0003-1734-1429; AHLUWALIA, Amrita/0000-0001-7626-6399; Bascands, Jean-loup/0000-0002-1667-5913; Bader, Michael/0000-0003-4780-4164	INSERM; Universite Toulouse III Paul Sabatier; Sanofi-Aventis; Basic Science Fellowship of the Barts and the London Charity	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Toulouse III Paul Sabatier; Sanofi-Aventis(Sanofi-Aventis); Basic Science Fellowship of the Barts and the London Charity	This study was mainly funded by INSERM and the Universite Toulouse III Paul Sabatier and by grants from Sanofi-Aventis. J.D. is supported by a Basic Science Fellowship of the Barts and the London Charity. P.C. is an employee of Sanofi-Aventis. We thank S. Schaak for technical advice and help.	Ahluwalia A, 1996, J IMMUNOL, V156, P269; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Bockmann S, 2000, J LEUKOCYTE BIOL, V68, P587; Boor P, 2007, NEPHROL DIAL TRANSPL, V22, P3391, DOI 10.1093/ndt/gfm393; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Campos MM, 2006, TRENDS PHARMACOL SCI, V27, P646, DOI 10.1016/j.tips.2006.10.007; Chatziantoniou C, 2008, CURR OPIN NEPHROL HY, V17, P76, DOI 10.1097/MNH.0b013e3282f1bb69; Chevalier RL, 2006, NAT CLIN PRACT NEPHR, V2, P157, DOI 10.1038/ncpneph0098; Cuaz-Perolin C, 2008, ARTERIOSCL THROM VAS, V28, P272, DOI 10.1161/ATVBAHA.107.155606; de Winther Menno P J, 2003, Methods Mol Biol, V209, P281; Diez J, 2005, NAT CLIN PRACT CARD, V2, P209, DOI 10.1038/ncpcardio0158; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Gougat J, 2004, J PHARMACOL EXP THER, V309, P661, DOI 10.1124/jpet.103.059527; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Kakoki M, 2007, P NATL ACAD SCI USA, V104, P7576, DOI 10.1073/pnas.0701617104; Khwaja A, 2007, KIDNEY INT, V72, P1316, DOI 10.1038/sj.ki.5002489; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Kluth DC, 2004, KIDNEY INT, V66, P542, DOI 10.1111/j.1523-1755.2004.00773.x; Kovescly CP, 2008, EXPERT OPIN INV DRUG, V17, P451, DOI [10.1517/13543784.17.4.451, 10.1517/13543784.17.4.451 ]; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Marin-Castano ME, 2002, CIRCULATION, V105, P627, DOI 10.1161/hc0502.102965; Marin-Castano ME, 1998, KIDNEY INT, V54, P1888, DOI 10.1046/j.1523-1755.1998.00201.x; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Mori MA, 2008, DIABETES, V57, P1491, DOI 10.2337/db07-1508; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nguyen TQ, 2008, PHARM RES-DORDR, V25, P2416, DOI 10.1007/s11095-008-9548-9; Ni AG, 2003, J BIOL CHEM, V278, P219, DOI 10.1074/jbc.M209490200; Okada H, 2005, J AM SOC NEPHROL, V16, P133, DOI 10.1681/ASN.2004040339; Okada H, 2004, J AM SOC NEPHROL, V15, P2404, DOI 10.1097/01.ASN.0000136132.20189.95; Pawluczyk IZA, 2004, KIDNEY INT, V65, P1240, DOI 10.1111/j.1523-1755.2004.00494.x; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Ricupero DA, 2000, J BIOL CHEM, V275, P12475, DOI 10.1074/jbc.275.17.12475; Schanstra JP, 2002, J CLIN INVEST, V110, P371, DOI 10.1172/JCI200215493; Schanstra JP, 2000, J AM SOC NEPHROL, V11, P1208, DOI 10.1681/ASN.V1171208; Schanstra JP, 1998, J CLIN INVEST, V101, P2080, DOI 10.1172/JCI1359; Seccia TM, 2006, J HYPERTENS, V24, P1419, DOI 10.1097/01.hjh.0000234124.94013.ac; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Seguin T, 2008, INT IMMUNOPHARMACOL, V8, P217, DOI 10.1016/j.intimp.2007.08.008; Souza DG, 2004, J IMMUNOL, V172, P2542, DOI 10.4049/jimmunol.172.4.2542; Strutz F, 2001, EXPERT OPIN INV DRUG, V10, P1989, DOI 10.1517/13543784.10.11.1989; SUNG SA, 2007, EXP NEPHROL, V105, pE1; TIFFANY CW, 1989, FEBS LETT, V247, P189, DOI 10.1016/0014-5793(89)81331-6; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wang PHM, 2006, INT IMMUNOPHARMACOL, V6, P1960, DOI 10.1016/j.intimp.2006.07.031; Wuyts WA, 2003, RESP MED, V97, P811, DOI 10.1016/S0954-6111(03)00036-2	49	55	57	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					134	142		10.1096/fj.08-115600	http://dx.doi.org/10.1096/fj.08-115600			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18809736	Green Submitted			2022-12-25	WOS:000262095500016
J	Fischer, M; Kaldenhoff, R				Fischer, Matthias; Kaldenhoff, Ralf			On the pH Regulation of Plant Aquaporins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; WATER TRANSPORT; VESICLES; WHEAT; CELLS	The majority of plants are unable to evade unfavorable conditions such as flooding, salinity, or drought. Therefore, a fine-tuned water homeostasis appears to be of crucial importance for plant survival, and it was assumed that aquaporins play a significant role in these processes. Regulation of plant aquaporin conductivity was suggested to be achieved by a gating mechanism that involves protein phosphorylation under drought stress conditions and protonation after cytosolic acidification during flooding. The effect of protein phosphorylation or protonation of aquaporins was studied on two plasma membrane intrinsic proteins, NtPIP2;1 and NtAQP1 from tobacco, which were heterologously expressed in yeast. Our results on mutated aquaporins with serine-to-alanine exchange indicate that phosphorylation of the two key serine residues did not affect the pH-dependent modification of water permeability. Protonation on a conserved histidine residue decreased water conductivity of NtPIP2;1. Although cells expressing NtPIP2; 1 with a replacement of the histidine by an alanine were found to be pH-insensitive with regard to water permeability, these maintain high water transport rates, similar to those obtained under acidic conditions. The data clearly support the role of histidine at 196 as a component of pH dependent modification of aquaporin-facilitated water transport. The predictions of combined effects from phosphorylation at conserved serines and histidine protonation were not supported by the results of functional analysis. The obtained results challenge the gating model as a general regulation mechanism for plant plasma membrane aquaporins.	[Fischer, Matthias; Kaldenhoff, Ralf] Tech Univ Darmstadt, D-64287 Darmstadt, Germany	Technical University of Darmstadt	Kaldenhoff, R (corresponding author), Tech Univ Darmstadt, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	kaldenhoff@bio.tu-darmstadt.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a grant from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Gerbeau P, 2002, PLANT J, V30, P71, DOI 10.1046/j.1365-313X.2002.01268.x; Kamaluddin M, 2004, TREE PHYSIOL, V24, P1173, DOI 10.1093/treephys/24.10.1173; NAKAMOTO RK, 1991, J BIOL CHEM, V266, P7940; SANFORD JC, 1993, METHOD ENZYMOL, V217, P483; SLAVIK J, 1982, FEBS LETT, V140, P22, DOI 10.1016/0014-5793(82)80512-7; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; Zhang WH, 1999, PLANT PHYSIOL, V120, P849, DOI 10.1104/pp.120.3.849	11	57	58	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33889	33892		10.1074/jbc.M803865200	http://dx.doi.org/10.1074/jbc.M803865200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818207	hybrid, Green Published			2022-12-25	WOS:000261277700014
J	Smadja-Lamere, N; Boulanger, MC; Champagne, C; Branton, PE; Lavoie, JN				Smadja-Lamere, Nicolas; Boulanger, Marie-Chloe; Champagne, Claudia; Branton, Philip E.; Lavoie, Josee N.			JNK-mediated Phosphorylation of Paxillin in Adhesion Assembly and Tension-induced Cell Death by the Adenovirus Death Factor E4orf4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; C-JUN; TRANSFORMED-CELLS; MATRIX ADHESIONS; P53-INDEPENDENT APOPTOSIS; ALPHA-1-FETOPROTEIN GENE; ACTIN POLYMERIZATION; MYOSIN-II; KINASE; ACTIVATION	The adenovirus type 2 Early Region 4 ORF4 (E4orf4) protein induces a caspase-independent death program in tumor cells involving changes in actin dynamics that are functionally linked to cell killing. Because an increase in myosin II-based contractility is needed for the death of E4orf4-expressing cells, we have proposed that alteration of cytoskeletal tension is part of the signals engaging the death pathway. Yet the mechanisms involved are poorly defined. Herein, we show that the Jun N-terminal kinase JNK is activated in part through a pathway involving Src, Rho, and ROCK (Rho kinase) and contributes to dysregulate adhesion dynamics and to kill cells in response to E4orf4. JNK supports the formation of atypically robust focal adhesions, which are bound to the assembly of the peculiar actomyosin network typifying E4orf4-induced cell death and which are required for driving nuclear condensation. Remarkably, the dramatic enlargement of focal adhesions, actin remodeling, and cell death all rely on paxillin phosphorylation at Ser-178, which is induced by E4orf4 in a JNK-dependent way. Furthermore, we found that Ser-178-paxillin phosphorylation is necessary to decrease adhesion turnover and to enhance the time residency of paxillin at focal adhesions, promoting its recruitment from an internal pool. Our results indicate that perturbation of tensional homeostasis by E4orf4 involves JNK-regulated changes in paxillin adhesion dynamics that are required to engage the death pathway. Moreover, our findings support a role for JNK-mediated paxillin phosphorylation in adhesion growth and stabilization during tension signaling.	[Smadja-Lamere, Nicolas; Boulanger, Marie-Chloe; Champagne, Claudia; Lavoie, Josee N.] Univ Laval, Hotel Dieu, Ctr Rech Cancerol, CRCHUQ, Quebec City, PQ G1R 2J6, Canada; [Branton, Philip E.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Branton, Philip E.] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	Laval University; McGill University; McGill University	Lavoie, JN (corresponding author), Univ Laval, Hotel Dieu, Ctr Rech Cancerol, CRCHUQ, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	josee.lavoie@crhdq.ulaval.ca		Lavoie, Josee N/0000-0001-6912-1132	Canadian Institutes of Health Research Operating [MOP-49450]; National Cancer Institute of Canada	Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported by the Canadian Institutes of Health Research Operating Grant MOP-49450 (to J. N. L.), a maintenance Grant for the Cell imaging core facility (to J. N. L.), and by the National Cancer Institute of Canada (to P. E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amagasaki K, 2006, J BIOL CHEM, V281, P22173, DOI 10.1074/jbc.M513307200; BERNIER D, 1993, MOL CELL BIOL, V13, P1619, DOI 10.1128/MCB.13.3.1619; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Branton PE, 2001, ONCOGENE, V20, P7855, DOI 10.1038/sj.onc.1204862; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; BROWN PH, 1993, ONCOGENE, V8, P877; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Champagne C, 2004, J BIOL CHEM, V279, P25905, DOI 10.1074/jbc.M400933200; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Gingras MC, 2002, MOL CELL BIOL, V22, P41, DOI 10.1128/MCB.22.1.41-56.2002; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GUERTIN M, 1988, MOL CELL BIOL, V8, P1398, DOI 10.1128/MCB.8.4.1398; Gupta P, 2006, PHARMACOL THERAPEUT, V111, P596, DOI 10.1016/j.pharmthera.2005.11.005; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; Hinz B, 2006, EUR J CELL BIOL, V85, P175, DOI 10.1016/j.ejcb.2005.09.004; Hsieh MH, 2005, INT REV CYTOL, V245, P45, DOI 10.1016/S0074-7696(05)45003-2; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; Kleinberger T, 2004, PROG MOL SUBCELL BIO, V36, P245; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Landry MC, 2006, B CANCER, V93, P921; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Lavoie JN, 2000, J CELL BIOL, V150, P1037, DOI 10.1083/jcb.150.5.1037; Lele TP, 2006, J CELL BIOCHEM, V97, P1175, DOI 10.1002/jcb.20761; LI S, 2008, ONCOGENE IN PRESS; Livne A, 2001, J VIROL, V75, P789, DOI 10.1128/JVI.75.2.789-798.2001; Llense F, 2008, CURR BIOL, V18, P538, DOI 10.1016/j.cub.2008.03.029; LUFTIG RB, 1977, J HISTOCHEM CYTOCHEM, V25, P175, DOI 10.1177/25.3.402414; Ma Z, 2007, J CELL BIOL, V179, P23, DOI 10.1083/jcb.200706097; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Marinissen MJ, 2005, TRENDS BIOCHEM SCI, V30, P423, DOI 10.1016/j.tibs.2005.06.006; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Melani M, 2008, CURR BIOL, V18, P532, DOI 10.1016/j.cub.2008.03.024; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Noteborn MHM, 2005, CELL MOL BIOL, V51, P49, DOI 10.1170/T597; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Robert A, 2002, J CELL BIOL, V158, P519, DOI 10.1083/jcb.200201106; Robert A, 2006, MOL BIOL CELL, V17, P3329, DOI 10.1091/mbc.E05-12-1146; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xu B, 2006, ORG BIOMOL CHEM, V4, P4149, DOI 10.1039/b609143a; Zaidel-Bar R, 2005, J CELL SCI, V118, P3997, DOI 10.1242/jcs.02523; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 1999, J CELL SCI, V112, P1655	73	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34352	34364		10.1074/jbc.M803364200	http://dx.doi.org/10.1074/jbc.M803364200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818208	hybrid, Green Published			2022-12-25	WOS:000261277700063
J	Dixit, R; Levy, JR; Tokito, M; Ligon, LA; Holzbaur, ELF				Dixit, Ram; Levy, Jennifer R.; Tokito, Mariko; Ligon, Lee A.; Holzbaur, Erika L. F.			Regulation of Dynactin through the Differential Expression of p150(Glued) Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DISEASE; CYTOPLASMIC DYNEIN; MICROTUBULE-BINDING; G59S MUTATION; DCTN1 GENE; IN-VITRO; TRANSPORT; ENDS; DEGENERATION; PROCESSIVITY	Cytoplasmic dynein and dynactin interact to drive microtubule-based transport in the cell. The p150(Glued) subunit of dynactin binds to dynein, and directly to microtubules. We have identified alternatively spliced isoforms of p150(Glued) that are expressed in a tissue-specific manner and which differ significantly in their affinity for microtubules. Live cell assays indicate that these alternatively spliced isoforms also differ significantly in their microtubule plus end-tracking activity, suggesting a mechanism by which the cell may regulate the dynamic localization of dynactin. To test the function of the microtubule-binding domain of p150(Glued), we used RNAi to deplete the endogenous polypeptide from HeLa cells, followed by rescue with constructs encoding either the full-length polypeptide or an isoform lacking the microtubule-binding domain. Both constructs fully rescued defects in Golgi morphology induced by depletion of p150(Glued), indicating that an independent microtubule-binding site in dynactin may not be required for dynactin-mediated trafficking in some mammalian cell types. In neurons, however, a mutation within the microtubule-binding domain of p150(Glued) results in motor neuron disease; here we investigate the effects of four other mutations in highly conserved domains of the polypeptide (M571T, R785W, R1101K, and T1249I) associated in genetic studies with Amyotrophic Lateral Sclerosis. Both biochemical and cellular assays reveal that these amino acid substitutions do not result in functional differences, suggesting that these sequence changes are either allelic variants or contributory risk factors rather than causative for motor neuron disease. Together, these studies provide further insight into the regulation of dynein-dynactin function in the cell.	[Dixit, Ram; Levy, Jennifer R.; Tokito, Mariko; Ligon, Lee A.; Holzbaur, Erika L. F.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Holzbaur, ELF (corresponding author), Univ Penn, Sch Med, Dept Physiol, D400 Richards Bldg,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu		Ligon, Lee/0000-0002-5735-3654	National Institutes of Health [GM068591, GM48661]; ALS Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068591, R01GM048661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by Grants GM068591 and GM48661 from the National Institutes of Health. This work was also supported by the ALS Association (to E. L. F. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Chevalier-Larsen ES, 2008, HUM MOL GENET, V17, P1946, DOI 10.1093/hmg/ddn092; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lai C, 2007, J NEUROSCI, V27, P13982, DOI 10.1523/JNEUROSCI.4226-07.2007; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Tokito MK, 1998, BBA-GENE STRUCT EXPR, V1442, P432, DOI 10.1016/S0167-4781(98)00195-X; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan KT, 1999, J CELL SCI, V112, P1437; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	28	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33611	33619		10.1074/jbc.M804840200	http://dx.doi.org/10.1074/jbc.M804840200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18812314	Green Published, hybrid			2022-12-25	WOS:000261183700067
J	Porubsky, PR; Meneely, KM; Scott, EE				Porubsky, Patrick R.; Meneely, Kathleen M.; Scott, Emily E.			Structures of Human Cytochrome P-450 2E1 INSIGHTS INTO THE BINDING OF INHIBITORS AND BOTH SMALL MOLECULAR WEIGHT AND FATTY ACID SUBSTRATES.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P450 2E1; ACETAMINOPHEN ACTIVATION; BACULOVIRUS EXPRESSION; LIVER-MICROSOMES; ACTIVE-SITE; ETHANOL; OXIDATION; CYP2E1; B(5); RAT	Human microsomal cytochrome P-450 2E1 (CYP2E1) monooxygenates > 70 low molecular weight xenobiotic compounds, as well as much larger endogenous fatty acid signaling molecules such as arachidonic acid. In the process, CYP2E1 can generate toxic or carcinogenic compounds, as occurs with acetaminophen overdose, nitrosamines in cigarette smoke, and reactive oxygen species from uncoupled catalysis. Thus, the diverse roles that CYP2E1 has in normal physiology, toxicity, and drug metabolism are related to its ability to metabolize diverse classes of ligands, but the structural basis for this was previously unknown. Structures of human CYP2E1 have been solved to 2.2 A for an indazole complex and 2.6 angstrom for a 4-methylpyrazole complex. Both inhibitors bind to the heme iron and hydrogen bond to Thr(303) within the active site. Complementing its small molecular weight substrates, the hydrophobic CYP2E1 active site is the smallest yet observed for a human cytochrome P-450. The CYP2E1 active site also has two adjacent voids: one enclosed above the I helix and the other forming a channel to the protein surface. Minor repositioning of the Phe(478) aromatic ring that separates the active site and access channel would allow the carboxylate of fatty acid substrates to interact with conserved (216)QXXNN(220) residues in the access channel while positioning the hydrocarbon terminus in the active site, consistent with experimentally observed omega-1 hydroxylation of saturated fatty acids. Thus, these structures provide insights into the ability of CYP2E1 to effectively bind and metabolize both small molecule substrates and fatty acids.	[Porubsky, Patrick R.; Meneely, Kathleen M.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of Kansas	Scott, EE (corresponding author), 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu			National Institutes of Health [RR016475, RR017708, GM076343]; University of Kansas New Faculty General Research Grant Program; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343, R01GM076343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas New Faculty General Research Grant Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RR016475 (to P.R.P.) and RR017708 and GM076343 (to E.E.S.). This work was also supported by the University of Kansas New Faculty General Research Grant Program (to E.E.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adas F, 1999, J LIPID RES, V40, P1990; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARNETT CR, 1993, BIOCHEM PHARMACOL, V45, P313, DOI 10.1016/0006-2952(93)90066-6; Bell LC, 1997, J BIOL CHEM, V272, P29643, DOI 10.1074/jbc.272.47.29643; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; Bieche I, 2007, PHARMACOGENET GENOM, V17, P731, DOI 10.1097/FPC.0b013e32810f2e58; Blobaum AL, 2004, J PHARMACOL EXP THER, V310, P281, DOI 10.1124/jpet.104.065508; Bronstein AC, 2007, CLIN TOXICOL, V45, P815, DOI 10.1080/15563650701754763; Chen WQ, 1996, ARCH BIOCHEM BIOPHYS, V335, P123, DOI 10.1006/abbi.1996.0489; Chen WQ, 1998, CHEM RES TOXICOL, V11, P295, DOI 10.1021/tx9701687; Collom SL, 2008, J BIOL CHEM, V283, P3487, DOI 10.1074/jbc.M707630200; Das A, 2007, J AM CHEM SOC, V129, P13778, DOI 10.1021/ja074864x; DeLano WL, 2002, PYMOL USERS MANUAL; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Dostalek M, 2008, J BIOL CHEM, V283, P17147, DOI 10.1074/jbc.M802447200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fairbrother KS, 1998, PHARMACOGENETICS, V8, P543, DOI 10.1097/00008571-199812000-00011; FUKUDA T, 1994, J BIOCHEM-TOKYO, V115, P338, DOI 10.1093/oxfordjournals.jbchem.a124339; FUKUDA T, 1993, J BIOCHEM-TOKYO, V113, P7, DOI 10.1093/oxfordjournals.jbchem.a124006; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; GILLAM EMJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P59, DOI 10.1006/abbi.1994.1280; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hu Y, 1997, MOL PHARMACOL, V51, P370; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; Ioannides C, 2004, CURR TOP MED CHEM, V4, P1767, DOI 10.2174/1568026043387188; JOHANSSON I, 1988, BIOCHEMISTRY-US, V27, P1925, DOI 10.1021/bi00406a019; Kharasch ED, 1996, LANCET, V347, P1367, DOI 10.1016/S0140-6736(96)91011-9; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KOOP DR, 1986, MOL PHARMACOL, V29, P399; KOOP DR, 1986, ALCOHOL CLIN EXP RES, V10, pS44, DOI 10.1111/j.1530-0277.1986.tb05179.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; LASKER JM, 1987, BIOCHEM BIOPH RES CO, V148, P232, DOI 10.1016/0006-291X(87)91100-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Mackman R, 1996, CHEM RES TOXICOL, V9, P223, DOI 10.1021/tx950130z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moran JH, 2000, TOXICOL APPL PHARM, V168, P268, DOI 10.1006/taap.2000.9053; Moreno RL, 2001, ARCH BIOCHEM BIOPHYS, V391, P99, DOI 10.1006/abbi.2001.2390; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; PATTEN CJ, 1995, ARCH BIOCHEM BIOPHYS, V317, P504, DOI 10.1006/abbi.1995.1194; PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019; PETER R, 1990, CHEM RES TOXICOL, V3, P566, DOI 10.1021/tx00018a012; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; RAUCY JL, 1991, MOL PHARMACOL, V39, P275; RAY DC, 1991, BRIT J ANAESTH, V67, P84, DOI 10.1093/bja/67.1.84; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Roy U, 2005, BIOCHEM J, V390, P719, DOI 10.1042/BJ20050681; SALAZAR DE, 1988, BIOCHEM BIOPH RES CO, V157, P315, DOI 10.1016/S0006-291X(88)80049-4; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Smith SV, 2000, BIOCHEMISTRY-US, V39, P5731, DOI 10.1021/bi000129l; SONG BJ, 1987, MOL ENDOCRINOL, V1, P542, DOI 10.1210/mend-1-8-542; Spatzenegger M, 2003, J PHARMACOL EXP THER, V304, P477, DOI 10.1124/jpet.102.043323; SWANSON BA, 1991, J BIOL CHEM, V266, P19258; TASSANEEYAKUL W, 1994, BIOCHEM PHARMACOL, V47, P1767, DOI 10.1016/0006-2952(94)90304-2; Vaz ADN, 1998, P NATL ACAD SCI USA, V95, P3555, DOI 10.1073/pnas.95.7.3555; Vaz ADN, 1996, P NATL ACAD SCI USA, V93, P4644, DOI 10.1073/pnas.93.10.4644; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; WRIGHTON SA, 1986, BIOCHEMISTRY-US, V25, P6731, DOI 10.1021/bi00370a001; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	71	174	182	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33698	33707		10.1074/jbc.M805999200	http://dx.doi.org/10.1074/jbc.M805999200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18818195	hybrid, Green Published			2022-12-25	WOS:000261183700076
J	Sakakura, M; Oo-Puthinan, S; Moriyama, C; Kimura, T; Moriya, J; Irimura, T; Shimada, I				Sakakura, Masayoshi; Oo-Puthinan, Sarawut; Moriyama, Chifumi; Kimura, Tomomi; Moriya, Jun; Irimura, Tatsuro; Shimada, Ichio			Carbohydrate Binding Mechanism of the Macrophage Galactose-type C-type Lectin 1 Revealed by Saturation Transfer Experiments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGALACTOSAMINE BINDING; IMMATURE DENDRITIC CELLS; MOLECULAR-CLONING; ASIALOGLYCOPROTEIN RECEPTOR; IMPROVED SENSITIVITY; RECOGNITION DOMAIN; STRUCTURAL BASIS; NMR EXPERIMENTS; MOUSE EMBRYOS; PROTEIN	Macrophage galactose-type C-type lectins 1 and 2 (MGL1/2) are expressed on the surfaces of macrophages and immature dendritic cells. Despite the high similarity between the primary sequences of MGL1 and MGL2, they display different ligand specificities. MGL1 shows high affinity for the Lewis(X) trisaccharide, whereas MGL2 shows affinity for N-acetylgalactosamine. To elucidate the structural basis for the ligand specificities of the MGLs, we performed NMR analyses of the MGL1-Lewis(X) complex. To identify the Lewis(X) binding site on MGL1, a saturation transfer experiment for the MGL1-Lewis(X) complex where sugar-CH/CH2-selective saturation was applied was carried out. To obtain sugar moiety-specific information on the interface between MGL1 and the Lewis(X) trisaccharide, saturation transfer experiments where each of galactose-H5-, fucose-CH3-, and N-acetylglucosamine-CH3-selective saturations was applied to the MGL1-Lewis(X) complex were performed. Based on these results, we present a Lewis(X) binding mode on MGL1 where the galactose moiety is bound to the primary sugar binding site, including Asp-94, Trp-96, and Asp-118, and the fucose moiety interacts with the secondary sugar binding site, including Ala-89 and Thr-111. Ala-89 and Thr-111 in MGL1 are replaced with arginine and serine in MGL2, respectively. The hydrophobic environment formed by a small side chain of Ala-89 and a methyl group of Thr-111 is a requisite for the accommodation of the fucose moiety of the Lewis(X) trisaccharide within the sugar binding site of MGL1.	[Sakakura, Masayoshi; Moriyama, Chifumi; Kimura, Tomomi; Moriya, Jun; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Phys Chem Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Oo-Puthinan, Sarawut; Irimura, Tatsuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan	University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Phys Chem Lab, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [17035020]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research on Priority Areas 17035020 from The Ministry of Education, Culture, Sports, Science and Technology (MEXT). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Coombs PJ, 2006, GLYCOBIOLOGY, V16, p1C, DOI 10.1093/glycob/cwj126; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; Denda-Nagai K, 2002, GLYCOBIOLOGY, V12, P443, DOI 10.1093/glycob/cwf061; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; EDISON AS, 1994, METHOD ENZYMOL, V239, P3; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Higashi N, 2002, J BIOL CHEM, V277, P20686, DOI 10.1074/jbc.M202104200; Ichii S, 1997, J LEUKOCYTE BIOL, V62, P761, DOI 10.1002/jlb.62.6.761; Ichii S, 2000, CANCER IMMUNOL IMMUN, V49, P1, DOI 10.1007/s002620050021; Karlsson Robert, 1994, Methods (Orlando), V6, P99, DOI 10.1006/meth.1994.1013; KAWAKAMI K, 1994, JPN J CANCER RES, V85, P744, DOI 10.1111/j.1349-7006.1994.tb02423.x; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kise KJ, 2001, BIOORGAN MED CHEM, V9, P2485, DOI 10.1016/S0968-0896(01)00216-4; Kogelberg H, 2001, CURR OPIN STRUC BIOL, V11, P635, DOI 10.1016/S0959-440X(00)00259-1; Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679; Kolatkar AR, 1998, J BIOL CHEM, V273, P19502, DOI 10.1074/jbc.273.31.19502; Linehan SA, 2000, MICROBES INFECT, V2, P279, DOI 10.1016/S1286-4579(00)00300-2; Mal TK, 2004, J MOL BIOL, V339, P681, DOI 10.1016/j.jmb.2004.04.020; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Mizuochi S, 1998, GLYCOCONJUGATE J, V15, P397, DOI 10.1023/A:1006930019886; Mizuochi S, 1997, GLYCOBIOLOGY, V7, P137, DOI 10.1093/glycob/7.1.137; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Oo-Puthinan S, 2008, BBA-GEN SUBJECTS, V1780, P89, DOI 10.1016/j.bbagen.2007.10.017; SATO M, 1992, J BIOCHEM-TOKYO, V111, P331, DOI 10.1093/oxfordjournals.jbchem.a123758; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Suzuki N, 1996, J IMMUNOL, V156, P128; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuita H, 2005, GLYCOBIOLOGY, V15, P1368, DOI 10.1093/glycob/cwj028	42	20	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33665	33673		10.1074/jbc.M804067200	http://dx.doi.org/10.1074/jbc.M804067200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18790731	hybrid, Green Published			2022-12-25	WOS:000261183700073
J	Oswald, C; Smits, SHJ; Hoing, M; Sohn-Bosser, L; Dupont, L; Le Rudulier, D; Schmitt, L; Bremer, E				Oswald, Christine; Smits, Sander H. J.; Hoeing, Marina; Sohn-Boesser, Linda; Dupont, Laurence; Le Rudulier, Daniel; Schmitt, Lutz; Bremer, Erhard			Crystal Structures of the Choline/Acetylcholine Substrate-binding Protein ChoX from Sinorhizobium meliloti in the Liganded and Unliganded-Closed States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SOLUTES GLYCINE BETAINE; CATION-PI INTERACTIONS; COMPATIBLE SOLUTES; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; ABC TRANSPORTER; MATHEMATICAL TREATMENT; MALTOSE TRANSPORT; DIFFRACTION DATA	The ATP-binding cassette transporter ChoVWX is one of several choline import systems operating in Sinorhizobium meliloti. Here fluorescence-based ligand binding assays were used to quantitate substrate binding by the periplasmic ligand-binding protein ChoX. These data confirmed that ChoX recognizes choline and acetylcholine with high and medium affinity, respectively. We also report the crystal structures of ChoX in complex with either choline or acetylcholine. These structural investigations revealed an architecture of the ChoX binding pocket and mode of substrate binding similar to that reported previously for several compatible solute-binding proteins. Additionally the ChoX-acetylcholine complex permitted a detailed structural comparison with the carbamylcholine-binding site of the acetylcholine-binding protein from the mollusc Lymnaea stagnalis. In addition to the two liganded structures of ChoX, we were also able to solve the crystal structure of ChoX in a closed, substrate-free conformation that revealed an architecture of the ligand-binding site that is superimposable to the closed, ligand-bound form of ChoX. This structure is only the second of its kind and raises the important question of how ATP-binding cassette transporters are capable of distinguishing liganded and unliganded-closed states of the binding protein.	[Oswald, Christine; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Hoeing, Marina; Sohn-Boesser, Linda; Bremer, Erhard] Univ Marburg, Microbiol Lab, Dept Biol, D-35032 Marburg, Germany; [Dupont, Laurence; Le Rudulier, Daniel] Univ Nice Sophia Antipolis, Unite Interact Plantes Microorganismes & Sante Ve, UMR6192, CNRS,INRA,Ctr INRA Agrobiotech, Sophia Antipolis, France	Heinrich Heine University Dusseldorf; Philipps University Marburg; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@uni-duesseldorf.de			University of Duesseldorf; Deutsche Forschungsgemeinschaft [SFB 395]; Fonds der chemischen Industrie; Planck Institute for terrestrial Microbiology (Marburg, Germany)	University of Duesseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Planck Institute for terrestrial Microbiology (Marburg, Germany)	This work was supported in part by grants from the University of Duesseldorf ( to L. S.) and the Deutsche Forschungsgemeinschaft through SFB 395, the Fonds der chemischen Industrie, and the Max Planck Institute for terrestrial Microbiology ( Marburg, Germany) ( to E. B.).	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Ames GFL, 1996, J BIOL CHEM, V271, P14264, DOI 10.1074/jbc.271.24.14264; BERNARD T, 1986, ARCH MICROBIOL, V143, P359, DOI 10.1007/BF00412803; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; BOHL E, 1995, J THEOR BIOL, V172, P83, DOI 10.1006/jtbi.1995.0006; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Rudder KEE, 1999, J BIOL CHEM, V274, P20011, DOI 10.1074/jbc.274.28.20011; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dupont L, 2004, J BACTERIOL, V186, P5988, DOI 10.1128/JB.186.18.5988-5996.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOCCO MM, 1994, J BIOL CHEM, V269, P8931; Hanekop N, 2007, J MOL BIOL, V374, P1237, DOI 10.1016/j.jmb.2007.09.071; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; Horn C, 2005, FEBS LETT, V579, P5765, DOI 10.1016/j.febslet.2005.09.063; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kempf B, 1997, J BACTERIOL, V179, P6213, DOI 10.1128/jb.179.20.6213-6220.1997; KORTSTEE GJ, 1970, ARCH MIKROBIOL, V71, P235, DOI 10.1007/BF00410157; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Magnusson U, 2002, J BIOL CHEM, V277, P14077, DOI 10.1074/jbc.M200514200; MAO B, 1982, J BIOL CHEM, V257, P1131; MERINO G, 1995, J THEOR BIOL, V177, P171, DOI 10.1006/jtbi.1995.0236; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Osteras M, 1998, P NATL ACAD SCI USA, V95, P11394, DOI 10.1073/pnas.95.19.11394; Oswald C, 2008, INT J MOL SCI, V9, P1131, DOI 10.3390/ijms9071131; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; POCARD JA, 1989, J BACTERIOL, V171, P531, DOI 10.1128/jb.171.1.531-537.1989; QILKINSON J, 2003, ABC PROTEINS BACTERI, P178; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; Schiefner A, 2004, J BIOL CHEM, V279, P48270, DOI 10.1074/jbc.M403540200; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Smit AB, 2006, J MOL NEUROSCI, V30, P9, DOI 10.1385/JMN:30:1:9; Smits SHJ, 2008, J BACTERIOL, V190, P5663, DOI 10.1128/JB.00346-08; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780	55	79	80	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32848	32859		10.1074/jbc.M806021200	http://dx.doi.org/10.1074/jbc.M806021200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18779321	Green Published, hybrid			2022-12-25	WOS:000260893700074
J	Dam, TK; Torres, M; Brewer, CF; Casadevall, A				Dam, Tarun K.; Torres, Marcela; Brewer, C. Fred; Casadevall, Arturo			Isothermal Titration Calorimetry Reveals Differential Binding Thermodynamics of Variable Region-identical Antibodies Differing in Constant Region for a Univalent Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTOCOCCUS-NEOFORMANS; FINE SPECIFICITY; CARBOHYDRATE-BINDING; ANTIGEN RECOGNITION; CONCANAVALIN-A; COMBINING SITE; PEPTIDE; ISOTYPE; LIPOPOLYSACCHARIDE; IDENTIFICATION	The classical view of immunoglobulin molecules posits two functional domains defined by the variable (V) and constant (C) regions, which are responsible for antigen binding and antibody effector functions, respectively. These two domains are thought to function independently. However, several lines of evidence strongly suggest that C region domains can affect the specificity and affinity of an antibody for its antigen (Ag), independent of avidity-type effects. In this study, we used isothermal titration calorimetry to investigate the thermodynamic properties of the interactions of four V region-identical monoclonal antibodies with a univalent peptide antigen. Comparison of the binding of IgG1, IgG2a, IgG2b, and IgG3 with a 12-mer peptide mimetic of Cryptococcus neoformans polysaccharide revealed a stoichiometry of 1.9-2.0 with significant differences in thermodynamic binding parameters. Binding of this peptide to the antibodies was dominated by favorable entropy. The interaction of these antibodies with biotinylated peptides manifested greater enthalpy than for native peptides indicating that biotin labeling affected the types of Ag-Ab complexes formed. Our results provide unambiguous thermodynamic evidence for the notion that the C region can affect the interaction of the V region with an Ag.	[Dam, Tarun K.; Brewer, C. Fred] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Torres, Marcela; Brewer, C. Fred; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Dam, TK (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tdam@aecom.yu.edu; casadeva@aecom.yu.edu			National Institutes of Health [AI033142-15, AI033774-15, HL059842-11, AI052733-05, 5U54AI057158-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733, R01AI033142, R37AI033142, U54AI057158, R01AI033774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI033142-15, AI033774-15, HL059842-11, AI052733-05, and 5U54AI057158-05 (to A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; CYGLER M, 1993, BIOCHEM SOC T, V21, P437, DOI 10.1042/bst0210437; GREENSPAN NS, 1989, FASEB J, V3, P2203, DOI 10.1096/fasebj.3.10.2666233; Gupta D, 1996, BIOCHEMISTRY-US, V35, P15236, DOI 10.1021/bi961458+; HERRON JN, 1986, BIOCHEMISTRY-US, V25, P4602, DOI 10.1021/bi00364a022; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; LEMIEUX RU, 1989, CHEM SOC REV, V18, P347, DOI 10.1039/cs9891800347; LEMIEUX RU, 1991, CIBA F SYMP, V158, P231; MARIUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50, DOI 10.1016/0952-7915(93)90080-C; McCloskey N, 1996, IMMUNOLOGY, V88, P169, DOI 10.1111/j.1365-2567.1996.tb00001.x; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; MORELOCK MM, 1994, J BIOL CHEM, V269, P13048; MUNSKE GR, 1984, ARCH BIOCHEM BIOPHYS, V233, P582, DOI 10.1016/0003-9861(84)90482-X; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; SCHREIBER JR, 1993, J INFECT DIS, V167, P221, DOI 10.1093/infdis/167.1.221; SCHWARZ FP, 1993, J BIOL CHEM, V268, P7668; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; SPIRA G, 1992, J IMMUNOL METHODS, V148, P121, DOI 10.1016/0022-1759(92)90165-P; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001310; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; Vyas NK, 2003, P NATL ACAD SCI USA, V100, P15023, DOI 10.1073/pnas.2431286100; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Welfle K, 2003, J MOL RECOGNIT, V16, P54, DOI 10.1002/jmr.607; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Young ACM, 1997, J MOL BIOL, V274, P622, DOI 10.1006/jmbi.1997.1407	31	54	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31366	31370		10.1074/jbc.M806473200	http://dx.doi.org/10.1074/jbc.M806473200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18806257	hybrid, Green Published			2022-12-25	WOS:000260760800014
J	Rodland, KD; Bollinger, N; Ippolito, D; Opresko, LK; Coffey, RJ; Zangar, R; Wiley, HS				Rodland, Karin D.; Bollinger, Nikki; Ippolito, Danielle; Opresko, Lee K.; Coffey, Robert J.; Zangar, Richard; Wiley, H. Steven			Multiple Mechanisms Are Responsible for Transactivation of the Epidermal Growth Factor Receptor in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MATRIX-METALLOPROTEINASE INHIBITOR; EGFR SIGNAL TRANSACTIVATION; PROTEIN-COUPLED RECEPTORS; CANCER-CELLS; CARCINOMA CELLS; ACTIVATION; LIGANDS; PROLIFERATION; MIGRATION	The number of distinct signaling pathways that can transactivate the epidermal growth factor receptor (EGFR) in a single cell type is unclear. Using a single strain of human mammary epithelial cells, we found that a wide variety of agonists, such as lysophosphatidic acid (LPA), uridine triphosphate, growth hormone, vascular endothelial growth factor, insulin-like growth factor-1 (IGF-1), and tumor necrosis factor-alpha, require EGFR activity to induce ERK phosphorylation. In contrast, hepatocyte growth factor can stimulate ERK phosphorylation independent of the EGFR. EGFR transactivation also correlated with an increase in cell proliferation and could be inhibited with metalloprotease inhibitors. However, there were significant differences with respect to transactivation kinetics and sensitivity to different inhibitors. In particular, IGF-1 displayed relatively slow transactivation kinetics and was resistant to inhibition by the selective ADAM-17 inhibitor WAY-022 compared with LPA-induced transactivation. Studies using anti-ligand antibodies showed that IGF-1 transactivation required amphiregulin production, whereas LPA was dependent on multiple ligands. Direct measurement of ligand shedding confirmed that LPA treatment stimulated shedding of multiple EGFR ligands, but paradoxically, IGF-1 had little effect on the shedding rate of any ligand, including amphiregulin. Instead, IGF-1 appeared to work by enhancing EGFR activation of Ras in response to constitutively produced amphiregulin. This enhancement of EGFR signaling was independent of both receptor phosphorylation and PI-3-kinase activity, suggestive of a novel mechanism. Our studies demonstrate that within a single cell type, the EGFR autocrine system can couple multiple signaling pathways to ERK activation and that this modulation of EGFR autocrine signaling can be accomplished at multiple regulatory steps.	[Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Wiley, H. Steven] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99354 USA; [Rodland, Karin D.; Bollinger, Nikki; Ippolito, Danielle; Opresko, Lee K.; Zangar, Richard] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99354 USA; [Rodland, Karin D.; Bollinger, Nikki; Ippolito, Danielle; Opresko, Lee K.; Zangar, Richard; Wiley, H. Steven] Pacific NW Natl Lab, Syst Biol Program, Richland, WA 99354 USA	Vanderbilt University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Rodland, KD (corresponding author), Pacific NW Natl Lab, P7-56,POB 999, Richland, WA 99352 USA.	karin.rodland@pnl.gov	Rodland, Karin/R-6186-2019	Wiley, Steven/0000-0003-0232-6867	National Institutes of Health, NCI, [CA 46413]; Biomolecular Systems Initiative Laboratory Directed Research; Pacific Northwest National Laboratory; Department of Energy [DE-AC05-76RL01830]; Gastrointestinal Special Program of Research Excellence [P50 95103]; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA046413] Funding Source: NIH RePORTER	National Institutes of Health, NCI,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomolecular Systems Initiative Laboratory Directed Research; Pacific Northwest National Laboratory(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); Gastrointestinal Special Program of Research Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA 46413 (to R. J. C.). This work was also supported by the Biomolecular Systems Initiative Laboratory Directed Research and Development Program at the Pacific Northwest National Laboratory, a multiprogram national laboratory operated by Battelle for the United States Department of Energy under Contract DE-AC05-76RL01830 and by Gastrointestinal Special Program of Research Excellence Grant P50 95103 (to R. J. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Obeidi FA, 2000, ONCOGENE, V19, P5690, DOI 10.1038/sj.onc.1203926; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; BERCHERER JD, 2003, CURR TOP DEV BIOL, V54, P2031; Brown PD, 1998, BREAST CANCER RES TR, V52, P125, DOI 10.1023/A:1006119319695; Chen WNU, 2004, J BIOL CHEM, V279, P18488, DOI 10.1074/jbc.M310874200; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; DeWitt A, 2002, DEV BIOL, V250, P305, DOI 10.1006/dbio.2002.0807; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dong JY, 2005, MOL BIOL CELL, V16, P2984, DOI 10.1091/mbc.E04-11-0994; Dong JY, 2000, J BIOL CHEM, V275, P557, DOI 10.1074/jbc.275.1.557; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; El-Shewy HM, 2004, MOL ENDOCRINOL, V18, P2727, DOI 10.1210/me.2004-0174; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Hendriks BS, 2005, J BIOL CHEM, V280, P6157, DOI 10.1074/jbc.M410491200; Jacobs JM, 2004, J PROTEOME RES, V3, P68, DOI 10.1021/pr034062a; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Kue PF, 2002, INT J CANCER, V102, P572, DOI 10.1002/ijc.10734; Lauffenburger DA, 1998, P NATL ACAD SCI USA, V95, P15368, DOI 10.1073/pnas.95.26.15368; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Liu T, 2005, PROTEOMICS, V5, P1263, DOI 10.1002/pmic.200401055; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Merchant NB, 2005, SURGERY, V138, P415, DOI 10.1016/j.surg.2005.06.030; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; Monine MI, 2005, BIOPHYS J, V88, P2384, DOI 10.1529/biophysj.104.051425; Montero JC, 2002, BIOCHEM J, V363, P211, DOI 10.1042/0264-6021:3630211; Ohtsu H, 2006, ARTERIOSCL THROM VAS, V26, pE133, DOI 10.1161/01.ATV.0000236203.90331.d0; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Sampaio C, 2008, MOL CELL BIOL, V28, P587, DOI 10.1128/MCB.01318-07; Santiskulvong C, 2003, EXP CELL RES, V290, P437, DOI 10.1016/S0014-4827(03)00355-0; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Shah BH, 2003, J BIOL CHEM, V278, P19118, DOI 10.1074/jbc.M212932200; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Solorzano CC, 1997, SHOCK, V7, P427, DOI 10.1097/00024382-199706000-00007; Stampfer M R, 1988, Cancer Treat Res, V40, P1; STAMPFER MR, 1993, CANCER SURV, V18, P7; Stortelers C, 2003, J BIOL CHEM, V278, P12055, DOI 10.1074/jbc.M211948200; Tomlins SA, 2005, EXP CELL RES, V308, P439, DOI 10.1016/j.yexcr.2005.04.032; Vacca F, 2000, CANCER RES, V60, P5310; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Xi SC, 2003, J BIOL CHEM, V278, P31574, DOI 10.1074/jbc.M303499200; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Zhang Q, 2004, CANCER RES, V64, P6166, DOI 10.1158/0008-5472.CAN-04-0504; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	54	47	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31477	31487		10.1074/jbc.M800456200	http://dx.doi.org/10.1074/jbc.M800456200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782770	hybrid, Green Published			2022-12-25	WOS:000260760800027
J	Zalzali, H; Naudin, C; Bastide, P; Quittau-Prevostel, C; Yaghi, C; Poulat, F; Jay, P; Blache, P				Zalzali, H.; Naudin, C.; Bastide, P.; Quittau-Prevostel, C.; Yaghi, C.; Poulat, F.; Jay, P.; Blache, P.			CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium	ONCOGENE			English	Article						CEACAM1; colon epithelium; SOX9	CARCINOEMBRYONIC ANTIGEN; GENE; EXPRESSION; ENHANCER; PROTEIN; CELLS; MODEL	A deletion of the transcription factor SOX9 gene in the mice intestine affects the morphology of the colon epithelium and leads to hyperplasia. Nevertheless, direct transcriptional targets of SOX9 in this tissue are still unknown. A microarray analysis identified the tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) as a possible SOX9 target gene and we demonstrate here that SOX9 upregulates CEACAM1 in human colonic cells. Moreover, CEACAM1 expression is reduced in colon of SOX9-deficient mouse, suggesting an important function for SOX9 in the transcriptional activation of the CEACAM1 gene. We further identified SOX9-binding sequences in the human and rat CEACAM1 promoters, and an electrophoretic mobility shift together with a chromatin immunoprecipitation provided an additional evidence of the SOX9 binding to the human promoter. In addition, we established that histone acyl-transferase p300 behaves as an SOX9 coactivator of the rat and human CEACAM1 promoters. These results highlight CEACAM1 as the first direct target of SOX9 identified in the colon epithelium.	[Blache, P.] Univ Montpellier, CNRS, UMR 5203, Inst Genome Fonct, F-34094 Montpellier 5, France; [Zalzali, H.; Naudin, C.; Bastide, P.; Quittau-Prevostel, C.; Jay, P.; Blache, P.] INSERM, U661, Montpellier, France; [Zalzali, H.; Naudin, C.; Bastide, P.; Quittau-Prevostel, C.; Jay, P.; Blache, P.] Univ Montpellier 1, Montpellier, France; [Yaghi, C.] Univ St Joseph Achrafieh, Serv Gastroenterol, CHU Hotel Dieu France, Beirut, Lebanon; [Poulat, F.] Inst Genet Humaine, CNRS, UPR 1142, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Blache, P (corresponding author), Univ Montpellier, CNRS, UMR 5203, Inst Genome Fonct, 141 Rue Cardonille, F-34094 Montpellier 5, France.	philippe.blache@igf.cnrs.fr	Jay, Philippe/ABD-9223-2020; POULAT, FRANCIS/AAV-2170-2020; Prevostel, Corinne/AAO-1433-2020; Jay, Philippe/I-7116-2016	Jay, Philippe/0000-0003-0156-5700; POULAT, FRANCIS/0000-0003-2070-1296; Jay, Philippe/0000-0003-0156-5700; Yaghi, Cesar/0000-0003-4130-2606; PREVOSTEL, Corinne/0000-0002-7553-087X	Agence Nationale pour la Recherche; Association pour la Recherche contre le Cancer [3570, 3636]; Ligue Nationale contre le Cancer (Equipe Labellisee); Fondation pour la Recherche Medicale; Groupement des Entreprises Francaises dans la Lutte contre le Cancer; National Council for Scientific Research Lebanon	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Groupement des Entreprises Francaises dans la Lutte contre le Cancer; National Council for Scientific Research Lebanon	This work was supported by Agence Nationale pour la Recherche, Association pour la Recherche contre le Cancer (nos. 3570 and 3636), Ligue Nationale contre le Cancer (Equipe Labellisee), Fondation pour la Recherche Medicale, Groupement des Entreprises Francaises dans la Lutte contre le Cancer and the National Council for Scientific Research Lebanon. We thank Dr Horst and Dr Beauchemin for the anti-CEACAM1 antibodies, Dr Najjar and Dr Beauchemin for the luciferase reporter.	Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Chen CJ, 1996, J BIOL CHEM, V271, P28181, DOI 10.1074/jbc.271.45.28181; Darido C, 2008, CANCER RES, V68, P4258, DOI 10.1158/0008-5472.CAN-07-5805; HAUCK W, 1994, EUR J BIOCHEM, V223, P529, DOI 10.1111/j.1432-1033.1994.tb19022.x; Hemmila E, 2004, J VIROL, V78, P10156, DOI 10.1128/JVI.78.18.10156-10165.2004; Jay P, 2005, CANCER RES, V65, P2193, DOI 10.1158/0008-5472.CAN-04-1484; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Lu BJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-40; Mertin S, 1999, NUCLEIC ACIDS RES, V27, P1359, DOI 10.1093/nar/27.5.1359; Najjar SM, 1996, J BIOL CHEM, V271, P8809, DOI 10.1074/jbc.271.15.8809; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Notarnicola C, 2006, GENE EXPR PATTERNS, V6, P695, DOI 10.1016/j.modgep.2006.01.001; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; WAGENER C, 1983, J IMMUNOL, V130, P2308; Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989	18	36	36	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2008	27	56					7131	7138		10.1038/onc.2008.331	http://dx.doi.org/10.1038/onc.2008.331			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	376PQ	18794798				2022-12-25	WOS:000261195900007
J	Lin, JJ; Xu, P; LaVallee, P; Hoidal, JR				Lin, Junji; Xu, Ping; LaVallee, Patricia; Hoidal, John R.			Identification of Proteins Binding to E-Box/Ku86 Sites and Function of the Tumor Suppressor SAFB1 in Transcriptional Regulation of the Human Xanthine Oxidoreductase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL EPITHELIAL-CELLS; BREAST-CANCER; URIC-ACID; OXIDASE ACTIVITY; MAMMARY-GLAND; NITRIC-OXIDE; DNA-BINDING; RAT-LIVER; DEHYDROGENASE GENE; MOLECULAR-CLONING	The xanthine oxidoreductase gene (XOR) encodes an important source of reactive oxygen species and uric acid, and its expression is associated with various human diseases including several forms of cancer. We previously reported that basal human XOR (hXOR) expression is restricted or repressed by E-box and TATA-like elements and a cluster of transcriptional proteins, including AREB6-like proteins and DNA-dependent protein kinase (DNA-PK). We now demonstrate that the cluster contains the tumor suppressors SAFB1, BRG1, and SAF-A. We further demonstrate that SAFB1 silencing increases hXOR expression and that SAFB1 directly binds to the E-box. Multiple studies in vitro and in vivo including pull-down, immunoprecipitation and chromatin immunoprecipitation analyses indicate that SAFB1, Ku86, and BRG1 associate with each other. The results suggest that the SAFB1 complex binds to the hXOR promoter in a chromatin environment and plays a critical role in restricting hXOR expression via its direct interaction with the E-box, DNA-PK, and tumor suppressors. Moreover, we demonstrate that the cytokine, oncostatinM(OSM), induces the phosphorylation of SAFB1 and that the OSM-induced hXOR mRNA expression is significantly inhibited by silencing the DNA-PK catalytic subunit or SAFB1 expression. The present studies for the first time demonstrate that hXOR is a tumor suppressor-targeted gene and that the phosphorylation of SAFB1 is regulated by OSM, providing a molecular basis for understanding the role of SAFB1-regulated hXOR transcription in cytokine stimulation and tumorigenesis.	[Lin, Junji; Xu, Ping] Fudan Univ, State Key Lab Neurosci, Lab Genom Physiol, Shanghai 200032, Peoples R China; [Xu, Ping; LaVallee, Patricia; Hoidal, John R.] Univ Utah, Dept Internal Med, Div Resp Crit Care & Occupat Med, Hlth Sci Ctr, Salt Lake City, UT 84132 USA; [Xu, Ping; LaVallee, Patricia; Hoidal, John R.] Vet Affairs Med Ctr, Salt Lake City, UT 84132 USA	Fudan University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Xu, P (corresponding author), Fudan Univ, State Key Lab Neurosci, Lab Genom Physiol, Shanghai 200032, Peoples R China.	matibuck@yahoo.com; john.hoidal@hsc.utah.edu			National Institutes of Health [5RO1HL40665]; Veterans Administration Research Service; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Research Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1HL40665. This work was also supported by the Veterans Administration Research Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABADEH S, 1992, BIOCHIM BIOPHYS ACTA, V1117, P25, DOI 10.1016/0304-4165(92)90157-P; AKAIKE T, 1990, J CLIN INVEST, V85, P739, DOI 10.1172/JCI114499; AMAYA Y, 1990, J BIOL CHEM, V265, P14170; Ambrosone CB, 2000, ANTIOXID REDOX SIGN, V2, P903, DOI 10.1089/ars.2000.2.4-903; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ATHAR M, 1989, J CLIN INVEST, V83, P1137, DOI 10.1172/JCI113993; BECKER BF, 1989, PFLUG ARCH EUR J PHY, V415, P127, DOI 10.1007/BF00370582; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Bonifacino J.S., 2001, CURR PROTOC MOL BIOL, V10; Castro GD, 2001, TOXICOLOGY, V160, P11, DOI 10.1016/S0300-483X(00)00433-9; Chae YH, 1999, CHEM RES TOXICOL, V12, P180, DOI 10.1021/tx9802318; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; COWELL IG, 1994, TRENDS BIOCHEM SCI, V19, P38, DOI 10.1016/0968-0004(94)90172-4; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; DIAMOND JR, 1986, KIDNEY INT, V29, P478, DOI 10.1038/ki.1986.24; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Donovan J, 2000, BREAST CANCER RES, V2, P116, DOI 10.1186/bcr43; DUPONT GP, 1992, J CLIN INVEST, V89, P197, DOI 10.1172/JCI115563; Elend M, 1999, CURR BIOL, V9, pR936, DOI 10.1016/S0960-9822(00)80109-8; FALCIANI F, 1992, BIOCHEM J, V285, P1001, DOI 10.1042/bj2851001; FINNIE N, 1993, BIOCHEM SOC T, V21, P930, DOI 10.1042/bst0210930; Fu YP, 2003, CANCER RES, V63, P2440; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; GIFFIN W, 1994, J BIOL CHEM, V269, P1449; Giffin W, 1999, MOL CELL BIOL, V19, P4065; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; Harrison R, 1997, BIOCHEM SOC T, V25, P786, DOI 10.1042/bst0250786; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; HASSOUN PM, 1994, AM J PHYSIOL, V266, pL163, DOI 10.1152/ajplung.1994.266.2.L163; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; HOWELL RR, 1960, J BIOL CHEM, V235, P3544; Hu DE, 2004, CANCER RES, V64, P5059, DOI 10.1158/0008-5472.CAN-04-1586; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; Kang Duck-Hee, 2002, AACN Clin Issues, V13, P540, DOI 10.1097/00044067-200211000-00007; KAWAMURA T, 1991, KIDNEY INT, V40, P291, DOI 10.1038/ki.1991.213; Kaynar H, 2005, CANCER LETT, V227, P133, DOI 10.1016/j.canlet.2004.12.005; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; Kopnin BP, 2000, BIOCHEMISTRY-MOSCOW+, V65, P2; LINAS SL, 1990, AM J PHYSIOL, V258, pF711, DOI 10.1152/ajprenal.1990.258.3.F711; MASSEY V, 1969, J BIOL CHEM, V244, P1682; Miyamoto Y, 1996, P SOC EXP BIOL MED, V211, P366; MUXFELDT M, 1987, BASIC RES CARDIOL, V82, P486, DOI 10.1007/BF01907096; Oesterreich S, 2001, BRIT J CANCER, V84, P493, DOI 10.1054/bjoc.2000.1606; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; PALLER MS, 1991, KIDNEY INT, V40, P1041, DOI 10.1038/ki.1991.312; PEDEN DB, 1990, P NATL ACAD SCI USA, V87, P7638, DOI 10.1073/pnas.87.19.7638; PFEFFER KD, 1994, J IMMUNOL, V153, P1789; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Reisman DN, 2003, CANCER RES, V63, P560; Renz A, 1996, NUCLEIC ACIDS RES, V24, P843, DOI 10.1093/nar/24.5.843; Ritter CL, 2002, CHEM RES TOXICOL, V15, P536, DOI 10.1021/tx010172p; Ritter CL, 2000, CHEM RES TOXICOL, V13, P793, DOI 10.1021/tx0000567; RODELL TC, 1987, J APPL PHYSIOL, V63, P2159, DOI 10.1152/jappl.1987.63.5.2159; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; Ross JS, 2003, EXPERT REV MOL DIAGN, V3, P573, DOI 10.1586/14737159.3.5.573; SANDERS KA, 1999, CHEST S1, V116, P56; Sanders SA, 1997, EUR J BIOCHEM, V245, P541, DOI 10.1111/j.1432-1033.1997.00541.x; Schild-Poulter C, 2001, J BIOL CHEM, V276, P16848, DOI 10.1074/jbc.M100768200; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Slot O, 1994, Ugeskr Laeger, V156, P2396; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; SULCINER DJ, 1996, BIOCHEM J, V318, P379; Tsao SM, 2007, NUTR CANCER, V59, P8, DOI 10.1080/01635580701365043; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; WAJNER M, 1989, BIOCHIM BIOPHYS ACTA, V991, P79, DOI 10.1016/0304-4165(89)90031-7; WAUD WR, 1976, ARCH BIOCHEM BIOPHYS, V172, P365, DOI 10.1016/0003-9861(76)90088-6; Wright RM, 1999, FREE RADICAL BIO MED, V26, P348, DOI 10.1016/S0891-5849(98)00204-4; Xu P, 2000, J BIOL CHEM, V275, P5918, DOI 10.1074/jbc.275.8.5918; XU P, 1994, GENOMICS, V23, P289, DOI 10.1006/geno.1994.1498; Xu P, 1996, GENOMICS, V34, P173, DOI 10.1006/geno.1996.0262; Xu P, 2004, J BIOL CHEM, V279, P16057, DOI 10.1074/jbc.M305856200; XU P, 1994, BIOCHEM BIOPH RES CO, V199, P998, DOI 10.1006/bbrc.1994.1328	80	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29681	29689		10.1074/jbc.M802076200	http://dx.doi.org/10.1074/jbc.M802076200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772145	Green Published, hybrid			2022-12-25	WOS:000260366900011
J	Liu, DQ; Li, LM; Guo, YL; Bai, R; Wang, C; Bian, Z; Zhang, CY; Zen, K				Liu, Dan-Qing; Li, Li-Min; Guo, Ya-Lan; Bai, Rui; Wang, Chen; Bian, Zhen; Zhang, Chen-Yu; Zen, Ke			Signal Regulatory Protein alpha Negatively Regulates beta(2) Integrin-Mediated Monocyte Adhesion, Transendothelial Migration and Phagocytosis	PLOS ONE			English	Article								Background: Signal regulate protein alpha (SIRP alpha) is involved in many functional aspects of monocytes. Here we investigate the role of SIRP alpha in regulating beta(2) integrin-mediated monocyte adhesion, transendothelial migration (TEM) and phagocytosis. Methodology/Principal Findings: THP-1 monocytes/macropahges treated with advanced glycation end products (AGEs) resulted in a decrease of SIRP alpha expression but an increase of beta(2) integrin cell surface expression and beta(2) integrin-mediated adhesion to tumor necrosis factor-alpha (TNF alpha)-stimulated human microvascular endothelial cell (HMEC-1) monolayers. In contrast, SIRP alpha overexpression in THP-1 cells showed a significant less monocyte chemotactic protein-1 (MCP-1)-triggered cell surface expression of beta(2) integrins, in particular CD11b/CD18. SIRP alpha overexpression reduced beta(2) integrin-mediated firm adhesion of THP-1 cells to either TNF alpha-stimulated HMEC-1 monolayers or to immobilized intercellular adhesion molecule-1 (ICAM-1). SIRP alpha overexpression also reduced MCP-1-initiated migration of THP-1 cells across TNF alpha-stimulated HMEC-1 monolayers. Furthermore, beta(2) integrin-mediated THP-1 cell spreading and actin polymerization in response to MCP-1, and phagocytosis of bacteria were both inhibited by SIRP alpha overexpression. Conclusions/Significance: SIRP alpha negatively regulates beta(2) integrin-mediated monocyte adhesion, transendothelial migration and phagocytosis, thus may serve as a critical molecule in preventing excessive activation and accumulation of monocytes in the arterial wall during early stage of atherosclerosis.	[Liu, Dan-Qing; Li, Li-Min; Guo, Ya-Lan; Bai, Rui; Wang, Chen; Bian, Zhen; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Res Ctr, Nanjing, Jiangsu, Peoples R China; [Li, Li-Min; Zen, Ke] Nanjing Univ, Joint Inst Virol, Jiangsu CDC, Nanjing, Peoples R China	Nanjing University; Nanjing University	Liu, DQ (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Res Ctr, Nanjing, Jiangsu, Peoples R China.	kzen@nju.edu.cn	wang, chen/GWM-9481-2022		China Basic Science 973 program	China Basic Science 973 program(National Basic Research Program of China)	This work was supported in part by China Basic Science 973 program (CYZ, KZ).	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Brown E, 2001, J CLIN INVEST, V107, P1499, DOI 10.1172/JCI13315; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Capo C, 2003, J IMMUNOL, V170, P4217, DOI 10.4049/jimmunol.170.8.4217; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gafa V, 2005, J MED VIROL, V76, P361, DOI 10.1002/jmv.20358; GERRITY RG, 1981, AM J PATHOL, V103, P181; Han KH, 2003, J LIPID RES, V44, P1332, DOI 10.1194/jlr.M200427-JLR200; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2005, J BIOL CHEM, V280, P36132, DOI 10.1074/jbc.M506419200; Luscinskas FW, 1996, J IMMUNOL, V157, P326; Mateo W, 2002, BLOOD, V100, P2882, DOI 10.1182/blood-2001-12-0217; MIYAGAWA K, 1994, CARDIOL ELDER, V2, P1; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oshima K, 2002, FEBS LETT, V519, P1, DOI 10.1016/S0014-5793(02)02703-5; Papayannopoulou T, 2003, BLOOD, V101, P4739, DOI 10.1182/blood-2002-09-2741; Patel V, 2002, EUR J IMMUNOL, V32, P1865, DOI 10.1002/1521-4141(200207)32:7<1865::AID-IMMU1865>3.0.CO;2-F; Peppa M, 2003, DIABETES, V52, P2805, DOI 10.2337/diabetes.52.11.2805; Rosenfeld ME, 2002, ARTERIOSCL THROM VAS, V22, P361, DOI 10.1161/hq0302.104847; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Ryu JW, 2004, ARTERIOSCL THROM VAS, V24, P864, DOI 10.1161/01.ATV.0000125705.28058.eb; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shahabuddin S, 2000, J IMMUNOL, V164, P3847, DOI 10.4049/jimmunol.164.7.3847; Sharlow ER, 2000, J CELL SCI, V113, P3093; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Sotiriou SN, 2006, FASEB J, V20, P559, DOI 10.1096/fj.05-4857fje; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Valcourt U, 2007, J BIOL CHEM, V282, P5691, DOI 10.1074/jbc.M610536200; van Royen N, 2003, CIRC RES, V92, P218, DOI 10.1161/01.RES.0000052313.23087.3F; Weber KSC, 1999, MOL BIOL CELL, V10, P861, DOI 10.1091/mbc.10.4.861; Wu CJ, 2000, ONCOGENE, V19, P3999, DOI 10.1038/sj.onc.1203748; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Zen K, 2002, J IMMUNOL, V169, P5270, DOI 10.4049/jimmunol.169.9.5270; ZEN K, 2007, J MOL BIOL; Zhang H, 2002, AM J PATHOL, V160, P2219, DOI 10.1016/S0002-9440(10)61169-8	49	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3291	10.1371/journal.pone.0003291	http://dx.doi.org/10.1371/journal.pone.0003291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820737	Green Submitted, Green Published, gold			2022-12-25	WOS:000264432500002
J	Taylor, WD; Kuchibhatla, M; Payne, ME; MacFall, JR; Sheline, YI; Krishnan, KR; Doraiswamy, PM				Taylor, Warren D.; Kuchibhatla, Maragatha; Payne, Martha E.; MacFall, James R.; Sheline, Yvette I.; Krishnan, K. Ranga; Doraiswamy, P. Murali			Frontal White Matter Anisotropy and Antidepressant Remission in Late-Life Depression	PLOS ONE			English	Article							MRI SUBCORTICAL HYPERINTENSITIES; DORSOLATERAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; TREATMENT RESPONSE; MAJOR DEPRESSION; DIFFUSION-TENSOR; MICROSTRUCTURAL ABNORMALITIES; GERIATRIC DEPRESSION; WATER DIFFUSION; NERVOUS-SYSTEM	Introduction: Neuroanatomic features associated with antidepressant treatment outcomes in older depressed individuals are not well established. This study used diffusion tensor imaging to examine frontal white matter structure in depressed subjects undergoing a 12-week trial of sertraline. We hypothesized that remission would be associated with higher frontal anisotropy measures, and failure to remit with lower anisotropy. Methods: 74 subjects with Major Depressive Disorder and age 60 years or older were enrolled in a twelve-week open-label trial of sertraline and completed clinical assessments and 1.5T magnetic resonance brain imaging. The apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in regions of interest placed in the white matter of the dorsolateral prefrontal cortex, anterior cingulate cortex, and corpus callosum. Differences in ADC and FA values between subjects who did and did not remit to treatment over the study period were assessed using generalized estimating equations, controlling for age, sex, medical comorbidity and baseline depression severity. Results: Subjects who did not remit to sertraline exhibited higher FA values in the superior frontal gyri and anterior cingulate cortices bilaterally. There were no statistically significant associations between ADC measures and remission. Conclusions: Failure to remit to sertraline is associated with higher frontal FA values. Functional imaging studies demonstrate that depression is characterized by functional disconnection between frontal and limbic regions. Those individuals where this disconnection is related to structural changes as detected by DTI may be more likely to respond to antidepressants.	[Taylor, Warren D.; Kuchibhatla, Maragatha; Payne, Martha E.; Krishnan, K. Ranga] Dept Psychiat, Durham, NC USA; [Kuchibhatla, Maragatha; Doraiswamy, P. Murali] Dept Biostat & Bioinformat, Durham, NC USA; [MacFall, James R.] Dept Radiol, Durham, NC USA; [Kuchibhatla, Maragatha] Ctr Study Aging & Human Dev, Durham, NC USA; [Taylor, Warren D.; Payne, Martha E.; MacFall, James R.] Neuropsychiat Imaging Res Lab, Durham, NC USA; [Sheline, Yvette I.] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Krishnan, K. Ranga] Duke NUS Grad Med Sch, Singapore, Singapore	Washington University (WUSTL); National University of Singapore	Taylor, WD (corresponding author), Dept Psychiat, Durham, NC USA.	taylo066@mc.duke.edu	Taylor, Warren D/J-3687-2014	Sheline, Yvette/0000-0002-6929-9659	NIMH [K23 MH 65939, R01 MH 62158, R01 MH 078216]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078216, K23MH065939, R01MH062158] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by NIMH grants K23 MH 65939, R01 MH 62158, and R01 MH 078216. Sertraline was provided by Pfizer. These funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Baldwin R, 2004, PSYCHOL MED, V34, P125, DOI 10.1017/S0033291703008870; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fujikawa T, 1996, STROKE, V27, P2040, DOI 10.1161/01.STR.27.11.2040; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Hawley CJ, 2002, J AFFECT DISORDERS, V72, P177, DOI 10.1016/S0165-0327(01)00451-7; HICKIE I, 1995, BIOL PSYCHIAT, V37, P151, DOI 10.1016/0006-3223(94)00174-2; Iosifescu DV, 2006, BRIT J PSYCHIAT, V188, P180, DOI 10.1192/bjp.188.2.180; Janssen J, 2007, INT J GERIATR PSYCH, V22, P468, DOI 10.1002/gps.1790; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Krishnan K R, 1998, Depress Anxiety, V8, P142, DOI 10.1002/(SICI)1520-6394(1998)8:4<142::AID-DA2>3.0.CO;2-N; Kubicki M, 2003, BIOL PSYCHIAT, V54, P1171, DOI 10.1016/S0006-3223(03)00419-0; LATOUR LL, 1994, P NATL ACAD SCI USA, V91, P1229, DOI 10.1073/pnas.91.4.1229; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; Oslin DW, 2002, J AM GERIATR SOC, V50, P823, DOI 10.1046/j.1532-5415.2002.50206.x; Papakostas GI, 2005, PSYCHIAT RES-NEUROIM, V140, P301, DOI 10.1016/j.pscychresns.2005.09.001; Patankar TF, 2007, J AFFECT DISORDERS, V97, P265, DOI 10.1016/j.jad.2006.06.024; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pillay SS, 1997, BIOL PSYCHIAT, V42, P79, DOI 10.1016/S0006-3223(96)00335-6; Rajkowska G, 2005, BIOL PSYCHIAT, V58, P297, DOI 10.1016/j.biopsych.2005.04.013; Salloway S, 2002, AM J GERIAT PSYCHIAT, V10, P107, DOI 10.1176/appi.ajgp.10.1.107; Salloway S, 2002, J NEUROL SCI, V203, P227, DOI 10.1016/S0022-510X(02)00296-4; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Simpson S, 1998, PSYCHOL MED, V28, P1015, DOI 10.1017/S003329179800693X; Sneed JR, 2007, AM J GERIAT PSYCHIAT, V15, P553, DOI 10.1097/JGP.0b013e3180302513; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Steffens DC, 2005, INT PSYCHOGERIATR, V17, P41, DOI 10.1017/S1041610205000979; Taylor WD, 2007, AM J ROENTGENOL, V188, P1695, DOI 10.2214/AJR.06.1163; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Taylor WD, 2001, BIOL PSYCHIAT, V50, P179, DOI 10.1016/S0006-3223(01)01160-X; Taylor WD, 2003, ARCH GEN PSYCHIAT, V60, P1090, DOI 10.1001/archpsyc.60.11.1090; Taylor WD, 2005, PSYCHIAT RES-NEUROIM, V139, P1, DOI 10.1016/j.pscychresns.2004.08.004; Thomas AJ, 2002, ARCH GEN PSYCHIAT, V59, P785, DOI 10.1001/archpsyc.59.9.785; Yang Q, 2007, INT PSYCHOGERIATR, V19, P757, DOI 10.1017/S1041610207004875	50	76	82	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3267	10.1371/journal.pone.0003267	http://dx.doi.org/10.1371/journal.pone.0003267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422MG	18813343	Green Submitted, gold, Green Published			2022-12-25	WOS:000264431800006
J	Kielbasa, SM; Vingron, M				Kielbasa, Szymon M.; Vingron, Martin			Transcriptional Autoregulatory Loops Are Highly Conserved in Vertebrate Evolution	PLOS ONE			English	Article								Background: Feedback loops are the simplest building blocks of transcriptional regulatory networks and therefore their behavior in the course of evolution is of prime interest. Methodology: We address the question of enrichment of the number of autoregulatory feedback loops in higher organisms. First, based on predicted autoregulatory binding sites we count the number of autoregulatory loops. We compare it to estimates obtained either by assuming that each (conserved) gene has the same chance to be a target of a given factor or by assuming that each conserved sequence position has an equal chance to be a binding site of the factor. Conclusions: We demonstrate that the numbers of putative autoregulatory loops conserved between human and fugu, danio or chicken are significantly higher than expected. Moreover we show, that conserved autoregulatory binding sites cluster close to the factors' starts of transcription. We conclude, that transcriptional autoregulatory feedback loops constitute a core transcriptional network motif and their conservation has been maintained in higher vertebrate organism evolution.	[Kielbasa, Szymon M.; Vingron, Martin] Max Planck Inst Mol Genet, Berlin, Germany	Max Planck Society	Kielbasa, SM (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	szymon.kielbasa@molgen.mpg.de	Kiełbasa, Szymon M./K-2792-2019; Kiełbasa, Szymon/G-1636-2018	Kiełbasa, Szymon/0000-0003-2805-6535	German Ministry for Research and Education (NGFN/BMBF)	German Ministry for Research and Education (NGFN/BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from the German Ministry for Research and Education (NGFN/BMBF).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Conant GC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-62; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Packer AI, 1998, DEVELOPMENT, V125, P1991; RAHMANN S, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1032; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SETH A, 1990, ONCOGENE, V5, P1761; Smith SB, 2000, J BIOL CHEM, V275, P36910, DOI 10.1074/jbc.M005202200; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Tao Y, 2004, J THEOR BIOL, V229, P147, DOI 10.1016/j.jtbi.2004.03.011; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	23	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3210	10.1371/journal.pone.0003210	http://dx.doi.org/10.1371/journal.pone.0003210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791639	Green Published, gold			2022-12-25	WOS:000264427700005
J	Faye, B; Arnaud, F; Peyretaillade, E; Brasset, E; Dastugue, B; Vaury, C				Faye, Babacar; Arnaud, Frederick; Peyretaillade, Eric; Brasset, Emilie; Dastugue, Bernard; Vaury, Chantal			Functional Characteristics of a Highly Specific Integrase Encoded by an LTR-Retrotransposon	PLOS ONE			English	Article								Background: The retroviral Integrase protein catalyzes the insertion of linear viral DNA into host cell DNA. Although different retroviruses have been shown to target distinctive chromosomal regions, few of them display a site-specific integration. ZAM, a retroelement from Drosophila melanogaster very similar in structure and replication cycle to mammalian retroviruses is highly site-specific. Indeed, ZAM copies target the genomic 5'-CGCGCg-3' consensus-sequences. To enlighten the determinants of this high integration specificity, we investigated the functional properties of its integrase protein denoted ZAM-IN. Principal Findings: Here we show that ZAM-IN displays the property to nick DNA molecules in vitro. This endonuclease activity targets specific sequences that are present in a 388 bp fragment taken from the white locus and known to be a genomic ZAM integration site in vivo. Furthermore, ZAM-IN displays the unusual property to directly bind specific genomic DNA sequences. Two specific and independent sites are recognized within the 388 bp fragment of the white locus: the CGCGCg sequence and a closely apposed site different in sequence. Conclusion: This study strongly argues that the intrinsic properties of ZAM-IN, ie its binding properties and its endonuclease activity, play an important part in ZAM integration specificity. Its ability to select two binding sites and to nick the DNA molecule reminds the strategy used by some site-specific recombination enzymes and forms the basis for site-specific integration strategies potentially useful in a broad range of genetic engineering applications.	[Faye, Babacar; Arnaud, Frederick; Peyretaillade, Eric; Brasset, Emilie; Dastugue, Bernard; Vaury, Chantal] Univ Clermont Ferrand, INSERM, CNRS, Fac Med,UMR 6247,U931, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Faye, B (corresponding author), Univ Clermont Ferrand, INSERM, CNRS, Fac Med,UMR 6247,U931, Clermont Ferrand, France.	Chantal.VAURY@inserm.u-clermont1.fr	Brasset, Emilie/J-6684-2015; Vaury, Chantal/I-4658-2015; Arnaud, Frédérick/F-4892-2019	Vaury, Chantal/0000-0002-7725-5760; Arnaud, Frédérick/0000-0001-6893-9848; Brasset, Emilie/0000-0003-2479-7969	CNRS [GDR2157]; Action Concertee Incitative [BCMS408]; Canceropcle Lyon Auvergne Rhcne-Alpes; Region Auvergne; Ministere de l'Enseignement Superieur et de la Recherche (MESR); Fondation Recherche Medicale (FRM)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Action Concertee Incitative; Canceropcle Lyon Auvergne Rhcne-Alpes; Region Auvergne(Region Auvergne-Rhone-Alpes); Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); Fondation Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	Our research is supported by grants from CNRS (GDR2157), Action Concertee Incitative (ACI BCMS408), Canceropcle Lyon Auvergne Rhcne-Alpes (CLARA, Projet EpiPro), and Region Auvergne to CV. F.A. received a grant from the Ministere de l'Enseignement Superieur et de la Recherche (MESR), and the Fondation Recherche Medicale (FRM).	Arnaud F, 2005, INSECT BIOCHEM MOLEC, V35, P323, DOI 10.1016/j.ibmb.2004.12.008; Baldrich E, 1997, GENETICA, V100, P131, DOI 10.1023/A:1018317209658; Boeke JD, 1998, CELL, V93, P1087, DOI 10.1016/S0092-8674(00)81450-6; Brady Troy L., 2008, V435, P153, DOI 10.1007/978-1-59745-232-8_11; BUSHMAN F, 1995, SCIENCE, V267, P1443, DOI 10.1126/science.7878462; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; CHALKER DL, 1993, P NATL ACAD SCI USA, V90, P4927, DOI 10.1073/pnas.90.11.4927; Check E, 2002, NATURE, V419, P545, DOI 10.1038/419545a; Christensen SM, 2005, MOL CELL BIOL, V25, P6617, DOI 10.1128/MCB.25.15.6617-6628.2005; Coffin JMHS, 1997, RETROVIRUS; Dai JB, 2007, MOL CELL, V27, P289, DOI 10.1016/j.molcel.2007.06.010; Desset S, 1999, MOL BIOL EVOL, V16, P54, DOI 10.1093/oxfordjournals.molbev.a026038; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; Engelman A, 2003, CURR TOP MICROBIOL, V281, P209; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; FINNEGAN DJ, 1994, CURR BIOL, V4, P641, DOI 10.1016/S0960-9822(00)00142-1; GOFF SP, 1992, ANNU REV GENET, V26, P527, DOI 10.1146/annurev.ge.26.120192.002523; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Johnson EP, 2001, VIROLOGY, V286, P304, DOI 10.1006/viro.2001.0978; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; Leblanc P, 1997, EMBO J, V16, P7521, DOI 10.1093/emboj/16.24.7521; Leblanc P, 1999, J VIROL, V73, P7061, DOI 10.1128/JVI.73.8.7061-7064.1999; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Maxfield LF, 2005, P NATL ACAD SCI USA, V102, P1436, DOI 10.1073/pnas.0409204102; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, EMBO J, V11, P291, DOI 10.1002/j.1460-2075.1992.tb05052.x; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; Wah DA, 1997, NATURE, V388, P97, DOI 10.1038/40446; Wu X, 2004, CELL MOL LIFE SCI, V61, P2588, DOI 10.1007/s00018-004-4206-9; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Zhu YX, 1999, GENE DEV, V13, P2738, DOI 10.1101/gad.13.20.2738; Zhu YX, 2003, P NATL ACAD SCI USA, V100, P5891, DOI 10.1073/pnas.1036705100	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3185	10.1371/journal.pone.0003185	http://dx.doi.org/10.1371/journal.pone.0003185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784842	Green Published, Green Submitted, gold			2022-12-25	WOS:000264425900006
J	Pacheco, AG; Durovni, B; Cavalcante, SC; Lauria, LM; Moore, RD; Moulton, LH; Chaisson, RE; Golub, JE				Pacheco, Antonio G.; Durovni, Betina; Cavalcante, Solange C.; Lauria, L. M.; Moore, Richard D.; Moulton, Lawrence H.; Chaisson, Richard E.; Golub, Jonathan E.			AIDS-Related Tuberculosis in Rio de Janeiro, Brazil	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; IMPACT; AFRICA; BURDEN; RISK; ERA	Background: We studied the incidence of tuberculosis, AIDS, AIDS deaths and AIDS-TB co-infection at the population level in Rio de Janeiro, Brazil where universal and free access to combination antiretroviral therapy has been available since 1997. Methodology/Principal Findings: This was a retrospective surveillance database match of Rio de Janeiro databases from 1995-2004. Proportions of tuberculosis occurring within 30 days and between 30 days and 1 year after AIDS diagnosis were determined. Generalized additive models fitted with cubic splines with appropriate estimating methods were used to describe rates and proportions over time. Overall, 90,806 tuberculosis cases and 16,891 AIDS cases were reported; 3,125 tuberculosis cases within 1 year of AIDS diagnosis were detected. Tuberculosis notification rates decreased after 1997 from a fitted rate (fR per 100,000) of 166.5 to 138.8 in 2004. AIDS incidence rates increased 26% between 1995 and 1998 (30.7 to 38.7) followed by a 33.3% decrease to 25.8 in 2004. AIDS mortality rates decreased dramatically after antiretroviral therapy was introduced between 1995 (27.5) and 1999 (13.4). The fitted proportion (fP) of patients with tuberculosis diagnosed within one year of AIDS decreased from 1995 (24.4%) to 1998 (15.2%), remaining stable since. Seventy-five percent of tuberculosis diagnoses after an AIDS diagnosis occurred within 30 days of AIDS diagnosis. Conclusions/Significance: Our results suggest that while combination ART should be considered an essential component of the response to the HIV and HIV/tuberculosis epidemics, it may not be sufficient alone to prevent progression from latent TB to active disease among HIV-infected populations. When tuberculosis is diagnosed prior to or at the same time as AIDS and ART has not yet been initiated, then ART is ineffective as a tuberculosis prevention strategy for these patients. Earlier HIV/AIDS diagnosis and ART initiation may reduce TB incidence in HIV/AIDS patients. More specific interventions will be required if HIV-related tuberculosis incidence is to continue to decline.	[Pacheco, Antonio G.] Fiocruz MS, PROCC, ENSP, BR-21045900 Rio De Janeiro, Brazil; [Cavalcante, Solange C.] Fiocruz MS, IPEC, Rio De Janeiro, Brazil; [Durovni, Betina; Cavalcante, Solange C.; Lauria, L. M.] Municipal Hlth Secretariat, Rio De Janeiro, Brazil; [Durovni, Betina] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Chaisson, Richard E.; Golub, Jonathan E.] Johns Hopkins Univ, Ctr Tuberculosis Res, Baltimore, MD 21218 USA; [Moore, Richard D.; Chaisson, Richard E.; Golub, Jonathan E.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Moore, Richard D.; Chaisson, Richard E.; Golub, Jonathan E.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21218 USA; [Moulton, Lawrence H.; Chaisson, Richard E.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21218 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Pacheco, AG (corresponding author), Fiocruz MS, PROCC, ENSP, BR-21045900 Rio De Janeiro, Brazil.	jgolub@jhmi.edu	Pacheco, Antonio Guilherme/E-6378-2013	Pacheco, Antonio Guilherme/0000-0003-3095-1774; Moulton, Lawrence/0000-0001-7041-7387	Bill and Melinda Gates Foundation; USAID; NIH [AI066994, AI01637, AI45432, D43 TW05574]; FOGARTY INTERNATIONAL CENTER [D43TW005574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI045432, K24AI001637, K01AI066994] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); USAID(United States Agency for International Development (USAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Bill and Melinda Gates Foundation, USAID, and NIH Grants AI066994, AI01637, AI45432 and D43 TW05574. Funders had no role in the design and conduct of the study or in the collection, analysis, or interpretation of the data. The funders had no input in the preparation, review or approval of the manuscript.	Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Brito Ana Maria de, 2005, Braz J Infect Dis, V9, P9, DOI 10.1590/S1413-86702005000100004; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Hastie TJ., 1990, GEN ADDITIVE MODELS; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Kritski AL, 2004, J BRAS PNEUMOL S2, pS62; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lutz M., 2006, PROGRAMMING PYTHON; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; *MIN SAUD SECR VIG, 2006, REC TER ANT AD AD IN; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; R Development Core Team, 2006, R LANG ENV STAT COMP; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Soares Elizabeth Cristina Coelho, 2006, J. bras. pneumol., V32, P444, DOI 10.1590/S1806-37132006000500012; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; World Health Organisation, 2007, WHO CAS DEF HIV SURV	21	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3132	10.1371/journal.pone.0003132	http://dx.doi.org/10.1371/journal.pone.0003132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781195	Green Submitted, Green Published, gold			2022-12-25	WOS:000264425700002
J	van Waterschoot, RAB; Rooswinkel, RW; Wagenaar, E; van der Kruijssen, CMM; van Herwaarden, AE; Schinkel, AH				van Waterschoot, Robert A. B.; Rooswinkel, Rogier W.; Wagenaar, Els; van der Kruijssen, Cornelia M. M.; van Herwaarden, Antonius E.; Schinkel, Alfred H.			Intestinal cytochrome P450 3A plays an important role in the regulation of detoxifying systems in the liver	FASEB JOURNAL			English	Article						drug metabolism; xenobiotic metabolism; intestinal metabolism; drug-drug interactions; diet	DRUG-METABOLISM; DIETARY PHYTOCHEMICALS; PHENYTOIN INDUCTION; IN-VITRO; EXPRESSION; RECEPTOR; ENZYMES; KNOCKOUT; CYP3A4; CYP2C	CYP3A4 is an important xenobiotic metabolizing enzyme. We previously found that CYP2C55 is highly up-regulated in Cyp3a(-/-) mice. Here, we have further investigated the mechanism of regulation of CYP2C55 and other detoxifying systems in Cyp3a(-/-) mice. Induction studies with prototypical inducers demonstrated an important role for the nuclear receptors PXR and CAR in the up-regulation of CYP2C55. Subsequent diet-switch experiments revealed that food-derived xenobiotics are primarily responsible for the increased induction of CYP2C55, as well as of several other primary detoxifying systems in Cyp3a(-/-) mice. Our data suggest that CYP3A normally metabolizes food-derived activators of PXR and/or CAR, explaining the increased levels of such activators in Cyp3a(-/-) mice and subsequent up- regulation of a range of detoxifying systems. Interestingly, our studies with tissue-specific CYP3A4 transgenic Cyp3a(-/-) mice revealed that not only hepatic but also intestinal expression of CYP3A4 could reduce the hepatic expression of detoxifying systems to near wild-type levels. Apparently, intestinal CYP3A4 can limit the hepatic exposure to food-derived activators of nuclear receptors, thereby regulating the expression of a range of detoxifying systems in the liver. This broad biological effect further emphasizes the importance of intestinal CYP3A activity and could have profound implications for the prediction of drug exposure.-Van Waterschoot, R. A. B., Rooswinkel, R. W., Wagenaar, E., van der Kruijssen, C. M. M., van Herwaarden, A. E., Schinkel, A. H. Intestinal cytochrome P450 3A plays an important role in the regulation of detoxifying systems in the liver. FASEB J. 23, 224-231 (2009)	[van Waterschoot, Robert A. B.; Rooswinkel, Rogier W.; Wagenaar, Els; van der Kruijssen, Cornelia M. M.; van Herwaarden, Antonius E.; Schinkel, Alfred H.] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Schinkel, AH (corresponding author), Netherlands Canc Inst, Div Expt Therapy, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.schinkel@nki.nl	Herwaarden, A.E./L-4369-2015		Technical Sciences Foundation of the Netherlands Organization for Scientific Research (NWO/STW)	Technical Sciences Foundation of the Netherlands Organization for Scientific Research (NWO/STW)(Technologiestichting STWNetherlands Organization for Scientific Research (NWO))	We thank Drs. Conchita Vens and Christian Zimmermann ( Division of Experimental Therapy, The Netherlands Cancer Institute) for assistance with RT-PCR analysis. This work was supported by the Technical Sciences Foundation of the Netherlands Organization for Scientific Research (NWO/STW).	DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; Doherty MM, 2002, CLIN PHARMACOKINET, V41, P235, DOI 10.2165/00003088-200241040-00001; Dresser GK, 2000, CLIN PHARMACOKINET, V38, P41, DOI 10.2165/00003088-200038010-00003; Gorski JC, 2003, CLIN PHARMACOL THER, V74, P275, DOI 10.1016/S0009-9236(03)00187-5; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Ito SJ, 2007, J CLIN INVEST, V117, P1940, DOI 10.1172/JCI31647; Jackson JP, 2006, DRUG METAB DISPOS, V34, P2003, DOI 10.1124/dmd.106.012005; Jackson JP, 2004, MOL PHARMACOL, V65, P1397, DOI 10.1124/mol.65.6.1397; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWN KS, 1994, DRUG METAB DISPOS, V22, P947; Lown KS, 1997, J CLIN INVEST, V99, P2545, DOI 10.1172/JCI119439; Mandlekar S, 2006, CURR DRUG METAB, V7, P661, DOI 10.2174/138920006778017795; MCNAMARA DJ, 1982, BIOCHIM BIOPHYS ACTA, V711, P252, DOI 10.1016/0005-2760(82)90033-9; Mouly SJ, 2005, CLIN PHARMACOL THER, V78, P605, DOI 10.1016/j.clpt.2005.08.014; Ogura K, 2001, BIOCHEM BIOPH RES CO, V281, P431, DOI 10.1006/bbrc.2001.4387; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Thummel KE, 2007, J CLIN INVEST, V117, P3173, DOI 10.1172/JCI34007; Urquhart BL, 2007, J CLIN PHARMACOL, V47, P566, DOI 10.1177/0091270007299930; van de Kerkhof EG, 2007, CURR DRUG METAB, V8, P658, DOI 10.2174/138920007782109742; van Herwaarden AE, 2007, J CLIN INVEST, V117, P3583, DOI 10.1172/JCI33435; van Waterschoot RAB, 2008, MOL PHARMACOL, V73, P1029, DOI 10.1124/mol.107.043869; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	25	37	37	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					224	231		10.1096/fj.08-114876	http://dx.doi.org/10.1096/fj.08-114876			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18794335				2022-12-25	WOS:000262095500025
J	Guo, X; Waddell, DS; Wang, W; Wang, Z; Liberati, NT; Yong, S; Liu, X; Wang, XF				Guo, X.; Waddell, D. S.; Wang, W.; Wang, Z.; Liberati, N. T.; Yong, S.; Liu, X.; Wang, X-F			Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling	ONCOGENE			English	Article						Smad3; TGF-beta; CKI gamma 2; ubiquitination; phosphorylation	GROWTH-FACTOR-BETA; TRANSCRIPTION FACTORS; CELL-MEMBRANE; MH1 DOMAIN; I FAMILY; DEGRADATION; ACTIVATION; WNT; MECHANISM; PROTEINS	Transforming growth factor-beta (TGF-beta) elicits a variety of cellular activities primarily through a signaling cascade mediated by two key transcription factors, Smad2 and Smad3. Numerous regulatory mechanisms exist to control the activity of Smad3, thereby modulating the strength and specificity of TGF-beta responses. In search for potential regulators of Smad3 through a yeast two-hybrid screen, we identified casein kinase 1 gamma 2 (CKI gamma 2) as a novel Smad3-interacting protein. In mammalian cells, CKI gamma 2 selectively and constitutively binds Smad3 but not Smad1, -2 or -4. Functionally, CKI gamma 2 inhibits Smad3-mediated TGF-beta responses including induction of target genes and cell growth arrest, and this inhibition is dependent on CKI gamma 2 kinase activity. Mechanistically, CKI gamma 2 does not affect the basal levels of Smad proteins or activity of the receptors. Rather, CKI gamma 2 preferentially promotes the ubiquitination and degradation of activated Smad3 through direct phosphorylation of its MH2 domain at Ser418. Importantly, mutation of Ser418 to alanine or aspartic acid causes an increase or decrease of Smad3 activity, respectively, in the presence of TGF-beta. CKI gamma 2 is the first kinase known to mark activated Smad3 for destruction. Given its negative function in TGF-beta signaling and its reported overexpression in human cancers, CKI gamma 2 may act as an oncoprotein during tumorigenesis.	[Guo, X.; Waddell, D. S.; Liberati, N. T.; Yong, S.; Wang, X-F] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Wang, W.; Liu, X.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Z.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; University of Colorado System; University of Colorado Boulder; Duke University	Wang, XF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, C218 LSRC Bldg,La Salle St Extens, Durham, NC 27710 USA.	wang0011@mc.duke.edu	Waddell, David/J-7435-2015; Waddell, David/AAG-3774-2020	Waddell, David/0000-0001-6749-4461; Waddell, David/0000-0001-6749-4461; LIU, XUEDONG/0000-0001-7209-4964	NIH [DK064113, GM083000, GM083172]; Department of Defense Breast Cancer [DAMD17-00-1-0299]; National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083172, R01GM083000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs Jun Kusuda, Joan Massague, Xin-Hua Feng, Rik Derynck, Jun-Lin Guan, James Woodgett and Anita Roberts for valuable reagents. We appreciate the Wang laboratory members for insightful scienti. c discussions and excellent technical support. We thank Natalie Ahn, Kathryn Resing and Will Old for MS facility and support. This work was supported by NIH grants DK064113 and GM083000 to X-F W, and an NIH Grant GM083172 to XL. DSW was supported by Department of Defense Breast Cancer Predoctoral Fellowship DAMD17-00-1-0299. NTL was supported by a National Science Foundation Predoctoral Fellowship.	Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Dunn NR, 2005, GENE DEV, V19, P152, DOI 10.1101/gad.1243205; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Heldin CH, 1999, NAT CELL BIOL, V1, pE195, DOI 10.1038/70223; Imoto S, 2005, FEBS LETT, V579, P2853, DOI 10.1016/j.febslet.2005.04.023; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Kitabayashi AN, 1997, GENOMICS, V46, P133, DOI 10.1006/geno.1997.4991; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Liberati NT, 2001, J BIOL CHEM, V276, P22595, DOI 10.1074/jbc.M010778200; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Poncelet AC, 2007, J BIOL CHEM, V282, P15534, DOI 10.1074/jbc.M701991200; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Reguly T, 2003, TRENDS CELL BIOL, V13, P216, DOI 10.1016/S0962-8924(03)00075-8; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Schilling SH, 2006, CELL, V125, P838, DOI 10.1016/j.cell.2006.05.015; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Vielhaber E, 2001, IUBMB LIFE, V51, P73, DOI 10.1080/15216540152122049; Waddell DS, 2004, J BIOL CHEM, V279, P29236, DOI 10.1074/jbc.M400880200; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; ZHAI LM, 1995, J BIOL CHEM, V270, P12717, DOI 10.1074/jbc.270.21.12717	46	25	28	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	58					7235	7247		10.1038/onc.2008.337	http://dx.doi.org/10.1038/onc.2008.337			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	382FI	18794808	Green Accepted			2022-12-25	WOS:000261590300002
J	Hartl, D; He, CH; Koller, B; Da Silva, CA; Homer, R; Lee, CG; Elias, JA				Hartl, Dominik; He, Chuan Hua; Koller, Barbara; Da Silva, Carla A.; Homer, Robert; Lee, Chun G.; Elias, Jack A.			Acidic Mammalian Chitinase Is Secreted via an ADAM17/Epidermal Growth Factor Receptor-dependent Pathway and Stimulates Chemokine Production by Pulmonary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; SIGNAL-TRANSDUCTION; MUCIN PRODUCTION; ASTHMA; ADAM17; INFLAMMATION; ALPHA; ACTIVATION; INTERNALIZATION; INTERLEUKIN-13	Acidic mammalian chitinase (AMCase) is expressed in an exaggerated fashion in epithelial cells at sites of pulmonary T helper cell type 2 inflammation and plays important roles in the pathogenesis of anti-parasite and asthma-like responses. However, the mechanisms that control epithelial cell AMCase secretion and its effector responses have not been adequately defined. To address these issues, we used in vivo and in vitro experimental systems to define the pathways of epithelial AMCase secretion and its epithelial regulatory effects. Here we demonstrate that, in murine T helper cell type 2 modeling systems, AMCase colocalizes with the epidermal growth factor receptor (EGFR) and ADAM17 (a membrane disintegrin and metallopeptidase 17) in lung epithelial cells. In vitro cotransfection experiments in A549 cells demonstrated that AMCase and EGFR physically interact with each other. Cotransfection of AMCase and EGFR also increased, whereas EGFR inhibition decreased AMCase secretion. Interestingly, AMCase secretion was not significantly altered by treatment with EGF but was significantly decreased when the upstream EGFR transactivator ADAM17 was inhibited. AMCase secretion was also decreased when the EGFR-downstream Ras was blocked. Transfected and recombinant AMCase induced epithelial cell production of CCL2, CCL17, and CXCL8. These studies demonstrate that lung epithelial cells secrete AMCase via an EGFR-dependent pathway that is activated by ADAM17 and mediates its effects via Ras. They also demonstrate that the AMCase that is secreted feeds back in an autocrine and/or paracrine fashion to stimulate pulmonary epithelial cell chemokine production.	[Elias, Jack A.] Yale Univ, Yale New Haven Hosp, Sch Med,Sect Pulm & Crit Care Med, Dept Internal Med,Beeson Serv, New Haven, CT 06520 USA	Yale University	Elias, JA (corresponding author), Yale Univ, Yale New Haven Hosp, Sch Med,Sect Pulm & Crit Care Med, Dept Internal Med,Beeson Serv, 333 Cedar St,1072 LMP,POB 208056, New Haven, CT 06520 USA.	jack.elias@yale.edu	homer, robert/P-3884-2019; Lee, Chun Geun/AAC-2838-2021	homer, robert/0000-0002-2055-5885; Lee, Chun Geun/0000-0002-9514-3658	National Institutes of Health; NHLB [R01-HL-081639, P01-HL-056389]; Deutsche Forschungsgemeinschaft [HA 5274/2-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056389, R01HL081639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLB; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLB, Grants R01-HL-081639 and P01-HL-056389 ( to J. E.). This work was also supported by Deutsche Forschungsgemeinschaft Research Scholarship HA 5274/2-1 (to D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Booth BW, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-51; Chan HW, 2006, PULM PHARMACOL THER, V19, P74, DOI 10.1016/j.pupt.2005.04.005; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Davies DE, 1999, ALLERGY, V54, P771; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Elias JA, 2003, CHEST, V123, p339S, DOI 10.1378/chest.123.3_suppl.339S-a; Elias JA, 2003, AM J RESP CELL MOL, V28, P401, DOI 10.1165/rcmb.F264; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Gao JX, 2005, ACTA BIOCH BIOPH SIN, V37, P525, DOI 10.1111/j.1745-7270.2005.00076.x; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Heijink IH, 2007, AM J RESP CELL MOL, V36, P351, DOI 10.1165/rcmb.2006-0160OC; Holbrook MR, 1999, BIOCHEMISTRY-US, V38, P9348, DOI 10.1021/bi990195r; Homer RJ, 2006, AM J PHYSIOL-LUNG C, V291, pL502, DOI 10.1152/ajplung.00364.2005; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; McKenna WG, 2003, ONCOGENE, V22, P5866, DOI 10.1038/sj.onc.1206699; Morcillo EJ, 2006, CURR OPIN PULM MED, V12, P1, DOI 10.1097/01.mcp.0000198064.27586.37; Motulsky H., 1995, INTUITIVE BIOSTATIST; Nadel JA, 2001, RESP RES, V2, P85, DOI 10.1186/rr43; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; ROCHAT TR, 1988, J LAB CLIN MED, V112, P418; SCHUTTE B, 1995, CYTOMETRY, V21, P177, DOI 10.1002/cyto.990210210; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; Shim JJ, 2001, AM J PHYSIOL-LUNG C, V280, pL134, DOI 10.1152/ajplung.2001.280.1.L134; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; Spindler KD, 1999, EXS, V87, P201; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Takeyama K, 2001, AM J RESP CRIT CARE, V163, P511, DOI 10.1164/ajrccm.163.2.2001038; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; Walcheck B, 2006, EUR J IMMUNOL, V36, P968, DOI 10.1002/eji.200535257; Watson EL, 1999, CRIT REV ORAL BIOL M, V10, P284, DOI 10.1177/10454411990100030301; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; Zhu Z, 2001, AM J RESP CRIT CARE, V164, pS67, DOI 10.1164/ajrccm.164.supplement_2.2106070	48	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33472	33482		10.1074/jbc.M805574200	http://dx.doi.org/10.1074/jbc.M805574200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824549	hybrid, Green Published			2022-12-25	WOS:000261183700052
J	Jarnaess, E; Ruppelt, A; Stokka, AJ; Lygren, B; Scott, JD; Tasken, K				Jarnaess, Elisabeth; Ruppelt, Anja; Stokka, Anne Jorunn; Lygren, Birgitte; Scott, John D.; Tasken, Kjetil			Dual Specificity A-kinase Anchoring Proteins (AKAPs) Contain an Additional Binding Region That Enhances Targeting of Protein Kinase A Type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT RII; SECONDARY STRUCTURE; SIGNALING PATHWAY; MOLECULAR-BASIS; CAMP; ALPHA; TRIFLUOROETHANOL; IDENTIFICATION; LOCALIZATION; ASSOCIATION	A-kinase anchoring proteins (AKAPs) target protein kinase A (PKA) to a variety of subcellular locations. Conventional AKAPs contain a 14-18-amino acid sequence that forms an amphipathic helix that binds with high affinity to the regulatory (R) subunit of PKA type II. More recently, a group of dual specificity AKAPs has been classified on the basis of their ability to bind the PKA type I and the PKA type II isozymes. In this study we show that dual specificity AKAPs contain an additional PKA binding determinant called the RI Specifier Region (RISR). A variety of protein interaction assays and immunoprecipitation and immunolocalization experiments indicates that the RISR augments RI binding in vitro and inside cells. Cellular delivery of the RISR peptide uncouples RI anchoring to Ezrin leading to release of T cell inhibition by cAMP. Likewise, expression of mutant Ezrin forms where RI binding has been abrogated by substitution of the RISR sequence prevents cAMP-mediated inhibition of T cell function. Thus, we propose that the RISR acts in synergy with the amphipathic helix in dual specificity anchoring proteins to enhance anchoring of PKA type I.	[Jarnaess, Elisabeth; Ruppelt, Anja; Stokka, Anne Jorunn; Lygren, Birgitte; Tasken, Kjetil] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Jarnaess, Elisabeth; Ruppelt, Anja; Stokka, Anne Jorunn; Lygren, Birgitte; Tasken, Kjetil] Univ Oslo, Ctr Mol Med Norway, Nord EMBL Partnership, N-0317 Oslo, Norway; [Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA	University of Oslo; University of Oslo; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Tasken, K (corresponding author), Univ Oslo, Biotechnol Ctr Oslo, POB 1125, N-0317 Oslo, Norway.	kjetil.tasken@biotek.uio.no		Tasken, Kjetil/0000-0003-2841-4697	Norwegian Functional Genomics Programme; The Research Council of Norway; The Norwegian Cancer Society; Novo Nordic Foundation; European Union [037189]; thera-cAMP; National Institutes of Health [DK 54441]; Foundation Leducq; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	Norwegian Functional Genomics Programme(Research Council of Norway); The Research Council of Norway(Research Council of Norway); The Norwegian Cancer Society(Norwegian Cancer SocietyEuropean Commission); Novo Nordic Foundation(Novo Nordisk Foundation); European Union(European Commission); thera-cAMP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq(Leducq Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants ( to K. T.) from the Norwegian Functional Genomics Programme, The Research Council of Norway, The Norwegian Cancer Society, Novo Nordic Foundation, the European Union Grant 037189, thera-cAMP and Grants ( to J.D.S.) from the National Institutes of Health (DK 54441) and Foundation Leducq. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aandahl EM, 1998, FASEB J, V12, P855, DOI 10.1096/fasebj.12.10.855; Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Angelo R, 1998, J BIOL CHEM, V273, P14633, DOI 10.1074/jbc.273.23.14633; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Banky P, 2000, J BIOL CHEM, V275, P35146, DOI 10.1074/jbc.M003961200; Banky P, 1998, J BIOL CHEM, V273, P35048, DOI 10.1074/jbc.273.52.35048; Birkemo GA, 2004, BBA-PROTEINS PROTEOM, V1699, P221, DOI 10.1016/j.bbapap.2004.03.001; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; DURGERIAN S, 1989, J BIOL CHEM, V264, P9807; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gronholm M, 2003, J BIOL CHEM, V278, P41167, DOI 10.1074/jbc.M306149200; Hausken ZE, 1998, METH MOL B, V88, P47; Hausken ZE, 1996, BIOCHEM SOC T, V24, P986, DOI 10.1042/bst0240986; Hausken ZE, 1996, J BIOL CHEM, V271, P29016, DOI 10.1074/jbc.271.46.29016; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kussel-Andermann P, 2000, J BIOL CHEM, V275, P29654, DOI 10.1074/jbc.M004393200; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; Leon DA, 1997, J BIOL CHEM, V272, P28431, DOI 10.1074/jbc.272.45.28431; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; SKALHEGG BS, 1994, SCIENCE, V263, P84, DOI 10.1126/science.8272870; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Stokka AJ, 2006, BIOCHEM J, V400, P493, DOI 10.1042/BJ20060962; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	52	55	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33708	33718		10.1074/jbc.M804807200	http://dx.doi.org/10.1074/jbc.M804807200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824551	Green Published, hybrid			2022-12-25	WOS:000261183700077
J	Krivosheya, D; Tapia, L; Levinson, JN; Huang, K; Kang, Y; Hines, R; Ting, AK; Craig, AM; Mei, L; Bamji, SX; El-Husseini, A				Krivosheya, Daria; Tapia, Lucia; Levinson, Joshua N.; Huang, Kun; Kang, Yunhee; Hines, Rochelle; Ting, Annie K.; Craig, Ann Marie; Mei, Lin; Bamji, Shernaz X.; El-Husseini, Alaa			ErbB4-Neuregulin Signaling Modulates Synapse Development and Dendritic Arborization through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVOUS-SYSTEM; ERBB RECEPTORS; INTRACELLULAR DOMAIN; INHIBITORY SYNAPSES; CONTAINING PROTEINS; NEURONAL MIGRATION; NEURAL DEVELOPMENT; NEURITE OUTGROWTH; PREFRONTAL CORTEX; TYROSINE KINASE	Perturbations in neuregulin-1 (NRG1)/ErbB4 function have been associated with schizophrenia. Affected patients exhibit altered levels of these proteins and display hypofunction of glutamatergic synapses as well as altered neuronal circuitry. However, the role of NRG1/ErbB4 in regulating synapse maturation and neuronal process formation has not been extensively examined. Here we demonstrate that ErbB4 is expressed in inhibitory interneurons at both excitatory and inhibitory postsynaptic sites. Overexpression of ErbB4 postsynaptically enhances size but not number of presynaptic inputs. Conversely, knockdown of ErbB4 using shRNA decreases the size of presynaptic inputs, demonstrating a specific role for endogenous ErbB4 in synapse maturation. Using ErbB4 mutant constructs, we demonstrate that ErbB4-mediated synapse maturation requires its extracellular domain, whereas its tyrosine kinase activity is dispensable for this process. We also demonstrate that depletion of ErbB4 decreases the number of primary neurites and that stimulation of ErbB4 using a soluble form of NRG1 results in exuberant dendritic arborization through activation of the tyrosine kinase domain of ErbB4 and the phosphoinositide 3-kinase pathway. These findings demonstrate that NRG1/ErbB4 signaling differentially regulates synapse maturation and dendritic morphology via two distinct mechanisms involving trans-synaptic signaling and tyrosine kinase activity, respectively.	[Tapia, Lucia; Levinson, Joshua N.; Bamji, Shernaz X.] Univ British Columbia, Brain Res Ctr, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Krivosheya, Daria; Levinson, Joshua N.; Huang, Kun; Kang, Yunhee; Hines, Rochelle; Craig, Ann Marie; El-Husseini, Alaa] Univ British Columbia, Brain Res Ctr, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; [Ting, Annie K.] Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA	University of British Columbia; University of British Columbia; University System of Georgia; Augusta University	Bamji, SX (corresponding author), Univ British Columbia, Brain Res Ctr, Dept Cellular & Physiol Sci, Life Sci Bldg,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	sbamji@interchange.ubc.ca	Hines, Rochelle/AAE-3784-2020; Craig, Ann Marie/M-2054-2014; Mei, Lin/G-8755-2012	Hines, Rochelle/0000-0002-0459-7911	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860, R21MH083563, R01MH083317] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from Canadian Institutes of Health Research and Michael Smith Foundation for Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anton ES, 1997, DEVELOPMENT, V124, P3501; Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; El-Hussein AE, 2000, SCIENCE, V290, P1364; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fox IJ, 2005, J NEUROSCI RES, V79, P584, DOI 10.1002/jnr.20381; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Huang YZ, 2002, INT J DEV NEUROSCI, V20, P173, DOI 10.1016/S0736-5748(02)00011-4; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Law AJ, 2004, NEUROSCIENCE, V127, P125, DOI 10.1016/j.neuroscience.2004.04.026; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Linggi B, 2006, ONCOGENE, V25, P160, DOI 10.1038/sj.onc.1209003; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Petryshen TL, 2005, MOL PSYCHIATR, V10, P366, DOI 10.1038/sj.mp.4001608; Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Rodgers EE, 2002, INT J DEV NEUROSCI, V20, P187, DOI 10.1016/S0736-5748(02)00047-3; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Vartanian T, 1999, P NATL ACAD SCI USA, V96, P731, DOI 10.1073/pnas.96.2.731; Vaskovsky A, 2000, J NEUROCHEM, V74, P979, DOI 10.1046/j.1471-4159.2000.0740979.x; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xie F, 2007, J NEUROCHEM, V100, P62, DOI 10.1111/j.1471-4159.2006.04182.x; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252	56	85	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32944	32956		10.1074/jbc.M800073200	http://dx.doi.org/10.1074/jbc.M800073200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819924	hybrid, Green Published			2022-12-25	WOS:000260893700083
J	Sobhany, M; Kakuta, Y; Sugiura, N; Kimata, K; Negishi, M				Sobhany, Mack; Kakuta, Yoshimitsu; Sugiura, Nobuo; Kimata, Koji; Negishi, Masahiko			The Chondroitin Polymerase K4CP and the Molecular Mechanism of Selective Bindings of Donor Substrates to Two Active Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASTEURELLA-MULTOCIDA; HYALURONAN SYNTHASE; ENZYME-ACTIVITY; SULFATE; GLYCOSYLTRANSFERASES; BIOSYNTHESIS; PROTEOGLYCAN; EXPRESSION; CARTILAGE; CLONING	Bacterial chondroitin polymerase K4CP is a multifunctional enzyme with two active sites. K4CP catalyzes alternative transfers of glucoronic acid (GlcA) and N-acetylgalactosamine (GalNAc) to elongate a chain consisting of the repeated disaccharide sequence GlcA beta 1-3GalNAc beta 1-4. Unlike the polymerization reactions of DNA and RNA and polypeptide synthesis, which depend upon templates, the monosaccharide polymerization by K4CP does not. To investigate the catalytic mechanism of this reaction, we have used isothermal titration calorimetry to determine the binding of the donor substrates UDP-GlcA and UDP-GalNAc to purified K4CP protein and its mutants. Only one donor molecule bound to one molecule of K4CP at a time. UDP-GlcA bound only to the C-terminal active site at a high affinity (K-d = 6.81 mu M), thus initiating the polymerization reaction. UDP-GalNAc could bind to either the N-terminal or C-terminal active sites at a low affinity (K-d = 266-283 mu M) but not to both sites at the same time. The binding affinity of UDP-GalNAc to a K4CP N-terminal fragment (residues 58-357) was profoundly decreased, yielding the average K-d value of 23.77 mu M, closer to the previously reported K-m value for the UDP-GalNAc transfer reaction that takes place at the N-terminal active site. Thus, the first step of the reaction appears to be the binding of UDP-GlcA to the C-terminal active site, whereas the second step involves the C-terminal region of the K4CP molecule regulating the binding of UDP-GalNAc to only the N-terminal active site. Alternation of these two specific bindings advances the polymerization reaction by K4CP.	[Sobhany, Mack; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Kakuta, Yoshimitsu] Kyushu Univ, Fac Agr, Dept Biochem, Fukuoka 8128581, Japan; [Sugiura, Nobuo; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kyushu University; Aichi Medical University	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, Z01ES080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Grant Intramural Research Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BERTON C, 2001, BIOCHIMIE, V83, P713; BOUNRNE Y, 2001, CURR OPT STRUCT BIOL, V11, P593; Breton C, 1998, J BIOCHEM, V123, P1000; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; DAVID G, 1989, J CELL BIOL, V108, P1165, DOI 10.1083/jcb.108.3.1165; Fitch MT, 1999, J NEUROSCI, V19, P8182; Gotting C, 2004, J BIOL CHEM, V279, P42566, DOI 10.1074/jbc.M401340200; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; OOHIRA A, 1994, NEUROSCI RES, V20, P195, DOI 10.1016/0168-0102(94)90088-4; OSAWA T, 2009, BIOCH BIOPH IN PRESS; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; PRESS WH, 1989, NUMERICAL RECIPES FO; Roughley P, 2006, EUR CELLS MATER, V11, P1; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; SEGEL IH, 1976, BIOCH CALCULATIONS, P145; Sobhany M, 2005, J BIOL CHEM, V280, P23441, DOI 10.1074/jbc.M413379200; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Zako M, 1997, J NEUROCHEM, V69, P2155	26	21	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32328	32333		10.1074/jbc.M804332200	http://dx.doi.org/10.1074/jbc.M804332200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806260	hybrid, Green Published			2022-12-25	WOS:000260893700019
J	Wilbur, JD; Chen, CY; Manalo, V; Hwang, PK; Fletterick, RJ; Brodsky, FM				Wilbur, Jeremy D.; Chen, Chih-Ying; Manalo, Venus; Hwang, Peter K.; Fletterick, Robert J.; Brodsky, Frances M.			Actin Binding by Hip1 (Huntingtin-interacting Protein 1) and Hip1R (Hip1-related Protein) Is Regulated by Clathrin Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CRYSTAL-STRUCTURE; F-ACTIN; ENDOCYTOSIS; MEMBRANE; YEAST; FLEXIBILITY; TROPOMYOSIN; DISRUPTION; VESICLES	The huntingtin-interacting protein family members (Hip1 and Hip1R in mammals and Sla2p in yeast) link clathrin-mediated membrane traffic to actin cytoskeleton dynamics. Genetic data in yeast have implicated the light chain subunit of clathrin in regulating this link. To test this hypothesis, the biophysical properties of mammalian Hip1 and Hip1R and their interaction with clathrin light chain and actin were analyzed. The coiled-coil domains (clathrin light chain-binding) of Hip1 and Hip1R were found to be stable homodimers with no propensity to heterodimerize in vitro. Homodimers were also predominant in vivo, accounting for cellular segregation of Hip1 and Hip1R functions. Coiled-coil domains of Hip1 and Hip1R differed in their stability and flexibility, correlating with slightly different affinities for clathrin light chain and more markedly with effects of clathrin light chain binding on Hip protein-actin interactions. Clathrin light chain binding induced a compact conformation of both Hip1 and Hip1R and significantly reduced actin binding by their THATCH domains. Thus, clathrin is a negative regulator of Hip-actin interactions. These observations necessarily change models proposed for Hip protein function.	[Chen, Chih-Ying; Manalo, Venus; Brodsky, Frances M.] Univ Calif San Francisco, George Williams Hooper Fdn, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Wilbur, Jeremy D.] Univ Calif San Francisco, Grad Program Biophys, San Francisco, CA 94143 USA; [Hwang, Peter K.; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Brodsky, FM (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, Dept Biopharmaceut Sci, Box 0552,513 Parnassus Ave, San Francisco, CA 94143 USA.	frances.brodsky@ucsf.edu		Brodsky, Frances/0000-0002-1334-9258	National Institutes of Health [GM038093]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM038093 (to F.M.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ACTON SL, 1993, MOL BIOL CELL, V4, P647, DOI 10.1091/mbc.4.6.647; Bradley SV, 2007, HUM MOL GENET, V16, P1279, DOI 10.1093/hmg/ddm076; Brett TJ, 2006, NAT STRUCT MOL BIOL, V13, P121, DOI 10.1038/nsmb1043; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Brown JH, 1996, PROTEINS, V26, P134; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chen CY, 2005, J BIOL CHEM, V280, P6109, DOI 10.1074/jbc.M408454200; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DEMELER B, 2005, MODERN ANAL ULTRACEN; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Engqvist-Goldstein AEY, 1999, J CELL BIOL, V147, P1503, DOI 10.1083/jcb.147.7.1503; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Hackam AS, 2000, J BIOL CHEM, V275, P41299, DOI 10.1074/jbc.M008408200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Legendre-Guillemin V, 2002, J BIOL CHEM, V277, P19897, DOI 10.1074/jbc.M112310200; Legendre-Guillemin V, 2005, J BIOL CHEM, V280, P6101, DOI 10.1074/jbc.M408430200; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Mills IG, 2005, J CELL BIOL, V170, P191, DOI 10.1083/jcb.200503106; Newpher TM, 2006, MOL BIOL CELL, V17, P4343, DOI 10.1091/mbc.E06-07-0606; Niu Q, 2008, J MOL BIOL, V375, P1197, DOI 10.1016/j.jmb.2007.11.036; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Yang S, 1999, MOL BIOL CELL, V10, P2265, DOI 10.1091/mbc.10.7.2265; Ybe JA, 2007, J MOL BIOL, V367, P8, DOI 10.1016/j.jmb.2006.12.052	36	59	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32870	32879		10.1074/jbc.M802863200	http://dx.doi.org/10.1074/jbc.M802863200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790740	Green Published, hybrid			2022-12-25	WOS:000260893700076
J	Salah, Z; Haupt, S; Maoz, M; Baraz, L; Rotter, V; Peretz, T; Haupt, Y; Bar-Shavit, R				Salah, Z.; Haupt, S.; Maoz, M.; Baraz, L.; Rotter, V.; Peretz, T.; Haupt, Y.; Bar-Shavit, R.			p53 controls hPar1 function and expression	ONCOGENE			English	Article						PAR1; p53; protease; promoter activity; transcription factor	PROTEASE-ACTIVATED RECEPTOR-1; WILD-TYPE P53; HUMAN ENDOTHELIAL-CELLS; GAIN-OF-FUNCTION; MUTANT P53; THROMBIN RECEPTOR; TUMOR-SUPPRESSOR; PROSTATE-CANCER; TRANSCRIPTIONAL REGULATION; MUTATION ANALYSIS	Human protease-activated receptor 1(hPar1) is a bonafide receptor of the hemostatic protease thrombin, and has a central function in tumor progression. Inactivation of the tumor suppressor gene p53 is one of the most common genomic alterations occurring in cancer. Here, we address the interrelations between p53 and hPar1 in cancer. We demonstrate an inverse correlation between hPar1 gene expression and wild-type (wt) p53 levels, and a direct correlation with levels of the mutant (mt) p53. Bioinformatic search revealed the presence of at least two p53 motifs in the hPar1 promoter. Indeed, temperature-sensitive (ts) p53 forms reduced hPar1 promoter activity on wt p53 expression. Ectopic introduction of the p53R175H mutant into cells lacking p53 caused a moderate two-fold induction of hPar1 promoter activity. Chromatin immunoprecipitation (ChIP) analyses confirmed a physical association between the p53 protein and hPar1 chromatin fragments. In parallel, PAR1 function is attenuated by p53, as shown by inhibition of pFAK levels and a Matrigel invasion assay. Ectopic reinforcement of hPar1 rescued the inhibition conferred by p53, confirming that p53 directly affects hPar1 expression and function. Altogether, we provide evidence for a direct binding between p53 and hPar1 chromatin, and assign hPar1 as a target of p53. Oncogene (2008) 27, 6866-6874; doi: 10.1038/onc.2008.324; published online 29 September 2008	[Salah, Z.; Maoz, M.; Baraz, L.; Peretz, T.; Bar-Shavit, R.] Hadassah Univ, Med Ctr, Dept Oncol, Jerusalem, Israel; [Haupt, S.; Haupt, Y.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Immunol, Lautenberg Ctr, IL-91010 Jerusalem, Israel; [Rotter, V.] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Weizmann Institute of Science	Bar-Shavit, R (corresponding author), Hadassah Hebrew Univ Hosp, Dept Oncol, POB 12000, IL-91120 Jerusalem, Israel.	rachel.bar-shavit@ekmd.huji.ac.il		Haupt, Ygal/0000-0001-5925-0096	Israel Science Foundation by the Israel Academy of Science and Humanities; The Israel Cancer Association; MECC (Middle East Cancer Consortium)	Israel Science Foundation by the Israel Academy of Science and Humanities(Israel Science Foundation); The Israel Cancer Association; MECC (Middle East Cancer Consortium)	Grant support: Israel Science Foundation by the Israel Academy of Science and Humanities, The Israel Cancer Association and MECC (Middle East Cancer Consortium) Small Grant Program (R Bar-Shavit).	Ahn J, 1999, ONCOGENE, V18, P5954, DOI 10.1038/sj.onc.1202986; ALBINI A, 1987, CANCER RES, V47, P3239; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; Caunt M, 2006, CANCER RES, V66, P4125, DOI 10.1158/0008-5472.CAN-05-2570; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Darmoul D, 2003, AM J PATHOL, V162, P1503, DOI 10.1016/S0002-9440(10)64283-6; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Farmer G, 1996, MOL CELL BIOL, V16, P4295; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; ISAACS WB, 1991, CANCER RES, V51, P4716; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li FZ, 1996, J BIOL CHEM, V271, P26320, DOI 10.1074/jbc.271.42.26320; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Menendez D, 2006, P NATL ACAD SCI USA, V103, P1406, DOI 10.1073/pnas.0508103103; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Prowald A, 2007, PROSTATE, V67, P1751, DOI 10.1002/pros.20660; Resnick MA, 2003, P NATL ACAD SCI USA, V100, P9934, DOI 10.1073/pnas.1633803100; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Salah Z, 2005, FASEB J, V19, P62, DOI 10.1096/fj.04-2386com; Salah Z, 2007, CANCER RES, V67, P9835, DOI 10.1158/0008-5472.CAN-07-1886; Salah Z, 2007, MOL CANCER RES, V5, P229, DOI 10.1158/1541-7786.MCR-06-0261; Schmidt VA, 1996, J BIOL CHEM, V271, P9307, DOI 10.1074/jbc.271.16.9307; Sharpless NE, 2007, NATURE, V445, P606, DOI 10.1038/nature05567; Sigal A, 2000, CANCER RES, V60, P6788; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415; Yin YJ, 2003, FASEB J, V17, P163, DOI 10.1096/fj.02-0316com	53	17	17	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 20	2008	27	54					6866	6874		10.1038/onc.2008.324	http://dx.doi.org/10.1038/onc.2008.324			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	375IS	18820708				2022-12-25	WOS:000261108000007
J	Arredondo, S; Segatori, L; Gilbert, HF; Georgiou, G				Arredondo, Silvia; Segatori, Laura; Gilbert, Hiram F.; Georgiou, George			De Novo Design and Evolution of Artificial Disulfide Isomerase Enzymes Analogous to the Bacterial DsbC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; RIBONUCLEASE-A; BOND FORMATION; ALKALINE-PHOSPHATASE; CRYSTAL-STRUCTURE; CXXC MOTIF; IN-VIVO; PROTEIN; THIOREDOXIN	The Escherichia coli disulfide isomerase, DsbC is a V-shaped homodimer with each monomer comprising a dimerization region that forms part of a putative peptide-binding pocket and a thioredoxin catalytic domain. Disulfide isomerases from prokaryotes and eukaryotes exhibit little sequence homology but display very similar structural organization with two thioredoxin domains facing each other on top of the dimerization/peptide- binding region. To aid the understanding of the mechanistic significance of thioredoxin domain dimerization and of the peptide-binding cleft of DsbC, we constructed a series of protein chimeras comprising unrelated protein dimerization domains fused to thioredoxin superfamily enzymes. Chimeras consisting of the dimerization domain and the alpha-helical linker of the bacterial proline cis/trans isomerase FkpA and the periplasmic oxidase DsbA gave rise to enzymes that catalyzed the folding of multidisulfide substrate proteins in vivo with comparable efficiency to E. coli DsbC. In addition, expression of FkpA-DsbAs conferred modest resistance to CuCl2, a phenotype that depends on disulfide bond isomerization. Selection for resistance to elevated CuCl2 concentrations led to the isolation of FkpA-DsbA mutants containing a single amino acid substitution that changed the active site of the DsbAdo main from CP (H) under barC into CP (Y) under barC, increasing the similarity to the DsbC active site ( CG (Y) under barC). Unlike DsbC, which is resistant to oxidation by DsbB-DsbA and does not normally catalyze disulfide bond formation under physiological conditions, the FkpA-DsbA chimeras functioned both as oxidases and isomerases. The engineering of these efficient artificial isomerases delineates the key features of catalysis of disulfide bond isomerization and enhances our understanding of its evolution.	[Gilbert, Hiram F.] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Georgiou, George] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Arredondo, Silvia; Segatori, Laura; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	Baylor College of Medicine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), 1 Univ Stn Stop C0400, Austin, TX 78712 USA.	gg@che.utexas.edu			National Institutes of Health [GM 55090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 55090. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Debarbieux L, 1998, P NATL ACAD SCI USA, V95, P10751, DOI 10.1073/pnas.95.18.10751; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LUNDSTROMLJUNG J, 1995, J BIOL CHEM, V270, P7822, DOI 10.1074/jbc.270.14.7822; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; PACK P, 1992, BIOCHEMISTRY-US, V31, P1579, DOI 10.1021/bi00121a001; Qiu J, 1998, APPL ENVIRON MICROB, V64, P4891; Ruoppolo M, 2003, PROTEIN SCI, V12, P939, DOI 10.1110/ps.0242803; Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Segatori L, 2004, P NATL ACAD SCI USA, V101, P10018, DOI 10.1073/pnas.0403003101; Sun XX, 2000, J BIOL CHEM, V275, P22743, DOI 10.1074/jbc.M002406200; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Yeh SM, 2007, ACTA CRYSTALLOGR D, V63, P465, DOI 10.1107/S0907444907003320; Zhao Z, 2003, J BIOL CHEM, V278, P43292, DOI 10.1074/jbc.M306945200	43	14	14	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31469	31476		10.1074/jbc.M803346200	http://dx.doi.org/10.1074/jbc.M803346200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782764	Green Published, hybrid			2022-12-25	WOS:000260760800026
J	Madan, D; Lin, Z; Rye, HS				Madan, Damian; Lin, Zong; Rye, Hays S.			Triggering Protein Folding within the GroEL-GroES Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC CHAPERONIN GROEL; CRYSTAL-STRUCTURE; ATPASE CYCLE; CRYOELECTRON MICROSCOPY; ALLOSTERIC SITE; CENTRAL CAVITY; SUBSTRATE; BINDING; POLYPEPTIDE; MECHANISM	The folding of many proteins depends on the assistance of chaperonins like GroEL and GroES and involves the enclosure of substrate proteins inside an internal cavity that is formed when GroES binds to GroEL in the presence of ATP. Precisely how assembly of the GroEL-GroES complex leads to substrate protein encapsulation and folding remains poorly understood. Here we use a chemically modified mutant of GroEL (EL43Py) to uncouple substrate protein encapsulation from release and folding. Although EL43Py correctly initiates a substrate protein encapsulation reaction, this mutant stalls in an intermediate allosteric state of the GroEL ring, which is essential for both GroES binding and the forced unfolding of the substrate protein. This intermediate conformation of the GroEL ring possesses simultaneously high affinity for both GroES and non-native substrate protein, thus preventing escape of the substrate protein while GroES binding and substrate protein compaction takes place. Strikingly, assembly of the folding-active GroEL-GroES complex appears to involve a strategic delay in ATP hydrolysis that is coupled to disassembly of the old, ADP-bound GroEL-GroES complex on the opposite ring.	[Madan, Damian; Lin, Zong; Rye, Hays S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Rye, HS (corresponding author), Shultz Lab, Rm 216, Princeton, NJ 08544 USA.	hrye@princeton.edu		Rye, Hays/0000-0002-9420-3137	National Institutes of Health [GM065421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065421. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Poso D, 2004, J MOL BIOL, V338, P969, DOI 10.1016/j.jmb.2004.03.010; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Rye HS, 2001, METHODS, V24, P278, DOI 10.1006/meth.2001.1188; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1994, J MOL BIOL, V243, P397, DOI 10.1006/jmbi.1994.1667; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	46	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32003	32013		10.1074/jbc.M802898200	http://dx.doi.org/10.1074/jbc.M802898200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782766	Green Published, hybrid			2022-12-25	WOS:000260760800082
J	Song, QJ; Saucerman, JJ; Bossuyt, J; Bers, DM				Song, Qiujing; Saucerman, Jeffrey J.; Bossuyt, Julie; Bers, Donald M.			Differential Integration of Ca2+-Calmodulin Signal in Intact Ventricular Myocytes at Low and High Affinity Ca2+-Calmodulin Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; FREQUENCY-DEPENDENT ACCELERATION; LIGHT-CHAIN PHOSPHORYLATION; CALMODULIN-BINDING; CARDIAC MYOCYTES; SKELETAL-MUSCLE; HEART-FAILURE; LIVING CELLS; RYANODINE RECEPTOR; ACTIVITY SENSOR	Cardiac myocyte intracellular calcium varies beat-to-beat and calmodulin (CaM) transduces Ca2+ signals to regulate many cellular processes (e. g. via CaM targets such as CaM-dependent kinase and calcineurin). However, little is known about the dynamics of how CaM targets process the Ca2+ signals to generate appropriate biological responses in the heart. We hypothesized that the different affinities of CaM targets for the Ca2+-bound CaM (Ca2+-CaM) shape their actions through dynamic and tonic interactions in response to the repetitive Ca2+ signals in myocytes. To test our hypothesis, we used two fluorescence resonance energy transfer-based biosensors, BsCaM-45 (K-d = similar to 45 nM) and BsCaM-2 (K-d = similar to 2 nM), to monitor the real time Ca2+-CaM dynamics at low and high affinity CaM targets in paced adult ventricular myocytes. Compared with BsCaM-2, BsCaM-45 tracks the beat-to-beat Ca2+-CaM alterations more closely following the Ca2+ oscillations at each myocyte contraction. When pacing frequency is raised from 0.1 to 1.0 Hz, the higher affinity BsCaM-2 demonstrates significant elevation of diastolic Ca2+-CaM binding compared with the lower affinity BsCaM-45. Biochemically detailed computational models of Ca2+-CaM biosensors in beating cardiac myocytes revealed that the different Ca2+-CaM binding affinities of BsCaM-2 and BsCaM-45 are sufficient to predict their differing kinetics and diastolic integration. Thus, data from both experiments and computational modeling suggest that CaM targets with low versus high Ca2+-CaM affinities (like CaM-dependent kinase versus calcineurin) respond differentially to the same Ca2+ signal (phasic versus integrating), presumably tuned appropriately for their respective and distinct Ca2+ signaling pathways.	[Bossuyt, Julie; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Song, Qiujing; Bossuyt, Julie; Bers, Donald M.] Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA; [Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of California System; University of California Davis; Loyola University Chicago; University of Virginia	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, Genome Bldg 3513,451 E Hlth Sci Dr, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483; Saucerman, Jeffrey/0000-0001-9464-8374; Bossuyt, Julie/0000-0001-8874-4765	National Institutes of Health [HL30077, HL80101]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030077, P01HL080101, R37HL030077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL30077 and HL80101 (to D. M. B.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to Q. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; BASSANI JWM, 1995, BIOPHYS J, V68, P1453, DOI 10.1016/S0006-3495(95)80318-8; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Biermann M, 1998, J CARDIOVASC ELECTR, V9, P1348, DOI 10.1111/j.1540-8167.1998.tb00110.x; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; DAVIS BA, 1983, J BIOL CHEM, V258, P3587; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; DeSantiago J, 2002, J MOL CELL CARDIOL, V34, P975, DOI 10.1006/jmcc.2002.2034; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; HUBBARD MJ, 1987, J BIOL CHEM, V262, P15062; Huke S, 2007, J MOL CELL CARDIOL, V42, P590, DOI 10.1016/j.yjmcc.2006.12.007; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; KLEE CB, 1988, INTERACTION CALMODUL; Lakatta EG, 2004, CELL CALCIUM, V35, P629, DOI 10.1016/j.ceca.2004.01.017; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Maier LS, 2006, J MOL CELL CARDIOL, V41, P451, DOI 10.1016/j.yjmcc.2006.04.020; Mattiazzi A, 2007, CARDIOVASC RES, V73, P648, DOI 10.1016/j.cardiores.2006.12.002; McCullagh KJA, 2004, P NATL ACAD SCI USA, V101, P10590, DOI 10.1073/pnas.0308035101; Newman RH, 2008, MOL BIOSYST, V4, P496, DOI 10.1039/b720034j; Peersen OB, 1997, PROTEIN SCI, V6, P794; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Picht E, 2007, J MOL CELL CARDIOL, V42, P196, DOI 10.1016/j.yjmcc.2006.09.007; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Quintana AR, 2005, BIOCHEM BIOPH RES CO, V334, P674, DOI 10.1016/j.bbrc.2005.06.152; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sanhueza M, 2007, J NEUROSCI, V27, P5190, DOI 10.1523/JNEUROSCI.5049-06.2007; SAUCERMAN JJ, 2008, BIOPHYS J IN PRESS; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Spratt DE, 2007, BIOCHEMISTRY-US, V46, P8288, DOI 10.1021/bi062130b; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Tanaka H, 1998, J PHYSIOL-LONDON, V508, P145, DOI 10.1111/j.1469-7793.1998.145br.x; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Wu X, 2007, CELL CALCIUM, V41, P353, DOI 10.1016/j.ceca.2006.07.011; Wu YJ, 2001, P NATL ACAD SCI USA, V98, P2877, DOI 10.1073/pnas.051449198; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	53	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31531	31540		10.1074/jbc.M804902200	http://dx.doi.org/10.1074/jbc.M804902200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18790737	Green Published, hybrid			2022-12-25	WOS:000260760800032
J	Zang, MW; Gong, J; Luo, LQ; Zhou, J; Xiang, XQ; Huang, W; Huang, QR; Luo, XX; Olbrot, M; Peng, YH; Chen, CY; Luo, ZJ				Zang, Mengwei; Gong, Jun; Luo, Lingqi; Zhou, Jing; Xiang, Xiaoqin; Huang, Wei; Huang, Qiren; Luo, Xixi; Olbrot, Martin; Peng, Yihong; Chen, Changyan; Luo, Zhijun			Characterization of Ser(338) Phosphorylation for Raf-1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-CASCADE ACTIVATION; PROTEIN-KINASE; B-RAF; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATED KINASE; BRAF MUTATIONS; SIGNALING PATHWAYS; SERINE; PAK; IDENTIFICATION	Raf kinases are essential for regulating cell proliferation, survival, and tumorigenesis. However, the mechanisms by which Raf is activated are still incompletely understood. Phosphorylation plays a critical role in Raf activation in response to mitogens. The present study characterizes phosphorylation of Ser(338), a crucial event for Raf-1 activation. Here we report that mutation of Lys(375) to Met diminishes phosphorylation of Ser(338) on both wild type Raf-1 in cells treated with epidermal growth factor (EGF) or 12-O-tetradecanoylphorbol-13-acetate (TPA) and a constitutively active mutant in which Tyr(340)/Tyr(341) are replaced by 2 aspartic acids, a conserved substitution present in natural B-Raf. The loss of Ser(338) phosphorylation in these Raf mutants is not engendered by a mutation-induced conformational change, inasmuch as mutation of another site (Ser(471) to Ala) in the activation segment also abolishes Ser(338) phosphorylation, whereas both the kinase-dead mutants of Raf-1 are phosphorylated well by active Pak1. Furthermore, our data demonstrate that EGF-stimulated phosphorylation of Ser(338) is inhibited by Sorafenib, a Raf kinase inhibitor, but not by the MEK inhibitor U0126. Interestingly, a kinase-dead mutation and Sorafenib also markedly reduce phosphorylation of Ser(445) on B-Raf, a site equivalent to Raf-1 Ser(338). Finally, our data reveal that Ser(338) is phosphorylated on inactive Raf-1 by an active mutant of Raf-1 when they are dimerized in cells and that artificial dimerization of Raf-1 causes Ser(338) phosphorylation, accompanied by activation of ERK1/2. Altogether, our data suggest that Ser(338) on Raf-1 is autophosphorylated in response to mitogens.	[Gong, Jun; Luo, Lingqi; Zhou, Jing; Luo, Zhijun] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Zang, Mengwei; Xiang, Xiaoqin; Luo, Xixi; Olbrot, Martin; Luo, Zhijun] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Huang, Wei; Huang, Qiren; Luo, Zhijun] Boston Univ, Sch Med, Genome Sci Inst, Boston, MA 02118 USA; [Peng, Yihong] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100083, Peoples R China; [Chen, Changyan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiol & Oncol, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Peking University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Luo, ZJ (corresponding author), 715 Albany St,Evans 645, Boston, MA 02118 USA.	zluo@bu.edu	Luo, Zhijun/AAE-9302-2019	Luo, Zhijun/0000-0001-8105-5289; Zang, Mengwei/0000-0002-2502-2586; Luo, Zhijun/0000-0003-3509-4046	National Institutes of Health [GM057959, CA118918]; NATIONAL CANCER INSTITUTE [R01CA118918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM057959 and CA118918 (to Z. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Brose MS, 2002, CANCER RES, V62, P6997; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chiloeches A, 2001, MOL CELL BIOL, V21, P2423, DOI 10.1128/MCB.21.7.2423-2434.2001; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Chong HR, 2003, J BIOL CHEM, V278, P36269, DOI 10.1074/jbc.M212803200; Cohen Yossi, 2003, Hematol J, V4, P151, DOI 10.1038/sj.thj.6200208; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dhillon AS, 2007, CELL CYCLE, V6, P3, DOI 10.4161/cc.6.1.3593; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; Kimura ET, 2003, CANCER RES, V63, P1454; King AJ, 2001, FEBS LETT, V497, P6, DOI 10.1016/S0014-5793(01)02425-5; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lang J, 2003, HUM MUTAT, V21, P327, DOI 10.1002/humu.10188; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Michaloglou C, 2008, ONCOGENE, V27, P877, DOI 10.1038/sj.onc.1210704; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Park S, 2006, FEBS LETT, V580, P6405, DOI 10.1016/j.febslet.2006.10.054; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pollock PM, 2002, CANCER CELL, V2, P5, DOI 10.1016/S1535-6108(02)00089-2; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Rommel C, 1996, ONCOGENE, V12, P609; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; STORM SM, 1990, ONCOGENE, V5, P345; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; Tannapfel A, 2003, GUT, V52, P706, DOI 10.1136/gut.52.5.706; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Tran NH, 2003, J BIOL CHEM, V278, P11221, DOI 10.1074/jbc.M210318200; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Weber CK, 2001, CANCER RES, V61, P3595; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7; Yuen ST, 2002, CANCER RES, V62, P6451; Zang MW, 2001, J BIOL CHEM, V276, P25157, DOI 10.1074/jbc.M100152200; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhu J, 2005, MOL BIOL CELL, V16, P4733, DOI 10.1091/mbc.E05-02-0090	70	47	48	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31429	31437		10.1074/jbc.M802855200	http://dx.doi.org/10.1074/jbc.M802855200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18775988	hybrid, Green Published			2022-12-25	WOS:000260760800022
J	Burton, RL; Hanes, JW; Grant, GA				Burton, Rodney L.; Hanes, Jeremiah W.; Grant, Gregory A.			A Stopped Flow Transient Kinetic Analysis of Substrate Binding and Catalysis in Escherichia coli D-3-Phosphoglycerate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END PRODUCT INHIBITION; PHOSPHOGLYCERATE DEHYDROGENASE; SERINE BIOSYNTHESIS; EFFECTOR-BINDING; MECHANISM; PURIFICATION; SITE	Pre-steady state, stopped flow analysis of Escherichia coli D-3-phosphoglycerate dehydrogenase was performed by following the fluorescence of protein tryptophan and the fluorescence resonance energy transfer from protein tryptophan to bound NADH. The results indicate that binding of substrates is ordered, with coenzyme, NADH, binding first. Furthermore, the analysis indicated that there are two sets of sites on the tetrameric enzyme that can be differentiated by their kinetic behavior. NADH binding was consistent with an initial binding event followed by a slow conformational change for each site. The slow conformational change is responsible for the apparent tight binding of NADH to the apoenzyme but is too slow to participate in the catalytic cycle when the enzyme is rapidly turning over. Subsequent binding of the substrate, alpha-ketoglutarate, was characterized by a rapid equilibrium binding event followed by a conformational change for each site. Catalysis in the direction of NAD(+) reduction showed a distinct burst of activity followed by a slow rate of turnover, indicating that the rate-limiting step is after hydride transfer. Catalysis in the direction of NADH oxidation did not display burst kinetics, indicating that the rate-limiting step is at or before the hydride transfer step. The burst data indicated that the rate of NAD(+) reduction (3.8 s(-1)) is similar to the k(cat) of the enzyme (2-3 s(-1)) in that direction. However, analysis of the reaction with deuterated NADH failed to show an effect on the velocity of the reaction with aV(H)/V-D = 1.07 +/- 0.06. None of the other rates determined by stopped flow analysis could account for the k(cat) of the enzyme in either direction (forward k(cat) = 0.01 s(-1), reverse k(cat) = 2-3 s(-1)), suggesting that the rate-limiting step in both directions is a conformational change in the enzyme that is not detected optically.	[Burton, Rodney L.; Grant, Gregory A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Grant, Gregory A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hanes, Jeremiah W.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Washington University (WUSTL); Washington University (WUSTL); Cornell University	Grant, GA (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	ggrant@wustl.edu			National Institutes of Health [GM 56676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 56676 (to G. A. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AlRabiee R, 1996, J BIOL CHEM, V271, P13013, DOI 10.1074/jbc.271.22.13013; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bell JK, 2004, BIOCHEMISTRY-US, V43, P3450, DOI 10.1021/bi035462e; DUBROW R, 1977, J BIOL CHEM, V252, P1527; DUBROW R, 1977, J BIOL CHEM, V252, P1539; Grant GA, 2004, J BIOL CHEM, V279, P13452, DOI 10.1074/jbc.M313593200; Grant GA, 2002, J BIOL CHEM, V277, P39548, DOI 10.1074/jbc.M208019200; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Johnson K. A., 1992, ENZYMES, P1; Johnson Kenneth A., 2003, P1; MERRILL DK, 1981, ARCH BIOCHEM BIOPHYS, V212, P717, DOI 10.1016/0003-9861(81)90416-1; Pizer L. I, 1971, METHOD ENZYMOL, V17, P325, DOI [10.1016/0076-6879(71)17056-5, DOI 10.1016/0076-6879(71)17056-5]; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; SCHULLER DJ, 1989, J BIOL CHEM, V264, P2645; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2090; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; WALSH DA, 1966, J BIOL CHEM, V241, P4068; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	19	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29706	29714		10.1074/jbc.M805180200	http://dx.doi.org/10.1074/jbc.M805180200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18776184	Green Published, hybrid			2022-12-25	WOS:000260366900014
J	Jarvinen, AP; Hiissa, J; Elo, LL; Aittokallio, T				Jarvinen, Aki P.; Hiissa, Jukka; Elo, Laura L.; Aittokallio, Tero			Predicting Quantitative Genetic Interactions by Means of Sequential Matrix Approximation	PLOS ONE			English	Article								Despite the emerging experimental techniques for perturbing multiple genes and measuring their quantitative phenotypic effects, genetic interactions have remained extremely difficult to predict on a large scale. Using a recent high-resolution screen of genetic interactions in yeast as a case study, we investigated whether the extraction of pertinent information encoded in the quantitative phenotypic measurements could be improved by computational means. By taking advantage of the observation that most gene pairs in the genetic interaction screens have no significant interactions with each other, we developed a sequential approximation procedure which ranks the mutation pairs in order of evidence for a genetic interaction. The sequential approximations can efficiently remove background variation in the double-mutation screens and give increasingly accurate estimates of the single-mutant fitness measurements. Interestingly, these estimates not only provide predictions for genetic interactions which are consistent with those obtained using the measured fitness, but they can even significantly improve the accuracy with which one can distinguish functionally-related gene pairs from the non-interacting pairs. The computational approach, in general, enables an efficient exploration and classification of genetic interactions in other studies and systems as well.	[Jarvinen, Aki P.; Hiissa, Jukka; Elo, Laura L.; Aittokallio, Tero] Univ Turku, Dept Math, Biomat Res Grp, SF-20500 Turku, Finland; [Elo, Laura L.; Aittokallio, Tero] Turku Ctr Biotechnol, Data Mining Res Grp, Turku, Finland	University of Turku; University of Turku	Jarvinen, AP (corresponding author), Univ Turku, Dept Math, Biomat Res Grp, SF-20500 Turku, Finland.	tero.aittokallio@utu.fi	Elo, Laura/A-9449-2015; Aittokallio, Tero/B-6583-2009	Elo, Laura/0000-0001-5648-4532; Aittokallio, Tero/0000-0002-0886-9769	Academy of Finland [120569]; Graduate School in Computational Biology, Bioinformatics and Biometry (ComBi)	Academy of Finland(Academy of Finland); Graduate School in Computational Biology, Bioinformatics and Biometry (ComBi)	The Academy of Finland (grant 120569) and the Graduate School in Computational Biology, Bioinformatics and Biometry (ComBi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axler S., 1997, LINEAR ALGEBRA DONE; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; DELEEUW J, 2006, DEP STAT PAPERS; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Dror O, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-69; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Taylor RJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r160; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034	30	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3284	10.1371/journal.pone.0003284	http://dx.doi.org/10.1371/journal.pone.0003284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818762	Green Submitted, Green Published, gold			2022-12-25	WOS:000264432300006
J	Richards, ZT; van Oppen, MJH; Wallace, CC; Willis, BL; Miller, DJ				Richards, Zoe T.; van Oppen, Madeleine J. H.; Wallace, Carden C.; Willis, Bette L.; Miller, David J.			Some Rare Indo-Pacific Coral Species Are Probable Hybrids	PLOS ONE			English	Article								Background: Coral reefs worldwide face a variety of threats and many coral species are increasingly endangered. It is often assumed that rare coral species face higher risks of extinction because they have very small effective population sizes, a predicted consequence of which is decreased genetic diversity and adaptive potential. Methodology/Principal Findings: Here we show that some Indo-Pacific members of the coral genus Acropora have very small global population sizes and are likely to be unidirectional hybrids. Whether this reflects hybrid origins or secondary hybridization following speciation is unclear. Conclusions/Significance: The interspecific gene flow demonstrated here implies increased genetic diversity and adaptive potential in these coral species. Rare Acropora species may therefore be less vulnerable to extinction than has often been assumed because of their propensity for hybridization and introgression, which may increase their adaptive potential.	[Richards, Zoe T.; van Oppen, Madeleine J. H.; Willis, Bette L.; Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Richards, Zoe T.; Wallace, Carden C.] Museum Trop Queensland, Townsville, Qld, Australia; [van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld, Australia; [Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Miller, David J.] James Cook Univ, Comparative Genom Ctr, Townsville, Qld, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; James Cook University	Richards, ZT (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	David.Miller@jcu.edu.au	van Oppen, Madeleine JH/C-3261-2008	van Oppen, Madeleine/0000-0003-4607-0744	Australian Research Council; Queensland State Government (Smart State PhD funding); Winifred Violet Scott Estate; International Society for Reef Studies	Australian Research Council(Australian Research Council); Queensland State Government (Smart State PhD funding); Winifred Violet Scott Estate; International Society for Reef Studies	Principal funding source: Australian Research Council. Other funding: Queensland State Government (Smart State PhD funding), Winifred Violet Scott Estate, International Society for Reef Studies (fellowship to ZR)	Ayre DJ, 2000, EVOLUTION, V54, P1590; CABALLERO A, 1994, HEREDITY, V73, P6657; Frankham R., 1995, GENETIC RESOURCES, V66, P995; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Marquez LM, 2002, MOL ECOL, V11, P1339, DOI 10.1046/j.1365-294X.2002.01526.x; NYLANDER JAA, 2004, MRMODELTEST2 2; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; Van Oppen MJH, 2002, MOL ECOL, V11, P1363, DOI 10.1046/j.1365-294X.2002.01527.x; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Wolstenholme JK, 2003, CORAL REEFS, V22, P155, DOI 10.1007/s00338-003-0299-0	20	52	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3240	10.1371/journal.pone.0003240	http://dx.doi.org/10.1371/journal.pone.0003240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813338	Green Published, gold, Green Accepted			2022-12-25	WOS:000264431800001
J	Parone, PA; Da Cruz, S; Tondera, D; Mattenberger, Y; James, DI; Maechler, P; Barja, F; Martinou, JC				Parone, Philippe A.; Da Cruz, Sandrine; Tondera, Daniel; Mattenberger, Yves; James, Dominic I.; Maechler, Pierre; Barja, Francois; Martinou, Jean-Claude			Preventing Mitochondrial Fission Impairs Mitochondrial Function and Leads to Loss of Mitochondrial DNA	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MAMMALIAN-CELLS; FUSION; DYNAMICS; APOPTOSIS; DYSFUNCTION; MORPHOLOGY; GTPASE; YEAST; FIS1	Mitochondria form a highly dynamic tubular network, the morphology of which is regulated by frequent fission and fusion events. However, the role of mitochondrial fission in homeostasis of the organelle is still unknown. Here we report that preventing mitochondrial fission, by down-regulating expression of Drp1 in mammalian cells leads to a loss of mitochondrial DNA and a decrease of mitochondrial respiration coupled to an increase in the levels of cellular reactive oxygen species (ROS). At the cellular level, mitochondrial dysfunction resulting from the lack of fission leads to a drop in the levels of cellular ATP, an inhibition of cell proliferation and an increase in autophagy. In conclusion, we propose that mitochondrial fission is required for preservation of mitochondrial function and thereby for maintenance of cellular homeostasis.	[Parone, Philippe A.; Da Cruz, Sandrine; Tondera, Daniel; Mattenberger, Yves; James, Dominic I.; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva, Switzerland; [Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Barja, Francois] Univ Geneva, Lab Bioenerget Microbiol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Parone, PA (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	Jean-Claude.Martinou@cellbio.unige.ch	James, Dominic/G-6435-2016	James, Dominic/0000-0002-0452-2178; Maechler, Pierre/0000-0002-2005-1433; martinou, Jean-claude/0000-0002-9847-2051; Mattenberger, Yves/0000-0002-1651-7691	Swiss National Science Foundation [3100A0-109419/1]; OncoSuisse Trust; Geneva Department of Education	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); OncoSuisse Trust; Geneva Department of Education	This work was funded by the Swiss National Science Foundation (subside: 3100A0-109419/1), OncoSuisse Trust and the Geneva Department of Education.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ESTAQUIER J, 2007, CELL DEATH DIFFER; FRANCIS B, 2001, SEX ED, V1, P1; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Gemin A, 2005, BIOCHEM BIOPH RES CO, V332, P1122, DOI 10.1016/j.bbrc.2005.05.061; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VANDENBOGERT C, 1988, EXP CELL RES, V178, P143, DOI 10.1016/0014-4827(88)90385-0; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Xu JX, 2004, ANN NY ACAD SCI, V1011, P57, DOI 10.1196/annals.1293.006; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yoon YS, 2004, ANN NY ACAD SCI, V1011, P123, DOI 10.1196/annals.1293.013; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	44	304	325	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3257	10.1371/journal.pone.0003257	http://dx.doi.org/10.1371/journal.pone.0003257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806874	Green Published, gold, Green Submitted			2022-12-25	WOS:000264430800007
J	Tully, T; Ferriere, R				Tully, Thomas; Ferriere, Regis			Reproductive Flexibility: Genetic Variation, Genetic Costs and Long-Term Evolution in a Collembola	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; ADAPTIVE PHENOTYPIC PLASTICITY; FOLSOMIA-CANDIDA COLLEMBOLA; EGG SIZE PLASTICITY; OFFSPRING SIZE; TRADE-OFFS; ENVIRONMENT INTERACTIONS; SEED BEETLE; FOOD; ALLOCATION	In a variable yet predictable world, organisms may use environmental cues to make adaptive adjustments to their phenotype. Such phenotypic flexibility is expected commonly to evolve in life history traits, which are closely tied to Darwinian fitness. Yet adaptive life history flexibility remains poorly documented. Here we introduce the collembolan Folsomia candida, a soil-dweller, parthenogenetic (all-female) microarthropod, as a model organism to study the phenotypic expression, genetic variation, fitness consequences and long-term evolution of life history flexibility. We demonstrate that collembola have a remarkable adaptive ability for adjusting their reproductive phenotype: when transferred from harsh to good conditions (in terms of food ration and crowding), a mother can fine-tune the number and the size of her eggs from one clutch to the next. The comparative analysis of eleven clonal populations of worldwide origins reveals (i) genetic variation in mean egg size under both good and bad conditions; (ii) no genetic variation in egg size flexibility, consistent with convergent evolution to a common physiological limit; (iii) genetic variation of both mean reproductive investment and reproductive investment flexibility, associated with a reversal of the genetic correlation between egg size and clutch size between environmental conditions; (iv) a negative genetic correlation between reproductive investment flexibility and adult lifespan. Phylogenetic reconstruction shows that two life history strategies, called HIFLEX and LOFLEX, evolved early in evolutionary history. HIFLEX includes six of our 11 clones, and is characterized by large mean egg size and reproductive investment, high reproductive investment flexibility, and low adult survival. LOFLEX (the other five clones) has small mean egg size and low reproductive investment, low reproductive investment flexibility, and high adult survival. The divergence of HIFLEX and LOFLEX could represent different adaptations to environments differing in mean quality and variability, or indicate that a genetic polymorphism of reproductive investment reaction norms has evolved under a physiological tradeoff between reproductive investment flexibility and adult lifespan.	[Tully, Thomas; Ferriere, Regis] Ecole Normale Super, CNRS, UMR 7625, Lab Fonctionnement & Evolut Syst Ecol, Paris, France; [Tully, Thomas] Univ Paris 04, Inst Univ Format Maitres, F-75230 Paris, France; [Ferriere, Regis] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Arizona	Tully, T (corresponding author), Ecole Normale Super, CNRS, UMR 7625, Lab Fonctionnement & Evolut Syst Ecol, Paris, France.	tully@biologie.ens.fr	Ferriere, Regis/S-8050-2017	Ferriere, Regis/0000-0002-5806-5566; Tully, Thomas/0000-0003-1847-7504	French Ministry of Education and Research; French Ministry of Environment; The European Research Training Network ModLife [HPRN-CT-2000-00051]; NSF [0623632]	French Ministry of Education and Research; French Ministry of Environment; The European Research Training Network ModLife; NSF(National Science Foundation (NSF))	Our research was funded by: 1) The French Ministry of Education and Research (ACI "Jeunes Chercheurs 2001"), the French Ministry of Environment (ACI "Invasions biologiques"); 2) The European Research Training Network ModLife (HPRN-CT-2000-00051); 3) The NSF REU Biomath program; 4) The NSF FIBR grant #0623632.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Badyaev AV, 2003, J EVOLUTION BIOL, V16, P1065, DOI 10.1046/j.1420-9101.2003.00628.x; Badyaev AV, 2002, BEHAV ECOL, V13, P591, DOI 10.1093/beheco/13.5.591; Bashey F, 2006, EVOLUTION, V60, P348, DOI 10.1554/05-087.1; Bernardo J, 1996, AM ZOOL, V36, P216; Brauer VS, 2007, EVOLUTION, V61, P216, DOI 10.1111/j.1558-5646.2007.00018.x; Caley MJ, 2001, EVOLUTION, V55, P1245; Czesak ME, 2006, AM NAT, V168, P323, DOI 10.1086/506919; Czesak ME, 2003, EVOLUTION, V57, P1121; DEJONG G, 1992, AM NAT, V139, P749, DOI 10.1086/285356; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DRAHEIM R, 1995, ACTA ZOOL FENN, P168; Ernande B, 2004, J EVOLUTION BIOL, V17, P342, DOI 10.1046/j.1420-9101.2003.00674.x; Evans MEK, 2007, AM NAT, V169, P184, DOI 10.1086/510599; Evans MEK, 2005, Q REV BIOL, V80, P431, DOI 10.1086/498282; Fischer K, 2006, J EVOLUTION BIOL, V19, P380, DOI 10.1111/j.1420-9101.2005.01046.x; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Fox CW, 1999, EVOLUTION, V53, P552, DOI [10.2307/2640791, 10.1111/j.1558-5646.1999.tb03790.x]; Fox CW, 1997, AM NAT, V149, P149, DOI 10.1086/285983; Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x; GEBHARDTHENRICH SG, 1991, J EVOLUTION BIOL, V4, P341, DOI 10.1046/j.1420-9101.1991.4030341.x; GLIWICZ ZM, 1992, OECOLOGIA, V91, P463, DOI 10.1007/BF00650317; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; Gutteling EW, 2007, HEREDITY, V98, P206, DOI 10.1038/sj.hdy.6800929; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Hopkin S. P., 1997, BIOL SPRINGTAILS; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jordan MA, 2002, OECOLOGIA, V130, P44, DOI 10.1007/s004420100776; Kingsolver JG, 2006, EVOL ECOL RES, V8, P703; Kontiainen P, 2008, J EVOLUTION BIOL, V21, P88, DOI 10.1111/j.1420-9101.2007.01468.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LEVINS RICHARD, 1968; Lorenzon P, 2001, EVOLUTION, V55, P392; LYNCH M, 1997, GENETIC ANAL QUANTIT; Manly BFJ, 1997, RANDOMIZATION BOOTST; MARSHALL V. G., 1962, CANADIAN ENTOMOL, V94, P575; MASSOT M, 1995, BEHAV ECOL SOCIOBIOL, V37, P413, DOI 10.1007/s002650050209; Merila J, 2004, J EVOLUTION BIOL, V17, P1132, DOI 10.1111/j.1420-9101.2004.00744.x; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Meylan S, 2007, OIKOS, V116, P650, DOI 10.1111/j.2007.0030-1299.15432.x; Milne S., 1960, Proceedings of the Royal Entomological Society of London (A), V35, P133; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Oda GA, 2000, J THEOR BIOL, V206, P515, DOI 10.1006/jtbi.2000.2151; PALEVODY C, 1974, PEDOBIOLOGIA, V14, P196; Phelan JP, 2003, EVOLUTION, V57, P527, DOI 10.1111/j.0014-3820.2003.tb01544.x; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pike N, 2004, P ROY SOC B-BIOL SCI, V271, P2143, DOI 10.1098/rspb.2004.2834; Pinheiro J, 2001, MIXED EFFECTS MODELS; POTAPOW M, 2001, ISOTOMIDAE; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Rasband W., 2003, IMAGEJ; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Ris N, 2004, OIKOS, V106, P451, DOI 10.1111/j.0030-1299.2004.13274.x; ROFF DA, 2001, LIFE HIST EVOLUTION; Rueffler C, 2004, THEOR POPUL BIOL, V65, P165, DOI 10.1016/j.tpb.2003.10.001; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Sgro CM, 2004, HEREDITY, V93, P241, DOI 10.1038/sj.hdy.6800532; SINERVO B, 1991, SCIENCE, V252, P1300, DOI 10.1126/science.252.5010.1300; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stam EM, 1996, OECOLOGIA, V107, P283, DOI 10.1007/BF00328444; STEARNS S, 1991, TRENDS ECOL EVOL, V6, P122, DOI 10.1016/0169-5347(91)90090-K; Stearns S.C., 2000, EVOLUTION INTRO; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Stillwell RC, 2007, OECOLOGIA, V153, P309, DOI 10.1007/s00442-007-0748-5; Svensson E, 1998, OIKOS, V83, P466, DOI 10.2307/3546674; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; Therneau TM, 2000, MODELING SURVIVAL DA; Tully T, 2005, OIKOS, V111, P479, DOI 10.1111/j.1600-0706.2005.14062.x; TULLY T, 2004, FOLSOMIA CANDIDA; Tully T, 2006, PEDOBIOLOGIA, V50, P95, DOI 10.1016/j.pedobi.2005.11.003; VANAMELSVOORT PAM, 1989, PEDOBIOLOGIA, V33, P61; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; WESTEBERHARD MJ, 2003, DEV PLASTICITY EVOLU, P1; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216; WINKLER DW, 1987, AM NAT, V129, P708, DOI 10.1086/284667; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	88	38	40	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3207	10.1371/journal.pone.0003207	http://dx.doi.org/10.1371/journal.pone.0003207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791644	Green Published, Green Submitted, gold			2022-12-25	WOS:000264427700002
J	Sommer, WH; Kraft, A; Schmidt, S; Olma, MC; Brandt, SA				Sommer, Wieland H.; Kraft, Antje; Schmidt, Sein; Olma, Manuel C.; Brandt, Stephan A.			Dynamic Spatial Coding within the Dorsal Frontoparietal Network during a Visual Search Task	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SCALE NEURAL-NETWORK; VISUOSPATIAL ATTENTION; TOP-DOWN; CONJUNCTION SEARCH; PARAMETRIC FMRI; HUMAN BRAIN; BOTTOM-UP; VOLUNTARY; NEGLECT	To what extent are the left and right visual hemifields spatially coded in the dorsal frontoparietal attention network? In many experiments with neglect patients, the left hemisphere shows a contralateral hemifield preference, whereas the right hemisphere represents both hemifields. This pattern of spatial coding is often used to explain the right-hemispheric dominance of lesions causing hemispatial neglect. However, pathophysiological mechanisms of hemispatial neglect are controversial because recent experiments on healthy subjects produced conflicting results regarding the spatial coding of visual hemifields. We used an fMRI paradigm that allowed us to distinguish two attentional subprocesses during a visual search task. Either within the left or right hemifield subjects first attended to stationary locations (spatial orienting) and then shifted their attentional focus to search for a target line. Dynamic changes in spatial coding of the left and right hemifields were observed within subregions of the dorsal front-parietal network: During stationary spatial orienting, we found the well-known spatial pattern described above, with a bilateral hemifield representation in the right hemisphere and a contralateral preference in the left hemisphere. However, during search, the right hemisphere had a contralateral preference and the left hemisphere equally represented both hemifields. This finding leads to novel perspectives regarding models of visuospatial attention and hemispatial neglect.	[Sommer, Wieland H.; Kraft, Antje; Schmidt, Sein; Olma, Manuel C.; Brandt, Stephan A.] Berlin Neuroimaging Ctr, Dept Neurol, Berlin, Germany; [Sommer, Wieland H.; Schmidt, Sein; Brandt, Stephan A.] Bernstein Ctr Computat Neurosci, Berlin, Germany; [Sommer, Wieland H.] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Clin Radiol, Munich, Germany	University of Munich	Sommer, WH (corresponding author), Berlin Neuroimaging Ctr, Dept Neurol, Berlin, Germany.	stephan.brandt@charite.de	Schmidt, Sein/AFR-1244-2022; Schmidt, Sein/AAT-2308-2021		Bernstein Center for Computational Neuroscience Berlin; German Research Foundation [BR 1691/3-2]	Bernstein Center for Computational Neuroscience Berlin; German Research Foundation(German Research Foundation (DFG))	Funding was obtained from the Bernstein Center for Computational Neuroscience Berlin (W.H.S., S.S., C3-CH) and the German Research Foundation (A.K., S.S.; BR 1691/3-2).	Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Collie A, 2000, J EXP PSYCHOL HUMAN, V26, P1733, DOI 10.1037//0096-1523.26.6.1733; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; Danckert JA, 2003, BRADFORD BOOKS, P29; Donner T, 2000, EUR J NEUROSCI, V12, P3407, DOI 10.1046/j.1460-9568.2000.00223.x; Donner TH, 2002, NEUROIMAGE, V15, P16, DOI 10.1006/nimg.2001.0951; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; FORSTER DH, 1991, P ROY SOC LOND B BIO, V243, P75; Gainotti G, 1996, NEUROSCI BIOBEHAV R, V20, P617, DOI 10.1016/0149-7634(95)00074-7; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; Hagler DJ, 2007, NEUROIMAGE, V35, P1562, DOI 10.1016/j.neuroimage.2007.01.033; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Heilman K. M, 1983, LOCALIZATION NEUROPS, P471; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hung J, 2005, J NEUROSCI, V25, P9602, DOI 10.1523/JNEUROSCI.0879-05.2005; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Kraft A, 2005, COGNITIVE BRAIN RES, V24, P19, DOI 10.1016/j.cogbrainres.2004.12.004; Kraft A, 2007, BRAIN RES, V1133, P123, DOI 10.1016/j.brainres.2006.11.043; Macaluso E, 2007, EXP BRAIN RES, V180, P23, DOI 10.1007/s00221-006-0841-8; Macmillan N. A., 2004, DETECTION THEORY USE; Mayer AR, 2004, NEUROIMAGE, V23, P534, DOI 10.1016/j.neuroimage.2004.06.027; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Milner AD, 2005, CURR OPIN NEUROL, V18, P748, DOI 10.1097/01.wco.0000191512.60368.ee; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Muller NG, 2003, NEUROIMAGE, V20, P1578, DOI 10.1016/S1053-8119(03)00416-6; Muller NG, 2003, J NEUROSCI, V23, P3561; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; ROBERTSON LC, 1988, J NEUROSCI, V8, P3757; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Talairach I., 1988, COPLANAR STEREOTACTI; TSAL Y, 1988, PERCEPT PSYCHOPHYS, V44, P15, DOI 10.3758/BF03207469; Turatto M, 2000, PERCEPT PSYCHOPHYS, V62, P935, DOI 10.3758/BF03212079; VALLAR G, 1988, CORTEX, V24, P399, DOI 10.1016/S0010-9452(88)80003-0; Vandenberghe R, 2005, BRAIN, V128, P2843, DOI 10.1093/brain/awh522; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; Wolfe JM, 2003, J EXP PSYCHOL HUMAN, V29, P483, DOI 10.1037/0096-1523.29.2.483; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zenger B, 1997, J EXP PSYCHOL HUMAN, V23, P1783, DOI 10.1037/0096-1523.23.6.1783	58	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3167	10.1371/journal.pone.0003167	http://dx.doi.org/10.1371/journal.pone.0003167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422JY	18779857	Green Published, Green Submitted, gold			2022-12-25	WOS:000264425100003
J	Zhu, ZH; Yu, YP; Shi, YK; Nelson, JB; Luo, JH				Zhu, Z-H; Yu, Y. P.; Shi, Y-K; Nelson, J. B.; Luo, J-H			CSR1 induces cell death through inactivation of CPSF3	ONCOGENE			English	Article						CSR1; CPSF3; cell death; RNA polyadenylation	POLYADENYLATION FACTOR CPSF-73; PROSTATE-CANCER; METASTASIS; HETEROZYGOSITY; STATISTICS; 8P21-23; MARKERS	CSR1 (cellular stress response 1), a newly characterized tumor-suppressor gene, undergoes hypermethylation in over 30% of prostate cancers. Re-expression of CSR1 inhibits cell growth and induces cell death, but the mechanism by which CSR1 suppresses tumor growth is not clear. In this study, we screened a prostate cDNA library using a yeast two-hybrid system and found that the cleavage and polyadenylation-specific factor 3 (CPSF3), an essential component for converting heteronuclear RNA to mRNA, binds with high affinity to the CSR1 C terminus. Further analyses determined that the binding motifs for CPSF3 are located between amino acids 440 and 543. The interaction between CSR1 and CPSF3 induced CPSF3 translocation from the nucleus to the cytoplasm, resulting in inhibition of polyadenylation both in vitro and in vivo. Downregulation of CPSF3 using small interfering RNA induced cell death in a manner similar to CSR1 expression. A CSR1 mutant unable to bind to CPSF3 did not alter CPSF3 subcellular distribution, did not inhibit its polyadenylation activity and did not induce cell death. In summary, CSR1 appears to induce cell death through a novel mechanism by hijacking a critical RNA processing enzyme.	[Zhu, Z-H; Yu, Y. P.; Shi, Y-K; Luo, J-H] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Nelson, J. B.] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luo, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	luoj@msx.upmc.edu			National Cancer Institute [RO1 CA098249]; NATIONAL CANCER INSTITUTE [R01CA098249] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by grants from the National Cancer Institute to JHL (RO1 CA098249), the development fund from the Department of Urology, University of Pittsburgh and the John Rangos Foundation for Enhancement of Research in Pathology.	Coon SW, 2004, INT J CANCER, V111, P206, DOI 10.1002/ijc.20254; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; Gallucci M, 2006, CANCER LETT, V237, P76, DOI 10.1016/j.canlet.2005.05.033; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Isaacs JT, 1997, AM J PATHOL, V150, P1511; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kurimoto F, 2001, INT J MOL MED, V8, P89; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; OHATA H, 1993, GENE CHROMOSOME CANC, V7, P85, DOI 10.1002/gcc.2870070204; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; Wistuba II, 1999, CANCER RES, V59, P1973; Yu GY, 2006, AM J PATHOL, V168, P597, DOI 10.2353/ajpath.2006.050620; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	18	34	40	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					41	51		10.1038/onc.2008.359	http://dx.doi.org/10.1038/onc.2008.359			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18806823	Green Accepted			2022-12-25	WOS:000262294100005
J	Cartmell, A; Topakas, E; Ducros, VMA; Suits, MDL; Davies, GJ; Gilbert, HJ				Cartmell, Alan; Topakas, Evangelos; Ducros, Valerie M-A.; Suits, Michael D. L.; Davies, Gideon J.; Gilbert, Harry J.			The Cellvibrio japonicus Mannanase CjMan26C Displays a Unique exo-Mode of Action That Is Conferred by Subtle Changes to the Distal Region of the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT CONFORMATIONAL ITINERARIES; GLYCOSIDE HYDROLASE FAMILY-5; CELL-WALL DEGRADATION; CLOSTRIDIUM-THERMOCELLUM; ALPHA-AMYLASE; PSEUDOMONAS-CELLULOSA; SUBSTRATE DISTORTION; CRYSTAL-STRUCTURE; BETA-MANNANASE; HYDROLYSIS	The microbial degradation of the plant cell wall is a pivotal biological process that is of increasing industrial significance. One of the major plant structural polysaccharides is mannan, a beta-1,4-linked D-mannose polymer, which is hydrolyzed by endo- and exo-acting mannanases. The mechanisms by which the exoacting enzymes target the chain ends of mannan and how galactose decorations influence activity are poorly understood. Here we report the crystal structure and biochemical properties of CjMan26C, a Cellvibrio japonicus GH26 mannanase. The exoacting enzyme releases the disaccharide mannobiose from the nonreducing end of mannan and mannooligosaccharides, harnessing four mannose-binding subsites extending from -2 to +2. The structure of CjMan26C is very similar to that of the endo- acting C. japonicus mannanase CjMan26A. The exo-activity displayed by CjMan26C, however, reflects a subtle change in surface topography in which a four-residue extension of surface loop creates a steric block at the distal glycone -2 subsite. endo-Activity can be introduced into enzyme variants through truncation of an aspartate side chain, a component of a surface loop, or by removing both the aspartate and its flanking residues. The structure of catalytically competent CjMan26C, in complex with a decorated manno-oligosaccharide, reveals a predominantly unhydrolyzed substrate in an approximate S-1(5) conformation. The complex structure helps to explain how the substrate "side chain" decorations greatly reduce the activity of the enzyme; the galactose side chain at the -1 subsite makes polar interactions with the aglycone mannose, possibly leading to suboptimal binding and impaired leaving group departure. This report reveals how subtle differences in the loops surrounding the active site of a glycoside hydrolase can lead to a change in the mode of action of the enzyme.	[Cartmell, Alan; Topakas, Evangelos; Gilbert, Harry J.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Ducros, Valerie M-A.; Suits, Michael D. L.; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England	Newcastle University - UK; University of York - UK	Gilbert, HJ (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	davies@ysbl.york.ac.uk	Topakas, Evangelos/J-7554-2019; Topakas, Evangelos/C-6528-2012; Davies, Gideon J/A-9042-2011	Topakas, Evangelos/0000-0003-0078-5904; Davies, Gideon J/0000-0002-7343-776X; Cartmell, Alan/0000-0002-5512-249X	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/B/05974, BB/D000475/1, BB/E000568/1] Funding Source: researchfish; BBSRC [BB/E000568/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (to H. J. G. and G. J. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRAITHWAITE KL, 1995, BIOCHEM J, V305, P1005, DOI 10.1042/bj3051005; Brett C. T., 1996, TOPICS PLANT FUNCTIO; Brumer H, 1999, BIOCHEM J, V339, P43, DOI 10.1042/0264-6021:3390043; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P9099, DOI 10.1021/bi0000317; Centeno MSJ, 2006, FEMS MICROBIOL LETT, V261, P123, DOI 10.1111/j.1574-6968.2006.00342.x; Dauter Z, 1999, BIOCHEMISTRY-US, V38, P8385, DOI 10.1021/bi990256l; Davies G., 1997, COMPREHENSIVE BIOL C; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DAVIES GJ, 2008, BIOCH J IN PRESS; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Emami K, 2002, J BACTERIOL, V184, P4124, DOI 10.1128/JB.184.15.4124-4133.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; Halstead JR, 1999, MICROBIOL-SGM, V145, P3101, DOI 10.1099/00221287-145-11-3101; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Kiyohara M, 2005, BIOCHEM J, V388, P949, DOI 10.1042/BJ20050190; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurokawa J, 2001, BIOSCI BIOTECH BIOCH, V65, P548, DOI 10.1271/bbb.65.548; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; MCCLEARY BV, 1988, METHOD ENZYMOL, V160, P523; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Money VA, 2006, ANGEW CHEM INT EDIT, V45, P5136, DOI 10.1002/anie.200600802; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nerinckx W, 2006, ARKIVOC, P90, DOI 10.3998/ark.5550190.0007.d10; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages S, 2001, J BIOL CHEM, V276, P33652, DOI 10.1074/jbc.M105770200; Pell G, 2004, J BIOL CHEM, V279, P11777, DOI 10.1074/jbc.M311947200; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Puchart V, 2004, BBA-GEN SUBJECTS, V1674, P239, DOI 10.1016/j.bbagen.2004.06.022; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; SAMSON R, 1978, J CHEM PHYS, V68, P285, DOI 10.1063/1.435494; Stoll D, 1999, APPL ENVIRON MICROB, V65, P2598; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Taylor EJ, 2005, J BIOL CHEM, V280, P32761, DOI 10.1074/jbc.M506580200; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Vincent F, 2004, CHEMBIOCHEM, V5, P1596, DOI 10.1002/cbic.200400169; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183	47	67	68	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34403	34413		10.1074/jbc.M804053200	http://dx.doi.org/10.1074/jbc.M804053200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18799462	Green Published, hybrid			2022-12-25	WOS:000261277700068
J	Kurita, S; Watanabe, Y; Gunji, E; Ohashi, K; Mizuno, K				Kurita, Souichi; Watanabe, Yosuke; Gunji, Emi; Ohashi, Kazumasa; Mizuno, Kensaku			Molecular Dissection of the Mechanisms of Substrate Recognition and F-actin-mediated Activation of Cofilin-phosphatase Slingshot-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; LIM-KINASE; CATALYTIC ACTIVATION; CRYSTAL-STRUCTURE; REGULATES COFILIN; CORONIN 1B; PHOSPHORYLATION; BINDING; REORGANIZATION; SPECIFICITY	Slingshot-1 (SSH1), a member of a dual-specificity protein phosphatase family, regulates actin dynamics by dephosphorylating and reactivating cofilin, an actin-depolymerizing factor. SSH1 has the SSH family-specific, N-terminal, noncatalytic (SSH-N) domain, consisting of the A and B subdomains. SSH1 is activated by binding to actin filaments. In this study, we examined the mechanisms of SSH1 substrate recognition of phospho-cofilin (P-cofilin) and SSH1 activation by F-actin. We found that P-cofilin binds to a phosphatase-inactive mutant, SSH1(CS), in which the catalytic Cys-393 is replaced by Ser. Using a series of deletion mutants, we provided evidence that both the phosphatase (P) domain and the adjacent B domain are indispensable for P-cofilin binding of SSH1(CS) and cofilin-phosphatase activity of SSH1. In contrast, the A domain is required for the F-actin-mediated activation of SSH1, but not for P-cofilin binding or basal cofilin-phosphatase activity. The P domain alone is sufficient for the phosphatase activity toward p-nitrophenyl phosphate (pNPP), indicating that the SSH-N domain is not essential for the basal phosphatase activity of SSH1. Addition of F-actin increased the cofilin-phosphatase activity of SSH1 more than 1200-fold,but the pNPP-phosphatase activity only 2.2-fold, which suggests that F-actin principally affects the cofilin-specific phosphatase activity of SSH1. When expressed in cultured cells, SSH1, but not its mutant deleted of SSH-N, accumulated in the rear of the lamellipodium. Together, these findings suggest that the conserved SSH-N domain plays critical roles in P-cofilin recognition, F-actin-mediated activation, and subcellular localization of SSH1.	[Kurita, Souichi; Watanabe, Yosuke; Gunji, Emi; Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Mizuno, Kensaku/G-8631-2015; Ohashi, Kazumasa/U-7028-2019	Ohashi, Kazumasa/0000-0001-7617-403X	Ministry of Education, Culture, Science, Sports and Technology of Japan	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Science, Sports and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jung SK, 2007, PROTEINS, V68, P408, DOI 10.1002/prot.21399; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kolmodin K, 2001, FEBS LETT, V498, P208, DOI 10.1016/S0014-5793(01)02479-6; Kurita S, 2007, GENES CELLS, V12, P663, DOI 10.1111/j.1365-2443.2007.01078.x; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nichols A, 2000, J BIOL CHEM, V275, P24613, DOI 10.1074/jbc.M001515200; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YONEZAWA N, 1988, BIOCHEM J, V251, P121, DOI 10.1042/bj2510121; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4	35	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32542	32552		10.1074/jbc.M804627200	http://dx.doi.org/10.1074/jbc.M804627200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809681	hybrid			2022-12-25	WOS:000260893700043
J	Gakh, O; Smith, DY; Isaya, G				Gakh, Oleksandr; Smith, Douglas Y.; Isaya, Grazia			Assembly of the Iron-binding Protein Frataxin in Saccharomyces cerevisiae Responds to Dynamic Changes in Mitochondrial Iron Influx and Stress Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; HEAT-SHOCK RESPONSE; YEAST FRATAXIN; FRIEDREICH ATAXIA; PROCESSING PEPTIDASE; ESCHERICHIA-COLI; REPEAT EXPANSION; OXIDATIVE STRESS; DEFICIENT STRAIN; 2FE-2S CLUSTERS	Defects in frataxin result in Friedreich ataxia, a genetic disease characterized by early onset of neurodegeneration, cardiomyopathy, and diabetes. Frataxin is a conserved mitochondrial protein that controls iron needed for iron-sulfur cluster assembly and heme synthesis and also detoxifies excess iron. Studies in vitro have shown that either monomeric or oligomeric frataxin delivers iron to other proteins, whereas ferritin-like frataxin particles convert redox-active iron to an inert mineral. We have investigated how these different forms of frataxin are regulated in vivo. In Saccharomyces cerevisiae, only monomeric yeast frataxin (Yfh1) was detected in unstressed cells when mitochondrial iron uptake was maintained at a steady, low nanomolar level. Increments in mitochondrial iron uptake induced step-wise assembly of Yfh1 species ranging from trimer to >= 24-mer, independent of interactions between Yfh1 and its major iron-binding partners, Isu1/Nfs1 or aconitase. The rate-limiting step in Yfh1 assembly was a structural transition that preceded conversion of monomer to trimer. This step was induced, independently or synergistically, by mitochondrial iron increments, overexpression of wild type Yfh1 monomer, mutations that stabilize Yfh1 trimer, or heat stress. Faster assembly kinetics correlated with reduced oxidative damage and higher levels of aconitase activity, respiratory capacity, and cell survival. However, deregulation of Yfh1 assembly resulted in Yfh1 aggregation, aconitase sequestration, and mitochondrial DNA depletion. The data suggest that Yfh1 assembly responds to dynamic changes in mitochondrial iron uptake or stress exposure in a highly controlled fashion and that this may enable frataxin to simultaneously promote respiratory function and stress tolerance.	Mayo Clin, Coll Med, Dept Adolescent Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Isaya, Grazia] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin, Coll Med, Dept Pediat, 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health [AG15709]; Friedreich Ataxia Research Alliance/Muscular Dystrophy Association; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich Ataxia Research Alliance/Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709. This work was also supported by the Friedreich Ataxia Research Alliance/Muscular Dystrophy Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Branda SS, 1999, J BIOL CHEM, V274, P22763, DOI 10.1074/jbc.274.32.22763; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; KAEBERLEIN M, 2001, SCI AGING KNOWLEDGE, pE1, DOI DOI 10.1126/SAGEKE.2001.1.PE1; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Kondapalli KC, 2008, BIOCHEMISTRY-US, V47, P6917, DOI 10.1021/bi800366d; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Molik S, 2007, METHOD CELL BIOL, V80, P261, DOI 10.1016/S0091-679X(06)80013-0; Moraitis C, 2004, YEAST, V21, P313, DOI 10.1002/yea.1078; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Popescu BFG, 2007, J INORG BIOCHEM, V101, P957, DOI 10.1016/j.jinorgbio.2007.03.004; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schoenfeld RA, 2005, HUM MOL GENET, V14, P3787, DOI 10.1093/hmg/ddi393; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; Sugiyama K, 2000, J BIOL CHEM, V275, P15535, DOI 10.1074/jbc.275.20.15535; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Velagapudi VR, 2006, PROCESS BIOCHEM, V41, P2170, DOI 10.1016/j.procbio.2006.06.016; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zanella I, 2008, BBA-MOL BASIS DIS, V1782, P90, DOI 10.1016/j.bbadis.2007.11.006; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200	65	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31500	31510		10.1074/jbc.M805415200	http://dx.doi.org/10.1074/jbc.M805415200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784075	Green Published, hybrid			2022-12-25	WOS:000260760800029
J	Bal, M; Zhang, J; Zaika, O; Hernandez, CC; Shapiro, MS				Bal, Manjot; Zhang, Jie; Zaika, Oleg; Hernandez, Ciria C.; Shapiro, Mark S.			Homomeric and Heteromeric Assembly of KCNQ (Kv7) K+ Channels Assayed by Total Internal Reflection Fluorescence/Fluorescence Resonance Energy Transfer and Patch Clamp Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-MODIFYING REAGENT; NUCLEOTIDE-GATED CHANNELS; ANCHORING PROTEIN YOTIAO; HEART POTASSIUM CHANNEL; NEURONAL M-CURRENT; SUBUNIT STOICHIOMETRY; FLUORESCENCE MICROSCOPY; FUNCTIONAL EXPRESSION; TRANSMITTER RELEASE; DOMINANT DEAFNESS	M-type K+ channels, consisting of KCNQ1-5 (Kv7.1-7.5) subunits, form a variety of homomeric and heteromeric channels. Whereas all the subunits can assemble into homomeric channels, the ability of the subunits to assemble into heteromultimers is highly variable. KCNQ3 is widely thought to co-assemble with several other KCNQ subtypes, whereas KCNQ1 and KCNQ2 do not. However, the existence of other subunit assemblies is not well studied. To systematically explore the heteromeric assembly of KCNQ channels in individual living cells, we performed fluorescence resonance energy transfer (FRET) between cyan fluorescent protein- and yellow fluorescent protein- tagged KCNQ subunits expressed in Chinese hamster ovary cells under total internal reflection fluorescence microscopy in which excitation light only penetrates several hundred nanometers into the cell, thus isolating membrane events. We found significant FRET between homomeric subunits as expected from their functional expression in heterologous expression systems. Also as expected from previous work, robust FRET was observed between KCNQ2 and KCNQ3. KCNQ3 and KCNQ4 also showed substantial FRET as did KCNQ4 and KCNQ5. To determine functional assembly of KCNQ4/KCNQ5 heteromers, we performed two types of experiments. In the first, we constructed a mutant tetraethylammonium ion-sensitive KCNQ4 subunit and tested its assembly with KCNQ5 by patch clamp analysis of the tetraethylammonium ion sensitivity of the resulting current; however, those data were not conclusive. In the second, we co-expressed a KCNQ4 (G285S) pore mutant with KCNQ5 and found the former to act as a dominant negative, suggesting co-assembly of the two types of subunits. These data confirm that among the allowed assembly conformations are KCNQ3/4 and KCNQ4/5 heteromers.	[Bal, Manjot; Zhang, Jie; Zaika, Oleg; Hernandez, Ciria C.; Shapiro, Mark S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Shapiro, MS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, MS 7756,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu		Hernandez, Ciria/0000-0001-9715-1734	National Institutes of Health [R01 NS043394]; American Heart Association-Texas; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Texas(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS043394 (to M. S. S.). This work was also supported by an American Heart Association-Texas affiliate grant-in-aid (to M. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Anantharam A, 2003, J BIOL CHEM, V278, P11739, DOI 10.1074/jbc.M212751200; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Castaldo P, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0003.2002; Centonze VE, 2003, METHOD ENZYMOL, V360, P542; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chen S, 2008, J PHYSIOL-LONDON, V586, P1351, DOI 10.1113/jphysiol.2007.148171; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Coppola G, 2003, NEUROLOGY, V61, P131, DOI 10.1212/01.WNL.0000069465.53698.BD; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J NEUROSCI, V23, P84; Gamper Nikita, 2005, Journal of Pharmacological and Toxicological Methods, V51, P177, DOI 10.1016/j.vascn.2004.08.008; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Hadley JK, 2003, J NEUROSCI, V23, P5012; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Hurley KM, 2006, J NEUROSCI, V26, P10253, DOI 10.1523/JNEUROSCI.2596-06.2006; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Lawrence JJ, 2006, J NEUROSCI, V26, P12325, DOI 10.1523/JNEUROSCI.3521-06.2006; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Lerche H, 2001, AM J MED GENET, V106, P146, DOI 10.1002/ajmg.1582; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loussouarn Gildas, 2006, V337, P167; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Marx SO, 2006, HANDB EXP PHARMACOL, V171, P221; Nakajo K, 2008, J PHYSIOL-LONDON, V586, P2827, DOI 10.1113/jphysiol.2007.148601; Nicolas MT, 2001, HEARING RES, V153, P132, DOI 10.1016/S0378-5955(00)00268-9; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Piccinin S, 2006, J NEUROPHYSIOL, V95, P3105, DOI 10.1152/jn.01083.2005; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roche JP, 2002, BRIT J PHARMACOL, V137, P1173, DOI 10.1038/sj.bjp.0704989; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Strutz-Seebohm N, 2006, CELL PHYSIOL BIOCHEM, V18, P57, DOI 10.1159/000095158; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Vervaeke K, 2006, J PHYSIOL-LONDON, V576, P235, DOI 10.1113/jphysiol.2006.111336; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickenden AD, 2001, BRIT J PHARMACOL, V132, P381, DOI 10.1038/sj.bjp.0703861; Wladyka CL, 2008, J PHYSIOL-LONDON, V586, P795, DOI 10.1113/jphysiol.2007.145284; Wladyka CL, 2006, J PHYSIOL-LONDON, V575, P175, DOI 10.1113/jphysiol.2006.113308; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419; Yue CY, 2006, J NEUROPHYSIOL, V95, P3480, DOI 10.1152/jn.01333.2005; Yus-Najera E, 2003, NEUROSCIENCE, V120, P353, DOI 10.1016/S0306-4522(03)00321-X; ZAIKA O, 2008, BIOPHYS J IN PRESS; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1	81	56	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30668	30676		10.1074/jbc.M805216200	http://dx.doi.org/10.1074/jbc.M805216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18786918	Green Published, hybrid			2022-12-25	WOS:000260544800024
J	Crespo, PM; Silvestre, DC; Gil, GA; Maccioni, HJF; Daniotti, JL; Caputto, BL				Crespo, Pilar M.; Silvestre, David C.; Gil, German A.; Maccioni, Hugo J. F.; Daniotti, Jose L.; Caputto, Beatriz L.			c-Fos Activates Glucosylceramide Synthase and Glycolipid Synthesis in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; IMMEDIATE-EARLY GENES; PHOSPHOLIPID-SYNTHESIS; GLYCOSPHINGOLIPID SYNTHESIS; PHEOCHROMOCYTOMA CELLS; ENDOPLASMIC-RETICULUM; EXPRESSION; GOLGI; SYSTEM; LIGHT	It has been demonstrated that c-Fos has, in addition to its well recognized AP-1 transcription factor activity, the capacity to associate to the endoplasmic reticulum and activate key enzymes involved in the synthesis of phospholipids required for membrane biogenesis during cell growth and neurite formation. Because membrane genesis requires the coordinated supply of all its integral membrane components, the question emerges as to whether c-Fos also activates the synthesis of glycolipids, another ubiquitous membrane component. We show that c-Fos activates the metabolic labeling of glycolipids in differentiating PC12 cells. Specifically, c-Fos activates the enzyme glucosylceramide synthase (GlcCerS), the product of which, GlcCer, is the first glycosylated intermediate in the pathway of synthesis of glycolipids. By contrast, the activities of GlcCer galactosyltransferase 1 and lactosylceramide sialyltransferase 1 are essentially unaffected by c-Fos. Co-immunoprecipitation experiments in cells co-transfected with c-Fos and a V5-tagged version of GlcCerS evidenced that both proteins participate in a physical association. c-Fos expression is tightly regulated by specific environmental cues. This strict regulation assures that lipid metabolism activation will occur as a response to cell requirements thus pointing to c-Fos as an important regulator of key membrane metabolisms in membrane biogenesis-demanding processes.	[Crespo, Pilar M.; Silvestre, David C.; Gil, German A.; Maccioni, Hugo J. F.; Daniotti, Jose L.; Caputto, Beatriz L.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, UNC Consejo Nacl Invest Cient & Tecn, CIQUIBIC,Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Caputto, BL (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, UNC Consejo Nacl Invest Cient & Tecn, CIQUIBIC,Dept Quim Biol,Fac Ciencias Quim, Ciudad Univ,Cordoba X5000HUA, RA-5000 Cordoba, Argentina.	bcaputto@mail.fcq.unc.edu.ar	GIL, GERMAN A./T-3018-2019	GIL, GERMAN A./0000-0001-6714-2693	Aqencia Nacional de Promocion Cientifica y Tecnologica Ministerio de Ciencia; Tecnologia e Innovacion Productiva de Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Sectretaria de Ciencia y Tecnologia-Universidad Nacional de Cordoba; McDonnell Foundation; Howard Hughes Medical Institute	Aqencia Nacional de Promocion Cientifica y Tecnologica Ministerio de Ciencia(ANPCyT); Tecnologia e Innovacion Productiva de Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sectretaria de Ciencia y Tecnologia-Universidad Nacional de Cordoba; McDonnell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported in part by grants from the Aqencia Nacional de Promocion Cientifica y Tecnologica Ministerio de Ciencia, Tecnologia e Innovacion Productiva de Argentina, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), and Sectretaria de Ciencia y Tecnologia-Universidad Nacional de Cordoba (to H.J.F.M., J.L.D., and B.L.C.), the J.S. McDonnell Foundation (to B.L.C.), and the Howard Hughes Medical Institute (to H.J.F.M.).	AKARI W, 1997, P NATL ACAD SCI USA, V94, P11946; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borioli GA, 2005, BBA-BIOMEMBRANES, V1668, P41, DOI 10.1016/j.bbamem.2004.11.007; Borioli GA, 2004, FEBS LETT, V570, P82, DOI 10.1016/j.febslet.2004.06.033; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; Bussolino DF, 2001, FASEB J, V15, P556; Bussolino DF, 1998, MOL BRAIN RES, V58, P10, DOI 10.1016/S0169-328X(98)00065-5; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; COSTE H, 1986, BIOCHIM BIOPHYS ACTA, V858, P6, DOI 10.1016/0005-2736(86)90285-3; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DANIOTTI JL, 1994, J NEUROCHEM, V62, P1131; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HUGHES P, 1995, PHARMACOL REV, V47, P133; Ichikawa S, 1998, BIOCHEM BIOPH RES CO, V253, P707, DOI 10.1006/bbrc.1998.9855; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; MACCIONI HJ, 1974, BIOCHEM J, V138, P291, DOI 10.1042/bj1380291; Maccioni HJF, 2007, J NEUROCHEM, V103, P81, DOI 10.1111/j.1471-4159.2007.04717.x; MARGOLIS RK, 1983, J BIOL CHEM, V258, P4110; MARGOLIS RU, 1984, FEBS LETT, V172, P339, DOI 10.1016/0014-5793(84)81153-9; MAXZUD MK, 1995, J BIOL CHEM, V270, P20207, DOI 10.1074/jbc.270.34.20207; MITZUTANI A, 1996, BIOCHEM BIOPH RES CO, V222, P494; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MUTOH T, 1993, J NEUROCHEM, V60, P1540, DOI 10.1111/j.1471-4159.1993.tb03319.x; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; SCHWARZ A, 1995, J BIOL CHEM, V270, P10990, DOI 10.1074/jbc.270.18.10990; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; UEMURA K, 1991, J BIOCHEM-TOKYO, V110, P96, DOI 10.1093/oxfordjournals.jbchem.a123549; Uliana AS, 2006, J BIOL CHEM, V281, P32852, DOI 10.1074/jbc.M605805200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Veldman RJ, 2003, FASEB J, V17, P1144, DOI 10.1096/fj.02-1053fje; Yanagisawa M, 2006, J NEUROSCI RES, V84, P1343, DOI 10.1002/jnr.21031; Yu RK, 2004, J LIPID RES, V45, P783, DOI 10.1194/jlr.R3000020-JLR200; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x	46	31	31	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31163	31171		10.1074/jbc.M709257200	http://dx.doi.org/10.1074/jbc.M709257200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784083	hybrid, Green Published			2022-12-25	WOS:000260544800070
J	Dabert-Gay, AS; Czarny, B; Devel, L; Beau, F; Lajeunesse, E; Bregant, S; Thai, R; Yiotakis, A; Dive, V				Dabert-Gay, Anne-Sophie; Czarny, Bertrand; Devel, Laurent; Beau, Fabrice; Lajeunesse, Evelyne; Bregant, Sarah; Thai, Robert; Yiotakis, Athanasios; Dive, Vincent			Molecular Determinants of Matrix Metalloproteinase-12 Covalent Modification by a Photoaffinity Probe INSIGHTS INTO ACTIVITY- BASED PROBE DEVELOPMENT AND CONFORMATIONAL VARIABILITY OF MATRIX METALLOPROTEINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE ELASTASE MMP-12; STRUCTURAL BASIS; INHIBITOR; CANCER; COMPLEXES; SUBSTRATE; OPINION; DESIGN; LIGAND; ROLES	Mass spectroscopy, microsequencing, and site-directed mutagenesis studies have been performed to identify in human matrix metalloelastase (hMMP-12) residues covalently modified by a photoaffinity probe, previously shown to be able to covalently label specifically the active site of matrix metalloproteinases (MMPs). Results obtained led us to conclude that photoactivation of this probe in complex with hMMP-12 affects a single residue in human MMP-12, Lys(241), through covalent modification of its side chain epsilon NH2 group. Because x-ray and NMR studies of hMMP-12 indicate that Lys241 side chain is highly flexible, our data reveal the existence of particular Lys241 side-chain conformation in which the epsilon NH2 group points toward the photolabile group of the probe, an event explaining the high levels of cross-linking yield between hMMP-12 and the probe. Lys241 is not conserved in MMPs, thus differences in cross-linking yields observed with this probe between MMP members may be linked to the residue variability observed at position 241 in this family.	[Dabert-Gay, Anne-Sophie; Czarny, Bertrand; Devel, Laurent; Beau, Fabrice; Lajeunesse, Evelyne; Bregant, Sarah; Thai, Robert; Dive, Vincent] CEA Saclay, CEA, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France; [Yiotakis, Athanasios] Univ Athens, Dept Organ Chem, Organ Chem Lab, GR-15771 Athens, Greece	CEA; UDICE-French Research Universities; Universite Paris Saclay; National & Kapodistrian University of Athens	Dive, V (corresponding author), CEA Saclay, CEA, Serv Ingn Mol Prot, 152, F-91191 Gif Sur Yvette, France.	vincent.dive@cea.fr	Czarny, Bertrand/F-2001-2018; CZARNY, bertrand/AAP-6603-2020	Czarny, Bertrand/0000-0002-9586-0913; CZARNY, bertrand/0000-0002-9586-0913; Thai, Robert/0000-0001-9438-4225	Commissariat a l'Energie Atomique; European Commission [FP6RDT, LSHC-CT-2003-503297]	Commissariat a l'Energie Atomique(French Atomic Energy Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by funds from the Commissariat a l'Energie Atomique and from the European Commission (Grant FP6RDT, Cancer Degradome project, LSHC-CT-2003-503297).	Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; Bayley H., 1984, AZIDES NITRENES REAC, P433; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bhaskaran R, 2007, J MOL BIOL, V374, P1333, DOI 10.1016/j.jmb.2007.10.028; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chan EWS, 2004, J AM CHEM SOC, V126, P14435, DOI 10.1021/ja047044i; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; David A, 2007, ANGEW CHEM INT EDIT, V46, P3275, DOI 10.1002/anie.200604408; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; FLEMING SA, 1995, TETRAHEDRON, V51, P12479; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Hesek D, 2006, CHEM BIOL, V13, P379, DOI 10.1016/j.chembiol.2006.01.012; HOROVITZ A, 1987, P NATL ACAD SCI USA, V84, P6654, DOI 10.1073/pnas.84.19.6654; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Kramer F, 2008, BIOMARKERS, V13, P270, DOI 10.1080/13547500801903123 ; Lang R, 2001, J MOL BIOL, V312, P731, DOI 10.1006/jmbi.2001.4954; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nar H, 2001, J MOL BIOL, V312, P743, DOI 10.1006/jmbi.2001.4953; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rizk MS, 2006, BIOCHEMISTRY-US, V45, P543, DOI 10.1021/bi0516632; Rosenblum G, 2003, J BIOL CHEM, V278, P27009, DOI 10.1074/jbc.M301139200; Rydlova M, 2008, ANTICANCER RES, V28, P1389; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Unsal D, 2008, AM J CLIN ONCOL-CANC, V31, P55, DOI 10.1097/COC.0b013e318068b4e2; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543	43	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31058	31067		10.1074/jbc.M805795200	http://dx.doi.org/10.1074/jbc.M805795200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18775985	Green Published, hybrid			2022-12-25	WOS:000260544800060
J	Hou, T; Ray, S; Lee, C; Brasier, AR				Hou, Tieying; Ray, Sutapa; Lee, Chang; Brasier, Allan R.			The STAT3 NH2-terminal Domain Stabilizes Enhanceosome Assembly by Interacting with the p300 Bromodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE ACETYLTRANSFERASE; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; SIGNAL TRANSDUCER; STRUCTURAL BASIS; ACETYLATION; PROTEIN; GENE; EXPRESSION	Signal transducer and activator of transcription 3(STAT3) is a latent transcription factor mainly activated by the interleukin-6 cytokine family. Previous studies have shown that activated STAT3 recruits p300, a coactivator whose intrinsic histone acetyltransferase activity is essential for transcription. Here we investigated the function of the STAT3 NH2-terminal domain and how its interaction with p300 regulates STAT3 signal transduction. In STAT3(-/-) mouse embryonic fibroblasts, a stably expressed NH2 terminus-deficient STAT3 mutant (STAT3-Delta N) was unable to efficiently induce either STAT3-mediated reporter activity or endogenous mRNA expression. Chromatin immunoprecipitation assays were performed to determine whether the NH2-terminal domain regulates p300 recruitment or stabilizes enhanceosome assembly. Despite equivalent levels of STAT3 binding, cells expressing the STAT3-Delta N mutant were unable to recruit p300 and RNA polymerase II to the native socs3 promoter as efficiently as those expressing STAT3-full length. We previously reported that the STAT3 NH2-terminal domain is acetylated by p300 at Lys-49 and Lys-87. By introducing K49R/K87R mutations, here we found that the acetylation status of the STAT3 NH2-terminal domain regulates its interaction with p300. In addition, the STAT3 NH2-terminal binding site maps to the p300 bromodomain, a region spanning from amino acids 995 to 1255. Finally a p300 mutant lacking the bromodomain (p300-Delta B) exhibited a weaker binding to STAT3, and the enhanceosome formation on the socs3 promoter was inhibited when p300-Delta B was overexpressed. Taken together, our data suggest that the STAT3 NH2-terminal domain plays an important role in the interleukin-6 signaling pathway by interacting with the p300 bromodomain, thereby stabilizing enhanceosome assembly.	[Brasier, Allan R.] Univ Texas Galveston, Med Branch, Div Endocrinol, Dept Internal Med, Galveston, TX 77555 USA; [Hou, Tieying] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Galveston, Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brasier, AR (corresponding author), Univ Texas Galveston, Med Branch, Div Endocrinol, Dept Internal Med, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	arbrasie@utmb.edu	Ray, Sutapa/D-3272-2012	Brasier, Allan/0000-0002-5012-4090; Ray, Sutapa/0000-0003-4234-2124	National Institutes of Health [P30 ES06676]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Stephanie Watowich from University of Texas M. D. Anderson Cancer Center and Dr. David Levy from New York University for generously providing STAT3<SUP>+/-</SUP> and STAT3<SUP>-/-</SUP> MEFs. Core laboratory support was provided by National Institutes of Health Grant P30 ES06676 (to J. Ward, University of Texas Medical Branch).	Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Bayle JH, 1997, CHEM BIOL, V4, P885, DOI 10.1016/S1074-5521(97)90296-9; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Chan HM, 2001, J CELL SCI, V114, P2363; Chang HC, 2003, J BIOL CHEM, V278, P32471, DOI 10.1074/jbc.M302776200; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herrera JE, 1999, MOL CELL BIOL, V19, P3466; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; Hou T, 2007, J BIOL CHEM, V282, P37091, DOI 10.1074/jbc.M706458200; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; John S, 1999, MOL CELL BIOL, V19, P1910; Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Meyer T, 2004, J BIOL CHEM, V279, P18998, DOI 10.1074/jbc.M400766200; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Paul C, 2000, EUR J BIOCHEM, V267, P5849, DOI 10.1046/j.1432-1327.2000.01395.x; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Ray S, 2002, MOL ENDOCRINOL, V16, P824, DOI 10.1210/me.16.4.824; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Sun W, 2006, FEBS LETT, V580, P5880, DOI 10.1016/j.febslet.2006.09.054; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200	62	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30725	30734		10.1074/jbc.M805941200	http://dx.doi.org/10.1074/jbc.M805941200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782771	hybrid, Green Published			2022-12-25	WOS:000260544800028
J	Wang, Y; Mikhailova, M; Bose, S; Pan, CX; White, RD; Ghosh, PM				Wang, Y.; Mikhailova, M.; Bose, S.; Pan, C-X; White, Rw deVere; Ghosh, P. M.			Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival	ONCOGENE			English	Article						androgen independence; Akt; apoptosis; mTOR; raptor; rictor	SIGNAL-TRANSDUCTION PATHWAYS; MAMMALIAN TARGET; MTOR; KINASE; PHOSPHORYLATION; PROTEIN; GROWTH; RICTOR; CYTOSKELETON; PROGRESSION	The mTOR (mammalian target of rapamycin) inhibit or rapamycin caused growth arrest in both androgen-dependent and androgen-independent prostate cancer cells; however, long-term treatment induced resistance to the drug. The aim of this study was to investigate methods that can overcome this resistance. Here, we show that rapamycin treatment stimulated androgen receptor (AR) transcriptional activity, whereas suppression of AR activity with the antiandrogen bicalutamide sensitized androgen-dependent, as well as AR-sensitive androgen-independent prostate cancer cells, to growth inhibition by rapamycin. Further, the combination of rapamycin and bicalutamide, but not the individual drugs, induced significant levels of apoptosis in prostate cancer cells. The net effect of rapamycin is determined by its individual effects on the mTOR complexes mTORC1 (mTOR/raptor/G beta L) and mTORC2 (mTOR/rictor/sin1/G beta L). Inhibition of both mTORC1 and mTORC2 by rapamycin-induced apoptosis, whereas rapamycin-stimulation of AR transcriptional activity resulted from the inhibition of mTORC1, but not mTORC2. The effect of rapamycin on AR transcriptional activity was mediated by the phosphorylation of the serine/threonine kinase Akt, which also partially mediated apoptosis induced by rapamycin and bicalutamide. These results indicate the presence of two parallel cell-survival pathways in prostate cancer cells: a strong Akt-independent, but rapamycin-sensitive pathway downstream of mTORC1, and an AR-dependent pathway downstream of mTORC2 and Akt, that is stimulated by mTORC1 inhibition. Thus, the combination of rapamycin and bicalutamide induce apoptosis in prostate cancer cells by simultaneously inhibiting both pathways and hence would be of therapeutic value in prostate cancer treatment.	[Wang, Y.; Bose, S.; Pan, C-X; White, Rw deVere; Ghosh, P. M.] VA No Calf Hlth Care Syst, Res Serv, Mather, CA 95655 USA; [Wang, Y.; Pan, C-X; Ghosh, P. M.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Mikhailova, M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of California System; University of California Davis; University of Texas System; University of Texas Health San Antonio	Ghosh, PM (corresponding author), VA No Calf Hlth Care Syst, Res Serv, 10535 Hosp Way, Mather, CA 95655 USA.	paramita.ghosh@ucdmc.ucdavis.edu	WANG, YU/E-4655-2013		Department of Veterans Affairs; National Cancer Institute [CA109057]; NATIONAL CANCER INSTITUTE [R21CA109057, R01CA133209] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Hsing-Jien Kung for critical reading of the manuscript, Dr Barry Furr, AstraZeneca, Cheshire, UK, for the gift of bicalutamide (Casodex), Dr Bandana Chatterjee, University of Texas Health Science Center at San Antonio (UTHSCSA) for hPSA-luc construct; Dr LuZhe Sun, UTHSCSA, for beta-gal construct and LNAI cell line. We are grateful to Sherra Johnson and Naveen K Krishnegowda for technical assistance in some of the experiments described. This study was supported by a Merit award from the Department of Veterans Affairs and award CA109057 from the National Cancer Institute.	Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Boehmer A, 2005, ANTICANCER RES, V25, P4481; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Cinar B, 2005, CANCER RES, V65, P2547, DOI 10.1158/0008-5472.CAN-04-3411; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Ghosh PM, 1999, ONCOGENE, V18, P4120, DOI 10.1038/sj.onc.1202792; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Ghosh PM, 2002, CANCER RES, V62, P2630; Ghosh PM, 2001, AM J PHYSIOL-RENAL, V280, pF972, DOI 10.1152/ajprenal.2001.280.6.F972; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Hartig PC, 2002, TOXICOL SCI, V66, P82, DOI 10.1093/toxsci/66.1.82; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Petrylak D, 2005, BJU INT, V96, P41, DOI 10.1111/j.1464-410X.2005.05946.x; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sharef S, 2006, J CLIN ONCOL, V24, P14584; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Wu LC, 2005, CANCER RES, V65, P2825, DOI 10.1158/0008-5472.CAN-04-3137	30	78	81	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2008	27	56					7106	7117		10.1038/onc.2008.318	http://dx.doi.org/10.1038/onc.2008.318			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	376PQ	18776922	Green Accepted			2022-12-25	WOS:000261195900005
J	Klein, S; Partisani, M; Franco, M; Luton, F				Klein, Stephanie; Partisani, Mariagrazia; Franco, Michel; Luton, Frederic			EFA6 Facilitates the Assembly of the Tight Junction by Coordinating an Arf6-dependent and -independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; ADP-RIBOSYLATION FACTOR-6; ACTIN CYTOSKELETON; EXCHANGE FACTOR; CELL-ADHESION; E-CADHERIN; ARF6; MEMBRANE; RAC1; DOMAIN	We have previously reported that EFA6, exchange factor for Arf6, is implicated upon E-cadherin engagement in the process of epithelial cell polarization. We had found that EFA6 acts through stabilization of the apical actin ring onto which the tight junction is anchored. Mutagenesis experiments showed that both the catalytic domain of EFA6 and its C-terminal domain were required for full EFA6 function. Here we address the contribution of the specific substrate of EFA6, the small G protein Arf6. Unexpectedly, depletion of Arf6 by RNA interference or expression of the constitutively active fast-cycling mutant (Arf6T157N) revealed that Arf6 plays an opposing role to EFA6 by destabilizing the apical actin cytoskeleton and the associated tight junction. However, in complementation experiments, when the C-terminal domain of EFA6 is co-expressed with Arf6T157N, it reverts the effects of Arf6T157N expressed alone to faithfully mimic the phenotypes induced by EFA6. In addition, we find that the two signaling pathways downstream of EFA6, i.e. the one originating from the activated Arf6GTP and the other one from the EFA6 C-terminal domain, need to be tightly balanced to promote the proper reorganization of the actin cytoskeleton. Altogether, our results indicate that to regulate the tight junction, EFA6 activates Arf6 through its Sec7 catalytic domain as it modulates this activity through its C-terminal domain.	[Klein, Stephanie; Partisani, Mariagrazia; Franco, Michel; Luton, Frederic] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR 6097, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Luton, F (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR 6097, 660 Route Lucioles, F-06560 Valbonne, France.	luton@ipmc.cnrs.fr	Luton, Frederic/N-7673-2017; Franco, Michel/ABH-4993-2020; FRANCO, michel/AAA-9735-2021	Franco, Michel/0000-0003-1853-8661; 	Association pour la Recherche sur le Cancer; Canceropole PACA; Agence Nationale de la Recherche	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Canceropole PACA(Region Grand-Est); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported in part by a grant from the Association pour la Recherche sur le Cancer, the Canceropole PACA, and the Agence Nationale de la Recherche. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Awar O, 2000, MOL CELL BIOL, V20, P5998, DOI 10.1128/MCB.20.16.5998-6007.2000; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Derrien V, 2002, J CELL SCI, V115, P2867; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Luton F, 2005, METHOD ENZYMOL, V404, P332, DOI 10.1016/S0076-6879(05)04029-2; Luton F, 2004, MOL BIOL CELL, V15, P1134, DOI 10.1091/mbc.E03-10-0751; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Marshansky V, 1997, ELECTROPHORESIS, V18, P538, DOI 10.1002/elps.1150180334; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tushir JS, 2007, EMBO J, V26, P1806, DOI 10.1038/sj.emboj.7601644; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2	36	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30129	30138		10.1074/jbc.M803375200	http://dx.doi.org/10.1074/jbc.M803375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18779331	Green Published, hybrid			2022-12-25	WOS:000260366900058
J	Nasr, S; Moeeny, A; Esteky, H				Nasr, Shahin; Moeeny, Ali; Esteky, Hossein			Neural Correlate of Filtering of Irrelevant Information from Visual Working Memory	PLOS ONE			English	Article							FRONTAL EYE FIELDS; PREFRONTAL CORTEX; PARIETAL CORTEX; ATTENTION; CONNECTIVITY; MODULATION; CAPACITY	In a dynamic environment stimulus task relevancy could be altered through time and it is not always possible to dissociate relevant and irrelevant objects from the very first moment they come to our sight. In such conditions, subjects need to retain maximum possible information in their WM until it is clear which items should be eliminated from WM to free attention and memory resources. Here, we examined the neural basis of irrelevant information filtering from WM by recording human ERP during a visual change detection task in which the stimulus irrelevancy was revealed in a later stage of the task forcing the subjects to keep all of the information in WM until test object set was presented. Assessing subjects' behaviour we found that subjects' RT was highly correlated with the number of irrelevant objects and not the relevant one, pointing to the notion that filtering, and not selection, process was used to handle the distracting effect of irrelevant objects. In addition we found that frontal N150 and parietal N200 peak latencies increased systematically as the amount of irrelevancy load increased. Interestingly, the peak latency of parietal N200, and not frontal N150, better correlated with subjects' RT. The difference between frontal N150 and parietal N200 peak latencies varied with the amount of irrelevancy load suggesting that functional connectivity between modules underlying fronto-parietal potentials vary concomitant with the irrelevancy load. These findings suggest the existence of two neural modules, responsible for irrelevant objects elimination, whose activity latency and functional connectivity depend on the number of irrelevant object.	[Nasr, Shahin; Moeeny, Ali; Esteky, Hossein] IPM, Sch Cognit Sci, Tehran, Iran; [Nasr, Shahin; Moeeny, Ali; Esteky, Hossein] Shahid Beheshti Univ, Sch Med, Res Ctr Brain & Cognit Sci, Tehran, Iran; [Esteky, Hossein] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran	Shahid Beheshti University; Shahid Beheshti University Medical Sciences	Nasr, S (corresponding author), IPM, Sch Cognit Sci, Tehran, Iran.	esteky@ipm.ir		Lauwereyns, Jan/0000-0003-0551-2550				Banich MT, 2001, PROG BRAIN RES, V134, P459; Barbas H, 2005, CEREB CORTEX, V15, P1356, DOI 10.1093/cercor/bhi018; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; CHAO LL, 1995, NEUROREPORT, V6, P1605, DOI 10.1097/00001756-199508000-00005; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Honey GD, 2002, NEUROIMAGE, V17, P573, DOI 10.1006/nimg.2002.1193; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Medalla M, 2007, CEREB CORTEX, V17, pI136, DOI 10.1093/cercor/bhm068; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Muggleton NG, 2003, J NEUROPHYSIOL, V89, P3340, DOI 10.1152/jn.01086.2002; O'Shea J, 2006, VIS COGN, V14, P934, DOI 10.1080/13506280500197363; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Posner MI, 1998, ATTENTIVE BRAIN, P401; Rainer G, 2002, NEUROSCIENTIST, V8, P6, DOI 10.1177/107385840200800104; Rowe J, 2002, NEUROIMAGE, V17, P988, DOI 10.1006/nimg.2002.1156; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3282	10.1371/journal.pone.0003282	http://dx.doi.org/10.1371/journal.pone.0003282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422ML	18818772	Green Submitted, Green Published, gold			2022-12-25	WOS:000264432300004
J	Hall, KJ; Harper, MT; Gilio, K; Cosemans, JM; Heemskerk, JWM; Poole, AW				Hall, Kellie J.; Harper, Matthew T.; Gilio, Karen; Cosemans, Judith M.; Heemskerk, Johan W. M.; Poole, Alastair W.			Genetic Analysis of the Role of Protein Kinase C theta in Platelet Function and Thrombus Formation	PLOS ONE			English	Article								Background: PKC theta is a novel protein kinase C isozyme, predominately expressed in T cells and platelets. PKC theta(-/-) T cells exhibit reduced activation and PKC theta(-/-) mice are resistant to autoimmune disease, making PKC theta an attractive therapeutic target for immune modulation. Collagen is a major agonist for platelets, operating through an immunoreceptor-like signalling pathway from its receptor GPVI. Although it has recently been shown that PKC theta positively regulates outside-in signalling through integrin alpha(IIb)beta(3) in platelets, the role of PKC theta in GPVI-dependent signalling and functional activation of platelets has not been assessed. Methodology/Principal Findings: In the present study we assessed static adhesion, cell spreading, granule secretion, integrin alpha(IIb)beta(3) activation and platelet aggregation in washed mouse platelets lacking PKC theta. Thrombus formation on a collagen-coated surface was assessed in vitro under flow. PKC theta(-/-) platelets exhibited reduced static adhesion and filopodia generation on fibrinogen, suggesting that PKC theta positively regulates outside-in signalling, in agreement with a previous report. In contrast, PKC theta(-/-) platelets also exhibited markedly enhanced GPVI-dependent alpha-granule secretion, although dense granule secretion was unaffected, suggesting that PKC theta differentially regulates these two granules. Inside-out regulation of alpha(IIb)beta(3) activation was also enhanced downstream of GPVI stimulation. Although this did not result in increased aggregation, importantly thrombus formation on collagen under high shear (1000 s(-1)) was enhanced. Conclusions/Significance: These data suggest that PKC theta is an important negative regulator of thrombus formation on collagen, potentially mediated by alpha-granule secretion and aIIbb3 activation. PKC theta therefore may act to restrict thrombus growth, a finding that has important implications for the development and safe clinical use of PKC theta inhibitors.	[Hall, Kellie J.; Harper, Matthew T.; Poole, Alastair W.] Univ Bristol, Dept Physiol & Pharmacol, Bristol, Avon, England; [Gilio, Karen; Cosemans, Judith M.; Heemskerk, Johan W. M.] Univ Maastricht, Dept Biochem, Maastricht, Netherlands	University of Bristol; Maastricht University	Hall, KJ (corresponding author), Univ Bristol, Dept Physiol & Pharmacol, Bristol, Avon, England.	a.poole@bris.ac.uk	Cosemans, Judith MEM/C-8161-2016; Heemskerk, Johan/AAM-8323-2021; Harper, Matthew T/G-5630-2013	Cosemans, Judith MEM/0000-0001-7429-0109; Heemskerk, Johan/0000-0002-2848-5121; Harper, Matthew T/0000-0002-4740-637X; Poole, Alastair/0000-0002-0868-297X	British Heart Foundation [RG/05/015]; Netherlands Foundation for Scientific research [11-400-076]; BBSRC Research Development Fellow [BB/E024637/1]; BBSRC [BB/E024637/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E024637/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Netherlands Foundation for Scientific research(Netherlands Organization for Scientific Research (NWO)); BBSRC Research Development Fellow(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a British Heart Foundation programme grant to AWP (grant no. RG/05/015) and a grant from the Netherlands Foundation for Scientific research to JWMH (11-400-076). AWP is a BBSRC Research Development Fellow (BB/E024637/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2006, AUTOIMMUNITY, V39, P469, DOI 10.1080/08916930600907954; BAIER G, 1993, J BIOL CHEM, V268, P4997; BALDWIN BG, 1992, MOL PHYLOGENET EVOL, V1, P2; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; CHANG JD, 1993, J BIOL CHEM, V268, P14208; CRABOS M, 1991, BIOCHEM BIOPH RES CO, V178, P878, DOI 10.1016/0006-291X(91)90973-B; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Crosby D, 2002, J BIOL CHEM, V277, P9958, DOI 10.1074/jbc.M108965200; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; GRABAREK J, 1992, J BIOL CHEM, V267, P10011; Harper MT, 2007, BIOCHEM SOC T, V35, P1005, DOI 10.1042/BST0351005; Healy AM, 2006, J IMMUNOL, V177, P1886, DOI 10.4049/jimmunol.177.3.1886; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Mosyak L, 2007, BIOCHEM SOC T, V35, P1027, DOI 10.1042/BST0351027; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; Nesbitt WS, 2006, J MOL MED, V84, P989, DOI 10.1007/s00109-006-0101-1; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Strehl A, 2007, J BIOL CHEM, V282, P7046, DOI 10.1074/jbc.M611367200; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tabuchi A, 2003, J BIOL CHEM, V278, P26374, DOI 10.1074/jbc.M212407200; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Thornber K, 2006, FEBS J, V273, P5032, DOI 10.1111/j.1742-4658.2006.05500.x; WANG F, 1993, BIOCHEM BIOPH RES CO, V191, P240, DOI 10.1006/bbrc.1993.1208; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200	32	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3277	10.1371/journal.pone.0003277	http://dx.doi.org/10.1371/journal.pone.0003277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815612	Green Submitted, Green Published, gold			2022-12-25	WOS:000264431900004
J	Wamstad, JA; Corcoran, CM; Keating, AM; Bardwell, VJ				Wamstad, Joseph Alan; Corcoran, Connie Marie; Keating, Anne Marjorie; Bardwell, Vivian J.			Role of the Transcriptional Corepressor Bcor in Embryonic Stem Cell Differentiation and Early Embryonic Development	PLOS ONE			English	Article								Bcor (BCL6 corepressor) is a widely expressed gene that is mutated in patients with X-linked Oculofaciocardiodental (OFCD) syndrome. BCOR regulates gene expression in association with a complex of proteins capable of epigenetic modification of chromatin. These include Polycomb group (PcG) proteins, Skp-Cullin-F-box (SCF) ubiquitin ligase components and a Jumonji C (Jmjc) domain containing histone demethylase. To model OFCD in mice and dissect the role of Bcor in development we have characterized two loss of function Bcor alleles. We find that Bcor loss of function results in a strong parent-of-origin effect, most likely indicating a requirement for Bcor in extraembryonic development. Using Bcor loss of function embryonic stem (ES) cells and in vitro differentiation assays, we demonstrate that Bcor plays a role in the regulation of gene expression very early in the differentiation of ES cells into ectoderm, mesoderm and downstream hematopoietic lineages. Normal expression of affected genes (Oct3/4, Nanog, Fgf5, Bmp4, Brachyury and Flk1) is restored upon re-expression of Bcor. Consistent with these ES cell results, chimeric animals generated with the same loss of function Bcor alleles show a low contribution to B and T cells and erythrocytes and have kinked and shortened tails, consistent with reduced Brachyury expression. Together these results suggest that Bcor plays a role in differentiation of multiple tissue lineages during early embryonic development.	[Wamstad, Joseph Alan; Bardwell, Vivian J.] Univ Minnesota, Mol Cellular Dev Biol & Genet Grad Program, Minneapolis, MN 55455 USA; [Corcoran, Connie Marie; Bardwell, Vivian J.] Univ Minnesota, Canc Ctr, Dept Genet, Cell Biol & Dev, Minneapolis, MN USA; [Keating, Anne Marjorie] Univ Minnesota, Biochem, Mol Biol & Biophys Grad Program, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wamstad, JA (corresponding author), Univ Minnesota, Mol Cellular Dev Biol & Genet Grad Program, Minneapolis, MN 55455 USA.	bardw001@umn.edu			NCI [R01 CA071540]; NIH [T32DE07288]; University of Minnesota Cancer Center; NATIONAL CANCER INSTITUTE [R01CA071540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Cancer Center(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this work was provided by NCI (R01 CA071540), NIH (T32DE07288) and the University of Minnesota Cancer Center. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, MAMM GENOME, V11, P238, DOI 10.1007/s003350010044; Asari S, 2005, EXP HEMATOL, V33, P26, DOI 10.1016/j.exphem.2004.10.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Carter M, 2005, P NATL ACAD SCI USA, V102, P12843, DOI 10.1073/pnas.0501963102; Choi YJ, 2005, CRIT REV EUKAR GENE, V15, P207, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.30; Collins EC, 2002, MOL CELL BIOL, V22, P7313, DOI 10.1128/MCB.22.20.7313-7324.2002; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; HAUB O, 1991, DEVELOPMENT, V112, P397; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Hedera P, 2003, AM J MED GENET A, V123A, P261, DOI 10.1002/ajmg.a.20444; Hemberger M, 2002, CYTOGENET GENOME RES, V99, P210, DOI 10.1159/000071595; HILTON E, 2008, INBORN ERRO IN PRESS; Hilton EN, 2007, HUM MOL GENET, V16, P1773, DOI 10.1093/hmg/ddm125; Huynh KD, 2000, GENE DEV, V14, P1810; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Jardin F, 2007, PATHOL BIOL, V55, P73, DOI 10.1016/j.patbio.2006.04.001; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kennedy M, 2003, METHOD ENZYMOL, V365, P39; Kojima S, 2001, DEVELOPMENT, V128, P57; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; LEDBETTER JA, 1979, IMMUNOGENETICS, V8, P347, DOI 10.1007/BF01561445; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; McGovern E, 2006, INT J ORAL MAX SURG, V35, P1060, DOI 10.1016/j.ijom.2006.05.001; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Newkirk KM, 2007, TOXICOL PATHOL, V35, P817, DOI 10.1080/01926230701584197; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Ng D, 2002, AM J MED GENET, V110, P308, DOI 10.1002/ajmg.10484; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Osoegawa K, 2000, GENOME RES, V10, P116; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Park C, 2005, EXP HEMATOL, V33, P965, DOI 10.1016/j.exphem.2005.06.003; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; ROVERA G, 1978, ANAL BIOCHEM, V85, P506, DOI 10.1016/0003-2697(78)90248-8; Russell JE, 1998, BLOOD, V92, P3057, DOI 10.1182/blood.V92.9.3057.421k57_3057_3063; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Staudt L M, 1999, Int Rev Immunol, V18, P381, DOI 10.3109/08830189909088490; STOTT D, 1993, GENE DEV, V7, P197, DOI 10.1101/gad.7.2.197; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tovar V, 2000, IMMUNOGENETICS, V51, P788, DOI 10.1007/s002510000209; Wamstad JA, 2007, GENE EXPR PATTERNS, V7, P550, DOI 10.1016/j.modgep.2007.01.006; WHITNEY JB, 1979, P NATL ACAD SCI USA, V76, P867, DOI 10.1073/pnas.76.2.867; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wolf NS, 2000, EXP EYE RES, V70, P683, DOI 10.1006/exer.2000.0835; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhang WJ, 2003, METHOD ENZYMOL, V365, P186	66	58	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2814	10.1371/journal.pone.0002814	http://dx.doi.org/10.1371/journal.pone.0002814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18795143	gold, Green Submitted, Green Published			2022-12-25	WOS:000264304300033
J	Wilson, TR; McEwan, M; McLaughlin, K; Le Clorennec, C; Allen, WL; Fennell, DA; Johnston, PG; Longley, DB				Wilson, T. R.; McEwan, M.; McLaughlin, K.; Le Clorennec, C.; Allen, W. L.; Fennell, D. A.; Johnston, P. G.; Longley, D. B.			Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells	ONCOGENE			English	Article						FLIP; Bax; XIAP; colorectal cancer; caspase 3	X-LINKED INHIBITOR; RECEPTOR-INDUCED APOPTOSIS; C-FLIP; CASPASE-9 INHIBITOR; PROGNOSTIC MARKER; DEATH RECEPTORS; EXPRESSION; TRAIL; TUMOR; PROTEIN	Death receptors can directly(type I cells) or indirectly induce apoptosis by activating mitochondrial-regulated apoptosis (type II cells). The level of caspase 8 activation is thought to determine whether a cell is type I or II, with type II cells less efficient at activating this caspase following death receptor activation. FLICE-inhibitory protein (FLIP) blocks death receptor-mediated apoptosis by inhibiting caspase 8 activation; therefore, we assessed whether silencing FLIP could convert type II cells into type I. FLIP silencing-induced caspase 8 activation in Bax wild-type and null HCT116 colorectal cancer cells; however, complete caspase 3 processing and apoptosis were only observed in Bax wild-type cells. Bax-null cells were also more resistant to chemotherapy and tumor necrosis factor-related apoptosis inducing ligand and, unlike the Bax wild-type cells, were not sensitized to these agents by FLIP silencing. Further analyses indicated that release of second mitochondrial activator of caspases from mitochondria and subsequent inhibition of X-linked inhibitor of apoptosis protein ( XIAP) was required to induce full caspase 3 processing and apoptosis following FLIP silencing. These results indicate that silencing FLIP does not necessarily by pass the requirement for mitochondrial involvement in type II cells. Furthermore, targeting FLIP and XIAP may represent a therapeutic strategy for the treatment of colorectal tumors with defects in mitochondrial-regulated apoptosis.	[Wilson, T. R.; McEwan, M.; McLaughlin, K.; Le Clorennec, C.; Allen, W. L.; Fennell, D. A.; Johnston, P. G.; Longley, D. B.] Queens Univ Belfast, Drug Resistance Lab, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Longley, DB (corresponding author), Queens Univ Belfast, Drug Resistance Lab, Ctr Canc Res & Cell Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	d.longley@qub.ac.uk	McEwan, Miranda V/A-6900-2012; Wilson, Timothy R/F-8210-2012	McLaughlin, Kirsty/0000-0002-3584-4911	Cancer Research UK, the Medical Research Council; Ulster Cancer Foundation; Medical Research Council [G0400302] Funding Source: researchfish; MRC [G0400302] Funding Source: UKRI	Cancer Research UK, the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UK); Ulster Cancer Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by: Cancer Research UK, the Medical Research Council and the Ulster Cancer Foundation.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Arango D, 2004, BRIT J CANCER, V91, P1931, DOI 10.1038/sj.bjc.6602215; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Berger AB, 2006, CELL RES, V16, P961, DOI 10.1038/sj.cr.7310112; Bratton SB, 2003, CELL DEATH DIFFER, V10, P4, DOI 10.1038/sj.cdd.4401176; Broaddus VC, 2005, J BIOL CHEM, V280, P12486, DOI 10.1074/jbc.M408190200; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; Dean EJ, 2007, EXPERT OPIN THER TAR, V11, P1459, DOI 10.1517/14728222.11.11.1459; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ekert PG, 2001, CELL DEATH DIFFER, V8, P662, DOI 10.1038/sj.cdd.4400895; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Guo F, 2002, BLOOD, V99, P3419, DOI 10.1182/blood.V99.9.3419; Han J, 2004, LEUKEMIA, V18, P1671, DOI 10.1038/sj.leu.2403496; Hu YP, 2003, CLIN CANCER RES, V9, P2826; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Jansson A, 2002, J CLIN ONCOL, V20, P811, DOI 10.1200/JCO.20.3.811; Jonsson G, 2003, ANTICANCER RES, V23, P1213; Kang SY, 2007, CLIN CANCER RES, V13, P4146, DOI 10.1158/1078-0432.CCR-06-3063; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; LaCasse EC, 2006, CLIN CANCER RES, V12, P5231, DOI 10.1158/1078-0432.CCR-06-0608; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li M, 2007, CHINESE MED J-PEKING, V120, P469, DOI 10.1097/00029330-200703020-00007; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Mathas S, 2004, J EXP MED, V199, P1041, DOI 10.1084/jem.20031080; Mizutani Y, 2007, INT J ONCOL, V30, P919; Ozoren N, 2000, CANCER RES, V60, P6259; Ozoren N, 2002, NEOPLASIA, V4, P551, DOI 10.1038/sj.neo.7900270; Ryu BK, 2001, J PATHOL, V194, P15, DOI 10.1002/path.835; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schimmer AD, 2003, CANCER RES, V63, P1242; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Tamm I, 2004, HEMATOL J, V5, P489, DOI 10.1038/sj.thj.6200549; Theodorakis P, 2002, CANCER RES, V62, P3373; Valnet-Rabier MB, 2005, BRIT J HAEMATOL, V128, P767, DOI 10.1111/j.1365-2141.2005.05378.x; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; von Haefen C, 2004, ONCOGENE, V23, P8320, DOI 10.1038/sj.onc.1207971; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; Wang XD, 2001, GENE DEV, V15, P2922; Werner AB, 2002, J BIOL CHEM, V277, P40760, DOI 10.1074/jbc.M204351200; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhou XD, 2004, CLIN SCI, V106, P397, DOI 10.1042/CS20030238; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	54	37	37	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2009	28	1					63	72		10.1038/onc.2008.366	http://dx.doi.org/10.1038/onc.2008.366			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	392HP	18820704				2022-12-25	WOS:000262294100007
J	Jeon, BN; Yoo, JY; Choi, WI; Lee, CE; Yoon, HG; Hur, MW				Jeon, Bu-Nam; Yoo, Jung-Yoon; Choi, Won-Il; Lee, Choong-Eun; Yoon, Ho-Geun; Hur, Man-Wook			Proto-oncogene FBI-1 (Pokemon/ZBTB7A) Represses Transcription of the Tumor Suppressor Rb Gene via Binding Competition with Sp1 and Recruitment of Co-repressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; DNA-BINDING; POZ DOMAIN; RETINOBLASTOMA GENE; PROMOTER; EXPRESSION; SEQUENCE; ELEMENTS; MIZF	FBI-1 (also called Pokemon/ZBTB7A) is a BTB/POZ-domain Kruppel-like zinc-finger transcription factor. Recently, FBI-1 was characterized as a proto-oncogenic protein, which represses tumor suppressor ARF gene transcription. The expression of FBI-1 is increased in many cancer tissues. We found that FBI-1 potently represses transcription of the Rb gene, a tumor suppressor gene important in cell cycle arrest. FBI-1 binds to four GC-rich promoter elements (FREs) located at bp -308 to -188 of the Rb promoter region. The Rb promoter also contains two Sp1 binding sites: GC-box 1 (bp -65 to -56) and GC-box 2 ( bp -18 to -9), the latter of which is also bound by FBI-1. We found that FRE3 ( bp -244 to -236) is also a Sp1 binding element. FBI-1 represses transcription of the Rb gene not only by binding to the FREs, but also by competing with Sp1 at the GC-box 2 and the FRE3. By binding to the FREs and/or the GC-box, FBI-1 represses transcription of the Rb gene through its POZ-domain, which recruits a co-repressor-histone deacetylase complex and deacetylates histones H3 and H4 at the Rb gene promoter. FBI-1 inhibits C2C12 myoblast cell differentiation by repressing Rb gene expression.	[Jeon, Bu-Nam; Yoo, Jung-Yoon; Choi, Won-Il; Yoon, Ho-Geun; Hur, Man-Wook] Yonsei Univ, Sch Med, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, Seoul 120752, South Korea; [Lee, Choong-Eun] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Yonsei University; Sungkyunkwan University (SKKU)	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac		Yoon, Ho-Geun Yoon/0000-0003-2718-3372; Yoo, Jung-Yoon/0000-0001-9366-3863; Hur, Man-Wook/0000-0002-3416-1334; CHOI, WONIL/0000-0002-4837-0436	National Research Laboratory [ROA-2003000-10318-0]; Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology [R13-2002054-05002-0]	National Research Laboratory(Korea Science and Engineering Foundation); Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology(Korea Science and Engineering Foundation)	This work was supported by National Research Laboratory Grant ROA-2003000-10318-0 (to M.W.H.) and Medical Research Center Grant R13-2002054-05002-0 from Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Delehouzee S, 2005, GENES CELLS, V10, P717, DOI 10.1111/j.1365-2443.2005.00873.x; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GILL RM, 1994, CELL GROWTH DIFFER, V5, P467; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Kwon HS, 1999, J BIOL CHEM, V274, P20, DOI 10.1074/jbc.274.1.20; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Magenta A, 2003, MOL CELL BIOL, V23, P2893, DOI 10.1128/MCB.23.8.2893-2906.2003; Morrison DJ, 1999, NUCLEIC ACIDS RES, V27, P1251, DOI 10.1093/nar/27.5.1251; NEVINS JR, 1992, SCIENCE, V258, P424; Pendergrast PS, 2002, MOL BIOL CELL, V13, P915, DOI 10.1091/mbc.01-08-0383; Pessler F, 2003, J BIOL CHEM, V278, P29327, DOI 10.1074/jbc.M302980200; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; Scambia G, 2006, ONCOGENE, V25, P5302, DOI 10.1038/sj.onc.1209620; Sekimata M, 2004, BIOCHEM BIOPH RES CO, V325, P653, DOI 10.1016/j.bbrc.2004.10.090; Sekimata M, 2004, NUCLEIC ACIDS RES, V32, P590, DOI 10.1093/nar/gkh249; Sowa Y, 1997, CANCER RES, V57, P3145; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1	29	78	87	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33199	33210		10.1074/jbc.M802935200	http://dx.doi.org/10.1074/jbc.M802935200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18801742	Green Published, hybrid			2022-12-25	WOS:000261183700023
J	El Gazzar, M; Yoza, BK; Chen, X; Hu, J; Hawkins, GA; Mccall, CE				El Gazzar, Mohamed; Yoza, Barbara K.; Chen, Xiaoping; Hu, Jean; Hawkins, Gregory A.; Mccall, Charles E.			G9a and HP1 Couple Histone and DNA Methylation to TNF alpha Transcription Silencing during Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3 LYSINE-9 METHYLATION; NF-KAPPA-B; HETEROCHROMATIN PROTEIN-1; SUBSTRATE-SPECIFICITY; GENE-REGULATION; DE-NOVO; CHROMATIN; BINDING; METHYLTRANSFERASES; DNMT3A	TNF alpha gene expression is silenced in the endotoxin tolerant phenotype that develops in blood leukocytes after the initial activation phase of severe systemic inflammation or sepsis. The silencing phase can be mimicked in vitro by LPS stimulation. We reported that the TNF alpha transcription is disrupted in endotoxin tolerant THP-1 human promonocyte due to changes in transcription factor binding and enrichment with histone H3 dimethylated on lysine 9 (H3K9). Here we show that the TNF alpha promoter is hypermethylated during endotoxin tolerance and that H3K9 methylation and DNA methylation interact to silence TNF alpha expression. Chromatin immunoprecipitation and RNA interference analysis demonstrated that, in tolerant cells, TNF alpha promoter is bound by the H3K9 histone methyltransferase G9a which dimethylates H3K9 and creates a platform for HP1 binding, leading to the recruitment of the DNA methyltransferase Dnmt3a/b and an increase in promoter CpG methylation. Knockdown of HP1 resulted in a decreased Dnmt3a/b binding, sustained G9a binding, and a modest increase in TNF alpha transcription, but had no effect on H3K9 dimethylation. In contrast, G9a knockdown-disrupted promoter silencing and restored TNF alpha transcription in tolerant cells. This correlated with a near loss of H3K9 dimethylation, a significant decrease in HP1 and Dnmt3a/b binding and promoter CpG methylation. Our results demonstrate a central role for G9a in this process and suggest that histone methylation and DNA methylation cooperatively interact via HP1 to silence TNF alpha expression during endotoxin tolerance and may have implication for proinflammatory gene silencing associated with severe systemic inflammation.	[El Gazzar, Mohamed; Yoza, Barbara K.; Chen, Xiaoping; Hu, Jean; Mccall, Charles E.] Wake Forest Univ, Sch Med, Sect Mol Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Yoza, Barbara K.] Wake Forest Univ, Sch Med, Dept Gen Surg, Winston Salem, NC 27157 USA; [Hawkins, Gregory A.] Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	El Gazzar, M (corresponding author), Wake Forest Univ, Sch Med, Sect Mol Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	melgazza@wfubmc.edu			National Institutes of Health [R01AI-09169, R01AI-065791]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009169, R01AI065791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI-09169 and R01AI-065791. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Craig JM, 2005, BIOESSAYS, V27, P17, DOI 10.1002/bies.20145; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; Dormann HL, 2006, CELL CYCLE, V5, P2842, DOI 10.4161/cc.5.24.3540; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GOLDFELD AE, 1990, P NATL ACAD SCI USA, V87, P9769, DOI 10.1073/pnas.87.24.9769; Goriely S, 2003, BLOOD, V101, P4894, DOI 10.1182/blood-2002-09-2851; GRANOWITZ EV, 1993, J IMMUNOL, V151, P1637; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Heo K, 2007, J BIOL CHEM, V282, P15476, DOI 10.1074/jbc.M610270200; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; MATHISON JC, 1990, J CLIN INVEST, V85, P1108, DOI 10.1172/JCI114542; MCCALL CE, 1993, J CLIN INVEST, V91, P853, DOI 10.1172/JCI116306; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; MUNOZ C, 1991, EUR J IMMUNOL, V21, P2177, DOI 10.1002/eji.1830210928; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Paz MF, 2003, HUM MOL GENET, V12, P2209, DOI 10.1093/hmg/ddg226; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; RIGGS AD, 1983, ADV CANCER RES, V40, P1, DOI 10.1016/S0065-230X(08)60678-8; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Valinluck V, 2007, CANCER RES, V67, P5583, DOI 10.1158/0008-5472.CAN-07-0846; Vincent JL, 2006, AM J RESP CRIT CARE, V173, P256, DOI 10.1164/rccm.200510-1604OE; VIRCA GD, 1989, J BIOL CHEM, V264, P21951; Wade PA, 2001, ONCOGENE, V20, P3166, DOI 10.1038/sj.onc.1204340; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yoza BK, 2000, SHOCK, V13, P236, DOI 10.1097/00024382-200003000-00011	70	131	134	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32198	32208		10.1074/jbc.M803446200	http://dx.doi.org/10.1074/jbc.M803446200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809684	Green Published, hybrid			2022-12-25	WOS:000260893700006
J	Fitzgerald, ME; Drohat, AC				Fitzgerald, Megan E.; Drohat, Alexander C.			Coordinating the Initial Steps of Base Excision Repair APURINIC/APYRIMIDINIC ENDONUCLEASE 1 ACTIVELY STIMULATES THYMINE DNA GLYCOSYLASE BY DISRUPTING THE PRODUCT COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; AP-ENDONUCLEASE; CPG SITES; MISMATCH; BINDING; URACIL; MUTY; SPECIFICITY; TURNOVER	DNA glycosylases initiate base excision repair by removing damaged or mismatched bases, producing apurinic/apyrimidinic (AP) DNA. For many glycosylases, the AP-DNA remains tightly bound, impeding enzymatic turnover. A prominent example is thymine DNA glycosylase (TDG), which removes T from G.T mispairs and recognizes other lesions, with specificity for damage at CpG dinucleotides. TDG turnover is very slow; its activity appears to reach a plateau as the [product]/[enzyme] ratio approaches unity. The follow-on base excision repair enzyme, AP endonuclease 1 (APE1), stimulates the turnover of TDG and other glycosylases, involving a mechanism that remains largely unknown. We examined the catalytic activity of human TDG (hTDG), alone and with human APE1 (hAPE1), using pre-steady-state kinetics and a coupled-enzyme (hTDG-hAPE1) fluorescence assay. hTDG turnover is exceedingly slow for G.T (k(cat) = 0.00034 min(-1)) and G.U (k(cat) = 0.005 min(-1)) substrates, much slower than k(max) from single turnover experiments, confirming that AP-DNA release is rate-limiting. We find unexpectedly large differences in kcat for G.T, G.U, and G.FU substrates, indicating the excised base remains trapped in the product complex by AP-DNA. hAPE1 increases hTDG turnover by 42- and 26-fold for G.T and G.U substrates, the first quantitative measure of the effect of hAPE1. hAPE1 stimulates hTDG by disrupting the product complex rather than merely depleting (endonucleolytically) the AP-DNA. The enhancement is greater for hTDG catalytic core (residues 111-308 of 410), indicating the N- and C-terminal domains are dispensable for stimulatory interactions with hAPE1. Potential mechanisms for hAPE1 disruption of the of hTDG product complex are discussed.	[Fitzgerald, Megan E.; Drohat, Alexander C.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Drohat, AC (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, 108 N Greene St, Baltimore, MD 21201 USA.	adroh001@umaryland.edu		Drohat, Alex/0000-0002-7458-8770	National Institutes of Health [R01-GM72711]; University of Maryland Marlene and Stewart Greenebaum Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072711, T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Marlene and Stewart Greenebaum Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM72711 ( to A. C. D.). This work was also supported by the University of Maryland Marlene and Stewart Greenebaum Cancer Center.	Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Bellacosa A, 1999, P NATL ACAD SCI USA, V96, P3969, DOI 10.1073/pnas.96.7.3969; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Drohat AC, 2000, J AM CHEM SOC, V122, P1840, DOI 10.1021/ja993254x; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; JOHNSON MD, 1992, PHYSICIAN SPORTSMED, V20, P61; Jost JP, 1999, NUCLEIC ACIDS RES, V27, P3245, DOI 10.1093/nar/27.16.3245; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Leatherbarrow R.J., 1998, GRAFIT 5; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Loeb LA, 1996, MUTAT RES-FUND MOL M, V350, P279, DOI 10.1016/0027-5107(95)00117-4; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maksimenko A, 2004, BIOCHEM BIOPH RES CO, V319, P240, DOI 10.1016/j.bbrc.2004.04.179; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; McCann JAB, 2003, J BIOL CHEM, V278, P29587, DOI 10.1074/jbc.M212474200; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Nguyen LH, 2000, J MOL BIOL, V298, P447, DOI 10.1006/jmbi.2000.3653; Noll DM, 1999, BIOCHEMISTRY-US, V38, P6374, DOI 10.1021/bi990335x; O'Neill RJ, 2003, J BIOL CHEM, V278, P20526, DOI 10.1074/jbc.M210860200; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Pfeifer GP, 2000, MUTAT RES-FUND MOL M, V450, P155, DOI 10.1016/S0027-5107(00)00022-1; Pope MA, 2002, J BIOL CHEM, V277, P22605, DOI 10.1074/jbc.M203037200; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Privezentzev CV, 2001, MUTAT RES-FUND MOL M, V480, P277, DOI 10.1016/S0027-5107(01)00186-5; Scharer OD, 1997, P NATL ACAD SCI USA, V94, P4878, DOI 10.1073/pnas.94.10.4878; Scharer OD, 1998, J BIOL CHEM, V273, P8592, DOI 10.1074/jbc.273.15.8592; Sidorenko VS, 2007, DNA REPAIR, V6, P317, DOI 10.1016/j.dnarep.2006.10.022; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Sung JS, 2000, BIOCHEMISTRY-US, V39, P10224, DOI 10.1021/bi0007066; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Waters TR, 2000, MUTAT RES-REV MUTAT, V462, P137, DOI 10.1016/S1383-5742(00)00031-4; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Yang HJ, 2001, NUCLEIC ACIDS RES, V29, P743, DOI 10.1093/nar/29.3.743	57	77	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32680	32690		10.1074/jbc.M805504200	http://dx.doi.org/10.1074/jbc.M805504200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805789	Green Published, hybrid			2022-12-25	WOS:000260893700058
J	Garcia-Perez, C; Hajnoczky, G; Csordas, G				Garcia-Perez, Cecilia; Hajnoczky, Gyoergy; Csordas, Gyoergy			Physical Coupling Supports the Local Ca2+ Transfer between Sarcoplasmic Reticulum Subdomains and the Mitochondria in Heart Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM SIGNAL TRANSMISSION; SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTORS; RAT-HEART; CARDIAC MYOCYTES; RELEASE; DETERMINANTS; MICRODOMAINS; CONTRACTION	In many cell types, transfer of Ca2+ released via ryanodine receptors (RyR) to the mitochondrial matrix is locally supported by high [Ca2+] microdomains at close contacts between the sarcoplasmic reticulum (SR) and mitochondria. Here we studied whether the close contacts were secured via direct physical coupling in cardiac muscle using isolated rat heart mitochondria (RHMs). "Immuno-organelle chemistry" revealed RyR2 and calsequestrin-positive SR particles associated with mitochondria in both crude and Percoll-purified "heavy" mitochondrial fractions (cRHM and pRHM), to a smaller extent in the latter one. Mitochondria-associated vesicles were also visualized by electron microscopy in the RHMs. Western blot analysis detected greatly reduced presence of SR markers (calsequestrin, SERCA2a, and phospholamban) in pRHM, suggesting that the mitochondria-associated particles represented a small subfraction of the SR. Fluorescence calcium imaging in rhod2-loaded cRHM revealed mitochondrial matrix [Ca2+] ([Ca2+](m)) responses to caffeine-induced Ca2+ release that were prevented when thapsigargin was added to predeplete the SR or by mitochondrial Ca2+ uptake inhibitors. Importantly, caffeine failed to increase [Ca2+] in the large volume of the incubation medium, suggesting that local Ca2+ transfer between the SR particles and mitochondria mediated the [Ca2+](m) signal. Despite the substantially reduced SR presence, pRHM still displayed a caffeine-induced [Ca2+] m rise comparable with the one recorded in cRHM. Thus, a relatively small fraction of the total SR is physically coupled and transfers Ca2+ locally to the mitochondria in cardiac muscle. The transferred Ca2+ stimulates dehydrogenase activity and affects mitochondrial membrane permeabilization, indicating the broad significance of the physical coupling in mitochondrial function.	[Garcia-Perez, Cecilia; Hajnoczky, Gyoergy; Csordas, Gyoergy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Csordas, G (corresponding author), 1020 Locust St,Suites 260-261 JAH, Philadelphia, PA 19107 USA.	Gyorgy.Csordas@jefferson.edu	babakinejad, babak/G-2674-2012	Csordas, Gyorgy/0000-0003-3156-1460	American Heart Association [SDG 0435236N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051526] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an American Heart Association Grant SDG 0435236N.	Altschafl BA, 2007, BBA-BIOMEMBRANES, V1768, P1784, DOI 10.1016/j.bbamem.2007.04.011; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; BONCOMPAGNI S, 2008, BIOPHYS J, V94, pA306; Boncompagni S, 2007, BIOPHYS J, p313A; Brandes R, 1996, BIOPHYS J, V71, P1024, DOI 10.1016/S0006-3495(96)79303-7; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Csordas G, 2003, J BIOL CHEM, V278, P42273, DOI 10.1074/jbc.M305248200; Csordas G, 2001, TRENDS CARDIOVAS MED, V11, P269, DOI 10.1016/S1050-1738(01)00123-2; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; DENTON RM, 1980, BIOCHEM J, V190, P107, DOI 10.1042/bj1900107; DILISA F, 1993, CARDIOVASC RES, V27, P1840; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Feher JJ, 1998, J MOL CELL CARDIOL, V30, P1763, DOI 10.1006/jmcc.1998.0740; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; GANGULY PK, 1983, AM J PHYSIOL, V244, pE528, DOI 10.1152/ajpendo.1983.244.6.E528; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Isaeva EV, 2003, J PHYSIOL-LONDON, V547, P453, DOI 10.1113/jphysiol.2002.036129; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; KRONER H, 1986, ARCH BIOCHEM BIOPHYS, V251, P525, DOI 10.1016/0003-9861(86)90360-7; Maack C, 2007, BASIC RES CARDIOL, V102, P369, DOI 10.1007/s00395-007-0666-z; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; PRALONG WF, 1992, P NATL ACAD SCI USA, V89, P132, DOI 10.1073/pnas.89.1.132; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Saks VA, 2001, BIOCHEM J, V356, P643, DOI 10.1042/0264-6021:3560643; Shannon TR, 2005, CELL CALCIUM, V38, P497, DOI 10.1016/j.ceca.2005.07.002; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; SPAT A, 2008, CELL CALCIUM; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Xia RH, 2003, AM J PHYSIOL-CELL PH, V285, pC215, DOI 10.1152/ajpcell.00034.2002	44	110	112	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32771	32780		10.1074/jbc.M803385200	http://dx.doi.org/10.1074/jbc.M803385200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790739	hybrid, Green Published			2022-12-25	WOS:000260893700066
J	Jung, H; Seong, HA; Ha, H				Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung			Direct Interaction between NM23-H1 and Macrophage Migration Inhibitory Factor (MIF) Is Critical for Alleviation of MIF-mediated Suppression of p53 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; RECEPTOR-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; CANCER-CELLS; PHOSPHOTRANSFERASE ACTIVITY; PHYSICAL INTERACTION; SIGNAL-TRANSDUCTION; GROWTH; PROLIFERATION; CYTOKINE	Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that is involved in host immune and inflammatory responses, as well as tumorigenesis. However, the regulatory mechanism of MIF function is unclear. Here we report that the NM23-H1 interacts with MIF in cells, as demonstrated by cotransfection and coimmunoprecipitation experiments. Analysis of cysteine (Cys) to serine (Ser) substitution mutants of NM23-H1 (C4S, C109S, and C145S) and MIF (C57S, C60S, and C81S) revealed that Cys(145) of NM23-H1 and Cys(60) of MIF are responsible for complex formation. NM23-H1-MIF complexes were dependent on reducing conditions, such as the presence of dithiothreitol or beta-mercaptoethanol, but not H2O2. NM23-H1 alleviated the MIF-mediated suppression of p53-induced apoptosis and cell cycle arrest by promoting the dissociation of MIF from MIF-p53 complexes. In addition, NM23-H1 significantly inhibited the MIF-induced proliferation of quiescent NIH 3T3 cells through a direct interaction with MIF, and decreased the MIF-induced activation of phosphatidylinositol 3-kinase/PDK1 and p44/p42 extracellular signal-regulated (ERK) mitogen-activated protein kinase. The results of the current study suggest that the NM23-H1 functions as a negative regulator of MIF.	[Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung] Chungbuk Natl Univ, Dept Biochem, Biotechnol Res Inst, Sch Life Sci, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Dept Biochem, Biotechnol Res Inst, Sch Life Sci, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr			Korea Science and Engineering Foundation (KOSEF) [R0A-2007-000-20006-0]; Korea government (Ministry of Science and Technology); National R&D Program for Cancer Control, Ministry of Health Welfare [0620090]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (Ministry of Science and Technology)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); National R&D Program for Cancer Control, Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation (KOSEF) Grant R0A-2007-000-20006-0 funded by the Korea government ( Ministry of Science and Technology) and in part by funds from the National R&D Program for Cancer Control, Ministry of Health & Welfare ( 0620090).	Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bucala R, 1996, FASEB J, V10, P1607, DOI 10.1096/fasebj.10.14.9002552; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; del Vecchio MT, 2000, PROSTATE, V45, P51, DOI 10.1002/1097-0045(20000915)45:1<51::AID-PROS6>3.0.CO;2-9; DELAROSA A, 1995, BIOESSAYS, V17, P53, DOI 10.1002/bies.950170111; ENGEL M, 1995, EUR J BIOCHEM, V234, P200, DOI 10.1111/j.1432-1033.1995.200_c.x; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Inoue H, 1996, BIOCHEM BIOPH RES CO, V218, P887, DOI 10.1006/bbrc.1996.0158; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kimura N, 2000, J BIOENERG BIOMEMBR, V32, P309, DOI 10.1023/A:1005549315846; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Li YX, 2004, EXP CELL RES, V300, P379, DOI 10.1016/j.yexcr.2004.07.019; Lombardi D, 2000, J CELL PHYSIOL, V182, P144, DOI 10.1002/(SICI)1097-4652(200002)182:2<144::AID-JCP2>3.3.CO;2-Y; Lu Q, 1996, J BIOL CHEM, V271, P32886, DOI 10.1074/jbc.271.51.32886; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Meyer-Siegler K, 2000, J INTERF CYTOK RES, V20, P769, DOI 10.1089/10799900050151030; Mitchell RA, 2000, SEMIN CANCER BIOL, V10, P359, DOI 10.1006/scbi.2000.0328; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Ogawa H, 2000, CYTOKINE, V12, P309, DOI 10.1006/cyto.1999.0562; Otero AD, 2000, J BIOENERG BIOMEMBR, V32, P269, DOI 10.1023/A:1005589029959; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Rochdi MD, 2004, J BIOL CHEM, V279, P18981, DOI 10.1074/jbc.M312621200; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Shen L, 2003, FEBS LETT, V540, P86, DOI 10.1016/S0014-5793(03)00229-1; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Wagner PD, 2000, BIOCHEM J, V346, P623, DOI 10.1042/0264-6021:3460623; Wagner PD, 2000, J BIOL CHEM, V275, P35570, DOI 10.1074/jbc.M006106200; WALLET V, 1990, J NATL CANCER I, V82, P1199, DOI 10.1093/jnci/82.14.1199	38	46	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32669	32679		10.1074/jbc.M806225200	http://dx.doi.org/10.1074/jbc.M806225200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815136	hybrid			2022-12-25	WOS:000260893700057
J	Kothapalli, D; Flowers, J; Xu, T; Pure, E; Assoian, RK				Kothapalli, Devashish; Flowers, James; Xu, Tina; Pure, Ellen; Assoian, Richard K.			Differential Activation of ERK and Rac Mediates the Proliferative and Anti-proliferative Effects of Hyaluronan and CD44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CYCLIN D1 EXPRESSION; GENE-EXPRESSION; RECEPTOR ACTIVATION; KINASE ACTIVATION; TUMOR-SUPPRESSOR; TISSUE-INJURY; G1 PHASE; GROWTH; ADHESION	Hyaluronan, a widely distributed component of the extracellular matrix, exists in a high molecular weight (native) form and lower molecular weight form (HMW- and LMW-HA, respectively). These different forms of hyaluronan bind to CD44 but elicit distinct effects on cellular function. A striking example is the opposing effects of HMW- and LMW-HA on the proliferation of vascular smooth muscle cells; the binding of HMW-HA to CD44 inhibits cell cycle progression, whereas the binding of LMW-HA to CD44 stimulates cell cycle progression. We now report that cyclin D1 is the primary target of LMW-HA in human vascular smooth muscle cells, as it is for HMW- HA, and that the opposing cell cycle effects of these CD44 ligands result from differential regulation of signaling pathways to cyclin D1. HMW-HA binding to CD44 selectively inhibits the GTP loading of Rac and Rac-dependent signaling to the cyclin D1 gene, whereas LMW-HA binding to CD44 selectively stimulates ERK activation and ERK-dependent cyclin D1 gene expression. These data describe a novel mechanism of growth control in which a ligand-receptor system generates opposing effects on mitogenesis by differentially regulating signaling pathways to a common cell cycle target. They also emphasize how a seemingly subtle change in matrix composition can have a profound effect on cell proliferation.	[Kothapalli, Devashish; Flowers, James; Xu, Tina; Assoian, Richard K.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Pure, Ellen] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Pure, Ellen] Ludwig Inst Canc Res, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute; Ludwig Institute for Cancer Research	Assoian, RK (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	assoian@upenn.edu			National Institutes of Health [HL62250]; Commonwealth University Research Enhancement Program; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth University Research Enhancement Program; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL62250. This work was also supported by the Commonwealth University Research Enhancement Program, Pennsylvania Department of Health.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; Datto MB, 1997, MOL CELL BIOL, V17, P2030, DOI 10.1128/MCB.17.4.2030; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Hawkins CL, 1998, FREE RADICAL BIO MED, V24, P1396, DOI 10.1016/S0891-5849(98)00009-4; Heo SK, 2008, IMMUNOL LETT, V120, P57, DOI 10.1016/j.imlet.2008.07.002; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2; Klein EA, 2007, CELL CYCLE, V6, P1115, DOI 10.4161/cc.6.9.4147; Knudsen KE, 1999, J BIOL CHEM, V274, P27632, DOI 10.1074/jbc.274.39.27632; Kothapalli D, 2003, MOL PHARMACOL, V64, P249, DOI 10.1124/mol.64.2.249; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Otsui K, 2007, HEART VESSELS, V22, P416, DOI 10.1007/s00380-007-1001-1; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stewart SA, 2004, J BIOL CHEM, V279, P29109, DOI 10.1074/jbc.M404271200; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu Q, 2000, GENE DEV, V14, P163; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034	48	66	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31823	31829		10.1074/jbc.M802934200	http://dx.doi.org/10.1074/jbc.M802934200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18806267	Green Published, hybrid			2022-12-25	WOS:000260760800065
J	Lehtinen, DA; Harvey, S; Mulcahy, MJ; Hollis, T; Perrino, FW				Lehtinen, Duane A.; Harvey, Scott; Mulcahy, Matthew J.; Hollis, Thomas; Perrino, Fred W.			The TREX1 Double-stranded DNA Degradation Activity Is Defective in Dominant Mutations Associated with Autoimmune Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; FAMILIAL CHILBLAIN LUPUS; MEDIATED CELL-DEATH; EXONUCLEASE TREX1; 3' TERMINI; ERYTHEMATOSUS; COMPLEX; BINDING; PROTEIN	Mutations in TREX1 have been linked to a spectrum of human autoimmune diseases including Aicardi-Goutieres syndrome (AGS), familial chilblain lupus (FCL), systemic lupus erythematosus, and retinal vasculopathy and cerebral leukodystrophy. A common feature in these conditions is the frequent detection of antibodies to double-stranded DNA (dsDNA). TREX1 participates in a cell death process implicating this major 3' -> 5' exonuclease in genomic DNA degradation to minimize potential immune activation by persistent self DNA. The TREX1 D200N and D18N dominant heterozygous mutations were identified in AGS and FCL, respectively. TREX1 enzymes containing the D200N and D18N mutations were compared using nicked dsDNA and single-stranded DNA (ssDNA) degradation assays. The TREX1(WT/D200N) and TREX1(WT/D18N) heterodimers are completely deficient at degrading dsDNA and degrade ssDNA at an expected similar to 2-fold lower rate than TREX1WT enzyme. Further, the D200N- and D18N-containing TREX1 homo-and heterodimers inhibit the dsDNA degradation activity of TREX1(WT) enzyme, providing a likely explanation for the dominant phenotype of these TREX1 mutant alleles in AGS and FCL. By comparison, the TREX1 R114H homozygous mutation causes AGS and is found as a heterozygous mutation in systemic lupus erythematosus. The TREX1(R114H/R114H) homodimer has dysfunctional dsDNA and ssDNA degradation activities and does not detectibly inhibit the TREX1(WT) enzyme, whereas the TREX1(WT/R114H) heterodimer has a functional dsDNA degradation activity, supporting the recessive genetics of TREX1 R114H in AGS. The dysfunctional dsDNA degradation activities of these disease-related TREX1 mutants could account for persistent dsDNA from dying cells leading to an aberrant immune response in these clinically related disorders.	[Lehtinen, Duane A.; Harvey, Scott; Mulcahy, Matthew J.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University School of Medicine	Perrino, FW (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu		Mulcahy, Matthew/0000-0001-5588-8762	National Institutes of Health [GM069962]; Alliance for Lupus Research [67692]; American Cancer Society [RSG-04-187-01-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F. W. P.). This work was also supported by Alliance for Lupus Research Grant 67692 (to F. W. P.) and American Cancer Society Grant RSG-04-187-01-GMC (to T. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Kolivras A, 2008, J CUTAN PATHOL, V35, P774, DOI 10.1111/j.1600-0560.2007.00900.x; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Perrino FW, 2008, J BIOL CHEM, V283, P21441, DOI 10.1074/jbc.M803629200; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	24	91	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31649	31656		10.1074/jbc.M806155200	http://dx.doi.org/10.1074/jbc.M806155200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18805785	Green Published, hybrid			2022-12-25	WOS:000260760800046
J	Zuo, XS; Morris, JS; Shureiqi, I				Zuo, Xiangsheng; Morris, Jeffrey S.; Shureiqi, Imad			Chromatin Modification Requirements for 15-Lipoxygenase-1 Transcriptional Reactivation in Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLORECTAL-CARCINOMA; INDUCED APOPTOSIS; HISTONE ACETYLTRANSFERASE; ORGANELLE DEGRADATION; INDUCE APOPTOSIS; DOWN-REGULATION; UP-REGULATION; IN-VIVO; EXPRESSION; METHYLATION	15-Lipoxygenase-1 (15-LOX-1) contributes significantly to inflammation regulation and terminal cell differentiation. 15-LOX-1 is transcriptionally silenced in cancer cells, and its transcriptional reactivation (e. g. via histone deacetylase inhibitors (HDACIs)) is essential for restoring terminal cell differentiation to cancer cells. STAT-6 acetylation via the histone acetyltransferase KAT3B has been proposed to be necessary for 15-LOX-1 transcriptional activation. However, the exact mechanism underlying 15-LOX-1 transcriptional reactivation in cancer cells is still undefined, especially in regard to the contribution of 15-LOX-1 promoter histone modifications. We therefore examined the relative mechanistic contributions of 15-LOX-1 promoter histone modifications and STAT-6 to 15-LOX-1 transcriptional reactivation by HDACIs in colon cancer cells. We found that: 1) histone H3 and H4 acetylation in the 15-LOX-1 promoter through KAT3B was critical to 15-LOX-1 transcriptional activation; 2) 15-LOX-1 transcription was activated independently from STAT-6; and 3) dimethyl-histone H3 lysine 9 (H3K9me2) demethylation in the 15-LOX-1 promoter via the histone lysine demethylase KDM3A was an early and specific histone modification and was necessary for activation of transcription. These findings demonstrate that histone modification in the 15-LOX-1 promoter is important to 15-LOX-1 transcriptional silencing in colon cancer cells and that HDACIs can activate gene transcription via KDM3A demethylation of H3K9me2.	[Shureiqi, Imad] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Unit 1360, Houston, TX 77030 USA; [Morris, Jeffrey S.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA; [Shureiqi, Imad] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shureiqi, I (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Unit 1360, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ishureiqi@mdanderson.org	Shureiqi, imad/T-6214-2019	Shureiqi, Imad/0000-0003-2019-938X; Zuo, Xiangsheng/0000-0002-8593-1132	National Institutes of Health [CA106577, CA104278]; Caroline Wiess Law Endowment for Cancer Prevention; National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE [R01CA104278, R01CA106577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caroline Wiess Law Endowment for Cancer Prevention; National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106577 and CA104278. This work was also supported by the Caroline Wiess Law Endowment for Cancer Prevention and the National Colorectal Cancer Research Alliance. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; BAER AN, 1991, BIOCHEM BIOPH RES CO, V180, P98, DOI 10.1016/S0006-291X(05)81260-4; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Conrad DJ, 2000, AM J RESP CELL MOL, V22, P226, DOI 10.1165/ajrcmb.22.2.3786; Deguchi A, 2005, CANCER RES, V65, P8442, DOI 10.1158/0008-5472.CAN-05-1109; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Furumai R, 2002, CANCER RES, V62, P4916; Grullich C, 2001, FEBS LETT, V489, P51, DOI 10.1016/S0014-5793(01)02080-4; Hennig R, 2007, NEOPLASIA, V9, P917, DOI 10.1593/neo.07565; Heslin MJ, 2005, ANN SURG, V241, P941, DOI 10.1097/01.sla.0000164177.95620.c1; Heydeck D, 1998, BLOOD, V92, P2503, DOI 10.1182/blood.V92.7.2503.2503_2503_2510; Hill EM, 1998, AM J RESP CELL MOL, V18, P662, DOI 10.1165/ajrcmb.18.5.2985; Hsi LC, 2005, MOL CANCER THER, V4, P1740, DOI 10.1158/1535-7163.MCT-05-0218; Hsi LC, 2004, CANCER RES, V64, P8778, DOI 10.1158/0008-5472.CAN-04-1867; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P235, DOI 10.1016/j.plefa.2006.01.009; Kamitani H, 2001, CARCINOGENESIS, V22, P187, DOI 10.1093/carcin/22.1.187; Kamitani H, 2000, FEBS LETT, V467, P341, DOI 10.1016/S0014-5793(00)01155-8; Kim KS, 2005, PROSTAG LEUKOTR ESS, V73, P77, DOI 10.1016/j.plefa.2005.05.023; KROSCHWALD P, 1989, BIOCHEM BIOPH RES CO, V160, P954, DOI 10.1016/0006-291X(89)92528-X; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Liu C, 2004, EXP CELL RES, V297, P61, DOI 10.1016/j.yexcr.2004.02.014; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Munger KA, 1999, P NATL ACAD SCI USA, V96, P13375, DOI 10.1073/pnas.96.23.13375; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Nixon JB, 2004, PROSTAG LEUKOTR ESS, V70, P7, DOI 10.1016/j.plefa.2003.06.001; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shureiqi I, 2000, J NATL CANCER I, V92, P1136, DOI 10.1093/jnci/92.14.1136; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Shureiqi I, 2005, CANCER RES, V65, P11486, DOI 10.1158/0008-5472.CAN-05-2180; Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100; Shureiqi I, 2002, CANCER RES, V62, P1178; Shureiqi I, 2001, CANCER RES, V61, P4879; Shureiqi I, 2007, FASEB J, V21, P743, DOI 10.1096/fj.06-6830com; Spanbroek R, 2001, P NATL ACAD SCI USA, V98, P5152, DOI 10.1073/pnas.091076998; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; Wu J, 2003, CARCINOGENESIS, V24, P243, DOI 10.1093/carcin/24.2.243; Wu Y, 2008, MOL THER, V16, P886, DOI 10.1038/mt.2008.44; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160; Zuo XS, 2008, FASEB J, V22, P1981, DOI 10.1096/fj.07-098301	51	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31341	31347		10.1074/jbc.M803729200	http://dx.doi.org/10.1074/jbc.M803729200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799463	Green Published, hybrid			2022-12-25	WOS:000260760800011
J	Chacinska, A; Guiard, B; Muller, JM; Schulze-Specking, A; Gabriel, K; Kutik, S; Pfanner, N				Chacinska, Agnieszka; Guiard, Bernard; Mueller, Judith M.; Schulze-Specking, Agnes; Gabriel, Kipros; Kutik, Stephan; Pfanner, Nikolaus			Mitochondrial Biogenesis, Switching the Sorting Pathway of the Intermembrane Space Receptor Mia40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; PROTEIN IMPORT; PRESEQUENCE TRANSLOCASE; TARGETING SEQUENCES; ERV1	Mitochondrial precursor proteins are directed into the intermembrane space via two different routes, the presequence pathway and the redox-dependent MIA pathway. The pathways were assumed to be independent and transport different proteins. We report that the intermembrane space receptor Mia40 can switch between both pathways. In fungi, Mia40 is synthesized as large protein with an N-terminal presequence, whereas in metazoans and plants, Mia40 consists only of the conserved C-terminal domain. Human MIA40 and the C-terminal domain of yeast Mia40 (termed Mia40(core)) rescued the viability of Mia40-deficient yeast independently of the presence of a presequence. Purified Mia40(core) was imported into mitochondria via the MIA pathway. With cells expressing both full-length Mia40 and Mia40(core), we demonstrate that yeast Mia40 contains dual targeting information, directing the large precursor onto the presequence pathway and the smaller Mia40(core) onto the MIA pathway, raising interesting implications for the evolution of mitochondrial protein sorting.	[Chacinska, Agnieszka; Mueller, Judith M.; Schulze-Specking, Agnes; Gabriel, Kipros; Kutik, Stephan; Pfanner, Nikolaus] Univ Freiburg, Inst Biochem & Molekularbiol, ZBMZ, D-79104 Freiburg, Germany; [Chacinska, Agnieszka; Kutik, Stephan; Pfanner, Nikolaus] Univ Freiburg, Ctr Biol Signalling Studies Bioss, D-79104 Freiburg, Germany; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Molekularbiol, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Nikolaus.Pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021	Chacinska, Agnieszka/0000-0002-2832-2568	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 746); Excellence Initiative of the German Federal and State Governments [EXC 294]; Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 746)(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 746), the Excellence Initiative of the German Federal and State Governments (EXC 294), the Gottfried Wilhelm Leibniz Program, and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oka T, 2005, MOL CELL, V18, P145, DOI 10.1016/j.molcel.2005.03.022; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stojanovski D, 2008, BBA-MOL CELL RES, V1783, P610, DOI 10.1016/j.bbamcr.2007.10.004; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635	30	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29723	29729		10.1074/jbc.M805356200	http://dx.doi.org/10.1074/jbc.M805356200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18779329	Green Published, hybrid			2022-12-25	WOS:000260366900016
J	Chain, FJJ; Ilieva, D; Evans, BJ				Chain, Frederic J. J.; Ilieva, Dora; Evans, Ben J.			Single-Species Microarrays and Comparative Transcriptomics	PLOS ONE			English	Article							DENSITY OLIGONUCLEOTIDE ARRAYS; GENE-EXPRESSION ANALYSIS; SEQUENCE DIVERGENCE; DNA MICROARRAYS; XENOPUS-LAEVIS; CLAWED FROGS; EVOLUTION; NORMALIZATION; MODEL; STERILITY	Background: Prefabricated expression microarrays are currently available for only a few species but methods have been proposed to extend their application to comparisons between divergent genomes. Methodology/Principal Findings: Here we demonstrate that the hybridization intensity of genomic DNA is a poor basis on which to select unbiased probes on Affymetrix expression arrays for studies of comparative transcriptomics, and that doing so produces spurious results. We used the Affymetrix Xenopus laevis microarray to evaluate expression divergence between X. laevis, X. borealis, and their F1 hybrids. When data are analyzed with probes that interrogate only sequences with confirmed identity in both species, we recover results that differ substantially analyses that use genomic DNA hybridizations to select probes. Conclusions/Significance: Our findings have implications for the experimental design of comparative expression studies that use single-species microarrays, and for our understanding of divergent expression in hybrid clawed frogs. These findings also highlight important limitations of single-species microarrays for studies of comparative transcriptomics of polyploid species.	[Chain, Frederic J. J.; Evans, Ben J.] McMaster Univ, Dept Biol, Ctr Environm Genom, Hamilton, ON, Canada; [Ilieva, Dora] McMaster Univ, Michael DeGroote Sch Med, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Chain, FJJ (corresponding author), McMaster Univ, Dept Biol, Ctr Environm Genom, Hamilton, ON, Canada.	evansb@mcmaster.ca		Chain, Frederic/0000-0001-6169-7399; Evans, Ben/0000-0002-9512-8845	Canadian Foundation for Innovation; National Science and Engineering Research Council; McMaster University	Canadian Foundation for Innovation(Canada Foundation for Innovation); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University	This research was supported by the Canadian Foundation for Innovation, the National Science and Engineering Research Council, and McMaster University.	*AFF, 2001, AFF GENECHIP EXPR AN; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bar-Or C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-110; Becher M, 2004, PLANT J, V37, P251, DOI 10.1046/j.1365-313X.2003.01959.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOLSTAD B, 2007, RMA EXPRESS; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buckley BA, 2007, J EXP BIOL, V210, P1602, DOI 10.1242/jeb.002402; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Cambon AC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-146; Chain FJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-43; Chain FJJ, 2006, PLOS GENET, V2, P478, DOI 10.1371/journal.pgen.0020056; Chismar JD, 2002, BIOTECHNIQUES, V33, P516, DOI 10.2144/02333st01_11836a; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Evans BJ, 2007, GENETICS, V176, P1119, DOI 10.1534/genetics.106.069690; Evans BJ, 2005, MOL BIOL EVOL, V22, P1193, DOI 10.1093/molbev/msi104; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Grigoryev DN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-62; Hammond JP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-10; Hammond JP, 2006, NEW PHYTOL, V170, P239, DOI 10.1111/j.1469-8137.2006.01662.x; Hellsten U, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-31; Hsieh WP, 2003, GENETICS, V165, P747; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Ji W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh084; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Kirst M, 2006, PLANT BIOTECHNOL J, V4, P489, DOI 10.1111/j.1467-7652.2006.00198.x; Malone JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000781; Malone JH, 2008, SCIENCE, V319, P59, DOI 10.1126/science.1148231; Malone JH, 2006, J MOL EVOL, V63, P427, DOI 10.1007/s00239-005-0263-4; Malone JH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-82; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Oshlack A, 2007, BIOINFORMATICS, V23, P1235, DOI 10.1093/bioinformatics/btm111; Poole R, 2007, FUNCT INTEGR GENOMIC, V7, P207, DOI 10.1007/s10142-007-0046-7; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sartor MA, 2006, NUCLEIC ACIDS RES, V34, P185, DOI 10.1093/nar/gkj413; Semon M, 2008, P NATL ACAD SCI USA, V105, P8333, DOI 10.1073/pnas.0708705105; Sinner D, 2006, DEVELOPMENT, V133, P1955, DOI 10.1242/dev.02358; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; TINSLEY RC, 1996, BIOL XENOPUS, P81; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Weber M, 2004, PLANT J, V37, P269, DOI 10.1046/j.1365-313X.2003.01960.x; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zakharkin SO, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-214	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3279	10.1371/journal.pone.0003279	http://dx.doi.org/10.1371/journal.pone.0003279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815615	gold, Green Published, Green Submitted			2022-12-25	WOS:000264431900005
J	Frazier, CRM; Mason, P; Zhuang, XX; Beeler, JA				Frazier, Cristianne R. M.; Mason, Peggy; Zhuang, Xiaoxi; Beeler, Jeff A.			Sucrose Exposure in Early Life Alters Adult Motivation and Weight Gain	PLOS ONE			English	Article							LOW-PROTEIN DIET; THRIFTY PHENOTYPE HYPOTHESIS; ENERGY-BALANCE; FOOD STORES; HIGH-FAT; NEIGHBORHOOD CHARACTERISTICS; DIABETES-MELLITUS; CHILDHOOD OBESITY; PRENATAL EXPOSURE; LEPTIN SYNTHESIS	The cause of the current increase in obesity in westernized nations is poorly understood but is frequently attributed to a 'thrifty genotype,' an evolutionary predisposition to store calories in times of plenty to protect against future scarcity. In modern, industrialized environments that provide a ready, uninterrupted supply of energy-rich foods at low cost, this genetic predisposition is hypothesized to lead to obesity. Children are also exposed to this 'obesogenic' environment; however, whether such early dietary experience has developmental effects and contributes to adult vulnerability to obesity is unknown. Using mice, we tested the hypothesis that dietary experience during childhood and adolescence affects adult obesity risk. We gave mice unlimited or no access to sucrose for a short period post-weaning and measured sucrose-seeking, food consumption, and weight gain in adulthood. Unlimited access to sucrose early in life reduced sucrose-seeking when work was required to obtain it. When high-sugar/high-fat dietary options were made freely-available, however, the sucrose-exposed mice gained more weight than mice without early sucrose exposure. These results suggest that early, unlimited exposure to sucrose reduces motivation to acquire sucrose but promotes weight gain in adulthood when the cost of acquiring palatable, energy dense foods is low. This study demonstrates that early post-weaning experience can modify the expression of a ` thrifty genotype' and alter an adult animal's response to its environment, a finding consistent with evidence of pre- and peri-natal programming of adult obesity risk by maternal nutritional status. Our findings suggest the window for developmental effects of diet may extend into childhood, an observation with potentially important implications for both research and public policy in addressing the rising incidence of obesity.	[Frazier, Cristianne R. M.; Mason, Peggy; Zhuang, Xiaoxi] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Mason, Peggy; Zhuang, Xiaoxi; Beeler, Jeff A.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Frazier, CRM (corresponding author), Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA.	jabeeler@uchicago.edu		Beeler, Jeff/0000-0002-1344-1337	NIMH [MH66216]; NIDA [1 F32 DA020427-01]; USPHS [T32-DA-07255]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA020427, T32DA007255] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by NIMH MH66216 (XZ), NIDA 1 F32 DA020427-01 (JB), USPHS T32-DA-07255 (CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bellinger L, 2005, CLIN SCI, V109, P413, DOI 10.1042/CS20050127; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berthoud HR, 2007, PHYSIOL BEHAV, V91, P486, DOI 10.1016/j.physbeh.2006.12.016; BINDRA D, 1974, PSYCHOL REV, V81, P199, DOI 10.1037/h0036330; Clark HR, 2007, J PUBLIC HEALTH-UK, V29, P132, DOI 10.1093/pubmed/fdm012; COUSINS MS, 1993, PHARMACOL BIOCHEM BE, V46, P943, DOI 10.1016/0091-3057(93)90226-J; Delva J, 2007, AM J PREV MED, V33, pS226, DOI 10.1016/j.amepre.2007.07.018; Delva J, 2007, AM J PREV MED, V33, pS178, DOI 10.1016/j.amepre.2007.07.008; Drewnowski A, 2007, EPIDEMIOL REV, V29, P160, DOI 10.1093/epirev/mxm011; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; ELIZALDE G, 1990, APPETITE, V15, P189, DOI 10.1016/0195-6663(90)90019-5; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Figlewicz DP, 2007, PHYSIOL BEHAV, V91, P473, DOI 10.1016/j.physbeh.2006.10.008; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gibson SA, 1996, INT J FOOD SCI NUTR, V47, P405, DOI 10.3109/09637489609006954; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hoek J, 2006, J HEALTH COMMUN, V11, P409, DOI 10.1080/10810730600671888; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Kelly B, 2007, PUBLIC HEALTH NUTR, V10, P1234, DOI 10.1017/S1368980007687126; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Langley-Evans SC, 2005, MATERN CHILD NUTR, V1, P142, DOI 10.1111/j.1740-8709.2005.00015.x; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Levine AS, 2003, AM J CLIN NUTR, V78, p834S, DOI 10.1093/ajcn/78.4.834S; Levitsky DA, 2005, PHYSIOL BEHAV, V86, P623, DOI 10.1016/j.physbeh.2005.08.053; Lewis SR, 2005, PHYSIOL BEHAV, V85, P546, DOI 10.1016/j.physbeh.2005.06.003; McMillen IC, 2004, P NUTR SOC, V63, P405, DOI 10.1079/PNS2004370; McMillen IC, 2006, REPRODUCTION, V131, P415, DOI 10.1530/rep.1.00303; Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040; MOORE LV, 2008, AM J EPIDEMIOL; Moreno LA, 2007, CURR OPIN CLIN NUTR, V10, P336, DOI 10.1097/MCO.0b013e3280a94f59; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ogden Cynthia L, 2004, Adv Data, P1; Poppitt SD, 2002, AM J CLIN NUTR, V75, P11, DOI 10.1093/ajcn/75.1.11; Powell LM, 2007, PEDIATRICS, V120, P576, DOI 10.1542/peds.2006-3595; Ravussin E, 2000, BRIT J NUTR, V83, pS17; Saris WHM, 2000, INT J OBESITY, V24, P1310, DOI 10.1038/sj.ijo.0801451; Sumiyoshi M, 2006, J NUTR, V136, P582, DOI 10.1093/jn/136.3.582; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wing RR, 2001, DIABETES CARE, V24, P117, DOI 10.2337/diacare.24.1.117; WURTMAN JJ, 1979, SCIENCE, V205, P321, DOI 10.1126/science.451607; Zheng HY, 2007, CURR OPIN PHARMACOL, V7, P607, DOI 10.1016/j.coph.2007.10.011	56	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3221	10.1371/journal.pone.0003221	http://dx.doi.org/10.1371/journal.pone.0003221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422LB	18797507	gold, Green Submitted, Green Published			2022-12-25	WOS:000264428200005
J	Kawamori, T; Kaneshiro, T; Okumura, M; Maalouf, S; Uflacker, A; Bielawski, J; Hannun, YA; Obeid, LM				Kawamori, Toshihiko; Kaneshiro, Tatsuya; Okumura, Masae; Maalouf, Samer; Uflacker, Andre; Bielawski, Jacek; Hannun, Yusuf A.; Obeid, Lina M.			Role for sphingosine kinase 1 in colon carcinogenesis	FASEB JOURNAL			English	Article						inflammation; azoxymethane; dextran sodium sulfate; cell proliferation; apoptosis	CYCLOOXYGENASE-2 INHIBITOR; TNF-ALPHA; MICE; SPHINGOSINE-1-PHOSPHATE; INDUCTION; CELECOXIB; TISSUES; FTY720; CELLS	Sphingosine kinase 1 (SphK1) phosphorylates sphingosine to form sphingosine-1-phosphate (S1P) and is a critical regulator of sphingolipid-mediated functions. Cell-based studies suggest a tumor-promoting function for the SphK1/S1P pathway. Also, our previous studies implicated the SphK1/S1P pathway in the induction of the arachidonic acid cascade, a major inflammatory pathway involved in colon carcinogenesis. Therefore, we investigated whether the SphK1/S1P pathway is necessary for mediating carcinogenesis in vivo. Here, we report that 89% (42/47) of human colon cancer samples stained positively for SphK1, whereas normal colon mucosa had negative or weak staining. Adenomas had higher expression of SphK1 vs. normal mucosa, and colon cancers with metastasis had higher expression of SphK1 than those without metastasis. In the azoxymethane (AOM) murine model of colon cancer, SphK1 and S1P were significantly elevated in colon cancer tissues compared to normal mucosa. Moreover, blood levels of S1P were higher in mice with colon cancers than in those without cancers. Notably, SphK1(-/-) mice subjected to AOM had significantly less aberrant crypt foci (ACF) formation and significantly reduced colon cancer development. These results are the first in vivo evidence that the SphK1/S1P pathway contributes to colon carcinogenesis and that inhibition of this pathway is a potential target for chemoprevention. - Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y. A., Obeid, L. M. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23, 405-414 (2009)	[Kawamori, Toshihiko; Kaneshiro, Tatsuya; Okumura, Masae; Maalouf, Samer; Uflacker, Andre] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Bielawski, Jacek; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Kawamori, T (corresponding author), Med Univ S Carolina, Dept Pathol & Lab Med, 165 Ashley Ave,Ste 309, Charleston, SC 29425 USA.	kawamori@musc.edu	Kawamori, Toshihiko/G-7636-2012	obeid, lina/0000-0002-0734-0847	NIH [P20RR17677, P01CA097132, R01GM62887]; NIH Extramural Research Facilities Program of the National Center for Research Resources [C06RR015455]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Margaret Romano and the Tumor Bank for technical assistance and Dr. Takuji Tanaka (Kanazawa Medical University, Kanazawa, Japan) for his diagnostic review of colon tumors. Also, we thank the Lipidomics Core Facility and Animal Carcinogenesis Core, the Hollings Cancer Center, MUSC. This work was supported by NIH grants (P20RR17677 to T. K.; P01CA097132 to Y.A.H. and L.M.O.; R01GM62887 to L.M.O.) and a seed grant to T. K. from the Hollings Cancer Center, MUSC. This work was conducted in a facility constructed with support from the NIH Extramural Research Facilities Program of the National Center for Research Resources (C06RR015455).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; French KJ, 2003, CANCER RES, V63, P5962; Fukuda Y, 2003, BIOCHEM BIOPH RES CO, V309, P155, DOI 10.1016/S0006-291X(03)01551-1; Hansen-Petrik MB, 2002, CANCER RES, V62, P403; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kawamori T, 2003, CARCINOGENESIS, V24, P985, DOI 10.1093/carcin/bgg033; Kawamori T, 1998, CANCER RES, V58, P409; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Krutovskikh V A, 1994, IARC Sci Publ, P195; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Murate T, 2001, J HISTOCHEM CYTOCHEM, V49, P845, DOI 10.1177/002215540104900705; Nakatsugi S, 1997, JPN J CANCER RES, V88, P1117, DOI 10.1111/j.1349-7006.1997.tb00337.x; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	27	194	207	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2009	23	2					405	414		10.1096/fj.08-117572	http://dx.doi.org/10.1096/fj.08-117572			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	400TZ	18824518	Green Published			2022-12-25	WOS:000262892900012
J	Callewaert, F; Venken, K; Ophoff, J; De Gendt, K; Torcasio, A; van Lenthe, GH; Van Oosterwyck, H; Boonen, S; Bouillon, R; Verhoeven, G; Vanderschueren, D				Callewaert, Filip; Venken, Katrien; Ophoff, Jill; De Gendt, Karel; Torcasio, Antonia; van Lenthe, G. Harry; Van Oosterwyck, Hans; Boonen, Steven; Bouillon, Roger; Verhoeven, Guido; Vanderschueren, Dirk			Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha	FASEB JOURNAL			English	Article						sex steroid action; trabecular bone; cortical bone; bone strength; muscle and fat mass	ADULT MALE-MICE; MINERAL METABOLISM; TRABECULAR BONE; GROWTH-HORMONE; KNOCKOUT MICE; CORTICAL BONE; ER-ALPHA; IN-VIVO; RATS; TESTOSTERONE	Osteoporosis and muscle frailty are important health problems in elderly men and may be partly related to biological androgen activity. This androgen action can be mediated directly through stimulation of the androgen receptor (AR) or indirectly through stimulation of estrogen receptor-alpha (ER alpha) following aromatization of androgens into estrogens. To assess the differential action of AR and ER alpha pathways on bone and body composition, AR-ER alpha double-knockout mice were generated and characterized. AR disruption decreased trabecular bone mass, whereas ER alpha disruption had no additional effect on the AR-dependent trabecular bone loss. In contrast, combined AR and ER alpha inactivation additionally reduced cortical bone and muscle mass compared with either AR or ER alpha disruption alone. ER alpha inactivation-in the presence or absence of AR-increased fat mass. We demonstrate that AR activation is solely responsible for the development and maintenance of male trabecular bone mass. Both AR and ER alpha activation, however, are needed to optimize the acquisition of cortical bone and muscle mass. ER alpha activation alone is sufficient for the regulation of fat mass. Our findings clearly define the relative importance of AR and ER alpha signaling on trabecular and cortical bone mass as well as body composition in male mice.-Callewaert, F., Venken, K., Ophoff, J., De Gendt, K., Torcasio, A., van Lenthe, G. H., Van Oosterwyck, H., Boonen, S., Bouillon, R., Verhoeven, G., Vanderschueren, D. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha. FASEB J. 23, 232-240 (2009)	[Callewaert, Filip; Venken, Katrien; Ophoff, Jill; De Gendt, Karel; Boonen, Steven; Bouillon, Roger; Verhoeven, Guido; Vanderschueren, Dirk] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Dept Expt Med, B-3000 Leuven, Belgium; [Torcasio, Antonia; van Lenthe, G. Harry; Van Oosterwyck, Hans] Katholieke Univ Leuven, Div Biomech & Engn Design, Dept Mech Engn, B-3000 Leuven, Belgium	KU Leuven; KU Leuven	Verhoeven, G (corresponding author), Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Dept Expt Med, Herestr 49, B-3000 Leuven, Belgium.	vanderschueren@uz.kuleuven.be	van Lenthe, Harry (GH)/C-1030-2008; Van Oosterwyck, Hans/C-2528-2016; De Gendt, Karel/A-6332-2009	van Lenthe, Harry (GH)/0000-0001-8303-4959; Van Oosterwyck, Hans/0000-0002-2142-9717; vanderschueren, dirk/0000-0003-1395-0104	Katholieke Universiteit Leuven [OT/05/53, OT/04/26]; Fund for Scientific Research Flanders; Roche; GlaxoSmithKline	Katholieke Universiteit Leuven(KU Leuven); Fund for Scientific Research Flanders(FWO); Roche(Roche Holding); GlaxoSmithKline(GlaxoSmithKline)	The authors thank E. Van Herck, W. Coopmans, and L. Deboel for excellent technical assistance. This study was supported by grants OT/05/53 and OT/04/26 from the Katholieke Universiteit Leuven. K. V. and K. D. are postdoctoral fellows of the Fund for Scientific Research Flanders ( F. W. O.-Vlaanderen). S. B. and D. V. are senior clinical researchers of the Fund for Scientific Research Flanders. S. B. is holder of the Leuven University Chair in Metabolic Bone Diseases, supported by Roche and GlaxoSmithKline.	Akingbemi BT, 2003, ENDOCRINOLOGY, V144, P84, DOI 10.1210/en.2002-220292; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; Boonen S, 2007, EUR J INTERN MED, V18, P6, DOI 10.1016/j.ejim.2006.09.005; Bouillon R, 2004, J CLIN ENDOCR METAB, V89, P6025, DOI 10.1210/jc.2004-0602; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; Dupont S, 2000, DEVELOPMENT, V127, P4277; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Gao WQ, 2005, ENDOCRINOLOGY, V146, P4887, DOI 10.1210/en.2005-0572; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Juul A, 2001, HUM REPROD UPDATE, V7, P303, DOI 10.1093/humupd/7.3.303; Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358; Kawano H, 2003, P NATL ACAD SCI USA, V100, P9416, DOI 10.1073/pnas.1533500100; Khosla S, 2008, ENDOCR REV, V29, P441, DOI 10.1210/er.2008-0002; Kos M, 2002, J MOL ENDOCRINOL, V29, P281, DOI 10.1677/jme.0.0290281; Lindberg MK, 2002, J BONE MINER RES, V17, P555, DOI 10.1359/jbmr.2002.17.4.555; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Marcus R, 2000, J CLIN ENDOCR METAB, V85, P1032, DOI 10.1210/jc.85.3.1032; Marin P, 1996, J CLIN ENDOCR METAB, V81, P1018, DOI 10.1210/jc.81.3.1018; Moverare S, 2003, P NATL ACAD SCI USA, V100, P13573, DOI 10.1073/pnas.2233084100; Moverare-Skrtic S, 2006, OBESITY, V14, P662, DOI 10.1038/oby.2006.75; Muller ME, 2003, OSTEOPOROSIS INT, V14, P345, DOI 10.1007/s00198-003-1380-9; Pendaries C, 2002, P NATL ACAD SCI USA, V99, P2205, DOI 10.1073/pnas.042688499; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Salmon PL, 2003, J BONE MINER RES, V18, pS256; Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Smith EP, 2008, J CLIN ENDOCR METAB, V93, P3088, DOI 10.1210/jc.2007-2397; TURNER RT, 1990, J ORTHOPAED RES, V8, P612, DOI 10.1002/jor.1100080418; Vandenput L, 2001, BIOCHEM BIOPH RES CO, V285, P70, DOI 10.1006/bbrc.2001.5101; VANDERSCHUEREN D, 1993, J BONE MINER RES, V8, P801; Vanderschueren D, 1997, ENDOCRINOLOGY, V138, P2301, DOI 10.1210/en.138.6.2301; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Venken K, 2006, J BONE MINER RES, V21, P576, DOI 10.1359/JBMR.060103; Venken K, 2005, J BONE MINER RES, V20, P2138, DOI 10.1359/JBMR.050811; VERHAEGHE J, 1989, J ENDOCRINOL, V120, P143, DOI 10.1677/joe.0.1200143; VERHAEGHE J, 1990, DIABETES, V39, P477, DOI 10.2337/diabetes.39.4.477; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474	44	100	106	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					232	240		10.1096/fj.08-113456	http://dx.doi.org/10.1096/fj.08-113456			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18809737				2022-12-25	WOS:000262095500026
J	Chou, AP; Maidment, N; Klintenberg, R; Casida, JE; Li, S; Fitzmaurice, AG; Fernagut, PO; Mortazavi, F; Chesselet, MF; Bronstein, JM				Chou, Arthur P.; Maidment, Nigel; Klintenberg, Rebecka; Casida, John E.; Li, Sharon; Fitzmaurice, Arthur G.; Fernagut, Pierre-Olivier; Mortazavi, Farzad; Chesselet, Marie-Francoise; Bronstein, Jeff M.			Ziram Causes Dopaminergic Cell Damage by Inhibiting E1 Ligase of the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; NEURONAL DEVELOPMENT; PESTICIDE EXPOSURE; MODEL; DITHIOCARBAMATE; SYSTEM; GLUTATHIONE; DYSFUNCTION; IMPAIRMENT	The etiology of Parkinson disease (PD) is unclear but may involve environmental toxins such as pesticides leading to dysfunction of the ubiquitin proteasome system (UPS). Here, we measured the relative toxicity of ziram (a UPS inhibitor) and analogs to dopaminergic neurons and examined the mechanism of cell death. UPS (26 S) activity was measured in cell lines after exposure to ziram and related compounds. Dimethyl- and diethyldithiocarbamates including ziram were potent UPS inhibitors. Primary ventral mesencephalic cultures were exposed to ziram, and cell toxicity was assessed by staining for tyrosine hydroxylase (TH) and NeuN antigen. Ziram caused a preferential damage to TH+ neurons and elevated alpha-synuclein levels but did not increase aggregate formation. Mechanistically, ziram altered UPS function through interfering with the targeting of substrates by inhibiting ubiquitin E1 ligase. Sodium dimethyldithiocarbamate administered to mice for 2 weeks resulted in persistent motor deficits and a mild reduction in striatal TH staining but no nigral cell loss. These results demonstrate that ziram causes selective dopaminergic cell damage in vitro by inhibiting an important degradative pathway implicated in the etiology of PD. Chronic exposure to widely used dithiocarbamate fungicides may contribute to the development of PD, and elucidation of its mechanism would identify a new potential therapeutic target.	[Chou, Arthur P.; Li, Sharon; Fitzmaurice, Arthur G.; Fernagut, Pierre-Olivier; Mortazavi, Farzad; Chesselet, Marie-Francoise; Bronstein, Jeff M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Maidment, Nigel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Fernagut, Pierre-Olivier; Mortazavi, Farzad; Chesselet, Marie-Francoise] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Bronstein, Jeff M.] Greater Angeles Vet Adm Med Ctr, Los Angeles, CA 90095 USA; [Klintenberg, Rebecka; Casida, John E.] Univ Calif Berkeley, Environm Chem & Toxicol Lab, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Berkeley	Bronstein, JM (corresponding author), Univ Calif Los Angeles, Sch Med, Reed Neurol Res Ctr, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jbronste@ucla.edu	Mortazavi, Farzad/AAI-8136-2021; Mortazavi, Farzad/AFT-4660-2022	Mortazavi, Farzad/0000-0002-1911-5428; Mortazavi, Farzad/0000-0002-1911-5428; Fitzmaurice, Arthur/0000-0002-1509-3831; Fernagut, Pierre-Olivier/0000-0002-7737-5439	National Institutes of Health [5 U54 ESO12078]; Veterans Administration Grant SW PADRREC; National Institutes of Health Medical Scientist Training Program; Swedish Research Council; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Grant SW PADRREC; National Institutes of Health Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 U54 ESO12078. This work was also supported by Veterans Administration Grant SW PADRREC, the National Institutes of Health Medical Scientist Training Program (to A. P. C.), a postdoctoral fellowship from the Swedish Research Council (to R. K.), and funds from the Michael J. Fox Foundation (to F. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bordelon YM, 1999, NEUROSCIENCE, V93, P843, DOI 10.1016/S0306-4522(99)00239-0; Bove J, 2006, ANN NEUROL, V60, P260, DOI 10.1002/ana.20937; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; Burkitt MJ, 1998, ARCH BIOCHEM BIOPHYS, V353, P73, DOI 10.1006/abbi.1998.0618; Chow E, 2005, MOL CELL NEUROSCI, V29, P405, DOI 10.1016/j.mcn.2005.03.007; Cohen J., 1983, APPL MULTIPLE REGRES; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Hwang DY, 2005, J NEUROSCI, V25, P2132, DOI 10.1523/JNEUROSCI.3718-04.2005; Jha N, 2002, J NEUROCHEM, V80, P555, DOI 10.1046/j.0022-3042.2001.00009.x; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kikuchi S, 2003, BRAIN RES, V964, P228, DOI 10.1016/S0006-8993(02)04030-1; Kordower JH, 2006, ANN NEUROL, V60, P264, DOI 10.1002/ana.20935; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Manning-Bog AB, 2006, ANN NEUROL, V60, P256, DOI 10.1002/ana.20938; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; McNaught KS, 2006, ANN NEUROL, V60, P243, DOI 10.1002/ana.20936; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; MONTINE TJ, 1995, NEURODEGENERATION, V4, P283, DOI 10.1016/1055-8330(95)90017-9; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Quilty MC, 2003, EXP NEUROL, V182, P195, DOI 10.1016/S0014-4886(03)00108-0; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Rideout HJ, 2004, J BIOL CHEM, V279, P46915, DOI 10.1074/jbc.M405146200; Rideout HJ, 2005, J NEUROCHEM, V93, P1304, DOI 10.1111/j.1471-4159.2005.03124.x; SCHMITT A, 1989, DEUT LEBENSM-RUNDSCH, V85, P111; Singleton AB, 2005, TRENDS NEUROSCI, V28, P416, DOI 10.1016/j.tins.2005.05.009; STAUB RE, 1995, CHEM RES TOXICOL, V8, P1063, DOI 10.1021/tx00050a010; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Wang XF, 2006, NEUROBIOL DIS, V23, P198, DOI 10.1016/j.nbd.2006.02.012; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zhou Y, 2004, NEUROSCIENCE, V128, P281, DOI 10.1016/j.neuroscience.2004.06.048	37	60	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34696	34703		10.1074/jbc.M802210200	http://dx.doi.org/10.1074/jbc.M802210200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18818210	Green Published, hybrid			2022-12-25	WOS:000261469100025
J	Steiner, H; Winkler, E; Haass, C				Steiner, Harald; Winkler, Edith; Haass, Christian			Chemical Cross-linking Provides a Model of the gamma-Secretase Complex Subunit Architecture and Evidence for Close Proximity of the C-terminal Fragment of Presenilin with APH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; DISEASE-ASSOCIATED PRESENILIN-1; TRANSMEMBRANE DOMAIN; NICASTRIN; PEN-2; EXPRESSION; BINDING; PROTEIN; ORGANIZATION; ABSENCE	gamma-Secretase is an intramembrane cleaving aspartyl protease complex intimately implicated in Alzheimer disease pathogenesis. The protease is composed of the catalytic subunit presenilin (PS1 or PS2), the substrate receptor nicastrin (NCT), and two additional subunits, APH-1 (APH-1a, as long and short splice forms (APH-1aL, APH-1aS), or APH-1b) and PEN-2. Apart from the Alzheimer disease-associated beta-amyloid precursor protein, gamma-secretase has been shown to cleave a large number of other type I membrane proteins. Despite the progress in elucidating gamma-secretase function, basic questions concerning the precise organization of its subunits, their molecular interactions, and their exact stoichiometry in the complex are largely unresolved. Here we isolated endogenous human gamma-secretase from human embryonic kidney 293 cells and investigated the subunit architecture of the gamma-secretase complex formed by PS1, NCT, APH-1aL, and PEN-2 by chemical cross-linking. Using this approach, we provide evidence for the close neighborhood of the PS1 N- and C-terminal fragments (NTF and CTF, respectively), the PS1 NTF and PEN-2, the PS1 CTF and APH-1aL, and NCT and APH-1aL. We thus identify a previously unrecognized PS1 CTF/APH-1aL interaction, verify subunit interactions deduced previously from indirect approaches, and provide a model of the gamma-secretase complex subunit architecture. Finally, we further show that, like the PS1 CTF, the PS2 CTF also interacts with APH-1aL, and we provide evidence that these interactions also occur with the other APH-1 variants, suggesting similar subunit architectures of all gamma-secretase complexes.	[Steiner, Harald] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany	University of Munich; University of Munich	Steiner, H (corresponding author), Univ Munich, Dept Biochem, Adolf Butenandt Inst, Lab Neurodegenerat Dis Res, Schillerstr 44, D-80336 Munich, Germany.	harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB 596]; Alzheimer Research Award of the Hans and Ilse Breuer Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alzheimer Research Award of the Hans and Ilse Breuer Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 596 (to C. H. and H. S.) and the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Capell A, 2003, J BIOL CHEM, V278, P52519, DOI 10.1074/jbc.C300435200; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Edbauer D, 2004, J BIOL CHEM, V279, P37311, DOI 10.1074/jbc.M406228200; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2006, BIOCHEMISTRY-US, V45, P7598, DOI 10.1021/bi060107k; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Morais VA, 2003, J BIOL CHEM, V278, P43284, DOI 10.1074/jbc.M305685200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Steiner Harald, 2004, Current Alzheimer Research, V1, P175, DOI 10.2174/1567205043332081; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200	52	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34677	34686		10.1074/jbc.M709067200	http://dx.doi.org/10.1074/jbc.M709067200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18801744	hybrid, Green Published			2022-12-25	WOS:000261469100023
J	Moos, MPW; Mewburn, JD; Kan, FWK; Ishii, S; Abe, M; Sakimura, K; Noguchi, K; Shimizu, T; Funk, CD				Moos, Michael P. W.; Mewburn, Jeffrey D.; Kan, Frederick W. K.; Ishii, Satoshi; Abe, Manabu; Sakimura, Kenji; Noguchi, Kyoko; Shimizu, Takao; Funk, Colin D.			Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport	FASEB JOURNAL			English	Article						inflammation; intravital microscopy; transgenic mice; caveolae	ENDOTHELIAL PERMEABILITY; PROTEIN-KINASES; CALCIUM; CELLS; EXOCYTOSIS; EXPRESSION; ATHEROSCLEROSIS; TRANSCYTOSIS; MECHANISMS; RESPONSES	Cysteinyl leukotrienes (CysLTs) are potent mediators of inflammation synthesized by the concerted actions of 5-lipoxygenase (5-LO), 5-LO-activating protein (FLAP), leukotriene C4 synthase, and additional downstream enzymes, starting with arachidonic acid substrate. CysLTs produced by macrophages, eosinophils, mast cells, and other inflammatory cells activate 3 different high-affinity CysLT receptors: CysLT1R, CysLT2R, and GPR 17. We sought to investigate vascular sites of CysLT2R expression and the role and mechanism of this receptor in mediating vascular permeability events. Vascular expression of CysLT2R was investigated by reporter gene expression in a novel CysLT2R deficient-LacZ mouse model. CysLT2R was expressed in small, but not large, vessels in mouse brain, bladder, skin, and cremaster muscle. Intravital, in addition to confocal and electron, microscopy investigations using FITC-labeled albumin in cremaster postcapillary venule preparations indicated rapid CysLT-mediated permeability, which was blocked by application of BAY-u9773, a dual CysLT(1)R/CysLT(2)R antagonist or by CysLT2R deficiency. Endothelial human CysLT2R overexpression in mice exacerbated vascular leakage even in the absence of exogenous ligand. The enhanced vascular permeability mediated by CysLT2R takes place via a transendothelial vesicle transport mechanism as opposed to a paracellular route and is controlled via Ca2+ signaling. Our results reveal that CysLT2R can mediate inflammatory reactions in a vascular bed-specific manner by altering transendothelial vesicle transport-based vascular permeability. Moos, M. P. W., Mewburn, J. D., Kan, F. W. K., Ishii, S., Abe, M., Sakimura, K., Noguchi, K., Shimizu, T., Funk, C. D. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport. FASEB J. 22, 4352-4362 (2009)	[Moos, Michael P. W.; Funk, Colin D.] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada; [Funk, Colin D.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Mewburn, Jeffrey D.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada; [Kan, Frederick W. K.] Queens Univ, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada; [Ishii, Satoshi; Noguchi, Kyoko; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan; [Ishii, Satoshi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan; [Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Tokyo; Japan Science & Technology Agency (JST); Niigata University	Funk, CD (corresponding author), Queens Univ, Dept Physiol, 433 Botterell Hall,Stuart St, Kingston, ON K7L 3N6, Canada.	funkc@queensu.ca	Abe, Manabu/A-9221-2008; Shimizu, Takao/AAV-7052-2021; Funk, Colin D/A-9518-2010	Funk, Colin/0000-0001-7029-4233	German Academy of Sciences Leopoldina with the German Federal Ministry of Education and Research [BMBF-LPD9901/8-132]	German Academy of Sciences Leopoldina with the German Federal Ministry of Education and Research	We thank Dr. Yves St. Pierre ( University of Quebec) for kindly supplying the murine b-end. 3 cells. This work was supported by Canadian Institutes of Health Research grant MOP-68930 and the Canadian Foundation for Innovation. C. D. F. holds a Tier I Canada Research Chair in Molecular, Cellular, and Physiological Medicine and is recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario. M. P. W. M. was supported by the German Academy of Sciences Leopoldina with the German Federal Ministry of Education and Research, BMBF-LPD9901/8-132.	Aller MA, 2006, MED SCI MONITOR, V12, pRA225; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Bates DO, 2002, J ANAT, V200, P581, DOI 10.1046/j.1469-7580.2002.00066.x; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; Casillan AJ, 2003, J APPL PHYSIOL, V94, P2313, DOI 10.1152/japplphysiol.00047.2002; Chen XK, 2006, NEUROSCIENTIST, V12, P375, DOI 10.1177/1073858406291588; Choileain NN, 2006, ARCH SURG-CHICAGO, V141, P1132, DOI 10.1001/archsurg.141.11.1132; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; El-Mestrah M, 1999, ANAT REC, V255, P227, DOI 10.1002/(SICI)1097-0185(19990601)255:2<227::AID-AR12>3.0.CO;2-E; Ferri LE, 2002, CRIT CARE MED, V30, P1842, DOI 10.1097/00003246-200208000-00028; FLEMING I, 1995, CIRC RES, V76, P522, DOI 10.1161/01.RES.76.4.522; Fredholm BB, 2007, ACTA PHYSIOL, V190, P3, DOI 10.1111/j.1365-201X.2007.01689.x; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GERICKE M, 1993, PFLUG ARCH EUR J PHY, V422, P552, DOI 10.1007/BF00374001; GHITESCU L, 1986, J CELL BIOL, V102, P1304, DOI 10.1083/jcb.102.4.1304; Hashizume K, 2002, J NEUROPATH EXP NEUR, V61, P725, DOI 10.1093/jnen/61.8.725; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Huang QB, 2003, SHOCK, V20, P363, DOI 10.1097/01.shk.0000079425.0000.db; Hui YQ, 2004, CIRCULATION, V110, P3360, DOI 10.1161/01.CIR.0000147775.50954.AA; Hui YQ, 2001, J BIOL CHEM, V276, P47489, DOI 10.1074/jbc.M107556200; Jiang W, 2008, AM J PATHOL, V172, P592, DOI 10.2353/ajpath.2008.070834; Koopman WJH, 2001, PFLUG ARCH EUR J PHY, V443, P250, DOI 10.1007/s004240100680; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Lominadze D, 2006, AM J PHYSIOL-HEART C, V290, pH1206, DOI 10.1152/ajpheart.00376.2005; Lotzer K, 2005, BBA-MOL CELL BIOL L, V1736, P30, DOI 10.1016/j.bbalip.2005.07.001; Lotzer K, 2003, ARTERIOSCL THROM VAS, V23, pE32, DOI 10.1161/01.ATV.0000082690.23131.CB; McCafferty DM, 2002, J IMMUNOL, V168, P4930, DOI 10.4049/jimmunol.168.10.4930; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Nothacker HP, 2000, MOL PHARMACOL, V58, P1601, DOI 10.1124/mol.58.6.1601; Ogasawara H, 2002, J BIOL CHEM, V277, P18763, DOI 10.1074/jbc.M109447200; Oheim M, 2006, CELL CALCIUM, V40, P423, DOI 10.1016/j.ceca.2006.08.007; Predescu D, 2004, AM J PHYSIOL-LUNG C, V287, pL895, DOI 10.1152/ajplung.00075.2004; Rusakov DA, 2006, NEUROSCIENTIST, V12, P317, DOI 10.1177/1073858405284672; Shiels IA, 2000, MED HYPOTHESES, V54, P193, DOI 10.1054/mehy.1999.0017; Warren M, 2007, CIRC RES, V101, pE90, DOI 10.1161/CIRCRESAHA.107.162735	39	43	44	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2008	22	12					4352	4362		10.1096/fj.08-113274	http://dx.doi.org/10.1096/fj.08-113274			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	377MH	18779380				2022-12-25	WOS:000261254800033
J	Coste, O; Brenneis, C; Linke, B; Pierre, S; Maeurer, C; Becker, W; Schmidt, H; Gao, W; Geisslinger, G; Scholich, K				Coste, Ovidiu; Brenneis, Christian; Linke, Bona; Pierre, Sandra; Maeurer, Christian; Becker, Wiebke; Schmidt, Helmut; Gao, Wei; Geisslinger, Gerd; Scholich, Klaus			Sphingosine 1-Phosphate Modulates Spinal Nociceptive Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPONTANEOUS TRANSMITTER RELEASE; DEPENDENT PROTEIN-KINASE; GLABROUS SKIN AFFERENTS; DORSAL-HORN; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; CAMP; HYPERALGESIA; EXPRESSION; CYCLASE	Sphingosine 1-Phosphate (S1P) modulates various cellular functions such as apoptosis, cell differentiation, and migration. Although S1P is an abundant signaling molecule in the central nervous system, very little is known about its influence on neuronal functions. We found that S1P concentrations were selectively decreased in the cerebrospinal fluid of adult rats in an acute and an inflammatory pain model. Pharmacological inhibition of sphingosine kinases (SPHK) decreased basal pain thresholds and SphK2 knock-out mice, but not SphK1 knock-out mice, had a significant decrease in withdrawal latency. Intrathecal application of S1P or sphinganine 1-phosphate (dihydro-S1P) reduced the pain-related (nociceptive) behavior in the formalin assay. S1P and dihydro-S1P inhibited cyclic AMP(cAMP) synthesis, a key second messenger of spinal nociceptive processing, in spinal cord neurons. By combining fluorescence resonance energy transfer (FRET)-based cAMP measurements with Multi Epitope Ligand Cartography (MELC), we showed that S1P decreased cAMP synthesis in excitatory dorsal horn neurons. Accordingly, intrathecal application of dihydro-S1P abolished the cAMP-dependent phosphorylation of NMDA receptors in the outer laminae of the spinal cord. Taken together, the data show that S1P modulates spinal nociceptive processing through inhibition of neuronal cAMP synthesis.	[Coste, Ovidiu; Brenneis, Christian; Linke, Bona; Pierre, Sandra; Maeurer, Christian; Becker, Wiebke; Schmidt, Helmut; Gao, Wei; Geisslinger, Gerd; Scholich, Klaus] Univ Frankfurt Klinikum, Inst Clin Pharmacol, ZAFES, Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Scholich, K (corresponding author), Univ Frankfurt Klinikum, Inst Clin Pharmacol, ZAFES, Pharmazentrum Frankfurt, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	scholich@em.uni-frankfurt.de			DFG [SCHO817-1, SCHO817-2]; LOEWE Lipid Signaling Forschungszentrum Frankfurt (LIFF); Aventis, Frankfurt, Germany	DFG(German Research Foundation (DFG)); LOEWE Lipid Signaling Forschungszentrum Frankfurt (LIFF); Aventis, Frankfurt, Germany(Sanofi-Aventis)	This work was supported in part by DFG (German Research Association) Grants SCHO817-1 and SCHO817-2, the LOEWE Lipid Signaling Forschungszentrum Frankfurt (LIFF), and in part by an unrestricted grant from Aventis, Frankfurt, Germany. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Bonnekoh B, 2006, EUR J DERMATOL, V16, P623, DOI 10.1684/ejd.2006.0005; Brailoiu E, 2003, BIOCHEM J, V373, P313, DOI 10.1042/BJ20030472; Brailoiu E, 2002, BRIT J PHARMACOL, V136, P1093, DOI 10.1038/sj.bjp.0704839; Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com; Choi SS, 2006, BRAIN RES, V1108, P28, DOI 10.1016/j.brainres.2006.06.048; Colombaioni L, 2004, BRAIN RES REV, V46, P328, DOI 10.1016/j.brainresrev.2004.07.014; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Ehnert C, 2004, J NEUROCHEM, V88, P948, DOI 10.1046/j.1471-4159.2003.02229.x; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hofacker A, 2005, J NEUROSCI, V25, P9005, DOI 10.1523/JNEUROSCI.2190-05.2005; Hornuss C, 2001, EUR J PHARMACOL, V429, P303, DOI 10.1016/S0014-2999(01)01329-2; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; Kim HW, 2006, BRIT J PHARMACOL, V148, P490, DOI 10.1038/sj.bjp.0706764; Kim KS, 2006, P NATL ACAD SCI USA, V103, P3908, DOI 10.1073/pnas.0508812103; Li S, 2006, MOL PHARMACOL, V70, P1742, DOI 10.1124/mol.106.025783; Lissandron V, 2005, J MOL BIOL, V354, P546, DOI 10.1016/j.jmb.2005.09.089; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Murata N, 2000, ANAL BIOCHEM, V282, P115, DOI 10.1006/abio.2000.4580; Nicholson R, 2005, NEUROSCI LETT, V380, P316, DOI 10.1016/j.neulet.2005.01.079; Persson S, 2006, J COMP NEUROL, V497, P683, DOI 10.1002/cne.20987; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; SHORTLAND P, 1993, J COMP NEUROL, V329, P491, DOI 10.1002/cne.903290406; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Suzuki M, 2006, NEUROSCI LETT, V399, P202, DOI 10.1016/j.neulet.2006.01.066; TAIWO YO, 1992, NEUROSCIENCE, V48, P479, DOI 10.1016/0306-4522(92)90507-X; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Tegeder I, 2004, P NATL ACAD SCI USA, V101, P3253, DOI 10.1073/pnas.0304076101; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Vasquez E, 2001, J NEUROSCI, V21, P9001, DOI 10.1523/JNEUROSCI.21-22-09001.2001; Watson AHD, 2003, J COMP NEUROL, V464, P497, DOI 10.1002/cne.10812; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Willis WD, 2001, ANN NY ACAD SCI, V933, P142; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhang YH, 2006, J NEUROPHYSIOL, V96, P1042, DOI 10.1152/jn.00120.2006; Zhao J, 2006, MOL CELL NEUROSCI, V31, P539, DOI 10.1016/j.mcn.2005.11.008; Zhao MG, 2006, J NEUROSCI, V26, P8923, DOI 10.1523/JNEUROSCI.2103-06.2006	48	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32442	32451		10.1074/jbc.M806410200	http://dx.doi.org/10.1074/jbc.M806410200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805787	hybrid			2022-12-25	WOS:000260893700032
J	Higashi, K; Terui, Y; Suganami, A; Tamura, Y; Nishimura, K; Kashiwagi, K; Igarashi, K				Higashi, Kyohei; Terui, Yusuke; Suganami, Akiko; Tamura, Yutaka; Nishimura, Kazuhiro; Kashiwagi, Keiko; Igarashi, Kazuei			Selective Structural Change by Spermidine in the Bulged-out Region of Double-stranded RNA and Its Effect on RNA Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOPEPTIDE-BINDING PROTEIN; ESCHERICHIA-COLI; RAT-LIVER; POLYAMINE STIMULATION; THERMOPHILIC EUBACTERIA; BOVINE LYMPHOCYTES; CELL-PROLIFERATION; THERMAL-STABILITY; DNA INTERACTIONS; MESSENGER-RNA	Polyamines play important roles in cell growth mainly through their interaction with RNA. We have previously reported that polyamines stimulate the synthesis of oligopeptide-binding protein OppA in Escherichia coli and the formation of Ile-tRNA in rat liver (Igarashi, K., and Kashiwagi, K. (2000) Biochem. Biophys. Res. Commun. 271, 559-564). These effects involve an interaction of polyamines with the bulged-out region of double-stranded RNA in the initiation region of OppA mRNA and in the acceptor stem of rat liver tRNAIle. In this study, the effects of polyamines on E. coli OppA synthesis and rat liver Ile-tRNA formation were compared using OppA mRNA and tRNAIle with or without the bulged-out region of double-stranded RNA. The results indicate that the bulged-out region is involved in polyamine stimulation of OppA synthesis and Ile-tRNA formation. A selective structural change by spermidine in the bulged-out region of double-stranded RNA was confirmed by circular dichroism.	[Higashi, Kyohei; Nishimura, Kazuhiro; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chuo Ku, Chiba 2600856, Japan; [Terui, Yusuke; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Chiba 2880025, Japan; [Suganami, Akiko; Tamura, Yutaka] Chiba Univ, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University	Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	iga16077@p.chiba-u.ac.jp		Igarashi, Kazuei/0000-0003-3751-3187; Higashi, Kyohei/0000-0002-2622-4825; Nishimura, Kazuhiro/0000-0002-6209-5522	Ministry of Education, Science, Sports, and Culture of Japan; Futaba Electronics Memorial Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Futaba Electronics Memorial Foundation	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan and by a research grant from the Futaba Electronics Memorial Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; FEUERSTEIN BG, 1986, P NATL ACAD SCI USA, V83, P5948, DOI 10.1073/pnas.83.16.5948; HAMANA K, 1991, J BIOCHEM-TOKYO, V109, P444, DOI 10.1093/oxfordjournals.jbchem.a123401; HAMANA K, 1982, J BIOCHEM-TOKYO, V91, P1321, DOI 10.1093/oxfordjournals.jbchem.a133818; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Higashi K, 2008, BIOCHEM BIOPH RES CO, V370, P572, DOI 10.1016/j.bbrc.2008.03.137; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P271, DOI 10.2323/jgam.50.271; Hou MH, 2001, NUCLEIC ACIDS RES, V29, P5121, DOI 10.1093/nar/29.24.5121; Hyvonen MT, 2007, J BIOL CHEM, V282, P34700, DOI 10.1074/jbc.M704282200; IGARASHI K, 1975, BIOCHEM BIOPH RES CO, V64, P897, DOI 10.1016/0006-291X(75)90132-1; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Igarashi K, 1997, J BIOL CHEM, V272, P4058, DOI 10.1074/jbc.272.7.4058; IGARASHI K, 1982, ARCH BIOCHEM BIOPHYS, V219, P438, DOI 10.1016/0003-9861(82)90175-8; IGARASHI K, 1984, CANCER RES, V44, P5326; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; KUSAMAEGUCHI K, 1991, BIOCHEM BIOPH RES CO, V177, P745, DOI 10.1016/0006-291X(91)91851-3; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; NORRIS AT, 1964, P NATL ACAD SCI USA, V52, P330, DOI 10.1073/pnas.52.2.330; OGASAWARA T, 1989, J BIOCHEM-TOKYO, V105, P164, DOI 10.1093/oxfordjournals.jbchem.a122633; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Park MH, 1997, BIOL SIGNAL, V6, P115; PENG ZH, 1990, ARCH BIOCHEM BIOPHYS, V279, P138, DOI 10.1016/0003-9861(90)90473-C; PHILIPSON L, 1978, CELL, V13, P189, DOI 10.1016/0092-8674(78)90149-6; Sambrook J, 2001, MOL CLONING LAB MANU; SRIVENUGOPAL KS, 1987, NUCLEIC ACIDS RES, V15, P2563, DOI 10.1093/nar/15.6.2563; Tanabe T, 2004, J BIOCHEM, V135, P501, DOI 10.1093/jb/mvh066; Tereshko V, 2001, RNA, V7, P405, DOI 10.1017/S1355838201001935; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Yoshida M, 1999, J BIOL CHEM, V274, P22723, DOI 10.1074/jbc.274.32.22723; ZUBAY G, 1962, J MOL BIOL, V50, P689; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	36	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32989	32994		10.1074/jbc.M806027200	http://dx.doi.org/10.1074/jbc.M806027200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18824545	hybrid			2022-12-25	WOS:000260893700087
J	Soshilov, A; Denison, MS				Soshilov, Anatoly; Denison, Michael S.			Role of the Per/Arnt/Sim Domains in Ligand-dependent Transformation of the Aryl Hydrocarbon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR COMPLEX; SOLUBLE GUANYLYL CYCLASE; DNA-BINDING ACTIVITY; DIOXIN RECEPTOR; AH RECEPTOR; PAS DOMAINS; NUCLEAR TRANSLOCATOR; INDUCED ACTIVATION	The aryl hydrocarbon receptor (AhR) mediates the toxic and biological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. In a process termed transformation, ligand binding converts the AhR into its high affinity DNA binding form that represents a dimer of the AhR and Arnt, a closely related nuclear protein. During transformation, protein chaperone Hsp90 is thought to be replaced by Arnt in overlapping binding sites in the basic helix loop helix and PASB domains of the AhR. Here, analysis of AhR variants containing a modified PASB domain and AhR PASA-PASB fragments of various lengths revealed (i) an inhibitory effect on transformation concomitant with Hsp90 binding in the PASB domain, (ii) an ability of the PASA-PASB fragment of the AhR to reproduce key steps in the transformation process, and (iii) a ligand-dependent conformational change in the PASA domain consistent with increased PASA exposure during AhR transformation. Based on these results, we propose a new mechanism of AhR transformation through initiation of Arnt dimerization and Hsp90 displacement in AhR PASA/B domains. This study provides insights into mechanisms of AhR transformation, dimerization of PAS domain proteins, and Hsp90 dissociation in activation of its client proteins.	[Soshilov, Anatoly; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis	Denison, MS (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Meyer Hall,1 Shields Ave, Davis, CA 95616 USA.	msdenison@ucdavis.edu			National Institutes of Health NIEHS [R01ES007685, R01ES012498]; California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012498, R01ES007685] Funding Source: NIH RePORTER	National Institutes of Health NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health NIEHS Grants R01ES007685 and R01ES012498. This work was also supported by the California Agricultural Experiment Station. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTONSSON C, 1995, MOL CELL BIOL, V15, P756; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Bohonowych JE, 2007, TOXICOL SCI, V98, P99, DOI 10.1093/toxsci/kfm085; Chapman-Smith A, 2004, J BIOL CHEM, V279, P5353, DOI 10.1074/jbc.M310041200; COUMAILLEAU P, 1995, J BIOL CHEM, V270, P25291, DOI 10.1074/jbc.270.42.25291; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; DENISON MS, 2002, CURRENT PROTOCOLS TO; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Fukunaga BN, 1996, J BIOL CHEM, V271, P3743; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Heid SE, 2000, MOL PHARMACOL, V57, P82; Henry EC, 2003, MOL PHARMACOL, V63, P392, DOI 10.1124/mol.63.2.392; HENRY EC, 1993, BIOCHEM J, V294, P95, DOI 10.1042/bj2940095; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kronenberg S, 2000, NUCLEIC ACIDS RES, V28, P2286, DOI 10.1093/nar/28.12.2286; Lees MJ, 1999, MOL CELL BIOL, V19, P5811; LI H, 1994, J BIOL CHEM, V269, P28098; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; MCGUIRE J, 1994, MOL CELL BIOL, V14, P2438, DOI 10.1128/MCB.14.4.2438; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; McGuire J, 1995, J BIOL CHEM, V270, P31353, DOI 10.1074/jbc.270.52.31353; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Papapetropoulos A, 2005, MOL PHARMACOL, V68, P1133, DOI 10.1124/mol.105.012682; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; PERDEW GH, 1991, ARCH BIOCHEM BIOPHYS, V291, P284, DOI 10.1016/0003-9861(91)90136-7; Perdew GH, 1996, BIOCHEM MOL BIOL INT, V39, P589; Petrulis JR, 2003, J BIOL CHEM, V278, P2677, DOI 10.1074/jbc.M209331200; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; Pollenz RS, 2006, MOL PHARMACOL, V70, P1369, DOI 10.1124/mol.106.027672; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; PROBST MR, 1993, MOL PHARMACOL, V44, P511; Ramadoss P, 2005, BIOCHEMISTRY-US, V44, P11148, DOI 10.1021/bi050948b; Rushing SR, 2002, ARCH BIOCHEM BIOPHYS, V403, P189, DOI 10.1016/S0003-9861(02)00233-3; SANCHEZ ER, 1987, J BIOL CHEM, V262, P6986; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Sun WM, 1997, J BIOL CHEM, V272, P31845, DOI 10.1074/jbc.272.50.31845; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Zhou ZM, 2004, J BIOL CHEM, V279, P24935, DOI 10.1074/jbc.M402105200	48	61	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32995	33005		10.1074/jbc.M802414200	http://dx.doi.org/10.1074/jbc.M802414200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806268	Green Published, hybrid			2022-12-25	WOS:000260893700088
J	von Marschall, Z; Fisher, LW				von Marschall, Zofia; Fisher, Larry W.			Dentin Matrix Protein-1 Isoforms Promote Differential Cell Attachment and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT-MEDIATED ATTACK; INTEGRIN-BINDING LIGAND; BONE SIALOPROTEIN; SIBLING PROTEINS; IN-VITRO; ALPHA-V-BETA-5 INTEGRINS; PHOSPHATE HOMEOSTASIS; SUBSTRATUM ADHESION; OSTEOPONTIN; EXPRESSION	Dentin matrix protein-1 (DMP1), bone sialoprotein (BSP), and osteopontin (OPN) are three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) co-expressed/secreted by skeletal and active ductal epithelial cells. Although etiological mechanisms remain unclear, DMP1 is the only one of these three genes currently known to have mutations resulting in human disease, and yet it remains the least studied. All three contain the highly conserved integrin-binding tripeptide, RGD, and experiments comparing the cell attachment and haptotactic migration-enhancing properties of DMP1 to BSP and OPN were performed using human skeletal (MG63 and primary dental pulp cells) and salivary gland (HSG) cells. Mutation of any SIBLING's RGD destroyed all attachment and migration activity. Using its alpha V beta 5 integrin, HSG cells attached to BSP but not to DMP1 or OPN. However, HSG cells could not migrate onto BSP in a modified Boyden chamber assay. Expression of alpha V beta 3 integrin enhanced HSG attachment to DMP1 and OPN and promoted haptotactic migration onto all three proteins. Interchanging the first four coding exons or the conserved amino acids adjacent to the RGD of DMP1 with corresponding sequences of BSP did not enhance the ability of DMP1 to bind alpha V beta 5. For alpha V beta 3 expressing cells, intact DMP1, its BMP1-cleaved C-terminal fragment, and exon six lacking all post-translational modifications worked equally well but the proteoglycan isoform of DMP1 had greatly reduced ability for cell attachment and migration. The sequence specificity of the proposed BMP1-cleavage site of DMP1 was verified by mutation analysis. Direct comparison of the three proteins showed that cells discriminate among these SIBLINGs and among DMP1 isoforms.	[von Marschall, Zofia; Fisher, Larry W.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Fisher, LW (corresponding author), Bldg 30,Room 228,9000 Rockville Pike, Bethesda, MD 20892 USA.	lfisher@dir.nidcr.nih.gov			National Institutes of Health Division of Intramural Research, NIDCR; Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000074] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Division of Intramural Research, NIDCR, and the Intramural Research Program.	AOTA S, 1994, J BIOL CHEM, V269, P24756; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; Bucciarelli E, 2007, BREAST CANCER RES TR, V105, P95, DOI 10.1007/s10549-006-9436-0; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6; Fedarko NS, 2000, J BIOL CHEM, V275, P16666, DOI 10.1074/jbc.M001123200; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FISHER LW, 1990, J BIOL CHEM, V265, P2347; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GEORGE A, 1993, J BIOL CHEM, V268, P12624; GREEN MR, 1973, ANAL BIOCHEM, V56, P43, DOI 10.1016/0003-2697(73)90167-X; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Helluin O, 2000, J BIOL CHEM, V275, P18337, DOI 10.1074/jbc.M001529200; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Huq NL, 2005, ARCH ORAL BIOL, V50, P599, DOI 10.1016/j.archoralbio.2004.12.009; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Kulkarni GV, 2000, ARCH ORAL BIOL, V45, P475, DOI 10.1016/S0003-9969(00)00010-8; LAMPUGNANI MG, 1991, LAB INVEST, V65, P96; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Ogbureke KUE, 2007, J HISTOCHEM CYTOCHEM, V55, P403, DOI 10.1369/jhc.6A7075.2007; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2006, J BIOL CHEM, V281, P8034, DOI 10.1074/jbc.M512964200; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Sung V, 1998, J CELL PHYSIOL, V176, P482, DOI 10.1002/(SICI)1097-4652(199809)176:3<482::AID-JCP5>3.0.CO;2-K; TAKADA Y, 2007, GENOME BIOL; Takagi H, 2002, J CELL SCI, V115, P3309; Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; YAMAGATA M, 1993, J CELL SCI, V106, P55; YAMAGATA M, 1994, J CELL SCI, V107, P2581; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005	41	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32730	32740		10.1074/jbc.M804283200	http://dx.doi.org/10.1074/jbc.M804283200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819913	Green Published, hybrid			2022-12-25	WOS:000260893700062
J	Kim, MH; Kim, Y; Park, HJ; Lee, JS; Kwak, SN; Jung, WH; Lee, SG; Kim, D; Lee, YC; Oh, TK				Kim, Myung Hee; Kim, Yoonjeong; Park, Hyo-Jung; Lee, Jong Suk; Kwak, Su-Nam; Jung, Woo-Hyuk; Lee, Seung-Goo; Kim, Dooil; Lee, Young-Choon; Oh, Tae-Kwang			Structural Insight into Bioremediation of Triphenylmethane Dyes by Citrobacter sp Triphenylmethane Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALACHITE GREEN; PROTEIN; DECOLORIZATION; AZO; BIOTRANSFORMATION; PURIFICATION; PROGRAM; FUNGUS	Triphenylmethane dyes are aromatic xenobiotic compounds that are widely considered to be one of the main culprits of environmental pollution. Triphenylmethane reductase (TMR) from Citrobacter sp. strain KCTC 18061P was initially isolated and biochemically characterized as an enzyme that catalyzes the reduction of triphenylmethane dyes. Information from the primary amino acid sequence suggests that TMR is a dinucleotide-binding motif-containing enzyme; however, no other functional clues can be derived from sequence analysis. We present the crystal structure of TMR in complex with NADP(+) at 2.0-angstrom resolution. Despite limited sequence similarity, the enzyme shows remarkable structural similarity to short-chain dehydrogenase/reductase (SDR) family proteins. Functional assignments revealed that TMR has features of both classic and extended SDR family members and does not contain a conserved active site. Thus, it constitutes a novel class of SDR family proteins. On the basis of simulated molecular docking using the substrate malachite green and the TMR/NADP(+) crystal structure, together with site-directed mutagenesis, we have elucidated a potential molecular mechanism for triphenylmethane dye reduction.	[Kim, Myung Hee; Kim, Yoonjeong; Park, Hyo-Jung; Lee, Jong Suk; Kwak, Su-Nam; Jung, Woo-Hyuk; Lee, Seung-Goo; Kim, Dooil; Oh, Tae-Kwang] Korea Res Inst Biosci & Biotechnol, Syst Microbiol Res Ctr, Taejon 305806, South Korea; [Lee, Young-Choon] Dong A Univ, Coll Nat Resources & Life Sci, Pusan 604714, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Dong A University	Kim, MH (corresponding author), Korea Res Inst Biosci & Biotechnol, Syst Microbiol Res Ctr, Taejon 305806, South Korea.	mhk8n@kribb.re.kr; otk@kribb.re.kr	Lee, Seung-Goo/AAS-1613-2021; Lee, Seung-Goo/AAR-9823-2021	Lee, Seung-Goo/0000-0003-4539-9812; Park, Hyo-Jung/0000-0002-1601-7638	21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea	21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by funding from the 21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jadhav JP, 2006, YEAST, V23, P315, DOI 10.1002/yea.1356; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu WX, 2004, J IND MICROBIOL BIOT, V31, P127, DOI 10.1007/s10295-004-0123-z; Louie GV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000993; Min TP, 2003, J BIOL CHEM, V278, P50714, DOI 10.1074/jbc.M308493200; Mulichak AM, 1999, P NATL ACAD SCI USA, V96, P13097, DOI 10.1073/pnas.96.23.13097; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; Schluter A, 2007, APPL ENVIRON MICROB, V73, P6345, DOI 10.1128/AEM.01177-07; Shedbalkar U, 2008, J HAZARD MATER, V157, P472, DOI 10.1016/j.jhazmat.2008.01.023; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shin KS, 1998, BIOTECHNOL LETT, V20, P569; Stammers DK, 2001, EMBO J, V20, P6619, DOI 10.1093/emboj/20.23.6619; Tekere M, 2001, ENZYME MICROB TECH, V28, P420, DOI 10.1016/S0141-0229(00)00343-4; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weisburger JH, 2002, MUTAT RES-FUND MOL M, V506, P9, DOI 10.1016/S0027-5107(02)00147-1; Zheng XF, 2007, P NATL ACAD SCI USA, V104, P8809, DOI 10.1073/pnas.0700480104	39	31	32	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31981	31990		10.1074/jbc.M804092200	http://dx.doi.org/10.1074/jbc.M804092200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782772	hybrid			2022-12-25	WOS:000260760800080
J	Sorensen, HP; Vives, RR; Manetopoulos, C; Albrechtsen, R; Lydolph, MC; Jacobsen, J; Couchman, JR; Wewer, UM				Sorensen, Hans Peter; Vives, Romain R.; Manetopoulos, Christina; Albrechtsen, Reidar; Lydolph, Magnus C.; Jacobsen, Jonas; Couchman, John R.; Wewer, Ulla M.			Heparan Sulfate Regulates ADAM12 through a Molecular Switch Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; 12 MELTRIN ALPHA; SURFACE-PLASMON RESONANCE; CYSTEINE-RICH DOMAIN; INTRACELLULAR MATURATION; CHONDROCYTE PROLIFERATION; PROTEOLYTIC ACTIVITY; TUMOR PROGRESSION; CELL-SURFACE; GROWTH	The disintegrin and metalloproteases (ADAMs) are emerging as therapeutic targets in human disease, but specific drug design is hampered by potential redundancy. Unlike other metzincins, ADAM prodomains remain bound to the mature enzyme to regulate activity. Here ADAM12, a protease that promotes tumor progression and chondrocyte proliferation in osteoarthritic cartilage, is shown to possess a prodomain/catalytic domain cationic molecular switch, regulated by exogenous heparan sulfate and heparin but also endogenous cell surface proteoglycans and the polyanion, calcium pentosan polysulfate. Sheddase functions of ADAM12 are regulated by the switch, as are proteolytic functions in placental tissue and sera of pregnant women. Moreover, human heparanase, an enzyme also linked to tumorigenesis, can promote ADAM12 sheddase activity at the cell surface through cleavage of the inhibitory heparan sulfate. These data present a novel concept that might allow targeting of ADAM12 and suggest that other ADAMs may have specific regulatory activity embedded in their prodomain and catalytic domain structures.	[Sorensen, Hans Peter; Manetopoulos, Christina; Albrechtsen, Reidar; Lydolph, Magnus C.; Jacobsen, Jonas; Couchman, John R.; Wewer, Ulla M.] Univ Copenhagen, Dept Biomed, DK-2200 Copenhagen N, Denmark; [Sorensen, Hans Peter; Manetopoulos, Christina; Albrechtsen, Reidar; Lydolph, Magnus C.; Jacobsen, Jonas; Couchman, John R.; Wewer, Ulla M.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Vives, Romain R.] Univ Grenoble 1, Inst Biol Struct, CNRS, Commissariat Energie Atom,UMR 5075, F-38027 Grenoble, France	University of Copenhagen; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Wewer, UM (corresponding author), Univ Copenhagen, Dept Biomed, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	ullaw@pai.ku.dk	Vives, Romain/I-9372-2012	Albrechtsen, Reidar/0000-0003-4180-1827	Danish Cancer Society [DP06052, DP05076]; Lundbeck Foundation; Novo Nordisk Foundation; Danish Medical Research Council; Carlsberg Foundation; Munksholm Foundation; Hartmann Foundation	Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Carlsberg Foundation(Carlsberg Foundation); Munksholm Foundation; Hartmann Foundation	This work was supported by Danish Cancer Society Grants DP06052 and DP05076, the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Medical Research Council, the Carlsberg Foundation, the Munksholm Foundation, and the Hartmann Foundation.	Beattie J, 2008, MOL CELL BIOCHEM, V307, P221, DOI 10.1007/s11010-007-9601-8; Booth BA, 1996, AM J PHYSIOL-ENDOC M, V271, pE465, DOI 10.1152/ajpendo.1996.271.3.E465; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; ESKO JD, 1987, J BIOL CHEM, V262, P12189; Fowlkes JL, 1996, J BIOL CHEM, V271, P14676, DOI 10.1074/jbc.271.25.14676; Fowlkes JL, 1997, ENDOCRINOLOGY, V138, P2280, DOI 10.1210/en.138.6.2280; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Garlisi CG, 2003, BIOCHEM BIOPH RES CO, V301, P35, DOI 10.1016/S0006-291X(02)02976-5; Ghosh P, 2002, BIOGERONTOLOGY, V3, P85, DOI 10.1023/A:1015219716583; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Irwin JC, 2000, ENDOCRINOLOGY, V141, P666, DOI 10.1210/en.141.2.666; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kristensen J, 2005, INT J BIOL MACROMOL, V37, P212, DOI 10.1016/j.ijbiomac.2005.10.011; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Kveiborg M, 2006, J BONE MINER RES, V21, P1288, DOI 10.1359/JBMR.060502; Laigaard J, 2003, PRENATAL DIAG, V23, P1086, DOI 10.1002/pd.762; Laigaard J, 2006, PRENATAL DIAG, V26, P689, DOI 10.1002/pd.1480; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Li JP, 2008, ANTI-CANCER AGENT ME, V8, P64, DOI 10.2174/187152008783330824; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Martel-Pelletier J, 1998, INFLAMM RES, V47, P90, DOI 10.1007/s000110050288; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oh M, 2004, BIOORG MED CHEM LETT, V14, P6071, DOI 10.1016/j.bmcl.2004.09.082; Okada A, 2008, ARTHRITIS RHEUM-US, V58, P778, DOI 10.1002/art.23262; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P5324, DOI 10.1021/bi060056r; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Scholefield Z, 2003, J CELL BIOL, V163, P97, DOI 10.1083/jcb.200303059; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Sorensen HP, 2008, PROTEIN EXPRES PURIF, V61, P175, DOI 10.1016/j.pep.2008.05.020; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Vives RR, 2004, J BIOL CHEM, V279, P54327, DOI 10.1074/jbc.M409760200; Vives RR, 2004, VIROLOGY, V321, P332, DOI 10.1016/j.virol.2004.01.015; Vives RR, 2001, BIOCHEM J, V354, P141, DOI 10.1042/0264-6021:3540141; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Warda M, 2008, GLYCOCONJUGATE J, V25, P441, DOI 10.1007/s10719-007-9090-8; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183	65	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31920	31932		10.1074/jbc.M804113200	http://dx.doi.org/10.1074/jbc.M804113200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801731	hybrid			2022-12-25	WOS:000260760800074
J	Harmon, S; Preston, RJS; Ainle, FN; Johnson, JA; Cunningham, MS; Smith, OP; White, B; O'Donnell, JS				Harmon, Shona; Preston, Roger J. S.; Ainle, Fionnuala Ni; Johnson, Jennifer A.; Cunningham, Moya S.; Smith, Owen P.; White, Barry; O'Donnell, James S.			Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-SENSITIVE REGION; ENDOTHELIAL BARRIER PROTECTION; RANDOMIZED CONTROLLED-TRIAL; FACTOR PATHWAY INHIBITOR; HUMAN BRAIN ENDOTHELIUM; TISSUE FACTOR PATHWAY; SEVERE SEPSIS; GLA DOMAIN; ANTICOAGULANT ACTIVITY; PHOSPHOLIPID-BINDING	Activated protein C (APC) plays a critical anticoagulant role in vivo by inactivating procoagulant factor Va and factor VIIIa and thus down-regulating thrombin generation. In addition, APC bound to the endothelial cell protein C receptor can initiate protease-activated receptor-1 (PAR-1)-mediated cytoprotective signaling. Protein S constitutes a critical cofactor for the anticoagulant function of APC but is not known to be involved in regulating APC-mediated protective PAR-1 signaling. In this study we utilized a site-directed mutagenesis strategy to characterize a putative protein S binding region within the APC Gla domain. Three single amino acid substitutions within the APC Gla domain (D35T, D36A, and A39V) were found to mildly impair protein S-dependent anticoagulant activity (<2-fold) but retained entirely normal cytoprotective activity. However, a single amino acid substitution (L38D) ablated the ability of protein S to function as a cofactor for this APC variant. Consequently, in assays of protein S-dependent factor Va proteolysis using purified proteins or in the plasma milieu, APC-L38D variant exhibited minimal residual anticoagulant activity compared with wild type APC. Despite the location of Leu-38 in the Gla domain, APC-L38D interacted normally with endothelial cell protein C receptor and retained its ability to trigger PAR-1 mediated cytoprotective signaling in a manner indistinguishable from that of wild type APC. Consequently, elimination of protein S cofactor enhancement of APC anticoagulant function represents a novel and effective strategy by which to separate the anticoagulant and cytoprotective functions of APC for potential therapeutic gain.	[Harmon, Shona; Preston, Roger J. S.; Ainle, Fionnuala Ni; Johnson, Jennifer A.; Cunningham, Moya S.; O'Donnell, James S.] Trinity Coll Dublin, St James Hosp, Inst Mol Med, Haemostasis Res Grp, Dublin 8, Ireland; [Smith, Owen P.] Our Ladys Childrens Hosp Crumlin, Dept Haematol, Dublin 12, Ireland; [White, Barry; O'Donnell, James S.] St James Hosp, Natl Ctr Hereditary Coagulat Disorders, Dublin 8, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Preston, RJS (corresponding author), Trinity Coll Dublin, St James Hosp, Inst Mol Med, Haemostasis Res Grp, Dublin 8, Ireland.	prestonr@tcd.ie	Smith, Owen/AAU-8929-2020; O'Donnell, James/A-6171-2009	Preston, Roger/0000-0003-0108-4077; Ni Ainle, Fionnuala/0000-0003-0163-792X; O'Donnell, James/0000-0003-0309-3313	Health Research Board [PD/2006/24]; Irish Heart Foundation; Children's Medical Research Foundation; Science Foundation Ireland President of Ireland Young Researcher [06/Y12/0925]	Health Research Board; Irish Heart Foundation; Children's Medical Research Foundation; Science Foundation Ireland President of Ireland Young Researcher(Science Foundation Ireland)	This work was supported by a Health Research Board Fellowship PD/2006/24 (to R. J. S. P.), an Irish Heart Foundation grant (to J. S. O. D.), a Children's Medical Research Foundation Award (to F. N. A. and O. P. S.), and Science Foundation Ireland President of Ireland Young Researcher Award 06/Y12/0925 (to J. S. O. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Berg DT, 2003, P NATL ACAD SCI USA, V100, P4423, DOI 10.1073/pnas.0736918100; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bertolini G, 2007, INTENS CARE MED, V33, P426, DOI 10.1007/s00134-007-0554-x; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; DAHLBACK B, 1990, J BIOL CHEM, V265, P8127; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FAY PJ, 1991, J BIOL CHEM, V266, P20139; Feistritzer C, 2005, J THROMB HAEMOST, V3, P2798, DOI 10.1111/j.1538-7836.2005.01610.x; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Giri TK, 1999, THROMB HAEMOSTASIS, V82, P1627, DOI 10.1055/s-0037-1614890; Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; He XH, 1998, J BIOL CHEM, V273, P27449, DOI 10.1074/jbc.273.42.27449; HE XH, 1995, EUR J BIOCHEM, V227, P433, DOI 10.1111/j.1432-1033.1995.tb20406.x; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kanji S, 2007, INTENS CARE MED, V33, P517, DOI 10.1007/s00134-007-0555-9; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Mille-Baker B, 2003, BLOOD, V101, P1416, DOI 10.1182/blood-2002-08-2353; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; REITSMA PH, 1993, THROMB HAEMOSTASIS, V69, P77; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Saller F, 2006, J THROMB HAEMOST, V4, P704, DOI 10.1111/j.1538-7836.2006.01827.x; Saller F, 2005, BLOOD, V105, P122, DOI 10.1182/blood-2004-06-2176; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; Smirnov MD, 1998, J BIOL CHEM, V273, P9031, DOI 10.1074/jbc.273.15.9031; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; WALKER FJ, 1984, SEMIN THROMB HEMOST, V10, P131, DOI 10.1055/s-2007-1004415; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; White B, 2000, BRIT J HAEMATOL, V110, P130, DOI 10.1046/j.1365-2141.2000.02128.x; Yegneswaran S, 1999, J BIOL CHEM, V274, P5462, DOI 10.1074/jbc.274.9.5462	42	38	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30531	30539		10.1074/jbc.M802338200	http://dx.doi.org/10.1074/jbc.M802338200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18779332	Green Published, hybrid			2022-12-25	WOS:000260544800011
J	Cavarelli, M; Karlsson, I; Zanchetta, M; Antonsson, L; Plebani, A; Giaquinto, C; Fenyo, EM; De Rossi, A; Scarlatti, G				Cavarelli, Mariangela; Karlsson, Ingrid; Zanchetta, Marisa; Antonsson, Liselotte; Plebani, Anna; Giaquinto, Carlo; Fenyo, Eva Maria; De Rossi, Anita; Scarlatti, Gabriella			HIV-1 with Multiple CCR5/CXCR4 Chimeric Receptor Use Is Predictive of Immunological Failure in Infected Children	PLOS ONE			English	Article								Background: HIV-1 R5 viruses are characterized by a large phenotypic variation, that is reflected by the mode of coreceptor use. The ability of R5 HIV-1 to infect target cells expressing chimeric receptors between CCR5 and CXCR4 (R5(broad) viruses), was shown to correlate with disease stage in HIV-1 infected adults. Here, we ask the question whether phenotypic variation of R5 viruses could play a role also in mother-to-child transmission (MTCT) of HIV-1 and pediatric disease progression. Methodology/Principal Findings: Viral isolates obtained from a total of 59 HIV-1 seropositive women (24 transmitting and 35 non transmitting) and 28 infected newborn children, were used to infect U87. CD4 cells expressing wild type or six different CCR5/CXCR4 chimeric receptors. HIV-1 isolates obtained from newborn infants had predominantly R5(narrow) phenotype (n = 20), but R5(broad) and R5X4 viruses were also found in seven and one case, respectively. The presence of R5(broad) and R5X4 phenotypes correlated significantly with a severe decline of the CD4+ T cells (CDC stage 3) or death within 2 years of age. Forty-three percent of the maternal R5 isolates displayed an R5(broad) phenotype, however, the presence of the R5(broad) virus was not predictive for MTCT of HIV-1. Of interest, while only 1 of 5 mothers with an R5X4 virus transmitted the dualtropic virus, 5 of 6 mothers carrying R5(broad) viruses transmitted viruses with a similar broad chimeric coreceptor usage. Thus, the maternal R5(broad) phenotype was largely preserved during transmission and could be predictive of the phenotype of the newborn's viral variant. Conclusions/Significance: Our results show that R5(broad) viruses are not hampered in transmission. When transmitted, immunological failure occurs earlier than in children infected with HIV-1 of R5(narrow) phenotype. We believe that this finding is of utmost relevance for therapeutic interventions in pediatric HIV-1 infection.	[Cavarelli, Mariangela; Scarlatti, Gabriella] Fdn Ctr San Raffaele, DIBIT, Viral Evolut & Transmiss Unit, Milan, Italy; [Karlsson, Ingrid; Fenyo, Eva Maria] Lund Univ, Dept Lab Med, Div Med Microbiol Virol, S-22100 Lund, Sweden; [Zanchetta, Marisa; De Rossi, Anita] Univ Padua, AIDS Reference Ctr, Dept Oncol & Surgical Sci, Unit Viral Oncol, I-35100 Padua, Italy; [Antonsson, Liselotte] Lund Univ, Dept Expt Med Sci, Div Cellular & Mol Pharmacol, S-22100 Lund, Sweden; [Plebani, Anna] Univ Milan, Clin Marchi, Dept Pediat, I-20122 Milan, Italy; [Giaquinto, Carlo] Univ Padua, Dept Pediat, I-35100 Padua, Italy	Lund University; University of Padua; Lund University; University of Milan; University of Padua	Cavarelli, M (corresponding author), Fdn Ctr San Raffaele, DIBIT, Viral Evolut & Transmiss Unit, Milan, Italy.	cavarelli.mariangela@hsr.it	Plebani, Alessandro/C-8593-2011; De Rossi, A./L-3128-2015; De Rossi, Anita/Q-4845-2019; scarlatti, gabriella/H-1482-2018; Giaquinto, Carlo/AAB-5016-2020	De Rossi, A./0000-0001-6435-7509; De Rossi, Anita/0000-0001-6435-7509; scarlatti, gabriella/0000-0003-2316-2689; CAVARELLI, MARIANGELA/0000-0002-8468-0263; GIAQUINTO, CARLO/0000-0001-9365-0413	Swedish Research Council; Istituto Superiore di Sanita within the framework of the National program for AIDS research [40G.21, 45G.12, 40G.56]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Istituto Superiore di Sanita within the framework of the National program for AIDS research	The financial support was received by the Swedish Research Council and by the Istituto Superiore di Sanita within the framework of the National program for AIDS research, Grant no.40G.21, 45G.12 and 40G.56. Only financial support.	Antonsson L, 2003, AIDS, V17, P2571, DOI 10.1097/00002030-200312050-00004; Bjorndal A, 1997, J VIROL, V71, P7478; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Casper C, 2002, AIDS RES HUM RETROV, V18, P343, DOI 10.1089/088922202753519124; CONTROL CFD, 1993, MMWR-MORBID MORTAL W, V41, P1; CONTROL CFD, 1994, MMWR-MORBID MORTAL W, V43, P1; DEROSSI A, 1991, AIDS, V5, P15, DOI 10.1097/00002030-199101000-00002; Jansson M, 1996, P NATL ACAD SCI USA, V93, P15382, DOI 10.1073/pnas.93.26.15382; KARLSSON A, 1994, J CLIN MICROBIOL, V32, P364, DOI 10.1128/JCM.32.2.364-370.1994; Karlsson I, 2004, J VIROL, V78, P11807, DOI 10.1128/JVI.78.21.11807-11815.2004; Karlsson I, 2003, AIDS, V17, P2561, DOI 10.1097/00002030-200312050-00003; Koning FA, 2003, J INFECT DIS, V188, P864, DOI 10.1086/377105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Mo HM, 1998, AIDS RES HUM RETROV, V14, P607, DOI 10.1089/aid.1998.14.607; MOK JQ, 1987, LANCET, V1, P1164; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; OMETTO L, 1995, AIDS, V9, P427, DOI 10.1097/00002030-199509050-00003; Ometto L, 1999, AIDS RES HUM RETROV, V15, P1441, DOI 10.1089/088922299309955; Ometto L, 2000, AIDS, V14, P1721, DOI 10.1097/00002030-200008180-00006; Pasquier C, 1998, J VIROL, V72, P8493, DOI 10.1128/JVI.72.11.8493-8501.1998; Peters PJ, 2006, J VIROL, V80, P6324, DOI 10.1128/JVI.02328-05; Salvatori F, 2001, AIDS RES HUM RETROV, V17, P925, DOI 10.1089/088922201750290041; SCARLATTI G, 1991, AIDS, V5, P1173, DOI 10.1097/00002030-199110000-00003; Scarlatti G, 2004, AIDS REV, V6, P67; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SCARLATTI G, 1993, VIROLOGY, V197, P624, DOI 10.1006/viro.1993.1637; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; Sleasman JW, 1996, AIDS, V10, P1477, DOI 10.1097/00002030-199611000-00004; Tuttle DL, 2004, AIDS RES HUM RETROV, V20, P305, DOI 10.1089/088922204322996545; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; UNAIDS, 2007, REP GLOB AIDS EP; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316	34	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3292	10.1371/journal.pone.0003292	http://dx.doi.org/10.1371/journal.pone.0003292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820725	gold, Green Published, Green Submitted			2022-12-25	WOS:000264432500003
J	Tella, JL; Lemus, JA; Carrete, M; Blanco, G				Tella, Jose L.; Lemus, Jesus A.; Carrete, Martina; Blanco, Guillermo			The PHA Test Reflects Acquired T-Cell Mediated Immunocompetence in Birds	PLOS ONE			English	Article								Background: cological immunology requires techniques to reliably measure immunocompetence in wild vertebrates. The PHA-skin test, involving subcutaneous injection of a mitogen (phytohemagglutinin, PHA) and measurement of subsequent swelling as a surrogate of T-cell mediated immunocompetence, has been the test of choice due to its practicality and ease of use in the field. However, mechanisms involved in local immunological and inflammatory processes provoked by PHA are poorly known, and its use and interpretation as an acquired immune response is currently debated. Methodology: Here, we present experimental work using a variety of parrot species, to ascertain whether PHA exposure produces larger secondary than primary responses as expected if the test reflects acquired immunocompetence. Moreover, we simultaneously quantified T-lymphocyte subsets (CD4(+), CD5(+) and CD8(+)) and plasma proteins circulating in the bloodstream, potentially involved in the immunological and inflammatory processes, through flow cytometry and electrophoresis. Principal Findings: Our results showed stronger responses after a second PHA injection, independent of species, time elapsed and changes in body mass of birds between first and second injections, thus supporting the adaptive nature of this immune response. Furthermore, the concomitant changes in the plasma concentrations of T-lymphocyte subsets and globulins indicate a causal link between the activation of the T-cell mediated immune system and local tissue swelling. Conclusions/Significance: These findings justify the widespread use of the PHA-skin test as a reliable evaluator of acquired T-cell mediated immunocompetence in diverse biological disciplines. Further experimental research should be aimed at evaluating the relative role of innate immunocompetence in wild conditions, where the access to dietary proteins varies more than in captivity, and to ascertain how PHA responses relate to particular host-parasite interactions.	[Tella, Jose L.; Carrete, Martina] CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Lemus, Jesus A.; Blanco, Guillermo] CSIC, Museo Nacl Ciencias Naturales, Dept Evolut Ecol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Tella, JL (corresponding author), CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	tella@ebd.csic.es	Carrete, Martina/A-6376-2009; Tella, José L/I-3707-2015; Carrete, Martina/D-2618-2017; Blanco, Guillermo/L-3170-2014	Carrete, Martina/0000-0002-0491-2950; Tella, José L/0000-0002-3038-7424; Blanco, Guillermo/0000-0001-5742-4929				Alonso-Alvarez C, 2001, CAN J ZOOL, V79, P101, DOI 10.1139/cjz-79-1-101; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Amo L, 2007, BIOL CONSERV, V135, P77, DOI 10.1016/j.biocon.2006.09.020; Baos R, 2006, ENVIRON TOXICOL CHEM, V25, P1153, DOI 10.1897/05-395R.1; Bayyari GR, 1997, POULTRY SCI, V76, P289, DOI 10.1093/ps/76.2.289; Bize P, 2008, AM NAT, V171, P107, DOI 10.1086/523943; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P207, DOI 10.1890/070075; Cho BK, 2001, P NATL ACAD SCI USA, V98, P1723, DOI 10.1073/pnas.98.4.1723; Clotfelter ED, 2007, BEHAV ECOL, V18, P1139, DOI 10.1093/beheco/arm090; Cooper MD, 2002, IMMUNOL REV, V185, P175, DOI 10.1034/j.1600-065X.2002.18515.x; Cray C, 1998, J AVIAN MED SURG, V12, P4; Del Hoyo, 1997, HDB BIRDS WORLD SAND; ELGERT KD, 1996, IMMUNOLOGY; Finkelstein M, 2003, ARCH ENVIRON CON TOX, V44, P502, DOI 10.1007/s00244-002-2075-5; Franson JC, 2007, J TOXICOL ENV HEAL A, V70, P861, DOI 10.1080/15287390701212760; GENTRY PA, 1999, CLIN CHEM LAB ANIMAL; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; GOTO N, 1978, POULTRY SCI, V57, P246, DOI 10.3382/ps.0570246; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Hawley DM, 2007, FUNCT ECOL, V21, P520, DOI 10.1111/j.1365-2435.2007.01254.x; Horak P, 2002, CAN J ZOOL, V80, P636, DOI 10.1139/Z02-038; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Hueza IM, 2007, J VET MED A, V54, P179, DOI 10.1111/j.1439-0442.2007.00917.x; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Kaneko JJ., 1997, CLIN BIOCH DOMESTIC, V5th edn, P117137; Keller JM, 2005, VET IMMUNOL IMMUNOP, V103, P269, DOI 10.1016/j.vetimm.2004.09.029; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Laiolo P, 2007, BEHAV ECOL, V18, P507, DOI 10.1093/beheco/arm008; Lavoie ET, 2005, ARCH ENVIRON CON TOX, V48, P552, DOI 10.1007/s00244-004-0128-7; Lehmer EM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P514, DOI 10.1086/520128; Lumeij J. T., 1996, Journal of Avian Medicine and Surgery, V10, P150; Martinez MC, 2006, EDUC POLICY, V20, P299, DOI 10.1177/0895904805285017; Milston RH, 2003, FISH SHELLFISH IMMUN, V15, P145, DOI 10.1016/S1050-4648(02)00151-1; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; Nguyen HT, 1999, CLIN CHEM LAB ANIMAL; Owen JP, 2007, TRENDS ECOL EVOL, V22, P228, DOI 10.1016/j.tree.2007.02.003; Pitala N, 2007, BIOL LETTERS, V3, P418, DOI 10.1098/rsbl.2007.0135; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; Roulin A, 2007, BIOL J LINN SOC, V90, P703, DOI 10.1111/j.1095-8312.2007.00759.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Spottiswoode CN, 2008, BEHAV ECOL SOCIOBIOL, V62, P963, DOI 10.1007/s00265-007-0521-0; STADECKER MJ, 1977, J IMMUNOL, V118, P1564; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; Tella JL, 2000, OECOLOGIA, V123, P453, DOI 10.1007/s004420000331; TIZARD I, 2000, INTRO VET IMMUNOLOGY; Uchiyama R, 2005, J VET MED SCI, V67, P441, DOI 10.1292/jvms.67.441; Vance CK, 2004, J ZOO WILDLIFE MED, V35, P435, DOI 10.1638/04-014; Vila JM, 2001, J IMMUNOL, V166, P396, DOI 10.4049/jimmunol.166.1.396	50	127	130	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3295	10.1371/journal.pone.0003295	http://dx.doi.org/10.1371/journal.pone.0003295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820730	Green Published, Green Submitted, gold			2022-12-25	WOS:000264432500005
J	Carroll, RG; Carpenito, C; Shan, XC; Danet-Desnoyers, G; Liu, RH; Jiang, SG; Albelda, SM; Golovina, T; Coukos, G; Riley, JL; Jonak, ZL; June, CH				Carroll, Richard G.; Carpenito, Carmine; Shan, Xiaochuan; Danet-Desnoyers, Gwenn; Liu, Ronghua; Jiang, Shuguang; Albelda, Steven M.; Golovina, Tatiana; Coukos, George; Riley, James L.; Jonak, Zdenka L.; June, Carl H.			Distinct Effects of IL-18 on the Engraftment and Function of Human Effector CD8(+) T Cells and Regulatory T Cells	PLOS ONE			English	Article								IL-18 has pleotropic effects on the activation of T cells during antigen presentation. We investigated the effects of human IL-18 on the engraftment and function of human T cell subsets in xenograft mouse models. IL-18 enhanced the engraftment of human CD8(+) effector T cells and promoted the development of xenogeneic graft versus host disease (GVHD). In marked contrast, IL-18 had reciprocal effects on the engraftment of CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) in the xenografted mice. Adoptive transfer experiments indicated that IL-18 prevented the suppressive effects of Tregs on the development of xenogeneic GVHD. The IL-18 results were robust as they were observed in two different mouse strains. In addition, the effects of IL-18 were systemic as IL-18 promoted engraftment and persistence of human effector T cells and decreased Tregs in peripheral blood, peritoneal cavity, spleen and liver. In vitro experiments indicated that the expression of the IL-18R alpha was induced on both CD4 and CD8 effector T cells and Tregs, and that the duration of expression was less sustained on Tregs. These preclinical data suggest that human IL-18 may have use as an adjuvant for immune reconstitution after cytotoxic therapies, and to augment adoptive immunotherapy, donor leukocyte infusions, and vaccine strategies.	[Carroll, Richard G.; Carpenito, Carmine; Shan, Xiaochuan; Liu, Ronghua; Jiang, Shuguang; Golovina, Tatiana; Coukos, George; Riley, James L.; June, Carl H.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Carroll, Richard G.; Riley, James L.; June, Carl H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Danet-Desnoyers, Gwenn; Albelda, Steven M.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Jonak, Zdenka L.] GlaxoSmithKline Inc, Biopharm CEDD, King Of Prussia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; GlaxoSmithKline	Carroll, RG (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	cjune@mail.med.upenn.edu	Coukos, George/ABG-7389-2020	Coukos, George/0000-0001-8813-7367; Riley, James/0000-0002-1057-576X	GlaxoSmithKline; NATIONAL CANCER INSTITUTE [R01CA105216] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by research funding from GlaxoSmithKline to CHJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAUGUE S, 2008, BLOOD           0625; BASU S, 2008, J IMMUNOL IN PRESS; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Calvani N, 2005, AUTOIMMUN REV, V4, P542, DOI 10.1016/j.autrev.2005.04.009; Cho D, 2000, CANCER RES, V60, P2703; Christianson SW, 1997, J IMMUNOL, V158, P3578; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Dai SM, 2007, ANN RHEUM DIS, V66, P1411, DOI 10.1136/ard.2006.067793; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Efthimiou P, 2007, NAT CLIN PRACT RHEUM, V3, P328, DOI 10.1038/ncprheum0510; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Godfrey WR, 2004, BLOOD, V104, P453, DOI 10.1182/blood-2004-01-0151; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Greene CM, 2000, J IMMUNOL, V165, P4718, DOI 10.4049/jimmunol.165.8.4718; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Herzyk DJ, 2002, CYTOKINE, V20, P38, DOI 10.1006/cyto.2002.1978; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Hultgren O, 2007, AUTOIMMUNITY, V40, P529, DOI 10.1080/08916930701622783; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; June CH, 2006, SEMIN IMMUNOL, V18, P78, DOI 10.1016/j.smim.2006.01.006; Kirkpatrick RB, 2003, PROTEIN EXPRES PURIF, V27, P279, DOI 10.1016/S1046-5928(02)00606-X; Leonard JP, 1997, BLOOD, V90, P2541; Lin YJ, 2008, LUPUS, V17, P124, DOI 10.1177/0961203307086031; Logan Theodore F, 2006, Curr Oncol Rep, V8, P114, DOI 10.1007/s11912-006-0046-0; Luo YP, 2005, CANCER RES, V65, P3419, DOI 10.1158/0008-5472.CAN-04-3120; Marshall DJ, 2006, VACCINE, V24, P244, DOI 10.1016/j.vaccine.2005.07.087; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pittoni V, 2002, ANN RHEUM DIS, V61, P723, DOI 10.1136/ard.61.8.723; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Reddy P, 2001, J EXP MED, V194, P1433, DOI 10.1084/jem.194.10.1433; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Son YI, 2001, CANCER RES, V61, P884; Stoll S, 1998, EUR J IMMUNOL, V28, P3231, DOI 10.1002/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Takada H, 1999, BRIT J HAEMATOL, V106, P182, DOI 10.1046/j.1365-2141.1999.01504.x; Takeuchi M, 1997, CELL TISSUE RES, V289, P499, DOI 10.1007/s004410050895; Tanaka Y, 2002, J AUTOIMMUN, V18, P9, DOI 10.1006/jaut.2001.0559; Tatsumi T, 2002, CANCER RES, V62, P5853; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Tedeschi A, 2007, CLIN EXP DERMATOL, V32, P568, DOI 10.1111/j.1365-2230.2007.02450.x; Trenado A, 2006, J IMMUNOL, V176, P1266, DOI 10.4049/jimmunol.176.2.1266; Tsutsui H, 1996, J IMMUNOL, V157, P3967; Ushio S, 1996, J IMMUNOL, V156, P4274; Vidal-Vanaclocha F, 2006, CANCER METAST REV, V25, P417, DOI 10.1007/s10555-006-9013-3; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Woo EY, 2001, CANCER RES, V61, P4766; Xu B, 2007, GENE THER, V14, P1181, DOI 10.1038/sj.gt.3302966; Zeiser R, 2007, BIOL BLOOD MARROW TR, V13, P1427, DOI 10.1016/j.bbmt.2007.08.041; Zhang B, 2004, LEUKEMIA RES, V28, P91, DOI 10.1016/S0145-2126(03)00121-8; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	65	38	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3289	10.1371/journal.pone.0003289	http://dx.doi.org/10.1371/journal.pone.0003289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818761	Green Submitted, Green Published, gold			2022-12-25	WOS:000264432300011
J	Peters, JH; Preijers, FW; Woestenenk, R; Hilbrands, LB; Koenen, HJPM; Joosten, I				Peters, Jorieke H.; Preijers, Frank W.; Woestenenk, Rob; Hilbrands, Luuk B.; Koenen, Hans J. P. M.; Joosten, Irma			Clinical Grade Treg: GMP Isolation, Improvement of Purity by CD127(pos) Depletion, Treg Expansion, and Treg Cryopreservation	PLOS ONE			English	Article								Background: Treg based immunotherapy is of great interest to facilitate tolerance in autoimmunity and transplantation. For clinical trials, it is essential to have a clinical grade Treg isolation protocol in accordance with Good Manufacturing Practice (GMP) guidelines. To obtain sufficient Treg for immunotherapy, subsequent ex vivo expansion might be needed. Methodology/Principal Findings: Treg were isolated from leukapheresis products by CliniMACS based GMP isolation strategies, using anti-CD25, anti-CD8 and anti-CD19 coated microbeads. CliniMACS isolation procedures led to 40-60% pure CD4(pos) CD25(high) FoxP3(pos) Treg populations that were anergic and had moderate suppressive activity. Such CliniMACS isolated Treg populations could be expanded with maintenance of suppressive function. Alloantigen stimulated expansion caused an enrichment of alloantigen-specific Treg. Depletion of unwanted CD19(pos) cells during CliniMACS Treg isolation proved necessary to prevent B-cell outgrowth during expansion. CD4(pos) CD127(pos) conventional T cells were the major contaminating cell type in CliniMACS isolated Treg populations. Depletion of CD127(pos) cells improved the purity of CD4(pos) CD25(high) FoxP3(pos) Treg in CliniMACS isolated cell populations to approximately 90%. Expanded CD127(neg) CliniMACS isolated Treg populations showed very potent suppressive capacity and high FoxP3 expression. Furthermore, our data show that cryopreservation of CliniMACS isolated Treg is feasible, but that activation after thawing is necessary to restore suppressive potential. Conclusions/Significance: The feasibility of Treg based therapy is widely accepted, provided that tailor-made clinical grade procedures for isolation and ex vivo cell handling are available. We here provide further support for this approach by showing that a high Treg purity can be reached, and that isolated cells can be cryopreserved and expanded successfully.	[Peters, Jorieke H.; Koenen, Hans J. P. M.; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands; [Preijers, Frank W.; Woestenenk, Rob] Radboud Univ Nijmegen, Cent Hematol Lab, Nijmegen, Netherlands; [Hilbrands, Luuk B.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Peters, JH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands.	I.Joosten@abti.umcn.nl	Hilbrands, Luuk/B-4921-2011; Woestenenk, Rob/C-6119-2016; Koenen, Hans J.P.M./A-2852-2014; Joosten, Irma/N-4418-2013; Preijers, Frank/L-4586-2015	Hilbrands, Luuk/0000-0002-4935-9765; Joosten, Irma/0000-0003-2950-4977; 	Dutch Kidney Foundation [C05-2106]	Dutch Kidney Foundation	This study was supported by a grant of the Dutch Kidney Foundation (C05-2106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushell A, 2005, J IMMUNOL, V174, P3290, DOI 10.4049/jimmunol.174.6.3290; Curtis RE, 1999, BLOOD, V94, P2208; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Golshayan D, 2006, BLOOD, V6, P1879; Gross TG, 1999, BONE MARROW TRANSPL, V23, P251, DOI 10.1038/sj.bmt.1701554; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hoffmann P, 2006, BIOL BLOOD MARROW TR, V12, P267, DOI 10.1016/j.bbmt.2006.01.005; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Joffre O, 2004, BLOOD, V103, P4216, DOI 10.1182/blood-2004-01-0005; Jones SC, 2003, BIOL BLOOD MARROW TR, V9, P243, DOI 10.1053/bbmt.2003.50027; Karakhanova S, 2006, J IMMUNOTHER, V29, P336, DOI 10.1097/01.cji.0000203080.43235.9e; Koenen HJPM, 2005, J IMMUNOL, V174, P7573, DOI 10.4049/jimmunol.174.12.7573; Koenen HJPM, 2003, J IMMUNOL, V171, P6431, DOI 10.4049/jimmunol.171.12.6431; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kreijveld E, 2006, J IMMUNOL METHODS, V314, P103, DOI 10.1016/j.jim.2006.06.001; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Peters JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002233; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P155, DOI 10.1016/j.critrevonc.2005.03.015; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Wichlan DG, 2006, J IMMUNOL METHODS, V315, P27, DOI 10.1016/j.jim.2006.06.014; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103	28	80	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3161	10.1371/journal.pone.0003161	http://dx.doi.org/10.1371/journal.pone.0003161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776930	gold, Green Published, Green Submitted			2022-12-25	WOS:000264424300006
J	Turville, SG; Aravantinou, M; Miller, T; Kenney, J; Teitelbaum, A; Hu, LY; Chudolij, A; Zydowsky, TM; Piatak, M; Bess, JW; Lifson, JD; Blanchard, J; Gettie, A; Robbiani, M				Turville, Stuart G.; Aravantinou, Meropi; Miller, Todd; Kenney, Jessica; Teitelbaum, Aaron; Hu, Lieyu; Chudolij, Anne; Zydowsky, Tom M.; Piatak, Michael, Jr.; Bess, Julian W., Jr.; Lifson, Jeffrey D.; Blanchard, James; Gettie, Agegnehu; Robbiani, Melissa			Efficacy of Carraguard (R)-Based Microbicides In Vivo Despite Variable In Vitro Activity	PLOS ONE			English	Article								Anti-HIV microbicides are being investigated in clinical trials and understanding how promising strategies work, coincident with demonstrating efficacy in vivo, is central to advancing new generation microbicides. We evaluated Carraguard (R) and a new generation Carraguard-based formulation containing the non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 (PC-817). Since dendritic cells (DCs) are believed to be important in HIV transmission, the formulations were tested for the ability to limit DC-driven infection in vitro versus vaginal infection of macaques with RT-SHIV (SIVmac239 bearing HIV reverse transcriptase). Carraguard showed limited activity against cell-free and mature DC-driven RT-SHIV infections and, surprisingly, low doses of Carraguard enhanced infection. However, nanomolar amounts of MIV-150 overcame enhancement and blocked DC-transmitted infection. In contrast, Carraguard impeded infection of immature DCs coincident with DC maturation. Despite this variable activity in vitro, Carraguard and PC-817 prevented vaginal transmission of RT-SHIV when applied 30 min prior to challenge. PC-817 appeared no more effective than Carraguard in vivo, due to the limited activity of a single dose of MIV-150 and the dominant barrier effect of Carraguard. However, 3 doses of MIV-150 in placebo gel at and around challenge limited vaginal infection, demonstrating the potential activity of a topically applied NNRTI. These data demonstrate discordant observations when comparing in vitro and in vivo efficacy of Carraguard-based microbicides, highlighting the difficulties in testing putative anti-viral strategies in vitro to predict in vivo activity. This work also underscores the potential of Carraguard-based formulations for the delivery of anti-viral drugs to prevent vaginal HIV infection.	[Turville, Stuart G.; Aravantinou, Meropi; Miller, Todd; Kenney, Jessica; Teitelbaum, Aaron; Hu, Lieyu; Chudolij, Anne; Zydowsky, Tom M.; Robbiani, Melissa] Ctr Biomed Res, Populat Council, HIV & AIDS Program, New York, NY USA; [Piatak, Michael, Jr.; Bess, Julian W., Jr.; Lifson, Jeffrey D.] NCI, SAIC Frederick, AIDS & Canc Virus Program, Frederick, MD USA; [Blanchard, James] Tulane Univ Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY USA	Population Council; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tulane University; Rockefeller University	Turville, SG (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Ctr Virus Res, Sydney, NSW, Australia.	mrobbiani@popcouncil.org		Turville, Stuart/0000-0003-1918-5343	USAID [GPO-A-00-04-00019-00]; NIH [R37 AI040877, AI065412, RR00164]; 2002 Elizabeth Glaser Scientist; NH&MRC of Australia [CJ Martin Fellowship]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065412, R37AI040877] Funding Source: NIH RePORTER	USAID(United States Agency for International Development (USAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2002 Elizabeth Glaser Scientist; NH&MRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the USAID Cooperative Agreement GPO-A-00-04-00019-00, NIH grants R37 AI040877 and AI065412, and the NIH base grant RR00164. MR is a 2002 Elizabeth Glaser Scientist. SGT is supported by a CJ Martin Fellowship of the NH&MRC of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; Bakri Y, 2001, J IMMUNOL, V166, P3780, DOI 10.4049/jimmunol.166.6.3780; Balzarini J, 1998, AIDS, V12, P1129, DOI 10.1097/00002030-199810000-00004; Bartolini B, 2003, ANTIVIR RES, V58, P139, DOI 10.1016/S0166-3542(02)00209-7; Bollen LJM, 2008, JAIDS-J ACQ IMM DEF, V47, P253, DOI 10.1097/QAI.0b013e31815d2f12; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Canque B, 1999, BLOOD, V93, P3866, DOI 10.1182/blood.V93.11.3866.411k43_3866_3875; Cavrois M, 2006, J VIROL, V80, P1992, DOI 10.1128/JVI.80.4.1992-1999.2006; *CDCP, 2000, JAMA-J AM MED ASSOC, V284, P1376; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Cline AN, 2005, J MED PRIMATOL, V34, P303; CRUBLET E, 2008, J BIOL CHEM; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; DiClemente RJ, 2004, JAMA-J AM MED ASSOC, V292, P171, DOI 10.1001/jama.292.2.171; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Frank I, 2008, J VIROL, V82, P5329, DOI 10.1128/JVI.01987-07; Frank I, 2003, JAIDS-J ACQ IMM DEF, V34, P7, DOI 10.1097/00126334-200309010-00002; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; *I LAB AN RES COMM, 1985, GUID CAR US LAB AN, P1; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; Jagodzinski PP, 1999, VIRAL IMMUNOL, V12, P23, DOI 10.1089/vim.1999.12.23; Kaiser J, 2008, SCIENCE, V320, P30, DOI 10.1126/science.320.5872.30; Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491; Ketas TJ, 2003, AIDS RES HUM RETROV, V19, P177, DOI 10.1089/088922203763315678; Ketas TJ, 2003, J VIROL, V77, P2762, DOI 10.1128/JVI.77.4.2762-2767.2003; Kilmarx PH, 2008, SEX TRANSM DIS, V35, P226, DOI 10.1097/OLQ.0b013e31815d6e0d; Lederman MM, 2006, NAT REV IMMUNOL, V6, P371, DOI 10.1038/nri1848; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lifson JD, 2004, AIDS RES HUM RETROV, V20, P772, DOI 10.1089/0889222041524661; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Maguire RA, 2001, SEX TRANSM DIS, V28, P259, DOI 10.1097/00007435-200105000-00003; Maguire RA, 1998, SEX TRANSM DIS, V25, P494, DOI 10.1097/00007435-199810000-00010; McDermott AB, 2004, J VIROL, V78, P3140, DOI 10.1128/JVI.78.6.3140-3144.2004; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; MCDONALD D, 2003, ENHANCEMENT HIV INFE; MEYLAN PRA, 1994, ANTIMICROB AGENTS CH, V38, P2910, DOI 10.1128/AAC.38.12.2910; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Reece JC, 1998, J EXP MED, V187, P1623, DOI 10.1084/jem.187.10.1623; Richardson BA, 2002, JAMA-J AM MED ASSOC, V287, P1171, DOI 10.1001/jama.287.9.1171; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; SKOLER S, 2008, EFFICACY CARRA UNPUB; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; TRAPP S, 2008, DOUBLE STRANDE UNPUB; Trapp S, 2006, J LEUKOCYTE BIOL, V80, P1076, DOI 10.1189/jlb.0206121; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Turville SG, 2005, J VIROL, V79, P13519, DOI 10.1128/JVI.79.21.13519-13527.2005; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Vachot L, 2008, JAIDS-J ACQ IMM DEF, V48, P398, DOI 10.1097/QAI.0b013e3181776bc7; van de Wiigert JHHM, 2007, JAIDS-J ACQ IMM DEF, V46, P538, DOI 10.1097/QAI.0b013e318159d5a8; van de Wijgert JHHM, 2007, AIDS, V21, P2369, DOI 10.1097/QAD.0b013e3282ef83fd; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; West JT, 2002, J VIROL, V76, P3338, DOI 10.1128/JVI.76.7.3338-3349.2002; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zacharopoulos VR, 1997, CLIN DIAGN LAB IMMUN, V4, P465, DOI 10.1128/CDLI.4.4.465-468.1997; ZARETZKY FR, 1995, INFECT IMMUN, V63, P3520, DOI 10.1128/IAI.63.9.3520-3526.1995; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	81	67	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3162	10.1371/journal.pone.0003162	http://dx.doi.org/10.1371/journal.pone.0003162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776937	gold, Green Published, Green Submitted			2022-12-25	WOS:000264424300007
J	Xu, GL; Karch, C; Li, N; Lin, NW; Fromholt, D; Gonzales, V; Borchelt, DR				Xu, Guilian; Karch, Celeste; Li, Ning; Lin, Nianwei; Fromholt, David; Gonzales, Victoria; Borchelt, David R.			Receptor-Associated Protein (RAP) Plays a Central Role in Modulating A beta Deposition in APP/PS1 Transgenic Mice	PLOS ONE			English	Article								Background: Receptor associated protein ( RAP) functions in the endoplasmic reticulum ( ER) to assist in the maturation of several membrane receptor proteins, including low density lipoprotein receptor-related protein (LRP) and lipoprotein receptor 11 (SorLA/LR11). Previous studies in cell and mouse model systems have demonstrated that these proteins play roles in the metabolism of the amyloid precursor protein (APP), including processes involved in the generation, catabolism and deposition of beta-amyloid (A beta) peptides. Methodology/Principal Findings: Mice transgenic for mutant APPswe and mutant presenilin 1 (PS1dE9) were mated to mice with homozygous deletion of RAP. Unexpectedly, mice that were homozygous null for RAP and transgenic for APPswe/PS1dE9 showed high post-natal mortality, necessitating a shift in focus to examine the levels of amyloid deposition in APPswe/PS1dE9 that were hemizygous null for RAP. Immunoblot analysis confirmed 50% reductions in the levels of RAP with modest reductions in the levels of proteins dependent upon RAP for maturation [ LRP trend towards a 20% reduction; SorLA/LR11 statistically significant 15% reduction (p<0.05)]. Changes in the levels of these proteins in the brains of [APPswe/PS1dE9](+/-)/RAP(+/-) mice correlated with 30-40% increases in amyloid deposition by 9 months of age. Conclusions/Significance: Partial reductions in the ER chaperone RAP enhance amyloid deposition in the APPswe/PS1dE9 model of Alzheimer amyloidosis. Partial reductions in RAP also affect the maturation of LRP and SorLA/LR11, which are each involved in several different aspects of APP processing and Ab catabolism. Together, these findings suggest a central role for RAP in Alzheimer amyloidogenesis.	[Xu, Guilian; Karch, Celeste; Fromholt, David; Borchelt, David R.] Univ Florida, Santa Fe Hlth Alzheimers Dis Res Ctr, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA; [Karch, Celeste; Li, Ning; Lin, Nianwei] Univ Florida, Interdisciplin Grad Program, Gainesville, FL 32611 USA; [Xu, Guilian; Fromholt, David; Gonzales, Victoria; Borchelt, David R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21218 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Johns Hopkins University	Xu, GL (corresponding author), Univ Florida, Santa Fe Hlth Alzheimers Dis Res Ctr, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA.	borchelt@mbi.ufl.edu	Lin, Nianwei/AAD-9805-2019; Lin, Nianwei/I-4919-2012; Lin, Nianwei/I-4653-2013	Lin, Nianwei/0000-0002-0811-8797; Karch, Celeste/0000-0002-6854-5547	Alzheimer's Association [Zenith Award]	Alzheimer's Association(Alzheimer's Association)	We gratefully thank Joachim Herz for sharing the RAP KO mice through Jackson Laboratory and providing us LRP and RAP antibodies. This work was supported by grants from the Alzheimer's Association (Zenith Award [DRB]).	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Causevic M, 2003, J NEUROPATH EXP NEUR, V62, P999, DOI 10.1093/jnen/62.10.999; Clatworthy AE, 1997, ARCH NEUROL-CHICAGO, V54, P1289, DOI 10.1001/archneur.1997.00550220087019; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Fallin D, 1997, NEUROSCI LETT, V233, P145, DOI 10.1016/S0304-3940(97)00634-4; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lesuisse C, 2001, HUM MOL GENET, V10, P2525, DOI 10.1093/hmg/10.22.2525; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Narita M, 1997, J NEUROCHEM, V69, P1904; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Rebeck GW, 2001, MOL BRAIN RES, V87, P238, DOI 10.1016/S0169-328X(01)00006-7; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Savonenko AV, 2003, NEUROBIOL DIS, V12, P194, DOI 10.1016/S0969-9961(02)00012-8; Scott WK, 1998, NEUROGENETICS, V1, P179, DOI 10.1007/s100480050026; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Van Uden E, 2000, MICROSC RES TECHNIQ, V50, P268, DOI 10.1002/1097-0029(20000815)50:4<268::AID-JEMT3>3.0.CO;2-1; Van Uden E, 1999, MOL CELL NEUROSCI, V14, P129, DOI 10.1006/mcne.1999.0772; Van Uden E, 2002, J NEUROSCI, V22, P9298; Veinbergs I, 2001, EXP NEUROL, V170, P15, DOI 10.1006/exnr.2001.7684; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; WavrantDeVrieze F, 1997, NEUROSCI LETT, V227, P68, DOI 10.1016/S0304-3940(97)00304-2; Willnow TE, 1999, J MOL MED-JMM, V77, P306, DOI 10.1007/s001090050356; Willnow TE, 1998, BIOL CHEM, V379, P1025; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Xu GL, 2002, ALZ DIS ASSOC DIS, V16, P191, DOI 10.1097/00002093-200207000-00010; YAMAMOTO T, 1986, NEUROPATH APPL NEURO, V12, P3, DOI 10.1111/j.1365-2990.1986.tb00677.x; Yoon IS, 2005, J BIOL CHEM, V280, P20140, DOI 10.1074/jbc.M413729200; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101	45	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3159	10.1371/journal.pone.0003159	http://dx.doi.org/10.1371/journal.pone.0003159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776935	Green Published, Green Submitted, gold			2022-12-25	WOS:000264424300004
J	Goz, D; Studholme, K; Lappi, DA; Rollag, MD; Provencio, I; Morin, LP				Goez, Didem; Studholme, Keith; Lappi, Douglas A.; Rollag, Mark D.; Provencio, Ignacio; Morin, Lawrence P.			Targeted Destruction of Photosensitive Retinal Ganglion Cells with a Saporin Conjugate Alters the Effects of Light on Mouse Circadian Rhythms	PLOS ONE			English	Article								Non-image related responses to light, such as the synchronization of circadian rhythms to the day/night cycle, are mediated by classical rod/cone photoreceptors and by a small subset of retinal ganglion cells that are intrinsically photosensitive, expressing the photopigment, melanopsin. This raises the possibility that the melanopsin cells may be serving as a conduit for photic information detected by the rods and/or cones. To test this idea, we developed a specific immunotoxin consisting of an anti-melanopsin antibody conjugated to the ribosome-inactivating protein, saporin. Intravitreal injection of this immunotoxin results in targeted destruction of melanopsin cells. We find that the specific loss of these cells in the adult mouse retina alters the effects of light on circadian rhythms. In particular, the photosensitivity of the circadian system is significantly attenuated. A subset of animals becomes non-responsive to the light/dark cycle, a characteristic previously observed in mice lacking rods, cones, and functional melanopsin cells. Mice lacking melanopsin cells are also unable to show light induced negative masking, a phenomenon known to be mediated by such cells, but both visual cliff and light/dark preference responses are normal. These data suggest that cells containing melanopsin do indeed function as a conduit for rod and/or cone information for certain non-image forming visual responses. Furthermore, we have developed a technique to specifically ablate melanopsin cells in the fully developed adult retina. This approach can be applied to any species subject to the existence of appropriate anti-melanopsin antibodies.	[Goez, Didem; Rollag, Mark D.; Provencio, Ignacio] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Studholme, Keith; Morin, Lawrence P.] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; [Morin, Lawrence P.] SUNY Stony Brook, Med Ctr, Program Neurosci, Stony Brook, NY 11794 USA; [Lappi, Douglas A.] Adv Targeting Syst, San Diego, CA USA	University of Virginia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goz, D (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	lawrence.morin@stonybrook.edu	Morin, Lawrence P/B-7487-2009	Morin, Lawrence/0000-0002-6580-6545; Provencio, Ignacio/0000-0003-1175-920X; Lappi, Douglas/0000-0003-4239-7387; studholme, keith/0000-0002-0037-514X	NIH [R01 NS22168, R01 NS052112]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052112, R01NS022168] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH grant R01 NS22168 to LPM NIH grant R01 NS052112 to IP The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the mansuscript.	BALL SL, 2003, INVEST OPHTHALMOLVIS, V44, P7; BAVER SB, 2008, EUR J NEURO IN PRESS; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berger-Sweeney J, 2001, J NEUROSCI, V21, P8164, DOI 10.1523/JNEUROSCI.21-20-08164.2001; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Gunhan E, 2002, J NEUROSCI, V22, P2265, DOI 10.1523/JNEUROSCI.22-06-02265.2002; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Kline RH, 2008, J NEUROSCI, V28, P904, DOI 10.1523/JNEUROSCI.4452-07.2008; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; LIKHTIK E, 2008, NATURE; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Martin JL, 2001, J COMP NEUROL, V436, P127; MICHON JJ, 1991, INVEST OPHTH VIS SCI, V32, P280; Molina A, 2008, ANNU REV MED, V59, P237, DOI 10.1146/annurev.med.59.060906.220345; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Morin LP, 2002, J BIOL RHYTHM, V17, P217, DOI 10.1177/07430402017003005; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Pagano L, 2007, ONCOGENE, V26, P3679, DOI 10.1038/sj.onc.1210364; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pappas BA, 1996, DEV BRAIN RES, V96, P52, DOI 10.1016/0165-3806(96)00095-8; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; THORPE PE, 1985, J NATL CANCER I, V75, P151; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Whenham N, 2008, CLIN BREAST CANCER, V8, P38, DOI 10.3816/CBC.2008.n.002; WILEY RG, 1991, BRAIN RES, V562, P149, DOI 10.1016/0006-8993(91)91199-B; Wrenn CC, 1999, BRAIN RES, V847, P284, DOI 10.1016/S0006-8993(99)02099-5; YOSHIMURA T, 1994, J BIOL RHYTHM, V9, P51, DOI 10.1177/074873049400900105; ZHANG DQ, 2008, PNAS IN PRESS	39	119	120	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3153	10.1371/journal.pone.0003153	http://dx.doi.org/10.1371/journal.pone.0003153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773079	Green Submitted, Green Published, gold			2022-12-25	WOS:000264420100010
J	Cristofanon, S; Morceau, F; Scovassi, AI; Dicato, M; Ghibelli, L; Diederich, M				Cristofanon, Silvia; Morceau, Franck; Scovassi, A. Ivana; Dicato, Mario; Ghibelli, Lina; Diederich, Marc			Oxidative, multistep activation of the noncanonical NF-kappa B pathway via disulfide Bcl-3/p50 complex	FASEB JOURNAL			English	Article						glutathione; Bcl-2; ROS; p38	GLUTATHIONE DEPLETION; MAP KINASE; NUCLEAR TRANSLOCATION; BCL-2 EXPRESSION; P50 HOMODIMERS; CELLS; APOPTOSIS; TRANSCRIPTION; BINDING; MODULATION	Buthionine sulfoximine ( BSO) is a well-known inhibitor of glutathione synthesis, producing slow glutathione ( GSH) depletion and oxidative stress; some "responder" cells avoid BSO-induced death by trans-activating the prosurvival protein Bcl-2. Here we show that BSO activates a noncanonical, inhibitory NF-kappa B- and p65-independent NF-kappa B pathway via a multistep process leading to the up-regulation of Bcl-2. The slow BSO-induced GSH depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a p50-p50 homodimer. The early phase, coinciding with substantial thiol depletion, produces a cytosolic preparative complex, consisting of p50 and its interactor Bcl-3 linked by interprotein disulfide bridges. The late phase, coinciding with reactive oxygen species production, is responsible, probably via p38 activation, for nuclear targeting of the complex and trans-activation of Bcl-2. Cristofanon, S., Morceau, F., Scovassi, A. I., Dicato, M., Ghibelli, L., Diederich, M. Oxidative, multistep activation of the noncanonical NF-kappa B pathway via disulfide Bcl-3/p50 complex. FASEB J. 23, 45-57 ( 2009)	[Cristofanon, Silvia; Ghibelli, Lina] Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; [Cristofanon, Silvia; Morceau, Franck; Dicato, Mario; Diederich, Marc] Hop Kirchberg, Lab Biol Mol & Ecllulaire Canc, Fdn Rech Canc & Maladies Sang, L-2540 Luxembourg, Luxembourg; [Scovassi, A. Ivana] Ist Genet Mol Consiglio Nazl Ric, Pavia, Italy	University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Diederich, M (corresponding author), Hop Kirchberg, Lab Biol Mol & Ecllulaire Canc, Fdn Rech Canc & Maladies Sang, 9 Rue Edward Steichen, L-2540 Luxembourg, Luxembourg.	ghibelli@uniroma2.it; marc.diederich@lbmcc.lu	Diederich, Marc/O-7335-2015; Scovassi, Anna Ivana/F-2458-2010	Diederich, Marc/0000-0003-0115-4725; Scovassi, Anna Ivana/0000-0003-3484-9881	Bourse de Formation-Recherche of the Ministere de la Culture; de l'Enseignement superieur et de la Recherche of Luxembourg; Televie; Fondation de Recherche Cancer et Sang; Recherches Scientifiques Luxembourg association; Een Haerz fir Kriibskrank Kanner association; Action Lions Vaincre le Cancer; Fonds National de la Recherche-Luxembourg	Bourse de Formation-Recherche of the Ministere de la Culture; de l'Enseignement superieur et de la Recherche of Luxembourg; Televie; Fondation de Recherche Cancer et Sang; Recherches Scientifiques Luxembourg association; Een Haerz fir Kriibskrank Kanner association; Action Lions Vaincre le Cancer; Fonds National de la Recherche-Luxembourg(Luxembourg National Research Fund)	C.S. was supported by a Bourse de Formation-Recherche of the Ministere de la Culture, de l'Enseignement superieur et de la Recherche of Luxembourg. Research was supported in part by Televie, the Fondation de Recherche Cancer et Sang and Recherches Scientifiques Luxembourg association. The authors thank Een Haerz fir Kriibskrank Kanner association and the Action Lions Vaincre le Cancer for additional support. Printing costs were covered by Fonds National de la Recherche-Luxembourg.	Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Brasier AR, 2001, J BIOL CHEM, V276, P32080, DOI 10.1074/jbc.M102949200; Byun MS, 2002, EXP MOL MED, V34, P332, DOI 10.1038/emm.2002.47; Casini A F, 1984, Toxicol Pathol, V12, P295; Celli A, 1998, AM J PHYSIOL-GASTR L, V275, pG749, DOI 10.1152/ajpgi.1998.275.4.G749; D'Alessio M, 2005, FASEB J, V19, P1504, DOI 10.1096/fj.04-3329fje; D'Alessio M, 2004, FASEB J, V18, P1609, DOI 10.1096/fj.04-1813fje; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Duvoix A, 2004, CANCER LETT, V216, P207, DOI 10.1016/j.canlet.2004.05.004; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; Frouin I, 2003, J BIOL CHEM, V278, P39265, DOI 10.1074/jbc.C300098200; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Ghibelli L, 1999, FASEB J, V13, P2031, DOI 10.1096/fasebj.13.14.2031; Ghibelli L, 1998, FASEB J, V12, P479, DOI 10.1096/fasebj.12.6.479; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Keutgens A, 2006, BIOCHEM PHARMACOL, V72, P1069, DOI 10.1016/j.bcp.2006.06.011; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; MIHM S, 1995, FASEB J, V9, P246, DOI 10.1096/fasebj.9.2.7781927; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Nishikori M, 2003, BLOOD, V101, P2789, DOI 10.1182/blood-2002-08-2464; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Rahman A, 2004, AM J PHYSIOL-LUNG C, V287, pL1017, DOI 10.1152/ajplung.00072.2004; Ramos AM, 2006, J CELL PHYSIOL, V209, P1006, DOI 10.1002/jcp.20806; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Viatour P, 2003, LEUKEMIA, V17, P1349, DOI 10.1038/sj.leu.2402982; Watanabe N, 1997, EMBO J, V16, P3609, DOI 10.1093/emboj/16.12.3609; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Xiao WH, 2004, CELL MOL IMMUNOL, V1, P425; Zhang MY, 1998, BLOOD, V92, P1225, DOI 10.1182/blood.V92.4.1225.416k20_1225_1234	43	26	28	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					45	57		10.1096/fj.07-104109	http://dx.doi.org/10.1096/fj.07-104109			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18796561				2022-12-25	WOS:000262095500007
J	Hirosawa-Takamori, M; Ossipov, D; Novoselov, SV; Turanov, AA; Zhang, Y; Gladyshev, VN; Krol, A; Vorbruggen, G; Jackle, H				Hirosawa-Takamori, Mitsuko; Ossipov, Dmitri; Novoselov, Sergey V.; Turanov, Anton A.; Zhang, Yan; Gladyshev, Vadim N.; Krol, Alain; Vorbrueggen, Gerd; Jaeckle, Herbert			A novel stem loop control element-dependent UGA read-through system without translational selenocysteine incorporation in Drosophila	FASEB JOURNAL			English	Article						conserved; GAP factor; eEFsec; GAPsec mutant; selenoprotein; biosynthesis	SELENOPROTEIN SYNTHESIS; STRUCTURAL-ANALYSIS; PROTEIN-SYNTHESIS; MECHANISMS; STOP; INSERTION; INSIGHTS; DOMAIN; YEAST; GENE	Translational read-through of the UGA stop codon is an evolutionarily conserved feature that most prominently represents the basis of selenoprotein biosynthesis. It requires a specific cis-acting stem loop control element, termed SECIS, which is located in the 3'-untranslated region of eukaryotic selenoprotein mRNAs. In a search for novel factors underlying the SECIS-directed UGA read-through process, we identified an evolutionary conserved GTPase-activating protein, termed GAPsec. We show that the activity of the Drosophila GAPsec (dGAPsec) is necessary to support SECIS-dependent UGA read-through activity in flies and the mouse homolog mGAPsec in mice tissue culture cells. However, selenoprotein biosynthesis is not impaired in flies that lack dGAPsec activity. The results indicate that GAPsec is part of a novel SECIS-dependent translational read-through system that does not involve selenocysteine incorporation.-Hirosawa- Takamori, M., Ossipov, D., Novoselov, S.V., Turanov, A.A., Zhang, Y., Gladyshev, V.N., Krol, A., Vorbruggen, G., Jackle, H. A novel stem loop control element-dependent UGA readthrough system without translational selenocysteine incorporation in Drosophila. FASEB J. 23, 107-113 (2009)	[Hirosawa-Takamori, Mitsuko; Ossipov, Dmitri; Vorbrueggen, Gerd; Jaeckle, Herbert] Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, D-37077 Gottingen, Germany; [Novoselov, Sergey V.; Turanov, Anton A.; Zhang, Yan; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Krol, Alain] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, Strasbourg, France	Max Planck Society; University of Nebraska System; University of Nebraska Lincoln; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Jackle, H (corresponding author), Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, Fassberg 11, D-37077 Gottingen, Germany.	vp-bms@gv.mpg.de	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	Novoselov, Sergey/0000-0003-0104-6492; Gladyshev, Vadim/0000-0002-0372-7016	Max-Planck-Society; Deutsche Forschungsgemeinschaft; U.S. National Institutes of Health [GM061603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our colleagues in the laboratory for various contributions and critical discussions, G. Dowe for sequencing, and U. Jahns-Meyer for generating fly transformants. This work was supported by the Max-Planck-Society, the SP "Selenoproteine" of the Deutsche Forschungsgemeinschaft (G.V. and H.J.), and U.S. National Institutes of Health grant GM061603 (V.N.G.).	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Atkins JF, 2000, NATURE, V407, P463, DOI 10.1038/35035189; Blanke S, 2006, FASEB J, V20, P683, DOI 10.1096/fj.05-5376com; Bock A, 2000, Biofactors, V11, P77; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Hirosawa-Takamori M, 2000, EMBO REP, V1, P441, DOI 10.1093/embo-reports/kvd087; Hirosawa-Takamori M, 2004, EMBO REP, V5, P317, DOI 10.1038/sj.embor.7400097; Kollmus H, 1996, NUCLEIC ACIDS RES, V24, P1195, DOI 10.1093/nar/24.7.1195; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Novoselov SV, 2002, EMBO J, V21, P3681, DOI 10.1093/emboj/cdf372; Persson BC, 1997, J MOL BIOL, V274, P174, DOI 10.1006/jmbi.1997.1371; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rodnina MV, 2000, BIOL CHEM, V381, P377, DOI 10.1515/BC.2000.050; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; VALLE RPC, 1988, FEBS LETT, V235, P1, DOI 10.1016/0014-5793(88)81225-0; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3	27	11	11	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2009	23	1					107	113		10.1096/fj.08-116640	http://dx.doi.org/10.1096/fj.08-116640			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	389LZ	18772345	Green Published			2022-12-25	WOS:000262095500013
J	Cao, Q; Yu, J; Dhanasekaran, SM; Kim, JH; Mani, RS; Tomlins, SA; Mehra, R; Laxman, B; Cao, X; Yu, J; Kleer, CG; Varambally, S; Chinnaiyan, AM				Cao, Q.; Yu, J.; Dhanasekaran, S. M.; Kim, J. H.; Mani, R-S; Tomlins, S. A.; Mehra, R.; Laxman, B.; Cao, X.; Yu, J.; Kleer, C. G.; Varambally, S.; Chinnaiyan, A. M.			Repression of E-cadherin by the polycomb group protein EZH2 in cancer	ONCOGENE			English	Article						polycomb group protein; histone; EZH2; E-cadherin; epigenetics	CELL-CELL-ADHESION; HUMAN BREAST-CANCER; H3 LYSINE-27 METHYLATION; EMBRYONIC STEM-CELLS; PROSTATE-CANCER; DOWN-REGULATION; TARGET GENES; DEVELOPMENTAL REGULATORS; CATENIN EXPRESSION; EPITHELIAL-CELLS	Enhancer of zeste homolog 2 (EZH2) is a critical component of the polycomb-repressive complex 2 (PRC2), which is involved in gene silencing and histone H3 lysine 27 methylation. EZH2 has a master regulatory function in controlling such processes as stem cell differentiation, cell proliferation, early embryogenesis and X chromosome inactivation. Although benign epithelial cells express very low levels of EZH2, increased levels of EZH2 have been observed in aggressive solid tumors such as those of the prostate, breast and bladder. The mechanism by which EZH2 mediates tumor aggressiveness is unclear. Here, we demonstrate that EZH2 mediates transcriptional silencing of the tumor suppressor gene E-cadherin by trimethylation of H3 lysine 27. Histone deacetylase inhibitors can prevent EZH2-mediated repression of E-cadherin and attenuate cell invasion, suggesting a possible mechanism that may be useful for the development of therapeutic treatments. Taken together, these observations provide a novel mechanism of E-cadherin regulation and establish a functional link between dysregulation of EZH2 and repression of E-cadherin during cancer progression.	[Cao, Q.; Yu, J.; Dhanasekaran, S. M.; Kim, J. H.; Mani, R-S; Tomlins, S. A.; Mehra, R.; Laxman, B.; Yu, J.; Kleer, C. G.; Varambally, S.; Chinnaiyan, A. M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Cao, Q.; Yu, J.; Dhanasekaran, S. M.; Kim, J. H.; Mani, R-S; Tomlins, S. A.; Mehra, R.; Laxman, B.; Cao, X.; Yu, J.; Varambally, S.; Chinnaiyan, A. M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Mehra, R.; Kleer, C. G.; Varambally, S.; Chinnaiyan, A. M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Cao, X.; Chinnaiyan, A. M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, A. M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1400 E Med Ctr Dr,5316 CCGC, Ann Arbor, MI 48109 USA.	arul@umich.edu	Cao, Qi/A-5517-2010	Cao, Qi/0000-0002-5140-3681; Tomlins, Scott/0000-0001-8661-9821; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Mani, Ram/0000-0003-3552-7905; Varambally, Sooryanarayana/0000-0002-2277-1127	National Institutes of Health [R01 CA97063, U01 CA111275, P50 CA69568]; Department of Defense [PC040517, PC051081, PC060266, R01CA107469]; NATIONAL CANCER INSTITUTE [R01CA097063, R01CA107469, P50CA069568, U01CA111275, K99CA129565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Professor Eric Fearon for providing the E-cadherin promoter-reporter constructs. We thank Jill Granger for critically reading the paper and for her thoughtful suggestions. We thank R Kunkel for help in figure preparation and the staff of the Microscopy and Image Analyses laboratory at the University of Michigan for their assistance in the microscopic analyses employed in this study. We thank the University of Michigan Vector Core for virus generation. AMC is supported by a Burroughs Welcome Foundation Award in Clinical Translational Research. SAT is supported by the Medical Scientist Training Program and a Rackham Pre-doctoral Award. This research was supported in part by National Institutes of Health Grant R01 CA97063 (to AMC); U01 CA111275 (to AMC); P50 CA69568 (to AMC); Department of Defense Grants PC040517 (to RM), PC051081 (to AMC and SV), PC060266 (to JY) and R01CA107469 (to CGK).	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Breuer RHJ, 2004, NEOPLASIA, V6, P736, DOI 10.1593/neo.04160; Bryant RJ, 2007, PROSTATE, V67, P547, DOI 10.1002/pros.20550; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; DAMSKY CH, 1983, CELL, V34, P455, DOI 10.1016/0092-8674(83)90379-3; Day ML, 1999, J BIOL CHEM, V274, P9656, DOI 10.1074/jbc.274.14.9656; DORUDI S, 1995, BRIT J CANCER, V71, P614, DOI 10.1038/bjc.1995.119; FRIXEN UH, 1993, CANCER RES, V53, P3618; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujii S, 2008, CANCER SCI, V99, P738, DOI 10.1111/j.1349-7006.2008.00743.x; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Hajra KM, 2002, CANCER RES, V62, P1613; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jacobs JJL, 1999, SEMIN CELL DEV BIOL, V10, P227, DOI 10.1006/scdb.1999.0304; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; MAYER B, 1993, CANCER RES, V53, P1690; MOLL R, 1993, AM J PATHOL, V143, P1731; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; OKA H, 1993, CANCER RES, V53, P1696; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; PALACIOS J, 1995, VIRCHOWS ARCH, V427, P259; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; PIERCEALL WE, 1995, ONCOGENE, V11, P1319; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RASBRIDGE SA, 1993, J PATHOL, V169, P245, DOI 10.1002/path.1711690211; Rhodes DR, 2003, J NATL CANCER I, V95, P661, DOI 10.1093/jnci/95.9.661; ROSEN PP, 1990, SURG CLIN N AM, V70, P937; Saito T, 2004, ONCOGENE, V23, P8629, DOI 10.1038/sj.onc.1207960; Satijn DPE, 1999, BBA-GENE STRUCT EXPR, V1447, P1, DOI 10.1016/S0167-4781(99)00130-X; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Taghavi P, 2006, NATURE, V439, P794, DOI 10.1038/439794a; Takeno S, 2004, AM J CLIN PATHOL, V122, P78, DOI 10.1309/WJL90JPEM17RBUHT; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; UMBAS R, 1994, CANCER RES, V54, P3929; Umbas R, 1997, INT J CANCER, V74, P374, DOI 10.1002/(SICI)1097-0215(19970822)74:4<374::AID-IJC2>3.0.CO;2-S; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weikert S, 2005, INT J MOL MED, V16, P349; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Wu ZY, 2005, WORLD J GASTROENTERO, V11, P3139, DOI 10.3748/wjg.v11.i20.3139; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498	61	429	453	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2008	27	58					7274	7284		10.1038/onc.2008.333	http://dx.doi.org/10.1038/onc.2008.333			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	382FI	18806826	Green Accepted			2022-12-25	WOS:000261590300005
J	Han, MF; Yan, WM; Guo, W; Xi, D; Zhou, YY; Li, WN; Gao, S; Liu, MG; Levy, G; Luo, XP; Ning, Q				Han, Meifang; Yan, Weiming; Guo, Wei; Xi, Dong; Zhou, Yaoyong; Li, Weina; Gao, Sui; Liu, Mingfeng; Levy, Gary; Luo, Xiaoping; Ning, Qin			Hepatitis B Virus-induced hFGL2 Transcription Is Dependent on c-Ets-2 and MAPK Signal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-INDUCED FULMINANT-HEPATITIS; HEPATOCYTE GROWTH-FACTOR; FIBRINOGEN-LIKE PROTEIN; NECROSIS-FACTOR-ALPHA; X-PROTEIN; BREAST-CANCER; UP-REGULATION; MATRIX METALLOPROTEINASE-1; MEDIATED PHOSPHORYLATION; NUCLEOCAPSID PROTEIN	Fibrinogen-like protein 2 (FGL2)/fibroleukin plays a pivotal role in the pathogenesis of experimental and human fulminant and chronic viral hepatitis. To define the transcription factor(s) and upstream signal transduction pathways involved in the transcription of human FGL2 (hFGL2) in response to hepatitis B (HB) virus, hepatitis B core (HBc), hepatitis B virus S protein (HBs), or hepatitis B virus X protein (HBx) protein, expression plasmids were cotransfected with an hFGL2 promoter luciferase reporter construct into Chinese hamster ovary and HepG2 cells, respectively. HBc and HBx proteins, but not HBs protein, enhanced hFGL2 transcription in both cell lines. A strong regulatory region from -712 to -568 (relative to the transcriptional starting site) was shown to be responsible for hFGL2 gene transcription in response to both HBc and HBx proteins. c-Ets-2 was shown to be translocated to the nucleus in association with hFGL2 expression in response to both HBc and HBx proteins. Short hair pin RNA(shRNA) interference of c-Ets-2 expression inhibited hFGL2 gene transcription by 64.8 and 60.0% in response to HBc and HBx, respectively. c-Ets-2 protein was highly expressed in peripheral blood mononuclear cells from patients with severe chronic hepatitis B (CHB) in contrast to patients with mild CHB. Increased phosphorylation of ERK and JNK was detected in peripheral blood mononuclear cells from patients with severe CHB. ERK inhibitor PD098059 or ERK shRNA abolished the nuclear c-Ets-2 DNA binding activity and hFGL2 induction in response to HBc, whereas JNK inhibitor SP600125 or JNK shRNA abolished the nuclear c-Ets-2 DNA binding activity and hFGL2 induction in response to HBx. In conclusion, HBc and HBx proteins enhance transcription of hFGL2 through c-Ets-2 dependent on MAPK signal pathways.	[Luo, Xiaoping] Huazhong Univ Sci & Technol, Dept Pediat, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China; [Han, Meifang; Yan, Weiming; Guo, Wei; Xi, Dong; Zhou, Yaoyong; Li, Weina; Gao, Sui; Ning, Qin] Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China; [Liu, Mingfeng; Levy, Gary] Univ Toronto, Univ Hlth Network, Toronto, ON M5G 2N2, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Luo, XP (corresponding author), Huazhong Univ Sci & Technol, Dept Pediat, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	xpluo@tjh.tjmu.edu.cn; qning@tjh.tjmu.edu.cn		Han, Meifang/0000-0002-1948-8128	National Science Fund of China [30571643, 30672380]; National Key Basic Research Program of China [2005CB522901, 2007CB512904]; 11th Five-Year Plan Key Project [2006BAI05A07, 2008ZX10202]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); 11th Five-Year Plan Key Project(National Key Technology R&D Program)	This work was supported by the National Science Fund of China Grants 30571643 and 30672380, National Key Basic Research Program of China Grants 2005CB522901 and 2007CB512904, and 11th Five-Year Plan Key Project Grants 2006BAI05A07 and 2008ZX10202.	Bonello MR, 2005, AM J PATHOL, V167, P1149, DOI 10.1016/S0002-9440(10)61203-5; Choi M, 2002, IUBMB LIFE, V53, P309, DOI 10.1080/15216540213466; Chung TW, 2003, CANCER RES, V63, P3453; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Ding JW, 1998, ADV EXP MED BIOL, V440, P609; FAKTOR O, 1990, J VIROL, V64, P1861, DOI 10.1128/JVI.64.4.1861-1863.1990; Fernandez M, 2003, J GEN VIROL, V84, P2073, DOI 10.1099/vir.0.18966-0; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Hyodo N, 2004, CLIN EXP IMMUNOL, V135, P462, DOI 10.1111/j.1365-2249.2003.02376.x; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Klein A, 2003, ONCOGENE, V22, P2910, DOI 10.1038/sj.onc.1206539; Kojima H, 2003, J HEPATOL, V39, P262, DOI 10.1016/S0168-8278(03)00215-0; Kwon JA, 2003, BIOL CHEM, V384, P203, DOI 10.1515/BC.2003.022; Lakatoo S, 2002, HEPATOLOGY, V36, p272A; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; LEVY GA, 1983, HEPATOLOGY, V3, P964; Levy GA, 2000, AM J PATHOL, V156, P1217, DOI 10.1016/S0002-9440(10)64992-9; LI C, 1992, J EXP MED, V176, P689, DOI 10.1084/jem.176.3.689; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Lindemann RK, 2003, INT J ONCOL, V22, P799; Liu MF, 2003, EUR J BIOCHEM, V270, P2274, DOI 10.1046/j.1432-1033.2003.03595.x; Liu MF, 2006, J IMMUNOL, V176, P7028, DOI 10.4049/jimmunol.176.11.7028; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; MACPHEE PJ, 1985, HEPATOLOGY, V5, P649, DOI 10.1002/hep.1840050422; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Manigold T, 2003, J MED VIROL, V71, P31, DOI 10.1002/jmv.10445; Marazzi S, 1998, J IMMUNOL, V161, P138; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; McGilvray ID, 1998, J BIOL CHEM, V273, P32222, DOI 10.1074/jbc.273.48.32222; Milich DR, 1998, J IMMUNOL, V160, P2013; MONDELLI M, 1986, J HEPATOL, V3, pS279, DOI 10.1016/S0168-8278(86)80132-5; Ning Q, 2005, J IMMUNOL, V174, P7403, DOI 10.4049/jimmunol.174.11.7403; Ning Q, 2003, J BIOL CHEM, V278, P15541, DOI 10.1074/jbc.M212806200; Ning Q, 1999, J BIOL CHEM, V274, P9930, DOI 10.1074/jbc.274.15.9930; Ozaki I, 2002, J HEPATOL, V36, P169, DOI 10.1016/S0168-8278(01)00245-8; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; PARR RL, 1995, J VIROL, V69, P5033, DOI 10.1128/JVI.69.8.5033-5038.1995; Petrovic N, 2003, J BIOL CHEM, V278, P49358, DOI 10.1074/jbc.M308071200; Rasul I, 1999, HEPATOLOGY, V30, p594A; RUEGG C, 1995, GENE, V160, P257, DOI 10.1016/0378-1119(95)00240-7; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; SETO E, 1990, NATURE, V344, P72, DOI 10.1038/344072a0; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; TYMMS MJ, 1994, MOL REPROD DEV, V39, P208, DOI 10.1002/mrd.1080390214; Wang HD, 1998, MOL CELL BIOL, V18, P7086, DOI 10.1128/MCB.18.12.7086; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yi YS, 2003, BBA-MOL BASIS DIS, V1638, P249, DOI 10.1016/S0925-4439(03)00090-5; Yoo YG, 2004, J BIOL CHEM, V279, P36242, DOI 10.1074/jbc.M401290200; Yuwaraj S, 2001, GENOMICS, V71, P330, DOI 10.1006/geno.2000.6444; Zhu CL, 2005, WORLD J GASTROENTERO, V11, P6936, DOI 10.3748/wjg.v11.i44.6936; Zhu CL, 2006, HUM GENE THER, V17, P589, DOI 10.1089/hum.2006.17.589; Zoulim F, 1996, J HEPATOL, V24, P155, DOI 10.1016/S0168-8278(96)80024-9	57	38	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32715	32729		10.1074/jbc.M806769200	http://dx.doi.org/10.1074/jbc.M806769200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801734	hybrid			2022-12-25	WOS:000260893700061
J	Wang, YY; Chang, RB; Waters, HN; Mckemy, DD; Liman, ER				Wang, Yuanyuan Y.; Chang, Rui B.; Waters, Hang N.; Mckemy, David D.; Liman, Emily R.			The Nociceptor Ion Channel TRPA1 Is Potentiated and Inactivated by Permeating Calcium Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR TRPV1; EPITHELIAL CA2+ CHANNEL; ROOT GANGLION NEURONS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CATION CHANNEL; MUSTARD OIL; PROTEIN-KINASE; COVALENT MODIFICATION; CAPSAICIN RECEPTOR; INFLAMMATORY PAIN	The transient receptor potential A1 (TRPA1) channel is the molecular target for environmental irritants and pungent chemicals, such as cinnamaldehyde and mustard oil. Extracellular Ca2+ is a key regulator of TRPA1 activity, both potentiating and subsequently inactivating it. In this report, we provide evidence that the effect of extracellular Ca2+ on these processes is indirect and can be entirely attributed to entry through TRPA1 and subsequent elevation of intracellular calcium. Specifically, we found that in a pore mutant of TRPA1, D918A, in which Ca2+ permeability was greatly reduced, extracellular Ca2+ produced neither potentiation nor inactivation. Both processes were restored by reducing intracellular Ca2+ buffering, which allowed intracellular Ca2+ levels to become elevated upon entry through D918A channels. Application of Ca2+ to the cytosolic face of excised patches was sufficient to produce both potentiation and inactivation of TRPA1 channels. Moreover, in whole cell recordings, elevation of intracellular Ca2+ by UV uncaging of 1-(4,5-dimethoxy-2-nitrophenyl)-EDTA-potentiated TRPA1 currents. In addition, our data show that potentiation and inactivation are independent processes. TRPA1 currents could be inactivated by Mg2+, Ba2+, and Ca2+ but potentiated only by Ba2+ and Ca2+. Saturating activation by cinnamaldehyde or mustard oil occluded potentiation but did not interfere with inactivation. Last, neither process was affected by mutation of a putative intracellular Ca2+-binding EF-hand motif. In conclusion, we have further clarified the mechanisms of potentiation and inactivation of TRPA1 using the D918A pore mutant, an important tool for investigating the contribution of Ca2+ influx through TRPA1 to nociceptive signaling.	[Wang, Yuanyuan Y.; Chang, Rui B.; Waters, Hang N.; Mckemy, David D.; Liman, Emily R.] Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Wang, Yuanyuan Y.; Chang, Rui B.; Mckemy, David D.; Liman, Emily R.] Univ So Calif, Program Neurosci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Liman, ER (corresponding author), Univ So Calif, Neurobiol Sect, 3641 Watt Way, Los Angeles, CA 90089 USA.	liman@usc.edu	Wang, Yuanyuan/H-3651-2012; Liman, Emily/AAC-7383-2021	liman, emily/0000-0003-4765-5496	National Institutes of Health, NIDCD [004564]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054069] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NIDCD, Grant 004564 ( to E. L.).	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Brand G, 2002, CHEM SENSES, V27, P593, DOI 10.1093/chemse/27.7.593; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHOLEWINSKI A, 1993, NEUROSCIENCE, V55, P1015, DOI 10.1016/0306-4522(93)90315-7; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Karashima Y, 2008, PFLUG ARCH EUR J PHY, V457, P77, DOI 10.1007/s00424-008-0493-6; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kim D, 2008, AM J PHYSIOL-CELL PH, V295, pC92, DOI 10.1152/ajpcell.00023.2008; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee SP, 2008, BRIT J PHARMACOL, V153, P1739, DOI 10.1038/bjp.2008.85; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu CH, 2007, J NEUROSCI, V27, P604, DOI 10.1523/JNEUROSCI.4099-06.2007; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Okuse K, 2007, INT J BIOCHEM CELL B, V39, P490, DOI 10.1016/j.biocel.2006.11.016; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; Simons CT, 2003, CHEM SENSES, V28, P459, DOI 10.1093/chemse/28.6.459; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wang HB, 2006, BIOL CHEM, V387, P11, DOI 10.1515/BC.2006.003; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zagotta WN, 2006, NATURE, V440, P427, DOI 10.1038/440427a; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007; Zhu Michael X, 2004, Novartis Found Symp, V258, P44; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	89	193	202	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32691	32703		10.1074/jbc.M803568200	http://dx.doi.org/10.1074/jbc.M803568200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18775987	hybrid, Green Published			2022-12-25	WOS:000260893700059
J	Yonus, H; Neumann, P; Zimmermann, S; May, JJ; Marahiel, MA; Stubbs, MT				Yonus, Huma; Neumann, Piotr; Zimmermann, Stephan; May, Juergen J.; Marahiel, Mohamed A.; Stubbs, Milton T.			Crystal Structure of DltA IMPLICATIONS FOR THE REACTION MECHANISM OF NON-RIBOSOMAL PEPTIDE SYNTHETASE ADENYLATION DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANYL-LIPOTEICHOIC ACID; FORMING ENZYME SUPERFAMILY; CARRIER PROTEIN; FIREFLY LUCIFERASE; BACILLUS-SUBTILIS; D-ALANINE; DIFFRACTION DATA; TEICHOIC-ACIDS; BIOSYNTHESIS; STAPHYLOCOCCUS	DltA, the D-alanine:D-alanyl carrier protein ligase responsible for the initial step of lipoteichoic acid D-alanylation in Gram-positive bacteria, belongs to the adenylation domain superfamily, which also includes acetyl-CoA synthetase and the adenylation domains of non-ribosomal synthetases. The two-step reaction catalyzed by these enzymes ( substrate adenylation followed by transfer to the reactive thiol group of CoA or the phosphopantheinyl prosthetic group of peptidyl carrier proteins) has been suggested to proceed via large scale rearrangements of structural domains within the enzyme. The structures of DltA reported here reveal the determinants for D-Ala substrate specificity and confirm that the peptidyl carrier protein-activating domains are able to adopt multiple conformational states, in this case corresponding to the thiolation reaction. Comparisons of available structures allow us to propose a mechanism whereby small perturbations of finely balanced metastable structural states would be able to direct an ordered formation of non-ribosomal synthetase products.	[Yonus, Huma; Neumann, Piotr; Zimmermann, Stephan; Stubbs, Milton T.] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [May, Juergen J.; Marahiel, Mohamed A.] Univ Marburg, Fachbereich Chem Biochem, D-35032 Marburg, Germany; [Stubbs, Milton T.] Univ Halle Wittenberg, Mitteldeutsch Zentrum Struktur & Dynam Prot, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Philipps University Marburg; Martin Luther University Halle Wittenberg	Stubbs, MT (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	stubbs@biochemtech.uni-halle.de	Stubbs, Milton/ABC-7585-2020	Stubbs, Milton/0000-0003-1278-9013	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Schwerpunktprogramm SPP1152 "Evolution metabolischer Diversitat" and the Graduiertenkolleg 1026 "Conformational transitions in macromolecular interactions" of the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Ayabe K, 2005, FEBS LETT, V579, P4389, DOI 10.1016/j.febslet.2005.07.004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyd DA, 2000, J BACTERIOL, V182, P6055, DOI 10.1128/JB.182.21.6055-6065.2000; Branchini BR, 2005, BIOCHEMISTRY-US, V44, P1385, DOI 10.1021/bi047903f; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Clemans DL, 1999, INFECT IMMUN, V67, P2464, DOI 10.1128/IAI.67.5.2464-2474.1999; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Debabov DV, 2000, J BACTERIOL, V182, P2855, DOI 10.1128/JB.182.10.2855-2864.2000; Dieckmann R, 1997, EUR J BIOCHEM, V247, P1074, DOI 10.1111/j.1432-1033.1997.01074.x; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; GOCHT M, 1994, J BACTERIOL, V176, P2654, DOI 10.1128/JB.176.9.2654-2662.1994; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Lai JR, 2006, J AM CHEM SOC, V128, P11002, DOI 10.1021/ja063238h; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; May JJ, 2005, FEBS J, V272, P2993, DOI 10.1111/j.1742-4658.2005.04700.x; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarzer D, 2001, NATURWISSENSCHAFTEN, V88, P93, DOI 10.1007/s001140100211; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stevens BW, 2006, BIOCHEMISTRY-US, V45, P15495, DOI 10.1021/bi061788m; Stuible HP, 2000, FEBS LETT, V467, P117, DOI 10.1016/S0014-5793(00)01133-9; Tang GL, 2007, J BIOL CHEM, V282, P20273, DOI 10.1074/jbc.M702814200; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Volkman BF, 2001, BIOCHEMISTRY-US, V40, P7964, DOI 10.1021/bi010355a; Weber T, 2001, STRUCTURE, V9, pR3, DOI 10.1016/S0969-2126(00)00560-8; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Zhou Z, 2007, P NATL ACAD SCI USA, V104, P11621, DOI 10.1073/pnas.0705122104	58	100	105	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32484	32491		10.1074/jbc.M800557200	http://dx.doi.org/10.1074/jbc.M800557200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18784082	hybrid			2022-12-25	WOS:000260893700036
J	Bode, G; Luken, A; Kerkhoff, C; Roth, J; Ludwig, S; Nacken, W				Bode, Guenther; Lueken, Aloys; Kerkhoff, Claus; Roth, Johannes; Ludwig, Stephan; Nacken, Wolfgang			Interaction between S100A8/A9 and Annexin A6 Is Involved in the Calcium-induced Cell Surface Exposition of S100A8/A9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE ACTIVATION; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; HUMAN NEUTROPHILS; BINDING PROTEINS; GENE-EXPRESSION; BREAST-CANCER; S100 PROTEINS; S100A8/S100A9; MRP14	The calcium binding S100A8/A9 complex (MRP8/14; calgranulin) is considered as an important proinflammatory mediator in acute and chronic inflammation and has recently gained attention as a molecular marker up-regulated in various human cancers. Here, we report that S100A8/A9 is expressed in breast cancer cell lines and is up-regulated by interleukin-1 beta and tumor necrosis factor-alpha in SKBR3 and MCF-7 cells. We identified the phospholipid-binding protein annexin A6 as a potential S100A8/A9 binding protein by affinity chromatography. This finding was verified by Southwestern overlay experiments and by coimmunoprecipitation with the S100A8/A9-specific monoclonal antibody 27E10. Immunocytochemical experiments demonstrated that S100A8/A9 and annexin A6 colocalize in SKBR3 breast cancer cells predominantly in membranous structures. Upon calcium influx both S100A8/A9 and annexin A6 are exposed on the cell surface of SKBR3 cells. Subcellular fractionation studies suggested that after A23187 stimulation membrane association of S100A8/A9 is not enhanced. However, both S100A8/A9 and annexin A6 are exposed on the cell surface of SKBR3 cells upon calcium influx. Experiments with artificial liposomes indicated that S100A8/A9 is able to associate with membranes independently of both annexin A6 and independently of calcium. Finally, cell surface expression of S100A8/A9 could not be observed in A23187-treated A431 and HaCaT cells. Both cell lines are known to be devoid of annexin A6. Repression of annexin A6 expression by small interfering RNA in SKBR3 cells abolishes the cell surface exposition of S100A8/A9 upon calcium influx, suggesting that annexin A6 contributes to the calcium-dependent cell surface exposition of the membrane associated-S100A8/A9 complex.	[Ludwig, Stephan; Nacken, Wolfgang] Univ Munster, Inst Mol Virol, ZMBE, D-48149 Munster, Germany; [Bode, Guenther; Lueken, Aloys; Kerkhoff, Claus; Roth, Johannes; Nacken, Wolfgang] Univ Munster, Inst Immunol, ZMBE, D-48149 Munster, Germany	University of Munster; University of Munster	Nacken, W (corresponding author), Univ Munster, Inst Mol Virol, ZMBE, Esmarch Str 56, D-48149 Munster, Germany.	nacken@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052	Interdisciplinary Center for Clinical Research (IZKF) [Na2/009/04]; Deutsche Forschungsgemeinschaft [KE 820/2-4, KE 820/6-1, SFB293 A16]	Interdisciplinary Center for Clinical Research (IZKF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded in part by the Interdisciplinary Center for Clinical Research (IZKF) Project Na2/009/04 (to W.N.) and by Deutsche Forschungsgemeinschaft Projects KE 820/2-4 and KE 820/6-1 (to C. K.) and SFB293 A16 (J. R.).	Anceriz N, 2007, BIOCHEM BIOPH RES CO, V354, P84, DOI 10.1016/j.bbrc.2006.12.203; Arai K, 2004, EUR J CANCER, V40, P1179, DOI 10.1016/j.ejca.2004.01.022; Berthier S, 2003, J BIOL CHEM, V278, P25499, DOI 10.1074/jbc.M209755200; Carlsson H, 2005, CANCER BIOL THER, V4, P998, DOI 10.4161/cbt.4.9.1969; Celis JE, 2006, FEBS LETT, V580, P2935, DOI 10.1016/j.febslet.2006.03.080; Chang N, 2007, AM J PHYSIOL-CELL PH, V292, pC1417, DOI 10.1152/ajpcell.00439.2006; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; Doussiere J, 2002, EUR J BIOCHEM, V269, P3246, DOI 10.1046/j.1432-1033.2002.03002.x; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Guignard F, 1996, EUR J BIOCHEM, V241, P265, DOI 10.1111/j.1432-1033.1996.0265t.x; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Li C, 2004, BREAST CANCER RES TR, V87, P123, DOI 10.1023/B:BREA.0000041594.36418.f6; Lominadze G, 2005, J IMMUNOL, V174, P7257, DOI 10.4049/jimmunol.174.11.7257; Nacken W, 2004, FEBS LETT, V572, P289, DOI 10.1016/j.febslet.2004.07.024; Nacken W, 2007, FEBS LETT, V581, P5127, DOI 10.1016/j.febslet.2007.09.060; Newton RA, 1998, J IMMUNOL, V160, P1427; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Rammes A, 1997, J BIOL CHEM, V272, P9496; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; SMYTHE E, 1994, J CELL BIOL, V124, P301, DOI 10.1083/jcb.124.3.301; Stroncek DF, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-36; Strzelecka-Kiliszek A, 2008, J CELL BIOCHEM, V104, P418, DOI 10.1002/jcb.21632; Thomas DDH, 2002, J BIOL CHEM, V277, P35496, DOI 10.1074/jbc.M110917200; Tiacci E, 2005, BLOOD, V105, P2812, DOI 10.1182/blood-2004-07-2630; vandenBos C, 1996, J IMMUNOL, V156, P1247; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Yui S, 2003, BIOL PHARM BULL, V26, P753	42	31	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31776	31784		10.1074/jbc.M803908200	http://dx.doi.org/10.1074/jbc.M803908200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786929	hybrid			2022-12-25	WOS:000260760800060
J	Fraczek, J; Kim, TW; Xiao, H; Yao, JH; Wen, Q; Li, YL; Casanova, JL; Pryjma, J; Li, XX				Fraczek, Jerzy; Kim, Tae Whan; Xiao, Hui; Yao, Jianhong; Wen, Qian; Li, Yali; Casanova, Jean-Laurent; Pryjma, Juliusz; Li, Xiaoxia			The Kinase Activity of IL-1 Receptor-associated Kinase 4 Is Required for Interleukin-1 Receptor/Toll-like Receptor-induced TAK1-dependent NF kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE-RECEPTOR; IRAK-4; INNATE; FAMILY; MEMBER; CELLS; TAK1	Two parallel interleukin-1 (IL-1)-mediated signaling pathways have been uncovered for IL-1R-TLR-mediated NF kappa B activation: TAK1-dependent and MEKK3-dependent pathways, respectively. The TAK1-dependent pathway leads to IKK alpha/beta phosphorylation and IKK beta activation, resulting in classic NF kappa B activation through I kappa B alpha phosphorylation and degradation. The TAK1-independent MEKK3-dependent pathway involves IKK gamma phosphorylation and IKK beta activation, resulting in NF kappa B activation through dissociation of phosphorylated I kappa B alpha from NF kappa B without I kappa B alpha degradation. IL-1 receptor-associated kinase 4 (IRAK4) belongs to the IRAK family of proteins and plays a critical role in IL-1R/TLR-mediated signaling. IRAK4 kinase-inactive mutant failed to mediate the IL-1R-TLR-induced TAK1-dependent NF kappa B activation pathway, but mediated IL-1-induced TAK1-independent NF kappa B activation and retained the ability to activate substantial gene expression, indicating a structural role of IRAK4 in mediating this alternative NF kappa B activation pathway. Deletion analysis of IRAK4 indicates the essential structural role of the IRAK4 death domain in receptor proximal signaling for mediating IL-1R-TLR-induced NF kappa B activation.	[Fraczek, Jerzy; Kim, Tae Whan; Xiao, Hui; Yao, Jianhong; Wen, Qian] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; [Fraczek, Jerzy; Pryjma, Juliusz] Jagiellonian Univ, Dept Immunol, Fac Biotechnol, PL-30387 Krakow, Poland; [Casanova, Jean-Laurent] Univ Paris 05, Unite Immunol & Hematol Pediat, Lab Genet Humaine Malad Infect, Unite Mixte Rech,INSERM,U550, F-75270 Paris 06, France; [Kim, Tae Whan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Li, Yali] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Jagiellonian University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Case Western Reserve University; Case Western Reserve University	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org	Casanova, Jean-Laurent/I-3418-2017	Casanova, Jean-Laurent/0000-0002-7782-4169	National Institutes of Health [GM060020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060020 (to X.L.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Koziczak-Holbro M, 2008, EUR J IMMUNOL, V38, P788, DOI 10.1002/eji.200737886; Koziczak-Holbro M, 2007, J BIOL CHEM, V282, P13552, DOI 10.1074/jbc.M700548200; Lasker MV, 2005, J IMMUNOL, V175, P4175, DOI 10.4049/jimmunol.175.7.4175; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Li XX, 1999, MOL CELL BIOL, V19, P4643; Lye E, 2004, J BIOL CHEM, V279, P40653, DOI 10.1074/jbc.M402666200; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	29	44	51	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31697	31705		10.1074/jbc.M804779200	http://dx.doi.org/10.1074/jbc.M804779200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18794297	Green Published, hybrid			2022-12-25	WOS:000260760800052
J	Gonzalez, AM; Claiborne, J; Jones, JCR				Gonzalez, Annette M.; Claiborne, Jessica; Jones, Jonathan C. R.			Integrin Cross-talk in Endothelial Cells Is Regulated by Protein Kinase A and Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; TRANSDOMINANT INHIBITION; LIGAND-BINDING; IN-VITRO; PHOSPHORYLATION; MIGRATION; ALPHA(5)BETA(1); RECEPTOR; SUBUNIT; GROWTH	In endothelial cells (ECs) beta 1 integrin function-blocking antibodies inhibit alpha v beta 3 integrin-mediated adhesion to a recombinant alpha 4-laminin fragment (r alpha 4LN fragment). beta 1 integrin sequestration of talin is not the mechanism by which beta 1 integrin modulates alpha v beta 3 integrin ligand binding. Rather, treatment of the ECs with beta 1 integrin function-blocking antibodies enhances cAMP-dependent protein kinase (PKA) activity and increases beta 3 integrin serine phosphorylation. The PKA inhibitor H-89 abrogates the effect of beta 1 integrin function-blocking antibodies on beta 3 integrin serine phosphorylation and EC-r alpha 4LN fragment binding. beta 3 integrin contains a serine residue at position 752. To confirm the importance of this residue in alpha v beta 3 integrin-r alpha 4LN fragment binding, we mutated it to alanine (beta 3S752A) or aspartic acid (beta 3S752D). Chinese hamster ovary (CHO) cells expressing wild type or beta 3S752A integrin attach robustly to ligand. CHO cells expressing beta 3S752D integrin do not. Because the beta 3 cytoplasmic tail lacks a PKA consensus site, it is unlikely that PKA acts directly on beta 3 integrin. Instead, we have tested an hypothesis that PKA regulates beta 3 integrin serine phosphorylation indirectly through phosphorylation of inhibitor-1, which, when phosphorylated, inhibits protein phosphatase 1 (PP1). Treatment of ECs with beta 1 integrin function-blocking antibodies significantly increases phosphorylation of inhibitor-1. Furthermore, blocking PP1 activity pharmacologically inhibits alpha v beta 3-mediated cell adhesion to the r alpha 4LN fragment when both PKA and beta 1 integrin function are inhibited. Concomitantly, there is an increase in serine phosphorylation of the beta 3 integrin cytoplasmic tail. These results indicate a novel mechanism by which beta 1 integrin negatively modulates alpha v beta 3 integrin-ligand binding via activation of PKA and inhibition of PP1 activity.	[Gonzalez, Annette M.; Claiborne, Jessica; Jones, Jonathan C. R.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Gonzalez, AM (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	a-gonzalez2@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922	National Institutes of Health [RO1 HL67016, KO1 CA106386]; NATIONAL CANCER INSTITUTE [K01CA106386] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL67016 (to J. C. R. J.) and KO1 CA106386 (to A. M. G.).	Alt A, 2001, CANCER RES, V61, P4591; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Baker SE, 1997, CELL MOTIL CYTOSKEL, V37, P271, DOI 10.1002/(SICI)1097-0169(1997)37:3<271::AID-CM9>3.0.CO;2-9; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Bibbb JA, 2001, J BIOL CHEM, V276, P14490, DOI 10.1074/jbc.M007197200; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Borza CM, 2006, J BIOL CHEM, V281, P20932, DOI 10.1074/jbc.M601147200; Butler B, 2003, J BIOL CHEM, V278, P5264, DOI 10.1074/jbc.M206997200; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; CHEN YP, 1994, BLOOD, V84, P1857; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; DiazGonzalez F, 1996, MOL BIOL CELL, V7, P1939, DOI 10.1091/mbc.7.12.1939; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gonzalez AM, 2002, P NATL ACAD SCI USA, V99, P16075, DOI 10.1073/pnas.252649399; Harlow E., 1988, ANTIBODIES LAB MANUA; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hynes RO, 1999, BRAZ J MED BIOL RES, V32, P501, DOI 10.1590/S0100-879X1999000500002; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Imhof BA, 1997, EUR J IMMUNOL, V27, P3242, DOI 10.1002/eji.1830271223; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Kim S, 2002, J CLIN INVEST, V110, P933, DOI 10.1172/JCI200214268; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Ly DP, 2003, J BIOL CHEM, V278, P21878, DOI 10.1074/jbc.M212538200; MEHTA RJ, 1998, BIOCHEM J, P861; Nguyen BP, 2001, J BIOL CHEM, V276, P43860, DOI 10.1074/jbc.M103404200; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; PACIFICI R, 1994, J IMMUNOL, V153, P2222; Porter JC, 1998, TRENDS CELL BIOL, V8, P390, DOI 10.1016/S0962-8924(98)01344-0; Riedel G, 1999, CELL MOL LIFE SCI, V55, P549, DOI 10.1007/s000180050313; Riederer MA, 2002, THROMB HAEMOSTASIS, V88, P858, DOI 10.1055/s-0037-1613314; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Schweitzer KM, 1997, LAB INVEST, V76, P25; SHIGENORI H, 2001, BLOOD, V97, P175; Simon KO, 1997, J BIOL CHEM, V272, P29380, DOI 10.1074/jbc.272.46.29380; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223	52	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31849	31860		10.1074/jbc.M801345200	http://dx.doi.org/10.1074/jbc.M801345200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18806263	Green Published, hybrid			2022-12-25	WOS:000260760800068
J	Pham, P; Zhang, K; Goodman, MF				Pham, Phuong; Zhang, Ke; Goodman, Myron F.			Hypermutation at A/T Sites during G center dot U Mismatch Repair in Vitro by Human B-cell Lysates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; INDUCED CYTIDINE DEAMINASE; DNA-POLYMERASE-ETA; SINGLE-STRANDED-DNA; IMMUNOGLOBULIN GENE HYPERMUTATION; ANTIBODY DIVERSIFICATION ENZYME; ACTIVATION-INDUCED DEAMINASE; SOMATIC HYPERMUTATION; IG GENES; APOBEC PROTEINS	Somatic hypermutation in the variable regions of immunoglobulin genes is required to produce high affinity antibody molecules. Somatic hypermutation results by processing G.U mismatches generated when activation-induced cytidine deaminase (AID) deaminates C to U. Mutations at C/G sites are targeted mainly at deamination sites, whereas mutations at A/T sites entail error-prone DNA gap repair. We used B-cell lysates to analyze salient features of somatic hypermutation with in vitro mutational assays. Tonsil and hypermutating Ramos B-cells convert C -> U in accord with AID motif specificities, whereas HeLa cells do not. Using tonsil cell lysates to repair a G.U mismatch, A/T and G/C targeted mutations occur about equally, whereas Ramos cell lysates make fewer mutations at A/T sites (similar to 24%) compared with G/C sites (similar to 76%). In contrast, mutations in HeLa cell lysates occur almost exclusively at G/C sites (> 95%). By recapitulating two basic features of B-cell-specific somatic hypermutation, G/C mutations targeted to AID hot spot motifs and elevated A/T mutations dependent on error-prone processing of G.U mispairs, these cell free assays provide a practical method to reconstitute error-prone mismatch repair using purified B-cell proteins.	[Pham, Phuong; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Pham, Phuong; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Zhang, Ke] Univ Calif Los Angeles, Sch Med, Div Clin Immunol Allergy, Dept Med, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, RRI-201, Los Angeles, CA 90089 USA.	mgoodman@usc.edu			UGI protein; National Institutes of Health [ES013192, R37GM21422]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422] Funding Source: NIH RePORTER	UGI protein; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Dale Mosbaugh and Samuel Bennett for their generous gift of UGI protein, and we also thank Dr. Matthew D. Scharff for reading and commenting on the manuscript.; This work was supported, in whole or in part, by National Institutes of Health Grants ES013192 and R37GM21422 (to M. F. G.).	Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bennett SE, 2001, J BIOL CHEM, V276, P42588, DOI 10.1074/jbc.M106212200; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; EBELING SB, 1993, EUR J IMMUNOL, V23, P1405, DOI 10.1002/eji.1830230636; Faili A, 2004, J EXP MED, V199, P265, DOI 10.1084/jem.20031831; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Foster SJ, 1999, EUR J IMMUNOL, V29, P3122, DOI 10.1002/(SICI)1521-4141(199910)29:10<3122::AID-IMMU3122>3.3.CO;2-F; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2001, J VIROL, V75, P10488, DOI 10.1128/JVI.75.21.10488-10492.2001; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Larson ED, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.3.e14; Li ZQ, 2007, ADV EXP MED BIOL, V596, P93; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Masuda K, 2005, P NATL ACAD SCI USA, V102, P13986, DOI 10.1073/pnas.0505636102; Masuda K, 2007, J BIOL CHEM, V282, P17387, DOI 10.1074/jbc.M611849200; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Ouchida R, 2008, DNA REPAIR, V7, P1392, DOI 10.1016/j.dnarep.2008.04.014; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Perlot T, 2008, P NATL ACAD SCI USA, V105, P3843, DOI 10.1073/pnas.0712291105; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2005, BIOCHEMISTRY-US, V44, P2703, DOI 10.1021/bi047481+; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Pham P, 2007, DNA REPAIR, V6, P689, DOI 10.1016/j.dnarep.2007.01.001; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; RAJEWSKY K, 1987, SCIENCE, V238, P1088, DOI 10.1126/science.3317826; Razanajaona D, 1997, J IMMUNOL, V159, P3347; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Sanderson RJ, 2001, PROG NUCLEIC ACID RE, V68, P165; Seki M, 2005, EMBO REP, V6, P1143, DOI 10.1038/sj.embor.7400582; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Unniraman S, 2007, SCIENCE, V317, P1227, DOI 10.1126/science.1145065; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Wilson SH, 2000, COLD SPRING HARB SYM, V65, P143, DOI 10.1101/sqb.2000.65.143; Xiao Z, 2007, MOL IMMUNOL, V44, P2659, DOI 10.1016/j.molimm.2006.12.006; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zan H, 2005, EMBO J, V24, P3757, DOI 10.1038/sj.emboj.7600833; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang K, 2002, J ALLERGY CLIN IMMUN, V110, P421, DOI 10.1067/mai.2002.126382; Zhu Yi, 2003, Journal of Medical and Dental Sciences, V50, P41	84	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31754	31762		10.1074/jbc.M805524200	http://dx.doi.org/10.1074/jbc.M805524200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786917	hybrid, Green Published			2022-12-25	WOS:000260760800058
J	Torrelles, JB; Knaup, R; Kolareth, A; Slepushkina, T; Kaufman, TM; Kang, P; Hill, PJ; Brennan, PJ; Chatterjee, D; Belisle, JT; Musser, JM; Schlesinger, LS				Torrelles, Jordi B.; Knaup, Rose; Kolareth, Avina; Slepushkina, Tatiana; Kaufman, Thomas M.; Kang, Peter; Hill, Preston J.; Brennan, Patrick J.; Chatterjee, Delphi; Belisle, John T.; Musser, James M.; Schlesinger, Larry S.			Identification of Mycobacterium tuberculosis Clinical Isolates with Altered Phagocytosis by Human Macrophages Due to a Truncated Lipoarabinomannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE RECEPTOR; STRUCTURAL DEFINITION; ATTENUATED STRAINS; VIRULENT-STRAIN; BOVIS BCG; BIOSYNTHESIS; NUCLEOTIDE; RESIDUES; FEATURES; BINDING	Phenotypically distinct clinical isolates of Mycobacterium tuberculosis are capable of altering the balance that exists between the pathogen and human host and ultimately the outcome of infection. This study has identified two M. tuberculosis strains (i.e. HN885 and HN1554) among a bank of clinical isolates with a striking defect in phagocytosis by primary human macrophages when compared with strain Erdman, a commonly used laboratory strain for studies of pathogenesis. Mass spectrometry in conjunction with NMR studies unequivocally confirmed that both HN885 and HN1554 contain truncated and more branched forms of mannose-capped lipoarabinomannan(ManLAM) with a marked reduction of their linear arabinan (corresponding mainly to the inner Araf-alpha(1 -> 5)-Araf unit) and mannan (with fewer 6-Manp residues and more substitutions in the linear Manp-alpha(1 -> 6)-Manp unit) domains. The truncation in the ManLAM molecules produced by strains HN885 and HN1554 led to a significant reduction in their surface availability. In addition, there was a marked reduction of higher order phosphatidyl-myo-inositol mannosides and the presence of dimycocerosates, triglycerides, and phenolic glycolipid in their cell envelope. Less exposed ManLAM and reduced higher order phosphatidyl-myo-inositol mannosides in strains HN885 and HN1554 resulted in their low association with the macrophage mannose receptor. Despite reduced phagocytosis, ingested bacilli replicated at a fast rate following serum opsonization. Our results provide evidence that the clinical spectrum of tuberculosis may be dictated not only by the host but also by the amounts and ratios of surface exposed mycobacterial adherence factors defined by strain genotype.	[Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Internal Med, Div Infect Dis, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Dept Mol Virol, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Dept Med Genet, Columbus, OH 43210 USA; [Kolareth, Avina; Slepushkina, Tatiana; Kaufman, Thomas M.; Kang, Peter] Univ Iowa, Dept Med, Iowa City, IA 52240 USA; [Kolareth, Avina; Slepushkina, Tatiana; Kaufman, Thomas M.; Kang, Peter] Univ Iowa, Dept Microbiol, Iowa City, IA 52240 USA; [Kolareth, Avina; Slepushkina, Tatiana; Kaufman, Thomas M.; Kang, Peter] Univ Iowa, Dept Pathol, Iowa City, IA 52240 USA; [Hill, Preston J.; Brennan, Patrick J.; Chatterjee, Delphi; Belisle, John T.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Musser, James M.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Musser, James M.] Methodist Hosp, Res Inst, Dept Pathol, Houston, TX 77030 USA; [Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Dept Immunol, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Iowa; University of Iowa; University of Iowa; Colorado State University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Schlesinger, LS (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Dept Med, Div Infect Dis, 460 W 12th Ave,Biomed Res Tower,Rm 1004, Columbus, OH 43210 USA.	larry.schlesinger@osumc.edu	Belisle, John T/B-8944-2017; Torrelles, Jordi/E-4204-2011	Belisle, John T/0000-0002-2539-2798; 	National Institutes of Health [AI052458, AI33004, NO1 AI-040091]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033004, R00AI073856, R29AI033004, R01AI052458, R21AI052458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI052458 and AI33004 (to L. S. S.) and Contract NO1 AI-040091 (to J. T. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	[Anonymous], 2007, GLOB TUB CONTR SURV; Berg S, 2005, J BIOL CHEM, V280, P5651, DOI 10.1074/jbc.M411418200; Bhamidi S, 2008, J BIOL CHEM, V283, P12992, DOI 10.1074/jbc.M800222200; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Draper P, 1997, BIOCHEM J, V327, P519, DOI 10.1042/bj3270519; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Fenton MJ, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P405; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kaur D, 2002, MICROBIOL-SGM, V148, P3049, DOI 10.1099/00221287-148-10-3049; Khoo HH, 2001, J BIOL CHEM, V276, P3863, DOI 10.1074/jbc.M004010200; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Manca C, 1999, J IMMUNOL, V162, P6740; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Martinez-Pomares L, 2001, IMMUNOBIOLOGY, V204, P527, DOI 10.1078/0171-2985-00089; McCarthy TR, 2005, MOL MICROBIOL, V58, P774, DOI 10.1111/j.1365-2958.2005.04862.x; MCNEIL MR, 1994, GLYCOBIOLOGY, V4, P165, DOI 10.1093/glycob/4.2.165; Nigou J, 1999, GLYCOCONJUGATE J, V16, P257, DOI 10.1023/A:1007046609341; Olakanmi O, 2000, INFECT IMMUN, V68, P5619, DOI 10.1128/IAI.68.10.5619-5627.2000; PRINZIS S, 1993, J GEN MICROBIOL, V139, P2649, DOI 10.1099/00221287-139-11-2649; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Schlesinger L. S., 2008, HDB TUBERCULOSIS IMM; Schlesinger LS, 1996, J IMMUNOL, V157, P4568; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Turnbull WB, 2004, ANGEW CHEM INT EDIT, V43, P3918, DOI 10.1002/anie.200454119; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; VENISSE A, 1993, J BIOL CHEM, V268, P12401; WILEMAN TE, 1986, P NATL ACAD SCI USA, V83, P2501, DOI 10.1073/pnas.83.8.2501	43	50	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31417	31428		10.1074/jbc.M806350200	http://dx.doi.org/10.1074/jbc.M806350200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784076	hybrid, Green Published			2022-12-25	WOS:000260760800021
J	McDaniel, L; Breitbart, M; Mobberley, J; Long, A; Haynes, M; Rohwer, F; Paul, JH				McDaniel, Lauren; Breitbart, Mya; Mobberley, Jennifer; Long, Amy; Haynes, Matthew; Rohwer, Forest; Paul, John H.			Metagenomic Analysis of Lysogeny in Tampa Bay: Implications for Prophage Gene Expression	PLOS ONE			English	Article							MARINE VIRUSES; BACTERIOPLANKTON; COMMUNITIES; INDUCTION; ABUNDANCE; BACTERIA; SEA	Phage integrase genes often play a role in the establishment of lysogeny in temperate phage by catalyzing the integration of the phage into one of the host's replicons. To investigate temperate phage gene expression, an induced viral metagenome from Tampa Bay was sequenced by 454/Pyrosequencing. The sequencing yielded 294,068 reads with 6.6% identifiable. One hundred-three sequences had significant similarity to integrases by BLASTX analysis (e <= 0.001). Four sequences with strongest amino-acid level similarity to integrases were selected and real-time PCR primers and probes were designed. Initial testing with microbial fraction DNA from Tampa Bay revealed 1.9x10(7), and 1300 gene copies of Vibrio-like integrase and Oceanicola-like integrase L-1 respectively. The other two integrases were not detected. The integrase assay was then tested on microbial fraction RNA extracted from 200 ml of Tampa Bay water sampled biweekly over a 12 month time series. Vibrio-like integrase gene expression was detected in three samples, with estimated copy numbers of 2.4-1280 L-1. Clostridium-like integrase gene expression was detected in 6 samples, with estimated copy numbers of 37 to 265 L-1. In all cases, detection of integrase gene expression corresponded to the occurrence of lysogeny as detected by prophage induction. Investigation of the environmental distribution of the two expressed integrases in the Global Ocean Survey Database found the Vibrio-like integrase was present in genome equivalents of 3.14% of microbial libraries and all four viral metagenomes. There were two similar genes in the library from British Columbia and one similar gene was detected in both the Gulf of Mexico and Sargasso Sea libraries. In contrast, in the Arctic library eleven similar genes were observed. The Clostridium-like integrase was less prevalent, being found in 0.58% of the microbial and none of the viral libraries. These results underscore the value of metagenomic data in discovering signature genes that play important roles in the environment through their expression, as demonstrated by integrases in lysogeny.	[McDaniel, Lauren; Breitbart, Mya; Mobberley, Jennifer; Paul, John H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Long, Amy] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commission, St Petersburg, FL USA; [Haynes, Matthew; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	State University System of Florida; University of South Florida; Florida Fish & Wildlife Conservation Commission; California State University System; San Diego State University	McDaniel, L (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	mcdaniel@marine.usf.edu	Breitbart, Mya/B-1366-2009; Rohwer, Forest/AAC-5315-2019	Breitbart, Mya/0000-0003-3210-2899; Mobberley, Jennifer/0000-0001-5865-8145; Rohwer, Forest/0000-0003-1548-5429; Long, Amy/0000-0002-9670-981X	National Science Foundation [OCE-0221763, EF-0801593, MCB-0701984]; Alfred P. Sloan Foundation [BR-4772]	National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	L.M. and J.P. were supported by grants OCE-0221763 and EF-0801593 from the National Science Foundation. M.B. was supported by grant MCB-0701984 from the National Science Foundation. M.B. also received grant support from the Alfred P. Sloan Foundation (BR-4772).	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Ackermann HW, 1987, VIRUSES PROKARYOTES, V1; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; CARPENTER DJ, 1980, PRIMARY PRODUCTIVITY, P161; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Jiang SC, 1996, MAR ECOL PROG SER, V142, P27, DOI 10.3354/meps142027; JIANG SC, 1994, MAR ECOL PROG SER, V104, P163, DOI 10.3354/meps104163; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Laybourn-Parry J, 2007, POLAR BIOL, V30, P351, DOI 10.1007/s00300-006-0191-9; Leitet C, 2006, J MAR BIOL ASSOC UK, V86, P567, DOI 10.1017/S0025315406013488; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McDaniel L, 2005, APPL ENVIRON MICROB, V71, P842, DOI 10.1128/AEM.71.2.842-850.2005; McDaniel L, 2002, NATURE, V415, P496, DOI 10.1038/415496a; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; *NAT RES COUNC NAT, 2007, NEW SCI MET REV SECR; PAUL JH, 2008, ISME J IN PRESS; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sambrook J, 2001, MOL CLONING LAB MANU; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; STOPAR D, 2006, MICROB ECOL, V46, P249; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Williamson SJ, 2002, APPL ENVIRON MICROB, V68, P4307, DOI 10.1128/AEM.68.9.4307-4314.2002; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	37	46	49	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2008	3	9							e3263	10.1371/journal.pone.0003263	http://dx.doi.org/10.1371/journal.pone.0003263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MA	18810270	gold, Green Published, Green Submitted			2022-12-25	WOS:000264431000005
J	Gocke, CB; Yu, HT				Gocke, Christian B.; Yu, Hongtao			ZNF198 Stabilizes the LSD1-CoREST-HDAC1 Complex on Chromatin through Its MYM-Type Zinc Fingers	PLOS ONE			English	Article								Histone modifications in chromatin regulate gene expression. A transcriptional co-repressor complex containing LSD1-CoREST-HDAC1 (termed LCH hereafter for simplicity) represses transcription by coordinately removing histone modifications associated with transcriptional activation. RE1-silencing transcription factor (REST) recruits LCH to the promoters of neuron-specific genes, thereby silencing their transcription in non-neuronal tissues. ZNF198 is a member of a family of MYM-type zinc finger proteins that associate with LCH. Here, we show that ZNF198-like proteins are required for the repression of E-cadherin (a gene known to be repressed by LSD1), but not REST-responsive genes. ZNF198 binds preferentially to the intact LCH ternary complex, but not its individual subunits. ZNF198- and REST-binding to the LCH complex are mutually exclusive. ZNF198 associates with chromatin independently of LCH. Furthermore, modification of HDAC1 by small ubiquitin-like modifier (SUMO) in vitro weakens its interaction with CoREST whereas sumoylation of HDAC1 stimulates its binding to ZNF198. Finally, we mapped the LCH- and HDAC1-SUMO-binding domains of ZNF198 to tandem repeats of MYM-type zinc fingers. Therefore, our results suggest that ZNF198, through its multiple protein-protein interaction interfaces, helps to maintain the intact LCH complex on specific, non-REST-responsive promoters and may also prevent SUMO-dependent dissociation of HDAC1.	[Gocke, Christian B.; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gocke, CB (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu		Yu, Hongtao/0000-0002-8861-049X	Welch foundation; WM Keck Foundation; March of Dimes Foundation; Leukemia and Lymphoma Society; Howard Hughes Medical Institute [Investigator]	Welch foundation(The Welch Foundation); WM Keck Foundation(W.M. Keck Foundation); March of Dimes Foundation(March of Dimes); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Welch foundation, the WM Keck Foundation, the March of Dimes Foundation, and the Leukemia and Lymphoma Society. HY is an Investigator at the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DAVIDSSON P, 2002, INT J ENTREPRENEURSH, V1, P1; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kunapuli P, 2006, EXP CELL RES, V312, P3739, DOI 10.1016/j.yexcr.2006.06.037; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Raffa GD, 2005, MOL CELL, V20, P821, DOI 10.1016/j.molcel.2005.12.003; Reiter A, 1998, BLOOD, V92, P1735, DOI 10.1182/blood.V92.5.1735.417k11_1735_1742; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Smedley D, 1999, GENOMICS, V60, P244, DOI 10.1006/geno.1999.5918; Smedley D, 1998, HUM MOL GENET, V7, P637, DOI 10.1093/hmg/7.4.637; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Warren JT, 2001, MOL CELL ENDOCRINOL, V181, P1, DOI 10.1016/S0303-7207(01)00404-X; Wismar J, 2000, DEV BIOL, V226, P1, DOI 10.1006/dbio.2000.9811; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200	56	58	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3255	10.1371/journal.pone.0003255	http://dx.doi.org/10.1371/journal.pone.0003255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806873	Green Published, gold, Green Submitted			2022-12-25	WOS:000264430800005
J	Sullivan, PS; Denniston, M; Mokotoff, E; Buskin, S; Broyles, S; McNaghten, AD				Sullivan, Patrick S.; Denniston, Maxine; Mokotoff, Eve; Buskin, Susan; Broyles, Stephanie; McNaghten, A. D.			Quality of Care for HIV Infection Provided by Ryan White Program-Supported versus Non-Ryan White Program-Supported Facilities	PLOS ONE			English	Article							UNITED-STATES; CLINICAL SURVEILLANCE; SERVICES	Background: The Ryan White HIV/AIDS Care Act (now the Treatment Modernization Act; Ryan White Program, or RWP) is a source of federal public funding for HIV care in the United States. The Health Services and Resources Administration requires that facilities or providers who receive RWP funds ensure that HIV health services are accessible and delivered according to established HIV-related treatment guidelines. We used data from population-based samples of persons in care for HIV infection in three states to compare the quality of HIV care in facilities supported by the RWP, with facilities not supported by the RWP. Methodology/Principal Findings: Within each area (King County in Washington State; southern Louisiana; and Michigan), a probability sample of patients receiving care for HIV infection in 1998 was drawn. Based on medical records abstraction, information was collected on prescription of antiretroviral therapy according to treatment recommendations, prescription of prophylactic therapy, and provision of recommended vaccinations and screening tests. We calculated population-level estimates of the extent to which HIV care was provided according to then-current treatment guidelines in RWP-supported and non-RWP-supported facilities. For all treatment outcomes analyzed, the compliance with care guidelines was at least as good for patients who received care at RWP-supported (vs non-RWP supported) facilities. For some outcomes in some states, delivery of recommended care was significantly more common for patients receiving care in RWP-supported facilities: for example, in Louisiana, patients receiving care in RWP-supported facilities were more likely to receive indicated prophylaxis for Pneumocystis jirovecii pneumonia and Mycobacterium avium complex, and in all three states, women receiving care in RWP-supported facilities were more likely to have received an annual Pap smear. Conclusions/Significance: The quality of HIV care provided in 1998 to patients in RWP-supported facilities was of equivalent or better quality than in non-RWP supported facilities; however, there were significant opportunities for improvement in all facility types. Data from population-based clinical outcomes surveillance data can be used as part of a broader strategy to evaluate the quality of publicly-supported HIV care.	[Sullivan, Patrick S.; Denniston, Maxine; McNaghten, A. D.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Mokotoff, Eve] Michigan Dept Community Hlth, Detroit, MI USA; [Buskin, Susan] Publ Hlth Seattle & King County, Seattle, WA USA; [Broyles, Stephanie] Louisiana Dept Publ Hlth, New Orleans, LA USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Sullivan, PS (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	patrick.sullivan@emory.edu	Broyles, Stephanie/C-8647-2011	Broyles, Stephanie/0000-0003-3168-0056; Sullivan, Patrick Sean/0000-0002-7728-0587	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work and the effort of its authors was supported by a cooperative agreement from the Centers for Disease Control and Prevention (CDC). CDC authors conducted the analyses reported in this manuscript.	[Anonymous], 1997, MMWR RECOMM REP, V46, P1; Coyne KM, 2008, INT J STD AIDS, V19, P351, DOI 10.1258/ijsa.2007.007263; Fleming PL, 2000, AM J PUBLIC HEALTH, V90, P1037, DOI 10.2105/AJPH.90.7.1037; Frankel MR, 1999, HEALTH SERV RES, V34, P969; Gallagher KM, 2007, J INFECT DIS, V196, P339, DOI 10.1086/519165; Hirschhorn LR, 2006, WOMEN HEALTH ISS, V16, P104, DOI 10.1016/j.whi.2006.02.004; *HLTH RES SERV ADM, CLIENT LEV DAT PROJ; *HLTH RES SERV ADM, HIV AIDS BUR CLIN PE; Landon BE, 2005, ARCH INTERN MED, V165, P1133, DOI 10.1001/archinte.165.10.1133; McInnes K, 2004, AIDS CARE, V16, P851, DOI 10.1080/09540120412331290202; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; OSTER A, 2008, 2008 EP INT SERV C A; Sullivan PS, 2007, PUBLIC HEALTH REP, V122, P1; Sullivan PS, 2005, PUBLIC HEALTH REP, V120, P230, DOI 10.1177/003335490512000304; TESHALE EH, 2006, INF DIS SOC AM ANN C; Teshale EH, 2007, CLIN INFECT DIS, V44, P879, DOI 10.1086/511862; Tobias C, 2006, AIDS PATIENT CARE ST, V20, P205, DOI 10.1089/apc.2006.20.205; *US PUBL HLTH SERV, 1998, GUID US ANT AG HIV I; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; WILSON IB, 2007, BRIT MED J, V335, P1055	20	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3250	10.1371/journal.pone.0003250	http://dx.doi.org/10.1371/journal.pone.0003250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422LY	18806878	Green Submitted, Green Published, gold			2022-12-25	WOS:000264430800002
J	Luo, Y; Alvarez, M; Xia, LC; Casadevall, A				Luo, Yong; Alvarez, Mauricio; Xia, Lingchuan; Casadevall, Arturo			The Outcome of Phagocytic Cell Division with Infectious Cargo Depends on Single Phagosome Formation	PLOS ONE			English	Article								Given that macrophages can proliferate and that certain microbes survive inside phagocytic cells, the question arises as to the post-mitotic distribution of microbial cargo. Using macrophage-like cells we evaluated the post-mitotic distribution of intracellular Cryptococcus yeasts and polystyrene beads by comparing experimental data to a stochastic model. For beads, the post-mitotic distribution was that expected from chance alone. However, for yeast cells the post-mitotic distribution was unequal, implying preferential sorting to one daughter cell. This mechanism for unequal distribution was phagosomal fusion, which effectively reduced the intracellular particle number. Hence, post-mitotic intracellular particle distribution is stochastic, unless microbial and/or host factors promote unequal distribution into daughter cells. In our system unequal cargo distribution appeared to benefit the microbe by promoting host cell exocytosis. Post-mitotic infectious cargo distribution is a new parameter to consider in the study of intracellular pathogens since it could potentially define the outcome of phagocytic-microbial interactions.	[Luo, Yong; Alvarez, Mauricio; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Xia, Lingchuan] Jiaomen 13th Yuan, Beijing, Peoples R China; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Luo, Y (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	yluo@aecom.yu.edu			NIH [AI033142-11, AI033774-11, HL059842]; Northeastern Biodefense Center [AI057158-05]; National Cancer Institute under Immunology and Immunooncology training program [5T32CA009173]; NATIONAL CANCER INSTITUTE [T32CA009173] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI033774, R37AI033142, R01AI033142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern Biodefense Center; National Cancer Institute under Immunology and Immunooncology training program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present study was supported by NIH grants AI033142-11, AI033774-11 and HL059842. AC is also supported in part by the Northeastern Biodefense Center under grant AI057158-05. YL is also supported by the National Cancer Institute under Immunology and Immunooncology training program 5T32CA009173.	Alvarez M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-16; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; CINATL J, 1982, NATURE, V298, P388, DOI 10.1038/298388a0; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; De S. P., 2005, Journal of Infection and Chemotherapy, V11, P115, DOI 10.1007/s10156-005-0387-x; DEBAKKER JM, 1985, J SUBMICR CYTOL PATH, V17, P133; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; FORBES IJ, 1966, J IMMUNOL, V96, P734; FORBES IJ, 1963, LANCET, V2, P1203; Goldman DL, 2000, INFECT IMMUN, V68, P832, DOI 10.1128/IAI.68.2.832-838.2000; GORDON S, 1973, INT REV CYTOL, V36, P171, DOI 10.1016/S0074-7696(08)60218-1; HECHEMY KE, 1993, INFECT IMMUN, V61, P4485, DOI 10.1128/IAI.61.10.4485-4488.1993; KOZEL TR, 1984, INFECT IMMUN, V43, P879, DOI 10.1128/IAI.43.3.879-886.1984; LIN HS, 1974, J CELL PHYSIOL, V83, P369, DOI 10.1002/jcp.1040830307; LIN HS, 1973, NATURE-NEW BIOL, V243, P176, DOI 10.1038/newbio243176a0; Luo Y, 2006, CLIN EXP IMMUNOL, V145, P380, DOI 10.1111/j.1365-2249.2006.03132.x; Luo Y, 2005, J IMMUNOL, V174, P7226, DOI 10.4049/jimmunol.174.11.7226; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381; Meyuhas D, 1996, BIOPHYS J, V71, P2602, DOI 10.1016/S0006-3495(96)79452-3; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; RALPH P, 1975, J IMMUNOL, V114, P898; ROMAN MJ, 1986, J GEN MICROBIOL, V132, P1415; Santangelo R, 2004, INFECT IMMUN, V72, P2229, DOI 10.1128/IAI.72.4.2229-2239.2004; Shao XP, 2005, J IMMUNOL, V175, P3244, DOI 10.4049/jimmunol.175.5.3244; SMALL JM, 1986, INFECT IMMUN, V54, P742, DOI 10.1128/IAI.54.3.742-750.1986; Steenbergen JN, 2003, MICROBES INFECT, V5, P667, DOI 10.1016/S1286-4579(03)00092-3; STEWART CC, 1975, J EXP MED, V141, P1114, DOI 10.1084/jem.141.5.1114; STEWART CC, 1981, METHODS STUDYING MON, P5; STEWART CC, 1980, MONONUCLEAR PHAGOC 1; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; VANDERZEIJST BAM, 1978, J EXP MED, V147, P1253, DOI 10.1084/jem.147.4.1253; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VOLKMAN A, 1965, BRIT J EXP PATHOL, V46, P50; VOLKMAN A, 1965, BRIT J EXP PATHOL, V46, P62; WALKER WS, 1988, CELL IMMUNOL, V111, P492, DOI 10.1016/0008-8749(88)90112-8; WESTERMANN J, 1989, J LEUKOCYTE BIOL, V46, P263, DOI 10.1002/jlb.46.3.263; Zaragoza O, 2003, EUR J IMMUNOL, V33, P1957, DOI 10.1002/eji.200323848	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3219	10.1371/journal.pone.0003219	http://dx.doi.org/10.1371/journal.pone.0003219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795151	Green Published, gold, Green Submitted			2022-12-25	WOS:000264428000003
J	Diep, BA; Palazzolo-Ballance, AM; Tattevin, P; Basuino, L; Braughton, KR; Whitney, AR; Chen, L; Kreiswirth, BN; Otto, M; Deleo, FR; Chambers, HF				Diep, Binh An; Palazzolo-Ballance, Amy M.; Tattevin, Pierre; Basuino, Li; Braughton, Kevin R.; Whitney, Adeline R.; Chen, Liang; Kreiswirth, Barry N.; Otto, Michael; DeLeo, Frank R.; Chambers, Henry F.			Contribution of Panton-Valentine Leukocidin in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis	PLOS ONE			English	Article								Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains typically carry genes encoding Panton-Valentine leukocidin (PVL). We used wild-type parental and isogenic PVL-deletion (Delta pvl) strains of USA300 (LAC and SF8300) and USA400 (MW2) to test whether PVL alters global gene regulatory networks and contributes to pathogenesis of bacteremia, a hallmark feature of invasive staphylococcal disease. Microarray and proteomic analyses revealed that PVL does not alter gene or protein expression, thereby demonstrating that any contribution of PVL to CA-MRSA pathogenesis is not mediated through interference of global gene regulatory networks. Inasmuch as a direct role for PVL in CA-MRSA pathogenesis remains to be determined, we developed a rabbit bacteremia model of CA-MRSA infection to evaluate the effects of PVL. Following experimental infection of rabbits, an animal species whose granulocytes are more sensitive to the effects of PVL compared with the mouse, we found a contribution of PVL to pathogenesis over the time course of bacteremia. At 24 and 48 hours post infection, PVL appears to play a modest, but measurable role in pathogenesis during the early stages of bacteremic seeding of the kidney, the target organ from which bacteria were not cleared. However, the early survival advantage of this USA300 strain conferred by PVL was lost by 72 hours post infection. These data are consistent with the clinical presentation of rapid-onset, fulminant infection that has been associated with PVL-positive CA-MRSA strains. Taken together, our data indicate a modest and transient positive effect of PVL in the acute phase of bacteremia, thereby providing evidence that PVL contributes to CA-MRSA pathogenesis.	[Diep, Binh An; Tattevin, Pierre; Basuino, Li; Chambers, Henry F.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Palazzolo-Ballance, Amy M.; Braughton, Kevin R.; Whitney, Adeline R.; Otto, Michael; DeLeo, Frank R.] National Inst Allergy & Infect Dis, NIH, Rocky Mt Lab, Lab Human Bacterial Pathogenesis, Hamilton, MT USA; [Chen, Liang; Kreiswirth, Barry N.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center	Diep, BA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.	hchambers@medsfgh.ucsf.edu	Chen, Liang/D-3583-2009	Chen, Liang/0000-0001-5845-2235; Otto, Michael/0000-0002-2222-4115; DeLeo, Frank/0000-0003-3150-2516	US Public Health Service [AI070289]; Intramural Research Program of the National Institutes of Health, National Institutes of Allergy and Infectious Diseases; Societe de Pathologie Infectieuse de Langue Francaise (SPILF); Pontchaillou University Hospital, Rennes, France; Microbial Pathogenesis and Host Defense Postdoctoral Fellowship [5T32AI060537-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904, Z01AI001079, T32AI060537, R01AI070289] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Intramural Research Program of the National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Societe de Pathologie Infectieuse de Langue Francaise (SPILF); Pontchaillou University Hospital, Rennes, France; Microbial Pathogenesis and Host Defense Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US Public Health Service Grant AI070289 (H.F. Chambers) and the Intramural Research Program of the National Institutes of Health, National Institutes of Allergy and Infectious Diseases (F.R. DeLeo and M. Otto). P. Tattevin was supported by a grant from the Societe de Pathologie Infectieuse de Langue Francaise (SPILF) and by the Pontchaillou University Hospital, Rennes, France. B.A. Diep was supported by a Microbial Pathogenesis and Host Defense Postdoctoral Fellowship (5T32AI060537-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Chen J, 2007, MICROBIOL-SGM, V153, P1604, DOI 10.1099/mic.0.2007/006247-0; Colin DA, 2003, INFECT IMMUN, V71, P3724, DOI 10.1128/IAI.71.7.3724-3729.2003; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Hota B, 2007, ARCH INTERN MED, V167, P1026, DOI 10.1001/archinte.167.10.1026; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; KONIG B, 1994, INFECT IMMUN, V62, P4831; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nguyen DM, 2005, EMERG INFECT DIS, V11, P526, DOI 10.3201/eid1104.041094; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; SZMIGIELSKI S, 1966, J PATHOL BACTERIOL, V91, P599, DOI 10.1002/path.1700910237; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; WARDENBURG JB, 2008, J INFECT DI IN PRESS; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405	32	154	156	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3198	10.1371/journal.pone.0003198	http://dx.doi.org/10.1371/journal.pone.0003198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787708	Green Published, gold, Green Submitted			2022-12-25	WOS:000264426200004
J	Madan, M; Amar, S				Madan, Monika; Amar, Salomon			Toll-Like Receptor-2 Mediates Diet and/or Pathogen Associated Atherosclerosis: Proteomic Findings	PLOS ONE			English	Article								Background: Accumulating evidence implicates a fundamental link between the immune system and atherosclerosis. Toll-like receptors are principal sensors of the innate immune system. Here we report an assessment of the role of the TLR2 pathway in atherosclerosis associated with a high-fat diet and/or bacteria in ApoE(+/)-mice. Methods and Results: To explore the role of TLR2 in inflammation-and infection-associated atherosclerosis, 10 week-old ApoE(+/-)-TLR(2+/+), ApoE(+/-)-TLR2(+/-) and ApoE(+/-)-TLR2(-/-) mice were fed either a high fat diet or a regular chow diet. All mice were inoculated intravenously, once per week for 24 consecutive weeks, with 50 mu l live Porphyromonas gingivalis (P. g) (10(7) CFU) or vehicle (normal saline). Animals were euthanized 24 weeks after the first inoculation. ApoE(+/-)-TLR2(+/+) mice showed a significant increase in atheromatous lesions in proximal aorta and aortic tree compared to ApoE(+/-)-TLR2(+/-) and ApoE(+/-)-TLR2(-/-) mice for all diet conditions. They also displayed profound changes in plaque composition, as evidenced by increased macrophage infiltration and apoptosis, increased lipid content, and decreased smooth muscle cell mass, all reflecting an unstable plaque phenotype. SAA levels from ApoE(+/-)TLR2(+/+) mice were significantly higher than from ApoE(+/-)-TLR2(+/-) and ApoE(+/-)-TLR(+/-) mice. Serum cytokine analysis revealed increased levels of pro-inflammatory cytokines in ApoE(+/-)-TLR2(+/+) mice compared to ApoE(+/-)-TLR(+/-) and TLR2(-/-)-mice, irrespective of diet or bacterial challenge. ApoE(+/)--TLR(2+/+) mice injected weekly for 24 weeks with FSL-1 (a TLR2 agonist) also demonstrated significant increases in atherosclerotic lesions, SAA and serum cytokine levels compared to ApoE(+/-)-TLR2(-/-) mice under same treatment condition. Finally, mass-spectrometry (MALDI-TOF-MS) of aortic samples analyzed by 2-dimentional gel electrophoresis differential display, identified 6 proteins upregulated greater than 2-fold in ApoE(+/)-TLR(2+/+) mice fed the high fat diet and inoculated with P. g compared to any other group. Conclusion: Genetic deficiency of TLR2 reduces diet-and/or pathogen- associated atherosclerosis in ApoE(+/)-mice, along with differences in plaque composition suggesting greater structural stability while TLR-2 ligand-specific activation triggers atherosclerosis. The present data offers new insights into the pathophysiological pathways involved in atherosclerosis and paves the way for new pharmacological interventions aimed at reducing atherosclerosis.	[Madan, Monika; Amar, Salomon] Boston Univ, Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA	Boston University	Madan, M (corresponding author), Boston Univ, Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA.	samar@bu.edu		Amar, Salomon/0000-0002-0017-5930	NHLBI [R01 HL076801]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076801] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NHLBI grant R01 HL076801 supported the study.	Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Barillari G, 2001, ATHEROSCLEROSIS, V154, P377, DOI 10.1016/S0021-9150(00)00506-2; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Chi HH, 2004, CIRCULATION, V110, P1678, DOI 10.1161/01.CIR.0000142085.39015.31; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hajishengallis G, 2002, INFECT IMMUN, V70, P6658, DOI 10.1128/IAI.70.12.6658-6664.2002; Hajishengallis George, 2002, Ann Periodontol, V7, P72, DOI 10.1902/annals.2002.7.1.72; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Howe J, 2008, INNATE IMMUN-LONDON, V14, P39, DOI 10.1177/1753425907087257; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kockx MM, 2000, CARDIOVASC RES, V45, P736, DOI 10.1016/S0008-6363(99)00235-7; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Madan M, 2008, ATHEROSCLEROSIS, V197, P504, DOI 10.1016/j.atherosclerosis.2007.02.023; Madan M, 2007, ATHEROSCLEROSIS, V190, P62, DOI 10.1016/j.atherosclerosis.2006.02.026; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; MEDHITOV RHC, 2000, N ENGL J MED; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P151, DOI 10.1111/j.1348-0421.2002.tb02680.x; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Ozinsky A, 2000, J ENDOTOXIN RES, V6, P393, DOI 10.1179/096805100101532333; Prescott SM, 2002, ARTERIOSCL THROM VAS, V22, P727, DOI 10.1161/01.ATV.0000016153.47693.B2; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Rifai N, 2001, CLIN CHEM, V47, P403; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schoneveld AH, 2005, CARDIOVASC RES, V66, P162, DOI 10.1016/j.cardiores.2004.12.016; Shah PK, 2000, CIRCULATION, V101, P1758, DOI 10.1161/01.CIR.101.15.1758; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; Shiomi M, 2001, ANN NY ACAD SCI, V947, P419; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang JC, 2000, CIRCULATION, V102, P3046; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1	48	76	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3204	10.1371/journal.pone.0003204	http://dx.doi.org/10.1371/journal.pone.0003204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787704	gold, Green Published, Green Submitted			2022-12-25	WOS:000264426200009
J	Hatada, I; Namihira, M; Morita, S; Kimura, M; Horii, T; Nakashima, K				Hatada, Izuho; Namihira, Masakazu; Morita, Sumiyo; Kimura, Mika; Horii, Takuro; Nakashima, Kinichi			Astrocyte-Specific Genes Are Generally Demethylated in Neural Precursor Cells Prior to Astrocytic Differentiation	PLOS ONE			English	Article							DNA METHYLATION; EMBRYONIC STEM; METHYLTRANSFERASE ACTIVITY; CHANNEL GENE; EXPRESSION; LINEAGE; ASSOCIATION; BRAIN; NANOG; PLURIPOTENCY	Epigenetic changes are thought to lead to alterations in the property of cells, such as differentiation potential. Neural precursor cells (NPCs) differentiate only into neurons in the midgestational brain, yet they become able to generate astrocytes in the late stage of development. This differentiation-potential switch could be explained by epigenetic changes, since the promoters of astrocyte-specific marker genes, glial fibrillary acidic protein (Gfap) and S100b, have been shown to become demethylated in late-stage NPCs prior to the onset of astrocyte differentiation; however, whether demethylation occurs generally in other astrocyctic genes remains unknown. Here we analyzed DNA methylation changes in mouse NPCs between the mid-(E11.5) and late (E14.5) stage of development by a genome-wide DNA methylation profiling method using microarrays and found that many astrocytic genes are demethylated in late-stage NPCs, enabling the cell to become competent to express these genes. Although these genes are already demethylated in late-stage NPCs, they are not expressed until cells differentiate into astrocytes. Thus, late-stage NPCs have epigenetic potential which can be realized in their expression after astrocyte differentiation.	[Hatada, Izuho; Morita, Sumiyo; Kimura, Mika; Horii, Takuro] Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, Maebashi, Gunma 371, Japan; [Namihira, Masakazu; Nakashima, Kinichi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol Neurosci, Ikoma, Japan	Gunma University; Nara Institute of Science & Technology	Hatada, I (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, Maebashi, Gunma 371, Japan.	ihatada@showa.gunma-u.ac.jp	Namihira, Masakazu/M-7531-2018	Namihira, Masakazu/0000-0003-2108-5712	Japanese Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by grants from the Japanese Science and Technology Agency, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; Hatada I, 2002, J HUM GENET, V47, P448, DOI 10.1007/s100380200063; Hatada I, 2008, J HUM GENET, V53, P185, DOI 10.1007/s10038-007-0228-0; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; McKinnon PJ, 1996, BRAIN RES, V709, P27, DOI 10.1016/0006-8993(95)01224-9; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Namihira M, 2004, FEBS LETT, V572, P184, DOI 10.1016/j.febslet.2004.07.029; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ohgane J, 1998, DEV GENET, V22, P132, DOI 10.1002/(SICI)1520-6408(1998)22:2<132::AID-DVG3>3.0.CO;2-7; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rajan P, 1998, J NEUROSCI, V18, P3620; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; Scalabrini D, 2007, NEUROSCI LETT, V425, P173, DOI 10.1016/j.neulet.2007.08.020; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Walther EU, 1998, P NATL ACAD SCI USA, V95, P2615, DOI 10.1073/pnas.95.5.2615; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	37	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3189	10.1371/journal.pone.0003189	http://dx.doi.org/10.1371/journal.pone.0003189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784832	Green Published, Green Submitted, gold			2022-12-25	WOS:000264425900009
J	Beretta, M; Gruber, K; Kollau, A; Russwurm, M; Koesling, D; Goessler, W; Keung, WM; Schmidt, K; Mayer, B				Beretta, Matteo; Gruber, Karl; Kollau, Alexander; Russwurm, Michael; Koesling, Doris; Goessler, Walter; Keung, Wing Ming; Schmidt, Kurt; Mayer, Bernd			Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE GUANYLYL CYCLASE; NITRIC-OXIDE; NITRATE TOLERANCE; IN-VITRO; MECHANISM; PEROXYNITRITE; OXIDATION; 1H-<1,2,4>OXADIAZOLO<4,3-A>QUINOXALIN-1-ONE; PURIFICATION; METABOLISM	Metabolism of nitroglycerin (GTN) to 1,2-glycerol dinitrate (GDN) and nitrite by mitochondrial aldehyde dehydrogenase (ALDH2) is essentially involved in GTN bioactivation resulting in cyclic GMP-mediated vascular relaxation. The link between nitrite formation and activation of soluble guanylate cyclase (sGC) is still unclear. To test the hypothesis that the ALDH2 reaction is sufficient for GTN bioactivation, we measured GTN-induced formation of cGMP by purified sGC in the presence of purified ALDH2 and used a Clark-type electrode to probe for nitric oxide ( NO) formation. In addition, we studied whether GTN bioactivation is a specific feature of ALDH2 or is also catalyzed by the cytosolic isoform ( ALDH1). Purified ALDH1 and ALDH2 metabolized GTN to 1,2- and 1,3-GDN with predominant formation of the 1,2- isomer that was inhibited by chloral hydrate ( ALDH1 and ALDH2) and daidzin ( ALDH2). GTN had no effect on sGC activity in the presence of bovine serum albumin but caused pronounced cGMP accumulation in the presence of ALDH1 or ALDH2. The effects of the ALDH isoforms were dependent on the amount of added protein and, like 1,2- GDN formation, were sensitive to ALDH inhibitors. GTN caused biphasic sGC activation with apparent EC50 values of 42 +/- 2.9 and 3.1 +/- 0.4 mu M in the presence of ALDH1 and ALDH2, respectively. Incubation of ALDH1 or ALDH2 with GTN resulted in sustained, chloral hydrate-sensitive formation of NO. These data may explain the coupling of ALDH2-catalyzed GTN metabolism to sGC activation in vascular smooth muscle.	[Beretta, Matteo; Kollau, Alexander; Schmidt, Kurt; Mayer, Bernd] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Gruber, Karl; Goessler, Walter] Karl Franzens Univ Graz, Dept Chem, A-8010 Graz, Austria; [Russwurm, Michael; Koesling, Doris] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44780 Bochum, Germany; [Keung, Wing Ming] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Graz; University of Graz; Ruhr University Bochum; Harvard University; Harvard Medical School	Mayer, B (corresponding author), Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria.	mayer@uni-graz.at	Gruber, Karl/GPP-6706-2022; Beretta, Matteo/D-8573-2012; Mayer, Bernd/B-9391-2008; Goessler, Walter/A-1084-2016	Gruber, Karl/0000-0002-3485-9740; Goessler, Walter/0000-0002-0142-9373; Kollau, Alexander/0000-0002-3326-0517; Gorren, Antonius Cornelis Franciscus/0000-0003-3476-6162; Mayer, Bernd/0000-0002-2921-3494; Beretta, Matteo/0000-0001-5564-4282	Austrian Science Fund FWF [W 901, P 20669] Funding Source: Medline; Austrian Science Fund FWF [P 20669, W 901] Funding Source: Medline; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		BENNETT BM, 1994, TRENDS PHARMACOL SCI, V15, P245, DOI 10.1016/0165-6147(94)90319-0; Booth BP, 2000, BIOCHEM PHARMACOL, V59, P1603, DOI 10.1016/S0006-2952(00)00290-2; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Chen ZQ, 2006, TRENDS CARDIOVAS MED, V16, P259, DOI 10.1016/j.tcm.2006.05.001; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; Difabio J, 2003, MOL PHARMACOL, V64, P1109, DOI 10.1124/mol.64.5.1109; Dikalov S, 1998, J PHARMACOL EXP THER, V286, P938; Fink B, 2000, FREE RADICAL BIO MED, V28, P121, DOI 10.1016/S0891-5849(99)00228-2; Fung HL, 2004, ANNU REV PHARMACOL, V44, P67, DOI 10.1146/annurev.pharmtox.44.101802.121646; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GHENBOT G, 1992, PROTEIN EXPRES PURIF, V3, P470, DOI 10.1016/1046-5928(92)90064-4; Gorren ACF, 2005, BIOCHEM J, V390, P625, DOI 10.1042/BJ20050565; Ho KK, 2005, BIOCHEMISTRY-US, V44, P8022, DOI 10.1021/bi050038u; ISHII K, 1991, AM J PHYSIOL, V261, pH598, DOI 10.1152/ajpheart.1991.261.2.H598; KEUNG WM, 1993, P NATL ACAD SCI USA, V90, P1247, DOI 10.1073/pnas.90.4.1247; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; Kollau A, 2007, MOL PHARMACOL, V72, P191, DOI 10.1124/mol.107.035642; KOMURA S, 1974, ACTA PHARMACOL TOX, V35, P145; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Mackenzie IS, 2005, ARTERIOSCL THROM VAS, V25, P1891, DOI 10.1161/01.ATV.0000179599.71086.89; MAYER B, 1995, J BIOL CHEM, V270, P655, DOI 10.1074/jbc.270.2.655; Miranda KM, 2003, P NATL ACAD SCI USA, V100, P9196, DOI 10.1073/pnas.1430507100; MUKERJEE N, 1994, J BIOL CHEM, V269, P21664; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Munzel T, 2000, CIRC RES, V86, pE7, DOI 10.1161/01.RES.86.1.e7; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; Rocha JBT, 2005, BIOL PHARM BULL, V28, P1485, DOI 10.1248/bpb.28.1485; Russwurm M, 2005, METHOD ENZYMOL, V396, P492, DOI 10.1016/S0076-6879(05)96041-2; SCHMIDT K, 1994, BIOCHEM J, V301, P645, DOI 10.1042/bj3010645; Schrammel A, 2003, FREE RADICAL BIO MED, V34, P1078, DOI 10.1016/S0891-5849(03)00038-8; Schrammel A, 1996, MOL PHARMACOL, V50, P1; Schultz G., 1984, METHOD ENZYMAT AN, P379; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Thatcher GRJ, 2004, FREE RADICAL BIO MED, V37, P1122, DOI 10.1016/j.freeradbiomed.2004.06.013; TOWELL J, 1985, ALCOHOL CLIN EXP RES, V9, P438, DOI 10.1111/j.1530-0277.1985.tb05579.x; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Zhang J, 2004, CIRCULATION, V110, P750, DOI 10.1161/01.CIR.0000138105.17864.6B; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x	40	86	87	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					17873	17880		10.1074/jbc.M801182200	http://dx.doi.org/10.1074/jbc.M801182200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18786921	Green Published, hybrid			2022-12-25	WOS:000256949200015
